PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trivino, M; Rodenas, E; Lupianez, J; Arnedo, M				Trivino, Monica; Rodenas, Estrella; Lupianez, Juan; Arnedo, Marisa			Effectiveness of a neuropsychological treatment for confabulations after brain injury: A clinical trial with theoretical implications	PLOS ONE			English	Article							TEMPORAL CONTEXT CONFUSION; STRATEGIC RETRIEVAL; ATTENTION; MECHANISMS; DAMAGE	Confabulators consistently generate false memories without intention to deceive and with great feelings of rightness. However, to our knowledge, there is currently no known effective treatment for them. In order to fill this gap, our aim was to design a neuropsychological treatment based on current theoretical models and test it experimentally in 20 confabulators sequentially allocated to two groups: an experimental and a control group. The experimental group received nine sessions of treatment for three weeks (three sessions per week). The sessions consisted of some brief material that participants had to learn and recall at both immediate and delayed time points. After this, patients were given feedback about their performance (errors and correct responses). Pre- and post- treatment measurements were recorded. Confabulators in the control group were included in a waiting list for three weeks, performed the pre- and post-measurements without treatment, and only then received the treatment, after which a post-treatment measurement was recorded. This applied to only half of the participants; the other half quit the study prematurely. Results showed a significant decrease in confabulations and a significant increase in correct responses in the experimental group; by contrast, patients in the control group did not improve during the waiting list period. Only control group patients who subsequently received the treatment after serving as controls improved. The effects of the treatment were generalized to patients' everyday lives, as reported by relatives, and persisted over time. This treatment seems to be effective and easy to implement and consequently of clinical interest. Moreover, it also has theoretical implications regarding the processes related to the genesis and/or maintenance of confabulations. In particular, results point to a deficit in early stages of memory retrieval with the preservation of later strategic monitoring processes. Specifically, some of the processes involved may include selective attention or early conflict detection deficits. Future research should test these hypotheses.	[Trivino, Monica] San Rafael Univ Hosp, Dept Neuropsychol, Granada, Spain; [Trivino, Monica; Rodenas, Estrella; Lupianez, Juan; Arnedo, Marisa] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Lupianez, Juan] Univ Granada, Dept Expt Psychol, Granada, Spain; [Arnedo, Marisa] Univ Granada, Dept Psychobiol, Granada, Spain	University of Granada; University of Granada; University of Granada	Trivino, M (corresponding author), San Rafael Univ Hosp, Dept Neuropsychol, Granada, Spain.; Trivino, M (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain.	mtrivino@ugr.es	Lupiáñez, Juan/G-1453-2010; Trivino, Monica/K-9589-2017	Lupiáñez, Juan/0000-0001-6157-9894; Trivino, Monica/0000-0003-2498-318X	Spanish Ministry of Science and Education [PSI2011-22416, PSI2014-52764-P, PSI2012-34158]; Regional Government of Andalusia [SEJ-6351]; Progress and Health Foundation of the Regional Government of Andalusia to Monica Trivino [PI-0361-2014]	Spanish Ministry of Science and Education(Spanish Government); Regional Government of Andalusia(Junta de Andalucia); Progress and Health Foundation of the Regional Government of Andalusia to Monica Trivino	This research was carried out in San Rafael University Hospital in Granada, Spain, and was supported by the research grants from the Spanish Ministry of Science and Education to Juan Lupianez (PSI2011-22416 and PSI2014-52764-P) and to Maria Jesus Funes (PSI2012-34158), the research grant from the Regional Government of Andalusia to Maria Jesus Funes (SEJ-6351), and the research grant from the Progress and Health Foundation of the Regional Government of Andalusia to Monica Trivino (PI-0361-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is part of a doctoral dissertation by Estrella Rodenas, supervised by the other three authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda JR, 1996, REV ELECT METODOL AP, V1, P11; Ciaramelli E, 2009, CORTEX, V45, P141, DOI 10.1016/j.cortex.2007.10.006; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalla Barba G, 1999, COGN NEUROPSYCHOL, V16, P385; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Destreri ND, 2002, ARCH PHYS MED REHAB, V83, P423, DOI 10.1053/apmr.2002.29646; Devinsky O, 2009, NEUROLOGY, V72, P80, DOI 10.1212/01.wnl.0000338625.47892.74; Donaldson DI, 2010, J COGNITIVE NEUROSCI, V22, P377, DOI 10.1162/jocn.2009.21242; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ghosh VE, 2014, NEUROPSYCHOLOGIA, V53, P104, DOI 10.1016/j.neuropsychologia.2013.11.010; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gilboa A., 2002, HDB MEMORY DISORDERS, V2, P315; Gilboa A, 2010, COGN NEUROPSYCHIATRY, V15, P145, DOI 10.1080/13546800903056965; Gilboa A, 2009, J NEUROSCI, V29, P4871, DOI 10.1523/JNEUROSCI.5210-08.2009; Hebscher M, 2015, CEREB CORTEX; Johnson MK, 1998, TRENDS COGN SCI, V2, P137, DOI 10.1016/S1364-6613(98)01152-8; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Kan IP, 2010, J INT NEUROPSYCH SOC, V16, P1006, DOI 10.1017/S1355617710000536; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Llorente AI, 2008, THESIS; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Nahum L, 2012, NEUROPSYCHOLOGIA, V50, P2524, DOI 10.1016/j.neuropsychologia.2012.06.026; Nahum L, 2010, J INT NEUROPSYCH SOC, V16, P995, DOI 10.1017/S1355617710000780; Nahum L, 2009, BIOL PSYCHIAT, V65, P966, DOI 10.1016/j.biopsych.2009.01.007; P?rez M.-A., 2003, PSICOLOGICA, V24, P215; Ptak R, 1999, NEUROCASE, V5, P243, DOI 10.1093/neucas/5.3.243; RATCLIFF R, 1982, J EXP PSYCHOL-HUM L, V8, P16, DOI 10.1037/0278-7393.8.1.16; Rodenas E, 2015, 10 SCI M ATT MAY 201; Rodenas E, 2015, INT WORKSH LEARN MEM; Rodriguez-Bailon M, 2012, SPAN J PSYCHOL, V15, P967, DOI 10.5209/rev_SJOP.2012.v15.n3.39388; Roelfsema PR, 2011, ATTEN PERCEPT PSYCHO, V73, P2542, DOI 10.3758/s13414-011-0200-0; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A., 2008, CONFABULATING MIND B; Schnider A, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00067; Shallice T., 2001, PERSPECTIVES HUMAN M; Trivino M, 2011, NEUROPSYCHOLOGIA, V49, P3917, DOI 10.1016/j.neuropsychologia.2011.10.009; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; Turner M, 2010, COGN NEUROPSYCHIATRY, V15, P346, DOI 10.1080/13546800903441902; Turner MS, 2008, CORTEX, V44, P637, DOI 10.1016/j.cortex.2007.01.002; Turner MS, 2008, NEUROPSYCHOLOGIA, V46, P1442, DOI 10.1016/j.neuropsychologia.2007.12.029; Turner MS, 2007, NEUROPSYCHOLOGIA, V45, P1540, DOI 10.1016/j.neuropsychologia.2006.11.013; Turner MS, 2010, J INT NEUROPSYCH SOC, V16, P984, DOI 10.1017/S1355617710001104; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Venneri A, 2004, NEUROPSYCHOLOGIA, V42, P230, DOI 10.1016/S0028-3932(03)00171-4; Yotsumoto Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6504	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173166	10.1371/journal.pone.0173166	http://dx.doi.org/10.1371/journal.pone.0173166			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257420	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100068
J	Chowanski, S; Lubawy, J; Paluch-Lubawa, E; Spochacz, M; Rosinski, G; Slocinska, M				Chowanski, Szymon; Lubawy, Jan; Paluch-Lubawa, Ewelina; Spochacz, Marta; Rosinski, Grzegorz; Slocinska, Malgorzata			The physiological role of fat body and muscle tissues in response to cold stress in the tropical cockroach Gromphadorhina coquereliana	PLOS ONE			English	Article							HARDY GALL INSECTS; MEGAPHORURA-ARCTICA TULLBERG; SHOCK-PROTEIN TRANSCRIPT; FREEZE-TOLERANT INSECT; EUROSTA-SOLIDAGINIS; FLESH FLY; DROSOPHILA-MELANOGASTER; CRYOPROTECTIVE DEHYDRATION; SARCOPHAGA-CRASSIPALPIS; TERRESTRIAL ARTHROPODS	Protective mechanisms against cold stress are well studied in terrestrial and polar insects; however, little is known about these mechanisms in tropical insects. In our study, we tested if a tropical cockroach Gromphadorhina coquereliana, possesses any protective mechanisms against cold stress. Based on the results of earlier studies, we examined how shortterm (3 h) cold (4 degrees C) influences biochemical parameters, mitochondrial respiration activity, and the level of HSPs and aquaporins expression in the fat body and leg muscles of G. coquereliana. Following cold exposure, we found that the level of carbohydrates, lipids and proteins did not change significantly. Nevertheless, we observed significant changes in mitochondrial respiration activity. The oxygen consumption of resting (state 4) and phosphorylating (state 3) mitochondria was altered following cold exposure. The increase in respiratory rate in state 4 respiration was observed in both tissues. In state 3, oxygen consumption by mitochondria in fat body was significantly lower compared to control insects, whereas there were no changes observed for mitochondria in muscle tissue. Moreover, there were cold-induced changes in UCP protein activity, but the changes in activity differed in fat body and in muscles. Additionally, we detected changes in the level of HSP70 and aquaporins expression. Insects treated with cold had significantly higher levels of HSP70 in fat body and muscles. On the other hand, there were lower levels of aquaporins in both tissues following exposure to cold. These results suggest that fat body play an important role in protecting tropical insects from cold stress.	[Chowanski, Szymon; Lubawy, Jan; Spochacz, Marta; Rosinski, Grzegorz; Slocinska, Malgorzata] Adam Mickiewicz Univ, Dept Anim Physiol & Dev, Fac Biol, Poznan, Poland; [Paluch-Lubawa, Ewelina] Adam Mickiewicz Univ, Dept Plant Physiol, Fac Biol, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Chowanski, S; Lubawy, J; Slocinska, M (corresponding author), Adam Mickiewicz Univ, Dept Anim Physiol & Dev, Fac Biol, Poznan, Poland.	szyymon@amu.edu.pl; j.lubawy@amu.edu.pl; slocina@amu.edu.pl	Lubawy, Jan/AAD-4259-2019; Chowanski, Szymon/J-5465-2015	Lubawy, Jan/0000-0003-4030-3471; Chowanski, Szymon/0000-0002-5667-1781; Slocinska, Malgorzata/0000-0002-6367-5123; Paluch-Lubawa, Ewelina/0000-0003-4456-0758; Spochacz, Marta/0000-0003-3944-519X	Leading National Research Centre [KNOW-87/2016]	Leading National Research Centre	The funder (Leading National Research Centre "RNA Research Center in Poznah") had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The founder gave only the money for proofreading (to improve English style of manuscript). The funds were given to Szymon Chowanski. Grant number KNOW-87/2016. The funder is a part of our Faculty. It requires the information about given help in manuscript. There was no additional external funding received for this study.; The article was partially supported by Leading National Research Centre "RNA Research Center in Poznan" (supported author: SC; grant number KNOW-87/2016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The founder supported only the proofreading (to improve English style of manuscript). The funds were given to Szymon Chowanski. The funder is a part of our Faculty. There was no additional external funding received for this study. Web site of National Research Centre "RNA Research Center in Poznan: http://know-rna.amu.edu.pl/en/	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Alves-Bezerra M, 2014, INSECT BIOCHEM MOLEC, V50, P24, DOI 10.1016/j.ibmb.2014.03.011; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Chowanski S, 2015, COMP BIOCHEM PHYS A, V183, P57, DOI 10.1016/j.cbpa.2015.01.007; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Cohen E, 2012, ORNITHOL HERPETOL S, VS1, P1, DOI DOI 10.4172/2161-0983.S1-001; Colinet H, 2011, COMP BIOCHEM PHYS A, V160, P63, DOI 10.1016/j.cbpa.2011.05.003; Colinet H, 2017, INSECT BIOCHEM MOLEC, V80, P52, DOI 10.1016/j.ibmb.2016.11.007; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Da-Re C, 2014, EMBO REP, V15, P586, DOI 10.1002/embr.201337972; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster Nicola L., 2015, Communicative & Integrative Biology, V8, pe1040954, DOI 10.1080/19420889.2015.1040954; Garcia-Garcia E, 2009, DEV COMP IMMUNOL, V33, P728, DOI 10.1016/j.dci.2008.12.006; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hayward SAL, 2004, J EXP BIOL, V207, P963, DOI 10.1242/jeb.00842; Izumi Y, 2006, J INSECT PHYSIOL, V52, P215, DOI 10.1016/j.jinsphys.2005.11.001; Joanisse DR, 1996, PHYSIOL ZOOL, V69, P1079, DOI 10.1086/physzool.69.5.30164247; JOANISSE DR, 1994, INSECT BIOCHEM MOLEC, V24, P145, DOI 10.1016/0965-1748(94)90080-9; JOANISSE DR, 1995, ARCH INSECT BIOCHEM, V28, P339, DOI 10.1002/arch.940280404; Kayukawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008277; Khani A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8301; KUKAL O, 1989, J COMP PHYSIOL B, V158, P661, DOI 10.1007/BF00693004; Lalouette L, 2011, COMP BIOCHEM PHYS A, V158, P229, DOI 10.1016/j.cbpa.2010.11.007; Lee R., 1991, INSECTS LOW TEMPERAT; Levin DB, 2003, INSECT MOL BIOL, V12, P281, DOI 10.1046/j.1365-2583.2003.00413.x; Levis NA, 2012, J EXP BIOL, V215, P3768, DOI 10.1242/jeb.076885; Lyytinen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031446; McMullen DC, 2008, J INSECT PHYSIOL, V54, P1023, DOI 10.1016/j.jinsphys.2008.04.001; Michaud MR, 2007, MOL PHYSL INSECT LOW; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Philip BN, 2008, J EXP BIOL, V211, P1114, DOI 10.1242/jeb.016758; Philip BN, 2011, J EXP BIOL, V214, P848, DOI 10.1242/jeb.051276; Qin W, 2007, INSECT MOL BIOL, V16, P423, DOI 10.1111/j.1365-2583.2007.00743.x; Rinehart JP, 2000, INSECT MOL BIOL, V9, P641, DOI 10.1046/j.1365-2583.2000.00230.x; Rozsypal J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061745; Singh A., 2013, J BIOCH RES, V1, P26; Slocinska M, 2016, PROTEIN PEPTIDE LETT, V23, P63, DOI 10.2174/0929866523666151106121943; Slocinska M, 2013, COMP BIOCHEM PHYS A, V166, P52, DOI 10.1016/j.cbpa.2013.05.009; Slocinska M, 2011, J BIOENERG BIOMEMBR, V43, P717, DOI 10.1007/s10863-011-9385-0; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Somme L, 1999, EUR J ENTOMOL, V96, P1; STOREY JM, 1985, J COMP PHYSIOL B, V155, P333, DOI 10.1007/BF00687475; Storey KB, 2013, COMPR PHYSIOL, V3, P1283, DOI 10.1002/cphy.c130007; Strok NE, 2003, ENCY INSECTS, P85; Sujak P, 1984, OXIDATIVE METABOLISM; Tamang AM, 2017, COMP BIOCHEM PHYS A, V203, P304, DOI 10.1016/j.cbpa.2016.10.011; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Thorne MAS, 2011, INSECT MOL BIOL, V20, P303, DOI 10.1111/j.1365-2583.2010.01062.x; Tomkowiak E, 2009, POSTEPY BIOL KOMORKI, V36, P203; Urbanski A., 2016, INSECT SCI; Urbanski A, 2014, J INSECT PHYSIOL, V60, P98, DOI 10.1016/j.jinsphys.2013.11.009; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Walters KR, 2009, J BIOL CHEM, V284, P16822, DOI 10.1074/jbc.M109.013870; Wharton DA, 2009, J INSECT PHYSIOL, V55, P27, DOI 10.1016/j.jinsphys.2008.09.007; WheaterSpark, 2015, HIST WEATH 2014 ANT; Yi SX, 2011, J INSECT PHYSIOL, V57, P1096, DOI 10.1016/j.jinsphys.2011.02.006; Yi W, 2013, SLEEP, V36, P1809, DOI 10.5665/sleep.3206; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhou XR, 2015, CRYOLETTERS, V36, P270	73	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173100	10.1371/journal.pone.0173100	http://dx.doi.org/10.1371/journal.pone.0173100			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253309	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300074
J	Furusawa, T; Naka, I; Yamauchi, T; Natsuhara, K; Eddie, R; Kimura, R; Nakazawa, M; Ishida, T; Ohtsuka, R; Ohashi, J				Furusawa, Takuro; Naka, Izumi; Yamauchi, Taro; Natsuhara, Kazumi; Eddie, Ricky; Kimura, Ryosuke; Nakazawa, Minato; Ishida, Takafumi; Ohtsuka, Ryutaro; Ohashi, Jun			Polymorphisms associated with a tropical climate and root crop diet induce susceptibility to metabolic and cardiovascular diseases in Solomon Islands	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FADS GENE-CLUSTER; DIABETES-MELLITUS; POPULATION HISTORY; ALLELE FREQUENCY; PATHWAY GENES; HAN CHINESE; VARIANTS; KCNQ1; ADAPTATIONS	The people of the Solomon Islands represent an Austronesian (AN)-speaking population's adaptation to a humid tropical environment and subsistence of tuberous crops. Genome-wide association studies (GWASs) of other populations (e.g. the Human Genome Diversity Project [HGDP]) have suggested the existence of genotypes adaptive to ecoregion, diet, and subsistence, and that those genotypes are also associated with metabolic and cardiovascular diseases. Recently, the incidence of non-communicable diseases has been increasing in the Solomon Islands. In the present study, we explored the association of genotypes adaptive to a tropical environment and tuberous crop diet with metabolic and cardiovascular conditions in rural and urban AN-speaking Melanesian and Micronesian populations of the Solomon Islands. A total of 561 participants were genotyped for single nucleotide polymorphisms (SNPs) potentially associated with a tropical environment (rs174570 and rs2237892) and a tuberous crop diet (rs162036, rs185819, and rs2722425). The results showed that the allele frequencies of the Solomon Islands populations adopted patterns similar to those in populations from other hot, tropical areas with a tuberous crop diet in previous studies. Furthermore, rs162036, rs185819, rs2237892, and rs2722425 were all strongly associated with one or more metabolic and cardiovascular conditions. The derived allele of rs2722425 (i.e. rs2722425-G) was significantly associated with an elevated LDL level (P = 0.000264) even after the significance level was adjusted for multiple testing (i.e., alpha = 0.0005). Our results suggest that the inhabitants of the Solomon Islands exhibit the effects of the tropical environment and tuberous crop diet on their allele frequencies, and that their susceptibility to metabolic and cardiovascular diseases is therefore considered to be associated with their environment and diet.	[Furusawa, Takuro] Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan; [Naka, Izumi; Ishida, Takafumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Tokyo, Japan; [Yamauchi, Taro] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido 060, Japan; [Natsuhara, Kazumi] Japanese Red Cross Akita Coll Nursing, Akita, Japan; [Eddie, Ricky] Minist Hlth & Med Serv, Natl Gizo Hosp, Gizo, Solomon Islands; [Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Okinawa, Japan; [Nakazawa, Minato] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo, Japan; [Ohtsuka, Ryutaro] Japan Wildlife Res Ctr, Tokyo, Japan	Kyoto University; University of Tokyo; Hokkaido University; University of the Ryukyus; Kobe University	Ohashi, J (corresponding author), Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan.	furusawa@asafas.kyoto-u.ac.jp; juno-tky@umin.ac.jp		Furusawa, Takuro/0000-0001-7772-3053	Japan Society for the Promotion of Science, Japan [25291103, 14255008, 15H05123]; Grants-in-Aid for Scientific Research [16H05828, 15H05123] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the KAKENHI Grant-in-Aid for Scientific Research (Project Number: 25291103 (JO), Project Number: 14255008 (RO), and Project Number: 15H05123 (TF)) of the Japan Society for the Promotion of Science, Japan. http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECHN REP SER; Aslibekyan S., 2012, Frontiers in Genetics, V3, P72, DOI 10.3389/fgene.2012.00072; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bellwood P., 1995, AUSTRONESIAN PREHIST; Bokor S, 2011, INT J PEDIATR OBES, V6, pE336, DOI 10.3109/17477166.2010.500386; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen Z, 2010, MOL BIOL REP, V37, P207, DOI 10.1007/s11033-009-9597-0; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Duan QH, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/347675; EASON RJ, 1987, MED J AUSTRALIA, V146, P465, DOI 10.5694/j.1326-5377.1987.tb120359.x; Furusawa T, 2016, ETHNOBIOLOGY, P1, DOI 10.1007/978-981-287-904-2; Furusawa T, 2011, NZ MED J, V366, P234; Furusawa T, 2013, J HUM GENET, V58, P142, DOI 10.1038/jhg.2012.147; Furusawa T, 2011, AM J HUM BIOL, V23, P435, DOI 10.1002/ajhb.21124; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Huang T, 2014, J NUTRIGENET NUTRIGE, V7, P63, DOI 10.1159/000365007; InterAct Consortium, 2016, DIABETOLOGIA, V59, P2613, DOI 10.1007/s00125-016-4090-5; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Saif-Ali R, 2011, INT J MOL SCI, V12, P5705, DOI 10.3390/ijms12095705; Shin HD, 2010, J CLIN ENDOCR METAB, V95, P445, DOI 10.1210/jc.2009-1393; Soares PA, 2016, HUM GENET, V135, P309, DOI 10.1007/s00439-015-1620-z; Sone Y, 2013, J NUTR SCI VITAMINOL, V59, P325, DOI 10.3177/jnsv.59.325; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; Tan JT, 2009, DIABETES, V58, P1445, DOI 10.2337/db08-1138; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wu M., 2010, STUDIES COLL MATH, V13, P13; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8	50	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172676	10.1371/journal.pone.0172676	http://dx.doi.org/10.1371/journal.pone.0172676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253292	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300026
J	Kong, WY; Zhu, XP; Han, XJ; Nuo, M; Wang, H				Kong, Wuyi; Zhu, Xiao Ping; Han, Xiu Juan; Nuo, Mu; Wang, Hong			Epithelial stem cells are formed by small-particles released from particle-producing cells	PLOS ONE			English	Article							NICHE; SKIN; POPULATIONS; HOMEOSTASIS; FOLLICLE	Recent spatiotemporal report demonstrated that epidermal stem cells have equal potential to divide or differentiate, with no asymmetric cell division observed. Therefore, how epithelial stem cells maintain lifelong stem-cell support still needs to be elucidated. In mouse blood and bone marrow, we found a group of large cells stained strongly for eosin and containing coiled-tubing-like structures. Many were tightly attached to each other to form large cellular clumps. After sectioning, these large cell-clumps were composed of not cells but numerous small particles, however with few small "naked" nuclei. The small particles were about 2 to 3 mu m in diameter and stained dense red for eosin, so they may be rich in proteins. Besides the clumps composed of small particles, we identified clumps formed by fusion of the small particles and clumps of newly formed nucleated cells. These observations suggest that these small particles further fused and underwent cellularization. E-cadherin was expressed in particle-fusion areas, some "naked" nuclei and the newly formed nucleated cells, which suggests that these particles can form epithelial cells via fusion and nuclear remodeling. In addition, we observed similar-particle fusion before epithelial cellularization in mouse kidney ducts after kidney ischemia, which suggests that these particles can be released in the blood and carried to the target tissues for epithelial-cell regeneration. Oct4 and E-cadherin expressed in the cytoplasmic areas in cells that were rich in protein and mainly located in the center of the cellular clumps, suggesting that these newly formed cells have become tissue-specific epithelial stem cells. Our data provide evidence that these large particle-producing cells are the origin of epithelial stem cells. The epithelial stem cells are newly formed by particle fusion.	[Kong, Wuyi; Zhu, Xiao Ping; Han, Xiu Juan; Nuo, Mu; Wang, Hong] Beijing Khasar Med Technol Co Ltd, Beijing, Peoples R China		Kong, WY (corresponding author), Beijing Khasar Med Technol Co Ltd, Beijing, Peoples R China.	wuyikong@yahoo.com			Department of Technology, Inner Mongolia government, China for research and development	Department of Technology, Inner Mongolia government, China for research and development	Beijing Khasar Medical Technology Co. Ltd is a commercial affiliation that was funded by the Department of Technology, Inner Mongolia government, China for research and development. Both the government and the commercial affiliation did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The government funding provided financial support in the form of research materials and equipment. The commercial affiliation provided support in the form of salaries for authors XZ, XH, MN, and HW.	Al-Awqati Q, 2006, STEM CELL REV, V2, P181, DOI 10.1007/s12015-006-0046-3; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Berika M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00033; Donne ML, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0082-9; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Fuchs E, 2013, EMBO REP, V14, P39, DOI 10.1038/embor.2012.197; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Kong WY, 2008, EXP CELL RES, V314, P1529, DOI 10.1016/j.yexcr.2008.01.022; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Rompolas P, 2016, SCIENCE, V352, P1471, DOI 10.1126/science.aaf7012; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sipos F, 2012, WORLD J GASTROENTERO, V18, P295, DOI 10.3748/wjg.v18.i4.295; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173072	10.1371/journal.pone.0173072	http://dx.doi.org/10.1371/journal.pone.0173072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253358	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300068
J	Palmer, CL; Thomer, AK; Baker, KS; Wickett, KM; Hendrix, CL; Rodman, A; Sigler, S; Fouke, BW				Palmer, Carole L.; Thomer, Andrea K.; Baker, Karen S.; Wickett, Karen M.; Hendrix, Christie L.; Rodman, Ann; Sigler, Stacey; Fouke, Bruce W.			Site-based data curation based on hot spring geobiology	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT	Site-Based Data Curation (SBDC) is an approach to managing research data that prioritizes sharing and reuse of data collected at scientifically significant sites. The SBDC framework is based on geobiology research at natural hot spring sites in Yellowstone National Park as an exemplar case of high value field data in contemporary, cross-disciplinary earth systems science. Through stakeholder analysis and investigation of data artifacts, we determined that meaningful and valid reuse of digital hot spring data requires systematic documentation of sampling processes and particular contextual information about the site of data collection. We propose a Minimum Information Framework for recording the necessary metadata on sampling locations, with anchor measurements and description of the hot spring vent distinct from the outflow system, and multi-scale field photography to capture vital information about hot spring structures. The SBDC framework can serve as a global model for the collection and description of hot spring systems field data that can be readily adapted for application to the curation of data from other kinds scientifically significant sites.	[Palmer, Carole L.] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [Thomer, Andrea K.; Baker, Karen S.] Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA; [Wickett, Karen M.] Univ Texas Austin, Sch Informat, Austin, TX 78712 USA; [Hendrix, Christie L.; Rodman, Ann; Sigler, Stacey] Yellowstone Natl Pk, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY USA; [Fouke, Bruce W.] Univ Illinois, Dept Geol, Urbana, IL USA; [Fouke, Bruce W.] Univ Illinois, Dept Microbiol, Urbana, IL USA; Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Fouke, Bruce W.] Univ Illinois, Inst Genom Biol 2613, Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Fouke, Bruce W.] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman	Thomer, AK (corresponding author), Univ Illinois, Sch Informat Sci, Champaign, IL 61820 USA.	thomer2@illinois.edu		Thomer, Andrea/0000-0001-6238-3498; Wickett, Karen/0000-0002-3625-1253	Institute of Museum and Library Services National Leadership [LG-06-120706-12]	Institute of Museum and Library Services National Leadership	This work was funded by Institute of Museum and Library Services (https://www.imls gov/) National Leadership grant number LG-06-120706-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouron, 2010, GEOB CURR TECHN RES; [Anonymous], MAND CUR RESP RES PE; [Anonymous], WELC SESAH SYST EART; ASM, 2001, GEOB EXPL INT BIOSPH; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Chao TC, 2014, P AM SOC INFO SCI TE, V51, P1; Chao TC, 2015, J ASSOC INF SCI TECH, V66, P616, DOI 10.1002/asi.23184; Committee on Strategy and Budget Task Force on Data Policies, 2011, NAT SCI FDN TASK FOR; Cragin M.H., 2011, P 11 ANN INT ACM IEE, P441, DOI DOI 10.1145/1998076.1998175; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; Cragin Melissa H., 2007, AM LIB ASS C SCI TEC; Curry E, 2010, LINKING ENTERPRISE DATA, P25, DOI 10.1007/978-1-4419-7665-9_2; Fegraus E.H., 2005, B ECOLOGICAL SOC AM, V86, P158, DOI DOI 10.1890/0012-9623(2005)86[158:MTVOED]2.0.CO;2; Fouke BW, 2011, SEDIMENTOLOGY, V58, P170, DOI 10.1111/j.1365-3091.2010.01209.x; Gordon SC, 2014, P ASIST ANNU MEET, V51, P1; Grimble R, 1997, AGR SYST, V55, P173, DOI 10.1016/S0308-521X(97)00006-1; Hey T., 2009, 4 PARADIGM DATA INTE; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Kandianis MT, 2008, GEOL SOC AM BULL, V120, P442, DOI 10.1130/B26188.1; Karasti H., 2006, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V15, P321, DOI 10.1007/s10606-006-9023-2; Karasti H., 2008, INT J DIGITAL CURATI, V2, P42, DOI DOI 10.2218/IJDC.V3I2.57; Mayernik Matthew S., 2011, P 2011 ICONFERENCE, P417, DOI DOI 10.1145/1940761.1940818; Mayernik MS, 2008, PROCEEDINGS OF THE 2; National Research Council, 2015, PREP WORKF DIG CUR; National Science and Technology Council, HARN POW DIG DAT SCI; National Science Board, 2005, LONG LIV DIG DAT COL; Palmer CL, 2013, P ASIST 2013, V2013, P1; Palmer CL, 2011, P AM SOC INF SCI TEC; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Sackman H., 1974, DELPHI ASSESSMENT; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826; Thomer AK, 2014, WORKSH APR 16 17; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Wright RG, 1999, ECOL APPL, V9, P30, DOI 10.2307/2641165; Yarmey L, 2013, INT J DIGITAL CURATI, V8, P157, DOI DOI 10.2218/IJDC.V8I1.252	37	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172090	10.1371/journal.pone.0172090	http://dx.doi.org/10.1371/journal.pone.0172090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253269	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300013
J	Sletner, L; Jenum, AK; Yajnik, CS; Morkrid, K; Nakstad, B; Rognerud-Jensen, OH; Birkeland, KI; Vangen, S				Sletner, Line; Jenum, Anne Karen; Yajnik, Chittaranjan S.; Morkrid, Kjersti; Nakstad, Britt; Rognerud-Jensen, Odd Harald; Birkeland, Kare I.; Vangen, Siri			Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study	PLOS ONE			English	Article							ETHNIC-DIFFERENCES; BIRTH-WEIGHT; RISK; TYPE-1; MODEL; SIZE	Objective Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diagnosis is made, on fetal growth trajectories, and to compare it in Europeans and South Asians; two ethnic groups with dissimilar fetal growth patterns. Methods We studied European (n = 349) and South Asian (n = 184) pregnant women, from the population-based STORK-Groruddalen cohort in Oslo, Norway. Mothers were enrolled in early pregnancy, screened for GDM in gestational week 28 +/- 2, and classified as "non-GDM", "mild GDM" or "moderate/severe GDM". We measured fetal head circumference, abdominal circumference and femur length by ultrasound, and estimated fetal weight in gestational week 24, 32 and 37, and performed corresponding measurements at birth. Results In non-GDM pregnancies, South Asian fetuses (n = 156) had a slower growth from gestational week 24, compared with Europeans (n = 310). More than two thirds of the European mothers later diagnosed with GDM were overweight or obese in early pregnancy, while this was not observed in South Asians. Fetuses of GDM mothers tended to be smaller than fetuses of non-GDM mothers in week 24, but thereafter grew faster until birth. This pattern was especially pronounced in fetuses of South Asian mothers with moderate/severe GDM. In week 24 these fetuses had a -0.95 SD (95% CI: -1.53, -0.36) lower estimated fetal weight than their non-GDM counterparts. In contrast, at birth they were 0.45 SD (0.09, 0.81) larger. Conclusions Offspring of GDM mothers were smaller in mid pregnancy, but subsequently grew faster until birth, compared with offspring of non-GDM mothers. This pattern was most prominent in South Asian mothers with moderate to severe GDM. However, the most remarkable characteristic of these fetuses was not a large size at birth, but the small size in mid pregnancy, before the GDM diagnosis was set.	[Sletner, Line; Nakstad, Britt] Akershus Univ Hosp, Dept Pediat & Adolescents Med, Lorenskog, Norway; [Jenum, Anne Karen] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Oslo, Norway; [Yajnik, Chittaranjan S.] King Edward Mem Hosp Res Ctr, Diabet Unit, Pune, Maharashtra, India; [Morkrid, Kjersti] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Nakstad, Britt] Univ Oslo, Inst Clin Med, Campus Ahus, Lorenskog, Norway; [Rognerud-Jensen, Odd Harald] Oslo & Akershus Univ Coll Appl Sci, Fac Hlth, Oslo, Norway; [Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Birkeland, Kare I.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Vangen, Siri] Oslo Univ Hosp, Dept Woman & Child Hlth, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; University of Oslo	Sletner, L (corresponding author), Akershus Univ Hosp, Dept Pediat & Adolescents Med, Lorenskog, Norway.	line.sletner@medisin.uio.no	Birkeland, Kåre I/E-9750-2010		South-Eastern Norway Regional Health Authority [2016126]	South-Eastern Norway Regional Health Authority	The South-Eastern Norway Regional Health Authority has funded the post-doc fellowship for L.S (Grant number 2016126), http://www.helse-sorost.no/omoss_/english. The funder had no role in study design, data collection	Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; Bhopal RS, 2013, DIABETIC MED, V30, P35, DOI 10.1111/dme.12016; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Drooger JC, 2005, ULTRASOUND OBST GYN, V26, P115, DOI 10.1002/uog.1962; Farrar D, 2015, LANCET DIABETEENDO; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Hammoud NM, 2013, ULTRASOUND OBST GYN, V41, P390, DOI 10.1002/uog.11221; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Jenum Anne Karen, 2013, Food Nutr Res, V57, DOI 10.3402/fnr.v57i0.18889; Johnsen SL, 2006, ACTA OBSTET GYN SCAN, V85, P286, DOI 10.1080/00016340600569133; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kuc S, 2011, BJOG-INT J OBSTET GY, V118, P748, DOI 10.1111/j.1471-0528.2011.02904.x; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1066, DOI 10.1080/00016340600697306; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P1091, DOI 10.1111/j.1471-0528.2012.03388.x; Maso G, 2014, SCI WORLD J, DOI 10.1155/2014/474809; MULDER EJH, 1991, EARLY HUM DEV, V25, P91, DOI 10.1016/0378-3782(91)90188-9; Sattar N, 2015, LANCET DIABETES ENDO, V3, P1004, DOI 10.1016/S2213-8587(15)00326-5; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sletner L, 2015, EARLY HUM DEV, V91, P547, DOI 10.1016/j.earlhumdev.2015.07.002; Sletner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073058; Sommer C, 2015, EUR J ENDOCRINOL, V172, P649, DOI 10.1530/EJE-15-0060; Sovio U, 2016, DIABETES CARE; Tomar AS, 2015, CURR OBES REP, V4, P418, DOI 10.1007/s13679-015-0175-6; Tran AT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-145; Wells JCK, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00145; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Xiang AH, 2015, DIABETOLOGIA, V58, P272, DOI 10.1007/s00125-014-3420-8	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172946	10.1371/journal.pone.0172946	http://dx.doi.org/10.1371/journal.pone.0172946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253366	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300050
J	Alley, SJ; Duncan, MJ; Schoeppe, S; Rebar, AL; Vandelanotte, C				Alley, Stephanie J.; Duncan, Mitch J.; Schoeppe, Stephanie; Rebar, Amanda L.; Vandelanotte, Corneel			8-year trends in physical activity, nutrition, TV viewing time, smoking, alcohol and BMI: A comparison of younger and older Queensland adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; SEDENTARY BEHAVIOR; TEMPORAL TRENDS; UNITED-STATES; SCREEN-TIME; LIFE-STYLE; OBESITY; ASSOCIATIONS	Lifestyle behaviours significantly contribute to high levels of chronic disease in older adults. The aims of the study were to compare the prevalence and the prevalence trends of health behaviours (physical activity, fruit and vegetable consumption, fast food consumption, TV viewing, smoking and alcohol consumption), BMI and a summary health behaviour indicator score in older (65+ years) versus younger adults (18-65 years). The self-report outcomes were assessed through the Queensland Social Survey annually between 2007-2014 (n = 12,552). Regression analyses were conducted to compare the proportion of older versus younger adults engaging in health behaviours and of healthy weight in all years combined and examine trends in the proportion of younger and older adults engaging in health behaviours and of healthy weight over time. Older adults were more likely to meet recommended intakes of fruit and vegetable (OR = 1.43, 95% CI = 1.23-1.67), not consume fast food (OR = 2.54, 95% CI = 2.25-2.86) and be non-smokers (OR = 3.02, 95% CI = 2.53-3.60) in comparison to younger adults. Conversely, older adults were less likely to meet the physical activity recommendations (OR = 0.86, 95% CI = 0.78-0.95) and watch less than 14 hours of TV per week (OR = 0.65, 95% CI = 0.58-0.74). Overall, older adults were more likely to report engaging in 3, or at least 4 out of 5 healthy behaviours. The proportion of both older and younger adults meeting the physical activity recommendations (OR = 0.97, 95% CI = 0.95-0.98 and OR = 0.94, 95% CI = 0.91-0.97 respectively), watching less than 14 hours of TV per week (OR = 0.96, 95% CI = 0.94-0.99 and OR = 0.94, 95% CI = 0.90-0.99 respectively) and who were a healthy weight (OR = 0.95, 95% CI = 0.92-0.99 and OR = 0.96, 95% CI = 0.94-0.98 respectively) decreased over time. The proportion of older adults meeting the fruit and vegetable recommendations (OR = 0.90, 95% CI = 0.84-0.96) and not consuming fast food (OR = 0.94, 95% CI = 0.88-0.99) decreased over time. Although older adults meet more health behaviours than younger adults, the decreasing prevalence of healthy nutrition behaviours in this age group needs to be addressed.	[Alley, Stephanie J.; Schoeppe, Stephanie; Rebar, Amanda L.; Vandelanotte, Corneel] Cent Queensland Univ, Sch Med Hlth & Appl Sci, Phys Act Res Grp, Rockhampton, Qld, Australia; [Duncan, Mitch J.] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Duncan, Mitch J.] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Phys Act & Nutr, Callaghan, NSW, Australia	Central Queensland University; University of Newcastle; University of Newcastle	Alley, SJ (corresponding author), Cent Queensland Univ, Sch Med Hlth & Appl Sci, Phys Act Res Grp, Rockhampton, Qld, Australia.	s.alley@cqu.edu.au	Duncan, Mitch/V-1708-2019; Vandelanotte, Corneel/ABF-5580-2020	Duncan, Mitch/0000-0002-9166-6195; Rebar, Amanda/0000-0003-3164-993X; Alley, Stephanie/0000-0001-9666-5071	National Heart Foundation of Australia [100029, 100427, 101240]; Early Career Fellowship from the National Health Medical Research Council [GNT1105926]; Early Career Fellowships from the National Health and Medical Research Council [GNT1125586]	National Heart Foundation of Australia(National Heart Foundation of Australia); Early Career Fellowship from the National Health Medical Research Council; Early Career Fellowships from the National Health and Medical Research Council	MJD is supported by a Future Leader Fellowship (ID 100029) from the National Heart Foundation of Australia. CV is supported by a Future Leader Fellowship (ID 100427) also from the National Heart Foundation of Australia (www.heartfoundation.org.au). AR (GNT1105926) is supported by an Early Career Fellowship from the National Health Medical Research Council (www.nhmrc.gov.au). SS is supported by Early Career Fellowships from the National Health and Medical Research Council (GNT1125586) and the National Heart Foundation of Australia (ID 101240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair T, 2011, CANCER CAUSE CONTROL, V22, P1047, DOI 10.1007/s10552-011-9781-0; [Anonymous], 2013, AG AUSTR PREP FUT; Australian Bureau of Statistics, 2013, 43380 ABS; Australian Bureau of Statistics, 2016, 65230 ABS; Australian Bureau of Statistics, 2016, RET RET INT AUSTR JU; Australian Bureau of Statistics, 2010, 43640 ABS; Australian Bureau of Statistics, 2015, 4364055001 ABS; Australian Bureau of Statistics, 2013, 4364055004 ABS; Australian Bureau of Statistics, 2012, 32220 AUSTR BUR STAT; Australian Institute of Health and Welfare, 2009, HLTH EXP AUSTR 2007; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Brown WJ, 2012, BRIT J SPORT MED, V46, P664, DOI 10.1136/bjsports-2011-090529; Burns C, 2015, PUBLIC HEALTH NUTR, V18, P143, DOI 10.1017/S1368980013002796; Chau J, 2008, AUST NZ J PUBL HEAL, V32, P82, DOI 10.1111/j.1753-6405.2008.00170.x; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; Delva J, 2006, J ADOLESCENT HEALTH, V39, P536, DOI 10.1016/j.jadohealth.2006.02.013; Department of Health and Ageing, 2014, AUSTR PHYS ACT SED B; Department of Health and Aging, 2009, AB OV OB; Ding D, 2016, AM J PREV MED, V51, P170, DOI 10.1016/j.amepre.2016.01.019; Duncan MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1060; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Fjeldsoe BS, 2013, HEALTH PROMOT J AUST, V24, P26, DOI 10.1071/HE12912; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Government Q, 2010, LIQ OTH LEG AM BILL; Grimm K. A., 2010, Morbidity and Mortality Weekly Report, V59, P1125; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Kwek G., 2014, SYDNEY MORNING HERAL; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McNaughton SA, 2012, J NUTR, V142, P320, DOI 10.3945/jn.111.148692; National Health and Medical Reseach Council, 2009, DS10 NAT HLTH MED RE; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Powell LM, 2010, J NUTR, V140, P1175, DOI 10.3945/jn.109.111526; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Short CE, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-25; Spring B, 2012, J PUBLIC HEALTH-UK, V34, pI3, DOI 10.1093/pubmed/fdr111; Stamatakis E, 2014, PREV MED, V63, P72, DOI 10.1016/j.ypmed.2014.03.009; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Tabachnick BG, 2007, MULTIVARIATE STAT, V5th, P437; Vandelanotte C, 2002, AUST NZ J PUBL HEAL, V2010, P248, DOI DOI 10.1111/J.1753-6405.2010.00521.X; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Xiang XL, 2016, J AGING HEALTH, V28, P995, DOI 10.1177/0898264315614573	46	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172510	10.1371/journal.pone.0172510	http://dx.doi.org/10.1371/journal.pone.0172510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248975	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500044
J	Huang, YT; Chang, YM; Chen, IL; Yang, CL; Leu, SC; Su, HL; Kao, JL; Tsai, SC; Jhen, RN; Tang, WR; Shiao, CC				Huang, Ya-Ting; Chang, Yu-Ming; Chen, I-Ling; Yang, Chuan-Lan; Leu, Show-Chin; Su, Hung-Li; Kao, Jsun-Liang; Tsai, Shih-Ching; Jhen, Rong-Na; Tang, Woung-Ru; Shiao, Chih-Chung		SMHRG Saint Mary's Hosp Res Grp	Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients	PLOS ONE			English	Article							NERVOUS-SYSTEM FUNCTION; STAGE RENAL-DISEASE; BAROREFLEX SENSITIVITY; SPECTRAL-ANALYSIS; KIDNEY FAILURE; RISK; ESRD; CONSEQUENCES; EMBOLECTOMY; DYSFUNCTION	Background Vascular access (VA) is the lifeline of hemodialysis patients. Although the autonomic nervous system might be associated with VA failure (VAF), it has never been addressed in previous studies. This study aimed to evaluate the predictive values of the heart rate variability (HRV) indices for long-term VA outcomes. Methods This retrospective study was conducted using a prospectively established cohort enrolling 175 adult chronic hemodialysis patients (100 women, mean age 65.1 +/- 12.9 years) from June 2010 to August 2010. Each participant received a series of HRV measurements at enrollment. After a 60-month follow-up period, we retrospectively reviewed all events and therapeutic procedures of the VAs which existed at the enrollment and during the follow-up period. Results During the 60-month follow-up period, 37 (26.8%) had VAF but 138 (73.2%) didn't. The values of most HRV indices were statistically increased during hemodialysis since initiation in the non-VAF group, but not in the VAF group. Among all participants, the independent indicators for VAF included higher normalized high-frequency (nHF) activity [hazard ratio (HR) 1.04, p = 0.005], lower low-frequency/high-frequency (LF/HF) ratio (HR 0.80, p = 0.015), experience of urokinase therapy (HR 11.18, p = 0.002), percutaneous transluminal angioplasty (HR 2.88, p = 0.003) and surgical thrombectomy (HR 2.36, p = 0.035), as well as higher baseline serum creatinine (HR 1.07, p = 0.027) and potassium level (HR 1.58, p = 0.037). In subgroup analysis, a lower sympathetic activity indicated by lower LF/HF ratio was an independent indicator for VAF (HR 0.61, p = 0.03) for tunneled cuffed catheter, but conversely played a protective role against VAF (HR 1.27, p = 0.002) for arteriovenous fistula. Conclusions HRV is a useful tool for predicting long-term VAF among hemodialysis patients.	[Huang, Ya-Ting] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Huang, Ya-Ting; Chen, I-Ling; Yang, Chuan-Lan; Leu, Show-Chin; Su, Hung-Li] St Marys Hosp Luodong, Dept Nursing, Yilan, Taiwan; [Chang, Yu-Ming; Kao, Jsun-Liang; Tsai, Shih-Ching; Jhen, Rong-Na; Shiao, Chih-Chung] St Marys Hosp Luodong, Dept Internal Med, Div Nephrol, Yilan, Taiwan; [Tang, Woung-Ru] Chang Gung Univ, Grad Inst Nursing, Taoyuan, Taiwan; [Shiao, Chih-Chung] St Marys Med Nursing & Management Coll, Yilan, Taiwan	Chang Gung University; Chang Gung University	Shiao, CC (corresponding author), St Marys Hosp Luodong, Dept Internal Med, Div Nephrol, Yilan, Taiwan.; Shiao, CC (corresponding author), St Marys Med Nursing & Management Coll, Yilan, Taiwan.	chungyy2001@yahoo.com.tw	Shiao, Chih-Chung/AAM-2716-2020	Shiao, Chih-Chung/0000-0003-2220-7574	Saint Mary's Hospital Research Fund [SMHRF-2010004]	Saint Mary's Hospital Research Fund	The research was supported by Saint Mary's Hospital Research Fund (SMHRF-2010004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agharazii M, 2000, ASAIO J, V46, P452, DOI 10.1097/00002480-200007000-00017; Annuk M, 2001, NEPHROL DIAL TRANSPL, V16, P302, DOI 10.1093/ndt/16.2.302; Asar O, 2015, INT J EPIDEMIOL, V44, P334, DOI 10.1093/ije/dyu262; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Barnas MGW, 1999, J AM SOC NEPHROL, V10, P2577; BESARAB A, 1995, KIDNEY INT, V47, P1364, DOI 10.1038/ki.1995.192; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Blankestijn PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1068, DOI 10.1093/ndt/14.5.1068; BOWLES CR, 1988, J VASC SURG, V7, P487, DOI 10.1067/mva.1988.avs0070487; Brotman DJ, 2010, J AM SOC NEPHROL, V21, P1560, DOI 10.1681/ASN.2009111112; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Camm AJ, 1996, EUR HEART J, V17, P354; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Cavalcanti S, 1997, CLIN SCI, V92, P351, DOI 10.1042/cs0920351; Chandra P, 2012, NEPHROL DIAL TRANSPL, V27, P700, DOI 10.1093/ndt/gfr340; Chang YM, 2016, CLIN EXP NEPHROL, V20, P650, DOI 10.1007/s10157-015-1189-9; Chen KY, 2006, AM J MED SCI, V332, P164, DOI 10.1097/00000441-200610000-00002; Di Iorio BR, 2004, J NEPHROL, V17, P19; Elghozi JL, 2007, FUND CLIN PHARMACOL, V21, P337, DOI 10.1111/j.1472-8206.2007.00502.x; EWING DJ, 1975, NEPHRON, V15, P424, DOI 10.1159/000180525; FORSSTROM J, 1986, SCAND J CLIN LAB INV, V46, P665, DOI 10.3109/00365518609083729; FRIEDMAN M, 1965, ARCH PATHOL, V79, P345; Giordano M, 2001, NEPHROL DIAL TRANSPL, V16, P566, DOI 10.1093/ndt/16.3.566; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; GREENWOOD LH, 1984, AM J ROENTGENOL, V142, P141, DOI 10.2214/ajr.142.1.141; Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x; Hathaway DK, 1998, NURS RES, V47, P171, DOI 10.1097/00006199-199805000-00008; JORGENSEN RA, 1983, SURGERY, V93, P798; Kim YH, 1997, PACE, V20, P1936, DOI 10.1111/j.1540-8159.1997.tb03599.x; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Les J, 2013, ANAESTH INTENSIVE TH, V45, P171, DOI 10.5603/AIT.2013.0035; Lin YH, 2013, PSYCHOPHYSIOLOGY, V50, P521, DOI 10.1111/psyp.12038; Lok CE, 2011, KIDNEY INT, V79, P587, DOI 10.1038/ki.2010.471; Mathew AT, 2016, KIDNEY INT, V90, P262, DOI 10.1016/j.kint.2016.02.037; May RE, 1997, KIDNEY INT, V52, P1656, DOI 10.1038/ki.1997.499; Monroy-Cuadros M, 2010, CLIN J AM SOC NEPHRO, V5, P1787, DOI 10.2215/CJN.09441209; PALDER SB, 1985, ANN SURG, V202, P235, DOI 10.1097/00000658-198508000-00015; Pelosi E, 1999, CLIN SCI, V96, P23, DOI 10.1042/CS19980180; Ranpuria R, 2008, NEPHROL DIAL TRANSPL, V23, P444, DOI 10.1093/ndt/gfm634; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Rubinger D, 2004, NEPHROL DIAL TRANSPL, V19, P2053, DOI 10.1093/ndt/gfh306; Rubinger D, 1999, J AM SOC NEPHROL, V10, P1972; Rubinger D, 2013, SEMIN DIALYSIS, V26, P333, DOI 10.1111/sdi.12093; Sahni R, 2000, DEV PSYCHOBIOL, V37, P73, DOI 10.1002/1098-2302(200009)37:2<73::AID-DEV2>3.0.CO;2-C; Santoro D, 2014, INT J NEPHROL RENOV, V7, P281, DOI 10.2147/IJNRD.S46643; Silva TNV, 2014, HEMODIAL INT, V18, P15, DOI 10.1111/hdi.12071; Steinberg AA, 1998, AM J CARDIOL, V82, P1156, DOI 10.1016/S0002-9149(98)00580-3; Strozecki P, 2008, NEPHROL DIAL TRANSPL, V23, P4085, DOI 10.1093/ndt/gfn481; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Woods JD, 1997, AM J KIDNEY DIS, V30, P50, DOI 10.1016/S0272-6386(97)90564-3	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172212	10.1371/journal.pone.0172212	http://dx.doi.org/10.1371/journal.pone.0172212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249028	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500032
J	Li, YJ; Yang, H; Ni, W; Gu, YX				Li, Yanjiang; Yang, Heng; Ni, Wei; Gu, Yuxiang			Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL HEMORRHAGE; FREE-RADICALS; INJURY; IRON; EDEMA; RATS; PROTEINS; DAMAGE; PERMEABILITY	Blood brain barrier (BBB) disruption is a key mechanism of subarachnoid hemorrhage (SAH)-induced brain injury. This study examined the mechanism of iron-induced BBB disruption after SAH and investigated the potential therapeutic effect of iron chelation on SAH. Male adult Sprague-Dawley rats had an endovascular perforation of left internal carotid artery bifurcation or sham operation. The rats were treated with deferoxamine (DFX) or vehicle (100mg/kg) for a maximum of 7 days. Brain edema, BBB leakage, behavioral and cognitive impairment were examined. In SAH rat, the peak time of brain edema and BBB impairment in the cortex was at day 3 after SAH. SAH resulted in a significant increase in ferritin expression in the cortex. The ferritin positive cells were colocalized with endothelial cells, pericytes, astrocytes, microglia and neurons. Compared with vehicle, DFX caused less ferritin upregulation, brain water content, BBB impairment, behavioral and cognitive deficits in SAH rats. The results suggest iron overload could be a therapeutic target for SAH induced BBB damage.	[Li, Yanjiang; Yang, Heng; Ni, Wei; Gu, Yuxiang] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China	Fudan University	Ni, W; Gu, YX (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	hsniwei@fudan.edu.cn; Guyuxiang1972@126.com	gu, yu/GSD-4507-2022		National Natural Science Foundation of China (NSFC) [81500987]; Science and Technology Commission of Shanghai Municipality(STCSM) [15140902300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants 81500987 from the National Natural Science Foundation of China (NSFC) and grants 15140902300 from Science and Technology Commission of Shanghai Municipality(STCSM), http://www.nsfc.gov.cn.	Bederson JB, 1995, STROKE, V26, P91; BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F; Burdo JR, 2004, J CEREBR BLOOD F MET, V24, P67, DOI 10.1097/01.WCB.0000095800.98378.03; Cao SL, 2016, NEUROSCI LETT, V621, P88, DOI 10.1016/j.neulet.2016.04.018; Chi OZ, 2008, NEUROL RES, V30, P288, DOI 10.1179/016164107X230135; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Guo C, 2016, EXP NEUROL, V280, P13, DOI 10.1016/j.expneurol.2016.03.016; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Imaizumi S, 1996, NEUROCHEM INT, V29, P205, DOI 10.1016/0197-0186(95)00120-4; Jia W, 2014, MOL MED REP, V9, P779, DOI 10.3892/mmr.2013.1875; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-18; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Ni W, 2015, J CEREBR BLOOD F MET, V35, P1454, DOI 10.1038/jcbfm.2015.52; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Paul T, 2000, ARCH BIOCHEM BIOPHYS, V382, P253, DOI 10.1006/abbi.2000.2027; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Scholler K, 2007, BRAIN RES, V1142, P237, DOI 10.1016/j.brainres.2007.01.034; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; ZUCCARELLO M, 1993, J NEUROTRAUM, V10, P397, DOI 10.1089/neu.1993.10.397	34	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172784	10.1371/journal.pone.0172784	http://dx.doi.org/10.1371/journal.pone.0172784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249040	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500057
J	Matsuda, F; Kinoshita, S; Nishino, S; Tomita, A; Shimizu, H				Matsuda, Fumio; Kinoshita, Syohei; Nishino, Shunsuke; Tomita, Atsumi; Shimizu, Hiroshi			Targeted proteome analysis of single-gene deletion strains of Saccharomyces cerevisiae lacking enzymes in the central carbon metabolism	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; GLYCOLYTIC-ENZYMES; TRANSLATIONAL REGULATION; MASS-SPECTROMETRY; REDOX METABOLISM; YEAST; EXPRESSION; CELLS; SOFTWARE; NETWORKS	Central carbon metabolism is controlled by modulating the protein abundance profiles of enzymes that maintain the essential systems in living organisms. In this study, metabolic adaptation mechanisms in the model organism Saccharomyces cerevisiae were investigated by direct determination of enzyme abundance levels in 30 wild type and mutant strains. We performed a targeted proteome analysis using S. cerevisiae strains that lack genes encoding the enzymes responsible for central carbon metabolism. Our analysis revealed that at least 30% of the observed variations in enzyme abundance levels could be explained by global regulatory mechanisms. A enzyme-enzyme co-abundance analysis revealed that the abundances of enzyme proteins involved in the trehalose metabolism and glycolysis changed in a coordinated manner under the control of the transcription factors for global regulation. The remaining variations were derived from local mechanisms such as a mutant-specific increase in the abundances of remote enzymes. The proteome data also suggested that, although the functional compensation of the deficient enzyme was attained by using more resources for protein biosynthesis, available resources for the biosynthesis of the enzymes responsible for central metabolism were not abundant in S. cerevisiae cells. These results showed that global and local regulation of enzyme abundance levels shape central carbon metabolism in S. cerevisiae by using a limited resource for protein biosynthesis.	[Matsuda, Fumio; Kinoshita, Syohei; Nishino, Shunsuke; Tomita, Atsumi; Shimizu, Hiroshi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Matsuda, Fumio] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan	Osaka University; RIKEN	Matsuda, F (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan.; Matsuda, F (corresponding author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan.	fmatsuda@ist.osaka-u.ac.jp	Shimizu, Hiroshi/C-3688-2017	Shimizu, Hiroshi/0000-0002-8986-0861; Matsuda, Fumio/0000-0003-1091-778X	Industrial Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan [11B05004c]; JSPS [15K06579]	Industrial Technology Research Grant Program of the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Industrial Technology Research Grant Program for 2011 of the New Energy and Industrial Technology Development Organization (NEDO, http://www.nedo.go.jp/) of Japan No 11B05004c and by JSPS (https://www.jsps.go.jp/) Grants in Aid for Scientific Research (C) No 15K06579.; We thank Dr. Katsuyuki Yugi, Dr. Atsushi Hatano (Universty of Tokyo), and Dr. Yoshihiro Toya (Osaka University) for helpful comment to this manuscript. This work was supported by the Industrial Technology Research Grant Program for 2011 of the New Energy and Industrial Technology Development Organization (NEDO) of Japan and by Grants in Aid for Scientific Research (C) No 15K06579. All raw data flies are deposited to jPOST (http://jpostdb.org, ID: JPST000167 and PXD004714).	Amoutzias GD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009555; Araiza-Olivera D, 2013, FEBS J, V280, P3887, DOI 10.1111/febs.12387; Arvas M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-616; Ben-Shitrit T, 2012, NAT METHODS, V9, P373, DOI [10.1038/NMETH.1890, 10.1038/nmeth.1890]; Bereman MS, 2012, PROTEOMICS, V12, P1134, DOI 10.1002/pmic.201200042; Bjorkqvist S, 1997, APPL ENVIRON MICROB, V63, P128; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Bro C, 2004, BIOTECHNOL BIOENG, V85, P269, DOI 10.1002/bit.10899; Bruckmann A, 2009, J PROTEOMICS, V71, P662, DOI 10.1016/j.jprot.2008.11.012; Carroll KM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007633; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Costenoble R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.122; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Diderich JA, 2001, APPL ENVIRON MICROB, V67, P1587, DOI 10.1128/AEM.67.4.1587-1593.2001; Eberhardt I, 1999, EUR J BIOCHEM, V262, P191, DOI 10.1046/j.1432-1327.1999.00370.x; Eleutherio E, 2015, CURR GENET, V61, P263, DOI 10.1007/s00294-014-0450-1; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.91; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Gustavsson AK, 2014, FEBS J, V281, P2784, DOI 10.1111/febs.12820; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hackett SR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf2786; Hauf J, 2000, ENZYME MICROB TECH, V26, P688, DOI 10.1016/S0141-0229(00)00160-5; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hubmann G, 2011, APPL ENVIRON MICROB, V77, P5857, DOI 10.1128/AEM.05338-11; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kintaka R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31774; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Liebermeister W, 2014, P NATL ACAD SCI USA, V111, P8488, DOI 10.1073/pnas.1314810111; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MARCHAND M, 1989, EUR J BIOCHEM, V184, P455, DOI 10.1111/j.1432-1033.1989.tb15038.x; Matsuda F, 2015, J BIOSCI BIOENG, V119, P117, DOI 10.1016/j.jbiosc.2014.06.010; Moriya H, 2012, MOL BIOSYST, V8, P2513, DOI 10.1039/c2mb25100k; Nissen TL, 2000, YEAST, V16, P463, DOI 10.1002/(SICI)1097-0061(20000330)16:5<463::AID-YEA535>3.0.CO;2-3; Oliveira AP, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.55; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; ROSENZWEIG RF, 1992, GENET RES, V59, P35, DOI 10.1017/S0016672300030159; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasaki H, 2005, YEAST, V22, P111, DOI 10.1002/yea.1198; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tripodi F, 2015, BBA-GEN SUBJECTS, V1850, P620, DOI 10.1016/j.bbagen.2014.12.010; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; van den Brink J, 2008, APPL ENVIRON MICROB, V74, P5710, DOI 10.1128/AEM.01121-08; van Heerden JH, 2015, BIOESSAYS, V37, P34, DOI 10.1002/bies.201400108; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; van Hoek P, 2000, ENZYME MICROB TECH, V26, P724, DOI 10.1016/S0141-0229(00)00164-2; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Zahringer H, 2000, MOL MICROBIOL, V35, P397, DOI 10.1046/j.1365-2958.2000.01706.x	63	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172742	10.1371/journal.pone.0172742	http://dx.doi.org/10.1371/journal.pone.0172742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241048	gold, Green Published, Green Submitted			2022-12-27	WOS:000395934400036
J	Wang, J; Liu, SH; Li, CC; Wang, TL; Zhang, PY; Chen, KS				Wang, Jing; Liu, Shenghao; Li, Chengcheng; Wang, Tailin; Zhang, Pengying; Chen, Kaoshan			PnLRR-RLK27, a novel leucine-rich repeats receptor-like protein kinase from the Antarctic moss Pohlia nutans, positively regulates salinity and oxidation-stress tolerance	PLOS ONE			English	Article							ABSCISIC-ACID; PHYSCOMITRELLA-PATENS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; SALT TOLERANCE; SUPEROXIDE DISMUTASES; DROUGHT TOLERANCE; ANION CHANNELS; ARABIDOPSIS	Leucine-rich repeats receptor-like kinases (LRR-RLKs) play important roles in plant growth and development as well as stress responses. Here, 56 LRR-RLK genes were identified in the Antarctic moss Pohlia nutans transcriptome, which were further classified into 11 subgroups based on their extracellular domain. Of them, PnLRR-RLK27 belongs to the LRR II subgroup and its expression was significantly induced by abiotic stresses. Subcellular localization analysis showed that PnLRR-RLK27 was a plasma membrane protein. The overexpression of PnLRR-RLK27 in Physcomitrella significantly enhanced the salinity and ABA tolerance in their gametophyte growth. Similarly, PnLRR-RLK27 heterologous expression in Arabidopsis increased the salinity and ABA tolerance in their seed germination and early root growth as well as the tolerance to oxidative stress. PnLRR-RLK27 overproduction in these transgenic plants increased the expression of salt stress/ABA-related genes. Furthermore, PnLRR-RLK27 increased the activities of reactive oxygen species (ROS) scavengers and reduced the levels of malondialdehyde (MDA) and ROS. Taken together, these results suggested that PnLRR-RLK27 as a signaling regulator confer abiotic stress response associated with the regulation of the stress-and ABA-mediated signaling network.	[Wang, Jing; Li, Chengcheng; Wang, Tailin; Zhang, Pengying; Chen, Kaoshan] Shandong Univ, Sch Life Sci, Jinan, Peoples R China; [Wang, Jing; Li, Chengcheng; Wang, Tailin; Zhang, Pengying; Chen, Kaoshan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Peoples R China; [Liu, Shenghao] State Ocean Adm, Inst Oceanog 1, Marine Ecol Res Ctr, Qingdao, Peoples R China; [Zhang, Pengying] Shandong Prov Key Lab Carbohydrate Chem & Glycobi, Jinan, Peoples R China	Shandong University; Shandong University; State Oceanic Administration	Zhang, PY (corresponding author), Shandong Univ, Sch Life Sci, Jinan, Peoples R China.; Zhang, PY (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Peoples R China.; Zhang, PY (corresponding author), Shandong Prov Key Lab Carbohydrate Chem & Glycobi, Jinan, Peoples R China.	zhangpy80@sdu.edu.cn			National Natural Science Foundation of China [41206176, 41476174]; Basic Scientific Fund for National Public Research Institutes of China [2014T04]; Natural Science Foundation of Shandong Province [ZR2014DQ012]; Excellent Creative Team Fund of Jinan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Scientific Fund for National Public Research Institutes of China; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Excellent Creative Team Fund of Jinan	This work was supported by the National Natural Science Foundation of China (41206176 and 41476174), Basic Scientific Fund for National Public Research Institutes of China (2014T04), Natural Science Foundation of Shandong Province (ZR2014DQ012) and the Excellent Creative Team Fund of Jinan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (41206176 and 41476174), Basic Scientific Fund for National Public Research Institutes of China (2014T04), Natural Science Foundation of Shandong Province (ZR2014DQ012) and Excellent Creative Team Fund of Jinan. We thank Dr. Tomoaki Nishiyama and Dr. Mitsuyasu Hasebe (NIBB, Japan) for providing the pTFH15.3 vector.	aan den Toorn M, 2015, MOL PLANT, V8, P762, DOI 10.1016/j.molp.2015.03.015; Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Brandt B, 2015, ELIFE, V4, DOI 10.7554/eLife.03599; Chae L, 2009, MOL PLANT, V2, P84, DOI 10.1093/mp/ssn083; Chater C, 2013, CURR OPIN PLANT BIOL, V16, P638, DOI 10.1016/j.pbi.2013.06.013; Chen XW, 2014, MOL PLANT, V7, P874, DOI 10.1093/mp/ssu003; Clarke LJ, 2008, NEW PHYTOL, V179, P776, DOI 10.1111/j.1469-8137.2008.02499.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cove DJ., 2009, COLD SPRING HARB PRO, V2009, P5143; Cove DJ, 2009, COLD SPRING HARB PRO, P5140; Cuming AC, 2015, NEW PHYTOL, V206, P5, DOI 10.1111/nph.13333; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; de Lorenzo L, 2009, PLANT CELL, V21, P668, DOI 10.1105/tpc.108.059576; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Dievart A, 2016, PLANT SCI, V242, P240, DOI 10.1016/j.plantsci.2015.06.019; Dievart A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-367; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hou SN, 2014, J NANOMATER, V2014, DOI 10.1155/2014/564694; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Huault E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004891; Hwang SG, 2011, GENETICA, V139, P1023, DOI 10.1007/s10709-011-9604-y; Kamei A, 2005, PLANT CELL ENVIRON, V28, P1267, DOI 10.1111/j.1365-3040.2005.01363.x; Khandelwal A, 2010, SCIENCE, V327, P546, DOI 10.1126/science.1183672; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Koller T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111185; Kroemer K, 2004, PLANT CELL REP, V22, P864, DOI 10.1007/s00299-004-0785-z; Kumar D, 2016, MOL PLANT; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee BH, 2010, COLD SPRING HARB PRO, P4969; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li CL, 2016, PLANT PHYSIOL, V170, P1090, DOI 10.1104/pp.15.01649; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu N, 2007, PLANTA, V226, P827, DOI 10.1007/s00425-007-0529-8; Liu SH, 2013, EXTREMOPHILES, V17, P391, DOI 10.1007/s00792-013-0528-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELOCK CE, 1995, PLANT PHYSIOL, V109, P955, DOI 10.1104/pp.109.3.955; Lunde C, 2006, PLANT MOL BIOL, V60, P259, DOI 10.1007/s11103-005-3881-8; Lunde C, 2007, PLANT PHYSIOL, V144, P1786, DOI 10.1104/pp.106.094946; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Meng XZ, 2015, CURR BIOL, V25, P2361, DOI 10.1016/j.cub.2015.07.068; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; NANKIVELL BJ, 1994, KIDNEY INT, V45, P1006, DOI 10.1038/ki.1994.136; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Ouyang SQ, 2010, PLANT J, V62, P316, DOI 10.1111/j.1365-313X.2010.04146.x; Park HJ, 2016, MOL CELLS, V39, P447, DOI 10.14348/molcells.2016.0083; Park S, 2014, J PLANT PHYSIOL, V171, P1645, DOI 10.1016/j.jplph.2014.08.002; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pereira BK, 2009, J PHOTOCH PHOTOBIO B, V96, P117, DOI 10.1016/j.jphotobiol.2009.04.011; Perez-Lopez U, 2009, PHYSIOL PLANTARUM, V135, P29, DOI 10.1111/j.1399-3054.2008.01174.x; Pitsch NT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-133; Pressel S., 2009, ANN BOT, V104, pVI, DOI [10.1093/aob/mcp111, DOI 10.1093/AOB/MCP111, DOI 10.1093/aob/mcp111]; Quatrano RS, 2007, CURR OPIN PLANT BIOL, V10, P182, DOI 10.1016/j.pbi.2007.01.005; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; SCHAEFER D, 1991, MOL GEN GENET, V226, P418, DOI 10.1007/BF00260654; Schlensog M, 2013, OECOLOGIA, V173, P59, DOI 10.1007/s00442-013-2608-9; Schroeter B, 2012, ANTARCT SCI, V24, P281, DOI 10.1017/S095410201200003X; Sewelam N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00187; Shi CC, 2014, PLANT SCI, V217, P63, DOI 10.1016/j.plantsci.2013.12.002; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sun XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016079; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; van Esse W, 2013, PLANT PHYSIOL, V163, P1472, DOI 10.1104/pp.113.222034; Wang J, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/6138251; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; Wang XQ, 2008, PLANT SIGNAL BEHAV, V3, P516, DOI 10.4161/psb.3.8.6337; Wasley J, 2006, FUNCT PLANT BIOL, V33, P443, DOI 10.1071/FP05306; Wolf L, 2010, PLANT PHYSIOL, V153, P1123, DOI 10.1104/pp.110.154658; Wrzaczek M, 2013, CURR OPIN PLANT BIOL, V16, P575, DOI 10.1016/j.pbi.2013.07.002; Wu FQ, 2015, J EXP BOT, V66, P271, DOI 10.1093/jxb/eru417; Wu YZ, 2016, MOL PLANT, V9, P289, DOI 10.1016/j.molp.2015.12.011; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang L, 2014, PLANT SCI, V215, P19, DOI 10.1016/j.plantsci.2013.10.009; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yin J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1336; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yotsui I, 2016, BIOCHEM BIOPH RES CO, V471, P589, DOI 10.1016/j.bbrc.2016.02.024; Zhang PY, 2015, PLANT MOL BIOL REP, V33, P1156, DOI 10.1007/s11105-014-0823-0; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zuniga-Gonzalez P, 2016, BIOL RES, V49, DOI 10.1186/s40659-015-0058-z	115	28	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172869	10.1371/journal.pone.0172869	http://dx.doi.org/10.1371/journal.pone.0172869			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241081	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400047
J	Wen, YF; Yang, XZ; Zeng, LS; Peng, HH; Huang, WJ; Cai, LM; Zhou, TC; Lin, XD				Wen, Yue-Feng; Yang, Xian-Zi; Zeng, Li-Si; Peng, Hai-Hua; Huang, Wen-Jin; Cai, Long-Mei; Zhou, Tong-Chong; Lin, Xiao-Dan			Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma	PLOS ONE			English	Article							BARR-VIRUS DNA; OXIDATIVE-STRESS; DRUG-RESISTANCE; CELLS; EXPRESSION; REDOX; GLUTATHIONE; MODULATION; GROWTH	Background Gamma-glutamyltransferase (GGT) is a membrane-bound enzyme involved in the metabolism of glutathione. Studies suggested that GGT played an important role in the tumor development, progression, invasion and drug resistance and prognosis. The association between GGT and prognosis of patients with nasopharyngeal carcinoma (NPC) was unknown. This study was conducted to investigate the association of pretherapeutic serum level of GGT with clinical-pathological parameters and survival in patients with NPC. Methods Two hundred and twenty-two patients with NPC were recruited in this study and were stratified into two GGT risk groups (<= 34.5 U/ L, > 34.5 U/ L). The association of pretherapeutic serum GGT levels with clinical -pathological parameters was examined. Univariate and multivariate survival analyses were performed. Findings The pretherapeutic serum level of GGT was not associated with gender, age, pathology, T stage, N stage, TNM stage, chemotherapy or radiotherapy in patients with NPC. Patients in the high-risk GGT group had a poorer survival than the low-risk GGT group (3-year overall survival, 74.2% vs. 50.2%, P = 0.001; 3-year progression-free survival, 76.4% vs. 47.1%, P < 0.001; 3-year loco-regional relapse-free survival, 76.4% vs. 51.3%, P < 0.001; 3-year distant metastasis-free survival, 89.5% vs. 66.4%, P < 0.001). Multivariate analysis suggested that patients in the high-risk GGT group had 2.117 (95% confidence interval [ CI], 1.225 similar to 3.659, P = 0.007) times the risk of death, 2.836 (95% CI, 1.765 similar to 4.557, P < 0.001) times the risk of progression, 2.551 (95% CI, 1.573 similar to 4.138, P < 0.001) times the risk of relapse, and 3.331 (95% CI, 1.676 similar to 6.622, P < 0.001) times the risk of metastasis compared with those in the low-risk GGT group. Conclusion The pretherapeutic serum level of GGT might serve as a novel independent prognostic factor for overall-survival, progression-free survival, loco-regional relapse-free survival and distant metastasis-free survival in patients with NPC.	[Wen, Yue-Feng; Peng, Hai-Hua; Huang, Wen-Jin; Cai, Long-Mei; Zhou, Tong-Chong; Lin, Xiao-Dan] Guangzhou Med Univ, Ctr Canc, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Yang, Xian-Zi; Zeng, Li-Si] Guangzhou Med Univ, Ctr Canc, Guangzhou Inst Oncol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Lin, XD (corresponding author), Guangzhou Med Univ, Ctr Canc, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China.	long_feng1984@126.com						Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Bouman L, 2002, BIOCHEM J, V364, P719, DOI 10.1042/BJ20011854; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Chen WH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-583; Choi J, 1997, BIOCHEM PHARMACOL, V53, P987, DOI 10.1016/S0006-2952(96)00867-2; Corti A, 2010, ANTICANCER RES, V30, P1169; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Daubeuf S, 2001, BBA-GEN SUBJECTS, V1568, P67, DOI 10.1016/S0304-4165(01)00201-X; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Grimm C, 2013, BRIT J CANCER, V109, P610, DOI 10.1038/bjc.2013.323; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hofbauer SL, 2014, BRIT J CANCER, V111, P1526, DOI 10.1038/bjc.2014.450; Kim Y, 2010, FEBS LETT, V584, P3550, DOI 10.1016/j.febslet.2010.07.006; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Li G, 2012, CHIN J CANCER, V31, P197, DOI 10.5732/cjc.011.10283; Lim JS, 2004, FREE RADICAL BIO MED, V37, P1018, DOI 10.1016/j.freeradbiomed.2004.06.032; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Pandur S, 2007, FREE RADICAL RES, V41, P1376, DOI 10.1080/10715760701739488; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Polterauer S, 2011, GYNECOL ONCOL, V122, P590, DOI 10.1016/j.ygyno.2011.05.027; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Reuter S, 2009, BIOCHEM PHARMACOL, V77, P397, DOI 10.1016/j.bcp.2008.09.041; Seebacher V, 2012, BRIT J CANCER, V106, P1551, DOI 10.1038/bjc.2012.16; Staudigl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125317; Takemura K, 2014, HUM PATHOL, V45, P331, DOI 10.1016/j.humpath.2013.09.009; Tang LQ, 2014, BRIT J CANCER, V111, P1102, DOI 10.1038/bjc.2014.393; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Wee JT, CHIN J CANC, V29, P517; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003; Yang F, 2015, DIS ESOPHAGUS, V28, P496, DOI 10.1111/dote.12227; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967	36	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172345	10.1371/journal.pone.0172345	http://dx.doi.org/10.1371/journal.pone.0172345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241022	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400020
J	Breveglieri, G; Travan, A; D'Aversa, E; Cosenza, LC; Pellegatti, P; Guerra, G; Gambari, R; Borgatti, M				Breveglieri, Giulia; Travan, Anna; D'Aversa, Elisabetta; Cosenza, Lucia Carmela; Pellegatti, Patrizia; Guerra, Giovanni; Gambari, Roberto; Borgatti, Monica			Postnatal and non-invasive prenatal detection of beta-thalassemia mutations based on Taqman genotyping assays	PLOS ONE			English	Article							FREE FETAL DNA; CELL-FREE DNA; MATERNAL PLASMA; DIAGNOSIS; CONFIRMATION; EXTRACTION; DOSAGE; MALAYS; GENE	The beta-thalassemias are genetic disorder caused by more than 200 mutations in the beta-globin gene, resulting in a total (beta(0)) or partial (beta(+)) deficit of the globin chain synthesis. The most frequent Mediterranean mutations for beta-thalassemia are: beta(0) 39, beta(+) IVSI-110, beta(+) IVSI-6 and beta(0) IVSI-1. Several molecular techniques for the detection of point mutations have been developed based on the amplification of the DNA target by polymerase chain reaction (PCR), but they could be labor-intensive and technically demanding. On the contrary, TaqMan (R) genotyping assays are a simple, sensitive and versatile method suitable for the single nucleotide polymorphism (SNP) genotyping affecting the human beta-globin gene. Four TaqMan r genotyping assays for the most common beta-thalassemia mutations present in the Mediterranean area were designed and validated for the genotype characterization of genomic DNA extracted from 94 subjects comprising 25 healthy donors, 33 healthy carriers and 36 beta-thalassemia patients. In addition, 15 specimens at late gestation (21-39 gestational weeks) and 11 at early gestation (5-18 gestational weeks) were collected from pregnant women, and circulating cell-free fetal DNAs were extracted and analyzed with these four genotyping assays. We developed four simple, inexpensive and versatile genotyping assays for the postnatal and prenatal identification of the thalassemia mutations beta(0) 39, beta(+) IVSI-110, beta(+) IVSI6, beta(0) IVSI-1. These genotyping assays are able to detect paternally inherited point mutations in the fetus and could be efficiently employed for non-invasive prenatal diagnosis of beta-globin gene mutations, starting from the 9 th gestational week.	[Breveglieri, Giulia; Travan, Anna; D'Aversa, Elisabetta; Cosenza, Lucia Carmela; Gambari, Roberto; Borgatti, Monica] Univ Ferrara, Biochem & Mol Biol Sect, Dept Life Sci & Biotechnol, Ferrara, Italy; [Breveglieri, Giulia; Cosenza, Lucia Carmela; Gambari, Roberto] Univ Ferrara, Ctr Biotechnol, Ferrara, Italy; [Pellegatti, Patrizia; Guerra, Giovanni] Univ Hosp S Anna, Operat Unit Lab Anal, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna	Borgatti, M (corresponding author), Univ Ferrara, Biochem & Mol Biol Sect, Dept Life Sci & Biotechnol, Ferrara, Italy.	monica.borgatti@unife.it	cosenza, lucia carmela/K-5475-2018	cosenza, lucia carmela/0000-0002-2949-7191; D'Aversa, Elisabetta/0000-0003-3058-5866	Italian Ministry of Health [098/GR-2009-1596647]; UE FP7 THALAMOSS Project [306201]; Telethon [GGP10124]; Fondazione Cassa di Risparmio di Padova e Rovigo (CARIPARO); Consorzio Interuniversitario di Biotecnologie (CIB); Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo	Italian Ministry of Health(Ministry of Health, Italy); UE FP7 THALAMOSS Project; Telethon(Fondazione Telethon); Fondazione Cassa di Risparmio di Padova e Rovigo (CARIPARO)(Fondazione Cariparo); Consorzio Interuniversitario di Biotecnologie (CIB); Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo	his work was supported by the Italian Ministry of Health under the project n. 098/GR-2009-1596647-Young Investigators-2009 to MB. RG is funded by UE FP7 THALAMOSS Project (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia; grant n. 306201-FP7-Health-2012-INNOVATION-1), Telethon (contract GGP10124), Consorzio Interuniversitario di Biotecnologie (CIB), Fondazione Cassa di Risparmio di Padova e Rovigo (CARIPARO) and Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo.	Alwazani WA, 2016, GENET TEST MOL BIOMA, V20, P154, DOI 10.1089/gtmb.2015.0222; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Breveglieri G, 2015, EXPERT OPIN THER PAT, V25, P1453, DOI 10.1517/13543776.2015.1090427; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Craig I, 2005, METH MOL B, V311, P147; de Dreuzy E, 2016, BIOMED J, V39, P24, DOI 10.1016/j.bj.2015.10.001; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Fucharoen G, 2003, PRENATAL DIAG, V23, P393, DOI 10.1002/pd.607; Fucharoen S, 2002, INT J HEMATOL, V76, P83, DOI 10.1007/BF03165094; Hudecova I, 2016, BEST PRACT RES CLIN; Illanes S, 2007, EARLY HUM DEV, V83, P563, DOI 10.1016/j.earlhumdev.2006.11.001; Kho SL, 2013, GENET MOL RES, V12, P2409, DOI 10.4238/2013.February.28.4; Kho SL, 2013, SENSORS-BASEL, V13, P2506, DOI 10.3390/s130202506; Kuzio Sylvain, 2004, J Immunol Methods, V287, P179; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Li Y, 2009, FETAL DIAGN THER, V25, P246, DOI 10.1159/000223442; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Luo HY, 2016, ANN NY ACAD SCI, V1368, P49, DOI 10.1111/nyas.13056; Mackie FL, 2016, BJOG; Mahdieh N, 2013, IRAN J PEDIATR, V23, P375; Martin M, 2016, CLIN J ONCOL NURS, V20, P310, DOI 10.1188/16.CJON.310-317; Page K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077963; Phylipsen M, 2012, PRENATAL DIAG, V32, P578, DOI 10.1002/pd.3864; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; Sekizawa A, 2001, Am J Pharmacogenomics, V1, P111, DOI 10.2165/00129785-200101020-00004; Steinber MH, 2011, J ROY SOC MED, V94, P602; Tang NLS, 1999, CLIN CHEM, V45, P2033; Teh LK, 2015, INT J LAB HEMATOL, V37, P79, DOI 10.1111/ijlh.12240; Thein SL, 2004, BRIT J HAEMATOL, V124, P264, DOI 10.1046/j.1365-2141.2003.04769.x; Thein SL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011700; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Velho RV, 2015, AN ACAD BRAS CIENC, V87, P1375, DOI 10.1590/0001-3765201520140711; Webb A, 2012, BALK J MED GENET, V15, P17, DOI 10.2478/v10034-012-0013-z; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Xiong L, 2015, PRENATAL DIAG, V35, P258, DOI 10.1002/pd.4536; Yenilmez ED, 2013, PRENATAL DIAG, V33, P1054, DOI 10.1002/pd.4196; Zappu A, 2010, MOL CELL PROBE, V24, P233, DOI 10.1016/j.mcp.2010.01.004; Zhou WJ, 2013, J MOL DIAGN, V15, P642, DOI 10.1016/j.jmoldx.2013.05.007	46	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172756	10.1371/journal.pone.0172756	http://dx.doi.org/10.1371/journal.pone.0172756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235086	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200131
J	Faizy, TD; Thaler, C; Ceyrowski, T; Broocks, G; Treffler, N; Sedlacik, J; Sturner, K; Stellmann, JP; Heesen, C; Fiehler, J; Siemonsen, S				Faizy, Tobias Djamsched; Thaler, Christian; Ceyrowski, Tim; Broocks, Gabriel; Treffler, Natascha; Sedlacik, Jan; Stuerner, Klarissa; Stellmann, Jan-Patrick; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period	PLOS ONE			English	Article							WHITE-MATTER; CONSENSUS GUIDELINES; COGNITIVE IMPAIRMENT; DISABILITY; ATROPHY; GRAY	Purpose In patients with multiple sclerosis (MS), Double Inversion Recovery (DIR) magnetic resonance imaging (MRI) can be used to identify cortical lesions (CL). We sought to evaluate the reliability of CL detection on DIR longitudinally at multiple subsequent time-points applying the MAGNIMs scoring criteria for CLs. Methods 26 MS patients received a 3T-MRI (Siemens, Skyra) with DIR at 12 time-points (TP) within a 16 months period. Scans were assessed in random order by two different raters. Both raters separately marked all CLs on each scan and total lesion numbers were obtained for each scan-TP and patient. After a retrospective re-evaluation, the number of consensus CLs (conL) was defined as the total number of CLs, which both raters finally agreed on. CLs volumes, relative signal intensities and CLs localizations were determined. Both ratings (conL vs. non-consensus scoring) were compared for further analysis. Results A total number of n = 334 CLs were identified by both raters in 26 MS patients with a first agreement of both raters on 160 out of 334 of the CLs found (kappa = 0.48). After the retrospective re-evaluation, consensus agreement increased to 233 out of 334 CL (kappa = 0.69). 93.8% of conL were visible in at least 2 consecutive TP. 74.7% of the conL were visible in all 12 consecutive TP. ConL had greater mean lesion volumes and higher mean signal intensities compared to lesions that were only detected by one of the raters (p<0.05). A higher number of CLs in the frontal, parietal, temporal and occipital lobe were identified by both raters than the number of those only identified by one of the raters (p<0.05). Conclusions After a first assessment, slightly less than a half of the CL were considered as reliably detectable on longitudinal DIR images. A retrospective re-evaluation notably increased the consensus agreement. However, this finding is narrowed, considering the fact that retrospective evaluation steps might not be practicable in clinical routine. Lesions that were not reliably identifiable by both raters seem to be characterized by lower signal intensity and smaller size, or located in distinct anatomical brain regions.	[Faizy, Tobias Djamsched; Thaler, Christian; Ceyrowski, Tim; Broocks, Gabriel; Treffler, Natascha; Sedlacik, Jan; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stuerner, Klarissa; Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stuerner, Klarissa; Stellmann, Jan-Patrick; Heesen, Christoph; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Faizy, TD (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	T.Faizy@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Sturner, Klarissa Hanja/0000-0003-2199-3315	German Federal Ministry of Education & Research (BMBF) [1615613, 161A130]	German Federal Ministry of Education & Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The basic concept of this study was funded by the "German Federal Ministry of Education & Research (BMBF)" (Award Numbers: 1615613 and 161A130). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135428; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Calabrese M, 2010, ANN NEUROL, V67, P376, DOI 10.1002/ana.21906; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Ciccarelli O, 2012, NEUROLOGY, V78, P296, DOI 10.1212/WNL.0b013e318245296f; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Faizy TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151496; Favaretto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127805; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; Francis PL, 2014, AM J NEURORADIOL, V35, P1910, DOI 10.3174/ajnr.A3974; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Maranzano J, 2016, AJNR AM J NEURORADIO; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sethi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078879; Simon B, 2010, EUR RADIOL, V20, P1675, DOI 10.1007/s00330-009-1705-y; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Wattjes MP, 2015, NAT REV NEUROL, V11, P597, DOI 10.1038/nrneurol.2015.157	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172923	10.1371/journal.pone.0172923	http://dx.doi.org/10.1371/journal.pone.0172923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235075	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200170
J	Forti, LR; Lingnau, R; Encarnacao, LC; Bertoluci, J; Toledo, LF				Forti, Lucas Rodriguez; Lingnau, Rodrigo; Encarnacao, Lais Carvalho; Bertoluci, Jaime; Toledo, Luis Felipe			Can treefrog phylogeographical clades and species' phylogenetic topologies be recovered by bioacoustical analyses?	PLOS ONE			English	Article							ADVERTISEMENT CALL; GEOGRAPHIC-VARIATION; ANURA; EVOLUTION; SIGNAL; AMPHIBIA; DIFFERENTIATION; COMMUNICATION; MULTILEVEL; TOADS	Phenotypic traits, such as the frog advertisement call, are generally correlated with interspecific genetic variation, and, as a consequence of strong sexual selection, these behaviors may carry a phylogenetic signal. However, variation in acoustic traits is not always correlated with genetic differences between populations (intraspecific variation); phenotypic plasticity and environmental variables may explain part of such variation. For example, local processes can affect acoustic properties in different lineages due to differences in physical structure, climatic conditions, and biotic interactions, particularly when populations are isolated. However, acoustic traits can be used to test phylogenetic hypotheses. We analyzed the advertisement calls of Dendropsophus elegans males from 18 sites and compared them with those of four closely related congeneric species, in order to test for differences between inter and intraspecific variation. We analyzed 451 calls of 45 males of these five species. Because males from distant sites were grouped together without population congruence, differences found in advertisement calls among individuals were not correlated with phylogeographical clades. Phylogenetic and cluster analyses of the D. elegans clades and those of closely related species grouped all five species into the same topology, as reported by previous molecular and morphological phylogenies. However, the topology of the D. elegans phylogeographical clades did not match the topology previously reported. Acoustic communication in D. elegans seems to be conserved among populations, and the phylogeographical history of the species does not explain the variation among lineages in call properties, despite some congruent phylogenetic signals evident at the species level. Based on molecular clocks retrieved from the literature, it seems that more than 6.5 million years of divergence (late Miocene) are necessary to allow significant changes to occur in the acoustic properties of these treefrog calls, making it possible to recover their phylogenetic history only based on acoustic evidence.	[Forti, Lucas Rodriguez; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Multiusuario Bioacust LMBio, Sao Paulo, Brazil; [Forti, Lucas Rodriguez; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Sao Paulo, Brazil; [Lingnau, Rodrigo] Univ Tecnol Fed Parana, Francisco Beltrao, Parana, Brazil; [Encarnacao, Lais Carvalho] Univ Fed Bahia, Inst Biol, Programa Posgrad Diversidade Anim, Campus Univ Ondina, Salvador, BA, Brazil; [Bertoluci, Jaime] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Tecnologica Federal do Parana; Universidade Federal da Bahia; Universidade de Sao Paulo	Forti, LR (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Multiusuario Bioacust LMBio, Sao Paulo, Brazil.; Forti, LR (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros LaHNAB, Sao Paulo, Brazil.	lucas_forti@yahoo.com.br	Toledo, Luís Felipe/I-4017-2012; Bertoluci, Jaime/C-2824-2012; Lingnau, Rodrigo/AAB-9052-2022; Lingnau, Rodrigo/F-9035-2010	Toledo, Luís Felipe/0000-0002-4929-9598; Bertoluci, Jaime/0000-0002-9959-9740; Lingnau, Rodrigo/0000-0001-8406-4439; Lingnau, Rodrigo/0000-0001-8406-4439	Sao Paulo Research Foundation (FAPESP) [2009/13987-2, 2013/215194, 2011/51694-7, 2011/52070-7]; National Council of Scientific and Technological Development [302589/2013-9, 405285/2013-2, 304938/2013-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sao Paulo Research Foundation (FAPESP) provided the financial supports #2009/13987-2, #2013/215194, #2011/51694-7, and #2011/52070-7 to LRF and LFT. The National Council of Scientific and Technological Development provided LFT and JB with the grants #302589/2013-9, #405285/2013-2, and #304938/2013-0. Our financial grants have supported the english review and fieldwork.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Bastos Rogerio Pereira, 1995, Naturalia (Rio Claro), V20, P165; Baugh AT, 2012, SCI WORLD J, DOI 10.1100/2012/680632; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Dawson B, 2009, COPEIA, P221, DOI 10.1643/CE-07-254; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; ESRI, 2012, ARC 10 1; Forti LR, 2016, PEERJ, V4, DOI 10.7717/peerj.2014; Frost D. R., 2016, AMPHIBIANS SPECIES W; Gerhardt HC, 2012, BIOACOUSTICS, V21, P9, DOI 10.1080/09524622.2011.647469; GERHARDT HC, 1980, COPEIA, P577; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gerhardt HC, 2001, ANURAN COMMUNICATION; Giacoma C, 2001, ANURAN COMMUNICATION; Gingras B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-134; Goicoechea N, 2010, ZOOL SCR, V39, P141, DOI 10.1111/j.1463-6409.2009.00413.x; Goloboff P.A., 2003, T N T TREE ANAL USIN; Goutte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078020; Grenat PR, 2013, AMPHIBIA-REPTILIA, V34, P471, DOI 10.1163/15685381-00002902; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heyer WR, 2003, AN ACAD BRAS CIENC, V75, P39, DOI 10.1590/S0001-37652003000100006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillis DM, 2000, SM S COMP E, P1; Jungfer KH, 2010, SALAMANDRA, V46, P204; Kaefer IL, 2012, ACTA ETHOL, V15, P187, DOI 10.1007/s10211-012-0126-0; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Marquez R, 1997, BEHAV ECOL, V8, P588, DOI 10.1093/beheco/8.6.588; Prohl H, 2007, ETHOLOGY, V113, P825, DOI 10.1111/j.1439-0310.2007.01396.x; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Ron SR, 2008, ANIM BEHAV, V76, P1783, DOI 10.1016/j.anbehav.2008.07.024; RYAN MJ, 1991, TRENDS ECOL EVOL, V6, P351, DOI 10.1016/0169-5347(91)90224-L; Schmidt AKD, 2011, J EXP BIOL, V214, P1754, DOI 10.1242/jeb.053819; Simoes PI, 2008, BIOTROPICA, V40, P607, DOI 10.1111/j.1744-7429.2008.00416.x; Smith MJ, 2003, COPEIA, P750, DOI 10.1643/HA02-133.1; Statsoft Inc, 2005, STATISTICA DAT AN SO; Toledo LF, 2015, ACTA ETHOL, V18, P87, DOI 10.1007/s10211-014-0194-4; Toledo LF, 2015, BIOACOUSTICS, V24, P31, DOI 10.1080/09524622.2014.926831; Tozetti AM, 2005, J HERPETOL, V39, P640, DOI 10.1670/155-04N.1; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; WELLS KD, 1986, BEHAV ECOL SOCIOBIOL, V19, P9, DOI 10.1007/BF00303837; Wong BBM, 2004, AUSTRAL ECOL, V29, P209, DOI 10.1111/j.1442-9993.2004.01338.x; Wycherley J, 2002, BIOL J LINN SOC, V77, P355, DOI 10.1046/j.1095-8312.2002.00104.x	45	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0169911	10.1371/journal.pone.0169911	http://dx.doi.org/10.1371/journal.pone.0169911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235089	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200005
J	Vall-Ilosera, M; Cassey, P				Vall-Ilosera, Miquel; Cassey, Phillip			Leaky doors: Private captivity as a prominent source of bird introductions in Australia	PLOS ONE			English	Article							BIOLOGICAL INVASION RISK; PROPAGULE PRESSURE; WILDLIFE TRADE; ESTABLISHMENT; MANAGEMENT; PATTERNS; SUCCESS; PETS; RESPONSES; SELECTION	The international pet trade is a major source of emerging invasive vertebrate species. We used online resources as a novel source of information for accidental bird escapes, and we investigated the factors that influence the frequency and distribution of bird escapes at a continental scale. We collected information on over 5,000 pet birds reported to be missing on animal websites during the last 15 years in Australia. We investigated whether variables linked to pet ownership successfully predicted bird escapes, and we assessed the potential distribution of these escapes. Most of the reported birds were parrots (>90%), thus, we analysed factors associated with the frequency of parrot escapes. We found that bird escapes in Australia are much more frequent than previously acknowledged. Bird escapes were reported more frequently within, or around, large Australian capital cities. Socio-economic factors, such as the average personal income level of the community, and the level of human modification to the environment were the best predictors of bird escapes. Cheaper parrot species, Australian natives, and parrot species regarded as peaceful or playful were the most frequently reported escapees. Accidental introductions have been overlooked as an important source of animal incursions. Information on bird escapes is available online in many higher income countries and, in Australia, this is particularly apparent for parrot species. We believe that online resources may provide useful tools for passive surveillance for non-native pet species. Online surveillance will be particularly relevant for species that are highly reported, such as parrots, and species that are either valuable or highly commensal.	[Vall-Ilosera, Miquel] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; Univ Adelaide, Ctr Conservat Sci & Technol CCoST, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Vall-Ilosera, M (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	mvallosera@gmail.com	Vall-llosera, Miquel/AAM-8895-2020	Vall-llosera, Miquel/0000-0003-2644-2643; Cassey, Phillip/0000-0002-2626-0172	Invasive Animals Cooperative Research Centre [1.L.4]; Australian Research Council Future Fellow [FT0914420]; Australian Research Council Discovery Grant [DP140102319]	Invasive Animals Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council Future Fellow(Australian Research Council); Australian Research Council Discovery Grant(Australian Research Council)	MV was funded by the Invasive Animals Cooperative Research Centre (http://www invasiveanimals.com) (Project No. 1.L.4). PC was an Australian Research Council (http://www.arc. gov.au/) Future Fellow (FT0914420) and this work was supported by the Australian Research Council Discovery Grant (DP140102319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2015, DIVERS DISTRIB; Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; ALBERT A, 1988, J MARRIAGE FAM, V50, P543, DOI 10.2307/352019; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Anderson PK, 2003, SOC ANIM, V11, P393, DOI 10.1163/156853003322796109; Angulo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005215; Angulo E, 2009, P ROY SOC B-BIOL SCI, V276, P1331, DOI 10.1098/rspb.2008.1475; Animal Health Aliance, 2013, PET OWN AUSTR CANB A; Australian Birdkeeper, 2011, CLASS; Baker J, 2014, EMU, V114, P1, DOI 10.1071/MU12122; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Barton K., MUMIN MULTIMODEL INF; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Boehrer BT., 2010, PARROT CULTURE OUR 2; Bomford M, 2002, EMU, V102, P29, DOI 10.1071/MU01028; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; Cabezas S, 2013, BIOL INVASIONS, V15, P521, DOI 10.1007/s10530-012-0304-z; Cadi A, 2004, BIODIVERS CONSERV, V13, P2511, DOI 10.1023/B:BIOC.0000048451.07820.9c; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Carrete M, 2012, TRENDS ECOL EVOL, V27, P67, DOI 10.1016/j.tree.2011.11.011; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Cassey P, 2015, BIOL INVASIONS CHANG; Cassey P, 2015, BIOL CONSERV, V181, P18, DOI 10.1016/j.biocon.2014.10.023; Chapman T, 2007, 200 DEP AGR FOOD DEP; Chiron F, 2010, BIOL CONSERV, V143, P351, DOI 10.1016/j.biocon.2009.10.021; Chiron F, 2009, P ROY SOC B-BIOL SCI, V276, P47, DOI 10.1098/rspb.2008.0994; Clubb SL, 1998, J AM VET MED ASSOC, V212, P1243; Collar N.J., 1997, HDB BIRDS WORLD, V4, P280; Cooney R, 2006, ORYX, V40, P18, DOI 10.1017/S0030605306000056; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; DAFWA, 2007, AN PEST AL IND RINGN; Derraik JGB, 2010, BIOL INVASIONS, V12, P1477, DOI 10.1007/s10530-009-9595-0; DPIPWE, 2011, IMP KEEP BIRDS TASM; Drechsler M, 1998, BIOL CONSERV, V84, P283, DOI 10.1016/S0006-3207(97)00124-9; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Duncan RP, 2003, ANNU REV ECOL EVOL S, V34, P71, DOI 10.1146/annurev.ecolsys.34.011802.132353; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Engebretson M, 2006, ANIM WELFARE, V15, P263; Garcia-Diaz P, 2015, GLOBAL CHANGE BIOL, V21, P1078, DOI 10.1111/gcb.12790; Goss JR, 2013, FRONT ECOL ENVIRON, V11, P243, DOI 10.1890/120213; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Guo QF, 2010, DIVERS DISTRIB, V16, P1034, DOI 10.1111/j.1472-4642.2010.00708.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haythornthwaite C., 2005, Information Communication & Society, V8, P125, DOI 10.1080/13691180500146185; Henderson W, 2011, DETECTING PREVENTING; Henderson W, 2011, WILDLIFE RES, V38, P501, DOI 10.1071/WR11089; Higgins PJ, 1999, HDB AUSTR NEW ZEALAN, V4; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hulme PE, 2015, J APPL ECOL, V52, P1418, DOI 10.1111/1365-2664.12470; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Juniper T, 1998, PARROTS GUIDE PARROT; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kidd AH, 1998, PSYCHOL REP, V83, P131, DOI 10.2466/PR0.83.5.131-138; Kikillus KH, 2012, BIOL INVASIONS, V14, P2657, DOI 10.1007/s10530-012-0262-5; Kirkpatrick W, 2013, IMPORTING KEEPING IN; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Marsden SJ, 2015, IBIS, V157, P219, DOI 10.1111/ibi.12236; Mason G, 2013, ANIM BEHAV, V85, P1113, DOI 10.1016/j.anbehav.2013.02.002; McCowan LSC, 2014, BEHAV PROCESS, V107, P150, DOI 10.1016/j.beproc.2014.08.020; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Meenken D., 2012, CURRENT STATE DOMEST; Olah G, 2016, BIODIVERS CONSERV, V25, P205, DOI 10.1007/s10531-015-1036-z; Orme D., 2013, CAPER COMP ANAL PHYL; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pires SF, 2015, EUR J CRIM POLICY RE, V21, P151, DOI 10.1007/s10610-014-9246-6; Pires SF, 2012, GLOB CRIME, V13, P176, DOI 10.1080/17440572.2012.700180; Pires S, 2011, EUR J CRIM POLICY RE, V17, P101, DOI 10.1007/s10610-011-9141-3; Poole CM, 2016, SHADES GREY LEGAL TR; R Core Team, R LANG ENV STAT COMP; Robinson JM, 2001, ENVIRON CONSERV, V28, P76, DOI 10.1017/S0376892901000078; Romagosa CM., 2015, BIOL INVASIONS CHANG; SABLE P, 1995, SOC WORK, V40, P334; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Snyder Noel, 2000, PARROTS STATUS SURVE; Strubbe D, 2009, J BIOGEOGR, V36, P2264, DOI 10.1111/j.1365-2699.2009.02177.x; Su S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127482; Su S, 2014, BIOL INVASIONS, V16, P2563, DOI 10.1007/s10530-014-0686-1; The Avicultural Society of Australia Inc, 2012, GUID BIRD PRIC 2012; The Avicultural Society of Australia Inc, 2011, MEMB NOT BIRDS SAL W; The United Bird Societies of South Australia Inc, 2003, BIRD PRIC GUID; Tracey J., 2007, MANAGING BIRD DAMAGE; TRELA JE, 1972, SOCIOL QUART, V13, P244, DOI 10.1111/j.1533-8525.1972.tb00808.x; Vall-llosera M, IMPROVED SURVEILLANC; Vall-Llosera M, 2017, ECOL ECON, V131, P407, DOI 10.1016/j.ecolecon.2016.07.015; Vall-llosera M, 2009, J APPL ECOL, V46, P787, DOI 10.1111/j.1365-2664.2009.01674.x; van Wilgen NJ, 2010, ANIM CONSERV, V13, P24, DOI 10.1111/j.1469-1795.2009.00298.x; Vidovic VV, 1999, ANTHROZOOS, V12, P211, DOI 10.2752/089279399787000129; Williams J. M., 2010, ED HLTH, V28, P12; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wilson A., 2011, EXOTIC PEST BIRDS CU	103	20	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172851	10.1371/journal.pone.0172851	http://dx.doi.org/10.1371/journal.pone.0172851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235000	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200152
J	Watanabe, M; Shimazu, A; Bakker, AB; Demerouti, E; Shimada, K; Kawakami, N				Watanabe, Mayumi; Shimazu, Akihito; Bakker, Arnold B.; Demerouti, Evangelia; Shimada, Kyoko; Kawakami, Norito			The impact of job and family demands on partner's fatigue: A study of Japanese dual-earner parents	PLOS ONE			English	Article							WORK ENGAGEMENT; GENDER-DIFFERENCES; CROSSOVER; COUPLES; STRESS; SPILLOVER; EXHAUSTION; RESOURCES; CONFLICT; DISTRESS	Objectives This study of Japanese dual-earner couples examined the impact of family and job demands on one's own and one's partner's fatigue as well as gender differences in these effects. Methods A total of 2,502 parents (1,251 couples) were surveyed using a self-administered questionnaire. A crossover model was tested using structural equation modeling. Results The results of structural equation modeling analyses showed that both job and family demands independently exacerbated fatigue. There was an indirect effect of job and family demands on partner fatigue through one's own fatigue only from husbands to wives. An indirect effect of job demands on partner fatigue through partner's family demands was identified only from wives to husbands. Furthermore, there were gender differences in the crossover of fatigue. Conclusions This study shows that job and family demands influence family circumstances. When considering means to reduce employees' fatigue, gender differences in the mechanism of fatigue need to be taken into account.	[Watanabe, Mayumi] Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan; [Shimazu, Akihito; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Bakker, Arnold B.] Erasmus Univ, Ctr Excellence Posit Org Psychol, Rotterdam, Netherlands; [Bakker, Arnold B.; Demerouti, Evangelia] Univ Johannesburg, Dept Management, Auckland Pk, South Africa; [Demerouti, Evangelia] Eindhoven Univ Technol, Dept Ind Engn & Innovat Sci, Eindhoven, Netherlands; [Shimada, Kyoko] Toyo Univ, Fac Sociol, Tokyo, Japan	Keio University; University of Tokyo; Erasmus University Rotterdam; University of Johannesburg; Eindhoven University of Technology; Toyo University	Watanabe, M (corresponding author), Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan.	yamam00@sfc.keio.ac.jp	Demerouti, E/AAD-1334-2019; Bakker, Arnold B./F-8494-2010	Demerouti, E/0000-0002-4615-6532; Bakker, Arnold B./0000-0003-1489-1847; Shimazu, Akihito/0000-0002-7172-0043	Ministry of Education, Culture, Sports, Science and Technology, Japan [19700536]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (Grant-in-Aid for Young Scientists) 2007-2009 (No.19700536) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-19700536/. AS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AB, 2005, HUM RELAT, V58, P661, DOI 10.1177/0018726705055967; Bakker AB, 2014, ANNU REV ORGAN PSYCH, V1, P389, DOI 10.1146/annurev-orgpsych-031413-091235; Bakker AB, 2013, CURR ISS WORK ORGAN, P54; Bakker AB, 2011, J OCCUP HEALTH PSYCH, V16, P112, DOI 10.1037/a0021297; Bakker AB, 2009, J MANAGE PSYCHOL, V24, P206, DOI 10.1108/02683940910939304; Bakker AB, 2008, J APPL PSYCHOL, V93, P901, DOI 10.1037/0021-9010.93.4.901; Bakker AB, 2009, J MANAGE PSYCHOL, V24, P220, DOI 10.1108/02683940910939313; Bekker MHJ, 2005, WORK STRESS, V19, P221, DOI 10.1080/02678370500286095; BOLGER N, 1989, J MARRIAGE FAM, V51, P175, DOI 10.2307/352378; Demerouti E, 2005, J VOCAT BEHAV, V67, P266, DOI 10.1016/j.jvb.2004.07.001; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2011, SA J IND PSYCHOL, DOI [10.4102/sajip.v37i2.974., DOI 10.4102/sajip.v37i2.974, 10.4102/ajip.v37i2.974]; Frone MR, 2000, J APPL PSYCHOL, V85, P888, DOI 10.1037//0021-9010.85.6.888; Furda J., 1995, THESIS; Gorgievski-Duijvesteijn M J, 2000, J Occup Health Psychol, V5, P359, DOI 10.1037/1076-8998.5.3.359; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hammer LB, 1997, J VOCAT BEHAV, V50, P185, DOI 10.1006/jvbe.1996.1557; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JACKSON SE, 1982, J OCCUP BEHAV, V3, P63, DOI 10.1002/job.4030030106; JONES F, 1993, HUM RELAT, V46, P881, DOI 10.1177/001872679304600705; Kenny D. A., 2006, DYADIC DATA ANAL; Lambrecht L, 2014, COGNITION EMOTION, V28, P452, DOI 10.1080/02699931.2013.837378; Lee KS, 2008, SOC SCI RES, V37, P1216, DOI 10.1016/j.ssresearch.2008.02.005; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Ministry of Internal Affairs and Communications, 2011, SURV TIM US LEIS ACT; Morrison DL, 1997, J OCCUP ORGAN PSYCH, V70, P307, DOI 10.1111/j.2044-8325.1997.tb00651.x; Mulder G., 1998, HDB WORK ORG PSYCHOL; Murdock KW, 2014, FAM PROCESS, V53, P120, DOI 10.1111/famp.12059; Muthen B., 2010, MPLUS USERS GUIDE; PARASURAMAN S, 1992, J ORGAN BEHAV, V13, P339, DOI 10.1002/job.4030130403; Peeters M.C., 2005, INT J STRESS MANAGE, V12, P43, DOI DOI 10.1037/1072-5245.12.1.43; Pittman JF, 1996, J MARRIAGE FAM, V58, P456, DOI 10.2307/353509; SCHAUBROECK J, 1990, J ORGAN BEHAV, V11, P17, DOI 10.1002/job.4030110105; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Shimada K, 2010, J OCCUP HEALTH, V52, P335, DOI 10.1539/joh.L9130; Shimazu A, 2011, SOC SCI MED, V73, P399, DOI 10.1016/j.socscimed.2011.05.049; Shimazu A, 2009, J OCCUP HEALTH, V51, P239, DOI 10.1539/joh.L8160; Shimomitsu T., 1998, REPORT RES GRANT PRE, P107; Sluiter JK, 2003, OCCUP ENVIRON MED, V60, P62; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; ten Brummelhuis LL, 2010, WORK STRESS, V24, P324, DOI 10.1080/02678373.2010.533553; ten Brummelhuis LL, 2008, J VOCAT BEHAV, V73, P387, DOI 10.1016/j.jvb.2008.07.006; Urmakshinova E., 2015, ARCTIC DIALOGUE GLOB, P487; Westman M, 2005, J APPL SOC PSYCHOL, V35, P1936, DOI 10.1111/j.1559-1816.2005.tb02203.x; WESTMAN M, 1995, J ORGAN BEHAV, V16, P169, DOI 10.1002/job.4030160207; Westman M, 2004, J APPL PSYCHOL, V89, P769, DOI 10.1037/0021-9010.89.5.769; Westman M, 2001, HUM RELAT, V54, P717, DOI 10.1177/0018726701546002; Westman M, 1998, HUM RELAT, V51, P137, DOI 10.1023/A:1016910118568; Wong CS, 1999, ORGAN RES METHODS, V2, P69, DOI 10.1177/109442819921005	51	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172291	10.1371/journal.pone.0172291	http://dx.doi.org/10.1371/journal.pone.0172291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235008	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200064
J	Formanowicz, D; Radom, M; Zawierucha, P; Formanowicz, P				Formanowicz, Dorota; Radom, Marcin; Zawierucha, Piotr; Formanowicz, Piotr			Petri net-based approach to modeling and analysis of selected aspects of the molecular regulation of angiogenesis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; NITRIC-OXIDE; ENDOTHELIAL-CELLS; BINDING; INVARIANTS; PATHWAYS; MONALISA	The functioning of both normal and pathological tissues depends on an adequate supply of oxygen through the blood vessels. A process called angiogenesis, in which new endothelial cells and smooth muscles interact with each other, forming new blood vessels either from the existing ones or from a primary vascular plexus, is particularly important and interesting, due to new therapeutic possibilities it offers. This is a multi-step and very complex process, so an accurate understanding of the underlying mechanisms is a significant task, especially in recent years, with the constantly increasing amount of new data that must be taken into account. A systems approach is necessary for these studies because it is not sufficient to analyze the properties of the building blocks separately and an analysis of the whole network of interactions is essential. This approach is based on building a mathematical model of the system, while the model is expressed in the formal language of a mathematical theory. Recently, the theory of Petri nets was shown to be especially promising for the modeling and analysis of biological phenomena. This analysis, based mainly on t-invariants, has led to a particularly important finding that a direct link (close connection) exist between transforming growth factor beta 1 (TGF-beta 1), endothelial nitric oxide synthase (eNOS), nitric oxide (NO), and hypoxia-inducible factor 1, the molecules that play a crucial roles during angiogenesis. We have shown that TGF-beta 1 may participate in the inhibition of angiogenesis through the upregulation of eNOS expression, which is responsible for catalyzing NO production. The results obtained in the previous studies, concerning the effects of NO on angiogenesis, have not been conclusive, and therefore, our study may contribute to a better understanding of this phenomenon.	[Formanowicz, Dorota] Poznan Univ Med Sci, Dept Clin Biochem & Lab Med, Grunwaldzka 6, PL-60780 Poznan, Poland; [Radom, Marcin; Formanowicz, Piotr] Poznan Univ Tech, Inst Comp Sci, Piotrowo 2, PL-60965 Poznan, Poland; [Zawierucha, Piotr] Poznan Univ Med Sci, Dept Histol & Embryol, Swiecickiego 6 St, PL-61781 Poznan, Poland; [Zawierucha, Piotr] Poznan Univ Med Sci, Dept Anat, Swiecickiego 6, PL-61781 Poznan, Poland; [Radom, Marcin; Formanowicz, Piotr] Polish Acad Sci, Inst Bioorgan Chem, Z Noskowskiego 12-14, PL-61704 Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Technology; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Formanowicz, P (corresponding author), Poznan Univ Tech, Inst Comp Sci, Piotrowo 2, PL-60965 Poznan, Poland.; Formanowicz, P (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Z Noskowskiego 12-14, PL-61704 Poznan, Poland.	piotr@cs.put.poznan.pl	Radom, Marcin/G-9534-2013; Radom, Marcin/AAJ-6958-2020; Formanowicz, Piotr/M-3606-2014; Formanowicz, Dorota/V-3901-2019	Radom, Marcin/0000-0002-4174-7069; Radom, Marcin/0000-0002-4174-7069; Formanowicz, Piotr/0000-0003-2719-3677; Formanowicz, Dorota/0000-0001-6691-3863; Zawierucha, Piotr/0000-0001-9087-3080	National Science Centre (Poland) [2012/07/6/ST6/01537]	National Science Centre (Poland)(National Science Centre, Poland)	This research has been supported by the National Science Centre (Poland) grant No. 2012/07/6/ST6/01537 (DF, MR, PF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazki P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0596-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Cordero F, 2011, THEOR COMPUT SCI, V412, P6036, DOI 10.1016/j.tcs.2011.06.013; David R, 2010, DISCRETE, CONTINUOUS, AND HYBRID PETRI NETS, SECOND EDITION, P1, DOI 10.1007/978-3-642-10669-9; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Einloft J, 2013, BIOINFORMATICS, V29, P1469, DOI 10.1093/bioinformatics/btt165; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Formanowicz D, 2015, SCI REP-UK, V5, DOI 10.1038/srep18332; Formanowicz D, 2013, J BIOMED INFORM, V46, P1030, DOI 10.1016/j.jbi.2013.07.013; Formanowicz D, 2011, BIOPROC BIOSYST ENG, V34, P581, DOI 10.1007/s00449-010-0507-6; FORMANOWICZ P, 2011, BIOTECHNOLOGIA, V92, P217; Goligorsky MS, 1999, CLIN EXP PHARMACOL P, V26, P269, DOI 10.1046/j.1440-1681.1999.03029.x; Grafahrend-Belau E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-90; Stefanie G, 2008, BIOSYSTEMS, V92, P189, DOI 10.1016/j.biosystems.2008.02.005; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hashimoto T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00033; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Hendrickson MD, 2015, RES REP BIOCHEM, V5, P147, DOI 10.2147/RRBC.S58280; Herrmann J, 2006, ARTERIOSCL THROM VAS, V26, P1948, DOI 10.1161/01.ATV.0000233387.90257.9b; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jain A., 1988, ALGORITHMS CLUSTERIN; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Kaufman L., 1990, FINDING GROUPS DATA; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Klipp Edda, 2009, SYSTEMS BIOL TXB; Koch I, 2011, COMPUT BIOL SER, V16, P3, DOI 10.1007/978-1-84996-474-6_1; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Matsuno H, 2006, IEICE T FUND ELECTR, VE89A, P3166, DOI 10.1093/ietfec/e89-a.11.3166; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Napione L, 2009, LECT N BIOINFORMAT, V5688, P281, DOI 10.1007/978-3-642-03845-7_19; Paik JY, 2005, J NUCL MED, V46, P365; Petri CA, 1962, COMMUNICATION, V3, P16; Raju Rajesh, 2014, J Signal Transduct, V2014, P962962, DOI 10.1155/2014/962962; Reisig W., 1985, PETRI NETS INTRO, DOI [10.1007/978-3-642-69968-9, DOI 10.1007/978-3-642-69968-9]; Reising W, 2013, UNDERSTANDING PETRI; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Szallasi Z, 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Trane AE, 2014, J BIOL CHEM, V289, P13273, DOI 10.1074/jbc.M113.528695; Winder K., 2006, THESIS; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X	53	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173020	10.1371/journal.pone.0173020	http://dx.doi.org/10.1371/journal.pone.0173020			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253310	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300059
J	Jensen, JK; Wilkerson, CG				Jensen, Jacob Kruger; Wilkerson, Curtis Gene			Brachypodium as an experimental system for the study of stem parenchyma biology in grasses	PLOS ONE			English	Article							CARBOHYDRATE STORAGE; FLOWERING TIME; STARCH; WHEAT; MOBILIZATION; DEPOSITION; BARLEY; CULM; YIELD	Stem parenchyma is a major cell type that serves key metabolic functions for the plant especially in large grasses, such as sugarcane and sweet sorghum, where it serves to store sucrose or other products of photosynthesis. It is therefore desirable to understand the metabolism of this cell type as well as the mechanisms by which it provides its function for the rest of the plant. Ultimately, this information can be used to selectively manipulate this cell type in a controlled manner to achieve crop improvement. In this study, we show that Brachypodium distachyon is a useful model system for stem pith parenchyma biology. Brachypodium can be grown under condition where it resembles the growth patterns of important crops in that it produces large amounts of stem material with the lower leaves senescing and with significant stores of photosynthate located in the stem parenchyma cell types. We further characterize stem plastid morphology as a function of tissue types, as this organelle is central for a number of metabolic pathways, and quantify gene expression for the four main classes of starch biosynthetic genes. Notably, we find several of these genes differentially regulated between stem and leaf. These studies show, consistent with other grasses, that the stem functions as a specialized storage compartment in Brachypodium.	[Jensen, Jacob Kruger; Wilkerson, Curtis Gene] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Jensen, Jacob Kruger; Wilkerson, Curtis Gene] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Wilkerson, Curtis Gene] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University	Wilkerson, CG (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Wilkerson, CG (corresponding author), Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.; Wilkerson, CG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	wilker13@msu.edu		Jensen, Jacob K/0000-0003-0502-2383	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494; http://science.energy.gov/ber/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Bonnett GD, 1992, ANN BOT; BORRELL AK, 1993, ANN BOT-LONDON, V71, P317, DOI 10.1006/anbo.1993.1041; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cooper GM, 2000, CELL MOL APPROACH; Dockter C, 2015, J EXP BOT, V66, P3499, DOI 10.1093/jxb/eru521; Gale SY, 1985, PROGR PLANT BREEDING; McCormick AJ, 2009, J EXP BOT, V60, P357, DOI 10.1093/jxb/ern310; McKinley B, 2016, PLANT J; O'Neill BP, 2013, BIOSCI BIOTECH BIOCH, V77, P487, DOI 10.1271/bbb.120682; Ream TS, 2014, PLANT PHYSIOL, V164, P694, DOI 10.1104/pp.113.232678; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Schwartz CJ, 2010, BIOENERG RES, V3, P38, DOI 10.1007/s12155-009-9069-3; Scofield GN, 2009, ANN BOT-LONDON, V103, P859, DOI 10.1093/aob/mcp010; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Tanackovic V, 2014, J EXP BOT, V65, P5179, DOI 10.1093/jxb/eru276; Tuncel A, 2013, PLANT SCI, V211, P52, DOI 10.1016/j.plantsci.2013.06.009; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Tyler L, 2016, PLANT GENOME, V9, P2; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Watt D.A., 2013, SUGARCANE PHYSL BIOC, P483, DOI DOI 10.1002/9781118771280.CH18; Wu LG, 2007, PLANT BIOTECHNOL J, V5, P109, DOI 10.1111/j.1467-7652.2006.00224.x; Xue GP, 2011, PLANT J, V68, P857, DOI 10.1111/j.1365-313X.2011.04737.x	32	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173095	10.1371/journal.pone.0173095	http://dx.doi.org/10.1371/journal.pone.0173095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248997	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500074
J	Martin, R; Cordova, C; Gutierrez, B; Hernandez, M; Nieto, ML				Martin, Ruben; Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.			A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells	PLOS ONE			English	Article							SECRETORY PHOSPHOLIPASE A(2); GROWTH-FACTOR RECEPTOR; ESOPHAGEAL ADENOCARCINOMA CELLS; TYPE-2 DIABETES-MELLITUS; PANCREATIC BETA-CELLS; BREAST-CANCER CELLS; PROTEIN PHOSPHATASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; BODY-WEIGHT	Glioblastoma, the most aggressive type of primary brain tumour, shows worse prognosis linked to diabetes or obesity persistence. These pathologies are chronic inflammatory conditions characterized by altered profiles of inflammatory mediators, including leptin and secreted phospholipase A(2)-IIA (sPLA(2)-IIA). Both proteins, in turn, display diverse pro-cancer properties in different cell types, including astrocytes. Herein, to understand the underlying relationship between obesity and brain tumors, we investigated the effect of leptin, alone or in combination with sPLA(2)-IIA on astrocytoma cell functions. sPLA(2)-IIA induced up-regulation of leptin receptors in 1321N1 human astrocytoma cells. Leptin, as well as sPLA(2)-IIA, increased growth and migration in these cells, through activation/phosphorylation of key proteins of survival cascades. Leptin, at concentrations with minimal or no activating effects on astrocytoma cells, enhanced growth and migration promoted by low doses of sPLA(2)-IIA. sPLA(2)-IIA alone induced a transient phosphorylation pattern in the Src/ERK/Akt/mTOR/p70S6K/rS6 pathway through EGFR transactivation, and co-addition of leptin resulted in a sustained phosphorylation of these signaling regulators. Mechanistically, EGFR transactivation and tyrosine-and serine/threonine-protein phosphatases revealed a key role in this leptin-sPLA(2)-IIA cross-talk. This cooperative partnership between both proteins was also found in primary astrocytes. These findings thus indicate that the adipokine leptin, by increasing the susceptibility of cells to inflammatory mediators, could contribute to worsen the prognosis of tumoral and neurodegenerative processes, being a potential mediator of some obesity- related medical complications.	[Martin, Ruben; Cordova, Claudia; Gutierrez, Beatriz; Hernandez, Marita; Nieto, Maria L.] UVa, CSIC, IBGM, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Nieto, ML (corresponding author), UVa, CSIC, IBGM, Valladolid, Spain.	mlnieto@ibgm.uva.es	Nieto, Maria L/G-7492-2015; hernández, marita/H-6122-2015	Nieto, Maria L/0000-0001-6842-799X; hernández, marita/0000-0002-3999-5653; Cordova Marcos, Claudia/0000-0002-2108-2629	FPI Program from the Autonomous Government of Castilla y Leon; FSE; Spanish Ministry of Science and Innovation [SAF2009-08407, SAF2016-81063]	FPI Program from the Autonomous Government of Castilla y Leon; FSE(European Social Fund (ESF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the FPI Program from the Autonomous Government of Castilla y Leon (to RM and CC) co-funded by FSE, and by the Spanish Ministry of Science and Innovation (grant SAF2009-08407 and SAF2016-81063).	Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Beales ILP, 2007, MOL CELL ENDOCRINOL, V274, P60, DOI 10.1016/j.mce.2007.05.017; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chambless LB, 2012, J NEURO-ONCOL, V106, P383, DOI 10.1007/s11060-011-0676-4; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Dong ZY, 2010, CARCINOGENESIS, V31, P1948, DOI 10.1093/carcin/bgq188; Eikelis N, 2004, AM J PHYSIOL-ENDOC M, V286, pE744, DOI 10.1152/ajpendo.00489.2003; Esler M, 1998, LANCET, V351, P879, DOI 10.1016/S0140-6736(05)70289-0; Ferla R, 2012, ONCOL LETT, V4, P1077, DOI 10.3892/ol.2012.843; Fiorio E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-305; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Gouwy M, 2002, MOL PHARMACOL, V62, P173, DOI 10.1124/mol.62.1.173; Han GS, 2012, BRAIN RES BULL, V87, P274, DOI 10.1016/j.brainresbull.2011.11.007; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Heldsinger A, 2011, J BIOL CHEM, V286, P11707, DOI 10.1074/jbc.M110.198945; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Hernandez M, 2010, NEURO-ONCOLOGY, V12, P1014, DOI 10.1093/neuonc/noq078; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Konukoglu D, 2007, OBES SURG, V17, P672, DOI 10.1007/s11695-007-9113-3; Kuehnen P, 2011, ENDOCRINOLOGY, V152, P1800, DOI 10.1210/en.2010-1094; Kupert E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-513; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu JC, 2009, MOL PHARMACOL, V76, P1186, DOI 10.1124/mol.109.058297; Tusell JM, 2009, GLIA, V57, P524, DOI 10.1002/glia.20781; Menschikowski M, 2013, PATHOL ONCOL RES, V19, P839, DOI 10.1007/s12253-013-9652-y; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Ogunwobi OO, 2008, BRIT J BIOMED SCI, V65, P121, DOI 10.1080/09674845.2008.11732814; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; Otero M, 2007, LIFE SCI, V81, P1452, DOI 10.1016/j.lfs.2007.09.007; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Riolfi M, 2010, BRAIN PATHOL, V20, P481, DOI 10.1111/j.1750-3639.2009.00323.x; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Soma D, 2008, J SURG RES, V149, P9, DOI 10.1016/j.jss.2007.10.012; SOZZANI S, 1994, BIOCHEM BIOPH RES CO, V199, P761, DOI 10.1006/bbrc.1994.1294; Umemoto Y, 1997, BLOOD, V90, P3438, DOI 10.1182/blood.V90.9.3438; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Wang L, 2011, BONE, V48, P1022, DOI 10.1016/j.bone.2011.02.012; Wang X, 2013, HUM PATHOL, V44, P2020, DOI 10.1016/j.humpath.2013.01.027; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773	51	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170675	10.1371/journal.pone.0170675	http://dx.doi.org/10.1371/journal.pone.0170675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249041	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500006
J	Poffenbarger, HJ; Barker, DW; Helmers, MJ; Miguez, FE; Olk, DC; Sawyer, JE; Six, J; Castellano, MJ				Poffenbarger, Hanna J.; Barker, Daniel W.; Helmers, Matthew J.; Miguez, Fernando E.; Olk, Daniel C.; Sawyer, John E.; Six, Johan; Castellano, Michael J.			Maximum soil organic carbon storage in Midwest US cropping systems when crops are optimally nitrogen-fertilized	PLOS ONE			English	Article							RESIDUE DECOMPOSITION; CEREAL PRODUCTION; GLOBAL DILEMMA; NO-TILLAGE; CORN; MATTER; QUALITY; STABILIZATION; MANAGEMENT; DYNAMICS	Nitrogen fertilization is critical to optimize short-term crop yield, but its long-term effect on soil organic C (SOC) is uncertain. Here, we clarify the impact of N fertilization on SOC in typical maize-based (Zea mays L.) Midwest U.S. cropping systems by accounting for site-to-site variability in maize yield response to N fertilization. Within continuous maize and maize-soybean [Glycine max (L.) Merr.] systems at four Iowa locations, we evaluated changes in surface SOC over 14 to 16 years across a range of N fertilizer rates empirically determined to be insufficient, optimum, or excessive for maximum maize yield. Soil organic C balances were negative where no N was applied but neutral (maize-soybean) or positive (continuous maize) at the agronomic optimum N rate (AONR). For continuous maize, the rate of SOC storage increased with increasing N rate, reaching a maximum at the AONR and decreasing above the AONR. Greater SOC storage in the optimally fertilized continuous maize system than in the optimally fertilized maize-soybean system was attributed to greater crop residue production and greater SOC storage efficiency in the continuous maize system. Mean annual crop residue production at the AONR was 22% greater in the continuous maize system than in the maize-soybean system and the rate of SOC storage per unit residue C input was 58% greater in the monocrop system. Our results demonstrate that agronomic optimum N fertilization is critical to maintain or increase SOC of Midwest U.S. cropland.	[Poffenbarger, Hanna J.; Barker, Daniel W.; Miguez, Fernando E.; Sawyer, John E.; Castellano, Michael J.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Helmers, Matthew J.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Olk, Daniel C.] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA; [Six, Johan] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Poffenbarger, HJ (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	hpoffenb@iastate.edu	six, johan/J-5228-2015; Castellano, Michael J/A-9687-2008	six, johan/0000-0001-9336-4185; Castellano, Michael J/0000-0003-1411-7931	United States Department of Agriculture National Institute of Food and Agriculture [2014-67019-21629]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture National Institute of Food and Agriculture grant number 2014-67019-21629 to MJC, DCO, JES and JS, https://nifa.usda.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NAT COORD MAJ LAND R; Barrett JE, 2002, ECOL APPL, V12, P878, DOI 10.1890/1051-0761(2002)012[0878:NRISEA]2.0.CO;2; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; Brown KH, 2014, GLOBAL CHANGE BIOL, V20, P1339, DOI 10.1111/gcb.12519; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Castellano MJ, 2015, GLOBAL CHANGE BIOL, V21, P3200, DOI 10.1111/gcb.12982; CERRATO ME, 1990, AGRON J, V82, P138, DOI 10.2134/agronj1990.00021962008200010030x; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Clapp CE, 2000, SOIL TILL RES, V55, P127, DOI 10.1016/S0167-1987(00)00110-0; COLE CV, 1993, WATER AIR SOIL POLL, V70, P357, DOI 10.1007/BF01105007; David MB, 2009, J ENVIRON QUAL, V38, P200, DOI 10.2134/jeq2008.0132; Fonte SJ, 2009, SOIL SCI SOC AM J, V73, P961, DOI 10.2136/sssaj2008.0204; Gardner JB, 2009, ECOL APPL, V19, P2167, DOI 10.1890/08-1122.1; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P1065, DOI 10.2136/sssaj1995.03615995005900040016x; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Gregorich EG, 1996, SOIL SCI SOC AM J, V60, P472, DOI 10.2136/sssaj1996.03615995006000020019x; Gregorich EG, 2001, CAN J SOIL SCI, V81, P21, DOI 10.4141/S00-041; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Hong N, 2007, J ENVIRON QUAL, V36, P354, DOI 10.2134/jeq2006.0173; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Huggins DR, 2007, SOIL SCI SOC AM J, V71, P145, DOI 10.2136/sssaj2005.0231; Iowa State University, 2016, IOW ENV MES; Johnson JMF, 2006, AGRON J, V98, P622, DOI 10.2134/agronj2005.0179; KASPAR TC, 1990, SOIL SCI SOC AM J, V54, P1112, DOI 10.2136/sssaj1990.03615995005400040032x; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Lawlor PA, 2008, T ASABE, V51, P83, DOI 10.13031/2013.24229; Lorenz AJ, 2010, CROP SCI, V50, P1, DOI 10.2135/cropsci2009.02.0086; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; National Agricultural Statistics Service, 2015, QUICK STATS DAT; Nehring R, 2013, FERTILIZER USE PRICE; Nieder R, 2011, BIOL FERT SOILS, V47, P1, DOI 10.1007/s00374-010-0506-4; Olson KR, 2005, SOIL TILL RES, V81, P217, DOI 10.1016/j.still.2004.09.009; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Paul EA, 2016, SOIL BIOL BIOCHEM, V98, P109, DOI 10.1016/j.soilbio.2016.04.001; Powlson DS, 2010, J ENVIRON QUAL, V39, P749, DOI 10.2134/jeq2010.0001le; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; PRISM Climate, 2016, 1981 2010 CLIM NORM; Puntel LA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01630; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Russell AE, 2009, ECOL APPL, V19, P1102, DOI 10.1890/07-1919.1; Sanford GR, 2012, AGR ECOSYST ENVIRON, V162, P68, DOI 10.1016/j.agee.2012.08.011; Sawyer J.E., 2006, CONCEPTS RATIONALE R; Schlesinger WH, 2000, AGR ECOSYST ENVIRON, V82, P121, DOI 10.1016/S0167-8809(00)00221-8; Stevens WB, 2005, AGRON J, V97, P1046, DOI 10.2134/agronj2003.0313; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; U.S. Environmental Protection Agency, 2014, INV US GREENH GAS EM; U. S. Soil Survey, 1998, MOLL MAP; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Varvel GE, 2006, SOIL SCI SOC AM J, V70, P426, DOI 10.2136/sssaj2005.0100; Weil RR, 2004, ADV AGROECOL, P1; Williams CL, 2008, CROP SCI, V48, P1545, DOI 10.2135/cropsci2006.12.0837; Zhao X, 2016, FIELD CROP RES, V199, P156, DOI 10.1016/j.fcr.2016.07.015	54	83	84	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172293	10.1371/journal.pone.0172293	http://dx.doi.org/10.1371/journal.pone.0172293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249014	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500035
J	Gibson, N; Prober, S; Meissner, R; van Leeuwen, S				Gibson, Neil; Prober, Suzanne; Meissner, Rachel; van Leeuwen, Stephen			Implications of high species turnover on the south-western Australian sandplains	PLOS ONE			English	Article							BETA-DIVERSITY; PLANT DIVERSITY; RANGE SIZE; BIODIVERSITY; PATTERNS; VEGETATION; CLIMATE; COEXISTENCE; SHRUBLANDS; COMPONENTS	Species turnover and its components related to replacement and nestedness form a significant element of diversity that is historically poorly accounted for in conservation planning. To inform biodiversity conservation and contribute to a broader understanding of patterns in species turnover, we undertook a floristic survey of 160 plots along an 870 km transect across oligotrophic sandplains, extending from the mesic south coast to the arid interior of south-western Australia. A nested survey design was employed to sample distances along the transect as evenly as possible. Species turnover was correlated with geographic distance at both regional and local scales, consistent with dispersal limitation being a significant driver of species turnover. When controlled for species richness, species replacement was found to be the dominant component of species turnover and was uniformly high across the transect, uncorrelated with either climatic or edaphic factors. This high replacement rate, well documented in the mega-diverse south-west, appears to also be a consistent feature of arid zone vegetation systems despite a decrease in overall species richness. Species turnover increased rapidly with increasing extent along the transect reaching an asymptote at ca. 50 km. These findings are consistent with earlier work in sandplain and mallee vegetation in the south-west and suggests reserve based conservation strategies are unlikely to be practicable in the south-western Australia sandplains when communities are defined by species incidence rather than dominance.	[Gibson, Neil; Meissner, Rachel; van Leeuwen, Stephen] Western Australian Dept Pk & Wildlife, Sci & Conservat Div, Kensington, WA, Australia; [Gibson, Neil] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Prober, Suzanne] CSIRO, Land & Water Flagship, Wembley, WA, Australia; [Meissner, Rachel; van Leeuwen, Stephen] Univ Adelaide, Terr Ecosyst Res Network, Australian Transect Network, Adelaide, SA 5005, Australia	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Gibson, N (corresponding author), Western Australian Dept Pk & Wildlife, Sci & Conservat Div, Kensington, WA, Australia.; Gibson, N (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	Neil.Gibson@dpaw.wa.gov.au	Prober, Suzanne/G-6465-2010	Prober, Suzanne/0000-0002-6518-239X; van Leeuwen, Stephen/0000-0003-3063-7785	Australian Transect Network, a facility of Australia's Terrestrial Ecosystem Research Network	Australian Transect Network, a facility of Australia's Terrestrial Ecosystem Research Network	Significant funding was received (SVL) from the Australian Transect Network, a facility of Australia's Terrestrial Ecosystem Research Network (http://www.tem.org.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello-Lammens ME, 2016, ECOGRAPHY IN PRESS; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Barwell LJ, 2015, J ANIM ECOL, V84, P1112, DOI 10.1111/1365-2656.12362; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2013, ECOGRAPHY, V36, P124, DOI 10.1111/j.1600-0587.2012.00124.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; BEARD JS, 1984, KWONGAN PLANT LIFE S, P1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brendonck L, 2015, OIKOS, V124, P741, DOI 10.1111/oik.01710; BROWN JM, 1983, AUST J ECOL, V8, P63, DOI 10.1111/j.1442-9993.1983.tb01519.x; Bureau of Meteorology, 2016, AUSTR CLIM AV RAINF; BURGMAN MA, 1988, AUST J ECOL, V13, P415, DOI 10.1111/j.1442-9993.1988.tb00990.x; Cahill DM, 2008, AUST J BOT, V56, P279, DOI 10.1071/BT07159; Carpenter RJ, 2015, AM J BOT, V102, P2092, DOI 10.3732/ajb.1500343; Chase JM, 2014, J VEG SCI, V25, P319, DOI 10.1111/jvs.12159; Coates D. J, 1997, CONSERVATION OUTSIDE, P432; Cook LG, 2015, NEW PHYTOL, V207, P390, DOI 10.1111/nph.13199; Cowling RM, 2015, J BIOGEOGR, V42, P552, DOI 10.1111/jbi.12429; COWLING RM, 1994, J BIOGEOGR, V21, P651, DOI 10.2307/2846038; COWLING RM, 1983, VEGETATIO, V54, P103, DOI 10.1007/BF00035145; Diels L., 1906, PFLANZENWELT W AUSTR; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fitzpatrick MC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1201; Gallagher RV, 2016, J BIOGEOGR, V43, P1287, DOI 10.1111/jbi.12711; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; Gibson N, 2015, GEOSSISTEMAS FERRUGI, P361; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hijmans R. J., 2013, GEOSPHERE SPHERICAL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HNATIUK RJ, 1981, AUST J ECOL, V6, P423, DOI 10.1111/j.1442-9993.1981.tb01496.x; HOPPER SD, 1979, ANNU REV ECOL SYST, V10, P399, DOI 10.1146/annurev.es.10.110179.002151; Hopper SD, 2016, PLANT SOIL, V403, P167, DOI 10.1007/s11104-015-2764-2; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Jones MM, 2016, J BIOGEOGR, V43, P289, DOI 10.1111/jbi.12628; Jupp T, 2015, RANGELAND J, V37, P571, DOI 10.1071/RJ15047; Laliberte E, 2014, SCIENCE, V345, P1602, DOI 10.1126/science.1256330; Lambers H., 2014, PLANT LIFE SANDPLAIN, P3; LAMONT BB, 1989, OIKOS, V56, P39, DOI 10.2307/3566085; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Main A.R., 1982, P163; Manion G., 2016, GDM FUNCTIONS GEN DI; Meissner Rachel, 2010, Conservation Science Western Australia, V7, P605; Merwin L, 2012, J BIOGEOGR, V39, P397, DOI 10.1111/j.1365-2699.2011.02614.x; Pebesma Edzer, 2016, SP CLASSES METHODS S; Perry GLW, 2009, OIKOS, V118, P1349, DOI 10.1111/j.1600-0706.2009.17096.x; Podani J, 2016, ECOL INFORM, V32, P63, DOI 10.1016/j.ecoinf.2016.01.002; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; R Core, 2013, R LANG ENV STAT COMP; Richards MB, 1997, PLANT ECOL, V130, P143, DOI 10.1023/A:1009742225383; Sander J, 2011, J VEG SCI, V22, P766, DOI 10.1111/j.1654-1103.2011.01293.x; Si X, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0132708; SPECHT RL, 1988, MEDITERRANEAN TYPE E; Thuiller W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000938; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Ulrich W, 2014, J BIOGEOGR, V41, P2307, DOI 10.1111/jbi.12377; Vellend M, 2014, OIKOS, V123, P1420, DOI 10.1111/oik.01493; Wardell-Johnson G, 2016, RESTOR ECOL, V24, P805, DOI 10.1111/rec.12372; WESTMAN WE, 1981, ECOLOGY, V62, P170, DOI 10.2307/1936680; WESTMAN WE, 1983, VEGETATIO, V52, P3; Zemunik G, 2016, J ECOL, V104, P792, DOI 10.1111/1365-2745.12546	65	22	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172977	10.1371/journal.pone.0172977	http://dx.doi.org/10.1371/journal.pone.0172977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245232	Green Submitted, Green Published, gold			2022-12-27	WOS:000395980200048
J	Luzak, A; Heier, M; Thorand, B; Laxy, M; Nowak, D; Peters, A; Schulz, H				Luzak, Agnes; Heier, Margit; Thorand, Barbara; Laxy, Michael; Nowak, Dennis; Peters, Annette; Schulz, Holger		KORA-Study Grp	Physical activity levels, duration pattern and adherence to WHO recommendations in German adults	PLOS ONE			English	Article							ACCELEROMETER; POPULATION; ASSOCIATION; CALIBRATION; INACTIVITY	Background Intensity and duration of physical activity are associated with the achievement of health benefits. Our aim was to characterize physical activity behavior in terms of intensity, duration pattern, and adherence to the WHO physical activity recommendations in a population-based sample of adults from southern Germany. Further, we investigated associations between physical activity and sex, age, and body mass index (BMI), considering also common chronic diseases. Methods We analyzed 475 subjects (47% males, mean age 58 years, range 48-68 years) who wore ActiGraph accelerometers for up to seven days. Measured accelerations per minute obtained from the vertical axis (uniaxial) and the vector magnitude of all three axes (triaxial) were classified as sedentary, light or moderate-to-vigorous physical activity (MVPA) according to predefined acceleration count cut-offs. The average minutes/day spent in each activity level per subject served as outcome. Associations of sex, age, BMI, and seven chronic diseases or health limitations, with the activity levels were analyzed by negative binomial regression. Results Most of the wear time was spent in sedentarism (median 61%/day), whereas the median time spent in MVPA was only 3%, with men achieving more MVPA than women (35 vs. 28 minutes/day, p<0.05). Almost two thirds of MVPA was achieved in short bouts of less than 5 minutes, and 35% of the subjects did not achieve a single 10-minute bout. Hence, only 14% adhered to the WHO recommendation of 2.5 hours of MVPA/week in at least 10-minute bouts. Females, older subjects and obese subjects spent less time in MVPA (p<0.05), but no clear association with hypertension, asthma, diabetes, chronic obstructive pulmonary disease, anxiety/depression, pain or walking difficulties was observed in regression analyses with MVPA as outcome. Conclusions Activity behavior among middle-aged German adults was highly insufficient, indicating a further need for physical activity promotion in order to gain health benefits.	[Luzak, Agnes; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Heier, Margit; Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Heier, Margit] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Laxy, Michael] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth Neuherberg, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Nowak, Dennis] Univ Hosp Munich LMU, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Nowak, Dennis; Schulz, Holger] CPC M, Munich, Germany; [Nowak, Dennis; Schulz, Holger] German Ctr Lung Res, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Schulz, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany.; Schulz, H (corresponding author), CPC M, Munich, Germany.; Schulz, H (corresponding author), German Ctr Lung Res, Munich, Germany.	schulz@helmholtz-muenchen.de	Thorand, Barbara/B-5349-2014; Heier, Margit/AAT-5280-2020; Schulz, Holger/J-5643-2015; Peters, Annette/A-6117-2011	Thorand, Barbara/0000-0002-8416-6440; Schulz, Holger/0000-0002-1157-200X; Peters, Annette/0000-0001-6645-0985	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Comprehensive Pneumology Center Munich (CPC-M); Competence Network Asthma and COPD (ASCONET); COSYCONET-German Federal Ministry of Education and Research (BMBF) [BMBF FKZ 01G10882]	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Comprehensive Pneumology Center Munich (CPC-M); Competence Network Asthma and COPD (ASCONET); COSYCONET-German Federal Ministry of Education and Research (BMBF)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. This work was further supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research and by the Competence Network Asthma and COPD (ASCONET), network COSYCONET (subproject 2, BMBF FKZ 01G10882) funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2007, EUR J EPIDEMIOL, V22, P369, DOI 10.1007/s10654-006-9100-3; Aresu M., 2008, HLTH SURVEY ENGLAND, V1-2; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Cavill Nick, 2006, Promot Educ, V13, P104, DOI 10.1177/10253823060130020104; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Ekelund U., 2016, LANCET; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Kruger J, 2007, MED SCI SPORTS EXERC, V39; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Ortlieb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111206; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; R Core Team, 2013, R LANG ENV STAT COMP; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152217; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vanhelst J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-26; Vorrink SNW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-33; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661	30	38	38	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172503	10.1371/journal.pone.0172503	http://dx.doi.org/10.1371/journal.pone.0172503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245253	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200022
J	Groendahl, S; Kahlert, M; Fink, P				Groendahl, Sophie; Kahlert, Maria; Fink, Patrick			The best of both worlds: A combined approach for analyzing microalgal diversity via metabarcoding and morphology-based methods	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; SPECIES RICHNESS; COPY NUMBER; BIODIVERSITY; DNA; MICROORGANISMS; IDENTIFICATION; COMMUNITIES; SENSITIVITY; INVENTORY	An increasing number of studies use next generation sequencing (NGS) to analyze complex communities, but is the method sensitive enough when it comes to identification and quantification of species? We compared NGS with morphology-based identification methods in an analysis of microalgal (periphyton) communities. We conducted a mesocosm experiment in which we allowed two benthic grazer species to feed upon benthic biofilms, which resulted in altered periphyton communities. Morphology-based identification and 454 (Roche) pyro-sequencing of the V4 region in the small ribosomal unit (18S) rDNA gene were used to investigate the community change caused by grazing. Both the NGS-based data and the morphology-based method detected a marked shift in the biofilm composition, though the two methods varied strongly in their abilities to detect and quantify specific taxa, and neither method was able to detect all species in the biofilms. For quantitative analysis, we therefore recommend using both metabarcoding and microscopic identification when assessing the community composition of eukaryotic microorganisms.	[Groendahl, Sophie; Fink, Patrick] Univ Cologne, Inst Zool, Aquat Chem Ecol, Cologne, Germany; [Kahlert, Maria] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Fink, Patrick] Univ Dusseldorf, Inst Cell Biol & Zool, Dusseldorf, Germany	University of Cologne; Swedish University of Agricultural Sciences; Heinrich Heine University Dusseldorf	Groendahl, S (corresponding author), Univ Cologne, Inst Zool, Aquat Chem Ecol, Cologne, Germany.	sgroenda@uni-koeln.de	Kahlert, Maria/G-7981-2014; Kahlert, Maria/Y-2044-2019; Fink, Patrick/A-5901-2009	Kahlert, Maria/0000-0001-9643-4281; Kahlert, Maria/0000-0001-9643-4281; Fink, Patrick/0000-0002-5927-8977	Deutsche Forschungsgemeinschaft [Fl 1548/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de), grant Fl 1548/5-1 to PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2920-0; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; BROWN D. SEYMOUR, 1960, HYDROBIOLOGIA, V16, P81; Brown EA, 2015, ECOL EVOL, V5, P2234, DOI 10.1002/ece3.1485; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; CALOW P, 1970, Proceedings of the Malacological Society of London, V39, P203; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Comtet T, 2015, BIOL INVASIONS, V17, P905, DOI 10.1007/s10530-015-0854-y; Cowart DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117562; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbrecht V, 2016, PEERJ, V4, DOI 10.7717/peerj.1966; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; FENCHEL T, 1975, MAR BIOL, V30, P119, DOI 10.1007/BF00391586; Flynn JM, 2015, ECOL EVOL, V5, P2252, DOI 10.1002/ece3.1497; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Groendahl S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158924; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; HANCOCK JM, 1995, J MOL EVOL, V40, P629, DOI 10.1007/BF00160511; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jaschinski S, 2009, OECOLOGIA, V159, P607, DOI 10.1007/s00442-008-1236-2; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; Lentendu G, 2014, MOL ECOL, V23, P3341, DOI 10.1111/mec.12819; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LOPEZ GR, 1978, OECOLOGIA, V32, P263, DOI 10.1007/BF00345106; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LYCKEGAARD EMS, 1991, MOL BIOL EVOL, V8, P458; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; PORTER KG, 1973, NATURE, V244, P179, DOI 10.1038/244179a0; POWER ME, 1983, OECOLOGIA, V60, P328, DOI 10.1007/BF00376847; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	62	32	34	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172808	10.1371/journal.pone.0172808	http://dx.doi.org/10.1371/journal.pone.0172808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234997	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000394688200142
J	Mizuno, M; Noto, D; Kaga, N; Chiba, A; Miyake, S				Mizuno, Miho; Noto, Daisuke; Kaga, Naoko; Chiba, Asako; Miyake, Sachiko			The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IMMUNE DEVIATION; T-CELLS; GM-CSF; MICROBIOTA; INDUCTION; BUTYRATE; DIFFERENTIATION; AUTOANTIBODIES; PROGRESSION	Autoimmune diseases are influenced by both genetic and environmental factors. The gut environment has attracted much attention as an essential component that modulates immune responses, and therefore immune-mediated disorders, such as autoimmune diseases. Growing evidence suggests that microbiota and their metabolites are critical factors for immune modulation. Recently, we reported that the microbiome in patients with multiple sclerosis, an autoimmune disease targeting the myelin sheath of the central nervous system, is characterized by a reduction of bacteria belonging to Clostridia clusters IV and XIVa, which are potent producers of short-chain fatty acids (SCFAs) by fermentation of indigestible carbohydrates. In the present study, we investigated the role of SCFAs in the regulation of inflammation. We demonstrated that oral administration of SCFAs ameliorated the disease severity of systemic autoimmune inflammatory conditions mediated by lymphocytes such as experimental autoimmune encephalitis and collagen-induced arthritis. Amelioration of disease was associated with a reduction of Th1 cells and an increase in regulatory T cells. In contrast, SCFAs contributed to the exaggeration of K/BxN serum transfer arthritis, representing the effector phase of inflammation in rheumatoid arthritis. An increased understanding of the effect of microbiota metabolites will lead to the effective treatment and prevention of systemic inflammatory disorders.	[Mizuno, Miho; Noto, Daisuke; Chiba, Asako; Miyake, Sachiko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo, Japan; [Kaga, Naoko] Juntendo Univ, Grad Sch Med, Lab Prote & Biomol Sci,Res Support Ctr, Bunkyo Ku, Tokyo, Japan	Juntendo University; Juntendo University	Miyake, S (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo, Japan.	s-miyake@juntendo.ac.jp		Noto, Daisuke/0000-0002-6098-6735	Japan Society for the Promotion of Science [26293234]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (B: 26293234 https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26293234/) to S.M.	Ang ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34145; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BOISSIER MC, 1995, EUR J IMMUNOL, V25, P1184, DOI 10.1002/eji.1830250508; Chang MC, 2013, J PERIODONTAL RES, V48, P66, DOI 10.1111/j.1600-0765.2012.01504.x; Cook AD, 2011, ARTHRITIS RHEUM-US, V63, P2340, DOI 10.1002/art.30354; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Fuggle NR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00080; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Gurav A, 2015, BIOCHEM J, V469, P267, DOI 10.1042/BJ20150242; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kaieda S, 2007, ARTHRITIS RHEUM, V56, P1836, DOI 10.1002/art.22714; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Park J, 2016, J IMMUNOL, V196, P2388, DOI 10.4049/jimmunol.1502046; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wang F, 2016, SCAND J IMMUNOL; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622	46	115	116	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173032	10.1371/journal.pone.0173032	http://dx.doi.org/10.1371/journal.pone.0173032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235016	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200188
J	Seeland, M; Rzanny, M; Alaqraa, N; Waldchen, J; Mader, P				Seeland, Marco; Rzanny, Michael; Alaqraa, Nedal; Waeldchen, Jana; Maeder, Patrick			Plant species classification using flower images - A comparative study of local feature representations	PLOS ONE			English	Article							FEATURE-DETECTORS; IDENTIFICATION; DESCRIPTORS; RECOGNITION	Steady improvements of image description methods induced a growing interest in imagebased plant species classification, a task vital to the study of biodiversity and ecological sensitivity. Various techniques have been proposed for general object classification over the past years and several of them have already been studied for plant species classification. However, results of these studies are selective in the evaluated steps of a classification pipeline, in the utilized datasets for evaluation, and in the compared baseline methods. No study is available that evaluates the main competing methods for building an image representation on the same datasets allowing for generalized findings regarding flower-based plant species classification. The aim of this paper is to comparatively evaluate methods, method combinations, and their parameters towards classification accuracy. The investigated methods span from detection, extraction, fusion, pooling, to encoding of local features for quantifying shape and color information of flower images. We selected the flower image datasets Oxford Flower 17 and Oxford Flower 102 as well as our own Jena Flower 30 dataset for our experiments. Findings show large differences among the various studied techniques and that their wisely chosen orchestration allows for high accuracies in species classification. We further found that true local feature detectors in combination with advanced encoding methods yield higher classification results at lower computational costs compared to commonly used dense sampling and spatial pooling methods. Color was found to be an indispensable feature for high classification results, especially while preserving spatial correspondence to gray-level features. In result, our study provides a comprehensive overview of competing techniques and the implications of their main parameters for flower-based plant species classification.	[Seeland, Marco; Alaqraa, Nedal; Maeder, Patrick] Tech Univ Ilmenau, Inst Comp & Syst Engn, Ilmenau, Germany; [Rzanny, Michael; Waeldchen, Jana] Max Planck Inst Biogeochem, Dept Biogeochem Integrat, Jena, Germany	Technische Universitat Ilmenau; Max Planck Society	Seeland, M; Mader, P (corresponding author), Tech Univ Ilmenau, Inst Comp & Syst Engn, Ilmenau, Germany.; Waldchen, J (corresponding author), Max Planck Inst Biogeochem, Dept Biogeochem Integrat, Jena, Germany.	marco.seeland@tu-ilmenau.de; jwald@bgc-jena.mpg.de; patrick.maeder@tu-ilmenau.de	Seeland, Marco/H-1028-2011; Mäder, Patrick/A-1848-2018; Rzanny, Michael/GOH-1028-2022	Seeland, Marco/0000-0001-7204-3972; Mäder, Patrick/0000-0001-6871-2707; Rzanny, Michael/0000-0002-7232-5547	German Ministry of Education and Research [01LC1319A, 01LC1319B]; German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety [3514 685C19]; Stiftung Naturschutz Thuringen [SNT-082-248-03/2014]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Stiftung Naturschutz Thuringen	We are funded by the German Ministry of Education and Research (www.bmbf.de) grants: 01LC1319A and 01LC1319B; the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (www.bmub.bund.de) grant: 3514 685C19; and the Stiftung Naturschutz Thuringen (www.stiftung-naturschutz-thueringen.de) grant: SNT-082-248-03/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanaes H, 2012, INT J COMPUT VISION, V97, P18, DOI 10.1007/s11263-011-0473-8; Akata Z, 2014, IEEE T PATTERN ANAL, V36, P507, DOI 10.1109/TPAMI.2013.146; Angelova A, 2013, IEEE WORK APP COMP, P39, DOI 10.1109/WACV.2013.6474997; Arandjelovic R, 2013, PROC CVPR IEEE, P1578, DOI 10.1109/CVPR.2013.207; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bekele D, 2013, IEEE IMAGE PROC, P3652, DOI 10.1109/ICIP.2013.6738753; Bianco S, 2015, DIGIT SIGNAL PROCESS, V44, P1, DOI 10.1016/j.dsp.2015.06.001; Caetano C., 2014, P 29 ANN ACM S APPL, P49, DOI [10.1145/2554850.2555058, DOI 10.1145/2554850.2555058]; Chai Y, 2012, P EUR C COMP VIS, P794; Chai YN, 2011, IEEE I CONF COMP VIS, P2579, DOI 10.1109/ICCV.2011.6126546; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chatzilari Elisavet, 2013, Machine Learning and Data Mining in Pattern Recognition. 9th International Conference, MLDM 2013. Proceedings: LNCS 7988, P442, DOI 10.1007/978-3-642-39712-7_34; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Dahl A. L., 2011, 2011 International Conference on 3D Imaging, Modeling, Processing, Visualization and Transmission (3DIMPVT), P318, DOI 10.1109/3DIMPVT.2011.47; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Decker P, 2008, IEEE IMAGE PROC, P1964, DOI 10.1109/ICIP.2008.4712167; Finlayson G. D., 1998, Computer Vision - ECCV'98. 5th European Conference on Computer Vision. Proceedings, P475, DOI 10.1007/BFb0055685; Galvez-Lopez D, 2012, IEEE T ROBOT, V28, P1188, DOI 10.1109/TRO.2012.2197158; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Gross, 2016, PROCEEDINGS OF ISR 2, P141; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Hassaballah M, 2016, STUD COMPUT INTELL, V630, P11, DOI 10.1007/978-3-319-28854-3_2; Hietanen A, 2016, NEUROCOMPUTING, V184, P3, DOI 10.1016/j.neucom.2015.08.106; Jegou H, 2010, PROC CVPR IEEE, P3304, DOI 10.1109/CVPR.2010.5540039; Ji R., 2011, P 19 ACM INT C MULT, P573, DOI [10.1145/2072298.2072372, DOI 10.1145/2072298.2072372]; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Jing Liu, 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P2417, DOI 10.1109/ICIP.2011.6116130; Khan R, 2013, PROC CVPR IEEE, P2866, DOI 10.1109/CVPR.2013.369; Lankinen J, 2012, INT C PATT RECOG, P780; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; Li J, 2008, NEUROCOMPUTING, V71, P1771, DOI 10.1016/j.neucom.2007.11.032; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE I CONF COMP VIS, P1792; Miksik O, 2012, INT C PATT RECOG, P2681; Moreels P, 2007, INT J COMPUT VISION, V73, P263, DOI 10.1007/s11263-006-9967-1; Mukherjee D, 2015, MACH VISION APPL, V26, P443, DOI 10.1007/s00138-015-0679-9; Nilsback M.-E., 2006, IEEE C COMP VIS PATT, V2, P1447, DOI [10.1109/CVPR.2006.42, 10.1109/CVPR.2006., DOI 10.1109/CVPR.2006.42]; Nilsback M. - E., 2009, THESIS; Nilsback M. E., 17 CATEGORY FLOWER D; Nilsback M. E., 102 CATEGORY FLOWER; Nilsback ME, 2008, I PUTER VISION GRAPH; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Saitoh T, 2004, INT C PATT RECOG, P27, DOI 10.1109/ICPR.2004.1333997; Seeland M, 2016, DESCRIPTION FLOWER C, P145; Seeland M, 2016, JENA FLOWERS 30 DATA; Siraj F, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTER, CONTROL, INFORMATICS AND ITS APPLICATIONS (IC3INA), P81, DOI 10.1109/IC3INA.2014.7042605; Skrypnyk I, 2004, ISMAR 2004: THIRD IEEE AND ACM INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, P110, DOI 10.1109/ISMAR.2004.53; Szeliski R, 2011, TEXTS COMPUT SCI, P181, DOI 10.1007/978-1-84882-935-0_4; Tuytelaars T, 2007, FOUND TRENDS COMPUT, V3, P177, DOI 10.1561/0600000017; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; van de Weijer J, 2007, PROC CVPR IEEE, P1898; van de Weijer J, 2006, LECT NOTES COMPUT SC, V3952, P334; van de Weijer J, 2013, LECT NOTES COMPUT SC, V7786, P25, DOI 10.1007/978-3-642-36700-7_3; van Gemert Jan C., 2008, Computer Vision. Proceedings 10th European Conference on Computer Vision, ECCV 2008, P696, DOI 10.1007/978-3-540-88690-7_52; Varma M., 2007, PROC INT C COMPUTING, P1, DOI DOI 10.1109/ICCV.2007.4408875; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Waldchen J, 2018, ARCH COMPUT METHOD E, V25, P507, DOI 10.1007/s11831-016-9206-z; Waldchen J, 2016, LANDSCH NATURSCH THU, V53, P121; Wang J., 2010, COMPUTER VISION PATT, DOI DOI 10.1109/CVPR.2010.5540018; Wohler C, 2009, ISPRS J PHOTOGRAMM, V64, P529, DOI 10.1016/j.isprsjprs.2009.03.004; Xie LX, 2014, IEEE T IMAGE PROCESS, V23, P1994, DOI 10.1109/TIP.2014.2310117; Yang LF, 2015, IEEE IMAGE PROC, P4873, DOI 10.1109/ICIP.2015.7351733; Yu Zhang, 2013, Advances in Information Retrieval. 35th European Conference on IR Research, ECIR 2013. Proceedings, P630, DOI 10.1007/978-3-642-36973-5_53; Yuan XT, 2012, IEEE T IMAGE PROCESS, V21, P4349, DOI 10.1109/TIP.2012.2205006; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029	73	38	38	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170629	10.1371/journal.pone.0170629	http://dx.doi.org/10.1371/journal.pone.0170629			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234999	Green Published, gold			2022-12-27	WOS:000394688200008
J	Tsubokura, M; Murakami, M; Nomura, S; Morita, T; Nishikawa, Y; Leppold, C; Kato, S; Kami, M				Tsubokura, Masaharu; Murakami, Michio; Nomura, Shuhei; Morita, Tomohiro; Nishikawa, Yoshitaka; Leppold, Claire; Kato, Shigeaki; Kami, Masahiro			Individual external doses below the lowest reference level of 1 mSv per year five years after the 2011 Fukushima nuclear accident among all children in Soma City, Fukushima: A retrospective observational study	PLOS ONE			English	Article							INTERNAL RADIATION-EXPOSURE; LONG-TERM; REMEDIATION STRATEGIES; SCHOOL-CHILDREN; DECONTAMINATION; IRRADIATION; PATTERNS; INCIDENT; FALLOUT; ADULTS	After the 2011 Fukushima Daiichi nuclear power plant accident, little information has been available on individual doses from external exposure among residents living in radioactively contaminated areas near the nuclear plant; in the present study we evaluated yearly changes in the doses from external exposure after the accident and the effects of decontamination on external exposure. This study considered all children less than 16 years of age in Soma City, Fukushima who participated in annual voluntary external exposure screening programs during the five years after the accident (n = 5,363). In total, 14,405 screening results were collected. The median participant age was eight years. The geometric mean levels of annual additional doses from external exposure attributable to the Fukushima accident, decreased each year: 0.60 mSv (range: not detectable (ND)-4.29 mSv), 0.37 mSv (range: ND-3.61 mSv), 0.22 mSv (range: ND-1.44 mSv), 0.20 mSv (range: ND-1.87 mSv), and 0.17 mSv (range: ND-0.85 mSv) in 2011, 2012, 2013, 2014, and 2015, respectively. The proportion of residents with annual additional doses from external exposure of more than 1 mSv dropped from 15.6% in 2011 to zero in 2015. Doses from external exposure decreased more rapidly than those estimated from only physical decay, even in areas without decontamination (which were halved in 395 days from November 15, 2011), presumably due to the weathering effects. While the ratios of geometric mean doses immediately after decontamination to before were slightly lower than those during the same time in areas without decontamination, annual additional doses reduced by decontamination were small (0.04-0.24 mSv in the year of immediately after decontamination was completed). The results of this study showed that the levels of external exposure among Soma residents less than 16 years of age decreased during the five years after the Fukushima Daiichi nuclear power plant accident. Decontamination had only limited and temporal effects on reducing individual external doses.	[Tsubokura, Masaharu] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Murakami, Michio] Fukushima Med Univ, Sch Med, Dept Hlth Risk Commun, Fukushima, Fukushima, Japan; [Nomura, Shuhei] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Nomura, Shuhei] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London, England; [Morita, Tomohiro] Soma Cent Hosp, Dept Internal Med, Soma, Fukushima, Japan; [Nishikawa, Yoshitaka] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Kyoto, Japan; [Leppold, Claire] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh, Midlothian, Scotland; [Kato, Shigeaki] Tokiwa Fdn, Res Inst Innovat Med, Iwaki, Fukushima, Japan; [Kami, Masahiro] Med Governance Res Inst, Minato Ku, Tokyo, Japan	Fukushima Medical University; University of Tokyo; Imperial College London; Kyoto University; University of Edinburgh	Tsubokura, M (corresponding author), Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan.	tsubokura-tky@umin.ac.jp	Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/AAV-4364-2021; Nishikawa, Yoshitaka/GLV-3579-2022	Tsubokura, Masaharu/0000-0001-8027-202X; Nishikawa, Yoshitaka/0000-0003-3313-1990; Nomura, Shuhei/0000-0002-2963-7297	JSPS KAKENHI [JP24223002, JP16H05894]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI [grant numbers JP24223002, JP16H05894].	Akiyama J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140482; Eckerman K., 2008, Annals of the ICRP, V38, P9, DOI 10.1016/j.icrp.2008.10.004; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1557; Fesenko S, 2013, J ENVIRON RADIOACTIV, V119, P39, DOI 10.1016/j.jenvrad.2010.08.012; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Hirayama Hideo, 2013, Radioisotopes, V62, P335; ICRP, 2009, ICRP PUBL, V111; Ishikawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12712; Jacob P, 2009, SCI TOTAL ENVIRON, V408, P14, DOI 10.1016/j.scitotenv.2009.09.006; Jacob P, 2001, J ENVIRON RADIOACTIV, V56, P51, DOI 10.1016/S0265-931X(01)00047-9; Japan Atomic Energy Agency, AIRB MON DISTR SURV; Kato T, 2013, FOOD ENVIRON VIROL, V5, P185, DOI 10.1007/s12560-013-9125-1; Kaul Alexander, 2008, Annals of the ICRP, V38, P1; Kinase S, 2014, RADIAT PROT DOSIM, V160, P318, DOI 10.1093/rpd/ncu014; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Likhtariov I, 1996, HEALTH PHYS, V70, P87, DOI 10.1097/00004032-199601000-00013; Ministry_of_the_Environment_Government_of_Japan, ENV REM LEG FRAM; Mori A, 2016, J ENVIRON RADIOACTIV; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Naito W, 2015, RADIAT PROT DOSIM, V163, P353, DOI 10.1093/rpd/ncu201; Nomura S, 2016, J RADIAT RES, V57, P1, DOI 10.1093/jrr/rrv051; Nomura S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009555; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Normile D, 2016, SCIENCE, V351, P1022, DOI 10.1126/science.351.6277.1022; Nuclear_Emergency_Response_Headquarters, 2011, GENZ KUK KAR SHOR KU; Raaf CL, 2006, SCI TOTAL ENVIRON, V367, P324, DOI 10.1016/j.scitotenv.2005.12.006; RITCHIE JC, 1990, J ENVIRON QUAL, V19, P215, DOI 10.2134/jeq1990.00472425001900020006x; Thornberg C, 2001, RADIAT ENVIRON BIOPH, V40, P287, DOI 10.1007/s00411-001-0123-6; Toohey RE, 2008, HEALTH PHYS, V95, P26, DOI 10.1097/01.HP.0000285798.55584.6d; Tsubokura M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010970; Tsubokura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129114; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; UNSCEAR, 2014, ANN LEV EFF RAD EXP; UNSCEAR, 1988, 1988 UNSCEAR; UNSCEAR, 2010, SUMM LOW DOS RAD EFF; World Health Organization, 2012, PREL DOS EST NUCL AC; Yasutaka T, 2016, J ENVIRON RADIOACTIV, V151, P512, DOI 10.1016/j.jenvrad.2015.05.012; Yasutaka T, 2013, CHEMOSPHERE, V93, P1222, DOI 10.1016/j.chemosphere.2013.06.083; Yasutaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075308; Yoshida K, 2012, RADIAT PROT DOSIM, V151, P144, DOI 10.1093/rpd/ncr466	42	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172305	10.1371/journal.pone.0172305	http://dx.doi.org/10.1371/journal.pone.0172305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235009	gold, Green Published			2022-12-27	WOS:000394688200066
J	Hettlich, BF; Cook, L; London, C; Fosgate, GT				Hettlich, Bianca F.; Cook, Laurie; London, Cheryl; Fosgate, Geoffrey T.			Comparison of harmonic blade versus traditional approach in canine patients undergoing spinal decompressive surgery for naturally occurring thoracolumbar disk extrusion	PLOS ONE			English	Article							ULTRASONICALLY-ACTIVATED SCALPEL; BLOOD-LOSS; TRANSFUSION REQUIREMENTS; NERVE PHYSIOLOGY; LAPAROSCOPIC USE; FUSION SURGERY; ELECTROSURGERY; MODEL; ELECTROCAUTERY; THYROIDECTOMY	Objectives To assess feasibility of the harmonic Osteovue blade (HOB) for use in the soft tissue approach for dogs undergoing hemilaminectomy and to compare outcomes between dogs undergoing HOB or traditional approach (TRAD). Methods A prospective randomized clinical trial was performed using 20 client-owned dogs with thoracolumbar intervertebral disk extrusion requiring hemilaminectomy. Dogs were randomly assigned to HOB or TRAD. Neurologic function and pain scores were assessed pre-operatively. Intraoperative blood loss and surgical approach time as well as postoperative pain and wound healing scores were recorded. Additionally, neurologic recovery and owner perceived quality of life were recorded at day 10 and 30 postoperative. Results There was no significant difference in sex distribution, weight, age, preoperative neurological grade and pain score, and perioperative outcome measures between groups. Intraoperative total blood loss was minimal for HOB and TRAD (median: 0 ml (range 0-9) and 2.2 ml (range 0-6.8), respectively; p = 0.165) and approach times were similar (median: 7 min (range 5-12) and 8 min (range 5-13), respectively; p = 0.315). While changes in wound healing scores were similar, changes in postoperative pain scores and neurological function were significantly improved in the HOB compared to the TRAD group. Postoperative complications in the HOB group consisted of automutilation of part of the incision and development of a small soft, non-painful subcutaneous swelling in 1 dog each. Conclusions The HOB is a safe and effective tool for the soft tissue approach for routine spinal surgery in dogs and is associated with decreased pain and increased neurological function postsurgery.	[Hettlich, Bianca F.; Cook, Laurie; London, Cheryl] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Fosgate, Geoffrey T.] Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Onderstepoort, South Africa; [Hettlich, Bianca F.] Vetsuisse Bern, Small Anim Clin, Bern, Switzerland	University System of Ohio; Ohio State University; University of Pretoria	Hettlich, BF (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.; Hettlich, BF (corresponding author), Vetsuisse Bern, Small Anim Clin, Bern, Switzerland.	bianca.hettlich@vetsuisse.unibe.ch	Fosgate, Geoffrey T/N-8700-2014	Fosgate, Geoffrey T/0000-0002-9432-0042	Ethicon Endo Surgery, Inc.; National Center for Advancing Translational Sciences [UL1TR001070]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	Ethicon Endo Surgery, Inc.; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this study was provided, in part, by a research grant from Ethicon Endo Surgery, Inc.; however none of the authors are employed by the company or were compensated for this study. The harmonic Osteovue blades and generator were provided by Ethicon for the duration of the study. This project was supported by the following grant: UL1TR001070 from the National Center for Advancing Translational Sciences to The Ohio State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JF, 1997, MINIM INVASIV THER, V6, P324, DOI 10.3109/13645709709153084; AMARAL JF, 1994, SURG LAPAROSC ENDOSC, V4, P92; Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Armstrong DN, 2001, DIS COLON RECTUM, V44, P558, DOI 10.1007/BF02234329; Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665; Cakir B, 2006, EUR SPINE J, V15, P48, DOI 10.1007/s00586-004-0812-3; Carlander J, 2012, WORLD J SURG, V36, P1361, DOI 10.1007/s00268-012-1471-x; Cha CW, 2002, SPINE, V27, P99, DOI 10.1097/00007632-200201010-00023; Chen CY, 2015, BRIT J NEUROSURG, V29, P569, DOI 10.3109/02688697.2015.1023772; Chen CY, 2012, BRIT J NEUROSURG, V26, P856, DOI 10.3109/02688697.2012.697216; Chettiar K, 2008, BONE JOINT J B, V90, P310; Collison Patrick J, 2004, Ear Nose Throat J, V83, P707; Copley LAB, 1999, SPINE, V24, P219, DOI 10.1097/00007632-199902010-00005; DUTOIT G, 1978, J BONE JOINT SURG BR, V60, P178, DOI 10.1302/0301-620X.60B2.659459; Ferrari R, 2015, VET WORLD, V8, P1247, DOI 10.14202/vetworld.2015.1247-1259; Florentino-Pineda I, 2001, SPINE, V26, P1147, DOI 10.1097/00007632-200105150-00011; Gerszten PC, 2000, NEUROSURGERY, V46, P1478, DOI 10.1097/00006123-200006000-00033; Hu SS, 2004, EUR SPINE J, V13, pS3, DOI 10.1007/s00586-004-0753-x; HUR SR, 1992, SPINE, V17, P867, DOI 10.1097/00007632-199208000-00002; Lentschener C, 1999, ANESTH ANALG, V89, P590, DOI 10.1097/00000539-199909000-00009; Lentschener C, 1999, ANESTHESIOLOGY, V91, pU137; Litta P, 2010, FERTIL STERIL, V94, P1882, DOI 10.1016/j.fertnstert.2009.08.049; Lynch S, 2011, VET COMP ONCOL, V9, P172, DOI 10.1111/j.1476-5829.2010.00244.x; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Miccoli P, 2006, ARCH OTOLARYNGOL, V132, P1069, DOI 10.1001/archotol.132.10.1069; Morton CM, 2005, AM J VET RES, V66, P2154, DOI 10.2460/ajvr.2005.66.2154; Nanduri B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073032; Ohtsuka T, 2000, SURG ENDOSC-ULTRAS, V14, P82, DOI 10.1007/s004649900018; Ott D, 1993, Endosc Surg Allied Technol, V1, P230; Pillen H, 2009, WOUND PRACT RES, V17, P208; Rubino LJ, 2010, SURG INNOV, V17, P85, DOI 10.1177/1553350610364531; Sharp NJH, 2005, SMALL ANIMAL SPINAL, p[136, 195, 241]; Sharp NJH, 2005, DORSOLATERAL HEMILAM, P136; Usas A, 2011, J SURG RES, V167, pE177, DOI 10.1016/j.jss.2010.12.042; Zhang ZJ, 2010, SURG INNOV, V17, P41, DOI 10.1177/1553350610362084	35	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172822	10.1371/journal.pone.0172822	http://dx.doi.org/10.1371/journal.pone.0172822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253289	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300040
J	Abraham, A; Alabdali, M; Alsulaiman, A; Albulaihe, H; Breiner, A; Katzberg, HD; Aljaafari, D; Lovblom, LE; Bril, V				Abraham, Alon; Alabdali, Majed; Alsulaiman, Abdulla; Albulaihe, Hana; Breiner, Ari; Katzberg, Hans D.; Aljaafari, Danah; Lovblom, Leif E.; Bril, Vera			The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations	PLOS ONE			English	Article							NEUROPATHY; SYMPTOMS; TESTS	Introduction Polyneuropathy is one of the most prevalent neurologic disorders. Although several studies explored the role of the neurological examination in polyneuropathy, they were mostly restricted to specific subgroups of patients and have not correlated examination findings with symptoms and electrophysiological results. Objectives To explore the sensitivity and specificity of different neurological examination components in patients with diverse etiologies for polyneuropathy, find the most sensitive combination of examination components for polyneuropathy detection, and correlate examination findings with symptoms and electrophysiological results. Methods Patients with polyneuropathy attending the neuromuscular clinic from 01/2013 to 09/2015 were evaluated. Inclusion criteria included symptomatic polyneuropathy, which was confirmed by electrophysiological studies. 47 subjects with no symptoms or electrophysiological findings suggestive for polyneuropathy, served as controls. Results The total cohort included 312 polyneuropathy patients, with a mean age of 60 +/- 14 years. Abnormal examination was found in 95%, most commonly sensory findings (86%). The most common abnormal examination components were impaired ankle reflexes (74%), vibration (73%), and pinprick (72%) sensation. Combining ankle reflex examination with vibration or pinprick perception had the highest sensitivity, of 88%. The specificities of individual examination component were generally high, excluding ankle reflexes (62%), and vibration perception (77%). Abnormal examination findings were correlated with symptomatic weakness and worse electrophysiological parameters. Conclusion The neurological examination is a valid, sensitive and specific tool for diagnosing polyneuropathy, and findings correlate with polyneuropathy severity. Ankle reflex examination combined with either vibration or pinprick sensory testing is the most sensitive combination for diagnosing polyneuropathy, and should be considered minimal essential components of the physical examination in patients with suspected polyneuropathy.	[Abraham, Alon; Breiner, Ari; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Dept Med,Div Neurol, Toronto, ON, Canada; [Alabdali, Majed; Alsulaiman, Abdulla; Aljaafari, Danah] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Albulaihe, Hana] King Saud Univ, King Khalid Univ Hosp, Dept Neurol, Riyadh, Saudi Arabia; [Lovblom, Leif E.] Univ Toronto, Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Lovblom, Leif E.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imam Abdulrahman Bin Faisal University; King Saud University; King Khalid University Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Dept Med,Div Neurol, Toronto, ON, Canada.	vera.bril@utoronto.ca	BRIL, vera/ABA-6509-2020; aljaafari, danah/AAN-2439-2021; Abraham, Alon/H-9343-2019	Abraham, Alon/0000-0002-9020-2399				Abraham A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165731; American Association of Electrodiagnostic Medicine, 1999, Muscle Nerve Suppl, V8, pS91; [Anonymous], 1995, Neurology, V45, P1832; [Anonymous], 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139689, DOI 10.1371/JOURNAL.PONE.0139689]; Bolton CF, 2000, CANADIAN J NEUROLOGI, P288; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Callaghan BC, 2014, JAMA NEUROL, V71, P1143, DOI 10.1001/jamaneurol.2014.1279; Campbell WW, 2020, DEJONGS NEUROLOGIC E; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Dyck PJ, 2012, ARCH NEUROL-CHICAGO, V69, P1609, DOI 10.1001/archneurol.2012.1481; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; England JD, 2005, DISTAL SYMMETRIC POL, P199; GEORGE J, 1986, AGE AGEING, V15, P247, DOI 10.1093/ageing/15.4.247; Johnston SC, 2011, ANN NEUROL, V70, pA9, DOI 10.1002/ana.22542; Lacomis D, 2002, MUSCLE NERVE, V26, P173, DOI 10.1002/mus.10181; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Preston DC, 2012, ELECTROMYOGRAPHY NEU; Russell J, 2015, NEUROMUSCULAR DISORD; Visser NA, 2015, NEUROLOGY, V84, P259, DOI 10.1212/WNL.0000000000001160; Vrethem M, 2002, CLIN J PAIN, V18, P122, DOI 10.1097/00002508-200203000-00008	22	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171597	10.1371/journal.pone.0171597	http://dx.doi.org/10.1371/journal.pone.0171597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249029	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500017
J	Afshin, A; Penalvo, JL; Del Gobbo, L; Silva, J; Michaelson, M; O'Flaherty, M; Capewell, S; Spiegelman, D; Danaei, G; Mozaffarian, D				Afshin, Ashkan; Penalvo, Jose L.; Del Gobbo, Liana; Silva, Jose; Michaelson, Melody; O'Flaherty, Martin; Capewell, Simon; Spiegelman, Donna; Danaei, Goodarz; Mozaffarian, Dariush			The prospective impact of food pricing on improving dietary consumption: A systematic review and meta-analysis	PLOS ONE			English	Article							NUTRITION EDUCATION; PREVENT OBESITY; PUBLIC-HEALTH; PURCHASES; PRICES; FRUIT; INTERVENTION; INCOME; TAXES; DISCOUNTS	Background While food pricing is a promising strategy to improve diet, the prospective impact of food pricing on diet has not been systematically quantified. Objective To quantify the prospective effect of changes in food prices on dietary consumption. Design We systematically searched online databases for interventional or prospective observational studies of price change and diet; we also searched for studies evaluating adiposity as a secondary outcome. Studies were excluded if price data were collected before 1990. Data were extracted independently and in duplicate. Findings were pooled using DerSimonianLaird's random effects model. Pre-specified sources of heterogeneity were analyzed using meta-regression; and potential for publication bias, by funnel plots, Begg's and Egger's tests. Results From 3,163 identified abstracts, 23 interventional studies and 7 prospective cohorts with 37 intervention arms met inclusion criteria. In pooled analyses, a 10% decrease in price (i.e., subsidy) increased consumption of healthful foods by 12% (95% CI = 10-15%; N = 22 studies/intervention arms) whereas a 10% increase price (i.e. tax) decreased consumption of unhealthful foods by 6% (95% CI = 4-8%; N = 15). By food group, subsidies increased intake of fruits and vegetables by 14% (95% CI = 11-17%; N = 9); and other healthful foods, by 16% (95% CI = 10-23%; N = 10); without significant effects on more healthful beverages (-3%; 95% CI = -16-11%; N = 3). Each 10% price increase reduced sugar-sweetened beverage intake by 7% (95% CI = 3-10%; N = 5); fast foods, by 3% (95% CI = 1-5%; N = 3); and other unhealthful foods, by 9% (95% CI = 6-12%; N = 3). Changes in price of fruits and vegetables reduced body mass index (-0.04 kg/m(2) per 10% price decrease, 95% CI = -0.08-0 kg/m(2); N = 4); price changes for sugar-sweetened beverages or fast foods did not significantly alter body mass index, based on 4 studies. Meta-regression identified direction of price change (tax vs. subsidy), number of intervention components, intervention duration, and study quality score as significant sources of heterogeneity (P-heterogeneity<0.05 each). Evidence for publication bias was not observed. Conclusions These prospective results, largely from interventional studies, support efficacy of subsidies to increase consumption of healthful foods; and taxation to reduce intake of unhealthful beverages and foods. Use of subsidies and combined multicomponent interventions appear most effective.	[Afshin, Ashkan] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Afshin, Ashkan; Penalvo, Jose L.; Del Gobbo, Liana; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Del Gobbo, Liana] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Silva, Jose] Boston Med Ctr, Dept Cardiol, Boston, MA USA; [Michaelson, Melody] Tufts Univ, Sch Med, Boston, MA 02111 USA; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Spiegelman, Donna; Danaei, Goodarz] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Spiegelman, Donna; Danaei, Goodarz] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Tufts University; Stanford University; Boston Medical Center; Tufts University; University of Liverpool; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Afshin, A (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Afshin, A (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	aafshin@uw.edu	Mozaffarian, Dariush/ABC-2822-2020; Penalvo, Jose L./AAA-9210-2020	Penalvo, Jose L./0000-0003-0096-6238	National Heart, Lung, and Blood Institute [T32 HL098048]; National Heart, Lung, and Blood Institute and a Research Award from The New York Academy of Sciences' Sacker Institute for Nutrition Science [R01 HL115189]; Bunge Fellowship in Global Nutrition; McKinsey Health Systems Institute; Foodminds; Nutrition Impact; Amarin; Omthera; Winston and Strawn LLP; GlaxoSmithKline; Sigma Tau; Pronova; Gates Foundation; Sackler Institute of Nutrition; National Institutes of Health; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute and a Research Award from The New York Academy of Sciences' Sacker Institute for Nutrition Science; Bunge Fellowship in Global Nutrition; McKinsey Health Systems Institute; Foodminds; Nutrition Impact; Amarin; Omthera; Winston and Strawn LLP; GlaxoSmithKline(GlaxoSmithKline); Sigma Tau; Pronova; Gates Foundation(Bill & Melinda Gates Foundation); Sackler Institute of Nutrition; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AA was supported by T32 HL098048 from the National Heart, Lung, and Blood Institute. DM was supported by R01 HL115189 from the National Heart, Lung, and Blood Institute and a Research Award from The New York Academy of Sciences' Sacker Institute for Nutrition Science. JP was partly supported by a Bunge Fellowship in Global Nutrition. DM reports ad hoc travel reimbursement or honoraria from Bunge, Pollock Institute, Quaker Oats, and Life Sciences Research Organization; ad hoc consulting fees from McKinsey Health Systems Institute, Foodminds, Nutrition Impact, Amarin, Omthera, and Winston and Strawn LLP; membership, Unilever North America Scientific Advisory Board; royalties from UpToDate; and research grants from GlaxoSmithKline, Sigma Tau, Pronova, the Gates Foundation, the Sackler Institute of Nutrition, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2014, HDB GLOBAL HLTH POLI, DOI DOI 10.1002/9781118509623.CH9; Afshin A, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0658-9; An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; An RP, 2013, AM J HEALTH BEHAV, V37, P56, DOI 10.5993/AJHB.37.1.6; Anderson JV, 2001, J AM DIET ASSOC, V101, P195, DOI 10.1016/S0002-8223(01)00052-9; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Anliker J, 1992, EVALUATION CONNECTIC; [Anonymous], 2011, POLITICAL DECLARATIO; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bihan H, 2012, EUR J CLIN NUTR, V66, P369, DOI 10.1038/ejcn.2011.173; Blakely T, 2011, J EPIDEMIOL COMMUN H, V65, P902, DOI 10.1136/jech.2010.118588; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Brown DM, 2009, J AM DIET ASSOC, V109, P2036, DOI 10.1016/j.jada.2009.09.008; Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545; Elbel B, 2013, AM J PREV MED, V45, P49, DOI 10.1016/j.amepre.2013.02.023; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fletcher JM, 2010, CONTEMP ECON POLICY, V28, P23, DOI 10.1111/j.1465-7287.2009.00182.x; French SA, 1997, J AM DIET ASSOC, V97, P1008, DOI 10.1016/S0002-8223(97)00242-3; French SA, 1997, AM J PUBLIC HEALTH, V87, P849, DOI 10.2105/AJPH.87.5.849; French SA, 2001, AM J PUBLIC HEALTH, V91, P112, DOI 10.2105/AJPH.91.1.112; French SA, 2010, PREV MED, V50, P180, DOI 10.1016/j.ypmed.2010.01.002; Gordon-Larsen P, 2011, HEALTH PLACE, V17, P1235, DOI 10.1016/j.healthplace.2011.07.011; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Herman DR, 2008, AM J PUBLIC HEALTH, V98, P98, DOI 10.2105/AJPH.2005.079418; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horgen KB, 2002, HEALTH PSYCHOL, V21, P505, DOI 10.1037/0278-6133.21.5.505; JEFFERY RW, 1994, PREV MED, V23, P788, DOI 10.1006/pmed.1994.1135; Jue JJS, 2012, PREV MED, V55, P629, DOI 10.1016/j.ypmed.2012.10.009; Khan T, 2012, J OBES, V2012, DOI 10.1155/2012/857697; Kocken PL, 2012, J SCHOOL HEALTH, V82, P115, DOI 10.1111/j.1746-1561.2011.00674.x; Kottke TE, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120214; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lowe MR, 2010, EAT BEHAV, V11, P144, DOI 10.1016/j.eatbeh.2010.01.002; Maniadakis N, 2013, CLINICOECONOMIC OUTC, V5, P519, DOI 10.2147/CEOR.S49659; Meyer KA, 2014, JAMA INTERN MED, V174, P434, DOI 10.1001/jamainternmed.2013.13922; Michels KB, 2008, J AM COLL NUTR, V27, P6, DOI 10.1080/07315724.2008.10719669; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MOZAFFARIAN D, 2011, CIRCULATION, V123, P2870, DOI [DOI 10.1161/CIRCULATI0NAHA.110.968735, 10.1161/circulationaha.110.968735]; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Paine-Andrews A, 1996, Health Mark Q, V14, P85; Powell L, 2011, AM J AGR EC, V93; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Powell LM, 2009, ECON HUM BIOL, V7, P64, DOI 10.1016/j.ehb.2009.01.004; Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thow AM, 2014, NUTR REV; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Wendt M., 2011, Economic Research Report - Economic Research Service, USDA; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2003, DIET NUTR PREV CHRON, V916, pi	57	155	156	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172277	10.1371/journal.pone.0172277	http://dx.doi.org/10.1371/journal.pone.0172277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249003	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500034
J	Goodson, JM; Hartman, ML; Shi, P; Hasturk, H; Yaskell, T; Vargas, J; Song, XQ; Cugini, M; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K				Goodson, J. Max; Hartman, Mor-Li; Shi, Ping; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Song, Xiaoqing; Cugini, Maryann; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem			The salivary microbiome is altered in the presence of a high salivary glucose concentration	PLOS ONE			English	Article							ORAL-HEALTH; METABOLIC SYNDROME; DENTAL-CARIES; CHILDREN; ADOLESCENTS; ASSOCIATION; MICROFLORA; DIVERSITY; BACTERIA; THERAPY	Background Type II diabetes (T2D) has been associated with changes in oral bacterial diversity and frequency. It is not known whether these changes are part of the etiology of T2D, or one of its effects. Methods We measured the glucose concentration, bacterial counts, and relative frequencies of 42 bacterial species in whole saliva samples from 8,173 Kuwaiti adolescents (mean age 10.00 +/- 0.67 years) using DNA probe analysis. In addition, clinical data related to obesity, dental caries, and gingivitis were collected. Data were compared between adolescents with high salivary glucose (HSG; glucose concentration >= 1.0 mg/d, n = 175) and those with low salivary glucose (LSG, glucose concentration <0.1 mg/dL n = 2,537). Results HSG was associated with dental caries and gingivitis in the study population. The overall salivary bacterial load in saliva decreased with increasing salivary glucose concentration. Under HSG conditions, the bacterial count for 35 (83%) of 42 species was significantly reduced, and relative bacterial frequencies in 27 species (64%) were altered, as compared with LSG conditions. These alterations were stronger predictors of high salivary glucose than measures of oral disease, obesity, sleep or fitness. Conclusions HSG was associated with a reduction in overall bacterial load and alterations to many relative bacterial frequencies in saliva when compared with LSG in samples from adolescents. We propose that hyperglycemia due to obesity and/or T2D results in HSG and subsequent acidification of the oral environment, leading to a generalized perturbation in the oral microbiome. This suggests a basis for the observation that hyperglycemia is associated with an increased risk of dental erosion, dental caries, and gingivitis. We conclude that HSG in adolescents may be predicted from salivary microbial diversity or frequency, and that the changes in the oral microbial composition seen in adolescents with developing metabolic disease may the consequence of hyperglycemia.	[Goodson, J. Max; Hartman, Mor-Li; Shi, Ping; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Song, Xiaoqing; Cugini, Maryann; Soparkar, Pramod] Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA USA; [Barake, Roula; Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha; Ariga, Jitendra] Minist Hlth, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait	Harvard University; Forsyth Institute; Kuwait University	Goodson, JM (corresponding author), Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA USA.	mgoodson@forsyth.org		Barake, Roula/0000-0002-9461-2897	Dasman Diabetes Institute in Kuwait [RA/065/2011, RA/005/2011]; Forsyth Institute, Cambridge, Massachusetts	Dasman Diabetes Institute in Kuwait; Forsyth Institute, Cambridge, Massachusetts	This work was supported by the Dasman Diabetes Institute in Kuwait (RA/065/2011 and RA/005/2011) to JMG, and by the Forsyth Institute, Cambridge, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken-Saavedra Juan, 2015, J Clin Exp Dent, V7, pe501, DOI 10.4317/jced.52329; Almstahl A, 2015, ARCH ORAL BIOL, V60, P1187, DOI 10.1016/j.archoralbio.2015.04.004; Belstrom D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147472; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Carneiro VL, 2015, ARCH ENDOCRIN METAB, V59, P535, DOI 10.1590/2359-3997000000117; Cetik S, 2014, CELL PHYSIOL BIOCHEM, V33, P1149, DOI 10.1159/000358684; Choromanska K, 2015, POSTEP HIG MED DOSW, V69, P1190; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Douglas CWI, 2014, ADV MICROB PHYSIOL, V65, P257, DOI 10.1016/bs.ampbs.2014.08.005; Duran-Pinedo AE, 2015, MICROBES INFECT, V17, P505, DOI 10.1016/j.micinf.2015.03.014; Eltas A, 2012, PERITON DIALYSIS INT, V32, P81, DOI 10.3747/pdi.2010.00113; Ertugrul F, 2003, TURKISH J PEDIATR, V45, P108; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Goodson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074461; Guobis Z, 2011, MEDICINA-LITHUANIA, V47, P646; Hagman E, 2014, INT J OBESITY, V38, P40, DOI 10.1038/ijo.2013.124; HARPER DS, 1984, ARCH ORAL BIOL, V29, P843, DOI 10.1016/0003-9969(84)90015-3; Hartman ML, 2015, DIABET METAB SYND OB, V8, P9, DOI 10.2147/DMSO.S72744; Haseeb M, 2012, JCPSP-J COLL PHYSICI, V22, P514, DOI 08.2012/JCPSP.514518; Hintao J, 2007, ORAL MICROBIOL IMMUN, V22, P175, DOI 10.1111/j.1399-302X.2007.00341.x; Horiuchi M, 2009, ORAL MICROBIOL IMMUN, V24, P319, DOI 10.1111/j.1399-302X.2009.00517.x; Kampoo K, 2014, APPL ENVIRON MICROB, V80, P662, DOI 10.1128/AEM.02821-13; Kim EK, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-64; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; López María Elena, 2003, Braz. Dent. J., V14, P26, DOI 10.1590/S0103-64402003000100005; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; MAIDEN MFJ, 1991, J PERIODONTAL RES, V26, P452, DOI 10.1111/j.1600-0765.1991.tb01735.x; Mascarenhas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101706; McDonald D, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0117-2; Nakajo K, 2010, CARIES RES, V44, P431, DOI 10.1159/000318582; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Ozturk LK, 2012, MOL BIOL REP, V39, P5677, DOI 10.1007/s11033-011-1374-1; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Prathibha KM, 2013, J CLIN DIAGN RES, V7, P1592, DOI 10.7860/JCDR/2013/5749.3232; Rai K, 2011, J CLIN PEDIATR DENT, V36, P181, DOI 10.17796/jcpd.36.2.x436ln878221g364; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Shillitoe E, 2012, J ORAL MICROBIOL, P4; Socransky SS, 2004, ORAL MICROBIOL IMMUN, V19, P352, DOI 10.1111/j.1399-302x.2004.00168.x; Stephan Robert M., 1943, JOUR DENTAL RES, V22, P45, DOI 10.1177/00220345430220010601; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner ACR, 2015, J ORAL BIOSCI, V57, P18, DOI 10.1016/j.job.2014.08.001; Tremblay M, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-40; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Whitmore SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003933; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	51	46	49	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170437	10.1371/journal.pone.0170437	http://dx.doi.org/10.1371/journal.pone.0170437			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249034	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500005
J	Van den Driessche, F; Vanhoutte, B; Brackman, G; Crabbe, A; Rigole, P; Vercruysse, J; Verstraete, G; Cappoen, D; Vervaet, C; Cos, P; Coenye, T				Van den Driessche, Freija; Vanhoutte, Bieke; Brackman, Gilles; Crabbe, Aurelie; Rigole, Petra; Vercruysse, Jurgen; Verstraete, Glenn; Cappoen, Davie; Vervaet, Chris; Cos, Paul; Coenye, Tom			Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; CYSTIC-FIBROSIS PATIENTS; CEPACIA COMPLEX; CELL-CULTURE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; MICROBIAL BIOFILMS; EPITHELIAL-CELLS; MICONAZOLE	Burkholderia cenocepacia is an opportunistic pathogen responsible for life-threatening infections in cystic fibrosis patients. B. cenocepacia is extremely resistant towards antibiotics and therapy is complicated by its ability to form biofilms. We investigated the efficacy of an alternative antimicrobial strategy for B. cenocepacia lung infections using in vitro and in vivo models. A screening of the NIH Clinical Collection 1&2 was performed against B. cenocepacia biofilms formed in 96-well microtiter plates in the presence of tobramycin to identify repurposing candidates with potentiator activity. The efficacy of selected hits was evaluated in a three-dimensional (3D) organotypic human lung epithelial cell culture model. The in vivo effect was evaluated in the invertebrate Galleria mellonella and in a murine B. cenocepacia lung infection model. The screening resulted in 60 hits that potentiated the activity of tobramycin against B. cenocepacia biofilms, including four imidazoles of which econazole and miconazole were selected for further investigation. However, a potentiator effect was not observed in the 3D organotypic human lung epithelial cell culture model. Combination treatment was also not able to increase survival of infected G. mellonella. Also in mice, there was no added value for the combination treatment. Although potentiators of tobramycin with activity against biofilms of B. cenocepacia were identified in a repurposing screen, the in vitro activity could not be confirmed nor in a more sophisticated in vitro model, neither in vivo. This stresses the importance of validating hits resulting from in vitro studies in physiologically relevant model systems.	[Van den Driessche, Freija; Brackman, Gilles; Crabbe, Aurelie; Rigole, Petra; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium; [Vanhoutte, Bieke; Cappoen, Davie; Cos, Paul] Univ Antwerp, LMPH, Antwerp, Belgium; [Vercruysse, Jurgen; Verstraete, Glenn; Vervaet, Chris] Univ Ghent, Lab Pharmaceut Technol, Ghent, Belgium	Ghent University; University of Antwerp; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	Tom.Coenye@UGent.be	cos, paul/AAU-3896-2020; Cos, Paul/L-9717-2015; Coenye, Tom/A-6291-2014; Coenye, Tom/Z-1928-2019	cos, paul/0000-0003-4361-8911; Cos, Paul/0000-0003-4361-8911; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Verstraete, Glenn/0000-0001-7811-3601; Cappoen, Davie/0000-0002-3115-8797; Crabbe, Aurelie/0000-0003-3084-4418	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [12005]; Research Foundation Flanders	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders(FWO)	This work was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, SBO programme) (grant no. 12005) and by the Research Foundation Flanders (Odysseus grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BD, 2008, AM J TRANSPLANT, V8, P1025, DOI 10.1111/j.1600-6143.2008.02186.x; Bang CS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-65; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bernal P, 2013, MICROB BIOTECHNOL, V6, P445, DOI 10.1111/1751-7915.12044; Bhandari K, 2009, EUR J MED CHEM, V44, P437, DOI 10.1016/j.ejmech.2008.01.006; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brown D, 2015, NAT REV DRUG DISCOV, V14, P821, DOI 10.1038/nrd4675; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Courtney J M, 2004, J Cyst Fibros, V3, P93, DOI 10.1016/j.jcf.2004.01.005; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Czaika VA, 2013, MYCOSES, V56, P16, DOI 10.1111/myc.12055; David J, 2014, MICROBES INFECT, V16, P735, DOI 10.1016/j.micinf.2014.04.001; DELOUVOIS J, 1980, J ANTIMICROB CHEMOTH, V6, P798, DOI 10.1093/jac/6.6.798; Douglas SG, RAUS RESP CARE PHARM; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Kikuchi K, 2005, BRIT J PHARMACOL, V144, P840, DOI 10.1038/sj.bjp.0706095; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lelkes PI, 1997, IN VITRO CELL DEV-AN, V33, P344; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; Nobre LS, 2010, J BACTERIOL, V192, P1527, DOI 10.1128/JB.01378-09; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Piel G, 1999, INT J PHARM, V180, P41, DOI 10.1016/S0378-5173(98)00403-7; Pietschmann S, 2009, VET RES COMMUN, V33, P489, DOI 10.1007/s11259-008-9194-z; Reik R, 2005, J CLIN MICROBIOL, V43, P2926, DOI 10.1128/JCM.43.6.2926-2928.2005; Schwab U, 2014, INFECT IMMUN, V82, P4729, DOI 10.1128/IAI.01876-14; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; SUD IJ, 1982, ANTIMICROB AGENTS CH, V22, P470, DOI 10.1128/AAC.22.3.470; Sugita T, 2010, BIOL PHARM BULL, V33, P125, DOI 10.1248/bpb.33.125; Van den Driessche F, 2014, J MICROBIOL METH, V98, P31, DOI 10.1016/j.mimet.2013.12.011; Washington JA, 1983, DIAGN MICROBIOL INFE, V1, P25; Younis W, 2015, CURR PHARM DESIGN, V21, P4106, DOI 10.2174/1381612821666150506154434	43	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172723	10.1371/journal.pone.0172723	http://dx.doi.org/10.1371/journal.pone.0172723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248999	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500053
J	Hanel, R; Corominas-Murtra, B; Liu, B; Thurner, S				Hanel, Rudolf; Corominas-Murtra, Bernat; Liu, Bo; Thurner, Stefan			Fitting power-laws in empirical data with estimators that work for all exponents	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; DISTRIBUTIONS	Most standard methods based on maximum likelihood (ML) estimates of power-law exponents can only be reliably used to identify exponents smaller than minus one. The argument that power laws are otherwise not normalizable, depends on the underlying sample space the data is drawn from, and is true only for sample spaces that are unbounded from above. Power-laws obtained from bounded sample spaces (as is the case for practically all data related problems) are always free of such limitations and maximum likelihood estimates can be obtained for arbitrary powers without restrictions. Here we first derive the appropriate ML estimator for arbitrary exponents of power-law distributions on bounded discrete sample spaces. We then show that an almost identical estimator also works perfectly for continuous data. We implemented this ML estimator and discuss its performance with previous attempts. We present a general recipe of how to use these estimators and present the associated computer codes.	[Hanel, Rudolf; Corominas-Murtra, Bernat; Liu, Bo; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, Spitalgasse 23, A-1090 Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Thurner, Stefan] IIASA, Schlosspl 1, A-2361 Laxenburg, Austria; [Thurner, Stefan] Complex Sci Hub Vienna, Josefstadterstr 39, A-1090 Vienna, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Spitalgasse 23, A-1090 Vienna, Austria.; Thurner, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.; Thurner, S (corresponding author), IIASA, Schlosspl 1, A-2361 Laxenburg, Austria.; Thurner, S (corresponding author), Complex Sci Hub Vienna, Josefstadterstr 39, A-1090 Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Corominas-Murtra, Bernat/0000-0001-9806-5643; Hanel, Rudolf/0000-0002-4045-9532	Austrian Science Foundation "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF) [P29252]; China Scholarship Council [201306230096]	Austrian Science Foundation "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF)(Austrian Science Fund (FWF)); China Scholarship Council(China Scholarship Council)	This work was supported in part by the Austrian Science Foundation "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF: https://www.fwf.ac.at/) under grant P29252. BL is grateful for the support by the China Scholarship Council, file-number 201306230096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Auerbach F, 1913, PETERMANNS MITT, V59, P74; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauke H, 2007, EUR PHYS J B, V58, P167, DOI 10.1140/epjb/e2007-00219-y; Berger J., 1985, STATUS REWARDS INFLU, P1, DOI [10.1007/978-1-4757-4286-2, DOI 10.1007/978-1-4757-4286-2]; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Christensen K, 2002, P NATL ACAD SCI USA, V99, P2509, DOI 10.1073/pnas.012581099; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corominas-Murtra B, 2015, P NATL ACAD SCI USA, V112, P5348, DOI 10.1073/pnas.1420946112; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; Fisher Ronald A., 1912, MESSENGER MATH, V41, P155; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hanel R, 2014, P NATL ACAD SCI USA, V111, P6905, DOI 10.1073/pnas.1406071111; KADANOFF LP, 1967, REV MOD PHYS, V39, P395, DOI 10.1103/RevModPhys.39.395; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman M. E. J., 2003, MODELING EXTINCTION; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Press SJ, 2010, WILEY SERIES PROB ST; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Roberts DC, 1998, FRACTALS, V6, P351, DOI 10.1142/S0218348X98000407; Shaffer CA, 2014, AM J PRIMATOL, V76, P472, DOI 10.1002/ajp.22227; SIMON HA, 1955, BIOMETRIKA, V42, P425; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Sornette D., 2006, CRITICAL PHENOMENA N; Takayasu H, 1997, PHYS REV LETT, V79, P966, DOI 10.1103/PhysRevLett.79.966; Tsallis C., 2009, INTRO NONEXTENSIVE S; Virkar Y, 2014, ANN APPL STAT, V8, P89, DOI 10.1214/13-AOAS710; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zipf GK, 1950, J CLIN PSYCHOL, V6, P306	35	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0170920	10.1371/journal.pone.0170920	http://dx.doi.org/10.1371/journal.pone.0170920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245249	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000395980200005
J	Qvortrup, K; Jensen, JF; Sorensen, MS; Kouskoumvekaki, I; Petersen, RK; Taboureau, O; Kristiansen, K; Nielsen, TE				Qvortrup, Katrine; Jensen, Jakob F.; Sorensen, Mikael S.; Kouskoumvekaki, Irene; Petersen, Rasmus K.; Taboureau, Olivier; Kristiansen, Karsten; Nielsen, Thomas E.			Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPAR gamma partial agonists	PLOS ONE			English	Article							DISCOVERY; THIAZOLIDINEDIONES; DERIVATIVES; NITRILES; LIGANDS	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a well-known target for thiazolidinedione antidiabetic drugs. In this paper, we present the synthesis and biological evaluation of a series of dihydropyrano[2,3-c]pyrazole derivatives as a novel family of PPAR gamma partial agonists. Two analogues were found to display high affinity for PPAR gamma with potencies in the micro molar range. Both of these hits were selective against PPAR gamma, since no activity was measured when tested against PPAR alpha, PPAR delta and RXR alpha. In addition, a novel modelling approach based on multiple individual flexible alignments was developed for the identification of ligand binding interactions in PPAR gamma. In combination with cell-based transactivation experiments, the flexible alignment model provides an excellent analytical tool to evaluate and visualize the effect of ligand chemical structure with respect to receptor binding mode and biological activity.	[Qvortrup, Katrine; Jensen, Jakob F.; Nielsen, Thomas E.] Tech Univ Denmark, Dept Chem, Lyngby, Denmark; [Sorensen, Mikael S.; Kouskoumvekaki, Irene; Taboureau, Olivier] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, Lyngby, Denmark; [Petersen, Rasmus K.; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, Copenhagen, Denmark; [Taboureau, Olivier] Univ Paris Diderot, Inserm UMR S 973, Mol Therapeut Silico MTi, Bat Lamarck A,35 Rue Helene Brion, Paris, France; [Nielsen, Thomas E.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	Technical University of Denmark; Technical University of Denmark; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nielsen, TE (corresponding author), Tech Univ Denmark, Dept Chem, Lyngby, Denmark.; Nielsen, TE (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.	ten@sund.ku.dk	Kristiansen, Karsten/J-5148-2014	Kristiansen, Karsten/0000-0002-6024-0917; Qvortrup, Katrine/0000-0003-3828-2069	Danish Council for Independent Research, Natural Sciences, Technology and Production Sciences; DSF Center for Antimicrobial Research; Lundbeck Foundation; Technical University of Denmark	Danish Council for Independent Research, Natural Sciences, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); DSF Center for Antimicrobial Research; Lundbeck Foundation(Lundbeckfonden); Technical University of Denmark	We thank the Danish Council for Independent Research, Natural Sciences, Technology and Production Sciences, DSF Center for Antimicrobial Research, Lundbeck Foundation, and Technical University of Denmark for financial support.	ABDOU S, 1981, HETEROCYCLES, V16, P2177; CARPINO LA, 1958, J AM CHEM SOC, V80, P599, DOI 10.1021/ja01536a021; El-Tamany ESH, 1999, J SERB CHEM SOC, V64, P9; Elte JWF, 2007, EUR J INTERN MED, V18, P18, DOI 10.1016/j.ejim.2006.09.007; Esser B, 2009, CHEM-EUR J, V15, P3368, DOI 10.1002/chem.200802297; Gerisch M, 2003, ORGANOMETALLICS, V22, P47, DOI 10.1021/om0207562; Gogoi S, 2009, TETRAHEDRON LETT, V50, P2252, DOI 10.1016/j.tetlet.2009.02.210; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; HARB AFA, 1989, LIEBIGS ANN CHEM, P585; Haslam E., 1993, SHIKIMIC ACID METABO; Henriksen K, 2011, DIABETES-METAB RES, V27, P392, DOI 10.1002/dmrr.1187; Hwang J, 2008, PHYTOTHER RES, V23, P262; Kouskoumvekaki I, 2013, J CHEM INF MODEL, V53, P923, DOI 10.1021/ci3006148; Kshirsagar SW, 2011, SYNTHETIC COMMUN, V41, P1320, DOI 10.1080/00397911.2010.481753; Kumar GS, 2013, ORG PREP PROCED INT, V45, P429, DOI 10.1080/00304948.2013.816220; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Lehmann F, 2008, J COMB CHEM, V10, P364, DOI 10.1021/cc800028m; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Mendes E, 1989, Eur. Patent, Patent No. [EP A1 346208, 19891213, 346208]; Pan HJ, 2006, VASC PHARMACOL, V45, P65, DOI 10.1016/j.vph.2005.11.011; Qvortrup K, 2014, ORG LETT, V16, P4782, DOI 10.1021/ol502219s; SHARANIN YA, 1983, ZH ORG KHIM+, V19, P2609; Shi DQ, 2004, SYNTHETIC COMMUN, V34, P4557, DOI 10.1081/SCC-200043224; Steindl TM, 2006, J CHEM INF MODEL, V46, P2146, DOI 10.1021/ci6002043; Vasuki G, 2008, TETRAHEDRON LETT, V49, P5636, DOI 10.1016/j.tetlet.2008.07.055; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; WOOD JH, 1950, J AM CHEM SOC, V72, P2992, DOI 10.1021/ja01163a052; Yuasa Y, 1998, ORG PROCESS RES DEV, V2, P412, DOI 10.1021/op980044g; Zaki MEA, 2006, Z NATURFORSCH C, V61, P1; Zou Y, 2013, J HETEROCYCLIC CHEM, V50, P1174, DOI 10.1002/jhet.1627	32	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0162642	10.1371/journal.pone.0162642	http://dx.doi.org/10.1371/journal.pone.0162642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245241	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200001
J	Seddigi, ZS; Gondal, MA; Baig, U; Ahmed, SA; Abdulaziz, MA; Danish, EY; Khaled, MM; Lais, A				Seddigi, Zaki S.; Gondal, Mohammed A.; Baig, Umair; Ahmed, Saleh A.; Abdulaziz, M. A.; Danish, Ekram Y.; Khaled, Mazen M.; Lais, Abul			Facile synthesis of light harvesting semiconductor bismuth oxychloride nano photo-catalysts for efficient removal of hazardous organic pollutants	PLOS ONE			English	Article							FRONTIER ORBITAL ENERGY; HYBRID PHOTOCATALYST; RHODAMINE-B; BIOCL; DEGRADATION; GROWTH; G-C3N4; ZNO; PHOTODEGRADATION; NANOPARTICLES	In the present work, bismuth oxychloride nanoparticles-a light harvesting semiconductor photocatalyst-were synthesized by a facile hydrolysis route, with sodium bismuthate and hydroxylammonium chloride as the precursor materials. The as-synthesized semiconductor photocatalysts were characterized using X-ray diffraction analysis, Fourier transform infrared spectroscopy, Raman spectroscopy, Field emission scanning electron microscopy, Xray photoelectron spectroscopy and Photoluminescence spectroscopy techniques. The crystal structure, morphology, composition, and optical properties of these facile synthesized bismuth oxychloride nanoparticles (BiOCl NPs) were compared to those of traditional bismuth oxychloride. In addition, the photocatalytic performance of facile-synthesized BiOCl NPs and traditional BiOCl, as applied to the removal of hazardous organic dyes under visible light illumination, is thoroughly investigated. Our results reveal that facile-synthesized BiOCl NPs display strong UV-Vis light adsorption, improved charge carrier mobility and an inhibited rate of charge carrier recombination, when compared to traditional BiOCl. These enhancements result in an improved photocatalytic degradation rate of hazardous organic dyes under UV-Vis irradiance. For instance, the facile-synthesized BiOCl NPs attained 100% degradation of methylene blue and methyl orange dyes in approximately 30 mins under UV-Vis irradiation, against 55% degradation for traditional BiOCl under similar experimental conditions.	[Seddigi, Zaki S.; Abdulaziz, M. A.] Umm Al Qura Univ, Fac Publ Hlth & Hlth Informat, Dept Environm Hlth, Mecca, Saudi Arabia; [Gondal, Mohammed A.; Baig, Umair; Lais, Abul] King Fahd Univ Petr & Minerals, Dept Phys, Laser Res Grp, Dhahran, Saudi Arabia; [Ahmed, Saleh A.] Umm Al Qura Univ, Coll Appl Sci, Dept Chem, Mecca, Saudi Arabia; [Danish, Ekram Y.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Khaled, Mazen M.] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran, Saudi Arabia	Umm Al Qura University; King Fahd University of Petroleum & Minerals; Umm Al Qura University; King Abdulaziz University; King Fahd University of Petroleum & Minerals	Gondal, MA (corresponding author), King Fahd Univ Petr & Minerals, Dept Phys, Laser Res Grp, Dhahran, Saudi Arabia.	magondal@kfupm.edu.sa	Gondal, Mohammed A/AAH-7023-2021; Baig, Umair/N-5309-2016; , Mazen/R-3349-2019; Gondal, Mohammed A A/A-9249-2010; Baig, Umair/ABB-8857-2020; , Mohammed/AAZ-7211-2020; Abdulaziz, Mohammed/P-5502-2015	Gondal, Mohammed A/0000-0001-9570-4569; Gondal, Mohammed A A/0000-0001-9570-4569; Baig, Umair/0000-0002-9881-1981; , Mohammed/0000-0003-1667-2138; Abdulaziz, Mohammed/0000-0003-1667-2138	King Abdul Aziz City for Science and Technology (KACST) through the Science & Technology Unit at Umm Al-Qura University, National Science, Technology and Innovation Plan [12-NAN02317-10]; King Fahd University of Petroleum and Minerals	King Abdul Aziz City for Science and Technology (KACST) through the Science & Technology Unit at Umm Al-Qura University, National Science, Technology and Innovation Plan; King Fahd University of Petroleum and Minerals	This work was supported by the King Abdul Aziz City for Science and Technology (KACST) through the Science & Technology Unit at Umm Al-Qura University for funding through Project No. 12-NAN02317-10 as part of the National Science, Technology and Innovation Plan. The support by King Fahd University of Petroleum and Minerals is also gratefully acknowledged. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding agencies supported in terms of financial support for equipment, chemicals, and salaries of Principal Investigator (ZSS) and Co-Investigators (SAA, MAA, EYD, MMK) and students.; The authors wish to acknowledge the support of King Abdul Aziz City for Science and Technology (KACST) through the Science & Technology Unit at Umm Al-Qura University for funding through Project No. 12-NAN02317-10 as part of the National Science, Technology and Innovation Plan. The support by King Fand University of Petroleum and Minerals is also gratefully acknowledged.	Ahmad N, 2016, DESALIN WATER TREAT, V57, P213, DOI 10.1080/19443994.2015.1012340; [Anonymous], 2008, SYNTHETIC DYES LOOK; Baig U, 2015, CHEM ENG J, V280, P494, DOI 10.1016/j.cej.2015.06.031; Chan SHS, 2011, J CHEM TECHNOL BIOT, V86, P1130, DOI 10.1002/jctb.2636; Chang XF, 2015, DALTON T, V44, P15888, DOI 10.1039/c5dt02217g; Chang XF, 2015, APPL CATAL B-ENVIRON, V176, P201, DOI 10.1016/j.apcatb.2015.03.047; Djurisic AB, 2014, MATER HORIZONS, V1, P400, DOI 10.1039/c4mh00031e; Faraji N, 2016, ADV ELECTRON MATER, V2, DOI 10.1002/aelm.201600138; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gondal MA, 2015, REACT KINET MECH CAT, V114, P357, DOI 10.1007/s11144-014-0787-y; Hernandez-Ramirez A., 2014, PHOTOCATALYTIC SEMIC; Hisatomi T, 2014, CHEM SOC REV, V43, P7520, DOI 10.1039/c3cs60378d; Holken I, 2016, ACS APPL MATER INTER, V8, P20491, DOI 10.1021/acsami.6b06387; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Kang S, 2016, J EXP NANOSCI, V11, P853, DOI 10.1080/17458080.2016.1174891; Kang S, 2016, J EXP NANOSCI, V11, P259, DOI 10.1080/17458080.2015.1047420; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Pawar RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31147; Pawar RC, 2016, CURR APPL PHYS, V16, P101, DOI 10.1016/j.cap.2015.11.002; Pelizzetti E., 1994, COMMENTS INORGANIC C, V15, P297, DOI DOI 10.1080/02603599408035846; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Seddigi ZS, 2016, J MOL CATAL A-CHEM, V420, P167, DOI 10.1016/j.molcata.2016.04.026; Seddigi ZS, 2015, PHOTOCHEM PHOTOBIOL, V91, P265, DOI 10.1111/php.12391; Shen K, 2015, RES CHEM INTERMEDIAT, V41, P2753, DOI 10.1007/s11164-013-1384-9; Shen K, 2014, J ADV OXID TECHNOL, V17, P121; Shen K, 2013, REACT KINET MECH CAT, V109, P247, DOI 10.1007/s11144-013-0540-y; Shi S, 2014, COLLOID SURFACE A, V461, P202, DOI 10.1016/j.colsurfa.2014.07.024; Shi S, 2014, J COLLOID INTERF SCI, V416, P212, DOI 10.1016/j.jcis.2013.10.052; Zhang B, 2013, CATAL COMMUN, V36, P25, DOI 10.1016/j.catcom.2013.02.021; Zhang J, 2012, APPL SURF SCI, V258, P7795; Zhang J, 2012, J ALLOY COMPD, V530, P107, DOI 10.1016/j.jallcom.2012.03.104	31	29	29	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172218	10.1371/journal.pone.0172218	http://dx.doi.org/10.1371/journal.pone.0172218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245225	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200015
J	Finnell, JE; Lombard, CM; Padi, AR; Moffitt, CM; Wilson, LB; Wood, CS; Wood, SK				Finnell, Julie E.; Lombard, Calliandra M.; Padi, Akhila R.; Moffitt, Casey M.; Wilson, L. Britt; Wood, Christopher S.; Wood, Susan K.			Physical versus psychological social stress in male rats reveals distinct cardiovascular, inflammatory and behavioral consequences	PLOS ONE			English	Article							WITNESSING TRAUMATIC EVENTS; TOLL-LIKE RECEPTOR; LOCUS-COERULEUS; EMOTIONAL-STRESS; TISSUE INHIBITOR; RISK-FACTORS; HEART-RATE; PROINFLAMMATORY CYTOKINE; INDIVIDUAL-DIFFERENCES; PSYCHOSOCIAL FACTORS	Repeated exposure to social stress can precipitate the development of psychosocial disorders including depression and comorbid cardiovascular disease. While a major component of social stress often encompasses physical interactions, purely psychological stressors (i.e. witnessing a traumatic event) also fall under the scope of social stress. The current study determined whether the acute stress response and susceptibility to stress-related consequences differed based on whether the stressor consisted of physical versus purely psychological social stress. Using a modified resident-intruder paradigm, male rats were either directly exposed to repeated social defeat stress (intruder) or witnessed a male rat being defeated. Cardiovascular parameters, behavioral anhedonia, and inflammatory cytokines in plasma and the stress-sensitive locus coeruleus were compared between intruder, witness, and control rats. Surprisingly intruders and witnesses exhibited nearly identical increases in mean arterial pressure and heart rate during acute and repeated stress exposures, yet only intruders exhibited stress-induced arrhythmias. Furthermore, re-exposure to the stress environment in the absence of the resident produced robust pressor and tachy-cardic responses in both stress conditions indicating the robust and enduring nature of social stress. In contrast, the long-term consequences of these stressors were distinct. Intruders were characterized by enhanced inflammatory sensitivity in plasma, while witnesses were characterized by the emergence of depressive-like anhedonia, transient increases in systolic blood pressure and plasma levels of tissue inhibitor of metalloproteinase. The current study highlights that while the acute cardiovascular responses to stress were identical between intruders and witnesses, these stressors produced distinct differences in the enduring consequences to stress, suggesting that witness stress may be more likely to produce long-term cardiovascular dysfunction and comorbid behavioral anhedonia while exposure to physical stressors may bias the system towards sensitivity to inflammatory disorders.	[Finnell, Julie E.; Lombard, Calliandra M.; Padi, Akhila R.; Moffitt, Casey M.; Wilson, L. Britt; Wood, Christopher S.; Wood, Susan K.] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Wood, SK (corresponding author), Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC 29208 USA.	Susan.Wood@uscmed.sc.edu			American Heart Association [15SDG22430017]; National Institute of General Medical Sciences [P20GM103641]; Veterans Administration [I21 BX002085]; Office of the Vice President for Research, University of South Carolina [18080-16-41861]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Administration(US Department of Veterans Affairs); Office of the Vice President for Research, University of South Carolina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the American Heart Association (15SDG22430017), the National Institute of General Medical Sciences (P20GM103641), the Veterans Administration (I21 BX002085), and the Office of the Vice President for Research, University of South Carolina (18080-16-41861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida DM, 2005, CURR DIR PSYCHOL SCI, V14, P64, DOI 10.1111/j.0963-7214.2005.00336.x; Anderson AA, 2016, J COGN ENG DECIS MAK, V10, P167, DOI 10.1177/1555343416653887; Aston-Jones G, 1995, LOCUS COERULEUS A5 A, P183; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bhatnagar S, 2003, HORM BEHAV, V43, P158, DOI 10.1016/S0018-506X(02)00011-9; Brougham RR, 2009, CURR PSYCHOL, V28, P85, DOI 10.1007/s12144-009-9047-0; Buwalda B, 1999, J NEUROENDOCRINOL, V11, P513; CAMPBELL RL, 1992, PERCEPT MOTOR SKILL, V75, P552, DOI 10.2466/pms.1992.75.2.552; Carnevali L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00118; Chen YY, 1997, ACTA PHARMACOL SIN, V18, P437; Cheng YY, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0169-z; Crestani CC, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00251; De Miguel Z, 2011, BEHAV BRAIN RES, V225, P554, DOI 10.1016/j.bbr.2011.08.011; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; DROLET G, 1985, CAN J PHYSIOL PHARM, V63, P599, DOI 10.1139/y85-100; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Feinstein A, 2014, JRSM OPEN, V5, DOI [10.1177/2054270414533323, DOI 10.1177/2054270414533323]; Finnell JE, 2017, BRAIN BEHAV IMMUN, V59, P147, DOI 10.1016/j.bbi.2016.08.019; Fonken LK, 2016, PSYCHONEUROENDOCRINO, V66, P82, DOI 10.1016/j.psyneuen.2016.01.006; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Glassman Alexander H, 2007, Dialogues Clin Neurosci, V9, P9; Gomez-Lazaro E, 2011, STRESS, V14, P537, DOI 10.3109/10253890.2011.562939; Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294; Gunnar MR, 2015, SOC NEUROSCI-UK, V10, P474, DOI 10.1080/17470919.2015.1070198; GURTU S, 1984, BRAIN RES, V301, P59, DOI 10.1016/0006-8993(84)90402-5; Halaris A, 2009, INT ANGIOL, V28, P92; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hansson J, 2009, EUR J CARDIOV PREV R, V16, P297, DOI 10.1097/HJR.0b013e3283213108; Health NIoM, 2013, MAJ DEPR AD; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Huang CS, 2014, J SURG RES, V188, P260, DOI 10.1016/j.jss.2013.12.011; Huffman Jeff C, 2013, Cardiovasc Psychiatry Neurol, V2013, P695925, DOI 10.1155/2013/695925; Islama Z, 2006, TOXICOL APPL PHARM, V211, P53, DOI 10.1016/j.taap.2005.04.031; Johnson JD, 2004, NEUROSCIENCE, V127, P569, DOI 10.1016/j.neuroscience.2004.05.046; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; KAWAMURA H, 1978, BRAIN RES, V140, P137, DOI 10.1016/0006-8993(78)90243-3; Kelly D, 2010, AM J CARDIOL, V106, P477, DOI 10.1016/j.amjcard.2010.03.060; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kwon MS, 2008, BRAIN RES, V1190, P122, DOI 10.1016/j.brainres.2007.11.009; Larsen BA, 2009, CARDIOVASCULAR PSYCH, V2009, DOI [10.1155/2009/791017, DOI 10.1155/2009/791017]; Li RP, 2015, NEUROSCI LETT, V594, P17, DOI 10.1016/j.neulet.2015.03.040; Lindsay MM, 2002, HYPERTENSION, V40, P136, DOI 10.1161/01.HYP.0000024573.17293.23; Lindsey ML, 2015, CARDIOLOGY, V132, P147, DOI 10.1159/000433419; Lopez R, 2016, PERS INDIV DIFFER, V96, P243, DOI 10.1016/j.paid.2016.03.014; Luan GM, 2016, EPILEPSY RES, V123, P36, DOI 10.1016/j.eplepsyres.2016.03.005; Lubos E, 2006, EUR HEART J, V27, P150, DOI 10.1093/eurheartj/ehi582; Martin Loren J, 2014, Curr Top Behav Neurosci, V20, P233, DOI 10.1007/7854_2014_287; McQuade R, 1999, PSYCHOPHARMACOLOGY, V145, P393, DOI 10.1007/s002130051073; MEEHAN WP, 1995, PHYSIOL BEHAV, V58, P81, DOI 10.1016/0031-9384(95)00036-I; Messerli FH, 2004, EUR HEART J, V25, P1475, DOI 10.1016/j.ehj.2004.07.015; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Nicodimos Semret, 2009, East Afr J Public Health, V6, P184; Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008; Patki G, 2015, NEUROSCI LETT, V600, P28, DOI 10.1016/j.neulet.2015.05.060; Patki G, 2014, INT J NEUROPSYCHOPH, V17, P2017, DOI 10.1017/S1461145714000923; Paxinos G., 2007, THE RAT BRAIN IN STE; Perez-Tejada J, 2013, NEUROENDOCRINOLOGY, V98, P73, DOI 10.1159/000353620; Pijiman FTA, 2003, BEHAV BRAIN RES, V139, P131, DOI 10.1016/S0166-4328(02)00124-9; Pijlman FTA, 2002, BEHAV BRAIN RES, V134, P393, DOI 10.1016/S0166-4328(02)00053-0; Prager G, 2013, J NEUROIMMUNE PHARM, V8, P42, DOI 10.1007/s11481-012-9373-0; RAMSEY NF, 1993, BRAIN RES, V608, P216, DOI 10.1016/0006-8993(93)91461-Z; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sanchis L, 2015, EUR J CLIN INVEST, V45, P842, DOI 10.1111/eci.12479; Sevoz-Couche C, 2013, J PHYSIOL-LONDON, V591, P1871, DOI 10.1113/jphysiol.2012.247791; Sgoifo A, 1999, PHYSIOL BEHAV, V67, P733, DOI 10.1016/S0031-9384(99)00134-1; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Sgoifo A, 2014, NEUROSCI BIOBEHAV R, V39, P51, DOI 10.1016/j.neubiorev.2013.12.005; Shah BM, 2016, J IMMIGR MINOR HEALT, V18, P1317, DOI 10.1007/s10903-016-0367-5; Sial OK, 2016, J NEUROSCI METH, V258, P94, DOI 10.1016/j.jneumeth.2015.10.012; Sim YB, 2010, ARCH PHARM RES, V33, P1679, DOI 10.1007/s12272-010-1018-3; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Smith RW, 2007, ARCH PEDIAT ADOL MED, V161, P578, DOI 10.1001/archpedi.161.6.578; Sundstrom J, 2004, EUR HEART J, V25, P1509, DOI 10.1016/j.ehj.2004.05.029; Suzuki T, 2016, CIRC J, V80, P2482, DOI 10.1253/circj.CJ-16-0829; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Tarr AJ, 2012, BEHAV BRAIN RES, V235, P334, DOI 10.1016/j.bbr.2012.07.038; Trainor BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017405; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; Verkuil B, 2015, PSYCHOPHYSIOLOGY, V52, P1682, DOI 10.1111/psyp.12541; Vezzani A, 2011, BRAIN BEHAV IMMUN, V25, P1281, DOI 10.1016/j.bbi.2011.03.018; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang W, 2015, CARDIOLOGY, V132, P151, DOI 10.1159/000430885; Wang X, 2014, J NEUROSCI, V34, P6182, DOI 10.1523/JNEUROSCI.5093-13.2014; Warren BL, 2013, BIOL PSYCHIAT, V73, P7, DOI 10.1016/j.biopsych.2012.06.006; Weber MD, 2013, BRAIN BEHAV IMMUN, V32, P112, DOI 10.1016/j.bbi.2013.03.004; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wood CS, 2016, PHYSL BEHAV; Wood SK, 2016, NEUROSCIENCE AND BIO; Wood SK, 2015, BIOL PSYCHIAT, V78, P38, DOI 10.1016/j.biopsych.2014.10.026; Wood SK, 2013, BIOL PSYCHIAT, V73, P1087, DOI 10.1016/j.biopsych.2013.01.026; Wood SK, 2012, PSYCHOPHARMACOLOGY, V222, P325, DOI 10.1007/s00213-012-2648-6; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648	98	61	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172868	10.1371/journal.pone.0172868	http://dx.doi.org/10.1371/journal.pone.0172868			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241050	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400046
J	Simon, L; Funes, AK; Yapur, MA; Cabrillana, ME; Moncius, MA; Boarelli, PV; Vincenti, AE; Lancellotti, TES; Fornes, MW				Simon, Layla; Funes, Abi K.; Yapur, Martin A.; Cabrillana, Maria E.; Moncius, Maria A.; Boarelli, Paola V.; Vincenti, Amanda E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.			Manchette-acrosome disorders during spermiogenesis and low efficiency of seminiferous tubules in hypercholesterolemic rabbit model	PLOS ONE			English	Article							METABOLIC SYNDROME; SPERMATID HEAD; LIPID RAFTS; REPRODUCTIVE FUNCTION; MEMBRANE RAFTS; T-LYMPHOCYTES; SPERMATOGENESIS; CHOLESTEROL; TESTIS; PROTEINS	Hypercholesterolemia is a marker for several adult chronic diseases. Recently we demonstrated that sub/infertility is also associated to Hypercholesterolemia in rabbits. Seminal alterations included: abnormal sperm morphology, decreased sperm number and declined percentage of motile sperm, among others. In this work, our objective was to evaluate the effects of hypercholesterolemia on testicular efficiency and spermiogenesis, as the latter are directly related to sperm number and morphology respectively. Tubular efficiency was determined by comparing total number of spermatogenic cells with each cell type within the proliferation/differentiation compartments. We found lower testicular efficiency related to both a decrease in spermatogonial cells and an increase in germ cell apoptosis in hypercholesterolemic rabbits. On the other hand, spermiogenesis-the last step of spermatogenesis involved in sperm shaping-was detaily analyzed, particularly the acrosome-nucleus-manchette complex. The manchette is a microtubular-based temporary structure responsible in sperm cell elongation. We analyzed the contribution of actin filaments and raft microdomains in the arrangement of the manchette. Under fluorescence microscopy, spermatocyte to sperm cell development was followed in cells isolated from V to VIII tubular stages. In cells from hypercholesterolemic rabbits, abnormal development of acrosome, nucleus and inaccurate tail implantation were associated with actin-alpha-tubulin-GM1 sphingolipid altered distribution. Morphological alterations were also observed at electron microscopy. We demonstrated for the first time that GM1-enriched microdomains together with actin filaments and microtubules are involved in allowing the correct anchoring of the manchette complex. In conclusion, cholesterol enriched diets promote male fertility alterations by affecting critical steps in sperm development: spermatogenesis and spermiogenesis. It was also demonstrated that hypercholesterolemic rabbit model is a useful tool to study serum cholesterol increment linked to sub/infertility.	[Simon, Layla; Funes, Abi K.; Yapur, Martin A.; Cabrillana, Maria E.; Moncius, Maria A.; Boarelli, Paola V.; Vincenti, Amanda E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.] Univ Nacl Cuyo, Fac Ciencias Med, LIAM, Inst & Area Histol & Embriol IHEM, Mendoza, Argentina; [Simon, Layla; Funes, Abi K.; Yapur, Martin A.; Cabrillana, Maria E.; Moncius, Maria A.; Boarelli, Paola V.; Vincenti, Amanda E.; Saez Lancellotti, Tania E.; Fornes, Miguel W.] Consejo Nacl Invest Cient & Tecn, CCT, Mendoza, Argentina; [Simon, Layla; Cabrillana, Maria E.; Moncius, Maria A.; Boarelli, Paola V.; Saez Lancellotti, Tania E.; Fornes, Miguel W.] Univ Aconcagua, Fac Ciencias Med, Inst Invest, Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fornes, MW (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, LIAM, Inst & Area Histol & Embriol IHEM, Mendoza, Argentina.; Fornes, MW (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT, Mendoza, Argentina.; Fornes, MW (corresponding author), Univ Aconcagua, Fac Ciencias Med, Inst Invest, Mendoza, Argentina.	mfornes@fcm.uncu.edu.ar	Lancellotti, T Estefania Saez/AAV-4007-2020	Lancellotti, T Estefania Saez/0000-0001-8830-6482; Funes, Abi/0000-0002-6540-3324; Cabrillana, Maria Eugenia/0000-0001-6794-8603	PIP (Proyectos de Investigacion Plurianuales); Conicet (Consejo Nacional de Investigaciones Cientfficas y Tecnicas); SECTyP (Secretaria de Ciencia, Tecnica y Posgrado); UNCuyo y CIUDA (Universidad Nacional de Cuyo, Consejo de Investigaciones de la Universidad del Aconcagua); UDA (Universidad del Aconcagua)	PIP (Proyectos de Investigacion Plurianuales); Conicet (Consejo Nacional de Investigaciones Cientfficas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECTyP (Secretaria de Ciencia, Tecnica y Posgrado); UNCuyo y CIUDA (Universidad Nacional de Cuyo, Consejo de Investigaciones de la Universidad del Aconcagua); UDA (Universidad del Aconcagua)	Support was provided by PIP (Proyectos de Investigacion Plurianuales), Conicet (Consejo Nacional de Investigaciones Cientfficas y Tecnicas); SECTyP (Secretaria de Ciencia, Tecnica y Posgrado), UNCuyo y CIUDA (Universidad Nacional de Cuyo, Consejo de Investigaciones de la Universidad del Aconcagua), and UDA (Universidad del Aconcagua).	ABDOU MSS, 1978, AUST J BIOL SCI, V31, P257, DOI 10.1071/BI9780257; Ashrafi H, 2013, AFR J TRADIT COMPLEM, V10, P277, DOI 10.4314/ajtcam.v10i2.12; Bataineh HN, 2005, SAUDI MED J, V26, P398; BERNDSTON WE, 1974, AM J ANAT, V140, P167, DOI 10.1002/aja.1001400204; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; Chemes HE, 2010, CELL TISSUE RES, V341, P349, DOI 10.1007/s00441-010-1007-3; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Goudenege S, 2007, PROTEOMICS, V7, P3289, DOI 10.1002/pmic.200700124; Guan YJ, 2014, ANIM REPROD SCI, V149, P163, DOI 10.1016/j.anireprosci.2014.07.014; GUPTA RS, 1988, Z ERNAHRUNGSWISS, V27, P236, DOI 10.1007/BF02019512; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Jain A, 2015, ANDROLOGY LOS ANGEL, V4, DOI [10.4172/2167-0250.1000141, DOI 10.4172/2167-0250.1000141]; JOHNSON L, 1995, MICROSC RES TECHNIQ, V32, P385, DOI 10.1002/jemt.1070320504; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kannan KB, 2007, J IMMUNOL, V178, P5253, DOI 10.4049/jimmunol.178.8.5253; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Lancellotti TES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052386; Larbi A, 2004, J LEUKOCYTE BIOL, V75, P373, DOI 10.1189/jlb.0703319; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Leisegang K, 2014, ANDROLOGIA, V46, P167, DOI 10.1111/and.12060; Marchiani S, 2015, MOL CELL ENDOCRINOL, V401, P12, DOI 10.1016/j.mce.2014.11.005; Martincic DS, 2001, PFLUGERS ARCH, V442, P59; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; MOLLENHAUER HH, 1976, J MICROSC BIOL CELL, V27, P33; MORTON D, 1986, VET PATHOL, V23, P214, DOI 10.1177/030098588602300221; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; PARVINEN LM, 1978, EXP PATHOL-JENA, V15, P85, DOI 10.1016/S0014-4908(78)80072-6; Purohit Ashok, 1999, Indian Journal of Experimental Biology, V37, P396; Rosety I, 2014, REV MED CHILE, V142, P732, DOI 10.4067/S0034-98872014000600007; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Shalaby MA, 2004, PHARMACOL RES, V50, P137, DOI 10.1016/j.phrs.2003.10.013; Shimamoto K, 1988, YONAGO ACTA MED, V41, P23; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki T, 2011, J NEUROCHEM, V119, P64, DOI 10.1111/j.1471-4159.2011.07404.x; SWIERSTRA EE, 1963, J REPROD FERTIL, V5, P309, DOI 10.1530/jrf.0.0050309; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tanaka M, 2001, ENDOCR RES, V27, P109, DOI 10.1081/ERC-100107174; Theau-Clement M, 2015, ANIM REPROD SCI, V157, P33, DOI 10.1016/j.anireprosci.2015.03.011; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Whitehead SN, 2012, BIOSCI TRENDS, V6, P183, DOI 10.5582/bst.2012.v6.4.183; Whitfield M, 2015, ASIAN J ANDROL; WHO, SER INF TECN, V916; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yamamoto Y, 1999, HUM REPROD, V14, P1516, DOI 10.1093/humrep/14.6.1516	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172994	10.1371/journal.pone.0172994	http://dx.doi.org/10.1371/journal.pone.0172994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241054	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400055
J	Castro, LNG; Mehta, JH; Brayanov, JB; Mullen, GJ				Castro, Luis N. Gonzalez; Mehta, Jaideep H.; Brayanov, Jordan B.; Mullen, Gary J.			Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SURGICAL-PATIENTS; PULSE OXIMETRY; ANESTHESIA; ALARMS	Background Pre-operative administration of benzodiazepines can cause hypoventilation-a decrease in minute ventilation (MV)-commonly referred to as "respiratory compromise or respiratory depression." Respiratory depression can lead to hypercarbia and / or hypoxemia, and may heighten the risk of other respiratory complications. Current anesthesia practice often places patients at risk for respiratory complications even before surgery, as respiratory monitoring is generally postponed until the patient is in the operating room. In the present study we examined and quantified the onset of respiratory depression following the administration of a single dose of midazolam in pre-operative patients, using a non-invasive respiratory volume monitor that reports MV, tidal volume (TV), and respiratory rate (RR). Methods Impedance-based Respiratory Volume Monitor (RVM) data were collected and analyzed from 30 patients prior to undergoing orthopedic or general surgical procedures. All patients received 2.0 mg of midazolam intravenously at least 20 minutes prior to the induction of anesthesia and the effects of midazolam on the patient's respiratory function were analyzed. Results Within 15 minutes of midazolam administration, we noted a significant decrease in both MV (average decrease of 14.3% +/- 5.9%, p<0.05) and TV (22.3% +/- 4.5%, p<0.001). Interestingly, the corresponding RR increased significantly by an average of 10.3% +/- 4.7% (p<0.05). Further analysis revealed an age-dependent response, in which elderly patients (age >= 65 years, n = 6) demonstrated greater reductions in MV and TV and a lack of compensatory RR increase. In fact, elderly patients experienced an average decrease in MV of 34% +/- 6% (p<0.05) compared to an average decrease of 9% +/- 6% (p<0.05) in younger patients. Conclusions We were able to quantify the effects of pre-operative midazolam administration on clinically significant respiratory parameters (MV, TV and RR) using a non-invasive RVM, uncovering that the respiratory depressive effect of benzodiazepines affect primarily TV rather than RR. Such respiratory monitoring data provide the opportunity for individualizing dosing and adjustment of clinical interventions, especially important in elderly patients. With additional respiratory data, clinicians may be able to better identify and quantify respiratory depression, reduce adverse effects, and improve overall patient safety.	[Castro, Luis N. Gonzalez] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mehta, Jaideep H.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA; [Brayanov, Jordan B.] Resp Motion Inc, Res Dept, Waltham, MA USA; [Mullen, Gary J.] Vidant Med Ctr, Dept Anesthesiol, Greenville, NC USA	Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston	Mehta, JH (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX 77030 USA.	Jaideep.H.Mehta@uth.tmc.edu	Castro, Luis Gonzalez/ABN-9912-2022	Castro, Luis Gonzalez/0000-0001-7699-5188	Respiratory Motion Inc.	Respiratory Motion Inc.	Respiratory Motion Inc. provided the devices used for data collection in this study. Jordan Brayanov, an employee of Respiratory Motion Inc., collaborated with co-authors on data analysis, manuscript preparation, and publication decision. Respiratory Motion Inc. provided support in the form of salaries for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bogunovic OJ, 2004, PSYCHIAT SERV, V55, P233, DOI 10.1176/appi.ps.55.3.233; Cheifetz IM, 2007, RESP CARE, V52, P636; D'Mello J, 2002, INDIAN J ANAESTH, V46, P269; Dundee J W, 1992, Anesth Prog, V39, P132; FORSTER A, 1980, ANESTHESIOLOGY, V53, P494, DOI 10.1097/00000542-198012000-00010; Goodchild MF, 1990, ASA REFRESHER LECTUR, V18, P175; GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006; Jubran A, 1999, CRIT CARE, V3, pR11, DOI 10.1186/cc341; Krauss B, 2008, ADV NONINTUBATED CAP, P8; LAWLESS ST, 1994, CRIT CARE MED, V22, P981, DOI 10.1097/00003246-199406000-00017; LIU SY, 1992, CHEST, V102, P1512, DOI 10.1378/chest.102.5.1512; Lynn LA, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-3; Nordt Sean Patrick, 1997, Journal of Emergency Medicine, V15, P357; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Schmid F, 2013, CRIT CARE, V17, DOI 10.1186/cc12525; Taenzer AH, 2010, ANESTHESIOLOGY, V112, P282, DOI 10.1097/ALN.0b013e3181ca7a9b; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Voscopoulos C, 2013, ANESTH ANALG, V117, P91, DOI 10.1213/ANE.0b013e3182918098; Voscopoulos CJ, 2015, J CLIN MONIT COMPUT, V29, P223, DOI 10.1007/s10877-014-9596-0; Voscopoulos CJ, 2014, J TRAUMA ACUTE CARE, V77, pS208, DOI 10.1097/TA.0000000000000400	20	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172750	10.1371/journal.pone.0172750	http://dx.doi.org/10.1371/journal.pone.0172750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235069	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200129
J	Kato, S; Murakami, H; Inaki, A; Mochizuki, T; Demura, S; Nakase, J; Yoshioka, K; Yokogawa, N; Igarashi, T; Takahashi, N; Yonezawa, N; Kinuya, S; Tsuchiya, H				Kato, Satoshi; Murakami, Hideki; Inaki, Anri; Mochizuki, Takafumi; Demura, Satoru; Nakase, Junsuke; Yoshioka, Katsuhito; Yokogawa, Noriaki; Igarashi, Takashi; Takahashi, Naoki; Yonezawa, Noritaka; Kinuya, Seigo; Tsuchiya, Hiroyuki			Innovative exercise device for the abdominal trunk muscles: An early validation study	PLOS ONE			English	Article							LOW-BACK-PAIN; EVIDENCE-INFORMED MANAGEMENT; GLUCOSE-UPTAKE; OLDER-ADULTS; REHABILITATION; STIMULATION; DISABILITY	Background Exercise is one of the few treatments that provide significant improvements in chronic low back pain (CLBP). We developed an innovative exercise device for abdominal trunk muscles. This device can be used in a sitting or standing position and contains a built-in system to measure abdominal trunk muscle strength. We examined whether subjects can adequately use the device to perform the exercises and measure their abdominal trunk muscle strength. Methods We collected data on the body height, body weight, body mass index, and girth of 30 healthy male volunteers, and measured their grip power and trunk extensor muscle strength using a dynamometer. The volunteers performed a sit-up test as an indicator of trunk flexor muscle strength, and we measured their abdominal muscle strength using the device. We then evaluated the correlations between abdominal trunk muscle strength and anthropometric parameters as well as the strength of other muscles. In subsequent tests, 5 of the 30 subjects participated in two positron emission tomography (PET) series consisting of examinations after a resting period (control study) and during exercise (exercise study). For the exercise study, the subjects performed 2 sets of exercises for 20 minutes using the device before and after an injection of 18 F-fluorodeoxyglucose (FDG). PET-computed tomography images were obtained 60 minutes after FDG injection in each study. We compared the skeletal muscle metabolism of the participants in both studies using the standardized uptake value. Results The muscle strength measured by the device and the 30-second sit-up frequency were correlated. FDG accumulation within the diaphragm and abdominal rectus muscles was significantly higher in the exercise study. Conclusion Our innovative exercise device facilitates a coordinated contraction of the abdominal trunk muscles at the anterior aspect and the roof of the core, and enables subjects to measure the strength of these muscles.	[Kato, Satoshi; Murakami, Hideki; Demura, Satoru; Nakase, Junsuke; Yoshioka, Katsuhito; Yokogawa, Noriaki; Igarashi, Takashi; Takahashi, Naoki; Yonezawa, Noritaka; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan; [Inaki, Anri; Kinuya, Seigo] Kanazawa Univ, Dept Nucl Med Biotracer Med, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan; [Mochizuki, Takafumi] Kanazawa Adv Med Ctr, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Kato, S (corresponding author), Kanazawa Univ, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan.	skato323@gmail.com	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	Daiwa Securities Health Foundation [42-18]; Suzuken Memorial Foundation [15-011]	Daiwa Securities Health Foundation; Suzuken Memorial Foundation	This research was supported by the Daiwa Securities Health Foundation (grant number:42-18, http://www.daiwa-grp.jp/dsh/) and the Suzuken Memorial Foundation (grant number:15-011, http://www.suzukenzaidan.or.jp/ index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparetion of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Akuthota V, 2004, ARCH PHYS MED REHAB, V85, pS86, DOI 10.1053/j.apmr.2003.12.005; Akuthota V, 2008, CURR SPORT MED REP, V7, P39, DOI 10.1097/01.CSMR.0000308663.13278.69; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1895, DOI 10.1152/japplphysiol.00671.2010; Bronfort G, 2008, SPINE J, V8, P213, DOI 10.1016/j.spinee.2007.10.023; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coyle PC, 2016, PAIN MED; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Fatemi R, 2015, J BACK MUSCULOSKELET, V28, P591, DOI 10.3233/BMR-150585; Fujimoto T, 2000, EUR J APPL PHYSIOL, V83, P297, DOI 10.1007/s004210000254; Hayden J A, 2005, Cochrane Database Syst Rev, pCD000335; Iversen MD, 2003, ARCH PHYS MED REHAB, V84, P1324, DOI 10.1016/S0003-9993(03)00198-9; Kavcic N, 2004, SPINE, V29, P1254, DOI 10.1097/00007632-200406010-00016; Kemppainen J, 2002, J PHYSIOL-LONDON, V542, P403, DOI 10.1113/jphysiol.2002.018135; Kolt GS, 2003, MANUAL THER, V8, P110, DOI 10.1016/S1356-689X(02)00156-X; Lizier DT, 2012, REV BRAS ANESTESIOL, V62, P838, DOI 10.1590/S0034-70942012000600008; Mannion AF, 2009, EUR SPINE J, V18, P1881, DOI 10.1007/s00586-009-1093-7; Mayer J, 2008, SPINE J, V8, P96, DOI 10.1016/j.spinee.2007.09.008; McGill S, 2007, LOW BACK DISORDERS E; Meng XG, 2015, AM J PHYS MED REHAB, V94, P358, DOI 10.1097/PHM.0000000000000188; Nakase J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073898; Numata H, 2016, J ORTHOP SCI, V21, P53, DOI 10.1016/j.jos.2015.09.003; Oesch P, 2010, J REHABIL MED, V42, P193, DOI 10.2340/16501977-0524; Ohnuma M, 2006, J ORTHOP SCI, V11, P42, DOI 10.1007/s00776-005-0972-y; Pappas GP, 2001, J APPL PHYSIOL, V90, P329, DOI 10.1152/jappl.2001.90.1.329; Patti A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000383; Phillips EM, 2004, ARCH PHYS MED REHAB, V85, pS52, DOI 10.1016/j.apmr.2004.03.012; Poitras S, 2008, SPINE J, V8, P226, DOI 10.1016/j.spinee.2007.10.022; Richardson C A, 1995, Man Ther, V1, P2, DOI 10.1054/math.1995.0243; Rudy TE, 2007, PAIN, V131, P293, DOI 10.1016/j.pain.2007.01.012; Saragiotto BT, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012004; Slade SC, 2006, J MANIP PHYSIOL THER, V29, P163, DOI 10.1016/j.jmpt.2005.12.011; Standaert CJ, 2008, SPINE J, V8, P114, DOI 10.1016/j.spinee.2007.10.015; Stanton TR, 2010, EUR SPINE J, V19, P533, DOI 10.1007/s00586-009-1214-3	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172934	10.1371/journal.pone.0172934	http://dx.doi.org/10.1371/journal.pone.0172934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235060	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200173
J	Kone, CT; Mathias, JD; De Sousa, G				Kone, Cheick Tidjane; Mathias, Jean-Denis; De Sousa, Gil			Adaptive management of energy consumption, reliability and delay of wireless sensor node: Application to IEEE 802.15.4 wireless sensor node	PLOS ONE			English	Article							VIABILITY THEORY; PERFORMANCE; NETWORK; MODEL; PROTOCOL; SYSTEM	Designing a Wireless Sensor Network (WSN) to achieve a high Quality of Service (QoS) (network performance and durability) is a challenging problem. We address it by focusing on the performance of the 802.15.4 communication protocol because the IEEE 802.15.4 Standard is actually considered as one of the reference technologies in WSNs. In this paper, we propose to control the sustainable use of resources (i.e., energy consumption, reliability and timely packet transmission) of a wireless sensor node equipped with photovoltaic cells by an adaptive tuning not only of the MAC (Medium Access Control) parameters but also of the sampling frequency of the node. To do this, we use one of the existing control approaches, namely the viability theory, which aims to preserve the functions and the controls of a dynamic system in a set of desirable states. So, an analytical model, describing the evolution over time of nodal resources, is derived and used by a viability algorithm for the adaptive tuning of the IEEE 802.15.4 MAC protocol. The simulation analysis shows that our solution allows ensuring indefinitely, in the absence of hardware failure, the operations (lifetime duration, reliability and timely packet transmission) of an 802.15.4 WSN and one can temporarily increase the sampling frequency of the node beyond the regular sampling one. This latter brings advantages for agricultural and environmental applications such as precision agriculture, flood or fire prevention. Main results show that our current approach enable to send more information when critical events occur without the node runs out of energy. Finally, we argue that our approach is generic and can be applied to other types of WSN.	[Kone, Cheick Tidjane] Esatic, DRIT, Abidjan, Cote Ivoire; [Mathias, Jean-Denis] Irstea, UR LISC, Aubiere, France; [De Sousa, Gil] Irstea, UR TSCF, Aubiere, France	INRAE; INRAE	Kone, CT (corresponding author), Esatic, DRIT, Abidjan, Cote Ivoire.	cheick.tidjane.kone@gmail.com	Mathias, Jean-Denis/R-5391-2016	Mathias, Jean-Denis/0000-0002-6172-9079	Auvergne region; European Regional Development Fund (ERDF)	Auvergne region(Region Auvergne-Rhone-Alpes); European Regional Development Fund (ERDF)(European Commission)	This research is partly supported by the grant of Auvergne region (www.auvergne.fr/) and the grant of the European Regional Development Fund (ERDF): http://ec.europa.eu/regional_policy/en/funding/erdf/.; This research is partly supported by the grant of Auvergne region and the grant of the European Regional Development Fund (ERDF).	Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Al-Nabhan N, 2014, IEEE SENS J, V14, P3782, DOI 10.1109/JSEN.2014.2329735; Anastasi G, 2011, IEEE T IND INFORM, V7, P52, DOI 10.1109/TII.2010.2085440; [Anonymous], 2006, WIRELESS MEDIUM ACCE; [Anonymous], 2001, PANARCHY UNDERSTANDI; Aubin J.P., 1991, VIABILITY THEORY; Brias A, 2016, COMPUT MANAG SCI, V13, P371, DOI 10.1007/s10287-015-0246-x; Crossbow Technology Inc, 2007, CROSSB MOT STARG XSC; Dunkels A, 2004, CONF LOCAL COMPUT NE, P455; Emmert-Streib F, 2016, INFORM SCIENCES, V346, P180, DOI 10.1016/j.ins.2016.01.074; Jean-Denis Mathias, 2017, SCI REPORTS IN PRESS; Kone CT, 2015, IEEE SENS J, V15, P5734, DOI 10.1109/JSEN.2015.2442259; Kone CT, 2015, INT J SENS NETW, V17, P263, DOI 10.1504/IJSNET.2015.069581; Kone CT, 2010, P IWCMC CAEN FRANC, P691, DOI [10.1016/j.comcom.2014.02.003, DOI 10.1016/J.COMCOM.2014.02.003]; Koubaa A, 2006, P 2 WORKSH REAL TIM, P574; Levis P, 2005, AMBIENT INTELLIGENCE, P115; Libelium Comunicaciones Distribuidas S L, 2012, WASPM TECHN GUID; Lorenzo E, 1994, SOLAR ELECT ENG PHOT; Ma Z, 2016, ENG COMPUTATION, V33, P2448, DOI 10.1108/EC-09-2015-0269; Markvart T., 1994, SOLAR ELECT, P0; Mathias JD, 2017, INT J COMMO IN PRESS; Mathias JD, 2015, ENVIRON MANAGE, V56, P1170, DOI 10.1007/s00267-015-0555-4; Pangun Park, 2009, 2009 IEEE 6th International Conference on Mobile Adhoc and Sensor Systems. MASS 2009, P130, DOI 10.1109/MOBHOC.2009.5337007; Park P, 2011, TECH REP; Park P, 2013, IEEE T PARALL DISTR, V24, P550, DOI 10.1109/TPDS.2012.159; Pollin S, 2008, IEEE T WIREL COMMUN, V7, P3359, DOI 10.1109/TWC.2008.060057; Rouge C, 2013, ECOL INDIC, V29, P420, DOI 10.1016/j.ecolind.2012.12.032; Sahota H, 2011, WIREL COMMUN MOB COM, V11, P1628, DOI 10.1002/wcm.1229; SAINTPIERRE P, 1994, APPL MATH OPT, V29, P187, DOI 10.1007/BF01204182; Souil M, 2014, COMPUT COMMUN, V43, P16, DOI 10.1016/j.comcom.2014.02.003; Sukamongkol Y, 2002, RENEW ENERG, V27, P237, DOI 10.1016/S0960-1481(02)00002-2; Tichit M, 2007, ECOL MODEL, V206, P277, DOI 10.1016/j.ecolmodel.2007.03.043; Willig A, 2008, IEEE T IND INFORM, V4, P102, DOI 10.1109/TII.2008.923194; Yedavalli K, 2008, 2008 6TH INTERNATIONAL SYMPOSIUM ON MODELING AND OPTIMIZATION IN MOBILE, AD HOC AND WIRELESS NETWORKS AND WORKSHOPS, VOLS 1 AND 2, P144; Zayani MH, 2011, INT WIREL COMMUN, P814, DOI 10.1109/IWCMC.2011.5982651; Zhang DG, 2014, IEEE T IND INFORM, V10, P766, DOI 10.1109/TII.2013.2250910; Zhang DG, 2012, COMPUT ELECTR ENG, V38, P694, DOI 10.1016/j.compeleceng.2012.02.016	37	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172336	10.1371/journal.pone.0172336	http://dx.doi.org/10.1371/journal.pone.0172336			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235097	Green Published, gold			2022-12-27	WOS:000394688200069
J	Mosepele, M; Hemphill, LC; Palai, T; Nkele, I; Bennett, K; Lockman, S; Triant, VA				Mosepele, Mosepele; Hemphill, Linda C.; Palai, Tommy; Nkele, Isaac; Bennett, Kara; Lockman, Shahin; Triant, Virginia A.			Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; T-CELL COUNT; IMMUNE ACTIVATION; ELIGIBILITY; EVENTS; STROKE; ADULTS; WOMEN	Objectives HIV-infected patients are at increased risk for cardiovascular disease (CVD). However, general population CVD risk prediction equations that identify HIV-infected patients at elevated risk have not been widely assessed in sub-Saharan African (SSA). Methods HIV-infected adults from 30-50 years of age with documented viral suppression were enrolled into a cross-sectional study in Gaborone, Botswana. Participants were screened for CVD risk factors. Bilateral carotid intima-media thickness (cIMT) was measured and 10year predicted risk of cardiovascular disease was calculated using the Pooled Cohorts Equation for atherosclerotic CVD (ASCVD) and the 2008 Framingham Risk Score (FRS) (National Cholesterol Education Program III-NCEP III). ASCVD >= 7.5%, FRS >= 10%, and cIMT >= 75 th percentile were considered elevated risk for CVD. Agreement in classification of participants as high-risk for CVD by cIMT and FRS or ASCVD risk score was assessed using McNemar's Test. The optimal cIMT cut off-point that matched ASCVD predicted risk of >= 7.5% was assessed using Youden's J index. Results Among 208 HIV-infected patients (female: 55%, mean age 38 years), 78 (38%) met criteria for ASCVD calculation versus 130 (62%) who did not meet the criteria. ASCVD classified more participants as having elevated CVD risk than FRS (14.1% versus 2.6%, McNemar's exact test p = 0.01), while also classifying similar proportion of participants as having elevated CVD like cIMT (14.1% versus 19.2%, McNemar's exact test p = 0.34). Youden's J calculated the optimal cut point at the 81 st percentile for cIMT to correspond to an ASCVD score >= 7.5% (sensitivity = 72.7% and specificity = 88.1% with area under the curve for the receiver operating characteristic [AUC] of 0.82, 95% Mann-Whitney CI: 0.66-0.99). Conclusion While the ASCVD risk score classified more patients at elevated CVD risk than FRS, ASCVD score classified similar proportion of patients as high risk when compared with established subclinical atherosclerosis. However, potential CVD risk category mis-classification by established equations such as ASCVD may still exist among HIV-infected patients; hence there is still a need for development of a CVD risk prediction equation tailored to HIV-infected patients in SSA.	[Mosepele, Mosepele; Palai, Tommy] Univ Botswana, Dept Med, Fac Med, Gaborone, Botswana; [Hemphill, Linda C.] Massachusetts Gen Hosp, Ctr Heart, Div Cardiol, Boston, MA 02114 USA; [Hemphill, Linda C.; Triant, Virginia A.] Harvard Med Sch, Boston, MA USA; [Nkele, Isaac; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Bennett, Kara] Bennett Stat Consulting Inc, Ballston Lake, NY USA; [Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Triant, Virginia A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	University of Botswana; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Botswana-Harvard AIDS Institute Partnership; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Mosepele, M (corresponding author), Univ Botswana, Dept Med, Fac Med, Gaborone, Botswana.	mosepelemosepele@gmail.com			National Institute of Allergy and Infectious Diseases [5P30A1060354-0]; Harvard Global Health Institute, BWH [2013D002079]; Fogarty International Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132786, R56HL125029, R21HL122138] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Global Health Institute, BWH; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by The National Institute of Allergy and Infectious Diseases, 5P30A1060354-0; Harvard Global Health Institute, BWH#2013D002079, Dr. Mosepele Mosepele; Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begovac J, 2015, CROAT MED J, V56, P14, DOI 10.3325/cmj.2015.56.14; Benjamin LA, 2016, NEUROLOGY, V86, P324, DOI 10.1212/WNL.0000000000002278; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Cho YK, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003410; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Clement ME, 2016, CLIN INFECT DIS, V63, P407, DOI 10.1093/cid/ciw289; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Elsamadisi P, 2015, J PHARM PRACTICE; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Goff DC, 2013, CIRCULATION, V2014, P129, DOI DOI 10.1161/01.CIR.0000437741.48606; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanna DB, 2016, CLIN INFECT DIS, V63, P249, DOI 10.1093/cid/ciw261; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hoffmann M, 2000, J NEUROVIROL, V6, P229, DOI 10.3109/13550280009015825; Jacoby D, 2015, CLIN CARDIOL, V38, P280, DOI 10.1002/clc.22389; Johnson KM, 2014, J AM COLL CARDIOL, V64, P910, DOI 10.1016/j.jacc.2014.05.056; Jung CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137478; Kandula NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001117; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Kingery JR, 2016, HEART, V102, P1200, DOI 10.1136/heartjnl-2015-309026; Krikke M, 2016, HIV MED, V17, P289, DOI 10.1111/hiv.12300; Lee DG, 2015, KOREAN J FAM MED, V35, P310, DOI 10.4082/kjfm.2015.36.6.310; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Longenecker CT, 2016, CURR OPIN HIV AIDS, V11, P216, DOI 10.1097/COH.0000000000000227; Ludwig M, 2003, ULTRASCHALL MED, V24, P162, DOI 10.1055/s-2003-40058; Nery MW, 2013, SCI WORLD J, DOI 10.1155/2013/969281; Nou E, 2016, LANCET DIABETES ENDO, V4, P598, DOI 10.1016/S2213-8587(15)00388-5; Nou E, 2016, AIDS, V30, P1495, DOI 10.1097/QAD.0000000000001109; Pursnani A, 2015, JAMA-J AM MED ASSOC, V314, P134, DOI 10.1001/jama.2015.7515; Raggi P, 2016, J ANTIMICROBIAL CHEM; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Syed FF, 2013, HEART, V99, P1146, DOI 10.1136/heartjnl-2012-303177; Thompson-Paul A M, 2016, CLIN INFECT DIS OFFI; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vos AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147484; Walker RW, 2013, LANCET GLOB HEALTH, V1, pE282, DOI 10.1016/S2214-109X(13)70068-8; Zanni MV, 2014, AIDS, V28, P2061, DOI 10.1097/QAD.0000000000000360	40	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172897	10.1371/journal.pone.0172897	http://dx.doi.org/10.1371/journal.pone.0172897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235058	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200164
J	Sridhar, A; Ross, GA; Biggin, PC				Sridhar, Akshay; Ross, Gregory A.; Biggin, Philip C.			Waterdock 2.0: Water placement prediction for Holo-structures with a pymol plugin	PLOS ONE			English	Article							EFFICIENT GENERATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; AM1-BCC MODEL; BINDING-SITES; DOCKING; HYDRATION; DESIGN; SPECIFICITY; AFFINITIES	Water is often found to mediate interactions between a ligand and a protein. It can play a significant role in orientating the ligand within a binding pocket and contribute to the free energy of binding. It would thus be extremely useful to be able to accurately predict the position and orientation of water molecules within a binding pocket. Recently, we developed the WaterDock protocol that was able to predict 97% of the water molecules in a test set. However, this approach generated false positives at a rate of over 20% in most cases and whilst this might be acceptable for some applications, in high throughput scenarios this is not desirable. Here we tackle this problem via the inclusion of knowledge regarding the solvation structure of ligand functional groups. We call this new protocol WaterDock2 and demonstrate that this protocol maintains a similar true positive rate to the original implementation but is capable of reducing the false-positive rate by over 50%. To improve the usability of the method, we have also developed a plugin for the popular graphics program PyMOL. The plugin also contains an implementation of the original WaterDock.	[Sridhar, Akshay; Ross, Gregory A.; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford, England; [Sridhar, Akshay] Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge, England; [Ross, Gregory A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	University of Oxford; University of Cambridge; Memorial Sloan Kettering Cancer Center	Biggin, PC (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.	Philip.biggin@bioch.ox.ac.uk	Ross, Gregory/AAA-5568-2021	Biggin, Philip/0000-0001-5100-8836	Memorial Sloan Kettering Cancer Center, NIH [P30 CA008748]	Memorial Sloan Kettering Cancer Center, NIH	GAR is supported by the Memorial Sloan Kettering Cancer Center, NIH grant P30 CA008748. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Afanasyeva A, 2015, J COMPUT CHEM, V36, P1973, DOI 10.1002/jcc.24022; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Amadasi A, 2008, J MED CHEM, V51, P1063, DOI 10.1021/jm701023h; Amiri S, 2007, PROTEIN ENG DES SEL, V20, P353, DOI 10.1093/protein/gzm029; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Callear SK, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4904291; Carugo O, 1999, ACTA CRYSTALLOGR D, V55, P479, DOI 10.1107/S0907444998012086; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chung E, 1998, STRUCTURE, V6, P1141, DOI 10.1016/S0969-2126(98)00115-4; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DENISOV VP, 1995, BIOCHEMISTRY-US, V34, P9046, DOI 10.1021/bi00028a013; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garcia-Sosa AT, 2010, MOL INFORM, V29, P589, DOI 10.1002/minf.201000007; Garcia-Sosa AT, 2003, J MOL MODEL, V9, P172, DOI 10.1007/s00894-003-0129-x; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Henao A, 2016, PHYS CHEM CHEM PHYS, V18, P23006, DOI 10.1039/c6cp04183c; Henchman RH, 2002, J COMPUT CHEM, V23, P861, DOI 10.1002/jcc.10074; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hu BJ, 2014, J COMPUT CHEM, V35, P1255, DOI 10.1002/jcc.23616; Huang N, 2008, J MED CHEM, V51, P4862, DOI 10.1021/jm8006239; Hussain A, 2010, J COMPUT AID MOL DES, V24, P1, DOI 10.1007/s10822-009-9307-y; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Johnston AJ, 2016, PHYS CHEM CHEM PHYS, V18, P991, DOI 10.1039/c5cp06090g; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; KARPLUS PA, 1994, CURR OPIN STRUC BIOL, V4, P770, DOI 10.1016/S0959-440X(94)90178-3; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087; Lemmon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067536; Lie MA, 2011, J CHEM INF MODEL, V51, P909, DOI 10.1021/ci100510m; Lopez ED, 2015, BIOINFORMATICS, V31, P3697, DOI 10.1093/bioinformatics/btv411; Lu YP, 2007, J CHEM INF MODEL, V47, P668, DOI 10.1021/ci6003527; Mancera RL, 2007, CURR OPIN DRUG DISC, V10, P275; Mancera RL, 2002, J COMPUT AID MOL DES, V16, P479, DOI 10.1023/A:1021273501447; Modenutti C, 2015, GLYCOBIOLOGY, V25, P181, DOI 10.1093/glycob/cwu102; Morozenko A, 2016, PROTEINS, V84, P1347, DOI 10.1002/prot.25081; Morozenko A, 2014, J CHEM THEORY COMPUT, V10, P4618, DOI 10.1021/ct500358r; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PITT WR, 1991, PROTEIN ENG, V4, P531, DOI 10.1093/protein/4.5.531; POOLE PL, 1983, INT J BIOL MACROMOL, V5, P308, DOI 10.1016/0141-8130(83)90047-8; QUIOCHO FA, 1989, NATURE, V340, P404, DOI 10.1038/340404a0; Raghavendra B, 2006, PHYS CHEM CHEM PHYS, V8, P5276, DOI 10.1039/b611033a; Raman EP, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817344; Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1; Ross GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032036; Rossato G, 2011, J CHEM INF MODEL, V51, P1867, DOI 10.1021/ci200150p; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Setny P, 2010, J PHYS CHEM B, V114, P8667, DOI 10.1021/jp102462s; Sindhikara DJ, 2012, J COMPUT CHEM, V33, P1536, DOI 10.1002/jcc.22984; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sridhar A, 2016, PHYS CHEM CHEM PHYS, V18, P22416, DOI 10.1039/c6cp02645a; Taha MO, 2011, J CHEM INF MODEL, V51, P647, DOI 10.1021/ci100368t; Tame JRH, 1998, NAT STRUCT BIOL, P998; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 1999, J MOL BIOL, V289, P1093, DOI 10.1006/jmbi.1999.2809; Vogt J, 2000, PROTEINS, V41, P545, DOI 10.1002/1097-0134(20001201)41:4<545::AID-PROT110>3.0.CO;2-8; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	67	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172743	10.1371/journal.pone.0172743	http://dx.doi.org/10.1371/journal.pone.0172743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235019	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200126
J	Chisha, Y; Terefe, W; Assefa, H; Lakew, S				Chisha, Yilma; Terefe, Wondwossen; Assefa, Huruy; Lakew, Serawit			Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study	PLOS ONE			English	Article								Background Currently 93 million people are estimated as living with diabetic retinopathy worldwide. The prevalence and risk factors of diabetic retinopathy in developed countries have been well documented; but in Ethiopia, data on prevalence and associated factors of diabetic retinopathy is lacking. Objective To determine prevalence and factors associated with development of diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia. Method Cross-sectional study design with record review of 400 diabetic patients was conducted at Arbaminch General Hospital from November to January 2015. Among 400 diabetic patients, 270 patients with baseline information and without history of hypertension at baseline were included in this study. But patients with gestational diabetes and with retinopathy at baseline were excluded from the study. Consecutive sampling technique was applied to select study participants. Data of cohorts was extracted from medical record using pre tested structured extraction check list. Data cleaning, coding, categorizing, merging and analysis carried out by STATA version 12. Descriptive statistics was done and presented accordingly. Bivariate binary logistic regression analysis was done to select potential candidates for the full model at P-value cutoff point <= 0.25 and multivariable binary logistic regression analysis was made to estimate the independent effect of predictors on the occurrence of diabetic retinopathy. Model diagnostic tests were done, final model fitness was checked using Hosmer and Lemeshow chi square test. Finally, statistical significance was tested at P-value <0.05. Result Prevalence of diabetic retinopathy among diabetic patients at Arbaminch General Hospital was 13%. Adjusted analysis showed that the odds of diabetic retinopathy were statistically and significantly associated with baseline age (AOR = 6.06: 95% CI; 2.42, 15.21), baseline systolic blood pressure level (AOR = 4.38: 95% CI; 1.64, 11.68), family history of diabetes (AOR = 0.22: 95% CI; 0.08, 0.58) and duration of diabetes (AOR = 8.84: 95% CI; 3.56, 12.89). Conclusion and recommendation In the current study, prevalence of diabetic retinopathy was 13%. Since baseline age >= 60 years, baseline systolic blood pressure level >140 mmhg, duration of diabetes >= 6 years and patients with family history of diabetes were statistically and significantly related with diabetic retinopathy, special care should be given in addition to routine care.	[Chisha, Yilma] Arbaminch Coll Hlth Sci, Dept Biostat & Hlth Informat, Arbaminch, Ethiopia; [Terefe, Wondwossen; Assefa, Huruy] Mekelle Univ, Dept Biostat, Mekelle, Ethiopia; [Lakew, Serawit] Wolaita Sodo Univ, Dept Matern & Reprod Hlth Nursing, Wolaita, Ethiopia	Mekelle University	Lakew, S (corresponding author), Wolaita Sodo Univ, Dept Matern & Reprod Hlth Nursing, Wolaita, Ethiopia.	lserawit@yahoo.com	Chisha, Yilma/GOH-2697-2022		World Bank	World Bank(The World Bank India)	This work was World Bank sponsored, because this is from sub-Saharan Africa.	Almahdi S., 2013, MED SCI, V2, P512; [Anonymous], 2008, VIS 2020THE RIGHT SI; Brazionis L., 2008, HOMOCYSTEINE DIABETI, V31, P50, DOI [10.2337/dc07-0632, DOI 10.2337/DC07-0632]; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Dormann CF, 2012, NORDIC SOC OIKOS, V1, pEV1; Fauci Anthony S., 2008, HARRISONS PRINCIPLES, V2; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; IDA, 2011, DIAB FACTS; IDF, 2011, DIAB DEV WORLD 2011; Jones CD, 2012, DIABETES CARE, V35, P592, DOI 10.2337/dc11-0943; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; Roaeid R.B., 2011, J DIABETOLOGY, V3, P1; Sleire Lene, 2011, THESIS; Surrena H., 2010, HDB BRUNNER SUDDARTH, V4; WHO, 2016, GLOB REP PSOR; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	18	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171987	10.1371/journal.pone.0171987	http://dx.doi.org/10.1371/journal.pone.0171987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253261	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300010
J	Connolly, A; Vigmond, E; Bishop, M				Connolly, Adam; Vigmond, Edward; Bishop, Martin			Virtual electrodes around anatomical structures and their roles in defibrillation	PLOS ONE			English	Article							CARDIAC TISSUE; FIELD STIMULATION; VENTRICULAR-FIBRILLATION; CORONARY VASCULATURE; PHOTON SCATTERING; ENERGY; HETEROGENEITY; SIMULATIONS; ARRHYTHMIAS; TERMINATION	Background Virtual electrodes from structural/conductivity heterogeneities are known to elicit wavefront propagation, upon field-stimulation, and are thought to be important for defibrillation. In this work we investigate how the constitutive and geometrical parameters associated with such anatomical heterogeneities, represented by endo/epicardial surfaces and intramural surfaces in the form of blood-vessels, affect the virtual electrode patterns produced. Methods and results The steady-state bidomain model is used to obtain, using analytical and numerical methods, the virtual electrode patterns created around idealized endocardial trabeculations and blood-vessels. The virtual electrode pattern around blood-vessels is shown to be composed of two dominant effects; current traversing the vessel surface and conductivity heterogeneity from the fibre-architecture. The relative magnitudes of these two effects explain the swapping of the virtual electrode polarity observed, as a function of the vessel radius, and aid in the understanding of the virtual electrode patterns predicted by numerical bidomain modelling. The relatively high conductivity of blood, compared to myocardium, is shown to cause stronger depolarizations in the endocardial trabeculae grooves than the protrusions. Conclusions The results provide additional quantitative understanding of the virtual electrodes produced by small-scale ventricular anatomy, and highlight the importance of faithfully representing the physiology and the physics in the context of computational modelling of field stimulation.	[Connolly, Adam; Bishop, Martin] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England; [Vigmond, Edward] Fdn Bordeaux Univ, Electrophysiol & Heart Modeling Inst, IHU Liryc, F-33600 Pessac, France; [Vigmond, Edward] Univ Bordeaux, IMB, UMR 5251, F-33400 Talence, France	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite de Bordeaux	Connolly, A (corresponding author), Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England.	adam.connolly@kcl.ac.uk		Bishop, Martin/0000-0002-6237-1902	National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Foundation Trust and King's College; Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC) [WT 088641/Z/09/Z]; British Heart Foundation [PG/14/66/30927]; Agence National de Recherche [ANR-13-MONU-0004-02]; MRC [MR/N011007/1] Funding Source: UKRI; Medical Research Council [MR/N011007/1] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Foundation Trust and King's College; Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Agence National de Recherche(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institute for Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Foundation Trust and King's College, in addition National to the Centre of Excellence in Medical Engineering funded by the Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC; WT 088641/Z/09/Z). The authors acknowledge the British Heart Foundation under project grant number PG/14/66/30927. EV was supported by the Agence National de Recherche grant ANR-13-MONU-0004-02.	Bayer JD, 2012, ANN BIOMED ENG, V40, P2243, DOI 10.1007/s10439-012-0593-5; Bishop M, 2009, LECT NOTES COMPUTER, P1; Bishop MJ, 2007, BIOPHYS J, V93, P3714, DOI 10.1529/biophysj.107.110981; Bishop MJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P210, DOI 10.1161/CIRCEP.111.965095; Bishop MJ, 2011, BIOPHYS J, V101, P2871, DOI 10.1016/j.bpj.2011.10.052; Bishop MJ, 2011, BIOPHYS J, V101, P307, DOI 10.1016/j.bpj.2011.06.012; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Bishop MJ, 2010, IEEE T BIO-MED ENG, V57, P2335, DOI 10.1109/TBME.2010.2051227; Bishop MJ, 2010, AM J PHYSIOL-HEART C, V298, pH699, DOI 10.1152/ajpheart.00606.2009; Bittihn P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118106; Caldwell BJ, 2015, CIRC-ARRHYTHMIA ELEC, V8, P685, DOI 10.1161/CIRCEP.114.002661; Childress S., 2009, INTRO THEORETICAL FL, P25; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Fenton FH, 2009, CIRCULATION, V120, P467, DOI 10.1161/CIRCULATIONAHA.108.825091; Gibb M, 2009, LECT NOTES COMPUT SC, V5528, P268, DOI 10.1007/978-3-642-01932-6_29; Hill AJ, 2005, CURR CLIN ONCOL, P81; Horning M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026218; Janardhan AH, 2012, J AM COLL CARDIOL, V60, P2393, DOI 10.1016/j.jacc.2012.08.1001; Jolley M, 2008, HEART RHYTHM, V5, P565, DOI 10.1016/j.hrthm.2008.01.018; Kandel MS, 2013, COMP MATH MATH PHYS, V1, P11, DOI DOI 10.1155/2013/134163; Larsen GK, 2011, HEART RHYTHM, V8, P1881, DOI 10.1016/j.hrthm.2011.07.036; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Podesser BK, 1998, ACTA ANAT, V163, P63; POLLARD AE, 1992, CRIT REV BIOMED ENG, V20, P171; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Pumir A, 1999, J THEOR BIOL, V199, P311, DOI 10.1006/jtbi.1999.0957; Rantner LJ, 2013, HEART RHYTHM, V10, P1209, DOI 10.1016/j.hrthm.2013.04.027; Roth BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051925; Roth BJ, 2013, HEART RHYTHM, V10, P1218, DOI 10.1016/j.hrthm.2013.05.002; Sidorov VY, 2005, AM J PHYSIOL-HEART C, V289, pH2602, DOI 10.1152/ajpheart.00968.2004; Sobie EA, 1997, BIOPHYS J, V73, P1410, DOI 10.1016/S0006-3495(97)78173-6; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Visser KR, 1989, ENG MED BIOL SOC 198, V5, P1540; Woods MC, 2006, HEART RHYTHM, V3, P751, DOI 10.1016/j.hrthm.2005.11.003; ZIPES DP, 1975, AM J CARDIOL, V36, P37, DOI 10.1016/0002-9149(75)90865-6	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173324	10.1371/journal.pone.0173324	http://dx.doi.org/10.1371/journal.pone.0173324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253365	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300100
J	Sasado, T; Kondoh, H; Furutani-Seiki, M; Naruse, K				Sasado, Takao; Kondoh, Hisato; Furutani-Seiki, Makoto; Naruse, Kiyoshi			Mutation in cpsf6/CFIm68 (Cleavage and Polyadenylation Specificity Factor Subunit 6) causes short 3 ' UTRs and disturbs gene expression in developing embryos, as revealed by an analysis of primordial germ cell migration using the medaka mutant naruto	PLOS ONE			English	Article							CLEAVAGE FACTOR-I; MICRORNA-MEDIATED REGULATION; POSTERIOR LATERAL-LINE; ALTERNATIVE POLYADENYLATION; CHEMOKINE RECEPTOR; ORYZIAS-LATIPES; CXC CHEMOKINE; ROBUSTNESS; ZEBRAFISH; GUIDANCE	Our previous studies analyzing medaka mutants defective in primordial germ cell (PGC) migration identified cxcr4b and cxcr7, which are both receptors of the chemokine sdf1/cxcl12, as key regulators of PGC migration. Among PGC migration mutants, naruto (nar) is unique in that the mutant phenotype includes gross morphological abnormalities of embryos, suggesting that the mutation affects a broader range of processes. A fine genetic linkage mapping and genome sequencing showed the nar gene encodes Cleavage and Polyadenylation Specificity Factor subunit 6 (CPSF6/CFIm68). CPSF6 is a component of the Cleavage Factor Im complex (CFIm) which plays a key role in pre-mRNA 3'-cleavage and polyadenylation. 3'RACE of sdf1a/b and cxcr7 transcripts in the mutant embryos indicated shorter 3'UTRs with poly A additions occurring at more upstream positions than wildtype embryos, suggesting CPSF6 functions to prevent premature 3'UTR cleavage. In addition, expression of the coding region sequences of sdf1a/b in nar mutants was more anteriorly extended in somites than wild-type embryos, accounting for the abnormally extended distribution of PGCs in nar mutants. An expected consequence of shortening 3'UTR is the escape from the degradation mechanism mediated by microRNAs interacting with distal 3'UTR sequence. The abnormal expression pattern of sdf1a coding sequence may be at least partially accounted for by this mechanism. Given the pleiotropic effects of nar mutation, further analysis using the nar mutant will reveal processes in which CPSF6 plays essential regulatory roles in poly A site selection and involvement of 3'UTRs in posttranscriptional gene regulation in various genes in vivo.	[Sasado, Takao; Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi, Japan; [Kondoh, Hisato] Kyoto Sangyo Univ, Fac Life Sci, Kyoto, Japan; [Furutani-Seiki, Makoto] Yamaguchi Univ, Sch Med, Ube, Yamaguchi, Japan; [Sasado, Takao] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto Sangyo University; Yamaguchi University; Tokyo Gakugei University	Sasado, T (corresponding author), Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi, Japan.; Sasado, T (corresponding author), Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan.	tsasado@gmail.com		Sasado, Takao/0000-0003-4356-4650; Naruse, Kiyoshi/0000-0001-9185-3495	Japan Society for the Promotion of Science [21770245, 16K07381]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists (B) (No. 21770245) and Grant-in-Aid for Scientific Research (C) (No. 16K07381) from the Japan Society for the Promotion of Science (https.//www.jsps.go.jp/english/e-grants/) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2009, ZOOL SCI, V26, P112, DOI 10.2108/zsj.26.112; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Geisler R, 2002, ZEBRAFISH PRACTICAL, V261, P175; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Goudarzi M, 2013, NAT GENET, V45, P1264, DOI 10.1038/ng.2793; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kamasawa Masami, 2008, In Silico Biology, V8, P347; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x; Kimura T, 2010, BIOTECHNIQUES, V49, P582, DOI 10.2144/000113467; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Lewellis SW, 2012, SEMIN CELL DEV BIOL, V23, P333, DOI 10.1016/j.semcdb.2012.03.009; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Oshikawa M, 2008, DNA RES, V15, P123, DOI 10.1093/dnares/dsn010; OZATO K, 1994, DEV GROWTH DIFFER, V36, P437; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774; Sasado T, 2004, MECH DEVELOP, V121, P817, DOI 10.1016/j.mod.2004.03.022; Sasado T, 2008, DEV BIOL, V320, P328, DOI 10.1016/j.ydbio.2008.05.544; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; SATOH N, 1972, J EMBRYOL EXP MORPH, V28, P385; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Staton AA, 2013, NAT GENET, V45, P1266, DOI 10.1038/ng.2812; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tanegashima K, 2013, FEBS LETT, V587, P1731, DOI 10.1016/j.febslet.2013.04.046; Tarbashevich K, 2010, CURR OPIN CELL BIOL, V22, P715, DOI 10.1016/j.ceb.2010.09.005; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Venkiteswaran G, 2013, CELL; Sanchez-Sanchez AV, 2010, STEM CELLS, V28, P1457, DOI 10.1002/stem.469; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yasuoka A, 2004, MECH DEVELOP, V121, P729, DOI 10.1016/j.mod.2004.03.032; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	81	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172467	10.1371/journal.pone.0172467	http://dx.doi.org/10.1371/journal.pone.0172467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253363	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300020
J	Schwartz, DL; Sosa, A; Chun, SG; Ding, CX; Xie, XJ; Nedzi, LA; Timmerman, RD; Sumer, BD				Schwartz, David L.; Sosa, Alan; Chun, Stephen G.; Ding, Chiuxiong; Xie, Xian-Jin; Nedzi, Lucien A.; Timmerman, Robert D.; Sumer, Baran D.			SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BODY RADIATION-THERAPY; LASER MICROSURGERY; VOCAL CORD; RADIOTHERAPY; SURVIVAL	Purpose To confirm safety and feasibility of hypofractionated SBRT for early-stage glottic laryngeal cancer. Methods Twenty consecutive patients with cTis-T2N0M0 carcinoma of glottic larynx were enrolled. Patients entered dose-fractionation cohorts of incrementally shorter bio-equivalent schedules starting with 50 Gy in 15 fractions (fx), followed by 45 Gy/10 fx and, finally, 42.5 Gy/5 fx. Maximum combined CTV-PTV expansion was limited to 5 mm. Patients were treated on a Model G5 Cyberknife (Accuray, Sunnyvale, CA). Results Median follow-up is 13.4 months (range: 5.6-24.6 months), with 12 patients followed for at least one year. Maximum acute toxicity consisted of grade 2 hoarseness and dysphagia. Maximum chronic toxicity was seen in one patient treated with 45 Gy/10 fx who continued to smoke > 1 pack/day and ultimately required protective tracheostomy. At 1-year follow-up, estimated local disease free survival for the full cohort was 82%. Overall survival is 100% at last follow-up. Conclusions We were able to reduce equipotent total fractions of SBRT from 15 to 5 without exceeding protocol-defined acute/subacute toxicity limits. With limited follow-up, disease control appears comparable to standard treatment. We continue to enroll to the 42.5 Gy/5 fx cohort and follow patients for late toxicity.	[Schwartz, David L.; Sosa, Alan; Chun, Stephen G.; Ding, Chiuxiong; Xie, Xian-Jin; Nedzi, Lucien A.; Timmerman, Robert D.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Sumer, Baran D.] Univ Texas Southwestern Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, Dallas, TX 75390 USA; [Schwartz, David L.] Univ Tennessee, West Canc Ctr, Dept Radiat Oncol, Memphis, TN USA; [Schwartz, David L.] Univ Tennessee, West Canc Ctr, Dept Prevent Hlth, Memphis, TN USA; [Chun, Stephen G.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Schwartz, DL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	dschwar4@uthsc.edu		Chun, Stephen/0000-0002-4324-8044	Cancer Prevention and Research Institute of Texas (CPRIT); Individual Investigator Research [RP150386, RP150485]; CPRIT Individual Investigator Research [RP150386, RP150485]; VisionRT; Sense Health	Cancer Prevention and Research Institute of Texas (CPRIT); Individual Investigator Research; CPRIT Individual Investigator Research; VisionRT; Sense Health	This work was supported by Cancer Prevention and Research Institute of Texas (CPRIT, http://www.cprit.state.tx.us/), Individual Investigator Research Awards RP150386 and RP150485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Schwartz was supported by CPRIT Individual Investigator Research Awards RP150386 and RP150485, and has received research support from VisionRT and Sense Health. Dr. Timmerman receives research funding unrelated to this manuscript from Accuray, Inc. (Sunny-vale, CA), which manufactures the Cyberknife.	EPSTEIN BE, 1990, RADIOLOGY, V175, P567, DOI 10.1148/radiology.175.2.2326483; Forastiere AA, 2000, ONCOLOGY-NY, V14, P163; Gowda RV, 2003, RADIOTHER ONCOL, V68, P105, DOI 10.1016/S0167-8140(03)00059-8; Ling DC, 2016, INT J RADIAT ONCOL, V95, P973, DOI 10.1016/j.ijrobp.2016.02.049; MENDENHALL WM, 1990, CA-CANCER J CLIN, V40, P150, DOI 10.3322/canjclin.40.3.150; Mendenhall WM, 2004, CANCER-AM CANCER SOC, V100, P1786, DOI 10.1002/cncr.20181; Mendenhall WM, 2001, J CLIN ONCOL, V19, P4029, DOI 10.1200/JCO.2001.19.20.4029; Ogura J H, 1963, Trans Pac Coast Otoophthalmol Soc Annu Meet, V44, P245; Osman SOS, 2008, RADIOTHER ONCOL, V89, P19, DOI 10.1016/j.radonc.2008.05.016; Osman SOS, 2012, INT J RADIAT ONCOL, V82, P989, DOI 10.1016/j.ijrobp.2010.12.022; Park C, 2008, INT J RADIAT ONCOL, V70, P847, DOI 10.1016/j.ijrobp.2007.10.059; Parsons, 1992, Semin Radiat Oncol, V2, P158, DOI 10.1016/1053-4296(92)90004-5; Rubinstein M, 2011, LASER MED SCI, V26, P113, DOI 10.1007/s10103-010-0834-5; RUDOLTZ MS, 1993, INT J RADIAT ONCOL, V26, P767, DOI 10.1016/0360-3016(93)90490-M; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith JC, 2003, LARYNGOSCOPE, V113, P68, DOI 10.1097/00005537-200301000-00013; STEINER W, 1993, AM J OTOLARYNG, V14, P116, DOI 10.1016/0196-0709(93)90050-H; Timmerman R, 2006, ACTA ONCOL, V45, P779, DOI 10.1080/02841860600902213; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Vargo JA, 2015, INT J RADIAT ONCOL, V91, P480, DOI 10.1016/j.ijrobp.2014.11.023; WETMORE SJ, 1986, ARCH OTOLARYNGOL, V112, P853; WIERNIK G, 1991, BRIT J RADIOL, V64, P232, DOI 10.1259/0007-1285-64-759-232; WOODHOUSE RJ, 1981, LARYNGOSCOPE, V91, P1155	23	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172055	10.1371/journal.pone.0172055	http://dx.doi.org/10.1371/journal.pone.0172055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253270	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300011
J	Bernstein, JM; Daly, MJ; Chan, H; Qiu, J; Goldstein, D; Muhanna, N; de Almeida, JR; Irish, JC				Bernstein, Jonathan M.; Daly, Michael J.; Chan, Harley; Qiu, Jimmy; Goldstein, David; Muhanna, Nidal; de Almeida, John R.; Irish, Jonathan C.			Accuracy and reproducibility of virtual cutting guides and 3D-navigation for osteotomies of the mandible and maxilla	PLOS ONE			English	Article							NAVIGATION; SURGERY; RECONSTRUCTION; HEAD	Background We set out to determine the accuracy of 3D-navigated mandibular and maxillary osteotomies with the ultimate aim to integrate virtual cutting guides and 3D-navigation into ablative and reconstructive head and neck surgery. Methods Four surgeons (two attending, two clinical fellows) completed 224 unnavigated and 224 3D-navigated osteotomies on anatomical models according to preoperative 3D plans. The osteotomized bones were scanned and analyzed. Results Median distance from the virtual plan was 2.1 mm unnavigated (IQR 2.6 mm, >= 3 mm in 33%) and 1.2 mm 3D-navigated (IQR 1.1 mm, >= 3 mm in 6%) (P<0.0001); median pitch was 4.5 degrees unnavigated (IQR 7.1 degrees) and 3.5 degrees 3D-navigated (IQR 4.0 degrees) (P<0.0001); median roll was 7.4 degrees unnavigated (IQR 8.5 degrees) and 2.6 degrees 3D-navigated (IQR 3.8 degrees) (P<0.0001). Conclusion 3D-rendering enables osteotomy navigation. 3 mm is an appropriate planning distance. The next steps are translating virtual cutting guides to free bone flap reconstruction and clinical use.	[Bernstein, Jonathan M.; Daly, Michael J.; Chan, Harley; Qiu, Jimmy; Goldstein, David; Muhanna, Nidal; Irish, Jonathan C.] Univ Toronto, Princess Margaret Canc Ctr, TECHNA Inst, Guided Therapeut GTx Program, Toronto, ON, Canada; [Bernstein, Jonathan M.; Muhanna, Nidal; de Almeida, John R.; Irish, Jonathan C.] Univ Toronto, Princess Margaret Canc Ctr, Dept Otolaryngol Head & Neck Surg Surg Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Irish, JC (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, TECHNA Inst, Guided Therapeut GTx Program, Toronto, ON, Canada.; Irish, JC (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Dept Otolaryngol Head & Neck Surg Surg Oncol, Toronto, ON, Canada.	jonathan.irish@uhn.ca	goldstein, David/AAT-6302-2020	Daly, Michael/0000-0002-2217-4146	Strobele Family GTx Research Fund; Kevin and Sandra Sullivan Chair in Surgical Oncology; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Centre Foundation	Strobele Family GTx Research Fund; Kevin and Sandra Sullivan Chair in Surgical Oncology; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Centre Foundation(University of Toronto)	The Guided Therapeutics Program (GTx) is funded by the Strobele Family GTx Research Fund, Kevin and Sandra Sullivan Chair in Surgical Oncology, Hatch Engineering Fellowship Fund, RACH Fund and the Princess Margaret Cancer Centre Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham T, 2014, PLAST RECONSTR SURG, V134, p628E, DOI 10.1097/PRS.0000000000000513; Bell RB, 2011, J ORAL MAXIL SURG, V69, P724, DOI 10.1016/j.joms.2009.12.040; Bell RB, 2010, ORAL MAXIL SURG CLIN, V22, P135, DOI 10.1016/j.coms.2009.10.010; Chien CY, 2012, LARYNGOSCOPE, V122, P2205, DOI 10.1002/lary.23461; Daly MJ, 2011, CLIN IMPLEMENTATION; Dixon BJ, 2014, LARYNGOSCOPE, V124, P853, DOI 10.1002/lary.24385; Enquobahrie A, 2008, INT J COMPUT ASS RAD, V3, P395, DOI 10.1007/s11548-008-0243-4; Hanasono MM, 2013, LARYNGOSCOPE, V123, P597, DOI 10.1002/lary.23717; King E, 2013, HEAD NECK-J SCI SPEC, V35, P959, DOI 10.1002/hed.23060; Labadie Robert F, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P27, DOI 10.1097/00020840-200502000-00008; Rodby KA, 2014, J PLAST RECONSTR AES, V67, P1171, DOI 10.1016/j.bjps.2014.04.038; Roser SM, 2010, J ORAL MAXIL SURG, V68, P2824, DOI 10.1016/j.joms.2010.06.177; Schramm A, 2000, Comput Aided Surg, V5, P343, DOI 10.1002/1097-0150(2000)5:5<343::AID-IGS4>3.3.CO;2-T; Wagner A, 2002, MED PHYS, V29, P905, DOI 10.1118/1.1469625; Yu H, 2013, INT J ORAL MAX SURG, V42, P1409, DOI 10.1016/j.ijom.2013.05.011	15	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173111	10.1371/journal.pone.0173111	http://dx.doi.org/10.1371/journal.pone.0173111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249001	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500076
J	Guerrero-Jimenez, CJ; Pena, F; Morales, P; Mendez, M; Sallaberry, M; Vila, I; Poulin, E				Jimena Guerrero-Jimenez, Claudia; Pena, Fabiola; Morales, Pamela; Mendez, Marco; Sallaberry, Michel; Vila, Irma; Poulin, Elie			Pattern of genetic differentiation of an incipient speciation process: The case of the high Andean killifish Orestias	PLOS ONE			English	Article							POPULATION-STRUCTURE; ADAPTIVE RADIATION; TELEOSTEI CYPRINODONTIDAE; BOLIVIAN ALTIPLANO; CICHLID FISH; LAKE; EVOLUTION; SOFTWARE; DNA; COMPLEX	During the Pleistocene and Holocene, the southwest Andean Altiplano (17 degrees-22 degrees S) was affected by repeated fluctuations in water levels, high volcanic activity and major tectonic movements. In the early Holocene the humid Tauca phase shifted to the arid conditions that have lasted until the present, producing endorheic rivers, lakes, lagoons and wetlands. The endemic fish Orestias (Cyprinodontidae) represents a good model to observe the genetic differentiation that characterizes an incipient speciation process in allopatry since the morphospecies described inhabit a restricted geographic area, with present habitat fragmentation. The genetic diversity and population structure of four endemic morphospecies of Orestias (Cyprinodontidae) found in the Lauca National Park (LNP) analyzed with mitochondrial markers (Control Region) and eight microsatellites, revealed the existence of genetic groups that matches the fragmentation of these systems. High values of genetic and phylogeographic differentiation indices were observed between Chungara Lake and Piacota lagoon. The group composed of the Lauca River, Copapujo and Chuviri wetlands sampling sites showed a clear signal of expansion, with a star-like haplotype network. Levels of genetic differentiation were lower than in Chungara A and Piacota, suggesting that these localities would have differentiated after the bottlenecks linked to the collapse of Parinacota volcano. The Parinacota sample showed a population signal that differed from the other localities revealing greater genetic diversity and a disperse network, presenting haplotypes shared with other LNP localities. A mixing pattern of the different genetic groups was evident using the microsatellite markers. The chronology of the vicariance events in LNP may indicate that the partition process of the Orestias populations was gradual. Considering this, and in view of the genetic results, we may conclude that the morphospecies from LNP are populations in ongoing differentiation process.	[Jimena Guerrero-Jimenez, Claudia; Morales, Pamela; Mendez, Marco; Sallaberry, Michel; Vila, Irma; Poulin, Elie] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Region Metropol, Chile; [Jimena Guerrero-Jimenez, Claudia] Univ Santo Tomas, Escuela Med Vet, Fac Recursos Nat & Med Vet, Talca, Region Del Maul, Chile; [Jimena Guerrero-Jimenez, Claudia] Univ Iberoamer Ciencias & Tecnol, Fac Recursos Nat & Ciencias Silvoagr, Escuela Med Vet, Santiago, Region Metropol, Chile; [Pena, Fabiola] Univ Utrecht, Fac Life Sci, Utrecht, Netherlands; [Poulin, Elie] Univ Chile, Inst Ecol & Biodiversidad Chile, Santiago, Region Metropol, Chile	Universidad de Chile; Universidad Santo Tomas; Universidad Iberoamericana de Ciencias y Tecnologia; Utrecht University; Universidad de Chile	Guerrero-Jimenez, CJ (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Region Metropol, Chile.; Guerrero-Jimenez, CJ (corresponding author), Univ Santo Tomas, Escuela Med Vet, Fac Recursos Nat & Med Vet, Talca, Region Del Maul, Chile.; Guerrero-Jimenez, CJ (corresponding author), Univ Iberoamer Ciencias & Tecnol, Fac Recursos Nat & Ciencias Silvoagr, Escuela Med Vet, Santiago, Region Metropol, Chile.	claudia.guerrero@uibero.cl	Morales, Pamela/D-5785-2011; Poulin, Elie/C-2654-2012; Mendez, Marco A/N-1919-2017	Poulin, Elie/0000-0001-7736-0969; 	Fondecyt [1110243, 1140543, 1080390, 1110188]; Institute de Ecologia y Biodiversidad de Chile IEB [ICM-P05-002, PFB 023]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Institute de Ecologia y Biodiversidad de Chile IEB	Support was provided by Fondecyt Projects 1110243,1140543,1080390 and 1110188. the Institute de Ecologia y Biodiversidad de Chile IEB, ICM-P05-002 and PFB 023.; We thank Dr. Sergio Scott, MSc Juan Pablo Oyanedel, MSc Christian Araya and Dr. Gonzalo Collado for his support in field trips and collection of individuals and Lafayette Eaton for the English correction. This research is part of a Ph.D. thesis. This study is part of the objectives of the projects FONDECYT Project 1110243 and 1140543. The samples of this study, were collected under permit from the Subsecretaria de Pesca RES 2231 on 19 August 2011, and approved by the Bioethical Committee at the Universidad de Chile. Fondecyt Project 1110243. Support was provided by Fondecyt Projects 1110243,1140543, 1080390 and 1110188. the Instituto de Ecologia y Biodiversidad de Chile IEB, ICM-P05-002 and PFB 023.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Arratia G., 1982, AMBIENTE NATURAL POB, V1, P93; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Belkhir K, 5171 CNRS UMR, V5171; Beltman JB, 2004, EVOLUTION, V58, P35; Bezault E, 2011, EVOLUTION, V65, P3381, DOI 10.1111/j.1558-5646.2011.01417.x; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Chong G., 1988, LECT NOTES EARTH SCI, V17, P137; Clavero JE, 2004, REV GEOL CHILE, V31, P317; Clavero JE, 2002, B VOLCANOL, V64, P40, DOI 10.1007/s00445-001-0183-0; Coyne J.A., 2004, SPECIATION; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; De la Barrera F, 2011, REV CHIL HIST NAT, V84, P181, DOI 10.4067/S0716-078X2011000200004; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; Dorador C, 2003, REV CHIL HIST NAT, V76, P15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Elmer KR, 2009, P NATL ACAD SCI USA, V106, P13404, DOI 10.1073/pnas.0902299106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Fitzpatrick BM, 2009, J EVOLUTION BIOL, V22, P2342, DOI 10.1111/j.1420-9101.2009.01833.x; Fornari M, 2001, PALAEOGEOGR PALAEOCL, V172, P269, DOI 10.1016/S0031-0182(01)00301-7; Fritz SC, 2004, QUATERNARY RES, V61, P95, DOI 10.1016/j.yqres.2003.08.007; Fu YX, 1997, GENETICS, V147, P915; Garrigos YE, 2013, ZOOTAXA, V3640, P373, DOI 10.11646/zootaxa.3640.3.3; Garrigos YE, 2011, CONSERV GENET RESOUR, V3, P17, DOI 10.1007/s12686-010-9269-3; Giralt S, 2008, J PALEOLIMNOL, V40, P195, DOI 10.1007/s10933-007-9151-9; Guerrero CJ, 2015, GAYANA, V79, P18, DOI 10.4067/S0717-65382015000100004; Herdegen M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-28; Hudson AG, 2007, ADV LIMNOL, V60, P111; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lavenu A, 1984, CAHIERS ORSTOM G, VXIV, P103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maggs CA, 2009, ECOLOV S, V89, pS108; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Marquez-Garcia M, 2009, LIMNOLOGICA, V39, P314, DOI 10.1016/j.limno.2009.06.007; Mehner T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-85; Morales P, 2011, CONSERV GENET, V12, P1639, DOI 10.1007/s10592-011-0245-6; Moyle LC, 2010, EVOLUTION, V64, P1541, DOI 10.1111/j.1558-5646.2010.00990.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nunez L, 2002, SCIENCE, V298, P821, DOI 10.1126/science.1076449; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parenti L.R., 1984, P85; PARKER A, 1995, COPEIA, P8; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Placzek C, 2006, GEOL SOC AM BULL, V118, P515, DOI 10.1130/B25770.1; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TRACER V1 5; Ribbink A.J., 1984, P21; Rigsby CA, 2005, J QUATERNARY SCI, V20, P671, DOI 10.1002/jqs.986; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saez A, 2007, SEDIMENTOLOGY, V54, P1191, DOI 10.1111/j.1365-3091.2007.00878.x; Schneider S, 1999, GENETICS, V152, P1079; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; TAJIMA F, 1989, GENETICS, V123, P585; Turgeon J, 2003, CONSERV GENET, V4, P67, DOI 10.1023/A:1021860910719; Vellard J., 1991, LAGO TITICACA SINTES, P453; Vila I, 2013, J FISH BIOL, V82, P927, DOI 10.1111/jfb.12031; Vila I, 2006, COPEIA, P472; Vila Irma, 2010, P471; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	72	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0170380	10.1371/journal.pone.0170380	http://dx.doi.org/10.1371/journal.pone.0170380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245250	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200003
J	Kamruzzaman, M; Shoma, S; Thomas, CM; Partridge, SR; Iredell, JR				Kamruzzaman, Muhammad; Shoma, Shereen; Thomas, Christopher M.; Partridge, Sally R.; Iredell, Jonathan R.			Plasmid interference for curing antibiotic resistance plasmids in vivo	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; SPECTRUM BETA-LACTAMASE; INTENSIVE-CARE UNITS; COMPLETE NUCLEOTIDE-SEQUENCES; ESCHERICHIA-COLI-CELLS; KLEBSIELLA-PNEUMONIAE; SELECTIVE DECONTAMINATION; ADDICTION SYSTEMS; DIGESTIVE-TRACT; BACTERIAL PLASMIDS	Antibiotic resistance increases the likelihood of death from infection by common pathogens such as Escherichia coli and Klebsiella pneumoniae in developed and developing countries alike. Most important modern antibiotic resistance genes spread between such species on self-transmissible (conjugative) plasmids. These plasmids are traditionally grouped on the basis of replicon incompatibility (Inc), which prevents coexistence of related plasmids in the same cell. These plasmids also use post-segregational killing ('addiction') systems, which poison any bacterial cells that lose the addictive plasmid, to guarantee their own survival. This study demonstrates that plasmid incompatibilities and addiction systems can be exploited to achieve the safe and complete eradication of antibiotic resistance from bacteria in vitro and in the mouse gut. Conjugative 'interference plasmids' were constructed by specifically deleting toxin and antibiotic resistance genes from target plasmids. These interference plasmids efficiently cured the corresponding antibiotic resistant target plasmid from different Enterobacteriaceae in vitro and restored antibiotic susceptibility in vivo to all bacterial populations into which plasmid-mediated resistance had spread. This approach might allow eradication of emergent or established populations of resistance plasmids in individuals at risk of severe sepsis, enabling subsequent use of less toxic and/or more effective antibiotics than would otherwise be possible, if sepsis develops. The generalisability of this approach and its potential applications in bioremediation of animal and environmental microbiomes should now be systematically explored.	[Kamruzzaman, Muhammad; Shoma, Shereen; Partridge, Sally R.; Iredell, Jonathan R.] Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW, Australia; [Thomas, Christopher M.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Partridge, Sally R.; Iredell, Jonathan R.] Westmead Hosp, Westmead, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Birmingham; University of Sydney	Iredell, JR (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW, Australia.	jonathan.iredell@sydney.edu.au	Thomas, Christopher M/J-8258-2017; Partridge, Sally R/Q-9374-2019; Kamruzzaman, Muhammad/S-2756-2019	Thomas, Christopher M/0000-0002-2810-0455; Kamruzzaman, Muhammad/0000-0003-2005-9846; Iredell, Jonathan/0000-0003-2469-7060	National Health and Medical Research Council (NHMRC), Australia [G1001021, G1084672]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grant numbers G1001021 and G1084672, National Health and Medical Research Council (NHMRC), Australia.	Amabile-Cuevas CF, 2004, DRUG DISCOV TODAY, V9, P465, DOI 10.1016/S1359-6446(03)02989-1; AUSTIN S, 1990, CELL, V60, P351, DOI 10.1016/0092-8674(90)90584-2; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BRAVO A, 1988, MOL GEN GENET, V215, P146, DOI 10.1007/BF00331316; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2422, DOI 10.1128/AAC.02587-13; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P269, DOI 10.1128/AAC.01648-12; Chu YW, 2001, ANTIMICROB AGENTS CH, V45, P710, DOI 10.1128/AAC.45.3.710-714.2001; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc13096; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; DeNap JCB, 2004, J AM CHEM SOC, V126, P15402, DOI 10.1021/ja044207u; Doumith M, 2012, J ANTIMICROB CHEMOTH, V67, P878, DOI 10.1093/jac/dkr553; Duncan EM, 2014, J CRIT CARE, V29, P634, DOI 10.1016/j.jcrc.2014.03.013; Espedido B, 2005, J CLIN MICROBIOL, V43, P4918, DOI 10.1128/JCM.43.9.4918-4919.2005; Espedido BA, 2008, ANTIMICROB AGENTS CH, V52, P2984, DOI 10.1128/AAC.01634-07; Espedido BA, 2007, J CLIN MICROBIOL, V45, P2034, DOI 10.1128/JCM.02538-06; Feng J, 2015, J ANTIMICROB CHEMOTH, V70, P2987, DOI 10.1093/jac/dkv232; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Gardner MN, 2004, MICROBIOL-SGM, V150, P1797, DOI 10.1099/mic.0.26951-0; Getino M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148098; Getino M, 2015, MBIO, V6, DOI 10.1128/mBio.01032-15; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hou JX, 2012, ANTIMICROB AGENTS CH, V56, P2135, DOI 10.1128/AAC.05104-11; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Kassis-Chikhani N, 2013, ANTIMICROB AGENTS CH, V57, P618, DOI 10.1128/AAC.01712-12; Mnif B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-147; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Ni B, 2008, LETT APPL MICROBIOL, V47, P235, DOI 10.1111/j.1472-765X.2008.02426.x; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6029, DOI 10.1128/AAC.01189-12; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P5933, DOI 10.1128/AAC.00639-11; Peleg AY, 2005, CLIN INFECT DIS, V41, P1549, DOI 10.1086/497831; Perez-Chaparro PJ, 2014, ANTIMICROB AGENTS CH, V58, P2958, DOI 10.1128/AAC.02341-13; Pimentel B, 2014, P NATL ACAD SCI USA, V111, P2734, DOI 10.1073/pnas.1308241111; Raz R, 2012, CLIN MICROBIOL INFEC, V18, P4, DOI 10.1111/j.1469-0691.2011.03636.x; Rocker A, 2016, CURR GENET, V62, P287, DOI 10.1007/s00294-015-0541-7; Rogers BA, 2012, EUR J CLIN MICROBIOL, V31, P2413, DOI 10.1007/s10096-012-1584-z; Sakuma T, 2013, PLASMID, V69, P138, DOI 10.1016/j.plasmid.2012.11.004; Schaufler K, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-34; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Tagg KA, 2014, ANTIMICROB AGENTS CH, V58, P4949, DOI 10.1128/AAC.02773-14; Thisted T, 1994, EMBO J, V13, P1960; Thomas JR, 2005, BIOCHEMISTRY-US, V44, P6800, DOI 10.1021/bi0473298; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; van Hal SJ, 2009, J CLIN MICROBIOL, V47, P2325, DOI 10.1128/JCM.02141-08; Wang DS, 2015, J MICROBIOL BIOTECHN, V25, P1614, DOI 10.4014/jmb.1503.03083; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang L, 2011, VOLUNTARY ORAL ADM D; Zong ZY, 2008, ANTIMICROB AGENTS CH, V52, P4198, DOI 10.1128/AAC.00107-08	61	30	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172913	10.1371/journal.pone.0172913	http://dx.doi.org/10.1371/journal.pone.0172913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245276	Green Submitted, Green Published, gold			2022-12-27	WOS:000395980200042
J	Kristensen, P; Keyes, KM; Susser, E; Corbett, K; Mehlum, IS; Irgens, LM				Kristensen, Petter; Keyes, Katherine M.; Susser, Ezra; Corbett, Karina; Mehlum, Ingrid Sivesind; Irgens, Lorentz M.			High birth weight and perinatal mortality among siblings: A register based study in Norway, 1967-2011	PLOS ONE			English	Article							GESTATIONAL-AGE; INTERNATIONAL ASSOCIATION; SUBSEQUENT PREGNANCY; INFANT-MORTALITY; UNITED-STATES; OUTCOMES; FETAL; RISK; STANDARDS; INTELLIGENCE	Background Perinatal mortality according to birth weight has an inverse J-pattern. Our aim was to estimate the influence of familial factors on this pattern, applying a cohort sibling design. We focused on excess mortality among macrosomic infants (> 2 SD above the mean) and hypothesized that the birth weight-mortality association could be explained by confounding shared family factors. We also estimated how the participant's deviation from mean sibling birth weight influenced the association. Methods and findings We included 1 925 929 singletons, born term or post-term to mothers with more than one delivery 1967-2011 registered in the Medical Birth Registry of Norway. We examined zscore birth weight and perinatal mortality in random-effects and sibling fixed-effects logistic regression models including measured confounders (e.g. maternal diabetes) as well as unmeasured shared family confounders (through fixed effects models). Birth weight-specific mortality showed an inverse J-pattern, being lowest (2.0 per 1000) at reference weight (zscore +1 to +2) and increasing for higher weights. Mortality in the highest weight category was 15-fold higher than reference. This pattern changed little in multivariable models. Deviance from mean sibling birth weight modified the mortality pattern across the birth weight spectrum: small and medium-sized infants had increased mortality when being smaller than their siblings, and large-sized infants had an increased risk when outweighing their siblings. Maternal diabetes and birth weight acted in a synergistic fashion with mortality among macrosomic infants in diabetic pregnancies in excess of what would be expected for additive effects. Conclusions The inverse J-pattern between birth weight and mortality is not explained by measured confounders or unmeasured shared family factors. Infants are at particularly high mortality risk when their birth weight deviates substantially from their siblings. Sensitivity analysis suggests that characteristics related to maternal diabetes could be important in explaining the increased mortality among macrosomic infants.	[Kristensen, Petter; Corbett, Karina; Mehlum, Ingrid Sivesind] Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Oslo, Norway; [Kristensen, Petter] Univ Oslo, Dept Community Med, Inst Hlth & Soc, Oslo, Norway; [Keyes, Katherine M.; Susser, Ezra] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Irgens, Lorentz M.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Oslo; Columbia University; New York State Psychiatry Institute; University of Bergen; Norwegian Institute of Public Health (NIPH)	Kristensen, P (corresponding author), Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Oslo, Norway.	petter.kristensen@stami.no	Mehlum, Ingrid Sivesind/S-7483-2019		National Institute of Occupational Health, Oslo, Norway	National Institute of Occupational Health, Oslo, Norway	This work was funded by the intramural program of the National Institute of Occupational Health, Oslo, Norway, www.stami.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Diabetes Association, 2017, Diabetes Care, V40, pS114; [Anonymous], 2013, ICD 10 INT STAT CLAS, V2; Bakketeig LS, 2006, PAEDIATR PERINAT EP, V20, P507, DOI 10.1111/j.1365-3016.2006.00755.x; BAKKETEIG LS, 1983, ACTA OBSTET GYN SCAN, V62, P385, DOI 10.3109/00016348309154207; Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Barfield WD, 2011, PEDIATRICS, V128, P177, DOI 10.1542/peds.2011-1037; Basso O, 2006, AM J EPIDEMIOL, V164, P303, DOI 10.1093/aje/kwj237; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Bentley-Lewis R, 2007, NAT CLIN PRACT ENDOC, V3, P696, DOI 10.1038/ncpendmet0616; Bjolstad AR, 2010, ACTA OBSTET GYNECOL, V89, P664, DOI [10.3109/00016341003686099, DOI 10.3109/00016341003686099]; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Colstrup M, 2013, J MATERN-FETAL NEO M, V26, P1682, DOI 10.3109/14767058.2013.794214; Conley D, 2006, ECON HUM BIOL, V4, P151, DOI 10.1016/j.ehb.2005.12.001; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DAVIS R, 1995, EPIDEMIOLOGY, V6, P607, DOI 10.1097/00001648-199511000-00008; Demissie K, 2002, OBSTET GYNECOL, V100, P474, DOI 10.1016/S0029-7844(02)01951-8; Donovan SJ, 2011, INT J EPIDEMIOL, V40, P345, DOI 10.1093/ije/dyr057; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gjessing HK, 1999, AM J PUBLIC HEALTH, V89, P213, DOI 10.2105/AJPH.89.2.213; HACKMAN E, 1983, JAMA-J AM MED ASSOC, V250, P2016, DOI 10.1001/jama.250.15.2016; Haig D, 2003, EPIDEMIOLOGY, V14, P490, DOI 10.1097/01.EDE.0000070402.42917.f4; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA., 2016, CAUSAL INFERENCE; Hernandez-Diaz S, 2008, EUR J EPIDEMIOL, V23, P163, DOI 10.1007/s10654-007-9220-4; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; KARN MN, 1951, ANN EUGENIC, V15, P306; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; Keyes KM, 2014, INT J EPIDEMIOL, V43, P1381, DOI 10.1093/ije/dyu166; Kristensen P, 2014, AM J EPIDEMIOL, V180, P876, DOI 10.1093/aje/kwu241; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Malin GL, 2014, BJOG-INT J OBSTET GY, V121, P515, DOI 10.1111/1471-0528.12517; Melve KK, 2003, INT J EPIDEMIOL, V32, P625, DOI 10.1093/ije/dyg163; Melve KK, 2002, PAEDIATR PERINAT EP, V16, P23, DOI 10.1046/j.1365-3016.2002.00363.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Norwegian Institute of Public Health, 2016, DIABETES IN NORWAY P; Pedersen Carsten B, 2007, BMC Pregnancy Childbirth, V7, P28, DOI 10.1186/1471-2393-7-28; RECORD RG, 1969, ANN HUM GENET, V33, P71, DOI 10.1111/j.1469-1809.1969.tb01631.x; Salihu HM, 2012, ANN EPIDEMIOL, V22, P764, DOI 10.1016/j.annepidem.2012.07.003; Schisterman EF, 2006, AM J EPIDEMIOL, V164, P312, DOI 10.1093/aje/kwj238; SKJAERVEN R, 1988, INT J EPIDEMIOL, V17, P830, DOI 10.1093/ije/17.4.830; Skjaerven R, 2000, AM J OBSTET GYNECOL, V183, P689, DOI 10.1067/mob.2000.106590; Skjaerven R, 1997, BRIT MED J, V314, P1376, DOI 10.1136/bmj.314.7091.1376; Svensson AC, 2006, AM J OBSTET GYNECOL, V194, P475, DOI 10.1016/j.ajog.2005.08.019; TANNER JM, 1972, LANCET, V2, P193; VanderWeele TJ, 2014, METHODS MEDIATION IN; Wang D, 2016, J MATERN-FETAL NEO M, V28, P1; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; WILCOX AJ, 1983, INT J EPIDEMIOL, V12, P319, DOI 10.1093/ije/12.3.319; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 1965, INT CLASS DIS; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P77, DOI 10.1016/j.siny.2008.09.002; Zhang X, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.005; ZHIVOTOVSKY LA, 1992, EVOLUTION, V46, P1574, DOI 10.1111/j.1558-5646.1992.tb01149.x	62	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172891	10.1371/journal.pone.0172891	http://dx.doi.org/10.1371/journal.pone.0172891			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245262	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200039
J	Pelarigo, JG; Machado, L; Fernandes, RJ; Greco, CC; Vilas-Boas, JP				Pelarigo, Jailton Gregorio; Machado, Leandro; Fernandes, Ricardo Jorge; Greco, Camila Coelho; Vilas-Boas, Joao Paulo			Oxygen uptake kinetics and energy system's contribution around maximal lactate steady state swimming intensity	PLOS ONE			English	Article							EXERCISE INTENSITY; SLOW COMPONENT; SPEED; DETERMINANT; ADAPTATIONS; HEAVY; TIME	The purpose of this study was to examine the oxygen uptake ((V) over dotO(2)) kinetics and the energy systems' contribution at 97.5, 100 and 102.5% of the maximal lactate steady state (MLSS) swimming intensity. Ten elite female swimmers performed three-to-five 30 min submaximal constant swimming bouts at imposed paces for the determination of the swimming velocity (v) at 100% MLSS based on a 7 x 200 m intermittent incremental protocol until voluntary exhaustion to find the v associated at the individual anaerobic threshold. (V) over dotO(2) kinetics (cardiodynamic, primary and slow component phases) and the aerobic and anaerobic energy contributions were assessed during the continuous exercises, which the former was studied for the beginning and second phase of exercise. Subjects showed similar time delay (TD) (mean = 11.5-14.3 s) and time constant (tau(p)) (mean = 13.8-16.3 s) as a function of v, but reduced amplitude of the primary component for 97.5% (35.7 +/- 7.3 mL.kg.min(-1)) compared to 100 and 102.5% MLSS (41.0 +/- 7.0 and 41.3 +/- 5.4 mL.kg.min(-1), respectively), and tau(p) decreased (mean = 9.6-10.8 s) during the second phase of exercise. Despite the slow component did not occur for all swimmers at all swim intensities, when observed it tended to increase as a function of v. Moreover, the total energy contribution was almost exclusively aerobic (98-99%) at 97.5, 100 and 102.5% MLSS. We suggest that well-trained endurance swimmers with a fast TD and tau(p) values may be able to adjust faster the physiological requirements to minimize the amplitude of the slow component appearance, parameter associated with the fatigue delay and increase in exhaustion time during performance, however, these fast adjustments were not able to control the progressive fatigue occurred slightly above MLSS, and most of swimmers reached exhaustion before 30min swam.	[Pelarigo, Jailton Gregorio] Univ Catholic Ctr Quixada UNICATOLICA, Quixada, Ceara, Brazil; [Pelarigo, Jailton Gregorio] Metropolitan Coll Grande Fortaleza FAMETRO, Fortaleza, Ceara, Brazil; [Pelarigo, Jailton Gregorio; Machado, Leandro; Fernandes, Ricardo Jorge; Vilas-Boas, Joao Paulo] Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal; [Pelarigo, Jailton Gregorio; Machado, Leandro; Fernandes, Ricardo Jorge; Vilas-Boas, Joao Paulo] Univ Porto, Porto Biomech Lab, LABIOMEP, Oporto, Portugal; [Greco, Camila Coelho] Sao Paulo State Univ, Dept Phys Educ, Human Performance Lab, Rio Claro, SP, Brazil	Universidade do Porto; Universidade do Porto; Universidade Estadual Paulista	Pelarigo, JG (corresponding author), Univ Catholic Ctr Quixada UNICATOLICA, Quixada, Ceara, Brazil.; Pelarigo, JG (corresponding author), Metropolitan Coll Grande Fortaleza FAMETRO, Fortaleza, Ceara, Brazil.; Pelarigo, JG (corresponding author), Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, Oporto, Portugal.; Pelarigo, JG (corresponding author), Univ Porto, Porto Biomech Lab, LABIOMEP, Oporto, Portugal.	jailtongp@hotmail.com	Machado, Leandro/AAI-7714-2020; Fernandes, Ricardo J./A-1040-2012	Machado, Leandro/0000-0001-5332-5974; Fernandes, Ricardo J./0000-0002-5811-0443; Vilas-Boas, J. Paulo/0000-0002-4109-2939	Capes Foundation; Ministry of Education of Brazil [BEX: 0536/10-5];  [PTDC/DES/101224/2008 (FCOMP-01-0124-FEDER-009577)]	Capes Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil; 	This investigation was supported by grants of the Capes Foundation, Ministry of Education of Brazil (BEX: 0536/10-5): JGP and project PTDC/DES/101224/2008 (FCOMP-01-0124-FEDER-009577): JPVB RF.; This investigation was supported by grants of the Capes Foundation, Ministry of Education of Brazil (BEX: 0536/10-5), and project PTDC/DES/101224/2008 (FCOMP-01-0124-FEDE-R009577).	Baldari C, 2013, INT J SPORTS MED, V34, P336, DOI 10.1055/s-0032-1321804; Baron B, 2005, J SPORT MED PHYS FIT, V45, P1; Beneke R, 1996, MED SCI SPORT EXER, V28, P241, DOI 10.1097/00005768-199602000-00013; Beneke R, 2003, EUR J APPL PHYSIOL, V88, P361, DOI 10.1007/s00421-002-0713-2; Berger NJA, 2007, APPL PHYSIOL NUTR ME, V32, P383, DOI 10.1139/H06-109; Billat V, 1998, ARCH PHYSIOL BIOCHEM, V106, P38, DOI 10.1076/apab.106.1.38.4396; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Borrani F, 2001, J APPL PHYSIOL, V90, P2212, DOI 10.1152/jappl.2001.90.6.2212; Bosquet L, 2002, SPORTS MED, V32, P675, DOI 10.2165/00007256-200232110-00002; Burnley M, 2001, EXP PHYSIOL, V86, P417, DOI 10.1113/eph8602122; Burnley M, 2007, EUR J SPORT SCI, V7, P63, DOI 10.1080/17461390701456148; Carter H, 2000, J APPL PHYSIOL, V89, P1744, DOI 10.1152/jappl.2000.89.5.1744; Carter H, 2002, EUR J APPL PHYSIOL, V86, P347, DOI 10.1007/s00421-001-0556-2; Crewther B, 2006, SPORTS MED, V36, P65, DOI 10.2165/00007256-200636010-00005; Dekerle J, 2005, INT J SPORTS MED, V26, P524, DOI 10.1055/s-2004-821227; Dekerle J, 2005, INT J SPORTS MED, V26, P53, DOI 10.1055/s-2004-817854; Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9; di Prampero P E, 1981, Rev Physiol Biochem Pharmacol, V89, P143; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Fernandes RJ, 2006, J SPORT MED PHYS FIT, V46, P373; Fernandes RJ, 2012, INT J SPORTS MED, V33, P1010, DOI 10.1055/s-0032-1316362; Figueiredo P, 2014, J SPORT SCI MED, V13, P610; Gaesser G A, 1996, Exerc Sport Sci Rev, V24, P35; Greco CC, 2007, J SPORT SCI MED, V6, P441; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Ingham SA, 2007, MED SCI SPORT EXER, V39, P865, DOI 10.1249/mss.0b013e31803350c7; Jones AM, 2003, SPORTS MED, V33, P949, DOI 10.2165/00007256-200333130-00002; Jones AM, 2009, INT J SPORT PHYSIOL, V4, P524, DOI 10.1123/ijspp.4.4.524; Koppo K, 2004, MED SCI SPORT EXER, V36, P225, DOI 10.1249/01.MSS.0000113473.48220.20; Machado L, 2006, 10 INT S BIOM MED SW; Margaria R, 1933, POSSIBLE MECHANISMS; Pelarigo Jailton G, 2011, J Sci Med Sport, V14, DOI 10.1016/j.jsams.2010.08.004; Pessoa DM, 2012, INT J SPORTS MED, V33, P744, DOI 10.1055/s-0031-1299753; Poole DC, 1997, SPORTS MED, V24, P310; POOLE DC, 1991, J APPL PHYSIOL, V71, P1245, DOI 10.1152/jappl.1991.71.4.1245; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Reis JF, 2012, EUR J APPL PHYSIOL, V112, P1689, DOI 10.1007/s00421-011-2126-6; Reis JF, 2012, J SCI MED SPORT, V15, P58, DOI 10.1016/j.jsams.2011.05.012; Reis VM, 2010, INT J SPORTS MED, V31, P421, DOI 10.1055/s-0030-1248286; Sousa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084208; Sousa AC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675363; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; WHIPP BJ, 1990, MED SCI SPORT EXER, V22, P62; WHIPP BJ, 1972, J APPL PHYSIOL, V33, P351, DOI 10.1152/jappl.1972.33.3.351; Xu F, 1999, SPORTS MED, V27, P313, DOI 10.2165/00007256-199927050-00003	48	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0167263	10.1371/journal.pone.0167263	http://dx.doi.org/10.1371/journal.pone.0167263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245246	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200002
J	Joe, IS; Kim, JH; Kim, H; Hong, JH; Kim, M; Park, M				Joe, I-Seul; Kim, Jong-Hwan; Kim, Hanna; Hong, Jung-Hwa; Kim, Mirang; Park, Mikyoung			Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LARGE GENE LISTS; ACTIN DYNAMICS; SYNAPTIC-TRANSMISSION; ALZHEIMERS-DISEASE; PROTEIN-SYNTHESIS; DENDRITIC SPINES; CELL-CYCLE; MYOSIN VB; PLASTICITY	Cyclin Y (CCNY), which is a cyclin protein known to play a role in cell division, is unexpectedly and thus interestingly expressed in non-proliferating neuronal cells. There have been only a few studies reporting the neuronal functions of CCNY in synapse remodeling and hippocampal long-term potentiation. Therefore, we here provide global and comprehensive information on the putative functions of CCNY in biological and functional pathways in neuronal systems. We adopted high-throughput RNA-sequencing technology for analyzing transcriptomes regulated by CCNY and utilized bioinformatics for identifying putative molecules, biological processes, and functional pathways that are possibly connected to CCNY functions in hippocampal neuronal cells of rats. We revealed that several enriched annotation terms and pathways associated with CCNY expression within neurons, including apoptosis, learning or memory, synaptic plasticity, actin cytoskeleton, focal adhesion, extracellular matrix-receptor interaction and chemokine signaling pathway are targeted by CCNY. In addition, the mRNA levels of some genes enriched for those annotation terms and pathways or genes reported to be altered in Alzheimer's disease mouse model were further validated by quantitative real-time PCR in hippocampal neuronal cells. The present study provides an excellent resource for future investigations of CCNY functions in neuronal systems.	[Joe, I-Seul; Kim, Hanna; Hong, Jung-Hwa; Park, Mikyoung] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Kim, Jong-Hwan; Kim, Mirang] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Jong-Hwan; Kim, Mirang] Korea Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea; [Hong, Jung-Hwa] Korea Univ, Dept Life Sci, Seoul, South Korea; [Park, Mikyoung] Korea Univ Sci & Technol, Dept Neurosci, Daejeon, South Korea	Korea Institute of Science & Technology (KIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea University; University of Science & Technology (UST)	Park, M (corresponding author), Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea.; Park, M (corresponding author), Korea Univ Sci & Technol, Dept Neurosci, Daejeon, South Korea.	mikyoungpark7@gmail.com			KIST Institutional Programs [2E26860, 2E26830]; KRIBB Research Initiative	KIST Institutional Programs; KRIBB Research Initiative	This work was supported by the KIST Institutional Programs (Project No. 2E26860 & 2E26830) and by grants from KRIBB Research Initiative.	An WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132721; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek SJ, 2016, ONCOTARGET; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bonin RP, 2015, TRENDS NEUROSCI, V38, P336, DOI 10.1016/j.tins.2015.04.007; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Chen BJ, 2016, METHODS MOL BIOL, V1303, P327, DOI 10.1007/978-1-4939-2627-5_20; Cho E, 2015, SCI REP, V5; Cho E, 2016, PHARMACOL RES, V111, P133, DOI 10.1016/j.phrs.2016.06.008; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Clopath C, 2012, COGN NEURODYNAMICS, V6, P251, DOI 10.1007/s11571-011-9177-6; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Hanley JG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00381; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lin L, 2016, HUM MOL GENET; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miller JR, 2016, HUM MOL GENET; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tarca AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079217; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wolf M, 2015, CEREB CORTEX, V25, P2863, DOI 10.1093/cercor/bhu081; Xu YG, 2009, ONCOL RES, V18, P359, DOI 10.3727/096504010X12644422320582; Yang SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15703; Yue WT, 2011, CLIN LUNG CANCER, V12, P43, DOI 10.3816/CLC.2011.n.006; Zeng LY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006055	54	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172547	10.1371/journal.pone.0172547	http://dx.doi.org/10.1371/journal.pone.0172547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241067	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400026
J	Song, Y; Choi, W; Baek, S				Song, Yujae; Choi, Wooyeol; Baek, Seungjae			Network switching strategy for energy conservation in heterogeneous networks	PLOS ONE			English	Article							HANDOFF DECISION ALGORITHM; WIRELESS	In heterogeneous networks (HetNets), the large-scale deployment of small base stations (BSs) together with traditional macro BSs is an economical and efficient solution that is employed to address the exponential growth in mobile data traffic. In dense HetNets, network switching, i.e., handovers, plays a critical role in connecting a mobile terminal (MT) to the best of all accessible networks. In the existing literature, a handover decision is made using various handover metrics such as the signal-to-noise ratio, data rate, and movement speed. However, there are few studies on handovers that focus on energy efficiency in HetNets. In this paper, we propose a handover strategy that helps to minimize energy consumption at BSs in HetNets without compromising the quality of service (QoS) of each MT. The proposed handover strategy aims to capture the effect of the stochastic behavior of handover parameters and the expected energy consumption due to handover execution when making a handover decision. To identify the validity of the proposed handover strategy, we formulate a handover problem as a constrained Markov decision process (CMDP), by which the effects of the stochastic behaviors of handover parameters and consequential handover energy consumption can be accurately reflected when making a handover decision. In the CMDP, the aim is to minimize the energy consumption to service an MT over the lifetime of its connection, and the constraint is to guarantee the QoS requirements of the MT given in terms of the transmission delay and call-dropping probability. We find an optimal policy for the CMDP using a combination of the Lagrangian method and value iteration. Simulation results verify the validity of the proposed handover strategy.	[Song, Yujae; Baek, Seungjae] Korea Inst Ocean Sci & Technol, ICT R&D Unit, Ansan, Gyeonggi Do, South Korea; [Choi, Wooyeol] Korea Aerosp Res Inst, Ground Syst Dev Team, Daejeon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Aerospace Research Institute (KARI)	Baek, S (corresponding author), Korea Inst Ocean Sci & Technol, ICT R&D Unit, Ansan, Gyeonggi Do, South Korea.	baeksj@kiost.ac.kr	Choi, Wooyeol/T-4540-2019		"Full Duplex Communication for Low-Latency Underwater Acoustic Network" - Korea Institute of Ocean Science & Technology (KIOST); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1C1B2009034]	"Full Duplex Communication for Low-Latency Underwater Acoustic Network" - Korea Institute of Ocean Science & Technology (KIOST); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by "Full Duplex Communication for Low-Latency Underwater Acoustic Network" funded by Korea Institute of Ocean Science & Technology (KIOST). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1C1B2009034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN E, 1999, STOCH MODEL SER; [Anonymous], [No title captured]; Bertsekas D.P., 1987, DYNAMIC PROGRAMMING; Boggia G, 2007, EURASIP J WIREL COMM, DOI 10.1155/2007/17826; Carvalho GHS, 2016, IEEE T VEH TECHNOL, V65, P6343, DOI 10.1109/TVT.2015.2478852; Chandrasekhar V, 2008, IEEE COMMUN MAG, V46, P59, DOI 10.1109/MCOM.2008.4623708; Cisco Visual Networking Index, 2014, GLOB MOB DAT TRAFF F; El Helou M, 2015, IEEE J SEL AREA COMM, V33, P1055, DOI 10.1109/JSAC.2015.2416987; Liang B, 2003, IEEE ACM T NETWORK, V11, P718, DOI 10.1109/TNET.2003.815301; Lim GB, 2014, IEEE T WIREL COMMUN, V13, P2696, DOI 10.1109/TWC.2014.032014.131410; Luo Z, 2014, IEEE COMMUN LETT, V18, P1615, DOI 10.1109/LCOMM.2014.2341566; Narasimhamurthy AB, 2012, IEEE T WIREL COMMUN, V11, P60, DOI 10.1109/TWC.2011.121911.111594; Oh E, 2013, IEEE T WIREL COMMUN, V12, P2126, DOI 10.1109/TWC.2013.032013.120494; Song Y, 2015, IEEE COMMUN LETT, V19, P1394, DOI 10.1109/LCOMM.2015.2443810; Song Y, 2014, IEEE COMMUN LETT, V18, P277, DOI 10.1109/LCOMM.2013.120713.132279; Stevens-Navarro E, 2008, IEEE T VEH TECHNOL, V57, P1243, DOI 10.1109/TVT.2007.907072; Sun C, 2008, IEEE ICC, P2169, DOI 10.1109/ICC.2008.415; Wang XP, 2010, 2010 2ND IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND FINANCIAL ENGINEERING (ICIFE), P283, DOI 10.1109/ICIFE.2010.5609303; Yan XH, 2010, COMPUT NETW, V54, P1848, DOI 10.1016/j.comnet.2010.02.006; [张华 ZHANG Hua], 2011, [高分子通报, Polymer Bulletin], P1; Zuo JK, 2014, ETRI J, V36, P685, DOI 10.4218/etrij.14.0213.0413	22	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172318	10.1371/journal.pone.0172318	http://dx.doi.org/10.1371/journal.pone.0172318			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241083	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400017
J	Svoboda, Z; Bizovska, L; Janura, M; Kubonova, E; Janurova, K; Vuillerme, N				Svoboda, Zdenek; Bizovska, Lucia; Janura, Miroslav; Kubonova, Eliska; Janurova, Katerina; Vuillerme, Nicolas			Variability of spatial temporal gait parameters and center of pressure displacements during gait in elderly fallers and nonfallers: A 6-month prospective study	PLOS ONE			English	Article							CONFIDENCE ABC SCALE; POSTURAL STABILITY; OLDER-ADULTS; RISK; HISTORY; SPEED; FORCE; WOMEN	Considering that most of the falls in elderly population arise during walking, tests derived from walking performance would be desirable for comprehensive fall risk assessment. The analysis of spatial temporal parameters and the center of pressure displacement, which represents the interaction between the human body and the ground, would be beneficial. The aim of this study was to compare spatial temporal gait parameters and their variability and the variability of the center of pressure displacement between elderly fallers and nonfallers during gait at self-selected, defined and fast speeds. A prospective study design was used. At the baseline, measurements of ground reaction force during gait at self-selected, defined and fast walking speeds by two force plates were performed. In addition, the Tinetti balance assessment tool, the Falls Efficacy Scale-International and the Activities-Specific Balance Confidence Scale were used. Mean and coefficient of variation of spatial temporal gait parameters and standard deviations of center of pressure displacement during loading response, midstance, terminal stance and preswing phases were calculated. Comparison of the fallers and nonfallers exhibited no significant difference in clinical tool, scales or spatial temporal parameters. Compared to nonfallers' increased variability of walking speed at selfselected and defined speed, step width at fast walking speed and center of pressure displacement during preswing phase in medial-lateral directions at defined walking speed was found in fallers. However, application of the Holm-Bonferroni procedure for multiple comparisons exhibited no significant effect of group in any of the gait parameters. In general, our study did not observe an effect of group (fallers vs. nonfallers) on variability of spatial temporal parameters and center of pressure movement during gait. However, walking speed, step width as well as standard deviation of COP displacement in the medial-lateral direction during preswing exhibited a certain potential for distinguishing between elderly fallers and nonfallers.	[Svoboda, Zdenek; Bizovska, Lucia; Janura, Miroslav; Kubonova, Eliska] Palacky Univ, Fac Phys Culture, Dept Nat Sci Kinanthropol, Olomouc, Czech Republic; [Janurova, Katerina] VSB Tech Univ Ostrava, IT4 Innovat Natl Supercomp Ctr, Ostrava, Czech Republic; [Vuillerme, Nicolas] Univ Grenoble Alpes, EA AGEIS, La Tronche, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Palacky University Olomouc; Technical University of Ostrava; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Svoboda, Z (corresponding author), Palacky Univ, Fac Phys Culture, Dept Nat Sci Kinanthropol, Olomouc, Czech Republic.	zdenek.svoboda@upol.cz	Bizovska, Lucia/J-3949-2017; Svoboda, Zdenek/N-8612-2019; Svoboda, Zdenek/D-6737-2014; Kubonova, Eliska/J-1968-2017; Janura, Miroslav/K-1832-2015; Janurová, Kateřina/X-6590-2019; VUILLERME, Nicolas/U-5767-2019	Bizovska, Lucia/0000-0002-6033-3611; Svoboda, Zdenek/0000-0002-0744-4689; Svoboda, Zdenek/0000-0002-0744-4689; Kubonova, Eliska/0000-0002-2267-890X; Janura, Miroslav/0000-0002-6220-4450; Janurová, Kateřina/0000-0002-4502-2372; VUILLERME, Nicolas/0000-0003-3773-393X	Czech Science Foundation [15-13980S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (grant no. 15-13980S) - https://gacr.cz/.	Barak Y, 2006, PHYS THER, V86, P1501, DOI 10.2522/ptj.20050387; Bizovska L, 2014, GAIT POSTURE, V40, P399, DOI 10.1016/j.gaitpost.2014.05.065; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Buatois S, 2006, GERONTOLOGY, V52, P345, DOI 10.1159/000094983; Coolican H., 2009, RES METHODS STAT PSY; Deshpande N, 2009, AGE AGEING, V38, P509, DOI 10.1093/ageing/afp093; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; HOLM S, 1979, SCAND J STAT, V6, P65; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Kurz I, 2013, J ELECTROMYOGR KINES, V23, P814, DOI 10.1016/j.jelekin.2013.04.001; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Merlo A, 2012, GAIT POSTURE, V36, P662, DOI 10.1016/j.gaitpost.2012.06.016; Mortaza N, 2014, EUR J PHYS REHAB MED, V50, P677; Muir JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070566; Muniz AMS, 2009, GAIT POSTURE, V29, P31, DOI 10.1016/j.gaitpost.2008.05.015; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Perry J, 2004, ATLAS AMPUTATIONS LI, P353; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Reguli Z., 2011, STUD SPORT, V5, P5, DOI [10.5817/StS2011-2-1, DOI 10.5817/STS2011-2-1]; Stein EC, 2005, J AM GERIATR, V53, P1618, DOI [10.1111/j.1532-5415.2005.53455.x, DOI 10.1111/J.1532-5415.2005.53455.X]; Svoboda Z, 2015, ACTA GYMNICA, V45, P203, DOI 10.5507/ag.2015.024; Svoboda Z, 2012, PROSTHET ORTHOT INT, V36, P225, DOI 10.1177/0309364612439572; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; World Health Organization, 2015, WHO GUID TRANSL AD I, P4; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196	31	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171997	10.1371/journal.pone.0171997	http://dx.doi.org/10.1371/journal.pone.0171997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241008	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400013
J	Das, S; Chowdhury, SR; Dey, S; Sen, U				Das, Samir; Chowdhury, Sanghati Roy; Dey, Sanjay; Sen, Udayaditya			Structural and biochemical studies on Vibrio cholerae Hsp31 reveals a novel dimeric form and Glutathione-independent Glyoxalase activity	PLOS ONE			English	Article							ESCHERICHIA-COLI HSP31; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; PROTEIN; CHAPERONE; MEMBER; METHYLGLYOXAL; SUPERFAMILY; EXPRESSION; DJ-1	Vibrio cholerae experiences a highly hostile environment at human intestine which triggers the induction of various heat shock genes. The hchA gene product of V. cholerae O395, referred to a hypothetical intracellular protease/amidase VcHsp31, is one such stress-inducible homodimeric protein. Our current study demonstrates that VcHsp31 is endowed with molecular chaperone, amidopeptidase and robust methylglyoxalase activities. Through site directed mutagenesis coupled with biochemical assays on VcHsp31, we have confirmed the role of residues in the vicinity of the active site towards amidopeptidase and methylglyoxalase activities. VcHsp31 suppresses the aggregation of insulin in vitro in a dose dependent manner. Through crystal structures of VcHsp31 and its mutants, grown at various temperatures, we demonstrate that VcHsp31 acquires two (Type-I and Type-II) dimeric forms. TypeI dimer is similar to EcHsp31 where two VcHsp31 monomers associate in eclipsed manner through several intersubunit hydrogen bonds involving their P-domains. Type-II dimer is a novel dimeric organization, where some of the intersubunit hydrogen bonds are abrogated and each monomer swings out in the opposite directions centering at their P-domains, like twisting of wet cloth. Normal mode analysis (NMA) of Type-I dimer shows similar movement of the individual monomers. Upon swinging, a dimeric surface of similar to 400 angstrom(2), mostly hydrophobic in nature, is uncovered which might bind partially unfolded protein substrates. We propose that, in solution, VcHsp31 remains as an equilibrium mixture of both the dimers. With increase in temperature, transformation to Type-II form having more exposed hydrophobic surface, occurs progressively accounting for the temperature dependent increase of chaperone activity of VcHsp31.	[Das, Samir] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, India; [Chowdhury, Sanghati Roy; Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India; [Dey, Sanjay] St Xaviers Coll, Dept Biotechnol, Kolkata, India; [Das, Samir] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics; St. Xavier's College Kolkata; University of British Columbia	Sen, U (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	udayaditya.sen@saha.ac.in		Sen, Udayaditya/0000-0001-5742-2907	Structural Proteomics and Genomics of Human Genetic Disorders (SPGHGD) project, Department of Atomic Energy (DAE), Government of India; Department of Atomic Energy (DAE), Government of India	Structural Proteomics and Genomics of Human Genetic Disorders (SPGHGD) project, Department of Atomic Energy (DAE), Government of India; Department of Atomic Energy (DAE), Government of India(Department of Atomic Energy (DAE))	This work was supported by the Structural Proteomics and Genomics of Human Genetic Disorders (SPGHGD) project, Department of Atomic Energy (DAE), Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the intramural grant MSACR from Department of Atomic Energy (DAE), Government of India. US is thankful to Abhijit Bhattacharya of SINP for help in data collection and to Dr. Jhimli Dasgupta of SXC, Kolkata for critically reading the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Bankapalli K, 2015, J BIOL CHEM, V290, P26491, DOI 10.1074/jbc.M115.673624; Bucala R, 1992, Adv Pharmacol, V23, P1; Choi D, 2013, BBA-PROTEINS PROTEOM, V1834, P621, DOI 10.1016/j.bbapap.2012.11.006; COOPER RA, 1970, FEBS LETT, V11, P273, DOI 10.1016/0014-5793(70)80546-4; Das S, 2011, ACTA CRYSTALLOGR F, V67, P1382, DOI 10.1107/S1744309111032970; Do CB, 2008, METHODS MOL BIOL, V484, P379, DOI 10.1007/978-1-59745-398-1_25; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILBERT RP, 1975, ANAL CHEM, V47, P2418, DOI 10.1021/ac60364a003; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon K, 2013, FEBS J, V280, P3328, DOI 10.1111/febs.12321; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Lee S, 2005, J BIOCHEM MOL BIOL, V38, P259; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Li HM, 2002, J BIOL CHEM, V277, P24522, DOI 10.1074/jbc.M202020200; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PARSOT C, 1990, P NATL ACAD SCI USA, V87, P9898, DOI 10.1073/pnas.87.24.9898; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Sastry MSR, 2009, PROTEIN SCI, V18, P1439, DOI 10.1002/pro.158; Sastry MSR, 2004, P NATL ACAD SCI USA, V101, P8587, DOI 10.1073/pnas.0403033101; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Schuyler AD, 2004, J MOL GRAPH MODEL, V22, P183, DOI 10.1016/S1093-3263(03)00158-X; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CJ, 2015, J BIOL CHEM, V290, P24816, DOI 10.1074/jbc.M115.678367; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Zhan DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103902; Zhao YH, 2003, PROTEIN SCI, V12, P2303, DOI 10.1110/ps.03121403	46	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172629	10.1371/journal.pone.0172629	http://dx.doi.org/10.1371/journal.pone.0172629			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235098	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200103
J	Kimulwo, MJ; Okendo, J; Aman, RA; Ogutu, BR; Kokwaro, GO; Ochieng, DJ; Muigai, AWT; Oloo, FA; Ochieng, W				Kimulwo, Maureen J.; Okendo, Javan; Aman, Rashid A.; Ogutu, Bernhards R.; Kokwaro, Gilbert O.; Ochieng, Dorothy J.; Muigai, Anne W. T.; Oloo, Florence A.; Ochieng, Washingtone			Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; PERFORMANCE LIQUID-CHROMATOGRAPHY; PUBLIC-HEALTH APPROACH; THERAPY; HIV; EFAVIRENZ; PHARMACOKINETICS; RESISTANCE; WOMEN; INDIVIDUALS	Treatment failure is a key challenge in the management of HIV-1 infection. We conducted a mixed-model survey of plasma nevirapine (NVP) concentrations (cNVP) and viral load in order to examine associations with treatment and adherence outcomes among Kenyan patients on prolonged antiretroviral therapy (ART). Blood plasma was collected at 1, 4 and 24 hours post-ART dosing from 58 subjects receiving NVP-containing ART and used to determine cNVP and viral load (VL). Median duration of treatment was 42 (range, 12-156) months, and 25 (43.1%) of the patients had virologic failure (VF). cNVP was significantly lower for VF than non-VF at 1hr (mean, 2,111ng/ml vs. 3,432ng/ml, p = 0.003) and at 4hr (mean 1,625ng/ml vs. 3,999ng/ml, p = 0.001) but not at 24hr post-ART dosing. Up to 53.4%, 24.1% and 22.4% of the subjects had good, fair and poor adherence respectively. cNVP levels peaked and were > = 3 mu g. ml at 4 hours in a majority of patients with good adherence and those without VF. Using a threshold of 3 mu g/ml for optimal therapeutic nevirapine level, 74% (43/58), 65.5% (38/58) and 86% (50/58) of all patients had sub-therapeutic cNVP at 1, 4 and 24 hours respectively. cNVP at 4 hours was associated with adherence (p = 0.05) and virologic VF (p = 0.002) in a chi-square test. These mean cNVP levels differed significantly in non-parametric tests between adherence categories at 1hr (p = 0.005) and 4hrs (p = 0.01) and between ART regimen categories at 1hr (p = 0.004) and 4hrs (p< 0.0001). Moreover, cNVP levels correlated inversely with VL (p< = 0.006) and positively with adherence behavior. In multivariate tests, increased early peak NVP (cNVP4) was independently predictive of lower VL (p = 0.002), while delayed high NVP peak (cNVP24) was consistent with increased VL (p = 0.033). These data strongly assert the need to integrate plasma concentrations of NVP and that of other ART drugs into routine ART management of HIV-1 patients.	[Kimulwo, Maureen J.; Okendo, Javan; Aman, Rashid A.; Ogutu, Bernhards R.; Oloo, Florence A.; Ochieng, Washingtone] Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya; [Kimulwo, Maureen J.; Muigai, Anne W. T.] Jomo Kenyatta Univ Sci & Technol, ITROMID, Nairobi, Kenya; [Aman, Rashid A.; Ogutu, Bernhards R.; Kokwaro, Gilbert O.; Ochieng, Washingtone] Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya; [Aman, Rashid A.] African Ctr Clin Trials, Nairobi, Kenya; [Ogutu, Bernhards R.; Ochieng, Washingtone] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Ochieng, Dorothy J.] MCPHS Univ, Sch Pharm, Worcester, MA USA; [Oloo, Florence A.] Tech Univ Kenya, Dept Chem Sci & Technol, Nairobi, Kenya; [Ochieng, Washingtone] Harvard Sch Publ Hlth, Immunol & Infect Dis Dept, Boston, MA 02115 USA	Strathmore University; Jomo Kenyatta University of Agriculture & Technology; Strathmore University; Kenya Medical Research Institute; Technical University of Kenya; Harvard University; Harvard T.H. Chan School of Public Health	Ochieng, W (corresponding author), Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya.; Ochieng, W (corresponding author), Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya.; Ochieng, W (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.; Ochieng, W (corresponding author), Harvard Sch Publ Hlth, Immunol & Infect Dis Dept, Boston, MA 02115 USA.	ochiengwashingtone@gmail.com	Okendo, Javan/GPP-6462-2022	Okendo, Javan Ochieng/0000-0001-6897-5224; Ochieng, Washingtone/0000-0002-9035-4405; Okendo, Javan/0000-0001-8218-5448	Consortium for National Health Research, Kenya [RCDG2012-005/5RG2014-12]	Consortium for National Health Research, Kenya	This study was supported by the Consortium for National Health Research, Kenya, RCDG2012-005/5RG2014-12.; All members of the CREATES HIV Research Group and staff at Ahero and Ndhiwa sub county hospitals who coordinated the work. The Consortium for National Health Research, Kenya, supported this study (Grant #: RCDG2012-005/SRG2014-12).	Abdissa A, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18979; Achieng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067259; Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; AIDSinfo, 2015, GUIDELINES USE ANTIR; [Anonymous], 2011, GUID ANT THER KEN; Aurpibul L, 2016, THER DRUG MONIT, V38, P791, DOI 10.1097/FTD.0000000000000329; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Bennett DE, 2008, ANTIVIR THER, V13, P1; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Dahri K, 2007, CLIN PHARMACOKINET, V46, P109, DOI 10.2165/00003088-200746020-00002; de Vries-Sluijs TEMS, 2003, CLIN PHARMACOKINET, V42, P599, DOI 10.2165/00003088-200342060-00009; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Holzinger ER, 2012, PHARMACOGENET GENOM, V22, P858, DOI 10.1097/FPC.0b013e32835a450b; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Jamshidi Y, 2010, J ANTIMICROB CHEMOTH, V65, P2614, DOI 10.1093/jac/dkq369; Kitawi RC, 2015, AIDS RES HUM RETROV, V31, P452, DOI [10.1089/aid.2014.0306, 10.1089/AID.2014.0306]; Kouanfack C, 2008, JAIDS-J ACQ IMM DEF, V48, P216, DOI 10.1097/QAI.0b013e3181743955; L'homme RFA, 2008, CLIN INFECT DIS, V47, P1339, DOI 10.1086/592694; L'homme RFA, 2006, JAIDS-J ACQ IMM DEF, V43, P193, DOI 10.1097/01.qai.0000234089.41785.c8; Labhardt ND, 2014, J INT AIDS SOC, V17, P115, DOI 10.7448/IAS.17.4.19666; Lamorde M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-473; Muro E, 2005, JAIDS-J ACQ IMM DEF, V39, P419, DOI 10.1097/01.qai.0000167154.37357.f9; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; Notari S, 2006, J CHROMATOGR B, V831, P258, DOI 10.1016/j.jchromb.2005.12.016; Nzomo TJ, 2015, AIDS RES HUM RETROV, V31, P550, DOI [10.1089/aid.2015.0031, 10.1089/AID.2015.0031]; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Talam N C, 2008, East Afr J Public Health, V5, P74; van Heeswijk RPG, 2000, AIDS, V14, pF77, DOI 10.1097/00002030-200005260-00001; Van Leth F, 2006, AIDS RES HUM RETROV, V22, P232, DOI 10.1089/aid.2006.22.232; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026739; WHO, 2014, CONS GUID GEN HIV CA; WHO, NASCOP2005; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172960	10.1371/journal.pone.0172960	http://dx.doi.org/10.1371/journal.pone.0172960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235021	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200177
J	Schumacher, A; Sikov, WM; Quesenberry, MI; Safran, H; Khurshid, H; Mitchell, KM; Olszewski, AJ				Schumacher, Andrew; Sikov, William M.; Quesenberry, Matthew I.; Safran, Howard; Khurshid, Humera; Mitchell, Kristen M.; Olszewski, Adam J.			Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study	PLOS ONE			English	Article							PARTICIPANTS; DOCUMENTS; QUALITY; INTERVENTIONS; PERCEPTIONS; FORMS; READ	Background Informed consent forms (ICFs) for oncology clinical trials have grown increasingly longer and more complex. We evaluated objective understanding of critical components of informed consent among patients enrolling in contemporary trials of conventional or novel biologic/targeted therapies. Methods We evaluated ICFs for cancer clinical trials for length and readability, and patients registered on those studies were asked to complete a validated 14-question survey assessing their understanding of key characteristics of the trial. Mean scores were compared in groups defined by trial and patient characteristics. Results Fifty patients, of whom half participated in trials of immunotherapy or biologic/targeted agents and half in trials of conventional therapy, completed the survey. On average, ICFs for industry-originated trials (N = 9 trials) were significantly longer (P <.0001) and had lower Flesch ease-of-reading scores (P = .003) than investigator-initiated trials (N = 11). At least 80% of patients incorrectly responded to three key questions which addressed the experimental nature of their trial therapy, its purported efficacy and potential risks relative to alternative treatments. The mean objective understanding score was 76.9 +/- 8.8, but it was statistically significantly lower for patients who had not completed high school (P = .011). The scores did not differ significantly by type of cancer therapy (P = .12) or trial sponsor (P = .38). Conclusions Many participants enrolled on cancer trials had poor understanding of essential elements of their trial. In order to ensure true informed consent, innovative approaches, such as expanded in-person counseling adapted to the patient's education level or cultural characteristics should be evaluated across socio-demographic groups.	[Schumacher, Andrew; Sikov, William M.; Quesenberry, Matthew I.; Safran, Howard; Khurshid, Humera; Mitchell, Kristen M.; Olszewski, Adam J.] Brown Univ, Oncol Res Grp, Providence, RI 02912 USA	Brown University	Olszewski, AJ (corresponding author), Brown Univ, Oncol Res Grp, Providence, RI 02912 USA.	adam_olszewski@brown.edu	Olszewski, Andrzej J/W-1825-2018; Olszewski, Adam J/F-8449-2013	Olszewski, Andrzej J/0000-0003-3368-5475; Olszewski, Adam J/0000-0002-6472-6658	Brown University Oncology Research Group, an academic research consortium	Brown University Oncology Research Group, an academic research consortium	Brown University Oncology Research Group, an academic research consortium, provided all financial and administrative support for this study.	Berger O, 2009, ANN ONCOL, V20, P379, DOI 10.1093/annonc/mdn623; Breese PE, 2007, J EMPIR RES HUM RES, V2, P69, DOI 10.1525/jer.2007.2.4.69; Coyne CA, 2003, J CLIN ONCOL, V21, P836, DOI 10.1200/JCO.2003.07.022; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Ferguson PR, 2002, J MED ETHICS, V28, P45, DOI 10.1136/jme.28.1.45; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gotay CC, 2001, CANCER EPIDEM BIOMAR, V10, P1097; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Hayes AF, 2016, BEHAV RES THER; Hoffner B, 2012, CANCER-AM CANCER SOC, V118, P1877, DOI 10.1002/cncr.26438; Holland J, 2013, JNCI-J NATL CANCER I, V105, P927, DOI 10.1093/jnci/djt152; Jefford M, 2011, SUPPORT CARE CANCER, V19, P371, DOI 10.1007/s00520-010-0829-6; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kincaid J. P., 1975, DTIC DOCUMENT; Koyfman SA, 2016, CANCER-AM CANCER SOC, V122, P464, DOI 10.1002/cncr.29759; Koyfman SA, 2013, JNCI-J NATL CANCER I, V105, P947, DOI 10.1093/jnci/djt143; Kutner M, 2006, 2006483 NCES US DEP; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; US Food and Drug Administration, 2016, GUID IRBS CLIN INV S	28	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172957	10.1371/journal.pone.0172957	http://dx.doi.org/10.1371/journal.pone.0172957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235011	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200176
J	Sae-Lim, P; Grova, L; Olesen, I; Varona, L				Sae-Lim, Panya; Grova, Lise; Olesen, Ingrid; Varona, Luis			A comparison of nonlinear mixed models and response to selection of tick-infestation on lambs	PLOS ONE			English	Article							TROPICAL BEEF-CATTLE; ANAPLASMA-PHAGOCYTOPHILUM; GENETIC-ANALYSIS; BOOPHILUS-MICROPLUS; GASTROINTESTINAL NEMATODES; TEMPERAMENT TRAITS; NELLORE CATTLE; RESISTANCE; SHEEP; POISSON	Tick-borne fever (TBF) is stated as one of the main disease challenges in Norwegian sheep farming during the grazing season. TBF is caused by the bacterium Anaplasma phagocytophilum that is transmitted by the tick Ixodes ricinus. A sustainable strategy to control tick-infestation is to breed for genetically robust animals. In order to use selection to genetically improve traits we need reliable estimates of genetic parameters. The standard procedures for estimating variance components assume a Gaussian distribution of the data. However, tick-count data is a discrete variable and, thus, standard procedures using linear models may not be appropriate. Thus, the objectives of this study were twofold: 1) to compare four alternative non-linear models: Poisson, negative binomial, zero-inflated Poisson and zero-inflated negative binomial based on their goodness of fit for quantifying genetic variation, as well as heritability for tick-count and 2) to investigate potential response to selection against tick-count based on truncation selection given the estimated genetic parameters from the best fit model. Our results showed that zero-inflated Poisson was the most parsimonious model for the analysis of tick count data. The resulting estimates of variance components and high heritability (0.32) led us to conclude that genetic determinism is relevant on tick count. A reduction of the breeding values for tick-count by one sire-dam genetic standard deviation on the liability scale will reduce the number of tick counts below an average of 1. An appropriate breeding scheme could control tick-count and, as a consequence, probably reduce TBF in sheep.	[Sae-Lim, Panya; Olesen, Ingrid] Nofima AS, Osloveien 1, As, Norway; [Grova, Lise] Norwegian Inst Bioecon Res NIBIO, Gunnars Veg 6, Tingvoll, Norway; [Varona, Luis] Univ Zaragoza, Fac Vet, Zaragoza, Spain	Nofima; Norwegian Institute of Bioeconomy Research; University of Zaragoza	Sae-Lim, P (corresponding author), Nofima AS, Osloveien 1, As, Norway.	panya.sae-lim@nofima.no	Varona, Luis/C-2744-2012	Varona, Luis/0000-0001-6256-5478	Norwegian Foundation for Research Levy on Agricultural Products [207737]; Agricultural Agreement Research Funds [207737]; More and Romsdal Council [127/2009]; County Governor in More and Romsdal [2010/5782/OTLO/]; More og Romsdal Council; County Governor in More og Romsdal	Norwegian Foundation for Research Levy on Agricultural Products; Agricultural Agreement Research Funds; More and Romsdal Council; County Governor in More and Romsdal; More og Romsdal Council; County Governor in More og Romsdal	This study was part of the TICKLESS project, which was funded by the Norwegian Foundation for Research Levy on Agricultural Products (FFL) and the Agricultural Agreement Research Funds (JA) (https://www.slf.dep.no/no/fou-midler/landbruks-og-matforskning), grant nr 207737, together with More and Romsdal Council (www.mrfylke.no), grant nr 127/2009, and the County Governor in More and Romsdal (www.fylkesmannen.no/More-og-Romsdal/), grant nr 2010/5782/OTLO/. PSL, LG and 10 received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of the TICKLESS project (project number 207737) which was funded by the Norwegian Foundation for Research Levy on Agricultural Products (FFL) and the Agricultural Agreement Research Funds (JA), the More og Romsdal Council and County Governor in More og Romsdal. We thank the farmers and technicians at NIBIO for collecting data of tick count on lambs.	Ali AA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-22; Ayres DR, 2015, J APPL GENET, V56, P107, DOI 10.1007/s13353-014-0238-5; Ayres DR, 2013, J ANIM BREED GENET, V130, P417, DOI 10.1111/jbg.12036; Bishop SC, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P3, DOI 10.1079/9781845935559.0003; Budeli MA, 2009, S AFR J ANIM SCI, V39, P321; Burrow HM, 2001, LIVEST PROD SCI, V70, P213, DOI 10.1016/S0301-6226(01)00178-6; Dawson M, 1998, VET REC, V142, P623; Dugat T, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00061; FOGGIE A, 1951, J PATHOL BACTERIOL, V63, P1, DOI 10.1002/path.1700630103; FOULLEY JL, 1993, GENET SEL EVOL, V25, P101, DOI 10.1051/gse:19930107; FOULLEY JL, 1987, THEOR APPL GENET, V73, P870, DOI 10.1007/BF00289392; FOULLEY JL, 1993, GENET SEL EVOL, V25, P297, DOI 10.1051/gse:19930307; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Granquist EG, 2008, INFECT IMMUN, V76, P120, DOI 10.1128/IAI.01206-07; Granquist EG, 2010, VET IMMUNOL IMMUNOP, V133, P117, DOI 10.1016/j.vetimm.2009.07.009; Grova L, 2011, TICK BORNE FEVER SHE; Henderson C. R, 1984, APPL LINEAR MODELS A; Henshall JM, 2004, AUST J AGR RES, V55, P1109, DOI 10.1071/AR03085; HEWETSON RW, 1972, AUST VET J, V48, P299, DOI 10.1111/j.1751-0813.1972.tb05161.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LEMOS AM, 1985, ANIM PROD, V41, P187, DOI 10.1017/S0003356100027847; Lynch M., 1998, GENETICS ANAL QUANTI; Matos CAP, 1997, J ANIM SCI, V75, P88; Meuwissen THE, 2001, GENETICS, V157, P1819; Mota RR, 2016, J ANIM SCI, V94, P1834, DOI 10.2527/jas.2015-0194; Muyobela J, 2015, TROP ANIM HEALTH PRO, V47, P1599, DOI 10.1007/s11250-015-0906-4; Mysterud A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-187; Naya H, 2008, GENET SEL EVOL, V40, P379, DOI 10.1051/gse:2008010; Neto LRP, 2011, VET PARASITOL, V180, P165, DOI 10.1016/j.vetpar.2011.05.048; NIBIO, 2016, NAT STAT SHEEP LOST; OLESEN I, 1994, J ANIM SCI, V72, P1166, DOI 10.2527/1994.7251166x; Passafaro TL, 2015, VET PARASITOL, V210, P224, DOI 10.1016/j.vetpar.2015.03.017; Pfeffer A, 2007, INT J PARASITOL, V37, P1589, DOI 10.1016/j.ijpara.2007.05.008; Porto-Neto LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113284; Prayaga KC, 2005, AUST J EXP AGR, V45, P971, DOI 10.1071/EA05045; Prayaga KC, 2003, AUST J AGR RES, V54, P1027, DOI 10.1071/AR03072; Raadsma HW, 2013, LIVEST SCI, V156, P115, DOI 10.1016/j.livsci.2013.06.011; RAADSMA HW, 1991, AUST J AGR RES, V42, P279, DOI 10.1071/AR9910279; Rajput Zahid Iqbal, 2006, J Zhejiang Univ Sci B, V7, P912, DOI 10.1631/jzus.2006.B0912; Regitano L, 2006, MOL ASPECTS BOVINE T; Rodrigues-Motta M, 2007, J DAIRY SCI, V90, P5306, DOI 10.3168/jds.2006-898; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Sorensen D, 1995, GENET SEL EVOL, V27, P1; Spiegelhalter D, 1996, MARKOV CHAIN MONTE C, P145; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEAR MJ, 1994, VET PARASITOL, V54, P161, DOI 10.1016/0304-4017(94)90089-2; Stear MJ, 2001, RES VET SCI, V71, P1, DOI 10.1053/rvsc.2001.0496; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Stuen S., 2000, INVESTIGATION LAMB D, P111; Stuen S, 2003, THESIS; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Stuen S, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-8; Tempelman RJ, 1996, BIOMETRICS, V52, P265, DOI 10.2307/2533161; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; Ulvund MJ, 2012, SMALL RUMINANT RES, V106, P6, DOI 10.1016/j.smallrumres.2012.04.011; UTECH KBW, 1978, AUST J AGR RES, V29, P885, DOI 10.1071/AR9780885; Varona L, 2010, GENETICS, V184, P277, DOI 10.1534/genetics.109.110759; Vassallo M, 2000, J MED ENTOMOL, V37, P335, DOI 10.1603/0022-2585(2000)037[0335:MFSQNO]2.0.CO;2; WHARTON RH, 1970, AUST J AGR RES, V21, P163, DOI 10.1071/AR9700163; Woldehiwet Z, 2010, VET PARASITOL, V167, P108, DOI 10.1016/j.vetpar.2009.09.013	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172711	10.1371/journal.pone.0172711	http://dx.doi.org/10.1371/journal.pone.0172711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257433	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396021100023
J	Aguilar-Rodea, P; Zuniga, G; Rodriguez-Espino, BA; Cervantes, ALO; Arroyo, AEG; Moreno-Espinosa, S; Zamboni, DD; Martinez, BL; Castellanos-Cruz, MD; Parra-Ortega, I; Rojas, VLJ; Galindo, JCV; Velazquez-Guadarrama, N				Aguilar-Rodea, Pamela; Zuniga, Gerardo; Antonio Rodriguez-Espino, Benjamin; Olivares Cervantes, Alma Lidia; Gamino Arroyo, Ana Estela; Moreno-Espinosa, Sarbelio; de la Rosa Zamboni, Daniela; Lopez Martinez, Briceida; del Carmen Castellanos-Cruz, Maria; Parra-Ortega, Israel; Jimenez Rojas, Veronica Leticia; Vigueras Galindo, Juan Carlos; Velazquez-Guadarrama, Norma			Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233	PLOS ONE			English	Article							GENETIC DIVERSITY; HOSPITALS; MARKERS	Several microorganisms produce nosocomial infections (NIs), among which Pseudomonas aeruginosa stands out as an opportunist pathogen with the capacity to develop multiresistance to first-choice antibiotics. From 2007 to 2013, forty-six NIs produced by P. aeruginosa were detected at a pediatric tertiary care hospital in Mexico with a significant mortality rate (17.39%). All isolates (n = 58/46 patients) were characterized by evaluating their response to several antibiotics as panresistant (PDR), extensively resistant (XDR), multiresistant (MDR) or sensitive (S). In addition, all isolates were typified through multilocus sequencing of seven genes: acsA, aroE, guaA, mutL, nuoD, ppsA and trpE. Furthermore, to establish the genetic relationships among these isolates, we carried out a phylogenetic inference analysis using maximum likelihood to construct a phylogenetic network. To assess evolutionary parameters, recombination was evaluated using the PHI test, and the ratio of nonsynonymous to synonymous substitutions was determined. Two of the strains were PDR (ST1725); 42 were XDR; four were MDR; and ten were S. Twenty-one new sequence types were detected. Thirty-three strains exhibited novel sequence type ST1725. The ratio of nonsynonym to synonym substitutions was 1: 1 considering all genes. Phylogenetic analysis showed that the genetic relationship of the PDR, XDR and MDR strains was mainly clonal; however, the PHI test and the phylogenetic network suggest that recombination events occurred to produce a non-clonal population. This study aimed not only to determine the genetic diversity of clinical P. aeruginosa but also to provide a warning regarding the identification and spreading of clone ST1725, its ability to cause outbreaks with high mortality rates, and to remain in the hospital environment for over seven years. These characteristics highlight the need to identify clonal outbreaks, especially where high resistance to most antibiotics is observed, and control measures are needed. This study also represents the first report of the PDR ST1725.	[Aguilar-Rodea, Pamela] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Posgrad Ciencias Quimicobiol, Mexico City, DF, Mexico; [Aguilar-Rodea, Pamela; Olivares Cervantes, Alma Lidia; Jimenez Rojas, Veronica Leticia; Vigueras Galindo, Juan Carlos; Velazquez-Guadarrama, Norma] Hosp Infantil Mexico Dr Federico Gomez, Lab Infectol, Mexico City, DF, Mexico; [Aguilar-Rodea, Pamela; Zuniga, Gerardo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Lab Variac Biol & Evoluc, Mexico City, DF, Mexico; [Antonio Rodriguez-Espino, Benjamin] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest & Diagnost Nefrol & Metab Mineral Oseo, Mexico City, DF, Mexico; [Gamino Arroyo, Ana Estela; Moreno-Espinosa, Sarbelio] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [de la Rosa Zamboni, Daniela] Hosp Infantil Mexico Dr Federico Gomez, Dept Epidemiol, Mexico City, DF, Mexico; [Lopez Martinez, Briceida] Hosp Infantil Mexico Dr Federico Gomez, Subdirecc Serv Auxiliares & Lab, Mexico City, DF, Mexico; [del Carmen Castellanos-Cruz, Maria; Parra-Ortega, Israel] Hosp Infantil Mexico Dr Federico Gomez, Dept Lab Clin, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez	Velazquez-Guadarrama, N (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Infectol, Mexico City, DF, Mexico.; Zuniga, G (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Zool, Lab Variac Biol & Evoluc, Mexico City, DF, Mexico.	capotezu@hotmail.com; normave@himfg.edu.mx	Parra-Ortega, Israel/CAE-8579-2022; Velazquez-Guadarrama, Norma/M-3119-2017	Velazquez-Guadarrama, Norma/0000-0002-3620-7260; Aguilar-Rodea, Pamela/0000-0002-1522-2138; Gamino-Arroyo, Ana Estela/0000-0002-4214-9239	Federal Resources of the Hospital Infantil de Mexico Federico Gomez of the Secretaria de Salud (SSA) [HIM/2015/023.1164]	Federal Resources of the Hospital Infantil de Mexico Federico Gomez of the Secretaria de Salud (SSA)	This project was supported by Federal Resources of the Hospital Infantil de Mexico Federico Gomez number grant HIM/2015/023.1164 of the Secretaria de Salud (SSA). PAR was a CONACyT fellow (254430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Rodea P., 2013, THESIS; Arias-Flores R, 2016, MICROORG RESPONSIBLE, V54, P20; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Clinical and Laboratory Standards Institute, 2016, M100S PERF STAND ANT; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Deplano A, 2005, J CLIN MICROBIOL, V43, P1198, DOI 10.1128/JCM.43.3.1198-1204.2005; Equiarte Luis E, 2007, ECOLOGIA MOL; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Giske CG, 2006, J CLIN MICROBIOL, V44, P4309, DOI 10.1128/JCM.00817-06; Gomila M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-138; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebeque Perez Y, 1999, REV CUBANA MED, V45; Lee JY, 2011, MICROB DRUG RESIST, V17, P299, DOI 10.1089/mdr.2010.0145; Lopez-Causape C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071001; Maatallah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082069; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McCarthy K, 2015, SEMIN RESP CRIT CARE, V36, P44, DOI 10.1055/s-0034-1396907; Mudau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055985; Mulet X, 2013, ANTIMICROB AGENTS CH, V57, P5527, DOI 10.1128/AAC.01481-13; Olaechea PM, 2010, MED INTENSIVA, V34, P256, DOI 10.1016/j.medin.2009.11.013; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Zafer MM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0861-8	31	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172882	10.1371/journal.pone.0172882	http://dx.doi.org/10.1371/journal.pone.0172882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253282	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300044
J	Delfino-Machin, M; Madelaine, R; Busolin, G; Nikaido, M; Colanesi, S; Camargo-Sosa, K; Law, EWP; Toppo, S; Blader, P; Tiso, N; Kelsh, RN				Delfino-Machin, Mariana; Madelaine, Romain; Busolin, Giorgia; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Toppo, Stefano; Blader, Patrick; Tiso, Natascia; Kelsh, Robert N.			Sox10 contributes to the balance of fate choice in dorsal root ganglion progenitors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; STEM-CELLS; WAARDENBURG-SYNDROME; SIGNALING PATHWAY; GENE-EXPRESSION; SENSORY NEURON; GLIAL FATE; IN-VIVO; HIRSCHSPRUNG-DISEASE	The development of functional peripheral ganglia requires a balance of specification of both neuronal and glial components. In the developing dorsal root ganglia (DRGs), these components form from partially-restricted bipotent neuroglial precursors derived from the neural crest. Work in mouse and chick has identified several factors, including Delta/Notch signaling, required for specification of a balance of these components. We have previously shown in zebrafish that the Sry-related HMG domain transcription factor, Sox10, plays an unexpected, but crucial, role in sensory neuron fate specification in vivo. In the same study we described a novel Sox10 mutant allele, sox10(baz1), in which sensory neuron numbers are elevated above those of wild-types. Here we investigate the origin of this neurogenic phenotype. We demonstrate that the supernumerary neurons are sensory neurons, and that enteric and sympathetic neurons are almost absent just as in classical sox10 null alleles; peripheral glial development is also severely abrogated in a manner similar to other sox10 mutant alleles. Examination of proliferation and apoptosis in the developing DRG reveals very low levels of both processes in wild-type and sox10(baz1), excluding changes in the balance of these as an explanation for the overproduction of sensory neurons. Using chemical inhibition of Delta-Notch-Notch signaling we demonstrate that in embryonic zebrafish, as in mouse and chick, lateral inhibition during the phase of trunk DRG development is required to achieve a balance between glial and neuronal numbers. Importantly, however, we show that this mechanism is insufficient to explain quantitative aspects of the baz1 phenotype. The Sox10(baz1) protein shows a single amino acid substitution in the DNA binding HMG domain; structural analysis indicates that this change is likely to result in reduced flexibility in the HMG domain, consistent with sequence-specific modification of Sox10 binding to DNA. Unlike other Sox10 mutant proteins, Sox10(baz1) retains an ability to drive neurogenin1 transcription. We show that overexpression of neurogenin1 is sufficient to produce supernumerary DRG sensory neurons in a wild-type background, and can rescue the sensory neuron phenotype of sox10 morphants in a manner closely resembling the baz1 phenotype. We conclude that an imbalance of neuronal and glial fate specification results from the Sox10 (baz1) protein's unique ability to drive sensory neuron specification whilst failing to drive glial development. The sox10(baz1) phenotype reveals for the first time that a Notch-dependent lateral inhibition mechanism is not sufficient to fully explain the balance of neurons and glia in the developing DRGs, and that a second Sox10-dependent mechanism is necessary. Sox10 is thus a key transcription factor in achieving the balance of sensory neuronal and glial fates.	[Delfino-Machin, Mariana; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Delfino-Machin, Mariana; Nikaido, Masataka; Colanesi, Sarah; Camargo-Sosa, Karen; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath, Avon, England; [Madelaine, Romain; Blader, Patrick] Univ Toulouse, CNRS, UMR5547, CBD,CBI,UPS, Toulouse, France; [Busolin, Giorgia; Tiso, Natascia] Univ Padua, Dept Biol, Padua, Italy; [Toppo, Stefano] Univ Padua, Dept Mol Med, Padua, Italy; [Delfino-Machin, Mariana] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Madelaine, Romain] Stanford Univ, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Nikaido, Masataka] Univ Hyogo, Grad Sch Life Sci, Kobe, Hyogo, Japan; [Colanesi, Sarah] Univ Saarland, Dept Ophthalmol, Homburg, Saar, Germany; [Law, Edward W. P.] Univ Leicester, Dept Canc Studies, Leicester, Leics, England	University of Bath; University of Bath; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Padua; University of Padua; University System of Georgia; Georgia Institute of Technology; Stanford University; University of Hyogo; Saarland University; University of Leicester	Kelsh, RN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; Kelsh, RN (corresponding author), Univ Bath, Ctr Regenerat Med, Bath, Avon, England.; Blader, P (corresponding author), Univ Toulouse, CNRS, UMR5547, CBD,CBI,UPS, Toulouse, France.; Tiso, N (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	patrick.blader@univ-tlse3.fr; natascia.tiso@unipd.it; bssrnk@bath.ac.uk	Toppo, Stefano/Z-5479-2019; Tiso, Natascia/E-2182-2011; Kelsh, Robert/B-6445-2008	Toppo, Stefano/0000-0002-0246-3119; Tiso, Natascia/0000-0002-5444-9853; Kelsh, Robert/0000-0002-9381-0066; Blader, Patrick/0000-0003-3299-6108	Biotechnological and Biological Sciences Research Council [BB/D000440/1]; University of Bath; Uehara Memorial Foundation; Wellcome Trust; Royal Society [JP100027]; CONACyT [329640/384511]; EU ZF-HEALTH grant [CT-2010-242048]; French Muscular Dystrophy Association [18572]; Ministry of Health [RF-2010-2309484]; University of Padova [CPDA128151, CPDA148582, CPDR124317/12, CPDA138081/13]; Fondation ARC [SFI20101201699]; BBSRC [BB/D000440/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000440/1] Funding Source: researchfish	Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Bath; Uehara Memorial Foundation(Uehara Memorial Foundation); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EU ZF-HEALTH grant; French Muscular Dystrophy Association(Association Francaise contre les Myopathies); Ministry of Health; University of Padova; Fondation ARC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the Biotechnological and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant BB/D000440/1, RNK) and University of Bath (http://www.bath.ac.uk/) for funding this work, as well as to the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/) and a Wellcome Trust VIP award (http://www.wellcome.ac.uk/; MN), Royal Society International Collaboration Grant JP100027 (https://royalsociety.org/) to RNK and CONACyT (http://www.conacyt.mx/) grant 329640/384511 to KCS. NT is supported by the EU ZF-HEALTH grant (CT-2010-242048) (www.zf-health.org), by the French Muscular Dystrophy Association (AFM Telethon project POLYGON, 18572) (www.afm-telethon.com), by the Ministry of Health grant RF-2010-2309484 (www.salute.gov.it) and by the University of Padova projects OPTOZEN (CPDA128151) and TIGRE (CPDA148582) (http://www.unipd.it). GB is recipient of a post-doc fellowship Assegno di Ricerca Junior (CPDR124317/12) from the University of Padova (http://www.unipd.it). ST is supported by PRAT grant CPDA138081/13 from University of Padova (http://www.unipd.it). Work by RM and PB was funded by the Fondation ARC (http://www.fondation-arc.org; grant SFI20101201699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; Haddon C, 1998, DEVELOPMENT, V125, P359; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hu ZL, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-14; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Jacob C, 2014, J NEUROSCI, V34, P6112, DOI 10.1523/JNEUROSCI.5212-13.2014; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lauter G, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-43; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Malmquist SJ, 2013, DEVELOPMENT, V140, P3986, DOI 10.1242/dev.084640; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; McGraw HF, 2008, J NEUROSCI, V28, P12558, DOI 10.1523/JNEUROSCI.2079-08.2008; McGraw HF, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-23; Mead TJ, 2012, DEV DYNAM, V241, P376, DOI 10.1002/dvdy.23717; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Moro E, 2013, MOL GENET GENOMICS, V288, P231, DOI 10.1007/s00438-013-0750-z; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Paratore C, 2001, DEVELOPMENT, V128, P3949; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Pasini A, 2004, DEVELOPMENT, V131, P1529, DOI 10.1242/dev.01031; Pavan WJ, 2012, DEV BIOL, V366, P55, DOI 10.1016/j.ydbio.2012.02.038; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Prasad MK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-40; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Schiavone M, 2014, DIS MODEL MECH, V7, P883, DOI 10.1242/dmm.014969; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Thisse B., 2001, EXPRESSION ZEBRAFISH; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zecchin E, 2005, DEV DYNAM, V233, P638, DOI 10.1002/dvdy.20366	88	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172947	10.1371/journal.pone.0172947	http://dx.doi.org/10.1371/journal.pone.0172947			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253350	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300051
J	Gschwantler-Kaulich, D; Tan, YY; Fuchs, EM; Hudelist, G; Kostler, WJ; Reiner, A; Leser, C; Salama, M; Attems, J; Deutschmann, C; Zielinski, CC; Singer, CF				Gschwantler-Kaulich, Daphne; Tan, Yen Y.; Fuchs, Eva-Maria; Hudelist, Gernot; Koestler, Wolfgang J.; Reiner, Angelika; Leser, Carmen; Salama, Mohamed; Attems, Johannes; Deutschmann, Christine; Zielinski, Christoph C.; Singer, Christian F.			PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer	PLOS ONE			English	Article							ADJUVANT TRASTUZUMAB; 1ST-LINE TREATMENT; PIK3CA MUTATIONS; PHASE-II; P-AKT; RESISTANCE; CHEMOTHERAPY; DOCETAXEL; RECEPTOR; GROWTH	Background Even though trastuzumab is an effective therapy in early stage Her-2+ breast cancer, 40-50% of advanced Her-2+ breast cancer patients develop trastuzumab resistance. A potential resistance mechanism is aberrant downstream signal transmission due to loss of phosphatase and tensin homologue (PTEN). This study investigated the relationship between the expression of PTEN and trastuzumab response in Her-2 overexpressing metastatic breast cancer patients. Methods Between 2000 and 2007, 164 patients with Her-2+ metastatic breast cancer received trastuzumab-based therapy in our institution. We analyzed PTEN status by immunohistochemistry of 115 available tumor tissues and analyzed associations with other histopathological parameters, response rate, progression free survival (PFS) and overall survival (OS) with a median follow-up of 60 months. Results Eighty patients were PTEN positive (69.6%) and 35 patients PTEN negative (30.4%). We found a significant association of the expression of PTEN and p53 (p = 0.041), while there was no association with grading, hormone receptor status, IGFR or MIB. We found significantly more cases with progressive disease under trastuzumab-based therapy in patients with PTEN positive breast cancers (p = 0.018), while there was no significant correlation with PFS or OS. Conclusion In Her-2-positive metastatic breast cancers, PTEN positivity was significantly associated with progressive disease, but not with PFS or OS.	[Gschwantler-Kaulich, Daphne; Tan, Yen Y.; Hudelist, Gernot; Leser, Carmen; Deutschmann, Christine; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria; [Tan, Yen Y.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Fuchs, Eva-Maria; Koestler, Wolfgang J.; Zielinski, Christoph C.] Med Univ Vienna, Div Clin Oncol, Dept Med 1, Vienna, Austria; [Fuchs, Eva-Maria; Koestler, Wolfgang J.; Zielinski, Christoph C.] Med Univ Vienna, Ctr Excellence Clin & Expt Oncol, Vienna, Austria; [Hudelist, Gernot] Wilhelminenspital Stadt Wien, Dept Obstet & Gynaecol, Vienna, Austria; [Reiner, Angelika] Sozialmed Zentrum Ost, Dept Pathol, Vienna, Austria; [Salama, Mohamed] Otto Wagner Hosp, Dept Thorac Surg, Vienna, Austria; [Attems, Johannes] Otto Wagner Hosp, Dept Pathol, Vienna, Austria	Medical University of Vienna; QIMR Berghofer Medical Research Institute; Medical University of Vienna; Medical University of Vienna; Wilhelminenspital; Donauspital	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Ctr Comprehens Canc, Vienna, Austria.	daphne.gschwantler@kaulich.at	Hudelist, Gernot/AAN-3849-2020; Tan, Yen/AAW-2357-2021; Salama, Mohamed/AAC-8377-2021	Tan, Yen/0000-0003-1063-5352; Salama, Mohamed/0000-0002-6191-1436; Attems, Johannes/0000-0003-1636-1700	Medical Research Council [G0400074, G0502157, G1100540, G0900652] Funding Source: Medline; MRC [G0400074, G1100540, G0900652, G0502157] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baraschesi M, 2012, VIRCHOWS ARCH, V461, DOI [doi: 10.1007/s00428-012-1267-2PMID: 22744290, DOI 10.1007/S00428-012-1267-2]; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brufsky Adam, 2005, Clin Breast Cancer, V6, P247, DOI 10.3816/CBC.2005.n.027; Burnett JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15821; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Debska-Szmich S, 2015, POSTEP HIG MED DOSW, V69, P586, DOI 10.5604/17322693.1151339; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fabi A, 2010, ONCOLOGY-BASEL, V78, P141, DOI 10.1159/000312656; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; GREEN S, 1992, INVEST NEW DRUG, V10, P239, DOI 10.1007/BF00944177; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Kocar M, 2014, J BUON, V19, P900; Koo DH, 2015, TUMOR BIOL, V36, P5865, DOI 10.1007/s13277-015-3258-9; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Li Xinjun, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P973, DOI 10.11817/j.issn.1672-7347.2015.09.005; Liu JC, 2016, ONCOTARGET, V7, P9060, DOI 10.18632/oncotarget.6985; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Murphy CG, 2009, BIOL-TARGETS THER, V3, P289; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Ning L, 2016, TUMOR BIOL, V37, P5445, DOI 10.1007/s13277-015-4392-0; Okutur Kerem, 2015, Asian Pac J Cancer Prev, V16, P2645; Pandolfi PP, 2004, NEW ENGL J MED, V351, P2337, DOI 10.1056/NEJMcibr043143; Park YH, 2014, BRIT J CANCER, V110, P384, DOI 10.1038/bjc.2013.757; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Peiro G, 2007, HUM PATHOL, V38, P26, DOI 10.1016/j.humpath.2006.07.013; Perez EA, 2013, J CLIN ONCOL, V31, P2115, DOI 10.1200/JCO.2012.42.2642; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Untch M, 2008, ANN ONCOL, V19, P1090, DOI 10.1093/annonc/mdn005; Viani GA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-153; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Yonemori K, 2009, MED ONCOL, V26, P344, DOI 10.1007/s12032-008-9127-2	42	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172911	10.1371/journal.pone.0172911	http://dx.doi.org/10.1371/journal.pone.0172911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253285	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300046
J	Zhao, Q; Lu, YZ; Yu, HY; Gan, XQ				Zhao, Qian; Lu, Yuezhi; Yu, Haiyang; Gan, Xueqi			Low magnitude high frequency vibration promotes adipogenic differentiation of bone marrow stem cells via P38 MAPK signal	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; INHIBITS ADIPOGENESIS; COMPRESSIVE FORCE; PATHWAY; PROLIFERATION; INCREASES	Low magnitude high frequency vibration (LMHFV) has been mainly reported for its influence on the musculoskeletal system, particularly the bone tissue. In the bone structure, osteogenic activity is the main focus of study with regards to LMHFV. However, adipogenesis, another important mode of differentiation in the bone marrow cavity that might be affected by LMHFV, is much less researched. Furthermore, the molecular mechanism of how LMHFV influences adipogenesis still needs to be understood. Here, we tested the effect of LMHFV (0.3g, 40 Hz, amplitude: 50 mu m), 15min/d, on multipotent stem cells (MSCs), which are the common progenitors of osteogenic, chondrogenic, adipogenic and myogenic cells. It is previously shown that LMHFV promotes osteogenesis of MSCs. In this study, we further revealed its effect on adipo-differentiation of bone marrow stem cells (BMSCs) and studied the underlying signaling pathway. We found that when treated with LMHFV, the cells showed a higher expression of PPAR gamma, C/EBP alpha, adiponectin and showed more oil droplets. After vibration, the protein expression of PPAR gamma increased, and the phosphorylation of p38 MAPK was enhanced. After treating cells with SB203580, a specific p38 inhibitor, both the protein level of PPAR. illustrated by immunofluorescent staining and the oil droplets number, were decreased. Altogether, this indicates that p38 MAPK is activated during adipogenesis of BMSCs, and this is promoted by LMHFV. Our results demonstrating that specific parameters of LMHFV promotes adipogenesis of MSCs and enhances osteogenesis, highlights an unbeneficial side effect of vibration therapy used for preventing obesity and osteoporosis.	[Zhao, Qian; Lu, Yuezhi; Yu, Haiyang; Gan, Xueqi] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China	Sichuan University	Yu, HY; Gan, XQ (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China.	Yhyang6812@foxmail.com; smiling99938@qq.com			State Key Laboratory of Oral Disease (Sichuan University, Chengdu); Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province [2014SZ0037]; National Natural Science Foundation of China [81400483]	State Key Laboratory of Oral Disease (Sichuan University, Chengdu); Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Laboratory of Oral Disease (Sichuan University, Chengdu), the Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province (no. 2014SZ0037, http://xmgl.scst.gov.cn/index.html), to XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by State Key Laboratory of Oral Disease (Sichuan University, Chengdu), and the National Natural Science Foundation of China (no. 81400483).	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Beck BR, 2006, J BONE MINER METAB, V24, P505, DOI 10.1007/s00774-006-0717-9; Cho YL, 2015, BIOCHEM BIOPH RES CO, V467, P211, DOI 10.1016/j.bbrc.2015.10.004; Colaianni G, 2014, WORLD J ORTHOP, V5, P242, DOI 10.5312/wjo.v5.i3.242; Cristi-Montero C, 2013, NUTR HOSP, V28, P1365, DOI 10.3305/nh.2013.28.5.6656; Dumas V, 2010, CALCIFIED TISSUE INT, V87, P351, DOI 10.1007/s00223-010-9394-8; Edwards JH, 2015, WORLD J STEM CELLS, V7, P568, DOI 10.4252/wjsc.v7.i3.568; Hossain MG, 2010, J BIOSCI BIOENG, V109, P297, DOI 10.1016/j.jbiosc.2009.09.003; Ji J, 2015, BIOCHEM BIOPH RES CO, V460, P578, DOI 10.1016/j.bbrc.2015.03.072; Kim KJ, 2010, LIFE SCI, V86, P791, DOI 10.1016/j.lfs.2010.03.010; Li G, 2013, CELL PROLIFERAT, V46, P586, DOI 10.1111/cpr.12053; Li J, 2009, J CELL PHYSIOL, V221, P609, DOI 10.1002/jcp.21890; Liu GX, 2015, GENET MOL RES, V14, P6968, DOI 10.4238/2015.June.26.5; Liu XX, 2015, INT J BIOCHEM CELL B, V62, P15, DOI 10.1016/j.biocel.2015.02.009; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Nikukar H, 2013, ACS NANO, V7, P2758, DOI 10.1021/nn400202j; Nuttall ME, 2014, CALCIFIED TISSUE INT, V94, P78, DOI 10.1007/s00223-013-9807-6; Oh ES, 2011, LIFE SCI, V88, P169, DOI 10.1016/j.lfs.2010.11.007; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shoham N, 2014, BIOPHYS J, V106, P1421, DOI 10.1016/j.bpj.2014.01.045; Tong ZX, 2014, TISSUE ENG PT A, V20, P1922, DOI [10.1089/ten.tea.2013.0496, 10.1089/ten.TEA.2013.0496]; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Uddin SMZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073914; Yanagisawa M, 2007, LIFE SCI, V81, P405, DOI 10.1016/j.lfs.2007.06.004; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang CC, 2012, ARCH ORAL BIOL, V57, P1395, DOI 10.1016/j.archoralbio.2012.04.010; Zhou Y, 2011, EUR CELLS MATER, V22, P12, DOI 10.22203/eCM.v022a02	32	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172954	10.1371/journal.pone.0172954	http://dx.doi.org/10.1371/journal.pone.0172954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253368	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300052
J	Mastroianno, S; Di Stolfo, G; Seripa, D; Pacilli, MA; Paroni, G; Coli, C; Urbano, M; d'Arienzo, C; Gravina, C; Potenza, DR; De Luca, G; Greco, A; Russo, A				Mastroianno, Sandra; Di Stolfo, Giuseppe; Seripa, Davide; Pacilli, Michele Antonio; Paroni, Giulia; Coli, Carlo; Urbano, Maria; d'Arienzo, Carmela; Gravina, Carolina; Potenza, Domenico Rosario; De Luca, Giovanni; Greco, Antonio; Russo, Aldo			Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy	PLOS ONE			English	Article							E GENE POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISMS; CORONARY-HEART-DISEASE; RISK-FACTORS; VASCULAR-DISEASE; ARTERY-DISEASE; PLASMA-LIPIDS; E GENOTYPES; E ISOFORMS; ATHEROSCLEROSIS	Background Atherosclerosis is a complex multifactorial disease and the apolipoprotein E (APOE) polymorphism has been associated to vascular complications of atherosclerosis. Objectives To investigate the relationship between the APOE genotypes and advanced peripheral vascular disease. Materials and methods 258 consecutive patients (201 males and 57 females, mean age 70.83 +/- 7.89 years) with severe PVD were enrolled in a 42-months longitudinal study (mean 31.65 +/- 21.11 months) for major adverse cardiovascular events. At follow-up genotypes of the APOE polymorphism were investigated in blinded fashion. Results As compared with epsilon 3/epsilon 3, in epsilon 4-carriers a significant higher incidence of major adverse cardiovascular events (35.58% vs. 20.79%; p = 0.025) and total peripheral revascularization (22.64% vs. 5.06%; p < 0.001) was observed. Prospective analysis, showed that e4-carriers have an increased hazard ratio for major adverse cardiovascular events (adjusted HR 1.829, 95% CI 1.017-3.287; p = 0.044) and total peripheral revascularization (adjusted HR = 5.916, 95% CI 2.405-14.554, p < 0.001). Conclusions The epsilon 4 allele seems to be risk factor for major adverse cardiovascular events, and in particular for total peripheral revascularization in patients with advanced atherosclerotic vascular disease.	[Mastroianno, Sandra; Di Stolfo, Giuseppe; Pacilli, Michele Antonio; Coli, Carlo; d'Arienzo, Carmela; Potenza, Domenico Rosario; De Luca, Giovanni; Russo, Aldo] IRCCS Casa Sollievo Sofferenza, Cardiol & Vasc Dept, Cardiol Unit, Foggia, Italy; [Seripa, Davide; Paroni, Giulia; Urbano, Maria; Gravina, Carolina; Greco, Antonio] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Complex Struct Geriatr Med Sci Dept, Foggia, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Di Stolfo, G (corresponding author), IRCCS Casa Sollievo Sofferenza, Cardiol & Vasc Dept, Cardiol Unit, Foggia, Italy.	giuseppedistolfo@yahoo.it	Greco, Antonio/C-1100-2017; Seripa, Davide/AAK-1342-2021; Paroni, Giulia/C-3768-2017; D'ARIENZO, CARMELA/AAC-3171-2022; Gravina, Carolina/AAA-2832-2021; Urbano, Maria/AAA-6042-2021; Seripa, Davide/B-9408-2017	Greco, Antonio/0000-0001-6674-5468; Paroni, Giulia/0000-0003-0240-8475; Di Stolfo, Giuseppe/0000-0003-1758-7138; Seripa, Davide/0000-0001-7331-0470; Mastroianno, Sandra/0000-0001-6898-4657	Ministero della Salute; I.R.C.C.S. Research Program; Ricerca Corrente; Linea; "5 x 1000" voluntary contribution	Ministero della Salute(Ministry of Health, Italy); I.R.C.C.S. Research Program; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Linea; "5 x 1000" voluntary contribution	This study was completely supported by "Ministero della Salute", I.R.C.C.S. Research Program, Ricerca Corrente 2015-2017, Linea n. 2 "Malattie complesse e terapie innovative" and by the "5 x 1000" voluntary contribution.	Alvim RO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-128; Anand R, 2014, J CANCER RES CLIN, V140, P1075, DOI 10.1007/s00432-014-1634-2; Behrouz R, 2016, EUR J NEUROL, V23, P262, DOI 10.1111/ene.12742; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bhatnagar P, 2016, HEART, V102, P1945, DOI 10.1136/heartjnl-2016-309573; Boemi M, 2003, EUR J CLIN INVEST, V33, P296, DOI 10.1046/j.1365-2362.2003.01141.x; Cecelja M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012016; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Di Stolfo G, 2015, J GERIATR CARDIOL, V12, P515, DOI 10.11909/j.issn.1671-5411.2015.05.008; Eifert S, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-46; El-Lebedy D, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0329-1; Elosua R, 2004, J LIPID RES, V45, P1868, DOI 10.1194/jlr.M400114-JLR200; Gultom LC, 2015, J PEDIATR ENDOCR MET, V28, P597, DOI 10.1515/jpem-2014-0070; Gustavsson J, 2012, ATHEROSCLEROSIS, V220, P486, DOI 10.1016/j.atherosclerosis.2011.10.011; Hillen T, 2000, J INTERN MED, V247, P679, DOI 10.1046/j.1365-2796.2000.00681.x; Huebbe P, 2011, FASEB J, V25, P3262, DOI 10.1096/fj.11-180935; Ingaramo RA, 2016, CURR HYPERTENS REP, P18; Kang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19930; Katan MB, 2004, INT J EPIDEMIOL, V33, P9, DOI 10.1093/ije/dyh312; Koopal C, 2016, ATHEROSCLEROSIS, V246, P187, DOI 10.1016/j.atherosclerosis.2016.01.009; Liu YL, 2016, ONCOTARGETS THER, V9, P1241, DOI 10.2147/OTT.S94228; Long JR, 2003, J MED GENET, V40, P918, DOI 10.1136/jmg.40.12.918; Lorkowski S, 2002, CURR OPIN LIPIDOL, V13, P689, DOI 10.1097/00041433-200212000-00013; Lusis AJ, 2012, TRENDS GENET, V28, P267, DOI 10.1016/j.tig.2012.03.001; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Marrocos MSM, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0182-y; McQueen RB, 2016, DIABET METAB SYND OB, V9, P233, DOI 10.2147/DMSO.S106809; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nandalur KR, 2005, AM J ROENTGENOL, V184, P295, DOI 10.2214/ajr.184.1.01840295; Nicholson G, 2016, CLINICOECONOMIC OUTC, V8, P495, DOI 10.2147/CEOR.S89331; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Rahilly-Tierney CR, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-167; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Saidi Sarra, 2007, J Stroke Cerebrovasc Dis, V16, P160; Seripa D, 2007, ANN HUM GENET, V71, P496, DOI 10.1111/j.1469-1809.2006.00344.x; Seripa D, 2006, DIAGN MOL PATHOL, V15, P180, DOI 10.1097/01.pdm.0000213451.99655.1d; Seripa D, 2012, J ALZHEIMERS DIS, V31, P731, DOI 10.3233/JAD-2012-120403; Seripa D, 2011, REJUV RES, V14, P491, DOI 10.1089/rej.2011.1169; Smith Jonathan D, 2006, Expert Rev Cardiovasc Ther, V4, P703, DOI 10.1586/14779072.4.5.703; Stoekenbroek RM, 2016, EUR HEART J, V37, P880, DOI 10.1093/eurheartj/ehv630; Taleb S, 2016, ARCH CARDIOVASC DIS, V109, P708, DOI 10.1016/j.acvd.2016.04.002; Teixeira AA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-174; Vaisi-Raygani A, 2007, CLIN BIOCHEM, V40, P1150, DOI 10.1016/j.clinbiochem.2007.06.010; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Weijmans M, 2015, ATHEROSCLEROSIS, V239, P451, DOI 10.1016/j.atherosclerosis.2015.02.008; Weijmans M, 2014, ATHEROSCLEROSIS, V234, P129, DOI 10.1016/j.atherosclerosis.2014.02.018; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104608; Zeljko HM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-9	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171055	10.1371/journal.pone.0171055	http://dx.doi.org/10.1371/journal.pone.0171055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249002	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500009
J	Meuldijk, D; McCarthy, A; Bourke, ME; Grenyer, BFS				Meuldijk, Denise; McCarthy, Alexandra; Bourke, Marianne E.; Grenyer, Brin F. S.			The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations	PLOS ONE			English	Article							DIALECTICAL BEHAVIOR-THERAPY; RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH; SOCIETAL COST; PARTIAL HOSPITALIZATION; SERVICE UTILIZATION; OF-ILLNESS; PSYCHOTHERAPY; COMMUNITY; DISABILITY	Aim Borderline Personality Disorder (BPD) is a common mental health condition with high patterns of service utilisation of inpatient and community treatment. Over the past five years there has been significant growth in research with economic data, making this systematic review a timely update. Methods Empirical studies written in English or German, published up to December 2015, and cited in major electronic databases were examined using the PRISMA systematic review method. Papers were included that had one of the following: data related to cost of BPD to society, the individual, the carer or families; cost benefits of interventions. Reported cost data were inflated to the year 2015 and converted into US-dollars (USD $) using purchasing power parities. Results We identified 30 economic evaluations providing cost data related to interventions for BPD across 134,136 patients. The methodological quality was good, almost all studies fulfilled >= 50% of the quality criteria. The mean cost saving for treating BPD with evidence-based psychotherapy across studies was USD $2,987.82 per patient per year. A further mean weighted reduction of USD $1,551 per patient per year (range $83-$29,392) was found compared to treatment as usual. Evidence-based psychological treatment was both less expensive as well as more effective, despite considerable differences in health cost arrangements between individual studies and countries. Where it was able to be calculated, a significant difference in cost-savings between different types of evidence-based psychotherapies was found. Discussion Individuals with BPD consistently demonstrate high patterns of service utilization and therefore high costs. The findings of this review present a strong argument in favour of prioritizing BPD treatments in reimbursement decisions, both for the affected individual and the family. The provision of evidence based treatment, irrespective of the type of psychological treatment, may lead to widespread reductions in healthcare costs.	[Grenyer, Brin F. S.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Grenyer, BFS (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	grenyer@uow.edu.au	Grenyer, Brin FS/AAB-6452-2020	Grenyer, Brin FS/0000-0003-1501-4336; Meuldijk, Denise/0000-0002-4895-8969	University of Wollongong	University of Wollongong	This study was funded in part by the University of Wollongong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external sources of funding were received.	Amianto F, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-181; Amner K, 2012, BRIT J PSYCHOTHER, V28, P336, DOI 10.1111/j.1752-0118.2012.01286.x; Bateman A, 2003, AM J PSYCHIAT, V160, P169, DOI 10.1176/appi.ajp.160.1.169; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2015, J CLIN PSYCHOL, V71, P792, DOI 10.1002/jclp.22206; Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; Berrino A, 2011, PSYCHIAT RES, V186, P287, DOI 10.1016/j.psychres.2010.06.018; Borschmann R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009353.pub2; Borschmann R, 2013, BRIT J PSYCHIAT, V202, P357, DOI 10.1192/bjp.bp.112.117762; Brazier J, 2006, HEALTH TECHNOL ASSES, V10, P1; Brettschneider C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107748; Davidson KM, 2010, BRIT J PSYCHIAT, V197, P456, DOI 10.1192/bjp.bp.109.074286; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Evers S, 2005, INT J TECHNOL ASSESS, V21, P240, DOI 10.1017/S0266462305050324; Gabbard GO, 2001, AM J PSYCHIAT, V158, P1, DOI 10.1176/appi.ajp.158.1.1; Goodman M, 2011, J PERS DISORD, V25, P59, DOI 10.1521/pedi.2011.25.1.59; Grenyer BFS, 2013, MED J AUSTRALIA, V198, P464, DOI 10.5694/mja13.10470; Gunderson JG, 2009, AM J PSYCHIAT, V166, P530, DOI 10.1176/appi.ajp.2009.08121825; Hall Jane, 2001, J Ment Health Policy Econ, V4, P3; Heard HL., 2000, THESIS; Hoffmann C, 2000, HEALTH POLICY, V52, P179, DOI 10.1016/S0168-8510(00)00076-2; Jackson HJ, 2004, SOC PSYCH PSYCH EPID, V39, P765, DOI 10.1007/s00127-004-0821-x; Koerner K., 2007, DIALECTICAL BEHAV TH, P19; Koons CR, 2001, BEHAV THER, V32, P371, DOI 10.1016/S0005-7894(01)80009-5; Kvarstein EH, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-315; Laurenssen EMP, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0301-0; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Luyten J, 2016, EVID-BASED MENT HEAL, V19, P49, DOI 10.1136/eb-2016-102354; Magnavita JJ, 2010, PROF PSYCHOL-RES PR, V41, P64, DOI 10.1037/a0017733; Meyers LL, 2014, MIL MED, V179, P1368, DOI 10.7205/MILMED-D-14-00248; Organisation for Economic Co-operation and Development (OECD), 2013, OECD HLTH DAT EC REF; Palmer S, 2006, J PERS DISORD, V20, P466, DOI 10.1521/pedi.2006.20.5.466; Pasieczny N, 2011, BEHAV RES THER, V49, P4, DOI 10.1016/j.brat.2010.09.006; Perseius K-I., 2004, V RD NORDEN, V24, P27; Prendergast N, 2007, BEHAV CHANGE, V24, P25, DOI 10.1375/bech.24.1.25; Priebe S, 2012, PSYCHOTHER PSYCHOSOM, V81, P356, DOI 10.1159/000338897; Richter C, 2014, PSYCHIAT PRAX, V41, P148, DOI 10.1055/s-0033-1343204; Rutten F, 1996, HEALTH POLICY, V36, P215, DOI 10.1016/0168-8510(96)00814-7; Sansone RA, 2011, GEN HOSP PSYCHIAT, V33, P343, DOI 10.1016/j.genhosppsych.2011.04.006; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Soeteman DI, 2008, J CLIN PSYCHIAT, V69, P259, DOI 10.4088/JCP.v69n0212; Stevenson J, 1999, AUST NZ J PSYCHIAT, V33, P473, DOI 10.1046/j.1440-1614.1999.00595.x; Sutton A J, 1998, Health Technol Assess, V2, P1; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Turner RM, 2000, COGN BEHAV PRACT, V7, P413, DOI 10.1016/S1077-7229(00)80052-8; Turri MG, 2014, PSYCHOANAL PSYCHOTHE, V28, P139, DOI 10.1080/02668734.2014.882390; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; van Asselt ADI, 2007, EUR PSYCHIAT, V22, P354, DOI 10.1016/j.eurpsy.2007.04.001; van Asselt ADI, 2008, VALUE HEALTH, V11, P637, DOI 10.1111/j.1524-4733.2007.00288.x; van Asselt ADI, 2008, BRIT J PSYCHIAT, V192, P450, DOI 10.1192/bjp.bp.106.033597; van den Bosch LMC, 2002, ADDICT BEHAV, V27, P911, DOI 10.1016/S0306-4603(02)00293-9; van den Bosch LMC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-152; Wagner T, 2014, BEHAV RES THER, V61, P12, DOI 10.1016/j.brat.2014.07.004; Wagner T, 2013, Z KL PSYCH PSYCHOTH, V42, P242, DOI 10.1026/1616-3443/a000227; Wetzelaer P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0319-3; Wunsch EM, 2014, BEHAV RES THER, V60, P1, DOI 10.1016/j.brat.2014.06.002	58	55	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171592	10.1371/journal.pone.0171592	http://dx.doi.org/10.1371/journal.pone.0171592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249032	Green Published, gold			2022-12-27	WOS:000395983500016
J	Horrocks, S; Wilkinson, T; Schnier, C; Ly, A; Woodfield, R; Rannikmae, K; Quinn, TJ; Sudlow, CLM				Horrocks, Sophie; Wilkinson, Tim; Schnier, Christian; Ly, Amanda; Woodfield, Rebecca; Rannikmae, Kristiina; Quinn, Terence J.; Sudlow, Cathie L. M.			Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic review	PLOS ONE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; HOSPITAL DISCHARGE DATA; DIAGNOSIS; VALIDITY; MORBIDITY; CRITERIA; RISK	Background Motor neurone disease (MND) is a rare neurodegenerative condition, with poorly understood aetiology. Large, population-based, prospective cohorts will enable powerful studies of the determinants of MND, provided identification of disease cases is sufficiently accurate. Follow-up in many such studies relies on linkage to routinely-collected health datasets. We systematically evaluated the accuracy of such datasets in identifying MND cases. Methods We performed an electronic search of MEDLINE, EMBASE, Cochrane Library and Web of Science for studies published between 01/01/1990-16/11/2015 that compared MND cases identified in routinely-collected, coded datasets to a reference standard. We recorded study characteristics and two key measures of diagnostic accuracy-positive predictive value (PPV) and sensitivity. We conducted descriptive analyses and quality assessments of included studies. Results Thirteen eligible studies provided 13 estimates of PPV and five estimates of sensitivity. Twelve studies assessed hospital and/or death certificate-derived datasets; one evaluated a primary care dataset. All studies were from high income countries (UK, Europe, USA, Hong Kong). Study methods varied widely, but quality was generally good. PPV estimates ranged from 55-92% and sensitivities from 75-93%. The single (UK-based) study of primary care data reported a PPV of 85%. Conclusions Diagnostic accuracy of routinely-collected health datasets is likely to be sufficient for identifying cases of MND in large-scale prospective epidemiological studies in high income country settings. Primary care datasets, particularly from countries with a widely-accessible national healthcare system, are potentially valuable data sources warranting further investigation.	[Horrocks, Sophie; Wilkinson, Tim; Schnier, Christian; Ly, Amanda; Woodfield, Rebecca; Rannikmae, Kristiina; Sudlow, Cathie L. M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Quinn, Terence J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Sudlow, Cathie L. M.] UK Biobank, Stockport, Lancs, England	University of Edinburgh; University of Glasgow	Wilkinson, T (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	tim.wilkinson@ed.ac.uk	Schnier, Christian/AAV-7458-2021; Quinn, Terence Joseph/H-7000-2019; Wilkinson, Tim/L-5184-2019	Schnier, Christian/0000-0001-7238-7871; Quinn, Terence Joseph/0000-0003-1401-0181; Wilkinson, Tim/0000-0001-8952-0982; Ly, Amanda/0000-0002-4348-5146; Sudlow, Cathie/0000-0002-7725-7520	Medical Research Council Dementias Platform UK; MRC [MR/L023784/1, MR/P001823/1, MC_U137686860, MR/L023784/2] Funding Source: UKRI; Medical Research Council [MC_U137686860, MR/L023784/1, MR/L023784/2, MR/P001823/1] Funding Source: researchfish; Stroke Association [PPA2015/01_CSO, TSA15LECT05] Funding Source: researchfish	Medical Research Council Dementias Platform UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association	This work is funded by the Medical Research Council Dementias Platform UK (www. dementiasplatform uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; [Anonymous], 2016, ICD 10 VERS 2016; Beghi E, 2001, AMYOTROPH LATERAL SC, V2, P99; Benatar M, 2011, AMYOTROPH LATERAL SC, V12, P130, DOI 10.3109/17482968.2010.515224; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; CHANCELLOR AM, 1993, J EPIDEMIOL COMMUN H, V47, P116, DOI 10.1136/jech.47.2.116; CHIO A, 1992, J EPIDEMIOL COMMUN H, V46, P517, DOI 10.1136/jech.46.5.517; Chio A, 2002, J CLIN EPIDEMIOL, V55, P723, DOI 10.1016/S0895-4356(02)00409-2; Doyle P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-25; Drigo D, 2013, NEUROEPIDEMIOLOGY, V41, P54, DOI 10.1159/000350015; Fong GCY, 2005, AMYOTROPH LATERAL SC, V6, P164, DOI 10.1080/14660820510028412; HERN JEC, 1992, J NEUROL NEUROSUR PS, V55, P536; Horrocks S, PROSPERO 2015; Kioumourtzoglou MA, 2015, AMYOTROPH LAT SCL FR, V16, P224, DOI 10.3109/21678421.2014.988161; NHS Digital, 2016, READ COD; NICE, 2016, MOTOR NEURONE DISEAS; Pisa FE, 2009, EUR J EPIDEMIOL, V24, P635, DOI 10.1007/s10654-009-9376-1; Stickler DE, 2012, AMYOTROPH LATERAL SC, V13, P69, DOI 10.3109/17482968.2011.614253; Stickler DE, 2011, MUSCLE NERVE, V44, P814, DOI 10.1002/mus.22195; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Woodfield R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140533; Worms PA, 2001, J NEUROL SCI, V191, P3, DOI 10.1016/S0022-510X(01)00630-X; Yeo L, 2010, J NEUROL, V257, P1235, DOI 10.1007/s00415-010-5494-7	25	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172639	10.1371/journal.pone.0172639	http://dx.doi.org/10.1371/journal.pone.0172639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245254	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000395980200025
J	Park, J; Kwon, OS; Cho, SY; Paick, JS; Kim, SW				Park, Juhyun; Kwon, Oh Seong; Cho, Sung Yong; Paick, Jae-Seung; Kim, Soo Woong			Chronic administration of atorvastatin could partially ameliorate erectile function in streptozotocin-induced diabetic rats	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUCOSE-METABOLISM; STATIN TREATMENT; DYSFUNCTION; CHOLESTEROL; METAANALYSIS; PREVENTION; DISEASE; UPDATE	The efficacy of statins is related to the 'common soil' hypothesis, which proposes oxidative stress and inflammation as main pathophysiologic processes in the disease group of diabetes and endothelial dysfunction. This study evaluated the recovery of erectile function after administration of chronic statin alone in streptozotocin (STZ)-induced diabetes mellitus (DM) rats, focusing on the anti-oxidative effects and consequentially recuperated endothelial function. A total of 45 male Sprague-Dawley rats (8 weeks old) were divided into three groups (n = 15 each): an age-matched normal control group (Control group), an uncontrolled DM group (DM group), and a statin-treated group (Statin group). The rats in the DM and Statin group received an injection of STZ (60 mg/kg). Beginning 10 weeks after the establishment of DM, the Statin group received daily treatment with atorvastatin (10 mg/kg) via oral gavage for four weeks. After 14 weeks, the results of the experiment were evaluated. The ratios of intracavernosal pressure (ICP) to mean arterial pressure (MAP) were recorded with cavernosometry (20 Hz, 3 V, 0.2 msec for 30 seconds) before and after the intravenous administration of udenafil (1 mg/kg). Expression of alpha-smooth muscle actin (a-SMA) was evaluated using cavernosal tissue. In addition, changes in RhoA translocation ratio and myosin phosphatase target subunit 1 (MYPT1) phosphorylation were evaluated with western blot. Superoxide dismutase (SOD) and malondialdehyde (MDA) levels were also analyzed as measurements of oxidative stress levels. The ICP/MAP and area under the curve (AUC)/MAP ratios of the Statin group were obviously superior to the DM group, but were not comparable to the Control group (P<0.001). The level of oxidative stress, namely SOD activity, was also significantly lower in the Statin group than in the DM group (P = 0.015), and was comparable to the Control group. In contrast, MDA levels were not considerably different among the groups (P = 0.217). The RhoA translocation ratio was not significantly different among the groups (P = 0.668), whereas MYPT1 phosphorylation in the Statin group was significantly lower than in the DM group (P = 0.030), and similar to the Control group. Expression of a-SMA in the Statin group was higher than in the DM group (P<0.001), and comparable to the Control group. Chronic statin treatment alone showed anti-oxidative effects and helped to restore the erectile mechanism, but did not lead to the full recovery of erectile function in STZ-induced DM rats. Therefore, combination therapy rather than a single agent should be the preferred treatment strategy for DM-associated erectile dysfunction, especially in the setting of severe diabetes.	[Park, Juhyun; Cho, Sung Yong] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Urol, Seoul, South Korea; [Kwon, Oh Seong] Hallym Univ, Hangang Sacred Heart Hosp, Dept Urol, Seoul, South Korea; [Paick, Jae-Seung; Kim, Soo Woong] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU); Seoul National University Hospital	Kim, SW (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	swkim@snu.ac.kr	Kwon, OhSeong/DBV-0709-2022; Kwon, Ohseong/W-8318-2019	Kwon, Ohseong/0000-0002-8933-6656	SNUH Research Fund [04-2010-0790]	SNUH Research Fund	This study was supported by grant no. 04-2010-0790 from the SNUH Research Fund.	Abdelhafiz AH, 2015, AGING DIS, V6, P262, DOI 10.14336/AD.2014.1022; Adel A, 2010, J CLIN HYPERTENS, V12, P820, DOI 10.1111/j.1751-7176.2010.00367.x; Castela A, 2015, J DIABETES, V7, P393, DOI 10.1111/1753-0407.12181; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chen YH, 2012, EXP CLIN ENDOCR DIAB, V120, P116, DOI 10.1055/s-0031-1297968; Cho SY, 2012, J SEX MED, V9, P1550, DOI 10.1111/j.1743-6109.2012.02720.x; Cho SY, 2011, J SEX MED, V8, P1352, DOI 10.1111/j.1743-6109.2010.02099.x; Cumaoglu A, 2011, EUR J PHARMACOL, V654, P80, DOI 10.1016/j.ejphar.2010.11.035; Desai CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3743; Esper RJ, 2008, ADV CARDIOL, V45, P17, DOI 10.1159/000115120; Ferrini MG, 2010, J SEX MED, V7, P3033, DOI 10.1111/j.1743-6109.2010.01884.x; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Goyal SN, 2016, CHEM-BIOL INTERACT, V244, P49, DOI 10.1016/j.cbi.2015.11.032; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hamilton Sandra J, 2013, Rev Diabet Stud, V10, P133, DOI 10.1900/RDS.2013.10.133; Kostis JB, 2014, J SEX MED, V11, P1626, DOI 10.1111/jsm.12521; Maiorino MI, 2014, DIABET METAB SYND OB, V7, P95, DOI 10.2147/DMSO.S36455; Park K, 2011, INT J ANDROL, V34, pE468, DOI 10.1111/j.1365-2605.2011.01196.x; Phe V, 2012, DIABETES METAB, V38, P1, DOI 10.1016/j.diabet.2011.09.003; Profumo E, 2014, CURR TOP MED CHEM, V14, P2542, DOI 10.2174/1568026614666141203130324; Redrow GP, 2014, EXPERT OPIN PHARMACO, V15, P1827, DOI 10.1517/14656566.2014.934809; Rosa GM, 2014, EUR J CLIN INVEST, V44, P501, DOI 10.1111/eci.12255; Shah S, 2007, ANTIOXID REDOX SIGN, V9, P911, DOI 10.1089/ars.2007.1629; Shaw A, 2014, BIOCHEM SOC T, V42, P928, DOI 10.1042/BST20140113; Solomon H, 2006, INT J CLIN PRACT, V60, P141, DOI 10.1111/j.1742-1241.2006.00793.x; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Xu Y, 2014, METABOLISM, V63, P716, DOI 10.1016/j.metabol.2014.02.010	27	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172751	10.1371/journal.pone.0172751	http://dx.doi.org/10.1371/journal.pone.0172751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245261	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200029
J	Lerner, N; Avissar, S; Beit-Yannai, E				Lerner, Natalie; Avissar, Sofia; Beit-Yannai, Elie			Extracellular vesicles mediate signaling between the aqueous humor producing and draining cells in the ocular system	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; BETA-CATENIN; EXOSOMES; WNT; EXPRESSION; MICRORNA; MYOCILIN; PATHWAY	Purpose Canonical Wnt signaling is associated with glaucoma pathogenesis and intraocular pressure (IOP) regulation. Our goal was to gain insight into the influence of non-pigmented ciliary epithelium (NPCE)-derived exosomes on Wnt signaling by trabecular meshwork (TM) cells. The potential impact of exosomes on Wnt signaling in the ocular drainage system remains poorly understood. Methods Exosomes isolated from media collected from cultured NPCE cells by differential ultracentrifugation were characterized by dynamic light scattering (DLS), tunable resistive pulse sensing (TRPS), and nanoparticle tracking analysis (NTA), sucrose density gradient migration and transmission electron microscopy (TEM). The cellular target specificity of the NPCE-derived exosomes was investigated by confocal microscopy-based monitoring of the uptake of DID-labeled exosomes over time, as compared to uptake by various cell lines. Changes in Wnt protein levels in TM cells induced by NPCE exosomes were evaluated by Western blot. Results Exosomes derived from NPCE cells were purified and detected as small rounded 50-140 nm membrane vesicles, as defined by DLS, NTA, TRPS and TEM. Western blot analysis indicated that the nanovesicles were positive for classic exosome markers, including Tsg101 and Alix. Isolated nanoparticles were found in sucrose density fractions typical of exosomes (1.118-1.188 g/mL sucrose). Using confocal microscopy, we demonstrated time-dependent specific accumulation of the NPCE-derived exosomes in NTM cells. Other cell lines investigated hardly revealed any exosome uptake. We further showed that exosomes induced changes in Wnt signaling protein expression in the TM cells. Western blot analysis further revealed decreased phosphorylation of GKS3 beta and reduced beta-catenin levels. Finally, we found that treatment of NTM cells with exosomes resulted in a greater than 2-fold decrease in the level of beta-catenin in the cytosolic fraction. In contrast, no remarkable difference in the amount of beta-catenin in the nuclear fraction was noted, relative to the control. Conclusions The data suggest that NPCE cells release exosome-like vesicles and that these nanoparticles affect canonical Wnt signaling in TM cells. These findings may have therapeutic relevance since canonical Wnt pathway is involved in intra-ocular pressure regulation. Further understanding of NPCE-derived exosome-responsive signaling pathways may reveal new targets for pharmacological intervention within the drainage system as a target for glaucoma therapy.	[Lerner, Natalie; Avissar, Sofia; Beit-Yannai, Elie] Ben Gurion Univ Negev, Fac Hlth Sci, Clin Biochem & Pharmacol Dept, Beer Sheva, Israel	Ben Gurion University	Beit-Yannai, E (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Clin Biochem & Pharmacol Dept, Beer Sheva, Israel.	bye@bgu.ac.il		Beit-Yannai, Elie/0000-0001-9347-822X	ISRAEL SCIENCE FOUNDATION [1315/14]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	This research was supported by the ISRAEL SCIENCE FOUNDATION (grant No. 1315/14). The sponsor or funding organization had no role in the research.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anderson W, 2013, J COLLOID INTERF SCI, V405, P322, DOI 10.1016/j.jcis.2013.02.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Dismuke WM, 2015, EXP EYE RES, V132, P73, DOI 10.1016/j.exer.2015.01.019; Dong N, 2013, MOL VIS, V19, P1734; Dunmire JJ, 2013, EXP EYE RES, V108, P68, DOI 10.1016/j.exer.2012.10.016; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Garfella M.L. Hernandez, 2015, J OPHTHALMIC VIS RES, V10, P49, DOI DOI 10.4103/2008-322X.156110; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huber HJ, 2015, CURR OPIN LIPIDOL, V26, P412, DOI 10.1097/MOL.0000000000000214; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Latarya G, 2012, INVEST OPHTH VIS SCI, V53, P1679, DOI 10.1167/iovs.11-9120; Lerner N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112259; Locke CJ, 2014, EXP EYE RES, V129, P1, DOI 10.1016/j.exer.2014.10.010; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macknight ADC, 2000, CLIN EXP PHARMACOL P, V27, P100, DOI 10.1046/j.1440-1681.2000.03208.x; Mao WM, 2012, INVEST OPHTH VIS SCI, V53, P7043, DOI 10.1167/iovs.12-9664; McKinnon Stuart J, 2008, Am J Manag Care, V14, pS20; Morgan JT, 2015, EXP EYE RES, V132, P174, DOI 10.1016/j.exer.2015.01.025; Murthy KR, 2015, OMICS, V19, P283, DOI 10.1089/omi.2015.0029; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nussdorf J, 2013, INVEST OPHTH VIS SCI, V54; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raimondo F, 2013, MOL BIOSYST, V9, P1139, DOI 10.1039/c2mb25396h; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shmulevich A, 2009, CURR EYE RES, V34, P466, DOI 10.1080/02713680902916090; Siegfried C, 2013, INVEST OPHTH VIS SCI, V54; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tanaka Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05089; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Villarreal G, 2014, INVEST OPHTH VIS SCI, V55, P7433, DOI 10.1167/iovs.13-12652; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wecker T, 2013, INVEST OPHTH VIS SCI, V54, P6456, DOI 10.1167/iovs.13-12669; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zhang MF, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-21	53	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171153	10.1371/journal.pone.0171153	http://dx.doi.org/10.1371/journal.pone.0171153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241021	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400004
J	Lou, JW; Sun, MN; Zhao, Y; Ji, ZS; Liu, FH; Li, DZ; Xu, WF; Lin, YY; Liu, YH				Lou, Jiwu; Sun, Manna; Zhao, Ying; Ji, Zhisong; Liu, Fenghua; Li, Dongzhi; Xu, Wanfang; Lin, Yangyang; Liu, Yanhui			Rapid and simultaneous detection of common aneuploidies by quadruplex real-time polymerase chain reaction combined with melting curve analysis	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; PRENATAL-DIAGNOSIS; PCR; TRISOMY-21; QUANTIFICATION; CHROMOSOMES; LOCI	lBackground During the prenatal period, the number variation of chromosomes 13, 18, 21, X and Y accounts for more than 80% of the clinically significant chromosomal abnormalities diagnosed. Rapid tests for prenatal diagnosis of these abnormalities can improve pregnancy management and alleviate parental anxiety. Here, we present a molecular alternative method for detecting common aneuploidies. Methods This method is based on co-amplification of segmental duplications located on two different chromosomes using a single pair of primers. Segmental duplications have a high degree of sequence identity, but have single-nucleotide differences in some regions. These sequence differences can be quantified using melting curve analysis of dual-labeled probes to estimate the relative dosages of different chromosomes. We designed two quadruplex realtime PCR assays to detect aneuploidies of chromosomes 13, 18, 21, X and Y. Results We examined 75 aneuploid DNA samples and 56 unaffected DNA control samples using these two assays and correctly identified all samples. Four cases of unbalanced translocation were also accurately detected. The observed averaged ratio for each chromosomal disorder was similar to the theoretically expected value. Conclusions Our real-time assay is a robust, rapid, and easy to conduct technique for prenatal diagnosis of common aneuploidies, representing a competitive alternative for use in diagnostic laboratories.	[Lou, Jiwu; Sun, Manna; Zhao, Ying; Ji, Zhisong; Xu, Wanfang; Lin, Yangyang; Liu, Yanhui] Dongguan Maternal & Child Hlth Hosp, Prenatal Diag Ctr, Dongguan, Guangdong, Peoples R China; [Liu, Fenghua] Guangdong Maternal & Child Hlth Hosp, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Dongzhi] Guangzhou Med Univ, Guangzhou Women & Children Med Ctr, Prenatal Diagnost Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, YH (corresponding author), Dongguan Maternal & Child Hlth Hosp, Prenatal Diag Ctr, Dongguan, Guangdong, Peoples R China.	liuliang71215@163.com			Project of Science and Technology of Guangdong Province [20136022000003]; Key project of Dongguan City [201310810102]; Medical Scientific Research Foundation of Guangdong Province [A2014860]	Project of Science and Technology of Guangdong Province; Key project of Dongguan City; Medical Scientific Research Foundation of Guangdong Province	This research was funded by Project of Science and Technology of Guangdong Province (20136022000003), Key project of Dongguan City (201310810102) and Medical Scientific Research Foundation of Guangdong Province (A2014860). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boormans EMA, 2009, BJOG-INT J OBSTET GY, V116, P1396, DOI 10.1111/j.1471-0528.2009.02229.x; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; de Jong A, 2011, EUR J HUM GENET, V19, P1020, DOI 10.1038/ejhg.2011.82; Deutsch S, 2004, J MED GENET, V41, P908, DOI 10.1136/jmg.2004.023184; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Faas BHW, 2011, SEMIN FETAL NEONAT M, V16, P81, DOI 10.1016/j.siny.2011.01.003; Guo QW, 2012, CLIN CHEM, V58, P1019, DOI 10.1373/clinchem.2011.178475; Guo QW, 2010, CLIN CHEM, V56, P1451, DOI 10.1373/clinchem.2010.146472; Kong XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088932; Lee HH, 1997, HUM GENET, V99, P364, DOI 10.1007/s004390050373; Nagy B, 2005, PRENATAL DIAG, V25, P1138, DOI 10.1002/pd.1288; Pont-Kingdon G, 2003, CLIN CHEM, V49, P1087, DOI 10.1373/49.7.1087; Rink BD, 2016, SEMIN PERINATOL, V40, P35, DOI 10.1053/j.semperi.2015.11.006; Sun L, 2014, GENE, V552, P272, DOI 10.1016/j.gene.2014.09.044; Zhou LM, 2015, CLIN CHEM, V61, P724, DOI 10.1373/clinchem.2014.236208; Zhou YL, 2014, GENET TEST MOL BIOMA, V18, P141, DOI 10.1089/gtmb.2013.0373; Zimmermann B, 2002, CLIN CHEM, V48, P362	17	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171886	10.1371/journal.pone.0171886	http://dx.doi.org/10.1371/journal.pone.0171886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241016	gold, Green Published, Green Submitted			2022-12-27	WOS:000395934400010
J	Elenius, V; Palomares, O; Waris, M; Turunen, R; Puhakka, T; Ruckert, B; Vuorinen, T; Allander, T; Vahlberg, T; Akdis, M; Camargo, CA; Akdis, CA; Jartti, T				Elenius, Varpu; Palomares, Oscar; Waris, Matti; Turunen, Riitta; Puhakka, Tuomo; Rueckert, Beate; Vuorinen, Tytti; Allander, Tobias; Vahlberg, Tero; Akdis, Muebeccel; Camargo, Carlos A., Jr.; Akdis, Cezmi A.; Jartti, Tuomas			The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; RETINOIC ACID; CHILDREN; ASTHMA; SUPPLEMENTATION; TOLERANCE; PREGNANCY; WHEEZE; RISK; DEFICIENCY	Background Tonsils have an active role in immune defence and inducing and maintaining tolerance to allergens. Vitamins A, D, and E, and antimicrobial peptide LL-37 may have immunomodulatory effects. We studied how their serum levels were associated with allergy status, intratonsillar/nasopharyngeal virus detection and intratonsillar expression of T cell-and innate immune response-specific cytokines, transcription factors and type I/II/III interferons in patients undergoing tonsillectomy. Methods 110 elective tonsillectomy patients participated. Serum levels of vitamins A, 25(OH)D, and E, LL-37 and allergen-specific IgE as well as nasopharyngeal/intratonsillar respiratory viruses were analyzed. The mRNA expression of IFN-alpha, IFN-beta, IFN-gamma, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, TGF-beta, FOXP3, GATA3, RORC2 and Tbet in tonsils were analyzed by quantitative RT-PCR. Results The median age of the patients was 16 years (range 3-60), 28% of subjects had atopy, and 57% carried >= 1 respiratory virus in nasopharynx. Detection of viruses decreased by age. Higher vitamin A levels showed borderline significance with less viral detection (P = 0.056). Higher 25(OH) D was associated with less allergic rhinitis and atopy (P < 0.05) and higher vitamin E with less self-reported allergy (P < 0.05). In gene expression analyses, 25(OH)D was associated with higher IL-37, vitamin A with higher IFN-gamma and vitamin E with less IL-28 (P < 0.05). LL-37 was associated with less FOXP3, RORC2 and IL-17 in tonsils (P < 0.05). Conclusions Vitamin D and E levels were associated with less allergic disorders. Vitamin A was linked to antiviral and vitamin D with anti-inflammatory activity. LL-37 and was linked to T regulatory cell effects.	[Elenius, Varpu; Turunen, Riitta; Jartti, Tuomas] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Palomares, Oscar; Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.] Univ Zurich, CK CARE, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Palomares, Oscar] Univ Complutense Madrid, Sch Chem, Dept Biochem & Mol Biol, Madrid, Spain; [Waris, Matti; Vuorinen, Tytti] Univ Turku, Dept Virol, Turku, Finland; [Puhakka, Tuomo] Turku Univ Hosp, Dept Otorhinolaryngol, Turku, Finland; [Puhakka, Tuomo] Satakunta Cent Hosp, Dept Otorhinolaryngol, Pori, Finland; [Allander, Tobias] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Vahlberg, Tero] Univ Turku, Dept Biostat, Turku, Finland; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Emergency Med, Boston, MA 02114 USA	University of Turku; Swiss Institute of Allergy & Asthma Research; University of Zurich; Complutense University of Madrid; University of Turku; University of Turku; Satakunta Central Hospital; Karolinska Institutet; Karolinska University Hospital; University of Turku; Harvard University; Harvard Medical School; Massachusetts General Hospital	Elenius, V (corresponding author), Turku Univ Hosp, Dept Pediat, Turku, Finland.	varpu.elenius@utu.fi	Palomares, Oscar/ABG-5229-2020; Camargo, Carlos A./C-2145-2008; Waris, Matti E/A-6418-2008; Akdis, Cezmi/AAV-4844-2020	Camargo, Carlos A./0000-0002-5071-7654; Akdis, Cezmi/0000-0001-8020-019X	Terveyden Tutkimuksen Toimikunta [114034, 132595]; Tampereen Tuberkuloosisdatio; Suomen Laaketieteen Saatio; Sigrid Juseliuksen Saatio; European Social Fund; EU; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [260895]; Christine Kuhne-Center for Allergy Research and Education	Terveyden Tutkimuksen Toimikunta; Tampereen Tuberkuloosisdatio; Suomen Laaketieteen Saatio; Sigrid Juseliuksen Saatio; European Social Fund(European Social Fund (ESF)); EU(European Commission); Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Christine Kuhne-Center for Allergy Research and Education	This work was supported by Terveyden Tutkimuksen Toimikunta 114034 and 132595 (to Tuomas Jartti), Tampereen Tuberkuloosisdatio (to Varpu Elenius), Suomen Laaketieteen Saatio (to Varpu Elenius), Sigrid Juseliuksen Saatio (to Tuomas Jartti), European Social Fund (to Oscar Palomares), EU Framework Program Predicta (to Mubeccel Akdis), Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung 260895 (to Cezmi A Akdis), and Christine Kuhne-Center for Allergy Research and Education (to Cezmi A Akdis).	Amaral CT, 2013, PEDIATR PULM, V48, P481, DOI 10.1002/ppul.22621; Arora P, 2002, PEDIATR ALLERGY IMMU, V13, P223, DOI 10.1034/j.1399-3038.2002.00010.x; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhan I, 2012, KIDNEY INT, V82, P84, DOI 10.1038/ki.2012.19; Bikle DD, 2007, CURR OPIN RHEUMATOL, V19, P383, DOI 10.1097/BOR.0b013e32818e9d58; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V137, P1063, DOI 10.1016/j.jaci.2015.11.031; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Christensen N, 2016, PEDIAT INFECT DIS J; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Feng H, 2016, J ALLERGY CLIN IMMUN; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Han YY, 2016, J ALLERGY CLIN IMMUN; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P963, DOI 10.1016/j.jaci.2010.02.011; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Jartti T, 2014, ALLERGY, V69, P658, DOI 10.1111/all.12396; Jartti T, 2010, J ALLERGY CLIN IMMUN, V126, P1074, DOI 10.1016/j.jaci.2010.09.004; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Martindale S, 2005, AM J RESP CRIT CARE, V171, P121, DOI 10.1164/rccm.200402-220OC; Mizuno Y, 2006, PEDIATR INT, V48, P261, DOI 10.1111/j.1442-200X.2006.02200.x; MORABIA A, 1990, AM J EPIDEMIOL, V132, P77, DOI 10.1093/oxfordjournals.aje.a115645; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Ogra PL, 2000, PEDIATR INFECT DIS J, V19, pS4, DOI 10.1097/00006454-200005001-00002; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Riccioni G, 2007, J ASTHMA, V44, P429, DOI 10.1080/02770900701421880; Riverin BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136841; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Smith NLD, 2014, IMMUNOLOGY, V143, P499, DOI 10.1111/imm.12362; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; Urrutia-Pereira M, 2016, J INVEST ALLERG CLIN, V26, P319, DOI 10.18176/jiaci.0077; Vahdaninia M, 2016, J ALLERGY CLIN IMMUN; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wei ZZ, 2016, PEDIAT ALLERG IMM-UK, V27, P612, DOI 10.1111/pai.12593; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	43	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172350	10.1371/journal.pone.0172350	http://dx.doi.org/10.1371/journal.pone.0172350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235040	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000394688200072
J	Kasada, M; Matsuba, M; Miyashita, T				Kasada, Minoru; Matsuba, Misako; Miyashita, Tadashi			Human interest meets biodiversity hotspots: A new systematic approach for urban ecosystem conservation	PLOS ONE			English	Article							HUMAN HEALTH; EXTINCTION; EXPERIENCE; FRAMEWORK; PARKS	Creating a win-win relationship between biodiversity and human well-being is one of the major current challenges for environmental policy. One way to approach this challenge is to identify sites with both high biodiversity and high human interest in urban areas. Here, we propose a new systematic approach to identify such sites by using land prices and biodiversity indexes for butterflies and birds from a nationwide perspective. As a result, we found sites that are valuable to humans and to other organisms, including national red-list species, and they are located in sites with cultural heritages and near seaside. By referencing the habitat features and landscape characteristics of these sites, we can establish high quality environments that provide a benefit to both humans and biodiversity in urban landscapes.	[Kasada, Minoru] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan; [Matsuba, Misako] Japan Agcy Marine Earth Sci & Technol, Project Team Anal Changes East Japan Marine Ecosy, Yokosuka, Kanagawa, Japan; [Miyashita, Tadashi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Ecosyst Studies, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo	Kasada, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan.	m.kasada@gmail.com	Matsuba, Misako/AAD-3272-2021	Kasada, Minoru/0000-0001-9023-430X	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]; JSPS KAKENHI [15H04325]	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan (http://www.env.go.jp/en/index.html), JSPS KAKENHI 15H04325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Avatefi Hemmat M., 2012, ARCH SCI, V65, P605; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Clark NE, 2014, TRENDS ECOL EVOL, V29, P198, DOI 10.1016/j.tree.2014.01.009; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Farinha-Marques P, 2011, INNOVATION-ABINGDON, V24, P247, DOI 10.1080/13511610.2011.592062; Fournier A, 2011, BIODIVERS CONSERV, V20, P1895, DOI 10.1007/s10531-011-0065-5; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Hough RL, 2014, BIODIVERS CONSERV, V23, P267, DOI 10.1007/s10531-013-0614-1; Ishii HT, 2010, LANDSC ECOL ENG, V6, P307, DOI 10.1007/s11355-010-0104-5; James P, 2009, URBAN FOR URBAN GREE, V8, P65, DOI 10.1016/j.ufug.2009.02.001; Jim CY, 2008, LANDSCAPE URBAN PLAN, V84, P312, DOI 10.1016/j.landurbplan.2007.09.001; Konta F, 2000, TOKYO MEM NATN SCI M, V34; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Luck Gary W., 2010, P88; MANABE T, 2007, LANDSC ECOL MANAGE, V12, P1; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Ministry of Land Infrastructure Transport and Tourism, NAT LAND NUM INF DOW; Mitchell MGE, 2015, TRENDS ECOL EVOL, V30, P190, DOI 10.1016/j.tree.2015.01.011; Naoe S, 2015, J NAT CONSERV, V24, P101, DOI 10.1016/j.jnc.2014.10.002; Nielsen AB, 2014, URBAN ECOSYST, V17, P305, DOI 10.1007/s11252-013-0316-1; Pyle R. M., 1993, THUNDER TREE LESSONS; Rafiee R, 2009, INT J APPL EARTH OBS, V11, P431, DOI 10.1016/j.jag.2009.08.005; Samways MJ, 2007, BIODIVERS CONSERV, V16, P1995, DOI 10.1007/s10531-006-9144-4; Shwartz A, 2014, GLOBAL ENVIRON CHANG, V28, P39, DOI 10.1016/j.gloenvcha.2014.06.002; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Tallis H, 2012, BIOSCIENCE, V62, P977, DOI 10.1525/bio.2012.62.11.7; United Nations, 2014, DEMOGR RES; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Zhou XL, 2011, LANDSCAPE URBAN PLAN, V100, P268, DOI 10.1016/j.landurbplan.2010.12.013	32	6	6	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172670	10.1371/journal.pone.0172670	http://dx.doi.org/10.1371/journal.pone.0172670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235020	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200109
J	Shin, DW; Kim, YI; Kim, SJ; Kim, JS; Chong, S; Park, YS; Song, SY; Lee, JH; Ahn, HK; Kim, EY; Yang, SH; Lee, MK; Cho, DG; Jang, TW; Son, JW; Ryu, JS; Cho, MJ				Shin, Dong Wook; Kim, Young Il; Kim, Seung Joon; Kim, Jung Soo; Chong, SeMin; Park, Young Sik; Song, Sang-Yun; Lee, Jin Han; Ahn, Hee Kyung; Kim, Eun Young; Yang, Sei Hoon; Lee, Myoung Kyu; Cho, Deog Gon; Jang, Tae Won; Son, Ji Woong; Ryu, Jeong-Seon; Cho, Moon-June			Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey	PLOS ONE			English	Article							NICOTINE DELIVERY-SYSTEMS; ELECTRONIC CIGARETTES; AWARENESS; PREVALENCE; ADULTS; HARM	Objectives Despite a sharp increase in e-cigarette use, there is debate about whether e-cigarettes are a viable alternative for harm reduction, and the forms that regulation should take. Healthcare providers can be effective in offering guidance to patients and their families and shaping regulatory policy. We described lung cancer specialists' attitudes toward e-cigarettes and its regulation. Methods We undertook a nationwide survey of pulmonologists, thoracic surgeons, medical and radiological oncologists who are members of Korean Association for Lung Cancer. Survey items included beliefs and attitudes toward e-cigarettes, attitudes toward e-cigarette regulation and preparedness on discussing e-cigarettes with their patients. Results Most respondents believed that e-cigarettes are not safer than conventional tobacco cigarettes (75.7%) or smokeless tobacco (83.2%), and feared that discussing e-cigarettes with the patients would encourage use (65.4%). They did not consider it a smoking cessation treatment (78.3%), and thus would not recommend it to smokers who do not want to quit (8 2.2%) or who failed to quit with conventional smoking cessation treatment (74.1%). Most respondents supported all examples of e-cigarette regulations, including the safety and quality check (97.8%), warning label (97.8%), advertisement ban (95.1%), restriction of flavoring (78.4%), minimum purchasing age (99.5%), and restriction of indoor use (94.6%). Most learned about e-cigarettes from media and advertisements, or conversation with patients rather than through professional scientific resources, and reported discomfort when discussing e-cigarette with patients. Conclusion Lung cancer specialist physicians in Korea doubt the safety of e-cigarette and use of e-cigarette as smoking cessation treatment, and supported strict regulation. However, only 20% reported that they obtained information on e-cigarettes from the scientific literature and many lacked adequate knowledge based on scientific evidence, suggesting the need for better preparedness. Nevertheless, the views of professionals revealed from our study could help to develop clinical guidelines and regulatory guidance.	[Shin, Dong Wook] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Shin, Dong Wook] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea; [Shin, Dong Wook] Seoul Natl Univ, Canc Hosp, Canc Survivorship Clin, Seoul, South Korea; [Kim, Young Il; Cho, Moon-June] Chungnam Natl Univ, Sch Med, Dept Radiat Oncol, Daejeon, South Korea; [Kim, Seung Joon] Catholic Univ Korea, Seoul St Mary Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jung Soo; Ryu, Jeong-Seon] Inha Univ, Inha Univ Hosp, Coll Med, Dept Internal Med, Incheon, South Korea; [Chong, SeMin] Chung Ang Univ, Coll Med, Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Young Sik] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Song, Sang-Yun] Chonnam Natl Univ, Hwasun Hosp, Sch Med, Dept Thorac & Cardiovasc Surg, Hwasun, South Korea; [Lee, Jin Han] Donga A Ilbo, Seoul, South Korea; [Ahn, Hee Kyung; Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Yang, Sei Hoon] Wonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea; [Lee, Myoung Kyu] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Cho, Deog Gon] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Suwon, South Korea; [Jang, Tae Won] Kosin Univ, Coll Med, Dept Internal Med, Pusan, South Korea; [Son, Ji Woong] Konyang Univ Hosp, Dept Internal Med, Daejeon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chungnam National University; Catholic University of Korea; Seoul St. Mary's Hospital; Inha University; Inha University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Chonnam National University; Gachon University; Wonkwang University; Yonsei University; Catholic University of Korea; Konyang University; Konyang University Hospital	Ryu, JS (corresponding author), Inha Univ, Inha Univ Hosp, Coll Med, Dept Internal Med, Incheon, South Korea.	jsryu@inha.ac.kr		Chong, Semin/0000-0002-7429-2566; KIM, YOUNG IL/0000-0003-3696-7187; Kim, Jung Soo/0000-0001-6603-6768	Korea government (MSIP) (Medical Research Center (MRC)) [2014009392]	Korea government (MSIP) (Medical Research Center (MRC))	This work was supported by the Korea government (MSIP) (Medical Research Center (MRC) No. 2014009392) to JSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Public Health Physicians, 2013, PRINC GUID AAPHP TOB; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Berg Carla J, 2014, Open J Prev Med, V4, P789; Borderud SP, 2014, CANCER-AM CANCER SOC, V120, P3527, DOI 10.1002/cncr.28811; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Cobb NK, 2015, TOB CONTROL, V24, P128, DOI 10.1136/tobaccocontrol-2013-051185; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Cummings KM, 2014, J THORAC ONCOL, V9, P438, DOI 10.1097/JTO.0000000000000129; Czogala J, 2014, NICOTINE TOB RES, V16, P655, DOI 10.1093/ntr/ntt203; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Hajek P, 2014, ADDICTION, V109, P1801, DOI 10.1111/add.12659; Kandra KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103462; Kelland K., 2016, REUTER          0104; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Lee JA, 2015, INT J PUBLIC HLTH; Martinez-Sanchez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114256; McNeill A., 2015, REPORT COMMISSIONED; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Pepper JK, 2014, J ADOLESCENT HEALTH, V54, P678, DOI 10.1016/j.jadohealth.2013.10.001; Primack BA, 2015, JAMA PEDIATR, V169, P1018, DOI 10.1001/jamapediatrics.2015.1742; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Tan ASL, 2014, AM J PREV MED, V47, P141, DOI 10.1016/j.amepre.2014.02.011; US Food and Drug Administration, 2016, FDA REG ENDS; Wackowski OA, 2015, TOB CONTROL, V24, P543, DOI 10.1136/tobaccocontrol-2014-051953; Wagener TL, 2012, ADDICTION, V107, P1545, DOI 10.1111/j.1360-0443.2012.03826.x; World Health Organisation (WHO) Framework Convention on Tobacco Control, 2014, EL NIC DEL SYST	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172568	10.1371/journal.pone.0172568	http://dx.doi.org/10.1371/journal.pone.0172568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235068	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200093
J	Zundel, M; Ehret, AE; Mazza, E				Zundel, Manuel; Ehret, Alexander E.; Mazza, Edoardo			Factors influencing the determination of cell traction forces	PLOS ONE			English	Article							FOCAL ADHESIONS; MICROSCOPY; RIGIDITY; MOMENTS; GUIDE; SHAPE	Methods summarized by the term Traction Force Microscopy are widely used to quantify cellular forces in mechanobiological studies. These methods are inverse, in the sense that forces must be determined such that they comply with a measured displacement field. This study investigates how several experimental and analytical factors, originating in the realization of the experiments and the procedures for the analysis, affect the determined traction forces. The present results demonstrate that even for very high resolution measurements free of noise, traction forces can be significantly underestimated, while traction peaks are typically overestimated by 50% or more, even in the noise free case. Compared to this errors, which are inherent to the nature of the mechanical problem and its discretization, the effect of ignoring the out-of-plane displacement component, the interpolation scheme used between the discrete measurement points and the disregard of the geometrical non-linearities when using a nearly linear substrate material are less consequential. Nevertheless, a nonlinear elastic substrate, with strain-stiffening response and some degree of compressibility, can substantially improve the robustness of the reconstruction of traction forces over a wide range of magnitudes. This poses the need for a correct mechanical representation of these non-linearities during the traction reconstruction and a correct mechanical characterization of the substrate itself, especially for the large strain shear domain which is shown to plays a major role in the deformations induced by cells.	[Zundel, Manuel; Ehret, Alexander E.; Mazza, Edoardo] ETH, Inst Mech Syst, Zurich, Switzerland; [Ehret, Alexander E.; Mazza, Edoardo] Swiss Fed Labs Mat Sci & Technol, Empa, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Zundel, M (corresponding author), ETH, Inst Mech Syst, Zurich, Switzerland.	zuendel@imes.mavt.ethz.ch		Zundel, Manuel/0000-0001-6254-6429; Ehret, Alexander/0000-0002-8740-8900; Mazza, Edoardo/0000-0001-9427-4157	Swiss National Science Foundation [SNSF 155918]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	M.Z. was supported by funding from the Swiss National Science Foundation under Grant SNSF 155918. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Bergert M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12814; Boudou T, 2009, BIORHEOLOGY, V46, P191, DOI 10.3233/BIR-2009-0540; Buhmann MD, 2003, C MO AP C M, DOI 10.1017/CBO9780511543241; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; del Alamo JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069850; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galliker P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1891; Han SJ, 2015, NAT METHODS, V12, P653, DOI [10.1038/NMETH.3430, 10.1038/nmeth.3430]; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jorge-Penas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144184; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lopez-Fagundo C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0247; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Schwarz US, 2015, BBA-MOL CELL RES, V1853, P3095, DOI 10.1016/j.bbamcr.2015.05.028; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4	36	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172927	10.1371/journal.pone.0172927	http://dx.doi.org/10.1371/journal.pone.0172927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235004	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200172
J	Wan, XJ; Wang, SB; Xu, JR; Zhuang, L; Xing, KP; Zhang, MY; Zhu, XT; Wang, LN; Gao, P; Xi, QY; Sun, JJ; Zhang, YL; Li, TJ; Shu, G; Jiang, QY				Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Li, Tiejun; Shu, Gang; Jiang, Qingyan			Dietary protein-induced hepatic IGF-1 secretion mediated by PPAR. activation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RIBONUCLEIC-ACID; GCN2 EIF2-ALPHA KINASE; ESSENTIAL AMINO-ACID; SIGNALING PATHWAY; RAT HEPATOCYTES; RECEPTOR-GAMMA; WEANLING PIGS; GROWING PIGS; TRANSFER-RNA	Dietary protein or amino acid (AA) is a crucial nutritional factor to regulate hepatic insulinlike growth factor-1 (IGF-1) expression and secretion. However, the underlying intracellular mechanism by which dietary protein or AA induces IGF-1 expression remains unknown. We compared the IGF-1 gene expression and plasma IGF-1 level of pigs fed with normal crude protein (CP, 20%) and low-protein levels (LP, 14%). RNA sequencing (RNA-seq) was performed to detect transcript expression in the liver in response to dietary protein. The results showed that serum concentrations and mRNA levels of IGF-1 in the liver were higher in the CP group than in the LP group. RNA-seq analysis identified a total of 1319 differentially expressed transcripts (667 upregulated and 652 downregulated), among which the terms "oxidative phosphorylation" , "ribosome", "gap junction", "PPAR signaling pathway", and "focal adhesion" were enriched. In addition, the porcine primary hepatocyte and HepG2 cell models also demonstrated that the mRNA and protein levels of IGF-1 and PPAR gamma increased with the increasing AA concentration in the culture. The PPAR gamma activator troglitazone increased IGF-1 gene expression and secretion in a dose dependent manner. Furthermore, inhibition of PPAR gamma effectively reversed the effects of the high AA concentration on the mRNA expression of IGF-1 and IGFBP-1 in HepG2 cells. Moreover, the protein levels of IGF-1 and PPAR gamma, as well as the phosphorylation of mTOR, significantly increased in HepG2 cells under high AA concentrations. mTOR phosphorylation can be decreased by the mTOR antagonist, rapamycin. The immunoprecipitation results also showed that high AA concentrations significantly increased the interaction of mTOR and PPAR gamma. In summary, PPAR gamma plays an important role in the regulation of IGF-1 secretion and gene expression in response to dietary protein.	[Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Shu, Gang; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Wan, Xiaojuan; Wang, Songbo; Xu, Jingren; Zhuang, Lu; Xing, Kongping; Zhang, Mengyuan; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Xi, Qianyun; Sun, Jiajie; Zhang, Yongliang; Shu, Gang; Jiang, Qingyan] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou, Guangdong, Peoples R China; [Li, Tiejun] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Subtrop Agroecol, Changsha, Hunan, Peoples R China	South China Agricultural University; South China Agricultural University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.; Jiang, QY (corresponding author), South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou, Guangdong, Peoples R China.	qyjiang@scau.edu.cn			National Key Basic Research Program of China (973 Program) [2013CB127304]; National Natural Science Foundation of China [31572480, 31372397]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We declared that this work was supported by grants from National Key Basic Research Program of China (973 Program) (No. 2013CB127304), National Natural Science Foundation of China (No. 31572480) and the National Natural Science Foundation of China (No. 31372397).	Abu Shehab M, 2014, ENDOCRINOLOGY, V155, P1327, DOI 10.1210/en.2013-1759; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; CAMPBELL RG, 1990, J ANIM SCI, V68, P3217; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Christiansen JJ, 2005, EUR J ENDOCRINOL, V152, P719, DOI 10.1530/eje.1.01898; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Deng D, 2007, LIVEST SCI, V109, P224, DOI 10.1016/j.livsci.2007.01.104; Deval C, 2008, BIOCHIMIE, V90, P1716, DOI 10.1016/j.biochi.2008.07.004; Fang XL, 2012, MOL BIOL REP, V39, P10987, DOI 10.1007/s11033-012-2000-6; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gannon MC, 2011, METABOLISM, V60, P1300, DOI 10.1016/j.metabol.2011.01.016; Genolet R, 2005, J BIOL CHEM, V280, P24143, DOI 10.1074/jbc.M502649200; Gietzen DW, 2016, CELL REP, V16, P2049, DOI 10.1016/j.celrep.2016.08.021; Goya L, 2001, ENDOCRINOLOGY, V142, P5089, DOI 10.1210/en.142.12.5089; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Guay F, 2006, J ANIM SCI, V84, P3010, DOI 10.2527/jas.2005-559; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kessler KL, 2012, J ANIM PHYSL ANIM NU; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecka-Czernik B, 2007, ENDOCRINOLOGY, V148, P903, DOI 10.1210/en.2006-1121; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Li XW, 2008, J CELL BIOCHEM, V104, P965, DOI 10.1002/jcb.21680; Li ZR, 2014, P NATL ACAD SCI USA, V111, P13163, DOI 10.1073/pnas.1411571111; Lian J, 2008, MOL NUTR FOOD RES, V52, P393, DOI 10.1002/mnfr.200700005; MIURA Y, 1992, BRIT J NUTR, V67, P257, DOI 10.1079/BJN19920029; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nyachoti CM, 2006, J ANIM SCI, V84, P125, DOI 10.2527/2006.841125x; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Okuno Y, 2010, ENDOCR J, V57, P303, DOI 10.1507/endocrj.K09E-113; Pedrosa RG, 2013, APPL PHYSIOL NUTR ME, V38, P694, DOI 10.1139/apnm-2012-0440; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Reindl KM, 2011, AM J PHYSIOL-REG I, V301, pR236, DOI 10.1152/ajpregu.00414.2010; Reynolds MR, 2015, BIOL CHEM; Savage MO, 2013, WORLD REV NUTR DIET, V106, P52, DOI 10.1159/000342577; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shu G, 2014, J NUTR BIOCHEM, V25, P1296, DOI 10.1016/j.jnutbio.2014.07.007; THISSEN JP, 1994, ENDOCRINOLOGY, V134, P1570, DOI 10.1210/en.134.3.1570; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Wu L, 2015, TOXINS, V7, P1341, DOI 10.3390/toxins7041341; Wu YL, 2013, J BIOL INORG CHEM, V18, P623, DOI 10.1007/s00775-013-1007-3; Xi PB, 2012, J NUTR BIOCHEM, V23, P1012, DOI 10.1016/j.jnutbio.2011.05.009; Xiao F, 2016, ONCOTARGET, V7, P63679, DOI 10.18632/oncotarget.11626; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zervas S, 2002, J ANIM SCI, V80, P3238; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173174	10.1371/journal.pone.0173174	http://dx.doi.org/10.1371/journal.pone.0173174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257428	gold, Green Submitted, Green Published			2022-12-27	WOS:000396021100069
J	Acquah, GE; Via, BK; Fasina, OO; Adhikari, S; Billor, N; Eckhardt, LG				Acquah, Gifty E.; Via, Brian K.; Fasina, Oladiran O.; Adhikari, Sushil; Billor, Nedret; Eckhardt, Lori G.			Chemometric modeling of thermogravimetric data for the compositional analysis of forest biomass	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; THERMAL-DECOMPOSITION; CHEMICAL-COMPOSITION; LOBLOLLY-PINE; WOOD; DEVOLATILIZATION; PREDICTION; COMPONENTS; CHEMISTRY; KINETICS	The objective of this study was to investigated the use of chemometric modeling of thermogravimetric (TG) data as an alternative approach to estimate the chemical and proximate (i.e. volatile matter, fixed carbon and ash contents) composition of lignocellulosic biomass. Since these properties affect the conversion pathway, processing costs, yield and / or quality of products, a capability to rapidly determine these for biomass feedstock entering the process stream will be useful in the success and efficiency of bioconversion technologies. The 38-minute long methodology developed in this study enabled the simultaneous prediction of both the chemical and proximate properties of forest-derived biomass from the same TG data. Conventionally, two separate experiments had to be conducted to obtain such information. In addition, the chemometric models constructed with normalized TG data outperformed models developed via the traditional deconvolution of TG data. PLS and PCR models were especially robust in predicting the volatile matter (R-2-0.92; RPD-3.58) and lignin (R-2-0.82; RPD-2.40) contents of the biomass. The application of chemometrics to TG data also made it possible to predict some monomeric sugars in this study. Elucidation of PC loadings obtained from chemometric models also provided some insights into the thermal decomposition behavior of the chemical constituents of lignocellulosic biomass. For instance, similar loadings were noted for volatile matter and cellulose, and for fixed carbon and lignin. The findings indicate that common latent variables are shared between these chemical and thermal reactivity properties. Results from this study buttresses literature that have reported that the less thermally stable polysaccharides are responsible for the yield of volatiles whereas the more recalcitrant lignin with its higher percentage of elementary carbon contributes to the yield of fixed carbon.	[Acquah, Gifty E.; Via, Brian K.] Auburn Univ, Sch Forestry & Wildlife Sci, Forest Prod Dev Ctr, Auburn, AL 36849 USA; [Via, Brian K.; Fasina, Oladiran O.; Adhikari, Sushil] Auburn Univ, Dept Biosyst Engn, Ctr Bioenergy & Bioprod, Auburn, AL 36849 USA; [Billor, Nedret] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA; [Eckhardt, Lori G.] Auburn Univ, Sch Forestry & Wildlife Sci, Forest Hlth Dynam Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Acquah, GE (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Forest Prod Dev Ctr, Auburn, AL 36849 USA.	gea0002@auburn.edu			NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals [1069004]; IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems [2011-68005-30410]; Forest Health Cooperative and Regions Bank	NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals; IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems; Forest Health Cooperative and Regions Bank	The authors are most grateful to NSF IGERT: Integrated Biorefining for Sustainable Production of Fuels and Chemicals (Award #: 1069004), The IGP, Good to Great Grant, USDA Southeastern Partnership for Integrated Biomass Supply Systems (Grant #: 2011-68005-30410), The Forest Health Cooperative and Regions Bank for supporting this research with funding and/or materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquah GE, 2010, THESIS; Acquah GE, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/1839598; Acquah GE, 2015, J NEAR INFRARED SPEC, V23, P93, DOI 10.1255/jnirs.1153; Acquah GE, 2016, FOREST PROD J, V66, P164, DOI 10.13073/FPJ-D-14-00098; Allison GG, 2009, BIORESOURCE TECHNOL, V100, P6428, DOI 10.1016/j.biortech.2009.07.015; [Anonymous], 2005, PRINCIPLES POLYM SCI; [Anonymous], 2014, E113108 ASTM; ASTM standards, 2006, FUELS 872 882; Bassilakis R, 2001, FUEL, V80, P1765, DOI 10.1016/S0016-2361(01)00061-8; Basu P., 2010, BIOMASS GASIFICATION; Becidan M., 2007, THESIS; Biagini E, 2006, IND ENG CHEM RES, V45, P4486, DOI 10.1021/ie0514049; BROIDO A, 1969, J POLYM SCI A2, V7, P1761, DOI 10.1002/pol.1969.160071012; Carrier M, 2011, BIOMASS BIOENERG, V35, P298, DOI 10.1016/j.biombioe.2010.08.067; Celikbag Y, 2016, FOREST PROD J, V66, P29, DOI 10.13073/FPJ-D-14-00110; Chow S. Z., 1971, Wood & Fiber, V3, P166; Pereira BLC, 2013, BIORESOURCES, V8, P4574; Cozzani V, 1997, CAN J CHEM ENG, V75, P127, DOI 10.1002/cjce.5450750120; Dworzanski JP, 1991, J AM CHEM SOC, V36, P725; Elder T, 2011, THERMOCHIM ACTA, V512, P170, DOI 10.1016/j.tca.2010.10.001; European Committee for Standardization (CEN), 2005, 151482005E CENTS; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Francisco-Fernandez M, 2012, CHEMOMETR INTELL LAB, V118, P159, DOI 10.1016/j.chemolab.2012.07.003; Garcia R, 2013, BIORESOURCE TECHNOL, V139, P1, DOI 10.1016/j.biortech.2013.03.197; Hein PRG, 2009, CERNE, V15, P133; Gronli MG, 2002, IND ENG CHEM RES, V41, P4201, DOI 10.1021/ie0201157; Klass DL., 1998, BIOMASS RENEWABLE EN; Kumar A, 2008, BIOMASS BIOENERG, V32, P460, DOI 10.1016/j.biombioe.2007.11.004; Lande S, 2010, WOOD SCI TECHNOL, V44, P189, DOI 10.1007/s00226-009-0278-x; Lapuerta M, 2004, BIOMASS BIOENERG, V27, P385, DOI 10.1016/j.biombioe.2003.11.010; Lee S, 2006, J ANAL APPL PYROL, V86, P39; Martens H., 1992, MULTIVARIATE CALIBRA; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Naik S, 2010, RENEW ENERG, V35, P1624, DOI 10.1016/j.renene.2009.08.033; National Renewable Energy Laboratory (NREL), 2008, NRELTP51042622; Natural Resources Canada, 2007, FOR BIOPR DIV CAN FO; Nkansah K, 2010, BIORESOURCE TECHNOL, V101, P4570, DOI 10.1016/j.biortech.2009.12.046; NREL, 2012, NRELTP51042618; Nuopponen MH, 2006, J AGR FOOD CHEM, V54, P34, DOI 10.1021/jf051066m; Ono K, 2003, J FOR RES, V8, P19; Owen K, 2015, T ASABE, V58, P509; Saldarriaga JF, 2015, FUEL, V140, P744, DOI 10.1016/j.fuel.2014.10.024; Singh S, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00062; Teleman A, 2009, PULP AND PAPER CHEMISTRY AND TECHNOLOGY, VOL 1: WOOD CHEMISTRY AND WOOD BIOTECHNOLOGY, P101; Toscano G, 2015, ENERGY, V83, P351, DOI 10.1016/j.energy.2015.02.032; Via BK, 2014, SENSORS-BASEL, V14, P13532, DOI 10.3390/s140813532; Werner K, 2014, J ANAL APPL PYROL, V110, P130, DOI 10.1016/j.jaap.2014.08.013; Williams PT, 2013, ADV THERMOCHEMICAL B, P771; Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117; Zhang JF, 2014, BIORESOURCE TECHNOL, V153, P379, DOI 10.1016/j.biortech.2013.12.004	50	16	16	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172999	10.1371/journal.pone.0172999	http://dx.doi.org/10.1371/journal.pone.0172999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253322	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300057
J	Caputo, M; Balzerano, A; Arisi, I; D'Onofrio, M; Brandi, R; Bongiorni, S; Brancorsini, S; Frontini, M; Proietti-De-Santis, L				Caputo, Manuela; Balzerano, Alessio; Arisi, Ivan; D'Onofrio, Mara; Brandi, Rossella; Bongiorni, Silvia; Brancorsini, Stefano; Frontini, Mattia; Proietti-De-Santis, Luca			CSB ablation induced apoptosis is mediated by increased endoplasmic reticulum stress response	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; COCKAYNE-SYNDROME B; I TRANSCRIPTION; CANCER; REPAIR; P53; COMPONENT; DISEASES; ROLES; HIF-1	The DNA repair protein Cockayne syndrome group B (CSB) has been recently identified as a promising anticancer target. Suppression, by antisense technology, of this protein causes devastating effects on tumor cells viability, through a massive induction of apoptosis, while being non-toxic to non-transformed cells. To gain insights into the mechanisms underlying the pro-apoptotic effects observed after CSB ablation, global gene expression patterns were determined, to identify genes that were significantly differentially regulated as a function of CSB expression. Our findings revealed that response to endoplasmic reticulum stress and response to unfolded proteins were ranked top amongst the cellular processes affected by CSB suppression. The major components of the endoplasmic reticulum stress-mediated apoptosis pathway, including pro-apoptotic factors downstream of the ATF3-CHOP cascade, were dramatically up-regulated. Altogether our findings add new pieces to the understanding of CSB mechanisms of action and to the molecular basis of CS syndrome.	[Caputo, Manuela; Balzerano, Alessio; Bongiorni, Silvia; Proietti-De-Santis, Luca] Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, Viterbo, Italy; [Arisi, Ivan; D'Onofrio, Mara; Brandi, Rossella] European Brain Res Inst EBRI Rita Levi Montalcini, Genom Facil, Rome, Italy; [Brancorsini, Stefano] Univ Perugia, Sect Terni, Dept Expt Med, Terni, Italy; [Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Frontini, Mattia] Natl Hlth Serv NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge, England; [Frontini, Mattia] Univ Cambridge, British Heart Fdn Ctr Excellence, Cambridge Biomed Campus, Cambridge, England	Tuscia University; University of Perugia; University of Cambridge; University of Cambridge	Proietti-De-Santis, L (corresponding author), Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, Viterbo, Italy.	proietti@unitus.it	Arisi, Ivan/AAM-1152-2021; De Santis, Luca Proietti/A-4119-2015	Arisi, Ivan/0000-0002-0536-2508; De Santis, Luca Proietti/0000-0002-2715-9113; Bongiorni, Silvia/0000-0001-5111-0566	AIRC [IG13074]; Telethon [GGP11176]; FP7 European Collaborative Project PAINCAGE [603191]; Italian Research Council (EBRI-CNR)	AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); FP7 European Collaborative Project PAINCAGE; Italian Research Council (EBRI-CNR)	This work was supported by grants from AIRC (IG13074), Telethon (GGP11176), FP7 European Collaborative Project PAINCAGE (603191) and Italian Research Council (EBRI-CNR 2015-2017).	Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Caputo M, 2013, DNA REPAIR, V12, P293, DOI 10.1016/j.dnarep.2013.01.008; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Cleaver JE, 2014, P NATL ACAD SCI USA, V111, P13487, DOI 10.1073/pnas.1414135111; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Frontini M, 2012, AGING-US, V4, P89, DOI 10.18632/aging.100439; Frontini M, 2009, CELL CYCLE, V8, P693, DOI 10.4161/cc.8.5.7754; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Latini P, 2011, CELL CYCLE, V10, P3719, DOI 10.4161/cc.10.21.17905; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Natale V, 2011, AM J MED GENET A, V155A, P1081, DOI 10.1002/ajmg.a.33933; Nicolai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128558; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172399	10.1371/journal.pone.0172399	http://dx.doi.org/10.1371/journal.pone.0172399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253359	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300018
J	Tasaki, S; Nakayama, M; Shoji, W				Tasaki, Sohei; Nakayama, Madoka; Shoji, Wataru			Self-organization of bacterial communities against environmental pH variation: Controlled chemotactic motility arranges cell population structures in biofilms	PLOS ONE			English	Article							DENSE-BRANCHING-MORPHOLOGY; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; COLONY FORMATION; FLAGELLAR ROTATION; AGAR PLATES; GROWTH; PATTERNS; DYNAMICS; GRADIENT	As with many living organisms, bacteria often live on the surface of solids, such as foods, organisms, buildings and soil. Compared with dispersive behavior in liquid, bacteria on surface environment exhibit significantly restricted mobility. They have access to only limited resources and cannot be liberated from the changing environment. Accordingly, appropriate collective strategies are necessarily required for long-term growth and survival. However, in spite of our deepening knowledge of the structure and characteristics of individual cells, strategic self-organizing dynamics of their community is poorly understood and therefore not yet predictable. Here, we report a morphological change in Bacillus subtilis biofilms due to environmental pH variations, and present a mathematical model for the macroscopic spatiotemporal dynamics. We show that an environmental pH shift transforms colony morphology on hard agar media from notched `volcano-like' to round and front-elevated `crater-like'. We discover that a pH-dependent dose-response relationship between nutritional resource level and quantitative bacterial motility at the population level plays a central role in the mechanism of the spatio-temporal cell population structure design in biofilms.	[Tasaki, Sohei; Shoji, Wataru] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Sendai, Miyagi, Japan; [Tasaki, Sohei] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi, Japan; [Nakayama, Madoka] Sendai Natl Coll Technol, Natori, Miyagi, Japan; [Shoji, Wataru] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Tasaki, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Sendai, Miyagi, Japan.; Tasaki, S (corresponding author), Tohoku Univ, Grad Sch Sci, Sendai, Miyagi, Japan.	tasaki@tohoku.ac.jp	Tasaki, Sohei/AAP-6885-2020	Tasaki, Sohei/0000-0002-4259-0075	Japan Society for the Promotion of Science, KAKENHI [23570246]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, KAKENHI Grant Number 23570246 (WS), (URL: https://www.jsps.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Allen B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001549; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; BENJACOB E, 1986, PHYS REV LETT, V57, P1903, DOI 10.1103/PhysRevLett.57.1903; BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; Blanchard AE, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0188-5; Borges S, 2012, ANTON LEEUW INT J G, V101, P677, DOI 10.1007/s10482-011-9666-y; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Chen XB, 2000, BIOPHYS J, V78, P2280, DOI 10.1016/S0006-3495(00)76774-9; D'Uzo N., 2014, APPL ENVIRON MICROB, V80, P2176; DAWES IW, 1970, J BACTERIOL, V103, P529, DOI 10.1128/JB.103.3.529-535.1970; Dervaux J, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0051; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eden M., 1961, P 4 BERK S MATH STAT, V4, P223; Fabian FW, 1933, J BACTERIOL, V26, P543, DOI 10.1128/JB.26.6.543-558.1933; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; FUJIKAWA H, 1992, PHYSICA A, V189, P15, DOI 10.1016/0378-4371(92)90123-8; Golding I, 1998, PHYSICA A, V260, P510, DOI 10.1016/S0378-4371(98)00345-8; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holt J., 1994, BERGEYS MANUAL DETER; Kawasaki K, 1997, J THEOR BIOL, V188, P177, DOI 10.1006/jtbi.1997.0462; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kitsunezaki S, 1997, J PHYS SOC JPN, V66, P1544, DOI 10.1143/JPSJ.66.1544; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; MANSON MD, 1980, J MOL BIOL, V138, P541, DOI 10.1016/S0022-2836(80)80017-9; MATSUSHITA M, 1990, PHYSICA A, V168, P498, DOI 10.1016/0378-4371(90)90402-E; Mimura M, 2000, PHYSICA A, V282, P283, DOI 10.1016/S0378-4371(00)00085-6; Moissoglu K, 2014, CURR BIOL, V24, pR23, DOI 10.1016/j.cub.2013.10.075; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00960; Muinonen-Martin AJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001966; Nostro A, 2012, APMIS, V120, P733, DOI 10.1111/j.1600-0463.2012.02900.x; OHGIWARI M, 1992, J PHYS SOC JPN, V61, P816, DOI 10.1143/JPSJ.61.816; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; SHIOI JI, 1978, J BACTERIOL, V133, P1083, DOI 10.1128/JB.133.3.1083-1088.1978; TSO WW, 1974, J BACTERIOL, V118, P560, DOI 10.1128/JB.118.2.560-576.1974; Tweedy L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002404; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; WAKITA J, 1994, J PHYS SOC JPN, V63, P1205, DOI 10.1143/JPSJ.63.1205; Wakita J, 1998, J PHYS SOC JPN, V67, P3630, DOI 10.1143/JPSJ.67.3630; Wakita J, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.094002; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173195	10.1371/journal.pone.0173195	http://dx.doi.org/10.1371/journal.pone.0173195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253348	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300090
J	Zhang, XY; Wen, HS; Wang, HL; Ren, YY; Zhao, J; Li, Y				Zhang, Xiaoyan; Wen, Haishen; Wang, Hailiang; Ren, Yuanyuan; Zhao, Ji; Li, Yun			RNA-Seq analysis of salinity stress-responsive transcriptome in the liver of spotted sea bass (Lateolabrax maculatus)	PLOS ONE			English	Article							CATFISH PANGASIANODON-HYPOPHTHALMUS; EXPRESSION; AQUAPORIN-3; ADAPTATION; TELEOST; OSMOREGULATION; ACCLIMATION; ANNOTATION; INTESTINE; INSIGHTS	Salinity is one of the most prominent abiotic factors, which greatly influence reproduction, development, growth, physiological and metabolic activities of fishes. Spotted sea bass (Lateolabrax maculatus), as a euryhaline marine teleost, has extraordinary ability to deal with a wide range of salinity changes. However, this species is devoid of genomic resources, and no study has been conducted at the transcriptomic level to determine genes responsible for salinity regulation, which impedes the understanding of the fundamental mechanism conferring tolerance to salinity fluctuations. Liver, as the major metabolic organ, is the key source supplying energy for iono- and osmoregulation in fish, however, little attention has been paid to its salinity-related functions but which should not be ignored. In this study, we perform RNA-Seq analysis to identify genes involved in salinity adaptation and osmoregulation in liver of spotted sea bass, generating from the fishes exposed to low and high salinity water (5 vs 30ppt). After de novo assembly, annotation and differential gene expression analysis, a total of 455 genes were differentially expressed, including 184 up-regulated and 271 down-regulated transcripts in low salinity-acclimated fish group compared with that in high salinity-acclimated group. A number of genes with a potential role in salinity adaptation for spotted sea bass were classified into five functional categories based on the gene ontology (GO) and enrichment analysis, which include genes involved in metabolites and ion transporters, energy metabolism, signal transduction, immune response and structure reorganization. The candidate genes identified in L. maculates liver provide valuable information to explore new pathways related to fish salinity and osmotic regulation. Besides, the transcriptomic sequencing data supplies significant resources for identification of novel genes and further studying biological questions in spotted sea bass.	[Zhang, Xiaoyan; Wen, Haishen; Wang, Hailiang; Ren, Yuanyuan; Zhao, Ji; Li, Yun] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	Ocean University of China	Li, Y (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China.	yunli0116@ouc.edu.cn			National Natural Science Foundation of China (NSFC) [31602147]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project is supported by National Natural Science Foundation of China (NSFC), http://www.nsfc.gov.cn/, grant number 31602147. YL, HW, XZ has been funded by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0622-4; Boutet I, 2006, GENE, V379, P40, DOI 10.1016/j.gene.2006.04.011; Cacabelos R, 2016, J ALZHEIMERS DIS PAR, V6, P2161; Cutler CP, 2007, COMP BIOCHEM PHYS A, V148, P82, DOI 10.1016/j.cbpa.2006.09.022; Cutler CP, 2002, J EXP BIOL, V205, P2643; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085535; Deane EE, 2006, MAR BIOTECHNOL, V8, P663, DOI 10.1007/s10126-006-6001-0; Du L, 2012, MOL ENDOCRINOL, V26, P1773, DOI 10.1210/me.2012-1122; Du Tao, 2013, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V44, P337; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2010, J FISH BIOL, V76, P1903, DOI 10.1111/j.1095-8649.2010.02590.x; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gao T, 2000, J OCEAN U CHINA, V31, P185; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Herath HMLPB, 2016, GENE, V575, P732, DOI 10.1016/j.gene.2015.09.082; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jung D, 2012, COMP BIOCHEM PHYS A, V161, P320, DOI 10.1016/j.cbpa.2011.11.014; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KIM Y, 2001, MARINE FISHES KOREA, P222; Lai KP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1325-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Malachowicz M, 2015, MAR GENOM, V23, P37, DOI 10.1016/j.margen.2015.04.005; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McCormick SD, 2003, J EXP BIOL, V206, P4575, DOI 10.1242/jeb.00711; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Thanh NM, 2015, MAR GENOM, V23, P87, DOI 10.1016/j.margen.2015.05.001; Thanh NM, 2014, COMP BIOCHEM PHYS D, V10, P52, DOI 10.1016/j.cbd.2014.04.001; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; Rocha AJD, 2005, J EXP MAR BIOL ECOL, V316, P157, DOI 10.1016/j.jembe.2004.11.006; Rocha AJS, 2007, ECOTOX ENVIRON SAFE, V68, P397, DOI 10.1016/j.ecoenv.2006.10.007; Ronkin D, 2015, COMP BIOCHEM PHYS D, V13, P35, DOI 10.1016/j.cbd.2015.01.003; Rubio VC, 2005, PHYSIOL BEHAV, V85, P333, DOI 10.1016/j.physbeh.2005.04.022; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Sangiao-Alvarellos S, 2003, AM J PHYSIOL-REG I, V285, pR897, DOI 10.1152/ajpregu.00161.2003; Scott GR, 2004, AM J PHYSIOL-CELL PH, V287, pC300, DOI 10.1152/ajpcell.00054.2004; Shao CW, 2009, CONSERV GENET, V10, P623, DOI 10.1007/s10592-008-9592-3; Thuong KV, 2016, J FISH DIS, V39, P1403, DOI 10.1111/jfd.12471; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Nguyen TV, 2016, MAR GENOM, V25, P75, DOI 10.1016/j.margen.2015.11.010; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	59	74	81	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173238	10.1371/journal.pone.0173238	http://dx.doi.org/10.1371/journal.pone.0173238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253338	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300093
J	Gartner, M; Sandberg, A				Gartner, Manja; Sandberg, Anna			Is there an omission effect in prosocial behavior? A laboratory experiment on passive vs. active generosity	PLOS ONE			English	Article							DICTATOR GAME; DEFAULTS; ALTRUISM; JUDGMENT; BIAS	We investigate whether individuals are more prone to act selfishly if they can passively allow for an outcome to be implemented (omission) rather than having to make an active choice (commission). In most settings, active and passive choice alternatives differ in terms of factors such as the presence of a suggested option, costs of taking an action, and awareness. We isolate the omission effect from confounding factors in three experiments, and find no evidence that the distinction between active and passive choices has an independent effect on the propensity to implement selfish outcomes. This suggests that increased selfishness through omission, as observed in various economic choice situations, is driven by other factors than a preference for selfish omissions.	[Gartner, Manja] Linkoping Univ, Div Econ, Dept Management & Engn, Linkoping, Sweden; [Sandberg, Anna] Stockholm Univ, IIES, Stockholm, Sweden	Linkoping University; Stockholm University	Sandberg, A (corresponding author), Stockholm Univ, IIES, Stockholm, Sweden.	anna.sandberg@iies.su.se		Gartner, Manja/0000-0002-7007-9661; Sandberg, Anna/0000-0001-5200-1628	Jan Wallander and Tom Hedelius Foundation [P2012-0002:1]; Ragnar Soderberg Foundation	Jan Wallander and Tom Hedelius Foundation; Ragnar Soderberg Foundation	The experiment was funded by contributions from the Jan Wallander and Tom Hedelius Foundation (URL: http://www.handelsbanken.se/shb/inet/IStartSv.nsf/FrameSet?OpenView&id=Forskningsstiftelserna, Grant number: "P2012-0002:1"). We also thank the Ragnar Soderberg Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2006, J HEALTH ECON, V25, P599, DOI 10.1016/j.jhealeco.2006.01.003; Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; Andreoni J, JOURNAL OF POLITICAL; Andreoni J, 2009, ECONOMETRICA, V77, P1607, DOI 10.3982/ECTA7384; ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Bardsley N, 2008, EXP ECON, V11, P122, DOI 10.1007/s10683-007-9172-2; BARON J, 1994, ORGAN BEHAV HUM DEC, V59, P475, DOI 10.1006/obhd.1994.1070; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Benabou R, 2011, Q J ECON, V126, P805, DOI 10.1093/qje/qjr002; Carroll GD, 2009, Q J ECON, V124, P1639, DOI 10.1162/qjec.2009.124.4.1639; Coffman LC, 2011, AM ECON J-MICROECON, V3, P77, DOI 10.1257/mic.3.4.77; COHEN BJ, 1994, J GEN INTERN MED, V9, P20, DOI 10.1007/BF02599137; Cox J, 2016, EXPT EC; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Cushman F, 2012, SOC COGN AFFECT NEUR, V7, P888, DOI 10.1093/scan/nsr072; Dana J, 2006, ORGAN BEHAV HUM DEC, V100, P193, DOI 10.1016/j.obhdp.2005.10.001; Dana J, 2007, ECON THEOR, V33, P67, DOI 10.1007/s00199-006-0153-z; DellaVigna S, 2012, Q J ECON, V127, P1, DOI 10.1093/qje/qjr050; DeScioli P, 2011, EVOL HUM BEHAV, V32, P204, DOI 10.1016/j.evolhumbehav.2011.01.003; DeScioli P, 2011, PSYCHOL SCI, V22, P442, DOI 10.1177/0956797611400616; Dhingra N, 2012, JUDGM DECIS MAK, V7, P69; Dreber A, 2013, EXP ECON, V16, P349, DOI 10.1007/s10683-012-9341-9; Ellingsen T, 2008, AM ECON REV, V98, P990, DOI 10.1257/aer.98.3.990; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gartner M, OMISSION EFFECTS TRO; Gill D, 2011, IZA DISCUSSION PAPER; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Grossman Z, 2014, MANAGE SCI, V60, P2659, DOI 10.1287/mnsc.2014.1989; Hayashi AT, 2013, J LAW ECON ORGAN, V29, P711, DOI 10.1093/jleo/ews046; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; JOHNSON EJ, 1993, J RISK UNCERTAINTY, V7, P35, DOI 10.1007/BF01065313; KordesdeVaal JH, 1996, ACTA PSYCHOL, V93, P161, DOI 10.1016/0001-6918(96)00027-3; Krupka EL, 2013, J EUR ECON ASSOC, V11, P495, DOI 10.1111/jeea.12006; Lazear EP, 2012, AM ECON J-APPL ECON, V4, P136, DOI 10.1257/app.4.1.136; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; List JA, 2007, J POLIT ECON, V115, P482, DOI 10.1086/519249; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; Ritov I, 1999, ORGAN BEHAV HUM DEC, V79, P79, DOI 10.1006/obhd.1999.2839; RITOV I, 1992, J RISK UNCERTAINTY, V5, P49; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099	43	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172496	10.1371/journal.pone.0172496	http://dx.doi.org/10.1371/journal.pone.0172496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248979	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500043
J	Tschinkel, WR; Dominguez, DJ				Tschinkel, Walter R.; Dominguez, Daniel J.			An illustrated guide to seeds found in nests of the Florida harvester ant, Pogonomyrmex badius	PLOS ONE			English	Article							HYMENOPTERA; SOCIOGENESIS; SOCIOMETRY	The Florida harvester ant, Pogonomyrmex badius collects the seeds of many plant species and stores them in underground nest chambers for later consumption. Seeds taken from multiple nests in 1989, 2014 and 2015 were separated by size and species and identified through published keys, comparison with herbarium specimens and with identified seed collections. Harvester ants stored at least 58 species of seeds from 20 plant families in their chambers. This paper presents images of each seed species in several aspects, their relative abundance in P. badius nests, their size relative to the smallest, and links to online data and images of the parent plant species, as well as to herbarium specimens. A number of seeds and plant families present at the site were not found in ant nests. These data and images will be valuable for future studies and experiments to untangle the choices the ants make in relation to what the plants and the seasons offer them.	[Tschinkel, Walter R.; Dominguez, Daniel J.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu						BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; CHEW AE, 1980, INSECT SOC, V27, P189, DOI 10.1007/BF02223663; Davison E.A., 1982, Geobotany, V4, P1; Eddy TA, 1970, THESIS; HANSEN SR, 1978, OECOLOGIA, V35, P109, DOI 10.1007/BF00345544; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Johnson RA, 2001, ANNU REV ENTOMOL, V46, P1, DOI 10.1146/annurev.ento.46.1.1; Jones CR, 1927, J COLORADO WYOMING A, V1; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Landers JLJ, 1976, TALL TIMBERS MISCELL, V4; LAVIGNE RJ, 1969, ANN ENTOMOL SOC AM, V62, P1166, DOI 10.1093/aesa/62.5.1166; MacGown JA, 2007, MISSISSIPPI NATIVE P, V25, p[1, 4]; MACKAY W P, 1981, Psyche (Cambridge), V88, P25, DOI 10.1155/1981/78635; MACKAY WP, 1984, SOCIOBIOLOGY, V9, P31; RISSING SW, 1981, BEHAV ECOL SOCIOBIOL, V9, P149, DOI 10.1007/BF00293586; RISSING SW, 1976, PAN-PAC ENTOMOL, V52, P63; Rosene WF, 1988, GUIDE CULTURE FLOWER; Smith CR, 2010, FUNCT ECOL, V24, P122, DOI 10.1111/j.1365-2435.2009.01604.x; Tschinkel WR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166907; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; Willard JRA, 1964, THESIS	23	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171419	10.1371/journal.pone.0171419	http://dx.doi.org/10.1371/journal.pone.0171419			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248988	gold, Green Submitted, Green Published			2022-12-27	WOS:000395983500013
J	Malik, NS; Ahmad, M; Minhas, MU				Malik, Nadia Shamshad; Ahmad, Mahmood; Minhas, Muhammad Usman			Cross-linked beta-cyclodextrin and carboxymethyl cellulose hydrogels for controlled drug delivery of acyclovir	PLOS ONE			English	Article							CONTROLLED-RELEASE; SUPERABSORBENT HYDROGEL; DICLOFENAC SODIUM; METHACRYLIC-ACID; CHITOSAN; CIPROFLOXACIN; COMPLEXATION; MICROSPHERES; DERIVATIVES; ALGINATE	To explore the potential role of polymers in the development of drug-delivery systems, this study investigated the use of beta-cyclodextrin (beta-CD), carboxymethyl cellulose (CMC), acrylic acid (AA) and N' N'-methylenebis-acrylamide (MBA) in the synthesis of hydrogels for controlled drug delivery of acyclovir (ACV). Different proportions of beta-CD, CMC, AA and MBA were blended with each other to fabricate hydrogels via free radical polymerization technique. Fourier transform infrared spectroscopy (FTIR) revealed successful grafting of components into the polymeric network. Thermal and morphological characterization confirmed the formation of thermodynamically stable hydrogels having porous structure. The pH-responsive behaviour of hydrogels has been documented by swelling dynamics and drug release behaviour in simulated gastrointestinal fluids. Drug release kinetics revealed controlled release behaviour of the antiviral drug acyclovir in developed polymeric network. Cross-linked beta-cyclodextrin and carboxymethyl cellulose hydrogels can be used as promising candidates for the design and development of controlled drug-delivery systems.	[Malik, Nadia Shamshad; Ahmad, Mahmood; Minhas, Muhammad Usman] Islamia Univ Bahawalpur, Fac Pharm & Alternat Med, Bahawalpur, Pakistan	Islamia University of Bahawalpur	Ahmad, M (corresponding author), Islamia Univ Bahawalpur, Fac Pharm & Alternat Med, Bahawalpur, Pakistan.	ma786_786@yahoo.com			Higher Education Commission of Pakistan; Islamia University of Bahawalpur, Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Islamia University of Bahawalpur, Pakistan	Higher Education Commission of Pakistan and The Islamia University of Bahawalpur, Pakistan funded the research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blanco-Fernandez B, 2011, CARBOHYD POLYM, V85, P765, DOI 10.1016/j.carbpol.2011.03.042; Cesteros LC, 2007, MACROMOL CHEM PHYS, V208, P1764, DOI 10.1002/macp.200700109; Chao GT, 2006, J POLYM RES, V13, P349, DOI 10.1007/s10965-006-9050-1; Das D, 2015, INT J BIOL MACROMOL, V72, P171, DOI 10.1016/j.ijbiomac.2014.08.007; El-Sayed S, 2011, PHYSICA B, V406, P4068, DOI 10.1016/j.physb.2011.07.050; Folch-Cano C, 2014, MOLECULES, V19, P14066, DOI 10.3390/molecules190914066; Guirguis OW, 2012, NAT SCI; Halib N, 2010, J APPL POLYM SCI, V116, P2920, DOI 10.1002/app.31857; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hosseinzadeh H, 2010, J CHEM SCI, V122, P651, DOI 10.1007/s12039-010-0100-1; Kono H, 2015, INT J BIOL MACROMOL, V72, P299, DOI 10.1016/j.ijbiomac.2014.08.030; Kono H, 2014, CARBOHYD POLYM, V106, P84, DOI 10.1016/j.carbpol.2014.02.020; Kono H, 2013, CARBOHYD POLYM, V98, P784, DOI 10.1016/j.carbpol.2013.06.065; Kopecek J, 2009, J POLYM SCI POL CHEM, V47, P5929, DOI 10.1002/pola.23607; Kumari S, 2014, IRAN POLYM J, V23, P111, DOI 10.1007/s13726-013-0206-7; Liu Y, 2015, BIORESOURCES, V10, P6479; Minhas MU, 2013, DARU, V21, DOI 10.1186/2008-2231-21-44; Park JS, 2001, POLYMER, V42, P4271, DOI 10.1016/S0032-3861(00)00768-0; Pinho E, 2014, CELLULOSE, V21, P4519, DOI 10.1007/s10570-014-0439-4; Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051; Rashid A, 2015, TROP J PHARM RES, V14, P1121, DOI 10.4314/tjpr.v14i7.1; Rodriguez-Tenreiro C, 2006, PHARM RES-DORDR, V23, P121, DOI 10.1007/s11095-005-8924-y; Rokhade AP, 2007, CARBOHYD POLYM, V67, P605, DOI 10.1016/j.carbpol.2006.07.001; dos Santos JFR, 2008, ACTA BIOMATER, V4, P745, DOI 10.1016/j.actbio.2007.12.008; Saravanan M, 2004, INT J PHARM, V283, P71, DOI 10.1016/j.ijpharm.2004.06.023; Siemoneit U, 2006, INT J PHARMACEUT, V312, P66, DOI 10.1016/j.ijpharm.2005.12.046; Silva DA, 2006, CARBOHYD POLYM, V66, P16, DOI 10.1016/j.carbpol.2006.02.021; Siritientong T, 2015, MACROMOL RES, V23, P861, DOI 10.1007/s13233-015-3116-z; Sohail M, 2015, INT J PHARMACEUT, V487, P110, DOI 10.1016/j.ijpharm.2015.04.013; Thatiparti TR, 2010, MACROMOL BIOSCI, V10, P82, DOI 10.1002/mabi.200900204; Tsao JY, 2010, INT J PHARMACEUT, V402, P123, DOI 10.1016/j.ijpharm.2010.09.033; Wang GF, 2014, CHEM PAP, V68, P1390, DOI 10.2478/s11696-014-0574-2; Wang YZ, 2013, TURK J CHEM, V37, P149, DOI 10.3906/kim-1204-52; Xin JY, 2010, INT J PHARMACEUT, V386, P221, DOI 10.1016/j.ijpharm.2009.11.024	34	79	79	2	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172727	10.1371/journal.pone.0172727	http://dx.doi.org/10.1371/journal.pone.0172727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245257	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200028
J	Parra, EJ; Mazurek, A; Gignoux, CR; Sockell, A; Agostino, M; Morris, AP; Petty, LE; Hanis, CL; Cox, NJ; Valladares-Salgado, A; Below, JE; Cruz, M				Parra, Esteban J.; Mazurek, Andrew; Gignoux, Christopher R.; Sockell, Alexandra; Agostino, Michael; Morris, Andrew P.; Petty, Lauren E.; Hanis, Craig L.; Cox, Nancy J.; Valladares-Salgado, Adan; Below, Jennifer E.; Cruz, Miguel			Admixture mapping in two Mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPID-LEVELS; GENETIC-VARIATION; VARIANTS; RISK; METAANALYSIS; POPULATIONS; PATTERNS; TRAITS	We carried out an admixture mapping study of lipid traits in two samples from Mexico City. Native American locus ancestry was significantly associated with triglyceride levels in a broad region of chromosome 11 overlapping the BUD13, ZNF259 and APOA5 genes. In our fine-mapping analysis of this region using dense genome-wide data, rs964184 is the only marker included in the 99% credible set of SNPs, providing strong support for rs964184 as the causal variant within this region. The frequency of the allele associated with increased triglyceride concentrations (rs964184-G) is between 30-40% higher in Native American populations from Mexico than in European populations. The evidence currently available for this variant indicates that it may be exerting its effect through three potential mechanisms: 1) modification of enhancer activity, 2) regulation of the expression of several genes in cis and/ortrans, or 3) modification of the methylation patterns of the promoter of the APOA5 gene.	[Parra, Esteban J.; Mazurek, Andrew; Agostino, Michael] Univ Toronto, Dept Anthropol, Mississauga, ON, Canada; [Gignoux, Christopher R.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sockell, Alexandra] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Petty, Lauren E.; Hanis, Craig L.; Below, Jennifer E.] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN USA; [Valladares-Salgado, Adan; Cruz, Miguel] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo 21, IMSS, Unidad Invest Med Bioquim, Mexico City, DF, Mexico	University of Toronto; University Toronto Mississauga; Stanford University; Stanford University; University of Liverpool; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Vanderbilt University; Instituto Mexicano del Seguro Social	Parra, EJ (corresponding author), Univ Toronto, Dept Anthropol, Mississauga, ON, Canada.	esteban.parra@utoronto.ca	Lopez, Miguel Cruz/O-5493-2018; Below, Jennifer E/W-2179-2018	Lopez, Miguel Cruz/0000-0001-9985-6172; Below, Jennifer E/0000-0002-1346-1872; parra, esteban J/0000-0002-2057-8577; Below, Jennifer/0000-0002-6372-6402; Sockell, Alexandra/0000-0002-8725-9415	Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT) project [150352]; Temas Prioritarios de Salud Institute Mexicano del Seguro Social [2014-FIS/IMSS/PROT/PRIO/14/34]; Fundacion IMSS; Canadian Institutes of Health Research (CIHR); Banting and Best Diabetes Centre; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto; NIH [HL102830, DK085501, DK073541, DK020595, AI085014]; University of Texas Health Science Center at Houston; Wellcome Trust [WT098017]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT) project; Temas Prioritarios de Salud Institute Mexicano del Seguro Social; Fundacion IMSS; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre; Canada Foundation for Innovation under the auspices of Compute Canada; Government of Ontario; Ontario Research Fund - Research Excellence; University of Toronto(University of Toronto); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	In Mexico, this work was supported by the Fondo Sectorial de Investigacion en Salud y Seguridad Social (SSA/IMSS/ISSSTE-CONACYT) project 150352, Temas Prioritarios de Salud Institute Mexicano del Seguro Social 2014-FIS/IMSS/PROT/PRIO/14/34, and Fundacion IMSS. In Canada, the research was supported by a Canadian Institutes of Health Research (CIHR) operating grant to EJP, and also by funding from the Banting and Best Diabetes Centre to EJP. In Canada, computations were performed on the GPC supercomputer at the SciNet HPC Consortium. SciNet is funded by: the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; Ontario Research Fund - Research Excellence; and the University of Toronto. The work in the Starr County cohort was supported by NIH grants HL102830, DK085501, DK073541, DK020595, AI085014 and funds from the University of Texas Health Science Center at Houston. APM is a Wellcome Trust Senior Fellow in Basic Biomedical Science (grant number WT098017).	Aguilar-Salinas CA, 2014, METABOLISM, V63, P887, DOI 10.1016/j.metabol.2014.03.012; Aguilar-Salinas CA, 2010, SALUD PUBLICA MEXICO, V52, pS44, DOI 10.1590/s0036-36342010000700008; [Anonymous], 2013, NAT GENET, DOI DOI 10.1038/NG.2797; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Biswas S, 2008, J CARDIOL, V52, P118, DOI 10.1016/j.jjcc.2008.06.005; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chavez-Tapia N, 2009, TOPICS IN PREVALENT; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Frank ATH, 2014, CIRCULATION, V129, P570, DOI 10.1161/CIRCULATIONAHA.113.005757; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Ganna A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004801; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Moen EL, 2013, GENETICS, V194, P987, DOI 10.1534/genetics.113.151381; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Morgenstern LB, 2004, AM J EPIDEMIOL, V160, P376, DOI 10.1093/aje/kwh225; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Parra EJ, 2015, PHARMACOGENOMICS, V16, P1253, DOI [10.2217/PGS.15.73, 10.2217/pgs.15.73]; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Rodriguez CJ, 2014, AM J MED, V127, P1186, DOI 10.1016/j.amjmed.2014.07.026; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Singh Vibhuti, 2006, Curr Atheroscler Rep, V8, P32, DOI 10.1007/s11883-006-0062-4; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Wu J, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-60; Yao C, 2015, CIRCULATION, V131, P536, DOI 10.1161/CIRCULATIONAHA.114.010696	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172880	10.1371/journal.pone.0172880	http://dx.doi.org/10.1371/journal.pone.0172880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245265	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200038
J	Rosset, EM; Trombetta-eSilva, J; Hepfer, G; Yao, H; Bradshaw, AD				Rosset, Emilie Moore; Trombetta-eSilva, Jessica; Hepfer, Glenn; Yao, Hai; Bradshaw, Amy Dodd			SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament	PLOS ONE			English	Article							EPITHELIAL-CELL RESTS; EXTRACELLULAR-MATRIX; MECHANICAL STRENGTH; GLOBULAR DOMAIN; NULL MICE; MALASSEZ; PROCOLLAGEN; EXPRESSION; CATARACTOGENESIS; PROTEINASE	The periodontal ligament (PDL) is a fibrous connective tissue that anchors tooth cementum into alveolar bone. Secreted protein acidic and rich in cysteine (SPARC) is a collagen-binding matricellular protein known to influence collagen fiber assembly in the PDL. In contrast, functional properties of the N-propeptide of collagen I, encoded in exon 2 of the COL1A1 gene, are poorly understood. In this study, the PDL of collagen I exon 2-deleted (wt/ko), SPARC-null (ko/wt), and double transgenic (ko/ko) mice were evaluated in terms of cellularity, collagen area, fiber morphology, and extraction force and compared to WT (wt/wt) mice. Picro sirius red staining indicated a decrease in total PDL collagen content in each of the transgenic mice compared to WT at 1 and 3 month age points. At 12 months, only SPARCn-ull (ko/wt) and double-null PDL demonstrated less total collagen versus WT. Likewise, an increase in thin PDL collagen fibers was observed at 1 and 3 months in each transgenic, with increases only in SPARC-null and double-null mice at 12 months. The force required for tooth extraction was significantly reduced in SPARC-null versus exon 2-deleted and WT mice, whereas double-null mice demonstrated further decreases in force required for tooth extraction. The number of proliferating fibroblasts and number and size of epithelial rests of Malassez were increased in each transgenic versus WT with double-null PDL exhibiting highest levels of proliferation and rests of Malassez at 1 month of age. Consistent with increases in PDL collagen in exon-2 deleted mice, with age, numbers of rests decreased at 12 months in this genotype. These results demonstrate for the first time a functional role of the N-propeptide in regulating collagen fiber assembly and cell behavior and suggest that SPARC and the N-propeptide of collagen I have distinct activities in regulating collagen fiber assembly and fibroblast function.	[Rosset, Emilie Moore; Trombetta-eSilva, Jessica; Yao, Hai; Bradshaw, Amy Dodd] Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Hepfer, Glenn; Yao, Hai] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Bradshaw, Amy Dodd] Med Univ South Carolina, Dept Med, Gazes Cardiac Res Inst, Div Cardiol, Charleston, SC USA; [Bradshaw, Amy Dodd] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Clemson University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rosset, EM (corresponding author), Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA.	rosset@musc.edu			NIDCR NIH HHS [T32 DE017551] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE017551] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Bornstein P, 2002, MATRIX BIOL, V21, P217, DOI 10.1016/S0945-053X(02)00008-2; Bornstein P, 2002, J BIOL CHEM, V277, P2605, DOI 10.1074/jbc.m106181200; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Card L, 2010, MATRIX BIOL, V29, P559, DOI 10.1016/j.matbio.2010.08.002; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; FOUSER L, 1991, P NATL ACAD SCI USA, V88, P10158, DOI 10.1073/pnas.88.22.10158; HALILA R, 1986, AM J HUM GENET, V39, P222; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kaku M, 2014, J PROSTHODONT RES, V58, P193, DOI 10.1016/j.jpor.2014.08.003; Lee JH, 2014, J NANOMATER, V2014, DOI 10.1155/2014/567827; Li S, 2015, J PERIODONTAL RES, V50, P846, DOI 10.1111/jre.12272; LILLIE RD, 1980, VIRCHOWS ARCH A, V386, P153, DOI 10.1007/BF00427227; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; OHSHIMA S, 1989, J PERIODONTAL RES, V24, P343, DOI 10.1111/j.1600-0765.1989.tb00880.x; Oka K, 2012, EUR J ORAL SCI, V120, P484, DOI 10.1111/eos.12003; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Talic NF, 2003, AM J ORTHOD DENTOFAC, V123, P527, DOI 10.1016/S0889-5406(02)00018-5; Trombetta JM, 2010, J HISTOCHEM CYTOCHEM, V58, P871, DOI 10.1369/jhc.2010.956144; Trombetta-eSilva J, 2015, J BONE MINER RES; Trombetta-eSilva J, 2015, J BONE MINER RES, V30, P1914, DOI 10.1002/jbmr.2522; van der Pauw MT, 2001, J PERIODONTOL, V72, P1340, DOI 10.1902/jop.2001.72.10.1340; Yan Q, 2002, J CELL SCI, V115, P2747	25	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173209	10.1371/journal.pone.0173209	http://dx.doi.org/10.1371/journal.pone.0173209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245286	Green Submitted, gold, Green Published			2022-12-27	WOS:000395980200059
J	Taguchi, S; Buti, S; Fukuhara, H; Otsuka, M; Bersanelli, M; Morikawa, T; Miyazaki, H; Nakagawa, T; Fujimura, T; Kume, H; Igawa, Y; Homma, Y				Taguchi, Satoru; Buti, Sebastiano; Fukuhara, Hiroshi; Otsuka, Masafumi; Bersanelli, Melissa; Morikawa, Teppei; Miyazaki, Hideyo; Nakagawa, Tohru; Fujimura, Tetsuya; Kume, Haruki; Igawa, Yasuhiko; Homma, Yukio			Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?	PLOS ONE			English	Article							RANDOMIZED-TRIAL; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; HIGH-RISK; STAGE-II; POSTOPERATIVE RADIOTHERAPY; PHASE-III; INTERLEUKIN-2; IMMUNOCHEMOTHERAPY; ADENOCARCINOMA	Background The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. Methods We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC who underwent radical or partial nephrectomy with curative intent at our institution between 1981 and 2009. Of them, 98 (22.5%) patients received adjuvant interferon-alpha (IFN-alpha) after surgery (adjuvant IFN-alpha group), while 338 (77.5%) did not (control group). The primary endpoint was cancer-specific survival (CSS). Univariate and multivariate analyses were conducted using log-rank tests and Cox proportional hazards models, respectively. Results Fifty-two (11.9%) patients died from RCC with a median follow-up period of 96 months. Preliminary univariate analyses comparing CSS among treatment groups in each TNM setting revealed that CSS in the control group was equal or superior to that in the adjuvant IFN-a group in earlier stages, while the opposite trend was observed in more advanced stages. We evaluated the TNM cutoffs and demonstrated maximized benefit of adjuvant IFN-a in patients with pT2b-3cN0 (P = 0.0240). In multivariate analysis, >= pT3 and pN1-2 were independent predictors for poor CSS in all patients. In the subgroups with >= pT2 disease (n = 123), pN1-2 and no adjuvant treatment were significant poor prognostic factors. Conclusions Adjuvant immunotherapy after nephrectomy may be beneficial in pT2b-3cN0 RCC. Careful consideration is, however, required for interpretation of this observational study because of its selection bias and adverse effects of IFN-alpha.	[Taguchi, Satoru; Fukuhara, Hiroshi; Otsuka, Masafumi; Miyazaki, Hideyo; Nakagawa, Tohru; Fujimura, Tetsuya; Kume, Haruki; Igawa, Yasuhiko; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Buti, Sebastiano; Bersanelli, Melissa] Univ Hosp Parma, Med Oncol Unit, Parma, Italy; [Morikawa, Teppei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Parma; University Hospital of Parma; University of Tokyo	Fukuhara, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan.	hfukuhara-jua@umin.ac.jp	Buti, Sebastiano/S-1314-2017; Bersanelli, Melissa/AAA-2024-2020; Igawa, Yasuhiko/AAY-9505-2021	Buti, Sebastiano/0000-0003-0876-0226; Bersanelli, Melissa/0000-0002-6527-6281; 				Atzpodien J, 2005, BRIT J CANCER, V92, P843, DOI 10.1038/sj.bjc.6602443; Basting R, 1999, ANTICANCER RES, V19, P1545; Bex A, 2016, INT J UROL, V23, P5, DOI 10.1111/iju.12891; Buti S, 2012, ONCOL REV, V6, P145, DOI 10.4081/oncol.2012.e18; Clark JI, 2003, J CLIN ONCOL, V21, P3133, DOI 10.1200/JCO.2003.02.014; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coit DG, 2016, J NATL COMPR CANC NE, V14, P450, DOI 10.6004/jnccn.2016.0051; Di Trolio R, 2015, CYTOKINE GROWTH F R, V26, P203, DOI 10.1016/j.cytogfr.2014.11.008; Eble J. N., 2004, WHO IARC CLASSIFICAT; Edge SB, 2010, AJCC CANC STAGING MA; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Haas NB, 2016, LANCET, V387, P2008, DOI 10.1016/S0140-6736(16)00559-6; Hinotsu S, 2013, INT J CLIN ONCOL, V18, P68, DOI 10.1007/s10147-011-0345-9; Hong SK, 2005, UROLOGY, V66, P518, DOI 10.1016/j.urology.2005.04.014; KJAER M, 1987, SCAND J UROL NEPHROL, V21, P285, DOI 10.3109/00365598709180784; KJAER M, 1987, INT J RADIAT ONCOL, V13, P665, DOI 10.1016/0360-3016(87)90283-5; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Levakov Ivan, 2011, Med Pregl, V64, P173; Messing EM, 2003, J CLIN ONCOL, V21, P1214, DOI 10.1200/JCO.2003.02.005; MIGLIARI R, 1995, J CHEMOTHERAPY, V7, P240, DOI 10.1179/joc.1995.7.3.240; Motzer RJ, 2014, NCCN CLIN PRACTICE G; Passalacqua R, 2014, J IMMUNOTHER, V37, P440, DOI 10.1097/CJI.0000000000000055; Pizzocaro G, 2001, J CLIN ONCOL, V19, P425, DOI 10.1200/JCO.2001.19.2.425; Smaldone MC, 2011, HEMATOL ONCOL CLIN N, V25, P765, DOI 10.1016/j.hoc.2011.06.002; The Japanese Urological Association The Japanese Society of Pathology Japan Radiological Society, 2011, GENERAL RULE FOR CLI, P522, DOI [10.1016/j.urology.2005.04.014, DOI 10.1016/J.UROLOGY.2005.04.014]; Yap TA, 2006, CLIN GENITOURIN CANC, V5, P120, DOI 10.3816/CGC.2006.n.028	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172341	10.1371/journal.pone.0172341	http://dx.doi.org/10.1371/journal.pone.0172341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241027	Green Submitted, gold, Green Published			2022-12-27	WOS:000395934400019
J	Pareek, CS; Blaszczyk, P; Dziuba, P; Czarnik, U; Fraser, L; Sobiech, P; Pierzchala, M; Feng, YP; Kadarmideen, HN; Kumar, D				Pareek, Chandra Shekhar; Blaszczyk, Pawel; Dziuba, Piotr; Czarnik, Urszula; Fraser, Leyland; Sobiech, Przemyslaw; Pierzchala, Mariusz; Feng, Yaping; Kadarmideen, Haja N.; Kumar, Dibyendu			Single nucleotide polymorphism discovery in bovine liver using RNA-seq technology	PLOS ONE			English	Article							GENOMIC SELECTION; TRANSCRIPTOME; GENE; CATTLE; ASSOCIATION; EXPRESSION; GENERATION; SEQUENCE; DESIGN	Background RNA-seq is a useful next-generation sequencing (NGS) technology that has been widely used to understand mammalian transcriptome architecture and function. In this study, a breed-specific RNA-seq experiment was utilized to detect putative single nucleotide polymorphisms (SNPs) in liver tissue of young bulls of the Polish Red, Polish Holstein-Friesian (HF) and Hereford breeds, and to understand the genomic variation in the three cattle breeds that may reflect differences in production traits. Results The RNA-seq experiment on bovine liver produced 107,114,4072 raw paired-end reads, with an average of approximately 60 million paired-end reads per library. Breed-wise, a total of 345.06, 290.04 and 436.03 million paired-end reads were obtained from the Polish Red, Polish HF, and Hereford breeds, respectively. Burrows-Wheeler Aligner (BWA) read alignments showed that 81.35%, 82.81% and 84.21% of the mapped sequencing reads were properly paired to the Polish Red, Polish HF, and Hereford breeds, respectively. This study identified 5,641,401 SNPs and insertion and deletion (indel) positions expressed in the bovine liver with an average of 313,411 SNPs and indel per young bull. Following the removal of the indel mutations, a total of 195,3804, 152,7120 and 205,3184 raw SNPs expressed in bovine liver were identified for the Polish Red, Polish HF, and Hereford breeds, respectively. Breed-wise, three highly reliable breed-specific SNP-databases (SNP-dbs) with 31,562, 24,945 and 28,194 SNP records were constructed for the Polish Red, Polish HF, and Hereford breeds, respectively. Using a combination of stringent parameters of a minimum depth of >= 10 mapping reads that support the polymorphic nucleotide base and 100% SNP ratio, 4,368, 3,780 and 3,800 SNP records were detected in the Polish Red, Polish HF, and Hereford breeds, respectively. The SNP detections using RNA-seq data were successfully validated by kompetitive allele-specific PCR (KASP TM) SNP genotyping assay. The comprehensive QTL/CG analysis of 110 QTL/CG with RNA-seq data identified 20 monomorphic SNP hit loci (CARTPT, GAD1, GDF5, GHRH, GHRL, GRB10, IGFBPL1, IGFL1, LEP, LHX4, MC4R, MSTN, NKAIN1, PLAG1, POU1F1, SDR16C5, SH2B2, TOX, UCP3 and WNT10B) in all three cattle breeds. However, six SNP loci (CCSER1, GHR, KCNIP4, MTSS1, EGFR and NSMCE2) were identified as highly polymorphic among the cattle breeds. Conclusions This study identified breed-specific SNPs with greater SNP ratio and excellent mapping coverage, as well as monomorphic and highly polymorphic putative SNP loci within QTL/CGs of bovine liver tissue. A breed-specific SNP-db constructed for bovine liver yielded nearly six million SNPs. In addition, a KASP TM SNP genotyping assay, as a reliable cost-effective method, successfully validated the breed-specific putative SNPs originating from the RNAseq experiments.	[Pareek, Chandra Shekhar; Blaszczyk, Pawel; Dziuba, Piotr] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Div Funct Genom Biol & Biomed Res, Torun, Poland; [Blaszczyk, Pawel] Nicolaus Copernicus Univ, Fac Biol & Environm Protect, Torun, Poland; [Czarnik, Urszula; Fraser, Leyland] Univ Warmia & Mazury, Fac Anim Bioengn, Olsztyn, Poland; [Sobiech, Przemyslaw] Univ Warmia & Mazury, Fac Vet Med, Olsztyn, Poland; [Pierzchala, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Feng, Yaping; Kumar, Dibyendu] Rutgers State Univ, Waksman Inst Microbiol, Piscataway Township, NJ USA; [Kadarmideen, Haja N.] Tech Univ Denmark, Dept Bio & Hlth Informat, Lyngby, Denmark	Nicolaus Copernicus University; Nicolaus Copernicus University; University of Warmia & Mazury; University of Warmia & Mazury; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Rutgers State University New Brunswick; Technical University of Denmark	Pareek, CS (corresponding author), Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Div Funct Genom Biol & Biomed Res, Torun, Poland.	pareekcs@umk.pl	pareek, chandra/M-2751-2014; Pierzchala, Mariusz/G-1052-2013	pareek, chandra/0000-0002-0329-787X; Pierzchala, Mariusz/0000-0001-7001-1336; Czarnik, Urszula/0000-0002-9065-2197; Kadarmideen, Haja/0000-0001-6294-382X; Fraser, Leyland/0000-0002-2997-9991	National Science Centre, Krakow, Poland [2012/05/B/NZ2/01629]	National Science Centre, Krakow, Poland	This research paper was financially supported by National Science Centre, Krakow, Poland, Project No. 2012/05/B/NZ2/01629, entitled Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji.	Alexandre PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2292-8; Alnasir J, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0064-7; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137087; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; Djari A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-307; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; GEORGES M, 1995, GENETICS, V139, P907; Ghosh M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0341-1; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Huang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030244; Iheshiulor OOM, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0193-1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kogelman LJA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0229-0; Koringa PG, 2013, GENE, V530, P119, DOI 10.1016/j.gene.2013.07.061; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Martinez-Montes AM, ANIM GENET; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; Pareek CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161370; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Roy M, 2013, MAMM GENOME, V24, P484, DOI 10.1007/s00335-013-9480-0; Seo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24375; Suravajhala P, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0217-x; van Dorland HA, 2013, SCHWEIZ ARCH TIERH, V155, P443, DOI 10.1024/0036-7281/a000490; Villanueva B, 2004, J ANIM SCI, V82, P1305; Wang L, 2015, ASIAN AUSTRAL J ANIM, V28, P1235, DOI 10.5713/ajas.15.0172; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113881	41	7	7	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172687	10.1371/journal.pone.0172687	http://dx.doi.org/10.1371/journal.pone.0172687			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234981	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200116
J	James, AK; Passow, U; Brzezinski, MA; Parsons, RJ; Trapani, JN; Carlson, CA				James, Anna K.; Passow, Uta; Brzezinski, Mark A.; Parsons, Rachel J.; Trapani, Jennifer N.; Carlson, Craig A.			Elevated pCO(2) enhances bacterioplankton removal of organic carbon	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GROWTH EFFICIENCY; OCEAN; SEAWATER; ACIDIFICATION; MATTER; CO2; PICOPLANKTON; MICROBES; DYNAMICS	Factors that affect the removal of organic carbon by heterotrophic bacterioplankton can impact the rate and magnitude of organic carbon loss in the ocean through the conversion of a portion of consumed organic carbon to CO2. Through enhanced rates of consumption, surface bacterioplankton communities can also reduce the amount of dissolved organic carbon (DOC) available for export from the surface ocean. The present study investigated the direct effects of elevated pCO(2) on bacterioplankton removal of several forms of DOC ranging from glucose to complex phytoplankton exudate and lysate, and naturally occurring DOC. Elevated pCO(2) (1000-1500 ppm) enhanced both the rate and magnitude of organic carbon removal by bacterioplankton communities compared to low (pre-industrial and ambient) pCO(2) (250-similar to 400 ppm). The increased removal was largely due to enhanced respiration, rather than enhanced production of bacterioplankton biomass. The results suggest that elevated pCO2 can increase DOC consumption and decrease bacterioplankton growth efficiency, ultimately decreasing the amount of DOC available for vertical export and increasing the production of CO2 in the surface ocean.	[James, Anna K.; Passow, Uta; Brzezinski, Mark A.; Carlson, Craig A.] Univ Calif Santa Barbara, Inst Marine Sci, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Parsons, Rachel J.; Trapani, Jennifer N.] BIOS, St Georges, Bermuda	University of California System; University of California Santa Barbara	James, AK (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	anna.james.k@gmail.com	Parsons, Rachel J/B-1475-2016	Parsons, Rachel/0000-0003-3634-8220	NSF [OCE 1041038, OCE 12-36905, OCE 1156626, OCE 1232779]; Division Of Ocean Sciences [1538428, 1436748] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	NSF OCE 1041038 - awarded to Uta Passow, Craig A Carlson, and Mark A Brzezinski NSF OCE 12-36905 - awarded to the Moorea Coral Reef LTER Simons Foundation International awarded to Craig A Carlson NSF OCE 1156626 awarded to Rachel A Parsons and Jennifer N Trapani NSF OCE 1232779 - awarded to the Santa Barbara Channel LTER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN JW, 1984, MAR ECOL PROG SER, V18, P31, DOI 10.3354/meps018031; [Anonymous], 2012, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-9-989-2012; Arnosti C, 2011, ANN REV MAR SCI; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bunse C, 2016, NATURE CLIM CHANGE; Carlson CA, 1999, AQUAT MICROB ECOL, V19, P229, DOI 10.3354/ame019229; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Cherrier J, 1996, MAR ECOL PROG SER, V139, P267, DOI 10.3354/meps139267; CHROST RJ, 1991, BROCK SPR S, P29; Del Giorgio P.A., 2000, MICROBIAL ECOLOGY OC, P289, DOI DOI 10.1146/ANNUREV.ECOLSYS.29.1.503; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Engel A, 2004, AQUAT MICROB ECOL; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; First MR, 2009, AQUAT MICROB ECOL, V57, P79, DOI 10.3354/ame01338; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Hales B, 2004, LIMNOL OCEANOGR-METH, V2, P356, DOI 10.4319/lom.2004.2.356; Halewood ER, 2012, AQUAT MICROB ECOL, V67, P189, DOI 10.3354/ame01586; Hansell DA, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P1; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hoppe HG, 1983, MAR ECOL PROG SER; Jiao N, 2011, MICROBIAL CARBON PUM; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; KING GM, 1986, APPL ENVIRON MICROB, V51, P373, DOI 10.1128/AEM.51.2.373-380.1986; LEGENDRE L, 1988, MAR ECOL PROG SER, V47, P153, DOI 10.3354/meps047153; Letscher R.T., 2015, MAR CHEM; Lomas MW, 2013, DEEP-SEA RES PT II, V93, P16, DOI 10.1016/j.dsr2.2013.01.008; Mass EW, 2013, AQUAT MICROB ECOL; Motegi C, 2013, BIOGEOSCIENCES, V10, P3285, DOI 10.5194/bg-10-3285-2013; MUNSTER U, 1991, BROCK SPR S, P96; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; Oliver AE, 2014, ENV MICROBIOL REP, V6, P574, DOI 10.1111/1758-2229.12159; Parsons RJ, 2014, ENV MICROBIOL; Passow U, 2012, MAR ECOL PROG SER; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Riebessell U, 2013, BIOGEOSCIENCES; Robbins L, 2010, 20101280 US GEOL SUR, V7, DOI DOI 10.1007/978-3-642-52335-9_1; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Roy AS, 2013, BIOGEOSCIENCES, V10, P555, DOI 10.5194/bg-10-555-2013; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; Sintes E, 2013, FEMS MICROBIOL ECOL, V83, P413, DOI 10.1111/1574-6941.12003; Siu N., 2014, OPEN J ECOL, V4, P434, DOI DOI 10.4236/oje.2014.48038; Sperling M, 2013, BIOGEOSCIENCES, V10, P181, DOI 10.5194/bg-10-181-2013; Taucher J, 2015, LIMNOL OCEANOGR; Tranvik LJ, 1993, COLLECTIONS; Wear EK, 2015, LIMNOL OCEANOGR, P1; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhang R, 2013, BIOGEOSCIENCES, V10, P3679, DOI 10.5194/bg-10-3679-2013	66	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173145	10.1371/journal.pone.0173145	http://dx.doi.org/10.1371/journal.pone.0173145			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257422	gold, Green Submitted, Green Published			2022-12-27	WOS:000396021100066
J	Nielson, JL; Cooper, SR; Yue, JK; Sorani, MD; Inoue, T; Yuh, EL; Mukherjee, P; Petrossian, TC; Paquette, J; Lum, PY; Carlsson, GE; Vassar, MJ; Lingsma, HF; Gordon, WA; Valadka, AB; Okonkwo, DO; Manley, GT; Ferguson, AR				Nielson, Jessica L.; Cooper, Shelly R.; Yue, John K.; Sorani, Marco D.; Inoue, Tomoo; Yuh, Esther L.; Mukherjee, Pratik; Petrossian, Tanya C.; Paquette, Jesse; Lum, Pek Y.; Carlsson, Gunnar E.; Vassar, Mary J.; Lingsma, Hester F.; Gordon, Wayne A.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.; Ferguson, Adam R.		TRACK-TBI Investigators	Uncovering precision phenotype-biomarker associations in traumatic brain injury using topological data analysis	PLOS ONE			English	Article							COMMON DATA ELEMENTS; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; POLYMORPHISM; COMT; CLASSIFICATION; PREDICTION; PROTEIN	Background Traumatic brain injury (TBI) is a complex disorder that is traditionally stratified based on clinical signs and symptoms. Recent imaging and molecular biomarker innovations provide unprecedented opportunities for improved TBI precision medicine, incorporating patho-ana-tomical and molecular mechanisms. Complete integration of these diverse data for TBI diag-nosis and patient stratification remains an unmet challenge. Methods and findings The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot multicenter study enrolled 586 acute TBI patients and collected diverse common data elements (TBI-CDEs) across the study population, including imaging, genetics, and clinical outcomes. We then applied topology-based data-driven discovery to identify natural sub-groups of patients, based on the TBI-CDEs collected. Our hypothesis was two-fold: 1) A machine learning tool known as topological data analysis (TDA) would reveal data-driven patterns in patient outcomes to identify candidate biomarkers of recovery, and 2) TDA-iden-tified biomarkers would significantly predict patient outcome recovery after TBI using more traditional methods of univariate statistical tests. TDA algorithms organized and mapped the data of TBI patients in multidimensional space, identifying a subset of mild TBI patients with a specific multivariate phenotype associated with unfavorable outcome at 3 and 6 months after injury. Further analyses revealed that this patient subset had high rates of post-trau-matic stress disorder (PTSD), and enrichment in several distinct genetic polymorphisms associated with cellular responses to stress and DNA damage (PARP1), and in striatal dopamine processing (ANKK1, COMT, DRD2). Conclusions TDA identified a unique diagnostic subgroup of patients with unfavorable outcome after mild TBI that were significantly predicted by the presence of specific genetic polymorphisms. Machine learning methods such as TDA may provide a robust method for patient stratifica-tion and treatment planning targeting identified biomarkers in future clinical trials in TBI patients.	[Nielson, Jessica L.; Cooper, Shelly R.; Yue, John K.; Inoue, Tomoo; Vassar, Mary J.; Manley, Geoffrey T.; Ferguson, Adam R.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94110 USA; [Nielson, Jessica L.; Cooper, Shelly R.; Yue, John K.; Sorani, Marco D.; Inoue, Tomoo; Vassar, Mary J.; Manley, Geoffrey T.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Cooper, Shelly R.; Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Petrossian, Tanya C.; Paquette, Jesse; Lum, Pek Y.; Carlsson, Gunnar E.] Ayasdi Inc, Palo Alto, CA USA; [Lingsma, Hester F.] Erasmus MC, Publ Hlth, Rotterdam, Netherlands; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA; [Ferguson, Adam R.] San Francisco VA Med Ctr, Dept Vet Affairs, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Manley, GT; Ferguson, AR (corresponding author), Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94110 USA.; Manley, GT; Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Ferguson, AR (corresponding author), San Francisco VA Med Ctr, Dept Vet Affairs, San Francisco, CA 94121 USA.	manleyg@neurosurg.ucsf.edu; adam.ferguson@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Petrossian, Tanya/0000-0002-1205-9144; Badjatia, Neeraj/0000-0003-1509-9034; Hemphill, Claude/0000-0003-4019-7525; Wang, Kevin/0000-0002-9343-6473; Ferguson, Adam/0000-0001-7102-1608; Nielson, Jessica/0000-0002-3677-3959; Schnyer, David/0000-0002-7472-2853; Cooper, Shelly/0000-0003-0026-6688; Stein, Deborah/0000-0003-3683-3963; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Markowitz, Amy/0000-0001-9314-2814; Martin, Alastair/0000-0002-7963-4000; Bodien, Yelena/0000-0003-4858-2903	Department of Defense (DoD) [W81XWH-131-0441]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [NS067092, NS069409, NS069409-0251]; Craig H. Neilsen Foundation (ARF); Wings for Life Foundation (ARF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086090, R01NS067092] Funding Source: NIH RePORTER	Department of Defense (DoD)(United States Department of Defense); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Craig H. Neilsen Foundation (ARF); Wings for Life Foundation (ARF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the following: Department of Defense (DoD) grant W81XWH-131-0441 (GTM): http://cdmrp.army.mil/funding/phtbi.shtml; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grants NS067092 (ARF), NS069409 (GTM) and NS069409-0251 (GTM): http://www.runds.nih.govt/; Craig H. Neilsen Foundation (ARF): http://chnfoundation.org/; and Wings for Life Foundation (ARF): http://www.wingsforlrie.com/en/.	Benedetti F, 2009, PSYCHOPHARMACOLOGY, V203, P155, DOI 10.1007/s00213-008-1381-7; Bodenmann S, 2009, CLIN PHARMACOL THER, V85, P296, DOI 10.1038/clpt.2008.222; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; CDC, GET FACTS CONC TRAUM; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chan JM, 2013, P NATL ACAD SCI USA, V110, P18566, DOI 10.1073/pnas.1313480110; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kyeong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137296; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lum PY, 2013, SCI REP, V3, P1518; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marshall Lawrence F., 2009, J NEUROSURGERY PUBLI; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Romano D, 2014, HUM BRAIN MAPP, V35, P4904, DOI 10.1002/hbm.22521; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sarikonda G, 2014, J AUTOIMMUNITY; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; The National Institute of Neurlogical Disorders and Stroke, 2015, NINDS COMM DAT EL TR; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Yue JK, 2016, NEUROGENETICS; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	41	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0169490	10.1371/journal.pone.0169490	http://dx.doi.org/10.1371/journal.pone.0169490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257413	Green Published, gold			2022-12-27	WOS:000396021100002
J	Ibanez, MI; Cabello, P; Luque-Almagro, VM; Saez, LP; Olaya, A; de Medina, VS; de Castro, MDL; Moreno-Vivian, C; Roldan, MD				Isabel Ibanez, Maria; Cabello, Purificacion; Manuel Luque-Almagro, Victor; Saez, Lara P.; Olaya, Alfonso; Sanchez de Medina, Veronica; Luque de Castro, Maria Dolores; Moreno-Vivian, Conrado; Dolores Roldan, Maria			Quantitative proteomic analysis of Pseudomonas pseudoalcaligenes CECT5344 in response to industrial cyanide-containing wastewaters using Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS)	PLOS ONE			English	Article							METAL-COMPLEXED CYANIDES; FLOW-INJECTION; GENOME SEQUENCE; ESCHERICHIA-COLI; WASTE-WATER; DEGRADATION; BIODEGRADATION; SIDEROPHORES; DESTRUCTION; RESISTANCE	Biological treatments to degrade cyanide are a powerful technology for cyanide removal from industrial wastewaters. It has been previously demonstrated that the alkaliphilic bacterium Pseudomonas pseudoalcaligenes CECT5344 is able to use free cyanide and several metal -cyanide complexes as the sole nitrogen source. In this work, the strain CECT5344 has been used for detoxification of the different chemical forms of cyanide that are present in alkaline wastewaters from the jewelry industry. This liquid residue also contains large concentrations of metals like iron, copper and zinc, making this wastewater even more toxic. To elucidate the molecular mechanisms involved in the bioremediation process, a quantitative proteomic analysis by LC-MS/MS has been carried out in P. pseudoalcaligenes CECT5344 cells grown with the jewelry residue as sole nitrogen source. Different proteins related to cyanide and cyanate assimilation, as well as other proteins involved in transport and resistance to metals were induced by the cyanide-containing jewelry residue. GntR-like regulatory proteins were also induced by this industrial residue and mutational analysis revealed that GntR-like regulatory proteins may play a role in the regulation of cyanide assimilation in P. pseudoalcaligenes CECT5344. The strain CECT5344 has been used in a batch reactor to remove at pH 9 the different forms of cyanide present in industrial wastewaters from the jewelry industry (0.3 g/L, ca. 12 mM total cyanide, including both free cyanide and metal-cyanide complexes). This is the first report describing the biological removal at alkaline pH of such as elevated concentration of cyanide present in a heterogeneous mixture from an industrial source.	[Isabel Ibanez, Maria; Manuel Luque-Almagro, Victor; Saez, Lara P.; Olaya, Alfonso; Moreno-Vivian, Conrado; Dolores Roldan, Maria] Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain; [Cabello, Purificacion] Univ Cordoba, Dept Bot Ecol & Fisiol Vegetal, Edificio Celestino Mutis,Campus Rabanales, Cordoba, Spain; [Sanchez de Medina, Veronica; Luque de Castro, Maria Dolores] Univ Cordoba, Dept Quim Analit, Edificio Marie Curie,Campus Rabanales, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba	Roldan, MD (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain.	bb2rorum@uco.es	Luque-Almagro, Victor M./A-3516-2011; Cabello, Purificación/K-2805-2014; Moreno, Conrado/K-3976-2014; Roldán Ruiz, María Dolores/K-4370-2014	Roldán Ruiz, María Dolores/0000-0001-7173-8641; Luque-Almagro, Victor M./0000-0003-1447-4795	Ministerio de Economia y Competitividad [BIO2015-64311-R]; FEDER, UE; Junta de Andalucia, Spain [CVI-7560]	Ministerio de Economia y Competitividad(Spanish Government); FEDER, UE(European Commission); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was funded by Grant BIO2015-64311-R (Ministerio de Economia y Competitividad and FEDER, UE), and Grant CVI-7560 (Junta de Andalucia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; Akcil A, 2003, BIOTECHNOL LETT, V25, P445, DOI 10.1023/A:1022608213814; Akcil A, 2003, BIOTECHNOL ADV, V21, P501, DOI 10.1016/S0734-9750(03)00099-5; Akcil A, 2003, MINER ENG, V16, P643, DOI 10.1016/S0892-6875(03)00101-8; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ASHCROFT JR, 1975, BIOCHEM J, V148, P349, DOI 10.1042/bj1480349; ASMUS E, 1953, FRESEN Z ANAL CHEM, V138, P414, DOI 10.1007/BF00461093; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051; DUBEY SK, 1995, WORLD J MICROB BIOT, V11, P257, DOI 10.1007/BF00367095; Dulermo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124358; Ebbs S, 2004, CURR OPIN BIOTECH, V15, P231, DOI 10.1016/j.copbio.2004.03.006; Estepa J, 2012, ENV MICROBIOL REP, V4, P326, DOI 10.1111/j.1758-2229.2012.00337.x; FRENZEL W, 1990, ANAL CHIM ACTA, V233, P77, DOI 10.1016/S0003-2670(00)83463-7; Gijzen HJ, 2000, WATER RES, V34, P2447, DOI 10.1016/S0043-1354(99)00418-2; Goncalves MMM, 1998, ENVIRON TECHNOL, V19, P133, DOI 10.1080/09593331908616665; GUERINOT ML, 1990, J BACTERIOL, V172, P3298, DOI 10.1128/jb.172.6.3298-3303.1990; Gupta N, 2010, J HAZARD MATER, V176, P1, DOI 10.1016/j.jhazmat.2009.11.038; Gurbuz F, 2004, HYDROMETALLURGY, V72, P167, DOI 10.1016/j.hydromet.2003.10.004; Gurbuz F, 2009, J HAZARD MATER, V162, P74, DOI 10.1016/j.jhazmat.2008.05.008; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Huertas MJ, 2010, J HAZARD MATER, V179, P72, DOI 10.1016/j.jhazmat.2010.02.059; Huertas MJ, 2006, BIOCHEM SOC T, V34, P152, DOI 10.1042/BST0340152; Hynninen A, 2009, MOL MICROBIOL, V74, P384, DOI 10.1111/j.1365-2958.2009.06868.x; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kavanaugh M., 2003, CYANIDE FORMATION FA; Luque-Almagro VM, 2015, J BIOTECHNOL, V214, P171, DOI 10.1016/j.jbiotec.2015.09.032; Luque-Almagro VM, 2008, APPL ENVIRON MICROB, V74, P6280, DOI 10.1128/AEM.00916-08; Luque-Almagro VM, 2007, ENVIRON MICROBIOL, V9, P1541, DOI 10.1111/j.1462-2920.2007.01274.x; Luque-Almagro VM, 2016, CURR OPIN BIOTECH, V38, P9, DOI 10.1016/j.copbio.2015.12.004; Luque-Almagro VM, 2013, ENVIRON MICROBIOL, V15, P253, DOI 10.1111/j.1462-2920.2012.02875.x; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P269, DOI 10.1042/BST0390269; Luque-Almagro VM, 2011, MICROBIOL-SGM, V157, P739, DOI 10.1099/mic.0.045286-0; Luque-Almagro VM, 2005, BIOCHEM SOC T, V33, P168, DOI 10.1042/BST0330168; Luque-Almagro VM, 2005, APPL ENVIRON MICROB, V71, P940, DOI 10.1128/AEM.71.2.940-947.2005; Manat G, 2014, MICROB DRUG RESIST, V20, P199, DOI 10.1089/mdr.2014.0035; Cobos IM, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0267-8; MILOSAVLJEVIC EB, 1995, ENVIRON SCI TECHNOL, V29, P426, DOI 10.1021/es00002a019; MORRISON GR, 1971, ANAL BIOCHEM, V43, P527, DOI 10.1016/0003-2697(71)90283-1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Papaefstathiou I, 1996, FRESEN J ANAL CHEM, V354, P442; Patil YB, 2000, PROCESS BIOCHEM, V35, P1139, DOI 10.1016/S0032-9592(00)00150-3; Patil YB, 2000, LETT APPL MICROBIOL, V30, P33, DOI 10.1046/j.1472-765x.2000.00648.x; Quan ZX, 2006, J MICROBIOL BIOTECHN, V16, P232; Quesada A, 2007, APPL ENVIRON MICROB, V73, P5118, DOI 10.1128/AEM.00503-07; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Sambrook J., 2001, MOL CLONING LAB MANU; SHAKIR FK, 1994, ANAL BIOCHEM, V216, P232, DOI 10.1006/abio.1994.1031; Snell FD, 1949, COLORIMETRIC METHODS; Sulistyarti H, 1999, ANAL CHIM ACTA, V390, P133, DOI 10.1016/S0003-2670(99)00158-0; Sulistyarti H, 1997, ANAL CHIM ACTA, V357, P103, DOI 10.1016/S0003-2670(97)00518-7; Truong-Bolduc QC, 2011, J BACTERIOL, V193, P6207, DOI 10.1128/JB.05847-11; Vallejo-Pecharroman B, 1999, ANALYST, V124, P1261, DOI 10.1039/a902443c; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wibberg D, 2016, J BIOTECHNOL, V232, P61, DOI 10.1016/j.jbiotec.2016.04.008; Wibberg D, 2014, J BIOTECHNOL, V175, P67, DOI 10.1016/j.jbiotec.2014.02.004; Zhou X, 2016, MOL PLANT PATHOL	61	15	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172908	10.1371/journal.pone.0172908	http://dx.doi.org/10.1371/journal.pone.0172908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253357	Green Published, gold			2022-12-27	WOS:000396011300045
J	Marchand, V; Charlier, N; Verrax, J; Buc-Calderon, P; Leveque, P; Gallez, B				Marchand, Valerie; Charlier, Nicolas; Verrax, Julien; Buc-Calderon, Pedro; Leveque, Philippe; Gallez, Bernard			Use of a cocktail of spin traps for fingerprinting large range of free radicals in biological systems	PLOS ONE			English	Article							DNA RADICALS; HYDROGEN-PEROXIDE; IN-VIVO; CELLS; HEPATOCYTES; SUPEROXIDE; METABOLISM; MECHANISMS; STABILITY; HYDROXYL	It is well established that the formation of radical species centered on various atoms is involved in the mechanism leading to the development of several diseases or to the appearance of deleterious effects of toxic molecules. The detection of free radical is possible using Electron Paramagnetic Resonance (EPR) spectroscopy and the spin trapping technique. The classical EPR spin-trapping technique can be considered as a "hypothesis-driven" approach because it requires an a priori assumption regarding the nature of the free radical in order to select the most appropriate spin-trap. We here describe a "data-driven" approach using EPR and a cocktail of spin-traps. The rationale for using this cocktail was that it would cover a wide range of biologically relevant free radicals and have a large range of hydrophilicity and lipophilicity in order to trap free radicals produced in different cellular compartments. As a proof-of-concept, we validated the ability of the system to measure a large variety of free radicals (O-, N-, C-, or S-centered) in well characterized conditions, and we illustrated the ability of the technique to unambiguously detect free radical production in cells exposed to chemicals known to be radical-mediated toxic agents.	[Marchand, Valerie; Charlier, Nicolas; Leveque, Philippe; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, Brussels, Belgium; [Verrax, Julien; Buc-Calderon, Pedro] Catholic Univ Louvain, Louvain Drug Res Inst, Toxicol & Canc Biol Res Grp, Brussels, Belgium; [Buc-Calderon, Pedro] Univ Arturo Prat, Fac Ciencias Salud, Iquique, Chile	Universite Catholique Louvain; Universite Catholique Louvain; Universidad Arturo Prat	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, Brussels, Belgium.	bernard.Gallez@uclouvain.be			Belgian National Fund for Scientific Research (FNRS); Televie; Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Televie; Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC	This work is supported by grants from the Belgian National Fund for Scientific Research (FNRS), the Televie, the "Actions de Recherches Concertees-Communaute Francaise de Belgique-ARC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A., 2008, SPIN TRAPPING ELECT, P285; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Davies MJ., 2008, ELECT PARAMAGNETIC R, P427; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; Fontmorin JM, 2016, WATER RES, V99, P24, DOI 10.1016/j.watres.2016.04.053; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008; HANNA PM, 1992, ARCH BIOCHEM BIOPHYS, V296, P640, DOI 10.1016/0003-9861(92)90620-C; Hix S, 2000, CHEM RES TOXICOL, V13, P1056, DOI 10.1021/tx000130l; Irwin ME, 2013, ANTIOXID REDOX SIGN, V18, P1349, DOI 10.1089/ars.2011.4258; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Khan N, 2003, FREE RADICAL BIO MED, V34, P1473, DOI 10.1016/S0891-5849(03)00182-5; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Leinisch F, 2011, CHEM RES TOXICOL, V24, P2217, DOI 10.1021/tx2003323; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Olive G, 2000, FREE RADICAL BIO MED, V28, P403, DOI 10.1016/S0891-5849(99)00254-3; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2006, NAT METHODS, V3, P123, DOI 10.1038/NMETH852; Ranguelova K, 2011, MAGN RESON CHEM, V49, P152, DOI 10.1002/mrc.2709; RUBIN R, 1984, ARCH BIOCHEM BIOPHYS, V228, P450, DOI 10.1016/0003-9861(84)90010-9; SINHA BK, 1983, J BIOL CHEM, V258, P796; THOR H, 1982, J BIOL CHEM, V257, P2419; TIMMINS GS, 1993, CARCINOGENESIS, V14, P1615, DOI 10.1093/carcin/14.8.1615; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; YAMAGUCHI S, 1994, FREE RADICAL BIO MED, V17, P389, DOI 10.1016/0891-5849(94)90165-1	30	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172998	10.1371/journal.pone.0172998	http://dx.doi.org/10.1371/journal.pone.0172998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253308	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300056
J	Nabeta, P; Havumaki, J; Ha, DTM; Caceres, T; Hang, PT; Collantes, J; Lan, NTN; Gotuzzo, E; Denkinger, CM				Nabeta, Pamela; Havumaki, Joshua; Dang Thi Minh Ha; Caceres, Tatiana; Pham Thu Hang; Collantes, Jimena; Nguyen Thi Ngoc Lan; Gotuzzo, Eduardo; Denkinger, Claudia M.			Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; FLUORESCENCE	Background Improved and affordable diagnostic or triage tests are urgently needed at the microscopy centre level. Automated digital microscopy has the potential to overcome issues related to conventional microscopy, including training time requirement and inconsistencies in results interpretation. Methods For this blinded prospective study, sputum samples were collected from adults with presumptive pulmonary tuberculosis in Lima, Peru and Ho Chi Minh City, Vietnam. TBDx performance was evaluated as a stand-alone and as a triage test against conventional microscopy and Xpert, with culture as the reference standard. Xpert was used to confirm positive cases. Findings A total of 613 subjects were enrolled between October 2014 and March 2015, with 539 included in the final analysis. The sensitivity of TBDx was 62-2% (95% CI 56.6-67.4) and specificity was 90.7% (95% CI 85.9-94.2) compared to culture. The algorithm assessing TBDx as a triage test achieved a specificity of 100% while maintaining sensitivity. Interpretation While the diagnostic performance of TBDx did not reach the levels obtained by experienced microscopists in reference laboratories, it is conceivable that it would exceed the performance of less experienced microscopists. In the absence of highly sensitive and specific molecular tests at the microscopy centre level, TBDx in a triage-testing algorithm would optimize specificity and limit overall cost without compromising the number of patients receiving up-front drug susceptibility testing for rifampicin. However, the algorithm would miss over one third of patients compared to Xpert alone.	[Nabeta, Pamela; Havumaki, Joshua; Denkinger, Claudia M.] FIND, Geneva, Switzerland; [Dang Thi Minh Ha; Pham Thu Hang; Nguyen Thi Ngoc Lan] Pham Ngoc Thach Hosp, TB Dept, Ho Chi Minh City, Vietnam; [Caceres, Tatiana; Collantes, Jimena; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru	Foundation For Innovative New Diagnostics; Universidad Peruana Cayetano Heredia	Nabeta, P (corresponding author), FIND, Geneva, Switzerland.	pamela.nabeta@finddx.org		CACERES, TATIANA/0000-0003-0516-5202	FIND; Department for International Development UK [204074-101]; Australian Agency for International Development [70957]; Bill and Melinda Gates Foundation [OPP1018924]	FIND; Department for International Development UK; Australian Agency for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	FIND funded the study, who in turn received funding from: Department for International Development UK (grant no. 204074-101) https://www.gov.uk/government/organisations/department-for-international-development, Australian Agency for International Development (grant no. 70957) http://dfat.gov.au/aid/pages/australias-aid-program.aspx, Bill and Melinda Gates Foundation (grant no. OPP1018924) http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WORLDS MOST PORT MOL; Cavanaugh JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152364; Chang J, 2012, LECT NOTES COMPUT SC, V7512, P345, DOI 10.1007/978-3-642-33454-2_43; Denkinger CM, 2015, J INFECT DIS, V211, pS39, DOI 10.1093/infdis/jiu682; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Ismail NA, 2015, AM J RESP CRIT CARE, V191, P1443, DOI 10.1164/rccm.201502-0390OC; Jha S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157554; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lewis JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050173; Lumb R, 2013, LAB DIAGNOSIS TUBERC, P3; Miotto P, 2012, EUR RESPIR J, V39, P1269, DOI 10.1183/09031936.00124711; Pantoja A, 2015, J INFECT DIS, V211, pS67, DOI 10.1093/infdis/jiu820; Siddiqi SH, 2006, MGIT BACTEC MGIT 960; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2013, POL UPD XPERT MTB RI; World Health Organization, 2014, HIGH PRIOR TARG PROD; World Health Organization, 2012, NAT EHLTH STRAT TOOL; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R; World Health Organization (WHO), 2012, TUB LAB BIOS MAN	23	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173092	10.1371/journal.pone.0173092	http://dx.doi.org/10.1371/journal.pone.0173092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253302	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300070
J	Shahzad, H; Giribabu, N; Karim, K; Kassim, NM; Muniandy, S; Salleh, N				Shahzad, Huma; Giribabu, Nelli; Karim, Kamarulzaman; Kassim, Normadiah M.; Muniandy, Sekaran; Salleh, Naguib			Combinatorial effects of quercetin and sex-steroids on fluid and electrolytes' (Na+, Cl-, HCO3-) secretory mechanisms in the uterus of ovariectomised female Sprague-Dawley rats	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; PROLIFERATIVE CHANGES; ADENYLYL-CYCLASE; EXPRESSION; ESTROGEN; CELLS; CFTR; PROGESTERONE; GENISTEIN; IMPLANTATION	Dysregulation of uterine fluid environment could impair successful reproduction and this could be due to the effect of environmental estrogens. Therefore, in this study, effect of quercetin, an environmental estrogen on uterine fluid and electrolytes concentrations were investigated under sex-steroid influence. Ovariectomised adult female Sprague-Dawley rats were given 10, 50 or 100mg/kg/day quercetin subcutaneously with 17-beta estradiol (E) for seven days or three days E, then three days E plus progesterone (P) (E+P) treatment. Uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations were determined by in-vivo perfusion. Following sacrifice, uteri were harvested and levels of the proteins of interest were identified by Western blotting and Realtime PCR. Distribution of these proteins in the uterus was observed by immunofluorescence. Levels of uterine cAMP were measured by enzyme-linked immunoassay (EIA). Administration of quercetin at increasing doses increased uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations, but to the levels lesser than that of E. In concordant, levels of CFTR, SLC4A4, ENaC (alpha, beta and gamma), Na+/K+-ATPase, GP alpha/beta, AC and cAMP in the uterus increased following increased in the doses of quercetin. Co-administration of quercetin with E caused uterine fluid secretion rate, Na+, Cl- and HCO3- concentrations to decrease. In concordant, uterine CFTR, SLC26A6, SLC4A4, ENaC (alpha, beta and.), Na+/K+-ATPase, GP alpha/beta, AC and cAMP decreased. Greatest effects were observed following co-administration of 10mg/kg/day quercetin with E. Co-administration of quercetin with E+P caused uterine fluid Na+ and HCO3- concentrations to increase but no changes in fluid secretion rate and Cl- concentration were observed. Co-administration of high dose quercetin (100 mg/kg/day) with E+P caused uterine CFTR, SLC26A6, AC, GP alpha/beta and ENaC (alpha, beta and gamma) to increase. Quercetin-induced changes in the uterine fluid secretion rate and electrolytes concentrations could potentially affect the uterine reproductive functions under female sex-steroid influence.	[Shahzad, Huma; Giribabu, Nelli; Karim, Kamarulzaman; Salleh, Naguib] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Kassim, Normadiah M.] Univ Malaya, Dept Anat, Fac Med, Kuala Lumpur, Malaysia; [Muniandy, Sekaran] MAHSA Univ, Fac Med & Biomed Sci, Dept Biochem, Jalan Elmu,Off Jalan Univ, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Mahsa University	Salleh, N (corresponding author), Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.	naguib.salleh@gmail.com	SALLEH, NAGUIB/T-6426-2019; karim, kamarulzaman/ABA-4335-2021; kassim, normadiah/AAH-1335-2019; Salleh, Naguib/ABG-6960-2021; Nelli, Giribabu/C-1203-2017	Salleh, Naguib/0000-0002-4926-0490; Nelli, Giribabu/0000-0003-1263-103X	PPP grants, University of Malaya, Kuala Lumpur, Malaysia [PG070-2014A, PG234-2015B]	PPP grants, University of Malaya, Kuala Lumpur, Malaysia	This study was funded by PPP grants (PG070-2014A and PG234-2015B), University of Malaya, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudouin-Legros M, 2008, CELL PHYSIOL BIOCHEM, V21, P75, DOI 10.1159/000113749; Bentin-Ley U, 2011, EUR J OBSTET GYN R B, V156, P60, DOI 10.1016/j.ejogrb.2010.12.040; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Chinigarzadeh A, 2016, ENV TOXICOLOGY; Chinigarzadeh A, 2015, THERIOGENOLOGY, V84, P911, DOI 10.1016/j.theriogenology.2015.05.029; Chinigarzadeh A, 2014, CLINICS, V69, P111, DOI 10.6061/clinics/2014(02)07; D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018; deMedina FS, 1997, LIFE SCI, V61, P2049; Deng WB, 2013, THERIOGENOLOGY, V79, P1196, DOI 10.1016/j.theriogenology.2013.02.018; Gholami K, 2014, RES VET SCI, V96, P164, DOI 10.1016/j.rvsc.2013.11.005; Gholami K, 2013, INT J MED SCI, V10, P1121, DOI 10.7150/ijms.5918; Gomes IBS, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-184; Hamilton JA, 1998, HUM REPROD, V13, P3357, DOI 10.1093/humrep/13.12.3357; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Kapiszewska M, 2007, DRUG CHEM TOXICOL, V30, P67, DOI 10.1080/01480540601017710; Li Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030167; Lin PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062462; Lu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078446; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Mokhtar HM, 2014, J STEROID BIOCHEM, V144, P361, DOI 10.1016/j.jsbmb.2014.08.007; Monteiro MMO, 2012, MOLECULES, V17, P12997, DOI 10.3390/molecules171112997; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Revuelta MP, 1999, J AUTON PHARMACOL, V19, P353, DOI 10.1111/j.1365-2680.1999.tb00008.x; Salleh N, 2005, J MEMBRANE BIOL, V206, P17, DOI 10.1007/s00232-005-0770-7; Shahzad H, 2015, J MED FOOD, V18, P1307, DOI 10.1089/jmf.2014.3293; Shahzad H, 2014, INT J CLIN EXP PATHO, V7, P5484; SI YM, 1993, MOL REPROD DEV, V36, P89, DOI 10.1002/mrd.1080360113; Uchiyama H, 2007, BIOMED RES-TOKYO, V28, P239, DOI 10.2220/biomedres.28.239; Wang Q, 2014, J IMMUNOL, V192, P3765, DOI 10.4049/jimmunol.1302421; Wang XD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/745262; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Yang JZ, 2011, FERTIL STERIL, V95, P2100, DOI 10.1016/j.fertnstert.2011.02.036	32	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172765	10.1371/journal.pone.0172765	http://dx.doi.org/10.1371/journal.pone.0172765			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253299	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300031
J	Ding, ZH; Fu, LL; Yan, Y; Tie, WW; Xia, ZQ; Wang, WQ; Peng, M; Hu, W; Zhang, JM				Ding, Zehong; Fu, Lili; Yan, Yan; Tie, Weiwei; Xia, Zhiqiang; Wang, Wenquan; Peng, Ming; Hu, Wei; Zhang, Jiaming			Genome-wide characterization and expression profiling of HD-Zip gene family related to abiotic stress in cassava	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; WATER-DEFICIT; PROTEIN; PLANT; DIFFERENTIATION; EVOLUTION; RESPONSES; DOMAINS; AUXIN	Homeodomain-leucine zipper (HD-Zip) gene family plays important roles in various abiotic stresses and hormone signaling in plants. However, no information is currently available regarding this family in cassava (Manihot esculenta), an important drought-tolerant crop in tropical and sub-tropical areas. Here, 57 HD-Zip genes (MeHDZ01-57) were identified in the cassava genome, and they were classified into four subfamilies based on phylogenetic analysis, which was further supported by their gene structure and conserved motif characteristics. Of which five gene pairs were involved in segmental duplication but none for tandem duplication, suggesting that segmental duplication was the main cause for the expansion of MeHDZ gene family in cassava. Global expression profiles revealed that MeHDZ genes were constitutively expressed, or not expressed, or tissue-specific expressed in examined tissues in both cultivated and wild subspecies. Transcriptomic analysis of three genotypes showed that most of MeHDZ genes responded differently to drought and polyethylene glycol treatments. Subsequently, quantitative RT-PCR analysis revealed comprehensive responses of twelve selected MeHDZ genes to various stimuli including cold, salt, and ABA treatments. These findings will increase our understanding of HD-Zip gene family involved in abiotic stresses and signaling transduction, and will provide a solid base for further functional characterization of MeHDZ genes in cassava.	[Ding, Zehong; Fu, Lili; Yan, Yan; Tie, Weiwei; Xia, Zhiqiang; Wang, Wenquan; Peng, Ming; Hu, Wei; Zhang, Jiaming] Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Trop Crops, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Ding, ZH; Hu, W; Zhang, JM (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Biol & Genet Resources Trop Crops, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China.	dingzehong@itbb.org.cn; huwei2010916@126.com; zhangjiaming@itbb.org.cn	Zhang, Jiaming/GSD-8224-2022	Wang, Wenquan/0000-0002-7603-3437	International Science and Technology Cooperation Program of China [2010DFA62040, 2014DFA30680]; Natural Science Foundation of China [31471561]; Natural Science Foundation of Hainan Province [20163120, 20153048]	International Science and Technology Cooperation Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province	This study was supported by the International Science and Technology Cooperation Program of China (2010DFA62040, 2014DFA30680), the Natural Science Foundation of China (31471561), and the Natural Science Foundation of Hainan Province (20163120, 20153048).	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Brandt R, 2014, J INTEGR PLANT BIOL, V56, P518, DOI 10.1111/jipb.12185; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chew W, 2013, INT J MOL SCI, V14, P8122, DOI 10.3390/ijms14048122; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Fu LL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030283; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep22783; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Khaja Razi, 2006, V338, P9; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Li Z, 2014, GENE, V533, P218, DOI 10.1016/j.gene.2013.09.084; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Palena CM, 1999, BIOCHEM J, V341, P81, DOI 10.1042/0264-6021:3410081; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Wei F, 2016, SCI REP, V6; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00025; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5564, 10.1038/ncomms6110]; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhang CH, 2014, GENET MOL RES, V13, P2654, DOI 10.4238/2014.April.8.8; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08414; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	52	31	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173043	10.1371/journal.pone.0173043	http://dx.doi.org/10.1371/journal.pone.0173043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249019	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500071
J	Chung, BH; Kim, BM; Doh, KC; Cho, ML; Kim, KW; Yang, CW				Chung, Byung Ha; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Kim, Kyoung Woon; Yang, Chul Woo			Protective effect of 1 alpha, 25-dihydroxyvitamin D3 on effector CD4(+) T cell induced injury in human renal proximal tubular epithelial cells	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; MAMMALIAN TARGET; PHOSPHATIDYLINOSITOL 3-KINASE; TUBULOINTERSTITIAL INJURY; CHEMOKINE PRODUCTION; 25-HYDROXYVITAMIN D; IMMUNE-SYSTEM; IN-VITRO; MTOR	Background The aim of this study was to investigate the protective effect of 1 alpha, 25-dihydroxyvitamin D3 [1,25(OH)(2)D3] on effector CD4(+) T cells or on inflammatory cytokine-induced injury in human renal proximal tubular epithelial cells (HRPTEpiC). Methods First, we investigated the effect of 1,25(OH)(2)D3 on CD4(+) T cell proliferation. Second, we examined the effect of 1,25(OH)(2)D3 on inflammatory cytokine secretion or fibrosis in HRPTEpiC induced by inflammatory cytokines or activated CD4(+) T cells using ELISA and real-time PCR. Lastly, we compared urine inflammatory-cytokine (IL-6, IL-8) or KIM-1 levels in kidney transplant recipients low serum 25-hydroxyvitamin D (25(OH) D) group (< 20 ng/mL) (n = 40) and normal 25(OH) D group (n = 50). Results Pre-incubation with 1,25(OH)(2)D3 significantly reduced the percentages of Th1 and Th17 cells compared to that of Th0 condition (P < 0.05 for each). In contrast, 1,25(OH)(2)D3 increased the proportion of Th2 and Treg cells in a dose-dependent manner (P < 0.05 for each). Treatment of HRPTEpiC with inflammatory cytokines (TNF-alpha, IL-17, and TGF-beta) or effector CD4(+) T cells resulted in increased production of IL-6, IL-8, or KIM-1 from HRPTEpiC in a dose-dependent manner. However, treatment with 1,25(OH)(2)D3 significantly reduced the level of these cytokines (P < 0.05 for all). Western blot analysis demonstrated that the mTOR/STAT3/ERK pathway was downregulated by 1,25(OH)(2)D3 in HRPTEpiC. Furthermore, the concentrations of urine IL-6/creatinine (P < 0.05) and Kim-1/creatinine (P < 0.05) were higher in the low 25(OH) D group than in the normal 25(OH) D group in kidney transplant recipients. Conclusion The results of this study suggests that vitamin D may have a significant role in the regulation of inflammation in allograft tissue in kidney transplant recipients.	[Chung, Byung Ha; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Kim, Kyoung Woon; Yang, Chul Woo] Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Chung, Byung Ha; Doh, Kyoung Chan; Kim, Kyoung Woon; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, KW; Yang, CW (corresponding author), Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea.; Kim, KW; Yang, CW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea.; Yang, CW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea.	woon1212@catholic.ac.kr; yangch@catholic.ac.kr			grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [H113C1704]	grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1232) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H113C1704).	Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; BHALLA AK, 1984, J IMMUNOL, V133, P1748; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Chung BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145258; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Gorman S, 2010, J INVEST DERMATOL, V130, P2368, DOI 10.1038/jid.2010.167; Hoerning A, 2015, TRANSPLANTATION, V99, P210, DOI 10.1097/TP.0000000000000273; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hullett DA, 2005, TRANSPL INT, V18, P1175, DOI 10.1111/j.1432-2277.2005.00187.x; Ishimura E, 1999, KIDNEY INT, V55, P1019, DOI 10.1046/j.1523-1755.1999.0550031019.x; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Keyzer CA, 2015, J CLIN ENDOCR METAB, V100, P81, DOI 10.1210/jc.2014-3012; Kuroiwa T, 2000, J IMMUNOL, V164, P3323, DOI 10.4049/jimmunol.164.6.3323; Kwon YE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000594; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee JR, 2014, TRANSPLANTATION, V98, P292, DOI 10.1097/TP.0000000000000055; Lisse TS, 2011, FASEB J, V25, P937, DOI 10.1096/fj.10-172577; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; Mattner F, 2000, EUR J IMMUNOL, V30, P498, DOI 10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Niculescu-Duvaz I, 2007, NEPHRON EXP NEPHROL, V105, pE108, DOI 10.1159/000100492; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1865, DOI 10.1002/art.37953; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Querings K, 2006, J CLIN ENDOCR METAB, V91, P526, DOI 10.1210/jc.2005-0547; Ranganathan P, 2013, J RHEUMATOL, V40, P1529, DOI 10.3899/jrheum.130012; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Smolders J, 2010, J STEROID BIOCHEM, V121, P243, DOI 10.1016/j.jsbmb.2010.03.001; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Van der Hauwaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066750; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; van Kooten C, 1999, KIDNEY INT, V56, P41, DOI 10.1046/j.1523-1755.1999.00514.x; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wang SQ, 2009, PROCEEDINGS OF THE 2009 CHINESE CONFERENCE ON PATTERN RECOGNITION AND THE FIRST CJK JOINT WORKSHOP ON PATTERN RECOGNITION, VOLS 1 AND 2, P1, DOI 10.1109/PLASMA.2009.5227540; Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004; Woltman AM, 2000, J AM SOC NEPHROL, V11, P2044, DOI 10.1681/ASN.V11112044; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2	50	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172536	10.1371/journal.pone.0172536	http://dx.doi.org/10.1371/journal.pone.0172536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245293	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200023
J	Krimsky, S; Schwab, T				Krimsky, Sheldon; Schwab, Tim			Conflicts of interest among committee members in the National Academies' genetically engineered crop study	PLOS ONE			English	Article							DISCLOSURE; PANEL	The National Academies of Sciences, Engineering and Medicine (NASEM) publishes numerous reports each year that are received with high esteem by the scientific community and public policy makers. The NASEM has internal standards for selecting committee members that author its reports, mostly from academia, and vetting conflicts of interest. This study examines whether there were any financial conflicts of interest (COIs) among the twenty invited committee members who wrote the 2016 report on genetically engineered (GE) crops. Our results showed that six panel members had one or more reportable financial COIs, none of which were disclosed in the report. We also report on institutional COIs held by the NASEM related to the report. The difference between our findings and the NASEM reporting standards are discussed.	[Krimsky, Sheldon] Tufts Univ, Dept Urban & Environm Policy & Planning, Medford, MA 02155 USA; [Schwab, Tim] Food & Water Watch, Washington, DC USA	Tufts University	Krimsky, S (corresponding author), Tufts Univ, Dept Urban & Environm Policy & Planning, Medford, MA 02155 USA.	sheldon.krimsky@tufts.edu			Committee on Faculty Research Awards, Tufts University	Committee on Faculty Research Awards, Tufts University	The authors acknowledge the Committee on Faculty Research Awards, Tufts University for their grant to fund the publication of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Universities task force on research accountability, 2001, REP REC IND I CONFL; Association of American Medical Colleges, 2002, PROT SUBJ PRES TRUST; Association of Governing Boards of Universities and Colleges, 2007, BOARD POL CONFL INT; Bero LA, 2005, PUBLIC HEALTH REP, V120, P200, DOI 10.1177/003335490512000215; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Boffey P. M., 1975, BRAIN BANK AM; Capps B, 2016, BRIT MED BULL, V118, P5, DOI 10.1093/bmb/ldw014; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Diels J, 2011, FOOD POLICY, V36, P197, DOI 10.1016/j.foodpol.2010.11.016; Dube L, 2014, LATEST STONYFIELDS G; Food & Water Watch, 2016, INFL NAT RES COUNC G; Goozner M., 2006, ENSURING INDEPENDENC; Gould F, 2016, PUBLIC RELEASE EVENT; Guillemaud T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167777; Harvest Plus, PROV MAIZ FLYER; Hauter Wenonah, 2014, COMMUNICATION; Iles A, 2014, COMMUNICATION; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; International Committee of Medical Journal Editors, ICMJE DISCL POT CONF; Kandianis CB, 2013, THEOR APPL GENET, V126, P2879, DOI 10.1007/s00122-013-2179-5; Krimsky S., 2010, STANFORD LAW POLICY, V21, P101; Krimsky S., 2006, LAW ETHICS BIOMEDICA, P63; Lopez J, 2015, PLAST RECONSTR SURG, V136, p690E, DOI 10.1097/PRS.0000000000001718; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; McCook A, 2006, SCIENTIST; Michaels D, 2006, ANN NY ACAD SCI, V1076, P149, DOI 10.1196/annals.1371.058; National Academies, 2003, POL COMM COMP BAL CO; National Academies of Science, 2009, BEING SCI GUID RESP; National Academies of Science Engineering and Medicine (NASEM), 2016, COMM GEN ENG CROPS G; National Academies of Science Engineering and Medicine (NASEM), 2016, BACKGR INF CONF CONF; National Academies of Science Engineering and Medicine: Public Interface in Life Sciences Roundtable, 2015, PUBL ENG GEN MOD ORG; National Academies of Sciences, 2016, REP TREAS NAT AC SCI; National Academy of Sciences, 2010, COMM IMP BIOT FARM L; National Academy of Sciences, 1987, AGR BIOT STRAT NAT C; Parascandola M, 2007, J CLIN ONCOL, V25, P3774, DOI 10.1200/JCO.2006.09.2890; Peterson M, 1999, NY TIMES; Resnik D, 2015, SCI ENG ETHICS; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Strom S, 2016, NY TIMES; Suwarno WB, 2015, THEOR APPL GENET, V128, P851, DOI 10.1007/s00122-015-2475-3; The National Academy of Sciences, 2014, IRS FIL FORM 990; US National Academy of Sciences, 2000, GEN MOD PEST PROT PL; Van Nierop LE, 2010, J C R PHYS, V11, P622; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wadman M, 1999, NATURE, V399, P7, DOI 10.1038/19817; Whistler Center Purdue University., PURD U ANN REP 2015	49	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172317	10.1371/journal.pone.0172317	http://dx.doi.org/10.1371/journal.pone.0172317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245228	Green Submitted, Green Published, gold			2022-12-27	WOS:000395980200017
J	Armstrong, CG; Shoemaker, AC; McKechnie, I; Ekblom, A; Szabo, P; Lane, PJ; McAlvay, AC; Boles, OJ; Walshaw, S; Petek, N; Gibbons, KS; Morales, EQ; Anderson, EN; Ibragimow, A; Podruczny, G; Vamosi, JC; Marks-Block, T; LeCompte, JK; Awasis, S; Nabess, C; Sinclair, P; Crumley, CL				Armstrong, Chelsey Geralda; Shoemaker, Anna C.; McKechnie, Iain; Ekblom, Anneli; Szabo, Peter; Lane, Paul J.; McAlvay, Alex C.; Boles, Oliver J.; Walshaw, Sarah; Petek, Nik; Gibbons, Kevin S.; Morales, Erendira Quintana; Anderson, Eugene N.; Ibragimow, Aleksandra; Podruczny, Grzegorz; Vamosi, Jana C.; Marks-Block, Tony; LeCompte, Joyce K.; Awasis, Sakihitowin; Nabess, Carly; Sinclair, Paul; Crumley, Carole L.			Anthropological contributions to historical ecology: 50 questions, infinite prospects	PLOS ONE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; RAPID EVOLUTION; LATE HOLOCENE; CONSERVATION; FOREST; MANAGEMENT; SCALE; BIODIVERSITY; ARCHAEOLOGY	This paper presents the results of a consensus-driven process identifying 50 priority research questions for historical ecology obtained through crowdsourcing, literature reviews, and in-person workshopping. A deliberative approach was designed to maximize discussion and debate with defined outcomes. Two in-person workshops (in Sweden and Canada) over the course of two years and online discussions were peer facilitated to define specific key questions for historical ecology from anthropological and archaeological perspectives. The aim of this research is to showcase the variety of questions that reflect the broad scope for historical-ecological research trajectories across scientific disciplines. Historical ecology encompasses research concerned with decadal, centennial, and millennial human-environmental interactions, and the consequences that those relationships have in the formation of contemporary landscapes. Six interrelated themes arose from our consensus-building workshop model: (1) climate and environmental change and variability; (2) multi-scalar, multi-disciplinary; (3) biodiversity and community ecology; (4) resource and environmental management and governance; (5) methods and applications; and (6) communication and policy. The 50 questions represented by these themes highlight meaningful trends in historical ecology that distill the field down to three explicit findings. First, historical ecology is fundamentally an applied research program. Second, this program seeks to understand long-term human-environment interactions with a focus on avoiding, mitigating, and reversing adverse ecological effects. Third, historical ecology is part of convergent trends toward transdisciplinary research science, which erodes scientific boundaries between the cultural and natural.	[Armstrong, Chelsey Geralda] Simon Fraser Univ, Dept Archaeol, Vancouver, BC, Canada; [Shoemaker, Anna C.; Ekblom, Anneli; Lane, Paul J.; Petek, Nik; Sinclair, Paul] Uppsala Univ, Dept Archaeol & Ancient Hist, Uppsala, Sweden; [McKechnie, Iain] Univ Victoria, Dept Anthropol, Victoria, BC, Canada; [McKechnie, Iain] Hakai Inst, Quadra Isl, BC, Canada; [Szabo, Peter] Czech Acad Sci, Inst Bot, Dept Vegetat Ecol, Brno, Czech Republic; [Lane, Paul J.] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [McAlvay, Alex C.] Univ Wisconsin, Dept Bot, Madison, WI USA; [Boles, Oliver J.] UCL, Inst Archaeol, London, England; [Walshaw, Sarah] Simon Fraser Univ, Dept Hist, Vancouver, BC, Canada; [Gibbons, Kevin S.] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Morales, Erendira Quintana] Rice Univ, Dept Anthropol, Houston, TX USA; [Anderson, Eugene N.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Ibragimow, Aleksandra; Podruczny, Grzegorz] Adams Mickiewicz Univ, Polish German Res Inst, Poznan, Poland; [Ibragimow, Aleksandra; Podruczny, Grzegorz] European Univ, Viadrina, Germany; [Vamosi, Jana C.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Marks-Block, Tony] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Awasis, Sakihitowin] Western Univ, Dept Geog, London, ON, Canada; [Awasis, Sakihitowin] Atlohsa Native Family Healing Serv, London, ON, Canada; [Nabess, Carly] Univ Northern British Columbia, Dept Anthropol, Prince George, BC, Canada; [Crumley, Carole L.] Univ North Carolina Chapel Hill, Dept Anthropol, Chapel Hill, NC USA; [Crumley, Carole L.] Integrated Hist Future People Earth IHOPE Initiat, Uppsala, Sweden	Simon Fraser University; Uppsala University; University of Victoria; Hakai Institute; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Witwatersrand; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; Simon Fraser University; University System of Maryland; University of Maryland College Park; Rice University; University of California System; University of California Santa Barbara; University of Calgary; Stanford University; Western University (University of Western Ontario); University of Northern British Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Armstrong, CG (corresponding author), Simon Fraser Univ, Dept Archaeol, Vancouver, BC, Canada.	cga7@sfu.ca	Ekblom, Anneli/Q-7941-2019; Szabó, Péter/B-1736-2010; McKechnie, Iain/N-8411-2019; McKechnie, Iain/O-2542-2013; Lane, Paul/AAK-1995-2020	Szabó, Péter/0000-0002-2985-0717; McKechnie, Iain/0000-0002-4989-2711; McKechnie, Iain/0000-0002-4989-2711; Lane, Paul/0000-0002-9936-1310; Boles, Oliver/0000-0002-3837-9103; Quintana Morales, Erendira M./0000-0001-5927-5058; Ekblom, Anneli/0000-0001-9248-5516; Petek-Sargeant, Nik/0000-0003-4552-0125; Ibragimow, Aleksandra/0000-0003-1719-2742; McAlvay, Alex C/0000-0001-7051-2018	Integrated History and Future of People on Earth (IHOPE); Department of Archaeology and Ancient History at Uppsala University; Mind and Nature research node at Uppsala University; SFU Faculty of Environment, Sustainability Simon Fraser University; office of the Vice-President, Academic and Provost of Simon Fraser University	Integrated History and Future of People on Earth (IHOPE); Department of Archaeology and Ancient History at Uppsala University; Mind and Nature research node at Uppsala University; SFU Faculty of Environment, Sustainability Simon Fraser University; office of the Vice-President, Academic and Provost of Simon Fraser University	The Integrated History and Future of People on Earth (IHOPE) research network, the Department of Archaeology and Ancient History at Uppsala University, the Mind and Nature research node at Uppsala University, the SFU Faculty of Environment, Sustainability Simon Fraser University, and the office of the Vice-President, Academic and Provost of Simon Fraser University all provided funding for web costs and workshops and conference organization.; The authors acknowledge all workshop participants from the 2014 Uppsala and 2015 Vancouver meetings as well as those who submitted questions and feedback in online surveys for their thoughtful contributions, especially Dr. William Sutherland. The Integrated History and Future of People on Earth (IHOPE) research network, the Department of Archaeology and Ancient History at Uppsala University, the Mind and Nature research node at Uppsala University, the SFU Faculty of Environment, SFU Department of Archaeology, Sustainable SFU, and VP Academic at SFU all provided funding for web costs, workshops, and conference organization. We would lastly like to thank our esteemed readers, Travis Freeland, Rachael O'Callahan, Felix Riede, Nancy J. Turner, Leslie Main Johnson, and the three anonymous reviewers for their helpful and critical comments.	Adamo SB, 2010, POPUL ENVIRON, V32, P105, DOI 10.1007/s11111-010-0130-0; Adderley WP, 2008, GEOARCHAEOLOGY, V23, P500, DOI 10.1002/gea.20228; Agnoletti M, 2006, CONSERVATION OF CULTURAL LANDSCAPES, P3, DOI 10.1079/9781845930745.0003; Altamirano-Jimenez I, 2013, INDIGENOUS ENCOUNTER; Anderies JM, 2011, ECOL SOC, V16; Anderson E, 1994, ECOLOGIES HEART EMOT; Anderson EN, 2014, CARING FOR PLACE: ECOLOGY, IDEOLOGY, AND EMOTION IN TRADITIONAL LANDSCAPE MANAGEMENT, P1; Anderson MK, 2005, TENDING THE WILD: NATIVE AMERICAN KNOWLEDGE AND THE MANAGEMENT OF CALIFORNIA'S NATURAL RESOURCES, P1; [Anonymous], 1995, ENCOUNTERING DEV MAK; Arkady B, 2005, ZOOL ZH, V85, P173; Armstrong CG, 2015, ETHNOBIOL LETT, V6, P5, DOI 10.14237/ebl.6.1.2015.313; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Bailey G, 2007, J ANTHROPOL ARCHAEOL, V26, P198, DOI 10.1016/j.jaa.2006.08.002; Balee W, 2006, ANNU REV ANTHROPOL, V35, P75, DOI 10.1146/annurev.anthro.35.081705.123231; Balee William, 1998, P13; Balee William L., 2013, CULTURAL FORESTS AMA; Barlow J, 2012, BIOL CONSERV, V151, P45, DOI 10.1016/j.biocon.2011.10.013; Baron N, 2010, ESCAPE IVORY TOWER G; Barthel S, 2013, GLOBAL ENVIRON CHANG, V23, P1142, DOI 10.1016/j.gloenvcha.2013.05.001; Bateson G, 1972, STEPS ECOLOGY MIND; Bean WT, 2008, ECOL MODEL, V211, P301, DOI 10.1016/j.ecolmodel.2007.09.014; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; BERKES F, 1981, J ENVIRON MANAGE, V12, P157; Berkes F., 2012, SACRED ECOLOGY TRADI; Berkes F., 1989, COMMON PROPERTY RESO; Bird DW, 2016, CURR ANTHROPOL, V57, pS65, DOI 10.1086/685763; Bird R, 2013, P R SOC LONDON B, V380; Bird RB, 2015, ANNU REV ANTHROPOL, V44, P241, DOI 10.1146/annurev-anthro-102214-013946; Black R, 1997, ENVIRON CONSERV, V24, P251, DOI 10.1017/S0376892997000337; Blaikie P M, 1987, LAND DEGRADATION SOC; Blancas J, 2010, ECON BOT, V64, P297; Blockley SPE, 2012, QUATERNARY SCI REV, V36, P2, DOI 10.1016/j.quascirev.2011.09.017; Bodley J., 2014, VICTIMS PROGR; Bowman DMJS, 2011, FIRE ECOL, V7, P5, DOI 10.4996/fireecology.0701005; Briggs JM, 2006, FRONT ECOL ENVIRON, V4, P180, DOI 10.1890/1540-9295(2006)004[0180:WENAAA]2.0.CO;2; Brody H, 1981, MAPS DREAMS INDIANS; Burgi M, 2008, GAIA, V17, P370, DOI 10.14512/gaia.17.4.12; Burgi M, 2017, ECOSYSTEMS, V20, P94, DOI 10.1007/s10021-016-0051-6; Cameron F, 2013, WIRES CLIM CHANGE, V4, P9, DOI 10.1002/wcc.200; Capers RS, 2007, ECOLOGY, V88, P3135, DOI 10.1890/06-1911.1; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; Chritz KL, 2015, P NATL ACAD SCI USA, V112, P3674, DOI 10.1073/pnas.1423953112; Codding BF, 2014, HUM ECOL, V42, P659, DOI 10.1007/s10745-014-9682-4; Cooper J, 2012, SURVIVING SUDDEN ENVIRONMENTAL CHANGE: UNDERSTANDING HAZARDS, MITIGATING IMPACTS, AVOIDING DISASTERS, P1; Cronon W, 1996, ENVIRON HIST, V1, P7, DOI 10.2307/3985059; Crosby Alfred W., 1986, ECOLOGICAL IMPERIALI; Crumley C, 2015, OXFORD HDB HIST ECOL; Crumley C, 2007, WORLD SYSTEM EARTH S, P15; Crumley C, 1987, REGIONAL DYNAMICS BU; CRUMLEY CL, 1994, SCH AM RES, P183; Crutzen P., 2000, IGBP GLOBAL CHANGE N, P17, DOI DOI 10.1007/3-540-26590-2_3; Dallimer M, 2015, TRENDS ECOL EVOL, V30, P132, DOI 10.1016/j.tree.2014.12.004; Daly L, 2016, J ETHNOBIOL, V36, P1; Dearing John A, 2012, Proc Natl Acad Sci U S A, V109, pE1111, DOI 10.1073/pnas.1118263109; DELEUZE G., 1987, 1000 PLATEAUS CAPITA; Denevan WM, 2016, GEOGR REV, V106, P381, DOI 10.1111/j.1931-0846.2016.12175.x; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Ekblom A., 2015, OXFORD HDB HIST ECOL; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Erickson C, 2006, DOMESTICATED LANDSCA; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Escobar A, 2008, TERRITORIES DIFFEREN; Fairhead J., 2009, P265, DOI 10.1007/978-1-4020-9031-8_13; Falcao N. P. S., 2009, P213, DOI 10.1007/978-1-4020-9031-8_11; Fan MM, 2014, AMBIO, V43, P673, DOI 10.1007/s13280-013-0445-z; Fine PVA, 2013, CALIF ARCHAOL, V5, P353, DOI 10.1179/1947461X13Z.00000000019; Ford A, 2015, NEW FRONTIERS HIST E; Foster DR, 2002, J BIOGEOGR, V29, P1533, DOI 10.1046/j.1365-2699.2002.t01-1-00788.x; Fraser JA, 2015, GLOBAL ENVIRON CHANG, V31, P226, DOI 10.1016/j.gloenvcha.2015.01.013; Frausin V, 2014, HUM ECOL, V42, P695, DOI 10.1007/s10745-014-9686-0; Frazier JG, 2010, ARCHAEOLOGY ANTHROPO, P341; Freeman M, 1988, TRADITIONAL KNOWLEDG; Gillson L, 2015, BIODIVERSITY CONSERVATION AND ENVIRONMENTAL CHANGE: USING PALAEOECOLOGY TO MANAGE DYNAMIC LANDSCAPES IN THE ANTHROPOCENE; Gimmi U., 2007, Environment and History, V13, P211, DOI 10.3197/096734007780473492; Girel J., 2006, GEOCARREFOUR, V81, P249, DOI DOI 10.4000/GE0CARREF0UR.1622; Glaser B, 2007, PHILOS T R SOC B, V362, P187, DOI 10.1098/rstb.2006.1978; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Griffith D., 2006, TRADITIONAL ECOLOGIC, P153; Habu J, 2011, QUATERN INT, V239, P19, DOI 10.1016/j.quaint.2011.03.014; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Harrison R, 2014, HUMAN ECODYNAMICS N; Harvey D, 2015, FUTURE HERITAGE CLIM; Harwell M, 1984, NUCL WINTER HUMAN EN; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Hegmon M, 2014, SHIFT ENV ARCH P 44, P53; Hernandez M, 2015, GEOFORUM, V60, P83, DOI 10.1016/j.geoforum.2015.01.013; Hinchliffe S, 2005, ENVIRON PLANN D, V23, P643, DOI 10.1068/d351t; Hjelle Kari Loe, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P321, DOI 10.1080/21513732.2012.739576; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hoffman KM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1415; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hornborg A, 2016, EUR J SOC THEORY; Howard AJ, 2016, J CULT HERIT, V19, P387, DOI 10.1016/j.culher.2015.11.007; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; INGERSON AE, 1994, SCH AM RES, P43; Ingold T., 2000, PERCEPTION ENV ESSAY; Ingold T, 2012, ANNU REV ANTHROPOL, V41, P427, DOI 10.1146/annurev-anthro-081309-145920; Isendahl C, 2015, OXFORD HDB HIST ECOL; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; Kanter DE, 2010, SCI EDUC, V94, P525, DOI 10.1002/sce.20381; Kearsley GW, 2006, PUBLIC HIST REV, V13, P23; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Kohler T, 2007, MODEL BASED ARCHAEOL; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Kuhl JD, 2014, UTAH HIST REV, V4, P133; Lane P, 2009, INT J AFR HIST STUD, V42, P457; Lane PJ, 2016, ARCHAEOLOGY OF ENTANGLEMENT, P127; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Latour B., 2005, REASSEMBLING SOCIAL; Latour B, 2014, HAU-J ETHNOGR THEORY, V4, P301, DOI 10.14318/hau4.1.016; Ledford H, 2015, NATURE, V525, P308, DOI 10.1038/525308a; Lefebvre Henri, 1991, PRODUCTION SPACE; Lepofsky D, 2008, BOTANY, V86, P129, DOI 10.1139/B07-094; Lepofsky D, 2015, AM ANTIQUITY, V80, P236, DOI 10.7183/0002-7316.80.2.236; Lertzman K, 2009, J ETHNOBIOL, V29, P339, DOI 10.2993/0278-0771-29.2.339; Levin PS, 2016, COAST MANAG, V44; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Liebmann MJ, 2016, P NATL ACAD SCI USA, V113, pE696, DOI 10.1073/pnas.1521744113; Lightfoot KG, 2013, CALIF ARCHAOL, V5, P371, DOI 10.1179/1947461X13Z.00000000020; Lightfoot KG, 2015, ANTHROPOGENIC BURNIN; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; LORD JM, 1990, CONSERV BIOL, V4, P197, DOI 10.1111/j.1523-1739.1990.tb00109.x; Lotze HK, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P165; Lowenthal D., 1985, IS FOREIGN COUNTRY; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Marchant R, 2014, J ARCHAEOL SCI, V51, P12, DOI 10.1016/j.jas.2013.07.005; Marquardt W, 1992, ARCHAEOLOGICAL METHO, P101; Martindale A, 2014, CAN J ARCHAEOL, V38, P434; Marzeion B, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034001; Massey D., 2005, FOR SPACE; Mathevet R., 2012, SOLIDARITE ECOLOGIQU; McClure SB, 2015, CURR ANTHROPOL, V56, P901, DOI 10.1086/684102; McKechnie I, 2014, P NATL ACAD SCI USA, V111, pE807, DOI 10.1073/pnas.1316072111; McKey DB, 2016, P NATL ACAD SCI USA, V113, P14938, DOI 10.1073/pnas.1613169114; Menzies C, 2006, TRADITIONAL ECOLOGIC; Merino G, 2012, GLOBAL ENVIRON CHANG, V22, P795, DOI 10.1016/j.gloenvcha.2012.03.003; Meyer M, 2011, ATLANTIC EUROPE 1 MI, P109; Millington AC, 2003, ISPRS J PHOTOGRAMM, V57, P289, DOI 10.1016/S0924-2716(02)00154-5; Morin-Rivat J, 2017, ELIFE, V6, DOI [10.7554/eLife.20343, 10.7554/elife.20343]; Muchiru AN, 2009, J ARID ENVIRON, V73, P322, DOI 10.1016/j.jaridenv.2008.09.018; Nabhan GP, 1982, J ETHNOBIOL, V2, P124; Nadasdy P., 2005, ANTHROPOLOGICA, V47, P215, DOI DOI 10.2307/40316502; Nadasdy Paul, 2004, HUNTERS BUREAUCRATS; Natcher DC, 2005, HUM ORGAN, V64, P240, DOI 10.17730/humo.64.3.23yfnkrl2ylapjxw; Nazarea VD, 2006, ANNU REV ANTHROPOL, V35, P317, DOI 10.1146/annurev.anthro.35.081705.123252; Nicholas G, 1999, ARCHAEOLOGICAL NE, P25; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nunn PD, 2013, SINGAPORE J TROP GEO, V34, P143, DOI 10.1111/sjtg.12021; Orlove B, 2005, ENVIRON SCI POLICY, V8, P589, DOI 10.1016/j.envsci.2005.06.009; Ostrom E, 2012, FUTURE COMMONS; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Parker KC, 2010, MOL ECOL, V19, P1622, DOI 10.1111/j.1365-294X.2010.04593.x; Parkes P, 2000, INDIGENOUS ENV KNOWL, P253; Parsons ECM, 2014, CONSERV BIOL, V28, P1206, DOI 10.1111/cobi.12303; Pennings S, 2013, ARCHAEOLOGY HIST ECO, P167; Perrings C, 1997, ECOL ECON, V22, P73, DOI 10.1016/S0921-8009(97)00565-X; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Rackham O, 2003, ANCIENT WOODLAND ITS; Rackham O, 2006, WOODLANDS; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; Redman CL, 2003, CONSERV ECOL, V7; Rettig B, 1989, COOPERATIVE MANAGEME, P273; Rick TC, 2014, BIOSCIENCE, V64, P680, DOI 10.1093/biosci/biu094; Rick TC, 2013, CONSERV BIOL, V27, P45, DOI 10.1111/j.1523-1739.2012.01920.x; Robbins P, 2013, CULT GEOGR, V20, P3, DOI 10.1177/1474474012469887; Ross A., 2011, INDIGENOUS PEOPLES C, pxx; Ross NJ, 2011, ECOL APPL, V21, P75, DOI 10.1890/09-0662.1; Ross NJ, 2011, BIOTROPICA, V43, P141, DOI 10.1111/j.1744-7429.2010.00666.x; Ruddiman WF, 2016, REV GEOPHYS, V54, P93, DOI 10.1002/2015RG000503; Russell E., 1997, PEOPLE LAND TIME LIN; Russell-Smith J, 2013, CLIMATIC CHANGE, V121, P1; Sadiq M, 1993, GULF WAR AFTERMATH E; Savo V, 2016, NAT CLIM CHANGE, V6, P462, DOI [10.1038/nclimate2958, 10.1038/NCLIMATE2958]; Sayre NF, 2005, PROG HUM GEOG, V29, P276, DOI 10.1191/0309132505ph546oa; Seddon AWR, 2014, J ECOL, V102, P256, DOI 10.1111/1365-2745.12195; Seno SKO, 2013, NOMAD PEOPLES, V17, P66, DOI 10.3167/np.2013.170104; Shahack-Gross R, 2004, J ARCHAEOL SCI, V31, P1395, DOI 10.1016/j.jas.2004.03.003; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Simpson IA, 2001, CATENA, V42, P175, DOI 10.1016/S0341-8162(00)00137-5; Simpson L., 2001, CANADIAN J NATIVE ST, V21, P137; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; Smith EA, 2000, ANNU REV ANTHROPOL, V29, P493, DOI 10.1146/annurev.anthro.29.1.493; Soja Edward W., 1989, POSTMODERN GEOGRAPHI; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Strandberg G, 2014, CLIM PAST, V10, P661, DOI 10.5194/cp-10-661-2014; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Stump D, 2013, CURR ANTHROPOL, V54, P268, DOI 10.1086/670330; Stump D, 2010, WORLD DEV, V38, P1251, DOI 10.1016/j.worlddev.2010.02.007; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Sutherland WJ, 2011, METHODS ECOL EVOL, V2, P238, DOI 10.1111/j.2041-210X.2010.00083.x; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Szabo P, 2015, BIOL REV, V90, P997, DOI 10.1111/brv.12141; Szabo P, 2011, CONSERV BIOL, V25, P680, DOI 10.1111/j.1523-1739.2011.01710.x; Szabo P, 2010, J HIST GEOGR, V36, P205, DOI 10.1016/j.jhg.2009.10.005; Tang RF, 2010, SOC NATUR RESOUR, V23, P193, DOI 10.1080/08941920903375503; Taylor D., 2014, TOXIC COMMUNITIES EN; Thom B, 2009, CULT GEOGR, V16, P179, DOI 10.1177/1474474008101516; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Thompson V, 2013, ARCHAEOLOGY HIST ECO; Tomimatsu H, 2009, MOL ECOL, V18, P3918, DOI 10.1111/j.1365-294X.2009.04341.x; Trant AJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12491; Trauernicht C, 2016, ECOSYSTEMS, V19, P896, DOI 10.1007/s10021-016-9973-2; Tsing AL, 2005, FRICTION: AN ETHNOGRAPHY OF GLOBAL CONNECTION, P1; Turner Nancy J, 2013, BC STUDIES, V179, P107, DOI DOI 10.14288/BCS.V0I179.184112; Turner NJ, 2014, ANCIENT PATHWAYS ANC; van der Leeuw S, 2011, ECOL SOC, V16, DOI 10.5751/ES-04341-160402; Veteto JR, 2015, J POLIT ECOL, V22, P357, DOI 10.2458/v22i1.21113; Vipat A, 2014, J ANTHR; Vollan B, 2010, SCIENCE, V330, P923, DOI 10.1126/science.1198349; Walker B, 2006, ECOL SOC, V11; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Werner C, 2009, MIGR LETT, V6, P49; Wiens J, 2012, HIST ENV VARIATION C; Williams M, 2015, ANTHR REV; Williams N, 1993, TRADITIONAL ECOLOGIC; Wolverton S, 2014, J ETHNOBIOL, V34, P273, DOI 10.2993/0278-0771-34.3.273; Woods W. I., 2009, P1, DOI 10.1007/978-1-4020-9031-8_1; Wyndham FS, 2009, J ETHNOBIOL, V29, P271, DOI 10.2993/0278-0771-29.2.271; Yateem A, 2013, ENVIRON SCI POLLUT R, V20, P100, DOI 10.1007/s11356-012-1182-8; Youatt R., 2015, COUNTING SPECIES; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004; Young OR, 2010, GLOBAL ENVIRON CHANG, V20, P378, DOI 10.1016/j.gloenvcha.2009.10.001; Younglove-Webb J, 1999, REV HIGH EDUC, V22, P425; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j	230	58	59	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171883	10.1371/journal.pone.0171883	http://dx.doi.org/10.1371/journal.pone.0171883			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EL5VB	28235093	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200037
J	Ferreira-Santos, L; Martinez, DG; Nicolau, JC; Moreira, HG; Alves, MJ; Pereira, AC; Trombetta, IC; Negrao, CE; Rondon, MUPB				Ferreira-Santos, Larissa; Martinez, Daniel G.; Nicolau, Jose Carlos; Moreira, Humberto G.; Alves, Maria Janieire; Pereira, Alexandre C.; Trombetta, Ivani C.; Negrao, Carlos Eduardo; Rondon, Maria Urbana P. B.			Neurovascular control during exercise in acute coronary syndrome patients with Gln27Glu polymorphism of beta(2)-adrenergic receptor	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; BETA-ADRENERGIC-RECEPTOR; MYOCARDIAL-INFARCTION; HEART-FAILURE; BETA-2-ADRENERGIC RECEPTOR; FUNCTIONAL-CAPACITY; SIGNAL-TRANSDUCTION; GENE POLYMORPHISMS; BLOOD-FLOW; RESPONSES	Background Gln27Glu ( rs1042714) polymorphism of the beta(2)-adrenergic receptor ADRB2) has been association with cardiovascular functionality in healthy subjects. However, it is unknown whether the presence of the ADRB2 Gln27Glu polymorphism influences neurovascular responses during exercise in patients with acute coronary syndromes ACS). We tested the hypothesis that patients with ACS homozygous for the Gln allele would have increased muscle sympathetic nerve activity MSNA) responses and decreased forearm vascular conductance FVC) responses during exercise compared with patients carrying the Glu allele Gln27Glu and Glu27Glu). In addition, exercise training would restore these responses in Gln27Gln patients. Methods and results Thirty-days after an ischemic event, 61 patients with ACS without ventricular dysfunction were divided into 2 groups: 1) Gln27Gln n = 35, 53 +/- 1years) and 2) Gln27Glu+Glu27Glu n = 26, 52 +/- 2years). MSNA was directly measured using the microneurography technique, blood pressure BP) was measured with an automatic oscillometric device, and blood flow was measured using venous occlusion plethysmography. MSNA, mean BP, and FVC were evaluated at rest and during a 3-min handgrip exercise. The MSNA P = 0.02) and mean BP P = 0.04) responses during exercise were higher in the Gln27Gln patients compared with that in the Gln27Glu+Glu27Glu patients. No differences were found in FVC. Two months of exercise training significantly decreased the MSNA levels at baseline P = 0.001) and in their response during exercise P = 0.02) in Gln27Gln patients, but caused no changes in Gln27Glu+Glu27Glu patients. Exercise training increased FVC responses in Gln27Glu +Glu27Glu patients P = 0.03), but not in Gln27Gln patients. Conclusion The exaggerated MSNA and mean BP responses during exercise suggest an increased cardiovascular risk in patients with ACS and Gln27Gln polymorphism. Exercise training emerges as an important strategy for restoring this reflex control. Gln27Glu polymorphism of ADRB2 influences exercise-induced vascular adaptation in patients with ACS.	[Ferreira-Santos, Larissa; Nicolau, Jose Carlos; Moreira, Humberto G.; Alves, Maria Janieire; Pereira, Alexandre C.; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Med, Heart Inst InCor HCFMUSP, Sao Paulo, Brazil; [Ferreira-Santos, Larissa; Negrao, Carlos Eduardo; Rondon, Maria Urbana P. B.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Martinez, Daniel G.] Univ Fed Juiz de Fora, Fac Phys Educ & Sports, Juiz De Fora, Brazil; [Trombetta, Ivani C.] Univ Nove Julho UNINOVE, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade Nove de Julho	Rondon, MUPB (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	urbana@usp.br	Pereira, Alexandre/HHN-1038-2022; Nicolau, Jose C/E-1487-2012; Rondon, Maria Urbana P B/G-5272-2012; Moreira, Humberto Graner/D-2001-2012; Martinez, Daniel Godoy/O-6617-2019; Ferreira-Santos, Larissa/AAB-1954-2021; Martinez, Daniel Godoy/D-9135-2015; Ferreira-Santos, Larissa/I-5972-2015; Negrao, Carlos E/C-4281-2012; Alves, Janieire/G-4548-2010; Trombetta, Ivani C/G-5839-2012	Nicolau, Jose C/0000-0002-9680-3689; Rondon, Maria Urbana P B/0000-0002-4134-6126; Moreira, Humberto Graner/0000-0001-6465-0780; Martinez, Daniel Godoy/0000-0003-0034-7963; Ferreira-Santos, Larissa/0000-0001-5738-1623; Martinez, Daniel Godoy/0000-0003-0034-7963; Ferreira-Santos, Larissa/0000-0001-5738-1623; Alves, Janieire/0000-0003-3207-623X; Trombetta, Ivani C/0000-0002-0979-0091; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2005/59740-7, 2010/50048-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 475911/2013-0, CNPq 301867/2010-0, CNPq 303518/2008-1, 309821/2014-2, CNPq 300588/2013-5]; Fundacao Zerbini; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Zerbini; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2005/59740-7 and 2010/50048-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 475911/2013-0), and in part by Fundacao Zerbini. LF Santos was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CE Negrao (CNPq 301867/2010-0), MUPB Rondon (CNPq 303518/2008-1 and 309821/2014-2), and JC Nicolau (CNPq 300588/2013-5) were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJNN, 2007, CLIN AUTON RES, V17, P364, DOI 10.1007/s10286-007-0448-6; Antunes-Correa LM, 2014, AM J PHYSIOL-HEART C, V307, pH1655, DOI 10.1152/ajpheart.00136.2014; Antunes-Correa LM, 2012, EUR J PREV CARDIOL, V19, P822, DOI 10.1177/1741826711414626; Antunes-Correa LM, 2010, EUR J HEART FAIL, V12, P58, DOI 10.1093/eurjhf/hfp168; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Brawley L, 2000, EUR J PHARMACOL, V398, P285, DOI 10.1016/S0014-2999(00)00319-8; Bruck H, 2003, PHARMACOGENETICS, V13, P59, DOI 10.1097/00008571-200302000-00001; Chuang D M, 1980, Adv Biochem Psychopharmacol, V21, P143; CHUANG DM, 1980, MOL PHARMACOL, V18, P348; CHUANG DM, 1979, P NATL ACAD SCI USA, V76, P3024, DOI 10.1073/pnas.76.6.3024; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; Dalli E, 2002, REV ESP CARDIOL, V55, P928, DOI 10.1016/S0300-8932(02)76731-6; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P82, DOI 10.1111/j.1748-1716.1972.tb05158.x; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Fichtlscherer S, 2004, CIRCULATION, V110, P1926, DOI 10.1161/01.CIR.0000143378.58099.8C; Fraga R, 2007, EUR J HEART FAIL, V9, P630, DOI 10.1016/j.ejheart.2007.03.003; Gomes MJ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8695716; Gowdak MMG, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-55; GRAY DW, 1992, BRIT J PHARMACOL, V107, P684, DOI 10.1111/j.1476-5381.1992.tb14507.x; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; LANDS A. M., 1967, LIFE SCI, V6, P2241, DOI 10.1016/0024-3205(67)90031-8; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; LAROVERE MT, 1988, CIRCULATION, V78, P816, DOI 10.1161/01.CIR.78.4.816; LEFKOWITZ RJ, 1976, BIOCHIM BIOPHYS ACTA, V457, P1, DOI 10.1016/0304-4157(76)90012-5; Linke A, 2008, FRONT BIOSCI-LANDMRK, V13, P424, DOI 10.2741/2689; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Martinez DG, 2013, INT J CARDIOL, V165, P210, DOI 10.1016/j.ijcard.2012.08.042; Martinez DG, 2011, HYPERTENSION, V58, P1049, DOI 10.1161/HYPERTENSIONAHA.111.176644; Mezzani A, 2009, EUR J CARDIOV PREV R, V16, P249, DOI 10.1097/HJR.0b013e32832914c8; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Schurks M, 2009, THROMB HAEMOSTASIS, V101, P351, DOI 10.1160/TH08-05-0284; SHEN WQ, 1995, MED SCI SPORT EXER, V27, P1125; Soares-Miranda L, 2011, INT J CARDIOL, V146, P122, DOI 10.1016/j.ijcard.2010.09.091; Tank J, 2011, CLIN AUTON RES, V21, P333, DOI 10.1007/s10286-011-0121-y; Trombetta IC, 2005, J APPL PHYSIOL, V98, P787, DOI 10.1152/japplphysiol.00503.2004; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wasserman K, 2005, PRINCIPLES EXERCISE; Yilmaz A, 2009, J CLIN LAB ANAL, V23, P237, DOI 10.1002/jcla.20327	43	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173061	10.1371/journal.pone.0173061	http://dx.doi.org/10.1371/journal.pone.0173061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235084	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200193
J	Greenwood, MA; Hammock, EAD				Greenwood, Maria A.; Hammock, Elizabeth A. D.			Oxytocin receptor binding sites in the periphery of the neonatal mouse	PLOS ONE			English	Article							VOLES MICROTUS-OCHROGASTER; MATERNAL-BEHAVIOR; DEFICIENT MICE; FETAL-BRAIN; DELIVERY; RAT; VASOPRESSIN; RECOGNITION; PARTURITION; INTRANASAL	Oxytocin (OXT) is a pleiotropic regulator of physiology and behavior. An emerging body of evidence demonstrates a role for OXT in the transition to postnatal life of the infant. To identify potential sites of OXT action via the OXT receptor (OXTR) in the newborn mouse, we performed receptor autoradiography on 20 m sagittal sections of whole postnatal day 0 male and female mice on a C57BL/6J background using the 125 iodinated ornithine vasotocin analog ([I-125]-OVTA) radioligand. A competitive binding assay on both wild-type (WT) and OXTR knockout (OXTR KO) tissue was used to assess the selectivity of [I-125]-OVTA for neonatal OXTR. Radioactive ligand (0.05 nM [I-125]-OVTA) was competed against concentrations of 0 nM, 10 nM, and 1000 nM excess unlabeled OXT. Autoradiographs demonstrated the high selectivity of the radioligand for infant peripheral OXTR. Specific ligand binding activity for OXTR was observed in the oronasal cavity, the eye, whisker pads, adrenal gland, and anogenital region in the neonatal OXTR WT mouse, but was absent in neonatal OXTR KO. Nonspecific binding was observed in areas with a high lipid content such as the scapular brown adipose tissue and the liver: in these regions, binding was present in both OXTR WT and KO mice, and could not be competed away with OXT in either WT or KO mice. Collectively, these data confirm novel OXT targets in the periphery of the neonate. These peripheral OXTR sites, coupled with the immaturity of the neonate's own OXT system, suggest a role for exogenous OXT in modulating peripheral physiology and development.	[Greenwood, Maria A.; Hammock, Elizabeth A. D.] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Greenwood, Maria A.; Hammock, Elizabeth A. D.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Hammock, EAD (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.; Hammock, EAD (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	ehammock@fsu.edu		Greenwood, Maria/0000-0001-6185-9634	Florida State University	Florida State University	This work was supported by funds from Florida State University. The funder had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; ANG VTY, 1984, J CLIN ENDOCR METAB, V58, P688, DOI 10.1210/jcem-58-4-688; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Bales KL, 2003, BEHAV NEUROSCI, V117, P854, DOI 10.1037/0735-7044.117.4.854; Bisagno V, 2014, BEHAV PHARMACOL, V25, P445, DOI 10.1097/FBP.0000000000000049; BLASS EM, 1984, INFANT BEHAV DEV, V7, P223, DOI 10.1016/S0163-6383(84)80060-0; BROUETTELAHLOU I, 1991, ANIM LEARN BEHAV, V19, P177, DOI 10.3758/BF03197874; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Carter CS, 2003, PHYSIOL BEHAV, V79, P383, DOI 10.1016/S0031-9384(03)00151-3; Dal Monte O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103677; Elands J, 1988, J Chem Neuroanat, V1, P293; ELANDS J, 1988, EUR J PHARMACOL, V147, P197, DOI 10.1016/0014-2999(88)90778-9; Fifer WP, 2010, P NATL ACAD SCI USA, V107, P10320, DOI 10.1073/pnas.1005061107; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Freeman SM, 2016, PSYCHONEUROENDOCRINO, V66, P185, DOI 10.1016/j.psyneuen.2016.01.014; Fuchs AR, 1997, BIOL REPROD, V57, P436, DOI 10.1095/biolreprod57.2.436; GUASTELLA AJ, 2012, HORM BEHAV, V61, P773, DOI DOI 10.1016/j.yhbeh.2012.04.008; Hammock EAD, 2015, NEUROPSYCHOPHARMACOL, V40, P24, DOI 10.1038/npp.2014.120; Hammock EAD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00195; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; Higashida H, 2010, J NEUROENDOCRINOL, V22, P373, DOI 10.1111/j.1365-2826.2010.01976.x; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Jimenez A, 2003, MOL REPROD DEV, V66, P162, DOI 10.1002/mrd.10345; Kenkel WM, 2014, J NEUROENDOCRINOL, V26, P739, DOI 10.1111/jne.12186; Khazipov R, 2008, PROG BRAIN RES, V170, P243, DOI 10.1016/S0079-6123(08)00421-4; Kojima S, 2011, HORM BEHAV, V60, P549, DOI 10.1016/j.yhbeh.2011.08.003; LEAKE RD, 1981, BIOL NEONATE, V39, P127, DOI 10.1159/000241417; LEGROS JJ, 1988, NEUROENDOCRINOLOGY, V48, P204, DOI 10.1159/000125009; Leknes S, 2013, SOC COGN AFFECT NEUR, V8, P741, DOI 10.1093/scan/nss062; Lenz KM, 2010, HORM BEHAV, V58, P575, DOI 10.1016/j.yhbeh.2010.07.010; Macbeth AH, 2009, GENES BRAIN BEHAV, V8, P558, DOI 10.1111/j.1601-183X.2009.00506.x; Mazzuca M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00003; Meziane H., 2014, BIOL PSYCHIAT; MILLER JA, 1987, NEUROSCI LETT, V81, P345, DOI 10.1016/0304-3940(87)90408-3; Mogi K, 2011, PROG NEURO-PSYCHOPH, V35, P1232, DOI 10.1016/j.pnpbp.2010.08.024; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Noonan L, 1994, BRAIN RES DEV BRAIN, V15, P115; Paloyelis Y, 2016, BIOL PSYCHIAT, V79, P693, DOI 10.1016/j.biopsych.2014.10.005; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; Prehn K, 2013, PSYCHOPHYSIOLOGY, V50, P528, DOI 10.1111/psyp.12042; Quintana DS, 2016, MOL PSYCHIATR, V21, P29, DOI 10.1038/mp.2015.166; Reeb-Sutherland BC, 2011, DEVELOPMENTAL SCI, V14, P1134, DOI 10.1111/j.1467-7687.2011.01062.x; Rosenblatt J. S., 1979, Advances in the Study of Behavior, V10, P225, DOI 10.1016/S0065-3454(08)60096-0; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; SULLIVAN RM, 1991, PEDIATRICS, V87, P511; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Tamborski S, 2016, J NEUROENDOCRINOL; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Vaidyanathan R, 2016, DEV NEUROBIOLOGY; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128; WITT DM, 1990, PHARMACOL BIOCHEM BE, V37, P63, DOI 10.1016/0091-3057(90)90042-G; Yamamoto Y, 2004, NEUROSCIENCE, V125, P947, DOI 10.1016/j.neuroscience.2004.02.028; Zheng JJ, 2014, NAT NEUROSCI, V17, P391, DOI 10.1038/nn.3634	58	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172904	10.1371/journal.pone.0172904	http://dx.doi.org/10.1371/journal.pone.0172904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235051	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200166
J	Poshyvailo, L; von Lieres, E; Kondrat, S				Poshyvailo, Liubov; von Lieres, Eric; Kondrat, Svyatoslav			Does metabolite channeling accelerate enzyme-catalyzed cascade reactions?	PLOS ONE			English	Article							DECREASE POOL SIZE; CONSTANT NET FLUX; BROWNIAN DYNAMICS; REACTION-RATES; ANOMALOUS DIFFUSION; SUBSTRATE; BINDING; FLAVOENZYME; SIMULATION; PROTEINS	Metabolite or substrate channeling is a direct transfer of metabolites from one enzyme to the next enzyme in a cascade. Among many potential advantages of substrate channeling, acceleration of the total reaction rate is considered as one of the most important and self-evident. However, using a simple model, supported by stochastic simulations, we show that it is not always the case; particularly at long times (i.e. in steady state) and high substrate concentrations, a channeled reaction cannot be faster, and can even be slower, than the original non-channeled cascade reaction. In addition we show that increasing the degree of channeling may lead to an increase of the metabolite pool size. We substantiate that the main advantage of channeling likely lies in protecting metabolites from degradation or competing side reactions.	[Poshyvailo, Liubov; von Lieres, Eric; Kondrat, Svyatoslav] Forschungszentrum Julich, IBG Biotechnol 1, Julich, Germany; [Poshyvailo, Liubov] Forschungszentrum Julich, IEK Inst Energy & Climate Res 7, Julich, Germany; [Kondrat, Svyatoslav] Univ Stuttgart, Inst Computat Phys, Stuttgart, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Stuttgart	Kondrat, S (corresponding author), Forschungszentrum Julich, IBG Biotechnol 1, Julich, Germany.; Kondrat, S (corresponding author), Univ Stuttgart, Inst Computat Phys, Stuttgart, Germany.	svyatoslav.kondrat@gmail.com	von Lieres, Eric/A-9562-2012; Kondrat, Svyatoslav/ABD-9677-2020	von Lieres, Eric/0000-0002-0309-8408; Poshyvailo-Strube, Liubov/0000-0002-4891-6988; Kondrat, Svyatoslav/0000-0003-4448-0686	Bundesministerium fur Bildung und Forschung [031A129]; BMBF [031A129]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung, Grant Number 031A129.r This work was in part supported by BMBF Grant No. 031A129. We are grateful to Wolfgang Wiechert, Olav Zimmermann, Marco Bocola, Andrey Cherstvy, Stephan Noack and especially Antje Spiess for fruitful and stimulating discussions.	Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Bauler P, 2010, J PHYS CHEM LETT, V1, P1332, DOI 10.1021/jz1002007; BERG OG, 1978, CHEM PHYS, V31, P47, DOI 10.1016/0301-0104(78)87025-6; Bisswanger H., 2008, ENZYME KINETICS PRIN; Buchner A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4823504; Buchner A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208104; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Cherstvy AG, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05010; Cherstvy AG, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/48/485002; COLLINS FC, 1949, J COLL SCI IMP U TOK, V4, P425, DOI 10.1016/0095-8522(49)90023-9; Cornish-Bowden A, 2004, BIOL CELL, V96, P713, DOI 10.1016/j.biolcel.2004.06.006; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; CORNISHBOWDEN A, 1993, EUR J BIOCHEM, V213, P87, DOI 10.1111/j.1432-1033.1993.tb17737.x; CORNISHBOWDEN A, 1991, EUR J BIOCHEM, V195, P103, DOI 10.1111/j.1432-1033.1991.tb15681.x; DeLisa MP, 2009, NAT BIOTECHNOL, V27, P728, DOI 10.1038/nbt0809-728; EASTERBY JS, 1981, BIOCHEM J, V199, P155, DOI 10.1042/bj1990155; Easterby JS, 1990, TEMPORAL ANAL TRANSI, V23, P281; Elcock AH, 1997, BIOCHEMISTRY-US, V36, P16049, DOI 10.1021/bi971709u; Eun C, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4867286; Fange D, 2010, P NATL ACAD SCI USA, V107, P19820, DOI 10.1073/pnas.1006565107; Hill AV, 1910, J PHYSL LOND; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Huber GA, 2010, COMPUT PHYS COMMUN, V181, P1896, DOI 10.1016/j.cpc.2010.07.022; Jandt U, 2013, ADV BIOCHEM ENG BIOT, V137, P41, DOI 10.1007/10_2013_221; Jeon EY, 2015, APPL MICROBIOL BIOT, V99, P6267, DOI 10.1007/s00253-015-6392-9; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kondrat S, 2016, EUR PHYS J E, V39, DOI 10.1140/epje/i2016-16011-0; Kondrat S, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046003; Korzeniewski B, 1997, MOL CELL BIOCHEM, V169, P135, DOI 10.1023/A:1006882029611; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LUTY BA, 1992, J CHEM PHYS, V97, P5682, DOI 10.1063/1.463777; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mendes P, 1996, BBA-GEN SUBJECTS, V1289, P175, DOI 10.1016/0304-4165(95)00152-2; MENDES P, 1992, EUR J BIOCHEM, V204, P257, DOI 10.1111/j.1432-1033.1992.tb16632.x; Metzger VT, 2014, BIOPHYS J, V107, P2394, DOI 10.1016/j.bpj.2014.09.039; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Minton AP, 2006, CURR BIOL, V16, pR269, DOI 10.1016/j.cub.2006.03.047; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NORTHRUP SH, 1984, J CHEM PHYS, V80, P1517, DOI 10.1063/1.446900; Proschel M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00168; Pulkkinen O, 2015, SCI REP-UK, V5, DOI 10.1038/srep17820; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; Rohwer JM, 1998, P NATL ACAD SCI USA, V95, P10547, DOI 10.1073/pnas.95.18.10547; Sanyal N, 2015, J BIOL CHEM, V290, P2225, DOI 10.1074/jbc.M114.625483; Segel IH., 1993, ENZYME KINETICS BEHA; Shearer G, 2005, FEBS J, V272, P3260, DOI 10.1111/j.1742-4658.2005.04712.x; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Smith NE, 2014, BIOPHYS J, V106, P1681, DOI 10.1016/j.bpj.2014.03.013; Smith NE, 2012, BIOPHYS J, V102, P868, DOI 10.1016/j.bpj.2012.01.029; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Wheeldon I, 2016, NAT CHEM, V8, P299, DOI [10.1038/NCHEM.2459, 10.1038/nchem.2459]; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497; You C, 2014, ACS SYNTH BIOL, V3, P380, DOI 10.1021/sb4000993; You C, 2012, ANGEW CHEM INT EDIT, V51, P8787, DOI 10.1002/anie.201202441; Zhang YHP, 2011, BIOTECHNOL ADV, V29, P715, DOI 10.1016/j.biotechadv.2011.05.020; Zhao Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10619	64	30	30	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172673	10.1371/journal.pone.0172673	http://dx.doi.org/10.1371/journal.pone.0172673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234973	Green Published, gold			2022-12-27	WOS:000394688200110
J	Cohen, AD; Nencka, AS; Lebel, RM; Wang, Y				Cohen, Alexander D.; Nencka, Andrew S.; Lebel, R. Marc; Wang, Yang			Multiband multi-echo imaging of simultaneous oxygenation and flow timeseries for resting state connectivity	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; BOLD-CONTRAST SENSITIVITY; FMRI TIME-SERIES; FUNCTIONAL CONNECTIVITY; WHOLE-BRAIN; DIFFERENTIATING BOLD; SIGNAL CHANGES; EPI; MRI; PERFUSION	A novel sequence has been introduced that combines multiband imaging with a multi-echo acquisition for simultaneous high spatial resolution pseudo-continuous arterial spin labeling (ASL) and blood-oxygenation-level dependent (BOLD) echo-planar imaging (MBME ASL/BOLD). Resting-state connectivity in healthy adult subjects was assessed using this sequence. Four echoes were acquired with a multiband acceleration of four, in order to increase spatial resolution, shorten repetition time, and reduce slice-timing effects on the ASL signal. In addition, by acquiring four echoes, advanced multi-echo independent component analysis (ME-ICA) denoising could be employed to increase the signal-to-noise ratio (SNR) and BOLD sensitivity. Seed-based and dual-regression approaches were utilized to analyze functional connectivity. Cerebral blood flow (CBF) and BOLD coupling was also evaluated by correlating the perfusion-weighted timeseries with the BOLD timeseries. These metrics were compared between single echo (E2), multi-echo combined (MEC), multi-echo combined and denoised (MECDN), and perfusion-weighted (PW) timeseries. Temporal SNR increased for the MECDN data compared to the MEC and E2 data. Connectivity also increased, in terms of correlation strength and network size, for the MECDN compared to the MEC and E2 datasets. CBF and BOLD coupling was increased in major resting-state networks, and that correlation was strongest for the MECDN datasets. These results indicate our novel MBME ASL/BOLD sequence, which collects simultaneous high-resolution ASL/BOLD data, could be a powerful tool for detecting functional connectivity and dynamic neurovascular coupling during the resting state. The collection of more than two echoes facilitates the use of ME-ICA denoising to greatly improve the quality of resting state functional connectivity MRI.	[Cohen, Alexander D.; Nencka, Andrew S.; Wang, Yang] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Lebel, R. Marc] GE Healthcare, Calgary, AB, Canada	Medical College of Wisconsin; General Electric	Cohen, AD (corresponding author), Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	acohen@mcw.edu			Daniel M. Soref Charitable Trust; GE Healthcare	Daniel M. Soref Charitable Trust; GE Healthcare(General ElectricGE Healthcare)	This work was partially supported by a grant from the Daniel M. Soref Charitable Trust (to Yang Wang). Author R. Marc Lebel is employed by GE Healthcare. The funder provided support in the form of salary for author RML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Beckmann CF, OHBM 2009; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blicher JU, 2012, J CEREBR BLOOD F MET, V32, P2044, DOI 10.1038/jcbfm.2012.105; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chen JJ, 2015, BRAIN CONNECT, V5, P527, DOI 10.1089/brain.2015.0344; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Dai WY, 2016, J CEREBR BLOOD F MET, V36, P463, DOI 10.1177/0271678X15615339; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Evans JW, 2015, NEUROIMAGE, V105, P189, DOI 10.1016/j.neuroimage.2014.10.051; Faraco CC, 2015, MAGN RESON MED, V73, P1579, DOI 10.1002/mrm.25268; Feinberg DA, 2013, MAGN RESON MED, V70, P1500, DOI 10.1002/mrm.24994; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Geranmayeh F, 2015, HUM BRAIN MAPP, V36, P1755, DOI 10.1002/hbm.22735; Ghariq E, 2014, NEUROIMAGE, V103, P316, DOI 10.1016/j.neuroimage.2014.09.051; Gonzalez-Castillo J, 2016, NEUROIMAGE, V141, P452, DOI 10.1016/j.neuroimage.2016.07.049; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Jann K, 2015, NEUROIMAGE, V106, P111, DOI 10.1016/j.neuroimage.2014.11.028; Jann K, 2013, BRAIN TOPOGR, V26, P569, DOI 10.1007/s10548-013-0280-3; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kim SG, 1997, MAGN RESON MED, V38, P59, DOI 10.1002/mrm.1910380110; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Kundu P, 2015, BRAIN IMAGING BEHAV, V9, P56, DOI 10.1007/s11682-014-9346-4; Kundu P, 2014, NEUROIMAGE, V102, P861, DOI 10.1016/j.neuroimage.2014.07.025; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Lee MS, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-7; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Li XF, 2015, NEUROIMAGE, V106, P170, DOI 10.1016/j.neuroimage.2014.10.029; Liang XY, 2014, NEUROIMAGE, V87, P265, DOI 10.1016/j.neuroimage.2013.11.013; Menon RS, 2002, MAGNET RESON MED, V47, P1, DOI 10.1002/mrm.10041; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nencka AS, 2007, NEUROIMAGE, V37, P177, DOI 10.1016/j.neuroimage.2007.03.075; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Olafsson V, 2015, NEUROIMAGE, V112, P43, DOI 10.1016/j.neuroimage.2015.02.052; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Poser BA, 2006, MAGN RESON MED, V55, P1227, DOI 10.1002/mrm.20900; Poser BA, 2009, NEUROIMAGE, V45, P1162, DOI 10.1016/j.neuroimage.2009.01.007; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Posse S, 2012, NEUROIMAGE, V62, P665, DOI 10.1016/j.neuroimage.2011.10.057; Schmithorst VJ, 2014, J MAGN RESON IMAGING, V39, P1104, DOI 10.1002/jmri.24273; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; St Lawrence KS, 2003, MAGNET RESON MED, V50, P99, DOI 10.1002/mrm.10502; Suchandrima Banerjee AT, 2012, INTERNATIONAL SOCIET; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Whittaker JR, 2016, NEUROIMAGE, V125, P198, DOI 10.1016/j.neuroimage.2015.10.023; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Zhou YX, 2015, MAGN RESON IMAGING, V33, P566, DOI 10.1016/j.mri.2015.02.018; Zhu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065884	65	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0169253	10.1371/journal.pone.0169253	http://dx.doi.org/10.1371/journal.pone.0169253			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253268	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300002
J	Cuomo, F; Roccabianca, S; Dillon-Murphy, D; Xiao, N; Humphrey, JD; Figueroa, CA				Cuomo, Federica; Roccabianca, Sara; Dillon-Murphy, Desmond; Xiao, Nan; Humphrey, Jay D.; Figueroa, C. Alberto			Effects of age-associated regional changes in aortic stiffness on human hemodynamics revealed by computational modeling	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; MECHANICAL CHARACTERIZATION; ASCENDING AORTA; ALL-CAUSE; PRESSURE; RISK; PATHOPHYSIOLOGY; HYPERTENSION; REFLECTION	Although considered by many as the gold standard clinical measure of arterial stiffness, carotid-to-femoral pulse wave velocity (cf-PWV) averages material and geometric properties over a large portion of the central arterial tree. Given that such properties may evolve differentially as a function of region in cases of hypertension and aging, among other conditions, there is a need to evaluate the potential utility of cf-PWV as an early diagnostic of progressive vascular stiffening. In this paper, we introduce a data-driven fluid-solid-interaction computational model of the human aorta to simulate effects of aging-related changes in regional wall properties (e.g., biaxial material stiffness and wall thickness) and conduit geometry (e.g., vessel caliber, length, and tortuosity) on several metrics of arterial stiffness, including distensibility, augmented pulse pressure, and cyclic changes in stored elastic energy. Using the best available biomechanical data, our results for PWV compare well to findings reported for large population studies while rendering a higher resolution description of evolving local and global metrics of aortic stiffening. Our results reveal similar spatio-temporal trends between stiffness and its surrogate metrics, except PWV, thus indicating a complex dependency of the latter on geometry. Lastly, our analysis highlights the importance of the tethering exerted by external tissues, which was iteratively estimated until hemodynamic simulations recovered typical values of tissue properties, pulse pressure, and PWV for each age group.	[Cuomo, Federica; Figueroa, C. Alberto] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Roccabianca, Sara] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Dillon-Murphy, Desmond; Xiao, Nan; Figueroa, C. Alberto] Kings Coll London, Dept Biomed Engn, London, England; [Humphrey, Jay D.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Humphrey, Jay D.] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT USA; [Figueroa, C. Alberto] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Michigan State University; University of London; King's College London; Yale University; University of Michigan System; University of Michigan	Figueroa, CA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Figueroa, CA (corresponding author), Kings Coll London, Dept Biomed Engn, London, England.; Figueroa, CA (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	figueroc@med.umich.edu	Figueroa, C. Alberto/B-7254-2012	Figueroa, C. Alberto/0000-0002-3934-6506; Dillon-Murphy, Desmond/0000-0002-5794-4593	NIH [R01 HL086418, R01 HL105297]; European Research Council [307532]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086418, R01HL105297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grants from the NIH (R01 HL086418, R01 HL105297) and by the European Research Council Starting Grant n. 307532.	Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Alastruey J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0073; Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bellini C, 2014, ANN BIOMED ENG, V42, P488, DOI 10.1007/s10439-013-0928-x; Boutouyrie P, 2008, FUND CLIN PHARMACOL, V22, P241, DOI 10.1111/j.1472-8206.2008.00584.x; Cioffi G, 2016, EUR J PREV CARDIOL; Craiem D, 2012, ANN BIOMED ENG, V40, P1028, DOI 10.1007/s10439-011-0487-y; Cuomo F, 2015, ANN BIOMED ENG, V43, P1555, DOI 10.1007/s10439-015-1272-0; Dillon-Murphy D, 2016, BIOMECH MODEL MECHAN, V15, P857, DOI 10.1007/s10237-015-0729-2; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Ferruzzi J, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029431; Figueroa CA, 2006, COMPUT METHOD APPL M, V195, P5685, DOI 10.1016/j.cma.2005.11.011; Figueroa CA, 2009, COMPUT METHOD APPL M, V198, P3583, DOI 10.1016/j.cma.2008.09.013; Flamini V, 2015, MED ENG PHYS, V37, P48, DOI 10.1016/j.medengphy.2014.10.006; Gaddum NR, 2013, ANN BIOMED ENG, V41, P2617, DOI 10.1007/s10439-013-0854-y; Garcia-Herrera CM, 2013, BIOMECH MODEL MECHAN, V12, P1143, DOI 10.1007/s10237-013-0471-6; Garcia-Herrera CM, 2012, COMPUT METHOD BIOMEC, V15, P185, DOI 10.1080/10255842.2010.520704; Haskett D, 2010, BIOMECH MODEL MECHAN, V9, P725, DOI 10.1007/s10237-010-0209-7; Hodis S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051913; Humphrey JD, 2016, CIRC RES, V118, P379, DOI 10.1161/CIRCRESAHA.115.307722; Humphrey JD, 2002, ANN BIOMED ENG, V30, P509, DOI 10.1114/1.1467676; Jacobsen JCB, 2008, AM J PHYSIOL-REG I, V294, pR1379, DOI 10.1152/ajpregu.00407.2007; Jondeau G, 1999, CIRCULATION, V99, P2677, DOI 10.1161/01.CIR.99.20.2677; Koullias G, 2005, J THORAC CARDIOVASC, V130; Labrosse MR, 2013, J MECH BEHAV BIOMED, V17, P44, DOI 10.1016/j.jmbbm.2012.08.004; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2015, CIRC RES, V116, P1007, DOI 10.1161/CIRCRESAHA.116.303596; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Martin C, 2011, EUR J CARDIO-THORAC, V40, P28, DOI 10.1016/j.ejcts.2010.08.056; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Moireau P, 2012, BIOMECH MODEL MECHAN, V11, P1, DOI 10.1007/s10237-011-0289-z; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Safar ME, 2010, NAT REV CARDIOL, V7, P442, DOI 10.1038/nrcardio.2010.96; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; Sorkin JD, 1999, AM J EPIDEMIOL, V150, P969, DOI 10.1093/oxfordjournals.aje.a010106; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Sugawara J, 2016, AM J HYPERTENS; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121; Vardoulis O, 2011, EUR J VASC ENDOVASC, V42, P704, DOI 10.1016/j.ejvs.2011.08.006; Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Weber T, 2009, J HYPERTENS, V27, P1624, DOI 10.1097/HJH.0b013e32832cb04e; Xiao N, 2012, SYSTEMATIC COMP 1 D, P1; Xiao N, 2013, J COMPUT PHYS, V244, P22, DOI 10.1016/j.jcp.2012.09.016; Zhou J, 1997, P NATL ACAD SCI USA, V94, P14255, DOI 10.1073/pnas.94.26.14255; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	61	38	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173177	10.1371/journal.pone.0173177	http://dx.doi.org/10.1371/journal.pone.0173177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253335	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300086
J	Ji, HH; Wang, YL; Liu, GL; Chang, L; Chen, ZM; Zhou, DS; Xu, XT; Cui, W; Hong, QX; Jiang, LT; Li, JF; Zhou, XH; Li, Y; Guo, ZP; Zha, Q; Niu, YF; Weng, QY; Duan, SW; Wang, QW				Ji, Huihui; Wang, Yunliang; Liu, Guili; Chang, Lan; Chen, Zhongming; Zhou, Dongsheng; Xu, Xuting; Cui, Wei; Hong, Qingxiao; Jiang, Liting; Li, Jinfeng; Zhou, Xiaohui; Li, Ying; Guo, Zhiping; Zha, Qin; Niu, Yanfang; Weng, Qiuyan; Duan, Shiwei; Wang, Qinwen			Elevated OPRD1 promoter methylation in Alzheimer's disease patients	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; DELTA-OPIOID RECEPTORS; DNA METHYLATION; TUMOR SUPPRESSORS; AMYLOID-BETA; RAT-BRAIN; BLOOD; HOMOCYSTEINE; PROTEIN; GENE	Aberrant DNA methylation has been observed in the patients with Alzheimer's disease (AD), a common neurodegenerative disorder in the elderly. OPRD1 encodes the delta opioid receptor, a member of the opioid family of G-protein-coupled receptors. In the current study, we compare the DNA methylation levels of OPRD1 promoter CpG sites (CpG1, CpG2, and CpG3) between 51 AD cases and 63 controls using the bisulfite pyrosequencing technology. Our results show that significantly higher CpG3 methylation is found in AD cases than controls. Significant associations are found between several biochemical parameters (including HDL-C and ALP) and CpG3 methylation. Subsequent luciferase reporter gene assay shows that DNA fragment containing the three OPRD1 promoter CpGs is able to regulate gene expression. In summary, our results suggest that OPRD1 promoter hyper-methylation is associated with the risk of AD.	[Ji, Huihui; Liu, Guili; Chang, Lan; Xu, Xuting; Cui, Wei; Hong, Qingxiao; Jiang, Liting; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China; [Wang, Yunliang; Li, Jinfeng] 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China; [Chen, Zhongming; Zhou, Dongsheng] Ningbo Kangning Hosp, Ningbo, Zhejiang, Peoples R China; [Zhou, Xiaohui] Xinjiang Med Univ, Dept Internal Med Cadres, Affiliated Hosp 1, Urumqi, Peoples R China; [Li, Ying] Ningbo 1 Hosp, Ningbo, Zhejiang, Peoples R China; [Guo, Zhiping] Lishui Univ, Sch Med, Lishui, Zhejiang, Peoples R China; [Zha, Qin; Niu, Yanfang; Weng, Qiuyan] Ningbo Univ, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Xinjiang Medical University; Lishui University; Ningbo University	Duan, SW; Wang, QW (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo, Zhejiang, Peoples R China.; Zha, Q (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo, Zhejiang, Peoples R China.	zhaq666@163.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	li, jinfeng/GVS-5425-2022; Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [81471398, 81070873, 81371469]; 973 program from Ministry of Science and Technology of China [2013CB835100]; National Natural Science Foundation of Zhejiang [LY15090010]; Public technology research and social development project of Zhejiang Province [2015C33155]; Natural Science Foundation of Zhejiang Province [Y15H090032]; Ningbo Natural Science Fund [2014A610257]; Graduate Outstanding Dissertation Fund of Ningbo University [014-F01660148000]; Disciplinary Project of Ningbo University [1301350104900]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program from Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of Zhejiang; Public technology research and social development project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ningbo Natural Science Fund; Graduate Outstanding Dissertation Fund of Ningbo University; Disciplinary Project of Ningbo University; K. C. Wong Magna Fund in Ningbo University	This research was supported by grants from the National Natural Science Foundation of China (81471398, 81070873, and 81371469), the 973 program from the Ministry of Science and Technology of China (2013CB835100), National Natural Science Foundation of Zhejiang (LY15090010), Public technology research and social development project of Zhejiang Province (2015C33155), Natural Science Foundation of Zhejiang Province (Y15H090032), Ningbo Natural Science Fund (2014A610257), Graduate Outstanding Dissertation Fund of Ningbo University (014-F01660148000), the Disciplinary Project of Ningbo University (1301350104900), and the K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the National Natural Science Foundation of China (81471398, 81070873, and 81371469), the 973 program from the Ministry of Science and Technology of China (2013CB835100), National Natural Science Foundation of Zhejiang (LY15090010), Public technology research and social development project of Zhejiang Province (2015C33155), Natural Science Foundation of Zhejiang Province (Y15H090032), Ningbo Natural Science Fund (2014A610257), Graduate Outstanding Dissertation Fund of Ningbo University (014-F01660148000), the Disciplinary Project of Ningbo University (B01350104900), and the K. C. Wong Magna Fund in Ningbo University.	Arosio B, 2012, NEURODEGENER DIS, V10, P207, DOI 10.1159/000333799; Arosio B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/169203; Barfield RT, 2014, GENET EPIDEMIOL, V38, P231, DOI 10.1002/gepi.21789; Chang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110773; Chao D, 2015, ACUPUNCTURE TREATMEN; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Cheng KC, 2013, PHARMACOL THERAPEUT, V139, P334, DOI 10.1016/j.pharmthera.2013.05.002; Cruz-Gordillo P, 2010, BRAIN BEHAV EVOLUT, V76, P154, DOI 10.1159/000320968; de la Monte SM, 2014, EUR NEUROPSYCHOPHARM, V24, P1954, DOI 10.1016/j.euroneuro.2014.06.008; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Dwyer BE, 2004, FREE RADICAL BIO MED, V36, P1471, DOI 10.1016/j.freeradbiomed.2004.03.009; EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Guido M, 2006, CURR PHARM DESIGN, V12, P1001, DOI 10.2174/138161206776055895; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; HILLER JM, 1994, NEUROSCIENCE, V62, P829, DOI 10.1016/0306-4522(94)90480-4; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houtepen LC, 2016, EPIGENOMICS; JANSEN KLR, 1990, NEUROSCIENCE, V39, P613, DOI 10.1016/0306-4522(90)90246-Z; Ji HH, 2015, NEUROSCI LETT, V606, P24, DOI 10.1016/j.neulet.2015.08.027; Kaut O, 2014, DEMENT GERIATR COGN, V38, P10, DOI 10.1159/000357126; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kinoshita M, 2014, NEUROMOL MED, V16, P697, DOI 10.1007/s12017-014-8319-5; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Kreek M J, 1978, Ann N Y Acad Sci, V311, P110, DOI 10.1111/j.1749-6632.1978.tb16769.x; Kubota Takeo, 2013, Rinsho Shinkeigaku, V53, P1339; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Llado-Saz S, 2015, NEUROBIOL AGING, V36, P2791, DOI 10.1016/j.neurobiolaging.2015.06.023; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Mathieu-Kia AM, 2001, BRAIN RES, V893, P121, DOI 10.1016/S0006-8993(00)03302-3; MINAMI M, 1995, NEUROSCI RES, V23, P121, DOI 10.1016/0168-0102(95)00933-K; Miwa K, 2016, J ALZHEIMERS DIS, V49, P503, DOI 10.3233/JAD-150458; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Olianas MC, 2012, MOL PHARMACOL, V81, P154, DOI 10.1124/mol.111.075267; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Polito L, 2016, EXP GERONTOL, V76, P9, DOI 10.1016/j.exger.2016.01.005; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Rhein M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00182; Sarajarvi T, 2015, J ALZHEIMERS DIS, V48, P507, DOI 10.3233/JAD-150221; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; Shang YL, 2015, J CELL BIOCHEM, V116, P252, DOI 10.1002/jcb.24962; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; Vitvitsky VM, 2012, BBA-MOL BASIS DIS, V1822, P1671, DOI 10.1016/j.bbadis.2012.07.004; Wachman EM, 2014, J PEDIATR-US, V165, P472, DOI 10.1016/j.jpeds.2014.05.040; Walton E., 2015, SCHIZOPHR B; Wang GL, 2003, J BIOL CHEM, V278, P40550, DOI 10.1074/jbc.M302879200; Xu LT, 2015, BIOMED PHARMACOTHER, V70, P80, DOI 10.1016/j.biopha.2015.01.014; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	56	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172335	10.1371/journal.pone.0172335	http://dx.doi.org/10.1371/journal.pone.0172335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253273	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300016
J	Martinez, PP; Reiner, RC; Cash, BA; Rodo, X; Mondal, MS; Roy, M; Yunus, M; Faruque, ASG; Huq, S; King, AA; Pascual, M				Martinez, Pamela P.; Reiner, Robert C., Jr.; Cash, Benjamin A.; Rodo, Xavier; Mondal, Mohammad Shahjahan; Roy, Manojit; Yunus, Mohammad; Faruque, A. S. G.; Huq, Sayeeda; King, Aaron A.; Pascual, Mercedes			Cholera forecast for Dhaka, Bangladesh, with the 2015-2016 El Nino: Lessons learned	PLOS ONE			English	Article							TROPICAL PACIFIC; ENDEMIC CHOLERA; CLIMATE; VARIABILITY; DISEASE; LINKS; ENSO; SST	A substantial body of work supports a teleconnection between the El Nino-Southern Oscillation (ENSO) and cholera incidence in Bangladesh. In particular, high positive anomalies during the winter (Dec-Feb) in sea surface temperatures (SST) in the tropical Pacific have been shown to exacerbate the seasonal outbreak of cholera following the monsoons from August to November. Climate studies have indicated a role of regional precipitation over Bangladesh in mediating this long-distance effect. Motivated by this previous evidence, we took advantage of the strong 2015-2016 El Nino event to evaluate the predictability of cholera dynamics for the city in recent times based on two transmission models that incorporate SST anomalies and are fitted to the earlier surveillance records starting in 1995. We implemented a mechanistic temporal model that incorporates both epidemiological processes and the effect of ENSO, as well as a previously published statistical model that resolves space at the level of districts (thanas). Prediction accuracy was evaluated with "out-of-fit" data from the same surveillance efforts (post 2008 and 2010 for the two models respectively), by comparing the total number of cholera cases observed for the season to those predicted by model simulations eight to twelve months ahead, starting in January each year. Although forecasts were accurate for the low cholera risk observed for the years preceding the 2015-2016 El Nino, the models also predicted a high probability of observing a large outbreak in fall 2016. Observed cholera cases up to Oct 2016 did not show evidence of an anomalous season. We discuss these predictions in the context of regional and local climate conditions, which show that despite positive regional rainfall anomalies, rainfall and inundation in Dhaka remained low. Possible explanations for these patterns are given together with future implications for cholera dynamics and directions to improve their prediction for the city.	[Martinez, Pamela P.; Pascual, Mercedes] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Reiner, Robert C., Jr.] Indiana Univ, Bloomington Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Cash, Benjamin A.] George Mason Univ, Ctr Ocean Land Atmosphere Studies, Fairfax, VA 22030 USA; [Rodo, Xavier] Catalan Inst Res & Adv Studies ICREA, Catalunya, Spain; [Rodo, Xavier] ISGlobal, Climate & Hlth Program, Catalunya, Spain; [Mondal, Mohammad Shahjahan] Bangladesh Univ Engn & Technol, Inst Water & Flood Management, Dhaka, Bangladesh; [Roy, Manojit; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Yunus, Mohammad; Faruque, A. S. G.; Huq, Sayeeda] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Chicago; Indiana University System; Indiana University Bloomington; Center for Ocean Land Atmosphere Studies; George Mason University; ICREA; ISGlobal; Bangladesh University of Engineering & Technology (BUET); University of Michigan System; University of Michigan; International Centre for Diarrhoeal Disease Research (ICDDR); University of Michigan System; University of Michigan; The Santa Fe Institute	Pascual, M (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.; Pascual, M (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	pascualmm@uchicago.edu	Mondal, M. Shahjahan/AAG-4055-2021; King, Aaron A/B-8092-2012; Rodó, Xavier/F-7663-2017	King, Aaron A/0000-0001-6159-3207; Rodó, Xavier/0000-0003-4843-6180; Martinez, Pamela/0000-0002-3607-0938; Cash, Benjamin/0000-0003-2295-3112; Yunus, Mohammed/0000-0003-1116-4978	Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate; Department of Homeland Security; Fogarty International Center; National Institutes of Health; MIDAS; National Institute of General Medical Sciences [U54-GM111274]; NSF [AGS 1338427]; NOAA MAPP NOM MAPP [NA140AR4310160]; NASA [NNX14AM19G]; EPRI; NSF (Ecology and Evolution of Infectious Diseases, EEID); ICREA Funding Source: Custom	Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIDAS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NOAA MAPP NOM MAPP; NASA(National Aeronautics & Space Administration (NASA)); EPRI; NSF (Ecology and Evolution of Infectious Diseases, EEID)(National Science Foundation (NSF)); ICREA(ICREA)	Current donors providing unrestricted support to the icddr,b include the Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), the Swedish International Development Cooperative Agency (SIDA) and the Department for International Development (UK Aid). A.A.K. was supported by the Research and Policy in Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security and the Fogarty International Center, National Institutes of Health and by MIDAS, National Institute of General Medical Sciences U54-GM111274. B.A.C acknowledges the support of NSF AGS 1338427, NOAA MAPP NOM MAPP NA140AR4310160, and NASA NNX14AM19G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The case data used in this paper were collected with the support of icddr,b and its donors who provide unrestricted support to icddr,b for its operation and research. We gratefully acknowledge these donors whose names are listed in the funding information. We are also grateful to past programs at NOAA, also jointly with EPRI AND NSF (Ecology and Evolution of Infectious Diseases, EEID) for their support of research at the interface of infectious diseases and climate; these programs enabled the development of the methods applied here.	Akanda AS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009914; Akanda AS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039312; Balandin S, 2009, AUGMENT ALTERN COMM, V25, P1, DOI 10.1080/07434610902813549; Bouma MJ, ECOLOGY ETIOLOGY NEW, V20, P147; Cash BA, 2008, J CLIMATE, V21, P4647, DOI 10.1175/2007JCLI2001.1; Cash BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107223; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Cash BA, 2009, J CLIMATE, V22, P1641, DOI 10.1175/2008JCLI2177.1; Chen MY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009132; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Faisal IM, 2003, NAT HAZARDS, V28, P85, DOI 10.1023/A:1021173832234; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060001; Hashizume M, 2009, EPIDEMIOLOGY, V20, pS153, DOI 10.1097/01.ede.0000362523.13023.65; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Jutla A, 2015, AM J TROP MED HYG, V93, P1179, DOI 10.4269/ajtmh.14-0648; King A.A., 2016, J STAT SOFTW, V69, P1, DOI [10.18637/jss.v069.i12, DOI 10.18637/JSS.V069.I12]; King AA, 2015, P R SOC LONDON B, V282; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Martinez PP, 2016, P NATL ACAD SCI USA, V113, P4092, DOI 10.1073/pnas.1518977113; Matsuda F, 2008, EPIDEMIOL INFECT, V136, P73, DOI 10.1017/S0950268807008175; Nasr-Azadani F, 2015, CLIM RES, V64, P257, DOI 10.3354/cr01310; Pascual M, 2008, CLIM RES, V36, P131, DOI 10.3354/cr00730; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Perez-Saez J, 2016, ADV WATER RESOURCES; Ramirez IJ, 2016, ECOHEALTH, V13, P83, DOI 10.1007/s10393-015-1095-3; Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Roy M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0937-3; Xie PP, 2007, J HYDROMETEOROL, V8, P607, DOI 10.1175/JHM583.1	30	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172355	10.1371/journal.pone.0172355	http://dx.doi.org/10.1371/journal.pone.0172355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253325	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300017
J	Szwarc, MM; Kommagani, R; Peavey, MC; Hai, L; Lonard, DM; Lydon, JP				Szwarc, Maria M.; Kommagani, Ramakrishna; Peavey, Mary C.; Hai, Lan; Lonard, David M.; Lydon, John P.			A bioluminescence reporter mouse that monitors expression of constitutively active beta-catenin	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR PROTEIN; SALIVARY-GLAND TUMORS; FUNCTIONAL INTERACTION; PROGESTERONE-RECEPTOR; IN-VIVO; ACTIVATION; TRANSDIFFERENTIATION; HOMOLOG; SYSTEM	This short technical report describes the generation and characterization of a bioluminescence reporter mouse that is engineered to detect and longitudinally monitor the expression of doxycycline-induced constitutively active beta-catenin. The new responder transgenic mouse contains the TetO-Delta N89 beta-Cat(TMILA) transgene, which consists of the tet-operator followed by a bicistronic sequence encoding a stabilized form of active beta-catenin (Delta N89 beta-catenin), an internal ribosome entry site, and the firefly luciferase gene. To confirm that the transgene operates as designed, TetO-Delta N89 beta-Cat(TMILA) transgenic mouse lines were crossed with an effector mouse that harbors the mouse mammary tumor virus-reverse tetracycline transactivator (MMTV-rtTA) transgene (termed MTB hereon), which primarily targets rtTA expression to the mammary epithelium. Following doxycycline administration, the resultant MTB/Cat(TMILA) bigenic reporter exhibited precocious lobuloalveologenesis, ductal hyperplasia, and mammary adenocarcinomas, which were visualized and monitored by in vivo bioluminescence detection. Therefore, we predict that the TetO-Delta N89 beta-Cat(TMILA) transgenic responder mouse-when crossed with the appropriate effector transgenic D will have wide-applicability to non-invasively monitor the influence of constitutively active beta-catenin expression on cell-fate specification, proliferation, differentiation, and neoplastic transformation in a broad spectrum of target tissues.	[Szwarc, Maria M.; Hai, Lan; Lonard, David M.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kommagani, Ramakrishna] Washington Univ, Sch Med, Dept Obstet Gynecol, St Louis, MO USA; [Peavey, Mary C.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu	Hai, Lan/Y-1993-2018	Kommagani, Ramakrishna/0000-0003-0403-0971	Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant [CPRIT: RP101499]; Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) [K99 HD080742]; NIH/NICHD [U01: HD-076596, R01: HD-042311]; Cancer Center Grant [P30 CA125123]; Knockout Mouse Project; NIH [U54 HG006348];  [U42 HG006352)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD080742, K99HD080742, U01HD076596, R01HD042311] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant; Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cancer Center Grant; Knockout Mouse Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded in part by: a Cancer Prevention Research Institute of Texas pre-doctoral fellowship grant (CPRIT: RP101499 (to MMS)); a Baylor College of Medicine Reproductive Endocrinology and Infertility Fellowship (to MCP); a National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) grant (K99 HD080742 (to RK)); a NIH/NICHD U01: HD-076596 (to DML)); and a NIH/NICHD: R01: HD-042311 grant (to JPL); and Cancer Center Grant (P30 CA125123) Knockout Mouse Project; (KOMP3) Grant (U42 HG006352) to the Genetically Engineered Mouse Core at Baylor College of Medicine and a NIH grant (U54 HG006348) to the Mouse Phenotyping Core at Baylor College of Medicine.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Chandrashekar C, 2011, INT J SURG PATHOL, V19, P433, DOI 10.1177/1066896909346366; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jarde T, 2013, ONCOGENE, V32, P883, DOI 10.1038/onc.2012.103; Kommagani R, 2014, GUIDE INVESTIGATION, P755; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Mukherjee A, 2007, GENESIS, V45, P639, DOI 10.1002/dvg.20336; Mukherjee A, 2011, TRANSGENIC RES, V20, P827, DOI 10.1007/s11248-010-9466-6; Mukherjee A, 2010, FASEB J, V24, P4408, DOI 10.1096/fj.10-157982; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Wend P, 2010, J Stem Cells Regen Med, V6, P134; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173014	10.1371/journal.pone.0173014	http://dx.doi.org/10.1371/journal.pone.0173014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253313	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300058
J	Zou, B; Wan, DL; Li, RL; Han, XM; Li, GJ; Wang, RG				Zou, Bo; Wan, Dongli; Li, Ruili; Han, Xiaomin; Li, Guojing; Wang, Ruigang			Calmodulin-binding protein CBP60g functions as a negative regulator in Arabidopsis anthocyanin accumulation	PLOS ONE			English	Article							PIGMENTATION; GENES; BIOSYNTHESIS; EXPRESSION; FAMILY; SUGAR; SUCROSE; LIGHT; CYTOKININS; INDUCTION	Anthocyanins, a kind of flavonoid, normally accumulate in the flowers and fruits and make them colorful. Anthocyanin accumulation is regulated via the different temporal and spatial expression of anthocyanin regulatory and biosynthetic genes. CBP60g, a calmodulin binding protein, has previously been shown to have a role in pathogen resistance, drought tolerance and ABA sensitivity. In this study, we found that CBP60g repressed anthocyanin accumulation induced by drought, sucrose and kinetin. The expression pattern of CBP60g was in accordance with the anthocyanin accumulation tissues. Real-time qPCR analysis revealed that the anthocyanin biosynthetic genes CHS, CHI and DFR, as well as two members of MBW complex, PAP1, a MYB transcription factor, and TT8, a bHLH transcription factor, were down regulated by CBP60g.	[Zou, Bo; Wan, Dongli; Li, Ruili; Han, Xiaomin; Li, Guojing; Wang, Ruigang] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China; [Wan, Dongli] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Li, Ruili] Wulanchabu Ctr Dis Control & Prevent, Jining, Peoples R China; [Han, Xiaomin] Baotou Med Coll, Dept Histol & Embryol, Baotou, Peoples R China	Inner Mongolia Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Baotou Medical College	Wang, RG (corresponding author), Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China.	wangruigang@imau.edu.cn		Li, Guojing/0000-0001-7882-3523	National Natural Science Foundation of China [31360056]; Inner Mongolia Science & Technology Plan-Innovation Team [20150304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Science & Technology Plan-Innovation Team	This work was supported by National Natural Science Foundation of China (No. 31360056), and Inner Mongolia Science & Technology Plan-Innovation Team (20150304) to Guojing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Das PK, 2012, MOL CELLS, V34, P501, DOI 10.1007/s10059-012-0151-x; Das PK, 2012, MOL CELLS, V34, P93, DOI 10.1007/s10059-012-0114-2; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Guo JC, 2005, J PLANT GROWTH REGUL, V24, P93, DOI 10.1007/s00344-005-0005-2; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; Jeong SW, 2010, PLANT PHYSIOL, V154, P1514, DOI 10.1104/pp.110.161869; Jun JH, 2015, PLANT CELL, V27, P2860, DOI 10.1105/tpc.15.00476; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Peng H, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0888-z; Peng Xin-Xiang, 1996, Acta Botanica Sinica, V38, P463; Pourcel L, 2013, PLANT J, V74, P383, DOI 10.1111/tpj.12129; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; REDDY ASN, 1993, PLANT SCI, V94, P109, DOI 10.1016/0168-9452(93)90012-O; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; SAUNDERS MJ, 1983, DEV BIOL, V99, P41, DOI 10.1016/0012-1606(83)90252-X; Schulz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037287; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Shin DH, 2015, PLANT CELL REP, V34, P805, DOI 10.1007/s00299-015-1743-7; Shin DH, 2013, BIOCHEM BIOPH RES CO, V430, P634, DOI 10.1016/j.bbrc.2012.11.100; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; Tanaka Y, 2008, CURR OPIN BIOTECH, V19, P190, DOI 10.1016/j.copbio.2008.02.015; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Truman W, 2013, PLANT PHYSIOL, V163, P1741, DOI 10.1104/pp.113.227108; Truman W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-216; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Wang L, 2011, PLANT J, V67, P1029, DOI 10.1111/j.1365-313X.2011.04655.x; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107	39	6	7	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173129	10.1371/journal.pone.0173129	http://dx.doi.org/10.1371/journal.pone.0173129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253311	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300080
J	Fievet, B; Bailly-du-Bois, P; Laguionie, P; Morillon, M; Arnaud, M; Cunin, P				Fievet, Bruno; Bailly-du-Bois, Pascal; Laguionie, Philippe; Morillon, Mehdi; Arnaud, Mireille; Cunin, Pascal			A dual pathways transfer model to account for changes in the radioactive caesium level in demersal and pelagic fish after the Fukushima Dai-ichi nuclear power plant accident	PLOS ONE			English	Article							MULTIPLE DETECTION LIMITS; S-LANGUAGE SOFTWARE; WATER-QUALITY DATA; STATISTICAL-ANALYSIS; MARINE PRODUCTS; HALF-LIFE; FOOD; RADIOCESIUM; BIOKINETICS; SIMULATION	The Fukushima Dai-ichi nuclear power plant (FDNPP) accident resulted in radioactive Cs being discharged into the local marine environment. While Cs bioaccumulates in biota and slowly depurates, the Cs concentrated in biota constitutes a source of Cs for animals feeding on each other. The marine biota therefore serves as a pool that recycles Cs, and this recycling process delays depuration in the fish feeding on this biota pool. Because the continental shelf is squeezed between the coast and very deep sea, the demersal marine species are confined to a narrow strip along the coast, close to the source of the radioactive input. Unlike demersal species, however, pelagic species are not restricted to the most contaminated area but instead spend some, if not most, of their time and feeding off-shore, far from the input source. We suggest that the feeding pathway for fish is a box whose size depends on their mobility, and that this feeding box is much larger and less contaminated (because of dilution through distance) for pelagic fish than for demersal fish. The aim of this paper is to test this hypothesis and to propose a simple operational model implementing two transfer routes: from seawater and from feeding. The model is then used to match the observational data in the aftermath of the FDNPP accident.	[Fievet, Bruno; Bailly-du-Bois, Pascal; Laguionie, Philippe; Morillon, Mehdi] IRSN PRP ENV SERIS, Lab Radioecol Cherbourg Octeville, Octeville, France; [Arnaud, Mireille; Cunin, Pascal] IRSN PRP ENV SERIS, Lab Rech Transferts Radionucleides Environm, St Paul Les Durance, France		Fievet, B (corresponding author), IRSN PRP ENV SERIS, Lab Radioecol Cherbourg Octeville, Octeville, France.	bruno.fievet@irsn.fr	Laguionie, Philippe/GPF-5447-2022	Laguionie, Philippe/0000-0002-0065-1837	AMORAD project [ANR-11-RSNR-0002]	AMORAD project	This work was carried out as part of the AMORAD project (French state financial support was managed by the National Agency for Research allocated in the "Investments for the Future" framework programme under reference ANR-11-RSNR-0002).; The authors wish to thank all their other colleagues for contributing to the tedious collection of data from the Internet, correcting typing errors and lastly formatting the data as rich and useful databases. They are also indebted to Frederic Fievet for his support in the mathematics. This work was co-funded by the AMORAD project (French state financial support was managed by the National Agency for Research allocated in the "Investments for the Future" framework programme under reference ANR-11-RSNR-0002).	Bezhenar R, 2016, BIOGEOSCIENCES, V13, P3021, DOI 10.5194/bg-13-3021-2016; Buesseler KO, 2012, SCIENCE, V338, P480, DOI 10.1126/science.1228250; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; du Bois PB, 2014, OCEAN DYNAM, V64, P361, DOI 10.1007/s10236-013-0682-5; DUMAS F., 2005, OCEAN MODEL, V9, P169, DOI [DOI 10.1016/j.ocemod.2004.07.004, DOI 10.HTTPS://D0I.0RG/10.1016/J.0CEM0D.2004.07.004]; Fievet B, 2003, J ENVIRON RADIOACTIV, V65, P91, DOI 10.1016/S0265-931X(02)00090-5; Fievet B, 2006, J ENVIRON RADIOACTIV, V90, P173, DOI 10.1016/j.jenvrad.2006.06.014; Fievet B, 2013, ENVIRON SCI TECHNOL, V47, P6696, DOI 10.1021/es400896t; Fievet B, 2010, J ENVIRON RADIOACTIV, V101, P1, DOI 10.1016/j.jenvrad.2009.07.007; Gomez L.S., 1991, SAND891585 SAND NAT; Helsel D. R., 2005, NONDETECTS DATA ANAL; HEWETT CJ, 1978, J FISH BIOL, V13, P143, DOI 10.1111/j.1095-8649.1978.tb03422.x; IAEA, 2014, IAEA TECHN REP SER, P479; IAEA, 2004, TECHN REP SER, V422; ISAACS JD, 1973, MAR BIOL, V22, P97, DOI 10.1007/BF00391775; Korsakissok I, 2013, ATMOS ENVIRON, V70, P267, DOI 10.1016/j.atmosenv.2013.01.002; Lee L, 2005, COMPUT GEOSCI-UK, V31, P1241, DOI 10.1016/j.cageo.2005.03.012; Lee L., 2013, NADA NONDETECTS DATA; Lee L, 2007, COMPUT GEOSCI-UK, V33, P696, DOI 10.1016/j.cageo.2006.09.006; Matsumoto A, 2015, J ENVIRON RADIOACTIV, V150, P68, DOI 10.1016/j.jenvrad.2015.08.003; R Development Core Team, 2012, R LANG ENV STAT COMP; Shigenobu Y., 2015, IMPACTS FUKUSHIMA NU, P91; Sohtome T, 2014, J ENVIRON RADIOACTIV, V138, P106, DOI 10.1016/j.jenvrad.2014.08.008; Tagami K, 2016, ENVIRON SCI TECHNOL, V50, P1804, DOI 10.1021/acs.est.5b04952; Tateda Y, 2017, J ENVIRON RADIOACTIV, V166, P67, DOI 10.1016/j.jenvrad.2016.02.028; Tateda Y, 2015, J ENVIRON RADIOACTIV, V147, P130, DOI 10.1016/j.jenvrad.2015.05.025; Tateda Y, 2013, J ENVIRON RADIOACTIV, V124, P1, DOI 10.1016/j.jenvrad.2013.03.007; Wada T, 2016, J ENVIRON RADIOACTIV, V164, P312, DOI 10.1016/j.jenvrad.2016.06.028; Wada T, 2013, J ENVIRON RADIOACTIV, V124, P246, DOI 10.1016/j.jenvrad.2013.05.008; Young D.R., 1978, Coastal Waters Research Project Annual Report, V1978, P185	30	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172442	10.1371/journal.pone.0172442	http://dx.doi.org/10.1371/journal.pone.0172442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248982	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500042
J	Kitsiou, S; Pare, G; Jaana, M; Gerber, B				Kitsiou, Spyros; Pare, Guy; Jaana, Mirou; Gerber, Ben			Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews	PLOS ONE			English	Article							HOME TELEMONITORING INTERVENTIONS; SELF-MANAGEMENT; GLYCEMIC CONTROL; HEALTH; ADOLESCENTS; EDUCATION; QUALITY; DISEASE; PHONES; ADULTS	Background Diabetes is a common chronic disease that places an unprecedented strain on health care systems worldwide. Mobile health technologies such as smartphones, mobile applications, and wearable devices, known as mHealth, offer significant and innovative opportunities for improving patient to provider communication and self-management of diabetes. Objective The purpose of this overview is to critically appraise and consolidate evidence from multiple systematic reviews on the effectiveness of mHealth interventions for patients with diabetes to inform policy makers, practitioners, and researchers. Methods A comprehensive search on multiple databases was performed to identify relevant systematic reviews published between January 1996 and December 2015. Two authors independently selected reviews, extracted data, and assessed the methodological quality of included reviews using AMSTAR. Results Fifteen systematic reviews published between 2008 and 2014 were eligible for inclusion. The quality of the reviews varied considerably and most of them had important methodological limitations. Focusing on systematic reviews that offered the most direct evidence, this overview demonstrates that on average, mHealth interventions improve glycemic control (HbA1c) compared to standard care or other non-mHealth approaches by as much as 0.8% for patients with type 2 diabetes and 0.3% for patients with type 1 diabetes, at least in the short-term (<= 12 months). However, limitations in the overall quality of evidence suggest that further research will likely have an important impact in these estimates of effect. Conclusions Findings are consistent with clinically relevant improvements, particularly with respect to patients with type 2 diabetes. Similar to home telemonitoring, mHealth interventions represent a promising approach for self-management of diabetes.	[Kitsiou, Spyros] Univ Illinois, Dept Biomed & Hlth Informat Sci, Coll Appl Hlth Sci, Chicago, IL 60607 USA; [Pare, Guy] HEC Montreal, Res Chair Digital Hlth, Dept Informat Technol, Montreal, PQ, Canada; [Jaana, Mirou] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada; [Gerber, Ben] Univ Illinois, Coll Med, Acad Internal Med & Geriatr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universite de Montreal; HEC Montreal; University of Ottawa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kitsiou, S (corresponding author), Univ Illinois, Dept Biomed & Hlth Informat Sci, Coll Appl Hlth Sci, Chicago, IL 60607 USA.	skitsiou@uic.edu		Kitsiou, Spyros/0000-0002-5281-321X; Gerber, Ben/0000-0003-4367-6396				Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS72, DOI 10.2337/dc16-S012; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS60, DOI 10.2337/dc16-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Arnhold M, 2014, J MED INTERNET RES, V16, P34, DOI 10.2196/jmir.2968; Baron Justine, 2012, J Diabetes Sci Technol, V6, P1185; Becker L.A., 2008, COCHRANE HDB SYSTEMA, V607, P607; Breland JY, 2013, TRANSL BEHAV MED, V3, P277, DOI 10.1007/s13142-013-0205-4; Buhi ER, 2013, HEALTH EDUC J, V72, P564, DOI 10.1177/0017896912452071; Cafazzo JA, 2012, J MED INTERNET RES, V14, P171, DOI 10.2196/jmir.2058; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; DEJONGH T, 2012, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD007459.PUB2; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gerber BS, 2007, DIABETES TECHNOL THE, V9, P60, DOI 10.1089/dia.2006.0058; Goyal S, 2013, QJM-INT J MED, V106, P1067, DOI 10.1093/qjmed/hct203; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Herbert L, 2013, DIABETES TECHNOL THE, V15, P362, DOI 10.1089/dia.2012.0291; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; International Telecommunication Union, 2014, COMMUNICATION; Kitsiou S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4174; Kitsiou S, 2013, J MED INTERNET RES, V15, P216, DOI 10.2196/jmir.2770; Krishna Santosh, 2008, J Diabetes Sci Technol, V2, P509; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x; Pal K, 2013, THE COCHRANE DATABAS, V3; Pal K, 2014, DIABETES CARE, V37, P1759, DOI 10.2337/dc13-1386; Pare G, 2016, EUR J INFORM SYST, V25, P493, DOI 10.1057/s41303-016-0020-3; Pare G, 2015, INFORM MANAGE-AMSTER, V52, P183, DOI 10.1016/j.im.2014.08.008; Pillay J, 2015, ANN INTERN MED, V163, P836, DOI 10.7326/M15-1399; Powers MA, 2015, DIABETES CARE, V38, P1372, DOI 10.2337/dc15-0730; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Russell-Minda Elizabeth, 2009, J Diabetes Sci Technol, V3, P1460; Saffari M, 2014, PRIM CARE DIABETES, V8, P275, DOI 10.1016/j.pcd.2014.03.004; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sutcliffe P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-1; Tao D, 2013, J TELEMED TELECARE, V19, P133, DOI 10.1177/1357633X13479701; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; Worswick J, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-26	41	150	150	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173160	10.1371/journal.pone.0173160	http://dx.doi.org/10.1371/journal.pone.0173160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249025	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500079
J	Terawaki, K; Kashiwase, Y; Sawada, Y; Hashimoto, H; Yoshimura, M; Ohbuchi, K; Sudo, Y; Suzuki, M; Miyano, K; Shiraishi, S; Higami, Y; Yanagihara, K; Hattori, T; Kase, Y; Ueta, Y; Uezono, Y				Terawaki, Kiyoshi; Kashiwase, Yohei; Sawada, Yumi; Hashimoto, Hirofumi; Yoshimura, Mitsuhiro; Ohbuchi, Katsuya; Sudo, Yuka; Suzuki, Masami; Miyano, Kanako; Shiraishi, Seiji; Higami, Yoshikazu; Yanagihara, Kazuyoshi; Hattori, Tomohisa; Kase, Yoshio; Ueta, Yoichi; Uezono, Yasuhito			Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y-INNERVATION; LEUKEMIA-INHIBITORY FACTOR; CISPLATIN-INDUCED ANOREXIA; NUDE-MICE; ARCUATE NUCLEUS; HERBAL MEDICINE; 5-HT2C RECEPTOR; PLASMA GHRELIN; MELANOMA-CELLS	Cancer cachexia (CC) is a multifactorial disease characterized by decreased food intake and loss of body weight due to reduced musculature with or without loss of fat mass. Patients with gastric cancer have a high incidence of cachexia. We previously established a novel CC rat model induced by human gastric cancer-derived 85As2 cells in order to examine the pathophysiology of CC and identify potential therapeutics. In patients with CC, anorexia is often observed, despite elevation of ghrelin, suggesting that ghrelin resistance may develop in these patients. In this study, we aimed to clarify the occurrence of ghrelin resistance in CC rats accompanied by anorexia and we investigated whether rikkunshito (RKT), a traditional Japanese Kampo medicine that potentiates ghrelin signaling, ameliorated CC-related anorexia through alleviation of ghrelin resistance. 85As2-tumor-bearing rats developed severe CC symptoms, including anorexia and loss of body weight/musculature, with the latter symptoms being greater in cachectic rats than in non-tumor-bearing or pair-fed rats. CC rats showed poor responses to intraperitoneal injection of ghrelin. In CC rats, plasma ghrelin levels were elevated and hypothalamic anorexigenic peptide mRNA levels were decreased, whereas hypothalamic growth hormone secretagogue receptor (GHS-R) mRNA was not affected. In vitro, RKT directly enhanced ghrelin-induced GHS-R activation. RKT administrated orally for 7 days partly alleviated the poor response to ghrelin and ameliorated anorexia without affecting the elevation of plasma ghrelin levels in CC rats. The expression of hypothalamic orexigenic neuropeptide Y mRNA but not hypothalamic GHS-R mRNA was increased by RKT. Thus, the 85As2 cell-induced CC rat model developed ghrelin resistance, possibly contributing to anorexia and body weight loss. The mechanism through which RKT ameliorated anorexia in the CC rat model may involve alleviation of ghrelin resistance by enhancement of ghrelin signaling. These findings suggest that RKT may be a promising agent for the treatment of CC.	[Terawaki, Kiyoshi; Kashiwase, Yohei; Sawada, Yumi; Ohbuchi, Katsuya; Sudo, Yuka; Suzuki, Masami; Miyano, Kanako; Shiraishi, Seiji; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo, Japan; [Terawaki, Kiyoshi; Ohbuchi, Katsuya; Hattori, Tomohisa; Kase, Yoshio] Tsumura & Co, Tsumura Res Labs, Kampo Sci Strategies Div, Ami, Ibaraki, Japan; [Kashiwase, Yohei; Sudo, Yuka; Higami, Yoshikazu] Tokyo Univ Sci, Lab Mol Pathol & Metab Dis, Fac Pharmaceut Sci, Noda, Chiba, Japan; [Hashimoto, Hirofumi; Yoshimura, Mitsuhiro; Ueta, Yoichi] Univ Occupat & Environm Hlth, Dept Physiol, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Biomarker Discovery, Kashiwa, Chiba, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Support Canc Res, Chuo Ku, Tokyo, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tokyo, Japan	National Cancer Center - Japan; Tsumura & Company; Tokyo University of Science; University of Occupational & Environmental Health - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Uezono, Y (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo, Japan.; Uezono, Y (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Support Canc Res, Chuo Ku, Tokyo, Japan.; Uezono, Y (corresponding author), Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tokyo, Japan.	yuezono@ncc.go.jp	Shiraishi, Seiji/GPX-5566-2022	Hashimoto, Hirofumi/0000-0003-1575-836X; Higami, Yoshikazu/0000-0003-1381-0777; Miyano, Kanako/0000-0003-1673-6074	Ministry of Education, Culture, Sports, Science and Technology, Japan [22590510, 24590740]; Foundation for Promotion of Cancer Research in Japan; Ministry of Health, Labour and Welfare, Japan [H22-General-035]; Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine [15lk0310003h0001, 16lk0310020h0001]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15ck0106059h0002, 16nk0101311h0002]; National Cancer Center Research and Development Fund [23-A-2, 23-A-29, 23-A-38]; Tsumura & Co. (Ibaraki, Japan); Grants-in-Aid for Scientific Research [16K08537] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research in Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Tsumura & Co. (Ibaraki, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support was provided to KT by: 1. Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan [http://www.jsps.go.jp/j-grantsinaid/index.html] Grant no. 22590510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. The Foundation for Promotion of Cancer Research in Japan [http://www.ncc.go.jp/jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant support was provided to Y. Uezono by: 1. The Third-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare, Japan; [http://www.mhlw.go.jp/] Grant no. H22-General-035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; [http://www.jsps.go.jp/j-grantsinaid/index.html] Grant no. 24590740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. Grants from the Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine [http://www.amed.go.jp/] Grant no. 15lk0310003h0001, 16lk0310020h0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 4. The Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED; [http://www.amed.go.jp/] Grant no. 15ck0106059h0002, 16nk0101311h0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 5. The National Cancer Center Research and Development Fund [http://www.ncc.go.jp/jp/] Grant nos. 23-A-2, 23-A-29, and 23-A-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 6. A grant from Tsumura & Co. (Ibaraki, Japan) [https://www.tsumura.co.jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2012, HEPATO-GASTROENTEROL, V59, P62, DOI 10.5754/hge11246; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Broberger C, 1999, NEUROENDOCRINOLOGY, V70, P295, DOI 10.1159/000054490; Chang JWC, 2003, J ENDOCRINOL, V179, P387, DOI 10.1677/joe.0.1790387; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fekete C, 2001, ENDOCRINOLOGY, V142, P2606, DOI 10.1210/en.142.6.2606; Fujitsuka N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.25; Fujitsuka N, 2016, MOL PSYCHIATR; Fujitsuka N, 2009, BIOL PSYCHIAT, V65, P748, DOI 10.1016/j.biopsych.2008.10.031; Garcia JM, 2005, J CLIN ENDOCR METAB, V90, P2920, DOI 10.1210/jc.2004-1788; Grossberg AJ, 2010, ENDOCRINOLOGY, V151, P606, DOI 10.1210/en.2009-1135; Hanada T, 2003, BIOCHEM BIOPH RES CO, V301, P275, DOI 10.1016/S0006-291X(02)03028-0; Hayakawa T, 1999, DRUG EXP CLIN RES, V25, P211; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Legradi G, 1998, ENDOCRINOLOGY, V139, P3262, DOI 10.1210/en.139.7.3262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumura T, 2010, J GASTROENTEROL, V45, P300, DOI 10.1007/s00535-009-0166-z; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; MORI M, 1991, CANCER RES, V51, P6656; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; PAXINOS G, 1982, THE RAT BRAIN IN STE; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; Ravasco P, 2004, SUPPORT CARE CANCER, V12, P246, DOI 10.1007/s00520-003-0568-z; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Shimizu Y, 2003, CLIN CANCER RES, V9, P774; Suzuki H, 2014, NEUROGASTROENT MOTIL, V26, P950, DOI 10.1111/nmo.12348; Suzuki H, 2009, NEUROGASTROENT MOTIL, V21, P688, DOI 10.1111/j.1365-2982.2009.01290.x; Suzuki M, 2012, SYNAPSE, V66, P747, DOI 10.1002/syn.21559; Tack J, 2006, GUT, V55, P327, DOI 10.1136/gut.2004.060426; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Terawaki K, 2014, AM J PHYSIOL-ENDOC M, V306, pE373, DOI 10.1152/ajpendo.00116.2013; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tominaga K, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1093/ECAM/NEP173; TONI R, 1990, ENDOCRINOLOGY, V126, P2444, DOI 10.1210/endo-126-5-2444; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vettor R, 2002, J ENDOCRINOL INVEST, V25, P836, DOI 10.1007/BF03344047; Walsh D, 2002, SUPPORT CARE CANCER, V10, P385, DOI 10.1007/s00520-001-0318-z; Wang W, 2006, INT J ONCOL, V28, P1393; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Yakabi K, 2010, REGUL PEPTIDES, V161, P97, DOI 10.1016/j.regpep.2010.02.003; Yanagihara K, 2013, NUTR CANCER, V65, P578, DOI 10.1080/01635581.2013.776089; Yanai M, 2013, J GASTROENTEROL, V48, P611, DOI 10.1007/s00535-012-0687-8; Yoshimura M, 2013, PEPTIDES, V46, P13, DOI 10.1016/j.peptides.2013.04.019; Zaki MH, 2004, INT J CANCER, V111, P592, DOI 10.1002/ijc.20270	52	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173113	10.1371/journal.pone.0173113	http://dx.doi.org/10.1371/journal.pone.0173113			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249026	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500077
J	Zhou, FC; Wang, CY; Ungvari, GS; Ng, CH; Zhou, Y; Zhang, L; Zhou, JJ; Shum, DHK; Man, D; Liu, DT; Li, J; Xiang, YT				Zhou, Fu-Chun; Wang, Chuan-Yue; Ungvari, Gabor S.; Ng, Chee H.; Zhou, Yan; Zhang, Liang; Zhou, Jingjing; Shum, David H. K.; Man, David; Liu, Deng-Tang; Li, Jun; Xiang, Yu-Tao			Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; NONAFFECTIVE PSYCHOSIS; SPECTRUM DISORDERS; COGNITIVE DEFICITS; BRAIN-REGIONS; 1ST EPISODE; HIGH-RISK; IMPAIRMENT; METAANALYSIS; PERFORMANCE	This study aimed to investigate prospective memory (PM) and the association with clinical factors at 1-year follow-up in first-episode schizophrenia (FES). Thirty-two FES patients recruited from a university-affiliated psychiatric hospital in Beijing and 17 healthy community controls (HCs) were included. Time-and event-based PM (TBPM and EBPM) performances were measured with the Chinese version of the Cambridge Prospective Memory Test (CCAMPROMPT) at baseline and at one-year follow-up. A number of other neurocognitive tests were also administered. Remission was determined at the endpoint according to the PANSS score <= 3 for selected items. Repeated measures analysis of variance revealed a significant interaction between time (baseline vs. endpoint) and group (FES vs. HCs) for EBPM (F-(1,F- (44)) = 8.8, p = 0.005) and for all neurocognitive components. Paired samples t-tests showed significant improvement in EBPM in FES (13.1 +/- 3.7 vs. 10.3 +/- 4.8; t = 3.065, p = 0.004), compared to HCs (15.7 +/- 3.6 vs. 16.5 +/- 2.3; t = -1.248, p = 0.230). A remission rate of 59.4% was found in the FES group. Analysis of covariance revealed that remitters performed significantly better on EBPM (14.9 +/- 2.6 vs. 10.4 +/- 3.6; F-(1,F- 25) = 12.2, p = 0.002) than non-remitters at study endpoint. The association between EBPM and 12-month clinical improvement in FES suggests that EBPM may be a potential neurocognitive marker for the effectiveness of standard pharmacotherapy. Furthermore, the findings also imply that PM may not be strictly a trait-related endophenotype as indicated in previous studies.	[Zhou, Fu-Chun; Wang, Chuan-Yue; Zhou, Yan; Zhang, Liang; Zhou, Jingjing] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Shum, David H. K.] Griffith Univ, Queensland & Sch Appl Psychol, Menzies Hlth Inst, Gold Coast, Qld, Australia; [Man, David] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Liu, Deng-Tang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Li, Jun] State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Li, Jun] IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Li, Jun] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Peoples R China	Capital Medical University; University of Notre Dame Australia; University of Western Australia; University of Melbourne; Griffith University; Menzies Health Institute Queensland; Hong Kong Polytechnic University; Shanghai Jiao Tong University; Beijing Normal University; University of Macau	Xiang, YT (corresponding author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Peoples R China.	xyutly@gmail.com	Wang, Chuan-Yue/C-9369-2015; Shum, David H. K./A-3914-2008	Wang, Chuan-Yue/0000-0001-6549-3713; Ng, Chee/0000-0002-3811-2732; Shum, David H. K./0000-0002-4810-9262	National Natural Science Foundation of China [81171270, 30800367, 30770776]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201403]; Beijing Sciences and Technology Nova Program [2008659]; National Scientific and Technical Supporting Programs of China [2007BAI17604]; National High Technology Research and Development Program of China (863 Program) [2009AA022702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Sciences and Technology Nova Program; National Scientific and Technical Supporting Programs of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	The study was supported by the following agencies and funds: National Natural Science Foundation of China (Grant No. 81171270, 30800367, 30770776), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201403), Beijing Sciences and Technology Nova Program (Grant No. 2008659), National Scientific and Technical Supporting Programs of China (Grant No. 2007BAI17604), and the National High Technology Research and Development Program of China (863 Program. Grant No. 2009AA022702).; The study was supported by the following agencies and funds: National Natural Science Foundation of China (Grant No. 81171270, 30800367, 30770776), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201403), Beijing Sciences and Technology Nova Program (Grant No. 2008B59), National Scientific and Technical Supporting Programs of China (Grant No. 2007BAI17B04), and the National High Technology Research and Development Program of China (863 Program. Grant No. 2009AA022702). No investigator benefited from participating in this study. The authors are grateful to Barbara A. Wilson, Hazel Emslie, Jennifer Foley, Agnes Shiel, Peter Watson, Kari Hawkins, Yvonne Groot and Jonathan J. Evans, who allowed us to use the CAMPROMT in this study.	Albus M, 2006, EUR ARCH PSY CLIN N, V256, P442, DOI 10.1007/s00406-006-0667-1; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Burgess P.W., 2007, ROLE ROSTRAL PREFRON; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chan RCK, 2008, SCHIZOPHR RES, V103, P229, DOI 10.1016/j.schres.2008.02.019; Chen XJ, 2016, NEUROPSYCHOLOGY, V30, P169, DOI 10.1037/neu0000225; Cheung EFC, 2015, SCHIZOPHR RES, V169, P147, DOI 10.1016/j.schres.2015.09.015; Crespo-Facorro B, 2009, J CLIN PSYCHIAT, V70, P717, DOI 10.4088/JCP.08m04634; Einstein G. O., 1995, MEM COGNITION, V21, P996, DOI [10.1037/0278-7393.21.4.996, DOI 10.1037/0278-7393.21.4.996]; Einstein G. O., 1990, MEM COGNITION, V16, P717, DOI [10.1037/0278-7393.16.4.717, DOI 10.1037/0278-7393.16.4.717]; Elvevag B, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-9; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; He Y.L., 1997, J CLIN PSYCHIAT, V7, P353; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Hill SK, 2004, SCHIZOPHR RES, V68, P49, DOI 10.1016/S0920-9964(03)00213-5; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Kay S.R., 1991, POSITIVE NEGATIVE SY; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kurtz MM, 2005, SCHIZOPHR RES, V74, P15, DOI 10.1016/j.schres.2004.07.005; Leeson VC, 2011, SCHIZOPHRENIA BULL, V37, P768, DOI 10.1093/schbul/sbp143; Lou Z., 2009, THESIS; Lui SSY, 2015, J PSYCHIATR RES, V61, P141, DOI 10.1016/j.jpsychires.2014.11.007; Man DW, 2015, NEUROPSYCHOL REHABIL, P1; Rodriguez-Sanchez JM, 2013, SCHIZOPHR RES, V150, P121, DOI 10.1016/j.schres.2013.06.042; Martin T, 2007, INT J PSYCHOPHYSIOL, V64, P247, DOI 10.1016/j.ijpsycho.2006.09.010; Matza LS, 2006, SCHIZOPHRENIA BULL, V32, P666, DOI 10.1093/schbul/sbl004; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McIntosh AM, 2011, BIOL PSYCHIAT, V69, P953, DOI 10.1016/j.biopsych.2010.11.003; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Nasrallah HA, 2009, J CLIN PSYCHIAT, V70, P4, DOI 10.4088/JCP.7124su1cj; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Reichenberg A, 2006, J CLIN EXP NEUROPSYC, V28, P193, DOI 10.1080/13803390500360372; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Ritsner MS, 2009, HANDBOOK OF NEUROPSYCHIATRIC BIOMARKERS, ENDOPHENOTYPES AND GENES, VOL 1, P3, DOI 10.1007/978-1-4020-9464-4_1; [石川 Shi Chuan], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P343; Rodriguez-Sanchez JM, 2008, SCHIZOPHR RES, V104, P165, DOI 10.1016/j.schres.2008.05.020; Schennach-Wolff R, 2011, EUROPEAN NEUROPSYCHO; Seaton BE, 2001, NEUROPSYCHOL REV, V11, P45, DOI 10.1023/A:1009013718684; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Slade P, 2001, J CARDIOTHOR VASC AN, V15, P4, DOI 10.1053/jcan.2001.20284; Swerdlow NR, 2011, SCHIZOPHR RES, V130, P1, DOI 10.1016/j.schres.2011.05.004; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; Takahashi S, 2013, AM J MED GENET B, V162, P648, DOI 10.1002/ajmg.b.32161; Torgalsboen AK, 2015, PSYCHIAT RES, V227, P185, DOI 10.1016/j.psychres.2015.03.037; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Ungvari GS, 2008, ARCH CLIN NEUROPSYCH, V23, P613, DOI 10.1016/j.acn.2008.06.005; Wang Y, 2008, SCHIZOPHR RES, V105, P114, DOI 10.1016/j.schres.2008.07.002; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Wang Y, 2008, SCHIZOPHR RES, V106, P70, DOI 10.1016/j.schres.2007.07.020; Whyte MC, 2006, BIOL PSYCHIAT, V59, P730, DOI 10.1016/j.biopsych.2005.08.028; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Wilson BA, 2005, CAMBRIDGE PROSPECTIV; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Zhou FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111562; Zhou FC, 2014, PERSPECT PSYCHIATR C, V50, P102, DOI 10.1111/ppc.12027; Zhou FC, 2012, SCHIZOPHR RES, V135, P34, DOI 10.1016/j.schres.2011.12.001; Zhuo KM, 2013, SCHIZOPHR RES, V143, P285, DOI 10.1016/j.schres.2012.12.002	67	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172114	10.1371/journal.pone.0172114	http://dx.doi.org/10.1371/journal.pone.0172114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245266	gold, Green Published			2022-12-27	WOS:000395980200011
J	Ishikawa, M; Park, Y; Kitazaki, M; Itakura, S				Ishikawa, Mitsuhiko; Park, Yun-hee; Kitazaki, Michiteru; Itakura, Shoji			Social information affects adults' evaluation of fairness in distributions: An ERP approach	PLOS ONE			English	Article							NEGATIVITY BIAS; BRAIN POTENTIALS; NEURAL BASIS; ATTENTION; INTENTIONALITY; NEUROSCIENCE; EMOTION	The sense of fairness has been observed in early infancy. Because many studies of fairness in adults have used economic games such as the Ultimatum Game, it has been difficult to compare fairness between adults and infants. Further, recent studies have suggested that social information about actors who behave fairly or unfairly may influence the judgement of fairness in infants. Therefore, to compare the sense of fairness between infants and adults, the study using paradigm in infant research is required. We examined how social information about two characters, either prosocial or antisocial, affects the event-related potential response (ERP) to fair or unfair resource distributions in adults. In the habituation phase, participants were informed about characters' social information through their actions. One character then distributed resources fairly or unfairly, and ERP was measured at the end of the distribution. Data from eighteen adult participants were analysed. A significant interaction of social information and fairness was found for late positive potential (LPP), but a posthoc t test revealed a significant difference between fair and unfair conditions only for actions of the antisocial character. We found that LPP can reflect the sense of fairness affected by social information. Comparison with infant studies suggests that the sense of fairness may change during development.	[Ishikawa, Mitsuhiko; Park, Yun-hee; Itakura, Shoji] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto, Japan; [Kitazaki, Michiteru] Toyohashi Univ Technol, Dept Comp Sci & Engn, Tempaku Cho, Toyohashi, Aichi, Japan	Kyoto University; Toyohashi University of Technology	Ishikawa, M (corresponding author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto, Japan.	ishikawa.mitsuhiko.23r@st.kyoto-u.ac.jp	Kitazaki, Mitchiteru/AAI-6554-2020; Ishikawa, Mitsuhiko/GVU-4566-2022	Kitazaki, Mitchiteru/0000-0003-0966-4842; Ishikawa, Mitsuhiko/0000-0002-5141-6511	JSPS [25245067, 25240020]; JSPS KAKENHI [JP 25245067]; Grants-in-Aid for Scientific Research [25245067] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported by JSPS, Grant #25245067, 25240020 (https://kaken.nii.ac jp/search/?kw=25245067; https://kaken.niLac.jp/search/?kw=25240020) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Number JP 25245067.	Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Cowell JM, 2015, CURR BIOL, V25, P93, DOI 10.1016/j.cub.2014.11.002; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; Derks B, 2014, SOCIAL COGNITIVE AFF; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaertig C, 2011, FRONTIERS NEUROSCIEN, V6, P103; Gredeback G, 2015, DEV COGN NEUROS-NETH, V12, P106, DOI 10.1016/j.dcn.2015.01.006; Gredeback G, 2010, SOC NEUROSCI-UK, V5, P441, DOI 10.1080/17470910903523327; Guroglu B, 2011, NEUROIMAGE, V57, P634, DOI 10.1016/j.neuroimage.2011.04.032; Guroglu B, 2010, SOC COGN AFFECT NEUR, V5, P414, DOI 10.1093/scan/nsq013; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Hajcak G, 2013, BIOL PSYCHOL, V92, P447, DOI 10.1016/j.biopsycho.2011.11.012; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kanakogi Y, 2013, BABY SCI, V13, P26; Kanakogi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065292; Loke IC, 2011, BRAIN RES, V1369, P140, DOI 10.1016/j.brainres.2010.10.109; Meristo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110553; Moser A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00031; Nelson CA, 2006, HUM DEV, V49, P260, DOI 10.1159/000095579; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Qu C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00505; Senju A, 2006, SOC NEUROSCI, V1, P220, DOI 10.1080/17470910600989797; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Van Duynslaeger M, 2008, SOC NEUROSCI-UK, V3, P164, DOI 10.1080/17470910801907226; van Hooff JC, 2011, SOC COGN AFFECT NEUR, V6, P477, DOI 10.1093/scan/nsq066; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009	40	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172974	10.1371/journal.pone.0172974	http://dx.doi.org/10.1371/journal.pone.0172974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235082	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200179
J	Li, RX; Chen, DD; Wang, TC; Wan, YZ; Li, RF; Fang, RJ; Wang, YT; Hu, F; Zhou, H; Li, L; Zhao, WG				Li, Ruixue; Chen, Dandan; Wang, Taichu; Wan, Yizhen; Li, Rongfang; Fang, Rongjun; Wang, Yuting; Hu, Fei; Zhou, Hong; Li, Long; Zhao, Weiguo			High throughput deep degradome sequencing reveals microRNAs and their targets in response to drought stress in mulberry (Morus alba)	PLOS ONE			English	Article							SMALL RNA; WIDE IDENTIFICATION; PARALLEL ANALYSIS; PLANT MICRORNAS; MIRNA TARGETS; ARABIDOPSIS; BIOGENESIS; EXPRESSION; GENES; TRANSLATION	MicroRNAs (miRNAs) play important regulatory roles by targeting mRNAs for cleavage or translational repression. Identification of miRNA targets is essential to better understanding the roles of miRNAs. miRNA targets have not been well characterized in mulberry (Morus alba). To anatomize miRNA guided gene regulation under drought stress, transcriptome-dwide high throughput degradome sequencing was used in this study to directly detect drought stress responsive miRNA targets in mulberry. A drought library (DL) and a contrast library (CL) were constructed to capture the cleaved mRNAs for sequencing. In CL, 409 target genes of 30 conserved miRNA families and 990 target genes of 199 novel miRNAs were identified. In DL, 373 target genes of 30 conserved miRNA families and 950 target genes of 195 novel miRNAs were identified. Of the conserved miRNA families in DL, mno-miR156, mno-miR172, and mno-miR396 had the highest number of targets with 54, 52 and 41 transcripts, respectively, indicating that these three miRNA families and their target genes might play important functions in response to drought stress in mulberry. Additionally, we found that many of the target genes were transcription factors. By analyzing the miRNA-target molecular network, we found that the DL independent networks consisted of 838 miRNA-mRNA pairs (63.34%). The expression patterns of 11 target genes and 12 correspondent miRNAs were detected using qRT-PCR. Six miRNA targets were further verified by RNA ligase-mediated 5' rapid amplification of cDNA ends (RLM-5' RACE). Gene Ontology (GO) annotations and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that these target transcripts were implicated in a broad range of biological processes and various metabolic pathways. This is the first study to comprehensively characterize target genes and their associated miRNAs in response to drought stress by degradome sequencing in mulberry. This study provides a framework for understanding the molecular mechanisms of drought resistance in mulberry.	[Li, Ruixue; Chen, Dandan; Wan, Yizhen; Li, Rongfang; Fang, Rongjun; Zhou, Hong; Li, Long; Zhao, Weiguo] Jiangsu Univ Sci & Technol, Sch Biol & Technol, Zhenjiang, Jiangsu, Peoples R China; [Li, Ruixue; Wang, Taichu; Wang, Yuting] Anhui Acad Agr Sci, Sericultural Res Inst, Hefei, Anhui, Peoples R China; [Hu, Fei] Anhui Acad Agr Sci, Plant Protect & Agroprod Safety Inst, Hefei, Anhui, Peoples R China	Jiangsu University of Science & Technology; Anhui Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences	Zhao, WG (corresponding author), Jiangsu Univ Sci & Technol, Sch Biol & Technol, Zhenjiang, Jiangsu, Peoples R China.	wgzsri@126.com	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034	Sericulture Industry Technology in China Agriculture Research System [CARS-22-ZJ0308]; Research and Innovation Project for Jiangsu University of Science and Technology [YCX16B-03]; Talent Development Special Project of Anhui Academy of Agricultural Sciences [17F0609]; Public Industry (Agriculture) Specific Research Program [201403049]	Sericulture Industry Technology in China Agriculture Research System; Research and Innovation Project for Jiangsu University of Science and Technology; Talent Development Special Project of Anhui Academy of Agricultural Sciences; Public Industry (Agriculture) Specific Research Program	We thank anonymous reviewers and the editor for critically reviewing the manuscript. This work was support by the Sericulture Industry Technology in China Agriculture Research System (project no. CARS-22-ZJ0308), Research and Innovation Project for Jiangsu University of Science and Technology (project no. YCX16B-03), Talent Development Special Project of Anhui Academy of Agricultural Sciences (project no. 17F0609), Public Industry (Agriculture) Specific Research Program (project no. 201403049).	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Budak H, 2015, PLANT SCI, V235, P1, DOI 10.1016/j.plantsci.2015.02.008; Butz H, 2015, ONCOTARGET, V6, P12543, DOI 10.18632/oncotarget.3815; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137773; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen QiLong, 2015, Evidence-based Complementary and Alternative Medicine, V2015, P238495; Chen X, 2005, ANNU REV CELL DEV BI, V25, P21, DOI DOI 10.1146/annurevcellbio042308113417; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Guo YC, 2011, EXP BIOL MED, V236, P628, DOI 10.1258/ebm.2011.010324; Hajyzadeh M, 2015, GENE, V555, P186, DOI 10.1016/j.gene.2014.11.002; [何宁佳 He Ningjia], 2012, [蚕业科学, Acta Sericologica Sinica], V38, P140; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104409; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li L, 2015, GUT, V64, P156, DOI 10.1136/gutjnl-2013-305715; Li T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139658; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Matsui A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303451; Millar Anthony A., 2005, Functional & Integrative Genomics, V5, P129, DOI 10.1007/s10142-005-0145-2; Nigam D, 2015, GENOM DATA, V5, P292, DOI 10.1016/j.gdata.2015.04.028; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Qin YR, 2011, PLANT CELL REP, V30, P1893, DOI 10.1007/s00299-011-1096-9; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; [宋鹏华 Song Penghua], 2013, [蚕业科学, Acta Sericologica Sinica], V39, P160; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Srivastava S, 2015, PLANT SCI, V235, P46, DOI 10.1016/j.plantsci.2015.03.002; Stief A, 2014, PLANT CELL, V26, P1792, DOI 10.1105/tpc.114.123851; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang Y., 2016, NANOADV, V1, P17, DOI DOI 10.1016/J.APENERGY.2016.05.081; Wu P, 2015, PLANT PHYSIOL BIOCH, V95, P75, DOI 10.1016/j.plaphy.2015.07.007; Wu R., 2007, BIOCH MANNH, V2, P12; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Xing Z, 2016, BIOCH BIOPH IN PRESS; Xu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-66; Xu YG, 2014, BIOINFORMATICS, V30, P94, DOI 10.1093/bioinformatics/btt605; Yang JS, 2013, IEEE GLOB COMM CONF, P1, DOI 10.1109/GLOCOM.2013.6831038; Yang X., 2012, P 20 ACM INT C MULT, P1057, DOI [10.1145/2393347.2396382, DOI 10.1145/2393347.2396382]; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin FQ, 2015, INT J MOL SCI, V16, P5714, DOI 10.3390/ijms16035714; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zhao YP, 2013, ANN BOT-LONDON, V112, P633, DOI 10.1093/aob/mct133; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhou M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28700	84	16	21	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172883	10.1371/journal.pone.0172883	http://dx.doi.org/10.1371/journal.pone.0172883			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235056	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200162
J	Pan, XF; Wang, YT; Lubke, T; Hinek, A; Pshezhetsky, AV				Pan, Xuefang; Wang, Yanting; Luebke, Torben; Hinek, Aleksander; Pshezhetsky, Alexey V.			Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; MESSENGER-RNA; AQUEOUS-HUMOR; ENDOTHELIN-1; RECEPTOR; PROLIFERATION; EXPRESSION; PROTEIN; GENE; IMMUNOREACTIVITY	Vasoactive and mitogenic peptide, endothelin-1 (ET-1) plays an important role in physiology of the ocular tissues by regulating the growth of corneal epithelial cells and maintaining the hemodynamics of intraocular fluids. We have previously established that ET-1 can be degraded in vivo by two lysosomal/secreted serine carboxypeptidases, Cathepsin A (CathA) and Serine Carboxypeptidase 1 (Scpep1) and that gene-targeted CathA(S190A)/Scpep1(-/-) mice, deficient in CathA and Scpep1 have a prolonged half-life of circulating ET-1 associated with systemic hypertension. In the current work we report that starting from 6 months of age, similar to 43% of CathA(S190A)/Scpep1(-/-) mice developed corneal clouding that eventually caused vision impairment. Histological evaluation of these mice demonstrated a selective fibrotic thickening and vacuolization of the corneas, resembling human hyperproliferative vesicular corneal stromal dystrophy and coexisting with a peculiar thickening of the skin epidermis. Moreover, we found that cultured corneal epithelial cells, skin fibroblasts and vascular smooth muscle cells derived from CathA/Scpep1-deficient mice, demonstrated a significantly higher proliferative response to treatment with exogenous ET-1, as compared with cells from wild type mice. We also detected increased activation level of ERK1/2 and AKT kinases involved in cell proliferation in the ET-1-treated cultured cells from CathA/Scpep1 deficient mice. Together, results from our experimental model suggest that; in normal tissues the tandem of serine carboxypeptidases, Scpep1 and CathA likely constitutes an important part of the physiological mechanism responsible for the balanced elimination of heightened levels of ET-1 that otherwise would accumulate in tissues and consequently contribute to development of the hyper-proliferative corneal dystrophy and abnormal skin thickening.	[Pan, Xuefang; Pshezhetsky, Alexey V.] Univ Montreal, CHU St Justine Res Ctr, Dept Med Genet, Montreal, PQ, Canada; [Wang, Yanting; Hinek, Aleksander] Univ Toronto, Cardiovasc Res Program, Hosp Sick Children, Toronto, ON M5S 1A1, Canada; [Wang, Yanting; Hinek, Aleksander] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Luebke, Torben] Univ Bielefeld, Dept Chem Biochem 1, Bielefeld, Germany; [Pshezhetsky, Alexey V.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Bielefeld; McGill University	Pshezhetsky, AV (corresponding author), Univ Montreal, CHU St Justine Res Ctr, Dept Med Genet, Montreal, PQ, Canada.; Pshezhetsky, AV (corresponding author), McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca	Hinek, Aleksander/V-8790-2019	Lubke, Torben/0000-0002-3342-0090; A, Pshezhetsky/0000-0002-6612-1062	operating grant from Canadian Institutes of Health Research [FRN 15079]	operating grant from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the operating grant from Canadian Institutes of Health Research to A.V.P. and A.H. (FRN 15079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; BURSELL SE, 1995, INVEST OPHTH VIS SCI, V36, P596; Chen JY, 2001, J BIOL CHEM, V276, P34175, DOI 10.1074/jbc.M104162200; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chen S, 2000, J MOL CELL CARDIOL, V32, P1621, DOI 10.1006/jmcc.2000.1197; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; Fernandez-Durango R, 2003, MOL VIS, V9, P103; Ghanem AA, 2011, OPHTHALMIC RES, V46, P98, DOI 10.1159/000323584; Goraca Anna, 2002, Endocr Regul, V36, P161; Hafizi S, 2004, CELL PHYSIOL BIOCHEM, V14, P285, DOI 10.1159/000080338; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Hocher B, 2000, AM J RESP CELL MOL, V23, P19, DOI 10.1165/ajrcmb.23.1.4030; KAISER HJ, 1995, GRAEF ARCH CLIN EXP, V233, P484, DOI 10.1007/BF00183429; Karnati R, 2015, EXPT EYE RES; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Kobayashi T, 2009, MOL VIS, V15, P1589; Kollmann K, 2009, FEBS J, V276, P1356, DOI 10.1111/j.1742-4658.2009.06877.x; Kuhlmann A, 2005, CORNEA, V24, P837, DOI 10.1097/01.ico.0000157400.81408.2b; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lee TH, 2009, CIRC RES, V105, P271, DOI 10.1161/CIRCRESAHA.109.199869; LEPPLEWIENHUES A, 1992, CURR EYE RES, V11, P1041, DOI 10.3109/02713689209015075; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Liu B, 2007, J VASC SURG, V45, P160, DOI 10.1016/j.jvs.2006.09.053; Meyers KEC, 2013, PEDIATR NEPHROL, V28, P711, DOI 10.1007/s00467-012-2316-4; Miklyaeva EI, 2004, BRAIN RES, V1001, P37, DOI 10.1016/j.brainres.2003.11.067; Miyagi T, 2008, P JPN ACAD B-PHYS, V84, P407, DOI 10.2183/pjab.84.407; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V160, P628, DOI 10.1016/0006-291X(89)92479-0; MUSTO L, 1986, Journal of Histotechnology, V9, P173; Nakahara T, 2013, J PHARMACOL SCI, V123, P79, DOI 10.1254/jphs.13R03CP; Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453; NEWMAN NJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P251, DOI 10.1001/archopht.1990.01070040103041; Obuchowska I, 1996, ACTA BIOCHIM POL, V43, P687; Ohta K, 2000, J IMMUNOL, V164, P1185, DOI 10.4049/jimmunol.164.3.1185; Pan XF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004146; Prasanna G, 2011, EXP EYE RES, V93, P170, DOI 10.1016/j.exer.2010.09.006; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Rosenthal R, 2011, BRIT J PHARMACOL, V162, P806, DOI 10.1111/j.1476-5381.2010.01103.x; Salvatore S, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/354645; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seyrantepe V, 2008, CIRCULATION, V117, P1973, DOI 10.1161/CIRCULATIONAHA.107.733212; Shoshani YZ, 2012, CURR EYE RES, V37, P1, DOI 10.3109/02713683.2011.622849; Solini A, 2007, GROWTH FACTORS, V25, P392, DOI 10.1080/08977190801892341; SUGIYAMA T, 1995, SURV OPHTHALMOL, V39, pS49, DOI 10.1016/S0039-6257(05)80073-6; TAKAGI H, 1994, INVEST OPHTH VIS SCI, V35, P134; TAO WH, 1995, INVEST OPHTH VIS SCI, V36, P2614; Tao WH, 1997, INVEST OPHTH VIS SCI, V38, P130; Thomas GH, 2001, METABOLIC MOL BASES; USUI T, 1991, OPHTHALMOLOGICA, V203, P176, DOI 10.1159/000310248; Wang XW, 2015, J MOL CELL CARDIOL, V80, P101, DOI 10.1016/j.yjmcc.2015.01.001; Weiss JS, 2011, DEV OPHTHALMOL, V48, P67, DOI 10.1159/000324078; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Wollensak G, 1998, CURR EYE RES, V17, P541, DOI 10.1076/ceyr.17.5.541.5187; Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; Yoshizumi M, 1998, BRIT J PHARMACOL, V125, P1019, DOI 10.1038/sj.bjp.0702141; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172854	10.1371/journal.pone.0172854	http://dx.doi.org/10.1371/journal.pone.0172854			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234994	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200153
J	Visseaux, B; Collin, G; Ichou, H; Charpentier, C; Bendhafer, S; Dumitrescu, M; Allal, L; Cojocaru, B; Desfrere, L; Descamps, D; Mandelbrot, L; Houhou-Fidouh, N				Visseaux, Benoit; Collin, Gilles; Ichou, Houria; Charpentier, Charlotte; Bendhafer, Samia; Dumitrescu, Madalina; Allal, Lahcene; Cojocaru, Bogdan; Desfrere, Luc; Descamps, Diane; Mandelbrot, Laurent; Houhou-Fidouh, Nadhira			Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VIRAL-INFECTIONS; FAST ASSAY; IDENTIFICATION; DISEASE; ILLNESS; CHINA; PANEL	Background To date, only influenza and RSV testing are recommended for respiratory viruses' detection in paediatric units. In this study, we described, according to seasons, ages and clinical units, the results obtained in children (< 15 years old) by multiplex-PCR (mPCR) tests allowing a quick and wide range detection of all respiratory viruses. These results were also compared with RSV specific detection. Methods All nasopharyngeal mPCR and RSV tests requested by clinicians in our French teaching hospitals group between 2011 and 2014 were retrospectively included. All repeated samples for the same children in the same month were discarded. Results Of the 381 mPCR tests (344 children) performed, 51.4% were positive. Positivity and viral co-infection rates were higher in the 6-36 months old strata (81% and 25%, p< 0.0001 and p = 0.04, respectively). Viral distribution showed strong variations across ages. During specific influenza epidemic periods, only 1/39 (2.5%) mPCR tests were positive for influenza and 19/39 (48.7%) for other viruses. During specific RSV epidemic periods, only 8/46 (17.4%) mPCR tests were positive for RSV and 14/46 (30.4%) for other viruses. 477/1529 (31.2%) of RSV immunochromatography-tests were positive. Among the negatives immunochromatography-test also explored by mPCR, 28/62 (31%) were positive for other respiratory viruses. Conclusion This study provides a wide description of respiratory viruses' distribution among children in hospital settings using mPCR over 3 years. It emphasizes the number of undiagnosed respiratory viruses according to the current diagnosis practice in France and gives a better picture of respiratory viruses identified in hospital settings by mPCR all over the year in France.	[Visseaux, Benoit; Collin, Gilles; Ichou, Houria; Charpentier, Charlotte; Descamps, Diane; Houhou-Fidouh, Nadhira] Univ Paris Diderot, Hop Bichat, AP HP, Sorbonne Paris Cite,Lab Virol,INSERM,IAME,UMR 113, Paris, France; [Bendhafer, Samia; Desfrere, Luc] Hop Louis Mourier, AP HP, Serv Neonatol, Colombes, France; [Dumitrescu, Madalina; Cojocaru, Bogdan] Hop Louis Mourier, AP HP, Serv Urgences Pediat, Colombes, France; [Allal, Lahcene] Hop Bichat Claude Bernard, AP HP, Serv Maternite, Paris, France; [Mandelbrot, Laurent] Hop Louis Mourier, AP HP, Serv Maternite, Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Visseaux, B (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Sorbonne Paris Cite,Lab Virol,INSERM,IAME,UMR 113, Paris, France.	benoit.visseaux@aphp.fr	Mandelbrot, Laurent/AAD-3554-2019	Mandelbrot, Laurent/0000-0002-5883-7597; Visseaux, Benoit/0000-0002-9279-5538				Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Belchior E., 2014, B EPIDEMIOLOGIQUE HE; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024; Houdouin V, 2014, ARCH PEDIATRIE, V21, P418, DOI 10.1016/j.arcped.2014.01.004; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Kieninger E, 2013, EUR RESPIR J, V41, P443, DOI 10.1183/09031936.00203511; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053614; Laurent C, 2012, PEDIATR INFECT DIS J, V31, P827, DOI 10.1097/INF.0b013e3182566005; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Meng J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004016; Mengelle C, 2014, J CLIN VIROL, V61, P411, DOI 10.1016/j.jcv.2014.08.023; Nelson RE, 2015, PEDIATR INFECT DIS J, V34, P577, DOI 10.1097/INF.0000000000000703; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Doan Q, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006452.pub4; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Self WH, 2015, J INFECT DIS; Sharland M, 2011, MANUAL CHILDHOOD INF, P230; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; Ushirogawa H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1738-1; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Xie L, 2012, J CLIN MICROBIOL, V50, P1879, DOI 10.1128/JCM.06523-11; Zhao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07365	34	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172809	10.1371/journal.pone.0172809	http://dx.doi.org/10.1371/journal.pone.0172809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235002	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200143
J	Wen, GY; Li, LT; Yu, QZ; Wang, HL; Luo, QP; Zhang, TF; Zhang, RR; Zhang, WP; Shao, HB				Wen, Guoyuan; Li, Lintao; Yu, Qingzhong; Wang, Hongling; Luo, Qingping; Zhang, Tengfei; Zhang, Rongrong; Zhang, Wanpo; Shao, Huabin			Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens	PLOS ONE			English	Article							TECHNOLOGY; EXPRESSION; EMBRYOS	In-ovo vaccination is an attractive immunization approach for poultry industry. However, most of the Newcastle disease virus (NDV) vaccine strains used after hatch are unsafe, as in-ovo vaccines, due to their high pathogenicity for chicken embryos. In this study, we evaluated the safety and immunogenicity of a thermostable NDV strain TS09-C, derived from V4 strain, as in-ovo vaccine. Chickens in-ovo vaccinated with the parental V4 strain displayed greatly reduced hatchability and severe histopathological lesions in both trachea and intestine tissues, while the hatchability was not affected by in-ovo vaccination withTS09-C strain. The safe dose that infected all chicken embryos without obviously histopathological lesions was 10(3.0) EID50 per bird. In-ovo vaccination of chickens with TS09-C virus conferred complete protection against virulent NDV challenge. Results suggest that the thermostable NDV strain TS09-C is a safe and immunogenic in-ovo vaccine candidate that can be delivered quickly and uniformly, and induce earlier immune response.	[Wen, Guoyuan; Wang, Hongling; Luo, Qingping; Zhang, Tengfei; Zhang, Rongrong; Shao, Huabin] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Peoples R China; [Wen, Guoyuan] Hubei Key Lab Anim Embryo & Mol Breeding, Wuhan, Peoples R China; [Wen, Guoyuan; Wang, Hongling; Luo, Qingping; Zhang, Tengfei; Zhang, Rongrong; Shao, Huabin] Minist Agr, Key Lab Prevent & Control Agents Anim Bacteriosis, Wuhan, Peoples R China; [Li, Lintao; Zhang, Wanpo] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Yu, Qingzhong] ARS, US Natl Poultry Res Ctr, USDA, Southeast Poultry Res Lab, Athens, GA USA	Hubei Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; United States Department of Agriculture (USDA)	Shao, HB (corresponding author), Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Peoples R China.; Shao, HB (corresponding author), Minist Agr, Key Lab Prevent & Control Agents Anim Bacteriosis, Wuhan, Peoples R China.; Zhang, WP (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	zwp@mail.hzau.edu.cn; shhb1961@163.com		Yu, Qingzhong/0000-0003-0386-793X	China Agriculture Research System [CARS-42]; Special Fund for Agro-scientific Research in the Public Interest [201303033]; National Natural Science Foundation of China [31670157]	China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China Agriculture Research System (http://www.zgri.org/, CARS-42), Special Fund for Agro-scientific Research in the Public Interest (http://www.hymof net.cn/, 201303033), and the National Natural Science Foundation (http://www.nfsc.gov.cn/, 31670157) of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander D J, 1974, Avian Pathol, V3, P269, DOI 10.1080/03079457409353840; Alexander DJ, 1998, LAB MANNUAL ISOLATIO; [Anonymous], [No title captured]; Bensink Z, 1999, VET MICROBIOL, V68, P131, DOI 10.1016/S0378-1135(99)00069-3; Dilaveris D, 2007, VACCINE, V25, P3792, DOI 10.1016/j.vaccine.2007.01.115; Johnston PA, 1997, POULTRY SCI, V76, P165, DOI 10.1093/ps/76.1.165; LIU C, 1953, J IMMUNOL, V70, P538; Mast J, 2006, VACCINE, V24, P1756, DOI 10.1016/j.vaccine.2005.10.020; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; Negash T, 2004, VET QUART, V26, P76, DOI 10.1080/01652176.2004.9695170; Pedersen JC, 2004, J CLIN MICROBIOL, V42, P2329, DOI 10.1128/JCM.42.5.2329-2334.2004; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Steel J, 2008, VACCINE, V26, P522, DOI 10.1016/j.vaccine.2007.11.032; Wakenell PS, 2002, AVIAN DIS, V46, P274, DOI 10.1637/0005-2086(2002)046[0274:EOIOVD]2.0.CO;2; Wen G., 2012, HUBEI AGR CULT SCI, V51, P5424; Wen GY, 2015, J GEN VIROL, V96, P1219, DOI 10.1099/vir.0.000067; Wen GY, 2013, VIRUS GENES, V46, P542, DOI 10.1007/s11262-012-0871-1; Williams CJ, 2011, POULTRY SCI, V90, P223, DOI 10.3382/ps.2010-00759; Williams CJ, 2010, POULTRY SCI, V89, P189, DOI 10.3382/ps.2009-00093; 2000, POULVAC OVOLINE ND S	20	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172812	10.1371/journal.pone.0172812	http://dx.doi.org/10.1371/journal.pone.0172812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234989	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200144
J	Zengin-Toktas, Y; Woolley, SC				Zengin-Toktas, Yildiz; Woolley, Sarah Cushing			Singing modulates parvalbumin interneurons throughout songbird forebrain vocal control circuitry	PLOS ONE			English	Article							BASAL GANGLIA CIRCUIT; NEURAL ACTIVITY; PERINEURONAL NETS; PROJECTION NEURONS; ZENK EXPRESSION; AREA-X; PLASTICITY; BRAIN; TRANSCRIPTION; VARIABILITY	Across species, the performance of vocal signals can be modulated by the social environment. Zebra finches, for example, adjust their song performance when singing to females ('female-directed' or FD song) compared to when singing in isolation ('undirected' or UD song). These changes are salient, as females prefer the FD song over the UD song. Despite the importance of these performance changes, the neural mechanisms underlying this social modulation remain poorly understood. Previous work in finches has established that expression of the immediate early gene EGR1 is increased during singing and modulated by social context within the vocal control circuitry. Here, we examined whether particular neural subpopulations within those vocal control regions exhibit similar modulations of EGR1 expression. We compared EGR1 expression in neurons expressing parvalbumin (PV), a calcium buffer that modulates network plasticity and homeostasis, among males that performed FD song, males that produced UD song, or males that did not sing. We found that, overall, singing but not social context significantly affected EGR1 expression in PV neurons throughout the vocal control nuclei. We observed differences in EGR1 expression between two classes of PV interneurons in the basal ganglia nucleus Area X. Additionally, we found that singing altered the amount of PV expression in neurons in HVC and Area X and that distinct PV interneuron types in Area X exhibited different patterns of modulation by singing. These data indicate that throughout the vocal control circuitry the singing-related regulation of EGR1 expression in PV neurons may be less influenced by social context than in other neuron types and raise the possibility of cell-type specific differences in plasticity and calcium buffering.	[Zengin-Toktas, Yildiz; Woolley, Sarah Cushing] McGill Univ, Dept Biol, Montreal, PQ, Canada	McGill University	Woolley, SC (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	sarah.woolley@mcgill.ca			Natural Sciences and Engineering Research Council [RGPIN 402186-11]; McGill University	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill University	This work was supported by Natural Sciences and Engineering Research Council Discovery Grant RGPIN 402186-11 to SCW (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jon Sakata for thoughtful comments on the manuscript. This work was supported by funding from the National Science and Engineering Research Council (SCW) and McGill University (SCW).	Abdi A, 2015, J NEUROSCI, V35, P6667, DOI 10.1523/JNEUROSCI.4662-14.2015; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Beecher MD, 1996, ANIM BEHAV, V51, P917, DOI 10.1006/anbe.1996.0095; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Caballero A, 2014, BRAIN STRUCT FUNCT, V219, P395, DOI 10.1007/s00429-013-0508-8; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Carrillo GD, 2004, J COMP NEUROL, V473, P415, DOI 10.1002/cne.20099; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Chard PS, 2003, J PHYSL, V472, P341; Chevaleyre V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00093; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; COWEN T, 1992, J NEUROSCI METH, V45, P107, DOI 10.1016/0165-0270(92)90048-I; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; EENS M, 1993, BEHAVIOUR, V125, P51, DOI 10.1163/156853993X00182; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Gittis AH, 2014, J NEUROSCI, V34, P15178, DOI 10.1523/JNEUROSCI.3252-14.2014; Goldberg JH, 2010, J NEUROSCI, V30, P7088, DOI 10.1523/JNEUROSCI.0168-10.2010; Goldberg JH, 2010, J NEUROPHYSIOL, V103, P2002, DOI 10.1152/jn.01038.2009; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kao MH, 2008, J NEUROSCI, V28, P13232, DOI 10.1523/JNEUROSCI.2250-08.2008; KARAKASHIAN SJ, 1988, J COMP PSYCHOL, V102, P129, DOI 10.1037/0735-7036.102.2.129; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kreutzer M, 1999, BEHAVIOUR, V136, P1325, DOI 10.1163/156853999500749; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; MARLER P, 1986, ANIM BEHAV, V34, P194, DOI 10.1016/0003-3472(86)90023-0; Matheson LE, 2016, DEV NEUROBIOL, V76, P47, DOI 10.1002/dneu.22298; Matheson LE, 2015, EUR J NEUROSCI, V41, P1180, DOI 10.1111/ejn.12885; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Mix A, 2015, DEV NEUROBIOL, V75, P1, DOI 10.1002/dneu.22205; NABORS LB, 1988, J NEUROSCI METH, V26, P25, DOI 10.1016/0165-0270(88)90126-4; NOTTEBOHM F, 1976, ANN NY ACAD SCI, V280, P643, DOI 10.1111/j.1749-6632.1976.tb25526.x; Orduz D, 2013, J PHYSIOL-LONDON, V591, P3215, DOI 10.1113/jphysiol.2012.250795; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Reiner A, 2004, J COMP NEUROL, V469, P239, DOI 10.1002/cne.11012; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schubloom HE, 2016, DEV NEUROBIOL, V76, P1029, DOI 10.1002/dneu.22373; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; THAL DR, 1995, ACTA HISTOCHEM, V97, P203, DOI 10.1016/S0065-1281(11)80100-5; Thimm A, 2015, J PHYSIOL-LONDON, V593, P967, DOI 10.1113/jphysiol.2014.282467; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Urbanavicius J, 2007, J NEUROCHEM, V102, P723, DOI 10.1111/j.1471-4159.2007.04560.x; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; VU ET, 1994, J NEUROSCI, V14, P6924; Whitney O, 2005, J NEUROBIOL, V65, P251, DOI 10.1002/neu.20187; Whitney O, 2000, MOL BRAIN RES, V80, P279, DOI 10.1016/S0169-328X(00)00178-9; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Wild JM, 2001, BRAIN RES, V917, P235; Woolley SC, 2015, NEUROSCIENCE, V296, P39, DOI 10.1016/j.neuroscience.2014.10.010; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Woolley SC, 2014, NEURON, V82, P208, DOI 10.1016/j.neuron.2014.01.039; Woolley SC, 2016, J NEUROPHYS IN PRESS; Yamada J, 2015, EUR J NEUROSCI, V41, P368, DOI 10.1111/ejn.12792; Zann RA., 1996, ZEBRA FINCH SYNTHESI	80	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172944	10.1371/journal.pone.0172944	http://dx.doi.org/10.1371/journal.pone.0172944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235074	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200174
J	Farra, SD; Cheung, SS; Thomas, SG; Jacobs, I				Farra, Saro D.; Cheung, Stephen S.; Thomas, Scott G.; Jacobs, Ira			Rate dependent influence of arterial desaturation on self-selected exercise intensity during cycling	PLOS ONE			English	Article							LOCOMOTOR MUSCLE FATIGUE; TIDAL CARBON-DIOXIDE; CENTRAL MOTOR OUTPUT; PERCEIVED EXERTION; SKELETAL-MUSCLE; GROUP-III; ANTICIPATORY REDUCTION; SUPRASPINAL FACTORS; PROLONGED EXERCISE; PACING STRATEGIES	The purpose of this study was to clarify if Ratings of Perceived Exertion (RPE) and self-selected exercise intensity are sensitive not only to alterations in the absolute level of arterial saturation (SPO2) but also the rate of change in SPO2. Twelve healthy participants (31.6 +/- 3.9 y, 175.5 +/- 7.7 cm, 73.3 +/- 10.3 kg, 51 +/- 7 mL +/- kg (-1) +/- min -1 VO (2peak)) exercised four times on a cycle ergometer, freely adjusting power output (PO) to maintain RPE at 5 on Borg's 10-point scale with no external feedback to indicate their exercise intensity. The fraction of inspired oxygen (FIO2) was reduced during three of those trials such that SPO2 decreased during exercise from starting values (> 98%) to 70%. These trials were differentiated by the time over which the desaturation occurred: 3.9 +/- 1.4 min, -8.7 +/- 4.2% center dot min (-1) (FAST), 11.0 +/- 3.7 min, -2.8 +/- 1.3% center dot min (-1) (MED), and 19.5 +/- 5.8 min, -1.5 +/- 0.8% center dot min (-1) (SLOW) (P < 0.001). Compared to stable PO throughout the control condition (no SPO2 manipulation), PO signifi-cantly decreased across the experimental conditions (FAST = 2.8 +/- 2.1 W center dot % SPO2 (-1); MED = 2.5 +/- 1.8 W center dot % SPO2 (-1); SLOW = 1.8 +/- 1.6 W center dot % SPO2 (-1); P < 0.001). The rates of decline in PO during FAST and MED were similar, with both greater than SLOW. Our results confirm that decreases in absolute SPO2 impair exercise performance and that a faster rate of oxygen desaturation magnifies that impairment.	[Farra, Saro D.; Cheung, Stephen S.; Thomas, Scott G.; Jacobs, Ira] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada	University of Toronto; Brock University	Jacobs, I (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	ira.jacobs@utoronto.ca	Cheung, Stephen/HGU-6191-2022; Cheung, Stephen/AAE-9136-2020; Thomas, Scott/G-4522-2012; Jacobs, Ira/AAE-9445-2021	Cheung, Stephen/0000-0002-6149-4978; Thomas, Scott/0000-0002-5564-4271; 	Province of Ontario's Research Program; Canada Research Chair	Province of Ontario's Research Program; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the Province of Ontario's Research Program in Applied Sport Science. S.S. Cheung was supported by a Canada Research Chair.	Abbiss CR, 2005, SPORTS MED, V35, P865, DOI 10.2165/00007256-200535100-00004; Allgood GO, 2000, IEEE SYS MAN CYBERN, P2198, DOI 10.1109/ICSMC.2000.886442; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; BALSOM PD, 1994, ACTA PHYSIOL SCAND, V152, P279, DOI 10.1111/j.1748-1716.1994.tb09807.x; BARNARD P, 1987, J APPL PHYSIOL, V63, P685, DOI 10.1152/jappl.1987.63.2.685; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bhambhani Y, 2001, EUR J APPL PHYSIOL, V84, P547, DOI 10.1007/s004210000372; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; BROWN RM, 1974, J NEURAL TRANSM, V35, P293, DOI 10.1007/BF02205226; CHERNICK V, 1982, SCIENCE, V216, P1252, DOI 10.1126/science.7200636; CHERNICK V, 1980, PEDIATR RES, V14, P357, DOI 10.1203/00006450-198004000-00021; Clark SA, 2007, EUR J APPL PHYSIOL, V102, P45, DOI 10.1007/s00421-007-0554-0; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DAVIS JN, 1973, J NEUROCHEM, V21, P783, DOI 10.1111/j.1471-4159.1973.tb07522.x; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; DUFFY TE, 1972, J NEUROCHEM, V19, P959, DOI 10.1111/j.1471-4159.1972.tb01417.x; EKBLOM B, 1975, J APPL PHYSIOL, V39, P71, DOI 10.1152/jappl.1975.39.1.71; ERECINSKA M, 1984, BRAIN RES, V304, P9, DOI 10.1016/0006-8993(84)90857-6; Eston R G, 1988, Br J Sports Med, V22, P153; ESTON RG, 1987, EUR J APPL PHYSIOL O, V56, P222, DOI 10.1007/BF00640648; Eston R, 2007, PSYCHOPHYSIOLOGY, V44, P779, DOI 10.1111/j.1469-8986.2007.00558.x; Farra SD, 2016, RESP PHYSIOL NEUROBI, V231, P28, DOI 10.1016/j.resp.2016.05.013; Faulkner J, 2008, J EXERC SCI FIT, V6, P1; Gallagher KM, 2001, J PHYSIOL-LONDON, V533, P861, DOI 10.1111/j.1469-7793.2001.t01-1-00861.x; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; GARNER SH, 1990, J APPL PHYSIOL, V68, P1167, DOI 10.1152/jappl.1990.68.3.1167; Gibson ASC, 2006, SPORTS MED, V36, P705; GIBSON GE, 1978, J NEUROCHEM, V31, P757, DOI 10.1111/j.1471-4159.1978.tb00107.x; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Goodall S, 2010, J APPL PHYSIOL, V109, P1842, DOI 10.1152/japplphysiol.00458.2010; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; HILL JM, 1992, J APPL PHYSIOL, V73, P2524, DOI 10.1152/jappl.1992.73.6.2524; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; IVERSEN K, 1983, ACTA PHYSIOL SCAND, V118, P91, DOI 10.1111/j.1748-1716.1983.tb07247.x; Johnson BD, 2009, EUR J APPL PHYSIOL, V106, P493, DOI 10.1007/s00421-009-1036-3; KAUFMAN MP, 1984, J APPL PHYSIOL, V57, P644, DOI 10.1152/jappl.1984.57.3.644; Kaufman MP, 1996, COMPREHENSIVE PHYSL; Kayser B, 2003, EUR J APPL PHYSIOL, V90, P411, DOI 10.1007/s00421-003-0902-7; LI KY, 1990, J PHYSIOL-LONDON, V430, P1; Marcora S, 2009, J APPL PHYSIOL, V106, P2060, DOI 10.1152/japplphysiol.90378.2008; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; MATEIKA JH, 1995, EUR J APPL PHYSIOL, V71, P1, DOI 10.1007/BF00511228; MCLELLAN TM, 1982, INT J SPORTS MED, V3, P224, DOI 10.1055/s-2008-1026092; MCLELLAN TM, 1985, INT J SPORTS MED, V6, P30, DOI 10.1055/s-2008-1025809; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Neary JP, 2008, CLIN PHYSIOL FUNCT I, V28, P364, DOI 10.1111/j.1475-097X.2008.00822.x; NEUBAUER JA, 1988, J APPL PHYSIOL, V65, P1324, DOI 10.1152/jappl.1988.65.3.1324; Noakes TD, 2007, J PHYSIOL-LONDON, V585, P919, DOI 10.1113/jphysiol.2007.145110; NOBLE BJ, 1973, MED SCI SPORT EXER, V5, P104; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; NOBLE BJ, 1973, MED SCI SPORT EXER, V5, P116; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; Pugh LG, 1964, J APPL PHYSIOL, V194, P31; Rasmussen P, 2010, J PHYSIOL-LONDON, V588, P1985, DOI 10.1113/jphysiol.2009.186767; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Renfree A, 2012, INT J SPORT PHYSIOL, V7, P121, DOI 10.1123/ijspp.7.2.121; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; Rosen R., 1985, ANTICIPATORY SYSTEMS, DOI DOI 10.1080/03081079.2012.726322; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P199, DOI 10.1111/j.1748-1716.1989.tb08653.x; SKINNER JS, 1973, MED SCI SPORT EXER, V5, P94; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Smith SA, 2003, J PHYSIOL-LONDON, V551, P1013, DOI 10.1113/jphysiol.2003.044925; Sommer LZ, 1998, EUR RESPIR J, V12, P698, DOI 10.1183/09031936.98.12030698; Somogyi RB, 2005, ANAESTH INTENS CARE, V33, P726, DOI 10.1177/0310057X0503300604; SQUIRES RW, 1982, MED SCI SPORT EXER, V14, P36, DOI 10.1249/00005768-198201000-00007; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; Webster MA, 2012, F1000 BIOL REP, P421; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9; West JB., 2008, RESP PHYSL ESSENTIAL; Wetter TJ, 1999, J APPL PHYSIOL, V87, P643, DOI 10.1152/jappl.1999.87.2.643; Williamson JW, 2006, EXP PHYSIOL, V91, P51, DOI 10.1113/expphysiol.2005.032037; WINN HR, 1981, AM J PHYSIOL, V241, pH235, DOI 10.1152/ajpheart.1981.241.2.H235; WOOD JD, 1968, J NEUROCHEM, V15, P603, DOI 10.1111/j.1471-4159.1968.tb08959.x	89	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171119	10.1371/journal.pone.0171119	http://dx.doi.org/10.1371/journal.pone.0171119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257415	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100005
J	Hock, BD; MacPherson, SA; McKenzie, JL				Hock, Barry D.; MacPherson, Sean A.; McKenzie, Judith L.			Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells	PLOS ONE			English	Article							HUMAN B-CELLS; TUMOR MICROENVIRONMENT; LYMPH-NODE; ADENOSINE RECEPTORS; IMMUNE SUPPRESSION; KINASE-ACTIVITIES; HUMAN CANCER; CLL-CELLS; INHIBITION; EXPRESSION	Chronic lymphocytic leukemia (CLL) is associated with T cell dysfunction. Activated CLL cells are found within the lymphoid tumor micro-environment and overcoming immuno-suppression induced by these cells may improve anti-CLL immune responses. However, the mechanisms by which activated CLL cells inhibit T cell responses, and reagents targeting such mechanisms have not been identified. Here we demonstrate that the ability of in vitro activated CLL cells to suppress T cell proliferation is not reversed by the presence of ecto-nuclease inhibitors or blockade of IL-10, PD-1 and CTLA-4 pathways. Caffeine is both an adenosine receptor antagonist and a phosphatidylinositol-3-kinase, p110d (PI3Kd) inhibitor and, at physiologically relevant levels, significantly reversed suppression. Significant reversal of suppression was also observed with the PI3Kd specific inhibitor Idelalisib but not with adenosine receptor specific antagonists. Furthermore, addition of caffeine or Idelalisib to activated CLL cells significantly inhibited phosphorylation of AKT, a downstream kinase of PI3K, but did not affect CLL viability. These results suggest that caffeine, in common with Idelalisib, reduces the immuno-suppressive activity of activated CLL cells by inhibiting PI3Kd. These findings raise the possibility that these compounds may provide a useful therapeutic adjunct by reducing immuno-suppression within the tumor micro-environment of CLL.	[Hock, Barry D.; McKenzie, Judith L.] Christchurch Hosp, Haematol Res Grp, Christchurch, New Zealand; [Hock, Barry D.; MacPherson, Sean A.; McKenzie, Judith L.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [MacPherson, Sean A.] Christchurch Hosp, Dept Haematol, Christchurch, New Zealand	Christchurch Hospital New Zealand; University of Otago; Christchurch Hospital New Zealand	Hock, BD (corresponding author), Christchurch Hosp, Haematol Res Grp, Christchurch, New Zealand.; Hock, BD (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	barry.hock@otago.ac.nz			Bone Marrow Cancer Research Trust; Ruth Spearing Cancer Research Trust	Bone Marrow Cancer Research Trust; Ruth Spearing Cancer Research Trust	This work was supported by grants from The Bone Marrow Cancer Research Trust and The Ruth Spearing Cancer Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouri MW, 2015, PURINERG SIGNAL, V11, P389, DOI 10.1007/s11302-015-9460-9; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Blanco B, 2015, IMMUNOL RES, V62, P175, DOI 10.1007/s12026-015-8648-y; Blunt Matthew D, 2015, Leuk Res Rep, V4, P60, DOI 10.1016/j.lrr.2015.09.001; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Brusa D, 2013, HAEMATOLOGICA, V98, P953, DOI 10.3324/haematol.2012.077537; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Davis JE, 2014, LEUKEMIA RES, V38, P1160, DOI 10.1016/j.leukres.2014.08.005; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Forconi F, 2015, BLOOD, V126, P573, DOI 10.1182/blood-2015-03-567388; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Gibbs BF, 2015, ONCOTARGET, V6, P28678, DOI 10.18632/oncotarget.5212; Gilling CE, 2012, BRIT J HAEMATOL, V158, P216, DOI 10.1111/j.1365-2141.2012.09148.x; Gockeritz E, 2015, INT J CANCER, V137, P2234, DOI 10.1002/ijc.29579; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gorgun G, 2005, J CLIN INVEST, V115, P1797, DOI 10.1172/JCI24176; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Hock BD, 2014, LEUKEMIA RES, V38, P1217, DOI 10.1016/j.leukres.2014.06.004; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Jitschin R, 2014, BLOOD, V124, P750, DOI 10.1182/blood-2013-12-546416; Lee JW, 2015, EUR J PEDIATR, V174, P1671, DOI 10.1007/s00431-015-2581-x; Lemoine S, 2011, J AUTOIMMUN, V36, P228, DOI 10.1016/j.jaut.2011.01.005; McClanahan F, 2015, BLOOD, V126, P203, DOI 10.1182/blood-2015-01-622936; Mercadante ER, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00193; Mohr A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1132977; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Muller-Haegele S, 2014, EXPERT REV CLIN IMMU, V10, P897, DOI 10.1586/1744666X.2014.915739; Musgrave IF, 2016, FORENSIC SCI MED PAT, V12, P299, DOI 10.1007/s12024-016-9786-9; Nicholas NS, 2016, BBA-MOL CELL RES, V1863, P471, DOI 10.1016/j.bbamcr.2015.11.003; Pasikowska M, 2016, BLOOD, V128, P563, DOI 10.1182/blood-2016-01-683128; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Podshivalova K, 2013, CRIT REV IMMUNOL, V33, P435, DOI 10.1615/CritRevImmunol.2013006858; Ramsay AG, 2013, BLOOD, V121, P2704, DOI 10.1182/blood-2012-08-448332; Ramsay AG, 2012, BLOOD, V120, P1412, DOI 10.1182/blood-2012-02-411678; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Routledge DJM, 2016, BRIT J HAEMATOL, V174, P351, DOI 10.1111/bjh.14184; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sarkaria JN, 1999, CANCER RES, V59, P4375; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Serra S, 2011, BLOOD, V118, P6141, DOI 10.1182/blood-2011-08-374728; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Spranger S, 2016, INT IMMUNOL, V28, P383, DOI 10.1093/intimm/dxw014; Stankovic T, 2014, LEUKEMIA LYMPHOMA, V55, P1227, DOI 10.3109/10428194.2013.829919; te Raa GD, 2014, BLOOD, V123, P717, DOI 10.1182/blood-2013-08-518183; ten Hacken E, 2016, BBA-MOL CELL RES, V1863, P401, DOI 10.1016/j.bbamcr.2015.07.009; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Till KJ, 2015, J IMMUNOL, V194, P2439, DOI 10.4049/jimmunol.1402304; Tretter T, 2008, BLOOD, V112, P4555, DOI 10.1182/blood-2008-02-140087; Varani K, 2005, CELL MOL LIFE SCI, V62, P2350, DOI 10.1007/s00018-005-5312-z; YELLIN MJ, 1994, J IMMUNOL, V153, P666; Zhuang JG, 2010, HAEMATOL-HEMATOL J, V95, P110, DOI 10.3324/haematol.2009.010272	61	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172858	10.1371/journal.pone.0172858	http://dx.doi.org/10.1371/journal.pone.0172858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257435	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100032
J	Friedrich, N; Pietzner, M; Cannet, C; Thuesen, BH; Hansen, T; Wallaschofski, H; Grarup, N; Skaaby, T; Budde, K; Pedersen, O; Nauck, M; Linneberg, A				Friedrich, Nele; Pietzner, Maik; Cannet, Claire; Thuesen, Betina H.; Hansen, Torben; Wallaschofski, Henri; Grarup, Niels; Skaaby, Tea; Budde, Kathrin; Pedersen, Oluf; Nauck, Matthias; Linneberg, Allan			Urinary metabolomics reveals glycemic and coffee associated signatures of thyroid function in two population-based cohorts	PLOS ONE			English	Article							IFCC WORKING GROUP; ASYMMETRIC DIMETHYLARGININE; HORMONE REGULATION; FUNCTION TESTS; IODINE INTAKE; METABOLISM; 3,5-DIIODOTHYRONINE; STANDARDIZATION; GLUCONEOGENESIS; THYROTOXICOSIS	Background Triiodothyronine (T3) and thyroxine (T4) as the main secretion products of the thyroid affect nearly every human tissue and are involved in a broad range of processes ranging from energy expenditure and lipid metabolism to glucose homeostasis. Metabolomics studies outside the focus of clinical manifest thyroid diseases are rare. The aim of the present investigation was to analyze the cross-sectional and longitudinal associations of urinary metabolites with serum free T4 (FT4) and thyroid-stimulating hormone (TSH). Methods Urine Metabolites of participants of the population-based studies Inter99 (n = 5620) and Health2006/Health2008 (n = 3788) were analyzed by H-1-NMR spectroscopy. Linear or mixed linear models were used to detect associations between urine metabolites and thyroid function. Results Cross-sectional analyses revealed positive relations of alanine, trigonelline and lactic acid with FT4 and negative relations of dimethylamine, glucose, glycine and lactic acid with log (TSH). In longitudinal analyses, lower levels of alanine, dimethylamine, glycine, lactic acid and N, N-dimethylglycine were linked to a higher decline in FT4 levels over time, whereas higher trigonelline levels were related to a higher FT4 decline. Moreover, the risk of hypothyroidism was higher in subjects with high baseline trigonelline or low lactic acid, alanine or glycine values. Conclusion The detected associations mainly emphasize the important role of thyroid hormones in glucose homeostasis. In addition, the predictive character of these metabolites might argue for a potential feedback of the metabolic state on thyroid function. Besides known metabolic consequences of TH, the link to the urine excretion of trigonelline, a marker of coffee consumption, represents a novel finding of this study and given the ubiquitous consumption of coffee requires further research.	[Friedrich, Nele; Thuesen, Betina H.; Skaaby, Tea; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Friedrich, Nele; Pietzner, Maik; Wallaschofski, Henri; Budde, Kathrin; Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Cannet, Claire] Bruker BioSpin, Rheinstetten, Germany; [Hansen, Torben; Grarup, Niels; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Wallaschofski, Henri] Private Practice Endocrinol, Erfurt, Germany; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Greifswald Medical School; Bruker Corporation; Bruker BioSpin GmbH; Novo Nordisk Foundation; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Friedrich, N (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.; Friedrich, N (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	nele.friedrich@uni-greifswald.de	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015	Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Pietzner, Maik/0000-0003-3437-9963; Hansen, Torben/0000-0001-8748-3831; Thuesen, Betina/0000-0001-9772-4344; Linneberg, Allan/0000-0002-0994-0184	Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; lb Henriksens foundation; Beckett foundation; Velux Foundation; Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health, the Capital Region of Denmark; European Union [657595]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; lb Henriksens foundation; Beckett foundation; Velux Foundation(Velux Fonden); Danish Medical Research Council, Danish Agency for Science, Technology and Innovation(Danish Medical Research Council); Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health, the Capital Region of Denmark; European Union(European Commission)	We would like to thank the participants in the Inter99, Health2006 and Health2008 cohort, all members of the Inter99/Health2006/Health2008 staff at Research Centre for Prevention and Health and The Steering Committee of the Inter99 study. The Inter99 study was supported by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Augustinus foundation, lb Henriksens foundation and Beckett foundation. Establishment of the Health2006/Health2008 cohort was financially supported by The Velux Foundation; The Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; The Aase and Ejner Danielsens Foundation; ALK-Abello NS (Hash Im, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark), and Research Centre for Prevention and Health, the Capital Region of Denmark. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skfodowska-Curie Grant Agreement number 657595. Bruker BioSpin supports the current study in form of metabolite quantification for the NMR measurements, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Acheson KJ, 2004, AM J CLIN NUTR, V79, P40; Arikan E, 2007, J ENDOCRINOL INVEST, V30, P186, DOI 10.1007/BF03347423; Benvenga S, 2008, THYROID, V18, P293, DOI 10.1089/thy.2007.0222; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; Cappelli C, 2014, EUR J ENDOCRINOL, V170, P95, DOI 10.1530/EJE-13-0693; Constantinou C, 2011, J PROTEOME RES, V10, P869, DOI 10.1021/pr100699m; FABER J, 1982, J CLIN ENDOCR METAB, V55, P8, DOI 10.1210/jcem-55-1-8; FELT V, 1982, HORM METAB RES, V14, P596, DOI 10.1055/s-2007-1019090; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gu LQ, 2011, ENDOCRINE, V39, P266, DOI 10.1007/s12020-011-9436-7; HARPER AE, 1956, AM J PHYSIOL, V184, P457, DOI 10.1152/ajplegacy.1956.184.3.457; Hermenegildo C, 2002, J CLIN ENDOCR METAB, V87, P5636, DOI 10.1210/jc.2002-020905; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; HIRATANI M, 1982, J ALLERGY CLIN IMMUN, V70, P481, DOI 10.1016/0091-6749(82)90012-4; Hu XL, 2011, ARTERIOSCL THROM VAS, V31, P1540, DOI 10.1161/ATVBAHA.110.222638; Ittermann T, 2016, THYROID, V26, P212, DOI 10.1089/thy.2015.0385; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Jourdan C, 2014, METABOLOMICS, V10, P152, DOI 10.1007/s11306-013-0563-4; Klieverik LP, 2008, AM J PHYSIOL-ENDOC M, V294, pE513, DOI 10.1152/ajpendo.00659.2007; Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656; Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Lehmphul I, 2014, THYROID, V24, P1350, DOI 10.1089/thy.2013.0688; Leiper JM, 2006, EUR J CLIN PHARMACOL, V62, P33, DOI 10.1007/s00228-005-0013-y; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; Millatt LJ, 2000, EUR J ENDOCRINOL, V142, P493, DOI 10.1530/eje.0.1420493; Mitchell SC, 2008, FOOD CHEM TOXICOL, V46, P1734, DOI 10.1016/j.fct.2008.01.010; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Ogawa M, 2011, IND HEALTH, V49, P195, DOI 10.2486/indhealth.MS1164; Pietzner M, 2015, EUR THYROID J, V4, P92, DOI 10.1159/000381308; Pietzner M, 2015, METABOLOMICS, V11, P1316, DOI 10.1007/s11306-015-0788-5; RABE KF, 1995, EUR RESPIR J, V8, P637; Rasmussen LB, 2002, BRIT J NUTR, V87, P61, DOI 10.1079/BJN2001474; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; SANDLER MP, 1983, J CLIN ENDOCR METAB, V56, P479, DOI 10.1210/jcem-56-3-479; Shibata T, 2003, POULTRY SCI, V82, P207, DOI 10.1093/ps/82.2.207; SINGH SP, 1978, ENDOCRINOLOGY, V102, P182, DOI 10.1210/endo-102-1-182; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Thienpont LM, 2010, CLIN CHEM, V56, P912, DOI 10.1373/clinchem.2009.140194; Thienpont LM, 2010, CLIN CHEM, V56, P902, DOI 10.1373/clinchem.2009.140178; Tsikas D, 2007, J CHROMATOGR B, V851, P1, DOI 10.1016/j.jchromb.2007.02.020; Vita R, 2013, ENDOCRINE, V43, P154, DOI 10.1007/s12020-012-9772-2; WAHREN J, 1981, J CLIN INVEST, V67, P1056, DOI 10.1172/JCI110117; Wilson A, 2016, CURR OPIN LIPIDOL, V27, P148, DOI 10.1097/MOL.0000000000000274; Wojakowska A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/258763; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Wu S, 2013, J PHARMACEUT BIOMED, V72, P109, DOI 10.1016/j.jpba.2012.09.030; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; ZHANG AQ, 1995, CLIN CHIM ACTA, V233, P81, DOI 10.1016/0009-8981(95)91628-E	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173078	10.1371/journal.pone.0173078	http://dx.doi.org/10.1371/journal.pone.0173078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253303	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300069
J	Guyomard-Rabenirina, S; Dartron, C; Falord, M; Sadikalay, S; Ducat, C; Richard, V; Breurec, S; Gros, O; Talarmin, A				Guyomard-Rabenirina, Stephanie; Dartron, Celia; Falord, Melanie; Sadikalay, Syndia; Ducat, Celia; Richard, Vincent; Breurec, Sebastien; Gros, Olivier; Talarmin, Antoine			Resistance to antimicrobial drugs in different surface waters and wastewaters of Guadeloupe	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; WASTE-WATER; ANTIBIOTIC-RESISTANCE; QUINOLONE RESISTANCE; ENTEROBACTERIACEAE; BACTERIA; EFFLUENT; MUNICIPAL; GENES	Objective The first aim of this study was to evaluate the antimicrobial resistance of Enterobacteriaceae in different water environments of Guadeloupe and especially those impacted by waste water treatment plants (WWTP) effluents. The second objective was to characterize the genetic basis for antibiotic resistance of extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing Enterobacteriaceae isolates (ESBLE and AmpCE). Methods We have collected 70 surface waters (river and sea samples) impacted or not by WWTP and 18 waste waters from 2 WWTPs in 2012 and 2013. We i) determined the total and resistant bacterial counts and ii) tested isolated Enterobacteriaceae for their antimicrobial susceptibility. We also studied the genetic basis for antibiotic resistance of ESBLE and AmpCE, and the genetic background of Escherichia coli. Results In rivers, contamination with Escherichia coli and antibiotic resistant coliforms (ARC) increased from the source to the mouth. Highest levels of river contamination with E. coli (9.26 x 10(5) MPN/100mL) and ARC (2.26 x 10(8) CFU/mL) were observed in surface water sampled near the discharge. A total of 246 Enterobacteriaceae strains resistant to antibiotics were isolated, mostly from waste waters and from river water collected near the discharge. Among these strains, 33 were Extended Spectrum Beta Lactamase (ESBLE) and 8 E. coli were AmpC beta-lactamase producers. All the ESBLE were isolated from waste waters or from river water collected near the discharge. The bla(CTX-M) gene was present in 29 of the 33 ESBLE strains, with 24 belonging to group 1. Numerous strains (68.7%) showed more than one acquired antibiotic resistance mechanism. E. coli strains belonged to different phylogenetic groups; among the B2 group, most strains belonged to the ST131 clone. Conclusion Our results demonstrated that many human activities can supply antibiotic-resistant bacteria in surface water. Nevertheless, WWTPs were the most important supplier of ESBLE in water environment of Guadeloupe.	[Guyomard-Rabenirina, Stephanie; Falord, Melanie; Sadikalay, Syndia; Ducat, Celia; Breurec, Sebastien; Talarmin, Antoine] Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France; [Dartron, Celia; Gros, Olivier] Univ Nice Sophia Antipolis, Univ Antilles, UPMC Univ Paris 06, Sorbonne Univ,EPS,IBPS,CNRS, Paris, France; [Richard, Vincent] Inst Pasteur Nouvelle Caledonie, BP61, Noumea 98845, New Caledonia; [Breurec, Sebastien] Univ Antilles, Pointe A Pitre, Guadeloupe, France; [Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre, Guadeloupe, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur; Universite des Antilles; CHU Guadeloupe	Guyomard-Rabenirina, S (corresponding author), Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France.	sguyomard@pasteur-guadeloupe.fr		Vincent, RICHARD/0000-0002-6961-1753	French overseas ministry; European Union [FEDER FED-1-1.4 32932]	French overseas ministry; European Union(European Commission)	This work was supported by the French overseas ministry and by grant FEDER FED-1-1.4 32932 from the European Union. https://www.europe-guadeloupe.fr/feder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, SCI TOTAL ENVIRON, V408, P6192, DOI 10.1016/j.scitotenv.2010.08.055; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2015, ANTIMICROBIALS AGR E; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Baquero F, 2015, EVOL APPL, V8, P223, DOI 10.1111/eva.12235; Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brechet C, 2014, CLIN INFECT DIS, V58, P1658, DOI 10.1093/cid/ciu190; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Colomer-Lluch M, 2012, J ANTIMICROB CHEMOTH, P1; Comite de Bassin de la Guadeloupe, 2010, GEST EAU GUAD SOURC; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Diwan V, 2012, J ANTIMICROB CHEMOTH, V67, P857, DOI 10.1093/jac/dkr564; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; Goni-Urriza M, 2000, APPL ENVIRON MICROB, V66, P125, DOI 10.1128/AEM.66.1.125-132.2000; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Guessennd N, 2008, PATHOL BIOL, V56, P439, DOI 10.1016/j.patbio.2008.07.025; Guyomard-Rabenirina S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0749-9; Harris S, 2014, SCI TOTAL ENVIRON, V468, P1078, DOI 10.1016/j.scitotenv.2013.09.017; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Huijbers PMC, 2015, ENVIRON SCI TECHNOL, V49, P11993, DOI 10.1021/acs.est.5b02566; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; McArthur JV, 2000, APPL ENVIRON MICROB, V66, P3722, DOI 10.1128/AEM.66.9.3722-3726.2000; Mokracka J, 2012, WATER RES, V46, P3353, DOI 10.1016/j.watres.2012.03.037; Navidinia M, 2014, BRAZ J MICROBIOL, V45, P509, DOI 10.1590/S1517-83822014000200019; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Roderova M, 2016, NEW MICROBIOL, V39, P124; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Servais P, 2009, SCI TOTAL ENVIRON, V408, P365, DOI 10.1016/j.scitotenv.2009.09.042; Societe Francaise de Microbiologie, 2013, COM ANT SOC FRANC MI; Watkinson AJ, 2007, APPL ENVIRON MICROB, V73, P5667, DOI 10.1128/AEM.00763-07; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013; [No title captured]	45	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173155	10.1371/journal.pone.0173155	http://dx.doi.org/10.1371/journal.pone.0173155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253356	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300083
J	Carlier, M; Delevoye-Turrell, Y				Carlier, Mauraine; Delevoye-Turrell, Yvonne		Fun2move Consortium	Tolerance to exercise intensity modulates pleasure when exercising in music: The upsides of acoustic energy for High Tolerant individuals	PLOS ONE			English	Article							PERCEIVED EXERTION; PHYSICAL-ACTIVITY; VENTILATORY THRESHOLD; AFFECTIVE RESPONSES; AFFECTIVE VALENCE; WOMEN; RATINGS; ADHERENCE; QUESTIONNAIRE; DISTRACTION	Moderate physical activity can be experienced by some as pleasurable and by others as discouraging. This may be why many people lack sufficient motivation to participate in the recommended 150 minutes of moderately intense exercise per week. In the present study, we assessed how pleasure and enjoyment were modulated differently by one's tolerance to self-paced physical activity. Sixty-three healthy individuals were allocated to three independent experimental conditions: a resting condition (watching TV), a cycling in silence condition, and a cycling in music condition. The tolerance threshold was assessed using the PRETIE-Questionnaire. Physical activity consisted in cycling during 30 minutes, at an intensity perceived as "somewhat difficult" on the Ratings of Perceived Exertion Scale. While controlling for self-reported physical activity level, results revealed that for the same perception of exertion and a similar level of enjoyment, the High Tolerance group produced more power output than the Low Tolerance group. There was a positive effect of music for High Tolerant individuals only, with music inducing greater power output and more pleasure. There was an effect of music on heart rate frequency in the Low Tolerant individuals without benefits in power output or pleasure. Our results suggest that for Low Tolerant individuals, energizing environments can interfere with the promised (positive) distracting effects of music. Hence, tolerance to physical effort must be taken into account to conceive training sessions that seek to use distracting methods as means to sustain pleasurable exercising over time.	[Carlier, Mauraine; Delevoye-Turrell, Yvonne; Fun2move Consortium] Univ Lille, Dept Psychol, SCALab, UMR CNRS 9193, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Delevoye-Turrell, Y (corresponding author), Univ Lille, Dept Psychol, SCALab, UMR CNRS 9193, Lille, France.	yvonne.delevoye@univ-lille3.fr	Campailla, Jasmin/AAK-2420-2021		French Research Agency [ANR-2009-CORD-014-INTERACT, ANR-11-EQPX-0023]; region Nord-Pas-de-Calais and Decathlon, S.A. [ARCIR2013]	French Research Agency(French National Research Agency (ANR)); region Nord-Pas-de-Calais and Decathlon, S.A.(Region Hauts-de-France)	This study was funded by grants from the French Research Agency ANR-2009-CORD-014-INTERACT and ANR-11-EQPX-0023, and by funding to YD from the region Nord-Pas-de-Calais and Decathlon, S.A. (ARCIR2013). The funders had no role in study design, data collection and alaysis, decision to publish or preparation of the manuscript.	Ahmaidi S, 1998, EUR J APPL PHYSIOL O, V78, P170, DOI 10.1007/s004210050403; Annesi JJ, 2001, CAN J BEHAV SCI, V33, P193, DOI 10.1037/h0087141; Bishop DT, 2007, J SPORT EXERCISE PSY, V29, P584, DOI 10.1123/jsep.29.5.584; Borg G., 1998, BORGS PERCEIVED EXER, V8; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Cabanac M., 1995, BIOL PERSPECT MOTIV, P399; Coquart JB, 2014, SPORTS MED, V44, P563, DOI 10.1007/s40279-013-0139-5; Cox KL, 2003, PREV MED, V36, P17, DOI 10.1006/pmed.2002.1134; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL, P40; Damasio A., 1995, NEUROSCIENTIST, V1, P19, DOI [10.1177/107385849500100104, DOI 10.1177/107385849500100104]; Damasio A.R., 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P111; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Decker ES, 2017, PSYCHOL SPORT EXERCI; Delignieres D., 1998, REV STAPS, V45, P7; DEMELLO JJ, 1987, MED SCI SPORT EXER, V19, P354; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; DWYER J, 1983, MED SCI SPORT EXER, V15, P72; EKBLOM B, 1971, ACTA PHYSIOL SCAND, V83, P399, DOI 10.1111/j.1748-1716.1971.tb05093.x; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P., 2006, PSYCHOBIOLOGY PHYS A, P91; Ekkekakis P, 2005, J SPORT EXERC PSYCHO; Ekkekakis P, 2007, MED SCI SPORT EXER, V39, P1193, DOI 10.1249/mss.0b013e318058a5ea; Ekkekakis P, 2008, J SPORT SCI, V26, P499, DOI 10.1080/02640410701624523; Elliott D., 2005, EUR J SPORT SCI, V5, P97, DOI DOI 10.1080/17461390500171310; Elliott D, 2004, J SPORT BEHAV, V27, P134; Eston R G, 1988, Br J Sports Med, V22, P153; Eston R, 2012, INT J SPORT PHYSIOL, V7, P175, DOI 10.1123/ijspp.7.2.175; Eurobarometer, 2010, PHYS ACTIVITY; EYSENCK HJ, 1983, PSYCHOL MED, V13, P447, DOI 10.1017/S0033291700051084; Feriche B, 1998, J SPORT MED PHYS FIT, V38, P35; FULKER DW, 1980, J RES PERS, V14, P261, DOI 10.1016/0092-6566(80)90033-1; Gordon N F, 1995, J Cardiopulm Rehabil, V15, P193; Hall EE, 2014, J STRENGTH COND RES, V28, P2443, DOI 10.1519/JSC.0000000000000420; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Hilz MJ, 2014, AUTON NEUROSCI-BASIC, V183, P83, DOI 10.1016/j.autneu.2014.02.004; Jones L, 2014, J SPORT EXERCISE PSY, V36, P528, DOI [10.1123/jsep.2013-0251, 10.1123/jsep.2014-0251]; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Leman M., 2007, EMBODIED MUSIC COGNI, DOI [10.7551/mitpress/7476.001.0001, DOI 10.7551/MITPRESS/7476.001.0001]; Lind E, 2005, PREV MED, V40, P407, DOI 10.1016/j.ypmed.2004.07.006; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Monnier-Benoit P, 2009, J STRENGTH COND RES, V23, P1752, DOI 10.1519/JSC.0b013e3181b74dc1; Panksepp J., 1998, J CONSCIOUSNESS STUD, V5, P566; Parfitt G, 1996, PERCEPT MOTOR SKILL, V82, P1035, DOI 10.2466/pms.1996.82.3.1035; Perri MG, 2002, HEALTH PSYCHOL, V21, P452, DOI 10.1037//0278-6133.21.5.452; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Privitera GJ, 2014, J SPORT SCI MED, V13, P266; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; ROBERTSON RJ, 1986, MED SCI SPORT EXER, V18, P114; Rose EA, 2012, SCAND J MED SCI SPOR, V22, P265, DOI 10.1111/j.1600-0838.2010.01161.x; Rose EA, 2007, J SPORT EXERCISE PSY, V29, P281, DOI 10.1123/jsep.29.3.281; Rose EA, 2008, MED SCI SPORT EXER, V40, P1852, DOI 10.1249/MSS.0b013e31817a8aea; Schulze G., 1995, BIOL PERSPECTIVES MO, P265; Shaulov N, 2009, PERCEPT MOTOR SKILL, V108, P597, DOI 10.2466/PMS.108.2.597-607; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Stojiljkovic Stanimir, 2004, Srp Arh Celok Lek, V132, P409; Thompson WR, 2010, ACSMS GUIDELINES EXE; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Wamain Y, COGNITION EMOT UNPUB; Welch AS, 2007, PSYCHOL SPORT EXERC, V8, P401, DOI 10.1016/j.psychsport.2006.09.002; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Williams DM, 2012, ANN BEHAV MED, V44, P43, DOI 10.1007/s12160-012-9362-9	63	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170383	10.1371/journal.pone.0170383	http://dx.doi.org/10.1371/journal.pone.0170383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248980	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500004
J	Gravett, N; Bhagwandin, A; Sutcliffe, R; Landen, K; Chase, MJ; Lyamin, OI; Siegel, JM; Manger, PR				Gravett, Nadine; Bhagwandin, Adhil; Sutcliffe, Robert; Landen, Kelly; Chase, Michael J.; Lyamin, Oleg I.; Siegel, Jerome M.; Manger, Paul R.			Inactivity/sleep in two wild free-roaming African elephant matriarchs - Does large body size make elephants the shortest mammalian sleepers?	PLOS ONE			English	Article							GIRAFFE GIRAFFA-CAMELOPARDALIS; CHOBE NATIONAL-PARK; PHYLOGENETIC ANALYSIS; BEHAVIORAL SLEEP; MEMORY CONSOLIDATION; NOCTURNAL BEHAVIOR; LOXODONTA-AFRICANA; PROCAVIA-CAPENSIS; NEURAL SYSTEMS; ROCK HYRAX	The current study provides details of sleep (or inactivity) in two wild, free-roaming African elephant matriarchs studied in their natural habitat with remote monitoring using an actiwatch subcutaneously implanted in the trunk, a standard elephant collar equipped with a GPS system and gyroscope, and a portable weather station. We found that these two elephants were polyphasic sleepers, had an average daily total sleep time of 2 h, mostly between 02:00 and 06:00, and displayed the shortest daily sleep time of any mammal recorded to date. Moreover, these two elephants exhibited both standing and recumbent sleep, but only exhibited recumbent sleep every third or fourth day, potentially limiting their ability to enter REM sleep on a daily basis. In addition, we observed on five occasions that the elephants went without sleep for up to 46 h and traversed around 30 km in 10 h, possibly due to disturbances such as potential predation or poaching events, or a bull elephant in musth. They exhibited no form of sleep rebound following a night without sleep. Environmental conditions, especially ambient air temperature and relative humidity, analysed as wet-bulb globe temperature, reliably predict sleep onset and offset times. The elephants selected novel sleep sites each night and the amount of activity between sleep periods did not affect the amount of sleep. A number of similarities and differences to studies of elephant sleep in captivity are noted, and specific factors shaping sleep architecture in elephants, on various temporal scales, are discussed.	[Gravett, Nadine; Bhagwandin, Adhil; Manger, Paul R.] Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa; [Sutcliffe, Robert; Landen, Kelly; Chase, Michael J.] Elephants Borders, Kasane, Botswana; [Lyamin, Oleg I.; Siegel, Jerome M.] Univ Calif Los Angeles, Dept Psychiat, Sepulveda VAMC, Neurobiol Res 151A3, Los Angeles, CA USA	University of Witwatersrand; University of California System; University of California Los Angeles	Manger, PR (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa.	Paul.Manger@wits.ac.za	Lyamin, Oleg/AAO-4881-2020	Lyamin, Oleg/0000-0003-2049-0943; Bhagwandin, Adhil/0000-0002-7748-0095; Bhagwandin, Adhil/0000-0003-0618-3314	National Research Foundation of South Africa [CPR20110602000019125, 81822]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034748] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001753] Funding Source: NIH RePORTER	National Research Foundation of South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This research was funded by the National Research Foundation of South Africa (www.nrf.ac.za) (reference: CPR20110602000019125, grant number: 81822, awarded to PRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1980, APPL ANIM ETHOL, V6, P257, DOI 10.1016/0304-3762(80)90027-9; ALLISON T, 1976, SCIENCE, V194, P732, DOI 10.1126/science.982039; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; BENEDICT FRANCIS G., 1938, JOUR MAMMAL, V19, P175, DOI 10.2307/1374612; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Capellini I, 2008, FUNCT ECOL, V22, P847, DOI 10.1111/j.1365-2435.2008.01449.x; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; DALLAIRE A, 1974, PHYSIOL BEHAV, V12, P789, DOI 10.1016/0031-9384(74)90015-8; DALLAIRE A, 1986, VET CLIN N AM-EQUINE, V2, P591, DOI 10.1016/S0749-0739(17)30708-3; Davimes JG, 2016, J BIOL RHYTHM, V31, P365, DOI 10.1177/0748730416645729; Dell LA, 2016, J COMP NEUROL, V524, P2018, DOI 10.1002/cne.23931; Dell LA, 2016, J COMP NEUROL, V524, P2036, DOI 10.1002/cne.23930; Dell LA, 2012, J CHEM NEUROANAT, V44, P98, DOI 10.1016/j.jchemneu.2012.06.001; Gravett N, 2012, BRAIN BEHAV EVOLUT, V79, P155, DOI 10.1159/000335342; Gravett N, 2009, J CHEM NEUROANAT, V38, P57, DOI 10.1016/j.jchemneu.2009.02.005; GUY PR, 1976, E AFR WILDL J, V14, P285; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153301; Horback KM, 2014, ZOO BIOL, V33, P403, DOI 10.1002/zoo.21160; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Joubert D, 2006, AFR J ECOL, V44, P279, DOI 10.1111/j.1365-2028.2006.00626.x; Khume W., 1963, INT ZOO YB, V4, P113; Kurt F., 1960, MAMMALIA, V24, P259; LAWS R. M., 1966, EAST AFR WILDLIFE J, V4, P1; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Liljegren James C., 2008, Journal of Occupational and Environmental Hygiene, V5, P645, DOI 10.1080/15459620802310770; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin OI, 2000, J SLEEP RES, V9, P261; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Manger PR, 2013, BRAIN BEHAV EVOLUT, V82, P68, DOI 10.1159/000352056; Manger PR, 2009, J NEUROSCI METH, V179, P16, DOI 10.1016/j.jneumeth.2009.01.001; Maseko BC, 2013, BRAIN BEHAV EVOLUT, V82, P83, DOI 10.1159/000352004; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; MUKHAMETOV LM, 1992, EXPERIENTIA, V48, P417, DOI 10.1007/BF01923447; Patzke N, 2014, BRAIN STRUCT FUNCT, V219, P1587, DOI 10.1007/s00429-013-0587-6; Power RJ, 2009, AFR ZOOL, V44, P36, DOI 10.3377/004.044.0104; Pryaslova JP, 2009, BEHAV BRAIN RES, V201, P80, DOI 10.1016/j.bbr.2009.01.033; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Stull R, 2011, J APPL METEOROL CLIM, V50, P2267, DOI 10.1175/JAMC-D-11-0143.1; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; TOBLER I, 1992, SLEEP, V15, P1; Tobler I, 1996, J SLEEP RES, V5, P21, DOI 10.1046/j.1365-2869.1996.00010.x; Vorster AP, 2015, NEUROSCI BIOBEHAV R, V50, P103, DOI 10.1016/j.neubiorev.2014.09.020; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Williams DC, 2008, J VET INTERN MED, V22, P630, DOI 10.1111/j.1939-1676.2008.0096.x; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; WYATT J R, 1974, East African Wildlife Journal, V12, P273; Yetish G, 2015, CURR BIOL, V25, P2862, DOI 10.1016/j.cub.2015.09.046; Zepelin H, 2000, PRINCIPLES PRACTICE, P82	56	48	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171903	10.1371/journal.pone.0171903	http://dx.doi.org/10.1371/journal.pone.0171903			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249035	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500020
J	Schulz, HM; Li, CF; Thies, B; Chang, SC; Bendix, J				Schulz, Hans Martin; Li, Ching-Feng; Thies, Boris; Chang, Shih-Chieh; Bendix, Joerg			Mapping the montane cloud forest of Taiwan using 12 year MODIS-derived ground fog frequency data	PLOS ONE			English	Article							CLIMATE-CHANGE; VULNERABILITY	Up until now montane cloud forest (MCF) in Taiwan has only been mapped for selected areas of vegetation plots. This paper presents the first comprehensive map of MCF distribution for the entire island. For its creation, a Random Forest model was trained with vegetation plots from the National Vegetation Database of Taiwan that were classified as "MCF" or "non-MCF". This model predicted the distribution of MCF from a raster data set of parameters derived from a digital elevation model (DEM), Landsat channels and texture measures derived from them as well as ground fog frequency data derived from the Moderate Resolution Imaging Spectroradiometer. While the DEM parameters and Landsat data predicted much of the cloud forest's location, local deviations in the altitudinal distribution of MCF linked to the monsoonal influence as well as the Massenerhebung effect (causing MCF in atypically low altitudes) were only captured once fog frequency data was included. Therefore, our study suggests that ground fog data are most useful for accurately mapping MCF.	[Schulz, Hans Martin; Thies, Boris; Bendix, Joerg] Philipps Univ Marburg, Lab Climatol & Remote Sensing, Marburg, Germany; [Li, Ching-Feng] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan; [Chang, Shih-Chieh] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan	Philipps University Marburg; National Taiwan University; National Dong Hwa University	Schulz, HM (corresponding author), Philipps Univ Marburg, Lab Climatol & Remote Sensing, Marburg, Germany.	martin.schulz@staff.uni-marburg.de	Li, Ching-Feng/I-6504-2015; Chang, Shih-Chieh/C-9620-2014	Li, Ching-Feng/0000-0003-0744-490X; Chang, Shih-Chieh/0000-0002-8236-227X	German Research Foundation; Ministry of Science and Technology of the Republic of China [TH1531/21]	German Research Foundation(German Research Foundation (DFG)); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was funded by the German Research Foundation (www.DEG.de) in cooperation with the Ministry of Science and Technology of the Republic of China (http//web.l most.gov.tw/en/public), Grant number: TH1531/21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich M, 2004, GLOBAL DIRECTORY TRO; ALDRICH M., 1997, WCMC BIODIVERSITY B, V2, P1; Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Alonso MC, 2011, P ASPRS 2001 ANN C M; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, TECHNICAL REPORT; Bruelheide H., 1995, DISS BOT, V244, P1; Bruijnzeel L.A., 2010, TROPICAL MONTANE CLO, P691, DOI DOI 10.1017/CBO9780511778384.074; BRUIJNZEEL LA, 1993, J ECOL, V81, P145, DOI 10.2307/2261231; Bubb P., 2004, CLOUD FOREST AGENDA; Campanella R, 1995, TROPICAL MONTANE CLO, V110, P116; Chang SC, 2002, ATMOS RES, V64, P159, DOI 10.1016/S0169-8095(02)00088-1; Chen TC, 1999, B AM METEOROL SOC, V80, P2299, DOI 10.1175/1520-0477(1999)080<2299:DASVOT>2.0.CO;2; Chen YF, 2001, VEGETATION TAIWAN; Chica-Olmo M, 2000, COMPUT GEOSCI, V26, P373, DOI 10.1016/S0098-3004(99)00118-1; Chytry M., 2007, VEGETATION CZECH REP; DUBAYAH R, 1995, INT J GEOGR INF SYST, V9, P405, DOI 10.1080/02693799508902046; Feng QL, 2015, REMOTE SENS-BASEL, V7, P1074, DOI 10.3390/rs70101074; Fernandez GFC, 2015, REMOTE SENS-BASEL, V7, P2509, DOI 10.3390/rs70302509; FLENLEY JR, 1995, ECOL STU AN, V110, P150; Foster P, 2001, EARTH-SCI REV, V55, P73, DOI 10.1016/S0012-8252(01)00056-3; HAMILTON LS, 1995, MT RES DEV, V15, P259, DOI 10.2307/3673933; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu J, 2016, OECOLOGIA, V180, P1061, DOI 10.1007/s00442-015-3533-x; Koci M, 2003, J VEG SCI, V14, P601, DOI 10.1111/j.1654-1103.2003.tb02187.x; Kuhn M, 2015, CARET CLASSIFICATION; Lai I-Ling, 2006, Taiwania, V51, P317; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Lawton RO, 2001, SCIENCE, V294, P584; Li CF, 2015, ECOL RES, V30, P771, DOI 10.1007/s11284-015-1284-0; Li CF, 2013, APPL VEG SCI, V16, P698, DOI 10.1111/avsc.12025; Liaw A, 2015, RANDOMFOREST VERSION; Loope LL, 1998, CLIMATIC CHANGE, V39, P503, DOI 10.1023/A:1005372118420; Martinuzzi S, 2007, IITF32 USDA; Mason I. B., 2003, FORECAST VERIFICATIO, P37; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mulligan M, 2005, ZF0216 DFID FRP; Nair US, 2008, J APPL METEOROL CLIM, V47, P2183, DOI 10.1175/2007JAMC1819.1; New MG, GLOBAL MONTHLY CLIMA; OHSAWA M, 1995, ECOL STU AN, V110, P254; Peh KSH, 2011, BIOSCIENCE, V61, P27, DOI 10.1525/bio.2011.61.1.8; Ponce-Reyes R, 2012, NAT CLIM CHANGE, V2, P448, DOI 10.1038/NCLIMATE1453; Pope I, 2015, INT J SUST DEV WORLD, V22, P201, DOI 10.1080/13504509.2014.998738; R Core Team, 2015, R VERS 3 2 2 LANG EN; Rodriguez-Galiano VF, 2012, REMOTE SENS ENVIRON, V121, P93, DOI 10.1016/j.rse.2011.12.003; Scatena F. N., 2010, TROPICAL MONTANE CLO, P3, DOI DOI 10.1017/CBO9780511778384.003; Schulz HM, 2016, ATMOS MEAS TECH, V9, P1135, DOI 10.5194/amt-9-1135-2016; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Su H. J., 1984, Quarterly Journal of Chinese Forestry, V17, P57; Teillet P., 1982, CAN J REMOTE SENS, V8, P84, DOI DOI 10.1080/07038992.1982.10855028; Thies B, 2015, REMOTE SENS-BASEL, V7, P12986, DOI 10.3390/rs71012986; United States Geological Survey, 2011, ASTER GDEM 2; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Wey TsongHuei, 2011, Journal of the Experimental Forest of National Taiwan University, V25, P149; Wijaya A., 2008, QUAL ASP SPAT DATA M, P199, DOI DOI 10.1201/9781420069273.SEC4; Wilson AM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002415	56	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172663	10.1371/journal.pone.0172663	http://dx.doi.org/10.1371/journal.pone.0172663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245279	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200027
J	Wren, TAL; Aggabao, PC; Poorghasamians, E; Chavez, TA; Ponrartana, S; Gilsanz, V				Wren, Tishya A. L.; Aggabao, Patricia C.; Poorghasamians, Ervin; Chavez, Thomas A.; Ponrartana, Skorn; Gilsanz, Vicente			Association between vertebral cross-sectional area and lumbar lordosis angle in adolescents	PLOS ONE			English	Article							LOW-BACK-PAIN; GENDER-DIFFERENCES; DEGENERATIVE SPONDYLOLISTHESIS; SPONDYLOLYSIS; ALIGNMENT; POSTURE; SPINE; ORIENTATION; SCOLIOSIS; EVOLUTION	Lumbar lordosis (LL) is more prominent in women than in men, but the mechanisms responsible for this discrepancy are poorly defined. A recent study indicates that newborn girls have smaller vertebral cross-sectional area (CSA) when compared to boys D a difference that persists throughout life and is independent of body size. We determined the relations between vertebral cross-sectional area (CSA) and LL angle and whether sex differences in lumbar lordosis are related to sex differences in vertebral CSA. Using multi-planar magnetic resonance imaging (MRI), we measured vertebral cross-sectional area (CSA) and vertebral height of the spine of 40 healthy boys and 40 girls, ages 9 +/- 13 years. Measures of the CSA of the lumbar vertebrae significantly differed between sexes (9.38 +/- 1.46 vs. 7.93 +/- 0.69 in boys and girls, respectively; P < 0.0001), while the degree of LL was significantly greater in girls than in boys (23.7 +/- 6.1 vs. 27.6 +/- 8.0 in boys and girls, respectively; P = 0.02). When all subjects were analyzed together, values for LL angle were negatively correlated to vertebral CSA (r = -0.47; P < 0.0001); this was also true when boys and girls were analyzed separately. Multivariate regression analysis indicated that vertebral CSA was independently associated with LL, even after accounting for sex, age, height or vertebral height, and weight. Similar negative relations were present when thoracic vertebrae were analyzed (Model P < 0.0001, R-2 = 0.37, thoracic vertebral CSA slope P < 0.0001), suggesting that deficient vertebral cross-sectional dimensions are not merely the consequence of the anterior lumbar curvature. We conclude that vertebral CSA is negatively associated with LL, and that the greater degree of LL in females could, at least in part, be due to smaller vertebral cross-sectional dimensions. Studies are needed to examine the potential relations between vertebral CSA and spinal conditions known to be associated with increased LL, such as spondylolysis and spondylolisthesis.	[Wren, Tishya A. L.; Gilsanz, Vicente] Univ Southern Calif, Dept Orthopaed Surg, Childrens Hosp Los Angeles, Los Angeles, CA 90007 USA; [Aggabao, Patricia C.; Poorghasamians, Ervin; Ponrartana, Skorn; Gilsanz, Vicente] Univ Southern Calif, Dept Radiol, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA; [Chavez, Thomas A.; Gilsanz, Vicente] Univ Southern Calif, Dept Pediat, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Gilsanz, V (corresponding author), Univ Southern Calif, Dept Orthopaed Surg, Childrens Hosp Los Angeles, Los Angeles, CA 90007 USA.; Gilsanz, V (corresponding author), Univ Southern Calif, Dept Radiol, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA.; Gilsanz, V (corresponding author), Univ Southern Calif, Dept Pediat, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA.	vgilsanz@chla.usc.edu	Wren, Tishya/AAS-4196-2021					Arfai K, 2002, RADIOLOGY, V224, P338, DOI 10.1148/radiol.2242011369; Been E, 2014, SPINE J, V14, P87, DOI 10.1016/j.spinee.2013.07.464; Been E, 2011, EUR SPINE J, V20, P1159, DOI 10.1007/s00586-010-1660-y; Chen IR, 2009, SPINE, V34, P1402, DOI 10.1097/BRS.0b013e31817b8fbd; Christensen ST, 2008, J MANIP PHYSIOL THER, V31, P690, DOI 10.1016/j.jmpt.2008.10.004; CHRISTIE HJ, 1995, ARCH PHYS MED REHAB, V76, P218, DOI 10.1016/S0003-9993(95)80604-0; Chung SB, 2012, CLIN ANAT, V25, P391, DOI 10.1002/ca.21222; Coates JE, 2001, MANUAL THER, V6, P139, DOI 10.1054/math.2001.0397; Dolphens M, 2013, J ANAT, V223, P629, DOI 10.1111/joa.12119; FERNAND R, 1985, SPINE, V10, P799, DOI 10.1097/00007632-198511000-00003; Ferrero E, 2015, EUR SPINE J, V24, P1219, DOI 10.1007/s00586-015-3778-4; GILSANZ V, 1994, RADIOLOGY, V190, P678, DOI 10.1148/radiology.190.3.8115610; GILSANZ V, 1994, RADIOLOGY, V190, P673, DOI 10.1148/radiology.190.3.8115609; HANSSON T, 1985, SPINE, V10, P154, DOI 10.1097/00007632-198503000-00008; Hay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133685; Hong JY, 2010, EUR SPINE J, V19, P1551, DOI 10.1007/s00586-010-1422-x; Huang KY, 2009, EUR SPINE J, V18, P1851, DOI 10.1007/s00586-009-1059-9; JACKSON DW, 1981, AM J SPORT MED, V9, P304, DOI 10.1177/036354658100900504; Jackson RP, 2003, SPINE, V28, P151, DOI 10.1097/00007632-200301150-00011; Jacobsen S, 2007, SPINE, V32, P120, DOI 10.1097/01.brs.0000250979.12398.96; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Leone A, 2007, RADIOLOGY, V245, P62, DOI 10.1148/radiol.2451051359; Letafatkar K, 2010, J RES REHAB SCI N AM, V4; Andreasen ML, 2007, J MANIP PHYSIOL THER, V30, P26, DOI 10.1016/j.jmpt.2006.11.009; Masharawi Y, 2004, SPINE, V29, P1755, DOI 10.1097/01.BRS.0000134575.04084.EF; Masharawi Y, 2010, EUR SPINE J, V19, P768, DOI 10.1007/s00586-009-1256-6; Mehta Vivek A, 2015, Neurosurgery, V76 Suppl 1, pS42, DOI 10.1227/01.neu.0000462077.50830.1a; Middleditch A, 2005, FUNCTIONAL ANATOMY S, P173; Middleditch A, 2005, INTERVERTEBRAL DISCS, P63; Middleditch A, 2005, FUNCTIONAL ANATOMY S, P1; Murrie VL, 2003, CLIN ANAT, V16, P144, DOI 10.1002/ca.10114; NISSINEN M, 1995, ACTA PAEDIATR, V84, P308, DOI 10.1111/j.1651-2227.1995.tb13634.x; Nitta A, 2016, ORTHOPEDICS, V39, pE434, DOI 10.3928/01477447-20160404-07; Nourbakhsh MR, 2002, J ORTHOP SPORT PHYS, V32, P447, DOI 10.2519/jospt.2002.32.9.447; Oh YM, 2013, J KOREAN NEUROSURG S, V54, P207, DOI 10.3340/jkns.2013.54.3.207; Ponrartana S, 2016, PEDIATR RADIOL, V46, P1424, DOI 10.1007/s00247-016-3633-8; Ponrartana S, 2015, J PEDIATR-US, V167, P416, DOI 10.1016/j.jpeds.2015.04.078; Schroeder GD, 2016, EUR SPINE J; Schuller S, 2011, EUR SPINE J, V20, P713, DOI 10.1007/s00586-010-1640-2; Shefi S, 2013, SPINE, V38, pE602, DOI 10.1097/BRS.0b013e31828b666b; Smith AJ, 2011, INT J PEDIATR OBES, V6, pE97, DOI 10.3109/17477166.2010.530664; Styne DM, 2016, WILLIAMS TXB ENDOCRI, V13th, P1074; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Vialle R, 2007, EUR SPINE J, V16, P1641, DOI 10.1007/s00586-007-0348-4; Ward CV, 2005, SPINE, V30, P1808, DOI 10.1097/01.brs.0000174273.85164.67; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172844	10.1371/journal.pone.0172844	http://dx.doi.org/10.1371/journal.pone.0172844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245271	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200035
J	Ferron, HG; Botella, H				Ferron, Humberto G.; Botella, Hector			Squamation and ecology of thelodonts	PLOS ONE			English	Article							JAWLESS VERTEBRATES; DRAG REDUCTION; SHARK SKIN; SCALES; DENTICLES; ORDOVICIAN; MORPHOLOGY; AGNATHA; FISHES; SPAIN	Thelodonts are an enigmatic group of Paleozoic jawless vertebrates that have been well studied from taxonomical, biostratigraphic and paleogeographic points of view, although our knowledge of their ecology and mode of life is still scant. Their bodies were covered by micrometric scales whose morphology, histology and the developmental process are extremely similar to those of extant sharks. Based on these similarities and on the well-recognized relationship between squamation and ecology in sharks, here we explore the ecological diversity and lifestyles of thelodonts. For this we use classic morphometrics and discriminant analysis to characterize the squamation patterns of a significant number of extant shark species whose ecology is well known. Multivariate analyses have defined a characteristic squamation pattern for each ecological group, thus establishing a comparative framework for inferring lifestyles in thelodonts. We then use this information to study the squamation of the currently described 147 species of thelodonts, known from both articulated and disarticulated remains. Discriminant analysis has allowed recognizing squamation patterns comparable to those of sharks and links them to specific ecological groups. Our results suggest a remarkable ecological diversity in thelodonts. A large number of them were probably demersal species inhabiting hard substrates, within caves and crevices in rocky environments or reefs, taking advantage of the flexibility provided by their micromeric squamations. Contrary to classical interpretations, only few thelodonts were placed among demersal species inhabiting sandy and muddy substrates. Schooling species with defensive scales against ectoparasites could be also abundant suggesting that social interactions and pressure of ectoparasites were present in vertebrates as early the Silurian. The presence of species showing scales suggestive of low to moderate speed and a lifestyle presumably associated with open water environments indicates adaptation of thelodonts to deep water habitats. Scale morphology suggests that some other thelodonts were strong-swimming pelagic species, most of them radiating during the Early Devonian in association with the Nekton Revolution.	[Ferron, Humberto G.; Botella, Hector] Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain		Botella, H (corresponding author), Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	Hector.Botella@uv.es	Ferron, Humberto/ABH-9895-2020	Ferron, Humberto/0000-0003-2254-8424	Spanish Ministry of Economy and Competitiveness [CGL2014-52662-P]; Valencian Generality [GV/2016/102]; SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program [DETAF-4466]; FPU Spanish Research Programme [FPU13/02660]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Generality; SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program; FPU Spanish Research Programme	This work has been funded by the Spanish Ministry of Economy and Competitiveness http://www.mineco.gob.es/portal/site/mineco/ (CGL2014-52662-P), the Valencian Generality http://www.ceice.gva.es/web/ciencia/becas-ayudas-y-subvenciones-cientificas (GV/2016/102), and the SYNTHESYS Project http://www.synthesys.into/ which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program (DETAF-4466). HGF is a recipient of a Fellowship from the FPU Spanish Research Programme (FPU13/02660) http://www.mecd.gob.es/mecd/servicios-al-ciudadanomecd/catalogo/general/educacion/998758/ficha.html.	ALBRECHT GH, 1980, AM ZOOL, V20, P679; [Anonymous], 1973, J GEOLOGICAL SOC, V129, P557; Atkinson CJL, 2012, BIOL BULL-US, V222, P26, DOI 10.1086/BBLv222n1p26; Ball P, 1999, NATURE, V400, P507, DOI 10.1038/22883; Bechert DW, 1985, 1985 AM I AER ASTR S; Blieck A, 2000, DEVONIAN VERTEBRATE, P161; Blom H, 2002, PALAEONTOLOGY, V45, P795, DOI 10.1111/1475-4983.00261; Blom Henning, 1999, Acta Geologica Polonica, V49, P97; Botella H, 2006, PALAEONTOLOGY, V49, P141, DOI 10.1111/j.1475-4983.2005.00534.x; Caldwell Michael W., 1995, Geobios Memoire Special (Villeurbanne), V19, P23; Ciena AP, 2016, ANAT HISTOL EMBRYOL, V45, P109, DOI 10.1111/ahe.12178; Compagno L.J.V., 2005, SHARKS WORLD; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Compagno LJV, 2001, FAO FISHERIES SYNOPS, V2; Compagno LJV., 1984, FAO FISH SYNOP, P20; Compagno LJV, 1984, FAO FISHERIES SYNO 2, V4; De Baets K, 2015, ADV PARASIT, V90, P93, DOI 10.1016/bs.apar.2015.06.002; Dean B, 2010, PHILOS T R SOC A, V368, P4775, DOI 10.1098/rsta.2010.0201; Ebert DA., 2013, SHARKS WORLD; Ferron H, 2014, J IBER GEOL, V40, P87, DOI 10.5209/rev_JIGE.2014.v40.n1.44089; FULGOSI FC, 1983, MONIT ZOOL ITAL, V17, P27; Garcia-Mayoral R, 2011, PHILOS T R SOC A, V369, P1412, DOI 10.1098/rsta.2010.0359; Gross W., 1967, Palaeontographica A, V127, P1; GROVER CA, 1974, CAN J ZOOL, V52, P359, DOI 10.1139/z74-043; Hairapetian V, 2015, SPECIAL PUBLICATIONS, V423; Hairapetian V, 2008, ACTA PALAEONTOL POL, V53, P85, DOI 10.4202/app.2008.0105; Halstead L. B., 1973, ATLAS PALAEOBIOGEOGR, P67; Harvey P.H., 1991, COMP METHOD EVOLUTIO; in't Hout W, 1990, ICHTHYOLITH ISSUES, V5, P21; in't Hout W, 1990, GRONDBOOR HAMER, P14; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Janvier P., 1996, EARLY VERTEBRATES; Karatajute-Talimaa V., 1978, SILURIAN DEVONIAN TH; Karatajute-Talimaa Valentina, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P21; Karatajute-Talimaa Valentina, 2002, Geodiversitas, V24, P405; Karatajute-Talimaa Valentina N., 2002, Geodiversitas, V24, P791; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Lang AW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/4/046005; Marss T, 2011, EST J EARTH SCI, V60, P137, DOI 10.3176/earth.2011.3.02; Marss T., 1982, Eesti NSV Teaduste Akadeemia Toimetised Geoloogia, V31, P112; Marss T, 1998, T ROY SOC EDIN-EARTH, V88, P143; Marss T., 1986, Journal of Vertebrate Paleontology, V6, P1; Marss T, 2006, SPEC PAP PALAEONTOL, P1; Marss T., 1996, J HALL S 2 INT S SIL, P73; Marss T, 2007, HDB PALAEOICHTHYOL B; Marss T., 1995, GEOBIOS, V19, P368; Marss Tiiu, 2002, Geodiversitas, V24, P381; Marss Tiiu, 2006, Proceedings of the Estonian Academy of Sciences Geology, V55, P43; Mojetta A, 2005, GUIA MUNDO SUBMARINO; Motta P, 2012, J MORPHOL, V273, P1096, DOI 10.1002/jmor.20047; MUNOZ-CHAPULI R, 1985, Miscellania Zoologica (Barcelona), V9, P396; Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; OLASO I., 2004, J NW ATL FISH SCI, V35, P481; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Raschi W, 1986, NASA CONTRACTOR REPO, P3963; Reif W.-E., 1985, Courier Forschungsinstitut Senckenberg, V78, P1; Reif W.-E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V157, P133; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P172; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P184; REIF W-E, 1978, Palaeontologische Zeitschrift, V52, P110; REIF WE, 1985, ACTA ZOOL-STOCKHOLM, V66, P111, DOI 10.1111/j.1463-6395.1985.tb00829.x; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Richards EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013285; Ricklefs Robert E., 1994, P13; Ritchie A., 1968, P81; Rohon JV, 1893, MEMOIRES ACAD IMPERI, V41, P1; Rohon JV., 1892, MEMOIRES ACAD IMPERI, V38, P1; Rohon JV., 1892, B ACAD IMPERIALE SCI, P269; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Sansom IJ, 2002, J VERTEBR PALEONTOL, V22, P867, DOI 10.1671/0272-4634(2002)022[0867:ATFTOO]2.0.CO;2; Southall E.J., 2003, P R SOC LOND B BIO S, V270, P47; Traquair RH, 1899, T ROY SOC EDINBURGH, V39, P595; Traquair RH, 1900, GEOLOGICAL MAGAZINE, V7, P463; Traquair RH, 1905, T ROY SOC EDINBURGH, V40, P879; Trust Shark, 2010, ILL COMP SHARKS SK 2; Turner S., 1976, Fossilium Catalogus 1 Animalia, VNo. 122, P1; Turner S, 1999, WORLD REG GEOL, V11, P42; TURNER S, 1982, PALAEONTOLOGY, V25, P879; Turner S., 1984, THESIS; Turner S., 1997, GEOLOGICAL SOC AM SP, V321, P1, DOI DOI 10.1130/0-8137-2321-3.295; Turner S, 2000, NEW LLANDOVERY EARLY, P91; TURNER S., 2005, ICHTHYOLITH ISSUES S, V8, P24; Turner S., 1985, AAP HORN S GEOL SURV, V9, P93; Turner S, 1994, ICHTHYOLITH ISSUES, V13, P12; Turner S, 1971, J GEOLOGICAL SOC LON, V127, P632; Turner Susan, 1991, P87; Turner Susan, 1992, Academia (Tallinn), V1, P21; VANDERBRUGGHEN W, 1993, NATURE, V364, P107; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Wilson MVH, 2012, EST J EARTH SCI, V61, P261, DOI 10.3176/earth.2012.4.06; Wilson MVH, 1998, J VERTEBR PALEONTOL, V18, P10, DOI 10.1080/02724634.1998.10011031; WILSON MVH, 1993, NATURE, V361, P442, DOI 10.1038/361442a0; Woodward A.S., 1891, CATALOGUE FOSSIL FIS, DOI [10.5962/bhl.title.61854, DOI 10.5962/BHL.TITLE.61854]; Zigaite Z, 2013, EARTH ENV SCI T R SO, V104, P123, DOI 10.1017/S1755691013000467; Zigaite Z, 2013, GFF, V135, P57, DOI 10.1080/11035897.2012.762549; Zigaite Z, 2012, GEODIVERSITAS, V34, P253, DOI 10.5252/g2012n2a1	97	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172781	10.1371/journal.pone.0172781	http://dx.doi.org/10.1371/journal.pone.0172781			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241029	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400042
J	Zhou, CJ; Zhong, JJ; Zou, B; Fang, L; Chen, JJ; Deng, X; Zhang, L; Zhao, X; Qu, ZH; Lei, Y; Lei, T				Zhou, Chanjuan; Zhong, Jiaju; Zou, Bin; Fang, Liang; Chen, Jianjun; Deng, Xiao; Zhang, Lin; Zhao, Xiang; Qu, Zehui; Lei, Yang; Lei, Ting			Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR LEVELS; MAJOR DEPRESSION; SERUM-LEVELS; SYNAPTIC MODULATION; DRUG TREATMENTS; BLOOD-BRAIN; FACTORS NGF; PLASMA; DISORDER; ESCITALOPRAM	Background Brain derived neurotrophic factor (BDNF) is one of the most important regulatory proteins in the pathophysiology of major depressive disorder (MDD). Increasing numbers of studies have reported the relationship between serum/plasma BDNF and antidepressants (ADs). However, the potential effects of several classes of antidepressants on BDNF concentrations are not well known. Hence, our meta-analyses aims to review the effects of differential antidepressant drugs on peripheral BDNF levels in MDD and make some recommendations for future research. Methods Electronic databases including PubMed, EMBASE, the Cochrane Library, Web of Science, and PsycINFO were searched from 1980 to June 2016. The change in BDNF levels were compared between baseline and post-antidepressants treatment by use of the standardized mean difference (SMD) with 95% confidence intervals (CIs). All statistical tests were twosided. Results We identified 20 eligible trials of antidepressants treatments for BDNF in MDD. The overall effect size for all drug classes showed that BDNF levels were elevated following a course of antidepressants use. For between-study heterogeneity by stratification analyses, we detect that length of treatment and blood samples are significant effect modifiers for BDNF levels during antidepressants treatment. While both SSRIs and SNRIs could increase the BDNF levels after a period of antidepressant medication treatment, sertraline was superior to other three drugs ( venlafaxine, paroxetine or escitalopram) in the early increase of BDNF concentrations with SMD 0.53( 95% CI = 0.13-0.93; P = 0.009). Conclusions There is some evidence that treatment of antidepressants appears to be effective in the increase of peripheral BDNF levels. More robust evidence indicates that different types of antidepressants appear to induce differential effects on the BDNF levels. Since sertraline makes a particular effect on BDNF concentration within a short amount of time, there is potential value in exploring its relationship with BDNF and its pharmacological mechanism concerning peripheral blood BDNF. Further confirmatory trials are required for both observations.	[Zhou, Chanjuan; Zhong, Jiaju; Fang, Liang] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Zou, Bin; Zhang, Lin; Zhao, Xiang; Qu, Zehui] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Chen, Jianjun] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China; [Deng, Xiao] Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China; [Lei, Yang] Chongqing Med Univ, Univ Town Hosp, Dept Neurol, Chongqing, Peoples R China; [Lei, Ting] Univ Fribourg, Dept Phys, Fribourg, Switzerland	Chongqing Medical University; Southwest University - China; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Fribourg	Lei, Y (corresponding author), Chongqing Med Univ, Univ Town Hosp, Dept Neurol, Chongqing, Peoples R China.; Lei, T (corresponding author), Univ Fribourg, Dept Phys, Fribourg, Switzerland.	leiyang339@outlook.com; 18983832332@189.comn	chen, jian-jun/J-9118-2019	chen, jian-jun/0000-0002-6439-5123	Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1600223]	Scientific and Technological Research Program of Chongqing Municipal Education Commission	The work was supported by Scientific and Technological Research Program of Chongqing Municipal Education Commission (grant no. KJ1600223).	Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; Basterzi AD, 2009, PROG NEURO-PSYCHOPH, V33, P281, DOI 10.1016/j.pnpbp.2008.11.016; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Brunoni AR, 2014, EUR NEUROPSYCHOPHARM, V24, P1144, DOI 10.1016/j.euroneuro.2014.03.006; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Bus BAA, 2015, MOL PSYCHIATR, V20, P602, DOI 10.1038/mp.2014.83; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Deuschle M, 2013, PHARMACOPSYCHIATRY, V46, P54, DOI 10.1055/s-0032-1321908; Dreimuller N, 2012, NEUROPHARMACOLOGY, V62, P264, DOI 10.1016/j.neuropharm.2011.07.017; Ghosh R, 2015, ASIAN J PSYCHIATR, V18, P37, DOI 10.1016/j.ajp.2015.10.006; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Hashimoto K, 2007, BIOESSAYS, V29, P116, DOI 10.1002/bies.20534; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Huang TL, 2008, J PSYCHIATR RES, V42, P521, DOI 10.1016/j.jpsychires.2007.05.007; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Ladea M, 2013, PSYCHIAT DANUB, V25, P128; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Martocchia A, 2014, AGING CLIN EXP RES, V26, P461, DOI 10.1007/s40520-014-0194-2; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Mikoteit T, 2016, PSYCHOPHARMACOLOGY, V233, P153, DOI 10.1007/s00213-015-4088-6; Mikoteit T, 2015, NEUROPSYCHOBIOLOGY, V72, P16, DOI 10.1159/000437439; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; Munno D, 2013, PANMINERVA MED, V55, P377; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Otte C, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.65; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Polyakova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141564; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Rojas PS, 2011, PSYCHIAT RES, V189, P239, DOI 10.1016/j.psychres.2011.04.032; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yoshimura R, 2007, PROG NEURO-PSYCHOPH, V31, P1034, DOI 10.1016/j.pnpbp.2007.03.001; Yoshimura R, 2014, ANN GEN PSYCHIATR, V13, DOI 10.1186/1744-859X-13-19; Yoshimura R, 2014, PSYCHIAT INVEST, V11, P84, DOI 10.4306/pi.2014.11.1.84	53	108	109	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172270	10.1371/journal.pone.0172270	http://dx.doi.org/10.1371/journal.pone.0172270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241064	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400016
J	Vaulet, LG; Grillova, L; Mikalova, L; Casco, R; Fermepin, MR; Pando, MA; Smajs, D				Gallo Vaulet, Lucia; Grillova, Linda; Mikalova, Lenka; Casco, Ricardo; Rodriguez Fermepin, Marcelo; Pando, Maria A.; Smajs, David			Molecular typing of Treponema pallidum isolates from Buenos Aires, Argentina: Frequent Nichols-like isolates and low levels of macrolide resistance	PLOS ONE			English	Article							SYPHILIS-CAUSING STRAINS; RIBOSOMAL-RNA A2058G; AZITHROMYCIN RESISTANCE; SAN-FRANCISCO; UNITED-STATES; TP0548 GENE; PREVALENCE; EPIDEMIOLOGY; MUTATIONS; SEQUENCE	A total of 54 clinical samples, including genital lesion swabs, whole blood and cerebrospinal fluid from patients diagnosed with syphilis were collected in 2006 and in 2013 in Buenos Aires, Argentina. Treponemal DNA was detected in 43 of the analyzed samples (79.6%) and further analyzed using Sequencing-based molecular typing (SBMT) and Enhanced CDC-typing (ECDCT). By SBMT, 10 different Treponema pallidum subsp. pallidum (TPA) genotypes were found, of which six were related to the TPA SS14 strain, and four to the TPA Nichols strain. The 23S rRNA gene was amplified in samples isolated from 42 patients, and in six of them (14.3%), either the A2058G (four patients, 9.5%) or the A2059G (two patients, 4.8%) mutations were found. In addition to Taiwan, Madagascar and Peru, Argentina is another country where the prevalence of Nichols-like isolates (26.8%) is greater than 10%.	[Gallo Vaulet, Lucia; Rodriguez Fermepin, Marcelo] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Catedra Microbiol Clin, Buenos Aires, DF, Argentina; [Gallo Vaulet, Lucia; Rodriguez Fermepin, Marcelo] Univ Buenos Aires, Inst Fisiopatol & Bioquim Clin INFIBIOC, Buenos Aires, DF, Argentina; [Grillova, Linda; Mikalova, Lenka; Smajs, David] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Casco, Ricardo] Univ Buenos Aires, Hosp Clin Jose de San Martin, PETS, Buenos Aires, DF, Argentina; [Pando, Maria A.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Masaryk University Brno; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Smajs, D (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.	dsmajs@med.muni.cz	Mikalová, Lenka/AAM-1068-2020; Grillova, Linda/AAA-8557-2020; RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262; Grillova, Linda/0000-0003-2371-3161; Pastekova, Lenka/0000-0003-4266-9952	MOBILITY program; Ministry of Education, Youth, and Sports of the Czech Republic; Ministerio de Ciencia, Tecnologia e Innovacion Productiva from Argentina; Grant Agency of the Czech Republic [P302/12/0574, GM 7-25455S]; Faculty of Medicine, Masaryk University [ROZV/20/LF/2015]	MOBILITY program; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministerio de Ciencia, Tecnologia e Innovacion Productiva from Argentina; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Faculty of Medicine, Masaryk University	This work was supported by the MOBILITY program and sponsored by the Ministry of Education, Youth, and Sports of the Czech Republic and the Ministerio de Ciencia, Tecnologia e Innovacion Productiva from Argentina to DS and MAP. Additional support was provided by grants from the Grant Agency of the Czech Republic to DS (P302/12/0574, GM 7-25455S) and by funds from the Faculty of Medicine, Masaryk University (ROZV/20/LF/2015), to junior researcher Lenka Mikalova-Pastekova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the MOBILITY program and sponsored by the Ministry of Education, Youth, and Sports of the Czech Republic and the Ministerio de Ciencia, Tecnologia e InnovaciOn Productiva from Argentina to DS and MAP. Additional support was provided by grants from the Grant Agency of the Czech Republic to DS (P302/12/0574, GA17-25455S) and by funds from the Faculty of Medicine, Masaryk University (ROZV/20/LF/2015), to junior researcher Lenka Mikalova-Pastekova. We would like to thank all participants who made this study possible, as well as Mr. Sergio Mazzini for editing the manuscript.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Flores JA, 2016, SEX TRANSM DIS, V43, P465, DOI 10.1097/OLQ.0000000000000465; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chen XS, 2013, CLIN MICROBIOL INFEC, V19, P975, DOI 10.1111/1469-0691.12098; Cruz AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000690; Dai T, 2012, J CLIN MICROBIOL, V50, P3674, DOI 10.1128/JCM.01195-12; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Falistocco C, 2012, VIH SIFILIS SEROPREV; Flasarova M., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P105; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Florindo C, 2008, J CLIN MICROBIOL, V46, P3802, DOI 10.1128/JCM.00128-08; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Katz Kenneth A, 2010, Sex Transm Dis, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; Khairullin R, 2016, APMIS, V124, P595, DOI 10.1111/apm.12541; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Li Z, 2013, J CLIN MICROBIOL, V51, P4270, DOI 10.1128/JCM.01261-13; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Martin IE, 2010, SEX TRANSM DIS, V37, P544, DOI 10.1097/OLQ.0b013e3181d73ce1; Martin IE, 2009, CLIN INFECT DIS, V49, P515, DOI 10.1086/600878; Mikalova L, 2017, SEX TRANSM IN PRESS; Mikalova L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-178; Mitchell SJ, 2006, CLIN INFECT DIS, V42, P337, DOI 10.1086/498899; Morshed MG, 2006, CAN MED ASSOC J, V174, P349, DOI 10.1503/cmaj.1050256; Muller EE, 2012, SEX TRANSM INFECT, V88, P470, DOI 10.1136/sextrans-2011-050322; Muldoon EG, 2012, SEX TRANSM DIS, V39, P784, DOI 10.1097/OLQ.0b013e318269995f; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Noda AA, 2016, SEX TRANSM DIS, V43, P332, DOI 10.1097/OLQ.0000000000000440; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Pando MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054147; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Peng RR, 2012, SEX TRANSM DIS, V39, P42, DOI 10.1097/OLQ.0b013e318232697d; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Pillay A, 2002, J CLIN MICROBIOL, V40, P256, DOI 10.1128/JCM.40.1.256-258.2002; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Read P, 2014, J CLIN MICROBIOL, V52, P2776, DOI 10.1128/JCM.00301-14; Salado-Rasmussen K, 2016, ACTA DERM-VENEREOL, V96, P202, DOI 10.2340/00015555-2190; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Schmunis GA, 2000, TRANSFUSION, V40, P1048, DOI 10.1046/j.1537-2995.2000.40091048.x; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; Su JR, 2012, SEX TRANSM DIS, V39, P794, DOI 10.1097/OLQ.0b013e31826f36de; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian HQ, 2014, SEX TRANSM DIS, V41, P551, DOI 10.1097/OLQ.0000000000000155; Tipple C, 2011, SEX TRANSM INFECT, V87, P486, DOI 10.1136/sextrans-2011-050082; Van Damme K, 2009, SEX TRANSM DIS, V36, P775, DOI 10.1097/OLQ.0b013e3181bd11dd; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445	55	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172905	10.1371/journal.pone.0172905	http://dx.doi.org/10.1371/journal.pone.0172905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235102	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200167
J	Haumann, I; Junghans, D; Anstotz, M; Frotscher, M				Haumann, Iris; Junghans, Dirk; Anstoetz, Max; Frotscher, Michael			Presynaptic localization of GluK5 in rod photoreceptors suggests a novel function of high affinity glutamate receptors in the mammalian retina	PLOS ONE			English	Article							MOSSY-FIBER SYNAPSES; CENTRAL-NERVOUS-SYSTEM; KAINATE RECEPTORS; RAT RETINA; SYNAPTIC-TRANSMISSION; NMDA RECEPTOR; NEUROTRANSMITTER RELEASE; ELECTRON-MICROSCOPY; MOLECULAR-CLONING; PLEXIFORM LAYER	Kainate receptors mediate glutamatergic signaling through both pre-and presynaptic receptors. Here, we studied the expression of the high affinity kainate receptor GluK5 in the mouse retina. Double-immunofluoresence labeling and electron microscopic analysis revealed a presynaptic localization of GluK5 in the outer plexiform layer. Unexpectedly, we found GluK5 almost exclusively localized to the presynaptic ribbon of photoreceptor terminals. Moreover, in GluK5-deficient mutant mice the structural integrity of synaptic ribbons was severely altered pointing to a novel function of GluK5 in organizing synaptic ribbons in the presynaptic terminals of rod photoreceptors.	[Haumann, Iris; Anstoetz, Max] Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, Hamburg, Germany; [Junghans, Dirk] Univ Basel, Inst Embryol & Stem Cell Biol, Dept Biomed, Basel, Switzerland; [Frotscher, Michael] Univ Med Ctr Hamburg Eppendorf, Inst Struct Neurobiol, Ctr Mol Neurobiol Hamburg ZMNH, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf	Haumann, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, Hamburg, Germany.; Frotscher, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Struct Neurobiol, Ctr Mol Neurobiol Hamburg ZMNH, Hamburg, Germany.	i.haumann@uke.de; michael.frotscher@zmnh.uni-hamburg.de	Anstötz, Max/AAV-3755-2021	Anstotz, Max/0000-0003-3071-5835	German Research Foundation [FR 620/14-1]; State of Hamburg [LFF-FV27]	German Research Foundation(German Research Foundation (DFG)); State of Hamburg	This work was supported by the German Research Foundation (FR 620/14-1 to MF); Landesforschungsforderung by the State of Hamburg (LFF-FV27, project P3) to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Sigrun Nestel and Barbara Joch for thin-sectioning and assistance with the EM studies. This work was supported by the German Research Foundation (FR 620/14-1 to MF) and the Landesforschungsforderung by the State of Hamburg (LFF-FV27, project P3) to MF). MF is Hertie Research Professor for Neuroscience.	AHNELT P, 1990, J COMP NEUROL, V293, P39, DOI 10.1002/cne.902930104; AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Bleakman D, 1996, MOL PHARMACOL, V49, P581; Bortolotto ZA, 2005, NEUROTOXICOLOGY, V26, P769, DOI 10.1016/j.neuro.2005.02.004; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Brandstatter JH, 2001, CELL TISSUE RES, V303, P1, DOI 10.1007/s004410000304; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Darstein M, 2003, J NEUROSCI, V23, P8013; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Fujikawa T, 2014, HEARING RES, V314, P20, DOI 10.1016/j.heares.2014.05.001; Hack I, 1999, EUR J NEUROSCI, V11, P2261, DOI 10.1046/j.1460-9568.1999.00647.x; HAMASSAKIBRITTO DE, 1993, J NEUROSCI, V13, P1888; Hellwig S, 2011, J NEUROSCI, V31, P2352, DOI 10.1523/JNEUROSCI.3984-10.2011; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; HUGHES TE, 1992, VISUAL NEUROSCI, V8, P49, DOI 10.1017/S0952523800006489; Jakobs TC, 2007, MOL VIS, V13, P933; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Katiyar R, 2015, INVEST OPHTH VIS SCI, V56, P2312, DOI 10.1167/iovs.15-16654; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KIDD M, 1962, J ANAT, V96, P179; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lee JG, 2012, ACTA HISTOCHEM CYTOC, V45, P35, DOI 10.1267/ahc.11043; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MASSEY SC, 1990, J NEUROPHYSIOL, V63, P16, DOI 10.1152/jn.1990.63.1.16; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLER F, 1992, NEUROSCI LETT, V138, P179, DOI 10.1016/0304-3940(92)90500-7; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; Nistico R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00103; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Regus-Leidig H, 2010, MOL VIS, V16, P2690; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; SAKIMURA K, 1992, NEURON, V8, P267, DOI 10.1016/0896-6273(92)90293-M; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Schmitz F, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00003; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schnee ME, 2005, NEURON, V47, P243, DOI 10.1016/j.neuron.2005.06.004; Sheets L, 2012, J NEUROSCI, V32, P17273, DOI 10.1523/JNEUROSCI.3005-12.2012; Sherry DM, 2005, J COMP NEUROL, V484, P440, DOI 10.1002/cne.20504; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	82	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172967	10.1371/journal.pone.0172967	http://dx.doi.org/10.1371/journal.pone.0172967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235022	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200178
J	Kuusela, P; Saraswat, M; Joenvaara, S; Kaartinen, J; Jarvinen, A; Renkonen, R				Kuusela, Pentti; Saraswat, Mayank; Joenvaara, Sakari; Kaartinen, Johanna; Jarvinen, Asko; Renkonen, Risto			Changes in plasma protein levels as an early indication of a bloodstream infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ALPHA-1-ACID GLYCOPROTEIN; SEPSIS; PROCALCITONIN; DEFINITIONS; BACTEREMIA; EXPRESSION; GUIDELINES; MORTALITY; FAILURE	Blood culture is the primary diagnostic test performed in a suspicion of bloodstream infection to detect the presence of microorganisms and direct the treatment. However, blood culture is slow and time consuming method to detect blood stream infections or separate septic and/or bacteremic patients from others with less serious febrile disease. Plasma proteomics, despite its challenges, remains an important source for early biomarkers for systemic diseases and might show changes before direct evidence from bacteria can be obtained. We have performed a plasma proteomic analysis, simultaneously at the time of blood culture sampling from ten blood culture positive and ten blood culture negative patients, and quantified 172 proteins with two or more unique peptides. Principal components analysis, Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) and ROC curve analysis were performed to select protein(s) features which can classify the two groups of samples. We propose a number of candidates which qualify as potential biomarkers to select the blood culture positive cases from negative ones. Pathway analysis by two methods revealed complement activation, phagocytosis pathway and alterations in lipid metabolism as enriched pathways which are relevant for the condition. Data are available via ProteomeXchange with identifier PXD005022.	[Kuusela, Pentti] Univ Helsinki, Div Clin Microbiol, HUSLAB, Helsinki, Finland; [Kuusela, Pentti; Jarvinen, Asko] Helsinki Univ Hosp, Helsinki, Finland; [Kuusela, Pentti] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Saraswat, Mayank; Joenvaara, Sakari; Renkonen, Risto] Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland; [Joenvaara, Sakari; Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland; [Kaartinen, Johanna] Helsinki Univ Hosp, Emergency Med & Serv, Helsinki, Finland; [Jarvinen, Asko] Univ Helsinki, Div Infect Dis, HUH Inflammat Ctr, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Saraswat, M (corresponding author), Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland.	sarawat.mk@gmail.com	Saraswat, Mayank/F-2985-2015	Saraswat, Mayank/0000-0002-5021-8150	Helsinki University Hospital [TYH2013346, TYH2016247]	Helsinki University Hospital	RR received the funding in the form of grants TYH2013346 and TYH2016247 from Helsinki University Hospital. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ali M, 2015, FEBS LETT, V589, P2213, DOI 10.1016/j.febslet.2015.06.045; Barroso-Sousa R, 2013, CLINICS, V68, P1134, DOI 10.6061/clinics/2013(08)12; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brebner JA, 2013, F1000 MED REPORTS, V5; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Dayon L., 2013, EUPA OPEN PROTEOM, V1, P8, DOI [10.1016/j.euprot.2013.08.001, DOI 10.1016/J.EUPROT.2013.08.001]; Di Luca A., 2015, DARU, V23, P1; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A; Fenollar F, INT J ANTIMICROBIAL, V30, P7; Foushee JA, 2012, J ANTIMICROB CHEMOTH, V67, P2560, DOI 10.1093/jac/dks265; GRIMALDI LME, 1991, J NEUROIMMUNOL, V32, P259, DOI 10.1016/0165-5728(91)90196-E; HALL MM, 1976, J CLIN MICROBIOL, V3, P643; Han Yong Y, 2003, Pediatr Crit Care Med, V4, P21, DOI 10.1097/00130478-200301000-00004; Hoeboer SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065564; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Kollef NH, 2000, CRIT CARE MED, V28, P3456, DOI 10.1097/00003246-200010000-00014; Kontro H, 2014, PROTEOMICS, V14, P1713, DOI 10.1002/pmic.201300270; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; McHugh L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001916; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Mestriner FLAC, 2007, P NATL ACAD SCI USA, V104, P19595, DOI 10.1073/pnas.0709681104; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; Nikfardjam M, 2000, J INTERN MED, V247, P341, DOI 10.1046/j.1365-2796.2000.00670.x; Paiva Rita Azevedo de, 2010, Rev Bras Ter Intensiva, V22, P403; Saraswat M, 2016, MOL CELLULAR PROTEOM; Sautter RL, 2006, J CLIN MICROBIOL, V44, P1245, DOI 10.1128/JCM.44.4.1245-1249.2006; Schwetz I, 2007, J CLIN MICROBIOL, V45, P2691, DOI 10.1128/JCM.00085-07; Serang O, 2012, J PROTEOME RES, V11, P5586, DOI 10.1021/pr300426s; Severa M, 2014, J IMMUNOL, V192, P2291, DOI 10.4049/jimmunol.1301799; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Skogberg K, 2008, EPIDEMIOL INFECT, V136, P108, DOI 10.1017/S0950268807008138; SPITZER JJ, 1988, JPEN-PARENTER ENTER, V12, pS53, DOI 10.1177/014860718801200604; Stenlund H, 2008, ANAL CHEM, V80, P6898, DOI 10.1021/ac8005318; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; TENNEY JH, 1982, J CLIN MICROBIOL, V15, P558, DOI 10.1128/JCM.15.4.558-561.1982; Towns ML, 2010, J MICROBIOL IMMUNOL, V43, P347, DOI 10.1016/S1684-1182(10)60054-0; Uusitalo-Seppala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053661; Vigano EF, DIAGNOSTIC MICROBIOL, V44, P235; Vincent JL, 2015, CRIT CARE, V19, DOI 10.1186/cc14728; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172987	10.1371/journal.pone.0172987	http://dx.doi.org/10.1371/journal.pone.0172987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235076	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200183
J	Lee, B; Song, T; Lee, K; Kim, J; Han, S; Berggren, PO; Ryu, SH; Jo, J				Lee, Boah; Song, Taegeun; Lee, Kayoung; Kim, Jaeyoon; Han, Seungmin; Berggren, Per-Olof; Ryu, Sung Ho; Jo, Junghyo			Phase modulation of insulin pulses enhances glucose regulation and enables inter-islet synchronization	PLOS ONE			English	Article							PANCREATIC-ISLETS; CA2+ CONCENTRATION; MOUSE ISLETS; OSCILLATIONS; SECRETION; ENTRAINMENT; RELEASE; SINGLE; FREQUENCY; PATTERNS	Insulin is secreted in a pulsatile manner from multiple micro-organs called the islets of Langerhans. The amplitude and phase (shape) of insulin secretion are modulated by numerous factors including glucose. The role of phase modulation in glucose homeostasis is not well understood compared to the obvious contribution of amplitude modulation. In the present study, we measured Ca2+ oscillations in islets as a proxy for insulin pulses, and we observed their frequency and shape changes under constant/alternating glucose stimuli. Here we asked how the phase modulation of insulin pulses contributes to glucose regulation. To directly answer this question, we developed a phenomenological oscillator model that drastically simplifies insulin secretion, but precisely incorporates the observed phase modulation of insulin pulses in response to glucose stimuli. Then, we mathematically modeled how insulin pulses regulate the glucose concentration in the body. The model of insulin oscillation and glucose regulation describes the glucose-insulin feedback loop. The data-based model demonstrates that the existence of phase modulation narrows the range within which the glucose concentration is maintained through the suppression/enhancement of insulin secretion in conjunction with the amplitude modulation of this secretion. The phase modulation is the response of islets to glucose perturbations. When multiple islets are exposed to the same glucose stimuli, they can be entrained to generate synchronous insulin pulses. Thus, we conclude that the phase modulation of insulin pulses is essential for glucose regulation and inter-islet synchronization.	[Lee, Boah; Ryu, Sung Ho] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Song, Taegeun; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea; [Lee, Kayoung; Han, Seungmin; Berggren, Per-Olof; Ryu, Sung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Kim, Jaeyoon; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Jo, Junghyo] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); Karolinska Institutet; Pohang University of Science & Technology (POSTECH)	Jo, J (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea.; Jo, J (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea.	jojunghyo@apctp.org		Song, Taegeun/0000-0002-1511-6626; Ryu, Sung Ho/0000-0003-0913-3048; Berggren, Per-Olof/0000-0001-8991-413X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03932264]; Max Planck Society; Korean Ministry of Education, Science and Technology; Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning [2016K1A1A2912722]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Max Planck Society(Max Planck SocietyFoundation CELLEX); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.).	Anello M, 1999, BRIT J PHARMACOL, V127, P1883, DOI 10.1038/sj.bjp.0702731; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERGGREN PO, 1993, ADV EXP MED BIOL, V334, P25; Bergsten P, 1998, AM J PHYSIOL-ENDOC M, V274, pE796, DOI 10.1152/ajpendo.1998.274.5.E796; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; BINGLEY PJ, 1992, DIABETOLOGIA, V35, P32, DOI 10.1007/BF00400849; BRABANT G, 1992, TRENDS ENDOCRIN MET, V3, P183, DOI 10.1016/1043-2760(92)90169-2; CHOU HF, 1990, DIABETES, V39, P112, DOI 10.2337/diabetes.39.1.112; Deeney JT, 2001, J BIOL CHEM, V276, P36946, DOI 10.1074/jbc.M105056200; Dhumpa R, 2014, BIOPHYS J, V106, P2275, DOI 10.1016/j.bpj.2014.04.015; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fendler B, 2009, BIOPHYS J, V97, P722, DOI 10.1016/j.bpj.2009.05.016; GILON P, 1995, ENDOCRINOLOGY, V136, P5725, DOI 10.1210/en.136.12.5725; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; Gylfe E, 2016, UPSALA J MED SCI, V121, P120, DOI 10.3109/03009734.2016.1154905; KARLSSON FA, 1979, P NATL ACAD SCI USA, V76, P809, DOI 10.1073/pnas.76.2.809; KINDMARK H, 1994, DIABETOLOGIA, V37, P1121, DOI 10.1007/s001250050225; Kullback S., 1968, INFORM THEORY STAT; KURRER C, 1995, PHYS REV E, V51, P6213, DOI 10.1103/PhysRevE.51.6213; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Larsson O, 1996, P NATL ACAD SCI USA, V93, P5161, DOI 10.1073/pnas.93.10.5161; LI YX, 1992, BIOPHYS J, V61, P161, DOI 10.1016/S0006-3495(92)81824-6; Magill JC, 2013, MATH BIOSCI, V246, P38, DOI 10.1016/j.mbs.2013.09.006; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; McKenna JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005143; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; Pakdaman K, 2002, NEURAL COMPUT, V14, P781, DOI 10.1162/089976602317318956; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; Pedersen MG, 2013, BIOPHYS J, V105, P29, DOI 10.1016/j.bpj.2013.05.036; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; Porksen N, 2000, AM J PHYSIOL-ENDOC M, V278, pE162; Press WH., 2002, NUMERICAL RECIPES C, V2; Ritzel RA, 2006, AM J PHYSIOL-ENDOC M, V290, pE750, DOI 10.1152/ajpendo.00381.2005; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; SANTEN RJ, 1973, J CLIN INVEST, V52, P2617, DOI 10.1172/JCI107454; Satin LS, 2015, MOL ASPECTS MED, V42, P61, DOI 10.1016/j.mam.2015.01.003; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; Yao NK, 1997, AM J PHYSIOL-ENDOC M, V272, pE981, DOI 10.1152/ajpendo.1997.272.6.E981; Zarkovic M, 2004, AM J PHYSIOL-ENDOC M, V287, pE340, DOI 10.1152/ajpendo.00069.2004; Zhang M, 2008, BIOPHYS J, V95, P4676, DOI 10.1529/biophysj.107.125088; Zhang XY, 2011, AM J PHYSIOL-ENDOC M, V301, pE742, DOI 10.1152/ajpendo.00248.2011	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172901	10.1371/journal.pone.0172901	http://dx.doi.org/10.1371/journal.pone.0172901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235104	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200165
J	Nikitin, AG; Potekhina, I; Rohland, N; Mallick, S; Reich, D; Lillie, M				Nikitin, Alexey G.; Potekhina, Inna; Rohland, Nadin; Mallick, Swapan; Reich, David; Lillie, Malcolm			Mitochondrial DNA analysis of eneolithic trypillians from Ukraine reveals neolithic farming genetic roots	PLOS ONE			English	Article							ANCIENT DNA; SEQUENCE; GENOMES; CULTURE; ORIGINS; FARMERS; EUROPE; CAVE	The agricultural revolution in Eastern Europe began in the Eneolithic with the Cucuteni-Trypillia culture complex. In Ukraine, the Trypillian culture (TC) existed for over two millennia (ca. 5,400-2,700 BCE) and left a wealth of artifacts. Yet, their burial rituals remain a mystery and to date almost nothing is known about the genetic composition of the TC population. One of the very few TC sites where human remains can be found is a cave called Verteba in western Ukraine. This report presents four partial and four complete mitochondrial genomes from nine TC individuals uncovered in the cave. The results of this analysis, combined with the data from previous reports, indicate that the Trypillian population at Verteba carried, for the most part, a typical Neolithic farmer package of mitochondrial DNA (mtDNA) lineages traced to Anatolian farmers and Neolithic farming groups of central Europe. At the same time, the find of two specimens belonging to haplogroup U8b1 at Verteba can be viewed as a connection of TC with the Upper Paleolithic European populations. At the level of mtDNA haplogroup frequencies, the TC population from Verteba demonstrates a close genetic relationship with population groups of the Funnel Beaker/Trichterbecker cultural complex from central and northern Europe (ca. 3,950-2,500 BCE).	[Nikitin, Alexey G.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Potekhina, Inna] Ukrainian Acad Sci, Inst Archaeol, Dept Bioarchaeol, Kiev, Ukraine; [Rohland, Nadin; Mallick, Swapan; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA USA; [Mallick, Swapan; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA USA; [Mallick, Swapan; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA USA; [Lillie, Malcolm] Univ Hull, Sch Environm Sci Geog, Kingston Upon Hull, N Humberside, England	Grand Valley State University; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Hull	Nikitin, AG (corresponding author), Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA.	nikitin@gvsu.edu	Potekhina, Inna D/C-2387-2019	Potekhina, Inna/0000-0001-5107-8922; Nikitin, Alexey/0000-0002-3897-4607; Lillie, Malcolm/0000-0002-6054-3651	Michigan Space Consortium Research Seed Grant; GVSU	Michigan Space Consortium Research Seed Grant; GVSU	The September 2007 excavations at Verteba were funded, in part, by a Michigan Space Consortium Research Seed Grant to AGN. The May-June 2008 excavations were conducted as part of the 2008 GVSU Study Abroad in Ukraine activities. The DNA analysis at GVSU was funded by a Research Grant-in-Aid and faculty development funds from GVSU. DR is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anthony DW, 2008, J INDO-EUR STUD, V36, P1; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dergachev VA, 1991, BESTATTUNGSKOMPLEXE; Dominguez E Fernandez, 2006, POLIMORFISMOS DNA MI; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Khvoika VV, 1909, T 11 ARKHEOLOGICHESK, V2, P789; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lee EJ, 2014, J ARCHAEOL SCI, V51, P174, DOI 10.1016/j.jas.2012.08.037; Lillie M, 2015, TRENDS BIOL ANTRHOPO, P54; Malmstrom H, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0373; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Muller J., 2016, TRYPILLIA MEGA SITES; Nedoluzhko AV, 2014, ACTA NATURAE, V6, P31, DOI 10.32607/20758251-2014-6-2-31-35; Nikitin A., 2010, INTERDISCIPLINARIA A, V1, P9, DOI DOI 10.24916/IANSA.2010.1-2.1; Nikitin AG, 2011, INTERDISCIP ARCHAEOL, V2, P9; Nikitin AG, 2017, J HUM GENET; Nikitin AG, 2012, J HUM GENET, V57, P610, DOI 10.1038/jhg.2012.69; Nikitin AG, 2009, HUM BIOL, V81, P43, DOI 10.3378/027.081.0104; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pelisiak A, 2007, ANALECTA ARCHAEOL RE, V2, P23; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Potekhina I.D., 1999, NASELENIE UKRAINY EP; Potekhina ID., 1989, PAMYATNIKI TRIPOLSKO, P125; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Santos C, 2004, HUM BIOL, V76, P431, DOI 10.1353/hub.2004.0049; Segeda SP., 2005, NAR TVORCHISTTA ETNO, P18; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sokolov AS, 2016, J ARCHAEOL SCI, V73, P138, DOI 10.1016/j.jas.2016.07.017; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Videiko MY, 2004, ENCY TRYPILLIAN CIVI; Zbenovich VG, 1996, J WORLD PREHIST, V10, P199, DOI 10.1007/BF02221076	43	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172952	10.1371/journal.pone.0172952	http://dx.doi.org/10.1371/journal.pone.0172952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235025	gold, Green Published			2022-12-27	WOS:000394688200175
J	Ozasa, K; Won, J; Song, S; Tamaki, S; Ishikawa, T; Maeda, M				Ozasa, Kazunari; Won, June; Song, Simon; Tamaki, Shun; Ishikawa, Takahiro; Maeda, Mizuo			Temporal change of photophobic step-up responses of Euglena gracilis investigated through motion analysis	PLOS ONE			English	Article							PHOTOTAXIS; BIOMASS; CELLS; FEEDBACK; ACCUMULATION; CHEMOTAXIS; MICROALGAE; CULTURE; STARCH; LIGHT	The adaptation to a strong light is one of the essential characteristics of green algae, yet lacking relatively the information about the photophobic responses of Eukaryotic microalgae. We investigated the photophobic step-up responses of Euglena gracilis over a time course of several hours with alternated repetition of blue-light pulse illumination and spatially patterned blue-light illumination. Four distinctive photophobic motions in response to strong blue light were identified in a trace image analysis, namely on-site rotation, running and tumbling, continuous circular swimming, and unaffected straightforward swimming. The cells cultured in autotrophic conditions under weak light showed mainly the on-site rotation response at the beginning of blue-light illumination, but they acquired more blue-light tolerant responses of running and tumbling, circular swimming, or straightforward swimming. The efficiency of escaping from a blue-light illuminated area improved markedly with the development of these photophobic motions. Time constant of 3.0 h was deduced for the evolution of photophobic responses of E. gracilis. The nutrient-rich metabolic status of the cells resulting from photosynthesis during the experiments, i.e., the accumulation of photo-synthesized nutrient products in balance between formation and consumption, was the main factor responsible for the development of photophobic responses. The reduction-oxidation status in and around E. gracilis cells did not affect their photophobic responses significantly, unlike the case of photophobic responses and phototaxis of Chlamydomonas reinhardtii cells. This study shows that the evolution of photophobic motion type of E. gracilis is dominated mainly by the nutrient metabolic status of the cells. The fact suggests that the nutrient-rich cells have a higher threshold for switching the flagellar motion from straightforward swimming to rotation under a strong light.	[Ozasa, Kazunari; Maeda, Mizuo] RIKEN, Bioengn Lab, Wako, Saitama, Japan; [Won, June; Song, Simon] Hanyang Univ, Dept Mech Convergence Engn, Seoul, South Korea; [Song, Simon] Hanyang Univ, Inst Nano Sci & Technol, Seoul, South Korea; [Tamaki, Shun; Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Dept Appl Biosci & Biotechnol, Matsue, Shimane, Japan; [Tamaki, Shun; Ishikawa, Takahiro] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Tamaki, Shun] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo, Japan	RIKEN; Hanyang University; Hanyang University; Shimane University; Japan Science & Technology Agency (JST); Kobe University	Ozasa, K (corresponding author), RIKEN, Bioengn Lab, Wako, Saitama, Japan.	ozasa@riken.jp	Song, Simon/P-4656-2015; Maeda, Mizuo/I-3498-2014; Ishikawa, Takahiro/AAX-5792-2021	Tamaki, Shun/0000-0001-8757-7512	JSPS KAKENHI [JP25280092]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A2A2A01014234, 2012R1A6A1029029]; Core Research of Evolutional Science and Technology program (CREST)from Japan Science and Technology Agency (JST)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Core Research of Evolutional Science and Technology program (CREST)from Japan Science and Technology Agency (JST)	This work was supported by JSPS KAKENHI Grant Number JP25280092. This research was also partially supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology [2013R1A2A2A01014234, 2012R1A6A1029029], and by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST).	Berteotti S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21339; Bertolini D, 2003, NATO SCI SER II-MATH, V96, P389; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Colombetti G, 1982, BIOL EUGLENA PHYSL, V3, P171; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; DIEHN B, 1969, EXP CELL RES, V56, P375, DOI 10.1016/0014-4827(69)90027-5; DIEHN B, 1973, SCIENCE, V181, P1009, DOI 10.1126/science.181.4104.1009; DOUGHTY MJ, 1991, J PHOTOCH PHOTOBIO B, V9, P75, DOI 10.1016/1011-1344(91)80005-3; GOTO K, 1985, SCIENCE, V228, P1284, DOI 10.1126/science.2988128; HADER DP, 1981, ARCH MICROBIOL, V130, P78, DOI 10.1007/BF00527076; Hagiwara S, 2002, PHOTOCHEM PHOTOBIOL, V76, P105, DOI 10.1562/0031-8655(2002)076<0105:CGOPOC>2.0.CO;2; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406; Kajikawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120446; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Matsunaga S, 1999, PLANT CELL PHYSIOL, V40, P213, DOI 10.1093/oxfordjournals.pcp.a029530; Matthaus F, 2009, BIOPHYS J, V97, P946, DOI 10.1016/j.bpj.2009.04.065; Metzler R, 2007, CHAOS SOLITON FRACT, V34, P129, DOI 10.1016/j.chaos.2007.01.055; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Ogawa T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0264-5; Ozasa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24602; Ozasa K, 2015, ARTIF LIFE, V21, P234, DOI 10.1162/ARTL_a_00159; Ozasa K, 2014, PLANT CELL PHYSIOL, V55, P1704, DOI 10.1093/pcp/pcu101; Ozasa K, 2014, NEUROCOMPUTING, V140, P291, DOI 10.1016/j.neucom.2014.03.009; Ozasa K, 2013, LAB CHIP, V13, P4033, DOI 10.1039/c3lc50696g; Ozasa K, 2013, APPL SOFT COMPUT, V13, P527, DOI 10.1016/j.asoc.2012.09.008; Ozasa K, 2011, INT J UNCONV COMPUT, V7, P481; Ozasa K, 2011, LAB CHIP, V11, P1933, DOI 10.1039/c0lc00719f; Rawat I, 2013, APPL ENERG, V103, P444, DOI 10.1016/j.apenergy.2012.10.004; RECHNITZ GA, 1990, J BIOTECHNOL, V15, P201, DOI 10.1016/0168-1656(90)90027-9; Rodriguez-Zavala JS, 2010, J APPL MICROBIOL, V109, P2160, DOI 10.1111/j.1365-2672.2010.04848.x; Schulz-Raffelt M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0469-2; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Tamaki S, 2015, PLANT SCI, V236, P29, DOI 10.1016/j.plantsci.2015.03.016; Tamaki S, 2014, BIOSCI BIOTECH BIOCH, V78, P593, DOI 10.1080/09168451.2014.890037; Wakabayashi K, 2006, J CELL BIOL, V173, P743, DOI 10.1083/jcb.200603019; Wakabayashi K, 2011, P NATL ACAD SCI USA, V108, P11280, DOI 10.1073/pnas.1100592108; WOLKEN JJ, 1958, J PROTOZOOL, V5, P39, DOI 10.1111/j.1550-7408.1958.tb02525.x; Yamada K, 2016, BIOSCI BIOTECH BIOCH, V80, P1650, DOI 10.1080/09168451.2016.1171702; Yamane Y, 2001, BIOTECHNOL LETT, V23, P1223, DOI 10.1023/A:1010573218863; Yoshida Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2540-6	42	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172813	10.1371/journal.pone.0172813	http://dx.doi.org/10.1371/journal.pone.0172813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234984	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200145
J	Pei, SF; Laws, EA; Zhang, HB; Ye, SY; Yuan, HM; Liu, HY				Pei, Shaofeng; Laws, Edward A.; Zhang, Haibo; Ye, Siyuan; Yuan, Hongming; Liu, Haiyue			Patchiness of phytoplankton and primary production in Liaodong Bay, China	PLOS ONE			English	Article							PHOSPHATE-LIMITED GROWTH; THIN-LAYERS; RIVER ESTUARY; MECHANISMS; NUTRIENT; EUTROPHICATION; MAINTENANCE; POPULATIONS; DYNAMICS; SURVIVAL	A comprehensive study of water quality, phytoplankton biomass, and photosynthetic rates in Liaodong Bay, China, during June and July of 2013 revealed two large patches of high biomass and production with dimensions on the order of 10 km. Nutrient concentrations were above growth-rate-saturating concentrations throughout the bay, with the possible exception of phosphate at some stations. The presence of the patches therefore appeared to reflect the distribution of water temperature and variation of light penetration restricted by water turbidity. There was no patch of high phytoplankton biomass or production in a third, linear patch of water with characteristics suitable for rapid phytoplankton growth; the absence of a bloom in that patch likely reflected the fact that the width of the patch was less than the critical size required to overcome losses of phytoplankton to turbulent diffusion. The bottom waters of virtually all of the eastern half of the bay were below the depth of the mixed layer, and the lowest bottom water oxygen concentrations, 3-5 mg L-1, were found in that part of the bay. The water column in much of the remainder of the bay was within the mixed layer, and oxygen concentrations in both surface and bottom waters exceeded 5 mg L-1.	[Pei, Shaofeng; Ye, Siyuan; Yuan, Hongming; Liu, Haiyue] China Geol Survey, Key Lab Coastal Wetland Biogeosci, Qingdao, Peoples R China; [Pei, Shaofeng] Natl Oceanog Lab, Funct Lab Marine Geol, Qingdao, Peoples R China; [Laws, Edward A.] Louisiana State Univ, Dept Environm Sci, Sch Coast & Environm, Baton Rouge, LA 70803 USA; [Zhang, Haibo] Ocean Univ China, Coll Chem & Chem Engn, Qingdao, Peoples R China	China Geological Survey; Louisiana State University System; Louisiana State University; Ocean University of China	Pei, SF; Ye, SY (corresponding author), China Geol Survey, Key Lab Coastal Wetland Biogeosci, Qingdao, Peoples R China.; Pei, SF (corresponding author), Natl Oceanog Lab, Funct Lab Marine Geol, Qingdao, Peoples R China.	peishaofeng@gmail.com; siyuanye@hotmail.com		Pei, Shaofeng/0000-0001-5420-6264	National Natural Science Foundation of China [41306175, 40872167]; Abroad, Science and Technology Development Fund Project in Shinan District [2013-14-007-JY]; Key Program for International Science & Technology Cooperation Projects of China [2016yee0109600]; Ministry of Land and Resources program [201111023]; Governmental Public Research Funds of China [DD20160144, GZH201200503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Abroad, Science and Technology Development Fund Project in Shinan District; Key Program for International Science & Technology Cooperation Projects of China; Ministry of Land and Resources program; Governmental Public Research Funds of China	This study was jointly funded by National Natural Science Foundation of China (Grant Nos. 41306175 and 40872167), Funding of Science and Technology Activities for Scholars from Abroad, Science and Technology Development Fund Project in Shinan District (2013-14-007-JY), the Key Program for International Science & Technology Cooperation Projects of China (Grant No. 2016yee0109600), Ministry of Land and Resources program (Grant No. 201111023), and Governmental Public Research Funds of China (Grant Nos. DD20160144 and GZH201200503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit-Bird KJ, 2009, LIMNOL OCEANOGR, V54, P1382, DOI 10.4319/lo.2009.54.4.1382; Boyd PW, 2016, NAT CLIM CHANGE, V6, P207, DOI [10.1038/NCLIMATE2811, 10.1038/nclimate2811]; Bu HM, 2011, SCI TOTAL ENVIRON, V409, P3394, DOI 10.1016/j.scitotenv.2011.05.030; Cai WQ, 2013, CHIN J OCEANOL LIMN, V31, P482, DOI 10.1007/s00343-013-2177-0; Cai Y., 2002, STUDIA MARINA SINICA, V44, P1; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; DENMAN K, 1977, LIMNOL OCEANOGR, V22, P1033, DOI 10.4319/lo.1977.22.6.1033; DENMAN KL, 1976, J MAR RES, V34, P593; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Flemming B. W., 2002, MUDDY COASTS WORLD P, P99, DOI DOI 10.1016/S1568-2692(02)80080-8; [傅明珠 FU Ming-zhu], 2009, [海洋科学进展, Advances in Marine Science], V27, P357; [高伟 Gao Wei], 2012, [海洋湖沼通报, Transactions of Oceanology and Limnology], P162; Glibert PM, 2011, CHIN J OCEANOL LIMN, V29, P719, DOI 10.1007/s00343-011-0501-0; Glibert PM, 2010, J MARINE SYST, V83, P262, DOI 10.1016/j.jmarsys.2010.05.004; Glibert PM, 2008, HARMFUL ALGAE, V8, P1, DOI 10.1016/j.hal.2008.08.020; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Grant SR, 2013, LIMNOL OCEANOGR, V58, P314, DOI 10.4319/lo.2013.58.1.0314; He BY, 2014, MAR CHEM, V167, P13, DOI 10.1016/j.marchem.2014.07.003; Hensen V, 1911, LEBEN OZEAN NACH ZAH; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; JACKSON GA, 1980, NATURE, V284, P439, DOI 10.1038/284439a0; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jiang WS, 2004, J MARINE SYST, V44, P175, DOI 10.1016/j.jmarsys.2003.09.009; KIERSTEAD H, 1953, J MAR RES, V12, P141; Kocum E, 2002, MAR ECOL PROG SER, V231, P1, DOI 10.3354/meps231001; Koroleff F, 1976, METHODS SEAWATER ANA, P149; LASKER R, 1975, FISH B-NOAA, V73, P453; Laws EA, 2013, J PHYCOL, V49, P241, DOI 10.1111/jpy.12047; Laws EA, 2011, AQUACULTURE, V322, P117, DOI 10.1016/j.aquaculture.2011.09.041; Laws EA, 2011, J PHYCOL, V47, P1089, DOI 10.1111/j.1529-8817.2011.01040.x; Li Zhe, 2013, Shuichanxue Zazhi, V26, P35; Lin I, 2012, ENV PROTECTION CIRCU, P60; MALLIN MA, 1992, LIMNOL OCEANOGR, V37, P54, DOI 10.4319/lo.1992.37.1.0054; McManus MA, 2008, ESTUAR COAST, V31, P396, DOI 10.1007/s12237-007-9025-4; Monterey G. I., 1997, NOAA ATLAS NESDIS, V14; Okubo A, 1978, SPATIAL PATTERN PLAN, P21, DOI DOI 10.1007/978-1-4899-2195-62; Pei S, 2016, ESTUAR COAS IN PRESS; Pei SF, 2009, J COASTAL RES, V25, P569, DOI 10.2112/07-0948.1; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Rines JEB, 2010, CONT SHELF RES, V30, P66, DOI 10.1016/j.csr.2009.11.001; Rines JEB, 2002, MAR ECOL PROG SER, V225, P123, DOI 10.3354/meps225123; Ryan JP, 2008, MAR ECOL PROG SER, V354, P21, DOI 10.3354/meps07222; Ryan JP, 2014, J EXP MAR BIOL ECOL, V459, P51, DOI 10.1016/j.jembe.2014.05.017; Shen ZL, 2006, ESTUAR COAST SHELF S, V69, P299, DOI 10.1016/j.ecss.2006.04.014; SHEPHERD JG, 1980, J CONSEIL, V39, P160; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; [宋伦 SONG Lun], 2007, [海洋环境科学, Marine Environmental Science], V26, P365; Steele J.H., 1978, NATO Conference Series IV Marine Sciences, V3, P1; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Sullivan JM, 2010, CONT SHELF RES, V30, P50, DOI 10.1016/j.csr.2009.07.009; Sullivan JM, 2010, CONT SHELF RES, V30, P1, DOI 10.1016/j.csr.2009.09.001; [孙军 Sun Jun], 2003, [生态学报, Acta Ecologica Sinica], V23, P517; Sun Jun, 2002, Oceanologia et Limnologia Sinica, V33, P461; Wang JJ, 2014, DEEP-SEA RES PT II, V101, P120, DOI 10.1016/j.dsr2.2013.09.020; Wang L, 2003, CHINESE GEOGR SCI, V13, P164, DOI 10.1007/s11769-003-0011-x; Wei QS, 2015, SCI CHINA EARTH SCI, V58, P628, DOI 10.1007/s11430-014-5007-0; Wernand MR, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10014s; Wroblewski J. S., 1975, MEMOIRES SOC ROY SCI, V7, P43; Yan T., 2002, NATL REPORT HARMFUL; Yu Z., 2000, MAR ENVIRON SCI, V19, P15, DOI [10.3969/j.issn:1007-6336.2000.01.004, DOI 10.3969/J.ISSN:1007-6336.2000.01.004]; Zhao D., 2010, OCCURRENCE RED TIDE; Zhou Zun-chun, 2002, Fisheries Science (Liaoning), V21, P9; Zou J.Z., 1983, MAR ENVIRON SCI, V2, P41	66	4	5	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173067	10.1371/journal.pone.0173067	http://dx.doi.org/10.1371/journal.pone.0173067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235070	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200194
J	Pelletier, A; Obbard, ME; Harnden, M; McConnell, S; Howe, EJ; Burrows, FG; White, BN; Kyle, CJ				Pelletier, Agnes; Obbard, Martyn E.; Harnden, Matthew; McConnell, Sabine; Howe, Eric J.; Burrows, Frank G.; White, Bradley N.; Kyle, Christopher J.			Determining causes of genetic isolation in a large carnivore (Ursus americanus) population to direct contemporary conservation measures	PLOS ONE			English	Article							BLACK BEAR POPULATION; LINKAGE DISEQUILIBRIUM; HABITAT FRAGMENTATION; DETECTING BOTTLENECKS; TEMPORAL CHANGES; SIZE; DIVERSITY; PROGRAM; EXTINCTION; SIMULATION	The processes leading to genetic isolation influence a population's local extinction risk, and should thus be identified before conservation actions are implemented. Natural or human-induced circumstances can result in historical or contemporary barriers to gene flow and/or demographic bottlenecks. Distinguishing between these hypotheses can be achieved by comparing genetic diversity and differentiation in isolated vs. continuous neighboring populations. In Ontario, American black bears (Ursus americanus) are continuously distributed, genetically diverse, and exhibit an isolation-by-distance structuring pattern, except on the Bruce Peninsula (BP). To identify the processes that led to the genetic isolation of BP black bears, we modelled various levels of historical and contemporary migration and population size reductions using forward simulations. We compared simulation results with empirical genetic indices from Ontario black bear populations under different levels of geographic isolation, and conducted additional simulations to determine if translocations could help achieve genetic restoration. From a genetic standpoint, conservation concerns for BP black bears are warranted because our results show that: i) a recent demographic bottleneck associated with recently reduced migration best explains the low genetic diversity on the BP; and ii) under sustained isolation, BP black bears could lose between 70% and 80% of their rare alleles within 100 years. Although restoring migration corridors would be the most effective method to enhance long-term genetic diversity and prevent inbreeding, it is unrealistic to expect connectivity to be re-established. Current levels of genetic diversity could be maintained by successfully translocating 10 bears onto the peninsula every 5 years. Such regular translocations may be more practical than landscape restoration, because areas connecting the peninsula to nearby mainland black bear populations have been irreversibly modified by humans, and form strong barriers to movement.	[Pelletier, Agnes; Kyle, Christopher J.] Trent Univ, Environm & Life Sci Program, Peterborough, ON, Canada; [Pelletier, Agnes; Harnden, Matthew; White, Bradley N.; Kyle, Christopher J.] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Obbard, Martyn E.; Howe, Eric J.] Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada; [McConnell, Sabine] Trent Univ, Dept Comp & Informat Syst, Peterborough, ON, Canada; [Burrows, Frank G.] Pk Canada, Bruce Peninsula Natl Pk, Tobermory, ON, Canada; [Burrows, Frank G.] Pk Canada, Fathom Five Natl Marine Pk, Tobermory, ON, Canada; [White, Bradley N.; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON, Canada	Trent University; Trent University; Ministry of Natural Resources & Forestry; Trent University; Trent University	Pelletier, A (corresponding author), Trent Univ, Environm & Life Sci Program, Peterborough, ON, Canada.; Pelletier, A (corresponding author), Trent Univ, Dept Biol, Peterborough, ON, Canada.	asg.pelletier@gmail.com	Pelletier, Agnès/H-9902-2019; Obbard, Martyn/AFU-0326-2022	Pelletier, Agnès/0000-0003-0372-1869; Obbard, Martyn/0000-0003-2064-0155	Science and Research Branch; Ontario Ministry of Natural Resources and Forestry	Science and Research Branch; Ontario Ministry of Natural Resources and Forestry	Funding for sample collection and DNA analysis was provided by Science and Research Branch, Ontario Ministry of Natural Resources and Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Alldredge MW, 2015, WILDLIFE SOC B, V39, P334, DOI 10.1002/wsb.526; Arenas M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002495; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; BARTLEY D, 1992, CONSERV BIOL, V6, P365, DOI 10.1046/j.1523-1739.1992.06030365.x; Belant JL, 2005, URSUS, V16, P85, DOI 10.2192/1537-6176(2005)016[0085:ABBPSA]2.0.CO;2; Berthier P, 2002, GENETICS, V160, P741; Boersen MR, 2003, WILDLIFE SOC B, V31, P197; Bouzat JL, 1998, CONSERV BIOL, V12, P836, DOI 10.1046/j.1523-1739.1998.97164.x; Bouzat JL, 2009, CONSERV GENET, V10, P191, DOI 10.1007/s10592-008-9547-8; Brown SK, 2009, J MAMMAL, V90, P1066, DOI 10.1644/08-MAMM-A-193.1; Campton D.E., 1987, POPULATION GENETICS, P161; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Carvajal-Rodriguez A, 2008, CURR GENOMICS, V9, P155, DOI 10.2174/138920208784340759; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Clark JD, 2002, URSUS, V13, P335; Comly-Gericke L.M., 1997, BEARS THEIR BIOL MAN, V9, P113; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Currat M, 2004, MOL ECOL NOTES, V4, P139, DOI 10.1046/j.1471-8286.2003.00582.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Dunbar MR, 1996, J WILDLIFE DIS, V32, P661, DOI 10.7589/0090-3558-32.4.661; Eastridge R, 2001, WILDLIFE SOC B, V29, P1163; Eidsvik H., 1997, PARKS, V2, P8; England PR, 2006, CONSERV GENET, V7, P303, DOI 10.1007/s10592-005-9103-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Growth Plan for Northern Ontario, 2011, ONT MIN MUN AFF; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Hoban SM, 2013, MOL ECOL, V22, P3444, DOI 10.1111/mec.12258; Hopkins JB, 2013, URSUS, V24, P120, DOI 10.2192/URSUS-D-12-00018.1; Howe EJ, 2016, TR04 ONT MIN NAT RES; Howe EJ, 2007, J WILDLIFE MANAGE, V71, P603, DOI 10.2193/2006-005; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; KOLENOSKY GB, 1990, INT C BEAR, V8, P385; Kramer P, 2013, DEMERELATE FUNCTIONS; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Lackey CW, 2013, J WILDLIFE MANAGE, V77, P812, DOI 10.1002/jwmg.548; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lee Daniel J., 2003, Ursus (Knoxville), V14, P162; Liley SG, 2015, URSUS, V26, P1, DOI 10.2192/URSUS-D-15-00006.1; McEachern MB, 2011, CONSERV GENET, V12, P285, DOI 10.1007/s10592-010-0139-z; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; Moreland P., 1996, MAMMALS BRUCE PENINS; Murphy SM, 2015, J WILDLIFE MANAGE, V79, P807, DOI 10.1002/jwmg.886; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Obbard ME, 2008, J WILDLIFE MANAGE, V72, P869, DOI 10.2193/2006-158; Obbard ME, 2014, URSUS, V25, P98, DOI 10.2192/URSUS-D-13-00018.1; Obbard ME, 2010, CAN J ZOOL, V88, P1063, DOI 10.1139/Z10-072; Obbard ME, 2016, TR13 ONT MIN NAT RES; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Peel D., 2004, NEESTIMATOR SOFTWARE; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pelletier A, 2012, CAN J ZOOL, V90, P999, DOI 10.1139/Z2012-068; Pelletier A, 2011, J MAMMAL, V92, P629, DOI 10.1644/10-MAMM-A-212.1; Pienaar EF, 2015, J WILDLIFE MANAGE, V79, P798, DOI 10.1002/jwmg.885; Pimm SL, 2006, ANIM CONSERV, V9, P115, DOI 10.1111/j.1469-1795.2005.00010.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rees EE, 2009, BIOL LETTERS, V5, P387, DOI 10.1098/rsbl.2009.0094; Robinson SJ, 2007, J MAMMAL, V88, P1288, DOI 10.1644/06-MAMM-A-284R.1; ROGERS LL, 1987, WILDLIFE MONOGR, P1; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Stratman MR, 2001, URSUS-SERIES, V12, P55; Stronen AV, 2012, CONSERV GENET, V13, P359, DOI 10.1007/s10592-011-0290-1; Suffling R, 1995, VEGETATION CHANGE VE; Sutton S, 1999, STUDY BLACK BEAR POP; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Triant DA, 2004, CONSERV GENET, V5, P647, DOI 10.1007/s10592-003-1861-6; Vaughan Michael R., 1995, P100; Walker CW, 2001, MOL ECOL, V10, P53, DOI 10.1046/j.1365-294X.2001.01184.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WAPLES RS, 1989, GENETICS, V121, P379; Wear BJ, 2005, WILDLIFE SOC B, V33, P1363, DOI 10.2193/0091-7648(2005)33[1363:FASSAV]2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weiser EL, 2012, MOL ECOL RESOUR, V12, P1161, DOI 10.1111/j.1755-0998.2012.03176.x; Wiegand T, 2005, CONSERV BIOL, V19, P108, DOI 10.1111/j.1523-1739.2005.00208.x; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zigouris J, 2012, CONSERV GENET, V13, P1543, DOI 10.1007/s10592-012-0399-x	106	15	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172319	10.1371/journal.pone.0172319	http://dx.doi.org/10.1371/journal.pone.0172319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235066	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200067
J	Echtler, K; Konrad, I; Lorenz, M; Schneider, S; Hofmaier, S; Plenagl, F; Stark, K; Czermak, T; Tirniceriu, A; Eichhorn, M; Walch, A; Enders, G; Massberg, S; Schulz, C				Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Schneider, Simon; Hofmaier, Sebastian; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Eichhorn, Martin; Walch, Axel; Enders, Georg; Massberg, Steffen; Schulz, Christian			Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis	PLOS ONE			English	Article							TUMOR-CELLS; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; IN-VIVO; INTEGRIN ALPHA(V)BETA(3); VASCULAR ENDOTHELIUM; ADHESION; GROWTH; ALPHA-IIB-BETA-3; EXPRESSION	Platelets modulate the process of cancer metastasis. However, current knowledge on the direct interaction of platelets and tumor cells is mostly based on findings obtained in vitro. We addressed the role of the platelet fibrinogen receptor glycoprotein IIb (integrin alpha IIb) for experimental melanoma metastasis in vivo. Highly metastatic B16-D5 melanoma cells were injected intravenously into GPIIb-deficient (GPIIb(-/-)) or wildtype (WT) mice. Acute accumulation of tumor cells in the pulmonary vasculature was assessed in real-time by confocal videofluorescence microscopy. Arrest of tumor cells was dramatically reduced in GPIIb(-/-) mice as compared to WT. Importantly, we found that mainly multicellular aggregates accumulated in the pulmonary circulation of WT, instead B16-D5 aggregates were significantly smaller in GPIIb(-/-) mice. While pulmonary arrest of melanoma was clearly dependent on GPIIb in this early phase of metastasis, we also addressed tumor progression 10 days after injection. Inversely, and unexpectedly, we found that melanoma metastasis was now increased in GPIIb(-/-) mice. In contrast, GPIIb did not regulate local melanoma proliferation in a subcutaneous tumor model. Our data suggest that the platelet fibrinogen receptor has a differential role in the modulation of hematogenic melanoma metastasis. While platelets clearly support early steps in pulmonary metastasis via GPIIb-dependent formation of platelet-tumor-aggregates, at a later stage its absence is associated with an accelerated development of melanoma metastases.	[Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Massberg, Steffen; Schulz, Christian] Ludwig Maximilians Univ Munchen, Klinikum Univ, Med Klin & Poliklin 1, Munich, Germany; [Echtler, Katrin; Konrad, Ildiko; Lorenz, Michael; Plenagl, Florian; Stark, Konstantin; Czermak, Thomas; Tirniceriu, Anca; Eichhorn, Martin; Enders, Georg; Massberg, Steffen; Schulz, Christian] Ludwig Maximilians Univ Munchen, Walter Brendel Zentrum Expt Med, Munich, Germany; [Schneider, Simon; Hofmaier, Sebastian] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, Munich, Germany; [Eichhorn, Martin] Ludwig Maximilians Univ Munchen, Klinikum Univ, Chirurg Klin, Munich, Germany; [Walch, Axel] German Res Ctr Environm Hlth, Res Unit Analyt Pathol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Konrad, Ildiko] Tech Univ Munich, Zentrum Praklin Forsch, Munich, Germany; [Eichhorn, Martin] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany	University of Munich; University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ruprecht Karls University Heidelberg	Schulz, C (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ, Med Klin & Poliklin 1, Munich, Germany.; Schulz, C (corresponding author), Ludwig Maximilians Univ Munchen, Walter Brendel Zentrum Expt Med, Munich, Germany.	Christian.Schulz@med.uni-muenchen.de	Eichhorn, Martin/GRE-9126-2022; Schulz, Christian/J-8545-2012; Massberg, Steffen/AAN-6054-2021; Walch, Axel/B-4554-2012; Stark, Konstantin/AAJ-2815-2020; Eichhorn, Martin/AAU-7204-2020	Eichhorn, Martin/0000-0002-0362-0374; Schulz, Christian/0000-0003-3878-7833; Walch, Axel/0000-0001-5578-4023; Stark, Konstantin/0000-0002-5369-8399; 	Wilhelm-Sander Foundation [2005.124.1.1]; Wilhelm Sander-Stiftung [2005.124.1.1]	Wilhelm-Sander Foundation; Wilhelm Sander-Stiftung	The study was supported the Wilhelm-Sander Foundation, grant 2005.124.1.1, http://www.wilhelm-sander-stiftung.de/cms/front_content.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are indebted to Sandra Kerstan, Lin Zhang, Christof Hoffmann and Birgit Niehuis for their help with in vitro experiments and Marie-Luise von Bruehl for support of intravital microscopy. We thank Luise Jennen for expert technical assistance in electron microscopy. We also thank Matthias Schiemann and Dirk Busch for help with fluorescence activated cell sorting. We thank Jon Frampton for providing GPIIb<SUP>-/-</SUP> mice. The study was supported by grants from the Wilhelm Sander-Stiftung (2005.124.1.1).	ALTERMAN AL, 1985, J NATL CANCER I, V75, P691; Amirkhosravi A, 1999, PLATELETS, V10, P285; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; BARTH A, 1995, J AM COLL SURGEONS, V181, pA193; Biggerstaff JP, 1999, CLIN EXP METASTAS, V17, P723, DOI 10.1023/A:1006763827882; Bombeli T, 1998, J EXP MED, V187, P329, DOI 10.1084/jem.187.3.329; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Cardones AR, 2003, CANCER RES, V63, P6751; Chandraratne S, 2015, ARTERIOSCL THROM VAS, V35, P589, DOI 10.1161/ATVBAHA.114.304447; Chen YQ, 1997, INT J CANCER, V72, P642, DOI 10.1002/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; Decristoforo C, 2006, NUCL MED BIOL, V33, P945, DOI 10.1016/j.nucmedbio.2006.09.001; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Erpenbeck L, 2010, J INVEST DERMATOL, V130, P576, DOI 10.1038/jid.2009.278; EVANS PM, 1984, CELL BIOL INT REP, V8, P659, DOI 10.1016/0309-1651(84)90046-8; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gobbi G, 2006, INT J MOL MED, V18, P309; HART IR, 1979, AM J PATHOL, V97, P587; HEINZMANN U, 1994, HISTOCHEMISTRY, V101, P127, DOI 10.1007/BF00269359; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; HONN KV, 1992, EXP CELL RES, V201, P23, DOI 10.1016/0014-4827(92)90344-8; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kroll MH, 1996, BLOOD, V88, P1525; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Nezos A, 2011, CANCER TREAT REV, V37, P284, DOI 10.1016/j.ctrv.2010.10.002; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Nieswandt B, 1999, CANCER RES, V59, P1295; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Pilch J, 2002, J BIOL CHEM, V277, P21930, DOI 10.1074/jbc.M201630200; Rakhmilevich AL, 2001, CLIN CANCER RES, V7, P952; Schreurs MWJ, 1997, MELANOMA RES, V7, P463, DOI 10.1097/00008390-199712000-00004; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Schwarte LA, 2000, BASIC RES CARDIOL, V95, P510, DOI 10.1007/s003950070029; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Tam SH, 1998, CIRCULATION, V98, P1085, DOI 10.1161/01.CIR.98.11.1085; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Trikha M, 2002, CANCER RES, V62, P2824; Wagner SN, 2000, J INVEST DERMATOL, V115, P1082, DOI 10.1046/j.1523-1747.2000.00157.x; WEISS L, 1991, CELL BIOPHYS, V18, P73, DOI 10.1007/BF02989807; Winter H, 1999, J IMMUNOL, V163, P4462; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	51	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172788	10.1371/journal.pone.0172788	http://dx.doi.org/10.1371/journal.pone.0172788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253287	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300032
J	Novakovic, P; Harding, JCS; Al-Dissi, AN; Detmer, SE				Novakovic, Predrag; Harding, John C. S.; Al-Dissi, Ahmad N.; Detmer, Susan E.			Type 2 porcine reproductive and respiratory syndrome virus infection increases apoptosis at the maternal-fetal interface in late gestation pregnant gilts	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; IMPLANTATION SITES; CELL-DEATH; IN-VITRO; REPLICATION; PATHOGENESIS; PATHOLOGY; FETUSES; ISOLATE; VIVO	The pathogenesis of fetal death associated with porcine reproductive and respiratory syndrome (PRRS) is hypothesized to be a consequence of PRRS virus-induced apoptosis at the maternal-fetal interface (MFI). The objectives of this study were to evaluate distribution and degree of apoptosis in the uterine and fetal placental tissues during the experimental type 2 PRRS virus (PRRSV) infection and determine associations between apoptosis at the MFI, PRRSV RNA concentration and antigen staining intensity, PRRSV-induced microscopic lesions, and fetal preservation status. A total of 114 naive, high-health pregnant gilts were inoculated with type 2 PRRSV on gestation day 85 +/- 1 with euthanasia 21 days later; 19 sham-inoculated gilts served as controls. Two hundred and fifty samples of uterine tissue with fetal placenta were selected based on negative, low PRRSV RNA, and high PRRSV RNA concentration (0, < or > 2.7 log(10) copies/mg, respectively). TUNEL assay was used to detect apoptosis in the endometrium and at the MFI. PRRSV RNA concentration and numbers of PRRSV immunopositive cells in uterine and placental tissue were positively associated with the severity of apoptosis in the endometrium and the MFI (P<0.001, P<0.05 and P<0.001, respectively). The number of TUNEL positive cells at the MFI was also positively associated with the severity (P<0.001) of vasculitis, but not total numbers of inflammatory cells in the endometrium. Increased numbers of TUNEL positive cells at the MFI were associated with PRRSV load in the fetal thymus, and greater odds of meconium staining of the fetus at 21 days post infection (P<0.001 for both). These findings suggest an important role of apoptosis in the pathogenesis of uterine epithelial and trophoblastic cell death at the MFI. Moreover, apoptosis at the MFI is significantly associated with fetal demise during in utero type 2 PRRSV infection.	[Novakovic, Predrag; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK, Canada; [Al-Dissi, Ahmad N.; Detmer, Susan E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Novakovic, P (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK, Canada.	predrag.novakovic@usask.ca		Detmer, Susan/0000-0002-4064-3460; Al-Dissi, Ahmad/0000-0002-3124-3502	Genome Canada; Genome Prairie (Saskatchewan Ministry of Agriculture and Food); Boehringer Ingelheim Vetmedica, Inc.	Genome Canada(Genome Canada); Genome Prairie (Saskatchewan Ministry of Agriculture and Food); Boehringer Ingelheim Vetmedica, Inc.(Boehringer Ingelheim)	Funding for this project was generously provided by Genome Canada, Genome Prairie (Saskatchewan Ministry of Agriculture and Food), and a Boehringer Ingelheim Vetmedica, Inc. PRRS Research Award, with administrative support provided by Genome Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dissi AN, 2007, VET PATHOL, V44, P823, DOI 10.1354/vp.44-6-823; Cano JP, 2009, CAN J VET RES, V73, P303; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; Choi K, 2015, J COMP PATHOL, V152, P317, DOI 10.1016/j.jcpa.2015.03.002; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Han K, 2012, J COMP PATHOL, V147, P275, DOI 10.1016/j.jcpa.2011.12.010; Karniychuk UU, 2012, THERIOGENOLOGY, V78, P1527, DOI 10.1016/j.theriogenology.2012.06.015; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kelly R, 2009, AM J EPIDEMIOL, V170, P148, DOI 10.1093/aje/kwp131; Kim TS, 2002, VIRUS RES, V85, P133, DOI 10.1016/S0168-1702(02)00029-1; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Ladinig A, 2014, PLOS ONE, V9, P96; Ladinig A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0251-7; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109541; Lager KM, 1996, J VET DIAGN INVEST, V8, P275, DOI 10.1177/104063879600800301; Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7; Novakovic P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151198; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989; Sur JH, 1998, VET PATHOL, V35, P506, DOI 10.1177/030098589803500605; Tanir H. Mete, 2005, Archives of Gynecology and Obstetrics, V273, P98, DOI 10.1007/s00404-005-0028-8; Thanawongnuwech R, 1997, VET IMMUNOL IMMUNOP, V59, P323, DOI 10.1016/S0165-2427(97)00078-0; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086	27	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173360	10.1371/journal.pone.0173360	http://dx.doi.org/10.1371/journal.pone.0173360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253336	Green Published, gold			2022-12-27	WOS:000396011300103
J	Ritter, A; Cabioch, L; Brillet-Gueguen, L; Corre, E; Cosse, A; Dartevelle, L; Durufle, H; Fasshauer, C; Goulitquer, S; Thomas, F; Correa, JA; Potin, P; Faugeron, S; Leblanc, C				Ritter, Andres; Cabioch, Lea; Brillet-Gueguen, Loraine; Corre, Erwan; Cosse, Audrey; Dartevelle, Laurence; Durufle, Harold; Fasshauer, Carina; Goulitquer, Sophie; Thomas, Francois; Correa, Juan A.; Potin, Philippe; Faugeron, Sylvain; Leblanc, Catherine			Herbivore-induced chemical and molecular responses of the kelps Laminaria digitata and Lessonia spicata	PLOS ONE			English	Article							DEFENSE RESPONSES; OXIDATIVE STRESS; INNATE IMMUNITY; ALGA; EVOLUTION; PATTERNS; INSIGHTS; IMPACT; BURST	Kelps are founding species of temperate marine ecosystems, living in intertidal coastal areas where they are often challenged by generalist and specialist herbivores. As most sessile organisms, kelps develop defensive strategies to restrain grazing damage and preserve their own fitness during interactions with herbivores. To decipher some inducible defense and signaling mechanisms, we carried out metabolome and transcriptome analyses in two emblematic kelp species, Lessonia spicata from South Pacific coasts and Laminaria digitata from North Atlantic, when challenged with their main specialist herbivores. Mass spectrometry based metabolomics revealed large metabolic changes induced in these two brown algae following challenges with their own specialist herbivores. Targeted metabolic profiling of L. spicata further showed that free fatty acid (FFA) and amino acid (AA) metabolisms were particularly regulated under grazing. An early stress response was illustrated by the accumulation of Sulphur containing amino acids in the first twelve hours of herbivory pressure. At latter time periods (after 24 hours), we observed FFA liberation and eicosanoid oxylipins synthesis likely representing metabolites related to stress. Global transcriptomic analysis identified sets of candidate genes specifically induced by grazing in both kelps. qPCR analysis of the top candidate genes during a 48-hours time course validated the results. Most of these genes were particularly activated by herbivore challenge after 24 hours, suggesting that transcriptional reprogramming could be operated at this time period. We demonstrated the potential utility of these genes as molecular markers for herbivory by measuring their inductions in grazed individuals of field harvested L. digitata and L. spicata. By unravelling the regulation of some metabolites and genes following grazing pressure in two kelps representative of the two hemispheres, this work contributes to provide a set of herbivore-induced chemical and molecular responses in kelp species, showing similar inducible responses upon specialist herbivores in their respective ecosystems.	[Ritter, Andres; Cabioch, Lea; Cosse, Audrey; Dartevelle, Laurence; Durufle, Harold; Fasshauer, Carina; Goulitquer, Sophie; Thomas, Francois; Potin, Philippe; Leblanc, Catherine] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR 8227,Integrat Biol Marine Models,Stn Biol, Roscoff, France; [Ritter, Andres; Cabioch, Lea; Correa, Juan A.; Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Santiago, Chile; [Ritter, Andres; Cabioch, Lea; Correa, Juan A.; Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, CeBiB, Santiago, Chile; [Brillet-Gueguen, Loraine; Corre, Erwan] UPMC Univ Paris 06, Sorbonne Univ, CNRS, FR2424,Anal & Bioinformat Marine Sci,Stn Biol, Roscoff, France; [Correa, Juan A.; Faugeron, Sylvain] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMI 3614,Evolutionary Biol & Ecol Algae,Stn Biol, Roscoff, France; [Ritter, Andres] UPMC, Sorbonne Univ, Inst Biol Paris Seine, CNRS,Lab Biol Computat & Quantitat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Leblanc, C (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR 8227,Integrat Biol Marine Models,Stn Biol, Roscoff, France.	catherine.leblanc@sb-roscoff.fr	corre, erwan/O-4669-2019	corre, erwan/0000-0001-6354-2278; Faugeron, Sylvain/0000-0001-7258-5229; Thomas, Francois/0000-0003-1896-0774; Durufle, Harold/0000-0002-6020-2822; Ritter, Andres/0000-0001-7011-6824	Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie, Paris; European Community through the ASSEMBLE [227799]; EU [GOCE-CT-2004-505403]; IDEALG project [ANR-10-BTBR-04-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie, Paris; European Community through the ASSEMBLE; EU(European Commission); IDEALG project	This work was supported by the 'Centre National de la Recherche Scientifique' and by the 'Universite Pierre et Marie Curie, Paris 06'. The Las Cruces experimental access was supported by the European Community through the ASSEMBLE programme no. 227799, and the sequencing costs through Marine Genomics Europe NoE 7 (EU contract no GOCE-CT-2004-505403). The project was also partly founded by the IDEALG project (grant ANR-10-BTBR-04-02), the GDRI DBMA, the GDR MediatEC, the Region Bretagne (L.C.'s PhD, allocation no. J13U220/ARED), and the CONICYT of Chile (A.R.'s Post-doc fellowship).	APT KE, 1995, MOL GEN GENET, V246, P455, DOI 10.1007/BF00290449; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Contreras L, 2005, J PHYCOL, V41, P1184, DOI 10.1111/j.1529-8817.2005.00151.x; Cosse A, 2007, DYNAMIC DEFENSE MARI, P221; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Dittami SM, 2011, PLANT CELL ENVIRON, V34, P629, DOI 10.1111/j.1365-3040.2010.02268.x; Flothe CR, 2014, J PHYCOL, V50, P564, DOI 10.1111/jpy.12186; Gasperini D, 2015, PLANT PHYSIOL, V169, P2244, DOI 10.1104/pp.15.01104; Gfeller A, 2011, PLANT PHYSIOL, V156, P1797, DOI 10.1104/pp.111.181008; Giacomoni F, 2015, BIOINFORMATICS, V31, P1493, DOI 10.1093/bioinformatics/btu813; Goulitquer S, 2009, CHEMBIOCHEM, V10, P977, DOI 10.1002/cbic.200900004; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hoque MA, 2007, J PLANT PHYSIOL, V164, P1457, DOI 10.1016/j.jplph.2006.10.004; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; Kupper FC, 2009, PLANT CELL PHYSIOL, V50, P789, DOI 10.1093/pcp/pcp023; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molis M, 2008, MAR ECOL PROG SER, V354, P97, DOI 10.3354/meps07255; Molis M, 2010, J PHYCOL, V46, P76, DOI 10.1111/j.1529-8817.2009.00787.x; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Ritter A, 2008, NEW PHYTOL, V180, P809, DOI 10.1111/j.1469-8137.2008.02626.x; Ritter A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-116; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Thomas F, 2014, NEW PHYTOL, V204, P567, DOI 10.1111/nph.12925	33	9	9	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173315	10.1371/journal.pone.0173315	http://dx.doi.org/10.1371/journal.pone.0173315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253346	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300099
J	Veelo, DP; Henegouwen, MIV; Ouwehand, KS; Geerts, BF; Anderegg, MCJ; van Dieren, S; Preckel, B; Binnekade, JM; Gisbertz, SS; Hollmann, MW				Veelo, Denise P.; Henegouwen, Mark I. van Berge; Ouwehand, Kirsten S.; Geerts, Bart F.; Anderegg, Maarten C. J.; van Dieren, Susan; Preckel, Benedikt; Binnekade, Jan M.; Gisbertz, Suzanne S.; Hollmann, Markus W.			Effect of goal-directed therapy on outcome after esophageal surgery: A quality improvement study	PLOS ONE			English	Article							STROKE VOLUME VARIATION; PERIOPERATIVE FLUID MANAGEMENT; RANDOMIZED CLINICAL-TRIAL; RISK SURGICAL-PATIENTS; GASTROINTESTINAL SURGERY; CLASSIFICATION; RESPONSIVENESS; METAANALYSIS; ALGORITHM; RESECTION	Background Goal-directed therapy (GDT) can reduce postoperative complications in high-risk surgery patients. It is uncertain whether GDT has the same benefits in patients undergoing esophageal surgery. Goal of this Quality Improvement study was to evaluate the effects of a stroke volume guided GDT on post-operative outcome. Methods and findings We compared the postoperative outcome of patients undergoing esophagectomy before (99 patients) and after (100 patients) implementation of GDT. There was no difference in the proportion of patients with a complication (56% vs. 54%, p = 0.82), hospital stay and mortality. The incidence of prolonged ICU stay (>48 hours) was reduced (28% vs. 12, p = .005) in patients treated with GDT. Secondary analysis of complication rate showed a decrease in pneumonia (29 vs. 15%, p = .02), mediastinal abscesses (12 vs. 3%, p = .02), and gastric tube necrosis (5% vs. 0%, p = .03) in patients treated with GDT. Patients in the GDT group received significantly less fluids but received more colloids. Conclusions The implementation of GDT during esophagectomy was not associated with reductions in overall morbidity, mortality and hospital length of stay. However, we observed a decrease in pneumonia, mediastinal abscesses, gastric tube necrosis, and ICU length of stay.	[Veelo, Denise P.; Ouwehand, Kirsten S.; Geerts, Bart F.; van Dieren, Susan; Preckel, Benedikt; Hollmann, Markus W.] Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Henegouwen, Mark I. van Berge; Anderegg, Maarten C. J.; van Dieren, Susan; Gisbertz, Suzanne S.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands; [Binnekade, Jan M.] Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Geerts, BF (corresponding author), Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands.	b.f.geerts@amc.uva.nl	veelo, Denise/AAU-2871-2021; Gisbertz, Suzanne/AAG-5370-2020	Gisbertz, Suzanne/0000-0001-9655-7601; Veelo, Denise/0000-0001-6196-1671; Hollmann, Markus/0000-0001-8248-0244; Preckel, Benedikt/0000-0003-4412-9183; van Berge Henegouwen, Mark/0000-0001-8689-3134	Edwards Life Sciences LLC, Irvine CA, United States of America	Edwards Life Sciences LLC, Irvine CA, United States of America	This project was funded by Edwards Life Sciences LLC, Irvine CA, United States of America (contract was made, under name: quality improvement project, AMC). Funding was only for a part of the material costs (probes). EV1000 monitors were borrowed. The authors state that they had full control of the design of the study, methods used, outcome parameters and results, analysis of data and production of the written report.	Assaad S, 2013, CURR OPIN ANESTHESIO, V26, P31, DOI 10.1097/ACO.0b013e32835c5cf5; Bellamy MC, 2006, BRIT J ANAESTH, V97, P755, DOI 10.1093/bja/ael290; Benes J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0584-z; Benes J, 2010, CRIT CARE, V14, DOI 10.1186/cc9070; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Challand C, 2012, BRIT J ANAESTH, V108, P53, DOI 10.1093/bja/aer273; Chau EHL, 2014, SEMIN CARDIOTHORAC V, V18, P36, DOI 10.1177/1089253213491014; Corcoran T, 2012, ANESTH ANALG, V114, P640, DOI 10.1213/ANE.0b013e318240d6eb; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Dalfino L, 2011, CRIT CARE, V15, DOI 10.1186/cc10284; de Waal EEC, 2009, CRIT CARE MED, V37, P510, DOI 10.1097/CCM.0b013e3181958bf7; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Feldheiser A, 2013, BRIT J ANAESTH, V110, P231, DOI 10.1093/bja/aes377; Feldheiser A, 2012, J INT MED RES, V40, P1227, DOI 10.1177/147323001204000402; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOB IN CHRON OBSTR; Grocott MP, 2012, COCHRANE DB SYST REV, V11, P535; Haas S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/687018; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Jaeger J Michael, 2012, Anesthesiol Clin, V30, P731, DOI 10.1016/j.anclin.2012.08.005; Kobayashi M, 2009, ANN SURG ONCOL, V16, P1371, DOI 10.1245/s10434-008-0139-0; Kotake Y, 2014, J ANESTH, V28, P180, DOI 10.1007/s00540-013-1704-7; Kuper M, 2011, BMJ-BRIT MED J, V342, P3016; Licker M, 2003, ANESTH ANALG, V97, P1558, DOI 10.1213/01.ANE.0000087799.85495.8A; McKenny M, 2013, ANAESTHESIA, V68, P1224, DOI 10.1111/anae.12355; Meybohm P, 2013, CRIT CARE, V17, DOI 10.1186/cc12845; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Rollins KE, 2016, ANN SURG, V263, P465, DOI 10.1097/SLA.0000000000001366; Scheeren TWL, 2013, J CLIN MONIT COMPUT, V27, P225, DOI 10.1007/s10877-013-9461-6; Seely AJE, 2010, ANN THORAC SURG, V90, P936, DOI 10.1016/j.athoracsur.2010.05.014; Srinivasa S, 2013, BRIT J SURG, V100, P66, DOI 10.1002/bjs.8940; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wei SH, 2008, ANN THORAC SURG, V86, P266, DOI 10.1016/j.athoracsur.2008.03.017; Yates DRA, 2014, BRIT J ANAESTH, V112, P281, DOI 10.1093/bja/aet307; Zheng H, 2013, WORLD J SURG, V37, P2820, DOI 10.1007/s00268-013-2203-6	37	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172806	10.1371/journal.pone.0172806	http://dx.doi.org/10.1371/journal.pone.0172806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253353	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300036
J	Biza, KV; Nastou, KC; Tsiolaki, PL; Mastrokalou, CV; Hamodrakas, SJ; Iconomidou, VA				Biza, Konstantina V.; Nastou, Katerina C.; Tsiolaki, Paraskevi L.; Mastrokalou, Chara V.; Hamodrakas, Stavros J.; Iconomidou, Vassiliki A.			The amyloid interactome: Exploring protein aggregation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; HIGH-DENSITY-LIPOPROTEIN; HUMAN SERUM-ALBUMIN; INTERACTION NETWORKS; ALZHEIMERS-DISEASE; SYSTEMS BIOLOGY; BETA-PROTEIN; A-BETA; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES	Protein-protein interactions are the quintessence of physiological activities, but also participate in pathological conditions. Amyloid formation, an abnormal protein-protein interaction process, is a widespread phenomenon in divergent proteins and peptides, resulting in a variety of aggregation disorders. The complexity of the mechanisms underlying amyloid formation/amyloidogenicity is a matter of great scientific interest, since their revelation will provide important insight on principles governing protein misfolding, self-assembly and aggregation. The implication of more than one protein in the progression of different aggregation disorders, together with the cited synergistic occurrence between amyloidogenic proteins, highlights the necessity for a more universal approach, during the study of these proteins. In an attempt to address this pivotal need we constructed and analyzed the human amyloid interactome, a protein-protein interaction network of amyloidogenic proteins and their experimentally verified interactors. This network assembled known interconnections between well-characterized amyloidogenic proteins and proteins related to amyloid fibril formation. The consecutive extended computational analysis revealed significant topological characteristics and unraveled the functional roles of all constituent elements. This study introduces a detailed protein map of amyloidogenicity that will aid immensely towards separate intervention strategies, specifically targeting sub-networks of significant nodes, in an attempt to design possible novel therapeutics for aggregation disorders.	[Biza, Konstantina V.; Nastou, Katerina C.; Tsiolaki, Paraskevi L.; Mastrokalou, Chara V.; Hamodrakas, Stavros J.; Iconomidou, Vassiliki A.] Univ Athens, Sect Cell Biol & Biophys, Dept Biol, Sch Sci, Athens, Greece	National & Kapodistrian University of Athens	Iconomidou, VA (corresponding author), Univ Athens, Sect Cell Biol & Biophys, Dept Biol, Sch Sci, Athens, Greece.	veconom@biol.uoa.gr	Iconomidou, Vassiliki/AAM-2003-2020	Iconomidou, Vassiliki/0000-0002-9472-5146; Tsiolaki, Paraskevi L./0000-0002-9525-6433; Nastou, Katerina/0000-0003-3611-5726	Greek State Scholarships Foundation	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT)	This project was financially supported by the Greek State Scholarships Foundation, through the program: "RESEARCH PROJECTS FOR EXCELLENCE IKY/SIEMENS" (2015-2017).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Bergman P, 2016, J INTERN MED, V280, P139, DOI 10.1111/joim.12479; Bergstrom J, 2004, LAB INVEST, V84, P981, DOI 10.1038/labinvest.3700124; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Calero M, 2012, METHODS MOL BIOL, V849, P213, DOI 10.1007/978-1-61779-551-0_15; Carter DB, 2005, SUB CELL BIOCHEM, V38, P255; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Csermely Peter, 2008, Novartis Found Symp, V291, P45; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; D'Souza A, 2014, AMYLOID, V21, P71, DOI 10.3109/13506129.2013.876984; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; Dominguez-Prieto M, 2017, J ALZHEIMERS DIS, V55, P171, DOI 10.3233/JAD-160346; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Fronczak A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056110; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gillis J, 2014, J PROTEOMICS, V100, P44, DOI 10.1016/j.jprot.2014.01.020; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Huang LQ, 2015, ARCH BIOCHEM BIOPHYS, V568, P46, DOI 10.1016/j.abb.2015.01.007; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; ISOBE T, 1993, INTERNAL MED, V32, P919, DOI 10.2169/internalmedicine.32.919; Jalili M, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012803; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kerrien S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-44; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Landreh M, 2015, J BIOL CHEM, V290, P26430, DOI 10.1074/jbc.R115.653097; Lee S, 2006, BIOCHEM BIOPH RES CO, V347, P527, DOI 10.1016/j.bbrc.2006.06.128; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Levy Efrat, 2008, Expert Rev Neurother, V8, P687, DOI 10.1586/14737175.8.5.687; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Licata L, 2016, METHODS MOL BIOL, V1415, P55, DOI 10.1007/978-1-4939-3572-7_3; Lotia S, 2013, BIOINFORMATICS, V29, P1350, DOI 10.1093/bioinformatics/btt138; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Nastou KC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/397145; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Petta I, 2016, MOL THER, V24, P707, DOI 10.1038/mt.2015.214; Rao L, 2013, J COMPUT CHEM, V34, P1636, DOI 10.1002/jcc.23303; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ray I, 2000, BRAIN RES, V853, P344, DOI 10.1016/S0006-8993(99)02315-X; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Silva JV, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0432-9; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Soti C, 2007, EXP GERONTOL, V42, P113, DOI 10.1016/j.exger.2006.05.017; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Ulbrich L, 2014, CELL MOL NEUROBIOL, V34, P205, DOI 10.1007/s10571-013-0004-y; Uversky V.N., 1999, MED SCI MONITOR, V5, P1001; Uversky V.N., 1999, MED SCI MONITOR, V5, P1238; Van Dongen S., 2000, THESIS; Vega L, 2009, J ALZHEIMERS DIS, V17, P795, DOI 10.3233/JAD-2009-1093; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Vinayagam A, 2014, NAT METHODS, V11, P94, DOI [10.1038/nmeth.2733, 10.1038/NMETH.2733]; Virok DP, 2011, J PROTEOME RES, V10, P1538, DOI 10.1021/pr1009096; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Westermark GT, 2008, EXP DIABETES RES, DOI 10.1155/2008/429274; Westermark P, 1997, AM J PATHOL, V150, P67; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Wilhelmus MMM, 2009, NEUROBIOL AGING, V30, P229, DOI 10.1016/j.neurobiolaging.2007.06.001; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wozniak PP, 2015, BIOINFORMATICS, V31, P3395, DOI 10.1093/bioinformatics/btv375; Xiao Fan Wang, 2003, IEEE Circuits and Systems Magazine, V3, P6, DOI 10.1109/MCAS.2003.1228503; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576; Yerbury J., 2010, CURR CHEM BIOL, V4, P89; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	114	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173163	10.1371/journal.pone.0173163	http://dx.doi.org/10.1371/journal.pone.0173163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249044	Green Submitted, gold, Green Published			2022-12-27	WOS:000395983500080
J	Englund-Ogge, L; Birgisdottir, BE; Sengpiel, V; Brantsaeter, AL; Haugen, M; Myhre, R; Meltzer, HM; Jacobsson, B				Englund-Ogge, Linda; Birgisdottir, Bryndis Eva; Sengpiel, Verena; Brantsaeter, Anne Lise; Haugen, Margareta; Myhre, Ronny; Meltzer, Helle Margrete; Jacobsson, Bo			Meal frequency patterns and glycemic properties of maternal diet in relation to preterm delivery: Results from a large prospective cohort study	PLOS ONE			English	Article							NORWEGIAN MOTHER; CHILD COHORT; INSULIN-RESISTANCE; PREGNANT-WOMEN; MULTIPLE-PROTEINS; AMNIOTIC-FLUID; LABOR; BIRTH; RISK; MOBA	Background Dietary habits are linked to high maternal glucose levels, associated with preterm delivery. The aim of this study was to examine the associations between meal frequency and glycemic properties of maternal diet in relation to preterm delivery. Methods This prospective cohort study included 66,000 women from the Norwegian Mother and Child Cohort Study (MoBa). Meal frequency and food intake data were obtained from a validated food frequency questionnaire during mid-pregnancy. Principal component factor analysis was used with a data-driven approach, and three meal frequency patterns were identified: "snack meal", "main meal", and "evening meal". Pattern scores were ranked in quartiles. Glycemic index and glycemic load were estimated from table values. Intakes of carbohydrates, added sugar, and fiber were reported in grams per day and divided into quartiles. Gestational age was obtained from the Medical Birth Registry of Norway. Preterm delivery was defined as birth at <37 gestational weeks. A Cox regression model was used to assess associations with preterm delivery. Results After adjustments, the "main meal" pattern was associated with a reduced risk of preterm delivery, with hazard ratios (HRs) of 0.89 (95% confidence interval (CI): 0.80, 0.98) and 0.90 (95% CI: 0.81, 0.99) for the third and fourth quartiles, respectively, and p for trend of 0.028. This was mainly attributed to the group of women with BMI >= 25 kg/m(2), with HRs of 0.87 (95% CI: 0.79, 0.96) and 0.89 (95% CI: 0.80, 0.98) for the third and fourth quartiles, respectively, and p for trend of 0.010. There was no association between glycemic index, glycemic load, carbohydrates, added sugar, fiber, or the remaining meal frequency patterns and pre-term delivery. Conclusion Regular consumption of main meals (breakfast, lunch, dinner) was associated with a lower risk of preterm delivery. Diet should be further studied as potential contributing factors for preterm delivery.	[Englund-Ogge, Linda; Sengpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Birgisdottir, Bryndis Eva; Brantsaeter, Anne Lise; Haugen, Margareta; Meltzer, Helle Margrete] Domain Infect Control & Environm Hlth, Dept Environm Exposure & Epidemiol, Oslo, Norway; [Birgisdottir, Bryndis Eva] Univ Iceland, Natl Univ Hosp, Fac Food Sci & Nutr, Unit Nutr Res, Reykjavik, Iceland; [Myhre, Ronny; Jacobsson, Bo] Inst Publ Hlth, Dept Genet & Bioinformat, Domain Hlth Data & Digitalizat, Oslo, Norway; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden	Sahlgrenska University Hospital; Landspitali National University Hospital; University of Iceland; University of Gothenburg	Englund-Ogge, L (corresponding author), Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.	linda.englund-ogge@vgregion.se	Brantsaeter, Anne Lise/H-7014-2016; Jacobsson, Bo/O-8007-2014	Brantsaeter, Anne Lise/0000-0001-6315-7134; Jacobsson, Bo/0000-0001-5079-2374; Birgisdottir, Bryndis Eva/0000-0002-5788-4551; Meltzer, Helle Margrete/0000-0002-3591-7017	Freemanson's Directorate Board for Children [ES236011]; Adlerbertska Foundation; Norwegian Research Council [FUGE 183220/S10, FRIMEDKLI-05 ES236011]; Jane and Dan Olsson Foundation; Swedish Medical Society [SLS 2008-21198]; Swedish government [ALFGBG-2863, ALFGBG-11522]; Norwegian Ministry of Health; Ministry of Education and Research [N01-ES-75558]; NIH/NINDS [UO1 NS 047537-01, UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]	Freemanson's Directorate Board for Children; Adlerbertska Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Jane and Dan Olsson Foundation; Swedish Medical Society; Swedish government; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway)	This work was supported by Freemanson's Directorate Board for Children, ES236011, MD Linda Englund Ogge; Adlerbertska Foundation, MD Linda Englund Ogge; the Norwegian Research Council, FUGE 183220/S10, MD Linda Englund Ogge; Norwegian Research Council, FRIMEDKLI-05 ES236011, MD Linda Englund Ogge; Jane and Dan Olsson Foundation, MD Linda Englund Ogge; Swedish Medical Society, SLS 2008-21198, MD Linda Englund Ogge; Swedish government grants to researchers in public health service, ALFGBG-2863, MD Linda Englund Ogge; Swedish government grants to researchers in public health service, ALFGBG-11522, MD Linda Englund Ogge; the Norwegian Ministry of Health and the Ministry of Education and Research, N01-ES-75558; NIH/NINDS, UO1 NS 047537-01; NIH/NINDS, UO1 NS 047537-06A1; Norwegian Research Council/FUGE, 151918/S10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; BINIENDA Z, 1989, AM J OBSTET GYNECOL, V160, P746, DOI 10.1016/S0002-9378(89)80073-0; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Carmichael SL, 2012, AM J PERINATOL; Carmichael SL, 2013, AM J PERINAT, V30, P579, DOI 10.1055/s-0032-1329686; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Dahl LB, 2000, ACTA OBSTET GYN SCAN, V79, P1075, DOI 10.1034/j.1600-0412.2000.0790121075.x; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166; Englund-Ogge L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1446; Englund-Ogge L, 2012, AM J CLIN NUTR, V96, P552, DOI 10.3945/ajcn.111.031567; Farshchi HR, 2004, EUR J CLIN NUTR, V58, P1071, DOI 10.1038/sj.ejcn.1601935; Hillesund ER, 2014, EUR J EPIDEMIOL, V29, P753, DOI 10.1007/s10654-014-9948-6; Holst RM, 2005, ACTA OBSTET GYN SCAN, V84, P551, DOI 10.1111/j.0001-6349.2005.00708.x; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jolliffe I. T, PRINCIPAL COMPONENT, Vsecond; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; KAPLAN M, 1983, JAMA-J AM MED ASSOC, V250, P1317, DOI 10.1001/jama.250.10.1317; Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38; Krentz AJ, 2013, DIABETIC MED, V30, P535, DOI 10.1111/dme.12063; Kulovitz MG, 2014, NUTRITION, V30, P386, DOI 10.1016/j.nut.2013.08.009; Lautt W Wayne, 2007, Ther Clin Risk Manag, V3, P761; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Matthan NR, 2016, AM J CLIN NUTR, V104, P1004, DOI 10.3945/ajcn.116.137208; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Monzavi R, 2006, PEDIATRICS, V117, pE1111, DOI 10.1542/peds.2005-1532; Moreli JB, 2015, DIABETES RES CLIN PR, V107, P362, DOI 10.1016/j.diabres.2015.01.005; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Morrens A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0958-0; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P2915, DOI 10.3109/14767058.2015.1112372; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordiska ministerradet NMs, 2004, NORD NUTR REC 2004 I; Overby NC, 2013, FOOD NUTR RES, P57; Owe KM, 2012, MED SCI SPORT EXER, V44, P1067, DOI 10.1249/MSS.0b013e3182442fc9; Rhodes ET, 2010, AM J CLIN NUTR, V92, P1306, DOI 10.3945/ajcn.2010.30130; RIMESTAD AH, 2001, NORWEGIAN FOOD COMPO; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Scifres C, 2015, OBSTET GYNECOL, V126, P316, DOI 10.1097/AOG.0000000000000928; Sheard NF, 2004, DIABETES CARE, V27, P2266, DOI 10.2337/diacare.27.9.2266; Siega-Riz AM, 2001, AM J EPIDEMIOL, V153, P647, DOI 10.1093/aje/153.7.647; Silver M, 1982, J Reprod Fertil Suppl, V32, P511; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Venn BJ, 2007, EUR J CLIN NUTR, V61, pS122, DOI 10.1038/sj.ejcn.1602942; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolever TMS, 2013, EUR J CLIN NUTR, V67, P522, DOI 10.1038/ejcn.2013.27; Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112; Yuan Wei, 2010, BMC Res Notes, V3, P119, DOI 10.1186/1756-0500-3-119	58	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172896	10.1371/journal.pone.0172896	http://dx.doi.org/10.1371/journal.pone.0172896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249018	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500062
J	Horibe, R; Hirohashi, Y; Asano, T; Mariya, T; Suzuki, T; Takaya, A; Saijo, H; Shionoya, Y; Kubo, T; Nakatsugawa, M; Kanaseki, T; Tsukahara, T; Watanabe, K; Atsuyama, E; Toji, S; Hirano, H; Hasegawa, T; Takahashi, H; Sato, N; Torigoe, T				Horibe, Ryota; Hirohashi, Yoshihiko; Asano, Takuya; Mariya, Tasuku; Suzuki, Takeshi; Takaya, Akari; Saijo, Hiroshi; Shionoya, Yosuke; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Watanabe, Kazue; Atsuyama, Eri; Toji, Shingo; Hirano, Hiroshi; Hasegawa, Tadashi; Takahashi, Hiroki; Sato, Noriyuki; Torigoe, Toshihiko			Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; GENE-EXPRESSION; T-LYMPHOCYTES; THERAPIES; ANTIGEN; PROTEIN; MARKER; DOCETAXEL; NIVOLUMAB; ABILITY	Lung cancer is one of the most common malignancies with a high rate of mortality. Lung cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) play major role in resistance to treatments, recurrence and distant metastasis and eradication of CSCs/CICs is crucial to improve recent therapy. Cytotoxic T lymphocytes (CTLs) are major effectors of cancer immunotherapy, and CTLs recognize antigenic peptides derived from antigens that are presented by major histocompatibility complex (MHC) class I molecules. In this study, we analyzed the potency of a cancer-testis (CT) antigen, brother of the regulator of the imprinted site variant subfamily 6 (BORIS sf6), in lung CSC/CIC immunotherapy. BORIS sf6 mRNA was expressed in lung carcinoma cells (9/19), especially in sphere-cultured lung cancer stem-like cells, and in primary lung carcinoma tissues (4/9) by RT-PCR. Immunohistochemical staining using BORIS sf6-specific antibody revealed that high expression of BORIS sf6 is related to poorer prognosis. CTLs could be induced by using a human leukocyte antigen, (HLA)-A2 restricted antigenic peptide (BORIS C34_24(9)), from all of 3 HLA-A2-positive individuals, and CTL clone cells specific for BORIS C34_24(9) peptide could recognize BORIS sf6-positive, HLA-A2-positive lung carcinoma cells. These results indicate that BORIS sf6 is a novel target of lung cancer immunotherapy that might be useful for targeting treatment-resistant lung cancer stem-like cells.	[Horibe, Ryota; Hirohashi, Yoshihiko; Asano, Takuya; Mariya, Tasuku; Takaya, Akari; Saijo, Hiroshi; Shionoya, Yosuke; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Watanabe, Kazue; Sato, Noriyuki; Torigoe, Toshihiko] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Horibe, Ryota; Saijo, Hiroshi; Shionoya, Yosuke; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Resp Med & Allergol, Sapporo, Hokkaido, Japan; [Asano, Takuya; Mariya, Tasuku] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Suzuki, Takeshi] Sapporo Med Univ, Sch Med, Dept Biol, Sapporo, Hokkaido, Japan; [Watanabe, Kazue; Atsuyama, Eri; Toji, Shingo] MED & BIOL LABS CO LTD, Nagoya, Aichi, Japan; [Hirano, Hiroshi; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Torigoe, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022	Torigoe, Toshihiko/0000-0002-9463-5917; Kanaseki, Takayuki/0000-0001-7294-6880	Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labor Sciences Research Grants; Ono Cancer Research Fund; Suharakinenzaidan Co., Ltd.; Northern Advancement Center for Science & Technology of Hokkaido Japan; Japan Agency for Medical Research and Development; AMED; MEDICAL and BIOLOGICAL LABORATORIES CO., LTD.; MEDICAL and BIOLOGICAL LABORATORIES CO., LTD	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ono Cancer Research Fund(Ono Cancer Research Fund); Suharakinenzaidan Co., Ltd.; Northern Advancement Center for Science & Technology of Hokkaido Japan; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); AMED; MEDICAL and BIOLOGICAL LABORATORIES CO., LTD.; MEDICAL and BIOLOGICAL LABORATORIES CO., LTD	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS), Health and Labor Sciences Research Grants, a grant-in-aid of Ono Cancer Research Fund (to TTo), Suharakinenzaidan Co., Ltd. (to YH), Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to YH and TTo) and the project for development of innovative research on cancer therapeutics from Japan Agency for Medical Research and Development, AMED and MEDICAL and BIOLOGICAL LABORATORIES CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEDICAL and BIOLOGICAL LABORATORIES CO., LTD provided support in the form of salaries for authors KW, EA and ST, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Asano T, 2016, ONCOTARGET; Boolell V, 2015, CANCERS, V7, P1815, DOI 10.3390/cancers7030864; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Cuffel C, 2011, INT J CANCER, V128, P2625, DOI 10.1002/ijc.25607; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Hashida S, 2015, CANCER SCI, V106, P1377, DOI 10.1111/cas.12749; HIRASAWA M, 1994, BRIT J CANCER, V70, P466, DOI 10.1038/bjc.1994.329; Hirohashi Y, 2016, CANCER SCI, V107, P12, DOI 10.1111/cas.12830; Hirohashi Y, 2010, EXP MOL PATHOL, V88, P128, DOI 10.1016/j.yexmp.2009.09.021; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hoivik EA, 2014, ONCOTARGET, V5, P1052, DOI 10.18632/oncotarget.1697; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; INOUE Y, 1990, JPN J CANCER RES, V81, P1012, DOI 10.1111/j.1349-7006.1990.tb03339.x; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Morita R, 2014, CANCER SCI, V105, P389, DOI 10.1111/cas.12362; Morita R, 2014, METHODS MOL BIOL, V1139, P345, DOI 10.1007/978-1-4939-0345-0_28; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2009, CANCER SCI, V100, P1485, DOI 10.1111/j.1349-7006.2009.01187.x; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Okabayashi K, 2012, CANCER SCI, V103, P1617, DOI 10.1111/j.1349-7006.2012.02355.x; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Freitas MRP, 2013, ONCOTARGET, V4, P636, DOI 10.18632/oncotarget.950; Qiu XF, 2012, CANCER LETT, V323, P161, DOI 10.1016/j.canlet.2012.04.004; Renaud S, 2011, NUCLEIC ACIDS RES, V39, P862, DOI 10.1093/nar/gkq827; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Saijo H, 2016, ONCOTARGET; Shapiro M, 2013, CHEST, V144, P1615, DOI 10.1378/chest.12-3069; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun FF, 2015, INT J CLIN EXP PATHO, V8, P6287; Takahashi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069095; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Yamada R, 2013, TISSUE ANTIGENS; Yasuda K, 2014, LAB INVESTIGATION J; Zampieri M, 2014, BBA-GENE REGUL MECH, V1839, P813, DOI 10.1016/j.bbagrm.2014.06.017; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171460	10.1371/journal.pone.0171460	http://dx.doi.org/10.1371/journal.pone.0171460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248963	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500014
J	Chen, CH; Lu, HI; Wang, YM; Chen, YH; Lo, CM; Huang, WT; Li, SH				Chen, Chang-Han; Lu, Hung-I; Wang, Yu-Ming; Chen, Yen-Hao; Lo, Chien-Ming; Huang, Wan-Ting; Li, Shau-Hsuan			Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma	PLOS ONE			English	Article							EXPRESSION; P53; CARCINOGENESIS; ARECOLINE; ALCOHOL; HABIT; RISK	Objective Areca nut chewing is carcinogenic to humans. However, little is known about the impact of areca nut chewing on esophageal squamous cell carcinoma (ESCC). Methods We retrospectively reviewed 286 ESCC patients who received surgery or preoperative chemoradiotherapy followed by surgery at our institution. Background characteristics including areca nut chewing history were analyzed. The 4-nitroquinoline 1-oxide (4-NQO)-induced murine ESCC model was used to test the impact of arecoline, a main constituent of areca nut, on ESCC. Results Compared to patients without areca nut chewing history, patients with areca nut chewing history had overall a younger age of onset (Mean age: 56.75 versus 52.68 yrs, P<0.001) and significantly worse overall survival than those without areca nut chewing history (P = 0.026). Among patients who received surgery, the overall survival rates were not significantly different between those with or without areca nut chewing history. Among patients who received preoperative chemoradiotherapy followed by surgery, those with areca nut chewing history had a significantly lower pathologic complete response rate (P = 0.002) and lower overall survival rate (P = 0.002) than those without. In the murine ESCC model, the incidence of esophageal invasive squamous cell carcinoma was 40% in mice exposed to concomitant 4-NQO and arecoline treatment for 8 weeks and 6% in mice exposed to 4-NQO only for 8 weeks (P = 0.037). Conclusions Our results indicate that areca nut chewing history is significantly associated with younger age of onset, poor response to chemoradiotherapy, and shorter overall survival in ESCC patients. Arecoline, a main constituent of areca nut, accelerates esophageal tumorigenesis in the 4-NQO-induced murine ESCC model.	[Chen, Chang-Han] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Chen, Chang-Han] Natl Chi Nan Univ, Dept Appl Chem, Nantou 54561, Taiwan; [Chen, Chang-Han] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou 54561, Taiwan; [Lu, Hung-I; Lo, Chien-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Kaohsiung, Taiwan; [Lu, Hung-I; Wang, Yu-Ming; Chen, Yen-Hao; Lo, Chien-Ming; Huang, Wan-Ting; Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Yu-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Huang, Wan-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; National Chi Nan University; National Chi Nan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Li, SH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	lee.a0928@msa.hinet.net		Wang, Yu-Ming/0000-0002-2441-7551	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-182A-069-MY3, MOST 105-2320-B-182A-016]; Chang Gung Memorial Hospital [CMRPG8E1531-2, CMRPG8B1263]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-182A-069-MY3 to SH Li; MOST 105-2320-B-182A-016 to CH Chen) and Chang Gung Memorial Hospital (CMRPG8B1263 and CMRPG8E1531-2 to SH Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, CANCER CAUSE CONTROL, V24, P257, DOI 10.1007/s10552-012-0113-9; [Anonymous], 2004, IARC MONOGRAPHS EVAL, V85, P1; Chang NW, 2010, CHEM-BIOL INTERACT, V183, P231, DOI 10.1016/j.cbi.2009.10.005; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chung CS, 2010, J FORMOS MED ASSOC, V109, P408, DOI 10.1016/S0929-6646(10)60072-1; Edge S., 2010, AJCC CANC STAGING MA, V7th; Goan YG, 2005, CANCER SCI, V96, P758, DOI 10.1111/j.1349-7006.2005.00115.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Li SH, 2012, EUR J CARDIOTHORAC S; Li SH, 2015, SURGERY, V157, P570, DOI 10.1016/j.surg.2014.10.014; Li SH, 2012, J THORAC CARDIOV SUR, V144, P1352, DOI 10.1016/j.jtcvs.2012.06.049; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025347; Makino T, 2010, ANN SURG ONCOL, V17, P804, DOI 10.1245/s10434-009-0786-9; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Tsai YS, 2008, TOXICOLOGY, V249, P230, DOI 10.1016/j.tox.2008.05.007; Wu IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055834; Zhang SS, 2013, ANN SURG ONCOL, V20, P2419, DOI 10.1245/s10434-012-2859-4	21	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172752	10.1371/journal.pone.0172752	http://dx.doi.org/10.1371/journal.pone.0172752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245263	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200030
J	Hu, Y; Hegde, V; Johansen, D; Loftin, AH; Dworsky, E; Zoller, SD; Park, HY; Hamad, CD; Nelson, GE; Francis, KP; Scaduto, A; Bernthal, NM				Hu, Yan; Hegde, Vishal; Johansen, Daniel; Loftin, Amanda H.; Dworsky, Erik; Zoller, Stephen D.; Park, Howard Y.; Hamad, Christopher D.; Nelson, George E.; Francis, Kevin P.; Scaduto, Anthony; Bernthal, Nicholas M.			Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection	PLOS ONE			English	Article							IN-VITRO; BIOFILM INFECTION; WOUND-INFECTION; MURINE MODEL; RISK-FACTORS; RIFAMPIN; VANCOMYCIN; EFFICACY; INSTRUMENTATION; EPIDERMIDIS	Background Management of spine implant infections (SII) are challenging. Explantation of infected spinal hardware can destabilize the spine, but retention can lead to cord compromise and biofilm formation, complicating management. While vancomycin monotherapy is commonly used, in vitro studies have shown reduced efficacy against biofilm compared to combination therapy with rifampin. Using an established in vivo mouse model of SII, we aim to evaluate whether combination therapy has increased efficacy compared to both vancomycin alone and infected controls. Methods An L-shaped, Kirschner-wire was transfixed into the L4 spinous process of 12-week-old C57BL/6 mice, and inoculated with bioluminescent Staphylococcus aureus. Mice were randomized into a vancomycin group, a combination group with vancomycin plus rifampin, or a control group receiving saline. Treatment began on post-operative day (POD) 7 and continued through POD 14. In vivo imaging was performed to monitor bioluminescence for 35 days. Colony-forming units (CFUs) were cultured on POD 35. Results Bioluminescence peaked around POD 7 for all groups. The combination group had a 10-fold decrease in signal by POD 10. The vancomycin and control groups reached similar levels on POD 17 and 21, respectively. On POD 25 the combination group dropped below baseline, but rebounded to the same level as the other groups, demonstrating a biofilm-associated infection by POD 35. Quantification of CFUs on POD 35 confirmed an ongoing infection in all three groups. Conclusions Although both therapies were initially effective, they were not able to eliminate implant biofilm bacteria, resulting in a rebound infection after antibiotic cessation. This model shows, for the first time, why histologic-based, static assessments of antimicrobials can be misleading, and the importance of longitudinal tracking of infection. Future studies can use this model to test combinations of antibiotic therapies to see if they are more effective in eliminating biofilm prior to human trials.	[Hu, Yan; Hegde, Vishal; Johansen, Daniel; Loftin, Amanda H.; Dworsky, Erik; Zoller, Stephen D.; Park, Howard Y.; Hamad, Christopher D.; Francis, Kevin P.; Scaduto, Anthony; Bernthal, Nicholas M.] Univ Calif Los Angeles, Dept Orthopaed Surg, David Geffen Sch Med, Santa Monica, CA 90404 USA; [Nelson, George E.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, Nashville, TN USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University	Bernthal, NM (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, David Geffen Sch Med, Santa Monica, CA 90404 USA.	NBernthal@mednet.ucla.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019; Hamad, Christopher/GQH-4790-2022; Hegde, Vishal/AAV-8074-2020	Hamblin, Michael R/0000-0001-6431-4605; Hamad, Christopher/0000-0002-8896-9857; Hegde, Vishal/0000-0001-6665-0442; Loftin, Amanda/0000-0002-6913-861X; Nelson, George/0000-0003-2701-1917; Hu, Yan/0000-0003-0451-4642	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [5K08AR069112-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033, K08AR069112] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number 5K08AR069112-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY DM, 1995, J SPINAL DISORD, V8, P278, DOI 10.1097/00002517-199508040-00003; ACKERMAN BH, 1988, DRUG INTEL CLIN PHAR, V22, P300, DOI 10.1177/106002808802200404; Ahmed R, 2012, J SPINAL DISORD TECH, V25, P299, DOI 10.1097/BSD.0b013e31821fbf72; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Brand AM, 2010, LETT APPL MICROBIOL, V51, P645, DOI 10.1111/j.1472-765X.2010.02948.x; CALVORI C, 1965, NATURE, V207, P417, DOI 10.1038/207417a0; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chahoud J, 2014, FRONT MED-LAUSANNE, V1, DOI 10.3389/fmed.2014.00007; Crandon JL, 2010, ANTIMICROB AGENTS CH, V54, P5115, DOI 10.1128/AAC.00062-10; Croes S, 2010, ANTIMICROB AGENTS CH, V54, P3907, DOI 10.1128/AAC.01811-09; DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522; Dworsky E, 2016, J ORTHOP RES; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Gerometta A, 2012, INT ORTHOP, V36, P457, DOI 10.1007/s00264-011-1426-0; Guiboux JP, 1998, SPINE, V23, P653, DOI 10.1097/00007632-199803150-00002; HEALY DP, 1987, ANTIMICROB AGENTS CH, V31, P393, DOI 10.1128/AAC.31.3.393; Hegde SS, 2010, J ANTIMICROB CHEMOTH, V65, P725, DOI 10.1093/jac/dkq028; Hegde V, 2012, WORLD J ORTHOP, V3, P182, DOI 10.5312/wjo.v3.i11.182; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; John AK, 2009, ANTIMICROB AGENTS CH, V53, P2719, DOI 10.1128/AAC.00047-09; Kadurugamuwa JL, 2004, ANTIMICROB AGENTS CH, V48, P2283, DOI 10.1128/AAC.48.6.2283-2287.2004; Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003; Kim M-H, 2009, AM J PHYSIOL-CELL PH, V296, P56; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Knudsen JD, 1997, ANTIMICROB AGENTS CH, V41, P1910, DOI 10.1128/AAC.41.9.1910; Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975; Liu C, 2011, CLINICAL INFECTIOUS; LOBO MC, 1972, ANTIMICROB AGENTS CH, V2, P195, DOI 10.1128/AAC.2.3.195; MANDELL GL, 1972, J INFECT DIS, V125, P486, DOI 10.1093/infdis/125.5.486; MANDELL GL, 1980, ANTIMICROB AGENTS CH, V17, P658, DOI 10.1128/AAC.17.4.658; Monzon M, 2001, J ANTIMICROB CHEMOTH, V48, P793, DOI 10.1093/jac/48.6.793; Niska JA, 2013, ANTIMICROB AGENTS CH, V57, P5080, DOI 10.1128/AAC.00702-13; Ofluoglu EA, 2007, ARCH ORTHOP TRAUM SU, V127, P391, DOI 10.1007/s00402-007-0365-0; Olsen MA, 2003, J NEUROSURG, V98, P149, DOI 10.3171/spi.2003.98.2.0149; Pappou IP, 2006, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.0000203446.06028.b5; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Picada R, 2000, J SPINAL DISORD, V13, P42, DOI 10.1097/00002517-200002000-00009; Poelstra KA, 2000, SPINE, V25, P406, DOI 10.1097/00007632-200002150-00003; Post V, 2016, J ORTHOP RES; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Reyes N, 2005, ANTIMICROB AGENTS CH, V49, P4344, DOI 10.1128/AAC.49.10.4344-4346.2005; Reyes N, 2006, J ANTIMICROB CHEMOTH, V58, P462, DOI 10.1093/jac/dkl222; Rose WE, 2009, J ANTIMICROB CHEMOTH, V63, P485, DOI 10.1093/jac/dkn513; Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006; Sakoulas G, 2003, ANTIMICROB AGENTS CH, V47, P1714, DOI 10.1128/AAC.47.5.1714-1718.2003; Sierra-Hoffman M, 2010, SOUTH MED J, V103, P25, DOI 10.1097/SMJ.0b013e3181c4e00b; Sivasubramaniam V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009011; Smith JS, 2011, SPINE, V36, P556, DOI 10.1097/BRS.0b013e3181eadd41; Stavrakis AI, 2014, ANTIMICROB AGENTS CH, V58, P2377, DOI 10.1128/AAC.01943-13; Traba C, 2011, BIOFOULING, V27, P763, DOI 10.1080/08927014.2011.602188; van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184; Verdrengh M, 2004, MICROBES INFECT, V6, P1268, DOI 10.1016/j.micinf.2004.08.009; Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009; Zavasky DM, 1998, JAMA-J AM MED ASSOC, V279, P1575, DOI 10.1001/jama.279.19.1575; Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173019	10.1371/journal.pone.0173019	http://dx.doi.org/10.1371/journal.pone.0173019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245229	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200050
J	Romero-Sanchiz, P; Nogueira-Arjona, R; Garcia-Ruiz, A; Luciano, JV; Campayo, JG; Gili, M; Botella, C; Banos, R; Castro, A; Lopez Del Hoyo, Y; Ara, MAP; Modrego-Alarcon, M; Cleries, FM				Romero-Sanchiz, Pablo; Nogueira-Arjona, Raquel; Garcia-Ruiz, Antonio; Luciano, Juan V.; Garcia Campayo, Javier; Gili, Margalida; Botella, Cristina; Banos, Rosa; Castro, Adoracion; Lopez Del Hoyo, Yolanda; Perez Ara, Ma Angeles; Modrego-Alarcon, Marta; Mayoral Cleries, Fermin			Economic evaluation of a guided and unguided internet-based CBT intervention for major depression: Results from a multi-center, three-armed randomized controlled trial conducted in primary care	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; PSYCHOLOGICAL TREATMENTS; HEALTH-PROFESSIONALS; COST-EFFECTIVENESS; DISORDERS; EXPECTATIONS	Depression is one of the most common mental disorders and will become one of the leading causes of disability in the world. Internet-based CBT programs for depression have been classified as "well established" following the American Psychological Association criteria for empirically supported treatments. The aim of this study is to analyze the cost effectiveness at 12-month follow-up of the Internet-based CBT program "Smiling is fun" with (LITG) and without psychotherapist support (TSG) compared to usual care. The perspective used in our analysis is societal. A sample of 296 depressed patients (mean age of 43.04 years; 76% female; BDI-II mean score = 22.37) from primary care services in four Spanish regions were randomized in the RCT. The complete case and intention-to-treat (ITT) perspectives were used for the analyses. The results demonstrated that both Internet-based CBT interventions exhibited cost utility and cost effectiveness compared with a control group. The complete case analyses revealed an incremental cost- effectiveness ratio (ICER) of (sic)-169.50 and an incremental cost-utility ratio (ICUR) of (sic)-11389.66 for the TSG group and an ICER of (sic)-104.63 and an ICUR of (sic)-6380.86 for the LITG group. The ITT analyses found an ICER of (sic)-98.37 and an ICUR of (sic)- 5160.40 for the TSG group and an ICER of (sic)-9.91 and an ICUR of (sic)496.72 for the LITG group. In summary, the results of this study indicate that the two Internet-based CBT interventions are appropriate from both economic and clinical perspectives for depressed patients in the Spanish primary care system. These interventions not only help patients to improve clinically but also generate societal savings.	[Romero-Sanchiz, Pablo; Mayoral Cleries, Fermin] Reg Univ Hosp Carlos Haya, Inst Biomed Res Malaga IBIMA, Mental Hlth Clin Management Unit, Malaga, Spain; [Nogueira-Arjona, Raquel] Univ Malaga, Fac Psychol, Dept Personal Assessment & Psychol Treatments, Malaga, Spain; [Garcia-Ruiz, Antonio] Univ Malaga, Dept Pediat & Pharmacol, Fac Med, Chair Hlth Econ & Rational Drug Use, Malaga, Spain; [Luciano, Juan V.] Parc Sanitari St Joan de Deu, Teaching Res & Innovat Unit, St Boi De Llobregat, Spain; [Luciano, Juan V.; Garcia Campayo, Javier; Gili, Margalida; Castro, Adoracion; Lopez Del Hoyo, Yolanda; Perez Ara, Ma Angeles; Mayoral Cleries, Fermin] RedIAPP, Primary Care Prevent & Hlth Promot Res Network, Madrid, Spain; [Garcia Campayo, Javier; Lopez Del Hoyo, Yolanda] Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Garcia Campayo, Javier] Univ Hosp Miguel Servet, Zaragoza, Spain; [Gili, Margalida; Castro, Adoracion; Perez Ara, Ma Angeles] Univ Balearic Isl, IUNICS IDISPA, Palma De Mallorca, Spain; [Botella, Cristina] Univ Jaume 1, Castellon De La Plana, Spain; [Botella, Cristina; Banos, Rosa] Carlos III Hlth Inst, CIBER Physiopathol Obes & Nutr CB06 03, Madrid, Spain; [Banos, Rosa] Univ Valencia, Valencia, Spain; [Lopez Del Hoyo, Yolanda; Modrego-Alarcon, Marta] Univ Zaragoza, Zaragoza, Spain; [Modrego-Alarcon, Marta] Fdn Inst Hlth Res Aragon IIS Aragon, Zaragoza, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Miguel Servet University Hospital; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; Universitat Jaume I; University of Valencia; University of Zaragoza	Cleries, FM (corresponding author), Reg Univ Hosp Carlos Haya, Inst Biomed Res Malaga IBIMA, Mental Hlth Clin Management Unit, Malaga, Spain.; Cleries, FM (corresponding author), RedIAPP, Primary Care Prevent & Hlth Promot Res Network, Madrid, Spain.	fermin.mayoral.sspa@juntadeandalucia.es	Ruiz, Antonio J Garcia/U-3916-2019; Romero-Sanchiz, Pablo/B-8454-2011; Nogueira-Arjona, Raquel/B-8457-2011; Gili, Margalida/H-7680-2013; Luciano, Juan V/H-5585-2012; BAÑOS, ROSA MARIA/C-6077-2011; López del Hoyo, Yolanda/W-4602-2018; Ruiz, Antonio J Garcia/H-4930-2017; Botella, Cristina/F-9230-2010	Romero-Sanchiz, Pablo/0000-0002-3683-3835; Nogueira-Arjona, Raquel/0000-0002-5998-701X; Gili, Margalida/0000-0002-0535-6773; Luciano, Juan V/0000-0003-0750-1599; BAÑOS, ROSA MARIA/0000-0003-0626-7665; López del Hoyo, Yolanda/0000-0002-1690-4130; Ruiz, Antonio J Garcia/0000-0001-6423-6993; Botella, Cristina/0000-0001-8783-6959; Modrego, Marta/0000-0003-1575-7738; Mayoral-Cleries, Fermin/0000-0002-9710-9672	Institute de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness [PI10/01083]; Network for Prevention and Health Promotion in primary Care [RD12/0005]; GIBER Physiopathology Obesity and Nutrition grants from the Institute de Salud Carlos III of the Ministry of Economy and Competitiveness (Spain) [CB06/03]; European Regional Development Fund/European Social Fund; Institute de Salud Carlos III [CM13/00115, CP14/00087]	Institute de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness; Network for Prevention and Health Promotion in primary Care; GIBER Physiopathology Obesity and Nutrition grants from the Institute de Salud Carlos III of the Ministry of Economy and Competitiveness (Spain); European Regional Development Fund/European Social Fund; Institute de Salud Carlos III(Instituto de Salud Carlos III)	This study was financed by the Institute de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness with the PI10/01083 grant (Eficacia y coste-efectividad de un programa de psicoterapia asistida por ordenador para el tratamiento de la depresion mayor en atencion primaria: estudio controlado, randomizado y cualitativo). The project also received funding from the Network for Prevention and Health Promotion in primary Care (RD12/0005) and GIBER Physiopathology Obesity and Nutrition (CB06/03) grants from the Institute de Salud Carlos III of the Ministry of Economy and Competitiveness (Spain). Both grants are co funded by European Regional Development Fund/European Social Fund) "Investing in your future"). The first author (PRS) has a Rio Hortega contract awarded by the Institute de Salud Carlos III (CM13/00115). The fourth author (JVL) has a Miguel Servet contract awarded by the Institute de Salud Carlos III (CP14/00087). http://www.isciii.esi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Andersson G, 2016, ANNU REV CLIN PSYCHO, V12, P157, DOI 10.1146/annurev-clinpsy-021815-093006; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Aragones E, 2004, INT J PSYCHIAT MED, V34, P331, DOI 10.2190/N835-FDYX-2E2E-V8XM; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Beck AT, 1996, PSYCHOL ASSESS; Botella Arbona C, 2016, TRATAMIENTO PSICOLOG; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Churchill R., 2002, HEALTH TECHNOL ASSES, V5, P1; Cuijpers P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021274; Donker T, 2015, PSYCHOL MED, V1, P1; Ferrando L, 1998, COMMUNICATION; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gerhards SAH, 2011, VALUE HEALTH, V14, P732, DOI 10.1016/j.jval.2010.12.004; Haro JM, 2006, MED CLIN BARC; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hollinghurst S, 2010, BRIT J PSYCHIAT, V197, P297, DOI 10.1192/bjp.bp.109.073080; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Karyotaki E, 2016, EPIDEMIOL PSYCHIAT S, V23, P1; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lopez del Hoyo Y, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-21; Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Montero-Marin J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5695; Montero-Marin J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3985; Montero-Marin J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-64; National Institute for Health and Clinical Excellence (NICE), 2009, CG90 NICE; Pares-Badell O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105471; Perdig?n AL., 2003, CLIN SALUD, V14, P249, DOI DOI 10.1016/S1130-5474(14)70025-8; Phillips R, 2014, PSYCHOL MED, V44, P741, DOI 10.1017/S0033291713001323; Raue PJ, 2009, PSYCHIAT SERV, V60, P337, DOI 10.1176/appi.ps.60.3.337; Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004; Rubio-Valera M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0448-3; Rubio-Valera M, 2012, FAM PRACT, V29, P154, DOI 10.1093/fampra/cmr078; Sanz J, 2005, CLIN SALUD, V16, P121; Serrano-Blanco A, 2010, SOC PSYCH PSYCH EPID, V45, P201, DOI 10.1007/s00127-009-0056-y; Sobocki P, 2007, INT SOC PHARMACOECON, V10, P153; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Vallejo-Torres L, 2015, VALOR MONETARIO VIDA; Vallejo-Torres L, 2016, VALUE HEALTH, V19, P558, DOI 10.1016/j.jval.2016.02.020; Vazquez-Barquero JL., 1997, ARCH NEUROBIOLOGIA, V60, P171	45	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172741	10.1371/journal.pone.0172741	http://dx.doi.org/10.1371/journal.pone.0172741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241025	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400035
J	Saran, I; Cohen, J				Saran, Indrani; Cohen, Jessica			Disparities between malaria infection and treatment rates: Evidence from a cross-sectional analysis of households in Uganda	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; COMBINATION THERAPIES; CASE DEFINITIONS; FEVER; TRANSMISSION; REDUCTION; CHILDREN; DETERMINANTS; PROPORTION; MICROSCOPY	Background In Sub-Saharan Africa, both under-treatment and over-treatment of malaria are common since illnesses are often diagnosed and treated on the basis of symptoms. We investigate whether malaria treatment rates among febrile individuals correspond to observed patterns of malaria infection by age and by local prevalence. Methods and findings We use data on treatment of febrile illnesses from a household survey that was conducted between March and May 2012 in 92 villages in six districts in Eastern Uganda. All household members were also tested for malaria using a rapid diagnostic test. We show that both the age of the febrile individual and the village prevalence rate are strongly associated with the odds that a febrile patient was infected with malaria, but not with the odds of ACT treatment. Compared to individuals who were aged 15 or above, febrile individuals aged 5-14 had 3.21 times the odds of testing positive for malaria (95% CI: [2.36 4.37], P<0.001), and febrile individuals who were under age 5 had 2.66 times the odds of testing positive for malaria (95% CI: [1.99 3.56], P<0.001). However, ACT treatment rates for febrile illnesses were not significantly higher for either children ages 5-14 (Unadjusted OR: 1.19, 95% CI: [0.88 1.62], P = 0.255) or children under the age of 5 (Unadjusted OR: 1.24, 95% CI: [0.92 1.68], P = 0.154). A one standard deviation increase in the village malaria prevalence rate was associated with a 2.03 times higher odds that a febrile individual under the age of five tested positive for malaria (95% CI: [1.63 2.54], p<0.001), but was not significantly associated with the odds of ACT treatment (Un-adjusted OR: 0.83, 95% CI: [0.66 1.05], P = 0.113). We present some evidence that this discrepancy may be because caregivers do not suspect a higher likelihood of malaria infection, conditional on fever, in young children or in high-prevalence villages. Conclusion Our findings suggest that households have significant mis-perceptions about malaria likelihood that may contribute to the under-treatment of malaria. Policies are needed to encourage caregivers to seek immediate diagnostic testing and treatment for febrile illnesses, particularly among young children.	[Saran, Indrani] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Cohen, Jessica] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Duke University; Harvard University; Harvard T.H. Chan School of Public Health	Saran, I (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	ins289@mail.harvard.edu			Bill and Melinda Gates Foundation; Clinton Health Access Initiative	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Clinton Health Access Initiative	The Bill and Melinda Gates Foundation and Clinton Health Access Initiative funded the collection of data used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, UG MAL IND SURV 2009; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Cohen J, 2015, B WORLD HEALTH ORGAN, V93, P142, DOI 10.2471/BLT.14.142489; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Cohen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070713; Cohen JM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S6; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Ghai RR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1502-4; Griffin JT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2657; Griffin JT, 2014, NATURE COMMUNICATION, V5; Hensen B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-218; Kabaghe AN, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1218-5; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Korenromp E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1461-9; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Odaga J, 2014, COCHRANE COLLABORATI; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Peak CM, 2015, AM J TROP MED HYG, V92, P811, DOI 10.4269/ajtmh.14-0461; Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Shah JA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0844-7; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; StataCorp, 2021, STATA STAT SOFTWARE; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Uganda Bureau of Statistics (UBOS) and ICF International, 2015, UG MAL IND SURV 2014; Vialle-Valentin CE, 2015, J PHARM POLICY PRACT, V8; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, WORLD MAL REP 2015; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, GUID TREATM MAL, Vthird	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171835	10.1371/journal.pone.0171835	http://dx.doi.org/10.1371/journal.pone.0171835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241041	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400009
J	Arikan, F; Martinez-Valverde, T; Sanhez-Guerrero, A; Campos, M; Esteves, M; Gandara, D; Torne, R; Castro, L; Dalmau, A; Tibau, J; Sahuquillo, J				Arikan, Fuat; Martinez-Valverde, Tamara; Sanchez-Guerrero, Angela; Campos, Mireia; Esteves, Marielle; Gandara, Dario; Torne, Ramon; Castro, Lidia; Dalmau, Antoni; Tibau, Joan; Sahuquillo, Juan			Malignant infarction of the middle cerebral artery in a porcine model. A pilot study	PLOS ONE			English	Article							SULFONYLUREA RECEPTOR 1; ISCHEMIC-STROKE; WHITE-MATTER; BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; INTERSTITIAL GLYCEROL; TISSUE OXYGENATION; HEMISPHERIC STROKE; GLOBAL BURDEN; OCCLUSION	Background and purpose Interspecies variability and poor clinical translation from rodent studies indicate that large gyrencephalic animal stroke models are urgently needed. We present a proof-of-principle study describing an alternative animal model of malignant infarction of the middle cerebral artery (MCA) in the common pig and illustrate some of its potential applications. We report on metabolic patterns, ionic profile, brain partial pressure of oxygen (PtiO(2)), expression of sulfonylurea receptor 1 (SUR1), and the transient receptor potential melastatin 4 (TRPM4). Methods A 5-hour ischemic infarct of the MCA territory was performed in 5 2.5-to-3-month-old female hybrid pigs (Large White x Landrace) using a frontotemporal approach. The core and penumbra areas were intraoperatively monitored to determine the metabolic and ionic profiles. To determine the infarct volume, 2,3,5-triphenyltetrazolium chloride staining and immunohistochemistry analysis was performed to determine SUR1 and TRPM4 expression. Results PtiO(2) monitoring showed an abrupt reduction in values close to 0 mmHg after MCA occlusion in the core area. Hourly cerebral microdialysis showed that the infarcted tissue was characterized by reduced concentrations of glucose (0.03 mM) and pyruvate (0.003 mM) and increases in lactate levels (8.87mM), lactate-pyruvate ratio (4202), glycerol levels (588 mu M), and potassium concentration (27.9 mmol/L). Immunohistochemical analysis showed increased expression of SUR1-TRPM4 channels. Conclusions The aim of the present proof-of-principle study was to document the feasibility of a large animal model of malignant MCA infarction by performing transcranial occlusion of the MCA in the common pig, as an alternative to lisencephalic animals. This model may be useful for detailed studies of cerebral ischemia mechanisms and the development of neuroprotective strategies.	[Arikan, Fuat; Gandara, Dario; Torne, Ramon; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Arikan, Fuat; Martinez-Valverde, Tamara; Sanchez-Guerrero, Angela; Torne, Ramon; Castro, Lidia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Campos, Mireia; Esteves, Marielle] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Expt Surg Unit, Barcelona, Spain; [Dalmau, Antoni; Tibau, Joan] IRTA, Anim Breeding & Genet Program, Monells, Girona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); IRTA	Arikan, F (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain.; Arikan, F (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.	arikan@neurotrauma.net	Arikan, Fuat/F-8900-2016; Torné, Ramon/ABI-3299-2020; Arikan, Fuat/GWZ-3694-2022; Castro, Lidia/J-3976-2017; Sahuquillo, Juan/B-3577-2008; Sabatini, Darío Fabián Gándara/AAB-6699-2019; Dalmau, Antoni/M-3745-2017	Arikan, Fuat/0000-0002-9459-0915; Torné, Ramon/0000-0001-7932-2528; Castro, Lidia/0000-0001-8513-7388; Sahuquillo, Juan/0000-0003-0713-5875; Sabatini, Darío Fabián Gándara/0000-0003-1303-9847; Dalmau, Antoni/0000-0003-2248-6796; Martinez-Valverde, Tamara/0000-0002-9529-8705	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion Sanitaria (Institute de Salud Carlos III) [FIS PI11/00700]; European Regional Development Fund (ERDF); Institute de Salud Carlos III [FI12/00074]	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Fondo de Investigacion Sanitaria (Institute de Salud Carlos III)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Institute de Salud Carlos III(Instituto de Salud Carlos III)	The Neurotraumatology and Neurosurgery Research Unit is supported by a grant from the Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (SGR 2014-844). This work has been supported in part by the Fondo de Investigacion Sanitaria (Institute de Salud Carlos III) with grant FIS PI11/00700, which was co-financed by the European Regional Development Fund (ERDF) and awarded to Dr. J. Sahuquillo. A. Sanchez-Guerrero is the recipient of a personal pre-doctoral grant from the Institute de Salud Carlos III (grant number grant number FI12/00074).	Arikan F, 2008, NEUROCIRUGIA, V19, P113; Arikan F, 2014, J NEUROSURG ANESTH, V26, P328, DOI 10.1097/ANA.0000000000000033; Barone R, 2004, ANATOMIE COMP MAMMIF, V6; Bennett DA, 2014, GLOB HEART, V9, P107, DOI 10.1016/j.gheart.2014.01.001; Bollen B JA, 2010, THE LAB SWINE; Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Engelhorn T, 1999, STROKE, V30, P1456, DOI 10.1161/01.STR.30.7.1456; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; FRAHM HD, 1982, J HIRNFORSCH, V23, P375; GILLILAN LA, 1976, AM J ANAT, V146, P237, DOI 10.1002/aja.1001460303; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123; Kuroiwa T, 2003, NEUROPATHOLOGY, V23, P79, DOI 10.1046/j.1440-1789.2003.00479.x; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; MACRAE IM, 1992, BRIT J CLIN PHARMACO, V34, P302; Martinez-Valverde T., 2016, J NEUROTRAUMA; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P7, DOI 10.1089/neu.2014.3473; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Morancho A, 2012, NEUROPATH APPL NEURO, V38, P617, DOI 10.1111/j.1365-2990.2012.01252.x; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Russell WMS BR, 1992, PRINCIPLES HUMANE EX; Sahuquillo J, 2002, ACT NEUR S, V81, P303; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Sakoh M, 2001, J NEUROSURG, V95, P450, DOI 10.3171/jns.2001.95.3.0450; Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2011, CURR TREAT OPTION NE, V13, P217, DOI 10.1007/s11940-010-0110-9; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Stokum JA, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0239-6; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003; Watanabe H, 2007, J NEUROSCI METH, V160, P109, DOI 10.1016/j.jneumeth.2006.08.016; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu SY, 2013, MED SCI MONIT BASIC, V19, P37, DOI 10.12659/MSMBR.883750; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	47	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172637	10.1371/journal.pone.0172637	http://dx.doi.org/10.1371/journal.pone.0172637			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235044	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200106
J	Faria, M; Matos, P; Pereira, T; Cabrera, R; Cardoso, BA; Bugalho, MJ; Silva, AL				Faria, Marcia; Matos, Paulo; Pereira, Teresa; Cabrera, Rafael; Cardoso, Bruno A.; Bugalho, Maria Joao; Silva, Ana Luisa			RAC1b overexpression stimulates proliferation and NF-kappa B-mediated anti-apoptotic signaling in thyroid cancer cells	PLOS ONE			English	Article							SPLICED RAC1B; RHO-FAMILY; EXPRESSION; PAPILLARY; GTPASES; ACTIVATION; CARCINOMA; PATHWAYS; MUTATION	Overexpression of tumor-associated RAC1b has been recently highlighted as one of the most promising targets for therapeutic intervention in colon, breast, lung and pancreatic cancer. RAC1b is a hyperactive variant of the small GTPase RAC1 and has been recently shown to be overexpressed in a subset of papillary thyroid carcinomas associated with unfavorable outcome. Using the K1 PTC derived cell line as an in vitro model, we observed that both RAC1 and RAC1b were able to induce a significant increase on NF-kB and cyclin D1 reporter activity. A clear p65 nuclear localization was found in cells transfected with RAC1b-WT, confirming NF-kB canonical pathway activation. Consistently, we observed a RAC1b-mediated decrease in I kappa B alpha (NF-kB inhibitor) protein levels. Moreover, we show that RAC1b overexpression stimulates G1/S progression and protects thyroid cells against induced apoptosis, the latter through a process involving the NF-kB pathway. Present data support previous findings suggesting an important role for RAC1b in the development of follicular cell-derived thyroid malignancies and point out NF-kB activation as one of the molecular mechanisms associated with the pro-tumorigenic advantage of RAC1b overexpression in thyroid carcinomas.	[Faria, Marcia; Cardoso, Bruno A.; Silva, Ana Luisa] Inst Portugues Oncol Lisboa Francisco Gentil EPE, Unidade Invest Patobiol Mol, Lisbon, Portugal; [Matos, Paulo] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Matos, Paulo] Inst Nacl Saude, Lisbon, Portugal; [Pereira, Teresa; Cabrera, Rafael] Inst Portugues Oncol Lisboa Francisco Gentil EPE, Serv Anat Patol, Lisbon, Portugal; [Bugalho, Maria Joao; Silva, Ana Luisa] Hosp Santa Maria, CHLN, Serv Endocrinol Diabet & Metab, Lisbon, Portugal; [Bugalho, Maria Joao; Silva, Ana Luisa] Univ Lisbon, Fac Med, ISAMB Inst Saude Ambiental, Lisbon, Portugal	BIOISI; Universidade de Lisboa; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa	Silva, AL (corresponding author), Inst Portugues Oncol Lisboa Francisco Gentil EPE, Unidade Invest Patobiol Mol, Lisbon, Portugal.; Silva, AL (corresponding author), Hosp Santa Maria, CHLN, Serv Endocrinol Diabet & Metab, Lisbon, Portugal.; Silva, AL (corresponding author), Univ Lisbon, Fac Med, ISAMB Inst Saude Ambiental, Lisbon, Portugal.	silva.r.analuisa@gmail.com	Bugalho, Maria João/AAF-5210-2020; Matos, Paulo/P-3012-2019; Matos, Paulo/F-5245-2012; Faria, Márcia C/U-7516-2017	Matos, Paulo/0000-0002-9379-9696; Matos, Paulo/0000-0002-9379-9696; Faria, Márcia C/0000-0002-6601-1138; Silva, Ana Luisa/0000-0002-4839-8279; Cardoso, Bruno/0000-0002-6521-7257				Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Bhaijee F, 2011, ENDOCR PATHOL, V22, P126, DOI 10.1007/s12022-011-9170-y; Bommarito A, 2011, ENDOCR-RELAT CANCER, V18, P669, DOI 10.1530/ERC-11-0076; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Faria M, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1972367; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Li XY, 2013, THYROID, V23, P209, DOI 10.1089/thy.2012.0237; Matos P, 2000, BIOCHEM BIOPH RES CO, V277, P741, DOI 10.1006/bbrc.2000.3743; Matos P, 2006, J BIOL CHEM, V281, P13724, DOI 10.1074/jbc.M513243200; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Raposo L, 2016, EUR J CANC PREV OFF; Romitti M, 2013, INT J ONCOL, V42, P19, DOI 10.3892/ijo.2012.1681; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silva AL, 2013, EUR J ENDOCRINOL, V168, P795, DOI 10.1530/EJE-12-0960; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yoo JY, 2016, SURG ONCOL CLIN N AM, V25, P41, DOI 10.1016/j.soc.2015.08.002	28	19	19	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172689	10.1371/journal.pone.0172689	http://dx.doi.org/10.1371/journal.pone.0172689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234980	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200117
J	Sanhueza, L; Melo, R; Montero, R; Maisey, K; Mendoza, L; Wilkens, M				Sanhueza, Loreto; Melo, Ricardo; Montero, Ruth; Maisey, Kevin; Mendoza, Leonora; Wilkens, Marcela			Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli	PLOS ONE			English	Article							IN-VITRO; ANTIBACTERIAL ACTIVITIES; BIOLOGICAL-ACTIVITY; DRUG-RESISTANCE; VITIS-VINIFERA; SEED EXTRACT; BETA-LACTAMS; BY-PRODUCTS; METHICILLIN; POTENTIATION	Synergy could be an effective strategy to potentiate and recover antibiotics nowadays useless in clinical treatments against multi-resistant bacteria. In this study, synergic interactions between antibiotics and grape pomace extract that contains high concentration of phenolic compounds were evaluated by the checkerboard method in clinical isolates of Staphylococcus aureus and Escherichia coli. To define which component of the extract is responsible for the synergic effect, phenolic compounds were identified by RP-HPLC and their relative abundance was determined. Combinations of extract with pure compounds identified there in were also evaluated. Results showed that the grape pomace extract combined with representatives of different classes of antibiotics as beta-lactam, quinolone, fluoroquinolone, tetracycline and amphenicol act in synergy in all S. aureus and E. coli strains tested with FICI values varying from 0.031 to 0.155. The minimal inhibitory concentration (MIC) was reduced 4 to 75 times. The most abundant phenolic compounds identified in the extract were quercetin, gallic acid, protocatechuic acid and luteolin with relative abundance of 26.3, 24.4, 16.7 and 11.4%, respectively. All combinations of the extract with the components also showed synergy with FICI values varying from 0.031 to 0.5 and MIC reductions of 4 to 125 times with both bacteria strains. The relative abundance of phenolic compounds has no correlation with the obtained synergic effect, suggesting that the mechanism by which the synergic effect occurs is by a multi-objective action. It was also shown that combinations of grape pomace extract with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic effect was observed (47 mu g/mL of extract and 0.6-375 mu g/mL antibiotics). Therefore, these combinations are good candidates for testing in animal models in order to enhance the effect of antibiotics of different classes and thus restore the currently unused clinical antibiotics due to the phenomenon of resistance. Moreover, the use of grape pomace is a good and low-cost alternative for this purpose being a waste residue of the wine industry.	[Sanhueza, Loreto; Melo, Ricardo] Univ Mayor, Fac Ciencias, Nucleo Quim & Bioquim, Santiago, Chile; [Montero, Ruth; Maisey, Kevin] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Inmunol Comparat, Santiago, Chile; [Mendoza, Leonora] Univ Santiago Chile, Fac Quim & Biol, Dept Quim Mat, Lab Micol, Santiago, Chile; [Wilkens, Marcela] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile	Universidad Mayor; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de Santiago de Chile	Wilkens, M (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile.	marcela.wilkens@usach.cl	Maisey, Kevin/AAP-2886-2021; Wilkens, Marcela/G-5928-2019	Maisey, Kevin/0000-0002-7423-6329; Montero, Ruth Tamara/0000-0002-3019-1800	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130389]; Direccion de Investigacion en Ciencia y Tecnologia (DICYT-USACH); Comision Nacional de Ciencia y Tecnologia (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion en Ciencia y Tecnologia (DICYT-USACH); Comision Nacional de Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was supported financially under Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) project 1130389 and by the Direccion de Investigacion en Ciencia y Tecnologia (DICYT-USACH). L.Sanhueza thanks the Comision Nacional de Ciencia y Tecnologia (CONICYT) for its support of her doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MU, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0580-0; Anastasiadi M, 2009, J AGR FOOD CHEM, V57, P457, DOI 10.1021/jf8024979; de Almeida MRA, 2013, PAK J PHARM SCI, V26, P881; Betoni JEC, 2006, MEM I OSWALDO CRUZ, V101, P387, DOI 10.1590/S0074-02762006000400007; Braga LKA, 2011, AFR J PHARM PHARMACO, V5, P2145, DOI 10.5897/AJPP11.414; Brown JC, 2009, APPL ENVIRON MICROB, V75, P848, DOI 10.1128/AEM.01595-08; Casagrande JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112748; *CLSI, 2005, PERF STAND ANT SUSC; Corrales M, 2010, FOOD CHEM TOXICOL, V48, P3471, DOI 10.1016/j.fct.2010.09.025; Coutinho HDM, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-13; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Eumkeb G, 2012, J PHOTOCH PHOTOBIO B, V117, P247, DOI 10.1016/j.jphotobiol.2012.10.006; Eumkeb G, 2012, J APPL MICROBIOL, V112, P55, DOI 10.1111/j.1365-2672.2011.05190.x; Fujita M, 2005, MICROBIOL IMMUNOL, V49, P391, DOI 10.1111/j.1348-0421.2005.tb03732.x; Furiga A, 2009, FOOD CHEM, V113, P1037, DOI 10.1016/j.foodchem.2008.08.059; Garvey MI, 2011, INT J ANTIMICROB AG, V37, P145, DOI 10.1016/j.ijantimicag.2010.10.027; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Isogai E, 2001, CURR MICROBIOL, V42, P248, DOI 10.1007/s002840010212; Kammerer D, 2004, J AGR FOOD CHEM, V52, P4360, DOI 10.1021/jf049613b; Kao TT, 2010, INT J FOOD MICROBIOL, V141, P17, DOI 10.1016/j.ijfoodmicro.2010.04.025; Kourtesi Christina, 2013, Open Microbiol J, V7, P34, DOI 10.2174/1874285801307010034; Kuete V, 2011, INT J ANTIMICROB AG, V37, P156, DOI 10.1016/j.ijantimicag.2010.10.020; Lafka TI, 2007, FOOD CHEM, V104, P1206, DOI 10.1016/j.foodchem.2007.01.068; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Mendoza L, 2013, IND CROP PROD, V43, P360, DOI [10.1016/j.indcrop.2012.07.048, 10.1016/j.indcroP.2012.07.048]; Motyl M., 2005, CURRENT PROTOCOLS PH; Mun SH, 2013, PHYTOMEDICINE, V20, P714, DOI 10.1016/j.phymed.2013.02.006; Nicoletti I, 2008, J AGR FOOD CHEM, V56, P8801, DOI 10.1021/jf801411m; Ozkan G, 2004, J SCI FOOD AGR, V84, P1807, DOI 10.1002/jsfa.1901; Rockenbach II, 2011, FOOD CHEM, V127, P174, DOI 10.1016/j.foodchem.2010.12.137; Sagdic O, 2011, FOOD CHEM, V126, P1749, DOI 10.1016/j.foodchem.2010.12.075; Sanhueza L, 2014, J ADV MICROBIOLOGY, V4, P225, DOI [DOI 10.4236/AIM.2014.45029, 10.4236/aim.2014.45029]; Shibata H, 2009, ANTIMICROB AGENTS CH, V53, P2218, DOI 10.1128/AAC.00829-08; Shiota S, 2004, MICROBIOL IMMUNOL, V48, P67, DOI 10.1111/j.1348-0421.2004.tb03489.x; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; Stefanovic O, 2011, J MED PLANTS RES, V5, P4074; Thimothe J, 2007, J AGR FOOD CHEM, V55, P10200, DOI 10.1021/jf0722405; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wilkens M, 2002, PLANTA MED, V68, P452, DOI 10.1055/s-2002-32086; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Xie YX, 2015, CURR MED CHEM, V22, P132	42	89	95	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172273	10.1371/journal.pone.0172273	http://dx.doi.org/10.1371/journal.pone.0172273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235054	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200061
J	Sim, LLW; Ban, KHK; Tan, TW; Sethi, SK; Loh, TP				Sim, Livvi Li Wei; Ban, Kenneth Hon Kim; Tan, Tin Wee; Sethi, Sunil Kumar; Loh, Tze Ping			Development of a clinical decision support system for diabetes care: A pilot study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; ELECTRONIC MEDICAL-RECORDS; GLYCATED HEMOGLOBIN; FUTURE-DIRECTIONS; MANAGEMENT; TOOL; METAANALYSIS; PERFORMANCE; IMPROVEMENT; PREVALENCE	Management of complex chronic diseases such as diabetes requires the assimilation and interpretation of multiple laboratory test results. Traditional electronic health records tend to display laboratory results in a piecemeal and segregated fashion. This makes the assembly and interpretation of results related to diabetes care challenging. We developed a diabetes-specific clinical decision support system (Diabetes Dashboard) interface for displaying glycemic, lipid and renal function results, in an integrated form with decision support capabilities, based on local clinical practice guidelines. The clinical decision support system included a dashboard feature that graphically summarized all relevant laboratory results and displayed them in a color-coded system that allowed quick interpretation of the metabolic control of the patients. An alert module informs the user of tests that are due for repeat testing. An interactive graph module was also developed for better visual appreciation of the trends of the laboratory results of the patient. In a pilot study involving case scenarios administered via an electronic questionnaire, the Diabetes Dashboard, compared to the existing laboratory reporting interface, significantly improved the identification of abnormal laboratory results, of the long-term trend of the laboratory tests and of tests due for repeat testing. However, the Diabetes Dashboard did not significantly improve the identification of patients requiring treatment adjustment or the amount of time spent on each case scenario. In conclusion, we have developed and shown that the use of the Diabetes Dashboard, which incorporates several decision support features, can improve the management of diabetes. It is anticipated that this dashboard will be most helpful when deployed in an outpatient setting, where physicians can quickly make clinical decisions based on summarized information and be alerted to pertinent areas of care that require additional attention.	[Sim, Livvi Li Wei; Ban, Kenneth Hon Kim; Tan, Tin Wee] Natl Univ Singapore, Dept Biochem, Singapore, Singapore; [Sethi, Sunil Kumar; Loh, Tze Ping] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore	National University of Singapore; National University of Singapore	Loh, TP (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	tploh@hotmail.com		Loh, Tze Ping/0000-0002-4272-0001	National University Hospital, Singapore [CS/SCL/15/055]	National University Hospital, Singapore(National University of Singapore)	We gratefully acknowledge the funding by the Vision 2020 fund (previously known as the Clinical Quality and Innovation Fund) from the National University Hospital, Singapore: Ref: CS/SCL/15/055. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA, 2016, CLIN DIABETES, V34, P3, DOI [DOI 10.2337/DIACLIN.34.1.3, 10.2337/diaclin.34.1.3., 10.2337/diaclin.34.1.3]; Ali SM, 2016, INT J MED INFORM, V87, P91, DOI 10.1016/j.ijmedinf.2015.12.017; Ash JS, 2010, STUD HEALTH TECHNOL, V160, P806, DOI 10.3233/978-1-60750-588-4-806; Berner ES, 1999, J AM MED INFORM ASSN, V6, P420, DOI 10.1136/jamia.1999.0060420; Black AD, IMPACT EHEALTH QUALI; Campbell Emily M, 2007, AMIA Annu Symp Proc, P94; Cleveringa FGW, 2013, DIABETES TECHNOL THE, V15, P180, DOI 10.1089/dia.2012.0201; Donsa K, 2016, INT J MED INFORM, V90, P58, DOI 10.1016/j.ijmedinf.2016.03.007; Driskell OJ, 2012, CLIN CHEM, V58, P906, DOI 10.1373/clinchem.2011.176487; Fong S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/274193; Ampudia-Blasco FJ, 2015, DIABETES TECHNOL THE, V17, P194, DOI 10.1089/dia.2014.0260; Jeffery R, 2013, DIABETIC MED, V30, P739, DOI 10.1111/dme.12087; Kantor M, 2011, APPL CLIN INFORM, V2, P284, DOI 10.4338/ACI-2011-02-RA-0012; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khalifa M, 2015, STUD HEALTH TECHNOL, V213, P67, DOI 10.3233/978-1-61499-538-8-67; Lau B, 2013, APPL CLIN INFORM, V4, P476, DOI 10.4338/ACI-2013-06-RA-0041; Loh TP, 2011, DIABETES RES CLIN PR, V94, pE40, DOI 10.1016/j.diabres.2011.07.034; Meigs JB, 2003, DIABETES CARE, V26, P750, DOI 10.2337/diacare.26.3.750; Moja L, 2014, AM J PUBLIC HEALTH, V104, pE12, DOI 10.2105/AJPH.2014.302164; Mollon B, 2009, BMC MED INFORM DECIS, V9, DOI [10.1186/1472-6947-9-1, 10.1186/1472-6947-9-11]; Musen M.A., 2014, BIOMEDICAL INFORM, P643, DOI [10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-8_22, DOI 10.1007/978-1-4471-4474-822]; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Nirantharakumar K, 2012, DIABETIC MED, V29, P698, DOI 10.1111/j.1464-5491.2011.03540.x; O'Connor P, 2011, APPL CLIN INFORM, V2, P350, DOI 10.4338/ACI-2011-05-IE-0032; O'Connor PJ, 2016, DIABETIC MED, V33, P734, DOI 10.1111/dme.13090; O'Connor PJ, 2013, CURR DIABETES REP, V13, P172, DOI 10.1007/s11892-012-0350-z; O'Connor PJ, 2003, DIABETES CARE, V26, P942, DOI 10.2337/diacare.26.3.942; O'Reilly D, 2012, J AM MED INFORM ASSN, V19, P341, DOI 10.1136/amiajnl-2011-000371; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Oxendine Victoria, 2014, Clin Diabetes, V32, P113, DOI 10.2337/diaclin.32.3.113; Pearson SA, 2009, BMC HEALTH SERV RES, V9, P154, DOI DOI 10.1186/1472-6963-9-154; Rasoolimoghadam Mehdi, 2015, Acta Inform Med, V23, P336, DOI 10.5455/aim.2015.23.336-338; Rodbard David, 2011, J Diabetes Sci Technol, V5, P402; Rodbard HW, 2012, DIABETES CARE, V35, P693, DOI 10.2337/dc11-1351; Roper NA, 2002, DIABETES CARE, V25, P43, DOI 10.2337/diacare.25.1.43; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-88; Schoen DE, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0128-z; Shaya Fadia T, 2011, Am J Manag Care, V17 Suppl 14, pS377; Varonen H, 2008, FAM PRACT, V25, P162, DOI 10.1093/fampra/cmn020; Weymann N, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-24; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wilkinson MJ, 2013, CURR DIABETES REP, V13, P205, DOI 10.1007/s11892-012-0348-6	42	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173021	10.1371/journal.pone.0173021	http://dx.doi.org/10.1371/journal.pone.0173021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235017	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200187
J	Sonntag, T; Moresco, JJ; Vaughan, JM; Matsumura, S; Yates, JR; Montminy, M				Sonntag, Tim; Moresco, James J.; Vaughan, Joan M.; Matsumura, Shigenobu; Yates, John R., III; Montminy, Marc			Analysis of a cAMP regulated coactivator family reveals an alternative phosphorylation motif for AMPK family members	PLOS ONE			English	Article							14-3-3 PROTEINS; SHOTGUN PROTEOMICS; ENERGY-BALANCE; CREB ACTIVITY; KINASE; ADIPOCYTES; TORC2; IDENTIFICATION; SPECIFICITY; DISRUPTION	The second messenger cAMP stimulates cellular gene expression via the PKA-mediated phosphorylation of the transcription factor CREB and through dephosphorylation of the cAMP-responsive transcriptional coactivators (CRTCs). Under basal conditions, CRTCs are phosphorylated by members of the AMPK family of Ser/Thr kinases and sequestered in the cytoplasm via a phosphorylation-dependent association with 14-3-3 proteins. Increases in cAMP promote the dephosphorylation and nuclear translocation of CRTCs, where they bind to CREB and stimulate relevant target genes. Although they share considerable sequence homology, members of the CRTC family exert non-overlapping effects on cellular gene expression through as yet unidentified mechanisms. Here we show that the three CRTCs exhibit distinct patterns of 14-3-3 binding at three conserved sites corresponding to S70, S171, and S275 (in CRTC2). S171 functions as the gatekeeper site for 14-3-3 binding; it acts cooperatively with S275 in stabilizing this interaction following its phosphorylation by the cAMP-responsive SIK and the cAMP-nonresponsive MARK kinases. Although S171 contains a consensus recognition site for phosphorylation by AMPK family members, S70 and S275 carry variant motifs (MNTGGS(275)LPDL), lacking basic residues that are otherwise critical for SIK/MARK recognition as well as 14-3-3 binding. Correspondingly, the activity of these motifs differs between CRTC family members. As the variant (SLPDL) motif is present and apparently phosphorylated in other mammalian proteins, our studies suggest that the regulation of cellular targets by AMPK family members is more extensive than previously appreciated.	[Sonntag, Tim; Vaughan, Joan M.; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Matsumura, Shigenobu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Oiwake Cho, Kyoto, Japan	Salk Institute; Scripps Research Institute; Kyoto University	Montminy, M (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Matsumura, Shigenobu/Z-2088-2019	Moresco, James/0000-0003-1178-1642	NIH [R01 DK083834]; Leona M. and Harry B. Helmsley Charitable Trust; Clayton Foundation for Medical Research; Kieckhefer Foundation; National Center for Research Resources [5P41RR011823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083834] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Clayton Foundation for Medical Research; Kieckhefer Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R01 DK083834, the Leona M. and Harry B. Helmsley Charitable Trust, the Clayton Foundation for Medical Research, and the Kieckhefer Foundation. JJM and JRY were supported by the National Center for Research Resources (5P41RR011823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Berggreen C, 2012, CELL SIGNAL, V24, P1863, DOI 10.1016/j.cellsig.2012.05.001; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deng SS, 2015, J BIOL CHEM, V290, P3149, DOI 10.1074/jbc.M114.629873; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang H, 2015, MOLECULAR CELLULAR P; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Kenna KP, 2016, NAT GENET, V48, P1037, DOI 10.1038/ng.3626; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Sonntag T, 2011, MOL BIOSYST, V7, P2031, DOI 10.1039/c1mb05025g; Spies J, 2016, MOL CELL, V62, P903, DOI 10.1016/j.molcel.2016.04.032; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	44	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173013	10.1371/journal.pone.0173013	http://dx.doi.org/10.1371/journal.pone.0173013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235073	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200186
J	Tanaka, M; Sato, Y; Haniu, H; Nomura, H; Kobayashi, S; Takanashi, S; Okamoto, M; Takizawa, T; Aoki, K; Usui, Y; Oishi, A; Kato, H; Saito, N				Tanaka, Manabu; Sato, Yoshinori; Haniu, Hisao; Nomura, Hiroki; Kobayashi, Shinsuke; Takanashi, Seiji; Okamoto, Masanori; Takizawa, Takashi; Aoki, Kaoru; Usui, Yuki; Oishi, Ayumu; Kato, Hiroyuki; Saito, Naoto			A three-dimensional block structure consisting exclusively of carbon nanotubes serving as bone regeneration scaffold and as bone defect filler	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; MECHANICAL-PROPERTIES; DELIVERY; CALCIFICATION; STERILIZATION; ATTACHMENT; PROTEINS; POROSITY; COLLAGEN	Many recent studies have been conducted to assess the ability of composite materials containing carbon nanotubes (CNTs) with high bone affinity to serve as scaffolds in bone regenerative medicine. These studies have demonstrated that CNTs can effectively induce bone formation. However, no studies have investigated the usefulness of scaffolds consisting exclusively of CNTs in bone regenerative medicine. We built a three-dimensional block entity with maximized mechanical strength from multi-walled CNTs (MWCNT blocks) and evaluated their efficacy as scaffold material for bone repair. When MWCNT blocks containing recombinant human bone morphogenetic protein-2 (rhBMP-2) were implanted in mouse muscle, ectopic bone was formed in direct contact with the blocks. Their bone marrow densities were comparable to those of PET-reinforced collagen sheets with rhBMP-2. On day 1 and day 3, MC3T3-E1 preosteoblasts were attached to the scaffold surface of MWCNT blocks than that of PET-reinforced collagen sheets. They also showed a maximum compression strength comparable to that of cortical bone. Our MWCNT blocks are expected to serve as bone defect filler and scaffold material for bone regeneration.	[Tanaka, Manabu; Haniu, Hisao; Nomura, Hiroki; Kobayashi, Shinsuke; Takanashi, Seiji; Okamoto, Masanori; Takizawa, Takashi; Kato, Hiroyuki] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Asahi 3-1-1, Matsumoto, Nagano, Japan; [Sato, Yoshinori] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Aoba 6-6-20, Sendai, Miyagi, Japan; [Haniu, Hisao; Oishi, Ayumu; Saito, Naoto] Shinshu Univ, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Asahi 3-1-1, Matsumoto, Nagano, Japan; [Aoki, Kaoru] Shinshu Univ, Sch Hlth Sci, Dept Appl Phys Therapy, Asahi 3-1-1, Matsumoto, Nagano, Japan; [Usui, Yuki] Aizawa Hosp, Ctr Sports Med, Honjou 2-5-1, Matsumoto, Nagano, Japan	Shinshu University; Tohoku University; Shinshu University; Shinshu University	Saito, N (corresponding author), Shinshu Univ, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Asahi 3-1-1, Matsumoto, Nagano, Japan.	saitoko@shinshu-u.ac.jp	Sato, Yoshinori/Q-7558-2019; 正則, 岡本/AAB-4681-2022	正則, 岡本/0000-0003-0351-865X	JSPS KAKENHI [24241045, 26670658]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24241045 and 26670658.	Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P; Bajaj P, 2006, INT J NANOMED, V1, P361; Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013; Bhattacharya M, 2011, J BIOMED MATER RES A, V96A, P75, DOI 10.1002/jbm.a.32958; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640; Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z; Elgrabli D, 2015, ACS NANO, V9, P10113, DOI 10.1021/acsnano.5b03708; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Hanseler P, 2015, J BIOMED MATER RES A, V103, P628, DOI 10.1002/jbm.a.35211; Haniu H, 2013, TOXICOL IN VITRO, V27, P1679, DOI 10.1016/j.tiv.2013.04.012; Hara K, 2011, MATER TODAY, V14, P434, DOI 10.1016/S1369-7021(11)70188-2; Hirano S, 2010, TOXICOL APPL PHARM, V249, P8, DOI 10.1016/j.taap.2010.08.019; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416; Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8; Kuik K, 2016, J CRANIO MAXILL SURG, V44, P364, DOI 10.1016/j.jcms.2015.12.019; Kujala S, 2004, ARCH ORTHOP TRAUM SU, V124, P26, DOI 10.1007/s00402-003-0599-4; Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039; Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539; Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011; Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mukozawa A, 2011, CLIN ORAL IMPLAN RES, V22, P1327, DOI 10.1111/j.1600-0501.2010.02135.x; Nasser M.E., 2013, EGYPT RHEUMATOL REH, V40, P211, DOI [10.4103/1110-161x.123809, DOI 10.4103/1110-161X.123809]; Niu LF, 2010, LANGMUIR, V26, P4069, DOI 10.1021/la9034722; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; Nomura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14314; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Renders GAP, 2007, J ANAT, V210, P239, DOI 10.1111/j.1469-7580.2007.00693.x; Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715; Saito N, 2008, CURR MED CHEM, V15, P523, DOI 10.2174/092986708783503140; Saito N, 2014, CHEM REV, V114, P6040, DOI 10.1021/cr400341h; Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c; Sato Y, 2008, ACS NANO, V2, P348, DOI 10.1021/nn700324z; Sato Y, 2012, CARBON, V50, P34, DOI 10.1016/j.carbon.2011.07.047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu M, 2012, ADV MATER, V24, P2176, DOI 10.1002/adma.201103832; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015; TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250; Tefferi A, 2006, BLOOD, V108, P1158, DOI 10.1182/blood-2006-02-004572; Tokunaga T, 2015, ARTHROSCOPY, V31, P1482, DOI 10.1016/j.arthro.2015.03.008; Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128; Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670; Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3105, DOI 10.1166/jbn.2014.1969; Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103	52	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172601	10.1371/journal.pone.0172601	http://dx.doi.org/10.1371/journal.pone.0172601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235026	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200098
J	Wahmkow, G; Cassel, M; Mayer, F; Baur, H				Wahmkow, Gunnar; Cassel, Michael; Mayer, Frank; Baur, Heiner			Effects of different medial arch support heights on rearfoot kinematics	PLOS ONE			English	Article							FOOT ORTHOSES; PATELLOFEMORAL PAIN; OVERUSE INJURIES; RUNNING ECONOMY; RUNNERS; WALKING; MOTION; REPEATABILITY; PRONATION; ORTHOTICS	Background Foot orthoses are usually assumed to be effective by optimizing mechanically dynamic rear-foot configuration. However, the effect from a foot orthosis on kinematics that has been demonstrated scientifically has only been marginal. The aim of this study was to examine the effect of different heights in medial arch-supported foot orthoses on rear foot motion during gait. Methods Nineteen asymptomatic runners (36 +/- 11years, 180 +/- 5cm, 79 +/- 10kg; 41 +/- 22km/week) participated in the study. Trials were recorded at 3.1 mph (5 km/h) on a treadmill. Athletes walked barefoot and with 4 different not customized medial arch-supported foot orthoses of various arch heights (N: 0 mm, M: 30 mm, H: 35 mm, E: 40mm). Six infrared cameras and the 'Oxford Foot Model A were used to capture motion. The average stride in each condition was calculated from 50 gait cycles per condition. Eversion excursion and internal tibia rotation were analyzed. Descriptive statistics included calculating the mean +/- SD and 95% CIs. Group differences by condition were analyzed by one factor (foot orthoses) repeated measures ANOVA (a = 0.05). Results Eversion excursion revealed the lowest values for N and highest for H (B: 4.6 degrees +/- 2.2 degrees; 95% CI [3.1; 6.2]/N: 4.0 degrees +/- 1.7 degrees; [2.9; 5.2]/M: 5.2 degrees +/- 2.6 degrees; [3.6;6.8]/H: 6.2 degrees +/- 3.3 degrees; [4.0;8.5]/E:5.1 degrees +/- 3.5 degrees; [2.8;7.5]) (p> 0.05). Range of internal tibia rotation was lowest with orthosis H and highest with E (B: 13.3 degrees +/- 3.2 degrees; 95% CI [11.0;15.6]/N: 14.5 degrees +/- 7.2 degrees; [9.2;19.6]/M: 13.8 degrees +/- 5.0 degrees; [10.8;16.8]/H: 12.3 degrees +/- 4.3 degrees; [9.0; 15.6]/E:14.9 degrees +/- 5.0 degrees; [11.5;18.3]) (p> 0.05). Differences between conditions were small and the intrasubject variation high. Conclusion Our results indicate that different arch support heights have no systematic effect on eversion excursion or the range of internal tibia rotation and therefore might not exert a crucial influence on rear foot alignment during gait.	[Wahmkow, Gunnar; Cassel, Michael; Mayer, Frank; Baur, Heiner] Univ Potsdam, Dept Sports Med, Univ Outpatient Clin, Potsdam, Germany; [Baur, Heiner] Bern Univ Appl Sci, Hlth, Physiotherapy, Bern, Switzerland	University of Potsdam	Wahmkow, G (corresponding author), Univ Potsdam, Dept Sports Med, Univ Outpatient Clin, Neuen Palais 10,Haus 12, Potsdam, Germany.	gwahmkow@uni-potsdam.de	Baur, Heiner/M-9995-2019; Baur, Heiner/A-8673-2017	Baur, Heiner/0000-0002-4780-225X	German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany [KA0121102KF7]	German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany	The study was supported by the German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft und Technologie), Berlin, Germany, Project KA0121102KF7 (Program: PRO INNO II "PROgramm zur Forderung der Erhohung der INNOvationskompetenz mittelstandischer Unternehmen"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Federal Ministry of Economics and Technology (BMWi Bundesministerium fur Wirtschaft and Technologie), Berlin, Germany, Project KA0121102KF7 (Program: PRO INNO II "PROgramm zur Forderung der Erhohung der INNOvationskompetenz mittelstandischer Unternehmen"). The authors deeply appreciate proofreading and language support from Caroline Curten, Freiburg (D).	Baur H, 2011, MED SCI SPORT EXER, V43, P1500, DOI 10.1249/MSS.0b013e31820c64ae; Borom AH, 2003, D DREZS ORTHOPAEDI D, P2276; Burns J, 2005, J AM PODIAT MED ASSN, V95, P235, DOI 10.7547/0950235; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Donoghue OA, 2008, SPORT BIOMECH, V7, P194, DOI 10.1080/14763140701841407; Fromme A, 1997, Sportverletz Sportschaden, V11, P52, DOI 10.1055/s-2007-993366; Hahni M, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0176-z; Heise GD, 1996, INT J SPORTS MED, V17, P128; Hirschmuller A, 2011, BRIT J SPORT MED, V45, P959, DOI 10.1136/bjsm.2008.055830; Kapandji IA., 2006, FUNKTIONELLE ANATOMI, V4; Liu AM, 2012, MED SCI SPORT EXER, V44, P2384, DOI 10.1249/MSS.0b013e318265df1d; MacLean C, 2006, CLIN BIOMECH, V21, P623, DOI 10.1016/j.clinbiomech.2006.01.005; Mann RW, 2002, CLIN J SPORT MED, V12, P57, DOI 10.1097/00042752-200201000-00019; MARTIN PE, 1993, MED SCI SPORT EXER, V25, P508; Mayer F, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.031732; McPoil TG, 2000, J AM PODIAT MED ASSN, V90, P2, DOI 10.7547/87507315-90-1-2; Mills K, 2010, BRIT J SPORT MED, V44, P1035, DOI 10.1136/bjsm.2009.066977; Mundermann A, 2003, CLIN BIOMECH, V18, P254, DOI 10.1016/S0268-0033(02)00186-9; Mundermann A, 2003, MED SCI SPORT EXER, V35, P1710, DOI 10.1249/01.MSS.0000089352.47259.CA; NAWOCZENSKI DA, 1995, J ORTHOP SPORT PHYS, V21, P317, DOI 10.2519/jospt.1995.21.6.317; Nester CJ, 2003, GAIT POSTURE, V17, P180, DOI 10.1016/S0966-6362(02)00065-6; Nester CJ, 2003, FOOT ANKLE INT, V24, P164, DOI 10.1177/107110070302400211; Nielsen RO, 2014, BRIT J SPORT MED, V48, P440, DOI 10.1136/bjsports-2013-092202; Nigg B M, 2001, Exerc Sport Sci Rev, V29, P37, DOI 10.1097/00003677-200101000-00008; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Huerta JP, 2009, J AM PODIAT MED ASSN, V99, P415, DOI 10.7547/0990415; Reschke A, 2012, MED SCI SPORTS EXERC, V44, pS715; Richards CE, 2009, BRIT J SPORT MED, V43, P159, DOI 10.1136/bjsm.2008.046680; Rodrigues P, 2013, GAIT POSTURE, V37, P526, DOI 10.1016/j.gaitpost.2012.09.027; Stacoff A, 2000, CLIN BIOMECH, V15, P54, DOI 10.1016/S0268-0033(99)00028-5; Stacoff A, 2001, MED SCI SPORT EXER, V33, P311; Stebbins J, 2006, GAIT POSTURE, V23, P401, DOI 10.1016/j.gaitpost.2005.03.002; Stefanyshyn DJ, 2006, AM J SPORT MED, V34, P1844, DOI 10.1177/0363546506288753; Theologis TN, 2003, J BONE JOINT SURG BR, V85B, P572, DOI 10.1302/0301-620X.85B4.13696; Wen DY, 1997, MED SCI SPORT EXER, V29, P1291, DOI 10.1097/00005768-199710000-00003; Williams DS, 2003, MED SCI SPORT EXER, V35, P2060, DOI 10.1249/01.MSS.0000098988.17182.8A; Williams DS, 2001, CLIN BIOMECH, V16, P341, DOI 10.1016/S0268-0033(01)00005-5	39	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172334	10.1371/journal.pone.0172334	http://dx.doi.org/10.1371/journal.pone.0172334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257426	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100016
J	Liu, HY; Chen, CC; Lin, YY; Chen, YJ; Liu, BH; Wong, SC; Wu, CY; Chang, YT; Chou, HYE; Ding, ST				Liu, Hui-Yu; Chen, Chih-Chien; Lin, Yuan-Yu; Chen, Yu-Jen; Liu, Bing-Hsien; Wong, Shiu-Chung; Wu, Cheng-Yu; Chang, Yun-Tsui; Chou, Han-Yi E.; Ding, Shih-Torng			Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; UMBILICAL-CORD BLOOD; ISLET-LIKE CLUSTERS; GROWTH-FACTOR-ALPHA; IN-VITRO; BONE-MARROW; SPHEROID FORMATION; PROGENITOR CELLS; ACTIVIN-A; EXPRESSION	The unique advantage of easy access and abundance make the adipose-derived stem cells (ADSCs) a promising system of multipotent cells for transplantation and regenerative medicine. Among the available sources, porcine ADSCs (pADSCs) deserve especial attention due to the close resemblance of human and porcine physiology, as well as for the upcoming availability of humanized porcine models. Here, we report on the isolation and conversion of pADSCs into glucose-responsive insulin-secreting cells. We used the stromal-vascular fraction of the dorsal subcutaneous adipose from 9-day-old male piglets to isolate pADSCs, and subjected the cells to an induction scheme for differentiation on chitosan-coated plates. This one-step procedure promoted differentiation of pADSCs into pancreatic islet-like clusters (PILC) that are characterized by the expression of a repertoire of pancreatic proteins, including pancreatic and duodenal homeobox (Pdx-1), insulin gene enhancer protein (ISL-1) and insulin. Upon glucose challenge, these PILC secreted high amounts of insulin in a dose-dependent manner. Our data also suggest that chitosan plays roles not only to enhance the differentiation potential of pADSCs, but also to increase the glucose responsiveness of PILCs. Our novel approach is, therefore, of great potential for transplantation-based amelioration of type 1 diabetes.	[Liu, Hui-Yu; Chen, Chih-Chien; Lin, Yuan-Yu; Liu, Bing-Hsien; Wong, Shiu-Chung; Chang, Yun-Tsui; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Liu, Hui-Yu; Chen, Yu-Jen; Wu, Cheng-Yu; Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Chou, Han-Yi E.] Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Chou, Han-Yi E.] Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Chou, HYE (corresponding author), Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Chou, HYE (corresponding author), Natl Taiwan Univ, Grad Inst Oral Biol, Taipei, Taiwan.	hyechou@gmail.com; sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Ding, Shih-Torng/0000-0002-9866-1776; Lin, Yuan-Yu/0000-0002-3397-3218	National Taiwan University Cutting-Edge Steering Research Project [NTU-CESRP-102R7615-2]; Ministry of Science and Technology in Taiwan [NSC 101-2811-B-029-003]	National Taiwan University Cutting-Edge Steering Research Project; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Taiwan University Cutting-Edge Steering Research Project (NTU-CESRP-102R7615-2). CCC was supported by the postdoctoral grant (NSC 101-2811-B-029-003) from Ministry of Science and Technology in Taiwan.	Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020615; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Chang CM, 2007, BIOCHEM BIOPH RES CO, V357, P414, DOI 10.1016/j.bbrc.2007.03.157; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chen CH, 2008, J NUTR, V138, P674, DOI 10.1093/jn/138.4.674; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Cignarelli A, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.13; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Dave SD, 2015, CLIN EXP MED, V15, P41, DOI 10.1007/s10238-013-0266-1; Dave Shruti D, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS65, DOI 10.4103/2230-8210.94264; Demeterco C, 2000, J CLIN ENDOCR METAB, V85, P3892, DOI 10.1210/jc.85.10.3892; Dufrane D, 2012, WORLD J GASTROENTERO, V18, P6885, DOI 10.3748/wjg.v18.i47.6885; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Hsu SH, 2012, BIOMATERIALS, V33, P2642, DOI 10.1016/j.biomaterials.2011.12.032; Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Khorsandi L, 2015, CELL TISSUE RES, V361, P745, DOI 10.1007/s00441-015-2140-9; Kim SJ, 2012, J BIOSCI BIOENG, V113, P771, DOI 10.1016/j.jbiosc.2012.02.007; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu BH, 2005, J ANIM SCI, V83, P1516; Liu BH, 2013, BIORESEARCH OPEN ACC, V2, P28, DOI 10.1089/biores.2012.0285; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moshtagh PR, 2013, J PHYSIOL BIOCHEM, V69, P451, DOI 10.1007/s13105-012-0228-1; Noguchi H, 2010, TRANSPL P, V42, P2081, DOI 10.1016/j.transproceed.2010.05.097; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Ramesh A, 2013, CURR DIABETES REV, V9, P294, DOI 10.2174/15733998113099990063; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Sun B, 2007, BIOCHEM BIOPH RES CO, V354, P919, DOI 10.1016/j.bbrc.2007.01.069; Tai CC, 2009, J BIOL CHEM, V284, P32239, DOI 10.1074/jbc.M109.024661; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Wang RN, 1997, DIABETOLOGIA, V40, P887, DOI 10.1007/s001250050764; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Wong RSY, 2011, EXP DIABETES RES, DOI 10.1155/2011/406182; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang KC, 2013, J BIOMED MATER RES A, V101, P2273, DOI 10.1002/jbm.a.34547; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yaturu S, 2013, WORLD J DIABETES, V4, P1, DOI 10.4239/wjd.v4.i1.1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	58	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172922	10.1371/journal.pone.0172922	http://dx.doi.org/10.1371/journal.pone.0172922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253305	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300047
J	Ozaki, R; Kuroda, K; Ikemoto, Y; Ochiai, A; Matsumoto, A; Kumakiri, J; Kitade, M; Itakura, A; Muter, J; Brosens, JJ; Takeda, S				Ozaki, Rie; Kuroda, Keiji; Ikemoto, Yuko; Ochiai, Asako; Matsumoto, Akemi; Kumakiri, Jun; Kitade, Mari; Itakura, Atsuo; Muter, Joanne; Brosens, Jan J.; Takeda, Satoru			Reprogramming of the retinoic acid pathway in decidualizing human endometrial stromal cells	PLOS ONE			English	Article							VITAMIN-A; RECEPTOR; PROTEIN; BIOSYNTHESIS; METABOLISM; ACTIVATION; EXPRESSION; HEALTH; DEHYDROGENASES; EXPANSION	Upon breaching of the endometrial surface epithelium, the implanting embryo embeds in the decidualizing stroma. Retinoic acid (RA), a metabolite of vitamin A, is an important morphogen during embryonic and fetal development, although the role of the RA pathway in the surrounding decidual cells is not understood. Here we show that decidual transformation of human endometrial stromal cells (HESCs) results in profound reprogramming of the RA signaling and metabolism pathways. Differentiating HESCs downregulate the intracellular carrier proteins CRABP2 and FABP5, responsible for transfer and binding of RA to the nuclear receptors RAR and PPAR beta/delta, respectively. Furthermore, the expression of RAR, the receptor that mediates the pro-apoptotic effects of RA, was also inhibited. By contrast, PPAR beta/delta, which transduces the differentiation responses of RA, was upregulated. Decidualization was also associated with increased expression of retinol-binding protein 4 (RBP4) and various enzymes involved in the metabolism of RA and its precursor, retinaldehyde (Rald), including CYP26A1, DHRS3, and RDH12. Exposure of differentiating HESCs to RA or Rald reversed the inhibition of the CRABP2-RAR pathway, perturbed the expression of decidual marker genes and triggered cell death. Taken together, the data demonstrate that decidualizing HESCs silence RA signaling by downregulating key cytoplasmic binding proteins and by increasing retinoid metabolism. However, excessive RA exposure is toxic for decidual cells and triggers a response that may lead to pregnancy failure.	[Ozaki, Rie; Kuroda, Keiji; Ikemoto, Yuko; Ochiai, Asako; Matsumoto, Akemi; Kumakiri, Jun; Kitade, Mari; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynaecol, Tokyo, Japan; [Muter, Joanne; Brosens, Jan J.] Warwick Med Sch, Div Biomed Sci, Clin Sci Res Labs, Coventry, W Midlands, England; [Brosens, Jan J.] Univ Hosp Coventry & Warwickshire, Tommys Natl Miscarriage Res Ctr, Coventry, W Midlands, England	Juntendo University; University of Warwick; University of Warwick	Kuroda, K (corresponding author), Juntendo Univ, Fac Med, Dept Obstet & Gynaecol, Tokyo, Japan.	arthur@juntendo.ac.jp		Brosens, Jan/0000-0003-0116-9329; Kuroda, Keiji/0000-0003-2759-9159	Japan society for the promotion of science [25861508]; Uehara Memorial Foundation; Juntendo university	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Juntendo university	Support was provided by the Japan society for the promotion of science, KAKENHI Grant Number 25861508 [https://www.jsps.go.jp/english/e-grants/index.html]; the Uehara Memorial Foundation [http://www.ueharazaidan.or.jp/]; and Juntendo university young investigator award 2013 [http://www2.med.juntendo.ac.jp/blog/intra/gakujyutsuka1/003/cat61/].	Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brar AK, 1996, MOL HUM REPROD, V2, P185, DOI 10.1093/molehr/2.3.185; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Cerignoli F, 2002, CANCER RES, V62, P1196; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Courtney R, 2008, J CLIN ENDOCR METAB, V93, P550, DOI 10.1210/jc.2007-1912; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Ding NZ, 2003, REPRODUCTION, V125, P817, DOI 10.1530/reprod/125.6.817; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Han BC, 2010, J CELL PHYSIOL, V223, P471, DOI 10.1002/jcp.22056; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kuroda K, 2013, MOL ENDOCRINOL, V27, P192, DOI 10.1210/me.2012-1247; Lee J, 2011, FERTIL STERIL, V95, P2599, DOI 10.1016/j.fertnstert.2011.04.065; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Muter J, 2015, FASEB J, V29, P1603, DOI 10.1096/fj.14-267195; NAPOLI JL, 1993, J NUTR, V123, P362, DOI 10.1093/jn/123.suppl_2.362; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Pavone ME, 2010, J CLIN ENDOCR METAB, V95, pE300, DOI 10.1210/jc.2010-0459; PILCH SM, 1987, J NUTR, V117, P636, DOI 10.1093/jn/117.4.636; SAFAVI K, 1992, ARCH DERMATOL, V128, P1130, DOI 10.1001/archderm.128.8.1130; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Teklenburg G., 2010, PLOS ONE, V5; Weimar CH, 2012, PLOS ONE, V7; Wolf G, 2008, NUTR REV, V66, P55, DOI 10.1111/j.1753-4887.2007.00006.x; Zheng WL, 2000, ENDOCRINOLOGY, V141, P802, DOI 10.1210/en.141.2.802; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	39	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173035	10.1371/journal.pone.0173035	http://dx.doi.org/10.1371/journal.pone.0173035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253328	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300063
J	Li, M; Konstantinova, J; Xu, GH; He, B; Aminzadeh, V; Xie, J; Wurdemann, H; Althoefer, K				Li, Min; Konstantinova, Jelizaveta; Xu, Guanghua; He, Bo; Aminzadeh, Vahid; Xie, Jun; Wurdemann, Helge; Althoefer, Kaspar			Evaluation of stiffness feedback for hard nodule identification on a phantom silicone model	PLOS ONE			English	Article							TISSUE ABNORMALITY IDENTIFICATION; SENSORY SUBTRACTION; REALITY; SYSTEM; PROBE	Haptic information in robotic surgery can significantly improve clinical outcomes and help detect hard soft-tissue inclusions that indicate potential abnormalities. Visual representation of tissue stiffness information is a cost-effective technique. Meanwhile, direct force feedback, although considerably more expensive than visual representation, is an intuitive method of conveying information regarding tissue stiffness to surgeons. In this study, real-time visual stiffness feedback by sliding indentation palpation is proposed, validated, and compared with force feedback involving human subjects. In an experimental tele-manipulation environment, a dynamically updated color map depicting the stiffness of probed soft tissue is presented via a graphical interface. The force feedback is provided, aided by a master haptic device. The haptic device uses data acquired from an F/T sensor attached to the end-effector of a tele-manipulated robot. Hard nodule detection performance is evaluated for 2 modes (force feedback and visual stiffness feedback) of stiffness feedback on an artificial organ containing buried stiff nodules. From this artificial organ, a virtual-environment tissue model is generated based on sliding indentation measurements. Employing this virtual-environment tissue model, we compare the performance of human participants in distinguishing differently sized hard nodules by force feedback and visual stiffness feedback. Results indicate that the proposed distributed visual representation of tissue stiffness can be used effectively for hard nodule identification. The representation can also be used as a sufficient substitute for force feedback in tissue palpation.	[Li, Min; Xu, Guanghua; He, Bo; Xie, Jun] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Li, Min; Xu, Guanghua; Xie, Jun] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Konstantinova, Jelizaveta] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Aminzadeh, Vahid] De Beers Technol, Maidenhead, Berks, England; [Wurdemann, Helge] UCL, Dept Mech Engn, London, England; [Althoefer, Kaspar] Queen Mary Univ London, Fac Sci & Engn, London, England	Xi'an Jiaotong University; Xi'an Jiaotong University; University of London; Queen Mary University London; University of London; University College London; University of London; Queen Mary University London	Li, M; Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.; Li, M; Xu, GH (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.	min.li@mail.xjtu.edu.cn; xugh@mail.xjtu.edu.cn	Li, Min/W-2652-2017; Althoefer, Kaspar/AAA-5984-2022	Li, Min/0000-0002-2959-9147; Konstantinova, Jelizaveta/0000-0002-4499-345X; Wurdemann, Helge/0000-0003-3082-146X	National Natural Science Foundation of China [91420301]; China Postdoctoral Science Foundation [2015M570821]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The research leading to these results has received funding from the National Natural Science Foundation of China (Received by GX, Approval No. 91420301, http://www.nsfc.gov.cn) and the China Postdoctoral Science Foundation Grant (Received by ML, Grant No. 2015M570821, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml).	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Currie ME, 2012, ANN THORAC SURG, V93, P1426, DOI 10.1016/j.athoracsur.2011.11.031; Everitt BS, 2003, CAMBRIDGE DICT STAT, V2nd; Gwilliam James C., 2010, 2010 IEEE Haptics Symposium (Formerly known as Symposium on Haptic Interfaces for Virtual Environment and Teleoperator Systems), P21, DOI 10.1109/HAPTIC.2010.5444685; Gwilliam JC, 2009, IEEE INT CONF ROBOT, P3315; Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505; Ji WB, 2011, SURG LAPARO ENDO PER, V21, P123, DOI 10.1097/SLE.0b013e31820ad553; Khaled W, 2004, ST HEAL T, V98, P147; Lee E. H., 1960, J APPL MECH, V27, P438; Li M, 2014, IEEE INT CONF ROBOT, P4188, DOI 10.1109/ICRA.2014.6907468; Li M, 2015, MED BIOL ENG COMPUT, V53, P1177, DOI 10.1007/s11517-015-1309-4; Liu HB, 2011, IEEE T ROBOT, V27, P450, DOI 10.1109/TRO.2011.2127210; Liu HB, 2010, IEEE INT CONF ROBOT, P3654, DOI 10.1109/ROBOT.2010.5509440; Liu HB, 2010, IEEE T BIO-MED ENG, V57, P404, DOI 10.1109/TBME.2009.2032164; Mahvash M, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P470; Mahvash M, 2008, SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS 2008, PROCEEDINGS, P465; Masroor S, 2010, J HEART VALVE DIS, V19, P593; Meli L, 2014, IEEE T BIO-MED ENG, V61, P1318, DOI 10.1109/TBME.2014.2303052; Miller AP, 2007, IEEE INT CONF ROBOT, P2996, DOI 10.1109/ROBOT.2007.363927; Noonan DP, 2007, IEEE INT CONF ROBOT, P2629, DOI 10.1109/ROBOT.2007.363862; Okamura AM, 2009, CURR OPIN UROL, V19, P102, DOI 10.1097/MOU.0b013e32831a478c; Ottensmeyer MP, 2002, STUD HEALTH TECHNOL, V85, P328; Prattichizzo D, 2012, IEEE T HAPTICS, V5, P289, DOI [10.1109/TOH.2012.15, 10.1109/ToH.2012.15]; Wagner CR, 2007, IEEE T ROBOT, V23, P1235, DOI 10.1109/TRO.2007.904891; Wallis S, 2013, J QUANT LINGUIST, V20, P178, DOI 10.1080/09296174.2013.799918; Wellman P, 1999, HARVARD BIOROBOTICS; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wilson T, 2011, CURR OPIN UROL, V21, P200, DOI 10.1097/MOU.0b013e32834493b3; Woodward WA, 2003, J CLIN ONCOL, V21, P3244, DOI 10.1200/JCO.2003.03.052; Yamamoto T, 2012, INT J MED ROBOT COMP, V8, P45, DOI 10.1002/rcs.421; Yau C., 2009, R TUTORIAL EBOOK; Zehnder P, 2011, CURR OPIN UROL, V21, P415, DOI 10.1097/MOU.0b013e3283490582; Zhou M, 2008, SURG ENDOSC, V22, P510, DOI 10.1007/s00464-007-9499-y; Zirjakova J., 2011, PROSTATE POSTSURGICA	36	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172703	10.1371/journal.pone.0172703	http://dx.doi.org/10.1371/journal.pone.0172703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248996	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500051
J	Koffi, D; Varela, ML; Loucoubar, C; Beourou, S; Vigan-Womas, I; Toure, A; Djaman, JA; Toure, AO; Perraut, R				Koffi, David; Varela, Marie-Louise; Loucoubar, Cheikh; Beourou, Sylvain; Vigan-Womas, Ines; Toure, Aissatou; Djaman, Joseph Allico; Toure, Andre Offianan; Perraut, Ronald			Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; CLINICAL MALARIA; ANTIGENS; EXPOSURE; PROTECTION; MULTIPLEX; ASSAY; INDIVIDUALS; FLUORESCENT	Background In the agenda towards malaria eradication, assessment of both malaria exposure and efficacy of anti-vectorial and therapeutic strategies is a key component of management and the follow-up of field interventions. The simultaneous use of several antigens (Ags) as serological markers has the potential for accurate evaluation of malaria exposure. Here we aimed to measure the longitudinal evolution of the background levels of immunity in an urban setting in confirmed clinical cases of malaria. Methods A retrospective serological cross-sectional study on was carried out using 234 samples taken from 2010 to 2013 in peri-urban sentinel facility of Cote d'Ivoire. Antibody responses to recombinant proteins or BSA-peptides, 8 Plasmodium falciparum (PfAMA1, PfMSP4, PfMSP1, PfEMP1-DBL1a1-PF13, PfLSA1-41, PfLSA3-NR2, PfGLURP and PfCSP), one P. malariae (PmCSP) and one Anopheles gambiae salivary (gSG6-P1) antigens were measured using magnetic bead-based multiplex immunoassay (MBA). Total anti-P. falciparum IgG responses against schizont lysate from african 07/03 strain (adapted to culture) and 3D7 strain was measured by ELISA. Results High prevalence (7-93%) and levels of antibody responses to most of the antigens were evidenced. However, analysis showed only marginal decreasing trend of Ab responses from 2010 to 2013 that did not parallel the reduction of clinical malaria prevalence following the implementation of intervention in this area. There was a significant inverse correlation between Ab responses and parasitaemia (P<10(-3), rho = 0.3). The particular recruitment of asymptomatic individuals in 2011 underlined a high background level of immunity almost equivalent to symptomatic patients, possibly obscuring observable yearly variations. Conclusion The use of cross-sectional clinical malaria surveys and MBA can help to identify endemic sites where control measures have unequal impact providing relevant information about population immunity and possible decrease of transmission. However, when immunity is substantially boosted despite observable clinical decline, a larger cohort including asymptomatic recruitment is needed to monitor the impact of control measures on level of immunity.	[Koffi, David; Beourou, Sylvain; Toure, Andre Offianan] Inst Pasteur Cote Ivoire, Unite Paludol, Abidjan, Cote Ivoire; [Koffi, David; Djaman, Joseph Allico] Univ Felix Houphouet Boigny, UFR Biosci, Abidjan, Cote Ivoire; [Varela, Marie-Louise; Toure, Aissatou; Perraut, Ronald] Inst Pasteur, Immunol Unit, Dakar, Senegal; [Loucoubar, Cheikh] Inst Pasteur, Biostat Bioinformat & Modelisat G4, Dakar, Senegal; [Vigan-Womas, Ines] Inst Pasteur, Unit Immunol Mol Parasites, Paris, France; [Vigan-Womas, Ines] Inst Pasteur Madagascar, Immunol Unit, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Perraut, R (corresponding author), Inst Pasteur, Immunol Unit, Dakar, Senegal.	perraut@pasteur.sn	Ines, VIGAN-WOMAS/I-8604-2012; Ines, VIGAN-WOMAS/A-7846-2017	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Ines, VIGAN-WOMAS/0000-0001-7848-9297; KOFFI, DAVID/0000-0003-3243-2476	Institut Pasteur Foundation; Institut Pasteur ACIP [25_2012]; Rotary International; Rotary Paris Alliance; Rotary Dakar Almadies	Institut Pasteur Foundation; Institut Pasteur ACIP; Rotary International; Rotary Paris Alliance; Rotary Dakar Almadies	The work was supported by grants from the Institut Pasteur Foundation, and grants from Institut Pasteur ACIP No25_2012 and from the Rotary International associated with Rotary Paris Alliance and Rotary Dakar Almadies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; Badu K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-318; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Goh YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159347; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112; Holm I, 1997, MOL BIOCHEM PARASIT, V89, P313, DOI 10.1016/S0166-6851(97)00128-X; Knoblauch AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-194; Koffi D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1043-2; Koudou BG, 2010, ANN TROP MED PARASIT, V104, P109, DOI 10.1179/136485910X12607012374154; Koudou BG, 2009, ACTA TROP, V111, P268, DOI 10.1016/j.actatropica.2009.05.006; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Perraut R, 2002, MICROBES INFECT, V4, P31, DOI 10.1016/S1286-4579(01)01506-4; Perraut R, 2015, J IMMUNOL TECH INFEC, V4, P1; Perraut R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-410; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Polson HEJ, 2005, MOL BIOCHEM PARASIT, V142, P110, DOI 10.1016/j.molbiopara.2005.02.009; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; van den Hoogen LL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0939-1; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WHO WORLD MALARIA RE	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172899	10.1371/journal.pone.0172899	http://dx.doi.org/10.1371/journal.pone.0172899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245264	Green Submitted, gold, Green Published			2022-12-27	WOS:000395980200040
J	Kang, JS; Lee, BY; Kwak, M				Kang, Jong-Soo; Lee, Byoung Yoon; Kwak, Myounghai			The complete chloroplast genome sequences of Lychnis wilfordii and Silene capitata and comparative analyses with other Caryophyllaceae genomes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLASTID GENOMES; EVOLUTION; MITOCHONDRIAL; ANGIOSPERMS; PLANTS; REPEAT; FAMILY; CLASSIFICATION; REARRANGEMENTS	The complete chloroplast genomes of Lychnis wilfordii and Silene capitata were determined and compared with ten previously reported Caryophyllaceae chloroplast genomes. The chloroplast genome sequences of L. wilfordii and S. capitata contain 152,320 bp and 150,224 bp, respectively. The gene contents and orders among 12 Caryophyllaceae species are consistent, but several microstructural changes have occurred. Expansion of the inverted repeat (IR) regions at the large single copy (LSC)/IRb and small single copy (SSC)/IR boundaries led to partial or entire gene duplications. Additionally, rearrangements of the LSC region were caused by gene inversions and/or transpositions. The 18 kb inversions, which occurred three times in different lineages of tribe Sileneae, were thought to be facilitated by the intermolecular duplicated sequences. Sequence analyses of the L. wilfordii and S. capitata genomes revealed 39 and 43 repeats, respectively, including forward, palindromic, and reverse repeats. In addition, a total of 67 and 56 simple sequence repeats were discovered in the L. wilfordii and S. capitata chloroplast genomes, respectively. Finally, we constructed phylogenetic trees of the 12 Caryophyllaceae species and two Amaranthaceae species based on 73 protein-coding genes using both maximum parsimony and likelihood methods.	[Kang, Jong-Soo; Lee, Byoung Yoon; Kwak, Myounghai] Natl Inst Biol Resources, Plant Resources Div, Incheon, South Korea; [Kang, Jong-Soo] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Kang, Jong-Soo] Univ Chinese Acad Sci, Beijing, Peoples R China	National Institute of Biological Resources; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kwak, M (corresponding author), Natl Inst Biol Resources, Plant Resources Div, Incheon, South Korea.	mhkwak1@korea.kr			National Institute of Biological Resources (NIBR) - Ministry of Environment of the Republic of Korea [NIBR201503102]	National Institute of Biological Resources (NIBR) - Ministry of Environment of the Republic of Korea	This work was supported by a grant from the National Institute of Biological Resources (NIBR) funded by the Ministry of Environment of the Republic of Korea (NIBR201503102).	Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Burke SV, 2012, AM J BOT, V99, P1951, DOI 10.3732/ajb.1200365; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Do HDK, 2013, GENE, V530, P229, DOI [10.1016/j.gene.2013.07.100, DOI 10.1016/J.GENE.2013.07.100]; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Greenberg AK, 2011, TAXON, V60, P1637, DOI 10.1002/tax.606009; GREUTER W, 1995, TAXON, V44, P543, DOI 10.2307/1223499; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Gurusamy R, 2016, MITOCHONDRIAL DNA A, V27, P2015, DOI 10.3109/19401736.2014.974167; Harris ME, 2013, PLANT MOL BIOL REP, V31, P21, DOI 10.1007/s11105-012-0461-3; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Hupfer H, 2000, MOL GEN GENET, V263, P581, DOI 10.1007/s004380051204; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Judd W.S., 2002, PLANT SYSTEMATICS PH, V2nd ed., P55; Kang Y, 2015, COMPLETE CHLOROPLAST; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KNOX EB, 1993, MOL BIOL EVOL, V10, P414; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li Xiao-hui, 2013, Mediators Inflamm, V2013, P354087, DOI 10.1155/2013/354087; Liden M, 2000, NORD J BOT, V20, P513, DOI 10.1111/j.1756-1051.2000.tb01595.x; Liu TJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2101; Logacheva MD, 2009, MOL BIOL+, V43, P757, DOI 10.1134/S0026893309050070; Lohse M, 2013, NUCL ACIDS RES; Lu D, 2016, FLORA CHINA, V6; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Mayer C., 2010, PHOBOS VERSION 3 3 1; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Ni LH, 2016, GENE, V577, P281, DOI 10.1016/j.gene.2015.12.005; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Sloan DB, 2014, MOL PHYLOGENET EVOL, V72, P82, DOI 10.1016/j.ympev.2013.12.004; Sloan DB, 2012, GENOME BIOL EVOL, V4, P294, DOI 10.1093/gbe/evs006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun QB, 2008, CROP SCI, V48, P1865, DOI 10.2135/cropsci2008.02.0074; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tsumura Y, 2000, MOL BIOL EVOL, V17, P1302, DOI 10.1093/oxfordjournals.molbev.a026414; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	60	11	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172924	10.1371/journal.pone.0172924	http://dx.doi.org/10.1371/journal.pone.0172924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241056	gold, Green Published, Green Submitted			2022-12-27	WOS:000395934400051
J	Moussette, S; Al Tuwaijri, A; Kohan-Ghadr, HR; Elzein, S; Farias, R; Berube, J; Ho, BC; Laprise, C; Goodyer, CG; Rousseau, S; Naumova, AK				Moussette, Sanny; Al Tuwaijri, Abeer; Kohan-Ghadr, Hamid-Reza; Elzein, Samar; Farias, Raquel; Berube, Julie; Ho, Bianca; Laprise, Catherine; Goodyer, Cynthia G.; Rousseau, Simon; Naumova, Anna K.			Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells	PLOS ONE			English	Article							GENOME-WIDE LINKAGE; GENE-EXPRESSION; CTCF-BINDING; ASTHMA; ORMDL3; ASSOCIATION; 17Q21; RISK; SUSCEPTIBILITY; POLYMORPHISMS	Chromosomal region 17q12-q21 is associated with asthma and harbors regulatory polymorphisms that influence expression levels of all five protein-coding genes in the region: IKAROS family zinc finger 3 (Aiolos) (IKZF3), zona pellucida binding protein 2 (ZPBP2), ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3), and gasdermins A and B (GSDMA, GSDMB). Furthermore, DNA methylation in this region has been implicated as a potential modifier of the genetic risk of asthma development. To further characterize the effect of DNA methylation, we examined the impact of treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) that causes DNA demethylation, on expression and promoter methylation of the five 17q12-q21 genes in the human airway epithelium cell line NuLi-1, embryonic kidney epithelium cell line 293T and human adenocarcinoma cell line MCF-7. 5-aza-dC treatment led to upregulation of expression of GSDMA in all three cell lines. ZPBP2 was upregulated in NuLi-1, but remained repressed in 293T and MCF-7 cells, whereas ORMDL3 was upregulated in 293T and MCF-7 cells, but not NuLi-1. Upregulation of ZPBP2 and GSDMA was accompanied by a decrease in promoter methylation. Moreover, 5-aza-dC treatment modified allelic expression of ZPBP2 and ORMDL3 suggesting that different alleles may respond differently to treatment. We also identified a polymorphic CTCF-binding site in intron 1 of ORMDL3 carrying a CG SNP rs4065275 and determined its methylation level. The site's methylation was unaffected by 5-aza-dC treatment in NuLi-1 cells. We conclude that modest changes (8-13%) in promoter methylation levels of ZPBP2 and GSDMA may cause substantial changes in RNA levels and that allelic expression of ZPBP2 and ORMDL3 is mediated by DNA methylation.	[Moussette, Sanny; Kohan-Ghadr, Hamid-Reza; Elzein, Samar; Goodyer, Cynthia G.; Naumova, Anna K.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Al Tuwaijri, Abeer; Ho, Bianca; Naumova, Anna K.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Farias, Raquel; Rousseau, Simon] McGill Univ, Ctr Hlth, Meakins Christie Labs, Res Inst, Montreal, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ, Dept Pediat & Expt Med, Montreal, PQ, Canada; [Naumova, Anna K.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Kohan-Ghadr, Hamid-Reza] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA	McGill University; McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; McGill University; McGill University; Wayne State University	Naumova, AK (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.; Naumova, AK (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Naumova, AK (corresponding author), McGill Univ, Dept Obstet & Gynecol, Montreal, PQ, Canada.	anna.naoumova@mcgill.ca	Farias, Raquel/ABB-7985-2020; Kohan-Ghadr, Hamid-Reza/ABB-4848-2020	Farias, Raquel/0000-0003-1729-2997; Naumova, Anna K./0000-0001-8481-5765; Laprise, Catherine/0000-0001-5526-9945; Rousseau, Simon/0000-0002-8773-575X	Canadian Institutes of Health Research (CIHR); Cystic Fibrosis Canada; CIHR (MOP) [123496]; Centre grant from Les Fonds de Recherche du Quebec-Sante (FRQ-S); FRSQ; Mexican program CONACYT; National Guard Health Affairs Saudi Arabia scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; CIHR (MOP)(Canadian Institutes of Health Research (CIHR)); Centre grant from Les Fonds de Recherche du Quebec-Sante (FRQ-S); FRSQ(Fonds de la Recherche en Sante du Quebec); Mexican program CONACYT; National Guard Health Affairs Saudi Arabia scholarship	This work was supported by funds from the Canadian Institutes of Health Research (CIHR) (to AN). We acknowledge the financial support of Cystic Fibrosis Canada and the CIHR (MOP#123496). The Meakins-Christie Laboratories - MUHC-RI are supported by a Centre grant from Les Fonds de Recherche du Quebec-Sante (FRQ-S). SR acknowledges a salary award from the FRSQ. RF acknowledges a salary award from the Mexican program CONACYT. CL is the director of the Asthma Strategic Group of the Respiratory Health Network (RHN), investigator of CHILD Study and is a member of the AllerGen NCE Inc. CL is the chairholder of the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergies. AA is a recipient of the National Guard Health Affairs Saudi Arabia scholarship.	Acevedo N, 2015, HUM MOL GENET, V24, P875, DOI 10.1093/hmg/ddu479; Aguet F., 2016, LOCAL GENETIC EFFECT; Al Tuwaijri A, 2016, J MED GENET, V53, P232, DOI 10.1136/jmedgenet-2015-103313; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berce V, 2013, PHARMACOGENOMICS J, V13, P523, DOI 10.1038/tpj.2012.36; Berlivet S, 2012, HUM GENET, V131, P1161, DOI 10.1007/s00439-012-1142-x; Bockmuhl Y, 2015, EPIGENETICS-US, V10, P247, DOI 10.1080/15592294.2015.1017199; Bouzigon E, 2010, EUR J HUM GENET, V18, P700, DOI 10.1038/ejhg.2009.224; Brauner EV, 2012, GENES IMMUN, V13, P94, DOI 10.1038/gene.2011.51; Dizier MH, 2007, EUR J HUM GENET, V15, P810, DOI 10.1038/sj.ejhg.5201830; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GUNTAKA RV, 1987, FEBS LETT, V221, P332, DOI 10.1016/0014-5793(87)80951-1; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; KRUCZEK I, 1983, P NATL ACAD SCI-BIOL, V80, P7586, DOI 10.1073/pnas.80.24.7586; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Light N, 2014, EPIGENETICS-US, V9, P1238, DOI 10.4161/epi.29920; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loser S, J ALLERGY CLIN IMMUN; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Naumova AK, 2013, HUM GENET, V132, P811, DOI 10.1007/s00439-013-1298-z; Ong Chin-Tong, 2009, Journal of Biology (London), V8, P73, DOI 10.1186/jbiol165; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pirinen M, 2015, BIOINFORMATICS, V31, P2497, DOI 10.1093/bioinformatics/btv074; Schaefer S, 2015, Q REV BIOL, V90, P381, DOI 10.1086/683699; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Smit LAM, 2010, EUR RESPIR J, V36, P57, DOI 10.1183/09031936.00154509; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VARDIMON L, 1981, EUR J CELL BIOL, V25, P13; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Yang IV, J ALLERGY CLIN IMMUN; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	44	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172707	10.1371/journal.pone.0172707	http://dx.doi.org/10.1371/journal.pone.0172707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241063	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000395934400033
J	Wszedybyl-Winklewska, M; Wolf, J; Swierblewska, E; Kunicka, K; Gruszecka, A; Gruszecki, M; Kucharska, W; Winklewski, PJ; Zabulewicz, J; Guminski, W; Pietrewicz, M; Frydrychowski, AF; Bieniaszewski, L; Narkiewicz, K				Wszedybyl-Winklewska, Magdalena; Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Gruszecka, Agnieszka; Gruszecki, Marcin; Kucharska, Wieslawa; Winklewski, Pawel J.; Zabulewicz, Joanna; Guminski, Wojciech; Pietrewicz, Michal; Frydrychowski, Andrzej F.; Bieniaszewski, Leszek; Narkiewicz, Krzysztof			Acute hypoxia diminishes the relationship between blood pressure and subarachnoid space width oscillations at the human cardiac frequency	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; PULSE-WAVE ENCEPHALOPATHY; PIAL ARTERY PULSATION; CEREBRAL EDEMA; VASCULAR-RESPONSE; BRAIN; HYPERTENSION; DISEASE; FLOW; HYDROCEPHALUS	Background Acute hypoxia exerts strong effects on the cardiovascular system. Heart-generated pulsatile cerebrospinal fluid motion is recognised as a key factor ensuring brain homeostasis. We aimed to assess changes in heart-generated coupling between blood pressure (BP) and subarachnoid space width (SAS) oscillations during hypoxic exposure. Methods Twenty participants were subjected to a controlled decrease in oxygen saturation (SaO(2) = 80%) for five minutes. BP and heart rate (HR) were measured using continuous finger-pulse photoplethysmography, oxyhaemoglobin saturation with an ear-clip sensor, end-tidal CO2 with a gas analyser, and cerebral blood flow velocity (CBFV), pulsatility and resistive indices with Doppler ultrasound. Changes in SAS were recorded with a recently-developed method called near-infrared transillumination/backscattering sounding. Wavelet transform analysis was used to assess the relationship between BP and SAS oscillations. Results Gradual increases in systolic, diastolic BP and HR were observed immediately after the initiation of hypoxic challenge (at fifth minute +20.1%, +10.2%, +16.5% vs. baseline, respectively; all P< 0.01), whereas SAS remained intact (P = NS). Concurrently, the CBFV was stable throughout the procedure, with the only increase observed in the last two minutes of deoxygenation (at the fifth minute +6.8% vs. baseline, P< 0.05). The cardiac contribution to the relationship between BP and SAS oscillations diminished immediately after exposure to hypoxia (at the fifth minute, right hemisphere -27.7% and left hemisphere -26.3% vs. baseline; both P< 0.05). Wavelet phase coherence did not change throughout the experiment (P = NS). Conclusions Cerebral haemodynamics seem to be relatively stable during short exposure to normobaric hypoxia. Hypoxia attenuates heart-generated BP SAS coupling.	[Wszedybyl-Winklewska, Magdalena; Winklewski, Pawel J.; Zabulewicz, Joanna; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Wolf, Jacek; Swierblewska, Ewa; Kunicka, Katarzyna; Kucharska, Wieslawa; Narkiewicz, Krzysztof] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Gruszecka, Agnieszka; Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Winklewski, Pawel J.] Pomeranian Univ Slupsk, Inst Hlth Sci, Slupsk, Poland; [Guminski, Wojciech] Gdansk Univ Technol, Fac Elect Telecommun & Informat, Dept Comp Commun, Gdansk, Poland; [Pietrewicz, Michal] Gdansk Univ Technol, Fac Elect Telecommun & Informat, Dept Biomed Engn, Gdansk, Poland; [Bieniaszewski, Leszek] Med Univ Gdansk, Ctr Med Simulat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Wszedybyl-Winklewska, M (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	magdalenawinklewska@gumed.edu.pl	Gumiński, Wojciech/B-5004-2013; Bieniaszewski, Leszek/U-9635-2018	Gumiński, Wojciech/0000-0002-3113-3450; Bieniaszewski, Leszek/0000-0001-6237-521X; Wszedybyl-Winklewska, Magdalena/0000-0001-5180-7224; Gruszecka, Agnieszka/0000-0003-4382-9540; Gruszecki, Marcin/0000-0003-1709-3939; Narkiewicz, Krzysztof/0000-0001-5949-5018; Winklewski, Pawel/0000-0002-1671-2163	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; REGPOT ICRC-ERA Human Bridge grant by the EU [316345]	European Regional Development Fund - Project FNUSA-ICRC; REGPOT ICRC-ERA Human Bridge grant by the EU	Drs. Jacek Wolf, and Krzysztof Narkiewicz are supported by the European Regional Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the REGPOT ICRC-ERA Human Bridge grant No. 316345 provided by the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguet JP, 2005, CHEST, V128, P3407, DOI 10.1378/chest.128.5.3407; Bateman GA, 2002, NEURORADIOLOGY, V44, P740, DOI 10.1007/s00234-002-0812-0; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Beggs CB, 2016, J NEUROIMAGING, V26, P136, DOI 10.1111/jon.12249; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; Brassard P, 2016, CAN J CARDIOL, V32, P475, DOI 10.1016/j.cjca.2015.12.021; Chen SJ, 2014, P NATL ACAD SCI USA, V111, P13199, DOI 10.1073/pnas.1404493111; Clemson PT, 2014, PHYS REP, V542, P297, DOI 10.1016/j.physrep.2014.04.001; DiPasquale DM, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.437; Dubowitz DJ, 2009, J APPL PHYSIOL, V107, P244, DOI 10.1152/japplphysiol.90349.2008; Egnor M, 2002, PEDIATR NEUROSURG, V36, P281, DOI 10.1159/000063533; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Foster GE, 2005, SCAND J MED SCI SPOR, V15, P3, DOI 10.1111/j.1600-0838.2005.00440.x; Foster GE, 2007, AM J RESP CRIT CARE, V175, P720, DOI 10.1164/rccm.200609-1271OC; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061936; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037529; Frydrychowski AF, 2012, MICROVASC RES, V83, P229, DOI 10.1016/j.mvr.2011.08.005; GREITZ D, 1993, ACTA RADIOL, V34, P321; Gunnarsson SI, 2015, J SLEEP RES, V24, P680, DOI 10.1111/jsr.12321; Himadri P, 2010, HIGH ALT MED BIOL, V11, P231, DOI 10.1089/ham.2009.1057; JENNUM P, 1989, CHEST, V95, P279, DOI 10.1378/chest.95.2.279; Jolly TAD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00782; Khoo SM, 2009, SLEEP BREATH, V13, P89, DOI 10.1007/s11325-008-0209-3; Li ZY, 2011, MICROVASC RES, V82, P304, DOI 10.1016/j.mvr.2011.08.004; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Song TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0528-4; Sovic and Sersic, 2012, ENG REV, V32, P70; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Talbot NP, 2005, J APPL PHYSIOL, V98, P1125, DOI 10.1152/japplphysiol.00903.2004; Tkacova R, 2014, EUR RESPIR J, V44, P931, DOI 10.1183/09031936.00225113; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Vestergaard MB, 2016, J CEREBR BLOOD F MET, V36, P1046, DOI 10.1177/0271678X15606460; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135429; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135751; Wolf J, 2016, INT J CARDIOL, V202, P67, DOI 10.1016/j.ijcard.2015.08.139; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	46	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172842	10.1371/journal.pone.0172842	http://dx.doi.org/10.1371/journal.pone.0172842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241026	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400045
J	Yu, LX; Chao, S; Singh, RP; Sorrells, ME				Yu, Long-Xi; Chao, Shiaoman; Singh, Ravi P.; Sorrells, Mark E.			Identification and validation of single nucleotide polymorphic markers linked to Ug99 stem rust resistance in spring wheat	PLOS ONE			English	Article							F-SP TRITICI; RACE TTKS; GENE; CULTIVARS; VIRULENCE; SELECTION; ELONGATUM; 7DL.7AG; AFRICA; TRAITS	Wheat stem rust (Puccinia graminis f. sp. tritici Eriks. and E. Henn.) is one of the most destructive diseases world-wide. Races belonging to Ug99 (or TTKSK) continue to cause crop losses in East Africa and threaten global wheat production. Developing and deploying wheat varieties with multiple race-specific genes or complex adult plant resistance is necessary to achieve durability. In the present study, we applied genome-wide association studies (GWAS) for identifying loci associated with the Ug99 stem rust resistance (SR) in a panel of wheat lines developed at the International Maize and Wheat Improvement Center (CIMMYT). Genotyping was carried out using the wheat 9K iSelect single nucleotide polymorphism (SNP) chip. Phenotyping was done in the field in Kenya by infection of Puccinia graminis f. sp. tritici race TTKST, the Sr24-virulent variant of Ug99. Marker-trait association identified 12 SNP markers significantly associated with resistance. Among them, 7 were mapped on five chromosomes. Markers located on chromosomes 4A and 4B overlapped with the location of the Ug99 resistance genes SrND643 and Sr37, respectively. Markers identified on 7DL were collocated with Sr25. Additional significant markers were located in the regions where no Sr gene has been reported. The chromosome location for five of the SNP markers was unknown. A BLASTN search of the NCBI database using the flanking sequences of the SNPs associated with Ug99 resistance revealed that several markers were linked to plant disease resistance analogues, while others were linked to regulatory factors or metabolic enzymes. A KASP (Kompetitive Allele Specific PCR) assay was used for validating six marker loci linked to genes with resistance to Ug99. Of those, four co-segregated with the Sr25-pathotypes while the rest identified unknown resistance genes. With further investigation, these markers can be used for marker-assisted selection in breeding for Ug99 stem rust resistance in wheat.	[Yu, Long-Xi] USDA ARS, Plant Germplasm Intro & Testing Res, Prosser, WA 99350 USA; [Sorrells, Mark E.] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND USA; [Singh, Ravi P.] Int Maize & Wheat Improvement Ctr CIMMYT, Apdo, El Batan, Mexico	United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Yu, LX (corresponding author), USDA ARS, Plant Germplasm Intro & Testing Res, Prosser, WA 99350 USA.; Sorrells, ME (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA.	Longxi.yu@ars.usda.gov; mes12@cornell.edu	Singh, Ravi Prakash/I-5575-2019		Bill & Melinda Gates Foundation; USDA-ARS [2090-21000-031-05-A, 149-430]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by funds provided by a grant from the Bill & Melinda Gates Foundation to Cornell University for the Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project, partial support from the USDA-ARS Cooperative Project 2090-21000-031-05-A and Hatch Project 149-430. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds provided by a grant from the Bill & Melinda Gates Foundation to Cornell University for the Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project, partial support from the USDA-ARS Cooperative Project 2090-21000-031-05-A and Hatch Project 149-430.	Bansal UK, 2008, EUPHYTICA, V164, P821, DOI 10.1007/s10681-008-9736-z; Bariana HS, 2007, AUST J AGR RES, V58, P576, DOI 10.1071/AR07124; Basnet BR, 2015, PHYTOPATHOLOGY, V105, P470, DOI 10.1094/PHYTO-01-14-0016-R; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Doyle J. J., 1987, PHYTOCHEM B, P11; FRIEBE B, 1994, CROP SCI, V34, P400, DOI 10.2135/cropsci1994.0011183X003400020018x; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Jin Y, 2007, PLANT DIS, V91, P1096, DOI 10.1094/PDIS-91-9-1096; Jin Y, 2009, PLANT DIS, V93, P367, DOI 10.1094/PDIS-93-4-0367; KNOTT DR, 1980, CAN J GENET CYTOL, V22, P651, DOI 10.1139/g80-071; McIntosh RA, 2012, ANN WHEAT NEWSLETT, V58, P259; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Olson EL, 2013, THEOR APPL GENET; Park R.F., 1995, WHEAT RUSTS ATLAS RE, DOI [DOI 10.1007/978-94-011-0083-0, 10.1007/978-94-011-0083-0]; Pretorius ZA, 2010, PLANT DIS, V94, P784, DOI 10.1094/PDIS-94-6-0784C; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Singh RP, 1998, CROP SCI, V38, P27, DOI 10.2135/cropsci1998.0011183X003800010005x; Wanyera R, 2006, PLANT DIS, V90, P113, DOI 10.1094/PD-90-0113A; Yu LX, 2014, THEOR APPL GENET, V127, P1561, DOI 10.1007/s00122-014-2326-7; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y	25	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171963	10.1371/journal.pone.0171963	http://dx.doi.org/10.1371/journal.pone.0171963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241006	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400012
J	Sama, CB; Takah, NF; Danwe, VK; Melo, UF; Dingana, TN; Angwafo, FF				Sama, Carlson-Babila; Takah, Noah F.; Danwe, Valery K.; Melo, Uzeru Forchu; Dingana, Therence Nwana; Angwafo, Fru F., III			Knowledge and utilization of the partograph: A cross-sectional survey among obstetric care providers in urban referral public health institutions in northwest and southwest Cameroon	PLOS ONE			English	Article								Background The enormous challenge to maternal well-being with associated maternal wastages during labour has remained an unsurmountable problem in Cameroon which reflects the current high maternal mortality rate. Evidence abounds that cost-effective and affordable health interventions like the use of the partograph will contribute to curb the alarming number of intrapartum maternal deaths. However, little is known about the level of knowledge and utilization of this simple life-saving tool in the North-and South-West Regions, Cameroon. Methods Using a self-administered structured questionnaire, a cross-sectional study was conducted from January 4th-March 25th 2016 among non-physician obstetric care providers (OCPs) across urban public health institutions in these regions. Logistic regression models were used to identify factors associated with good knowledge and routine utilization of the partograph. Results Of the 79 eligible participants, 71 (89.9%) took part in the study. The mean age of the respondents was 37.9-10.0 years with majority being female (85.9%). Less than one-third (29.6%) of the respondents had good knowledge on the partograph and only 23 (32.4%) routinely used it in monitoring labour. OCPs working in Maternal and Infant Welfare Clinics were about 4 times more likely than those working in Regional/District Hospitals to have good knowledge on the partograph [AOR = 3.88 (95% CI: 1.07-14.04)], p = 0.04. Little or no knowledge of the partograph and poor staff strength in the study centres were factors militating against its routine use. Conclusions The knowledge and use of the partograph in this study is sub-optimal. Regular in-service training of OCPs superimposed with periodic workshops and seminars, provision of reasonable staff numbers, and mandatory institutional policies on routine use of the partograph are recommended as vital first steps towards ensuring the safety of women in labour in the North-and South-West Regions of Cameroon.	[Sama, Carlson-Babila] Islamic Medicalized Hlth Ctr, Babessi, Cameroon; [Sama, Carlson-Babila; Danwe, Valery K.; Melo, Uzeru Forchu; Dingana, Therence Nwana] GCRG, Buea, Cameroon; [Takah, Noah F.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Danwe, Valery K.] St Blaise Catholic Hosp, Bamenda, Cameroon; [Melo, Uzeru Forchu] Buea Reg Hosp, Dept Obstet & Gynaecol, Buea, Cameroon; [Dingana, Therence Nwana] Catholic Gen Hosp, Njinikom, Cameroon; [Angwafo, Fru F., III] Gynaeco Obstet & Paediat Hosp, Yaounde, Cameroon; [Angwafo, Fru F., III] Univ Teaching Hosp Yaounde 1, Dept Surg, Yaounde, Cameroon	University of Glasgow	Sama, CB (corresponding author), Islamic Medicalized Hlth Ctr, Babessi, Cameroon.; Sama, CB (corresponding author), GCRG, Buea, Cameroon.	sama.carlson@yahoo.com						Abebe F, 2013, SCI J CLIN MED, V2, P26, DOI DOI 10.11648/j.sjcm.20130202.11; [Anonymous], TRENDS MAT MORT 1990; Asibong U, 2014, INT J WOMENS HEALTH, V6, P873, DOI 10.2147/IJWH.S49188; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Dohbit J. S., 2010, Clinics in Mother and Child Health, V7, P1215; Egbe T, 2016, GYNECOL OBSTET RES O, V2, P102, DOI DOI 10.17140/GOROJ-2-124; Fawole A, 2008, AFRICAN J REPROD HLT, V12, P23; Fawole AO, 2010, NIGER J CLIN PRACT, V13, P200; KWAST BE, 1994, LANCET, V343, P1399; Lavender T, 2011, AFR J MIDWIFERY WOME, V5, P117, DOI DOI 10.12968/AJMW.2011.5.3.117; Magon N., 2011, INT J CLIN CASES INV, V3, P6; Margaret K, 2012, USE DOCUMENTATION PA; Nakkazi S, 2001, GLOB HLTH ANN C AM C; Nyamtema AS, 2008, INT J GYNECOL OBSTET, V100, P37, DOI 10.1016/j.ijgo.2007.06.049; Ogwang S, 2009, AFR HEALTH SCI, V9, pS27; Okokon I, 2014, INT J FAMILY MED; Oladapo O T, 2006, J Obstet Gynaecol, V26, P538, DOI 10.1080/01443610600811243; Opiah Margaret M, 2012, Afr J Reprod Health, V16, P125; STUDD J, 1973, BRIT MED J, V4, P451, DOI 10.1136/bmj.4.5890.451; Umezulike AC, 1999, INT J GYNECOL OBSTET, V65, P203, DOI 10.1016/S0020-7292(98)00168-4; WAKGARI N, 2015, BMC RES NOTES, V8, P407, DOI DOI 10.1186/S13104-015-1363-X; WHO (World Health Organization), 2015, STRAT END PREV MAT M; Yisma E, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-23; Yisma E, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-17	24	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172860	10.1371/journal.pone.0172860	http://dx.doi.org/10.1371/journal.pone.0172860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234990	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200155
J	Acevedo, LM; Raya, AI; Martinez-Moreno, JM; Aguilera-Tejero, E; Rivero, JLL				Acevedo, Luz M.; Raya, Ana I.; Martinez-Moreno, Julio M.; Aguilera-Tejero, Escolastico; Rivero, Jose-Luis L.			Mangiferin protects against adverse skeletal muscle changes and enhances muscle oxidative capacity in obese rats	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; INSULIN-RESISTANCE; ANTIDIABETIC ACTIVITY; MEDICINAL PROPERTIES; ZUCKER RATS; FIBER TYPES; ACTIVATION; HYPERGLYCEMIA; HYPERLIPIDEMIA; METABOLISM	Obesity-related skeletal muscle changes include muscle atrophy, slow-to-fast fiber-type transformation, and impaired mitochondrial oxidative capacity. These changes relate with increased risk of insulin resistance. Mangiferin, the major component of the plant Mangifera indica, is a well-known anti-inflammatory, anti-diabetic, and antihyperlipidemic agent. This study tested the hypothesis that mangiferin treatment counteracts obesity-induced fiber atrophy and slow-to-fast fiber transition, and favors an oxidative phenotype in skeletal muscle of obese rats. Obese Zucker rats were fed gelatin pellets with (15 mg/kg BW/day) or without (placebo group) mangiferin for 8 weeks. Lean Zucker rats received the same gelatin pellets without mangiferin and served as non-obese and non-diabetic controls. Lesser diameter, fiber composition, and histochemical succinic dehydrogenase activity (an oxidative marker) of myosin-based fiber-types were assessed in soleus and tibialis cranialis muscles. A multivariate discriminant analysis encompassing all fiber-type features indicated that obese rats treated with mangiferin displayed skeletal muscle phenotypes significantly different compared with both lean and obese control rats. Mangiferin significantly decreased inflammatory cytokines, preserved skeletal muscle mass, fiber cross-sectional size, and fiber-type composition, and enhanced muscle fiber oxidative capacity. These data demonstrate that mangiferin attenuated adverse skeletal muscle changes in obese rats.	[Acevedo, Luz M.; Rivero, Jose-Luis L.] Univ Cordoba, Dept Comparat Anat & Pathol Anat, Lab Muscular Biopathol, Cordoba, Spain; [Raya, Ana I.; Aguilera-Tejero, Escolastico] Univ Cordoba, Dept Anim Med & Surg, Cordoba, Spain; [Raya, Ana I.; Martinez-Moreno, Julio M.; Aguilera-Tejero, Escolastico] Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Acevedo, Luz M.] Cent Univ Venezuela, Dept Ciencias Biomed, Maracay, Venezuela	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; University of Central Venezuela	Rivero, JLL (corresponding author), Univ Cordoba, Dept Comparat Anat & Pathol Anat, Lab Muscular Biopathol, Cordoba, Spain.	an1lorij@uco.es	Raya, Ana I/A-9548-2017; Martínez, Julio Manuel/AAA-6724-2020; RIVERO, JOSE/O-4129-2019	Raya, Ana I/0000-0002-4489-9447; Martínez, Julio Manuel/0000-0002-1945-5078; RIVERO, JOSE/0000-0001-7706-609X	Spanish Government Grant from the Institute de Salud Carlos III [PI14/00467]; European Funds; PAI Group [CTS-179]; Junta de Andalucia, Spain [P10 AGR-5963]	Spanish Government Grant from the Institute de Salud Carlos III; European Funds; PAI Group; Junta de Andalucia, Spain(Junta de Andalucia)	The work reported here was supported by a Spanish Government Grant from the Institute de Salud Carlos III (PI14/00467) with co-financing from European Funds. L.M.A., and J.L.L.R. were supported by grants of the PAI Group CTS-179 and Project P10 AGR-5963, Junta de Andalucia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2006, CELL TISSUE RES, V323, P283, DOI 10.1007/s00441-005-0057-4; Acevedo LM, 2016, J APPL PHYSIOL; Acevedo LM, 2015, AM J PHYSIOL-RENAL, V309, pF638, DOI 10.1152/ajprenal.00195.2015; Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;504::AID-PTR533&gt;3.0.CO;2-9; Apontes P, 2014, DIABETES, V63, P3626, DOI 10.2337/db14-0006; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Benard O, 2015, MINI-REV MED CHEM, V15, P582, DOI 10.2174/1389557515666150401111410; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Caiozzo VJ, 2003, AM J PHYSIOL-REG I, V285, pR570, DOI 10.1152/ajpregu.00646.2002; Couturier A, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-16; Couturier A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-48; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204; Giron MD, 2009, CLIN NUTR, V28, P565, DOI 10.1016/j.clnu.2009.04.018; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Han J, 2015, J ETHNOPHARMACOL, V172, P368, DOI 10.1016/j.jep.2015.05.016; Han J, 2015, MOL CELL ENDOCRINOL, V405, P63, DOI 10.1016/j.mce.2015.02.008; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huang THW, 2006, TOXICOL APPL PHARM, V210, P225, DOI 10.1016/j.taap.2005.05.003; Jakubiec-Puka A, 1999, ACTA BIOCHIM POL, V46, P823, DOI 10.18388/abp.1999_4154; Kumar BD, 2013, PHARMACOGN MAG, V9, P72, DOI 10.4103/0973-1296.108145; Lally JSV, 2012, DIABETOLOGIA, V55, P479, DOI 10.1007/s00125-011-2367-2; LARSSON L, 1988, J NEUROL SCI, V85, P27, DOI 10.1016/0022-510X(88)90033-0; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Lim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090137; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mahali SK, 2014, J CELL PHYSIOL, V229, P1972, DOI 10.1002/jcp.24647; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; Miura T, 2001, PHYTOMEDICINE, V8, P85, DOI 10.1078/0944-7113-00009; Miura T, 2001, BIOL PHARM BULL, V24, P1009, DOI 10.1248/bpb.24.1009; Miura T, 2001, BIOL PHARM BULL, V24, P1091, DOI 10.1248/bpb.24.1091; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pal PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107220; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Pompeani N, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/s12952-014-0019-z; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Ringseis R, 2013, J NUTR, V143, P125, DOI 10.3945/jn.112.164038; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Sellamuthu PS, 2014, PAK J PHARM SCI, V27, P161; Sellamuthu Periyar Selvam, 2013, ISRN Pharmacol, V2013, P750109, DOI 10.1155/2013/750109; Serrano AL, 2000, PFLUG ARCH EUR J PHY, V441, P263, DOI 10.1007/s004240000408; Shah K A, 2010, Pharmacogn Rev, V4, P42, DOI 10.4103/0973-7847.65325; Stohs SJ, 2015, PHYTOTHER RES, V29, P986, DOI 10.1002/ptr.5382; Tsubaki M, 2015, AM J TRANSL RES, V7, P1371; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Vyas A, 2012, MINI-REV MED CHEM, V12, P412, DOI 10.2174/138955712800493870; Wang F, 2014, PHARM BIOL, V52, P68, DOI 10.3109/13880209.2013.814691; Wessels B, 2015, DIABETES OBES METAB, V17, P52, DOI 10.1111/dom.12388	54	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173028	10.1371/journal.pone.0173028	http://dx.doi.org/10.1371/journal.pone.0173028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253314	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300061
J	Jo, YH; Kim, SB; Liu, Q; Do, SG; Hwang, BY; Lee, MK				Jo, Yang Hee; Kim, Seon Beom; Liu, Qing; Do, Seon-Gil; Hwang, Bang Yeon; Lee, Mi Kyeong			Comparison of pancreatic lipase inhibitory isoflavonoids from unripe and ripe fruits of Cudrania tricuspidata	PLOS ONE			English	Article							HIGH-FAT-DIET; INDUCED OBESITY; CONSTITUENTS; FLAVONOIDS; MICE; ROOTS; CULTIVARS; ORLISTAT; EXTRACT; FLOWERS	The composition and content of the active constituents and their biological activity vary according to diverse factors including their maturation stages. A previous study showed that the fruits of Cudrania tricuspidata inhibited pancreatic lipase activity, a key enzyme in fat absorption. In this study, we investigated the chemical composition and pancreatic lipase inhibitory activity of unripe and ripe fruits of C. tricuspidata. Unripe fruits of C. tricuspidata have a higher content of total phenolic and flavonoids and exhibited stronger pancreatic lipase inhibition compared to ripe fruits. HPLC analysis revealed the different chemical compositions of the unripe and ripe fruits. Further fractionation resulted in the isolation of 30 compounds including two new isoflavonoids. Analysis of the chemical constituents of the unripe and ripe fruits revealed that a 2,2-dimethylpyran ring, a cyclized prenyl, was the predominant side chain in the unripe fruits, whereas it was a linear prenyl group in the ripe fruits. In addition, a new isoflavonoid (19) from the unripe fruits showed the most potent inhibition on pancreatic lipase. Taken together, the maturation stage is an important factor for maximum efficacy and that unripe fruits of C. tricuspidata are a good source of new bioactive constituents for the regulation of obesity	[Jo, Yang Hee; Kim, Seon Beom; Liu, Qing; Hwang, Bang Yeon; Lee, Mi Kyeong] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Do, Seon-Gil] Univera Inc, Wellness R&D Ctr, Seoul, South Korea	Chungbuk National University	Lee, MK (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.	mklee@chungbuk.ac.kr	Kim, Seon Beom/P-3944-2018; Kim, Seon Beom/AGP-7639-2022	Kim, Seon Beom/0000-0001-8015-1404	Basic Science Research Program through the National Research Foundation of Korea [2015R1D1A1A09058498]; Medical Research Center program through the National Research Foundation of Korea [20101-0029480]; Eco-Innovation Project of the Ministry of Environment, Korea [416-111-006]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Medical Research Center program through the National Research Foundation of Korea(National Research Foundation of Korea); Eco-Innovation Project of the Ministry of Environment, Korea	This work was supported by Basic Science Research Program (2015R1D1A1A09058498) and Medical Research Center program (20101-0029480) through the National Research Foundation of Korea (http:// www.nrf.re.kr) and by the Eco-Innovation Project (grant no. 416-111-006) of the Ministry of Environment, Korea (http://www.me.go.kr). The commercial company Univera provided support in the form of salaries for the author [SGD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Basic Science Research Program (2015R1D1A1A09058498) and Medical Research Center program (2010-0029480) through the National Research Foundation of Korea (http://www.nrf.re.kr) and by the Eco-Innovation Project (grant no. 416-111-006) of the Ministry of Environment, Korea (http://www.me.go.kr). The commercial company Univera provided support in the form of salaries for the author [SGD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section	Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X; Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024; Bizjak J, 2013, J AGR FOOD CHEM, V61, P10283, DOI 10.1021/jf403064p; Caligiani A, 2010, NUTRIENTS, V2, P280, DOI 10.3390/nu2030280; Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016; Cho EJ, 2003, PHYTOMEDICINE, V10, P544, DOI 10.1078/094471103322331520; Choi HJ, 2010, LETT APPL MICROBIOL, V51, P1, DOI 10.1111/j.1472-765X.2010.02845.x; Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Fu MQ, 2012, CHIN HERB MED, V4, P8, DOI 10.3969/j.issn.1674-6384.2012.01.003; Han XH, 2005, ARCH PHARM RES, V28, P1324, DOI 10.1007/BF02977895; Hill JO, 1999, AM J CLIN NUTR, V69, P1108; Huang K.F., 2001, CHINESE J CHEM, V12, P61; JAIN AC, 1978, J ORG CHEM, V43, P3446, DOI 10.1021/jo00412a004; Jeong JY, 2014, BIOORG MED CHEM LETT, V24, P2329, DOI 10.1016/j.bmcl.2014.03.067; Jo YH, 2015, NUTRIENTS, V7, P10480, DOI 10.3390/nu7125544; Kazuma K, 2003, PHYTOCHEMISTRY, V62, P229, DOI 10.1016/S0031-9422(02)00486-7; Kim SB, 2014, J ETHNOPHARMACOL, V151, P478, DOI 10.1016/j.jep.2013.10.064; KINOSHITA T, 1990, CHEM PHARM BULL, V38, P2756, DOI 10.1248/cpb.38.2756; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lin S, 2014, FOOD CHEM, V145, P220, DOI 10.1016/j.foodchem.2013.08.048; Maver M, 2005, J NAT PROD, V68, P1094, DOI 10.1021/np0580107; Maximo P, 2000, Z NATURFORSCH C, V55, P506; Maximo P, 2002, Z NATURFORSCH C, V57, P609; NKENGFACK AE, 1989, PHYTOCHEMISTRY, V28, P2522, DOI 10.1016/S0031-9422(00)98025-7; NONAKA GI, 1987, CHEM PHARM BULL, V35, P1105; Norbaek R, 1999, PHYTOCHEMISTRY, V51, P1139, DOI 10.1016/S0031-9422(98)00738-9; Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508; Pensec F, 2014, J AGR FOOD CHEM, V62, P7998, DOI 10.1021/jf502033s; Prescott AG, 2002, PHYTOCHEMISTRY, V60, P589, DOI 10.1016/S0031-9422(02)00155-3; RAO KSRM, 1987, TETRAHEDRON, V43, P3015; RUSSELL GB, 1990, PHYTOCHEMISTRY, V29, P1287, DOI 10.1016/0031-9422(90)85444-K; Serradilla M.J., 2011, FOOD SCI TECHNOL, V44, P199; Susumu S, 1994, NIPPON SHOKUHIN KOGY, V41, P847; TAHARA S, 1989, PHYTOCHEMISTRY, V28, P901, DOI 10.1016/0031-9422(89)80140-2; Talukdar AC, 2000, PHYTOCHEMISTRY, V53, P155, DOI 10.1016/S0031-9422(99)00489-6; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wang SY, 2009, FOOD CHEM, V112, P676, DOI 10.1016/j.foodchem.2008.06.032; Wang Y, 2013, BIOORGAN MED CHEM, V21, P6398, DOI 10.1016/j.bmc.2013.08.049; Wei SP, 2012, INT J MOL SCI, V13, P7375, DOI 10.3390/ijms13067375; Wu T, 2008, CHEM NAT COMPD+, V44, P370, DOI 10.1007/s10600-008-9067-2; Xu J, 2005, ARCH PHARM RES, V28, P395, DOI 10.1007/BF02977667; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zhao SH, 2009, FOOD CHEM, V114, P869, DOI 10.1016/j.foodchem.2008.10.026; Zheng ZP, 2006, J INTEGR PLANT BIOL, V48, P996, DOI 10.1111/j.1744-7909.2006.00227.x	45	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172069	10.1371/journal.pone.0172069	http://dx.doi.org/10.1371/journal.pone.0172069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253267	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300012
J	Shetelig, C; Limalanathan, S; Eritsland, J; Hoffmann, P; Seljeflot, I; Gran, JM; Aukrust, P; Ueland, T; Andersen, GO				Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Hoffmann, Pavel; Seljeflot, Ingebjorg; Gran, Jon Michael; Aukrust, Pal; Ueland, Thor; Andersen, Geir Oystein			Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function	PLOS ONE			English	Article							SERUM OSTEOPROTEGERIN; MAGNETIC-RESONANCE; RANK LIGAND; SALVAGE; PLAQUE; STEMI	Background Elevated levels of osteoprotegerin (OPG) have been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI). However, the role of OPG in myocardial injury and adverse remodeling in STEMI patients remains unclear. The aims of this observational cohort study were to evaluate: 1) the temporal profile of OPG during STEMI, 2) possible associations between OPG measured acutely and after 4 months, with infarct size, adverse left ventricular (LV) remodeling, microvascular obstruction (MVO) and myocardial salvage and 3) the effect of heparin administration on OPG levels. Methods Blood samples were drawn repeatedly from 272 STEMI patients treated with primary percutaneous coronary intervention (PCI). Cardiac magnetic resonance imaging (CMR) was performed in the acute phase and after 4 months. The effect of heparin administration on OPG levels was studied in 20 patients referred to elective coronary angiography. Results OPG levels measured acutely were significantly higher than Day 1 and during follow-up. OPG levels were correlated with age. No association was found between early OPG levels and CMR measurements at 4 months. Patients with >median OPG levels measured at Day 1 had larger final infarct size, lower LV ejection fraction (LVEF) at 4 months and higher frequency of MVO. There were no associations between OPG and change in end-diastolic volume or myocardial salvage. OPG remained associated with infarct size and LVEF after adjustment for relevant covariates, except peak troponin T and CRP. A 77% increase in OPG levels following heparin administration was found in patients undergoing elective coronary angiography. Conclusions OPG was found to be associated with myocardial injury, but not with LV remodeling or myocardial salvage. The use of OPG as a biomarker in STEMI patients seems to be limited by a strong association with age, confounding effect of heparin administration, and little additive value to established biomarkers.	[Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Hoffmann, Pavel; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Shetelig, Christian; Limalanathan, Shanmuganathan; Eritsland, Jan; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Univ Oslo, Ulleval Hosp, Ctr Clin Heart Res, Oslo, Norway; [Shetelig, Christian; Seljeflot, Ingebjorg; Aukrust, Pal; Ueland, Thor] Univ Oslo, Fac Med, Oslo, Norway; [Limalanathan, Shanmuganathan] Feiring Heart Clin, Feiring, Norway; [Eritsland, Jan; Seljeflot, Ingebjorg; Andersen, Geir Oystein] Ctr Heart Failure Res, Oslo, Norway; [Hoffmann, Pavel] Univ Oslo, Ulleval Hosp, Sect Intervent Cardiol, Oslo, Norway; [Gran, Jon Michael] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Gran, Jon Michael] Univ Oslo, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Shetelig, C (corresponding author), Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway.; Shetelig, C (corresponding author), Univ Oslo, Ulleval Hosp, Ctr Clin Heart Res, Oslo, Norway.; Shetelig, C (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	chrshe@ous-hf.no	Andersen, Geir/AAR-3010-2020		Norwegian Health and Rehabilitation Foundation; Center for Heart Failure Research, University of Oslo, Oslo, Norway	Norwegian Health and Rehabilitation Foundation; Center for Heart Failure Research, University of Oslo, Oslo, Norway	This work was supported by The Norwegian Health and Rehabilitation Foundation and Center for Heart Failure Research, University of Oslo, Oslo, Norway.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; Andersen GO, 2011, HEART, V97, P460, DOI 10.1136/hrt.2010.206714; Bjerre M, 2014, SCAND CARDIOVASC J, V48, P209, DOI 10.3109/14017431.2014.917767; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Crisafulli A, 2005, CLIN SCI, V109, P389, DOI 10.1042/CS20050058; Desch S, 2012, INT J CARDIOVAS IMAG, V28, P263, DOI 10.1007/s10554-011-9802-9; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Erkol A, 2012, ATHEROSCLEROSIS, V221, P254, DOI 10.1016/j.atherosclerosis.2011.12.031; Fuernau G, 2013, INT J CARDIOL, V167, P2134, DOI 10.1016/j.ijcard.2012.05.101; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Limalanathan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071780; Limalanathan S, 2010, CARDIOLOGY, V116, P103, DOI 10.1159/000316965; Lindberg S, 2014, CAN J CARDIOL, V30, P1523, DOI 10.1016/j.cjca.2014.08.015; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Nybo M, 2008, ATHEROSCLEROSIS, V201, P33, DOI 10.1016/j.atherosclerosis.2008.03.026; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Ueland T, 2001, EUR J ENDOCRINOL, V145, P685, DOI 10.1530/eje.0.1450685; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Vik A, 2007, THROMB HAEMOSTASIS, V98, P148, DOI 10.1160/TH06-11-0671; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173034	10.1371/journal.pone.0173034	http://dx.doi.org/10.1371/journal.pone.0173034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253327	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300062
J	Mowat, G; Curtis, PJ; Lafferty, DJR				Mowat, Garth; Curtis, P. Jeff; Lafferty, Diana J. R.			The influence of sulfur and hair growth on stable isotope diet estimates for grizzly bears	PLOS ONE			English	Article							URSUS-ARCTOS; SEASONAL-CHANGES; BROWN BEARS; NITROGEN; BLACK; DELTA-N-15; DELTA-C-13; DISCRIMINATION; SALMON; CARBON	Stable isotope ratios of grizzly bear (Ursus arctos) guard hair collected from bears on the lower Stikine River, British Columbia (BC) were analyzed to: 1) test whether measuring delta S-34 values improved the precision of the salmon (Oncorhynchus spp.) diet fraction estimate relative to delta N-15 as is conventionally done, 2) investigate whether measuring delta S-34 values improves the separation of diet contributions of moose (Alces alces), marmot (Marmota caligata), and mountain goat (Oreamnos americanus) and, 3) examine the relationship between collection date and length of hair and stable isotope values. Variation in isotope signatures among hair samples from the same bear and year were not trivial. The addition of delta S-34 values to mixing models used to estimate diet fractions generated small improvement in the precision of salmon and terrestrial prey diet fractions. Although the delta S-34 value for salmon is precise and appears general among species and areas, sulfur ratios were strongly correlated with nitrogen ratios and therefore added little new information to the mixing model regarding the consumption of salmon. Mean delta S-34 values for the three terrestrial herbivores of interest were similar and imprecise, so these data also added little new information to the mixing model. The addition of sulfur data did confirm that at least some bears in this system ate marmots during summer and fall. We show that there are bears with short hair that assimilate >20% salmon in their diet and bears with longer hair that eat no salmon living within a few kilometers of one another in a coastal ecosystem. Grizzly bears are thought to re-grow hair between June and October however our analysis of sectioned hair suggested at least some hairs begin growing in July or August, not June and, that hair of wild bears may grow faster than observed in captive bears. Our hair samples may have been from the year of sampling or the previous year because samples were collected in summer when bears were growing new hair. The salmon diet fraction increased with later hair collection dates, as expected if samples were from the year of sampling because salmon began to arrive in mid-summer. Bears that ate salmon had shorter hair and delta N-15 and delta S-34 values declined with hair length, also suggesting some hair samples were grown the year of sampling. To be sure to capture an entire hair growth period, samples must be collected in late fall. Early spring samples are also likely to be from the previous year but the date when hair begins to grow appears to vary. Choosing the longest hair available should increase the chance the hair was grown during the previous year and, maximize the period for which diet is measured.	[Mowat, Garth] BC Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada; [Mowat, Garth; Curtis, P. Jeff] Univ British Columbia, Dept Earth & Environm Sci, Okanagan Campus, Kelowna, BC, Canada; [Lafferty, Diana J. R.] North Carolina State Univ, Dept Forestry & Environm Resources, Program Wildlife Fisheries & Conservat Biol, Raleigh, NC USA	University of British Columbia; University of North Carolina; North Carolina State University	Mowat, G (corresponding author), BC Minist Forests Lands & Nat Resource Operat, Nat Resource Sci Sect, Nelson, BC, Canada.; Mowat, G (corresponding author), Univ British Columbia, Dept Earth & Environm Sci, Okanagan Campus, Kelowna, BC, Canada.	garth.mowat@gov.bc.ca			NovaGold Inc; University of British Columbia; BC Ministry of Forest, Lands and Natural Resource Operations	NovaGold Inc; University of British Columbia; BC Ministry of Forest, Lands and Natural Resource Operations	This work was funded by NovaGold Inc, the University of British Columbia and the BC Ministry of Forest, Lands and Natural Resource Operations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; BenDavid M, 1997, CAN J ZOOL, V75, P803, DOI 10.1139/z97-102; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Ciarniello LM, 2005, URSUS, V16, P47, DOI 10.2192/1537-6176(2005)016[0047:DBADSS]2.0.CO;2; Felicetti LA, 2004, CAN J ZOOL, V82, P493, DOI 10.1139/Z04-013; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Flynn R.W., 2010, ALASKA DEP FISH GAME; Fritzsche F, 2006, RAPID COMMUN MASS SP, V20, P1679, DOI 10.1002/rcm.2488; Garneau DE, 2008, MAMM BIOL, V73, P85, DOI 10.1016/j.mambio.2007.02.002; Hicks BJ, 2005, OECOLOGIA, V144, P558, DOI 10.1007/s00442-005-0035-2; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hopkins JB, 2014, ISOT ENVIRON HEALT S, V50, P322, DOI 10.1080/10256016.2014.922555; Jones ES, 2006, WILDLIFE SOC B, V34, P1320, DOI 10.2193/0091-7648(2006)34[1320:TVISCA]2.0.CO;2; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Kurle CM, 2011, MAR BIOL, V158, P2389, DOI 10.1007/s00227-011-1741-4; LEFRANC MN, 1987, GRIZZLY BEAR COMPEND; MacHutchon AG, 2003, HABITAT USE GRIZZLY, P64; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; Milakovic B, 2013, J WILDLIFE MANAGE, V77, P39, DOI 10.1002/jwmg.434; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Nehlich O, 2015, EARTH-SCI REV, V142, P1, DOI 10.1016/j.earscirev.2014.12.002; Nevin OT, 2003, INFLUENCE PREY ABUND; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Rosing MN, 1998, J WILDLIFE MANAGE, V62, P380, DOI 10.2307/3802302; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Shackleton DM., 1999, HOOFED MAMMALS BRIT; Van Daele MB, 2013, CAN J ZOOL, V91, P164, DOI 10.1139/cjz-2012-0221; Woods JG, 1999, WILDLIFE SOC B, V27, P616	41	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172194	10.1371/journal.pone.0172194	http://dx.doi.org/10.1371/journal.pone.0172194			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248995	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500030
J	Triguero-Mas, M; Gidlow, CJ; Martinez, D; de Bont, J; Carrasco-Turigas, G; Martinez-Iniguez, T; Hurst, G; Masterson, D; Donaire-Gonzalez, D; Seto, E; Jones, MV; Nieuwenhuijsen, MJ				Triguero-Mas, Margarita; Gidlow, Christopher J.; Martinez, David; de Bont, Jeroen; Carrasco-Turigas, Gloria; Martinez-Iniguez, Tania; Hurst, Gemma; Masterson, Daniel; Donaire-Gonzalez, David; Seto, Edmund; Jones, Marc V.; Nieuwenhuijsen, Mark J.			The effect of randomised exposure to different types of natural outdoor environments compared to exposure to an urban environment on people with indications of psychological distress in Catalonia	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; FOREST ENVIRONMENTS; WALKING; EXERCISE; HEALTH	Introduction Experimental studies have reported associations between short-term exposure to natural outdoor environments (NOE) and health benefits. However, they lack insight into mechanisms, often have low external and ecological validity, and have rarely focused on people with some psycho-physiological affection. The aim of this study was to use a randomized, case-crossover design to investigate: (i) the effects of unconstrained exposure to real natural and urban environments on psycho-physiological indicators of people with indications of psychological distress, (ii) the possible differential effects of 30 and 30+ 180 minutes exposures, and (iii) the possible mechanisms explaining these effects. Material and methods People (n = 26) with indications of psychological distress were exposed to green (Collserola Natural Park), blue (Castelldefels beach) and urban (Eixample neighbourhood) environments in Catalonia. They were exposed to all environments in groups for a period of 30+180 minutes between October 2013 and January 2014. During the exposure period, participants were instructed to do what they would usually do in that environment. Before, during (at 30 and 30+180 minutes) and after each exposure, several psycho-physiological measures were taken: mood (measured as Total Mood Disturbance, TMD), attention capacity (measured as backwards digit-span task), stress levels (measures as salivary cortisol), systolic and diastolic blood pressure, heart rate, autonomous nervous system (assessed as heart rate variability and the indicators: low frequency power (LF), high frequency power (HF), ratio between LF and HF (LF: HF), and coefficients of component variance of LF, HF, and LF: HF). We also measured several potential mediators: air pollution, noise, physical activity, social interactions, and self-perceived restoration experience. Results When compared with responses to urban environment, we found statistically significantly lower TMD [-4.78 (-7.77, -1.79) points difference], and salivary cortisol [-0.21 (-0.34, -0.08) log nmol/L] in the green exposure environment, and statistically significantly lower TMD [-4.53 (-7.57, -1.49) points difference], and statistically significant favourable changes in heart rate variability indicators (specifically LF: HF and CCV-LF: HF with around -0.20 points of difference of the indicators) in the blue exposure environment. Physical activity and self-perceived restoration experience partially mediated the associations between NOE and TMD. Physical activity and air pollution partially mediated the associations between NOE and heart rate variability. Discussion and conclusions This study extends the existing evidence on the benefits of NOE for people's health. It also suggests NOE potential as a preventive medicine, specifically focusing on people with indications of psychological distress.	[Triguero-Mas, Margarita; Martinez, David; de Bont, Jeroen; Carrasco-Turigas, Gloria; Martinez-Iniguez, Tania; Donaire-Gonzalez, David; Nieuwenhuijsen, Mark J.] Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain; [Triguero-Mas, Margarita; Martinez, David; de Bont, Jeroen; Carrasco-Turigas, Gloria; Martinez-Iniguez, Tania; Donaire-Gonzalez, David; Nieuwenhuijsen, Mark J.] Univ Pompeu Fabra, Barcelona, Spain; [Triguero-Mas, Margarita; Martinez, David; de Bont, Jeroen; Carrasco-Turigas, Gloria; Martinez-Iniguez, Tania; Donaire-Gonzalez, David; Nieuwenhuijsen, Mark J.] CIBERESP, Barcelona, Spain; [Gidlow, Christopher J.; Hurst, Gemma; Masterson, Daniel; Jones, Marc V.] Staffordshire Univ, Ctr Sport Hlth & Exercise Res, Stoke On Trent, Staffs, England; [Donaire-Gonzalez, David] Ramon Llull Univ, Fundacio Blanquerna, Phys Act & Sports Sci Dept, Barcelona, Catalonia, Spain; [Seto, Edmund] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Staffordshire University; Universitat Ramon Llull; University of Washington; University of Washington Seattle	Triguero-Mas, M (corresponding author), Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain.; Triguero-Mas, M (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Triguero-Mas, M (corresponding author), CIBERESP, Barcelona, Spain.	mtriguero@creal.cat	Nieuwenhuijsen, Mark J/C-3914-2017; Triguero-Mas, Margarita/AAA-9148-2020; Gidlow, Christopher James/C-5796-2018; Gonzalez, David Donaire/AAB-9651-2020; martinez, david/GQI-0849-2022; de Bont, Jeroen/N-3544-2019; Triguero-Mas, Margarita/G-1131-2015	Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Gidlow, Christopher James/0000-0003-4990-4572; Gonzalez, David Donaire/0000-0003-2337-1712; de Bont, Jeroen/0000-0001-9924-5961; Martinez, David/0000-0001-7001-7674; Triguero-Mas, Margarita/0000-0002-1580-2693; Jones, Marc/0000-0003-2999-3942; Hurst, Gemma/0000-0001-6155-1189	European Community [282996 (ENV.2011.1.2.3-2)]; Catalan Government [AGAUR FI-DGR-2013]; Spanish Ministry of Economy and Competitiveness [CIBERESP-2014]	European Community(European Commission); Catalan Government; Spanish Ministry of Economy and Competitiveness(Spanish Government)	MTM, CJG, GCT, GH, D. Masterson, ES, MVJ, and MJN were supported by the European Community's Seventh Framework Programme (FP/2007-2013) [grant agreement no: 282996 (ENV.2011.1.2.3-2)] (http://ec.europa.eu/index_en.htm). MTM: is funded by a grant from the Catalan Government (AGAUR FI-DGR-2013) and one from the Spanish Ministry of Economy and Competitiveness (CIBERESP-2014) (http://web.gencat.cat/en/inici/index.html, http://www.mineco.gob.es/portal/site/mineco/, respectively).	Ajuntament de Barcelona, 2013, EIX XIFR 1991 2003; Annerstedt M, 2013, PHYSIOL BEHAV, V118, P240, DOI 10.1016/j.physbeh.2013.05.023; Balaguer I., 1993, J SPORT PSYCHOL, V4, P39; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barton J, 2012, PERSPECT PUBLIC HEAL, V132, P89, DOI 10.1177/1757913910393862; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Beil K, 2013, INT J ENV RES PUB HE, V10, P1250, DOI 10.3390/ijerph10041250; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Brown DK, 2013, ENVIRON SCI TECHNOL, V47, P5562, DOI 10.1021/es305019p; Fone D, 2007, SOC SCI MED, V64, P633, DOI 10.1016/j.socscimed.2006.09.020; Fuentes I., 1995, ACT 5 C NAC PSIC ACT; Gidlow CJ, 2016, J ENVIRON PSYCHOL, V45, P22, DOI 10.1016/j.jenvp.2015.11.003; Gladwell VF, 2012, EUR J APPL PHYSIOL, V112, P3379, DOI 10.1007/s00421-012-2318-8; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Heritage SN, HLTH IMP ASS GREENSP; Hojgaard MV, 1998, AM J PHYSIOL-HEART C, V275, pH213; Korpela KM, 2008, HEALTH PLACE, V14, P636, DOI 10.1016/j.healthplace.2007.10.008; Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Li Q, 2011, EUR J APPL PHYSIOL, V111, P2845, DOI 10.1007/s00421-011-1918-z; Mao GX, 2012, BIOMED ENVIRON SCI, V25, P317, DOI 10.3967/0895-3988.2012.03.010; Marselle MR, 2013, INT J ENV RES PUB HE, V10, P5603, DOI 10.3390/ijerph10115603; Mitsaki E., 2011, THESIS, P5; Nieuwenhuijsen MJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004951; Palladino P, 2004, LEARN INDIVID DIFFER, V14, P137, DOI 10.1016/j.lindif.2004.01.001; Peacock J, 2007, MENT HLTH BENEFITS G; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Sellers CE, 2012, PREV MED, V55, P438, DOI 10.1016/j.ypmed.2012.09.005; Servei Meteorologic de Catalunya, 2014, EL CLIMA COMARCA A C; Sonntag-Ostrom E, 2014, URBAN FOR URBAN GREE, V13, P344, DOI 10.1016/j.ufug.2013.12.007; Terkelsen AJ, 2004, ACTA PHYSIOL SCAND, V180, P405, DOI 10.1111/j.1365-201X.2004.01263.x; Thorn L, 2011, PSYCHONEUROENDOCRINO, V36, P816, DOI 10.1016/j.psyneuen.2010.11.003; Tsunetsugu Yuko, 2007, Journal of Physiological Anthropology, V26, P135, DOI 10.2114/jpa2.26.135; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Yamaguchi M, 2006, J INT MED RES, V34, P152, DOI 10.1177/147323000603400204	39	47	49	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172200	10.1371/journal.pone.0172200	http://dx.doi.org/10.1371/journal.pone.0172200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248974	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000395983500031
J	Westphal, R; Simmons, C; Mesquita, MB; Wood, TC; Williams, SCR; Vernon, AC; Cash, D				Westphal, Robert; Simmons, Camilla; Mesquita, Michel B.; Wood, Tobias C.; Williams, Steve C. R.; Vernon, Anthony C.; Cash, Diana			Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; MOTOR CORTEX; MODULAR ORGANIZATION; 6-OHDA LESION; MRI; REORGANIZATION; CONNECTOME; ISOFLURANE; PLASTICITY	Resting-state functional MRI (rsfMRI) is an imaging technology that has recently gained attention for its ability to detect disruptions in functional brain networks in humans, including in patients with Parkinson's disease (PD), revealing early and widespread brain network abnormalities. This methodology is now readily applicable to experimental animals offering new possibilities for cross-species translational imaging. In this context, we herein describe the application of rsfMRI to the unilaterally-lesioned 6-hydroxydopamine (6-OHDA) rat, a robust experimental model of the dopamine depletion implicated in PD. Using graph theory to analyse the rsfMRI data, we were able to provide meaningful and translatable measures of integrity, influence and segregation of the underlying functional brain architecture. Specifically, we confirm that rats share a similar functional brain network topology as observed in humans, characterised by small-worldness and modularity. Interestingly, we observed significantly reduced functional connectivity in the 6-OHDA rats, primarily in the ipsilateral (lesioned) hemisphere as evidenced by significantly lower node degree, local efficiency and clustering coefficient in the motor, orbital and sensorimotor cortices. In contrast, we found significantly, and bilaterally, increased thalamic functional connectivity in the lesioned rats. The unilateral deficits in the cortex are consistent with the unilateral nature of this model and further support the validity of the rsfMRI technique in rodents. We thereby provide a methodological framework for the investigation of brain networks in other rodent experimental models of PD, as well as of animal models in general, for cross-comparison with human data.	[Westphal, Robert; Simmons, Camilla; Mesquita, Michel B.; Wood, Tobias C.; Williams, Steve C. R.; Cash, Diana] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England; [Vernon, Anthony C.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England	University of London; King's College London; University of London; King's College London	Westphal, R (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England.	robert.westphal@kcl.ac.uk	Williams, Steve C/D-6979-2011; Wood, Tobias/B-7576-2012	Williams, Steve C/0000-0003-4299-1941; Cash, diana/0000-0001-5021-1234; Simmons, Camilla/0000-0002-8561-4241; Vernon, Anthony/0000-0001-7305-1069; opoku, anita/0000-0001-7243-8157; Wood, Tobias/0000-0001-7640-5520; Mesquita, Michel/0000-0002-5594-5605	Lily Safra Hope Foundation; BBSRC [BB/N009088/1] Funding Source: UKRI; MRC [MC_PC_14105, MR/N026063/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N009088/1] Funding Source: researchfish; Medical Research Council [MR/N026063/1, MC_PC_14105] Funding Source: researchfish	Lily Safra Hope Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was kindly supported by the Lily Safra Hope Foundation http://www.edmondjsafra.org/ (Imaging Parkinson's Pathology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Binicewicz FZ, 2015, BRAIN STRUCTURE FUNC; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Brett M, 2002, PRESENTED AT THE 8TH; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carlson JD, 1999, BRAIN RES, V828, P12, DOI 10.1016/S0006-8993(99)01268-8; Casteels C, 2008, EUR J NUCL MED MOL I, V35, P124, DOI 10.1007/s00259-007-0558-3; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Claassen DO, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.573; D'Souza DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106156; Debeir T, 2005, EXP NEUROL, V193, P444, DOI 10.1016/j.expneurol.2005.01.007; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DUNNETT SB, 1987, BRAIN RES, V415, P63, DOI 10.1016/0006-8993(87)90269-1; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Gass N, 2014, EUR NEUROPSYCHOPHARM, V24, P381, DOI 10.1016/j.euroneuro.2013.12.004; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Gozzi A, 2015, NEUROIMAGE; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hou ZY, 2010, J CLIN NEUROSCI, V17, P628, DOI 10.1016/j.jocn.2009.07.101; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jang DP, 2012, NEUROSCI LETT, V513, P187, DOI 10.1016/j.neulet.2012.02.034; KOZLOWSKI MR, 1980, BRAIN RES, V197, P167, DOI 10.1016/0006-8993(80)90442-4; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lebedev AV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00045; Liang ZF, 2015, NEUROIMAGE, V104, P89, DOI 10.1016/j.neuroimage.2014.10.013; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liu CR, 2016, NEUROIMAGE, V139, P259, DOI 10.1016/j.neuroimage.2016.06.037; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Luo CY, 2015, J NEUROL, V262, P1557, DOI 10.1007/s00415-015-7750-3; Machado AGG, 2003, EPILEPSIA, V44, P500, DOI 10.1046/j.1528-1157.2003.37602.x; Marin C, 2007, EUR J NEUROSCI, V25, P259, DOI 10.1111/j.1460-9568.2006.05265.x; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MOLINARI M, 1985, EXP BRAIN RES, V57, P305; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; MORELLI M, 1993, SYNAPSE, V13, P264, DOI 10.1002/syn.890130309; Nagano-Saito A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00187; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; PAPA SM, 1994, BRAIN RES, V662, P69, DOI 10.1016/0006-8993(94)90796-X; PAXINOS G, 1997, THE RAT BRAIN IN STE; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rolinski M, 2015, NEUROIMAGE-CLIN, V8, P126, DOI 10.1016/j.nicl.2015.04.003; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Sarkaki A, 2012, AVICENNA J PHYTOMEDI, V2, P222; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Sforazzini F, 2016, BRAIN STRUCT FUNCT, V221, P941, DOI 10.1007/s00429-014-0948-9; Skidmore FM, 2013, NEUROIMAGE, V75, P249, DOI 10.1016/j.neuroimage.2011.06.056; SPIRDUSO WW, 1985, BRAIN RES, V335, P45, DOI 10.1016/0006-8993(85)90274-4; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Ueno T, 2014, NEUROBIOLOGY DIS; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; Westphal R, 2016, NEUROSCIENCE, V334, P166, DOI 10.1016/j.neuroscience.2016.07.046; WOOTEN GF, 1981, J NEUROSCI, V1, P285; Yu QB, 2012, CURR TOP MED CHEM, V12, P2415, DOI 10.2174/156802612805289890; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zerbi V, 2014, J NEUROSCI, V34, P13963, DOI 10.1523/JNEUROSCI.0684-14.2014	76	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172394	10.1371/journal.pone.0172394	http://dx.doi.org/10.1371/journal.pone.0172394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249008	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500039
J	Brinkhof, B; van Tol, HTA; Koerkamp, MJAG; Wubbolts, RW; Haagsman, HP; Roelen, BAJ				Brinkhof, Bas; van Tol, Helena T. A.; Koerkamp, Marian J. A. Groot; Wubbolts, Richard W.; Haagsman, Henk P.; Roelen, Bernard A. J.			Characterization of bovine embryos cultured under conditions appropriate for sustaining human naive pluripotency	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; INNER CELL MASS; IN-VITRO; GENE-EXPRESSION; STEM-CELLS; POSTHATCHING DEVELOPMENT; SELF-RENEWAL; ES CELLS; BLASTOCYSTS; EPIBLAST	In mammalian preimplantation development, pluripotent cells are set aside from cells that contribute to extra-embryonic tissues. Although the pluripotent cell population of mouse and human embryos can be cultured as embryonic stem cells, little is known about the pathways involved in formation of a bovine pluripotent cell population, nor how to maintain these cells in vitro. The objective of this study was to determine the transcriptomic profile related to bovine pluripotency. Therefore, in vitro derived embryos were cultured in various culture media that recently have been reported capable of maintaining the naive pluripotent state of human embryonic cells. Gene expression profiles of embryos cultured in these media were compared using microarray analysis and quantitative RT-PCR. Compared to standard culture conditions, embryo culture in 'naive' media reduced mRNA expression levels of the key pluripotency markers NANOG and POU5F1. A relatively high percentage of genes with differential expression levels were located on the X-chromosome. In addition, reduced XIST expression was detected in embryos cultured in naive media and female embryos contained fewer cells with H3K27me3 foci, indicating a delay in X-chromosome inactivation. Whole embryos cultured in one of the media, 5iLA, could be maintained until 23 days post fertilization. Together these data indicate that 'naive' conditions do not lead to altered expression of known genes involved in pluripotency. Interestingly, X-chromosome inactivation and development of bovine embryos were dependent on the culture conditions.	[Brinkhof, Bas; van Tol, Helena T. A.; Roelen, Bernard A. J.] Univ Utrecht, Dept Farm Anim Hlth, Fac Vet Med, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Wubbolts, Richard W.] Univ Utrecht, Dept Biochem & Cell Biol, Ctr Cellular Imaging, Fac Vet Med, Utrecht, Netherlands; [Haagsman, Henk P.] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Roelen, BAJ (corresponding author), Univ Utrecht, Dept Farm Anim Hlth, Fac Vet Med, Utrecht, Netherlands.	b.a.j.roelen@uu.nl	Wubbolts, Richard/ABH-6667-2020; Haagsman, Henk P/F-8919-2010; Brinkhof, Bas/S-8687-2017	Wubbolts, Richard/0000-0001-8661-7594; Brinkhof, Bas/0000-0003-3617-0709; Groot Koerkamp, Marian JA/0000-0002-0867-0821	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Esther van 't Veld of the Center for Cell Imaging (CCI), Utrecht, The Netherlands is thanked for her instructions and assistance with microscopic imaging. This work was supported by the Dutch Ministry of Economic Affairs.	Aardema H, 2011, BIOL REPROD, V85, P62, DOI 10.1095/biolreprod.110.088815; Abe H, 2003, J REPROD DEVELOP, V49, P193; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Brinkhof B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1448-x; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Davidson KC, 2015, DEVELOPMENT, V142, P3090, DOI 10.1242/dev.116061; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferguson EM, 2006, MOL REPROD DEV, V73, P1195, DOI 10.1002/mrd.20494; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gandhi AP, 2000, HUM REPROD, V15, P395, DOI 10.1093/humrep/15.2.395; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Herrmann D, 2013, EPIGENETICS-US, V8, P281, DOI 10.4161/epi.23899; JIANG H S, 1992, Theriogenology, V37, P229, DOI 10.1016/0093-691X(92)90298-6; Kimura K, 2004, MOL REPROD DEV, V67, P193, DOI 10.1002/mrd.10389; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Madeja ZE, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-32; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; McLean Z, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120832; Minkovsky A, 2012, STEM CELLS, V30, P48, DOI 10.1002/stem.755; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Peippo JP, 2002, MOL HUM REPROD, V8, P923, DOI 10.1093/molehr/8.10.923; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Roepman P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r117; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stringfellow DA, 2009, INT EMBRYO TRANSFER, P151; Teklenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032701; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Wang YX, 2016, CELL STEM CELL, V18, P301, DOI 10.1016/j.stem.2016.02.012; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yue MH, 2014, JOVE-J VIS EXP, DOI 10.3791/52053	53	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172920	10.1371/journal.pone.0172920	http://dx.doi.org/10.1371/journal.pone.0172920			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241084	Green Published, Green Accepted, gold			2022-12-27	WOS:000395934400049
J	Brown, DV; Filiz, G; Daniel, PM; Hollande, F; Dworkin, S; Amiridis, S; Kountouri, N; Ng, W; Morokoff, AP; Mantamadiotis, T				Brown, Daniel V.; Filiz, Gulay; Daniel, Paul M.; Hollande, Frederic; Dworkin, Sebastian; Amiridis, Stephanie; Kountouri, Nicole; Ng, Wayne; Morokoff, Andrew P.; Mantamadiotis, Theo			Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity	PLOS ONE			English	Article							CANCER; REVEALS; TRANSITIONS; METABOLISM; LANDSCAPE; SUBTYPES; STATES; BRAIN	Glioblastoma (GBM) is a heterogeneous tumor of the brain with a poor prognosis due to recurrence and drug resistance following therapy. Genome-wide profiling has revealed the existence of distinct GBM molecular subtypes that respond differently to aggressive therapies. Despite this, molecular subtype does not predict recurrence or drug resistance and overall survival is similar across subtypes. One of the key features contributing to tumor recurrence and resistance to therapy is proposed to be an underlying subpopulation of resistant glioma stem cells (GSC). CD133 expression has been used as a marker of GSCs, however recent evidence suggests the relationship between CD133 expression, GSCs and molecular subtype is more complex than initially proposed. The expression of CD133, Olig2 and CD44 was investigated using patient derived glioma stem-like cells (PDGCs) in vitro and in vivo. Different PDGCs exhibited a characteristic equilibrium of distinct CD133+ and CD44+ subpopulations and the influence of environmental factors on the intra-tumor equilibrium of CD133+ and CD44+ cells in PDGCs was also investigated, with hypoxia inducing a CD44+ to CD133+ shift and chemo-radiotherapy inducing a CD133+ to CD44+ shift. These data suggest that surveillance and modulation of intra-tumor heterogeneity using molecular markers at initial surgery and surgery for recurrent GBM may be important for more effective management of GBM.	[Brown, Daniel V.; Filiz, Gulay; Daniel, Paul M.; Hollande, Frederic; Mantamadiotis, Theo] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Dworkin, Sebastian] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Amiridis, Stephanie] Univ Melbourne, Dept Surg RMH, Melbourne, Vic, Australia; [Kountouri, Nicole; Ng, Wayne; Morokoff, Andrew P.] Univ Melbourne, Dept Med RMH, Melbourne, Vic, Australia	University of Melbourne; La Trobe University; University of Melbourne; University of Melbourne	Mantamadiotis, T (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia.	theom@unimelb.edu.au	Morokoff, Andrew/ABC-2783-2020; Mantamadiotis, Theo/W-9010-2019; Mantamadiotis, Theo/AAM-1346-2020; Hollande, Frederic/GLS-4120-2022	Morokoff, Andrew/0000-0002-5159-3438; Mantamadiotis, Theo/0000-0003-3971-5380; Hollande, Frederic/0000-0002-7046-8392; Ng, Wayne/0000-0002-9438-8055; Dworkin, Sebastian/0000-0001-5828-9992; Brown, Daniel/0000-0002-3594-5851	Department of Pathology at University of Melbourne (Pathology Funds) [531-42]; CASS Foundation [6236]; Pathology Funds [531-42]; Cell Signalling Laboratory	Department of Pathology at University of Melbourne (Pathology Funds); CASS Foundation; Pathology Funds; Cell Signalling Laboratory	This study was supported by funds from the Department of Pathology at University of Melbourne (Pathology Funds 531-42) to DVB, PMD and GF. This study was also supported by a CASS Foundation grant #6236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Josh Kie, Daniel Blashki, Vanta Jameson and Desiree Anthony for flow cytometry assistance. We thank the technicians at the Royal Melbourne Hospital for assisting with animal husbandry and maintenance of colonies. We extend our gratitude to the donors of the tumor derived PDGC lines. Prof Paul Waring for scientific discussions and financial support (Pathology Funds 531-42) of DVB PMD, GF and the Cell Signalling Laboratory.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Barrantes-Freer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130519; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown DV, 2015, ONCOTARGET, V6, P6267, DOI 10.18632/oncotarget.3365; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Daniel P, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.21; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Halliday J, 2014, P NATL ACAD SCI USA, V111, P5248, DOI 10.1073/pnas.1321014111; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoge RD, 2001, J CHEM NEUROANAT, V22, P43, DOI 10.1016/S0891-0618(01)00114-4; Hou LC, 2006, NEUROSURG FOCUS, V20, pE3; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Meng J, 2014, ONCOTARGET, V5, P4683, DOI 10.18632/oncotarget.2088; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Rodriguez-Pardo VM, 2013, CELL MOL BIOL LETT, V18, P11, DOI 10.2478/s11658-012-0036-1; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130	39	74	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172791	10.1371/journal.pone.0172791	http://dx.doi.org/10.1371/journal.pone.0172791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241049	Green Published, gold			2022-12-27	WOS:000395934400043
J	Carter, AY; Letronne, F; Fitz, NF; Mounier, A; Wolfe, CM; Nam, KN; Reeves, VL; Kamboh, H; Lefterov, I; Koldamova, R				Carter, Alexis Y.; Letronne, Florent; Fitz, Nicholas F.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Reeves, Valerie L.; Kamboh, Hafsa; Lefterov, Iliya; Koldamova, Radosveta			Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo- deficient mice	PLOS ONE			English	Article							AD MOUSE MODELS; ALZHEIMERS-DISEASE; REVERSE DEFICITS; APOLIPOPROTEIN-E; AMYLOID DEPOSITION; LXR AGONIST; APP23 MICE; MEMORY DEFICITS; BETA; EXPRESSION	ATP-binding cassette transporter A1 (ABCA1) controls cholesterol and phospholipid efflux to lipid-poor apolipoprotein E (APOE) and is transcriptionally controlled by Liver X receptors (LXRs) and Retinoic X Receptors (RXRs). In APP transgenic mice, lack of Abca1 increased A beta deposition and cognitive deficits. Abca1 haplo-deficiency in mice expressing human APOE isoforms, increased level of A beta oligomers and worsened memory deficits, preferentially in APOE4 mice. In contrast upregulation of Abca1 by LXR/RXR agonists significantly ameliorated pathological phenotype of those mice. The goal of this study was to examine the effect of LXR agonist T0901317 (T0) on the phenotype and brain transcriptome of APP/E3 and APP/E4 Abca1 haplo-deficient (APP/E3/Abca1(+/-)and APP/E4/Abca1(+/-)) mice. Our data demonstrate that activated LXRs/RXR ameliorated APOE4-driven pathological phenotype and significantly affected brain transcriptome. We show that in mice expressing either APOE isoform, T0 treatment increased mRNA level of genes known to affect brain APOE lipidation such as Abca1 and Abcg1. In both APP/E3/Abca1(+/-)and APP/E4/Abca1(+/-)mice, the application of LXR agonist significantly increased ABCA1 protein level accompanied by an increased APOE lipidation, and was associated with restoration of APOE4 cognitive deficits, reduced levels of A beta oligomers, but unchanged amyloid load. Finally, using Gene set enrichment analysis we show a significant APOE isoform specific response to LXR agonist treatment: Gene Ontology categories "Microtubule Based Process" and "Synapse Organization" were differentially affected in T0-treated APP/E4/Abca1(+/-)mice. Altogether, the results are suggesting that treatment of APP/E4/Abca1(+/-)mice with LXR agonist T0 ameliorates APOE4-induced AD-like pathology and therefore targeting the LXR-ABCA1-APOE regulatory axis could be effective as a potential therapeutic approach in AD patients, carriers of APOEe4.	[Carter, Alexis Y.; Letronne, Florent; Fitz, Nicholas F.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Reeves, Valerie L.; Kamboh, Hafsa; Lefterov, Iliya; Koldamova, Radosveta] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lefterov, I; Koldamova, R (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA.	iliyal@pitt.edu; radak@pitt.edu	Lefterov, Iliya/B-4767-2008	Fitz, Nicholas/0000-0001-6938-6536; Letronne, Florent/0000-0002-5330-0395; Lefterov, Iliya/0000-0002-0249-0280; Nam, Kyongnyon/0000-0002-5140-6014	National Institutes of Health [AG037481, AG037919, ES024233, AG044490]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037919, R01AG037481, K01AG044490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by the National Institutes of Health: AG037481: R.K. AG037919: I.L. ES024233: I.L, R.K. AG044490: N.F.F.	Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Benitez BA, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.010; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Casali BT, 2015, J NEUROSCI, V35, P9173, DOI 10.1523/JNEUROSCI.1000-15.2015; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corona AW, 2015, J NEUROIMMUNE PHARM; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cronican AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053478; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2015, BRAIN, V138, P3699, DOI 10.1093/brain/awv293; Fitz NF, 2014, J ALZHEIMERS DIS, V41, P535, DOI 10.3233/JAD-132789; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Jankowsky Joanna L, 2002, Curr Neurol Neurosci Rep, V2, P457, DOI 10.1007/s11910-002-0073-7; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; McDonald CL, 2016, BRAIN BEHAV IMMUN, V58, P191, DOI 10.1016/j.bbi.2016.07.143; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mounier A, 2015, J NEUROSCI, V35, P11862, DOI 10.1523/JNEUROSCI.1001-15.2015; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Nordestgaard LT, 2015, ALZHEIMERS DEMENT, V11, P1430, DOI 10.1016/j.jalz.2015.04.006; OBATA S, 1995, J CELL SCI, V108, P3765; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Skerrett R, 2014, NEUROBIOL DIS, V72, P104, DOI 10.1016/j.nbd.2014.05.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Tuosto L, 2015, CELL MOL LIFE SCI, V72, P4461, DOI 10.1007/s00018-015-2013-0; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	54	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172161	10.1371/journal.pone.0172161	http://dx.doi.org/10.1371/journal.pone.0172161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241068	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400015
J	Chen, X; Ye, HY; Li, SL; Jiao, BH; Wu, JQ; Zeng, PB; Chen, LM				Chen, Xu; Ye, Haiyan; Li, Shilin; Jiao, Baihai; Wu, Jianqin; Zeng, Peibin; Chen, Limin			Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs in vitro	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; HEMORRHAGIC-FEVER; INTERFERON-PRODUCTION; MEDIATED INHIBITION; ALPHA-INTERFERON; DENGUE VIRUS; STAT1; BUNYAVIRUS; INFECTION; REPLICATION	Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus (SFTS virus, SFTSV). At present there is still no specific antiviral treatment for SFTSV; To understand which cells support SFTSV life cycle and whether SFTSV infection activates host innate immunity, four different cell lines (Vero, Hela, Huh7.5.1, and Huh7.0) were infected with SFTSV. Intracellular/extracellular viral RNA and expression of IFN alpha, and IFN beta were detected by real-time RT-PCR following infection. To confirm the role of non-structural protein (NSs) of SFTSV in exogenous IFNa-induced Jak/STAT signaling, p-STAT1 (Western Blot), ISRE activity (Luciferase assay) and ISG expression (real-time PCR) were examined following IFNa stimulation in the presence or absence of over-expression of NSs in Hela cells. Our study showed that all the four cell lines supported SFTSV life cycle and SFTSV activated host innate immunity to produce type I IFNs in Hela cells but not in Huh7.0, Huh7.5.1 or Vero cells. NSs inhibited exogenous IFN alpha-induced Jak/STAT signaling as shown by decreased p-STAT1 level, suppressed ISRE activity and down-regulated ISG expression. Suppression of the exogenous Type I IFN-induced Jak/STAT signaling by NSs might be one of the mechanisms of SFTSV to evade host immune surveillance.	[Chen, Xu; Ye, Haiyan; Li, Shilin; Jiao, Baihai; Wu, Jianqin; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Chen, Xu; Ye, Haiyan; Li, Shilin; Jiao, Baihai; Wu, Jianqin; Chen, Limin] Peking Union Med Coll, Chengdu, Peoples R China; [Zeng, Peibin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Chen, Limin] Univ Toronto, Toronto Gen Res Inst, Toronto, ON, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Chen, LM (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.; Chen, LM (corresponding author), Peking Union Med Coll, Chengdu, Peoples R China.; Zeng, PB (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Chen, LM (corresponding author), Univ Toronto, Toronto Gen Res Inst, Toronto, ON, Canada.	zengpeibin@live.cn; limin_chen_99@yahoo.com	Chen, Limin/A-8813-2012		Natural Science Foundation of China (NSFC) [81400096, 81471956, 91442128]; Funding of Scientific support, Science and Technology Department of Sichuan province [2014SZ0025]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Funding of Scientific support, Science and Technology Department of Sichuan province	This study was supported by Natural Science Foundation of China (NSFC, Grant No. 81400096, 81471956 and 91442128) and Funding of Scientific support, Science and Technology Department of Sichuan province (Grant No. 2014SZ0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam B, 2015, GENET MOL RES, V14, P4215, DOI 10.4238/2015.April.28.4; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chaudhary V, 2015, J GEN VIROLOGY; Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0; Chen S, 2016, J MED VIROL, V88, P109, DOI 10.1002/jmv.24302; Debing Y, 2013, CURR OPIN VIROL, V3, P217, DOI 10.1016/j.coviro.2013.03.001; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; EMENY JM, 1979, J GEN VIROL, V43, P253, DOI 10.1099/0022-1317-43-1-253; Fisgin NT, 2009, EUR J CLIN MICROBIOL, V28, P929, DOI 10.1007/s10096-009-0728-2; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hastings AK, 2016, VIROLOGY, V494, P248, DOI 10.1016/j.virol.2016.04.022; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17; Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li YJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7417648; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ohagi Y, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/918135; Qiu XS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148560; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Streitenfeld H, 2003, J VIROL, V77, P5507, DOI 10.1128/JVI.77.9.5507-5511.2003; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wang LY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-366; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Wu XD, 2014, FASEB J, V28, P2504, DOI 10.1096/fj.13-243857; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang APP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002550; Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou L, 2015, MOL HUM REPROD, V21, P917, DOI 10.1093/molehr/gav058	44	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172744	10.1371/journal.pone.0172744	http://dx.doi.org/10.1371/journal.pone.0172744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234991	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200127
J	Nakajima-Adachi, H; Shibahara, K; Fujimura, Y; Takeyama, J; Hiraide, E; Kikuchi, A; Murakami, H; Hosono, A; Nochi, T; Wakatsuki, Y; Shimojo, N; Kaminogawa, S; Sato, R; Kiyono, H; Hachimura, S				Nakajima-Adachi, Haruyo; Shibahara, Kyoko; Fujimura, Yoko; Takeyama, Jun; Hiraide, Erika; Kikuchi, Akira; Murakami, Hitoshi; Hosono, Akira; Nochi, Tomonori; Wakatsuki, Yoshio; Shimojo, Naoki; Kaminogawa, Shuichi; Sato, Ryuichiro; Kiyono, Hiroshi; Hachimura, Satoshi			Critical role of intestinal interleukin-4 modulating regulatory T cells for desensitization, tolerance, and inflammation of food allergy	PLOS ONE			English	Article							DENDRITIC CELLS; ORAL IMMUNOTHERAPY; ANTIGEN; TH2	Background and objective The mechanism inducing either inflammation or tolerance to orally administered food allergens remains unclear. To investigate this we analyzed mouse models of food allergy (OVA23-3) and tolerance (DO11.10 [D10]), both of which express ovalbumin (OVA)-specific T-cell receptors. Methods OVA23-3, recombination activating gene (RAG)-2-deficient OVA23-3 (R23-3), D10, and RAG-2-deficient D10 (RD10) mice consumed a diet containing egg white (EW diet) for 2-28 days. Interleukin (IL)-4 production by CD4(+) T cells was measured as a causative factor of enteropathy, and anti-IL-4 antibody was used to reveal the role of Foxp3(+) OVA-specific Tregs (aiTreg) in this process. Results Unlike OVA23-3 and R23-3 mice, D10 and RD10 mice did not develop enteropathy and weight loss on the EW diet. On days 7-10, in EW-fed D10 and RD10 mice, splenic CD4(+) T cells produced significantly more IL-4 than did those in the mesenteric lymph nodes (MLNs); this is in contrast to the excessive IL-4 response in the MLNs of EW-fed OVA23-3 and R23-3 mice. EW-fed R23-3 mice had few aiTregs, whereas EW-fed RD10 mice had them in both tissues. Intravenous injections of anti-IL-4 antibody recovered the percentage of aiTregs in the MLNs of R23-3 mice. On day 28, in EW-fed OVA23-3 and R23-3 mice, expression of Foxp3 on CD4(+) T cells corresponded with recovery from inflammation, but recurrence of weight loss was observed on restarting the EW diet after receiving the control-diet for 1 month. No recurrence developed in D10 mice. Conclusions Excessive IL-4 levels in the MLNs directly inhibited the induction of aiTregs and caused enteropathy. The aiTregs generated in the attenuation of T cell-dependent food allergic enteropathy may function differently than aiTregs induced in a tolerance model. Comparing the two models enables to investigate their aiTreg functions and to clarify differences between inflammation with subsequent desensitization versus tolerance.	[Nakajima-Adachi, Haruyo; Shibahara, Kyoko; Fujimura, Yoko; Takeyama, Jun; Hiraide, Erika; Kikuchi, Akira; Murakami, Hitoshi; Sato, Ryuichiro; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Nochi, Tomonori; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Nakajima-Adachi, Haruyo; Shibahara, Kyoko; Takeyama, Jun; Hiraide, Erika; Murakami, Hitoshi; Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan; [Murakami, Hitoshi; Hosono, Akira; Kaminogawa, Shuichi] Nihon Univ, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Wakatsuki, Yoshio] Kyoto Univ, Dept Clin Bioregulatory Sci, Grad Sch Med, Kyoto, Japan; [Shimojo, Naoki] Chiba Univ, Dept Pediat, Chiba, Japan; [Kiyono, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nihon University; Kyoto University; Chiba University; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of Tokyo	Nakajima-Adachi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.; Nakajima-Adachi, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan.; Nakajima-Adachi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan.	aryu@mail.ecc.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Nochi, Tomonori/U-2533-2019	Nochi, Tomonori/0000-0003-1800-6972	Japan Society for the Promotion of Science (JSPS) [1945206, 26292065]; Grants-in-Aid for Scientific Research [26292065, 16H06207] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Restart Postdoctoral Fellow (HNA, 1945206; http://www.jsps.go.jp/english/e-pd/index.html) and Grant-in-Aid for Scientific Research (B) (SH, 26292065; http://www.jsps.go.jp/english/e-grants/index.html) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begin P, 2014, HUM VACC IMMUNOTHER, V10, P2295, DOI 10.4161/hv.29233; Berin MC, 2013, CURR BIOL, V23, pR389, DOI 10.1016/j.cub.2013.02.043; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Burton OT, 2014, J ALLERGY CLIN IMMUN, V134, P1310, DOI 10.1016/j.jaci.2014.05.042; Chu DK, 2014, MUCOSAL IMMUNOL, V7, P1395, DOI 10.1038/mi.2014.29; Cox L, 2013, CURR ALLERGY ASTHM R, V13, P178, DOI 10.1007/s11882-012-0335-7; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Faustino L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721817; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Nakajima-Adachi H, 2006, J ALLERGY CLIN IMMUN, V117, P1125, DOI 10.1016/j.jaci.2006.01.016; Nakajima-Adachi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107492; Nakajima-Adachi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1979, DOI 10.1271/bbb.120349; Nemoto Y, 2007, GASTROENTEROLOGY, V132, P176, DOI 10.1053/j.gastro.2006.10.035; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; SATO T, 1994, EUR J IMMUNOL, V24, P1512, DOI 10.1002/eji.1830240708; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shibahara Kyoko, 2014, Biosci Microbiota Food Health, V33, P41, DOI 10.12938/bmfh.33.41; Shiokawa A, 2009, IMMUNOL LETT, V125, P7, DOI 10.1016/j.imlet.2009.05.002; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Yamashita H, 2012, ALLERGY, V67, P201, DOI 10.1111/j.1398-9995.2011.02742.x; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Yoshida T, 1997, CLIN IMMUNOL IMMUNOP, V82, P207, DOI 10.1006/clin.1996.4319	25	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172795	10.1371/journal.pone.0172795	http://dx.doi.org/10.1371/journal.pone.0172795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234975	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200139
J	Willis, SC				Willis, Stuart C.			One species or four? Yes!...and, no. Or, arbitrary assignment of lineages to species obscures the diversification processes of Neotropical fishes	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; POPULATION-STRUCTURE; INTERSPECIFIC HYBRIDIZATION; TAXONOMIC INFLATION; TELEOSTEI CICHLIDAE; SOUTH-AMERICA; GENUS CICHLA; DELIMITATION; PHYLOGEOGRAPHY; TREE	Species are fundamental units in many biological disciplines, but there is continuing disagreement as to what species are, how to define them, and even whether the concept is useful. While some of this debate can be attributed to inadequate data and insufficient statistical frameworks in alpha taxonomy, an equal part results from the ambiguity over what species are expected to represent by the many who use them. Here, mtDNA data, microsatellite data, and sequence data from 17 nuclear loci are used in an integrated and quantitative manner to resolve the presence of evolutionary lineages, their contemporary and historical structure, and their correspondence to species, in a species complex of Amazonian peacock "bass" cichlids (Cichla pinima sensu lato). Results suggest that the historical narrative for these populations is more complex than can be portrayed by recognizing them as one, two, or four species: their history and contemporary dynamics cannot be unambiguously rendered as discrete units (taxa) at any level without both choosing the supremacy of one delimitation criterion and obscuring the very information that provides insight into the diversification process. This calls into question the utility of species as a rank, term, or concept, and suggests that while biologists may have a reasonable grasp of the structure of evolution, our methods of conveying these insights need updating. The lack of correspondence between evolutionary phenomena and discrete species should serve as a null hypothesis, and researchers should focus on quantifying the diversity in nature at whatever hierarchical level it occurs.	[Willis, Stuart C.] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX 78412 USA	Texas A&M University System	Willis, SC (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX 78412 USA.	swillis4@gmail.com						Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; Amado Manuella Villar, 2011, Int J Evol Biol, V2011, P360654, DOI 10.4061/2011/360654; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bagley JC, 2016, BIOL J LINN SOC; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bouckaert R., 2015, BIORXIV; Brinn MNA, 2004, HEREDITAS, V141, P252; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carvalho-Costa LF, 2011, MOL PHYLOGENET EVOL, V59, P177, DOI 10.1016/j.ympev.2011.02.005; Colatreli Olavo Pinhatti, 2012, Int J Evol Biol, V2012, P915265, DOI 10.1155/2012/915265; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Coyne J.A., 2004, SPECIATION; Cracraft J., 1989, P28; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Darwin C., 1859, ORIGIN SPECIES NATUR; Darwin C, 1856, COMMUNICATION; de Pinna Mario C.C., 1996, P147; de Pinna MCC, 1999, REV FISH BIOL FISHER, V9, P353, DOI 10.1023/A:1008911414399; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Degnan JH, 2005, EVOLUTION, V59, P24; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dufresnes C, 2016, MOL ECOL, V25, P4285, DOI 10.1111/mec.13706; Edwards DL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2765; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fuchs J, 2015, MOL ECOL, V24, P5460, DOI 10.1111/mec.13337; Fujita MK, 2011, P ROY SOC B-BIOL SCI, V278, P493, DOI 10.1098/rspb.2010.1864; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Grummer JA, 2015, MOL ECOL, V24, P1523, DOI 10.1111/mec.13122; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hart MW, 2011, EVOLUTION, V65, P613, DOI 10.1111/j.1558-5646.2010.01202.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hendry Andrew P., 2000, Conservation Genetics, V1, P67, DOI 10.1023/A:1010133721121; Hey J, 2001, TRENDS ECOL EVOL, V16, P326, DOI 10.1016/S0169-5347(01)02145-0; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Huang JP, 2016, SYST BIOL, V65, P685, DOI 10.1093/sysbio/syv119; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Jones G, 2017, J MATH BIOL, V74, P447, DOI 10.1007/s00285-016-1034-0; Karl SA, 1999, CONSERV BIOL, V13, P990, DOI 10.1046/j.1523-1739.1999.97352.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kuchta SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150022; Kullander SO, 2006, ICHTHYOL EXPLOR FRES, V17, P289; Kullander SO, 2012, CYBIUM, V36, P247; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lovejoy NR, 2000, MOL ECOL, V9, P259, DOI 10.1046/j.1365-294x.2000.00845.x; Mallet J, 2007, ENCY BIODIVERSITY; Mallet J, 2007, ENCY BIODIVERSITY; Marengo JA, 2016, INT J CLIMATOL, V36, P1033, DOI 10.1002/joc.4420; Mayr E., 1942, P1; McKay BD, 2013, MOL ECOL, V22, P4943, DOI 10.1111/mec.12446; Melo BF, 2016, MOL PHYLOGENET EVOL, V102, P189, DOI 10.1016/j.ympev.2016.05.037; Mishler BD, 2010, CONT DEBATES PHILOS; Moritz C, 2016, MOL ECOL, V25, P1354, DOI 10.1111/mec.13511; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Olave M, 2014, SYST BIOL, V63, P263, DOI 10.1093/sysbio/syt106; Oliveira AV, 2006, J FISH BIOL, V69, P260, DOI 10.1111/j.1095-8649.2006.01291.x; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Popper K.R., 1959, LOGIC SCI DISCOVERY; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 2003, GENETICS, V164, P1645; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Reis R.E., 2003, CHECKLIST FRESHWATER; Rittmeyer EN, 2012, MOL PHYLOGENET EVOL, V65, P451, DOI 10.1016/j.ympev.2012.06.031; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SLATKIN M, 1995, GENETICS, V139, P457; Solis-Lemus C, 2015, EVOLUTION, V69, P492, DOI 10.1111/evo.12582; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Teixeira AS, 2005, GENET MOL RES, V4, P74; Twomey E, 2016, AM NAT, V187, P205, DOI 10.1086/684439; Waples RS, 2010, MOL ECOL, V19, P2599, DOI 10.1111/j.1365-294X.2010.04675.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Waples RS, 1995, AM FISH S S, V17, P8; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Willis SC, 2010, MOL ECOL, V19, P1014, DOI 10.1111/j.1365-294X.2010.04540.x; Willis SC, 2007, MOL PHYLOGENET EVOL, V44, P291, DOI 10.1016/j.ympev.2006.12.014; Willis SC, 2015, CONSERV GENET, V16, P1345, DOI 10.1007/s10592-015-0744-y; Willis SC, 2014, EVOLUTION, V68, P256, DOI 10.1111/evo.12230; Willis SC, 2013, MOL PHYLOGENET EVOL, V69, P479, DOI 10.1016/j.ympev.2013.07.031; Willis SC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-96; Willis SC, 2012, MOL PHYLOGENET EVOL, V63, P798, DOI 10.1016/j.ympev.2012.02.018; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Winemiller Kirk O., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P93; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zapata F, 2012, SYST BIOL, V61, P179, DOI 10.1093/sysbio/syr084; Zimmer C, 2008, SCI AM, V298, P72, DOI 10.1038/scientificamerican0608-72	113	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172349	10.1371/journal.pone.0172349	http://dx.doi.org/10.1371/journal.pone.0172349			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235096	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200071
J	Friedman, D; Fryzek, J; Jiang, XH; Bloomfield, A; Ambrose, CS; Wong, PC				Friedman, Deborah; Fryzek, Jon; Jiang, Xiaohui; Bloomfield, Adam; Ambrose, Christopher S.; Wong, Pierre C.			Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses	PLOS ONE			English	Article							YOUNG-CHILDREN; PALIVIZUMAB PROPHYLAXIS; INFANTS; EPIDEMIOLOGY; CONTEMPORARY; GUIDELINES; INFECTION; MORBIDITY; RATES	Children with hemodynamically significant congenital heart disease (CHD) are at elevated risk of morbidity and mortality due to respiratory syncytial virus (RSV) disease compared to their healthy peers. Previous studies have demonstrated lower RSV hospitalization risk among all children with CHD at 12-23 months of age versus 0-11 months of age. However, RSV hospitalization risk at 12-23 months of age by specific CHD diagnosis has not been characterized. Both case-control and cohort studies were conducted using data from the US National Inpatient Sample from 1997 to 2013 to characterize relative risk of RSV hospitalization among children 12-23 months of age with CHD. Related CHD diagnoses were combined for analysis. Hospitalizations for RSV and unspecified bronchiolitis were described by length of stay, mechanical ventilation use, mortality, and total charges. Over the 17-year period, 1,168,886 live birth hospitalizations with CHD were identified. Multiple specific CHD conditions had an elevated odds ratio or relative risk of RSV hospitalization. Mean total RSV hospitalization charges were significantly higher among children with CHD relative to those without CHD ($19,650 vs $7,939 in 2015 dollars) for this period. Compared to children without CHD, children with Ebstein's anomaly, transposition of the great arteries, aortic stenosis, heterotaxia, and aortic arch anomalies had 367-, 344-, 203-, 117- and 47-fold increased risk of inpatient RSV mortality, respectively. Unspecified bronchiolitis hospitalization odds and relative risk across CHD diagnoses were similar to those observed with RSV hospitalization; however, unspecified bronchiolitis hospitalizations were associated with shorter mean days of stay and less frequently associated with mechanical ventilation or mortality. Among children with more severe CHD diagnoses, RSV disease remains an important health risk through the second year of life. These data can help inform decisions regarding interventions to protect children with CHD from severe RSV disease during their second year of life.	[Friedman, Deborah] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Fryzek, Jon; Jiang, Xiaohui] EpidStat Inst, Rockville, MD USA; [Bloomfield, Adam; Ambrose, Christopher S.] AstraZeneca, Gaithersburg, MD 20878 USA; [Wong, Pierre C.] Childrens Hosp, Div Cardiol, Los Angeles, CA USA	New York Medical College; AstraZeneca; Children's Hospital Los Angeles	Friedman, D (corresponding author), New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA.; Bloomfield, A (corresponding author), AstraZeneca, Gaithersburg, MD 20878 USA.	Deborah_Friedman@NYMC.edu; Adam.Bloomfield@astrazeneca.com		Bloomfield, Adam/0000-0002-5429-7378; Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca	AstraZeneca(AstraZeneca)	This research was funded by AstraZeneca. DF is a consultant to AstraZeneca and a member of the Speakers Bureau. JF and XJ provided consultant/research support for AstraZeneca, as employees of EpidStat. AstraZeneca provided Epidstat with research support for this study. AB and CSA are employees of AstraZeneca and hold stock or stock options. PCW has received grant/research support through his institution from AstraZeneca. The specific roles of these authors are articulated in the 'author contributions' section. Editorial assistance was provided by The Lockwood Group (Stamford, CT, USA) and funded by AstraZeneca. Palivizumab is marketed by MedImmune, a specialty care division of AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JS, 2003, PEDIATRICS, V112, P1442; Agency for Healthcare Research and Quality, 2012, PED QUAL IND 7 TECHN; Agency for Healthcare Research and Quality, 2006, MEAS PED HLTH CAR QU; Altman CA, 2000, PEDIATR CARDIOL, V21, P433, DOI 10.1007/s002460010103; American Academy of Pediatrics, 2012, RED BOOK REP COMM IN; Bollani L, 2015, RECOMMENDATIONS PROP; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Cheng HH, 2016, CONGENIT HEART DIS, V11, P80, DOI 10.1111/chd.12293; Chu PY, 2016, CARDIOL YOUNG, V10, P1; Doucette A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152208; Feinstein JA, 2014, PEDIATRICS, V133, pE1575, DOI 10.1542/peds.2013-3060; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Figueras Aloy J, 2015, AN PEDIAT BARC, V82; Forster J, 2012, GUIDELINE PREVENTION; Friedman DM, 2016, CLIN PEDIATR, V55, P724, DOI 10.1177/0009922815604598; Frohnert Barbara Kathleen, 2005, J Perinatol, V25, P737, DOI 10.1038/sj.jp.7211382; Granbom E, 2016, PEDIAT CARDIOL; Granbom E, 2014, ACTA PAEDIATR, V103, P840, DOI 10.1111/apa.12658; Hon KL, 2012, J CRIT CARE, V27, P464, DOI 10.1016/j.jcrc.2011.12.001; Jung Jo Won, 2011, Korean J Pediatr, V54, P192, DOI 10.3345/kjp.2011.54.5.192; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Li A, 2016, PEDIAT INFECT DIS J; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Makari D, 2015, CLIN PEDIATR, V54, P594, DOI 10.1177/0009922814546040; MOLER FW, 1992, CRIT CARE MED, V20, P1406, DOI 10.1097/00003246-199210000-00008; Nakazawa M, 2006, PEDIATR INT, V48, P190, DOI 10.1111/j.1442-200X.2006.02179.x; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ozyurt A, 2015, PEDIATR PULM, V50, P1025, DOI 10.1002/ppul.23102; Paes BA, 2011, CAN RESPIR J, V18, pE10, DOI 10.1155/2011/493056; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Peter G, 1997, RED BOOK REP COMM IF; Public Health England, 2013, IMM INF DIS RESP SYN; Robinson Joan L, 2015, Paediatr Child Health, V20, P321; Simon A, 2007, EUR J PEDIATR, V166, P1273, DOI 10.1007/s00431-007-0426-y; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Strickland MJ, 2008, CARDIOL YOUNG, V18, P92, DOI 10.1017/S1047951108002515; Svensson B, 2011, ACTA PAEDIATR, V100, P407, DOI 10.1111/j.1651-2227.2010.02029.x; Welke KF, 2009, ANN THORAC SURG, V87, P216, DOI 10.1016/j.athoracsur.2008.10.032; Whelan Barbara, 2016, Drugs Ther Perspect, V32, P119	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172512	10.1371/journal.pone.0172512	http://dx.doi.org/10.1371/journal.pone.0172512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253361	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300023
J	Markovic, R; Peltan, J; Gosak, M; Horvat, D; Zalik, B; Seguy, B; Chauvel, R; Malandain, G; Couffinhal, T; Duplaa, C; Marhl, M; Roux, E				Markovic, Rene; Peltan, Julien; Gosak, Marko; Horvat, Denis; Zalik, Borut; Seguy, Benjamin; Chauvel, Remi; Malandain, Gregoire; Couffinhal, Thierry; Duplaa, Cecile; Marhl, Marko; Roux, Etienne			Planar cell polarity genes frizzled4 and frizzled6 exert patterning influence on arterial vessel morphogenesis	PLOS ONE			English	Article							RETINAL VASCULAR DEVELOPMENT; HUMAN CEREBRAL-CORTEX; BLOOD-BRAIN-BARRIER; WNT/BETA-CATENIN; TISSUE POLARITY; PATHWAY; ANGIOGENESIS; NORRIN; KIDNEY; TREE	Quantitative analysis of the vascular network anatomy is critical for the understanding of the vasculature structure and function. In this study, we have combined microcomputed tomography (microCT) and computational analysis to provide quantitative three-dimensional geometrical and topological characterization of the normal kidney vasculature, and to investigate how 2 core genes of the Wnt/planar cell polarity, Frizzled4 and Frizzled6, affect vascular network morphogenesis. Experiments were performed on frizzled4 (Fzd4(-/-)) and frizzled6 (Fzd6(-/-)) deleted mice and littermate controls (WT) perfused with a contrast medium after euthanasia and exsanguination. The kidneys were scanned with a high-resolution (16 mu m) microCT imaging system, followed by 3D reconstruction of the arterial vasculature. Computational treatment includes decomposition of 3D networks based on Diameter-Defined Strahler Order (DDSO). We have calculated quantitative (i) Global scale parameters, such as the volume of the vasculature and its fractal dimension (ii) Structural parameters depending on the DDSO hierarchical levels such as hierarchical ordering, diameter, length and branching angles of the vessel segments, and (iii) Functional parameters such as estimated resistance to blood flow alongside the vascular tree and average density of terminal arterioles. In normal kidneys, fractal dimension was 2.07 +/- 0.11 (n = 7), and was significantly lower in Fzd4(-/-)(1.71 +/- 0.04; n = 4), and Fzd6(-/-)(1.54 +/- 0.09; n = 3) kidneys. The DDSO number was 5 in WT and Fzd4(-/-), and only 4 in Fzd6(-/-). Scaling characteristics such as diameter and length of vessel segments were altered in mutants, whereas bifurcation angles were not different from WT. Fzd4 and Fzd6 deletion increased vessel resistance, calculated using the Hagen-Poiseuille equation, for each DDSO, and decreased the density and the homogeneity of the distal vessel segments. Our results show that our methodology is suitable for 3D quantitative characterization of vascular networks, and that Fzd4 and Fzd6 genes have a deep patterning effect on arterial vessel morphogenesis that may determine its functional efficiency.	[Markovic, Rene; Gosak, Marko; Marhl, Marko] Univ Maribor, Fac Nat Sci & Math, Dept Phys, Maribor, Slovenia; [Markovic, Rene; Marhl, Marko] Univ Maribor, Fac Educ, Maribor, Slovenia; [Peltan, Julien; Seguy, Benjamin; Chauvel, Remi; Couffinhal, Thierry; Duplaa, Cecile; Roux, Etienne] INSERM, Biol Cardiovasc Dis U1034, Pessac, France; [Peltan, Julien; Chauvel, Remi; Couffinhal, Thierry; Roux, Etienne] Univ Bordeaux, Biol Cardiovasc Dis U1034, Pessac, France; [Peltan, Julien; Seguy, Benjamin; Chauvel, Remi; Couffinhal, Thierry] Ctr Hosp Univ Bordeaux, Serv Malad Cardiaques & Vasc, Bordeaux, France; [Gosak, Marko; Marhl, Marko] Univ Maribor, Inst Physiol, Fac Med, Maribor, Slovenia; [Horvat, Denis; Zalik, Borut] Univ Maribor, Fac Elect Engn & Comp Sci, Maribor, Slovenia; [Malandain, Gregoire] INRIA, Morpheme Team, Sophia Antipolis, France	University of Maribor; University of Maribor; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; University of Maribor; University of Maribor; Inria	Roux, E (corresponding author), INSERM, Biol Cardiovasc Dis U1034, Pessac, France.	etienne.roux@u-bordeaux.fr	Žalik, Borut/X-1320-2019; Duplàa, cecile/GLU-6264-2022; Couffinhal, Thierry/M-6857-2014; Markovič, Rene/M-3148-2019	Duplàa, cecile/0000-0001-8003-3969; Couffinhal, Thierry/0000-0002-9217-2533; Markovič, Rene/0000-0001-9068-6373; Gosak, Marko/0000-0001-9735-0485	French-Slovenian Hubert-Curien partnership Proteus [33325NL]	French-Slovenian Hubert-Curien partnership Proteus	Financial support for researchers' mobility: French-Slovenian Hubert-Curien partnership Proteus no 33325NL Endothelial planar cell polarity and vascular network structure and functionality http://www.campusfrance.org/fr/PHC.	Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cassot F, 2009, MICROCIRCULATION, V16, P331, DOI 10.1080/10739680802662607; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; CROSS SS, 1993, J PATHOL, V170, P479, DOI 10.1002/path.1711700412; Cvjetkovic N, 2015, MOL GENET GENOM MED, V3, P440, DOI 10.1002/mgg3.155; Denton KM, 2000, AM J PHYSIOL-REG I, V279, pR629, DOI 10.1152/ajpregu.2000.279.2.R629; Descamps B, 2012, CIRC RES, V110, P47, DOI 10.1161/CIRCRESAHA.111.250936; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; El Abbadi NK, 2013, J COMPUT SCI, V9, P1389; Franco CA, 2016, ELIFE, V5, DOI 10.7554/eLife.07727; GILGARCIA J, 1992, HISTOL HISTOPATHOL, V7, P563; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Huo YL, 2016, J BIOMECH, V49, P2531, DOI 10.1016/j.jbiomech.2016.01.044; Huo YL, 2009, BIOPHYS J, V96, P339, DOI 10.1016/j.bpj.2008.09.038; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kaimovitz B, 2005, ANN BIOMED ENG, V33, P1517, DOI 10.1007/s10439-005-7544-3; KASSAB GS, 1993, AM J PHYSIOL, V265, pH366, DOI 10.1152/ajpheart.1993.265.1.H366; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Korn C, 2014, DEVELOPMENT, V141, P1757, DOI 10.1242/dev.104422; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Leandro JJG, 2001, P 14 BRAZ S COMP GRA; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Manniesing R, 2006, MED IMAGE ANAL, V10, P200, DOI 10.1016/j.media.2005.09.001; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ren Y, 2008, AM J PHYSIOL-HEART C, V298, pH1769; Rodriguez-Gomez I, 2013, J ENDOCRINOL, V216, P43, DOI 10.1530/JOE-12-0208; Serra J, 1983, IMAGE ANAL MATH MORP; Sewduth RN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5832; Shi OY, 2014, NEUROL SCI, V35, P1701, DOI 10.1007/s10072-014-1815-4; Stark MR, 2000, MECH DEVELOP, V98, P121, DOI 10.1016/S0925-4773(00)00440-8; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; STRAHLER AN, 1957, EOS T AM GEOPHYS UNI, V38, P913, DOI DOI 10.1029/TR038I006P00913; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wilson NJ, 2013, J DERMATOL SCI, V70, P58, DOI 10.1016/j.jdermsci.2012.12.005; Xie WJ, 2003, PATTERN RECOGN, V36, P1529, DOI 10.1016/S0031-3203(02)00348-5; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	54	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171033	10.1371/journal.pone.0171033	http://dx.doi.org/10.1371/journal.pone.0171033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253274	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300003
J	Miyaki, E; Hiraga, N; Imamura, M; Uchida, T; Kan, H; Tsuge, M; Abe-Chayama, H; Hayes, CN; Makokha, GN; Serikawa, M; Aikata, H; Ochi, H; Ishida, Y; Tateno, C; Ohdan, H; Chayama, K				Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Ochi, Hidenori; Ishida, Yuji; Tateno, Chise; Ohdan, Hideki; Chayama, Kazuaki			Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus	PLOS ONE			English	Article							HEPATOCYTE CHIMERIC MOUSE; DENDRITIC CELLS; T-CELLS; VIROLOGICAL RESPONSE; IMMUNE-RESPONSES; THERAPY; LIVER; HCV; EPIDEMIOLOGY; INFECTIONS	Interferon (IFN) inhibits hepatitis C virus (HCV) replication through up-regulation of intrahepatic IFN-stimulated gene expression but also through activation of host immune cells. In the present study, we analyzed the immune cell-mediated antiviral effects of IFN-alpha using HCV-infected mice. Urokinase-type plasminogen activator (uPA)-severe combined immunodeficiency (SCID) mice with transplanted human hepatocytes were infected with genotype 1b HCV and injected with human peripheral blood mononuclear cells (PBMCs). IFN-alpha treatment following human PBMC transplantation resulted in a significant reduction in serum HCV RNA titers and a higher human CD45-positive mononuclear cell chimerism compared to mice without human PBMC transplantation. In mice with human PBMCs treated with IFN-alpha, serum concentrations of IFN-gamma increased, and natural killer T (NKT) cells, especially type I NKT cells, produced IFN-gamma. Mice in which IFN-gamma signaling was blocked using antibody or in which transplanted PBMCs were depleted for type I NKT cells showed similar levels of anti-HCV effect compared with mice treated only with IFN-alpha. These results show that IFN-alpha stimulates IFN-gamma expression in type 1 NKT cells and enhances the inhibition of HCV replication. We propose that type 1 NKT cells might represent a new therapeutic target for chronic hepatitis C patients.	[Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan; [Miyaki, Eisuke; Hiraga, Nobuhiko; Imamura, Michio; Uchida, Takuro; Kan, Hiromi; Tsuge, Masataka; Abe-Chayama, Hiromi; Hayes, C. Nelson; Makokha, Grace Naswa; Serikawa, Masahiro; Aikata, Hiroshi; Ochi, Hidenori; Ishida, Yuji; Tateno, Chise; Ohdan, Hideki; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan; [Ishida, Yuji; Tateno, Chise] PhoenixBio Co Ltd, Higashihiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Programs Biomed Res,Dept Surg, Hiroshima, Japan	Hiroshima University; Hiroshima University; RIKEN; PHOENIXBIO CO. LTD.; Hiroshima University	Chayama, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan.; Chayama, K (corresponding author), Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan.; Chayama, K (corresponding author), Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsuge, Masataka/G-5246-2019; Ohdan, Hideki/G-4719-2019; Uchida, Takuro/G-5011-2019; Hayes, C. Nelson N/G-4596-2019; Abe-Chayama, Hiromi/M-8256-2019	Tsuge, Masataka/0000-0001-7591-8287; Ohdan, Hideki/0000-0002-9066-1288; Chayama, Kazuaki/0000-0002-5530-5341; Makokha, Grace Naswa/0000-0002-2171-5609	Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED [15fk0210001h0002]	Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research is supported by research funding from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (grant number: 15fk0210001h0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. PhoenixBio Co. Ltd. provided support in the form of salaries for authors YI and CT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044; Doherty DG, 1999, J IMMUNOL, V163, P2314; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Kim DY, 2014, GUT LIVER, V8, P471, DOI 10.5009/gnl14083; Klenerman P, 2012, GUT, V61, P1226, DOI 10.1136/gutjnl-2011-300620; Kosaka K, 2013, BIOCHEM BIOPH RES CO, V441, P230, DOI 10.1016/j.bbrc.2013.10.040; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Ohdan H, 2003, TRANSPLANTATION, V76, P791, DOI 10.1097/01.TP.0000074603.36553.BD; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Okazaki A, 2012, HEPATOLOGY, V56, P555, DOI 10.1002/hep.25651; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; REYES VE, 1987, TRANSPLANTATION, V43, P412, DOI 10.1097/00007890-198703000-00018; Rossini A, 2001, DIGEST DIS SCI, V46, P2389, DOI 10.1023/A:1012303315214; Sarrazin C., 2015, J HEPATOL; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172412	10.1371/journal.pone.0172412	http://dx.doi.org/10.1371/journal.pone.0172412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253324	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300019
J	Roy, A; Basak, R; Rai, U				Roy, Alivia; Basak, Reetuparna; Rai, Umesh			De novo sequencing and comparative analysis of testicular transcriptome from different reproductive phases in freshwater spotted snakehead Channa punctatus	PLOS ONE			English	Article							GENE-EXPRESSION; SERTOLI-CELLS; GERM-CELLS; RNA-SEQ; TESTIS; PROTEIN; RAT; IDENTIFICATION; PROFILES; STAGE	The spotted snakehead Channa punctatus is a seasonally breeding teleost widely distributed in the Indian subcontinent and economically important due to high nutritional value. The declining population of C. punctatus prompted us to focus on genetic regulation of its reproduction. The present study carried out de novo testicular transcriptome sequencing during the four reproductive phases and correlated differential expression of transcripts with various testicular events in C. punctatus. The Illumina paired-end sequencing of testicular transcriptome from resting, preparatory, spawning and postspawning phases generated 41.94, 47.51, 61.81 and 44.45 million reads, and 105526, 105169, 122964 and 106544 transcripts, respectively. Transcripts annotated using Rattus norvegicus reference protein sequences and classified under various subcategories of biological process, molecular function and cellular component showed that the majority of the subcategories had highest number of transcripts during spawning phase. In addition, analysis of transcripts exhibiting differential expression during the four phases revealed an appreciable increase in upregulated transcripts of biological processes such as cell proliferation and differentiation, cytoskeleton organization, response to vitamin A, transcription and translation, regulation of angiogenesis and response to hypoxia during spermatogenically active phases. The study also identified significant differential expression of transcripts relevant to spermatogenesis (mgat3, nqo1, hes2, rgs4, cxcl2, alcam, agmat), steroidogenesis (star, tkt, gipc3), cell proliferation (eef1a2, btg3, pif1, myo16, grik3, trim39, plbd1), cytoskeletal organization (espn, wipf3, cd276), sperm development (klhl10, mast1, hspa1a, slc6a1, ros1, foxj1, hipk1), and sperm transport and motility (hint1, muc13). Analysis of functional annotation and differential expression of testicular transcripts depending on reproductive phases of C. punctatus helped in developing a comprehensive understanding on genetic regulation of spermatogenic and steroidogenic events in seasonally breeding teleosts. Our findings provide the basis for future investigation on the precise role of testicular genes in regulation of seasonal reproduction in male teleosts.	[Roy, Alivia; Basak, Reetuparna; Rai, Umesh] Univ Delhi, Dept Zool, Delhi, India	University of Delhi	Rai, U (corresponding author), Univ Delhi, Dept Zool, Delhi, India.	rai_u@rediffmail.com			Delhi University (DU)/Department of Science and Technology (DST) PURSE Grant [Dean (R)/2012/1477]; University Grants Commission and University of Delhi (DU), India [2079]; University teaching assistantship [Sch./UTA/2010/56769, Sch./UTA/2010/56765]; Department of Science and Technology (DST), India; University of Delhi (DU), India [IF10530]	Delhi University (DU)/Department of Science and Technology (DST) PURSE Grant; University Grants Commission and University of Delhi (DU), India; University teaching assistantship; Department of Science and Technology (DST), India(Department of Science & Technology (India)); University of Delhi (DU), India	UR received financial support from Delhi University (DU)/Department of Science and Technology (DST) PURSE Grant (Dean (R)/2012/1477). AR is thankful to University Grants Commission and University of Delhi (DU), India for providing financial aid in form of Non-National eligibility test (NET) fellowship (2079) and University teaching assistantship (Sch./UTA/2010/56769), respectively. RB is grateful to Department of Science and Technology (DST), India and University of Delhi (DU), India for providing Inspire Fellowship (IF10530) and University teaching assistantship (Sch./UTA/2010/56765), respectively, as financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; Bajpai M, 1998, EUR J ENDOCRINOL, V138, P322, DOI 10.1530/eje.0.1380322; Bansal SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127007; Bar I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2397-8; Barman HK, 2011, AQUAC RES, V42, P1196, DOI 10.1111/j.1365-2109.2010.02710.x; Basak R, 2016, FISH PHYSL BIOCH; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Cameron RS, 2013, CYTOSKELETON, V70, P328, DOI 10.1002/cm.21109; Cheng BH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-103; Conrad S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/138350; FAO Fisheries and Aquaculture Department, 2014, STAT WORLD FISH AQ O; Gallo A, 2012, MAR DRUGS, V10, P2861, DOI 10.3390/md10122861; Gam L.-H., 2006, MALAYS J BIOCH MOL B, V14, P25; Garcia TX, 2013, CELL CYCLE, V12, P2538, DOI 10.4161/cc.25627; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V385, P570, DOI 10.1016/j.bbrc.2009.05.103; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hayashi M, 2012, MOL REPROD DEV, V79, P870, DOI 10.1002/mrd.22127; Hayashi T, 2001, J ANDROL, V22, P999; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Hua HJ, 2000, CELL RES, V10, P51, DOI 10.1038/sj.cr.7290035; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Khan SA, 2009, REPRODUCTION, V138, P81, DOI 10.1530/REP-09-0052; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; Kim IH, 2011, J GINSENG RES, V35, P272, DOI 10.5142/jgr.2011.35.3.272; Laiho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061558; Lee SS, 2009, EXP CELL RES, V315, P1313, DOI 10.1016/j.yexcr.2008.11.021; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Magre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040306; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Marti HH, 2002, MOL ENDOCRINOL, V16, P234, DOI 10.1210/me.16.2.234; Miura T, 1999, BIOCHEM BIOPH RES CO, V264, P230, DOI 10.1006/bbrc.1999.1494; Molur S, 1998, WORKSH CONS ASS MAN; Murta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113365; Murta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072767; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nelson D., 2013, LEHNINGER PRINC BIOC, P521; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; OLIVA R, 1982, BIOCHEM J, V208, P269, DOI 10.1042/bj2080269; Orimo A, 2000, BIOCHEM BIOPH RES CO, V276, P45, DOI 10.1006/bbrc.2000.3380; Pang ALY, 2006, PHYSIOL GENOMICS, V24, P75, DOI 10.1152/physiolgenomics.00215.2004; PLANAS JV, 1995, BIOL REPROD, V52, P697, DOI 10.1095/biolreprod52.3.697; Pollack SE, 1997, J CLIN ENDOCR METAB, V82, P4243, DOI 10.1210/jc.82.12.4243; Redon E, 2010, REPRODUCTION, V140, P57, DOI 10.1530/REP-10-0021; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Sahu DK, 2013, GENE, V524, P1, DOI 10.1016/j.gene.2013.03.111; Sahu DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132450; Sastre M, 1996, J NEUROCHEM, V67, P1761; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Seo JT, 2005, YONSEI MED J, V46, P667, DOI 10.3349/ymj.2005.46.5.667; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shen HS, 2015, MAR GENOM, V23, P15, DOI 10.1016/j.margen.2015.03.002; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Sluka P, 2006, J ENDOCRINOL, V189, P381, DOI 10.1677/joe.1.06634; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; Tully DB, 2005, REPROD TOXICOL, V19, P353, DOI 10.1016/j.reprotox.2004.06.009; TUNG PS, 1990, BIOL REPROD, V42, P351, DOI 10.1095/biolreprod42.2.351; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang PJ, 2007, CHROMOSOME RES, V15, P623, DOI 10.1007/s10577-007-1141-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Xiang WP, 2011, CELL TISSUE RES, V344, P519, DOI 10.1007/s00441-011-1159-9; Xu K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125609; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101; Yang B, 2004, ASIAN J ANDROL, V6, P35; Yeung CH, 2004, MOL REPROD DEV, V68, P159, DOI 10.1002/mrd.20067; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Yu ZR, 2003, BIOL REPROD, V69, P37, DOI 10.1095/biolreprod.102.012609; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zappa F, 2001, J HISTOCHEM CYTOCHEM, V49, P1187, DOI 10.1177/002215540104900913; Zeng QF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138818; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6; Zhou W, 2010, BIOL REPROD, V83, P759, DOI 10.1095/biolreprod.110.085472; Zhou YF, 2015, MAR GENOM, V24, P241, DOI 10.1016/j.margen.2015.06.007	78	14	16	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173178	10.1371/journal.pone.0173178	http://dx.doi.org/10.1371/journal.pone.0173178			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253373	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300087
J	Verdier, T; Gunzenhauser, J; Manley, S; Castelnovo, M				Verdier, Timothee; Gunzenhauser, Julia; Manley, Suliana; Castelnovo, Martin			Single particle maximum likelihood reconstruction from superresolution microscopy images	PLOS ONE			English	Article							RESOLUTION FLUORESCENCE MICROSCOPY; LOCALIZATION MICROSCOPY; ESCRT MACHINERY; REVEALS; PROTEIN; HIV-1; STOICHIOMETRY; ABSCISSION; VIRIONS; SITES	Point localization superresolution microscopy enables fluorescently tagged molecules to be imaged beyond the optical diffraction limit, reaching single molecule localization precisions down to a few nanometers. For small objects whose sizes are few times this precision, localization uncertainty prevents the straightforward extraction of a structural model from the reconstructed images. We demonstrate in the present work that this limitation can be overcome at the single particle level, requiring no particle averaging, by using a maximum likelihood reconstruction (MLR) method perfectly suited to the stochastic nature of such superresolution imaging. We validate this method by extracting structural information from both simulated and experimental PALM data of immature virus-like particles of the Human Immunodeficiency Virus (HIV-1). MLR allows us to measure the radii of individual viruses with precision of a few nanometers and confirms the incomplete closure of the viral protein lattice. The quantitative results of our analysis are consistent with previous cryoelectron microscopy characterizations. Our study establishes the framework for a method that can be broadly applied to PALM data to determine the structural parameters for an existing structural model, and is particularly well suited to heterogeneous features due to its single particle implementation.	[Verdier, Timothee; Castelnovo, Martin] Univ Claude Bernard, Ens Lyon, CNRS, Univ Lyon,Lab Phys, F-69342 Lyon, France; [Gunzenhauser, Julia; Manley, Suliana] Swiss Fed Inst Technol EPFL, Sch Basic Sci, Lab Expt Biophys, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Polytechnique Federale de Lausanne	Castelnovo, M (corresponding author), Univ Claude Bernard, Ens Lyon, CNRS, Univ Lyon,Lab Phys, F-69342 Lyon, France.	martin.castelnovo@ens-lyon.fr		Castelnovo, Martin/0000-0003-1118-7360	Fondation Simone; Cino Del Duca from Institut de France; PEPS PTI CNRS	Fondation Simone; Cino Del Duca from Institut de France; PEPS PTI CNRS	This research was partially supported by Fondation Simone and Cino Del Duca from Institut de France (MC) and by PEPS PTI CNRS (MC).	Badieirostami M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499652; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Briggs J, 2009, P NATL ACAD SCI USA, V106, P1; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; EFRON B, 1978, BIOMETRIKA, V65, P457, DOI 10.2307/2335893; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; GONCHAROV AB, 1988, ACTA APPL MATH, V11, P199, DOI 10.1007/BF00140118; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Keller D, 2014, J CELL BIOL, V204, P697, DOI 10.1083/jcb.201307049; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Mukamel Ea, 2012, PHYS REV LETT, V109, DOI [10.1103/PhysRevLett.109.168102, DOI 10.1103/PHYSREVLETT.109.168102]; Parthasarathy R, 2012, NAT METHODS, V9, P724, DOI [10.1038/NMETH.2071, 10.1038/nmeth.2071]; Pavani SRP, 2009, ADV IMAGING, pNMA5; PEACOCK JA, 1983, MON NOT R ASTRON SOC, V202, P615, DOI 10.1093/mnras/202.3.615; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sage D, 2015, NAT METHODS, V12, P717, DOI [10.1038/NMETH.3442, 10.1038/nmeth.3442]; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172943	10.1371/journal.pone.0172943	http://dx.doi.org/10.1371/journal.pone.0172943			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253349	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300049
J	Davies, BM; McHugh, M; Elgheriani, A; Kolias, AG; Tetreault, L; Hutchinson, PJA; Fehlings, MG; Kotter, MRN				Davies, Benjamin M.; McHugh, M.; Elgheriani, A.; Kolias, Angelos G.; Tetreault, Lindsay; Hutchinson, Peter J. A.; Fehlings, Michael G.; Kotter, Mark R. N.			The reporting of study and population characteristics in degenerative cervical myelopathy: A systematic review	PLOS ONE			English	Article							SPONDYLOTIC MYELOPATHY; SURGICAL DECOMPRESSION; EVOKED-POTENTIALS; CLINICAL-TRIALS; PROGNOSIS; OUTCOMES; SURGERY	Object Degenerative cervical myelopathy [DCM] is a disabling and increasingly prevalent condition. Variable reporting in interventional trials of study design and sample characteristics limits the interpretation of pooled outcomes. This is pertinent in DCM where baseline characteristics are known to influence outcome. The present study aims to assess the reporting of the study design and baseline characteristics in DCM as the premise for the development of a standardised reporting set. Methods A systematic review of MEDLINE and EMBASE databases, registered with PROSPERO (CRD42015025497) was conducted in accordance with PRISMA guidelines. Full text articles in English, with > 50 patients (prospective) or > 200 patients (retrospective), reporting outcomes of DCM were deemed to be eligible. Results A total of 108 studies involving 23,876 patients, conducted world- wide, were identified. 33 (31%) specified a clear primary objective. Study populations often included radiculopathy (51, 47%) but excluded patients who had undergone previous surgery (42, 39%). Diagnositic criteria for myelopathy were often uncertain; MRI assessment was specified in only 67 (62%) of studies. Patient comorbidities were referenced by 37 (34%) studies. Symptom duration was reported by 46 (43%) studies. Multivariate analysis was used to control for baseline characteristics in 33 (31%) of studies. Conclusions The reporting of study design and sample characteristics is variable. The development of a consensus minimum dataset for (CODE-DCM) will facilitate future research synthesis in the future.	[Davies, Benjamin M.; McHugh, M.; Kolias, Angelos G.; Hutchinson, Peter J. A.; Kotter, Mark R. N.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Elgheriani, A.; Tetreault, Lindsay; Fehlings, Michael G.; Kotter, Mark R. N.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Elgheriani, A.; Tetreault, Lindsay; Fehlings, Michael G.; Kotter, Mark R. N.] Univ Hlth Network, Toronto Western Hosp, Spine Program, Toronto, ON, Canada; [Elgheriani, A.; Tetreault, Lindsay; Fehlings, Michael G.; Kotter, Mark R. N.] Univ Toronto, Toronto, ON, Canada; [Kolias, Angelos G.; Kotter, Mark R. N.] Univ Cambridge, Anne McLaren Lab, WT MRC Cambridge Stem Cell Inst, Cambridge, England; [Hutchinson, Peter J. A.; Kotter, Mark R. N.] Univ Cambridge, John van Geest Brain Repair Ctr, Cambridge, England	University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge; University of Cambridge	Kotter, MRN (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Kotter, MRN (corresponding author), Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada.; Kotter, MRN (corresponding author), Univ Hlth Network, Toronto Western Hosp, Spine Program, Toronto, ON, Canada.; Kotter, MRN (corresponding author), Univ Toronto, Toronto, ON, Canada.; Kotter, MRN (corresponding author), Univ Cambridge, Anne McLaren Lab, WT MRC Cambridge Stem Cell Inst, Cambridge, England.; Kotter, MRN (corresponding author), Univ Cambridge, John van Geest Brain Repair Ctr, Cambridge, England.	Mrk25@cam.ac.uk	Davies, Benjamin/AAB-6000-2019	Davies, Benjamin/0000-0003-0591-5069; Kolias, Angelos/0000-0003-3992-0587; Fehlings, Michael/0000-0002-5722-6364; Kotter, Mark/0000-0001-5145-7199	Wellcome Trust; MRC; NIHR Clinician Scientist Award [CS-2015-15-023]; NIHR Cambridge Biomedical Research Centre; Halbert Chair in Neural Repair and Regeneration; Dezwirek Foundation; NIHR; National Institute for Health Research [CS-2015-15-023]; National Institute for Health Research [ACF-2015-14-009, NIHR-RP-R3-12-013] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Clinician Scientist Award; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Halbert Chair in Neural Repair and Regeneration; Dezwirek Foundation; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Research in the senior authors laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. MRNK is supported by a NIHR Clinician Scientist Award (CS-2015-15-023). PJAH holds a NIHR research professorship and is supported by the NIHR Cambridge Biomedical Research Centre. MGF acknowledges support from the Halbert Chair in Neural Repair and Regeneration and the Dezwirek Foundation.; Research in the senior author's laboratory is supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. MRNK is supported by a NIHR Clinician Scientist Award.; PJAH holds a NIHR research professorship and is supported by the NIHR Cambridge Biomedical Research Centre. MGF acknowledges support from the Halbert Chair in Neural Repair and Regeneration and the Dezwirek Foundation.; This report is independent reseach arising from a Clinician Scientist Award, CS-2015-15-023, supported by the National Institute for Health Research. The views expressed in this publication are those of the authours and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Boers M, 2014, J CLIN EPIDEMIOL, V67, P745, DOI 10.1016/j.jclinepi.2013.11.013; Chari A, 2015, J NEUROTRAUMA; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; COMET Initative, CODE DCM PROJECT; Davies BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157263; Ding Y, 2008, CHINESE MED J-PEKING, V121, P1374, DOI 10.1097/00029330-200808010-00008; Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fehlings MG, 2012, J NEUROSURG-SPINE, V17, P89, DOI 10.3171/2012.6.AOSPINE111069; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Floeth FW, 2013, J NUCL MED, V54, P1577, DOI 10.2967/jnumed.112.113183; Kalsi-Ryan S, 2013, SPINE, V38, pS111, DOI 10.1097/BRS.0b013e3182a7f499; Karadimas SK, 2015, EUR SPINE J, V24, pS132, DOI 10.1007/s00586-014-3264-4; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Lyu RK, 2004, J NEUROL NEUROSUR PS, V75, P256; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Schunemann HJ, 2009, Z EVIDENZ FORTBILD Q, V103, P391, DOI 10.1016/j.zefq.2009.05.023; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Tetreault L, 2016, J NEUROSURG-SPINE, V24, P77, DOI 10.3171/2015.3.SPINE14971; Tetreault LA, 2015, SPINE J, V15, P388, DOI 10.1016/j.spinee.2014.12.145; Tetreault LA, 2015, EUR SPINE J, V24, pS236, DOI 10.1007/s00586-013-2658-z; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Williamson P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000041; Wilson JR, 2013, SPINE, V38, pS37, DOI 10.1097/BRS.0b013e3182a7f2e7	28	43	45	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172564	10.1371/journal.pone.0172564	http://dx.doi.org/10.1371/journal.pone.0172564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249017	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500047
J	Wu, JB; Meng, QG; Deng, S; Huang, HB; Wu, YH; Badii, A				Wu, Jibing; Meng, Qinggang; Deng, Su; Huang, Hongbin; Wu, Yahui; Badii, Atta			Generic, network schema agnostic sparse tensor factorization for single-pass clustering of heterogeneous information networks	PLOS ONE			English	Article							K SIMILARITY SEARCH	Heterogeneous information networks (e.g. bibliographic networks and social media networks) that consist of multiple interconnected objects are ubiquitous. Clustering analysis is an effective method to understand the semantic information and interpretable structure of the heterogeneous information networks, and it has attracted the attention of many researchers in recent years. However, most studies assume that heterogeneous information networks usually follow some simple schemas, such as bi-typed networks or star network schema, and they can only cluster one type of object in the network each time. In this paper, a novel clustering framework is proposed based on sparse tensor factorization for heterogeneous information networks, which can cluster multiple types of objects simultaneously in a single pass without any network schema information. The types of objects and the relations between them in the heterogeneous information networks are modeled as a sparse tensor. The clustering issue is modeled as an optimization problem, which is similar to the well-known Tucker decomposition. Then, an Alternating Least Squares (ALS) algorithm and a feasible initialization method are proposed to solve the optimization problem. Based on the tensor factorization, we simultaneously partition different types of objects into different clusters. The experimental results on both synthetic and real-world datasets have demonstrated that our proposed clustering framework, STFClus, can model heterogeneous information networks efficiently and can outperform state-of-the-art clustering algorithms as a generally applicable single-pass clustering method for heterogeneous network which is network schema agnostic.	[Wu, Jibing; Deng, Su; Huang, Hongbin; Wu, Yahui] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Meng, Qinggang] Univ Loughborough, Dept Comp Sci, Loughborough, Leics, England; [Badii, Atta] Univ Reading, Dept Comp Sci, Whiteknights, England	National University of Defense Technology - China; Loughborough University; University of Reading	Wu, JB (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	wujibing@nudt.edu.cn		Jibing, Wu/0000-0002-4016-0901; Huang, Hongbin/0000-0002-5179-3640	National Science Foundation of China [61401482]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work reported in this paper is supported by National Science Foundation of China, No.61401482. Online: http://www.nsfc.gov.cn/. YW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BADER B. W, MATLAB TENSOR TOOLBO; Benson Austin R, 2015, Proc SIAM Int Conf Data Min, V2015, P118; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen J., 2015, P SIAM INT C DAT MIN, P424; Cichocki A, 2015, ARXIV150502343; Ermis B, 2015, DATA MIN KNOWL DISC, V29, P203, DOI 10.1007/s10618-013-0341-y; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Harshman RA, 2001, J CHEMOMETR, V15, P689, DOI 10.1002/cem.665; Kiers HAL, 2000, J CHEMOMETR, V14, DOI [10.1002/1099-128X(200005/06)14:3%3C105::AID-CEM582%3E3.0.CO;2-I, DOI 10.1002/1099-128X(200005/06)14:3<105::AID-CEM582>3.0.CO;2-I]; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kolda TG., 2006, SAND2006 2081; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Morup M, 2008, NEURAL COMPUT, V20, P2112, DOI 10.1162/neco.2008.11-06-407; Phan AH, 2010, IEEE INT WORKSH COMP, P316; Shi C., 2015, P 24 ACM INT C INF K, P453, DOI 10.1145/2806416.2806528; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun Y., 2009, EDBT 2009 INT C EXT, P439; Sun Y., 2012, P 18 ACM SIGKDD INT, P723; Sun YF, 2014, IEEE IJCNN, P1565, DOI 10.1109/IJCNN.2014.6889385; Sun YF, 2016, IEEE T PATTERN ANAL, V38, P476, DOI 10.1109/TPAMI.2015.2465901; Sun Y, 2012, PROC VLDB ENDOW, V5, P394, DOI 10.14778/2140436.2140437; Sun YZ, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P797; Sunt YZ, 2011, PROC VLDB ENDOW, V4, P992; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130086; Yu X, 2012, CIKM, P2025, DOI DOI 10.1145/2396761.2398565; Zhang M, 2013, IEEE I CONF COMP VIS, P2448, DOI 10.1109/ICCV.2013.304; Zhang MX, 2015, EXPERT SYST APPL, V42, P699, DOI 10.1016/j.eswa.2014.08.039; Zhang Zhihua, 2015, ABS151008532 CORR; Zhao QB, 2016, IEEE T NEUR NET LEAR, V27, P736, DOI 10.1109/TNNLS.2015.2423694; Zhou Y, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1563, DOI 10.1145/2783258.2783328	40	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172323	10.1371/journal.pone.0172323	http://dx.doi.org/10.1371/journal.pone.0172323			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245222	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000395980200018
J	Ranganathan, S; Nicolis, SC; Swain, RB; Sumpter, DJT				Ranganathan, Shyam; Nicolis, Stamatios C.; Swain, Ranjula Bali; Sumpter, David J. T.			Setting development goals using stochastic dynamical system models	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; MORTALITY	The Millennium Development Goals (MDG) programme was an ambitious attempt to encourage a globalised solution to important but often-overlooked development problems. The programme led to wide-ranging development but it has also been criticised for unrealistic and arbitrary targets. In this paper, we show how country-specific development targets can be set using stochastic, dynamical system models built from historical data. In particular, we show that the MDG target of two-thirds reduction of child mortality from 1990 levels was infeasible for most countries, especially in sub-Saharan Africa. At the same time, the MDG targets were not ambitious enough for fast-developing countries such as Brazil and China. We suggest that model-based setting of country-specific targets is essential for the success of global development programmes such as the Sustainable Development Goals (SDG). This approach should provide clear, quantifiable targets for policymakers.	[Ranganathan, Shyam] Virginia Polytech Inst & State Univ, Dept Stat, Blacksburg, VA 24061 USA; [Nicolis, Stamatios C.] Univ Libre Bruxelles, Fac Sci, Serv Chim Phys & Biol Theor, Campus Plaine,CP 231, Brussels, Belgium; [Swain, Ranjula Bali] Stockholm Sch Econ, Mistra Ctr Sustainable Markets, Stockholm, Sweden; [Swain, Ranjula Bali] Sodertorn Univ, Stockholm, Sweden; [Sumpter, David J. T.] Uppsala Univ, Dept Math, Uppsala, Sweden	Virginia Polytechnic Institute & State University; Universite Libre de Bruxelles; Stockholm School of Economics; Sodertorn University; Uppsala University	Ranganathan, S (corresponding author), Virginia Polytech Inst & State Univ, Dept Stat, Blacksburg, VA 24061 USA.	shyam81@vt.edu		Nicolis, Stamatios C./0000-0002-7118-5298; Ranganathan, Shyam/0000-0002-1337-5173	Swedish Research Council [D049040]; "back to Belgium" grant by the Belgian Science Policy Office	Swedish Research Council(Swedish Research CouncilEuropean Commission); "back to Belgium" grant by the Belgian Science Policy Office	This work was funded by Swedish Research Council grant D049040. SCN acknowledges financial support from the "back to Belgium" grant by the Belgian Science Policy Office.	[Anonymous], 2005, HDB EC GROWTH; [Anonymous], 1999, DEV FREEDOM; Attaran A, 2005, PLOS MED, V2, P955, DOI 10.1371/journal.pmed.0020318; BARRO RJ, 1989, ECONOMETRICA, V57, P481, DOI 10.2307/1912563; Becker Gary Stanley, 1991, TREATISE FAMILY; CALDWELL JC, 1976, POPUL DEV REV, V2, P321, DOI 10.2307/1971615; Clemens MA, 2007, WORLD DEV, V35, P735, DOI 10.1016/j.worlddev.2006.08.003; Easterly W, 2009, WORLD DEV, V37, P26, DOI 10.1016/j.worlddev.2008.02.009; Fukuda-Parr S, 2013, WORLD DEV, V41, P19, DOI 10.1016/j.worlddev.2012.06.014; Fukuda-Parr S, 2011, INT STUD REV, V13, P122, DOI 10.1111/j.1468-2486.2010.01003.x; Hulme D., 2007, MAKING MILLENNIUM DE; Kalemli-Ozcan S, 2002, J ECON GROWTH, V7, P411, DOI 10.1023/A:1020831902045; Klasen S, 2012, GETTING PROGR RIGHT; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Nelson PJ, 2007, WORLD DEV, V35, P2041, DOI 10.1016/j.worlddev.2007.02.006; Raftery AE, 1999, SOCIOL METHOD RES, V27, P411, DOI 10.1177/0049124199027003005; Ranganathan S, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.33; Ranganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086468; Saith A, 2006, DEV CHANGE, V37, P1167, DOI 10.1111/j.1467-7660.2006.00518.x; Ul-Haq M., 1995, REFLECTIONS HUMAN DE; UNAIDS, 2012, ABUJA 12 SHAP FUT HL; Vandemoortele J, 2009, DEV POLICY REV, V27, P355, DOI 10.1111/j.1467-7679.2009.00451.x; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WorldBank, 2015, LEV TRENDS CHILD MOR	24	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171560	10.1371/journal.pone.0171560	http://dx.doi.org/10.1371/journal.pone.0171560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241057	gold, Green Published, Green Submitted			2022-12-27	WOS:000395934400006
J	Shen, Y; Chen, YC; Wu, JG; Shaner, NC; Campbell, RE				Shen, Yi; Chen, Yingche; Wu, Jiahui; Shaner, Nathan C.; Campbell, Robert E.			Engineering of mCherry variants with long Stokes shift, red-shifted fluorescence, and low cytotoxicity	PLOS ONE			English	Article							MONOMERIC RED; CORRELATION SPECTROSCOPY; CRYSTAL-STRUCTURE; CA2+ INDICATORS; IN-VIVO; PROTEIN; GREEN; BRIGHT; ORANGE; AEQUOREA	MCherry, the Discosoma sp. mushroom coral-derived monomeric red fluorescent protein (RFP), is a commonly used genetically encoded fluorophore for live cell fluorescence imaging. We have used a combination of protein design and directed evolution to develop mCherry variants with low cytotoxicity to Escherichia coli and altered excitation and emission profiles. These efforts ultimately led to a long Stokes shift (LSS)-mCherry variant (lambda(ex) = 460 nm and lambda(em) = 610 nm) and a red-shifted (RDS)-mCherry variant (lambda(ex) = 600 nm and lambda(em) = 630 nm). These new RFPs provide insight into the influence of the chromophore environment on mCherry's fluorescence properties, and may serve as templates for the future development of fluorescent probes for live cell imaging.	[Shen, Yi; Chen, Yingche; Wu, Jiahui; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Shaner, Nathan C.] Scintillon Inst, Dept Photobiol & Bioimaging, San Diego, CA USA	University of Alberta	Campbell, RE (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB, Canada.	robert.e.campbell@ualberta.ca	Shen, Yi/AAS-7826-2021	Shen, Yi/0000-0003-4117-0279; Shaner, Nathan/0000-0002-0148-0769; Wu, Jiahui (Chris)/0000-0003-2406-6728	Natural Sciences and Engineering Research Council of Canada [RGPIN 288338-2010]; Alberta Innovates scholarship; Canada Research Chairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates scholarship; Canada Research Chairs(Canada Research ChairsCGIAR)	Natural Sciences and Engineering Research Council of Canada (RGPIN 288338-2010) http://www.nserc-crsng.gc.ca, Alberta Innovates scholarship to YS (no grant number) http://www.albertainnovates.ca, and Canada Research Chairs (no grant number) http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx.	Abbyad P, 2007, P NATL ACAD SCI USA, V104, P20189, DOI 10.1073/pnas.0706185104; Abdelfattah AS, 2016, J NEUROSCI, V36, P2458, DOI 10.1523/JNEUROSCI.3484-15.2016; Ai HW, 2014, NAT PROTOC, V9, P910, DOI 10.1038/nprot.2014.054; Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Guan Y, 2015, MOL BIOL CELL, V26, P2054, DOI 10.1091/mbc.E14-10-1473; Han LY, 2014, BIOCHEM BIOPH RES CO, V447, P508, DOI 10.1016/j.bbrc.2014.04.013; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; INOUYE S, 1994, FEBS LETT, V341, P277, DOI 10.1016/0014-5793(94)80472-9; Kawano H, 2008, NAT METHODS, V5, P373, DOI 10.1038/nmeth0508-373; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shimomura O, 2009, ANGEW CHEM INT EDIT, V48, P5590, DOI 10.1002/anie.200902240; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064849; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	50	31	33	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171257	10.1371/journal.pone.0171257	http://dx.doi.org/10.1371/journal.pone.0171257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241009	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400005
J	Kasch, J; Schumann, S; Schreiber, S; Klaus, S; Kanzleiter, I				Kasch, Juliane; Schumann, Sara; Schreiber, Saskia; Klaus, Susanne; Kanzleiter, Isabel			Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet	PLOS ONE			English	Article							ADIPOSE-TISSUE; LIVER-DISEASE; PREGNANCY; DYSFUNCTION; LACTATION; HOMEOSTASIS; CONSUMPTION; EXPRESSION; INDUCTION; PREVENTS	Scope We investigated the long-term effects of maternal high-fat consumption and post-weaning exercise on offspring obesity susceptibility and insulin resistance. Methods C57BL/6J dams were fed either a high-fat (HFD, 40% kcal fat) or low-fat (LFD, 10% kcal fat) semi-synthetic diet during pregnancy and lactation. After weaning, male offspring of both maternal diet groups (mLFD; mHFD) received a LFD. At week 7, half of the mice got access to a running wheel (+ RW) as voluntary exercise training. To induce obesity, all offspring groups (mLFD +/-RW and mHFD +/-RW) received HFD from week 15 until week 25. Results Compared to mLFD, mHFD offspring were more prone to HFD-induced body fat gain and exhibited an increased liver mass which was not due to increased hepatic triglyceride levels. RW improved the endurance capacity in mLFD, but not in mHFD offspring. Additionally, mHFD offspring + RW exhibited higher plasma insulin levels during glucose tolerance test and an elevated basal pancreatic insulin production compared to mLFD offspring. Conclusion Taken together, maternal HFD reduced offspring responsiveness to the beneficial effects of voluntary exercise training regarding the improvement of endurance capacity, reduction of fat mass gain, and amelioration of HFD-induced insulin resistance.	[Kasch, Juliane; Schumann, Sara; Schreiber, Saskia; Klaus, Susanne; Kanzleiter, Isabel] German Inst Human Nutr Potsdam Rehbrucke, Dept Physiol Energy Metab, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schumann, S; Klaus, S (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Physiol Energy Metab, Nuthetal, Germany.	sara.schumann@dife.de; klaus@dife.de	Klaus, Susanne/P-9299-2018	Klaus, Susanne/0000-0001-8726-185X; Schumann, Sara/0000-0002-6902-142X; Schwanbeck, Juliane/0000-0001-7944-6432	Deutsche Forschungsgemeinschaft [WA3125/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funding to IK from the Deutsche Forschungsgemeinschaft (http://www.dfg.eu); grant WA3125/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bayol SA, 2009, EUR J NUTR, V48, P62, DOI 10.1007/s00394-008-0760-5; Bider-Canfield Z., 2016, PEDIAT OBES; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; Dietz WH, 1998, PEDIATRICS, V101, P518; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008; Gregorio BM, 2013, EUR J NUTR, V52, P759, DOI 10.1007/s00394-012-0382-9; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P788, DOI 10.1152/japplphysiol.01219.2001; Hoevenaars FPM, 2012, GENES NUTR, V7, P399, DOI 10.1007/s12263-011-0262-6; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Janoschek R, 2016, OBESITY, V24, P1266, DOI 10.1002/oby.21486; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Krasnow SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1243, DOI 10.1152/ajpendo.00261.2011; Laitinen J, 2012, BJOG-INT J OBSTET GY, V119, P716, DOI 10.1111/j.1471-0528.2012.03319.x; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Linden MA, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12071; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Noatsch A, 2011, EUR J NUTR, V50, P479, DOI 10.1007/s00394-010-0155-2; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Raipuria M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120980; Rajia S, 2013, NUTR METAB CARDIOVAS, V23, P574, DOI 10.1016/j.numecd.2011.12.009; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Seet EL, 2015, LIPIDS, V50, P565, DOI 10.1007/s11745-015-4018-8; Stanford KI, 2015, DIABETES, V64, P427, DOI 10.2337/db13-1848; Thompson MD, 2016, GENE EXPR; Tsuduki T, 2016, MOL NUTR FOOD RES, V60, P1110, DOI 10.1002/mnfr.201500736; Voigt A, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0477-z; Walter I, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.55; Weitkunat K, 2015, J NUTR BIOCHEM, V26, P929, DOI 10.1016/j.jnutbio.2015.03.010; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173076	10.1371/journal.pone.0173076	http://dx.doi.org/10.1371/journal.pone.0173076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235071	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200196
J	Kwon, H; Ugarte, CM; Ogle, SM; Williams, SA; Wander, MM				Kwon, Hoyoung; Ugarte, Carmen M.; Ogle, Stephen M.; Williams, Stephen A.; Wander, Michelle M.			Use of inverse modeling to evaluate CENTURY-predictions for soil carbon sequestration in US rain-fed corn production systems	PLOS ONE			English	Article							ORGANIC-MATTER; CROPPING SYSTEMS; LITTER DECAY; TILLAGE; MANAGEMENT; ROTATION; RESIDUE; MIDWEST; INPUT	We evaluated the accuracy and precision of the CENTURY soil organic matter model for predicting soil organic carbon (SOC) sequestration under rainfed corn-based cropping systems in the US. This was achieved by inversely modeling long-term SOC data obtained from 10 experimental sites where corn, soybean, or wheat were grown with a range of tillage, fertilization, and organic matter additions. Inverse modeling was accomplished using a surrogate model for CENTURY's SOC dynamics sub-model wherein mass balance and decomposition kinetics equations from CENTURY are coded and solved by using a non-linear regression routine of a standard statistical software package. With this approach we generated statistics of CENTURY parameters that are associated with the effects of N fertilization and organic amendment on SOC decay, which are not as well quantified as those of tillage, and initial status of SOC. The results showed that the fit between simulated and observed SOC prior to inverse modeling (R-2 = 0.41) can be improved to R-2 = 0.84 mainly by increasing the rate of SOC decay up to 1.5 fold for the year in which N fertilizer application rates are over 200 kg N ha(-1). We also observed positive relationships between C inputs and the rate of SOC decay, indicating that the structure of CENTURY, and therefore model accuracy, could be improved by representing SOC decay as Michaelis-Menten kinetics rather than first-order kinetics. Finally, calibration of initial status of SOC against observed levels allowed us to account for site history, confirming that values should be adjusted to account for soil condition during model initialization. Future research should apply this inverse modeling approach to explore how C input rates and N abundance interact to alter SOC decay rates using C inputs made in various forms over a wider range of rates.	[Kwon, Hoyoung] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Ugarte, Carmen M.; Wander, Michelle M.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Ogle, Stephen M.; Williams, Stephen A.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	CGIAR; International Food Policy Research Institute (IFPRI); University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University	Kwon, H (corresponding author), Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA.	h.kwon@cgiar.org	Ugarte, Carmen M./AAX-3538-2020	Kwon, Hoyoung/0000-0002-3421-9292				Allmaras RR, 1998, ADVANCES IN SOIL AND WATER CONSERVATION, P99; BUYANOVSKY GA, 1986, PLANT SOIL, V93, P57, DOI 10.1007/BF02377145; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103720; Eckhardt K, 2001, J HYDROL, V251, P103, DOI 10.1016/S0022-1694(01)00429-2; Falloon PD, 2000, BIOL FERT SOILS, V30, P388; Fang C, 2005, GEODERMA, V129, P139, DOI 10.1016/j.geoderma.2004.12.038; Fujita Y, 2014, GLOBAL BIOGEOCHEM CY, V28, P223, DOI 10.1002/2013GB004595; Halvorson AD, 2002, AGRON J, V94, P1429, DOI 10.2134/agronj2002.1429; Huggins DR, 1998, SOIL TILL RES, V47, P219, DOI 10.1016/S0167-1987(98)00108-1; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kwon HY, 2013, BIOMASS BIOENERG, V55, P299, DOI 10.1016/j.biombioe.2013.02.021; Kwon HY, 2010, SOIL BIOL BIOCHEM, V42, P2241, DOI 10.1016/j.soilbio.2010.08.025; Leite LFC, 2004, GEODERMA, V120, P283, DOI 10.1016/j.geoderma.2003.09.010; Lugato E, 2014, GLOBAL CHANGE BIOL, V20, P313, DOI 10.1111/gcb.12292; Manzoni S, 2007, SOIL BIOL BIOCHEM, V39, P1542, DOI 10.1016/j.soilbio.2007.01.006; Matthews RB, 2005, AGR ECOSYST ENVIRON, V111, P119, DOI 10.1016/j.agee.2005.06.016; Meersmans J, 2013, PEDOSPHERE, V23, P422, DOI 10.1016/S1002-0160(13)60035-1; Mishra U, 2010, SOIL TILL RES, V107, P88, DOI 10.1016/j.still.2010.02.005; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Oelbermann M, 2005, AGR ECOSYST ENVIRON, V105, P163, DOI 10.1016/j.agee.2004.04.006; Ogle SM, 2007, ECOL MODEL, V205, P453, DOI 10.1016/j.ecolmodel.2007.03.007; Ogle SM, 2010, GLOBAL CHANGE BIOL, V16, P810, DOI 10.1111/j.1365-2486.2009.01951.x; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Paustian K., 1997, SOIL ORGANIC MATTER; Pedersen P, 2004, AGRON J, V96, P556, DOI 10.2134/agronj2004.0556; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; SAS Institute, 2012, SAS ETS SOFTW 2012; Stubbs TL, 2009, AGRON J, V101, P538, DOI 10.2134/agronj2008.0107x; Ugarte CM, 2014, J SOIL WATER CONSERV, V69, P422, DOI 10.2489/jswc.69.5.422; United States Department of Agriculture Natural Resources Conservation Service, 2016, WHOL FARM RANCH CARB; US-EPA, 2015, 430R15004 US EPA; Vetsch JA, 2004, AGRON J, V96, P502, DOI 10.2134/agronj2004.0502; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Yang XM, 2008, PEDOSPHERE, V18, P421, DOI 10.1016/S1002-0160(08)60033-8; Yeluripati JB, 2009, SOIL BIOL BIOCHEM, V41, P2579, DOI 10.1016/j.soilbio.2009.08.021	37	9	9	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172861	10.1371/journal.pone.0172861	http://dx.doi.org/10.1371/journal.pone.0172861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234992	gold, Green Published			2022-12-27	WOS:000394688200156
J	Mehaisen, GMK; Eshak, MG; Elkaiaty, AM; Atta, ARMM; Mashaly, MM; Abass, AO				Mehaisen, Gamal M. K.; Eshak, Mariam G.; Elkaiaty, Ahmed M.; Atta, Abdel-Rahman M. M.; Mashaly, Magdi M.; Abass, Ahmed O.			Comprehensive growth performance, immune function, plasma biochemistry, gene expressions and cell death morphology responses to a daily corticosterone injection course in broiler chickens	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID DEGRADATION; GALLUS-GALLUS-DOMESTICUS; PHYSIOLOGICAL STRESS; PROTEIN-SYNTHESIS; FAT ACCUMULATION; MEAT QUALITY; SHOWING LONG; FACTOR-I; APOPTOSIS; HORMONE	The massive meat production of broiler chickens make them continuously exposed to potential stressors that stimulate releasing of stress-related hormones like corticosterone (CORT) which is responsible for specific pathways in biological mechanisms and physiological activities. Therefore, this research was conducted to evaluate a wide range of responses related to broiler performance, immune function, plasma biochemistry, related gene expressions and cell death morphology during and after a 7-day course of CORT injection. A total number of 200 one-day-old commercial Cobb broiler chicks were used in this study. From 21 to 28 d of age, broilers were randomly assigned to one of 2 groups with 5 replicates of 20 birds each; the first group received a daily intramuscular injection of 5 mg/kg BW corticosterone dissolved in 0.5 ml ethanol: saline solution (CORT group), while the second group received a daily intramuscular injection of 0.5 ml ethanol: saline only (CONT group). Growth performance, including body weight (BW), daily weight gain (DG), feed intake (FI) and feed conversion ratio (FC), were calculated at 0, 3 and 7 d after the start of the CORT injections. At the same times, blood samples were collected in each group for hematological (TWBC's and H/L ratio), T-and B-lymphocytes proliferation and plasma biochemical assays (total protein, TP; free triiodothyronine hormone, fT3; aspartate amino transaminase, AST; and alanine amino transaminase, ALT). The liver, thymus, bursa of Fabricius and spleen were dissected and weighed, and the mRNA expression of insulin-like growth factor 1 gene (IGF1) in liver and cell-death-program gene (caspase-9) in bursa were analyzed for each group and time; while the apoptotic/necrotic cells were morphologically detected in the spleen. From 28 to 35 d of age, broilers were kept for recovery period without CORT injection and the same sampling and parameters were repeated at the end (at 14 d after initiation of the CORT injection). In general, all parameters of broiler performance were negatively affected by the CORT injection. In addition, CORT treatment decreased the plasma concentration of fT(3) and the mRNA expression of hepatic IGF-1. A significant increase in liver weight accompanied by an increase in plasma TP, AST and ALT was observed with CORT treatment, indicating an incidence of liver malfunction by CORT. Moreover, the relative weights of thymus, bursa and spleen decreased by the CORT treatment with low counts of TWBC's and low stimulation of T & B cells while the H/L ratio increased; indicating immunosuppressive effect for CORT treatment. Furthermore, high expression of caspase-9 gene occurred in the bursa of CORT-treated chickens, however, it was associated with a high necrotic vs. low apoptotic cell death pathway in the spleen. Seven days after termination of the CORT treatment in broilers, most of these aspects remained negatively affected by CORT and did not recover to its normal status. The current study provides a comprehensive view of different physiological modulations in broiler chickens by CORT treatment and may set the potential means to mount a successful defense against stress in broilers and other animals as well.	[Mehaisen, Gamal M. K.; Elkaiaty, Ahmed M.; Atta, Abdel-Rahman M. M.; Mashaly, Magdi M.; Abass, Ahmed O.] Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt; [Eshak, Mariam G.] Natl Res Ctr, Dept Cell Biol, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Mehaisen, GMK (corresponding author), Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt.	gamoka@cu.edu.eg	Mehaisen, Gamal/I-5277-2019	Mehaisen, Gamal/0000-0003-2006-4290; Nassar, Farid/0000-0003-0786-0612; Mohamed Atta, Abd El-Rahman/0000-0002-6092-6994	Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)	Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)(Cairo University)	This work was supported by Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP), funded from General Scientific Research Department at Cairo University (GSRD-CU); http://gsrd.cu.edu.egi. AOA was the principal investigator of the project and the fund was awarded to him during the management of the project. The funders have approved the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; This study was funded by the General Scientific Research Department at Cairo University (GSRD-CU) under activities carried out by the Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP). Dr. Ahmed O. Abass was the principal investigator and research team leader of the project. We would like to express our appreciation to all the personnel from the Poultry Biotechnology Lab and members of Poultry Services Center at Faculty of Agriculture, Cairo University, for their assistance in sample preparation and monitoring birds throughout the experimental period.	Agas D, 2008, J CELL PHYSIOL, V214, P145, DOI 10.1002/jcp.21170; Allan GJ, 2001, REPRODUCTION, V122, P31, DOI 10.1530/reprod/122.1.31; Aslam MA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115352; Babacanoglu E, 2013, BRIT POULTRY SCI, V54, P677, DOI 10.1080/00071668.2013.847901; Barbour E. K., 2010, Agriculture and Biology Journal of North America, V1, P65; Beccavin C, 2001, J ENDOCRINOL, V168, P297, DOI 10.1677/joe.0.1680297; Bourgeon S, 2010, J EXP BIOL, V213, P3810, DOI 10.1242/jeb.045484; COHEN JJ, 1972, J IMMUNOL, V108, P841; Collier SD, 1998, TOXICOL APPL PHARM, V148, P176, DOI 10.1006/taap.1997.8324; COMPTON MM, 1990, POULTRY SCI, V69, P1292, DOI 10.3382/ps.0691292; COMPTON MM, 1991, POULTRY SCI, V70, P521, DOI 10.3382/ps.0700521; Conlon MA, 2002, POULTRY SCI, V81, P1543, DOI 10.1093/ps/81.10.1543; Darras VM, 1996, GEN COMP ENDOCR, V104, P203, DOI 10.1006/gcen.1996.0163; DECUYPERE E, 1983, HORM METAB RES, V15, P233, DOI 10.1055/s-2007-1018680; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dong H, 2007, COMP BIOCHEM PHYS A, V147, P189, DOI 10.1016/j.cbpa.2006.12.034; Ellestad LE, 2009, J MOL ENDOCRINOL, V42, P171, DOI 10.1677/JME-08-0066; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Engler H, 2003, PSYCHONEUROENDOCRINO, V28, P951, DOI 10.1016/S0306-4530(02)00117-8; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FREEMAN BA, 1982, LAB INVEST, V47, P412; Frystyk J, 1999, AM J PHYSIOL-ENDOC M, V277, pE245, DOI 10.1152/ajpendo.1999.277.2.E245; Fu WY, 2014, POULTRY SCI, V93, P784, DOI 10.3382/ps.2013-03456; Gao HB, 2002, ENDOCRINOLOGY, V143, P130, DOI 10.1210/en.143.1.130; Gao J, 2008, POULTRY SCI, V87, P1609, DOI 10.3382/ps.2007-00007; Gehad A. E., 2008, International Journal of Poultry Science, V7, P193; Grasman KA, 2002, INTEGR COMP BIOL, V42, P34, DOI 10.1093/icb/42.1.34; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu XF, 2010, ASIAN AUSTRAL J ANIM, V23, P175; Hu XF, 2008, ASIAN AUSTRAL J ANIM, V21, P1773, DOI 10.5713/ajas.2008.80167; HUSBAND AJ, 1993, VACCINE, V11, P805, DOI 10.1016/0264-410X(93)90355-2; Jiang KJ, 2008, BRIT POULTRY SCI, V49, P625, DOI 10.1080/00071660802337241; JOHNSON BE, 1993, DEV COMP IMMUNOL, V17, P331, DOI 10.1016/0145-305X(93)90005-B; Kanduc D, 2002, INT J ONCOL, V21, P165; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kumar S, 1999, TRENDS BIOCHEM SCI, V24, P1, DOI 10.1016/S0968-0004(98)01332-2; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Lin H, 2006, COMP BIOCHEM PHYS A, V143, P400, DOI 10.1016/j.cbpa.2005.12.030; Ling Y, 2009, ANTICANCER RES, V29, P411; Mathivanan R., 2012, Journal of Medicinal Plants Research, V6, P5647; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McMurtry JP, 1998, J NUTR, V128, p302S, DOI 10.1093/jn/128.2.302S; Mehaisen GMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158314; MILLER AH, 1990, AM J PHYSIOL, V259, pE405, DOI 10.1152/ajpendo.1990.259.3.E405; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; PARDUE SL, 1985, J APPL PHYSIOL, V58, P1511, DOI 10.1152/jappl.1985.58.5.1511; Pazirandeh A, 2002, FASEB J, V16, P727, DOI 10.1096/fj.01-0891fje; Post J, 2003, POULTRY SCI, V82, P1313, DOI 10.1093/ps/82.8.1313; Post J, 2003, POULTRY SCI, V82, P591, DOI 10.1093/ps/82.4.591; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Puvadolpirod S, 2000, POULTRY SCI, V79, P363, DOI 10.1093/ps/79.3.363; RANELLETTI FO, 1987, J IMMUNOL, V138, P440; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Renvoize C, 1998, CELL BIOL TOXICOL, V14, P111, DOI 10.1023/A:1007429904664; Richards MP, 2005, COMP BIOCHEM PHYS A, V141, P76, DOI 10.1016/j.cbpb.2005.04.006; Rimoldi S, 2015, META GENE, V6, P17, DOI 10.1016/j.mgene.2015.08.003; Rosebrough RW, 2003, DOMEST ANIM ENDOCRIN, V24, P231, DOI 10.1016/S0739-7240(02)00236-9; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; SCHAUMBURG BP, 1971, BIOCHIM BIOPHYS ACTA, V237, P494, DOI 10.1016/0304-4165(71)90269-8; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Shini S, 2009, PHYSIOL BEHAV, V98, P73, DOI 10.1016/j.physbeh.2009.04.012; Shini S, 2008, VET IMMUNOL IMMUNOP, V122, P83, DOI 10.1016/j.vetimm.2007.10.009; Shini S, 2010, STRESS, V13, P185, DOI 10.3109/10253890903144639; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; SIEGEL HS, 1984, BRIT POULTRY SCI, V25, P477, DOI 10.1080/00071668408454889; Smith LK, 2010, PROG BRAIN RES, V182, P1, DOI 10.1016/S0079-6123(10)82001-1; Song ZG, 2011, J MOL ENDOCRINOL, V46, P217, DOI 10.1530/JME-10-0162; Song ZG, 2011, ASIAN AUSTRAL J ANIM, V24, P1736, DOI 10.5713/ajas.2011.11164; Sun Chenyou, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P543; THAKUR P, 2010, AM J BIOMED SCI, V2, P275; Tsukada A, 1998, GROWTH HORM IGF RES, V8, P235, DOI 10.1016/S1096-6374(98)80116-0; Vahdatpour T., 2011, Annals of Biological Research, V2, P283; Vahdatpour T, 2009, ASIAN J ANIM VET ADV, V4, P16, DOI 10.3923/ajava.2009.16.21; Van Hunsel F, 1998, PSYCHOL MED, V28, P301, DOI 10.1017/S0033291797006351; Virden WS, 2007, POULTRY SCI, V86, P2485, DOI 10.3382/ps.2006-00215; Vleck CM, 2000, CONDOR, V102, P392, DOI 10.1650/0010-5422(2000)102[0392:SCAHTL]2.0.CO;2; Wang S, 2013, COMP BIOCHEM PHYS A, V164, P537, DOI 10.1016/j.cbpa.2012.12.014; Wang XJ, 2015, STRESS, V18, P686, DOI 10.3109/10253890.2015.1083551; Yang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119750; Yuan L, 2008, BRIT POULTRY SCI, V49, P487, DOI 10.1080/00071660802251731; Zhang L, 2009, POULTRY SCI, V88, P2033, DOI 10.3382/ps.2009-00128; Zhang LB, 2008, POULTRY SCI, V87, P1370, DOI 10.3382/ps.2007-00366; Zhang WH, 2011, POULTRY SCI, V90, P2592, DOI 10.3382/ps.2011-01446; Zulkifli I, 2014, POULTRY SCI, V93, P3112, DOI 10.3382/ps.2014-04099	88	42	42	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172684	10.1371/journal.pone.0172684	http://dx.doi.org/10.1371/journal.pone.0172684			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235061	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200115
J	Raines, SA; Hodgkinson, MR; Dowle, AA; Pryor, PR				Raines, Sally A.; Hodgkinson, Michael R.; Dowle, Adam A.; Pryor, Paul R.			The Salmonella effector SseJ disrupts microtubule dynamics when ectopically expressed in normal rat kidney cells	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; ENTERICA SEROVAR TYPHIMURIUM; FILAMENTOUS STRUCTURES; PHAGOSOME MATURATION; III SECRETION; RHO GTPASES; PROTEIN; YEAST; TRAFFICKING; BIOGENESIS	Salmonella effector protein SseJ is secreted by Salmonella into the host cell cytoplasm where it can then modify host cell processes. Whilst host cell small GTPase RhoA has previously been shown to activate the acyl-transferase activity of SseJ we show here an undescribed effect of SseJ protein production upon microtubule dynamism. SseJ prevents microtubule collapse and this is independent of SseJ's acyl-transferase activity. We speculate that the effects of SseJ on microtubules would be mediated via its known interactions with the small GTPases of the Rho family.	[Raines, Sally A.; Hodgkinson, Michael R.; Pryor, Paul R.] Univ York, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Dowle, Adam A.] Univ York, Dept Biol, Technol Facil, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Pryor, Paul R.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of Hull; University of York - UK	Pryor, PR (corresponding author), Univ York, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.; Pryor, PR (corresponding author), Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	paul.pryor@york.ac.uk	Dowle, Adam/AAW-6410-2021	Dowle, Adam/0000-0002-6501-5444; Pryor, Paul Robert/0000-0001-9123-8329	Wellcome Trust Research Career Development Fellowship [079705]	Wellcome Trust Research Career Development Fellowship(Wellcome Trust)	This research was supported by a Wellcome Trust Research Career Development Fellowship (079705) to PRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Birmingham CL, 2005, INFECT IMMUN, V73, P1204, DOI 10.1128/IAI.73.2.1204-1208.2005; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Brumell JH, 2001, TRAFFIC, V2, P643, DOI 10.1034/j.1600-0854.2001.20907.x; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; Darsow T, 2000, METHOD ENZYMOL, V327, P95, DOI 10.1016/S0076-6879(00)27270-4; Dehmelt L, 2005, GENOME BIOL, V6; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Castro-Alvarez JF, 2011, BEHAV NEUROSCI, V125, P465, DOI 10.1037/a0023167; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Girotti M, 1996, J CELL SCI, V109, P2915; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; JAHRAUS A, 1994, J CELL SCI, V107, P145; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kolodziejek AM, 2015, CELL MICROBIOL, V17, P333, DOI 10.1111/cmi.12420; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Ledda FD, 2013, AQUAT TOXICOL, V140, P98, DOI 10.1016/j.aquatox.2013.05.013; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; LI WD, 1993, TOXICOLOGY, V77, P65; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pan JJ, 2014, BLOOD, V124, P3967, DOI 10.1182/blood-2013-12-544924; PHAIREWASHINGTON L, 1980, J CELL BIOL, V86, P641, DOI 10.1083/jcb.86.2.641; Quintero Cristian A, 2015, Small GTPases, V6, P108, DOI 10.4161/21541248.2014.991233; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON JM, 1986, J CELL BIOL, V102, P1615, DOI 10.1083/jcb.102.5.1615; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; Thi EP, 2013, CELL MICROBIOL, V15, P795, DOI 10.1111/cmi.12073; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]	55	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172588	10.1371/journal.pone.0172588	http://dx.doi.org/10.1371/journal.pone.0172588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235057	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200097
J	Teussink, MM; Lambertus, S; de Mul, FF; Rozanowska, MB; Hoyng, CB; Klevering, BJ; Theelen, T				Teussink, Michel M.; Lambertus, Stanley; de Mul, Frits F.; Rozanowska, Malgorzata B.; Hoyng, Carel B.; Klevering, B. Jeroen; Theelen, Thomas			Lipofuscin-associated photo-oxidative stress during fundus autofluorescence imaging	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; HUMAN RPE MELANOSOMES; AGE-RELATED-CHANGES; OXIDATIVE STRESS; STARGARDTS-DISEASE; LIGHT; FLUORESCENCE; PROTEIN; CELLS; PHOTOREACTIVITY	Purpose Current standards and guidelines aimed at preventing retinal phototoxicity during intentional exposures do not specifically evaluate the contribution of endogenous photosensitizers. However, certain retinal diseases are characterized by abnormal accumulations of potential photosensitizers such as lipofuscin bisretinoids in the retinal pigment epithelium (RPE). We sought to determine these contributions by a numerical assessment of in-vivo photo-oxidative stress during irradiation of RPE lipofuscin. Methods Based on the literature, we calculated the retinal exposure levels, optical filtering of incident radiation by the ocular lens, media, photoreceptors, and RPE melanin, light absorption by lipofuscin, and photochemical effects in the RPE in two situations: exposure to short-wavelength (lambda = 488 nm) fundus autofluorescence (SW-AF) excitation light and exposure to indirect (diffuse) sunlight. Results In healthy persons at age 20, 40, and 60, respectively, the rate of oxygen photoconsumption by lipofuscin increases by 1.3, 1.7, and 2.4 fold during SW-AF-imaging as compared to diffuse sunlight. In patients with STGD1 below the age of 30, this rate was 3.3-fold higher compared to age-matched controls during either sunlight or SW-AF imaging. Conclusions Our results suggest that the RPE of patients with STGD1 is generally at increased risk of photo-oxidative stress, while exposure during SW-AF-imaging amplifies this risk. These theoretical results have not yet been verified with in-vivo data due to a lack of sufficiently sensitive in-vivo measurement techniques.	[Teussink, Michel M.; Lambertus, Stanley; Hoyng, Carel B.; Klevering, B. Jeroen; Theelen, Thomas] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [de Mul, Frits F.] Univ Twente, Dept Appl Phys, Enschede, Netherlands; [Rozanowska, Malgorzata B.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	Radboud University Nijmegen; University of Twente; Cardiff University	Theelen, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.	thomas.theelen@radboudumc.nl	Rozanowska, Malgorzata B/B-7860-2014; Rozanowska, Malgorzata/AAD-4806-2021; Theelen, Thomas/A-3192-2012; Lambertus, Stanley/P-8153-2015	Rozanowska, Malgorzata B/0000-0003-2913-8954; Rozanowska, Malgorzata/0000-0003-2913-8954; Theelen, Thomas/0000-0001-9067-1171; Lambertus, Stanley/0000-0001-9600-9592	Foundation Fighting Blindness, Columbia, Maryland [C-CL-0811-0549-RAD05]; Gelderse Blindenstichting, Velp, the Netherlands	Foundation Fighting Blindness, Columbia, Maryland; Gelderse Blindenstichting, Velp, the Netherlands	Funding was provided by the Foundation Fighting Blindness, Columbia, Maryland (http:// www.blindness.org; grant nr. C-CL-0811-0549-RAD05), and by the Gelderse Blindenstichting, Velp, the Netherlands (http://gelderseblinden.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM), 2003, BOOK OF STAND; [Anonymous], 2007, Z1361 ANSI NAT EL MA; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bergougnoux L, 1996, APPL OPTICS, V35, P1735, DOI 10.1364/AO.35.001735; BONNIN M P, 1971, Bulletin des Societes d'Ophtalmologie de France, V71, P348; Bonnin MP, 1976, DOC OPHTHALMOL, P461; BOULTON M, 1990, VISION RES, V30, P1291, DOI 10.1016/0042-6989(90)90003-4; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Burns SA, 1994, HDB OPTICS, V3; Cideciyan AV, 2007, J OPT SOC AM A, V24, P1457, DOI 10.1364/JOSAA.24.001457; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Cracknell KPB, 2007, COMPUT METH PROG BIO, V87, P93, DOI 10.1016/j.cmpb.2007.04.010; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Delori F, 2011, INVEST OPHTH VIS SCI, V52, P9379, DOI 10.1167/iovs.11-8319; DRYJA TP, 1979, INVEST OPHTH VIS SCI, V18, P231; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; ELDRED GE, 1988, EXP EYE RES, V47, P71, DOI 10.1016/0014-4835(88)90025-5; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Feldman TB, 2015, ANAL BIOANAL CHEM, V407, P1075, DOI 10.1007/s00216-014-8353-z; FISH G, 1981, BRIT J OPHTHALMOL, V65, P359, DOI 10.1136/bjo.65.5.359; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; HAMMER M, 1995, PHYS MED BIOL, V40, P963, DOI 10.1088/0031-9155/40/6/001; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; KATZ ML, 1986, EXP EYE RES, V43, P561, DOI 10.1016/S0014-4835(86)80023-9; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kawauchi S, 2004, PHOTOCHEM PHOTOBIOL, V80, P216, DOI 10.1562/2004-03-27-RA-125.1; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Kurz T, 2009, AUTOPHAGY, V5, P494, DOI 10.4161/auto.5.4.7961; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Nofsinger JB, 1999, J PHYS CHEM B, V103, P11428, DOI 10.1021/jp992640y; Olchawa MM, 2013, INVEST OPHTH VIS SCI, V54, P2276, DOI 10.1167/iovs.12-11154; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Prahl S. A., 1989, SPIE SERIES, VIS 5, P102, DOI DOI 10.1117/12.2283590; Qin SF, 2008, J BIOL CHEM, V283, P6744, DOI 10.1074/jbc.M708848200; Rozanowska M, 2004, INVEST OPHTH VIS SCI, V45, P1052, DOI 10.1167/iovs.03-0277; Rozanowska M, 2002, INVEST OPHTH VIS SCI, V43, P2088; Rozanowski B, 2008, INVEST OPHTH VIS SCI, V49, P2838, DOI 10.1167/iovs.08-1700; Sharpe T., 1995, LENGTH OUTER SEGMENT; Sliney D, 2005, APPL OPTICS, V44, P2162, DOI 10.1364/AO.44.002162; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Teussink MM, 2015, AM J OPHTHALMOL, V159, P964, DOI 10.1016/j.ajo.2015.02.004; Tran NT, 2006, APPL OPTICS, V45, P7557, DOI 10.1364/AO.45.007557; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; ULISS AE, 1987, OPHTHALMOLOGY, V94, P1423; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; VANGEMERT JC, 1985, BRIT J CANCER, V52, P43, DOI 10.1038/bjc.1985.146; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Winkler B S, 1999, Mol Vis, V5, P32; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Yannuzzi L A, 1987, Trans Am Ophthalmol Soc, V85, P120; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zadlo A, 2009, PHOTOCH PHOTOBIO SCI, V8, P830, DOI 10.1039/b901820d; Zareba M, 2014, INVEST OPHTH VIS SCI, V55, P4982, DOI 10.1167/iovs.14-14310	68	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172635	10.1371/journal.pone.0172635	http://dx.doi.org/10.1371/journal.pone.0172635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235055	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000394688200104
J	Theuerkauf, SJ; Puckett, BJ; Theuerkauf, KW; Theuerkauf, EJ; Eggleston, DB				Theuerkauf, Seth J.; Puckett, Brandon J.; Theuerkauf, Kathrynlynn W.; Theuerkauf, Ethan J.; Eggleston, David B.			Density-dependent role of an invasive marsh grass, Phragmites australis, on ecosystem service provision	PLOS ONE			English	Article							PLANT DIVERSITY; TIDAL WETLANDS; COMMON REED; FRESH-WATER; SALT-MARSH; NEW-JERSEY; CARBON; EXPANSION; DISTURBANCE; MANAGEMENT	Invasive species can positively, neutrally, or negatively affect the provision of ecosystem services. The direction and magnitude of this effect can be a function of the invaders' density and the service(s) of interest. We assessed the density-dependent effect of an invasive marsh grass, Phragmites australis, on three ecosystem services (plant diversity and community structure, shoreline stabilization, and carbon storage) in two oligohaline marshes within the North Carolina Coastal Reserve and National Estuarine Research Reserve System (NCNERR), USA. Plant species richness was equivalent among low, medium and high Phragmites density plots, and overall plant community composition did not vary significantly by Phragmites density. Shoreline change was most negative (landward retreat) where Phragmites density was highest (-0.40 +/- 0.19m yr(-1) vs. -0.31 +/- 0.10 for low density Phragmites) in the high energy marsh of Kitty Hawk Woods Reserve and most positive (soundward advance) where Phragmites density was highest (0.19 +/- 0.05 m yr(-1) vs. 0.12 +/- 0.07 for low density Phragmites) in the lower energy marsh of Currituck Banks Reserve, although there was no significant effect of Phragmites density on shoreline change. In Currituck Banks, mean soil carbon content was approximately equivalent in cores extracted from low and high Phragmites density plots (23.23 +/- 2.0 kg C m(-3) vs. 22.81 +/- 3.8). In Kitty Hawk Woods, mean soil carbon content was greater in low Phragmites density plots (36.63 +/- 10.22 kg C m(-3)) than those with medium (13.99 +/- 1.23 kg C m(-3)) or high density (21.61 +/- 4.53 kg C m(-3)), but differences were not significant. These findings suggest an overall neutral density-dependent effect of Phragmites on three ecosystem services within two oligohaline marshes in different environmental settings within a protected reserve system. Moreover, the conceptual framework of this study can broadly inform an ecosystem services-based approach to invasive species management.	[Theuerkauf, Seth J.; Theuerkauf, Kathrynlynn W.; Eggleston, David B.] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA; [Puckett, Brandon J.] North Carolina Coastal Reserve, Beaufort, NC USA; [Puckett, Brandon J.] Natl Estuarine Res Reserve, Beaufort, NC USA; [Theuerkauf, Ethan J.] Univ Illinois, Illinois State Geol Survey, Champaign, IL USA	University of North Carolina; North Carolina State University; University of Illinois System; University of Illinois Urbana-Champaign	Theuerkauf, SJ (corresponding author), North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA.	sjtheuer@ncsu.edu	Theuerkauf, Seth/AAB-3290-2020	Puckett, Brandon/0000-0001-9615-6242; Theuerkauf, Seth/0000-0003-2556-5174; Theuerkauf, Kathrynlynn/0000-0003-3986-4167; Eggleston, David/0000-0001-7840-2665	North Carolina Sea Grant and North Carolina Coastal Reserve Fellowship; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; North Carolina Sea Grant [R12-HCE-2]; National Science Foundation [OCE-545 1155609]; Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a];  [FA9550-11-C-0028]	North Carolina Sea Grant and North Carolina Coastal Reserve Fellowship; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; North Carolina Sea Grant; National Science Foundation(National Science Foundation (NSF)); Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship; 	Funding for the project was provided by a North Carolina Sea Grant and North Carolina Coastal Reserve Fellowship, North Carolina Coastal Conservation Association Scholarship, and Beneath the Sea Foundation Scholarship to SJT, as well as North Carolina Sea Grant (R12-HCE-2) and the National Science Foundation (OCE-545 1155609) to DBE. Research for this paper was conducted with Government support under contract FA9550-11-C-0028 and awarded by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a to SJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailstock MS, 2001, RESTOR ECOL, V9, P49, DOI 10.1046/j.1526-100x.2001.009001049.x; [Anonymous], 2007, SIGM REL 10; Bart D, 2000, OIKOS, V89, P59, DOI 10.1034/j.1600-0706.2000.890107.x; Bernal B, 2012, GLOBAL CHANGE BIOL, V18, P1636, DOI 10.1111/j.1365-2486.2011.02619.x; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Caldwell WS, 2001, 014097 US GEOL SURV; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; Charles Heather, 2007, V193, P217; Clarke KR, 2015, PRIMER V7 USER MANUA; Coops H, 1996, AQUAT BOT, V53, P187, DOI 10.1016/0304-3770(96)01027-3; Craft C, 2002, RESTOR ECOL, V10, P248, DOI 10.1046/j.1526-100X.2002.01020.x; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Currin Carolyn A., 2008, Wetlands Ecology and Management, V16, P97, DOI 10.1007/s11273-007-9059-1; Davis JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142595; DOELLE M, 2003, INT J MARINE COASTAL, V18, P261; ESRI, 2016, ARCGIS DESKT VERS 10; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Grabowski JH, 2007, THEOR ECOL SER, P281; Gribben PE, 2013, OIKOS, V122, P816, DOI 10.1111/j.1600-0706.2012.20868.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Leonard LA, 2002, WETLANDS, V22, P415, DOI 10.1672/0277-5212(2002)022[0415:FDASIS]2.0.CO;2; MANN KH, 1988, LIMNOL OCEANOGR, V33, P910, DOI 10.4319/lo.1988.33.4_part_2.0910; MARKS M, 1994, NAT AREA J, V14, P285; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Meyerson L.A., 2009, HUMAN IMPACTS SALT M, P57; Moore GE, 2012, NORTHEAST NAT, V19, P611, DOI 10.1656/045.019.0406; North Carolina Department of Environmental Quality Division of Coastal Management, 2016, NC COAST RES NAT EST; North Carolina Department of Environmental Quality Division of Coastal Management, 2012, EST SHOR NC SPAT DAT; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Stalter Richard, 1994, Castanea, V59, P69; Theuerkauf EJ, 2015, ESTUAR COAST SHELF S, V164, P367, DOI 10.1016/j.ecss.2015.08.001; Thomsen MS, 2011, ENVIRON RES, V111, P899, DOI 10.1016/j.envres.2011.05.024; Williams H., 1992, RATES SHORELINE EROS; Windham L, 2001, WETLANDS, V21, P179, DOI 10.1672/0277-5212(2001)021[0179:COBPAD]2.0.CO;2; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	48	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173007	10.1371/journal.pone.0173007	http://dx.doi.org/10.1371/journal.pone.0173007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235024	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200184
J	Tkachenko, N; Jarvis, S; Procter, R				Tkachenko, Nataliya; Jarvis, Stephen; Procter, Rob			Predicting floods with Flickr tags	PLOS ONE			English	Article							EARTHQUAKE TWITTER	Increasingly, user generated content (UGC) in social media postings and their associated metadata such as time and location stamps are being used to provide useful operational information during natural hazard events such as hurricanes, storms and floods. The main advantage of these new sources of data are twofold. First, in a purely additive sense, they can provide much denser geographical coverage of the hazard as compared to traditional sensor networks. Second, they provide what physical sensors are not able to do: By documenting personal observations and experiences, they directly record the impact of a hazard on the human environment. For this reason interpretation of the content (e.g., hashtags, images, text, emojis, etc) and metadata (e.g., keywords, tags, geolocation) have been a focus of much research into social media analytics. However, as choices of semantic tags in the current methods are usually reduced to the exact name or type of the event (e.g., hashtags '#Sandy' or '#flooding'), the main limitation of such approaches remains their mere nowcasting capacity. In this study we make use of polysemous tags of images posted during several recent flood events and demonstrate how such volunteered geographic data can be used to provide early warning of an event before its outbreak.	[Tkachenko, Nataliya; Jarvis, Stephen; Procter, Rob] Univ Warwick, Warwick Inst Sci Cities, Coventry CV4 7AL, W Midlands, England; [Jarvis, Stephen; Procter, Rob] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Tkachenko, N (corresponding author), Univ Warwick, Warwick Inst Sci Cities, Coventry CV4 7AL, W Midlands, England.	Nataliya.Tkachenko@warwick.ac.uk	Jarvis, Stephen/AAT-3127-2021	Jarvis, Stephen/0000-0002-1249-2167	UK Engineering and Physical Sciences Research Council [EP/L016400/1]; EPSRC Centre for Doctoral Training in Urban Science and Progress; Engineering and Physical Sciences Research Council [1500267] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Centre for Doctoral Training in Urban Science and Progress(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The lead author gratefully acknowledges funding by the UK Engineering and Physical Sciences Research Council (grant no. EP/L016400/1), the EPSRC Centre for Doctoral Training in Urban Science and Progress. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported in part by the EPSRC Centre for Doctoral Training in Urban Science and Progress (EP/L016400/1). This project is conducted in collaboration with the British Geological Survey (BGS), and the authors are grateful for their support in this research.	Acar Adam, 2011, International Journal of Web Based Communities, V7, P392, DOI 10.1504/IJWBC.2011.041206; Al-Saggaf Y, 2015, TECHNOL FORECAST SOC, V95, P3, DOI 10.1016/j.techfore.2014.08.013; Alanyali M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150466; [Anonymous], 1990, ADV NEURAL INFORM PR; Carpuat M., 2015, P 6 WORKSHOP COMPUTA, P9; Coaffee J, 2008, ENERG POLICY, V36, P4633, DOI 10.1016/j.enpol.2008.09.048; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; Earle P, 2010, NAT GEOSCI, V3, P221, DOI 10.1038/ngeo832; Feng S., 2013, P 51 ANN M ASS COMPU, V1, P1774; INGOLD T, 1993, WORLD ARCHAEOL, V25, P152, DOI 10.1080/00438243.1993.9980235; Ingold T., 2002, PERCEPTION ENV ESSAY; Jarvis SA, 2014, LECT NOTES COMPUTER; Kaufhold MA, 2016, J HOMEL SECUR EMERG, V13, P137, DOI 10.1515/jhsem-2015-0063; May J., 2001, TIMESPACE; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Resnik P., 1999, Natural Language Engineering, V5, P113, DOI 10.1017/S1351324999002211; Schetinin V, 2003, NEURAL PROCESS LETT, V17, P21, DOI 10.1023/A:1022935810223; Schmitz A, 2010, MACHINE LEARNING; Spirn Anne W., 1998, LANGUAGE LANDSCAPE; Stephenson J, 2008, LANDSCAPE URBAN PLAN, V84, P127, DOI 10.1016/j.landurbplan.2007.07.003; Strang Veronica, 2004, MEANING WATER; Tang ZH, 2015, NAT HAZARDS, V79, P171, DOI 10.1007/s11069-015-1835-2; Thomee B, 2016, COMMUN ACM, V59, P64, DOI 10.1145/2812802; Tkachenko N, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160013; USGS, FLOODS DROUGHTS AR F	25	26	26	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172870	10.1371/journal.pone.0172870	http://dx.doi.org/10.1371/journal.pone.0172870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235035	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200158
J	Wilman, HR; Kelly, M; Jandor, A; Bell, J; Banerjee, R; Thomas, L				Wilman, H. R.; Kelly, M.; Jandor, A.; Bell, J.; Banerjee, R.; Thomas, L.			Characterisation of liver fat in the UK biobank cohort	JOURNAL OF HEPATOLOGY			English	Meeting Abstract	International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver	APR 19-23, 2017	Amsterdam, NETHERLANDS	European Assoc Study Liver					[Wilman, H. R.; Kelly, M.; Jandor, A.; Banerjee, R.] Perspectum Diagnost, Oxford, England; [Wilman, H. R.; Bell, J.; Thomas, L.] Univ Westminster, Life Sci, London, England	University of Westminster		henry.wilman@perspectum-diagnostics.com		Kelly, Matt/0000-0002-5834-635X; Banerjee, Rajarshi/0000-0003-2022-5218; Neubauer, Stefan/0000-0001-9017-5645; Wilman, Henry/0000-0002-3362-1204; Bell, Jimmy/0000-0003-3804-1281; Thomas, Elizabeth/0000-0003-4235-4694	MRC [MR/M024903/1, MC_U120061305, MC_PC_17114] Funding Source: UKRI; Medical Research Council [MC_U120061305, MC_QA137853, MC_PC_17114, MR/M024903/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	8	8	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.		2017	66	1		S		THU-499	S242	S243						2	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Gastroenterology & Hepatology	EU5FI	28241076	Green Published, gold, Green Accepted			2022-12-27	WOS:000401056600528
J	Butler, EK; Tran, TM; Nagarajan, N; Canner, J; Fuller, AT; Kushner, A; Haglund, MM; Smith, ER				Butler, Elissa K.; Tran, Tu M.; Nagarajan, Neeraja; Canner, Joseph; Fuller, Anthony T.; Kushner, Adam; Haglund, Michael M.; Smith, Emily R.		SOSAS 4 Country Res Grp	Epidemiology of pediatric surgical needs in low-income countries	PLOS ONE			English	Article							COUNTRYWIDE SURVEY; SURGERY	Objective According to recent estimates, at least 11% of the total global burden of disease is attribut-able to surgically-treatable diseases. In children, the burden is even more striking with up to 85% of children in low-income and middle-income countries (LMIC) having a surgically-treatable condition by age 15. Using population data from four countries, we estimated pedi-atric surgical needs amongst children residing in LMICs. Methods A cluster randomized cross-sectional countrywide household survey (Surgeons OverSeas Assessment of Surgical Need) was done in four countries (Rwanda, Sierra Leone, Nepal and Uganda) and included demographics, a verbal head to toe examination, and questions on access to care. Global estimates regarding surgical need among children were derived from combined data, accounting for country-level clustering. Results A total of 13,806 participants were surveyed and 6,361 (46.1%) were children (0-18 years of age) with median age of 8 (Interquartile range [IQR]: 4 -13) years. Overall, 19% (1,181/ 6,361) of children had a surgical need and 62% (738/1,181) of these children had at least one unmet need. Based on these estimates, the number of children living with a surgical need in these four LMICs is estimated at 3.7 million (95% CI: 3.4, 4.0 million). The highest percentage of unmet surgical conditions included head, face, and neck conditions, followed by conditions in the extremities. Over a third of the untreated conditions were masses while the overwhelming majority of treated conditions in all countries were wounds or burns. Conclusion Surgery has been elevated as an "indivisible, indispensable part of health care" in LMICs and the newly formed 2015 Sustainable Development Goals are noted as unachievable without the provision of surgical care. Given the large burden of pediatric surgical conditions in LMICs, scale-up of services for children is an essential component to improve pediatric health in LMICs.	[Butler, Elissa K.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Tran, Tu M.; Haglund, Michael M.; Smith, Emily R.] Duke Univ, Global Hlth Inst, Durham, NC 27708 USA; [Nagarajan, Neeraja; Canner, Joseph; Kushner, Adam] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Fuller, Anthony T.; Haglund, Michael M.; Smith, Emily R.] Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC 27708 USA; [Fuller, Anthony T.; Haglund, Michael M.] Duke Univ, Sch Med, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA	University of Washington; University of Washington Seattle; Duke University; Johns Hopkins University; Duke University; Duke University; Duke University	Smith, ER (corresponding author), Duke Univ, Global Hlth Inst, Durham, NC 27708 USA.; Smith, ER (corresponding author), Duke Univ, Div Global Neurosurg & Neurosci, Durham, NC 27708 USA.	emily.smith1@duke.edu		Smith, Emily/0000-0002-1745-5728; Kushner, Adam/0000-0002-7797-4837; Fuller, Anthony/0000-0001-8841-6948				Bickler SW, 2002, B WORLD HEALTH ORGAN, V80, P829; Butler EK, 2016, PEDIAT SURG INT; Fuller AT, 2016, WORLD NEUROSURGERY; Fuller AT, 2015, WORLD J SURG; Greenberg SLM, 2016, SEMIN PEDIATR SURG, V25, P51, DOI 10.1053/j.sempedsurg.2015.09.009; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Gupta S, 2015, BRIT J SURG, V102, P700, DOI 10.1002/bjs.9807; Hoyler M, 2014, WORLD J SURG, V38, P269, DOI 10.1007/s00268-013-2324-y; Meara JG, 2015, SURGERY, V386, P569, DOI DOI 10.1016/; Nakayama DK, 2009, J PEDIATR SURG, V44, P1677, DOI 10.1016/j.jpedsurg.2009.03.036; Nations U, 2015, MILL DEV GOALS REP 2; OFlynn E, 2016, WORLD J SURG; Ozgediz D, 2012, J PEDIATR SURG, V47, P2305, DOI 10.1016/j.jpedsurg.2012.09.030; Petroze RT, 2014, J PEDIATR SURG, V49, P1092, DOI 10.1016/j.jpedsurg.2014.01.059; Saxton AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165480	15	64	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0170968	10.1371/journal.pone.0170968	http://dx.doi.org/10.1371/journal.pone.0170968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257418	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100003
J	Kim, JI; Lee, I; Park, S; Bae, JY; Yoo, K; Cheong, HJ; Noh, JY; Hong, KW; Lemey, P; Vrancken, B; Kim, J; Nam, M; Yun, SH; Cho, WI; Song, JY; Kim, WJ; Park, MS; Song, JW; Kee, SH; Song, KJ; Park, MS				Kim, Jin Il; Lee, Ilseob; Park, Sehee; Bae, Joon-Yong; Yoo, Kirim; Cheong, Hee Jin; Noh, Ji Yun; Hong, Kyung Wook; Lemey, Philippe; Vrancken, Bram; Kim, Juwon; Nam, Misun; Yun, Soo-Hyeon; Cho, Woo In; Song, Joon Young; Kim, Woo Joo; Park, Mee Sook; Song, Jin-Won; Kee, Sun-Ho; Song, Ki-Joon; Park, Man-Seong			Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea	PLOS ONE			English	Article							RECEPTOR-BINDING; VIRUS; HEMAGGLUTININ; NEURAMINIDASE; EVOLUTION; GLYCOSYLATION; SITES; MODEL; MAFFT	Seasonal influenza is caused by two influenza A subtype (H1N1 and H3N2) and two influenza B lineage (Victoria and Yamagata) viruses. Of these antigenically distinct viruses, the H3N2 virus was consistently detected in substantial proportions in Korea during the 2010/11-2013/14 seasons when compared to the other viruses and appeared responsible for the influenza-like illness rate peak during the first half of the 2011/12 season. To further scrutinize possible causes for this, we investigated the evolutionary and serological relationships between the vaccine and Korean H3N2 strains during the 2011/12 season for the main antigenic determinants of influenza viruses, the hemagglutinin (HA) and neuraminidase (NA) genes. In the 2011/12 season, when the number of H3N2 cases peaked, the majority of the Korean strains did not belong to the HA clade of A/Perth/16/2009 vaccine, and no Korean strains were of this lineage in the NA segment. In a serological assay, post-vaccinated human sera exhibited much reduced hemagglutination inhibition antibody titers against the non-vaccine clade Korean H3N2 strains. Moreover, Korean strains harbored several amino acid differences in the HA antigenic sites and in the NA with respect to vaccine lineages during this season. Of these, the HA antigenic site C residues 45 and 261 and the NA residue 81 appeared to be the signatures of positive selection. In subsequent seasons, when H3N2 cases were lower, the HA and NA genes of vaccine and Korean strains were more phylogenetically related to each other. Combined, our results provide indirect support for using phylogenetic clustering patterns of the HA and possibly also the NA genes in the selection of vaccine viruses and the assessment of vaccine effectiveness.	[Kim, Jin Il; Lee, Ilseob; Park, Sehee; Bae, Joon-Yong; Yoo, Kirim; Kim, Juwon; Nam, Misun; Yun, Soo-Hyeon; Cho, Woo In; Park, Mee Sook; Song, Jin-Won; Kee, Sun-Ho; Song, Ki-Joon; Park, Man-Seong] Korea Univ, Coll Med, Inst Viral Dis, Dept Microbiol, Seoul, South Korea; [Cheong, Hee Jin; Noh, Ji Yun; Song, Joon Young; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Hong, Kyung Wook] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Lemey, Philippe; Vrancken, Bram] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hallym University; KU Leuven	Park, MS (corresponding author), Korea Univ, Coll Med, Inst Viral Dis, Dept Microbiol, Seoul, South Korea.	manseong.park@gmail.com	Lemey, Philippe/C-3755-2018; Vrancken, Bram/D-9538-2018; Kim, Young-jin/GSD-3168-2022; Vrancken, Bram/AAF-7901-2019; Park, Man-Seong/AAF-1207-2020; Hong, Kyung-Wook/T-3067-2018; Song, Jin/HHS-8731-2022	Lemey, Philippe/0000-0003-2826-5353; Vrancken, Bram/0000-0001-6547-5283; Vrancken, Bram/0000-0001-6547-5283; Hong, Kyung-Wook/0000-0002-3227-9558; Kim, Jin Il/0000-0001-8833-2138; Bae, Joon-Yong/0000-0002-2483-4208; Cheong, Hee Jin/0000-0002-2532-1463; PARK, Mee Sook/0000-0002-0665-3964; Song, Joon Young/0000-0002-0148-7194	National Research Foundation of Korea [NRF-2016M3A9B6915715]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea, NRF-2016M3A9B6915715, to Professor Man-Seong Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, DESCR PROC SEAS H5N1; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CDC. Centers for Disease Control and Prevention, 2014, FLU VIR CAN CHANG DR; Chan MCW, 2013, J CLIN VIROL, V56, P219, DOI 10.1016/j.jcv.2012.11.002; Choi WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0098716; Cowling BJ, 2016, VACCINE, V34, P61, DOI 10.1016/j.vaccine.2015.11.016; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fielding JE, 2016, VACCINE, V34, P4905, DOI 10.1016/j.vaccine.2016.08.067; Fonville JM, 2016, J INFECT DIS, V213, P31, DOI 10.1093/infdis/jiv367; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; HIERHOLZER JC, 1969, APPL MICROBIOL, V18, P824, DOI 10.1128/AEM.18.5.824-833.1969; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Ho HP, 2014, INFLUENZA OTHER RESP, V8, P557, DOI 10.1111/irv.12256; Il Kim Jin, 2012, Journal of Bacteriology and Virology, V42, P363, DOI 10.4167/jbv.2012.42.4.363; 이일섭, 2013, Journal of Bacteriology and Virology, V43, P9, DOI 10.4167/jbv.2013.43.1.9; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KCDC. Korea Centers for Disease Control and Prevention, 2016, WEEKL REP INC INFL O; Kim JI, 2013, J VIROL, V87, P7539, DOI 10.1128/JVI.00373-13; Kim JI, 2012, BMB REP, V45, P653, DOI 10.5483/BMBRep.2012.45.11.137; Kim JI, 2012, YONSEI MED J, V53, P886, DOI 10.3349/ymj.2012.53.5.886; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Memoli MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00417-16; Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381; Park Sehee, 2012, Journal of Bacteriology and Virology, V42, P284, DOI 10.4167/jbv.2012.42.4.284; Parker L, 2016, J GEN VIROL, V97, P1333, DOI 10.1099/jgv.0.000457; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Savulescu C, 2014, VACCINE, V32, P4404, DOI 10.1016/j.vaccine.2014.06.063; Shaw ML., 2013, FIELDS VIROLOGY, V6; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13; WHO, 2012, REC COMP INFL VIR VA; WHO, 2009, REC COMP INFL VIR VA; WHO, 2013, REC COMP INFL VIR VA; WHO. World Health Organization, 2016, INFL VACC REAG 19 SE; WHO. World Health Organization, 2009, EMERGENCIES PREPARED; WHO. World Health Organization, 2016, INFL LAB SURV INF GL; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685; Wikramaratna PS, 2015, VACCINE, V33, P5380, DOI 10.1016/j.vaccine.2015.08.065; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; World Health Organization, 2010, REC VIR INFL VACC US; World Health Organization, 2011, REC VIR INFL VACC US; World Health Organization (WHO), 2008, REC COMP INFL VIR VA; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	61	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172059	10.1371/journal.pone.0172059	http://dx.doi.org/10.1371/journal.pone.0172059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257427	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100011
J	Hien, AS; Soma, DD; Hema, O; Bayili, B; Namountougou, M; Gnankine, O; Baldet, T; Diabate, A; Dabire, KR				Hien, Aristide Sawdetuo; Soma, Dieudonne Diloma; Hema, Omer; Bayili, Bazoma; Namountougou, Moussa; Gnankine, Olivier; Baldet, Thierry; Diabate, Abdoulaye; Dabire, Kounbobr Roch			Evidence that agricultural use of pesticides selects pyrethroid resistance within Anopheles gambiae s.l. populations from cotton growing areas in Burkina Faso, West Africa	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; MALARIA CONTROL; MOLECULAR-FORMS; BENIN; SPECIATION; MORTALITY; MUTATION; CAMEROON; KNOCK; GENE	Many studies have shown the role of agriculture in the selection and spread of resistance of Anopheles gambiae s.l. to insecticides. However, no study has directly demonstrated the presence of insecticides in breeding sources as a source of selection for this resistance. It is in this context that we investigated the presence of pesticide residues in breeding habitats and their formal involvement in vector resistance to insecticides in areas of West Africa with intensive farming. This study was carried out from June to November 2013 in Dano, southwest Burkina Faso in areas of conventional (CC) and biological cotton (BC) growing. Water and sediment samples collected from breeding sites located near BC and CC fields were submitted for chromatographic analysis to research and titrate the residual insecticide content found there. Larvae were also collected in these breeding sites and used in toxicity tests to compare their mortality to those of the susceptible strain, Anopheles gambiae Kisumu. All tested mosquitoes (living and dead) were analyzed by PCR for species identification and characterization of resistance genes. The toxicity analysis of water from breeding sites showed significantly lower mortality rates in breeding site water from biological cotton (WBC) growing sites compared to that from conventional cotton (WCC) sites respective to both An. gambiae Kisumu (WBC: 80.75% vs WCC: 92.75%) and a wild-type strain (49.75% vs 66.5%). The allele frequencies L1014F, L1014S kdr, and G116S ace - 1(R) mutations conferring resistance, respectively, to pyrethroids and carbamates / organophosphates were 0.95, 0.4 and 0.12. Deltamethrin and lambda-cyhalothrin were identified in the water samples taken in October/November from mosquitoes breeding in the CC growing area. The concentrations obtained were respectively 0.0147ug/L and 1.49 ug/L to deltamethrin and lambdacyhalothrin. Our results provided evidence by direct analysis (biological and chromatographic tests) of the role of agriculture as a source of selection pressure on vectors to insecticides used in growing areas.	[Hien, Aristide Sawdetuo; Soma, Dieudonne Diloma; Bayili, Bazoma; Diabate, Abdoulaye; Dabire, Kounbobr Roch] IRSS DRO, Malaria & Trop Neglected Res Unit, Bobo Dioulasso, Burkina Faso; [Hema, Omer] INERA, Programme Coton, Farako Ba, Bobo Dioulasso, Burkina Faso; [Namountougou, Moussa] Univ Polytech Bobo Dioulasso, Inst Rural Dev, Bobo Dioulasso, Burkina Faso; [Gnankine, Olivier] Univ Joseph Ki Zerbo, UFR Life Sci, Ouagadougou, Burkina Faso; [Baldet, Thierry] CIRAD, Campus Baillarguet, Montpellier, France	CIRAD	Hien, AS; Dabire, KR (corresponding author), IRSS DRO, Malaria & Trop Neglected Res Unit, Bobo Dioulasso, Burkina Faso.	aristide.hien@yahoo.fr; dabire_roch@hotmail.com	Gnankine, Olivier/AAH-4974-2019; Dabire, Roch Kounbobr/ABF-3525-2020	Gnankine, Olivier/0000-0002-6006-6533; DIABATE, Abdoulaye/0000-0002-9666-9395	PRIPA of IDRC [104263-009]	PRIPA of IDRC	This study was financially supported by the PRIPA project 104263-009 of IDRC granted to DKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2012, INSECTICIDES - PEST ENGINEERING, P479; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141645; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; ELLIOTT M, 1989, PESTIC SCI, V27, P337, DOI 10.1002/ps.2780270403; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Guimaraes RM, 2007, CAD SAUDE PUBLICA, V23, P2835, DOI 10.1590/S0102-311X2007001200004; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2014, WORLD MAL REP 2014, P242; World Health Organization, 1998, WHOCDSCPCMAL1998; Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83	31	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173098	10.1371/journal.pone.0173098	http://dx.doi.org/10.1371/journal.pone.0173098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253316	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300073
J	Khan, SA; Manzoor, S; Alamgir; Ali, A; Khan, DM; Khalil, U				Khan, Sajjad Ahmad; Manzoor, Sadaf; Alamgir; Ali, Amjad; Khan, Dost Muhammad; Khalil, Umair			Rules for resolving Mendelian inconsistencies in nuclear pedigrees typed for two-allele markers	PLOS ONE			English	Article							GENOTYPING ERRORS; LINKAGE ANALYSIS; GENETIC-LINKAGE; IDENTIFICATION; MUTATIONS; LOCI; PAIR	Gene-mapping studies, regularly, rely on examination for Mendelian transmission of marker alleles in a pedigree as a way of screening for genotyping errors and mutations. For analysis of family data sets, it is, usually, necessary to resolve or remove the genotyping errors prior to consideration. At the Center of Inherited Disease Research (CIDR), to deal with their large-scale data flow, they formalized their data cleaning approach in a set of rules based on PedCheck output. We scrutinize via carefully designed simulations that how well CIDR's data cleaning rules work in practice. We found that genotype errors in siblings are detected more often than in parents for less polymorphic SNPs and vice versa for more polymorphic SNPs. Through computer simulations, we conclude that some of the CIDR's rules work poorly in some circumstances, and we suggest a set of modified data cleaning rules that may work better than CIDR's rules.	[Khan, Sajjad Ahmad; Khan, Dost Muhammad; Khalil, Umair] Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pukhtunkhwa, Pakistan; [Khan, Sajjad Ahmad; Manzoor, Sadaf; Ali, Amjad] Islamia Coll, Dept Stat, Peshawar, Khyber Pukhtunk, Pakistan; [Alamgir] Univ Peshawar, Dept Stat, Khyber Pukhtunkhwa, Pakistan	University of Peshawar	Khan, SA (corresponding author), Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pukhtunkhwa, Pakistan.; Khan, SA (corresponding author), Islamia Coll, Dept Stat, Peshawar, Khyber Pukhtunk, Pakistan.	sajjadkhan@awkum.edu.pk	Khan, Dost Muhammad/AAA-7465-2020; Khan, Sajjad Ahmad/AAE-5527-2020	Khan, Dost Muhammad/0000-0002-3919-8136; Khan, Sajjad Ahmad/0000-0001-6630-7222				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Badzioch MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S40; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cherny SS, 2001, GENET EPIDEMIOL, V21, pS117, DOI 10.1002/gepi.2001.21.s1.s117; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Hess MA, 2012, MOL ECOL RESOUR, V12, P1114, DOI 10.1111/1755-0998.12002; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1983, AM J HUM GENET, V35, P241; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Mukhopadhyay N, 2004, HUM HERED, V58, P175, DOI 10.1159/000083545; Neale BM, 2008, STAT GENETICS GENE M; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1992, AM J HUM GENET, V51, P283; Seaman SR, 2005, HUM HERED, V59, P157, DOI 10.1159/000085939; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Zhu ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133421; Ziegler A, 2006, STAT APPROACH GENETI	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172807	10.1371/journal.pone.0172807	http://dx.doi.org/10.1371/journal.pone.0172807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253278	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300037
J	Lacmata, ST; Kuiate, JR; Ding, YM; Xian, M; Liu, HZ; Boudjeko, T; Feng, XJ; Zhao, G				Lacmata, Stephen Tamekou; Kuiate, Jules-Roger; Ding, Yamei; Xian, Mo; Liu, Huizhou; Boudjeko, Thaddee; Feng, Xinjun; Zhao, Guang			Enhanced poly(3-hydroxypropionate) production via beta-alanine pathway in recombinant Escherichia coli	PLOS ONE			English	Article							ASPARTATE-ALPHA-DECARBOXYLASE; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; GLYCEROL; POLYESTERS	Poly(3-hydroxypropionate) (P3HP) is a thermoplastic with great compostability and biocompatibility, and can be produced through several biosynthetic pathways, in which the glycerol pathway achieved the highest P3HP production. However, exogenous supply of vitamin B-12 was required to maintain the activity of glycerol dehydratase, resulting in high production cost. To avoid the addition of VB12, we have previously constructed a P3HP biosynthetic route with beta-alanine as intermediate, and the present study aimed to improve the P3HP production of this pathway. L-aspartate decarboxylase PanD was found to be the rate-limiting enzyme in the beta-alanine pathway firstly. To improve the pathway efficiency, PanD was screened from four different sources (Escherichia coli, Bacillus subtilis, Pseudomonas fluorescens, and Corynebacterium glutamicum). And PanD from C. glutamicum was found to have the highest activity, the P3HP production was improved in flask cultivation with this enzyme. To further improve the production, the host strain was screened and the culture condition was optimized. Under optimal conditions, production and content of P3HP reached to 10.2 g/L and 39.1% (wt/wt [cell dry weight]) in an aerobic fed-batch fermentation. To date, this is the highest P3HP production without VB12.	[Lacmata, Stephen Tamekou; Xian, Mo; Liu, Huizhou; Feng, Xinjun; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China; [Lacmata, Stephen Tamekou; Kuiate, Jules-Roger] Univ Dschang, Fac Sci, Dept Biochem, Lab Microbiol & Antimicrobials Subst, Dschang, Cameroon; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Boudjeko, Thaddee] Univ Yaounde, Lab Phytoptotect & Valorizat Vegetals Resources, Biotechnol Nkolbisson Ctr, Dept Biochem, Yaounde, Cameroon; [Zhao, Guang] Randian Technol Co Ltd, Tianjin, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; University of Yaounde I	Feng, XJ; Zhao, G (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biobased Mat, Qingdao, Peoples R China.; Zhao, G (corresponding author), Randian Technol Co Ltd, Tianjin, Peoples R China.	fengxj@qibebt.ac.cn; zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013; Feng, Xinjun/G-5786-2017	zhao, guang/0000-0003-0002-5972; Feng, Xinjun/0000-0002-0195-4258	CAS [ZDRW-ZS-2016-3M, KGZD-EW-606-1-3]; Shandong Province Postdoctoral Innovation Foundation [201603076]; Taishan Scholars Climbing Program of Shandong [TSPD20150210]	CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); Shandong Province Postdoctoral Innovation Foundation; Taishan Scholars Climbing Program of Shandong	This work was supported by the 100-Talent Project of CAS (for GZ), CAS Key Program (ZDRW-ZS-2016-3M for GZ and KGZD-EW-606-1-3 for MX), Shandong Province Postdoctoral Innovation Foundation (201603076 for XF), and Taishan Scholars Climbing Program of Shandong (No. TSPD20150210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Andreessen B, 2010, APPL ENVIRON MICROB, V76, P4919, DOI 10.1128/AEM.01015-10; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Delvigne F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-15; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Feng XJ, 2015, BIOENGINEERED, V6, P77, DOI 10.1080/21655979.2015.1011027; Fernandez-Castane A, 2012, J BIOTECHNOL, V157, P391, DOI 10.1016/j.jbiotec.2011.12.007; Gao YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097845; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Nozaki S, 2012, MICROBIOLOGYOPEN, V1, P298, DOI 10.1002/mbo3.34; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Shen Y, 2014, BIOTECHNOL LETT, V36, P1681, DOI 10.1007/s10529-014-1527-0; Sorokin A, 1996, MICROBIOL-SGM, V142, P2005, DOI 10.1099/13500872-142-8-2005; Stuecker TN, 2012, MBIO, V3, DOI 10.1128/mBio.00158-12; Wang Q, 2014, BIOTECHNOL LETT, V36, P2257, DOI 10.1007/s10529-014-1600-8; Wang Q, 2013, BIORESOURCE TECHNOL, V131, P548, DOI 10.1016/j.biortech.2013.01.096; Wang Q, 2012, J MICROBIOL, V50, P693, DOI 10.1007/s12275-012-2234-y	18	9	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173150	10.1371/journal.pone.0173150	http://dx.doi.org/10.1371/journal.pone.0173150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253372	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300081
J	Prieto, I; del Puerto-Nevado, L; Gonzalez, N; Portal-Nunez, S; Zazo, S; Corton, M; Minguez, P; Gomez-Guerrero, C; Arce, JM; Sanz, AB; Mas, S; Aguilera, O; Alvarez-Llamas, G; Esbrit, P; Ortiz, A; Ayuso, C; Egido, J; Rojo, F; Garcia-Foncilias, J				Prieto, Isabel; del Puerto-Nevado, Laura; Gonzalez, Nieves; Portal-Nunez, Sergio; Zazo, Sandra; Corton, Marta; Minguez, Pablo; Gomez-Guerrero, Carmen; Miguel Arce, Jose; Belen Sanz, Ana; Mas, Sebastian; Aguilera, Oscar; Alvarez-Llamas, Gloria; Esbrit, Pedro; Ortiz, Alberto; Ayuso, Carmen; Egido, Jesus; Rojo, Federico; Garcia-Foncilias, Jesus		DiabetesCancerConnect Consortium	Colon cancer modulation by a diabetic environment: A single institutional experience	PLOS ONE			English	Article							COLORECTAL-CANCER; ANTITUMOR-ACTIVITY; DETECTION BIAS; METFORMIN; RISK; TYPE-2; MORTALITY; POPULATION; MELLITUS; IMPACT	Background Multiple observational studies suggest an increased risk of colon cancer in patients with diabetes mellitus (DM). This can theoretically be the result of an influence of the diabetic environment on carcinogenesis or the tumor biologic behavior. Aim To gain insight into the influence of a diabetic environment on colon cancer characteristics and outcomes. Material and methods Retrospective analysis of clinical records in an academic tertiary care hospital with detailed analysis of 81 diabetic patients diagnosed of colon cancer matched with 79 non-diabetic colon cancer patients. The impact of streptozotocin-induced diabetes on the growth of colon cancer xenografts was studied in mice. Results The incidence of DM in 1,137 patients with colorectal cancer was 16%. The diabetic colon cancer cases and non-diabetic colon cancer controls were well matched for demographic and clinical variables. The ECOG Scale Performance Status was higher (worse) in diabetics (ECOG >= 1, 29.1% of controls vs 46.9% of diabetics, p = 0.02), but no significant differences were observed in tumor grade, adjuvant therapy, tumor site, lymphovascular invasion, stage, recurrence, death or cancer-related death. Moreover, no differences in tumor variables were observed between patients treated or not with metformin. In the xenograft model, tumor growth and histopathological characteristics did not differ between diabetic and nondiabetic animals. Conclusion Our findings point towards a mild or negligible effect of the diabetes environment on colon cancer behavior, once cancer has already developed.	[Prieto, Isabel; Aguilera, Oscar] UAM, Oncohlth Inst, Radiat Oncol, IIS,Fdn Jimenez Diaz, Madrid, Spain; [del Puerto-Nevado, Laura; Garcia-Foncilias, Jesus] UAM, Oncohlth Inst, Translat Oncol Div, IIS,Fdn Jimenez Diaz, Madrid, Spain; [Gonzalez, Nieves; Gomez-Guerrero, Carmen; Belen Sanz, Ana; Mas, Sebastian; Ortiz, Alberto; Egido, Jesus] UAM, Renal Vasc & Diabet Res Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Gonzalez, Nieves; Gomez-Guerrero, Carmen; Mas, Sebastian; Egido, Jesus] Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain; [Portal-Nunez, Sergio; Esbrit, Pedro] UAM, Bone & Mineral Metab Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Zazo, Sandra; Rojo, Federico] UAM, Dept Pathol, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Corton, Marta; Minguez, Pablo; Ayuso, Carmen] UAM, Dept Genet, IIS, Fdn Jimenez Diaz, Madrid, Spain; [Miguel Arce, Jose] Fdn Jimenez Diaz, Hlth Informat Management Dept, Madrid, Spain; [Alvarez-Llamas, Gloria] UAM, Immunoallergy & Prote Lab, IIS, Fdn Jimenez Diaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz	Prieto, I (corresponding author), UAM, Oncohlth Inst, Radiat Oncol, IIS,Fdn Jimenez Diaz, Madrid, Spain.	iprieto@fjd.es	Llamas, Gloria Alvarez/AAA-8090-2020; Alvarez-Llamas, Gloria/C-8938-2015; Sanz, Ana Belen/C-9489-2013; ortiz, alberto/Y-7582-2018; Miguez, Pablo/D-4822-2013; Mas, S/T-1489-2018; Portal-Núñez, Sergio/L-7391-2014	Llamas, Gloria Alvarez/0000-0002-3313-721X; Alvarez-Llamas, Gloria/0000-0002-3313-721X; Sanz, Ana Belen/0000-0002-0255-5689; ortiz, alberto/0000-0002-9805-9523; Miguez, Pablo/0000-0003-4099-9421; Mas, S/0000-0001-6604-3327; Portal-Núñez, Sergio/0000-0003-0659-1545; Corton, Marta/0000-0003-0087-1626; Ayuso, Carmen/0000-0002-9242-7065; J, Garcia-Foncillas/0000-0002-7591-8006; Rojo, Federico/0000-0001-9989-0290	Institute de Salud Carlos III-Fondos FEDER [PIE13/00051, P114/00386]; Institute de Salud Carlos III and Alberto Ortiz [MS1114/00031, RETICEF RD12/0043/008, MS12/03256, MS12/03262, CPI115/00027, RD012/0021, RD016/007]; Institute de Salud Carlos III [PIE13/00051]	Institute de Salud Carlos III-Fondos FEDER; Institute de Salud Carlos III and Alberto Ortiz; Institute de Salud Carlos III(Instituto de Salud Carlos III)	This study was supported by a grant from the Institute de Salud Carlos III-Fondos FEDER (PIE13/00051; P114/00386). Nieves Gonzalez (MS1114/00031), Sergio Portal (RETICEF RD12/0043/008), Marta Colton (MS12/03256), Ana Belen Sanz (MS12/03262) and Gloria Alvarez-Llamas (CPI115/00027) are recipients of a research contract from Institute de Salud Carlos III and Alberto Ortiz belongs to REDINREN RD012/0021 and RD016/007. Pablo Minguez, Sebastian Mas and Irene Bejarano are recipients of a research contract from the Institute de Salud Carlos III (PIE13/00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algamas-Dimantov A, 2014, ONCOTARGET, V5, P9851, DOI 10.18632/oncotarget.2453; Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; Barbosa-Desongles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074179; Cogliano V, 2010, J NATL CANCER I, V102, P134, DOI 10.1093/jnci/djp446; Faria MCD, 2015, CHEM-BIOL INTERACT, V229, P119, DOI 10.1016/j.cbi.2015.01.027; Dankner R, 2016, AM J EPIDEMIOL, V183, P1098, DOI 10.1093/aje/kwv290; De Bruijn KMJ, 2014, EUR J CANCER, V50, P2449, DOI 10.1016/j.ejca.2014.06.019; de Kort S, 2016, EUR J GASTROEN HEPAT, V28, P896, DOI 10.1097/MEG.0000000000000626; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Graham ML, 2011, COMPARATIVE MED, V61, P356; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hajjar J, 2013, EXPERT OPIN INV DRUG, V22, P1511, DOI 10.1517/13543784.2013.833604; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; He J, 2010, BRIT J CANCER, V103, P120, DOI 10.1038/sj.bjc.6605721; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jarvandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074616; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Lee J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3233-y; Lee KM, 2016, ONCOTARGET, V7, P38500, DOI 10.18632/oncotarget.9522; Lega IC, 2014, CANCER EPIDEM BIOMAR, V23, P1974, DOI 10.1158/1055-9965.EPI-14-0327; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sharma A, 2014, CLIN COLORECTAL CANC, V13, P54, DOI 10.1016/j.clcc.2013.10.002; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Suh S, 2011, DIABETES METAB J, V35, P193, DOI 10.4093/dmj.2011.35.3.193; Sui XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097781; Vissers PAJ, 2016, J CANCER SURVIV, V10, P406, DOI 10.1007/s11764-015-0486-3; Wang JY, 2013, JPN J CLIN ONCOL, V43, P258, DOI 10.1093/jjco/hys228; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Wang Y, 2014, GENET MOL RES, V13, P7173, DOI 10.4238/2014.September.5.3; Wu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10147	39	5	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172300	10.1371/journal.pone.0172300	http://dx.doi.org/10.1371/journal.pone.0172300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253286	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300015
J	Ayers, JW; Leas, EC; Allem, JP; Benton, A; Dredze, M; Althouse, BM; Cruz, TB; Unger, JB				Ayers, John W.; Leas, Eric C.; Allem, Jon-Patrick; Benton, Adrian; Dredze, Mark; Althouse, Benjamin M.; Cruz, Tess B.; Unger, Jennifer B.			Why do people use electronic nicotine delivery systems (electronic cigarettes)? A content analysis of Twitter, 2012-2015	PLOS ONE			English	Article							SMOKING-CESSATION; REASONS; RISE	The reasons for using electronic nicotine delivery systems (ENDS) are p oorly understood and are primarily documented by expensive cross-sectional surveys that use preconceived close-ended response options rather than allowing respondents to use their own words. We passively identify the reasons for using ENDS longitudinally from a content analysis of public postings on Twitter. All English language public tweets including several ENDS terms (e.g., "e-cigarette" or "vape") were captured from the Twitter data stream during 2012 and 2015. After excluding spam, advertisements, and retweets, posts indicating a rationale for vaping were retained. The specific reasons for vaping were then inferred based on a supervised content analysis using annotators from Amazon's Mechanical Turk. During 2012 quitting combustibles was the most cited reason for using ENDS with 43% (95% CI 39-48) of all reason-related tweets cited quitting combustibles, e.g., "I couldn't quit till I tried ecigs," eclipsing the second most cited reason by more than double. Other frequently cited reasons in 2012 included ENDS's social image (21%; 95% CI 18-25), use indoors (14%; 95% CI 11-17), flavors (14%; 95% CI 11-17), safety relative to combustibles (9%; 95% CI 7-11), cost (3%; 95% CI 2-5) and favorable odor (2%; 95% CI 1-3). By 2015 the reasons for using ENDS cited on Twitter had shifted. Both quitting combustibles and use indoors significantly declined in mentions to 29% (95% CI 24-33) and 12% (95% CI 9-16), respectively. At the same time, social image increased to 37% (95% CI 32-43) and lack of odor increased to 5% (95% CI 2-5), the former leading all cited reasons in 2015. Our data suggest the reasons people vape are shifting away from cessation and toward social image. The data also show how the ENDS market is responsive to a changing policy landscape. For instance, smoking indoors was less frequently cited in 2015 as indoor smoking restrictions became more common. Because the data and analytic approach are scalable, adoption of our strategies in the field can inform follow-up survey-based surveillance (so the right questions are asked), interventions, and policies for ENDS.	[Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Leas, Eric C.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Allem, Jon-Patrick; Cruz, Tess B.; Unger, Jennifer B.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Benton, Adrian; Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Benton, Adrian; Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA; [Dredze, Mark] Bloomberg LP, New York, NY USA; [Althouse, Benjamin M.] Inst Dis Modeling, Bellevue, WA USA; [Dredze, Mark; Althouse, Benjamin M.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Althouse, Benjamin M.] New Mexico State Univ, Las Cruces, NM 88003 USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of Southern California; Johns Hopkins University; Johns Hopkins University; Bloomberg L.P.; The Santa Fe Institute; New Mexico State University	Ayers, JW (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	ayers.john.w@gmail.com		Unger, Jennifer/0000-0001-9064-6603; Dredze, Mark/0000-0002-0422-2474; Cruz, Tess Boley/0000-0002-5894-1802	National Cancer Institute; FDA Center for Tobacco Products [P50CA180905]; Bloomberg LP; NATIONAL CANCER INSTITUTE [P50CA180905] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products; Bloomberg LP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute and the FDA Center for Tobacco Products P50CA180905. The funders had no role in the design, conduct, or interpretation of the study; nor the preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or FDA. Bloomberg LP provided support in the form of salaries for authors MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Allem J. P., 2016, TOBACCO CONTROL; Allem JP, 2015, TOB CONTROL; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; American NonSmokes' Rights Foundation, 2016, STAT MUN LAWS REG US; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, AM J PREV MED, V50, pE173, DOI 10.1016/j.amepre.2015.12.008; Ayers John W, 2015, Am J Prev Med, V49, pe133, DOI 10.1016/j.amepre.2015.08.005; Ayers JW, 2015, AM J PREV MED, V48, pE27, DOI 10.1016/j.amepre.2015.03.015; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2014, NICOTINE TOB RES, V16, P576, DOI 10.1093/ntr/ntt186; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2012, J MED INTERNET RES, V14, P288, DOI 10.2196/jmir.2148; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Callison-Burch C, 2010, P NAACL HLT 2010 WOR, P1; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Chu KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145387; Chu KH, 2016, TOB CONTROL; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Czogala J, 2014, NICOTINE TOB RES, V16, P655, DOI 10.1093/ntr/ntt203; de Andrade M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7473; Fairchild AL, 2014, NEW ENGL J MED, V370, P293, DOI 10.1056/NEJMp1313940; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Harris JK, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551; Kavuluru R, 2016, J BIOMED INFORM, V61, P19, DOI 10.1016/j.jbi.2016.03.006; Kim AE, 2014, AM J PREV MED, V46, P409, DOI 10.1016/j.amepre.2013.11.003; Krippendorff K., 2012, CONTENT ANAL INTRO I; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lui Marco, 2012, P ACL 2012 SYST DEM; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Paul M.J., 2012, HEALTH-LONDON, V11, P1, DOI DOI 10.1002/YD.20024; Pepper JK, 2014, INT J ENV RES PUB HE, V11, P10345, DOI 10.3390/ijerph111010345; Prochaska JJ, 2012, TOB CONTROL, V21, P447, DOI 10.1136/tc.2010.042507; Saddleson ML, 2016, ADDICT BEHAV, V54, P33, DOI 10.1016/j.addbeh.2015.11.012; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Soule EK, 2016, ADDICT BEHAV, V56, P41, DOI 10.1016/j.addbeh.2016.01.008	43	95	95	8	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170702	10.1371/journal.pone.0170702	http://dx.doi.org/10.1371/journal.pone.0170702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248987	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500007
J	Tencatt, LFC; Bichuette, ME				Caserta Tencatt, Luiz Fernando; Bichuette, Maria Elina			Aspidoras mephisto, new species: The first troglobitic Callichthyidae (Teleostei: Siluriformes) from South America	PLOS ONE			English	Article							TOCANTINS BASIN SILURIFORMES; CENTRAL BRAZIL; KARST AREA; SUBTERRANEAN CATFISH; CORYDORAS LACEPEDE; TRICHOMYCTERIDAE; EVOLUTION; HOMOLOGY; PISCES; MAMBAI	Aspidoras mephisto n. sp. is described from the Ane A sio-Russao cave system, upper Tocantins River basin, Goias, Brazil. The species can be readily distinguished from its congeners by troglomorphic features and also by presenting the following combination of features: infraorbital 1 generally with well-developed ventral laminar; or moderately developed; poorly-developed serrations on posterior margin of pectoral spine; nuchal plate not externally visible; dorsal fin, even in conspicuously colored specimens, with only dark brown or black chromatophores concentrated on rays, forming spots in some specimens; membranes hyaline; or sparse dark brown or black chromatophores on membranes, not forming any conspicuous pattern; and inner laminar expansion of infraorbital 1 moderately developed. Information about its habitat, ecology, behaviour and conservation status are provided and also a brief description of the juvenile stage.	[Caserta Tencatt, Luiz Fernando] Univ Estadual Maringa, Dept Biol Nucleo Pesquisas Limnol Ictiol & Aquicu, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil; [Bichuette, Maria Elina] Univ Fed Sao Carlos, Dept Ecol & Evolut Biol, Lab Estudos Subterraneos, Sao Carlos, SP, Brazil	Universidade Estadual de Maringa; Universidade Federal de Sao Carlos	Tencatt, LFC (corresponding author), Univ Estadual Maringa, Dept Biol Nucleo Pesquisas Limnol Ictiol & Aquicu, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil.	luiztencatt@hotmail.com	Tencatt, Luiz/AAC-3595-2019; Bichuette, Maria Elina/C-5262-2013	Bichuette, Maria Elina/0000-0002-9515-4832	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - "National Counsel of Technological and Scientific Development" [141061/2014-6, 308557/2014-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - "National Counsel of Technological and Scientific Development"(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - "National Counsel of Technological and Scientific Development" (www.cnpq.br) provided grants to LFCT (141061/2014-6) and MEB (308557/2014-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Aquino AE, 2002, ZOOL ANZ, V241, P223, DOI 10.1078/0044-5231-00071; Arratia G, 1995, J VERTEBR PALEONTOL, V15, P482, DOI 10.1080/02724634.1995.10011243; Bichuette ME, 2008, NEOTROP ICHTHYOL, V6, P301, DOI 10.1590/S1679-62252008000300002; Bichuette ME, 2008, NEOTROP ICHTHYOL, V6, P9, DOI 10.1590/S1679-62252008000100002; Bichuette Maria Elina, 2004, Ichthyological Exploration of Freshwaters, V15, P243; Bichuette ME, 2006, NEOTROP ICHTHYOL, V4, P99, DOI 10.1590/S1679-62252006000100011; Bichuette ME, 2015, BIOL J LINN SOC, V114, P136, DOI 10.1111/bij.12405; Bichuette ME, 2003, J FISH BIOL, V63, P1100, DOI 10.1046/j.1095-8649.2003.00227.x; Britto Marcelo R., 2003, Neotrop. ichthyol., V1, P83, DOI 10.1590/S1679-62252003000200002; Britto MR, 2003, P ACAD NAT SCI PHILA, V153, P119, DOI 10.1635/0097-3157(2003)153[0119:POTSCH]2.0.CO;2; Christiansen K., 2012, ENCY CAVES, P517, DOI 10.1016/B978-0-12-383832-2.00075-X; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Eschmeyer W.N., 2016, CATALOG FISHES GENER; Fernandez Luis, 2002, Ichthyological Exploration of Freshwaters, V13, P273; Ford D.C., 2007, KARST HYDROGEOLOGY G, DOI DOI 10.1002/9781118684986.CH6; Huysentruyt F, 2005, CYBIUM, V29, P261; Ihering R., 1907, REV MUS PAULISTA, V1, P13; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Karmann I, 1979, ESPELEO TEMA MONTE S, V13, P105; Lundberg J. G., 1970, THESIS; MORRIS P.J., 2006, ACSIMAGEBASE DIGITAL; NIJSSEN H, 1980, BIJDR DIERKD, V50, P190; NIJSSEN H, 1976, Bijdragen tot de Dierkunde, V46, P107; Nimer E., 1979, CLIMATOLOGIA BRASIL, V4; Reis RE, 1998, ZOOL J LINN SOC-LOND, V124, P105; Reis RE, 2003, CHECK LIST FRESHWATE, P291; Reis Roberto E., 1997, Ichthyological Exploration of Freshwaters, V7, P299; Rizzato PP, 2014, ZOOLOGIA-CURITIBA, V31, P577, DOI 10.1590/S1984-46702014000600006; Sabaj M.H., 2016, STANDARD SYMBOLIC CO; SCHAEFER SA, 1988, J ZOOL, V214, P81, DOI 10.1111/j.1469-7998.1988.tb04988.x; Schaefer SA, 2000, J MORPHOL, V246, P212, DOI 10.1002/1097-4687(200012)246:3<212::AID-JMOR5>3.0.CO;2-S; Secutti S, 2011, NEOTROP ICHTHYOL, V9, P689, DOI 10.1590/S1679-62252011005000045; TAYLOR W R, 1985, Cybium, V9, P107; Tencatt LFC, 2013, NEOTROP ICHTHYOL, V11, P257, DOI 10.1590/S1679-62252013000200003; Trajano E., 2012, ENCY CAVES, P275, DOI DOI 10.1016/B978-0-12-383832-2.00035-9; Vera-Alcaraz HS, 2013, THESIS	37	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171309	10.1371/journal.pone.0171309	http://dx.doi.org/10.1371/journal.pone.0171309			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248959	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500011
J	Asensio-Lopez, MC; Soler, F; Pascual-Figal, D; Fernandez-Belda, F; Lax, A				Asensio-Lopez, Mari C.; Soler, Fernando; Pascual-Figal, Domingo; Fernandez-Belda, Francisco; Lax, Antonio			Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; K-ATP CHANNEL; NADPH OXIDASE; SUPEROXIDE GENERATION; HEART-FAILURE; FREE-RADICALS; INDUCED CARDIOTOXICITY; LIPID PEROXIDATION; POTASSIUM CHANNELS; HUMAN-NEUTROPHILS	The primary cardiotoxic action of doxorubicin when used as antitumor drug is attributed to the generation of reactive oxygen species (ROS) therefore effective cardioprotection therapies are needed. In this sense, the antianginal drug nicorandil has been shown to be effective in cardioprotection from ischemic conditions but the underlying molecular mechanism to cope with doxorubicin-induced ROS is unclear. Our in vitro study using the HL-1 cardiomyocyte cell line derived from mouse atria reveals that the endogenous nitric oxide (NO) production was stimulated by nicorandil and arrested by NO synthase inhibition. Moreover, while the NO synthase activity was inhibited by doxorubicin-induced ROS, the NO synthase inhibition did not affect doxorubicin-induced ROS. The inhibition of NO synthase activity by doxorubicin was totally prevented by preincubation with nicorandil. Nicorandil also concentration-dependently (10 to 100 mu M) decreased doxorubicin-induced ROS and the effect was antagonized by 5-hydroxydecanoate. The inhibition profile of doxorubicin-induced ROS by nicorandil was unaltered when an L-arginine derivative or a protein kinase G inhibitor was present. Preincubation with pinacidil mimicked the effect of nicorandil and the protection was eliminated by glibenclamide. Quantitative colocalization of fluorescence indicated that the mitochondrion was the target organelle of nicorandil and the observed response was a decrease in the mitochondrial inner membrane potential. Interference with H+ movement across the mitochondrial inner membrane, leading to depolarization, also protected from doxorubicin-induced ROS. The data indicate that activation of the mitochondrial ATP-sensitive K+ channel by nicorandil causing mitochondrial depolarization, without participation of the NO donor activity, was responsible for inhibition of the mitochondrial NADPH oxidase that is the main contributor to ROS production in cardiomyocytes. Impairment of the cytosolic Ca2+ signal induced by caffeine and the increase in lipid peroxidation, both of which are indicators of doxorubicin-induced oxidative stress, were also prevented by nicorandil.	[Asensio-Lopez, Mari C.; Pascual-Figal, Domingo; Lax, Antonio] Univ Murcia, Labs Invest Biomed, Cardiol Clin & Expt, Campus El Palmar, Murcia, Spain; [Soler, Fernando; Fernandez-Belda, Francisco] Univ Murcia, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain; [Pascual-Figal, Domingo] Univ Virgen Arrixaca, Hosp Clin, Serv Cardiol, Murcia, Spain	University of Murcia; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Fernandez-Belda, F (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain.	fbelda@um.es	Pascual-Figal, Domingo/B-3794-2008; LAX, ANTONIO/Q-3177-2016; del Carmen Asensio Lopez, Maria/AAB-2895-2021; LAX, ANTONIO MANUEL/AAB-2135-2020; Soler, Fernando/S-1441-2019	Pascual-Figal, Domingo/0000-0002-4993-9540; LAX, ANTONIO/0000-0001-5452-8781; del Carmen Asensio Lopez, Maria/0000-0002-8043-6925; LAX, ANTONIO MANUEL/0000-0001-5452-8781; 	Fundacion CajaMurcia, Murcia, Spain [FFIS/CM10/011]; Spanish Institute de Salud Carlos III [PI14/01637, CD13/00032]	Fundacion CajaMurcia, Murcia, Spain; Spanish Institute de Salud Carlos III	This study was supported by Grants FFIS/CM10/011 from Fundacion CajaMurcia, Murcia, Spain to AL and PI14/01637 from Spanish Institute de Salud Carlos III to DPF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. William C. Claycomb from the Louisiana State University Medical Center at New Orleans, LA, USA for the kindly gift of HL-1 cells. Dr. Antonio Lax was supported by a Sara Borrell employment contract (CD13/00032) from the Spanish Instituto de Salud Carlos III.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Ahmed LA, 2013, BIOCHEM PHARMACOL, V86, P1301, DOI 10.1016/j.bcp.2013.07.005; Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; Al-Mehdi AB, 2000, ANTIOXID REDOX SIGN, V2, P335, DOI 10.1089/ars.2000.2.2-335; Alberici LC, 2009, FREE RADICAL BIO MED, V47, P1432, DOI 10.1016/j.freeradbiomed.2009.08.013; Asensio-Lopez MC, 2016, ARCH BIOCHEM BIOPHYS, V594, P26, DOI 10.1016/j.abb.2016.02.021; Asensio-Lopez MC, 2013, FREE RADICAL BIO MED, V57, P188, DOI 10.1016/j.freeradbiomed.2012.09.009; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Brandes RP, 2005, HYPERTENSION, V45, P847, DOI 10.1161/01.HYP.0000165019.32059.b2; Brown DI, 2015, CIRC RES, V116, P531, DOI 10.1161/CIRCRESAHA.116.303584; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daiber A, 2008, CLIN RES CARDIOL, V97, P12, DOI 10.1007/s00392-007-0588-7; Elshazly SM, 2015, EUR J PHARMACOL, V748, P123, DOI 10.1016/j.ejphar.2014.12.017; Garlid KD, 1996, J BIOL CHEM, V271, P8796, DOI 10.1074/jbc.271.15.8796; Gianni L, 1997, J CLIN ONCOL, V15, P1906, DOI 10.1200/JCO.1997.15.5.1906; GOODMAN J, 1977, BIOCHEM BIOPH RES CO, V77, P797, DOI 10.1016/S0006-291X(77)80048-X; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; Henderson LM, 1997, BIOCHEM J, V325, P701, DOI 10.1042/bj3250701; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; Imagawa J, 1998, J CARDIOVASC PHARM, V31, P74, DOI 10.1097/00005344-199801000-00011; Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4; Kimura S, 2005, HYPERTENSION, V45, P860, DOI 10.1161/01.HYP.0000163462.98381.7f; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Mano T, 2000, METABOLISM, V49, P427, DOI 10.1016/S0026-0495(00)80003-7; MIZUMURA T, 1995, CARDIOVASC RES, V29, P482; Moens AL, 2008, CIRCULATION, V117, P2626, DOI 10.1161/CIRCULATIONAHA.107.737031; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; Nagata K, 2003, J MOL CELL CARDIOL, V35, P1505, DOI 10.1016/j.yjmcc.2003.09.018; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pain T, 2000, CIRC RES, V87, P460; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; PIEPER GM, 1992, CARDIOVASC DRUG THER, V6, P225, DOI 10.1007/BF00051143; Sakai K, 2000, J CARDIOVASC PHARM, V35, P723, DOI 10.1097/00005344-200005000-00007; Sakai K, 1999, J CARDIOVASC PHARM, V33, P163, DOI 10.1097/00005344-199901000-00025; Sato T, 2000, J AM COLL CARDIOL, V35, P514, DOI 10.1016/S0735-1097(99)00552-5; Serizawa K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-105; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; TAIRA N, 1987, J CARDIOVASC PHARM, V10, pS1, DOI 10.1097/00005344-198700108-00002; Tajima M, 2008, EUR J PHARMACOL, V579, P86, DOI 10.1016/j.ejphar.2007.10.074; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vasquez-Vivar J, 1999, J BIOL CHEM, V274, P26736, DOI 10.1074/jbc.274.38.26736; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Zhao FJ, 2014, CARDIOVASC THER, V32, P283, DOI 10.1111/1755-5922.12097; Zhou TY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/864946	51	65	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172803	10.1371/journal.pone.0172803	http://dx.doi.org/10.1371/journal.pone.0172803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245258	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200033
J	Coca, A; Valencia, AL; Bustamante, J; Mendiluce, A; Floege, J				Coca, Armando; Lucia Valencia, Ana; Bustamante, Jesus; Mendiluce, Alicia; Floege, Juergen			Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function	PLOS ONE			English	Article							POTASSIUM; KIDNEY; ASSOCIATION; MANAGEMENT	Background Hypoglycemia is a serious complication following the administration of insulin for hyperkalemia. We determined the incidence of hypoglycemia and severe hypoglycemia (blood glucose < 70 or <= 40 mg/dl, respectively) in a cohort of AKI and non-dialysis dependent CKD patients who received an intravenous infusion of insulin plus glucose to treat hyperkalemia. Methods We retrospectively reviewed charts of all AKI and non-dialysis dependent CKD patients who received 10 U of insulin plus 50 g glucose to treat hyperkalemia from December 1, 2013 to May 31, 2015 at our Department. Results One hundred sixty four episodes of hyperkalemia were treated with insulin plus glucose and were eligible for analysis. Serum potassium levels dropped by 1.18 +/- 1.01 mmol/l. Eleven treatments (6.1%) resulted in hypoglycemia and two (1.2%) in severe hypoglycemia. A lower pretreatment blood glucose tended to associate with a higher subsequent risk of hypoglycemia. Age, sex, renal function, an established diagnosis of diabetes or previous treatment were not associated with the development of this complication. We did not register any significant adverse events. Conclusion Our intravenous regimen combining an infusion of insulin plus glucose effectively reduced serum potassium levels compared to previous studies and associated a low risk of symptomatic hypoglycemia and other complications.	[Coca, Armando; Lucia Valencia, Ana; Mendiluce, Alicia] Hosp Clin Univ, Dept Nephrol, Valladolid, Spain; [Bustamante, Jesus; Mendiluce, Alicia] Univ Valladolid, Dept Med Dermatol & Toxicol, Sch Med, Valladolid, Spain; [Floege, Juergen] Rhein Westfal TH Aachen, Dept Nephrol, Aachen, Germany	Universidad de Valladolid; RWTH Aachen University	Coca, A (corresponding author), Hosp Clin Univ, Dept Nephrol, Valladolid, Spain.	a.coca.rojo@gmail.com	Coca, Armando/U-5201-2018	Coca, Armando/0000-0002-1724-5229				Ahee P, 2000, J ACCID EMERG MED, V17, P188; ALLON M, 1990, KIDNEY INT, V38, P869, DOI 10.1038/ki.1990.284; ALLON M, 1995, J AM SOC NEPHROL, V6, P1134; American Heart Association, 2005, CIRCULATION, V112, P121; Andreucci VE, 2012, ACUTE RENAL FAILURE; Apel J, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu026; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; BUTKIEWICZ EK, 1995, DIABETES CARE, V18, P1187, DOI 10.2337/diacare.18.8.1187; Chothia MY, 2014, NEPHRON PHYSIOL, V126, P1, DOI 10.1159/000358836; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1980, AM J PHYSIOL, V238, pE421, DOI 10.1152/ajpendo.1980.238.5.E421; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Estep P, 2015, ENDOCRINOL DIABETES, V01, P1; Fiaccadori E, 2016, CLIN NUTR, V35, P317, DOI 10.1016/j.clnu.2015.04.006; Gumz ML, 2015, NEW ENGL J MED, V373, P60, DOI 10.1056/NEJMra1313341; Harel Z, PLOS ONE; Haviv YS, 2000, RENAL FAILURE, V22, P219, DOI 10.1081/JDI-100100866; Ho K, 2011, CLIN J AM SOC NEPHRO, V6, P1513, DOI 10.2215/CJN.04540511; Holmes G, 2005, BRIT J CLIN PHARMACO, V60, P469, DOI 10.1111/j.1365-2125.2005.02476.x; Jain N, 2012, AM J CARDIOL, V109, P1510, DOI 10.1016/j.amjcard.2012.01.367; Janjua HS, 2011, NEPHROL DIAL TRANSPL, V26, P2503, DOI 10.1093/ndt/gfq734; Kalra Sanjay, 2013, Indian J Endocrinol Metab, V17, P819, DOI 10.4103/2230-8210.117219; Kocoglu H, 2002, CURR THER RES CLIN E, V63, P549, DOI 10.1016/S0011-393X(02)80060-1; Lehnhardt A, 2011, PEDIATR NEPHROL, V26, P377, DOI 10.1007/s00467-010-1699-3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Leyking S, 2014, CLIN J AM SOC NEPHRO, V9, P638, DOI 10.2215/CJN.01290214; Li TT, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu049; McMahon GM, 2012, INTENS CARE MED, V38, P1834, DOI 10.1007/s00134-012-2636-7; Mitrakou A, 2011, DIABETES RES CLIN PR, V93, pS66, DOI 10.1016/S0168-8227(11)70016-X; Pierce DA, 2015, ANN PHARMACOTHER, V49, P1322, DOI 10.1177/1060028015607559; Schafers S, 2012, J HOSP MED, V7, P239, DOI 10.1002/jhm.977; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Sterns RH, 2016, KIDNEY INT, V89, P546, DOI 10.1016/j.kint.2015.11.018	34	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172961	10.1371/journal.pone.0172961	http://dx.doi.org/10.1371/journal.pone.0172961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245289	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200045
J	Grundler, MR; Pianka, ER; Pelegrin, N; Cowan, MA; Rabosky, DL				Grundler, Maggie R.; Pianka, Eric R.; Pelegrin, Nicolas; Cowan, Mark A.; Rabosky, Daniel L.			Stable isotope ecology of a hyper-diverse community of scincid lizards from arid Australia	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; TEMPORAL VARIATION; FOOD-WEB; SPECIES INTERACTIONS; TROPHIC POSITION; DESERT LIZARDS; CARBON; NITROGEN; DELTA-N-15; DIET	We assessed the utility of stable isotope analysis as a tool for understanding community ecological structure in a species-rich clade of scincid lizards from one of the world's most diverse lizard communities. Using a phylogenetic comparative framework, we tested whether delta N-15 and delta C-13 isotopic composition from individual lizards was correlated with species-specific estimates of diet and habitat use. We find that species are highly divergent in isotopic composition with significant correlations to habitat use, but this relationship shows no phylogenetic signal. Isotopic composition corresponds to empirical observations of diet for some species but much variation remains unexplained. We demonstrate the importance of using a multianalytical approach to questions of long-term dietary preference, and suggest that the use of stable isotopes in combination with stomach content analysis and empirical data on habitat use can potentially reveal patterns in ecological traits at finer scales with important implications for community structuring.	[Grundler, Maggie R.; Rabosky, Daniel L.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; [Grundler, Maggie R.; Rabosky, Daniel L.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pianka, Eric R.] Univ Texas Austin, Dept Integrat Biol C0930, One Univ Stn, Austin, TX 78712 USA; [Pelegrin, Nicolas] CONICET UNC, IDEA, Lab Ecol & Conservac Herpetofauna, Cordoba, Spain; [Pelegrin, Nicolas] Ctr Zool Aplicada UNC, Cordoba, Spain; [Cowan, Mark A.] Dept Pk & Wildlife, Wanneroo, WA, Australia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin	Grundler, MR (corresponding author), Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA.; Grundler, MR (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	grumaggi@umich.edu	Pelegrin, Nicolás/I-3859-2019	Pelegrin, Nicolás/0000-0003-0546-3955	National Science Foundation (NSF) [OSIE-0612855, DEB-0814277]; David and Lucile Packard Foundation; National Geographic Society; Denton A. Cooley Centennial Professorship in Zoology at UT Austin; CONICET	National Science Foundation (NSF)(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); Denton A. Cooley Centennial Professorship in Zoology at UT Austin; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Science Foundation (NSF) grants OSIE-0612855 and DEB-0814277, and by the David and Lucile Packard Foundation. Field sampling at Matuwa/Lorna Glen Conservation Park was conducted under permit SF0004654 to D. L. Rabosky (Western Australia Department of Parks and Wildlife). E. R. Pianka thanks the National Geographic Society and the Denton A. Cooley Centennial Professorship in Zoology at UT Austin for financial support. N. Pelegrin thanks CONICET for the external postdoctoral fellowship to carry out research activities at the University of Texas at Austin. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank K. Sparks and staff at the Cornell University Stable Isotope Laboratory (COIL) for efficient isotopic analysis of the samples used in this study. We are also grateful to L. Wingate at the University of Michigan Stable Isotope Laboratory for preliminary analysis and advice supporting this work. We thank C. Dardia, P. Doughty, I. Kealley, and staff of the Kalgoorlie office of the WA Department of Parks and Wildlife for logistical assistance associated with fieldwork and sample procurement. This work was supported by National Science Foundation (NSF) grants OSIE-0612855 and DEB-0814277, and by the David and Lucile Packard Foundation. Field sampling at Matuwa/Lorna Glen Conservation Park was conducted under permit SF0004654 to DLR (Western Australia Department of Parks and Wildlife). Pianka thanks the National Geographic Society and the Denton A. Cooley Centennial Professorship in Zoology at UT Austin for financial support. NP thanks CONICET for the external postdoctoral fellowship to carry out research activities at the University of Texas at Austin.	Arrington DA, 2002, T AM FISH SOC, V131, P337, DOI 10.1577/1548-8659(2002)131<0337:PEOSIA>2.0.CO;2; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Bowman DMJS, 2007, HOLOCENE, V17, P311, DOI 10.1177/0959683607076442; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Durso AM, 2016, J ZOOL; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Goodyear SE, 2011, J HERPETOL, V45, P265, DOI 10.1670/10-190.1; Halaj J, 2005, PEDOBIOLOGIA, V49, P109, DOI 10.1016/j.pedobi.2004.09.002; Harmon LJ, 2010, EVOLUTION, V64, P2173, DOI 10.1111/j.1558-5646.2010.00973.x; Hart EA, 2002, LIMNOL OCEANOGR, V47, P580, DOI 10.4319/lo.2002.47.2.0580; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JAMES CD, 1991, OECOLOGIA, V85, P553, DOI 10.1007/BF00323768; Lapointe FJ, 2001, J CLASSIF, V18, P109, DOI 10.1007/s00357-001-0007-0; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lugendo BR, 2006, J FISH BIOL, V69, P1639, DOI 10.1111/j.1095-8649.2006.01231.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McNabb DM, 2001, PEDOBIOLOGIA, V45, P289, DOI 10.1078/0031-4056-00087; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Newsome SD, 2012, J MAMMAL, V93, P329, DOI 10.1644/11-MAMM-S-187.1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pianka E., 1986, ECOLOGY NATURAL HIST; PIANKA ER, 1972, COPEIA, P127; PIANKA ER, 1969, ECOLOGY, V50, P498, DOI 10.2307/1933908; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; Pianka ER, 2012, AUSTRAL ECOL, V37, P1, DOI 10.1111/j.1442-9993.2010.02234.x; Ponsard S, 2000, ECOLOGY, V81, P852, DOI 10.1890/0012-9658(2000)081[0852:WCSINA]2.0.CO;2; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; POUGH FH, 1973, ECOLOGY, V54, P837, DOI 10.2307/1935678; R Core Team, 2013, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; Rabosky DL, 2014, MOL PHYLOGENET EVOL, V77, P71, DOI 10.1016/j.ympev.2014.03.026; Rabosky DL, 2014, SYST BIOL, V63, P610, DOI 10.1093/sysbio/syu025; Rabosky DL, 2011, AM NAT, V178, P579, DOI 10.1086/662162; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Skinner A, 2011, J BIOGEOGR, V38, P1044, DOI 10.1111/j.1365-2699.2010.02471.x; Smith KF, 2002, J ARID ENVIRON, V52, P419, DOI 10.1006/jare.2002.1019; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Tayasu I, 2002, SOIL BIOL BIOCHEM, V34, P297, DOI 10.1016/S0038-0717(01)00181-X; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	55	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172879	10.1371/journal.pone.0172879	http://dx.doi.org/10.1371/journal.pone.0172879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245270	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200037
J	Bonsang-Kitzis, H; Mouttet-Boizat, D; Guillot, E; Feron, JG; Fourchotte, V; Alran, S; Pierga, JY; Cottu, P; Lerebours, F; Stevens, D; Vincent-Salomon, A; Sigal-Zafrani, B; Campana, F; Rouzier, R; Reyal, F				Bonsang-Kitzis, Helene; Mouttet-Boizat, Delphine; Guillot, Eugenie; Feron, Jean-Guillaume; Fourchotte, Virginie; Alran, Severine; Pierga, Jean-Yves; Cottu, Paul; Lerebours, Florence; Stevens, Denise; Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte; Campana, Francois; Rouzier, Roman; Reyal, Fabien			Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers	PLOS ONE			English	Article							AXILLARY LYMPH-NODES; PROGNOSTIC-SIGNIFICANCE; DISSECTION; MICROMETASTASES; METASTASES; INVOLVEMENT; BIOPSY; RECURRENCE; CARCINOMA; OUTCOMES	Background Avoiding axillary lymph node dissection (ALND) for invasive breast cancers with isolated tumor cells or micrometastatic sentinel node biopsy (SNB) could decrease morbidity with minimal clinical significance. Purpose The aim of this study is to simulate the medico-economic impact of the routine use of the MSKCC non-sentinel node (NSN) prediction nomogram for ER+ HER2-breast cancer patients. Methods We studied 1036 ER+ HER2-breast cancer patients with a metastatic SNB. All had a complementary ALND. For each patient, we calculated the probability of the NSN positivity using the MSKCC nomogram. After validation of this nomogram in the population, we described how the patients' characteristics spread as the threshold value changed. Then, we performed an economic simulation study to estimate the total cost of caring for patients treated according to the MSKCC predictive nomogram results. Results A 0.3 threshold discriminate the type of sentinel node (SN) metastases: 98.8% of patients with pN0(i+) and 91.6% of patients with pN1(mic) had a MSKCC score under 0.3 (false negative rate = 6.4%). If we use the 0.3 threshold for economic simulation, 43% of ALND could be avoided, reducing the costs of caring by 1 051 980 EUROS among the 1036 patients. Conclusion We demonstrated the cost-effectiveness of using the MSKCC NSN prediction nomogram by avoiding ALND for the pN0(i+) or pN1(mic) ER+ HER2-breast cancer patients with a MSKCC score of less than or equal to 0.3.	[Bonsang-Kitzis, Helene; Mouttet-Boizat, Delphine; Guillot, Eugenie; Feron, Jean-Guillaume; Fourchotte, Virginie; Alran, Severine; Rouzier, Roman; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Translat Res Dept, Team RT2Lab, Paris, France; [Pierga, Jean-Yves; Cottu, Paul; Lerebours, Florence] Inst Curie, Dept Med Oncol, Paris, France; [Stevens, Denise] Inst Curie, Dept Clin Epidemiol, Paris, France; [Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte] Inst Curie, Dept Tumor Biol, Paris, France; [Campana, Francois] Inst Curie, Dept Radiat Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), Inst Curie, Translat Res Dept, Team RT2Lab, Paris, France.	fabien.reyal@curie.fr	Cottu, Paul/ABC-8595-2020; Rouzier, Roman/G-2953-2018	Rouzier, Roman/0000-0002-8167-6808				Barranger E, 2005, BREAST CANCER RES TR, V91, P113, DOI 10.1007/s10549-004-5781-z; Berrang TS, 2012, BREAST CANCER RES TR, V133, P695, DOI 10.1007/s10549-012-1991-y; Burstein HJ, 2005, AM SOC CLIN ONCOLOGY, V23, P7703, DOI [10.1200/JCO.2005.08.001, DOI 10.1200/JCO.2005.08.001]; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; Chu KU, 1999, ANN SURG ONCOL, V6, P756, DOI 10.1007/s10434-999-0756-2; Coutant C, 2007, J CHIR-PARIS, V144, P492, DOI 10.1016/S0021-7697(07)79774-0; Cserni G, 2004, BRIT J SURG, V91, P1245, DOI 10.1002/bjs.4725; Cserni G, 2003, EUR J CANCER, V39, P1654, DOI 10.1016/S0959-8049(03)00203-X; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Fleming FJ, 2004, J CLIN PATHOL, V57, P73, DOI 10.1136/jcp.57.1.73; Fournier K, 2004, ANN SURG, V239, P859, DOI 10.1097/01.sla.0000128302.05898.a7; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Galimberti V, 2012, BREAST CANCER RES TR, V131, P819, DOI 10.1007/s10549-011-1486-2; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Glasgow PD, 2012, AM SURGEON, V78, P669; Guth U, 2012, EJSO-EUR J SURG ONC, V38, P645, DOI 10.1016/j.ejso.2012.04.018; Houvenaeghel G, 2012, BREAST, V21, P204, DOI 10.1016/j.breast.2011.09.013; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Kuijt GP, 2005, EJSO, V31, P500, DOI 10.1016/j.ejso.2005.01.001; Langer I, 2005, ANN SURG, V241, P152, DOI 10.1097/01.sla.0000149305.23322.3c; Nos C, 2003, BRIT J SURG, V90, P1354, DOI 10.1002/bjs.4325; Olson JA, 2008, J CLIN ONCOL, V26, P3530, DOI 10.1200/JCO.2007.15.5630; Reyal F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047390; Saidi RF, 2004, AM SURGEON, V70, P101; Silverberg SG, 2001, AM J SURG PATHOL, V25, P961; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Susnik B, 2004, ANN SURG ONCOL, V11, P568, DOI 10.1245/ASO.2004.10.021; Travagli JP, 2003, EUR J SURG ONCOL, V29, P403, DOI 10.1053/ejso.2002.1427; Truong PT, 2010, ANN SURG ONCOL, V17, P2138, DOI 10.1245/s10434-010-0954-y; van Iterson V, 2003, BREAST CANCER RES TR, V82, P39, DOI 10.1023/B:BREA.0000003918.59396.e4; Van Zee KJ, 2007, ANN SURG ONCOL, V14, P2177, DOI 10.1245/s10434-007-9361-4; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; Veronesi U, 2009, EUR J CANCER, V45, P1381, DOI 10.1016/j.ejca.2008.11.041; Viale G, 2005, ANN SURG, V241, P319, DOI 10.1097/01.sla.0000150255.30665.52; Wasif N, 2010, ARCH SURG-CHICAGO, V145, P161, DOI 10.1001/archsurg.2009.269; Zhu LL, 2013, BREAST CANCER RES TR, V137, P783, DOI 10.1007/s10549-012-2360-6	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0169962	10.1371/journal.pone.0169962	http://dx.doi.org/10.1371/journal.pone.0169962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241044	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400001
J	Scherf, T; Angenstein, F				Scherf, Thomas; Angenstein, Frank			Hippocampal CA3 activation alleviates fMRI-BOLD responses in the rat prefrontal cortex induced by electrical VTA stimulation	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NEURONS; PROTOCOL; PATHWAY; SEEKING; INPUT; CELLS; STATE	Functional magnetic resonance imaging (fMRI) was used to identify brain-wide networks that are activated by electrical stimulation of either the ventral tegmental area (VTA) or hippocampal CA3 region. Stimulation of either one of these regions caused significant BOLD responses in common structures, such as the septum and left and right hippocampus, but also in unique structures, such as the medial prefrontal cortex region/anterior cingulum region (mPFC/ACC) and striatum, which were only activated during VTA stimulation. Concurrent stimulations of the two structures resulted in no additive BOLD responses but significantly reduced BOLD responses in the mPFC/ACC when compared with sole VTA stimulation. This reduction is caused by costimulation of the hippocampal CA3 region, which was itself not sufficient to modify BOLD signal intensities in the mPFC/ACC. Under this experimental condition, functional connectivity between VTA and mPFC/ACC in terms of neurophysiological interactions was causative, driven by direct electrical stimulation of VTA projecting neurons, the resulting functional connectivity in terms of correlated BOLD time series becoming masked as soon as hippocampal projections concurrently coactivated mPFC neurons. This result warns against misinterpretation of the absence of functional connectivity in fMRI data sets, because strong existing neurophysiological interactions can be obscured by unrelated network activities.	[Scherf, Thomas; Angenstein, Frank] DZNE, Funct Neuroimaging Grp, Magdeburg, Germany; [Angenstein, Frank] Leibniz Inst Neurobiol, Magdeburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	Angenstein, F (corresponding author), DZNE, Funct Neuroimaging Grp, Magdeburg, Germany.; Angenstein, F (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	frank.angenstein@dzne.de						Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Angenstein F, 2014, J NEUROSCI, V34, P8529, DOI 10.1523/JNEUROSCI.0472-14.2014; Angenstein F, 2010, NEUROIMAGE, V50, P1364, DOI 10.1016/j.neuroimage.2010.01.070; Angenstein F, 2009, J NEUROSCI, V29, P2428, DOI 10.1523/JNEUROSCI.5015-08.2009; Decot H.K., 2016, NEUROPSYCHOPHARMACOL; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Helbing C, 2016, J CEREBR BLOOD F MET, V36, P2177, DOI 10.1177/0271678X15615535; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Lavin A, 2005, J NEUROSCI, V25, P5013, DOI 10.1523/JNEUROSCI.0557-05.2005; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Lohani S., 2016, MOL PSYCHIAT; Morales M, 2014, NEUROSCIENCE, V282, P60, DOI 10.1016/j.neuroscience.2014.05.032; Moreno A., 2015, CEREB CORTEX; Parent MA, 2010, CEREB CORTEX, V20, P393, DOI 10.1093/cercor/bhp108; Paxinos G, 1988, RAT BRAIN STEREOTAXI; Riemann S, 2016, J CEREB BLOOD FLOW M, DOI [10.1002/cne.23603, DOI 10.1002/CNE.23603]; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Scherf T, 2015, J CEREBR BLOOD F MET, V35, P565, DOI 10.1038/jcbfm.2014.252; Schmidt HD, 2009, EUR J NEUROSCI, V30, P1358, DOI 10.1111/j.1460-9568.2009.06904.x; Steinberg EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094771; Taylor SR, 2014, J COMP NEUROL, V522, P3308, DOI 10.1002/cne.23603; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028	26	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172926	10.1371/journal.pone.0172926	http://dx.doi.org/10.1371/journal.pone.0172926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241047	gold, Green Published			2022-12-27	WOS:000395934400052
J	Mattoso, AAA; Tsutsui, JM; Kowatsch, I; Cruz, VYL; Sbano, JCN; Ribeiro, HB; Kalil, R; Porter, TR; Mathias, W				Mattoso, Angele A. A.; Tsutsui, Jeane M.; Kowatsch, Ingrid; Cruz, Vitoria Y. L.; Sbano, Joao C. N.; Ribeiro, Henrique B.; Kalil Filho, Roberto; Porter, Thomas R.; Mathias, Wilson, Jr.			Prognostic value of dobutamine stress myocardial perfusion echocardiography in patients with known or suspected coronary artery disease and normal left ventricular function	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; AMERICAN-SOCIETY; PHARMACOLOGICAL STRESS; FLOW RESERVE; WALL-MOTION; BLOOD-FLOW; DIPYRIDAMOLE; QUANTIFICATION; ATROPINE	Objective We sought to determine the prognostic value of qualitative and quantitative analysis obtained by real-time myocardial perfusion echocardiography (RTMPE) in patients with known or suspected coronary artery disease (CAD). Background Quantification of myocardial blood flow reserve (MBFR) in patients with CAD using RTMPE has been demonstrated to further improve accuracy over the analysis of wall motion (WM) and qualitative analysis of myocardial perfusion (QMP). Methods From March 2003 to December 2008, we prospectively studied 168 patients with normal left ventricular function (LVF) who underwent dobutamine stress RTMPE. The replenishment velocity reserve (beta) and MBFR were derived from RTMPE. Acute coronary events were: cardiac death, myocardial infarction and unstable angina with need for urgent coronary revascularization. Results During a median follow-up of 34 months (5 days to 6.9 years), 17 acute coronary events occurred. Abnormal beta reserve in >= 2 coronary territories was the only independent predictor of events hazard ratio (HR) = 21, 95% CI = 4.5-99; p<0.001). Both, abnormal beta reserve and MBFR added significant incremental value in predicting events over qualitative analysis of WM and MP (chi(2) = 6.6 and chi(2) = 24.6, respectively; p = 0.001 and chi(2) = 6.6 and chi(2) = 15.5, respectively; p = 0.012, respectively). When coronary angiographic data was added to the multivariate analysis model, beta reserve remained the only predictor of events with HR of 21.0 (95% CI = 4.5-99); p<0.001. Conclusion Quantitative dobutamine stress RTMPE provides incremental prognostic information over clinical variables, qualitative analysis of WM and MP, and coronary angiography in predicting acute coronary events.	[Mattoso, Angele A. A.; Tsutsui, Jeane M.; Kowatsch, Ingrid; Cruz, Vitoria Y. L.; Ribeiro, Henrique B.; Kalil Filho, Roberto; Mathias, Wilson, Jr.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Sbano, Joao C. N.; Porter, Thomas R.] Univ Nebraska Med Ctr, Omaha, NE USA; [Tsutsui, Jeane M.] Fleury Grp, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Nebraska System; University of Nebraska Medical Center; FLEURY GROUP	Tsutsui, JM (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.; Tsutsui, JM (corresponding author), Fleury Grp, Sao Paulo, Brazil.	jeane.tsutsui@incor.usp.br	Filho, Roberto Kalil/D-4994-2014; Ribeiro, Henrique B./I-6248-2015; Tsutsui, Jeane/C-6051-2013; Sbano, João C. N./P-4445-2017; Mathias, Wilson/A-4772-2008	Ribeiro, Henrique B./0000-0003-1273-1823; Mathias, Wilson/0000-0003-0201-6754	Brazilian research agency, FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	Brazilian research agency, FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	This study has received a grant from a Brazilian research agency, FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil.	Abdelmoneim SS, 2009, EUR J ECHOCARDIOGR, V10, P813, DOI 10.1093/ejechocard/jep084; Basic D, 2006, J AM SOC ECHOCARDIOG, V19, P1203, DOI 10.1016/j.echo.2006.04.024; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Dawson D, 2009, J AM SOC ECHOCARDIOG, V22, P954, DOI 10.1016/j.echo.2009.04.034; Elhendy A, 2004, J AM COLL CARDIOL, V44, P2185, DOI 10.1016/j.jacc.2004.08.059; Elhendy A, 2004, J AM SOC ECHOCARDIOG, V17, P739, DOI 10.1016/j.echo.2004.04.019; Osorio AF, 2007, J AM SOC ECHOCARDIOG, V20, P709, DOI 10.1016/j.echo.2006.11.016; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Gaibazzi N, 2010, J AM SOC ECHOCARDIOG, V23, P1242, DOI 10.1016/j.echo.2010.09.003; Hachamovitch R, 1996, CIRCULATION, V93, P905, DOI 10.1161/01.CIR.93.5.905; Heinle SK, 2000, CIRCULATION, V102, P55, DOI 10.1161/01.CIR.102.1.55; Iskander S, 1998, J AM COLL CARDIOL, V32, P57, DOI 10.1016/S0735-1097(98)00177-6; Kaul S, 2008, CIRCULATION, V118, P291, DOI 10.1161/CIRCULATIONAHA.107.747303; Kowatsch I, 2007, J AM SOC ECHOCARDIOG, V20, P1109, DOI 10.1016/j.echo.2007.02.008; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Marwick TH, 2001, J AM COLL CARDIOL, V37, P754, DOI 10.1016/S0735-1097(00)01191-8; Mathias W, 2003, J AM COLL CARDIOL, V41, P1583, DOI 10.1016/S0735-1097(03)00242-0; Mattoso AAA, 2013, J AM SOC ECHOCARDIOG, V26, P539, DOI 10.1016/j.echo.2013.01.016; Miszalski-Jamka T, 2009, J AM SOC ECHOCARDIOG, V22, P1220, DOI 10.1016/j.echo.2009.07.020; Pellikka PA, 2007, J AM SOC ECHOCARDIOG, V20, P1021, DOI 10.1016/j.echo.2007.07.003; Peltier M, 2004, J AM COLL CARDIOL, V43, P257, DOI 10.1016/j.jacc.2003.07.040; PICANO E, 1994, LANCET, V344, P1190, DOI 10.1016/S0140-6736(94)90508-8; Pingitore A, 1999, J AM COLL CARDIOL, V34, P1769, DOI 10.1016/S0735-1097(99)00423-4; Porter TR, 2014, J AM SOC ECHOCARDIOG, V27, P797, DOI 10.1016/j.echo.2014.05.011; PORTER TR, 1995, CIRCULATION, V92, P2391, DOI 10.1161/01.CIR.92.9.2391; Rainbird AJ, 2001, J AM SOC ECHOCARDIOG, V14, P378, DOI 10.1067/mje.2001.111264; Reant P, 2010, J AM SOC ECHOCARDIOG, V23, P95, DOI 10.1016/j.echo.2009.10.001; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Senior R, 2004, AM HEART J, V147, P1100, DOI 10.1016/j.ahj.2003.12.030; Santos JMT, 2010, AM J CARDIOL, V105, P243, DOI 10.1016/j.amjcard.2009.09.009; Tsutsui JM, 2004, AM J CARDIOL, V94, P1367, DOI 10.1016/j.amjcard.2004.07.141; Tsutsui JM, 2005, CIRCULATION, V112, P1444, DOI 10.1161/CIRCULATIONAHA.105.537134; Vogel R, 2005, J AM COLL CARDIOL, V45, P754, DOI 10.1016/j.jacc.2004.11.044; Wei K, 1998, CIRCULATION, V97, P473; Wejner-Mik P, 2011, EUR J ECHOCARDIOGR, V12, P762, DOI 10.1093/ejechocard/jer133	35	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172280	10.1371/journal.pone.0172280	http://dx.doi.org/10.1371/journal.pone.0172280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234978	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200062
J	Minchella, PA; Chipungu, G; Kim, AA; Sarr, A; Ali, H; Mwenda, R; Nkengasong, JN; Singer, D				Minchella, Peter A.; Chipungu, Geoffrey; Kim, Andrea A.; Sarr, Abdoulaye; Ali, Hammad; Mwenda, Reuben; Nkengasong, John N.; Singer, Daniel			Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL TREATMENT; MORTALITY; QUALITY; THERAPY; AFRICA	Background Efforts to reach UNAIDS' treatment and viral suppression targets have increased demand for viral load (VL) testing and strained existing laboratory networks, affecting turnaround time. Longer VL turnaround times delay both initiation of formal adherence counseling and switches to second-line therapy for persons failing treatment and contribute to poorer health outcomes. Methods We utilized descriptive statistics and logistic regression to analyze VL testing data collected in Malawi between January 2013 and March 2016. The primary outcomes assessed were greater-than-median pretest phase turnaround time (days elapsed from specimen collection to receipt at the laboratory) and greater-than-median test phase turnaround time (days from receipt to testing). Results The median number of days between specimen collection and testing increased 3-fold between 2013 (8 days, interquartile range (IQR) = 6-16) and 2015 (24, IQR = 13-39) (p<0.001). Multivariable analysis indicated that the odds of longer pretest phase turnaround time were significantly higher for specimen collection districts without laboratories capable of conducting viral load tests (adjusted odds ratio (aOR) = 5.16; 95% confidence interval (CI) = 5.04-5.27) as well as for Malawi's Northern and Southern regions. Longer test phase turnaround time was significantly associated with use of dried blood spots instead of plasma (aOR = 2.30; 95% CI = 2.23-2.37) and for certain testing months and testing laboratories. Conclusion Increased turnaround time for VL testing appeared to be driven in part by categorical factors specific to the phase of turnaround time assessed. Given the implications of longer turnaround time and the global effort to scale up VL testing, addressing these factors via increasing efficiencies, improving quality management systems and generally strengthening the VL spectrum should be considered essential components of controlling the HIV epidemic.	[Minchella, Peter A.] Ctr Dis Control & Prevent, Lab Leadership Serv, Div Global HIV & TB, Atlanta, GA 30333 USA; [Chipungu, Geoffrey; Sarr, Abdoulaye; Singer, Daniel] Ctr Dis Control & Prevent, Div Global HIV & TB, Lilongwe, Malawi; [Kim, Andrea A.; Ali, Hammad; Nkengasong, John N.] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Mwenda, Reuben] Minist Hlth, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Minchella, PA (corresponding author), Ctr Dis Control & Prevent, Lab Leadership Serv, Div Global HIV & TB, Atlanta, GA 30333 USA.	klf9@cdc.gov; remwenda@yahoo.com		Minchella, Peter/0000-0002-6295-0998	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV and Tuberculosis (DGHT)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV and Tuberculosis (DGHT)	This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV and Tuberculosis (DGHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillot F, 2016, JAIDS-J ACQ IMM DEF, V71, pE9, DOI 10.1097/QAI.0000000000000844; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; HILBORNE LH, 1989, AM J CLIN PATHOL, V91, P331, DOI 10.1093/ajcp/91.3.331; HIV/AIDS JUNPo, 2014, 90 90 90 TRANST AG L; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Medicine ASoL, 2013, VIR LOAD MON AFR HIV; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; O'Kane MJ, 2011, CLIN CHEM, V57, P1267, DOI 10.1373/clinchem.2011.164517; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Peter TE, EARLY ANTIR IN PRESS; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Ramadhani HO, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw018; Roberts T, 2016, CLIN INFECT DIS; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Rutstein SE, 2016, AIDS CARE, V28, P1, DOI 10.1080/09540121.2015.1058896; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; UNAIDS, 2015, AIDSINFO; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2014, AV US HIV DIAGN 2012; World Health Organization, 2014, TECHN OP CONS IMPL H	24	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173009	10.1371/journal.pone.0173009	http://dx.doi.org/10.1371/journal.pone.0173009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235013	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200185
J	Vardi, O; Shamir, I; Javasky, E; Goren, A; Simon, I				Vardi, Oriya; Shamir, Inbal; Javasky, Elisheva; Goren, Alon; Simon, Itamar			Biases in the SMART-DNA library preparation method associated with genomic poly dA/dT sequences	PLOS ONE			English	Article							SINGLE CELLS; RNA-SEQ; LENGTH; AMPLIFICATION	Avoiding biases in next generation sequencing (NGS) library preparation is crucial for obtaining reliable sequencing data. Recently, a new library preparation method has been introduced which has eliminated the need for the ligation step. This method, termed SMART (switching mechanism at the 50 end of the RNA transcript), is based on template switching reverse transcription. To date, there has been no systematic analysis of the additional biases introduced by this method. We analysed the genomic distribution of sequenced reads prepared from genomic DNA using the SMART methodology and found a strong bias toward long (>= 12bp) poly dA/dT containing genomic loci. This bias is unique to the SMART-based library preparation and does not appear when libraries are prepared with conventional ligation based methods. Although this bias is obvious only when performing paired end sequencing, it affects single end sequenced samples as well. Our analysis demonstrates that sequenced reads originating from SMART-DNA libraries are heavily skewed toward genomic poly dA/dT tracts. This bias needs to be considered when deciding to use SMART based technology for library preparation.	[Vardi, Oriya; Shamir, Inbal; Javasky, Elisheva; Simon, Itamar] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, Jerusalem, Israel; [Goren, Alon] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego	Simon, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, Jerusalem, Israel.	itamarsi@ekmd.huji.ac.il		Simon, Itamar/0000-0002-8517-1903	Israel Science Foundation [567/10]; European Research Council [281306]; Israel Science Foundation Broad institute Joint Program [279152]	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation Broad institute Joint Program	This work was supported by the Israel Science Foundation (grant No. 567/10); The European Research Council Starting Grant (#281306) and the Israel Science Foundation Broad institute Joint Program (grant No. 279152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bhargava V, 2014, SCI REP-UK, V4, DOI 10.1038/srep03678; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Fu H, 2014, CURR PROTOC CELL BIO, V65; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Goetz JJ, 2012, NAT BIOTECHNOL, V30, P763, DOI 10.1038/nbt.2325; IVANOVICS G, 1969, J GEN MICROBIOL, V59, P337, DOI 10.1099/00221287-59-3-337; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; LUSTIG AJ, 1984, J MOL BIOL, V180, P753, DOI 10.1016/0022-2836(84)90036-6; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Motea EA, 2010, BBA-PROTEINS PROTEOM, V1804, P1151, DOI 10.1016/j.bbapap.2009.06.030; Ohashi H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104209; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salimullah Md, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5559; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Tang DTP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1128; Turchinovich A, 2014, RNA BIOL, V11, P817, DOI 10.4161/rna.29304; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016	38	8	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172769	10.1371/journal.pone.0172769	http://dx.doi.org/10.1371/journal.pone.0172769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235101	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200133
J	Zhang, D; Sun, M; Liu, X				Zhang, Dong; Sun, Min; Liu, Xin			Phase-specific expression of an insulin-like androgenic gland factor in a marine shrimp Lysmata wurdemanni: Implication for maintaining protandric simultaneous hermaphroditism	PLOS ONE			English	Article							CHERAX-QUADRICARINATUS; REPRODUCTIVE-SYSTEM; SEX ALLOCATION; GENE; HIPPOLYTIDAE; IMPLANTATION; CRAYFISH; HORMONE; CARIDEA; EVOLUTION	Background Shrimp in the genus Lysmata have a unique and rare sexual system referred to as protandric simultaneous hermaphroditism, whereby individuals mature first as male (male phase), and then the female function may also develop as the shrimp grow, so that the gonad is able to produce both eggs and sperms simultaneously, a condition called simultaneous hermaphroditism (euhermaphrodite phase). To date, the mechanisms of sex control in this sexual system still remain poorly understood. Many studies indicate that an insulin-like androgenic gland factor (IAG) is involved in controlling sex differentiation in gonochoric crustaceans, but its role in the protandric simultaneous hermaphrodite is still not clear. Results To determine whether an IAG is involved in sex control in the hermaphrodite, here we, for the first time, cloned the IAG gene cDNA sequence from Lysmata wurdemanni (termed LwIAG: L. wurdemanni insulin-like AG factor), a protandric simultaneous hermaphroditic shrimp. The IAG contains an open reading frame of 528 bp, corresponding to 176 amino acids, which consists of a signal peptide, B chain, C peptide, and A chain. The organization is similar to the IAGs found in other decapods. The IAG gene was expressed in both male and euhermaphrodite phases, but the expression level was significantly higher in the male phase than in the euhermaphrodite phase. Immunofluorescence analysis and Western Blotting revealed that the IAG protein was expressed in the androgenic gland, and its expression level was higher in the male phase than in the euhermaphrodite phase. Conclusions Data presented here suggest that the IAG gene may be a factor controlling sex in the protandric simultaneous hermaphrodite, and that the euhermaphrodite phase is maintained by reduced gene expression, i.e., the presence of the androgenic gland (or the androgenic hormone it produces) completely inhibits ovarian development in the male phase, and incomplete degeneration of the androgenic gland in the euhermaphrodite phase results in simultaneous hermaphroditism. The findings presented in the current study can help to reveal how protandric simultaneous hermaphroditism evolved in crustaceans.	[Zhang, Dong; Sun, Min; Liu, Xin] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Zhang, Dong; Sun, Min; Liu, Xin] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Zhang, D (corresponding author), Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China.; Zhang, D (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China.	zd_fit@hotmail.com			National Science Foundation of China [41276142]; Fundamental Research Fund of the East China Sea Fisheries Research Institute [2012M08]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund of the East China Sea Fisheries Research Institute	The project was supported by the National Science Foundation of China (No. 41276142) and the Fundamental Research Fund of the East China Sea Fisheries Research Institute (No. 2012M08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tingting Lin, Dongxue Xiao, Fen Gao, and Changbo Wang for their helpful comments and assistance in this research. The project was supported by the National Science Foundation of China (No. 41276142) and the Fundamental Research Fund of the East China Sea Fisheries Research Institute (No. 2012M08). Dr. Andrew Rhyne and Mr. Chad Zhang are thanked for editing the English manuscript.	Baeza JA, 2004, BEHAV ECOL SOCIOBIOL, V55, P544, DOI 10.1007/s00265-003-0744-7; Banzai K, 2012, JARQ-JPN AGR RES Q, V46, P105, DOI 10.6090/jarq.46.105; Bauer RT, 2006, INTEGR COMP BIOL, V46, P430, DOI 10.1093/icb/icj036; Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Bauer RT, 2004, J CRUSTACEAN BIOL, V24, P131, DOI 10.1651/C-2426; Bundy MH., 1983, THESIS; Charniaux-Cotton H., 1988, Endocrinology of selected invertebrate types., P279; CHARNIAUXCOTTON H, 1958, CR HEBD ACAD SCI, V246, P2814; CHARNIAUXCOTTON H, 1954, CR HEBD ACAD SCI, V238, P953; CHARNOV E L, 1982; Fiedler G. Curt, 1998, Pacific Science, V52, P161; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; KAGWADE P V, 1981, Indian Journal of Fisheries, V28, P189; Khalaila I, 1999, J EXP ZOOL, V283, P286, DOI 10.1002/(SICI)1097-010X(19990215)283:3&lt;286::AID-JEZ6&gt;3.0.CO;2-R; Khalaila I, 2001, GEN COMP ENDOCR, V121, P242, DOI 10.1006/gcen.2001.7607; Laubenheimer H, 2008, J MAR BIOL ASSOC UK, V88, P301, DOI 10.1017/S0025315408000702; Leonard JL, 2005, INTEGR COMP BIOL, V45, P856, DOI 10.1093/icb/45.5.856; Li SH, 2012, GEN COMP ENDOCR, V177, P246, DOI 10.1016/j.ygcen.2012.04.010; Lin J, 2001, MAR BIOL, V139, P1155; Ma KY, 2013, GEN COMP ENDOCR, V185, P90, DOI 10.1016/j.ygcen.2013.01.018; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Phoungpetchara I, 2011, TISSUE CELL, V43, P165, DOI 10.1016/j.tice.2011.02.001; PREMOLI MC, 1995, ETHOL ECOL EVOL, V7, P27, DOI 10.1080/08927014.1995.9522968; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Scharer L, 2003, P ROY SOC B-BIOL SCI, V270, P935, DOI 10.1098/rspb.2002.2323; SELLA G, 1990, ECOLOGY, V71, P27, DOI 10.2307/1940244; Suzuki S, 1998, GEN COMP ENDOCR, V111, P367, DOI 10.1006/gcen.1998.7121; Taketomi Y, 1996, J CRUSTACEAN BIOL, V16, P232, DOI 10.2307/1548879; THAMPY D M, 1974, International Journal for Parasitology, V4, P575, DOI 10.1016/0020-7519(74)90021-6; Tomiyama K, 1996, J MOLLUS STUD, V62, P101, DOI 10.1093/mollus/62.1.101; Ventura T, 2011, GEN COMP ENDOCR, V173, P381, DOI 10.1016/j.ygcen.2011.05.018; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Vizoso DB, 2007, J EVOLUTION BIOL, V20, P1046, DOI 10.1111/j.1420-9101.2007.01294.x; Zhang D, 1998, J WORLD AQUACULT SOC, V29, P471, DOI 10.1111/j.1749-7345.1998.tb00671.x; Zhang D, 2005, INVERTEBR REPROD DEV, V47, P11, DOI 10.1080/07924259.2005.9652142; Zhang D, 2007, MAR BIOL, V150, P639, DOI 10.1007/s00227-006-0381-6	37	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172782	10.1371/journal.pone.0172782	http://dx.doi.org/10.1371/journal.pone.0172782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235100	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200135
J	Haddad, SA; Palmer, JR; Lunetta, KL; Ng, MCY; Ruiz-Narvaez, EA				Haddad, Stephen A.; Palmer, Julie R.; Lunetta, Kathryn L.; Ng, Maggie C. Y.; Ruiz-Narvaez, Edward A.		MEDIA Consortium	A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women	PLOS ONE			English	Article							GENETIC ARCHITECTURE; WHITE ADULTS; RISK; ASSOCIATION; METAANALYSIS; MECHANISMS; VARIANTS; PATHWAY; LOCI	SNP rs7903146 in the Wnt pathway's TCF7L2 gene is the variant most significantly associated with type 2 diabetes to date, with associations observed across diverse populations. We sought to determine whether variants in other Wnt pathway genes are also associated with this disease. We evaluated 69 genes involved in the Wnt pathway, including TCF7L2, for associations with type 2 diabetes in 2632 African American cases and 2596 controls from the Black Women's Health Study. Tag SNPs for each gene region were genotyped on a custom Affymetrix Axiom Array, and imputation was performed to 1000 Genomes Phase 3 data. Gene-based analyses were conducted using the adaptive rank truncated product (ARTP) statistic. The PSMD2 gene was significantly associated with type 2 diabetes after correction for multiple testing (corrected p = 0.016), based on the nine most significant single variants in the +/-20 kb region surrounding the gene, which includes nearby genes EIF4G1, ECE2, and EIF2B5. Association data on four of the nine variants were available from an independent sample of 8284 African American cases and 15,543 controls; associations were in the same direction, but weak and not statistically significant. TCF7L2 was the only other gene associated with type 2 diabetes at nominal p <0.01 in our data. One of the three variants in the best gene-based model for TCF7L2, rs114770437, was not correlated with the GWAS index SNP rs7903146 and may represent an independent association signal seen only in African ancestry populations. Data on this SNP were not available in the replication sample.	[Haddad, Stephen A.; Palmer, Julie R.; Ruiz-Narvaez, Edward A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ng, Maggie C. Y.] Wake Forest Sch Med, Ctr Diabet Res, Ctr Genom & Personalized Med Res, Winston Salem, NC USA	Boston University; Boston University; Wake Forest University	Haddad, SA (corresponding author), Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.	sahaddad@bu.edu	Liu, Simin/I-3689-2014; Bielinski, Suzette/A-2238-2009; Loos, Ruth/Q-2862-2016	Liu, Simin/0000-0003-2098-3844; Bielinski, Suzette/0000-0002-2905-5430; Patel, Sanjay/0000-0002-9142-5172; Loos, Ruth/0000-0002-8532-5087; Rich, Stephen/0000-0003-3872-7793; Pankow, James/0000-0001-7076-483X; Pacheco, Jennifer/0000-0001-8021-5818; Evans, Michele/0000-0002-8546-2831; Lunetta, Kathryn/0000-0002-9268-810X	National Institute on Minority Health and Health Disparities [R01MD007015]; National Cancer Institute [R01CA058420, R01CA098663, UM1CA164974]; American Heart Association [11SDG7390014]; NATIONAL CANCER INSTITUTE [UM1CA164974] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01MD007015 (to EAR) from the National Institute on Minority Health and Health Disparities (http://www.nimhd.nih.gov/); R01CA058420, R01CA098663 (to JRP), and UM1CA164974 from the National Cancer Institute (http://www.cancer.gov/); and 11SDG7390014 (to EAR) from the American Heart Association (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cooke JN, 2012, DIABETES CARE, V35, P287, DOI 10.2337/dc11-0957; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2012, DIABETES, V61, P1642, DOI 10.2337/db11-1296; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Ortmann J, 2006, EXP BIOL MED, V231, P1030; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Qi QB, 2012, J DIABETES, V4, P203, DOI 10.1111/j.1753-0407.2012.00224.x; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rosenberg L, 1995, J Am Med Womens Assoc (1972), V50, P56; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Vimalananda VG, 2015, DIABETOLOGIA, V58, P699, DOI 10.1007/s00125-014-3480-9; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhang H, 2016, ARTP2 PATHWAY AND GE	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172577	10.1371/journal.pone.0172577	http://dx.doi.org/10.1371/journal.pone.0172577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253288	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300024
J	Izuhara, M; Kuwabara, Y; Saito, N; Yamamoto, E; Hakuno, D; Nakashima, Y; Horie, T; Baba, O; Nishiga, M; Nakao, T; Nishino, T; Nakazeki, F; Ide, Y; Kimura, M; Kimura, T; Ono, K				Izuhara, Masayasu; Kuwabara, Yasuhide; Saito, Naritatsu; Yamamoto, Erika; Hakuno, Daihiko; Nakashima, Yasuhiro; Horie, Takahiro; Baba, Osamu; Nishiga, Masataka; Nakao, Tetsushi; Nishino, Tomohiro; Nakazeki, Fumiko; Ide, Yuya; Kimura, Masahiro; Kimura, Takeshi; Ono, Koh			Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model	PLOS ONE			English	Article							OLIGONUCLEOTIDES; ANGIOGENESIS; TRANSLATION; MECHANISMS; THROMBOSIS; DELIVERY; PLATFORM; DISEASE; MIR-126	Background Despite recent progress with drug-eluting stents, restenosis and thrombosis after endovascular intervention are still major limitations in the treatment of cardiovascular diseases. These problems are possibly caused by inappropriate inhibition of neointimal formation and retardation of re-endothelialization on the surface of the stents. miR-126 has been shown to have the potential to enhance vascular endothelial cell proliferation. Methods and results We designed and constructed a 27-nt double strand RNA (dsRNA) conjugated to cholesterol, which has high membrane permeability, and formed mature miR-126 after transfection. For site-specific induction of miR-126, we utilized poly (DL-lactide-co-glycolide) nanoparticles (NPs). miR-126-dsRNA-containing NPs (miR-126 NPs) significantly reduced the protein expression of a previously identified miR-126 target, SPRED1, in human umbilical vascular endothelial cells (HUVECs), and miR-126 NPs enhanced the proliferation and migration of HUVECs. On the other hand, miR-126 NPs reduced the proliferation and migration of vascular smooth muscle cells, via the suppression of IRS-1. Finally, we developed a stent system that eluted miR-126. This delivery system exhibited significant inhibition of neointimal formation in a rabbit model of restenosis. Conclusions miR-126 NP-conjugated stents significantly inhibited the development of neointimal hyperplasia in rabbits. The present study may indicate the possibility of a novel therapeutic option to prevent restenosis after angioplasty.	[Izuhara, Masayasu; Kuwabara, Yasuhide; Saito, Naritatsu; Yamamoto, Erika; Hakuno, Daihiko; Nakashima, Yasuhiro; Horie, Takahiro; Baba, Osamu; Nishiga, Masataka; Nakao, Tetsushi; Nishino, Tomohiro; Nakazeki, Fumiko; Ide, Yuya; Kimura, Masahiro; Kimura, Takeshi; Ono, Koh] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kyoto University	Ono, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	kohono@kuhp.kyoto-u.ac.jp	NAKAO, TETSUSHI/GRF-6084-2022	NAKAO, TETSUSHI/0000-0001-9979-2682; Nishiga, Masataka/0000-0001-5676-7671	Ministry of Education, Science, and Culture of Japan [20590864]; Translational Research Network Program from the Japan Agency for Medical Research and Development	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Research Network Program from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported in part by grants from the Ministry of Education, Science, and Culture of Japan (20590864) and by Translational Research Network Program from the Japan Agency for Medical Research and Development. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 1998, CIRCULATION, V97, P2003, DOI 10.1161/01.CIR.97.20.2003; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Li HM, 2014, ONCOL REP, V32, P1225, DOI 10.3892/or.2014.3327; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tahara K, 2008, INT J PHARMACEUT, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002; Tahara K, 2011, BIOMATERIALS, V32, P870, DOI 10.1016/j.biomaterials.2010.09.034; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	21	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172798	10.1371/journal.pone.0172798	http://dx.doi.org/10.1371/journal.pone.0172798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253326	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300033
J	Li, P; Xiao, ZT; Braciak, TA; Ou, QJ; Chen, G; Oduncu, FS				Li, Pan; Xiao, Zhitao; Braciak, Todd A.; Ou, Qingjian; Chen, Gong; Oduncu, Fuat S.			A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; YOUNG-PATIENTS; COLON-CANCER; MORPHOLOGY; PROGNOSIS; PATTERN; IMPACT; MODEL; OLD	Background The progression of colorectal cancer (CRC) may differ depending on the location of the tumor and the age of onset of the disease. Previous studies also suggested that the molecular basis of CRC varies with tumor location, which could affect the clinical management of patients. Therefore, we performed survival analysis looking at different age groups and mismatch repair status (MMR) of CRC patients according to primary tumor location in an attempt to identify subgroups of CRC that might help in the prognosis of disease. Methods A group of 2233 patients operated on to remove their CRC tumors were analyzed (521 with right colon cancer, 740 with left colon cancer and 972 with rectal cancer). The expression of four MMR genes was assessed by immunohistochemistry (IHC), independent of clinical criteria. From the data collected, a predictive model for overall survival (OS) could be constructed for some associations of tumor location and age of onset using Kaplan-Meier, logistic and Cox regression analysis. Results When tumor location was considered as the lone factor, we found no statistical difference in overall survival (OS) between right cancer (68%), left cancer (67%) or rectal cancer tumor locations (71%) (HR: 1.17, 95% CI (confidence interval): 0.97-1.43, P = 0.057). When age of onset was considered, middle age (40-59 years) and older (60-85 years) patients were found to have higher OS than younger onset cancer (20-39 years) patients (69% vs 71% vs 59%, HR: 1.07, 95% confidence interval (CI): 0.91-1.25, P = 0.008). When both age of onset and tumor location were considered in combination as disease factors, we found that the subgroup of patients with left colon cancer from middle age (69%) and older (67%) aged patients had higher OS than younger (54%) patients (HR: 0.89, 95% CI: 0.68-1.16, P = 0.048). However in patients with right colon cancers, we found no statistical difference is OS between younger, middle age or older grouped patients (60% vs 71% vs 67%, HR: 0.84, 95% CI: 0.61-1.16, P = 0.194). With regard to rectal located cancers, we found that younger (62%) and middle age (68) patients had lower OS than older (77%) patients (HR: 1.46, 95% CI: 1.13-1.88, P = 0.004). The rates of deficient MMR (dMMR) was 10.4%. We found no statistical difference in OS stratified by tumor locations. However, right colon cancer patients with dMMR (86%) had higher OS than those with proficient MMR (pMMR) (63%) (HR: 3.01, 95% CI: 1.82-4.97, P<0.001). Left colon cancer patients with dMMR (76%) also had higher OS than those with pMMR (66%) (HR: 1.67, 95% CI: 0.95-2.92, P = 0.01). Oppositely, rectal cancer patients with dMMR (60%) had lower OS than those pMMR (68%) (HR: 0.77, 95% CI: 0.51-1.17, P = 0.04). Conclusions These data demonstrate that primary tumor location can be an important factor when considered along with age of onset for the prognosis of CRC. Primary tumor location is also an important factor to evaluate the predictive effect of MMR status for the prognosis of CRC.	[Li, Pan; Braciak, Todd A.; Oduncu, Fuat S.] Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany; [Xiao, Zhitao; Ou, Qingjian; Chen, Gong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China	University of Munich; State Key Lab Oncology South China; Sun Yat Sen University	Oduncu, FS (corresponding author), Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany.; Chen, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China.	chengong@sysucc.org.cn; fuat.oduncu@med.uni-muenchen.de						Andrieu N, 2004, GUT, V53, P1322, DOI 10.1136/gut.2003.036376; Boisen MK, 2013, ANN ONCOL, V24, P2554, DOI 10.1093/annonc/mdt253; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukatsu H, 2007, DIGEST LIVER DIS, V39, P40, DOI 10.1016/j.dld.2006.07.015; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Han NY, 2014, TURK J GASTROENTEROL, V25, P661, DOI 10.5152/tjg.2014.5616; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khodapasand Ehsan, 2015, Iranian Biomedical Journal, V19, P69, DOI 10.6091/ibj.1366.2015; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Papagiorgis PC, 2012, ONCOL LETT, V3, P1129, DOI 10.3892/ol.2012.621; Perea J, 2015, AM J CANCER RES, V5, P2308; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Sanchez JA, 2009, BRIT J SURG, V96, P1196, DOI 10.1002/bjs.6683; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Tan KK, 2009, J GASTROINTEST SURG, V13, P642, DOI 10.1007/s11605-008-0757-7; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172799	10.1371/journal.pone.0172799	http://dx.doi.org/10.1371/journal.pone.0172799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253296	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300034
J	Vonk, JM; Scholtens, S; Postma, DS; Moffatt, MF; Jarvis, D; Ramasamy, A; Wjst, M; Omenaas, ER; Bouzigon, E; Demenais, F; Nadif, R; Siroux, V; Polonikov, AV; Solodilova, M; Ivanov, VP; Curjuric, I; Imboden, M; Kumar, A; Probst-Hensch, N; Ogorodova, LM; Puzyrev, VP; Bragina, EY; Freidin, MB; Nolte, IM; Farrall, AM; Cookson, WOCM; Strachan, DP; Koppelman, GH; Boezen, HM				Vonk, J. M.; Scholtens, S.; Postma, D. S.; Moffatt, M. F.; Jarvis, D.; Ramasamy, A.; Wjst, M.; Omenaas, E. R.; Bouzigon, E.; Demenais, F.; Nadif, R.; Siroux, V.; Polonikov, A. V.; Solodilova, M.; Ivanov, V. P.; Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.; Ogorodova, L. M.; Puzyrev, V. P.; Bragina, E. Yu; Freidin, M. B.; Nolte, I. M.; Farrall, A. M.; Cookson, W. O. C. M.; Strachan, D. P.; Koppelman, G. H.; Boezen, H. M.			Adult onset asthma and interaction between genes and active tobacco smoking: The GABRIEL consortium	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; ENVIRONMENT INTERACTION; CHILDHOOD ASTHMA; HUMAN-DISEASES; LARGE-SCALE; EXPOSURE; DECLINE; EGEA	Background Genome-wide association studies have identified novel genetic associations for asthma, but without taking into account the role of active tobacco smoking. This study aimed to identify novel genes that interact with ever active tobacco smoking in adult onset asthma. Methods We performed a genome-wide interaction analysis in six studies participating in the GABRIEL consortium following two meta-analyses approaches based on 1) the overall interaction effect and 2) the genetic effect in subjects with and without smoking exposure. We performed a discovery meta-analysis including 4,057 subjects of European descent and replicated our findings in an independent cohort (LifeLines Cohort Study), including 12,475 subjects. Results First approach: 50 SNPs were selected based on an overall interaction effect at p<10(-4). The most pronounced interaction effect was observed for rs9969775 on chromosome 9 (discovery meta-analysis: ORint = 0.50, p = 7.63*10(-5), replication: ORint = 0.65, p = 0.02). Second approach: 35 SNPs were selected based on the overall genetic effect in exposed subjects (p <10(-4)). The most pronounced genetic effect was observed for rs5011804 on chromosome 12 (discovery meta-analysis ORint = 1.50, p = 1.21*10(-4); replication: ORint = 1.40, p = 0.03). Conclusions Using two genome-wide interaction approaches, we identified novel polymorphisms in non annotated intergenic regions on chromosomes 9 and 12, that showed suggestive evidence for interaction with active tobacco smoking in the onset of adult asthma.	[Vonk, J. M.; Scholtens, S.; Nolte, I. M.; Boezen, H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Vonk, J. M.; Postma, D. S.; Koppelman, G. H.; Boezen, H. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Postma, D. S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Moffatt, M. F.; Cookson, W. O. C. M.] Div Resp Sci, Imperial Coll, London, England; [Jarvis, D.; Ramasamy, A.] Imperial Coll, Populat Hlth & Occupat Disease, London, England; [Jarvis, D.] Imperial Coll, MRC PHE Ctr Environm & Hlth, London, England; [Wjst, M.] Tech Univ, Inst Med Stat & Epidemiol IMSE, Klinikum Rechts Isar, Munich, Germany; [Wjst, M.] Inst Lung Biol & Dis iLBD, Comprehens Pneumol Ctr CPC, Helmholtz Ctr Munich, Neuherberg, Germany; [Omenaas, E. R.] Haukeland Hosp, Clin Res Ctr, Bergen, Norway; [Bouzigon, E.; Demenais, F.] Univ Paris Diderot, Inst Univ Hernatol, Sorbonne Paris Cite, Paris, France; [Bouzigon, E.; Demenais, F.] INSERM, UMR 946, Paris, France; [Nadif, R.] INSERM, U1168, VIMA Aging & chron Dis, Epidemiol & publ Hlth approaches, Villejuif, France; [Nadif, R.] Univ Versailles St Quentin Yvelines, UMR S 1168, Montigny Le Bretonneux, France; [Siroux, V.] INSERM, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Siroux, V.] Univ Grenoble Alpes, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Siroux, V.] CHU Grenoble, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Vonk, J. M.; Polonikov, A. V.; Solodilova, M.; Ivanov, V. P.] Kursk State Med Univ, Dept Biol, Russian Federat, Med Genet & Ecol, Kursk, Russia; [Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, I.; Imboden, M.; Kumar, A.; Probst-Hensch, N.] Univ Basel, Basel, Switzerland; [Kumar, A.; Farrall, A. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ogorodova, L. M.; Puzyrev, V. P.] Siberian State Med Univ, Tomsk, Russia; [Puzyrev, V. P.; Bragina, E. Yu; Freidin, M. B.] Res Inst Med Genet, Tomsk, Russia; [Strachan, D. P.] Univ London, Populat Hlth Res Inst, St Georges, London, England; [Koppelman, G. H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Imperial College London; Imperial College London; Imperial College London; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bergen; Haukeland University Hospital; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Kursk State Medical University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Oxford; Wellcome Centre for Human Genetics; Siberian State Medical University; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; University of London; University of Groningen	Vonk, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	j.m.vonk@umcg.nl	Ivanov, Vladimir/U-3794-2019; Solodilova, Maria/GSJ-2104-2022; Vonk, Judith/K-8477-2019; siroux, valerie/N-1865-2013; Bouzigon, Emmanuelle/L-2766-2017; Vonk, Judith M/ABA-3009-2020; Koppelman, Gerard/AAG-9187-2020; Cookson, William/HHC-1790-2022; Bragina, Elena/AAF-7983-2019; Demenais, Florence/G-3298-2013; Polonikov, Alexey/R-7537-2016; Puzyrev, Valery P/S-3144-2016; Ogorodova, Ludmila M/S-5058-2016; Nadif, Rachel/R-2876-2016; Ramasamy, Adaikalavan/G-2632-2010; Freydin, Maxim/A-5603-2011; Bragina, Elena/A-8049-2014	Solodilova, Maria/0000-0003-4607-4913; Vonk, Judith/0000-0001-7531-4547; siroux, valerie/0000-0001-7329-7237; Bouzigon, Emmanuelle/0000-0001-5756-4286; Vonk, Judith M/0000-0001-7531-4547; Demenais, Florence/0000-0001-8361-0936; Polonikov, Alexey/0000-0001-6280-247X; Puzyrev, Valery P/0000-0002-2113-4556; Ogorodova, Ludmila M/0000-0002-2962-1076; Nadif, Rachel/0000-0003-4938-9339; Ramasamy, Adaikalavan/0000-0002-7598-2892; Freydin, Maxim/0000-0002-1439-6259; Bragina, Elena/0000-0002-1103-3073; Scholtens, Salome/0000-0002-0651-5203; Koppelman, Gerard/0000-0001-8567-3252; Jarvis, Deborah/0000-0002-1753-3896	European Commission [018996, LSH-2004-1.2.5-1]; National Institute for Health Research [NF-SI-0512-10126] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The GABRIEL study (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) was supported by the European Commission, contract number 018996 under the Integrated Program LSH-2004-1.2.5-1. The separate cohort were also supported by local funding organizations (see supplementary material). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Bookman EB, 2011, GENET EPIDEMIOL, V35, P217, DOI 10.1002/gepi.20571; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Curjuric I, 2011, EUR RESPIR J, V37, P492, DOI 10.1183/09031936.00188609; Curjuric I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040175; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Goodhead I, 2015, CURR OPIN MICROBIOL, V23, P102, DOI 10.1016/j.mib.2014.11.012; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Liu X, 2004, CURR OPIN GENET DEV, V14, P241, DOI 10.1016/j.gde.2004.04.011; MCWHORTER WP, 1989, AM REV RESPIR DIS, V139, P721, DOI 10.1164/ajrccm/139.3.721; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mukherjee B, 2012, AM J EPIDEMIOL, V175, P177, DOI 10.1093/aje/kwr367; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; PEAT JK, 1990, THORAX, V45, P32, DOI 10.1136/thx.45.1.32; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Scholtens S, 2014, J ALLERGY CLIN IMMUN, V133, P885, DOI 10.1016/j.jaci.2013.08.049; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Siroux V, 2000, EUR RESPIR J, V15, P470, DOI 10.1034/j.1399-3003.2000.15.08.x; Strachan DP, 1996, BRIT MED J, V312, P1195; Surakka I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002333; VESTERINEN E, 1988, THORAX, V43, P534, DOI 10.1136/thx.43.7.534; Vogelberg C, 2007, EUR RESPIR J, V30, P672, DOI 10.1183/09031936.00152906	28	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172716	10.1371/journal.pone.0172716	http://dx.doi.org/10.1371/journal.pone.0172716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253294	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396011300029
J	Voracova, K; Hajek, J; Mares, J; Urajova, P; Kuzma, M; Cheel, J; Villunger, A; Kapuscik, A; Bally, M; Novak, P; Kabelac, M; Krumschnabel, G; Lukes, M; Voloshko, L; Kopecky, J; Hrouzek, P				Voracova, Katerina; Hajek, Jan; Mares, Jan; Urajova, Petra; Kuzma, Marek; Cheel, Jose; Villunger, Andreas; Kapuscik, Alexandra; Bally, Marcel; Novak, Petr; Kabelac, Martin; Krumschnabel, Gerhard; Lukes, Martin; Voloshko, Ludmila; Kopecky, Jiri; Hrouzek, Pavel			The cyanobacterial metabolite nocuolin A is a natural oxadiazine that triggers apoptosis in human cancer cells	PLOS ONE			English	Article							ENZYMES; 1,3,4-OXADIAZOLE; 1,2,3-OXADIAZOLE; SCAFFOLD; BENZENE; PRODUCT; PATHWAY; GROWTH; AGENTS; GENES	Oxadiazines are heterocyclic compounds containing N-N-O or N-N-C-O system within a six membered ring. These structures have been up to now exclusively prepared via organic synthesis. Here, we report the discovery of a natural oxadiazine nocuolin A (NoA) that has a unique structure based on 1,2,3-oxadiazine. We have identified this compound in three independent cyanobacterial strains of genera Nostoc, Nodularia, and Anabaena and recognized the putative gene clusters for NoA biosynthesis in their genomes. Its structure was characterized using a combination of NMR, HRMS and FTIR methods. The compound was first isolated as a positive hit during screening for apoptotic inducers in crude cyanobacterial extracts. We demonstrated that NoA-induced cell death has attributes of caspase-dependent apoptosis. Moreover, NoA exhibits a potent anti-proliferative activity (0.7-4.5 mu M) against several human cancer lines, with p53-mutated cell lines being even more sensitive. Since cancers bearing p53 mutations are resistant to several conventional anti-cancer drugs, NoA may offer a new scaffold for the development of drugs that have the potential to target tumor cells independent of their p53 status. As no analogous type of compound was previously described in the nature, NoA establishes a novel class of bioactive secondary metabolites.	[Voracova, Katerina; Hajek, Jan; Mares, Jan; Urajova, Petra; Cheel, Jose; Kapuscik, Alexandra; Lukes, Martin; Kopecky, Jiri; Hrouzek, Pavel] CAS Vvi, Inst Microbiol, Ctr Algatech, Trebon, Czech Republic; [Voracova, Katerina; Hajek, Jan; Mares, Jan; Kabelac, Martin; Hrouzek, Pavel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Hajek, Jan; Mares, Jan] Biol Ctr CAS Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Mares, Jan] Inst Bot CAS Vvi, Ctr Phycol, Prague, Czech Republic; [Kuzma, Marek; Novak, Petr] Inst Microbiol CAS, Lab Mol Struct Characterizat, Prague, Czech Republic; [Villunger, Andreas; Krumschnabel, Gerhard] Med Univ Innsbruck, Div Dev Immunol, Bioctr Innsbruck, Innsbruck, Austria; [Villunger, Andreas] Tyrolean Canc Res Inst, Innsbruck, Austria; [Bally, Marcel] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada; [Voloshko, Ludmila] St Petersburg State Univ, St Petersburg, Russia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Innsbruck; British Columbia Cancer Agency; Saint Petersburg State University	Hrouzek, P (corresponding author), CAS Vvi, Inst Microbiol, Ctr Algatech, Trebon, Czech Republic.; Hrouzek, P (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	hrouzekp@gmail.com	Novak, Petr/F-9655-2014; Cheel, José/J-8401-2014; Voracova, Katerina/ABH-9514-2020; Kuzma, Marek/F-5468-2015; Mareš, Jan/B-2395-2009; Urajová, Petra/I-1663-2014; Lukeš, Martin/AAV-4722-2020	Novak, Petr/0000-0001-8688-529X; Cheel, José/0000-0001-5789-9297; Kuzma, Marek/0000-0001-7415-2734; Mareš, Jan/0000-0002-5745-7023; Lukeš, Martin/0000-0003-3493-9780; Krumschnabel, Gerhard/0000-0003-0804-1248; Hrouzek, Pavel/0000-0002-2061-0266	Czech Science Foundation [P503/12/P614, 14-18067S]; Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I [LO1416]; project ALGAIN [CZ.1.07/2.3.00/30.0059]; programme "Projects of Large Infrastructure for Research, Development, and Innovations" [LM2010005]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I; project ALGAIN; programme "Projects of Large Infrastructure for Research, Development, and Innovations"	This study was supported by Czech Science Foundation projects No. P503/12/P614 and No. 14-18067S and by the Ministry of Education, Youth and Sports of the Czech Republic, National Programme of Sustainability I, ID: LO1416. J. Cheel was supported by the project ALGAIN (reg. nr. CZ.1.07/2.3.00/30.0059). Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum, provided under the programme "Projects of Large Infrastructure for Research, Development, and Innovations" (LM2010005), is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; Bajaj S, 2015, EUR J MED CHEM, V97, P124, DOI 10.1016/j.ejmech.2015.04.051; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bohle DS, 2009, J ORG CHEM, V74, P1621, DOI 10.1021/jo802343k; Carbone M, 2011, ORG LETT, V13, P2516, DOI 10.1021/ol200234r; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; IRIE S, 1987, J BACTERIOL, V169, P5174, DOI 10.1128/jb.169.11.5174-5179.1987; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khalilullah H, 2012, MINI-REV MED CHEM, V12, P789, DOI 10.2174/138955712801264800; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; KUKOR JJ, 1991, J BACTERIOL, V173, P4587, DOI 10.1128/jb.173.15.4587-4594.1991; Marek R, 2007, CURR ORG CHEM, V11, P1154, DOI 10.2174/138527207781662519; Mares J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111904; Mares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066323; Mehlen P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001521; Mohareb RM, 2011, BIOORGAN MED CHEM, V19, P2707, DOI 10.1016/j.bmc.2011.02.051; NESMEYANOV AN, 1960, DOKL AKAD NAUK SSSR+, V133, P851; NGUYEN MT, 1985, ANGEW CHEM INT EDIT, V24, P713, DOI 10.1002/anie.198507131; Qiao Q, 2016, SCI REP, V6; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saha R, 2013, MINI-REV MED CHEM, V13, P1027, DOI 10.2174/1389557511313070007; Scheffner M, 1998, PHARMACOL THERAPEUT, V78, P129, DOI 10.1016/S0163-7258(98)00003-5; Semenov SG, 2011, RUSS J GEN CHEM+, V81, P1555, DOI 10.1134/S1070363211070243; Simunek P, 2004, EUR J ORG CHEM, V2004, P5055, DOI 10.1002/ejoc.200400287; Simunek P, 2003, ORG BIOMOL CHEM, V1, P3250, DOI 10.1039/b303206j; Sun J, 2013, MINI-REV MED CHEM, V13, P1725; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tondres ZV, 2012, CHALCOGENADIAZOLES C; Van Wagoner RM, 2007, ADV APPL MICROBIOL, V61, P89, DOI 10.1016/S0065-2164(06)61004-6; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x	37	24	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172850	10.1371/journal.pone.0172850	http://dx.doi.org/10.1371/journal.pone.0172850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253280	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300042
J	Asare-Kyei, D; Renaud, FG; Kloos, J; Walz, Y; Rhyner, J				Asare-Kyei, Daniel; Renaud, Fabrice G.; Kloos, Julia; Walz, Yvonne; Rhyner, Jakob			Development and validation of risk profiles of West African rural communities facing multiple natural hazards	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTIVE CAPACITY; VULNERABILITY ASSESSMENT; ADAPTATION; DROUGHT; LEVEL; FLOOD; GHANA; STRESSORS; SAHEL	West Africa has been described as a hotspot of climate change. The reliance on rain-fed agriculture by over 65% of the population means that vulnerability to climatic hazards such as droughts, rainstorms and floods will continue. Yet, the vulnerability and risk levels faced by different rural social-ecological systems (SES) affected by multiple hazards are poorly understood. To fill this gap, this study quantifies risk and vulnerability of rural communities to drought and floods. Risk is assessed using an indicator-based approach. A stepwise methodology is followed that combines participatory approaches with statistical, remote sensing and Geographic Information System techniques to develop community level vulnerability indices in three watersheds (Dano, Burkina Faso; Dassari, Benin; Vea, Ghana). The results show varying levels of risk profiles across the three watersheds. Statistically significant high levels of mean risk in the Dano area of Burkina Faso are found whilst communities in the Dassari area of Benin show low mean risk. The high risk in the Dano area results from, among other factors, underlying high exposure to droughts and rainstorms, longer dry season duration, low caloric intake per capita, and poor local institutions. The study introduces the concept of community impact score (CIS) to validate the indicator-based risk and vulnerability modelling. The CIS measures the cumulative impact of the occurrence of multiple hazards over five years. 65.3% of the variance in observed impact of hazards/CIS was explained by the risk models and communities with high simulated disaster risk generally follow areas with high observed disaster impacts. Results from this study will help disaster managers to better understand disaster risk and develop appropriate, inclusive and well integrated mitigation and adaptation plans at the local level. It fulfills the increasing need to balance global/regional assessments with community level assessments where major decisions against risk are actually taken and implemented.	[Asare-Kyei, Daniel; Renaud, Fabrice G.; Kloos, Julia; Walz, Yvonne; Rhyner, Jakob] United Nations Univ, UNU EHS, UN Campus,Pl Vereinten Nationen 1, Bonn, Germany		Asare-Kyei, D (corresponding author), United Nations Univ, UNU EHS, UN Campus,Pl Vereinten Nationen 1, Bonn, Germany.	asare-kyei@ehs.unu.edu	Rhyner, Jakob/AAH-8787-2021		German Federal Ministry of Education and Research (BMBF) under of the West African Science Service Centre for Climate Change and Adapted Land Use (WASCAL) project [01LG1202E]	German Federal Ministry of Education and Research (BMBF) under of the West African Science Service Centre for Climate Change and Adapted Land Use (WASCAL) project	This study was made possible with funding provided by the German Federal Ministry of Education and Research (BMBF) under the auspices of the West African Science Service Centre for Climate Change and Adapted Land Use (WASCAL) project (grant number 01LG1202E).	Adelekan IO, 2011, NAT HAZARDS, V56, P215, DOI 10.1007/s11069-010-9564-z; ADGER W. N., 2004, 7 U E ANGL NORW NR4; Adger WN, 2005, CR GEOSCI, V337, P399, DOI 10.1016/j.crte.2004.11.004; AL-ESSA A., 2011, THESIS; Antwi-Agyei P, 2012, APPL GEOGR, V32, P324, DOI 10.1016/j.apgeog.2011.06.010; Armah FA, 2011, MITIG ADAPT STRAT GL, V16, P291, DOI 10.1007/s11027-010-9263-9; Armah FA, 2010, WATER-SUI, V2, P120, DOI 10.3390/w2020120; ASARE-KYEI D. K., 2013, 1 ANDROID RESIDENTIA; Asare-Kyei D, 2015, WATER-SUI, V7, P3531, DOI 10.3390/w7073531; Asare-Kyei DK, 2015, INT J DISAST RISK RE, V11, P13, DOI 10.1016/j.ijdrr.2014.11.001; BACCI M., 2005, GEOINFORMATION DISAS, P819; Barbier B, 2009, ENVIRON MANAGE, V43, P790, DOI 10.1007/s00267-008-9237-9; Barron FH, 1996, MANAGE SCI, V42, P1515, DOI 10.1287/mnsc.42.11.1515; Beck W.M., 2012, WORLD RISK REPORT 20; Birkmann J., 2007, Environmental Hazards, V7, P20, DOI 10.1016/j.envhaz.2007.04.002; BIRKMANN J., 2006, MEASURING VULNERABIL, P150; Birkmann JD, 2011, WORLD RISK REPORT 20; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Cardona O.D., 2004, MAPPING VULNERABILIT; Damm M, 2010, THESIS RHEINISCHE FR; Depietri Y, 2013, INT J DISAST RISK RE, V6, P98, DOI 10.1016/j.ijdrr.2013.10.001; Dilley M, 2005, DISAST RISK MANAGE, P1; DRDLR, 2013, CLIM CHANG RISK VULN; European Commission, 2008, HDB CONSTRUCTING COM, DOI DOI 10.1787/9789264043466-EN; FAO GIEWS, 2015, FAO GIEWS 2015 GLOB; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Fields S, 2005, ENVIRON HEALTH PERSP, V113, pA534, DOI 10.1289/ehp.113-a534; FORKUOR G., COMPAGD1500279; FUSSEL H.-M., 2010, WORLD DEV REPORT 201; Gall M., 2007, ED RES INTRO; GROH A. P., 2007, ATTRACTIVNESS CENTRA; Ibrahim B, 2015, J HYDROL-REG STUD, V4, P386, DOI 10.1016/j.ejrh.2015.07.007; KLOOS J., 2015, UNU EHS PUBLICATION; KOGAN FN, 1995, B AM METEOROL SOC, V76, P655, DOI 10.1175/1520-0477(1995)076<0655:DOTLIT>2.0.CO;2; Kundzewicz ZW, 2014, HYDROLOG SCI J, V59, P1, DOI 10.1080/02626667.2013.857411; Linstadter A, 2016, ECOL SOC, V21, DOI 10.5751/ES-08737-210335; LOOTSMA F, 1999, MULTICRITERIA DECISI; Malczewski J., 2000, T GIS, V4, P5, DOI [10.1111/1467-9671.00035, DOI 10.1111/1467-9671.00035]; Martin R, 2016, ENVIRON MODELL SOFTW, V75, P414, DOI 10.1016/j.envsoft.2014.10.012; MEA, 2003, MEA 2003 EC HUM WELL; MOHAN D., 2011, VULNERABILITY ASSESS; Morjani Z.E., 2011, METHODOLOGY DOCUMENT; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Rojas O, 2011, REMOTE SENS ENVIRON, V115, P343, DOI 10.1016/j.rse.2010.09.006; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Stanturf J. A., 2011, GHANA CLIMATE CHANGE; STILLWELL WG, 1981, ORGAN BEHAV HUM PERF, V28, P62, DOI 10.1016/0030-5073(81)90015-5; SYLLA M., 2015, J CLIMATE; Trench P., 2007, ANY DROUGHT ROOT CAU; Tschakert P, 2007, GLOBAL ENVIRON CHANG, V17, P381, DOI 10.1016/j.gloenvcha.2006.11.008; UNDP, 2004, GLOB REP RED DIS RIS; UNFCCC, 2007, CLIM CHANG IMP VULN; van Aalst MK, 2008, GLOBAL ENVIRON CHANG, V18, P165, DOI 10.1016/j.gloenvcha.2007.06.002; VINCENT K., 2004, 56 TYND CONS TYND CT; Walz Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004217; WELLE T., 2013, WORLD RISK INDEX 201; Yamin F, 2005, IDS BULL-I DEV STUD, V36, P1, DOI 10.1111/j.1759-5436.2005.tb00231.x	58	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171921	10.1371/journal.pone.0171921	http://dx.doi.org/10.1371/journal.pone.0171921			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248969	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000395983500022
J	Chim, L; Salkeld, G; Kelly, P; Lipworth, W; Hughes, DA; Stockler, MR				Chim, Lesley; Salkeld, Glenn; Kelly, Patrick; Lipworth, Wendy; Hughes, Dyfrig A.; Stockler, Martin R.			Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia	PLOS ONE			English	Article							DISCRETE-CHOICE; CANCER DRUGS; PREFERENCES; HEALTH; COSTS; LIFE; CARE; END	Background Around the world government agencies responsible for the selection and reimbursement of prescribed medicines and other health technologies are considering how best to bring community preferences into their decision making. In particular, community views about the distribution or equity of funding across the population. These official committees and agencies often have access to the best available and latest evidence on clinical effectiveness, safety and cost from large clinical trials and population-based studies. All too often they do not have access to high quality evidence about community views. We therefore, conducted a large and representative population-based survey in Australia to determine what community members think about the factors that do and should influence government spending on prescribed medicines. Methods A choice-based survey was designed to elicit the importance of individual criteria when considering the equity of government spending on prescribed medicines. A representative sample of 3080 adult Australians completed the survey by allocating a hypothetical budget to different combinations of money spent on two patient populations. Societal preferences were inferred from absolute majority responses i.e. populations with more than 50% of respondents' allocation for a particular allocation criterion. Results This study shows that, all else being equal, severity of disease, diseases for which there is no alternative treatment available on the government formulary, diseases that affect patients who are not financially well off, and life-style unrelated diseases are supported by the public as resource allocation criteria. Where 'all else is not equal', participants allocated more resources to the patient population that gained considerable improvement in health and fewer resources to those that gained little improvement in health. This result held under all scenarios except for 'end-of-life treatments'. Responses to cost (and corresponding number of patients treated) trade-off scenarios indicated a significant reduction in the proportion of respondents choosing to divide resources equally and a shift in preference towards devoting resources to the population that were more costly to treat for all criteria with the exception of severity of disease. Conclusions The general public have clear views on what's fair in terms of government spending on prescribed medicines. In addition to supporting the application of the 'rule of rescue', important considerations for government spending included the severity of disease being treated, diseases for which there is no alternative treatment available on the government formulary, diseases that affect patients who are not financially well off and life-style unrelated diseases. This study shows that the general public are willing to share their views on what constitutes an equitable allocation of the government's drug budget. The challenge remains to how best to consider those views alongside clinical and economic considerations.	[Chim, Lesley; Kelly, Patrick] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Chim, Lesley] Alex Pharmaceut, Sydney, NSW, Australia; [Salkeld, Glenn] Univ Wollongong, Fac Social Sci, Wollongong, NSW, Australia; [Lipworth, Wendy] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW, Australia; [Hughes, Dyfrig A.] Bangor Univ, Bangor Inst Hlth & Med Res, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales; [Stockler, Martin R.] Univ Sydney, NHMRC, Clin Trials Ctr, Sydney, NSW, Australia; [Stockler, Martin R.] Concord Hosp, Concord Canc Ctr, Sydney, NSW, Australia; [Stockler, Martin R.] Chris OBrien Lifehouse, Sydney, NSW, Australia	University of Sydney; University of Wollongong; University of Sydney; Bangor University; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Chim, L (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Chim, L (corresponding author), Alex Pharmaceut, Sydney, NSW, Australia.	lesleychim@gmail.com	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; Kelly, Patrick/0000-0002-5015-0977; Lipworth, Wendy/0000-0002-0234-657X	National Health and Medical Research Council of Australia [6633003]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was undertaken as part of the Screening and Diagnostic Test Evaluation Program funded by the National Health and Medical Research Council of Australia under Program Grant number 6633003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PHARM BEN SCHEM QUIC; Australian Government Department of Health, 2015, GUID PREP SUBM PHARM; Campaigns, CAMP; Cancer Drugs Alliance, 2015, CANC DRUGS ALL SUBM; Chim L, 2010, PHARMACOECONOMICS, V28, P463, DOI 10.2165/11533000-000000000-00000; Daroudi R, 2016, INT J HEALTH POLICY, V5, P99, DOI 10.15171/ijhpm.2015.186; Department of Health, LIF SAV DRUGS PROGR; Desser AS, 2013, PHARMACOECONOMICS, V31, P1051, DOI 10.1007/s40273-013-0093-y; Dolan P, 2005, HEALTH ECON, P14; Finkelstein EA, 2015, HEALTH POLICY, V119, P1482, DOI 10.1016/j.healthpol.2015.09.001; Gallego G, 2007, HEALTH EXPECT, V10, P224, DOI 10.1111/j.1369-7625.2007.00439.x; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Ghinea N, 2016, MED J AUSTRALIA, V204, P214, DOI 10.5694/mja15.01309; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Hosmer D, 2000, APPL LOGISTIC RERESS; Lees Ann, 2002, Health Expect, V5, P47, DOI 10.1046/j.1369-6513.2002.00157.x; Linley WG, 2013, HEALTH ECON, V22, P948, DOI 10.1002/hec.2872; MacKenzie R, 2008, J ROY SOC MED, V101, P1; MacLeod TE, 2016, PATIENT, V9, P201, DOI 10.1007/s40271-015-0139-7; McKie John, 2009, Aust New Zealand Health Policy, V6, P11, DOI 10.1186/1743-8462-6-11; Mileshkin L, 2009, J CLIN ONCOL, V27, P5830, DOI 10.1200/JCO.2009.22.7793; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; NHS England, 2015, GUID SUPP OP CDF 201; Pharmaceutical Benfits Advisory Committee, 2015, PHARM BEN ADV COMM S; PharmaDispatch, 2015, PAT HAV SUFF SYST NE; Rare Cancer Australia, 2015, RAR CANC AUSTR SUBM; Senate Community Affairs Reference Committee, 2015, AV NEW INN SPEC CANC; Shah KK, 2015, SOC SCI MED, V124, P48, DOI 10.1016/j.socscimed.2014.11.022; Shah KK, 2009, HEALTH POLICY, V93, P77, DOI 10.1016/j.healthpol.2009.08.005; Tordrup D, 2013, APPL HEALTH ECON HEA, V11, P639, DOI 10.1007/s40258-013-0056-7; van Exel J, 2015, SOC SCI MED, V126, P128, DOI 10.1016/j.socscimed.2014.12.023; Vogler S, 2016, HEALTH POLICY TECHN, V5, P213, DOI 10.1016/j.hlpt.2016.03.009; Whitty JA, 2012, VALUE HEALTH, V15, pA306, DOI 10.1016/j.jval.2012.08.642; Whitty JA, 2011, APPL HEALTH ECON HEA, V9, P73, DOI 10.2165/11537150-000000000-00000; Whitty JA, 2015, HEALTH POLICY, V119, P127, DOI 10.1016/j.healthpol.2014.09.003; Whitty JA, 2014, MED DECIS MAKING, V34, P638, DOI 10.1177/0272989X14526640; Wilson A, 2011, VALUE HEALTH, V14, P944, DOI 10.1016/j.jval.2011.05.004; Wortley S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010265	38	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172971	10.1371/journal.pone.0172971	http://dx.doi.org/10.1371/journal.pone.0172971			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249013	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500066
J	Doguzhaeva, LA; Bengtson, S; Reguero, MA; Mors, T				Doguzhaeva, Larisa A.; Bengtson, Stefan; Reguero, Marcelo A.; Mors, Thomas			An Eocene orthocone from Antarctica shows convergent evolution of internally shelled cephalopods	PLOS ONE			English	Article							LA-MESETA FORMATION; CRETACEOUS SPIRULID COLEOIDS; ORGANIC SKELETAL STRUCTURE; SEYMOUR ISLAND; BELEMNITE; SEPIA; CUTTLEBONE; MORPHOLOGY; BASINS; ORIGIN	Background The Subclass Coleoidea (Class Cephalopoda) accommodates the diverse present-day internally shelled cephalopod mollusks (Spirula, Sepia and octopuses, squids, Vampyroteuthis) and also extinct internally shelled cephalopods. Recent Spirula represents a unique coleoid retaining shell structures, a narrow marginal siphuncle and globular protoconch that signify the ancestry of the subclass Coleoidea from the Paleozoic subclass Bactritoidea. This hypothesis has been recently supported by newly recorded diverse bactritoid-like coleoids from the Carboniferous of the USA, but prior to this study no fossil cephalopod indicative of an endochochleate branch with an origin independent from subclass Bactritoidea has been reported. Methodology/Principal findings Two orthoconic conchs were recovered from the Early Eocene of Seymour Island at the tip of the Antarctic Peninsula, Antarctica. They have loosely mineralized organic-rich chitincompatible microlaminated shell walls and broadly expanded central siphuncles. The morphological, ultrustructural and chemical data were determined and characterized through comparisons with extant and extinct taxa using Scanning Electron Microscopy/Energy Dispersive Spectrometry (SEM/EDS). Conclusions/Significance Our study presents the first evidence for an evolutionary lineage of internally shelled cephalopods with independent origin from Bactritoidea/Coleoidea, indicating convergent evolution with the subclass Coleoidea. A new subclass Paracoleoidea Doguzhaeva n. subcl. is established for accommodation of orthoconic cephalopods with the internal shell associated with a broadly expanded central siphuncle. Antarcticerida Doguzhaeva n. ord., Antarcticeratidae Doguzhaeva n. fam., Antarcticeras nordenskjoeldi Doguzhaeva n. gen., n. sp. are described within the subclass Paracoleoidea. The analysis of organic-rich shell preservation of A. nordenskjoeldi by use of SEM/EDS techniques revealed fossilization of hyposeptal cameral soft tissues. This suggests that a depositional environment favoring soft-tissue preservation was the factor enabling conservation of the weakly mineralized shell of A. nordenskjoeldi.	[Doguzhaeva, Larisa A.; Bengtson, Stefan; Mors, Thomas] Swedish Museum Nat Hist, Dept Palaeobiol, Stockholm, Sweden; [Reguero, Marcelo A.] Museo La Plata, Div Paleontol Vertebrados, Paseo Bosque S-N,B1900FWA, La Plata, Buenos Aires, Argentina	Swedish Museum of Natural History; National University of La Plata; Museo La Plata	Doguzhaeva, LA (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, Stockholm, Sweden.	larisa.doguzhaeva@nrm.se		Bengtson, Stefan/0000-0003-0206-5791; Doguzhaeva, Larisa/0000-0002-1231-2488	Swedish Research Council [2009-4447]; Argentine Research Council [PIP 0462]; Argentine National Agency for Promotion of Science and Technology [PICTO-2010-0093]; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Argentine Research Council; Argentine National Agency for Promotion of Science and Technology; Royal Swedish Academy of Sciences	This work was supported by Swedish Research Council, 2009-4447 (TM) (http://www.formas.se/en/); Argentine Research Council, PIP 0462 (MR) (http://www.conicet.gov.ar/); Argentine National Agency for Promotion of Science and Technology, PICTO-2010-0093 (MR) (http://www.agencia.mincyt.gob.ar/); and Royal Swedish Academy of Sciences (LD) (http://www.kva.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J AQUAT SCI; BERTHOLD T, 1987, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V29, P187; Bijl PK, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001905; Blind W., 1988, CEPHALOPODS PRESENT, P273; Bomfleur B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0431; Cadman J, 2012, J BIONIC ENG, V9, P367, DOI 10.1016/S1672-6529(11)60132-7; Checa AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11513; DELVALLE RA, 1992, ANTARCT SCI, V4, P477, DOI 10.1017/S0954102092000695; Dingle RV, 1998, J GEOL SOC LONDON, V155, P433, DOI 10.1144/gsjgs.155.3.0433; Doguzhaeva L., 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V218, P17; Doguzhaeva L.A., 2003, Berliner Palaeobiologische Abhandlungen, V3, P61; Doguzhaeva L. A., 2010, CEPHALOPODS PRESENT, P171; Doguzhaeva LA, 1996, PALAEONTOLOGY, V39, P681; DOGUZHAEVA LA, 1994, PALAEONTOLOGY, V37, P889; Doguzhaeva LA, 1999, ADVANCING RESEARCH ON LIVING AND FOSSIL CEPHALOPODS, P47; Doguzhaeva LA, 2015, SWISS J PALAEONT; Doguzhaeva LA, 2002, ACTA U CAROL GEOL, V49, P95; Doguzhaeva LA, 2015, TOPICS GEOBIOLOGY, V43, P593; Doguzhaeva Larisa A., 2000, Revue de Paleobiologie Volume Special, V8, P83; Doguzhaeva LA, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P121; Doguzhaeva Larisa A., 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P299; Doguzhaeva Larisa A., 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P321; Doguzhaeva LA, 2014, LETHAIA, V47, P49, DOI 10.1111/let.12037; Doguzhaeva LA, 2014, ACTA PALAEONTOL POL, V59, P147, DOI 10.4202/app.2011.0208; Doguzhaeva LA, 2012, NEUES JAHRB GEOL P-A, V266, P31, DOI 10.1127/0077-7749/2012/0266; Doguzhaeva LA, 2012, PALAEONTOLOGY, V55, P249, DOI 10.1111/j.1475-4983.2012.01136.x; Doguzhaeva LA, 2012, GEOBIOS-LYON, V45, P13, DOI 10.1016/j.geobios.2011.11.008; Doguzhaeva LA, 2011, PALAEONTOLOGY, V54, P397, DOI 10.1111/j.1475-4983.2010.01027.x; Douglas PMJ, 2014, P NATL ACAD SCI USA, V111, P6582, DOI 10.1073/pnas.1321441111; Drushchits VV, 1978, PALEONTOL ZH, V2, P36; Dutton AL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000593; Elliot D.H, 1988, GEOLOGICAL SOC AM ME, P541, DOI DOI 10.1130/MEM169-P541; Elliot D.H., 1982, ANTARCT GEOSCI, P287; Engeser T., 1990, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V124, P123; Erben HK, 1971, PALAEONTOGR ABT A, V132, P1; Florek M, 2009, MAT SCI ENG C-BIO S, V29, P1220, DOI 10.1016/j.msec.2008.09.040; FLOWER RH, 1959, J PALEONTOL, V33, P809; Fornasiero Mariagabriella, 1997, Memorie di Scienze Geologiche, V49, P65; Fuchs D, 2015, J SYST PALAEONTOL; Fuchs D, 2013, PALAEONTOLOGY, V56, P1081, DOI 10.1111/pala.12036; Fuchs D, 2012, PALAEONTOLOGY, V55, P285, DOI 10.1111/j.1475-4983.2011.01125.x; Fuchs D, 2012, CRETACEOUS RES, V34, P200, DOI 10.1016/j.cretres.2011.10.018; Gelfo J. N., 2009, MUS N ARIZ B; Gelfo JN, 2015, PALAEONTOLOGY, V58, P101, DOI 10.1111/pala.12121; Hathway B, 2000, J GEOL SOC LONDON, V157, P417, DOI 10.1144/jgs.157.2.417; Ivany LC, 2006, GEOLOGY, V34, P377, DOI 10.1130/G22383.1; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Jeletzky J. A., 1969, Paleontological Contributions University of Kansas, V41, P1; Jeletzky J.A., 1966, U KANSAS PALEONTOLOG, V7, P1; Kost'ak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081180; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Kulicki C, 2015, TOP GEOBIOL, V43, P321, DOI 10.1007/978-94-017-9630-9_8; Lindgren AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-129; Mapes R. H., 2010, CEPHALOPODS PRESENT, P155; Mapes Royal H., 2010, Ferrantia, V59, P126; Marenssi SA, 2002, SEDIMENT GEOL, V150, P301, DOI 10.1016/S0037-0738(01)00201-9; Marenssi SA, 1998, ASOC PAL ARGENT PUBL, P137; Marenssi SA, 2006, GEOL SOC SPEC PUBL, V258, P125, DOI 10.1144/GSL.SP.2006.258.01.09; Mutvei H, 2012, GFF, V134, P201, DOI 10.1080/11035897.2012.696134; Mutvei Harry, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V246, P33; MUTVEL H, 1972, B GEOLOGICAL I U U 3, V9, P263; Oehler Dorothy Z., 2009, V12, P3; Reguero M., 2013, SPRINGER BRIEFS EART; Reguero Marcelo A, 2012, Rev. peru biol., V19, P275; Ristedt H., 1971, Palaeontographica A, V137, P155; Sadler P. M, 1988, GEOLOGY PALEONTOLOGY, V169, P303, DOI DOI 10.1130/MEM169-P303; Schwarzhans W, 2016, J SYST PALAEONTOL, P1; Stilwell J.D., 1992, ANTARCT RES SER, V55, P1, DOI DOI 10.1029/AR055; Teichert C, 1988, PALEONTOLOGY NEONTOL, V12, P1179; Teichert C, 1964, DESCRIPTION SUBCLASS, V3, pK127; Tejedor MF, 2009, AM MUS NOVIT, P1, DOI 10.1206/577.1; Weaver PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028195; Yancey TE, 2010, J PALEONTOL, V84, P267, DOI 10.1666/09-018R.1; Young RE, 1998, S AFR J MARINE SCI, V20, P393; Zhuravleva FA, 1999, FOSSIL CEPHALOPODS L, P213	75	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172169	10.1371/journal.pone.0172169	http://dx.doi.org/10.1371/journal.pone.0172169			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248970	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500027
J	Kahn, HS; Bullard, KM				Kahn, Henry S.; Bullard, Kai McKeever			Indicators of abdominal size relative to height associated with sex, age, socioeconomic position and ancestry among US adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; WAIST CIRCUMFERENCE; ANTHROPOMETRIC MEASUREMENTS; SCIENTIFIC STATEMENT; FAT DISTRIBUTION; VISCERAL FAT; RATIO; OBESITY; DIAMETER	Background/Objectives The supine sagittal abdominal diameter (SAD) and standing waist circumference (WC) describe abdominal size. The SAD/height ratio (SADHtR) or WC/height ratio (WHtR) may better identify cardiometabolic disorders than BMI (weight/height(2)), but population-based distributions of SADHtR and WHtR are not widely available. Abdominal adiposity may differ by sociodemographic characteristics. Subjects/Methods Anthropometry, including SAD by sliding-beam caliper, was performed on 9894 non-pregnant adults >= 20 years in the US National Health and Nutrition Examination Surveys of 2011-2014. Applying survey design factors and sampling weights, we estimated nationally representative SADHtR and WHtR distributions by sex, age, educational attainment, and four ancestral groups. Results The median (10th percentile, 90th percentile) for men's SADHtR was 0.130 (0.103, 0.165) and WHtR 0.569 (0.467, 0.690). For women, median SADHtR was 0.132 (0.102, 0.175) and WHtR 0.586 (0.473, 0.738). Medians for SADHtR and WHtR increased steadily through age 79. The median BMI, however, reached maximum values at ages 40-49 (men) or 60-69 (women) and then declined. Low educational attainment, adjusted for age and ancestry, was associated with elevated SADHtR more strongly than elevated BMI. While non-Hispanic Asians had substantially lower BMI compared to all other ancestral groups (adjusted for sex, age and education), their relative reductions in SADHtR and WHtR, were less marked. Conclusions These cross-sectional data are consistent with monotonically increasing abdominal adipose tissue through the years of adulthood but decreasing mass in non-abdominal regions beyond middle age. They suggest also that visceral adipose tissue, estimated by SADHtR, expands differentially in association with low socioeconomic position. Insofar as Asians have lower BMIs than other populations, employing abdominal indicators may attenuate the adiposity differences reported between ancestral groups. Documenting the distribution and sociodemographic features of SADHtR and WHtR supports the clinical and epidemiologic adoption of these adiposity indicators.	[Kahn, Henry S.; Bullard, Kai McKeever] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Kahn, HS (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.	hkahn@cdc.gov	Kahn, Henry S/A-6946-2009	Kahn, Henry S/0000-0003-2533-1562				Albrecht SS, 2015, EUR J CLIN NUTR, V69, P1306, DOI 10.1038/ejcn.2015.71; Alves RF, 2015, REV SAUDE PUBL, P49; Anunciacao PC, 2014, J HUM NUTR DIET; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 1996, BRIT MED J, V313, P559; Ashwell M, 2014, BMC MED, P12; Ashwell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103483; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; CDC, 2014, NAT HLTH NUTR EX SUR; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Paula HAD, 2012, J HUM NUTR DIET, V25, P563, DOI 10.1111/j.1365-277X.2012.01267.x; Demerath EW, 2011, ANN HUM BIOL, V38, P247, DOI 10.3109/03014460.2010.524893; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Freedman DS, 2015, AM J CLIN NUTR, V101, P425, DOI 10.3945/ajcn.114.094672; Fryar CD, 2016, VITAL HLTH STAT SERI, V3; GARROW JS, 1985, INT J OBESITY, V9, P147; Hermann S, 2011, BMC PUBLIC HEALTH, P11; HSIEH SD, 1995, INT J OBESITY, V19, P585; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kahn HS, 2014, CLIN OBES, V4, P333, DOI 10.1111/cob.12078; Kahn HS, 2016, AM J MED, V129, P74, DOI 10.1016/j.amjmed.2015.08.010; Klimentidis YC, 2016, FRONT GENET, P7; Kowalkowska J, 2016, BRIT J NUTR, V115, P185, DOI 10.1017/S0007114515004055; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Kullberg J, 2007, CLIN PHYSIOL FUNCT I, V27, P148, DOI 10.1111/j.1475-097X.2007.00728.x; Kumlin L, 1997, BRIT MED J, V314, P830, DOI 10.1136/bmj.314.7083.830; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mason C, 2009, OBESITY, V17, P1789, DOI 10.1038/oby.2009.87; National Center for Health Statistics, 2015, NHANES 2013 2014 DAT; National Center for Health Statistics, 2013, ANTHR PROC MAN NAT H; Nordhamn K, 2000, INT J OBESITY, V24, P652, DOI 10.1038/sj.ijo.0801216; Ogden C.L., 2015, NCHS DATA BRIEF; Peng Y., 2015, PLOS ONE, V10; Ramirez-Velez R., 2016, EUR J CLIN NUTR; Rao G, 2015, CIRCULATION, V132, P457, DOI 10.1161/CIR.0000000000000223; RASMUSSEN MH, 1993, INT J OBESITY, V17, P323; RICHELSEN B, 1995, INT J OBESITY, V19, P169; Sampaio LR, 2007, ARQ BRAS ENDOCRINOL, V51, P980, DOI 10.1590/S0004-27302007000600013; Sardinha LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047883; Savva SC, 2013, DIABETES METAB SYNDR, P6; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Shields M, 2012, HEALTH REP, V23, P33; Sugihara M, 2011, INTERNAL MED, V50, P679, DOI 10.2169/internalmedicine.50.4292; Tanamas SK, 2016, QJM, V109; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; VANDERKOOY K, 1993, BRIT J NUTR, V70, P47, DOI 10.1079/BJN19930104; WILLIAMSON DF, 1993, AM J HUM BIOL, V5, P159, DOI 10.1002/ajhb.1310050205; World Health Organization, 1995, WHO TECHN REP SER; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yim JY, 2010, DIABETES CARE, V33, P2665, DOI 10.2337/dc10-0606; Yoon JM, 2013, KOREAN J FAM MED, V34	52	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172245	10.1371/journal.pone.0172245	http://dx.doi.org/10.1371/journal.pone.0172245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248983	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500033
J	Malchenko, S; Sredni, ST; Bi, Y; Margaryan, NV; Boyineni, J; Mohanam, I; Tomita, T; Davuluri, RV; Soares, MB				Malchenko, Sergey; Sredni, Simone Treiger; Bi, Yingtao; Margaryan, Naira V.; Boyineni, Jerusha; Mohanam, Indra; Tomita, Tadanori; Davuluri, Ramana V.; Soares, Marcelo B.			Stabilization of HIF-1 alpha and HIF-2 alpha, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model	PLOS ONE			English	Article							STEM-CELLS; C-MYC; NUCLEAR-LOCALIZATION; GENETIC INSTABILITY; EXPRESSION ANALYSIS; NESTIN EXPRESSION; FACTOR YB-1; TUMOR; CANCER; HYPOXIA	Recently, we described a new animal model of CNS primitive neuroectodermal tumors (CNS-PNET), which was generated by orthotopic transplantation of human Radial Glial (RG) cells into NOD-SCID mice's brain sub-ventricular zone. In the current study we conducted comprehensive RNA-Seq analyses to gain insights on the mechanisms underlying tumorigenesis in this mouse model of CNS-PNET. Here we show that the RNA-Seq profiles derived from these tumors cluster with those reported for patients' PNETs. Moreover, we found that (i) stabilization of HIF-1 alpha and HIF-2 alpha, which are involved in mediation of the hypoxic responses in the majority of cell types, (ii) up-regulation of MYCC, a key onco-protein whose dysregulation occurs in similar to 70% of human tumors, and (iii) accumulation of stabilized p53, which is commonly altered in human cancers, constitute hallmarks of our tumor model, and might represent the basis for CNS-PNET tumorigenesis in this model. We discuss the possibility that these three events might be interconnected. These results indicate that our model may prove invaluable to uncover the molecular events leading to MYCC and TP53 alterations, which would be of broader interest considering their relevance to many human malignancies. Lastly, this mouse model might prove useful for drug screening targeting MYCC and related members of its protein interaction network.	[Malchenko, Sergey; Boyineni, Jerusha; Mohanam, Indra; Soares, Marcelo B.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Sredni, Simone Treiger; Tomita, Tadanori] Northwestern Univ, Div Pediat Neurosurg, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Sredni, Simone Treiger] Ann & Robert H Lurie Childrens Hosp Chicago, Canc Biol & Epigen Program, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Bi, Yingtao; Davuluri, Ramana V.] Northwestern Univ, Dept Prevent Med, Div Hlth & Biomed Informat, Feinberg Sch Med, Chicago, IL 60611 USA; [Bi, Yingtao] Abbvie Biores Ctr, Worcester, MA USA; [Margaryan, Naira V.] West Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA	University of Illinois System; University of Illinois Peoria; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; AbbVie; West Virginia University	Malchenko, S (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	sergeynm@uicomp.uic.edu		Sredni, Simone/0000-0002-1715-3885	Abbvie Bioresearch Center; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011297] Funding Source: NIH RePORTER	Abbvie Bioresearch Center(AbbVie); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a gift from Mr Glen Barton, whose generosity and vision to contribute to the development of a Cancer Research Center at the University of Illinois College of Medicine at Peoria (UICOMP) has been transformative to this medical school. Abbvie Bioresearch Center provided support in the form of salary for author (YB) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Behdad A, 2010, BRAIN PATHOL, V20, P441, DOI 10.1111/j.1750-3639.2009.00314.x; BENNETT WP, 1992, CHEST, V101, pS19, DOI 10.1378/chest.101.3_Supplement.19S; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2016, ONCOGENE, P1; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Dolecek TA, 2013, NEURO-ONCOLOGY, V15, P646; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; Kahlert UD, 2012, FOLIA NEUROPATHOL, V50, P357, DOI 10.5114/fn.2012.32365; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Khan Z, 2013, CANCER INVEST, V31, P404, DOI 10.3109/07357907.2013.802800; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kozono D, 2015, P NATL ACAD SCI USA, V112, pE4055, DOI 10.1073/pnas.1501967112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZG, 2014, NEURO-ONCOLOGY, V16, P787, DOI 10.1093/neuonc/not244; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malchenko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121707; Malchenko S, 2014, GENE, V534, P400, DOI 10.1016/j.gene.2013.07.101; Manoranjan B, 2015, ADV EXP MED BIOL, V853, P49, DOI 10.1007/978-3-319-16537-0_4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Palma CS, 2013, GENET MOL RES, V12, P1054, DOI 10.4238/2013.April.2.22; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reynolds TY, 1996, CANCER RES, V56, P5754; Sakurada K, 2008, NEUROSURG REV, V31, P173, DOI 10.1007/s10143-007-0115-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seymour T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00159; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Young SL, 2011, MOL BIOL EVOL, V28, P2961, DOI 10.1093/molbev/msr132; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhang YF, 2003, ONCOGENE, V22, P2782, DOI 10.1038/sj.onc.1206357	78	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173106	10.1371/journal.pone.0173106	http://dx.doi.org/10.1371/journal.pone.0173106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249000	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500075
J	Papotto, PH; Marengo, EB; Sardinha, LR; Carvalho, KI; de Carvalho, AEZ; Castillo-Mendez, S; Jank, CC; Vanhove, B; Goldberg, AC; Rizzo, LV				Papotto, Pedro Henrique; Marengo, Eliana Blini; Sardinha, Luiz Roberto; Carvalho, Karina Inacio; Zulim de Carvalho, Ana Eduarda; Castillo-Mendez, Sheyla; Jank, Carina Calixto; Vanhove, Bernard; Goldberg, Anna Carla; Rizzo, Luiz Vicente			Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+T lymphocyte activation and IFN-gamma production	PLOS ONE			English	Article							REGULATORY T-CELLS; HEART ALLOGRAFT SURVIVAL; MONOVALENT FAB ANTIBODY; EFFECTOR RESPONSE; CYTOKINE STORM; UVEORETINITIS; MICE; DISEASE; COSTIMULATION; MECHANISMS	Autoimmune Uveitis is an important chronic inflammatory disease and a leading cause of impaired vision and blindness. This ocular autoimmune disorder is mainly mediated by T CD4(+) lymphocytes poising a TH1 phenotype. Costimulatory molecules are known to play an important role on T cell activation and therefore represent interesting therapeutical targets for autoimmune disorders. CD28 is the prototypical costimulatory molecule for T lymphocytes, and plays a crucial role in the initiation, and maintenance of immune responses. However, previous attempts to use this molecule in clinical practice achieved no success. Thus, we evaluated the efficacy of mPEG PV1-Fab' (PV1), a novel selective CD28 antagonist monovalent Fab fragment in the treatment of Experimental Autoimmune Uveitis (EAU). Here, we showed that PV1 treatment decreases both average disease score and incidence of EAU. A decrease in the activation profile of both T CD4(+) and T CD8(+) eye-infiltrating lymphocytes was evidenced. In the periphery, T CD4(+) cells from PV1-treated mice also showed a decrease in their activation status, with reduced expression of CD69, CD25, and PD-1 molecules. This suppression was not dependent on Treg cells, as both their frequency and absolute number were lower in PV1-treated mice. In addition, frequency of CD4(+) IFN-gamma+ T cells was significantly lower in PV1-treated group, but not of IL-17-producing T cells. Moreover, after specific restimulation, PV1 blockade selectively blocked IFN-gamma production by CD4(+) lymphocytes Taken together, our data suggest that mPEG PV1-Fab' acts mainly on IFN-gamma-producing CD4(+) T cells and emphasize that this specific CD28 blockade strategy is a potential specific and alternative tool for the treatment of autoimmune disorders in the eye.	[Papotto, Pedro Henrique; Marengo, Eliana Blini; Sardinha, Luiz Roberto; Carvalho, Karina Inacio; Zulim de Carvalho, Ana Eduarda; Castillo-Mendez, Sheyla; Jank, Carina Calixto; Goldberg, Anna Carla; Rizzo, Luiz Vicente] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Vanhove, Bernard] OSE Immunotherapeut SA, Nantes, France	Hospital Israelita Albert Einstein	Rizzo, LV (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	lvrizzo@einstein.br	Rizzo, Luiz Vicente/B-4458-2009; Vanhove, Bernard/AAE-8658-2019; Goldberg, Anna Carla/H-8594-2014; Carvalho, Karina IL/J-6789-2012	Goldberg, Anna Carla/0000-0003-2600-7940; Carvalho, Karina IL/0000-0002-7763-8139; Papotto, Pedro/0000-0002-2488-7182; Castillo, Sheyla/0000-0002-0655-1781; Vanhove, Bernard/0000-0002-2872-8648	European Union [ECGA 281493]; CNPq; FAPESP [2013/15448-7]	European Union(European Commission); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the European Union-sponsored project Tolerance Restoration in Autoimmune Disease (European Union FP7 Health Program Grant ECGA 281493).; www.triad-CD28. eu) project. LVR and ACG are recipients of personal fellowships from CNPq. PHP is a recipient of a fellowship from FAPESP (2013/15448-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1999, NAT MED, V5, P1345, DOI 10.1038/70905; ABE R, 1995, J IMMUNOL, V154, P985; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Bhuyan ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089266; Bornsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047578; Camperio C, 2014, IMMUNOL LETT, V158, P134, DOI 10.1016/j.imlet.2013.12.020; CASPI RR, 1990, J AUTOIMMUN, V3, P237, DOI 10.1016/0896-8411(90)90143-G; CASPI RR, 1990, CURR EYE RES, V9, P169, DOI 10.3109/02713689008999438; CASPI RR, 1988, J IMMUNOL, V140, P1490; Comarmond C, 2014, AUTOIMMUN REV, V13, P762, DOI 10.1016/j.autrev.2014.01.056; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P2568, DOI 10.1167/iovs.09-4769; GERY I, 1986, INVEST OPHTH VIS SCI, V27, P1296; GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Guo F, 2008, J IMMUNOL, V181, P2285, DOI 10.4049/jimmunol.181.4.2285; Haanstra KG, 2015, J IMMUNOL, V194, P1454, DOI 10.4049/jimmunol.1402563; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Jamilloux Y, 2014, AUTOIMMUN REV, V13, P840, DOI 10.1016/j.autrev.2014.04.001; Jang MS, 2008, TRANSPLANTATION, V85, P1051, DOI 10.1097/TP.0b013e31816846f6; Jones LS, 1997, J IMMUNOL, V158, P5997; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaufmann U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049008; Kwak HJ, 2001, MOL CELLS, V12, P178; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Marengo EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007912; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Papotto PH, 2014, AUTOIMMUN REV, V13, P909, DOI 10.1016/j.autrev.2014.05.003; Perrin PJ, 1999, J IMMUNOL, V163, P1704; Poirier N, 2015, AM J TRANSPLANT, V15, P88, DOI 10.1111/ajt.12964; Poirier N, 2012, AM J TRANSPLANT, V12, P2630, DOI 10.1111/j.1600-6143.2012.04164.x; Poirier N, 2012, AM J TRANSPLANT, V12, P1682, DOI 10.1111/j.1600-6143.2012.04032.x; Poirier N, 2016, J IMMUNOL, V196, P274, DOI 10.4049/jimmunol.1501810; Poirier N, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000116; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Rizzo LV, 1996, J IMMUNOL, V156, P1654; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roitt I M, 1993, Immunol Ser, V59, P119; Rudulier CD, 2014, J IMMUNOL, V192, P5140, DOI 10.4049/jimmunol.1301691; Selmi C, 2014, AUTOIMMUN REV, V13, P546, DOI 10.1016/j.autrev.2014.01.005; Shao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037773; Silver PB, 2000, J IMMUNOL, V165, P5041, DOI 10.4049/jimmunol.165.9.5041; SILVER PB, 1995, INVEST OPHTH VIS SCI, V36, P946; St Clair EW, 2008, J CLIN INVEST, V118, P1344, DOI 10.1172/JCI35382; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Szot GL, 2000, TRANSPLANTATION, V69, P904; Tang J, 2007, J IMMUNOL, V178, P5578, DOI 10.4049/jimmunol.178.9.5578; Tian LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019542; van Berkel MEAT, 2006, IMMUNOL LETT, V105, P115, DOI 10.1016/j.imlet.2006.02.007; Ville S, 2016, J AM SOC NEPHROLOGY; Wakefield D, 2012, OCUL IMMUNOL INFLAMM, V20, P277, DOI 10.3109/09273948.2012.684736; Waldmann H, 2008, IMMUNOL REV, V223, P361, DOI 10.1111/j.1600-065X.2008.00632.x; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P520, DOI 10.1001/archopht.1997.01100150522013; Zanotti C, 2012, CLIN IMMUNOL, V145, P19, DOI 10.1016/j.clim.2012.07.007; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171822	10.1371/journal.pone.0171822	http://dx.doi.org/10.1371/journal.pone.0171822			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248972	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500019
J	Schoenrock, A; Burnside, D; Moteshareie, H; Pitre, S; Hooshyar, M; Green, JR; Golshani, A; Dehne, F; Wong, A				Schoenrock, Andrew; Burnside, Daniel; Moteshareie, Houman; Pitre, Sylvain; Hooshyar, Mohsen; Green, James R.; Golshani, Ashkan; Dehne, Frank; Wong, Alex			Evolution of protein-protein interaction networks in yeast	PLOS ONE			English	Article							SHORT POLYPEPTIDE SEQUENCES; SACCHAROMYCES-CEREVISIAE; E. COLI; PREDICTION; GENOME; COMPLEXES; BIOLOGY; MODULES; GENES; IDENTIFICATION	Interest in the evolution of protein-protein and genetic interaction networks has been rising in recent years, but the lack of large-scale high quality comparative datasets has acted as a barrier. Here, we carried out a comparative analysis of computationally predicted protein-protein interaction (PPI) networks from five closely related yeast species. We used the Protein-protein Interaction Prediction Engine (PIPE), which uses a database of known interactions to make sequence-based PPI predictions, to generate high quality predicted interactomes. Simulated proteomes and corresponding PPI networks were used to provide null expectations for the extent and nature of PPI network evolution. We found strong evidence for conservation of PPIs, with lower than expected levels of change in PPIs for about a quarter of the proteome. Furthermore, we found that changes in predicted PPI networks are poorly predicted by sequence divergence. Our analyses identified a number of functional classes experiencing fewer PPI changes than expected, suggestive of purifying selection on PPIs. Our results demonstrate the added benefit of considering predicted PPI networks when studying the evolution of closely related organisms.	[Schoenrock, Andrew; Pitre, Sylvain; Dehne, Frank] Carleton Univ, Sch Comp Sci, Ottawa, ON, Canada; [Burnside, Daniel; Moteshareie, Houman; Hooshyar, Mohsen; Golshani, Ashkan; Wong, Alex] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Green, James R.] Carleton Univ, Dept Syst & Comp Engn, Ottawa, ON, Canada	Carleton University; Carleton University; Carleton University	Wong, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	alex.wong@carleton.ca		Green, James/0000-0002-6039-2355	Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery Grants to AW, JG, FD, and AG from the Natural Sciences and Engineering Research Council (NSERC). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2000, MOL CELL BIOL, V20, P8093, DOI 10.1128/MCB.20.21.8093-8102.2000; Amos-binks A., 2014, PERSONALIZED INTERAC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu M, 2009, METHODS MOL BIOL, V548, P187, DOI 10.1007/978-1-59745-540-4_11; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Brochado AR, 2013, HIGH THROUGHPUT APPR, P199; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Caudy AA, 2013, GENETICS, V195, P275, DOI 10.1534/genetics.113.152918; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Dutkowski J, 2013, J COMPUT BIOL, V20, P631, DOI 10.1089/cmb.2012.0295; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Jin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058134; Jordan IK, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-96; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kimura M., 1983, NEUTRAL THEORY MOL E; Knight CG, 2006, NAT GENET, V38, P1015, DOI 10.1038/ng1867; Knight CG, 2009, BIOESSAYS, V31, P1080, DOI 10.1002/bies.200900043; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lopez-Malo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060135; Makarova KS, 1999, GENOME RES, V9, P608; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Park Y, 2011, BIOINFORMATICS, V27, P3024, DOI 10.1093/bioinformatics/btr514; Park Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-419; Perez-Bercoff A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052581; Pitre S, 2008, NUCLEIC ACIDS RES, V36, P4286, DOI 10.1093/nar/gkn390; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Pitre S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00239; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Roemer T, 2012, NAT CHEM BIOL, V8, P46, DOI 10.1038/nchembio.744; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schoenrock A, MP PIPE MASSIVELY PA; Schoenrock A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0383-1; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Team RC, 2014, R LANG ENV STAT COMP; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	62	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171920	10.1371/journal.pone.0171920	http://dx.doi.org/10.1371/journal.pone.0171920			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248977	Green Published, gold			2022-12-27	WOS:000395983500021
J	Huber, T; Alber, G; Bette, S; Kaesmacher, J; Boeckh-Behrens, T; Gempt, J; Ringel, F; Specht, HM; Meyer, B; Zimmer, C; Wiestler, B; Kirschke, JS				Huber, Thomas; Alber, Georgina; Bette, Stefanie; Kaesmacher, Johannes; Boeckh-Behrens, Tobias; Gempt, Jens; Ringel, Florian; Specht, Hanno M.; Meyer, Bernhard; Zimmer, Claus; Wiestler, Benedikt; Kirschke, Jan S.			Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry	PLOS ONE			English	Article							BRAIN-TUMOR; REGISTRATION TECHNIQUES; RESPONSE ASSESSMENT; ADULT GLIOBLASTOMA; MRI; CRITERIA; SEGMENTATION; AGREEMENT; MULTIFORME; RESECTION	Purpose Unambiguous evaluation of glioblastoma (GB) progression is crucial, both for clinical trials as well as day by day routine management of GB patients. 3D-volumetry in the follow-up of GB provides quantitative data on tumor extent and growth, and therefore has the potential to facilitate objective disease assessment. The present study investigated the utility of absolute changes in volume (delta) or regional, segmentation-based subtractions for detecting disease progression in longitudinal MRI follow-ups. Methods 165 high resolution 3-Tesla MRIs of 30 GB patients (23m, mean age 60.2y) were retrospectively included in this single center study. Contrast enhancement (CV) and tumor-related signal alterations in FLAIR images (FV) were semi-automatically segmented. Delta volume (dCV, dFV) and regional subtractions (sCV, sFV) were calculated. Disease progression was classified for every follow-up according to histopathologic results, decisions of the local multidisciplinary CNS tumor board and a consensus rating of the neuro-radiologic report. Results A generalized logistic mixed model for disease progression (yes / no) with dCV, dFV, sCV and sFV as input variables revealed that only dCV was significantly associated with prediction of disease progression (P = .005). Delta volume had a better accuracy than regional, segmentation-based subtractions (79% versus 72%) and a higher area under the curve by trend in ROC curves (.83 versus .75). Conclusion Absolute volume changes of the contrast enhancing tumor part were the most accurate volumetric determinant to detect progressive disease in assessment of GB and outweighed FLAIR changes as well as regional, segmentation-based image subtractions. This parameter might be useful in upcoming objective response criteria for glioblastoma.	[Huber, Thomas; Alber, Georgina; Bette, Stefanie; Kaesmacher, Johannes; Boeckh-Behrens, Tobias; Zimmer, Claus; Wiestler, Benedikt; Kirschke, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany; [Huber, Thomas] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany; [Gempt, Jens; Ringel, Florian; Meyer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany; [Specht, Hanno M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, Munich, Germany	Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich	Kirschke, JS (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany.	jan.kirschke@tum.de	Meyer, Bernhard/AAH-3329-2019; Ringel, Florian/E-4933-2014; Kaesmacher, Johannes/I-6136-2019; Kirschke, Jan/E-2550-2012	Meyer, Bernhard/0000-0001-6486-7955; Kaesmacher, Johannes/0000-0002-9177-2289; Kirschke, Jan/0000-0002-7557-0003; Gempt, Jens/0000-0003-4123-4690; Wiestler, Benedikt/0000-0002-2963-7772	German Research Foundation (DFG); Technical University of Munich (TUM); KKF scholarship of the TUM	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM); KKF scholarship of the TUM	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. BW is supported through the KKF scholarship of the TUM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Bette S, 2016, WORLD NEUROSURG; Chow DS, 2014, AM J NEURORADIOL, V35, P498, DOI 10.3174/ajnr.A3724; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cordova JS, 2016, MOL IMAGING BIOL, V18, P454, DOI 10.1007/s11307-015-0900-2; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P401, DOI 10.1093/neuonc/noq206; Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005-005; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; Gibbs P, 1996, PHYS MED BIOL, V41, P2437, DOI 10.1088/0031-9155/41/11/014; Gzell CE, 2016, J NEURO-ONCOL, V128, P67, DOI 10.1007/s11060-016-2074-4; Hojjatoleslami SA, 1998, IEEE T IMAGE PROCESS, V7, P1079, DOI 10.1109/83.701170; Huber T, 2015, CLIN NEURORADIOL; Joe BN, 1999, RADIOLOGY, V212, P811, DOI 10.1148/radiology.212.3.r99se22811; Kanaly CW, 2014, J NEUROSURG, V121, P536, DOI 10.3171/2014.4.JNS121952; Kerkhof M, 2016, EUR J NEUROL; Kleesiek J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25007; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kubben PL, 2010, NEUROSURGERY, V67, P1329, DOI 10.1227/NEU.0b013e3181efbb08; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mazzara GP, 2004, INT J RADIAT ONCOL, V59, P300, DOI 10.1016/j.ijrobp.2004.01.026; Meier R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23376; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Porz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096873; Powell MJD, 2003, MATH PROGRAM, V97, P605, DOI 10.1007/s10107-003-0430-6; Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shah GD, 2006, NEURO-ONCOLOGY, V8, P38, DOI 10.1215/S1522851705000529; Szwarc P, 2015, COMPUT MED IMAG GRAP, V46, P178, DOI 10.1016/j.compmedimag.2015.06.002; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vos MJ, 2003, NEUROLOGY, V60, P826, DOI 10.1212/01.WNL.0000049467.54667.92; Wang MY, 2012, EUR J RADIOL, V81, P2370, DOI 10.1016/j.ejrad.2011.05.017; Wang MY, 2011, NEURORADIOLOGY, V53, P565, DOI 10.1007/s00234-010-0789-z; Weltens C, 2001, RADIOTHER ONCOL, V60, P49, DOI 10.1016/S0167-8140(01)00371-1; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WMA General Assembly, 1964, WORLD MED ASS DECL H; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173112	10.1371/journal.pone.0173112	http://dx.doi.org/10.1371/journal.pone.0173112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245291	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200056
J	Li, CC; Hou, YC; Yeh, CL; Yeh, SL				Li, Cheng-Chung; Hou, Yu-Chen; Yeh, Chiu-Li; Yeh, Sung-Ling			RETRACTION: Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages (Retraction of Vol 9, art no E99630, 2014)	PLOS ONE			English	Retraction																		Li CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099630	1	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173325	10.1371/journal.pone.0173325	http://dx.doi.org/10.1371/journal.pone.0173325			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245281	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200061
J	van Iperen, EPA; Hovingh, GK; Asselbergs, FW; Zwinderman, AH				van Iperen, E. P. A.; Hovingh, G. K.; Asselbergs, F. W.; Zwinderman, A. H.			Extending the use of GWAS data by combining data from different genetic platforms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; LOCI; VARIANTS	Background In the past decade many Genome-wide Association Studies (GWAS) were performed that discovered new associations between single-nucleotide polymorphisms (SNPs) and various phenotypes. Imputation methods are widely used in GWAS. They facilitate the phenotype association with variants that are not directly genotyped. Imputation methods can also be used to combine and analyse data genotyped on different genotyping arrays. In this study we investigated the imputation quality and efficiency of two different approaches of combining GWAS data from different genotyping platforms. We investigated whether combining data from different platforms before the actual imputation performs better than combining the data from different platforms after imputation. Methods In total 979 unique individuals from the AMC-PAS cohort were genotyped on 3 different platforms. A total of 706 individuals were genotyped on the MetaboChip, a total of 757 individuals were genotyped on the 50K gene-centric Human CVD BeadChip, and a total of 955 individuals were genotyped on the HumanExome chip. A total of 397 individuals were genotyped on all 3 individual platforms. After pre-imputation quality control (QC), Minimac in combination with MaCH was used for the imputation of all samples with the 1,000 genomes reference panel. All imputed markers with an r(2) value of <0.3 were excluded in our post-imputation QC. Results A total of 397 individuals were genotyped on all three platforms. All three datasets were carefully matched on strand, SNP ID and genomic coordinates. This resulted in a dataset of 979 unique individuals and a total of 258,925 unique markers. A total of 4,117,036 SNPs were available when imputation was performed before merging the three datasets. A total of 3,933,494 SNPs were available when imputation was done on the combined set. Our results suggest that imputation of individual datasets before merging performs slightly better than after combining the different datasets. Conclusions Imputation of datasets genotyped by different platforms before merging generates more SNPs than imputation after putting the datasets together.	[van Iperen, E. P. A.; Asselbergs, F. W.] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands; [van Iperen, E. P. A.; Zwinderman, A. H.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Hovingh, G. K.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Asselbergs, F. W.] UMC, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Asselbergs, F. W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	van Iperen, EPA (corresponding author), Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands.; van Iperen, EPA (corresponding author), Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands.	e.p.vaniperen@amc.uva.nl	Asselbergs, Folkert W./ABD-6752-2021	Asselbergs, Folkert W./0000-0002-1692-8669	Dekker scholarship [2014T001]; UCL Hospitals NIHR Biomedical Research Centre; Netherlands Organisation for Scientific Research (NWO) [016.156.445]; Cardiovascular Research Initiative [CVON-2011-19 Genius]; European Union [TransCard: FP7-3603091-2]	Dekker scholarship; UCL Hospitals NIHR Biomedical Research Centre; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Cardiovascular Research Initiative; European Union(European Commission)	Folkert W. Asselbergs is supported by a Dekker scholarship-Junior Staff Member 2014T001 - Netherlands Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre. Hovingh is holder of a VIDI grant (016.156.445) from the Netherlands Organisation for Scientific Research (NWO) and is supported by a grant from the Cardiovascular Research Initiative (CVON-2011-19 Genius) and the European Union (TransCard: FP7-3603091-2).; Folkert W. Asselbergs is supported by a Dekker scholarship-Junior Staff Member 2014T001 - Netherlands Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre.; G. Kees. Hovingh is holder of a VIDI grant (016.156.445) from the Netherlands Organisation for Scientific Research (NWO) and is supported by a grant from the Cardiovascular Research Initiative (CVON-2011-19 Genius) and the European Union (TransCard: FP7-3603091-2).	Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Southam L, 2011, EUR J HUM GENET, V19, P610, DOI 10.1038/ejhg.2010.242; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sung YJ, 2012, HUM HERED, V73, P18, DOI 10.1159/000334084; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Uh HW, 2012, EUR J HUM GENET, V20, P572, DOI 10.1038/ejhg.2011.231; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Zhang BS, 2011, STAT INTERFACE, V4, P339	17	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172082	10.1371/journal.pone.0172082	http://dx.doi.org/10.1371/journal.pone.0172082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245255	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200010
J	Maicas, N; van der Vlag, J; Bublitz, J; Florquin, S; Bakker-van Bebber, M; Dinarello, CA; Verweij, V; Masereeuw, R; Joosten, LA; Hilbrands, LB				Maicas, Nuria; van der Vlag, Johan; Bublitz, Janin; Florquin, Sandrine; Bakker-van Bebber, Marinka; Dinarello, Charles A.; Verweij, Vivienne; Masereeuw, Roos; Joosten, Leo A.; Hilbrands, Luuk B.			Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MOLECULE-1 EXPRESSION; INFLAMMATORY RESPONSE; AUGMENTATION THERAPY; ALLOGRAFT-REJECTION; NEUTROPHIL; BIOMARKER; KIM-1; GENE; PATHOPHYSIOLOGY	Several lines of evidence have demonstrated the anti-inflammatory and cytoprotective effects of alpha-1-antitrypsin (AAT), the major serum serine protease inhibitor. The aim of the present study was to investigate the effects of human AAT (hAAT) monotherapy during the early and recovery phase of ischemia-induced acute kidney injury. Mild renal ischemiareperfusion (I/R) injury was induced in male C57Bl/6 mice by bilateral clamping of the renal artery and vein for 20 min. hAAT (80 mg/kg, Prolastin ((R))) was administered daily intraperitoneally (i.p.) from day -1 until day 7 after surgery. Control animals received the same amount of human serum albumin (hAlb). Plasma, urine and kidneys were collected at 2h, 1, 2, 3, 8 and 15 days after reperfusion for histological and biochemical analysis. hAAT partially preserved renal function and tubular integrity after induction of bilateral kidney I/R injury, which was accompanied with reduced renal influx of macrophages and a significant decrease of neutrophil gelatinase-associated lipocalin (NGAL) protein levels in urine and plasma. During the recovery phase, hAAT significantly decreased kidney injury molecule-1 (KIM-1) protein levels in urine but showed no significant effect on renal fibrosis. Although the observed effect size of hAAT administration was limited and therefore the clinical relevance of our findings should be evaluated carefully, these data support the potential of this natural protein to ameliorate ischemic and inflammatory conditions.	[Maicas, Nuria; van der Vlag, Johan; Bublitz, Janin; Bakker-van Bebber, Marinka; Hilbrands, Luuk B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands; [Florquin, Sandrine] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands; [Dinarello, Charles A.; Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Dinarello, Charles A.] Univ Colorado, Hlth Sci Ctr Denver, Dept Med, Denver, CO 80202 USA; [Verweij, Vivienne] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; [Masereeuw, Roos] Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Radboud University Nijmegen; Utrecht University	Hilbrands, LB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.	Luuk.hilbrands@radboudumc.nl	Joosten, Leo AB/H-3138-2015; Van der Vlag, Johan/E-4636-2010; Verweij, Vivienne G.M/F-8447-2016; Masereeuw, Roos/N-3582-2014; Hilbrands, Luuk/B-4921-2011; Masereeuw, Roos/I-5276-2016; Dinarello, Charles/C-8524-2013	Joosten, Leo AB/0000-0001-6166-9830; Van der Vlag, Johan/0000-0001-7843-5918; Hilbrands, Luuk/0000-0002-4935-9765; Masereeuw, Roos/0000-0002-1560-1074; Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation [IP10.21]	Dutch Kidney Foundation	This study was supported by a grant from the Dutch Kidney Foundation (https://www.nierstichting.nl/). Project Code IP10.21 to LB Hilbrands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2015, AM J CARDIOL, V115, P8, DOI 10.1016/j.amjcard.2014.09.043; Alkhunaizi AM, 1996, AM J KIDNEY DIS, V28, P315, DOI 10.1016/S0272-6386(96)90487-4; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brunetti ND, 2007, EUR J INTERN MED, V18, P109, DOI 10.1016/j.ejim.2006.07.031; CARELL RW, 1990, LUNG, V168, P530, DOI 10.1007/BF02718175; Chung KY, 2008, TRANSPL P, V40, P2136, DOI 10.1016/j.transproceed.2008.06.040; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Dishart MK, 2000, DRUGS, V59, P79, DOI 10.2165/00003495-200059010-00005; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Gao WX, 2014, J HEART LUNG TRANSPL, V33, P309, DOI 10.1016/j.healun.2013.10.031; GILUTZ H, 1983, BRIT HEART J, V49, P26; Gottlieb PA, 2014, J CLIN ENDOCR METAB, V99, pE1418, DOI 10.1210/jc.2013-3864; Gotzsche PC, 2010, DAN MED BULL, V57; Grimstein C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-21; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Heyne N, 2012, TRANSPLANTATION, V93, P1252, DOI 10.1097/TP.0b013e31824fd892; Holzscheiter L, 2014, CLIN CHEM LAB MED, V52, P537, DOI 10.1515/cclm-2013-0693; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Kaner Z, 2015, J INFECT DIS, V211, P1489, DOI 10.1093/infdis/jiu620; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Kohei J, 2013, INT UROL NEPHROL, V45, P1159, DOI 10.1007/s11255-012-0321-y; Kuehn EW, 2002, AM J PHYSIOL-RENAL, V283, pF1326, DOI 10.1152/ajprenal.00166.2002; Kunzendorf U, 2010, DRUGS, V70, P1099, DOI 10.2165/11535890-000000000-00000; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Libert C, 1996, J IMMUNOL, V157, P5126; MASSI G, 1994, ACTA PAEDIATR, V83, P1, DOI 10.1111/j.1651-2227.1994.tb13197.x; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Petrache I, 2009, BIOL-TARGETS THER, V3, P193; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; RABB H, 1994, AM J PHYSIOL-RENAL, V267, pF1052, DOI 10.1152/ajprenal.1994.267.6.F1052; Rachmiel M, 2015, PEDIAT DIABETES; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; Rops AL, 2010, AM J PATHOL, V176, P2188, DOI 10.2353/ajpath.2010.090770; Schroppel B, 2010, J AM SOC NEPHROL, V21, P536, DOI 10.1681/ASN.2009040390; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; SOLEZ K, 1979, MEDICINE, V58, P362, DOI 10.1097/00005792-197909000-00003; Subramaniyam D, 2008, INT J BIOCHEM CELL B, V40, P258, DOI 10.1016/j.biocel.2007.07.016; THORNTON MA, 1989, AM J PATHOL, V135, P509; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; van Timmeren MM, 2007, TRANSPLANTATION, V84, P1625, DOI 10.1097/01.tp.0000295982.78039.ef; van Timmeren MM, 2006, AM J PHYSIOL-RENAL, V291, pF456, DOI 10.1152/ajprenal.00403.2005; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Waanders F, 2010, J PATHOL, V220, P7, DOI 10.1002/path.2642; Waikar SS, 2009, NEPHROL DIAL TRANSPL, V24, P3263, DOI 10.1093/ndt/gfp428; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Ye J, 2013, IMMUNOL LETT, V150, P61, DOI 10.1016/j.imlet.2013.01.009; Zager RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098380	64	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0168981	10.1371/journal.pone.0168981	http://dx.doi.org/10.1371/journal.pone.0168981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235038	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200003
J	Mouton, JP; Mehta, U; Rossiter, DP; Maartens, G; Cohen, K				Mouton, Johannes P.; Mehta, Ushma; Rossiter, Dawn P.; Maartens, Gary; Cohen, Karen			Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system	PLOS ONE			English	Article							DISAGREEMENT; KAPPA	Introduction A new method to assess causality of suspected adverse drug reactions, the Liverpool Adverse Drug Reaction Causality Assessment Tool (LCAT), showed high interrater agreement when used by its developers. Our aim was to compare the interrater agreement achieved by LCAT to that achieved by another causality assessment method, the World Health Organization-Uppsala Monitoring Centre system for standardised case causality assessment (WHO-UMC system), in our setting. Methods Four raters independently assessed adverse drug reaction causality of 48 drug-event pairs, identified during a hospital-based survey. A randomised design ensured that no washout period was required between assessments with the two methods. We compared the methods' interrater agreement by calculating agreement proportions, kappa statistics, and the intraclass correlation coefficient. We identified potentially problematic questions in the LCAT by comparing raters' responses to individual questions. Results Overall unweighted kappa was 0.61 (95% CI 0.43 to 0.80) on the WHO-UMC system and 0.27 (95% CI 0.074 to 0.46) on the LCAT. Pairwise unweighted Cohen kappa ranged from 0.33 to 1.0 on the WHO-UMC system and from 0.094 to 0.71 on the LCAT. The intraclass correlation coefficient was 0.86 (95% CI 0.74 to 0.92) on the WHO-UMC system and 0.61 (95% CI 0.39 to 0.77) on the LCAT. Two LCAT questions were identified as significant points of disagreement. Discussion We were unable to replicate the high interrater agreement achieved by the LCAT developers and instead found its interrater agreement to be lower than that achieved when using the WHO-UMC system. We identified potential reasons for this and recommend priority areas for improving the LCAT.	[Mouton, Johannes P.; Mehta, Ushma; Rossiter, Dawn P.; Maartens, Gary; Cohen, Karen] Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa	University of Cape Town	Cohen, K (corresponding author), Univ Cape Town, Div Clin Pharmacol, Dept Med, Cape Town, South Africa.	karen.cohen@uct.ac.za	Maartens, Gary/S-2788-2019; Cohen, Karen/D-4036-2017; Mouton, Hannes/U-5827-2019	Maartens, Gary/0000-0003-3080-6606; Mouton, Hannes/0000-0002-3511-1259; Mehta, Ushma/0000-0002-0032-3171; Cohen, Karen/0000-0002-1892-4207	US President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention (CDC) under terms of Cooperative [GGH000371]	US President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention (CDC) under terms of Cooperative	This research has been supported by the US President's Emergency Plan for AIDS Relief (PEPFAR, www.pepfar.gov) through the US Centers for Disease Control and Prevention (CDC, www.cdc.gov) under the terms of Cooperative Agreement Number GGH000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira V., 1999, QUESTIIO QUADERNS ES, V23, P561; Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Conroy EJ, 2015, INT J PHARM PRACT, V23, P447, DOI 10.1111/ijpp.12197; DAVIES EC, 2011, PHARM MED, V25, P17; de Vet HCW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2125; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093; HUTCHINSON TA, 1983, CLIN PHARMACOL THER, V34, P421, DOI 10.1038/clpt.1983.192; HUTCHINSON TA, 1989, J CLIN EPIDEMIOL, V42, P5, DOI 10.1016/0895-4356(89)90020-6; KOCHWESER J, 1977, EUR J CLIN PHARMACOL, V11, P75, DOI 10.1007/BF00562895; Kramer M. S., 1986, DRUG INF J, V20, P433, DOI DOI 10.1177/009286158602000409; KRAMER MS, 1979, JAMA-J AM MED ASSOC, V242, P623, DOI 10.1001/jama.242.7.623; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langerova P, 2014, BASIC CLIN PHARMACOL, V115, P560, DOI 10.1111/bcpt.12264; Lazaro J, 2008, KAPPA2 GEN WEIGHTED; LOUIK C, 1985, CLIN PHARMACOL THER, V38, P183, DOI 10.1038/clpt.1985.156; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Mouton JP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003437; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smyth R, 2014, PROGRAMME GRANTS APP, V2; Theophile H, 2013, DRUG SAFETY, V36, P1033, DOI 10.1007/s40264-013-0083-1; Uppsala Monitoring Centre, US WHO WMC SYST STAN	27	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172830	10.1371/journal.pone.0172830	http://dx.doi.org/10.1371/journal.pone.0172830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235001	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200148
J	Centellegher, S; Lopez, E; Saramaki, J; Lepri, B				Centellegher, Simone; Lopez, Eduardo; Saramaki, Jari; Lepri, Bruno			Personality traits and ego-network dynamics	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SOCIAL RELATIONSHIPS; SITUATIONS; HAPPINESS; CAPACITY; SIZE; TIME	Strong and supportive social relationships are fundamental to our well-being. However, there are costs to their maintenance, resulting in a trade-off between quality and quantity, a typical strategy being to put a lot of effort on a few high-intensity relationships while maintaining larger numbers of less close relationships. It has also been shown that there are persistent individual differences in this pattern; some individuals allocate their efforts more uniformly across their networks, while others strongly focus on their closest relationships. Furthermore, some individuals maintain more stable networks than others. Here, we focus on how personality traits of individuals affect this picture, using mobile phone calls records and survey data from the Mobile Territorial Lab (MTL) study. In particular, we look at the relationship between personality traits and the (i) persistence of social signatures, namely the similarity of the social signature shape of an individual measured in different time intervals; (ii) the turnover in egocentric networks, that is, differences in the set of alters present at two consecutive temporal intervals; and (iii) the rank dynamics defined as the variation of alter rankings in egocentric networks in consecutive intervals. We observe that some traits have effects on the stability of the social signatures as well as network turnover and rank dynamics. As an example, individuals who score highly in the Openness to Experience trait tend to have higher levels of network turnover and larger alter rank variations. On broader terms, our study shows that personality traits clearly affect the ways in which individuals maintain their personal networks.	[Centellegher, Simone] Univ Trento, Dept Informat Engn & Comp Sci, Trento, Italy; [Centellegher, Simone; Lepri, Bruno] FBK, Mobile & Social Comp Lab, Trento, Italy; [Lopez, Eduardo] Univ Oxford, Said Business Sch, CABDyN Complex Ctr, Oxford, England; [Lopez, Eduardo] George Mason Univ, Coll Sci, Dept Computat & Data Sci, Fairfax, VA 22030 USA; [Saramaki, Jari] Aalto Univ, Dept Comp Sci, Sch Sci, Espoo, Finland	University of Trento; Fondazione Bruno Kessler; University of Oxford; George Mason University; Aalto University	Centellegher, S (corresponding author), Univ Trento, Dept Informat Engn & Comp Sci, Trento, Italy.; Centellegher, S (corresponding author), FBK, Mobile & Social Comp Lab, Trento, Italy.	centellegher@fbk.eu	Saramaki, Jari P/E-5226-2011	Lopez, Eduardo/0000-0003-3940-2608				Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Alshamsi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152358; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bernard HR., 1973, SOCIAL SCI RES, V2, P145, DOI [10.1016/0049-089X(73)90016-1, DOI 10.1016/0049-089X(73)90016-1]; Centellegher S, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0064-6; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P580, DOI 10.1037/0022-3514.47.3.580; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Friggeri A, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P195, DOI 10.1109/SocialCom-PASSAT.2012.104; Funder DC, 2006, J RES PERS, V40, P21, DOI 10.1016/j.jrp.2005.08.003; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Graziano W. G., 2009, HDB INDIVIDUAL DIFFE, P46, DOI DOI 10.1037/0022-3514.50.1.212; Hansen MT, 2001, RES SOC ORG, V18, P21; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Matthews G, 2009, THEOR ISS ERGON SCI, V10, P417, DOI 10.1080/14639220903106395; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miritello G, 2013, SCI REPORTS, P3; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Perry-Smith JE, 2006, ACAD MANAGE J, V49, P85, DOI 10.2307/20159747; Perugini M, 2002, THE BIG FIVE MARKER; Powell J, 2012, P ROY SOC B-BIOL SCI, V279, P2157, DOI 10.1098/rspb.2011.2574; Quercia D, 2012, P ACM 2012 C COMP SU, P955, DOI DOI 10.1145/2145204.2145346; Reis HT, 2000, PERS SOC PSYCHOL B, V26, P419, DOI 10.1177/0146167200266002; Roberts SGB, 2011, PERS RELATIONSHIP, V18, P439, DOI 10.1111/j.1475-6811.2010.01310.x; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Sandstrom GM, 2014, PERS SOC PSYCHOL B, V40, P910, DOI 10.1177/0146167214529799; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Southerton D, 2003, TIME SOC, V12, P5, DOI 10.1177/0961463X03012001356; Staiano J, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P321; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Swickert RJ, 2002, PERS INDIV DIFFER, V32, P877, DOI 10.1016/S0191-8869(01)00093-9; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; Tov W, 2014, J PERSONALITY, V84; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Wilt J., 2009, HDB INDIVIDUAL DIFFE; Winship C., 1978, SOCIOL METHODOL, V9, P75	47	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173110	10.1371/journal.pone.0173110	http://dx.doi.org/10.1371/journal.pone.0173110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253333	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300079
J	Kim, MH; Lee, KY; Park, S; Kim, SI; Park, HS; Yoo, YC				Kim, Myoung Hwa; Lee, Ki Young; Park, Seho; Kim, Seung Il; Park, Hyung Seok; Yoo, Young Chul			Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial	PLOS ONE			English	Article							PERIOPERATIVE INTRAVENOUS LIDOCAINE; ABDOMINAL-SURGERY; PERSISTENT PAIN; MASTECTOMY; QUALITY; METAANALYSIS; ANALGESIA; QUESTIONNAIRE; ANESTHESIA; VALIDITY	Introduction We aimed to compare the effects of intraoperative lidocaine and magnesium on postoperative functional recovery and chronic pain after mastectomy due to breast cancer. Systemic lidocaine and magnesium reduce pain hypersensitivity to surgical stimuli; however, their effects after mastectomy have not been evaluated clearly. Methods In this prospective, double-blind, clinical trial, 126 female patients undergoing mastectomy were randomly assigned to lidocaine (L), magnesium (M), and control (C) groups. Lidocaine and magnesium were administered at 2 mg/kg and 20 mg/kg for 15 minutes immediately after induction, followed by infusions of 2 mg/kg/h and 20 mg/kg/h, respectively. The control group received the same volume of saline. Patient characteristics, perioperative parameters, and postoperative recovery profiles, including the Quality of Recovery 40 (QoR-40) survey, pain scales, length of hospital stay, and the short-form McGill pain questionnaire (SF-MPQ) at postoperative 1 month and 3 months were evaluated. Results The global QoR-40 scores on postoperative day 1 were significantly higher in group L than in group C (P = 0.003). Moreover, in sub-scores of the QoR-40 dimensions, emotional state and pain scores were significantly higher in group L than those in groups M and C (P = 0.027 and 0.023, respectively). At postoperative 3 months, SF-MPQ and SF-MPQ-sensitive scores were significantly lower in group L than in group C (P = 0.046 and 0.036, respectively). Conclusions Intraoperative infusion of lidocaine improved the quality of recovery and attenuated the intensity of chronic pain in patients undergoing breast cancer surgery.	[Kim, Myoung Hwa; Lee, Ki Young; Yoo, Young Chul] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, 50-1 Yonsei Ro, Seoul, South Korea; [Kim, Myoung Hwa; Lee, Ki Young; Yoo, Young Chul] Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, 50-1 Yonsei Ro, Seoul, South Korea; [Park, Seho; Kim, Seung Il; Park, Hyung Seok] Yonsei Univ, Coll Med, Dept Surg, Div Breast Surg, 50-1 Yonsei Ro, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoo, YC (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, 50-1 Yonsei Ro, Seoul, South Korea.; Yoo, YC (corresponding author), Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, 50-1 Yonsei Ro, Seoul, South Korea.	SEAOYSTER@yuhs.ac		Park, Seho/0000-0001-8089-2755; Kim, Myounghwa/0000-0003-4723-9425; Yoo, Young Chul/0000-0002-6334-7541; Park, Hyung Seok/0000-0001-5322-6036; Lee, Ki-Young/0000-0003-4893-3195				Albrecht E, 2013, ANAESTHESIA, V68, P79, DOI 10.1111/j.1365-2044.2012.07335.x; Amaya F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/641508; Andreae MH, 2013, BRIT J ANAESTH, V111, P711, DOI 10.1093/bja/aet213; Arnaud S, 2016, J CLIN ANESTH, V33, P20, DOI [10.1016/j.jclinane.2015.07.010, DOI 10.1016/J.JCLINANE.2015.07.010]; Bashandy GMN, 2015, REGION ANESTH PAIN M, V40, P68, DOI 10.1097/AAP.0000000000000163; Chang YC, 2016, PAIN PRACT IN PRESS; Chiu M, 2014, ANN SURG ONCOL, V21, P795, DOI 10.1245/s10434-013-3334-6; Choi SA, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-014-0195-z; De Oliveira GS, 2013, MAGNESIUM RES, V26, P156, DOI 10.1684/mrh.2014.0349; Dube L, 2003, CAN J ANAESTH, V50, P732, DOI 10.1007/BF03018719; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Grigoras A, 2012, CLIN J PAIN, V28, P567, DOI 10.1097/AJP.0b013e31823b9cc8; Herrera FJ, 2007, ANESTH ANALG, V105, P63, DOI 10.1213/01.ane.0000265534.73169.95; Hollmann MW, 2005, ANESTHESIOLOGY, V103, P1066, DOI 10.1097/00000542-200511000-00022; Hollmann MW, 2000, ANESTHESIOLOGY, V93, P858, DOI 10.1097/00000542-200009000-00038; Kaba A, 2007, ANESTHESIOLOGY, V106, P11, DOI 10.1097/00000542-200701000-00007; Kim SH, 2013, MINERVA ANESTESIOL, V79, P1248; Koppert W, 2004, ANESTH ANALG, V98, P1050, DOI 10.1213/01.ANE.0000104582.71710.EE; Koppert W, 2000, PAIN, V85, P217, DOI 10.1016/S0304-3959(99)00268-7; Kosharskyy B, 2013, PAIN PHYSICIAN, V16, P231; Lee A, 1996, ANAESTH INTENS CARE, V24, P685, DOI 10.1177/0310057X9602400610; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Macrae WA, 2001, BRIT J ANAESTH, V87, P88, DOI 10.1093/bja/87.1.88; Marret E, 2008, BRIT J SURG, V95, P1331, DOI 10.1002/bjs.6375; Mason Shawn T, 2008, Eplasty, V8, pe54; Myles PS, 1999, ANESTH ANALG, V88, P83, DOI 10.1097/00000539-199901000-00016; Myles PS, 2000, BRIT J ANAESTH, V84, P11, DOI 10.1093/oxfordjournals.bja.a013366; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Saadawy IM, 2010, ACTA ANAESTH SCAND, V54, P549, DOI 10.1111/j.1399-6576.2009.02165.x; Smith WCS, 1999, PAIN, V83, P91, DOI 10.1016/S0304-3959(99)00076-7; Tasmuth T, 1996, PAIN, V68, P343, DOI 10.1016/S0304-3959(96)03219-8; Terkawi AS, 2014, REGION ANESTH PAIN M, V39, P472, DOI 10.1097/AAP.0000000000000140; Tramer MR, 1996, ANESTHESIOLOGY, V84, P340, DOI 10.1097/00000542-199602000-00011; Vigneault L, 2011, CAN J ANESTH, V58, P22, DOI 10.1007/s12630-010-9407-0; Wright KD, 2001, EUR J PAIN, V5, P279, DOI 10.1053/eujp.2001.0243	35	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173026	10.1371/journal.pone.0173026	http://dx.doi.org/10.1371/journal.pone.0173026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253307	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300060
J	Cai, FC; Xiao, XY; Niu, X; Zhong, Y				Cai, Fucheng; Xiao, Xiyue; Niu, Xun; Zhong, Yi			Association between promoter methylation of DAPK lgene and HNSCC: A meta-analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROTEIN-KINASE; HYPERMETHYLATION; TUMOR; GENES; HEAD; APOPTOSIS; TIMP3; MGMT; P16	Background The death-associated protein kinase (DAPK) is a tumor suppressor gene, which is a mediator of cell death of INF-gamma-induced apoptosis. Aberrant methylation of DAPK promoter has been reported in patients with head and neck squamous cell carcinoma (HNSCC). However, the results of these studies are inconsistent. Hence, the present study aimed to evaluate the association between the promoter methylation of DAPK gene and HNSCC. Methods Relevant studies were systematically searched in PubMed, Web of Science, Ovid, and Embase. The association between DAPK promoter methylation and HNSCC was assessed by odds ratio (ORs) and 95% confidence intervals (CI). To evaluate the potential sources of heterogeneity, we conducted the meta-regression analysis and subgroup analysis. Results Eighteen studies were finally included in the meta-analysis. The frequency of DAPK promoter methylation in patients with HNSCC was 4.09-fold higher than the non-cancerous controls (OR = 3.96, 95% CI = 2.26-6.95). A significant association between DAPK promoter methylation and HNSCC was found among the Asian region and the Non-Asia region (Asian region, OR = 4.43, 95% CI = 2.29-8.58; Non-Asia region, OR = 3.39, 95% CI = 1.18-9.78). In the control source, the significant association between DAPK promoter methylation and HNSCC was seen among the autologous group and the heterogeneous group (autologous group, OR = 2.71, 95% CI = 1.49-4.93; heterogeneous group, OR = 9.50, 95% CI = 2.98 - 30.27). DAPK promoter methylation was significantly correlated with alcohol status (OR = 1.85, 95% CI = 1.07-3.21). Conclusion The results of this meta-analysis suggested that aberrant methylation of DAPK promoter was associated with HNSCC.	[Cai, Fucheng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China; [Xiao, Xiyue] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Niu, Xun; Zhong, Yi] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Otorhinolaryngol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhong, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Otorhinolaryngol, Wuhan, Peoples R China.	zyzy0411@163.com		Zhong, Yi/0000-0002-7138-5302	National Nature Science Foundation of China [81200745, 81501297]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 81200745 and No. 81501297). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes LMRB, 2015, EUR J CANCER, V51, P632, DOI 10.1016/j.ejca.2015.01.060; Bai J, 2016, ONCOTARGET; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Choudhury JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129808; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; Cohen O, 1999, J CELL BIOL, V146, P141; De Schutter H, 2009, ONCOL REP, V21, P507, DOI 10.3892/or_00000251; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fackler MJ, 2006, CLIN CANCER RES, V12, P3306, DOI 10.1158/1078-0432.CCR-05-2733; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Guerrero-Preston R, 2014, EPIGENETICS-US, V9, P1031, DOI 10.4161/epi.29025; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Ioannidis JP, PRISMA STATEMENT REP; Kong WJ, 2005, LARYNGOSCOPE, V115, P1395, DOI 10.1097/01.MLG.0000166708.23673.3A; Kulkarni V, 2004, ORAL ONCOL, V40, P145, DOI 10.1016/S1368-8375(03)00143-X; Laytragoon-Lewin N, 2010, ANTICANCER RES, V30, P4643; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li CY, 2013, ONCOL LETT, V6, P280, DOI 10.3892/ol.2013.1353; Liu Y, 2012, MED ONCOL, V29, P729, DOI 10.1007/s12032-011-9953-5; Misawa K, 2016, ONCOTARGET; Misawa Y, 2014, CANCER-AM CANCER SOC, V120, P205, DOI 10.1002/cncr.28411; Niklinska W, 2009, FOLIA HISTOCHEM CYTO, V47, P275, DOI 10.2478/v10042-009-0091-2; Ogi K, 2002, CLIN CANCER RES, V8, P3164; Paluszczak J, 2011, ORAL ONCOL, V47, P104, DOI 10.1016/j.oraloncology.2010.11.006; Pierini S, 2014, HEAD NECK-J SCI SPEC, V36, P1103, DOI 10.1002/hed.23413; Rettori MM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-316; Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Su PF, 2010, ORAL ONCOL, V46, P734, DOI 10.1016/j.oraloncology.2010.07.002; Supic G, 2009, ORAL ONCOL, V45, P1051, DOI 10.1016/j.oraloncology.2009.07.007; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200; Wang WM, 2016, ONCOL REP, V35, P139, DOI 10.3892/or.2015.4347; Wong YK, 2011, J DENT SCI, V6, P158, DOI 10.1016/j.jds.2011.05.006	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173194	10.1371/journal.pone.0173194	http://dx.doi.org/10.1371/journal.pone.0173194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249042	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500081
J	Lu, T; Zhang, Y; Kidane, Y; Feiveson, A; Stodieck, L; Karouia, F; Ramesh, G; Rohde, L; Wu, HL				Lu, Tao; Zhang, Ye; Kidane, Yared; Feiveson, Alan; Stodieck, Louis; Karouia, Fathi; Ramesh, Govindarajan; Rohde, Larry; Wu, Honglu			Cellular responses and gene expression profile changes due to bleomycin-induced DNA damage in human fibroblasts in space	PLOS ONE			English	Article							MODELED MICROGRAVITY; HUMAN-LYMPHOCYTES; SIMULATED MICROGRAVITY; IONIZING-RADIATION; IN-VITRO; X-RAY; REPAIR; CELLS; IRRADIATION; ABERRATIONS	Living organisms in space are constantly exposed to radiation, toxic chemicals or reactive oxygen species generated due to increased levels of environmental and psychological stresses. Understanding the impact of spaceflight factors, microgravity in particular, on cellular responses to DNA damage is essential for assessing the radiation risk for astronauts and the mutation rate in microorganisms. In a study conducted on the International Space Station, confluent human fibroblasts in culture were treated with bleomycin for three hours in the true microgravity environment. The degree of DNA damage was quantified by immunofluorescence staining for gamma-H2AX, which is manifested in three types of staining patterns. Although similar percentages of these types of patterns were found between flight and ground cells, there was a slight shift in the distribution of foci counts in the flown cells with countable numbers of gamma-H2AX foci. Comparison of the cells in confluent and in exponential growth conditions indicated that the proliferation rate between flight and the ground may be responsible for such a shift. We also performed a microarray analysis of gene expressions in response to bleomycin treatment. A qualitative comparison of the responsive pathways between the flown and ground cells showed similar responses with the p53 network being the top upstream regulator. The microarray data was confirmed with a PCR array analysis containing a set of genes involved in DNA damage signaling; with BBC3, CDKN1A, PCNA and PPM1D being significantly upregulated in both flight and ground cells after bleomycin treatment. Our results suggest that whether microgravity affects DNA damage response in space can be dependent on the cell type and cell growth condition.	[Lu, Tao; Kidane, Yared; Feiveson, Alan; Wu, Honglu] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Lu, Tao; Rohde, Larry] Univ Houston Clear Lake, Houston, TX USA; [Zhang, Ye] NASA, Kennedy Space Ctr, Houston, TX USA; [Kidane, Yared] Wyle Labs, Houston, TX USA; [Stodieck, Louis] BioServe Space Technol, Boulder, CO USA; [Karouia, Fathi] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ramesh, Govindarajan] Norfolk State Univ, Norfolk, VA USA	National Aeronautics & Space Administration (NASA); University of Houston System; University of Houston; University of Houston Clear Lake; National Aeronautics & Space Administration (NASA); University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Norfolk State University	Wu, HL (corresponding author), NASA, Johnson Space Ctr, Houston, TX 77058 USA.	honglu.wu-1@nasa.gov		Karouia, Fathi/0000-0002-1142-9684	NASA Fundamental Space Biology Program; BioServe Space Technologies; NASA	NASA Fundamental Space Biology Program; BioServe Space Technologies; NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Fundamental Space Biology Program. The project was supported by BioServe Space Technologies. We thank Ashleigh Ruggles and Satyanand Narayan of NASA Kennedy Space Center, and Kevin Sato of NASA Ames Research Center for the support during various phases of the project. This study involved participation of personnel from two commercial companies, Wyle Laboratories and BioServe. Wyle Laboratories is a NASA contractor and employs one of the coauthors (YZ). YZ performed the gene expression data analysis for the study. BioServe (LS) was the implementation partner for this spaceflight study and received funds from NASA to support the project. LS was responsible for the hardware development, and contributed to the study design. NASA was the funding agency of the study. The funder provided support in the form of salaries for TL, YZ, YK, AF, LS, FK, and HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016427; Araki T, 1998, BRAIN RES, V794, P239, DOI 10.1016/S0006-8993(98)00231-5; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; BENDER MA, 1967, RADIAT RES, V31, P91, DOI 10.2307/3572163; BENDER MA, 1968, RADIAT RES, V34, P228, DOI 10.2307/3572468; Biswas AK, 2014, CANCER RES, V74, P3369, DOI 10.1158/0008-5472.CAN-13-3216; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chylack LT, 2009, RADIAT RES, V172, P10, DOI 10.1667/RR1580.1; Cooper D, 1998, J LEUKOCYTE BIOL, V63, P550, DOI 10.1002/jlb.63.5.550; CORNFORTH MN, 1983, SCIENCE, V222, P1141, DOI 10.1126/science.6648528; Cucinotta FA, 2001, RADIAT RES, V156, P460, DOI 10.1667/0033-7587(2001)156[0460:SRACIA]2.0.CO;2; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; George K, 2001, INT J RADIAT BIOL, V77, P175, DOI 10.1080/0955300001003760; Gimonet D, 2004, INT J ONCOL, V24, P313; Greco O, 2003, ADV SPACE RES, V31, P1495, DOI 10.1016/S0273-1177(03)00087-5; Greene W.H., 2007, ECONOMETRIC ANAL; HARPER JW, 1993, CELL, V75, P805; Hawkey A, 2003, JBIS-J BRIT INTERPLA, V56, P152; Horneck G, 1999, MUTAT RES-FUND MOL M, V430, P221, DOI 10.1016/S0027-5107(99)00133-5; Horneck G, 1996, J BIOTECHNOL, V47, P99, DOI 10.1016/0168-1656(96)01382-X; Ishizaki K, 2001, AVIAT SPACE ENVIR MD, V72, P794; Lee YS, 2010, J BIOCHEM MOL TOXIC, V24, P260, DOI 10.1002/jbt.20334; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Manti L, 2005, INT J RADIAT BIOL, V81, P147, DOI 10.1080/09553000500091188; Mao XW, 2016, RADIAT RES, V185, P647, DOI 10.1667/RR14267.1; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; Mladenov E, 2009, RADIAT RES, V171, P397, DOI 10.1667/RR1487.1; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Moroni M, 2013, INT J MOL SCI, V14, P14119, DOI 10.3390/ijms140714119; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Obe G, 1997, INT J RADIAT BIOL, V72, P727, DOI 10.1080/095530097142889; Okudela K, 1999, AM J PATHOL, V155, P1341, DOI 10.1016/S0002-9440(10)65236-4; PINSKY LS, 1975, SCIENCE, V188, P928, DOI 10.1126/science.188.4191.928; Pross HD, 1999, RADIAT ENVIRON BIOPH, V38, P133, DOI 10.1007/s004110050149; PROSS HD, 1994, ADV SPACE RES, V14, P125, DOI 10.1016/0273-1177(94)90461-8; Pross HD, 2000, RADIAT RES, V153, P521, DOI 10.1667/0033-7587(2000)153[0521:IARODD]2.0.CO;2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Scarpato R, 2013, MUTAGENESIS, V28, P465, DOI 10.1093/mutage/get024; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; TOBIAS CA, 1971, NATURE, V230, P596, DOI 10.1038/230596a0; Tomilin NV, 2001, RADIAT RES, V156, P347, DOI 10.1667/0033-7587(2001)156[0347:VOFNSO]2.0.CO;2; Wei LJ, 2012, MICROGRAVITY SCI TEC, V24, P335, DOI 10.1007/s12217-012-9324-7; Wu H, 2006, RADIAT RES, V166, P583, DOI 10.1667/RR0535.1; Wu H, 2001, PHYS MEDICA, V17, P229; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Yang TC, 1997, RADIAT RES, V148, pS17, DOI 10.2307/3579712; Zhang Y, 2016, FASEB J, V30, P2211, DOI 10.1096/fj.201500121	52	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170358	10.1371/journal.pone.0170358	http://dx.doi.org/10.1371/journal.pone.0170358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248986	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500003
J	Saiwaew, S; Sritabal, J; Piaraksa, N; Keayarsa, S; Ruengweerayut, R; Utaisin, C; Sila, P; Niramis, R; Udomsangpetch, R; Charunwatthana, P; Pongponratn, E; Pukrittayakamee, S; Leitgeb, AM; Wahlgren, M; Lee, SJ; Day, NPJ; White, NJ; Dondorp, AM; Chotivanich, K				Saiwaew, Somporn; Sritabal, Juntima; Piaraksa, Nattaporn; Keayarsa, Srisuda; Ruengweerayut, Ronnatrai; Utaisin, Chirapong; Sila, Patima; Niramis, Rangsan; Udomsangpetch, Rachanee; Charunwatthana, Prakaykaew; Pongponratn, Emsri; Pukrittayakamee, Sasithon; Leitgeb, Anna M.; Wahlgren, Mats; Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.; Chotivanich, Kesinee			Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1 PFEMP1; MICROVASCULAR ENDOTHELIAL-CELLS; MULTIPLE ADHESION MOLECULES; HUMAN CEREBRAL MALARIA; IN-VITRO; PARASITIZED ERYTHROCYTES; HEPARAN-SULFATE; UNCOMPLICATED MALARIA; SEQUESTRATION; RECEPTOR	In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette formation) contribute to microcirculatory flow obstruction in vital organs. Heparin can reverse the underlying ligand-receptor interactions, but may increase the bleeding risks. As a heparin-derived polysaccharide, sevuparin has been designed to retain anti-adhesive properties, while the antithrombin-binding domains have been eliminated, substantially diminishing its anticoagulant activity. Sevuparin has been evaluated recently in patients with uncomplicated falciparum malaria, and is currently investigated in a clinical trial for sickle cell disease. The effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum isolates from Thailand were investigated. Trophozoite stages of P. falciparum-infected RBCs (Pf-iRBCs) were cultured from 49 patients with malaria. Pf-iRBCs were treated with sevuparin at 37 degrees C and assessed in rosetting and in cytoadhesion assays with human dermal microvascular endothelial cells (HDMECs) under static and flow conditions. The proportion of Pf-iRBCs forming rosettes ranged from 6.5% to 26.0% (median = 12.2%). Rosetting was dose dependently disrupted by sevuparin (50% disruption by 250 mu g/mL). Overall 57% of P. falciparum isolates bound to HDMECs under static conditions; median (interquartile range) Pf-iRBC binding was 8.5 (3.0-38.0) Pf-iRBCs/1000 HDMECs. Sevuparin in concentrations >= 100 mu g/mL inhibited cytoadherence. Sevuparin disrupts P. falciparum rosette formation in a dose dependent manner and inhibits cytoadherence to endothelial cells. The data support assessment of sevuparin as an adjunctive treatment to the standard therapy in severe falciparum malaria.	[Saiwaew, Somporn; Sritabal, Juntima; Piaraksa, Nattaporn; Keayarsa, Srisuda; Charunwatthana, Prakaykaew; Pukrittayakamee, Sasithon; Chotivanich, Kesinee] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Ruengweerayut, Ronnatrai] Mae Sot Hosp, Mae Sot, Tak, Thailand; [Utaisin, Chirapong; Sila, Patima] Mae Ramat Hosp, Mae Ramat, Tak, Thailand; [Niramis, Rangsan] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Pongponratn, Emsri] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Leitgeb, Anna M.] Dilaforette AB, Stockholm, Sweden; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Lee, Sue J.; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol University; Mahidol University; Mahidol University; Karolinska Institutet; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Chotivanich, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	nok@tropmedres.ac	White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Thailand Research Fund for The Royal Golden Jubilee Ph.D programme [PHD/0231/2552]; Wellcome Trust of Great Britain, United Kingdom	Thailand Research Fund for The Royal Golden Jubilee Ph.D programme; Wellcome Trust of Great Britain, United Kingdom	This study was supported by Thailand Research Fund for The Royal Golden Jubilee Ph.D programme (PHD/0231/2552)-(Main part of the study); this funder had no input on the study design, execution, analysis, or writing of the manuscript. Faculty of Tropical Medicine, Mahidol University, Mahidol-Oxford research unit (MORU), Bangkok, Thailand (this funder had no input on the study design, execution, analysis, or writing of the manuscript) funded by the Wellcome Trust of Great Britain, United Kingdom (this funder had no input on the study design, execution, analysis, or writing of the manuscript), and the Swedish Research Council (VR) (designed the experiments), the Swedish Foundation for Strategic Research (SSF) (designed the experiments), and the Swedish International Development Agency (SIDA) (designed the experiments). Dilaforette AB (designed the experiments, wrote the paper).	Abdi AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19882; Adams Y, 2005, PARASITOL RES, V97, P290, DOI 10.1007/s00436-005-1426-3; Adams Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073999; Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Barragan A, 1999, EXP PARASITOL, V91, P133, DOI 10.1006/expr.1998.4349; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bull PC, 2016, PARASITOLOGY, V143, P171, DOI 10.1017/S0031182015001274; CARLSON J, 1992, AM J TROP MED HYG, V46, P595, DOI 10.4269/ajtmh.1992.46.595; CARLSON J, 1993, SCAND J INFECT DIS, P1; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; JAROONVESAMA N, 1972, LANCET, V1, P221; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Lindgren M, 2015, J THROMB HAEMOST, V13, P369; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; MUNIR M, 1976, Paediatrica Indonesiana, V16, P489; MUNIR M, 1980, Paediatrica Indonesiana, V20, P47; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; PONGPONRATN E, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P219; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Rampengan T H, 1991, Paediatr Indones, V31, P59; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SHEEHY TW, 1967, ANN INTERN MED, V66, P807, DOI 10.7326/0003-4819-66-4-807; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Skidmore MA, 2008, J MED CHEM, V51, P1453, DOI 10.1021/jm701337t; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; SMITSKAM.H, 1971, BRIT MED J, V1, P714, DOI 10.1136/bmj.1.5751.714; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stevenson L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005022; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Udomsangpetch R, 1996, BLOOD, V88, P2754, DOI 10.1182/blood.V88.7.2754.bloodjournal8872754; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Vogt AM, 2004, BIOCHEM J, V381, P593, DOI 10.1042/BJ20040762; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; Xiao LH, 1996, INFECT IMMUN, V64, P1373, DOI 10.1128/IAI.64.4.1373-1378.1996; Xiao LH, 1996, EXP PARASITOL, V84, P42, DOI 10.1006/expr.1996.0088; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841	66	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172718	10.1371/journal.pone.0172718	http://dx.doi.org/10.1371/journal.pone.0172718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249043	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500052
J	Farre, N; Vela, E; Cleries, M; Bustins, M; Cainzos-Achirica, M; Enjuanes, C; Moliner, P; Ruiz, S; Verdu-Rotellar, JM; Comin-Colet, J				Farre, Nuria; Vela, Emili; Cleries, Montse; Bustins, Montse; Cainzos-Achirica, Miguel; Enjuanes, Cristina; Moliner, Pedro; Ruiz, Sonia; Maria Verdu-Rotellar, Jose; Comin-Colet, Josep			Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; SUBSEQUENT MORTALITY; RISK-STRATIFICATION; HOSPITALIZATION; CARE; READMISSION; IMPACT; PREDICTORS; MORBIDITY; COMORBIDITIES	Background Heart failure (HF) is frequent and its prevalence is increasing. We aimed to evaluate the epidemiologic features of HF patients, the 1-year follow-up outcomes and the independent predictors of those outcomes at a population level. Methods and results Population-based longitudinal study including all prevalent HF cases in Catalonia (Spain) on December 31st, 2012. Patients were divided in 3 groups: patients without a previous HF hospitalization, patients with a remote (>1 year) HF hospitalization and patients with a recent (<1 year) HF admission. We analyzed 1year all-cause and HF hospitalizations, and all-cause mortality. Logistic regression was used to identify the independent predictors of each of those outcomes. A total of 88,195 patients were included. Mean age was 77 years, 55% were women. Comorbidities were frequent. Fourteen percent of patients had never been hospitalized, 71% had a remote HF hospitalization and 15% a recent hospitalization. At 1year follow-up, all-cause and HF hospitalization were 53% and 8.8%, respectively. One-year all-cause mortality rate was 14%, and was higher in patients with a recent HF hospitalization (24%). The presence of diabetes mellitus, atrial fibrillation or chronic kidney disease was independently associated with all-cause and HF hospitalization and all-cause mortality. Hospital admissions and emergency department visits the previous year were also found to be independently associated with the three study outcomes. Conclusions Outcomes are different depending on the HF population studied. Some comorbidity, an all-cause hospitalization or emergency department visit the previous year were associated with a worse outcome.	[Farre, Nuria; Enjuanes, Cristina; Moliner, Pedro; Ruiz, Sonia] Hosp Mar, Dept Cardiol, Heart Failure Programme, Barcelona, Spain; [Farre, Nuria; Enjuanes, Cristina; Moliner, Pedro; Ruiz, Sonia; Maria Verdu-Rotellar, Jose; Comin-Colet, Josep] IMIM Hosp Mar Med Res Inst, Heart Dis Biomed Res Grp, Barcelona, Spain; [Farre, Nuria; Enjuanes, Cristina; Ruiz, Sonia; Maria Verdu-Rotellar, Jose; Comin-Colet, Josep] Univ Autonoma Barcelona, Sch Med, Barcelona, Spain; [Vela, Emili; Cleries, Montse; Bustins, Montse] Anal Demand & Act Div, Catalan Hlth Serv, Barcelona, Spain; [Cainzos-Achirica, Miguel] Johns Hopkins Med Inst, Dept Cardiol, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; [Cainzos-Achirica, Miguel] Johns Hopkins Univ, Welch Ctr Prevent, Epidemiol & Clin Res, Baltimore, MD USA; [Maria Verdu-Rotellar, Jose] Jordi Gol Primary Care Res Inst, Catalan Inst Heath, Barcelona, Spain; [Comin-Colet, Josep] Univ Hosp Bellvitge, Hospitalet Llobregat, Dept Cardiol, Heart Failure Program, Barcelona, Spain; [Comin-Colet, Josep] Univ Barcelona, Sch Med, Hospitalet Llobregat, Dept Clin Sci, Barcelona, Spain; [Comin-Colet, Josep] IDIBELL Bellvitge Biomed Res Inst, Hospitalet Llobregat, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Farre, N (corresponding author), Hosp Mar, Dept Cardiol, Heart Failure Programme, Barcelona, Spain.; Farre, N (corresponding author), IMIM Hosp Mar Med Res Inst, Heart Dis Biomed Res Grp, Barcelona, Spain.; Farre, N (corresponding author), Univ Autonoma Barcelona, Sch Med, Barcelona, Spain.	NFarreLopez@parcdesalutmar.cat	Ruiz, Sonia/GRK-0102-2022; Enjuanes, Cristina/ABG-2302-2020; Comin-Colet, Josep/AAM-3000-2021; Farre, Nuria/I-2668-2019; Bustillo, Sonia Ruiz/AAC-1329-2020	Enjuanes, Cristina/0000-0002-7916-1223; Comin-Colet, Josep/0000-0001-8780-720X; Farre, Nuria/0000-0003-3110-6572; Bustillo, Sonia Ruiz/0000-0002-6074-914X; Vela, Emili/0000-0002-8736-5365; Moliner Borja, Pedro/0000-0002-5511-8597	Spanish Society of Cardiology	Spanish Society of Cardiology	Miguel Cainzos-Achirica was funded by a research grant from the Spanish Society of Cardiology.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Sanchez MA, 2008, REV ESP CARDIOL, V61, P1041, DOI 10.1016/S1885-5857(09)60007-4; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Au AG, 2012, AM HEART J, V164, P365, DOI 10.1016/j.ahj.2012.06.010; Avaldi VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127796; Babayan ZV, 2003, CLIN CARDIOL, V26, P411, DOI 10.1002/clc.4960260906; Bakal JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106494; Bello NA, 2014, CIRC-HEART FAIL, V7, P590, DOI 10.1161/CIRCHEARTFAILURE.113.001281; Bhatia RS, 2014, BMJ QUAL SAF, V23, P981, DOI 10.1136/bmjqs-2014-002816; Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Carson PE, 2015, JACC-HEART FAIL, V3, P429, DOI 10.1016/j.jchf.2014.12.017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng RK, 2014, AM HEART J, V168, P721, DOI 10.1016/j.ahj.2014.07.008; Comin-Colet J, 2014, REV ESP CARDIOL, V67, P283, DOI 10.1016/j.rec.2013.12.005; Crespo-Leiro MG, 2015, REV ESP CARDIOL, V68, P785, DOI 10.1016/j.rec.2015.03.008; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Desai AS, 2014, CIRC-HEART FAIL, V7, P895, DOI 10.1161/CIRCHEARTFAILURE.114.001567; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farre N, 2016, EUR J HEART FAIL, V18, P1132, DOI 10.1002/ejhf.549; Feldman DE, 2013, AM HEART J, V165, P725, DOI 10.1016/j.ahj.2013.02.017; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; Gonzalez-Juanatey JR, 2008, REV ESP CARDIOL, V61, P611; Gotsman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041022; Haas LR, 2013, AM J MANAG CARE, V19, P725; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Hummel SL, 2014, MAYO CLIN PROC, V89, P623, DOI 10.1016/j.mayocp.2013.12.018; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Khan H, 2015, EUR J HEART FAIL, V17, P1022, DOI 10.1002/ejhf.282; Khazanie P, 2015, AM HEART J, V170, P290, DOI 10.1016/j.ahj.2015.04.006; Koudstaal S, 2016, EUR J HEART FAIL; Kristensen SL, 2015, JACC-HEART FAIL, V3, P478, DOI 10.1016/j.jchf.2015.01.014; Laskey WK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001626; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Maggioni AP, 2016, EUR J HEART FAIL, V18, P402, DOI 10.1002/ejhf.471; Maggioni AP, 2013, EUR J HEART FAIL, V15, P808, DOI 10.1093/eurjhf/hft050; Mahonen M, 2013, EUR J PREV CARDIOL, V20, P254, DOI 10.1177/2047487312438979; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naessens JM, 2011, AM J MANAG CARE, V17, P118; Nichols GA, 2015, AM J CARDIOL, V116, P1088, DOI [10.1016/j.amjcard.2015.07.018, 10.5935/2359-4802.20160060]; Otero-Ravina F, 2009, INT J CARDIOL, V136, P56, DOI 10.1016/j.ijcard.2008.04.025; Rich MW, 2016, J AM COLL CARDIOL, V67, P2419, DOI 10.1016/j.jacc.2016.03.004; Rogers JK, 2012, CIRCULATION, V126, P2317, DOI 10.1161/CIRCULATIONAHA.112.110536; Saito M, 2016, AM J CARDIOL, V117, P626, DOI 10.1016/j.amjcard.2015.11.048; Senni M, 2014, INT J CARDIOL, V173, P163, DOI 10.1016/j.ijcard.2014.02.018; Setoguchi S, 2007, AM HEART J, V154, P260, DOI 10.1016/j.ahj.2007.01.041; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437	52	86	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172745	10.1371/journal.pone.0172745	http://dx.doi.org/10.1371/journal.pone.0172745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235067	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200128
J	Keller, EJ; Crowley-Matoka, M; Collins, JD; Chrisman, HB; Milad, MP; Vogelzang, RL				Keller, Eric J.; Crowley-Matoka, Megan; Collins, Jeremy D.; Chrisman, Howard B.; Milad, Magdy P.; Vogelzang, Robert L.			Fostering better policy adoption and inter-disciplinary communication in healthcare: A qualitative analysis of practicing physicians' common interests	PLOS ONE			English	Article							PROFESSIONAL IDENTITY FORMATION; MEDICAL-EDUCATION; ETHICS; WORK	Purpose In response to limited physician adoption of various healthcare initiatives, we sought to propose and assess a novel approach to policy development where one first characterizes diverse physician groups' common interests, using a medical student and constructivist grounded theory. Methods In 6 months, a medical student completed 36 semi-structured interviews with interventional radiologists, gynecologists, and vascular surgeons that were systematically analyzed according to constructivist grounded theory to identifying common themes. Common drivers of clinical decision making and professional values across 3 distinct specialty groups were derived from physicians' descriptions of their clinical decision making, stories, and concerns. Results Common drivers of clinical decision making included patient preference/benefit, experience, reimbursement, busyness/volume, and referral networks. Common values included honesty, trustworthiness, loyalty, humble service, compassion and perseverance, and practical wisdom. Although personal gains were perceived as important interests, such values were easily sacrificed for the good of patients or other non-financial interests. This balance was largely dependent on the incentives and security provided by physicians' environments. Conclusions Using a medical student interviewer and constructivist grounded theory is a feasible means of collecting rich qualitative data to guide policy development. Healthcare administrators and medical educators should consider incorporating this methodology early in policy development to anticipate how value differences between physician groups will influence their acceptance of policies and other broad healthcare initiatives.	[Keller, Eric J.; Crowley-Matoka, Megan] Northwestern Univ, Feinberg Sch Med, Ctr Bioeth & Med Humanities, Chicago, IL 60611 USA; [Collins, Jeremy D.; Chrisman, Howard B.; Vogelzang, Robert L.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Milad, Magdy P.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Reprod Endocrinol & Infertil, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Vogelzang, RL (corresponding author), Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA.	vogelzang@northwestern.edu		Keller, Eric/0000-0003-4327-483X	Radiological Society of North America Research Medical Student Grant [RMS1521]	Radiological Society of North America Research Medical Student Grant	Author EJK received a 2015 Radiological Society of North America Research Medical Student Grant (#RMS1521, https://www.rsna.org/ Research_Medical_Student_Grant.aspx) to support this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allen B, 2015, J AM COLL RADIOL, V12, P1239, DOI 10.1016/j.jacr.2015.10.032; [Anonymous], CATECHISM CATHOLIC C; Bastron R Dennis, 2007, Proc (Bayl Univ Med Cent), V20, P18; Bosk CL, 2003, FORGIVE REMEMBER MAN; Brennan T, 2002, OBSTET GYNECOL, V100, P170; Burford B, 2012, MED EDUC, V46, P143, DOI 10.1111/j.1365-2923.2011.04099.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Chandratilake M, 2012, MED EDUC, V46, P257, DOI 10.1111/j.1365-2923.2011.04153.x; Ciulla JB., 2004, ETHICS HEART LEADERS, Vxix; Conrad L.I., 2008, W MED TRADITION 800; Cook DA, 2015, JAMA INTERN MED, V175, P35, DOI 10.1001/jamainternmed.2014.5437; Cruess RL, 2015, ACAD MED, V90, P718, DOI 10.1097/ACM.0000000000000700; De Brantes F, 2013, IMPROVING INCENTIVE; DuBois JM, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-235; Dunning D, 2011, ADV EXP SOC PSYCHOL, V44, P247, DOI 10.1016/B978-0-12-385522-0.00005-6; Eiser AR, 1999, J GEN INTERN MED, V14, pS58, DOI 10.1046/j.1525-1497.1999.00264.x; ENGELHARDT HT, 1988, NEW ENGL J MED, V319, P1086, DOI 10.1056/NEJM198810203191610; Fiol CM, 2009, ACAD MANAGE REV, V34, P32, DOI 10.5465/AMR.2009.35713276; Fisher Roger, 1997, GETTING YES NEGOTIAT; Fox E, 2010, INNOVATION J PUBLIC, V15; Freidson E, 1999, AM MED ETHICS REVOLU, P124; Galen Hippocrates, 1955, HIPPOCRATIC WRITINGS; Giordano James, 2007, Pain Physician, V10, P719; Gruner O. C., 1973, TREATISE CANON MED A; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gunderman RB, 2009, RADIOLOGY, V253, P597, DOI 10.1148/radiol.2533090741; Holden M, 2012, HEC FORUM, V24, P245, DOI 10.1007/s10730-012-9197-6; Holsinger JW, 2006, CLIN ANAT, V19, P473, DOI 10.1002/ca.20274; Imber J, 1994, NEW ENGL J MED, V331, P280, DOI [10.1001/jamainternmed.2014.5437, DOI 10.1001/JAMAINTERNMED.2014.5437]; Jea Bell, 1847, CODE MED ETHICS AM M; Joseph Meredith Toner Collection (Library of Congress), 1827, CODE I PRECEPTS ADAP; Joseph Meredith Toner Collection (Library of Congress), 1811, PHILADELPHIA PUBLISH, V4; Kenny M., 2014, QUAL REP, V19, P1; Kolber MJ, 2006, HEC FORUM, V18, P61, DOI 10.1007/s10730-006-7988-3; Miliard M., 2016, MEANINGFUL USE WILL; Oh H, 2014, YOUR MONEY YOUR LIFE; Pellegrino ED, 2002, MT SINAI J MED, V69, P378; Pellegrino ED, 1993, VIRTUES MED PRACTICE, Vxiv; Pink D.H., 2010, DRIVE SURPRISING TRU; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Pratt MG, 2006, ACAD MANAGE J, V49, P235, DOI 10.5465/AMJ.2006.20786060; Rodwin M. A., 1993, MED MONEY MORALS PHY; Rosenthal E, 2014, NY TIMES; Serra H, 2010, HEALTH, V14, P162, DOI 10.1177/1363459309353297; Solomon RC., 1992, ETHICS EXCELLENCE CO, Vxiv; Spradley J., 1979, ETHNOGRAPHIC INTERVI; Strauss A., 1998, BASICS QUALITATIVE R; Sugarman J, 2010, METHODS MED ETHICS, Vxiii; Thomas Katie, 2014, NY TIMES; Wald HS, 2015, ACAD MED, V90, P701, DOI 10.1097/ACM.0000000000000731; Weber LJ, 2001, BUSINESS ETHICS IN H, Vxiv; Weller J, 2012, MED EDUC, V46, P134, DOI 10.1111/j.1365-2923.2011.04178.x; Zetka JR, 2011, SOCIOL HEALTH ILL, V33, P837, DOI 10.1111/j.1467-9566.2011.01341.x; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	54	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172865	10.1371/journal.pone.0172865	http://dx.doi.org/10.1371/journal.pone.0172865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235088	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200157
J	Lewis, JE; Brameld, JM; Hill, P; Cocco, C; Noli, B; Ferri, GL; Barrett, P; Ebling, FJP; Jethwa, PH				Lewis, Jo E.; Brameld, John M.; Hill, Phil; Cocco, Cristina; Noli, Barbara; Ferri, Gian-Luca; Barrett, Perry; Ebling, Francis J. P.; Jethwa, Preeti H.			Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain	PLOS ONE			English	Article							DIET-INDUCED OBESITY; NERVE GROWTH-FACTOR; FEEDING-BEHAVIOR; NEUROPEPTIDE-Y; MESSENGER-RNA; PEPTIDE; BALANCE; ARCUATE; SYSTEM; BRAIN	VGF (non-acronymic) was first highlighted to have a role in energy homeostasis through experiments involving dietary manipulation in mice. Fasting increased VGF mRNA in the Arc and levels were subsequently reduced upon refeeding. This anabolic role for VGF was supported by observations in a VGF null (VGF(-/-)) mouse and in the diet-induced and gold-thioglucose obese mice. However, this anabolic role for VGF has not been supported by a number of subsequent studies investigating the physiological effects of VGF-derived peptides. Intracerebroventricular (ICV) infusion of TLQP-21 increased resting energy expenditure and rectal temperature in mice and protected against diet-induced obesity. Similarly, ICV infusion of TLQP-21 into Siberian hamsters significantly reduced body weight, but this was due to a decrease in food intake, with no effect on energy expenditure. Subsequently NERP-2 was shown to increase food intake in rats via the orexin system, suggesting opposing roles for these VGF-derived peptides. Thus to further elucidate the role of hypothalamic VGF in the regulation of energy homeostasis we utilised a recombinant adeno-associated viral vector to over-express VGF in adult male Siberian hamsters, thus avoiding any developmental effects or associated functional compensation. Initially, hypothalamic over-expression of VGF in adult Siberian hamsters produced no effect on metabolic parameters, but by 12 weeks post-infusion hamsters had increased oxygen consumption and a tendency to increased carbon dioxide production; this attenuated body weight gain, reduced interscapular white adipose tissue and resulted in a compensatory increase in food intake. These observed changes in energy expenditure and food intake were associated with an increase in the hypothalamic contents of the VGF-derived peptides AQEE, TLQP and NERP-2. The complex phenotype of the VGF(-/-) mice is a likely consequence of global ablation of the gene and its derived peptides during development, as well as in the adult.	[Lewis, Jo E.; Brameld, John M.; Hill, Phil; Jethwa, Preeti H.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Lewis, Jo E.; Ebling, Francis J. P.] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Life Sci, Nottingham, England; [Cocco, Cristina; Noli, Barbara; Ferri, Gian-Luca] Univ Cagliari, Dept Biomed Sci, I-09042 Cagliari, Italy; [Barrett, Perry] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Nottingham; University of Nottingham; University of Cagliari; University of Aberdeen	Jethwa, PH (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	preeti.jethwa@nottingham.ac.uk	Ferri, Luca Angelo/AAC-5890-2022; Ebling, Francis/Q-6193-2019; Jethwa, Preeti/Y-3123-2019; hill, phil/AAQ-1081-2020; Brameld, John/AAB-1745-2021; Jethwa, Preeti H/K-2549-2015	Ferri, Luca Angelo/0000-0001-9031-6284; Ebling, Francis/0000-0002-7316-9582; Jethwa, Preeti/0000-0003-4401-284X; hill, phil/0000-0002-2250-1397; Brameld, John/0000-0003-4942-080X; Jethwa, Preeti H/0000-0003-4401-284X; Lewis, Jo Edward/0000-0002-5722-6778; Barrett, Perry/0000-0003-3604-2950; FERRI, Gian-Luca/0000-0003-2768-349X	University of Nottingham Knowledge Transfer Award; BBSRC Strategic Skills Award	University of Nottingham Knowledge Transfer Award; BBSRC Strategic Skills Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by University of Nottingham Knowledge Transfer Award and the BBSRC Strategic Skills Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Dhillo WS, 2002, J NEUROENDOCRINOL, V14, P725, DOI 10.1046/j.1365-2826.2002.00832.x; Foglesong GD, 2016, ENDOCRINOLOGY, V157, P983, DOI 10.1210/en.2015-1627; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; Jethwa PH, 2010, J NEUROENDOCRINOL, V22, P564, DOI 10.1111/j.1365-2826.2010.02001.x; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Lewis JE, 2015, J NEUROSCIENCE METHO; Lewis JE, 2016, J MOL ENDOCRINOL, V56, P123, DOI 10.1530/JME-15-0224; Lewis JE, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00003; Murphy Kevin, 2005, Briefings in Functional Genomics & Proteomics, V4, P95, DOI 10.1093/bfgp/4.2.95; Noli B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141193; Paxinos G, 2012, PAXINOS FRANKLINS MO; Sadahiro M, 2015, ENDOCRINOLOGY, V156, P1724, DOI 10.1210/en.2014-1826; Saderi N, 2014, NEUROSCIENCE, V265, P184, DOI 10.1016/j.neuroscience.2014.01.060; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; Samms RJ, 2015, J ENDOCRINOL, V227, P37, DOI 10.1530/JOE-15-0334; Schmidlin T, 2015, ANAL CHEM, V87, P9966, DOI 10.1021/acs.analchem.5b03334; Snyder SE, 1998, J COMP NEUROL, V394, P91; Toshinai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE394, DOI 10.1152/ajpendo.00768.2009; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; VANDENPOL AN, 1994, J COMP NEUROL, V347, P455, DOI 10.1002/cne.903470311; VANDENPOL AN, 1989, J NEUROSCI, V9, P4122; Warner A, 2010, AM J PHYSIOL-REG I, V298, pR1409, DOI 10.1152/ajpregu.00279.2009; Watson E, 2005, ENDOCRINOLOGY, V146, P5151, DOI 10.1210/en.2005-0588; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744, DOI 10.1152/ajpregu.1995.268.3.R744; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172724	10.1371/journal.pone.0172724	http://dx.doi.org/10.1371/journal.pone.0172724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235047	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200122
J	Ager, AA; Evers, CR; Day, MA; Preisler, HK; Barros, AMG; Nielsen-Pincus, M				Ager, Alan A.; Evers, Cody R.; Day, Michelle A.; Preisler, Haiganoush K.; Barros, Ana M. G.; Nielsen-Pincus, Max			Network analysis of wildfire transmission and implications for risk governance	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; FUEL TREATMENT; FIRE; LANDSCAPE; RESTORATION; EXPOSURE; MANAGEMENT; FORESTS; COLORADO; OREGON	We characterized wildfire transmission and exposure within a matrix of large land tenures (federal, state, and private) surrounding 56 communities within a 3.3 million ha fire prone region of central Oregon US. Wildfire simulation and network analysis were used to quantify the exchange of fire among land tenures and communities and analyze the relative contributions of human versus natural ignitions to wildfire exposure. Among the land tenures examined, the area burned by incoming fires averaged 57% of the total burned area. Community exposure from incoming fires ignited on surrounding land tenures accounted for 67% of the total area burned. The number of land tenures contributing wildfire to individual communities and surrounding wildland urban interface (WUI) varied from 3 to 20. Community firesheds, i. e. the area where ignitions can spawn fires that can burn into the WUI, covered 40% of the landscape, and were 5.5 times larger than the combined area of the community core and WUI. For the major land tenures within the study area, the amount of incoming versus outgoing fire was relatively constant, with some exceptions. The study provides a multi-scale characterization of wildfire networks within a large, mixed tenure and fire prone landscape, and illustrates the connectivity of risk between communities and the surrounding wildlands. We use the findings to discuss how scale mismatches in local wildfire governance result from disconnected planning systems and disparate fire management objectives among the large landowners (federal, state, private) and local communities. Local and regional risk planning processes can adopt our concepts and methods to better define and map the scale of wildfire risk from large fire events and incorporate wildfire network and connectivity concepts into risk assessments.	[Ager, Alan A.] US Forest Serv, Missoula Fire Sci Lab, Rocky Mt Res Stn, USDA, Missoula, MT 59801 USA; [Evers, Cody R.; Nielsen-Pincus, Max] Portland State Univ, Dept Environm Sci & Management, Portland, OR 97207 USA; [Day, Michelle A.] Oregon State Univ, Dept Forest Ecosyst & Soc, Coll Forestry, Corvallis, OR 97331 USA; [Preisler, Haiganoush K.] US Forest Serv, Pacific Southwest Res Stn, USDA, Albany, CA USA; [Barros, Ana M. G.] Oregon State Univ, Coll Forestry, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Portland State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Ager, AA (corresponding author), US Forest Serv, Missoula Fire Sci Lab, Rocky Mt Res Stn, USDA, Missoula, MT 59801 USA.	aager@fs.fed.us	Nielsen-Pincus, Max/E-8278-2018; Evers, Cody/U-6303-2019	Evers, Cody/0000-0002-8449-7442	National Science Foundation; Coupled Human and Natural Systems Program [CHH-1013296]; United States Department of Agriculture, Forest Service, Pacific Northwest Research Station; Joint Fire Science Program [14-1-01-22]	National Science Foundation(National Science Foundation (NSF)); Coupled Human and Natural Systems Program; United States Department of Agriculture, Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Joint Fire Science Program	This work was supported by funding from the National Science Foundation (http://www.nsf.gov), Coupled Human and Natural Systems Program (CHH-1013296), the United States Department of Agriculture, Forest Service, Pacific Northwest Research Station (http://www.fs.fed.us/pnw/) and the Joint Fire Science Program (http://www.firescience.gov/) grant (14-1-01-22 to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2016, J ENVIRON PLANN MAN, V59, P557, DOI 10.1080/09640568.2015.1030498; Ager AA, 2015, GEOPH RES ABSTR, V17; Ager AA, 2012, MODELLING FIRE BEHAV, P108; Ager AA, 2016, LANDSCAPE URBAN PLAN, V147, P1, DOI 10.1016/j.landurbplan.2015.11.007; Ager AA, 2015, RISK ANAL, V35, P1393, DOI 10.1111/risa.12373; Ager AA, 2014, FOREST ECOL MANAG, V334, P377, DOI 10.1016/j.foreco.2014.09.017; Ager AA, 2014, J ENVIRON MANAGE, V145, P54, DOI 10.1016/j.jenvman.2014.05.035; Ager AA, 2012, FOREST ECOL MANAG, V267, P271, DOI 10.1016/j.foreco.2011.11.021; Andrews P, 2007, SCI AM, V297, P46, DOI 10.1038/scientificamerican0807-46; [Anonymous], 2014, FPAFOD20140428 USDA; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2012, CORINE LAND COVER 20; Arca B., 2006, FOREST ECOL MANAG, V234, pS110, DOI DOI 10.1016/J.FORECO.2006.08.146; Berman JD, 2015, ENVIRON TECHNOL INNO, V3, P1, DOI 10.1016/j.eti.2014.10.003; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Brummel RF, 2010, J ENVIRON PLANN MAN, V53, P681, DOI 10.1080/09640568.2010.488090; Butler WH, 2015, ENVIRON MANAGE, V55, P564, DOI 10.1007/s00267-014-0430-8; Calkin DE, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0033-8; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Carmel Y, 2009, FOREST ECOL MANAG, V257, P370, DOI 10.1016/j.foreco.2008.09.039; Carroll M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0344; Chaffin BC, 2014, ECOL SOC, V19, DOI 10.5751/ES-06824-190356; Charnley S, 2015, HUM ORGAN, V74, P329, DOI 10.17730/0018-7259-74.4.329; Crona BI, 2006, ECOL SOC, V11; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cumming GS, 2006, ECOL SOC, V11; CWPP Task Force, 2014, COMM GUID PREP IMPL; Donovan GH, 2007, FRONT ECOL ENVIRON, V5, P73, DOI 10.1890/1540-9295(2007)5[73:BCWYWF]2.0.CO;2; Finney MA, 2002, CAN J FOREST RES, V32, P1420, DOI 10.1139/X02-068; Finney MA, 2011, STOCH ENV RES RISK A, V25, P973, DOI 10.1007/s00477-011-0462-z; Fischer AP, 2016, FRONT ECOL ENVIRON, V14, P277, DOI 10.1002/fee.1283; Fischer AP, 2016, LANDSCAPE URBAN PLAN, V147, P18, DOI 10.1016/j.landurbplan.2015.10.006; Fischer AP, 2012, FOREST POLICY ECON, V25, P62, DOI 10.1016/j.forpol.2012.08.008; Fischer AP, 2012, ENVIRON MANAGE, V49, P1192, DOI 10.1007/s00267-012-9848-z; Fischer P, 2011, INT S SOC RES MAN 20; Fleming CJ, 2015, PUBLIC ADMIN REV, V75, P445, DOI 10.1111/puar.12353; Foltete JC, 2014, LANDSCAPE URBAN PLAN, V124, P140, DOI 10.1016/j.landurbplan.2013.12.012; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Gude P, 2008, J FOREST, V106, P198; Guerrero AM, 2013, CONSERV BIOL, V27, P35, DOI 10.1111/j.1523-1739.2012.01964.x; Haas JR, 2015, RISK ANAL, V35, P226, DOI 10.1111/risa.12270; Hill B. T., 2000, GAOTRCED00257; IRGC, 2017, WHAT IS RISK GOV; Ivery J., 2008, J SOC SOC WELF, V35, P53; Jakes PJ, 2011, INT J WILDLAND FIRE, V20, P350, DOI 10.1071/WF10038; Kininmonth S, 2011, ECOL MODEL, V222, P1272, DOI 10.1016/j.ecolmodel.2011.01.012; Krasnow K, 2009, FOREST ECOL MANAG, V257, P1603, DOI 10.1016/j.foreco.2009.01.020; LaCroix JJ, 2006, FOREST SCI, V52, P522; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Merschel AG, 2014, ECOL APPL, V24, P1670, DOI 10.1890/13-1585.1; Miller C, 2013, INT J WILDLAND FIRE, V22, P1, DOI 10.1071/WF11114; Millington J, 2008, JASSS-J ARTIF SOC S, V11; Mills M, 2014, BIOL CONSERV, V169, P6, DOI 10.1016/j.biocon.2013.10.015; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Monroe AS, 2016, J ENVIRON PLANN MAN, V59, P1054, DOI 10.1080/09640568.2015.1053562; Moritz MA, 2016, AM SCI, V104, P220; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Narayanaraj G, 2012, APPL GEOGR, V32, P878, DOI 10.1016/j.apgeog.2011.09.004; Nawrotzki RJ, 2014, SOC NATUR RESOUR, V27, P215, DOI 10.1080/08941920.2013.842275; Noonan-Wright EK, 2011, J COMBUST, V2011, DOI 10.1155/2011/168473; North MP, 2015, SCIENCE, V349, P1280, DOI 10.1126/science.aab2356; North M, 2015, J FOREST, V113, P40, DOI 10.5849/jof.14-058; Nowell B, 2015, J PUBL ADM RES THEOR, V25, P929, DOI 10.1093/jopart/muu021; Oliveira TM, 2016, INT J WILDLAND FIRE, V25, P619, DOI 10.1071/WF15146; Olsson P, 2007, ECOL SOC, V12; Paveglio TB, 2015, FOREST SCI, V61, P298, DOI 10.5849/forsci.14-036; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Penman TD, 2013, J ENVIRON MANAGE, V131, P325, DOI 10.1016/j.jenvman.2013.10.007; Preisler HK, 2004, INT J WILDLAND FIRE, V13, P133, DOI 10.1071/WF02061; Prestemon JP, 2010, FOREST SCI, V56, P181; Price OF, 2015, INT J WILDLAND FIRE, V24, P297, DOI 10.1071/WF14034; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Salis M, 2016, INT J WILDLAND FIRE, V25, P1015, DOI 10.1071/WF15081; Salis M, 2016, FOREST ECOL MANAG, V368, P207, DOI 10.1016/j.foreco.2016.03.009; Sander LM, 2002, MATH BIOSCI, V180, P293, DOI 10.1016/S0025-5564(02)00117-7; Sanderlin J.C., 1977, P 1 INT C MATH MOD S, P619; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schultz CA, 2012, J FOREST, V110, P381, DOI 10.5849/jof.11-082; Scott J. H., 2005, General Technical Report - Rocky Mountain Research Station, USDA Forest Service; Scott J. H., 2013, RMRSGTR315 USDA FOR, DOI [10.2737/RMRS-GTR-315, DOI 10.2737/RMRS-GTR-315]; Scott JH, 2017, GEOJOURNAL, V82, P201, DOI 10.1007/s10708-015-9679-6; Short KC, 2014, EARTH SYST SCI DATA, V6, P1, DOI 10.5194/essd-6-1-2014; Spies TA, 2014, ECOL SOC, V19, DOI 10.5751/ES-06584-190309; Steelman TA, 2008, FOREST COMMUNITY CON, P109; Steelman T, 2016, ECOL SOC, V21, DOI 10.5751/ES-08681-210403; Syphard AD, 2015, INT J WILDLAND FIRE, V24, P37, DOI 10.1071/WF14024; Thompson MP, 2013, NAT HAZARDS, V67, P627, DOI 10.1007/s11069-013-0593-2; Thompson MP, 2011, STOCH ENV RES RISK A, V25, P761, DOI 10.1007/s00477-011-0461-0; USDA and USDI, 2015, NAT COH WILDL FIR MA; USDA Forest Service, 1990, DESCH NAT FOR LAND R; USDA Forest Service, 2016, COLL FOR LANDSC REST; Williams DR, 2012, J FOREST, V110, P415, DOI 10.5849/jof.12-001; WWWRA, 2013, W WID WILDF RISK ASS; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433	97	61	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172867	10.1371/journal.pone.0172867	http://dx.doi.org/10.1371/journal.pone.0172867			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257416	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100034
J	Pauletto, M; Milan, M; Huvet, A; Corporeau, C; Suquet, M; Planas, JV; Moreira, R; Figueras, A; Novoa, B; Patarnello, T; Bargelloni, L				Pauletto, Marianna; Milan, Massimo; Huvet, Arnaud; Corporeau, Charlotte; Suquet, Marc; Planas, Josep V.; Moreira, Rebeca; Figueras, Antonio; Novoa, Beatriz; Patarnello, Tomaso; Bargelloni, Luca			Transcriptomic features of Pecten maximus oocyte quality and maturation	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; PROTEIN DISULFIDE-ISOMERASE; EARLY EMBRYONIC-DEVELOPMENT; PACIFIC OYSTER; BLASTOCYST FORMATION; GAMETE QUALITY; MESSENGER-RNA; EGG QUALITY; SCALLOP; GENE	The king scallop Pecten maximus is a high valuable species of great interest in Europe for both fishery and aquaculture. Notably, there has been an increased investment to produce seed for enhancement programmes of wild scallop populations. However, hatchery production is a relatively new industry and it is still underdeveloped. Major hurdles are spawning control and gamete quality. In the present study, a total of 14 scallops were sampled in the bay of Brest (Brittany, France) to compare transcriptomic profiles of mature oocytes collected by spawning induction or by stripping. To reach such a goal, a microarray analysis was performed by using a custom 8x60K oligonucleotide microarray representing 45,488 unique scallop contigs. First we identified genes that were differentially expressed depending on oocyte quality, estimated as the potential to produce D-larvae. Secondly, we investigated the transcriptional features of both stripped and spawned oocytes. Genes coding for proteins involved in cytoskeletal dynamics, serine/threonine kinases signalling pathway, mRNA processing, response to DNA damage, apoptosis and cell-cycle appeared to be of crucial importance for both oocyte maturation and developmental competence. This study allowed us to dramatically increase the knowledge about transcriptional features of oocyte quality and maturation, as well as to propose for the first time putative molecular markers to solve a major bottleneck in scallop aquaculture.	[Pauletto, Marianna; Milan, Massimo; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Huvet, Arnaud; Corporeau, Charlotte; Suquet, Marc] IFREMER, CNRS, UMR 6539,UBO,IRD, Lab Sci Environm Marin LEMAR, Plouzane, France; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Moreira, Rebeca; Figueras, Antonio; Novoa, Beatriz] Inst Invest Marinas IIM CSIC, Vigo, Pontevedra, Spain	University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Pauletto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	marianna.pauletto@unipd.it	Figueras, Antonio/AAB-8921-2019; Pauletto, Marianna/K-5518-2019; Novoa, Beatriz/K-3785-2014; MILAN, MASSIMO/ABE-6936-2021	Figueras, Antonio/0000-0002-0617-0030; Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Planas, Josep/0000-0002-6525-9617; Huvet, Arnaud/0000-0001-6912-881X; Moreira, Rebeca/0000-0001-7797-7221; Corporeau, charlotte/0000-0003-1187-358X; Novoa, Beatriz/0000-0003-4888-8419	EU [REPROSEED: FP 7-KBBE-2009-1-2-11]	EU(European Commission)	This research was supported by the EU Project "Research to improve Production of SEED" (REPROSEED: FP 7-KBBE-2009-1-2-11) (http://www.reproseed.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2007, J CELL SCI, V120, P1042, DOI 10.1242/jcs.03414; Agnese M, 2013, J CELL PHYSIOL, V228, P547, DOI 10.1002/jcp.24161; Aji L.P., 2011, JURNAL PENELITIAN SA, V14, P33; Andersen S, 2011, CAN J ZOOL, V89, P579, DOI [10.1139/Z11-035, 10.1139/z11-035]; Avazeri N, 2000, MOL BIOL CELL, V11, P4369, DOI 10.1091/mbc.11.12.4369; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BEAUMONT AR, 1983, MAR BIOL, V76, P285, DOI 10.1007/BF00393030; Bobe J., 2015, Animal Frontiers, V5, P66, DOI 10.2527/af.2015-0010; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boudry P, 2002, AQUACULTURE, V204, P283, DOI 10.1016/S0044-8486(01)00841-9; Boulais M, 2015, AQUACULTURE, V437, P201, DOI 10.1016/j.aquaculture.2014.11.025; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Cannuel R, 2005, AQUAT LIVING RESOUR, V18, P35, DOI 10.1051/alr:2005003; Castets MD, 2012, THERIOGENOLOGY, V78, P432, DOI 10.1016/j.theriogenology.2012.02.023; Corporeau C, 2012, J PROTEOMICS, V75, P5554, DOI 10.1016/j.jprot.2012.07.040; Cui XS, 2007, MOL REPROD DEV, V74, P785, DOI 10.1002/mrd.20571; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; de Sousa JT, 2015, AQUACULTURE, V446, P17, DOI 10.1016/j.aquaculture.2015.04.018; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; FAO, 2016, PECT MAX SPEC FACT S; Fava LL, 2012, J CELL SCI, V125, P5911, DOI 10.1242/jcs.115105; Fujii W, 2011, BIOL REPROD, V85, P1124, DOI 10.1095/biolreprod.111.091801; Fujino Y, 1996, HUM REPROD, V11, P1480; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Goode S, 1996, DEV BIOL, V178, P35, DOI 10.1006/dbio.1996.0196; Gosling E., 2015, MARINE BIVALVE MOLLU, V2nd; GRUFFYDD LD, 1970, HELGOLAND WISS MEER, V20, P486, DOI 10.1007/BF01609924; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; Hold N, 2013, CAN J FISH AQUAT SCI, V70, P330, DOI 10.1139/cjfas-2012-0378; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Ito M, 2008, FERTIL STERIL, V90, P1026, DOI 10.1016/j.fertnstert.2007.07.1389; Jarvis CD, 1996, GENE, V169, P203, DOI 10.1016/0378-1119(95)00843-8; Joaquim F, 2016, INT J INVER REP DEV; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Le Pennec M, 2003, ICES J MAR SCI, V60, P211, DOI 10.1016/S1054-3139(02)00270-9; Le Pennec M, 1998, J SHELLFISH RES, V17, P97; Lefevre B, 2007, CRIT REV EUKAR GENE, V17, P259, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.10; Liu RZ, 2003, EUR J BIOCHEM, V270, P3223, DOI 10.1046/j.1432-1033.2003.03705.x; Lo TS, 2007, MAR BIOTECHNOL, V9, P459, DOI 10.1007/s10126-007-9006-4; Ma H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1400-0; Ma JY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103374; MASON J, 1958, J MAR BIOL ASSOC UK, V37, P653, DOI 10.1017/S0025315400005701; Massapina C, 1999, AQUAT LIVING RESOUR, V12, P327, DOI 10.1016/S0990-7440(99)00115-1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Metcalfe AD, 2004, MOL REPROD DEV, V68, P35, DOI 10.1002/mrd.20055; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Milan M, 2016, AQUAT TOXICOL, V174, P123, DOI 10.1016/j.aquatox.2016.02.024; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Mommens M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-829; Morvezen R, 2016, HEREDITY, V117, P142, DOI 10.1038/hdy.2016.42; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Ohashi Y, 2013, ANIM SCI J, V84, P15, DOI 10.1111/j.1740-0929.2012.01030.x; Osada M, 1998, J EXP ZOOL, V281, P124, DOI 10.1002/(SICI)1097-010X(19980601)281:2&lt;124::AID-JEZ6&gt;3.0.CO;2-Q; OSANAI K, 1985, Bulletin of the Marine Biological Station of Asamushi, V18, P1; Osanai K, 1998, B MAR BIOL STN ASAMU, V182, P45; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pauletto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113925; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Peretz G, 2009, MECH DEVELOP, V126, P677, DOI 10.1016/j.mod.2009.05.004; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Polinko ES, 2000, CURR BIOL, V10, P1471, DOI 10.1016/S0960-9822(00)00808-3; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Revel A, 2005, FERTIL STERIL, V83, P580, DOI 10.1016/j.fertnstert.2004.11.008; Robert R, 1999, AQUAT LIVING RESOUR, V12, P121, DOI 10.1016/S0990-7440(99)80021-7; Robson AA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150679; Salilew-Wondim D, 2010, REPROD FERT DEVELOP, V22, P564, DOI 10.1071/RD09112; Samwer M, 2013, EMBO J, V32, P1886, DOI 10.1038/emboj.2013.108; Sandaa RA, 2003, SYST APPL MICROBIOL, V26, P302, DOI 10.1078/072320203322346164; Shumway SE, 2016, DEV AQUAC FISH SCI, V40, P1; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; Song YP, 2009, AQUACULTURE, V287, P311, DOI 10.1016/j.aquaculture.2008.10.018; Spruck CH, 2003, SCIENCE, V300, P647, DOI 10.1126/science.1084149; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Suquet M, 2012, THERIOGENOLOGY, V78, P462, DOI 10.1016/j.theriogenology.2012.02.014; Suquet M, 2010, THERIOGENOLOGY, V74, P111, DOI 10.1016/j.theriogenology.2010.01.021; Suquet M, 2016, GEN COMP ENDOCR, V229, P127, DOI 10.1016/j.ygcen.2016.02.023; TAKASE K, 1995, TOHOKU J EXP MED, V175, P69, DOI 10.1620/tjem.175.69; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Tatone C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/659687; Tatone C, 2014, BIOCHEM SOC T, V42, P433, DOI 10.1042/BST20140023; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Ucar H, 2013, J CELL SCI, V126, P5153, DOI 10.1242/jcs.130476; Valdebenito II, 2015, ZYGOTE, V23, P177, DOI 10.1017/S0967199413000506; Von Stetina JR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005553; Wang Q, 2014, GEN COMP ENDOCR, V204, P71, DOI 10.1016/j.ygcen.2014.05.010; Wang XG, 2014, NEUROENDOCRINOL LETT, V35, P523; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Wassarman PM, 1996, J CELL SCI, V109, P2001; Widowati I, 1992, ACTES COLL, V13, P47; Wu J, 2000, FERTIL STERIL, V74, P1137, DOI 10.1016/S0015-0282(00)01597-1; Zarnescu DC, 1999, J CELL BIOL, V146, P1075, DOI 10.1083/jcb.146.5.1075; Zhang JJ, 2016, GENE, V575, P680, DOI 10.1016/j.gene.2015.09.043; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132941; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	106	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172805	10.1371/journal.pone.0172805	http://dx.doi.org/10.1371/journal.pone.0172805			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253290	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300035
J	Marti, M; de Cola, M; MacDonald, NE; Dumolard, L; Duclos, P				Marti, Melanie; de Cola, Monica; MacDonald, Noni E.; Dumolard, Laure; Duclos, Philippe			Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns	PLOS ONE			English	Article								Vaccine hesitancy has become the focus of growing attention and concern globally despite overwhelming evidence of the value of vaccines in preventing disease and saving the lives of millions of individuals every year. Measuring vaccine hesitancy and its determinants worldwide is important in order to understand the scope of the problem and for the development of evidence-based targeted strategies to reduce hesitancy. Two indicators to assess vaccine hesitancy were developed to capture its nature and scope at the national and subnational level to collect data in 2014: 1) The top 3 reasons for not accepting vaccines according to the national schedule in the past year and whether the response was opinion-or assessment-based and 2) Whether an assessment (or measurement) of the level of confidence in vaccination had taken place at national or subnational level in the previous 5 years. The most frequently cited reasons for vaccine hesitancy globally related to (1) the risk-benefit of vaccines, (2) knowledge and awareness issues, (3) religious, cultural, gender or socio-economic factors. Major issues were fear of side effects, distrust in vaccination and lack of information on immunization or immunization services. The analysis revealed that 29% of all countries had done an assessment of the level of confidence in their country, suggesting that vaccine confidence was an issue of importance. Monitoring vaccine hesitancy is critical because of its influence on the success of immunization programs. To our knowledge, the proposed indicators provide the first global snapshot of reasons driving vaccine hesitancy and depicting its widespread nature, as well as the extent of assessments conducted by countries.	[Marti, Melanie; de Cola, Monica; Dumolard, Laure; Duclos, Philippe] WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland; [MacDonald, Noni E.] Dalhousie Univ, Dept Paediat, IWK Hlth Ctr, Halifax, NS, Canada; [MacDonald, Noni E.] Canadian Ctr Vaccinol, Halifax, NS, Canada	World Health Organization; Dalhousie University	Marti, M (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland.	MartiM@who.int		Marti, Melanie/0000-0002-6800-760X; de Cola, Monica/0000-0001-9444-8460	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, WORLD POP PROSP; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Duclos P, 2013, VACCINE, V31, P5314, DOI 10.1016/j.vaccine.2013.08.084; Eskola J, 2015, VACCINE, V33, P4215, DOI 10.1016/j.vaccine.2015.04.043; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Leask J, 2014, HUM VACC IMMUNOTHER, V10, P2600, DOI 10.4161/hv.29725; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Muscat M, 2011, J INFECT DIS, V204, pS353, DOI 10.1093/infdis/jir067	11	91	91	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172310	10.1371/journal.pone.0172310	http://dx.doi.org/10.1371/journal.pone.0172310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249006	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500036
J	Sekercioglu, N; Veroniki, AA; Thabane, L; Busse, JW; Akhtar-Danesh, N; Iorio, A; Lopes, LC; Guyatt, GH				Sekercioglu, Nigar; Veroniki, Argie Angeliki; Thabane, Lehana; Busse, Jason W.; Akhtar-Danesh, Noori; Iorio, Alfonso; Lopes, Luciane Cruz; Guyatt, Gordon H.			Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY CALCIFICATION; PERITONEAL-DIALYSIS PATIENTS; FERRIC CITRATE HYDRATE; HEMODIALYSIS-PATIENTS; LANTHANUM CARBONATE; NETWORK METAANALYSIS; DOUBLE-BLIND; SEVELAMER HYDROCHLORIDE; AORTIC CALCIFICATION	Background Chronic kidney disease-mineral and bone disorder (CKD-MBD), a complication of chronic kidney disease, has been linked to reduced quality and length of life. High serum phosphate levels that result from CKD-MBD require phosphate-lowering agents, also known as phosphate binders. The objective of this systematic review is to compare the effects of available phosphate binders on laboratory outcomes in patients with CKD-MBD. Methods Data sources included MEDLINE and EMBASE from January 1996 to April 2016, and the Cochrane Register of Controlled Trials up to April 2016. Teams of two reviewers, independently and in duplicate, screened titles and abstracts and potentially eligible full text reports to determine eligibility, and subsequently abstracted data and assessed risk of bias in eligible randomized controlled trials (RCTs). Eligible trials enrolled patients with CKD-MBD and randomized them to receive calcium-based phosphate binders (delivered as calcium acetate, calcium citrate or calcium carbonate), non-calcium-based phosphate binders (NCBPB) (sevelamer hydrochloride, sevelamer carbonate, lanthanum carbonate, sucroferric oxyhydroxide and ferric citrate), phosphorus restricted diet (diet), placebo or no treatment and reported effects on serum levels of phosphate, calcium and parathyroid hormone. We performed Bayesian network meta-analyses (NMA) to calculate the effect estimates (mean differences) and 95% credible intervals for serum levels of phosphate, calcium and parathyroid hormone. We calculated direct, indirect and network meta-analysis estimates using random-effects models. We applied the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to rate the quality of evidence for each pairwise comparison. Results Our search yielded 1108 citations; 71 RCTs were retrieved for full review and 16 proved eligible. Including an additional 13 studies from a previous review, 29 studies that enrolled 8335 participants proved eligible; 26 trials provided data for quantitative synthesis. Sevelamer, lanthanum, calcium, iron, diet and combinations of active treatments (calcium or sevelamer or lanthanum and combination of calcium and sevelamer) resulted in significantly lower serum phosphate as compared to placebo (moderate to very low quality of evidence). We found no statistically significant differences between active treatment categories in lowering serum phosphate. Sevelamer, lanthanum and diet resulted in lower serum calcium compared to calcium (moderate quality evidence for lanthanum and diet; low quality evidence for Sevelamer). Iron, sevelamer and calcium yielded lower parathyroid hormone levels as compared to lanthanum. Meta-regression analyses did not yield a statistically significant association between treatment effect and trial duration. Discussion/Conclusions We found few differences between treatments in impact on phosphate and differences in parathyroid hormone. Relative to calcium, sevelamer, lanthanum and diet showed significant reduction in serum calcium from baseline. Treatment recommendations should be based on impact on patient-important outcomes rather than on surrogate outcomes. Systematic review registration: PROSPERO CRD-42016032945	[Sekercioglu, Nigar; Thabane, Lehana; Busse, Jason W.; Akhtar-Danesh, Noori; Iorio, Alfonso; Guyatt, Gordon H.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Veroniki, Argie Angeliki] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat & Anesthesia, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Akhtar-Danesh, Noori] McMaster Univ, Sch Nursing, Hamilton, ON, Canada; [Iorio, Alfonso; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lopes, Luciane Cruz] Univ Sorocaba UNISO, Pharmaceut Sci Master Course, Sorocaba, Brazil	McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University; Universidade de Sorocaba	Sekercioglu, N (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	nigars2003@yahoo.com	Iorio, Alfonso/B-9478-2013; SEKERCIOGLU, Nigar/AFR-0250-2022; Busse, Jason/CAH-3696-2022; LOPES, LUCIANE CRUZ/H-1168-2012; Lopes, Luciane Cruz/H-3159-2019	Iorio, Alfonso/0000-0002-3331-8766; SEKERCIOGLU, Nigar/0000-0001-6461-8801; Busse, Jason/0000-0002-0178-8712; LOPES, LUCIANE CRUZ/0000-0002-3684-3275; Lopes, Luciane Cruz/0000-0002-3684-3275	Ontario Graduate Fellowship; Canadian Institutes for Health Research Banting Postdoctoral Fellowship Program	Ontario Graduate Fellowship; Canadian Institutes for Health Research Banting Postdoctoral Fellowship Program(Canadian Institutes of Health Research (CIHR))	NS received Ontario Graduate Fellowship. AAV is funded by the Canadian Institutes for Health Research Banting Postdoctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HYPERPHOSPHATAEMIA I; [Anonymous], 2016, PLOS ONE; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2015, AM J KIDNEY DIS, V65, P728, DOI 10.1053/j.ajkd.2014.10.014; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance, 2013, HYPER PHOSPHATAEMIA; Cernaro V, 2016, INT J NEPHROL RENOV, V9, P11, DOI 10.2147/IJNRD.S78040; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Chertow GM, 1997, AM J KIDNEY DIS, V29, P66, DOI 10.1016/S0272-6386(97)90009-3; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Cho Min Seok, 2002, Korean Journal of Internal Medicine, V17, P114; Cozzolino M, 2014, CURR DRUG METAB, V15, P953; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; Di Iorio B, 2013, AM J KIDNEY DIS, V62, P771, DOI 10.1053/j.ajkd.2013.03.023; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Floege J, 2014, KIDNEY INT, V86, P638, DOI 10.1038/ki.2014.58; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Gulati A, 2010, INT UROL NEPHROL, V42, P1055, DOI 10.1007/s11255-009-9688-9; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; IBELS LS, 1979, AM J MED, V66, P790, DOI 10.1016/0002-9343(79)91118-5; Iguchi A, 2015, NEPHRON, V131, P161, DOI 10.1159/000440968; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Lee CT, 2015, J NEPHROL, V28, P105, DOI 10.1007/s40620-014-0108-6; Lee YK, 2013, CLIN NEPHROL, V79, P136, DOI 10.5414/CN107362; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lewis JB, 2015, J AM SOC NEPHROL, V26, P493, DOI 10.1681/ASN.2014020212; Locatelli F, 2014, EXPERT OPIN DRUG SAF, V13, P551, DOI 10.1517/14740338.2014.907791; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Meyer Caitlin, 2012, CANNT J, V22, P33; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Navarro JF, 1999, PERITON DIALYSIS INT, V19, P455; O'Seaghdha CM, 2011, NEPHROL DIAL TRANSPL, V26, P2885, DOI 10.1093/ndt/gfq808; Ohtake T, 2013, J CARDIOVASC PHARM T, V18, P439, DOI 10.1177/1074248413486355; Palmer SC, 2015, AM J KIDNEY DIS, V66, P962, DOI 10.1053/j.ajkd.2015.03.036; Phan O, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/515606; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Rebic D, 2015, REN FAIL, V19, P1; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; Sadek T, 2003, NEPHROL DIAL TRANSPL, V18, P582, DOI 10.1093/ndt/18.3.582; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sanchez-Perales C, 2015, NEFROLOGIA, V35, P157, DOI 10.1016/j.nefro.2015.05.017; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Sekercioglu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156891; Suki WN, 2008, J RENAL NUTR, V18, P91, DOI 10.1053/j.jrn.2007.10.019; Takahara Y, 2014, CLIN NEPHROL, V82, P181, DOI 10.5414/CN108269; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Team RC, 2015, R A LANGUAGE AND ENV; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; Urena-Torres P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-71; van Valkenhoef Gert, 2016, KUIPER J GEMTC NETWO; Veroniki AA, 2016, JOURNAL OF CLINICAL; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wada K, 2014, THER APHER DIAL, V18, P353, DOI 10.1111/1744-9987.12153; Wei MX, 2006, INT UROL NEPHROL, V38, P317, DOI 10.1007/s11255-006-0082-6; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Wilkieson Trevor J, 2015, Can J Kidney Health Dis, V2, P29, DOI 10.1186/s40697-015-0065-6; Wilson R, 2009, CURR MED RES OPIN, V25, P3021, DOI 10.1185/03007990903399398; Wu HC, 2015, RENAL FAILURE, V37, P343, DOI 10.3109/0886022X.2015.1087862; Wuthrich RP, 2013, CLIN J AM SOC NEPHRO, V8, P280, DOI 10.2215/CJN.08230811; Xu J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-29; Yokoyama K, 2014, NEPHROL DIAL TRANSPL, V29, P1053, DOI 10.1093/ndt/gft483; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513; Zhai CJ, 2015, INT UROL NEPHROL, V47, P527, DOI 10.1007/s11255-014-0876-x	79	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171028	10.1371/journal.pone.0171028	http://dx.doi.org/10.1371/journal.pone.0171028			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248961	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500008
J	Borges, TS; Vargas-Ferreira, F; Kramer, PF; Feldens, CA				Borges, Tassia Silvana; Vargas-Ferreira, Fabiana; Kramer, Paulo Floriani; Feldens, Carlos Alberto			Impact of traumatic dental injuries on oral health-related quality of life of preschool children: A systematic review and meta-analysis	PLOS ONE			English	Review							PRIMARY DENTITION; ADOLESCENTS; DISORDERS; DISEASES; ENAMEL; CARIES; TEETH	Background Observational studies have suggested that traumatic dental injuries (TDI) can lead to pain, loss of function and esthetic problems, with physical, emotional and social consequences for children and their families. However, population-based studies that investigate the impact of TDI on oral health-related quality of life (OHRQoL) among preschool children are scarce and offer conflicting results. The aim of the systematic review and meta-analysis was to evaluate the impact of TDI on OHRQoL among preschool children (PROSPEROCRD42015032513). Methods An electronic search of six databases was performed in PubMed (MEDLINE), ISI Web of Science, Scopus, Science Direct, EMBASE and Google Scholar, with no language or publication date restrictions. The eligibility criteria were TDI as the exposure variable, OHRQoL as the outcome and a population of children up to six years of age. RevMan software was used for data analysis. Results are expressed as odds ratios with 95% confidence intervals for the total score of the Early Childhood Oral Health Impact Scale (ECOHIS) as well as the scores of the Child Impact Section (CIS) and Family Impact Section (FIS). The random effect model was chosen and heterogeneity was evaluated using the I 2 test. Results 2,013 articles were initially retrieved; 1,993 articles were excluded based on title and abstracts; 10 articles excluded after full-text analysis. Ten studies comprising a population of 7,461 preschool children were included in the systematic review and nine studies were included in the meta-analysis. TDI caused a negative impact on OHRQoL based on the overall ECOHIS (OR: 1.24; 95% CI: 1.08-1.43) and CIS (OR: 1.23; 95% CI: 1.07-1.41), but not the FIS (OR: 1.09; 95% CI: 0.90-1.32). Conclusions TDI negatively impacted on OHRQoL of preschool children. The present findings indicate the need for TDI prevention and treatment programs in early childhood.	[Borges, Tassia Silvana; Vargas-Ferreira, Fabiana; Kramer, Paulo Floriani; Feldens, Carlos Alberto] Univ Luterana Brasil, Dept Pediat Dent, Canoas, Brazil	Universidade Luterana do Brasil	Borges, TS (corresponding author), Univ Luterana Brasil, Dept Pediat Dent, Canoas, Brazil.	tassia.s.borges@hotmail.com	Feldens, Carlos Alberto/E-8405-2014; Vargas-Ferreira, Fabiana/V-6274-2017	Feldens, Carlos Alberto/0000-0002-9783-9309; Floriani Kramer, Paulo/0000-0002-3378-3545; Vargas-Ferreira, Fabiana/0000-0003-3567-4737	Brazilian Coordination of Higher Education, Ministry of Education (CAPES)	Brazilian Coordination of Higher Education, Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by the Brazilian Coordination of Higher Education, Ministry of Education (CAPES).	Abanto J, 2015, INT J PAEDIATR DENT, V25, P18, DOI 10.1111/ipd.12092; Abanto J, 2011, COMMUNITY DENT ORAL, V39, P105, DOI 10.1111/j.1600-0528.2010.00580.x; Aldrigui JM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-78; Andreasen J., 2007, TXB COLOR ATLAS TRAU; Browner W., 2013, DESIGNING CLIN RES, V4th, ppp65; Caldas AD, 2001, DENT TRAUMATOL, V17, P250; Correa-Faria P, 2016, DENT TRAUMATOL, V32, P367, DOI 10.1111/edt.12268; Deps TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127484; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feldens CA, 2016, DENT TRAUMATOL, V32, P429, DOI 10.1111/edt.12281; Feldens CA, 2016, DENT TRAUMATOL, V32, P103, DOI 10.1111/edt.12222; Feliciano KMPD, 2006, DENT TRAUMATOL, V22, P71, DOI 10.1111/j.1600-9657.2006.00342.x; Firmino RT, 2016, INT J PAEDIATR DENT, V26, P242, DOI 10.1111/ipd.12182; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5; Glendor U, 1996, SWED DENT J, V20, P15; Goettems ML, 2011, QUAL LIFE RES, V20, P951, DOI 10.1007/s11136-010-9816-0; Gomes MC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-55; Guedes RS, 2014, QUAL LIFE RES, V23, P2521, DOI 10.1007/s11136-014-0690-z; Guyatt G, 2007, QUAL LIFE RES, V16, P1097, DOI 10.1007/s11136-007-9223-3; Hermont AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111123; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jokovic A, 2002, J DENT RES, V81, P459, DOI 10.1177/154405910208100705; Kramer PF, 2013, COMMUNITY DENT ORAL, V41, P327, DOI 10.1111/cdoe.12035; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mejare I, 2014, ACTA ODONTOL SCAND, V72, P81, DOI 10.3109/00016357.2013.822548; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; O'Brien M., 1994, REPORT DENTAL SURVEY; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Petti S, 2015, DENT TRAUMATOL, V31, P1, DOI 10.1111/edt.12126; Ramos-Jorge ML, 2013, DENT TRAUMATOL, V29, P266, DOI 10.1111/edt.12005; Salas MMS, 2015, J DENT, V43, P42, DOI 10.1016/j.jdent.2014.10.012; Sharif MO, 2015, DENT TRAUMATOL, V31, P422, DOI 10.1111/edt.12227; Siqueira MB, 2013, INT J ENV RES PUB HE, V10, P6422, DOI 10.3390/ijerph10126422; Tesch FC, 2008, CAD SAUDE PUBLICA, V24, P1897, DOI 10.1590/S0102-311X2008000800018; Vargas-Ferreira F, 2015, J DENT, V43, P619, DOI 10.1016/j.jdent.2015.03.011; Viegas CM, 2014, DENT TRAUMATOL, V30, P338, DOI 10.1111/edt.12091; Viegas CM, 2012, PEDIATR DENT, V34, P300; Vieira-Andrade RG, 2015, INT DENT J, V65, P261, DOI 10.1111/idj.12182; Wallace A, 2016, DENT TRAUMATOL; Wells G.A., NEWCASTLE OTTAWA SCA; Wong HM, 2011, CARIES RES, V45, P370, DOI 10.1159/000330231	41	47	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172235	10.1371/journal.pone.0172235	http://dx.doi.org/10.1371/journal.pone.0172235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245226	Green Submitted, gold, Green Published			2022-12-27	WOS:000395980200016
J	Mangolim, CS; da Silva, TT; Fenelon, VC; Koga, LN; Ferreira, SBD; Bruschi, ML; Matioli, G				Mangolim, Camila Sampaio; da Silva, Thamara Thaiane; Fenelon, Vanderson Carvalho; Koga, Luciana Numata; de Souza Ferreira, Sabrina Barbosa; Bruschi, Marcos Luciano; Matioli, Graciette			Description of recovery method used for curdlan produced by Agrobacterium sp IFO 13140 and its relation to the morphology and physicochemical and technological properties of the polysaccharide	PLOS ONE			English	Article							GELLING CHARACTERISTICS; FUNCTIONAL-PROPERTIES; AQUEOUS DISPERSIONS; LOOFA SPONGE; RHEOLOGY; PROTEIN; MATRIX; CELLS; TIME; DSC	Curdlan is a linear polysaccharide considered a dietary fiber and with gelation properties. This study evaluated the structure, morphology and the physicochemical and technological properties of curdlan produced by Agrobacterium sp. IFO 13140 recovered by pre-gelation and precipitation methods. Commercial curdlan submitted or otherwise to the pre-gelation process was also evaluated. The data obtained from structural analysis revealed a similarity between the curdlan produced by Agrobacterium sp. IFO 13140 (recovered by both methods) and the commercial curdlans. The results showed that the curdlans evaluated differed significantly in terms of dispersibility and gelation, and only the pre-gelled ones had significant potential for food application, because this method influence on the size of the particles and in the presence of NaCl. In terms of technological properties, the curdlan produced by Agrobacterium sp. IFO 13140 (pre-gelation method) had a greater water and oil holding capacity (64% and 98% greater, respectively) and a greater thickening capacity than the pre-gelled commercial curdlan. The pre-gelled commercial curdlan displayed a greater gelling capacity at 95 degrees C than the others. When applied to food, only the pre-gelled curdlans improved the texture parameters of yogurts and reduced syneresis. The curdlan gels, which are rigid and stable in structure, demonstrated potential for improving the texture of food products, with potential industrial use.	[Mangolim, Camila Sampaio; Matioli, Graciette] State Univ Maringa UEM, Postgrad Program Food Sci, Maringa, Parana, Brazil; [da Silva, Thamara Thaiane] State Univ Maringa UEM, Dept Food Engn, Maringa, Parana, Brazil; [Fenelon, Vanderson Carvalho; Koga, Luciana Numata; de Souza Ferreira, Sabrina Barbosa; Bruschi, Marcos Luciano; Matioli, Graciette] State Univ Maringa UEM, Postgrad Program Pharmaceut Sci, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Matioli, G (corresponding author), State Univ Maringa UEM, Postgrad Program Food Sci, Maringa, Parana, Brazil.; Matioli, G (corresponding author), State Univ Maringa UEM, Postgrad Program Pharmaceut Sci, Maringa, Parana, Brazil.	gmatioli@uem.br	Bruschi, Marcos Luciano/J-1871-2012; de Souza Ferreira, Sabrina Barbosa/AAQ-1494-2020	Bruschi, Marcos Luciano/0000-0002-4838-5742; Barbosa de Souza Ferreira, Sabrina/0000-0001-8364-0449; Mangolim, Camila Sampaio/0000-0002-7156-0625	Brazilian Agency CAPES; Brazilian Agency CNPq; Brazilian Agency Fundacao Araucaria	Brazilian Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Agency Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	The authors are thankful to the Brazilian Agencies CAPES, CNPq and Fundacao Araucaria for their financial support of this work.	AOAC, 1995, OFFICIAL METHODS ANA, V16th; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Chan TWD, 2003, RAPID COMMUN MASS SP, V17, P887, DOI 10.1002/rcm.991; CHE MYB, 1999, J SCI FOOD AGR, V79, P1075, DOI DOI 10.1002/(SICI)1097-0010(199906)79:8<1075::AID-JSFA329>3.0.C0;2-Q; Chel-Guerrero L, 2002, J AGR FOOD CHEM, V50, P584, DOI 10.1021/jf010778j; Chen CG, 2010, INNOV FOOD SCI EMERG, V11, P538, DOI 10.1016/j.ifset.2010.05.004; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Favaro-Trindade CS, 2010, FOOD HYDROCOLLOID, V24, P336, DOI 10.1016/j.foodhyd.2009.10.012; Fenelon VC, 2015, BIOPROC BIOSYST ENG, V38, P1291, DOI 10.1007/s00449-015-1369-8; Funami T, 2000, FOOD HYDROCOLLOID, V14, P509, DOI 10.1016/S0268-005X(00)00031-X; Funami T, 2007, FOOD HYDROCOLLOID, V21, P59, DOI 10.1016/j.foodhyd.2006.01.009; Gagnon MA, 2007, APPL SPECTROSC, V61, P374, DOI 10.1366/000370207780466136; Hirashima M, 1997, THERMOCHIM ACTA, V306, P109, DOI 10.1016/S0040-6031(97)00310-9; Jin Y, 2006, CARBOHYD RES, V341, P90, DOI 10.1016/j.carres.2005.11.003; Keogh MK, 1998, J FOOD SCI, V63, P108, DOI 10.1111/j.1365-2621.1998.tb15687.x; Lee IY, 1997, J IND MICROBIOL BIOT, V18, P255, DOI 10.1038/sj.jim.2900378; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; MARCHESSAULT RH, 1979, CARBOHYD RES, V75, P231, DOI 10.1016/S0008-6215(00)84642-X; Martinez CO, 2016, J SCI FOOD AGR, V96, P2410, DOI 10.1002/jsfa.7357; Martinez CO, 2015, MOLECULES, V20, P7957, DOI 10.3390/molecules20057957; Mikkelsen MS, 2010, FOOD RES INT, V43, P2417, DOI 10.1016/j.foodres.2010.09.016; NAKANISH.I, 1974, CARBOHYD RES, V32, P47, DOI 10.1016/S0008-6215(00)82462-3; Novak M, 2012, CARBOHYD POLYM, V87, P2496, DOI 10.1016/j.carbpol.2011.11.031; SAITO H, 1989, MACROMOLECULES, V22, P3892, DOI 10.1021/ma00200a014; Sciarini LS, 2009, FOOD HYDROCOLLOID, V23, P306, DOI 10.1016/j.foodhyd.2008.02.011; Seguchi M, 2001, FOOD HYDROCOLLOID, V15, P177, DOI 10.1016/S0268-005X(00)00063-1; Shin HD, 2016, J IND MICROBIOL BIOT, V43, P1323, DOI 10.1007/s10295-016-1805-z; Spicer EJF, 1999, FOOD CHEM TOXICOL, V37, P455, DOI 10.1016/S0278-6915(99)00013-7; Triveni R, 2001, PROCESS BIOCHEM, V36, P787, DOI 10.1016/S0032-9592(00)00279-X; Wang MJ, 2010, STARCH-STARKE, V62, P429, DOI 10.1002/star.201000007; Wu CH, 2015, FOOD CHEM, V179, P222, DOI 10.1016/j.foodchem.2015.01.125; Wu Jianrong, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1035; Zhang HB, 2002, INT J BIOL MACROMOL, V30, P7, DOI 10.1016/S0141-8130(01)00187-8; Zhang RR, 2014, BIOMACROMOLECULES, V15, P1079, DOI 10.1021/bm500038g	35	14	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0171469	10.1371/journal.pone.0171469	http://dx.doi.org/10.1371/journal.pone.0171469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245244	Green Submitted, Green Published, gold			2022-12-27	WOS:000395980200007
J	Boyda, E; Basu, S; Ganguly, S; Michaelis, A; Mukhopadhyay, S; Nemani, RR				Boyda, Edward; Basu, Saikat; Ganguly, Sangram; Michaelis, Andrew; Mukhopadhyay, Supratik; Nemani, Ramakrishna R.			Deploying a quantum annealing processor to detect tree cover in aerial imagery of California	PLOS ONE			English	Article								Quantum annealing is an experimental and potentially breakthrough computational technology for handling hard optimization problems, including problems of computer vision. We present a case study in training a production-scale classifier of tree cover in remote sensing imagery, using early-generation quantum annealing hardware built by D-wave Systems, Inc. Beginning within a known boosting framework, we train decision stumps on texture features and vegetation indices extracted from four-band, one-meter-resolution aerial imagery from the state of California. We then impose a regulated quadratic training objective to select an optimal voting subset from among these stumps. The votes of the subset define the classifier. For optimization, the logical variables in the objective function map to quantum bits in the hardware device, while quadratic couplings encode as the strength of physical interactions between the quantum bits. Hardware design limits the number of couplings between these basic physical entities to five or six. To account for this limitation in mapping large problems to the hardware architecture, we propose a truncation and rescaling of the training objective through a trainable metaparameter. The boosting process on our basic 108- and 508-variable problems, thus constituted, returns classifiers that incorporate a diverse range of color-and texture-based metrics and discriminate tree cover with accuracies as high as 92% in validation and 90% on a test scene encompassing the open space preserves and dense suburban build of Mill Valley, CA.	[Boyda, Edward] St Marys Coll Calif, Dept Phys & Astron, Moraga, CA 94556 USA; [Boyda, Edward; Ganguly, Sangram] Bay Area Environm Res Inst, Moffett Field, CA 94952 USA; [Basu, Saikat; Mukhopadhyay, Supratik] Louisiana State Univ, Dept Comp Sci, Baton Rouge, LA 70803 USA; [Ganguly, Sangram; Michaelis, Andrew] NASA Ames Res Ctr, Div Earth Sci, Moffett Field, CA USA; [Michaelis, Andrew] CSU Monterey Bay, Univ Corp, Seaside, CA USA; [Nemani, Ramakrishna R.] NASA Ames Res Ctr, NASA Adv Supercomp Div, Moffett Field, CA USA	Saint Mary's College of California; Louisiana State University System; Louisiana State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; California State University Monterey Bay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Boyda, E (corresponding author), St Marys Coll Calif, Dept Phys & Astron, Moraga, CA 94556 USA.; Boyda, E (corresponding author), Bay Area Environm Res Inst, Moffett Field, CA 94952 USA.	ekb2@stmarys-ca.edu	Basu, Saikat/AAO-1143-2020		NASA Earth Science Division	NASA Earth Science Division	This work was supported by the NASA Earth Science Division and performed using the computing facilities of the NASA Advanced Supercomputing (NAS) division and NASA Earth Exchange (NEX). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect that of NASA or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S. H., 2015, APPL QUANTUM ANNEALI; Albash T, 2016, SIMULATED QUANTUM AN; Albash T, 2015, REEXAMINATION EVIDEN; Babbush R, 2013, PREPRINT; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Basu S, DEEPSAT LEARNING FRA; Basu S, 2015, IEEE T GEOSCI REMOTE, V53, P5690, DOI 10.1109/TGRS.2015.2428197; Bian ZB, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130505; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Boixo S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3067; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; Choi V, 2008, QUANTUM INF PROCESS, V7, P193, DOI 10.1007/s11128-008-0082-9; Das S., 2001, ICML, P74; DAURIAC JCA, 1985, J PHYS LETT-PARIS, V46, pL173, DOI 10.1051/jphyslet:01985004605017300; Denchev V., 2012, P 29 INT C MACH LEAR, P863; Denchev VS, 2015, PREPRINT; Farhi Edward, 2000, QUANTUM COMPUTATION; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hen I, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.042325; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Kohli P, 2009, INT J COMPUT VISION, V82, P302, DOI 10.1007/s11263-008-0202-0; Lanting T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021041; Neven H., 2008, TRAINING BINARY CLAS; Neven H., 2009, TRAINING LARGE SCALE; Neven Harmut, 2009, NIPS 2009 DEMONSTRAT; Perdomo-Ortiz A, 2015, EUR PHYS J-SPEC TOP, V224, P131, DOI 10.1140/epjst/e2015-02347-y; Pudenz KL, 2013, QUANTUM INF PROCESS, V12, P2027, DOI 10.1007/s11128-012-0506-4; Rieffel E., 2011, QUANTUM COMPUTING GE; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Rosenberg G, 2015, SOLVING OPTIMAL TRAD; Selby A., 2013, D WAVE COMMENT COMP; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Smelyanskiy VN, 2012, NEAR TERM QUANTUM CO; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Trummer I., 2015, MULTIPLE QUERY OPTIM; Venturelli D, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031040; Vinci W, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.042310	42	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172505	10.1371/journal.pone.0172505	http://dx.doi.org/10.1371/journal.pone.0172505			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241028	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400024
J	Jhun, J; Kwon, JE; Kim, SY; Jeong, JH; Na, HS; Kim, EK; Lee, SH; Jung, K; Min, JK; Cho, ML				Jhun, JooYeon; Kwon, Jeong-Eun; Kim, Se-Young; Jeong, Jeong-Hee; Na, Hyun Sik; Kim, Eun-Kyung; Lee, Seung Hoon; Jung, KyungAh; Min, Jun-Ki; Cho, Mi-La			Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation	PLOS ONE			English	Article							CD4(+) T-CELLS; DOUBLE-BLIND; TH17 CELLS; SEVERITY; PROGRESSION; INHIBITION; MECHANISMS; ARTHRITIS; EFFICACY; PLAQUES	Atherosclerosis is a chronic inflammatory disease caused by the accumulation of excess lipid in the aorta and the severity is regulated by T lymphocytes subsets. Rebamipide has therapeutic activity in collagen induced arthritis (CIA) by controlling the balance between T helper (Th) 17 and regulatory T (Treg) cells. In this study, we aimed to determine whether rebamipide reduces the development of atherosclerosis. To investigate the therapeutic effect of rebamipide, ApoE-KO mice fed a western diet were administered rebamipide orally for 8 weeks. Mice were sacrificed followed by the evaluation of plaque formation in the aorta or immunohistochemistry for IL-17 and Foxp3. Serum was also prepared to determine the pro-inflammatory cytokine levels. The ability of rebamipide to regulate lipid metabolism or inflammation was confirmed ex vivo. Results The oral administration of rebamipide decreased plaque formation in atherosclerotic lesions as well as the markers of metabolic disorder in ApoE-deficient mice with atherosclerosis. Pro-inflammatory cytokines were also suppressed by rebamapide. In addition, the population of Th17 was decreased, whereas Treg was increased in the spleen of rebamipide-treated ApoE deficient mice. Rebamipide also ameliorated the severity of obese arthritis and has the capability to reduce the development of atherosclerosis by controlling the balance between Th17 and Treg cells. Thus, rebamipide could be a therapeutic agent to improve the progression of inflammation in metabolic diseases.	[Jhun, JooYeon; Kwon, Jeong-Eun; Kim, Se-Young; Jeong, Jeong-Hee; Na, Hyun Sik; Kim, Eun-Kyung; Lee, Seung Hoon; Min, Jun-Ki; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Jung, KyungAh] Catholic Univ Korea, Catholic Res Inst Med Sci, IMPACT Biotech, Seoul, South Korea; [Min, Jun-Ki] Catholic Univ Korea, Coll Med, Dept Internal Med, Bucheon St Marys Hosp,Div Rheumatol, Bucheon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Min, JK; Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.; Min, JK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Bucheon St Marys Hosp,Div Rheumatol, Bucheon, South Korea.	min6403@catholic.ac.kr; iammila@catholic.ac.kr	Kim, SeYoung/GSE-5296-2022	Kim, SeYoung/0000-0001-9188-868X	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C1851]; National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01057072]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C1851) and the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01057072). The funders had no role in study design, data collection and analysis, decision to pubulish, or preparation of the manuscript.	Arakawa T, 1998, DIGEST DIS SCI, V43, p5S; Bang D, 2008, EUR J PHARMACOL, V598, P112, DOI 10.1016/j.ejphar.2008.09.005; Byun JK, 2014, CLIN EXP IMMUNOL, V178, P9, DOI 10.1111/cei.12355; Chen C, 1999, J IMMUNOL, V162, P1084; Chen Yu-lin, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P416; Cooke Anne, 2006, Review of Diabetic Studies, V3, P72, DOI 10.1900/RDS.2006.3.72; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Jeon US, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.19; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kim HK, 2007, DIGEST DIS SCI, V52, P1776, DOI 10.1007/s10620-006-9367-y; Kim SY, 2016, SCI TOTAL ENVIRON, V542, P1, DOI 10.1016/j.scitotenv.2015.10.115; Kohashi M, 2008, ARTHRITIS RHEUM, V58, P389, DOI 10.1002/art.23163; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Li WW, 2015, FEBS J, V282, P2317, DOI 10.1111/febs.13278; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P874, DOI 10.1002/art.38310; Murakami K, 1997, DIGEST DIS SCI, V42, P319, DOI 10.1023/A:1018861818023; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; Patel SS, 1998, CIRCULATION, V97, P75, DOI 10.1161/01.CIR.97.1.75; Ponnuswamy P, 2012, VASC PHARMACOL, V56, P193, DOI 10.1016/j.vph.2012.01.009; Sugai S, 2009, MOD RHEUMATOL, V19, P114, DOI 10.1007/s10165-008-0141-1; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Terano A, 2007, J GASTROENTEROL, V42, P690, DOI 10.1007/s00535-007-2076-2; van den Berg WB, 2013, SEMIN ARTHRITIS RHEU, V43, P158, DOI 10.1016/j.semarthrit.2013.04.006; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; YOSHIKAWA T, 1993, ARZNEIMITTEL-FORSCH, V43-1, P363; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2003, BIOMED PHARMACOTHER, V57, P287, DOI 10.1016/S0753-3322(03)00082-9	32	2	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171674	10.1371/journal.pone.0171674	http://dx.doi.org/10.1371/journal.pone.0171674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241014	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400008
J	Leao, ER; Dal Fabbro, DR; de Oliveira, RB; dos Santos, IR; Victor, ED; Aquarone, RL; Andrade, CB; Ribeiro, VF; de Oliveira, RC; Friedlander, R; Ferreira, DS				Leao, Eliseth Ribeiro; Dal Fabbro, Daniela Reis; de Oliveira, Rebeca Barqueiro; dos Santos, Ingrid Ribeiro; Victor, Elivane da Silva; Aquarone, Rita Lacerda; Andrade, Cristiane Benvenuto; Ribeiro, Vivian Finotti; de Oliveira, Roselaine Coelho; Friedlander, Rosa; Ferreira, Daniela Santos			Stress, self-esteem and well-being among female health professionals: A randomized clinical trial on the impact of a self-care intervention mediated by the senses	PLOS ONE			English	Article							LOW-BACK-PAIN; LIFE SATISFACTION; MASSAGE; NURSES	Background Stress levels are evident among health professionals. However, there are few studies on sensory-based self-care aimed at stress management, self-esteem and subjective wellbeing in this group of professionals. Objective To assess the impact of a self-care intervention mediated by the senses on the stress levels, self-esteem and well-being of health professionals in a hospital environment. Methods A total of 93 health professionals participated in an unblinded clinical trial, randomized into four groups: 1) control (no intervention); 2) Monosensory-daily body moisturizing (DBM) with odorless cream; 3) Bisensory-DBM with scented cream; 4) Multisensory-DBM with scented cream associated with audiovisual material. Participants answered specific questionnaires to assess stress, self-esteem and well-being and cortisol samples were collected at baseline, 15 and 30 days following intervention, and at the 30-day follow-up. Results Self-care was characterized as neglected, with most participants reporting inadequate hours of sleep (74%), irregular physical activity (68%), and inadequate nutrition (45%). Compared to the other groups, the Bisensory group had lower stress on all three assessments (p = 0.017; 0.012; 0.036), a life satisfaction 8% higher at follow-up than at baseline (95% CI: 2% to 15%, p = 0.016), a 10% increase in positive affect (95% CI: 2% to 19%, p = 0.011) and a 12% reduction in negative affect (95% CI: 3% to 21% less, p = 0.014) after 30 days. The Multisensory group showed improvement in self-esteem (p = 0.012) and reduced cortisol (p = 0.036) after 30 days of intervention. The control group showed no changes in the variables studied, except for cortisol: an increase at the 15-day evaluation (denoting higher risk for stress, p = 0.009) and a reduction at follow-up (p = 0.028), which was nevertheless within normal levels.	[Leao, Eliseth Ribeiro; Dal Fabbro, Daniela Reis; de Oliveira, Rebeca Barqueiro; dos Santos, Ingrid Ribeiro; Victor, Elivane da Silva; Andrade, Cristiane Benvenuto] Hosp Israelita Albert Einstein, Res Inst, Sao Paulo, Brazil; [Aquarone, Rita Lacerda] Univ Sao Paulo, Sao Paulo, Brazil; [Ribeiro, Vivian Finotti] Hosp Israelita Albert Einstein, Israeli Fac Heath Sci Albert Einstein, Sao Paulo, Brazil; [de Oliveira, Roselaine Coelho] Hosp Israelita Albert Einstein, Qual & Safety, Sao Paulo, Brazil; [Friedlander, Rosa; Ferreira, Daniela Santos] Nat Cosmet, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Leao, ER (corresponding author), Hosp Israelita Albert Einstein, Res Inst, Sao Paulo, Brazil.	eliseth.leao@einstein.br	Ribeiro, Vivian/AAD-6172-2021; Leao, Eliseth R/J-7143-2012	Leao, Eliseth R/0000-0003-0352-0549	Natura Cosmeticos	Natura Cosmeticos	Natura Cosmeticos provided support in the form of salaries for authors RF and DSF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almeida MCP, 1989, SABER ENFERMAGEM SUA; Bagglio Maria Aparecida, 2007, Rev Gaucha Enferm, V28, P233; Barros Dalton de Souza, 2008, Rev. bras. ter. intensiva, V20, P235, DOI 10.1590/S0103-507X2008000300005; BLEGEN MA, 1993, NURS RES, V42, P36; Borda RG, 1997, INT J NURS STUD, V34, P385, DOI 10.1016/S0020-7489(97)00031-X; Borges TP, 2012, REV LAT-AM ENFERM, V20, P511, DOI 10.1590/S0104-11692012000300012; Cady SH, 1997, PERCEPT MOTOR SKILL, V84, P157, DOI 10.2466/pms.1997.84.1.157; Camelo Silvia H. Henriques, 2004, Rev. Latino-Am. Enfermagem, V12, P14, DOI 10.1590/S0104-11692004000100003; CASCIO WF, 1995, AM PSYCHOL, V50, P928, DOI 10.1037/0003-066X.50.11.928; Castro Margaret, 2003, Arq Bras Endocrinol Metab, V47, P358, DOI 10.1590/S0004-27302003000400008; Chaves S. S. S., 2003, DISSERTACAO MESTRADO; Chaves SSS, 2007, THESIS; Cooper Marcus C., 1995, GARDENS HEALTHCARE F; Core-Team, 2015, LANG ENV STAT COMP; de Carvalho V T, 1999, Rev Lat Am Enfermagem, V7, P67; De Martino Milva Maria Figueiredo, 2004, Rev. esc. enferm. USP, V38, P161; Barbosa de Oliveira Luciana C, 2008, Rev. salud pública, V10, P405, DOI 10.1590/S0124-00642008000300005; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.68.4.653; Diener E, 1996, PSYCHOL SCI, V7, P181, DOI 10.1111/j.1467-9280.1996.tb00354.x; DIENER E, 1984, J PERS SOC PSYCHOL, V47, P1105, DOI 10.1037/0022-3514.47.5.1105; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkstra K, 2006, J ADV NURS, V56, P166, DOI 10.1111/j.1365-2648.2006.03990.x; Drahota A, COCHRANE DATABASE SY, V201, P23; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Ganzini L, 2013, PALLIAT SUPPORT CARE, V13, P1; Garcia-Huidobro D, 2008, REV MED CHILE, V136, P809, DOI /S0034-98872008000600019; Giuberti Ana Carolina, 2005, Econ. Apl., V9, P369, DOI 10.1590/S1413-80502005000300002; GOATS GC, 1994, BRIT J SPORT MED, V28, P153, DOI 10.1136/bjsm.28.3.153; Goncalves S., 2004, PSICOL ESTUD, V9, P499, DOI DOI 10.1590/S1413-73722004000300018; Gouveia VV, 2009, SOC INDIC RES, V90, P267, DOI 10.1007/s11205-008-9257-0; Grant F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067395; Guido LD, 2011, REV ESC ENFERM USP, V45, P1427; Headey B., 1991, SUBJECTIVE WELL BEIN, P49; Hutz CS, 2011, AVALIACAO PSICOLOGIC, V10, P41; Ignatt C, 2012, NURSES SUFFERING PSY; Kravits K, 2010, APPL NURS RES, V23, P130, DOI 10.1016/j.apnr.2008.08.002; Regis LFLV, 2011, REV ESC ENFERM USP, V45, P332; Lai HL, 2011, J ADV NURS, V67, P2414, DOI 10.1111/j.1365-2648.2011.05670.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipp MEN, 1994, ESTUD PSICOL-MADRID, V11; Liu SH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/853809; Lopes Guerrer FJ, 2011, ENFERM GLOB, V10, P1; Maslow A.H., 1987, MOTIVATION PERSONALI; Mc Cabe C, 2011, PSYCHOL ONCOLOGY; MCGEE RA, 1989, J COUNS PSYCHOL, V36, P345, DOI 10.1037/0022-0167.36.3.345; McGrath M., 1992, MY GENTLE HARP IRISH; Moraska A, 2010, EVID-BASED COMPL ALT, V7, P409, DOI 10.1093/ecam/nen029; Negeliskii C, 2011, REV LAT-AM ENFERM, V19, P606, DOI 10.1590/S0104-11692011000300021; Nilsson U., 2010, EUROPEAN J CARDIOVAS, V10, P73; Nooraee N, 2014, COMPUT STAT DATA AN, V77, P70, DOI 10.1016/j.csda.2014.03.009; Pafaro Roberta Cova, 2004, Rev. esc. enferm. USP, V38, P152, DOI 10.1590/S0080-62342004000200005; Rana D, 2013, PSYCHOL NURSES, P640; Randle J, 2003, LEARNING HLTH SOCIAL, V2, P51; Ribeiro Vivian F, 2014, Int Arch Med, V7, P22, DOI 10.1186/1755-7682-7-22; Rosenberg M, 1989, SOC ADOLESCENT SELF; Silva ID, 2009, REV ESC ENFERM USP, V43, P697; Silva Maria da Conceição de Melo, 2009, Estud. psicol. (Natal), V14, P239, DOI 10.1590/S1413-294X2009000300008; Stigsdotter U.A., 2003, J THERAPEUTIC HORTIC, V14, P38; Tsai YC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-199; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; VIEIRA A. B. D., 2007, TEXTO CONTEXTO ENFER, V16, P15, DOI DOI 10.1590/S0104-07072007000100002; Wu JJ, 2014, COMPLEMENT THER MED, V22, P456, DOI 10.1016/j.ctim.2014.04.001	62	13	18	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172455	10.1371/journal.pone.0172455	http://dx.doi.org/10.1371/journal.pone.0172455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241070	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400021
J	Cowley, JC; Gates, DH				Cowley, Jeffrey C.; Gates, Deanna H.			Proximal and distal muscle fatigue differentially affect movement coordination	PLOS ONE			English	Article							MULTIJOINT MOVEMENT; HAND; SHOULDER; MOTION; WRIST; TOOL; CONTRACTIONS; ADAPTATIONS; PARAMETERS; PATTERNS	Muscle fatigue can cause people to change their movement patterns and these changes could contribute to acute or overuse injuries. However, these effects depend on which muscles are fatigued. The purpose of this study was to determine the differential effects of proximal and distal upper extremity muscle fatigue on repetitive movements. Fourteen subjects completed a repetitive ratcheting task before and after a fatigue protocol on separate days. The fatigue protocol either fatigued the proximal (shoulder flexor) or distal (finger flexor) muscles. Pre/Post changes in trunk, shoulder, elbow, and wrist kinematics were compared to determine how proximal and distal fatigue affected multi-joint movement patterns and variability. Proximal fatigue caused a significant increase (7 degrees, p < 0.005) in trunk lean and velocity, reduced humeral elevation (11 degrees, p < 0.005), and increased elbow flexion (4 degrees, p < 0.01). In contrast, distal fatigue caused small but significant changes in trunk angles (2 degrees, p < 0.05), increased velocity of wrench movement relative to the hand (17 degrees/s, p < 0.001), and earlier wrist extension (4%, p < 0.005). Movement variability increased at proximal joints but not distal joints after both fatigue protocols (p < 0.05). Varying movements at proximal joints may help people adapt to fatigue at either proximal or distal joints. The identified differences between proximal and distal muscle fatigue adaptations could facilitate risk assessment of occupational tasks.	[Cowley, Jeffrey C.; Gates, Deanna H.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Gates, Deanna H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gates, DH (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.; Gates, DH (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	gatesd@umich.edu		Gates, Deanna/0000-0002-6086-0913	Graduate Research Grant from the University of Michigan; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [K12HD073945]	Graduate Research Grant from the University of Michigan; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	Funding was provided by a Graduate Research Grant from the University of Michigan. D. G. was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number K12HD073945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein N, 1967, COORDINATION REGULAT; Bonauto D, 2006, J OCCUP ENVIRON MED, V48, P840, DOI 10.1097/01.jom.0000225062.88285.b3; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cote JN, 2005, CLIN BIOMECH, V20, P581, DOI 10.1016/j.clinbiomech.2005.02.012; Cote JN, 2002, EXP BRAIN RES, V146, P394, DOI 10.1007/s00221-002-1186-6; Cote JN, 2008, MOTOR CONTROL, V12, P79, DOI 10.1123/mcj.12.2.79; Cowley JC, 2014, EXPERI BRAIN RES, V232, P3939; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dounskaia N, 2010, EXERC SPORT SCI REV, V38, P201, DOI 10.1097/JES.0b013e3181f45194; Dounskaia NV, 1998, EXP BRAIN RES, V121, P239, DOI 10.1007/s002210050457; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Fuller JR, 2011, EXP BRAIN RES, V211, P133, DOI 10.1007/s00221-011-2661-8; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Gates DH, 2011, EXP BRAIN RES, V209, P525, DOI 10.1007/s00221-011-2580-8; Goerlick M, 2003, APPL ERGON, V34, P317, DOI 10.1016/S0003-6870(03)00039-5; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hostens I, 2004, J ELECTROMYOGR KINES, V14, P205, DOI 10.1016/S1050-6411(03)00101-9; Huffenus AF, 2006, EXP BRAIN RES, V170, P438, DOI 10.1007/s00221-005-0227-3; Leger AB, 2000, EUR J APPL PHYSIOL, V82, P472, DOI 10.1007/s004210000227; Lin JH, 2003, HUM FACTORS, V45, P645, DOI 10.1518/hfes.45.4.645.27083; Lin JH, 2003, J BIOMECH, V36, P1845, DOI 10.1016/S0021-9290(03)00214-8; Lin JH, 2001, ERGONOMICS, V44, P295, DOI 10.1080/00140130118167; MARRAS WS, 1993, SPINE, V18, P617, DOI 10.1097/00007632-199304000-00015; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; Myers JB, 1999, J ATHL TRAINING, V34, P362; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Qin J, 2014, J ELECTROMYOGR KINES, V24, P404, DOI 10.1016/j.jelekin.2014.02.001; Sesto ME, 2005, ERGONOMICS, V48, P807, DOI 10.1080/00140130500142209; Sesto ME, 2004, CLIN BIOMECH, V19, P921, DOI 10.1016/j.clinbiomech.2004.06.005; Sparto PJ, 1997, SPINE, V22, P2647, DOI 10.1097/00007632-199711150-00013; Wilder DG, 1996, SPINE, V21, P2628, DOI 10.1097/00007632-199611150-00013; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	36	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172835	10.1371/journal.pone.0172835	http://dx.doi.org/10.1371/journal.pone.0172835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235005	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200150
J	de Castro, MAG; Hobartner, C; Opazo, F				de Castro, Maria Angela Gomes; Hoebartner, Claudia; Opazo, Felipe			Aptamers provide superior stainings of cellular receptors studied under super-resolution microscopy	PLOS ONE			English	Article							RNA; MOLECULES; PROTEIN; SELECTION; LIGANDS; GUIDE; BIND; GFP	Continuous improvements in imaging techniques are challenging biologists to search for more accurate methods to label cellular elements. This is particularly relevant for diffraction-unlimited fluorescence imaging, where the perceived resolution is affected by the size of the affinity probes. This is evident when antibodies, which are 10-15 nm in size, are used. Previously it has been suggested that RNA aptamers (similar to 3 nm) can be used to detect cellular proteins under super-resolution imaging. However, a direct comparison between several aptamers and antibodies is needed, to clearly show the advantages and/or disadvantages of the different probes. Here we have conducted such a comparative study, by testing several aptamers and antibodies using stimulated emission depletion microscopy (STED). We have targeted three membrane receptors, EGFR, ErbB2 and Epha2, which are relevant to human health, and recycle between plasma membrane and intracellular organelles. Our results suggest that the aptamers can reveal more epitopes than most antibodies, thus providing a denser labeling of the stained structures. Moreover, this improves the overall quality of the information that can be extracted from the images. We conclude that aptamers could become useful fluorescent labeling tools for light microscopy and super-resolution imaging, and that their development for novel targets is imperative.	[de Castro, Maria Angela Gomes; Opazo, Felipe] Univ Med Ctr Gottingen, Inst Neuro & Sensory Physiol, Gottingen, Germany; [Hoebartner, Claudia] Georg August Univ, Inst Organ & Biomol Chem, Gottingen, Germany; [Opazo, Felipe] Univ Gottingen Med Ctr, Ctr Biostruct Imaging Neurodegenerat BIN, Gottingen, Germany	University of Gottingen; University of Gottingen	Opazo, F (corresponding author), Univ Med Ctr Gottingen, Inst Neuro & Sensory Physiol, Gottingen, Germany.; Opazo, F (corresponding author), Univ Gottingen Med Ctr, Ctr Biostruct Imaging Neurodegenerat BIN, Gottingen, Germany.	fopazo@gwdg.de	Höbartner, Claudia/O-2182-2019; Höbartner, Claudia/E-8462-2010; de Castro, Maria Angela Gomes/GSE-3362-2022	Höbartner, Claudia/0000-0002-4548-2299; Höbartner, Claudia/0000-0002-4548-2299; de Castro, Maria Angela Gomes/0000-0002-2679-6102; Opazo, Felipe/0000-0002-4968-9713	Deutsche Forschungsgemeinschaft Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)	Deutsche Forschungsgemeinschaft Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)	This work was supported by the Deutsche Forschungsgemeinschaft Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christina Schafer for cell culture technical assistance and Silvio O. Rizzoli for help with the Matlab analysis routines and helpful advice. We thank Eugenio F. Fornasiero and Sven Truckenbrodt for comments on the manuscript. We also thank Aptamer Sciences, Inc. (Pohang, South Korea) for developing and AMS Biotechnology (Europe) for providing aptamers. This work was generously supported by the Deutsche Forschungsgemeinschaft Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB).	Alford S, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-41; Barr DJ, 2008, CLATHRIN INDEPENDENT; Boissier P, 2013, TRAFFIC, V14, P1255, DOI 10.1111/tra.12123; Ciesolka J, 1996, RNA, V2, P105; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ellenbecker M, 2012, ANTIVIR RES, V93, P330, DOI 10.1016/j.antiviral.2012.01.002; ELLINGTON AD, 1994, CURR BIOL, V4, P427, DOI 10.1016/S0960-9822(00)00093-2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fornasiero EF, 2015, BIOESSAYS NEWS REV M, P1; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; Kabatas S, 2015, CHEM COMMUN, V51, P13221, DOI 10.1039/c5cc03895b; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kim JC, 2005, INDIAN J BIOCHEM BIO, V42, P358; Kim M, 2009, ENVIRON SCI TECHNOL, V43, P9335, DOI 10.1021/es902407g; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lee KY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/168306; Maidorn M, 2016, BIOCHEM J, V473, P3385, DOI 10.1042/BCJ20160366; Mikhaylova M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8933; Opazo F, 2012, NATURE METHODS, P938; Opazo F, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.25; Perruchini C, 2009, ACTA NEUROPATHOL, V118, P685, DOI 10.1007/s00401-009-0572-6; Platonova E, 2015, METHODS, V88, P89, DOI 10.1016/j.ymeth.2015.06.018; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Saka S.K., 2014, NAT COMMUN, V5, P1; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Ta H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8977; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zeng ZH, 2010, MODERN PATHOL, V23, P1553, DOI 10.1038/modpathol.2010.151	36	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173050	10.1371/journal.pone.0173050	http://dx.doi.org/10.1371/journal.pone.0173050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235049	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200190
J	Gaston, AJ; Hashimoto, Y; Wilson, L				Gaston, Anthony J.; Hashimoto, Yuriko; Wilson, Laurie			Post-breeding movements of Ancient Murrelet Synthliboramphus antiquus family groups, subsequent migration of adults and implications for management	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; BRITISH-COLUMBIA; PELAGIC SEABIRD; ATLANTIC-OCEAN; PACIFIC; INSIGHTS; DISTANCE; CANADA; BIRDS	Increased shipping in British Columbia (BC) waters poses risks for marine birds from marine oil spills. Ancient Murrelets (Synthliboramphus antiquus), small marine diving birds of which half of the world's population breeds in BC, are especially susceptible to oiling immediately after departing from their breeding colonies, as their offspring are flightless, constraining their parents to remain with them. In 2014 we deployed geolocator loggers on Ancient Murrelets at four breeding colonies, two on the east and two on the west coast of Haida Gwaii to investigate patterns of post-breeding dispersal and subsequent migratory movements. Birds from east coast colonies moved south and east after leaving their colonies, remaining in Queen Charlotte Sound and adjacent waters for 4-6 weeks, whereas those from west coast colonies moved steadily north and west, so that they left BC waters earlier than those from east coast colonies. These movements were consistent with being driven by surface currents. In June, all birds moved rapidly to the eastern Aleutians, SE Bering Sea, and waters off Kamchatka, where they probably moulted. In August, most moved north, some passing through Bering Straits into the Chukchi Sea. In October-November some birds returned to waters off western N America (33%) and the remainder carried on westwards to waters off Japan, Korea and NE China. For the former group the movement to the Bering Sea in June constituted a moult migration and, as such, is the first described for an auk. Those birds wintering in Asia began moving east in February and arrived off BC in March, when observations at colonies show that burrow visits begin in Haida Gwaii. Our data suggest that, immediately after colony departure, birds from the east coast colonies (about half the population of Haida Gwaii) are at higher risk from potential oil spills in northern British Columbia waters than those breeding on the west coast.	[Gaston, Anthony J.] Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Hashimoto, Yuriko; Wilson, Laurie] Environm Canada, Pacific Wildlife Res Ctr, Canadian Wildlife Serv, 5421 Robertson Rd,RR 1, Delta, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Pacific Wildlife Research Centre	Gaston, AJ (corresponding author), Environm Canada, Sci & Technol Branch, Natl Wildlife Res Ctr, Ottawa, ON, Canada.	tonygastonconsult@gmail.com		Gaston, Anthony/0000-0002-9448-3212	Environment and Climate Change Canada, Canadian Wildlife Service (the Canada's World Class Tanker Safety System Program Conservation Planning and Stewardship and Wildlife and Habitat Assessment Units); Canada's World Class Tanker Safety System program and Environment and Climate Change Canada's Canadian Wildlife Service Species at Risk and Migratory Bird Population Assessment Units	Environment and Climate Change Canada, Canadian Wildlife Service (the Canada's World Class Tanker Safety System Program Conservation Planning and Stewardship and Wildlife and Habitat Assessment Units); Canada's World Class Tanker Safety System program and Environment and Climate Change Canada's Canadian Wildlife Service Species at Risk and Migratory Bird Population Assessment Units	Funding for this research was provided by Environment and Climate Change Canada, Canadian Wildlife Service (the Canada's World Class Tanker Safety System Program Conservation Planning and Stewardship and Wildlife and Habitat Assessment Units. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided the Canada's World Class Tanker Safety System program and Environment and Climate Change Canada's Canadian Wildlife Service Species at Risk and Migratory Bird Population Assessment Units. We thank Connie Smith, Sandi Lee, Louise Laurin, Gloria White, Sarah James, Molly Kirk, Carita Bergman, Barb Wojtaszek, Heather Stewart, Roz Dunsmuir, Lucy Stefanyk and Erica McClaren for assistance acquiring permits. We thank Glen Keddie, Dan Shervill, Erika Lok, Courtenay Albert, Rhonda Millikin, David Cunnington, Moira Lemon, Erica McClaren, Lucy Stefanyk, and Laskeek Bay Conservation Society (Jake Pattison, Stuart Crawford, Christopher Mainella, Sebastian Dalgarno) for assistance with the capture and recapture of the murrelets and Jamie McDonald and Lindsay Seegmiller for logistic assistance with the Laskeek Bay Conservation Society field crews. Transportation to the colonies was provided by Moresby Explorers and the MV Anvil Cove. We thank Robert Day, Adrian Gall, Kathy Kuletz, Elizabeth Labunski, Jonathan Plissner and Gus van Vliet for information on the plumage of Ancient Murrelets seen in the northern Bering and Chukchi seas in late summer and Caroline Fox of Raincoast Conservation Foundation for information on shipboard surveys of marine birds in Hecate Strait and Queen Charlotte Sound. Thanks to Caroline Fox and Sidney Gauthreaux for excellent, constructive comments.	Canadian Hydrographic Service, 1991, SAIL DIR BRIT COL CO, V2; Cummins PF, 1997, J PHYS OCEANOGR, V27, P762, DOI 10.1175/1520-0485(1997)027<0762:SOBABT>2.0.CO;2; Duncan D. C., 1990, STUDIES AVIAN BIOL, V14, P109; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; ESRI, 2012, ARCGIS DESKT VERS 10; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Fox CH, 2016, SCI TOTAL ENVIRON, V573, P799, DOI 10.1016/j.scitotenv.2016.08.145; Gaston, 1992, ANCIENT MURRELET NAT; Gaston A.J., 1998, THE AUKS ALCIDAE; GASTON AJ, 1994, CAN FIELD NAT, V108, P211; Gaston AJ, 2015, IBIS, V157, P877, DOI 10.1111/ibi.12300; Gaston Anthony J., 1997, Bird Conservation International, V7, P35; Gaston Anthony J., 1998, Pacific Seabirds, V25, P65; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Huettmann F, 2000, CAN J ZOOL, V78, P624, DOI 10.1139/cjz-78-4-624; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Living Ocean Society, 2011, SHIPP BRIT COL COAST; Martin PW, 1969, SYESIS, V1, P241; McKnight A, 2013, MARINE ECOLOGY PROGR, V491, P263; Migrate Technology Ltd, 2015, INTIPROC VERS 1 03; Morgan KH, 1991, CANADIAN WILDL SERV, V72, P1; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Oppel S, 2008, CONDOR, V110, P296, DOI 10.1525/cond.2008.8502; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Poole A.F., 2010, BIRDS N AM ONLINE; Raincoast Conservation Foundation, 2010, WHATS STAK COST OIL, P1; Rodway M. S., 1991, TECH PUBL, V11, P43; Royal Society of Canada, 2004, REP EXP PAN SCI ISS; Salomonsen F., 1968, WILDFOWL, V19, P5; SEALY S G, 1979, Western Birds, V10, P25; SEALY SG, 1976, CONDOR, V78, P294, DOI 10.2307/1367688; Sealy Spencer G., 2015, Northwestern Naturalist, V96, P212; Sealy Spencer G., 2013, Northwestern Naturalist, V94, P209; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; StatSoft Inc., 2005, MESQUITE MODULAR SYS; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Swift A., 2011, PIPELINE TANKER TROU; WILLIAMS JM, 1995, IBIS, V137, pS147, DOI 10.1111/j.1474-919X.1995.tb08435.x	41	15	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171726	10.1371/journal.pone.0171726	http://dx.doi.org/10.1371/journal.pone.0171726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235033	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200033
J	Krings, M; Klein, B; Heneka, MJ; Rodder, D				Krings, Markus; Klein, Benjamin; Heneka, Markus J.; Roedder, Dennis			Morphological comparison of five species of poison dart frogs of the genus Ranitomeya (Anura: Dendrobatidae) including the skeleton, the muscle system and inner organs	PLOS ONE			English	Article							PYXICEPHALUS-ADSPERSUS ANURA; LARVAL CHONDROCRANIUM; AMPHIBIA; PHYLOGENY; EVOLUTION; OSTEOLOGY; TADPOLE; CLASSIFICATION; OSSIFICATION; CHARACTERS	The morphology of larvae stages of most amphibians are often completely different than in adults. Tadpole descriptions have historically been based on external characters like morphometrics, color pattern and oral disc structure. Other papers described anatomical details by the use of dissections. The increase in micro- CT scanning technology provides an opportunity to quantify and describe in detail internal characters like skeleton, musculature and organs. To date, no such tadpole descriptions exist for the well- studied Neotropical poison dart frog genus Ranitomeya (Anura: Dendrobatidae). Here we provide descriptions of the internal skeletal, musculature and organ structures of five Ranitomeya species and then provide morphological comparisons. Contrary to previous observations, closely related species display several morphological differences. For example, we observed considerable variation in chondrocranial characters, the extent of cranial ossifications, the appearance of some cranial muscles and the arrangement of inner organs. Further studies on the tadpole morphology of more species of Ranitomeya and other dendrobatid genera are needed to enable us to understand the complete morphological variation in this group.	[Krings, Markus; Klein, Benjamin; Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Dept Herpetol, Bonn, Germany; [Heneka, Markus J.] RJL Micro & Analyt, Karlsdorf Neuthard, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Rodder, D (corresponding author), Zool Forsch Museum Alexander Koenig, Dept Herpetol, Bonn, Germany.	d.roedder@zfmk.de	Rödder, Dennis/AAT-8644-2021	Rödder, Dennis/0000-0002-6108-1639	Alexander Koenig Gesellschaft, Bonn, Germany [1-2015]; RJL Micro Analytic	Alexander Koenig Gesellschaft, Bonn, Germany; RJL Micro Analytic	MK was funded by the Alexander Koenig Gesellschaft, Bonn, Germany (grant number 1-2015; https://www.zfmk.de/de/akg). The funding organization had no influence on any applied techniques or interpretation of results. The funder RJL Micro & Analytic provided support in the form of salary for author MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JL, 2011, ZOOTAXA, P1; Candioti MFV, 2007, ZOOTAXA, P1; Cannatella D, 1999, TADPOLES, P52; Cardini A, 2008, BIOL J LINN SOC, V93, P813, DOI 10.1111/j.1095-8312.2008.01011.x; Clough M, 2000, BIOL J LINN SOC, V70, P515; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; de Sa RO, 1998, J HERPETOL, V32, P205, DOI 10.2307/1565298; DESA RO, 1988, J MORPHOL, V195, P345, DOI 10.1002/jmor.1051950308; Dias PHD, 2013, ZOOTAXA, V3683, P427, DOI 10.11646/zootaxa.3683.4.6; Fabrezi M, 1997, CARACTERIZACION MORF, P37; Fabrezi M, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0043-9; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gaupp E., 1893, Morphol Arbeit, Vii, P275; Gaupp E., 1894, MORPHOL ARB, V3, P399; Grant T., 2006, B AM MUS NAT HIST, V299, P1, DOI DOI 10.1206/0003-0090(2006)299[; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; Haas A, 1997, J ZOOL SYST EVOL RES, V35, P179; HAAS A, 1995, J MORPHOL, V224, P241, DOI 10.1002/jmor.1052240302; Haas A, 1999, ZOOMORPHOLOGY, V119, P23, DOI 10.1007/s004350050078; Haas A, 2014, ZOOMORPHOLOGY, V133, P321, DOI 10.1007/s00435-014-0226-7; Inger RF, 2009, RAFFLES B ZOOL, V57, P527; KEMP NE, 1969, J MORPHOL, V129, P415, DOI 10.1002/jmor.1051290404; Kolenc F, 2013, J HERPETOL, V47, P599, DOI 10.1670/13-028; Larson PM, 2005, J MORPHOL, V264, P34, DOI 10.1002/jmor.10313; Larson PM, 2004, ZOOMORPHOLOGY, V123, P95, DOI 10.1007/s00435-003-0092-1; Lotters S., 2007, POISON FROGS BIOL SP; Maglia AM, 2001, AM ZOOL, V41, P538, DOI 10.1668/0003-1569(2001)041[0538:CDOAUP]2.0.CO;2; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Myers C.W., 1991, American Museum Novitates, P1; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Reiss JO, 1997, J MORPHOL, V231, P63, DOI 10.1002/(SICI)1097-4687(199701)231:1<63::AID-JMOR6>3.0.CO;2-P; Sanchez DA, 2013, ZOOTAXA, V3637, P569, DOI 10.11646/zootaxa.3637.5.5; Santos JC, 2003, P NATL ACAD SCI USA, V100, P12792, DOI 10.1073/pnas.2133521100; Sheil CA, 2005, J MORPHOL, V265, P343, DOI 10.1002/jmor.10362; Sheil CA, 1999, J MORPHOL, V240, P49, DOI 10.1002/(SICI)1097-4687(199904)240:1<49::AID-JMOR5>3.0.CO;2-Z; SOKOL OM, 1981, J MORPHOL, V169, P161, DOI 10.1002/jmor.1051690204; SOKOL OM, 1977, J MORPHOL, V154, P357, DOI 10.1002/jmor.1051540304; SOKOL OM, 1975, COPEIA, P1; Valderrana-Vernaza M, 2009, J HERPETOL, V43, P114, DOI 10.1670/07-247R1.1; Vences M, 2000, MOL PHYLOGENET EVOL, V15, P34, DOI 10.1006/mpev.1999.0738; Vences M, 2003, ORG DIVERS EVOL, V3, P215, DOI 10.1078/1439-6092-00076; Viertel B, 1999, TADPOLES, P92; VIRAPONGSE C, 1984, AM J NEURORADIOL, V5, P147; WASSERSUG RJ, 1976, STAIN TECHNOL, V51, P131, DOI 10.3109/10520297609116684; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5; Ziermann JM, 2013, ACTA ZOOL-STOCKHOLM, V94, P101, DOI 10.1111/j.1463-6395.2011.00525.x	48	10	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e71669	10.1371/journal.pone.0171669	http://dx.doi.org/10.1371/journal.pone.0171669			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235032	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200029
J	Schalk, K; Lexhaller, B; Koehler, P; Scherf, KA				Schalk, Kathrin; Lexhaller, Barbara; Koehler, Peter; Scherf, Katharina Anne			Isolation and characterization of gluten protein types from wheat, rye, barley and oats for use as reference materials	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; EXERCISE-INDUCED ANAPHYLAXIS; CELIAC-DISEASE PATIENTS; MASS-SPECTROMETRY; STORAGE PROTEINS; OMEGA-5 GLIADIN; IDENTIFICATION; PROLAMIN; FLOUR; SECALINS	Gluten proteins from wheat, rye, barley and, in rare cases, oats, are responsible for triggering hypersensitivity reactions such as celiac disease, non-celiac gluten sensitivity and wheat allergy. Well-defined reference materials (RM) are essential for clinical studies, diagnostics, elucidation of disease mechanisms and food analyses to ensure the safety of gluten- free foods. Various RM are currently used, but a thorough characterization of the gluten source, content and composition is often missing. However, this characterization is essential due to the complexity and heterogeneity of gluten to avoid ambiguous results caused by differences in the RM used. A comprehensive strategy to isolate gluten protein fractions and gluten protein types (GPT) from wheat, rye, barley and oat flours was developed to obtain well-defined RM for clinical assays and gluten-free compliance testing. All isolated GPT (omega 5-gliadins,omega 1,2-gliadins, alpha-gliadins,gamma-gliadins and high-and low-molecular-weight glutenin subunits from wheat,omega-secalins,gamma-75k-secalins,gamma-40k-secalins and high-molecularweight secalins from rye, C-hordeins,gamma-hordeins, B-hordeins and D-hordeins from barley and avenins from oats) were fully characterized using analytical reversed-phase high-performance liquid chromatography (RP-HPLC), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), N-terminal sequencing, electrospray-ionization quadrupole time-of-flight mass spectrometry (LC-ESI-QTOF-MS) and untargeted LC-MS/MS of chymotryptic hydrolyzates of the single GPT. Taken together, the analytical methods confirmed that all GPT were reproducibly isolated in high purity from the flours and were suitable to be used as RM, e.g., for calibration of LC-MS/MS methods or enzyme-linked immunosorbent assays (ELISAs).	[Schalk, Kathrin; Lexhaller, Barbara; Koehler, Peter; Scherf, Katharina Anne] Leibniz Inst, Deutsch Forschungsanstalt Lebensmittelchem, Freising Weihenstephan, Germany	Leibniz-Institute for Food Systems Biology at the Technical University of Munich	Scherf, KA (corresponding author), Leibniz Inst, Deutsch Forschungsanstalt Lebensmittelchem, Freising Weihenstephan, Germany.	katharina.scherf@lrz.tum.de	SCHERF, Katharina/B-8141-2019; Scherf, Katharina/AAM-7029-2020	SCHERF, Katharina/0000-0001-8315-5400; 	German Celiac Society; German Federal Ministry of Education and Research via the VDI Technologiezentrum GmbH [13GW0042]; Deutsche Forschungsgemeinschaft (DFG) [KO 1762/12-1]; Open Access Fund of the Leibniz Association	German Celiac Society; German Federal Ministry of Education and Research via the VDI Technologiezentrum GmbH; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association	Katharina Anne Scherf wishes to acknowledge the German Celiac Society (Deutsche Zoliakie-Gesellschaft e.V.) for financial support (research grant 2014). Peter Koehler acknowledges funding by the German Federal Ministry of Education and Research via the VDI Technologiezentrum GmbH (Grant No. 13GW0042) and by the Deutsche Forschungsgemeinschaft (DFG, Project No. KO 1762/12-1). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083569; [Anonymous], 2000, 167 ICC INT ASS CER; Arentz-Hansen EH, 2000, GUT, V46, P46, DOI 10.1136/gut.46.1.46; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Brockow K, 2015, J ALLERGY CLIN IMMUN, V135, P977, DOI 10.1016/j.jaci.2014.08.024; Bundesministerium fur Ernahrung Landwirtschaft und Verbraucherschutz (BMELV), BES ERNT QUAL 2012; Camarca Alessandra, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P207; Celus I, 2006, J CEREAL SCI, V44, P203, DOI 10.1016/j.jcs.2006.06.003; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Colgrave ML, 2013, FOOD RES INT, V54, P1001, DOI 10.1016/j.foodres.2012.09.043; Colgrave ML, 2012, J PROTEOME RES, V11, P386, DOI 10.1021/pr2008434; Dewar DH, 2006, EUR J GASTROEN HEPAT, V18, P483, DOI 10.1097/00042737-200605000-00005; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Eggert K, 2010, EUR FOOD RES TECHNOL, V230, P893, DOI 10.1007/s00217-010-1234-6; Ellis HJ, 2012, INT ARCH ALLERGY IMM, V159, P428, DOI 10.1159/000338284; Fasano A, 2015, GASTROENTEROLOGY, V148, P1195, DOI 10.1053/j.gastro.2014.12.049; Gellrich C, 2003, CEREAL CHEM, V80, P102, DOI 10.1094/CCHEM.2003.80.1.102; Hajas L, 2016, ACTA ALIMENT; ICC, 1976, 1101 ICC INT ASS CER; ICC, 1990, 1041 ICC INT ASS CER; KASARDA DD, 1983, BIOCHIM BIOPHYS ACTA, V747, P138, DOI 10.1016/0167-4838(83)90132-2; Koenig A, 2015, FOOD CHEM, V168, P176, DOI 10.1016/j.foodchem.2014.07.040; Lagrain B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058682; Lagrain B, 2012, J CEREAL SCI, V56, P726, DOI 10.1016/j.jcs.2012.08.003; Lange M, 2007, J AGR FOOD CHEM, V55, P6074, DOI 10.1021/jf0709505; Lee JY, 2016, FUNCT INTEGR GENOMIC, V16, P269, DOI 10.1007/s10142-016-0482-3; LEW EJL, 1992, CEREAL CHEM, V69, P508; Lexhaller B, 2016, ANAL BIOANAL CHEM, V408, P6093, DOI 10.1007/s00216-016-9721-7; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Matsuo H, 2005, FEBS J, V272, P4431, DOI 10.1111/j.1742-4658.2005.04858.x; Pflaum T, 2013, J AGR FOOD CHEM, V61, P6485, DOI 10.1021/jf4012906; Piston F, 2007, THEOR APPL GENET, V115, P77, DOI 10.1007/s00122-007-0542-0; RECHINGER KB, 1993, PLANT J, V4, P841, DOI 10.1046/j.1365-313X.1993.04050841.x; ROBERT LS, 1985, CEREAL CHEM, V62, P276; Rocher A, 1996, BBA-PROTEIN STRUCT M, V1295, P13, DOI 10.1016/0167-4838(95)00269-3; Rombouts I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02279; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Scherf KA, 2016, J AGR FOOD CHEM, V64, P7622, DOI 10.1021/acs.jafc.6b02512; Scherf KA, 2016, EUR FOOD RES TECHNOL, V242, P1837, DOI 10.1007/s00217-016-2683-3; Scherf KA, 2016, J CEREAL SCI, V67, P2, DOI 10.1016/j.jcs.2015.07.008; Scherf KA, 2016, J CEREAL SCI, V67, P112, DOI 10.1016/j.jcs.2015.08.006; Schmid M, 2016, CEREAL CHEM, V93, P536, DOI 10.1094/CCHEM-04-16-0078-R; Schwalb K.P., 2011, P 24TH WORK PROLAMIN, P23; SHEWRY PR, 1985, FEBS LETT, V190, P61, DOI 10.1016/0014-5793(85)80427-0; SHEWRY PR, 1982, J EXP BOT, V33, P261, DOI 10.1093/jxb/33.2.261; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Srinivasan B, 2015, J ALLERGY CLIN IMMUN, V136, P1607, DOI 10.1016/j.jaci.2015.04.040; Stoven S, 2013, EXPERT OPIN DRUG DIS, V8, P445, DOI 10.1517/17460441.2013.761203; Takahashi H, 2012, CLIN EXP ALLERGY, V42, P1293, DOI 10.1111/j.1365-2222.2012.04039.x; Tanner GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056456; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Tatham AS, 2012, J CEREAL SCI, V55, P79, DOI 10.1016/j.jcs.2011.10.013; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H., 2014, CELIAC DIS GLUTEN MU, DOI DOI 10.1016/C2013-0-13353-3	55	98	100	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172819	10.1371/journal.pone.0172819	http://dx.doi.org/10.1371/journal.pone.0172819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234993	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200146
J	Stadem, PS; Hilgers, MV; Bengo, D; Cusick, SE; Ndidde, S; Slusher, TM; Lund, TC				Stadem, Paul S.; Hilgers, Megan V.; Bengo, Derrick; Cusick, Sarah E.; Ndidde, Susan; Slusher, Tina M.; Lund, Troy C.			Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT; NEONATAL JAUNDICE; HEMATOCRIT; HEMOLYSIS; NIGERIA; DNA	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked disorder that affects as many as 400 million people worldwide, making it the most common enzymatic defect. Subjects with G6PD deficiency are more likely to develop neonatal hyperbilirubinemia potentially leading to kernicterus and are at increased risk for acute hemolytic anemia when exposed to pro-oxidant compounds such as anti-alarial drugs. We collected umbilical cord blood from 300 males born in Uganda to assess for novel markers of systemic oxidative stress. We determined that 10.7% of the samples collected were G6PD A-deficient (G202A/A376G) and when these were compared with unaffected controls, there was significantly higher 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration, elevated ferritin, increased leukocyte count and higher small molecule antioxidant capacity. These data suggest increased baseline oxidative stress and an elevated antioxidant response in umbilical cord blood of patients with G6PD deficiency.	[Stadem, Paul S.] Mayo Clin, Sch Med, Rochester, MN USA; [Hilgers, Megan V.; Cusick, Sarah E.; Slusher, Tina M.; Lund, Troy C.] Univ Minnesota Univ, Div Global Hlth, Dept Pediat, Minneapolis, MN 55455 USA; [Bengo, Derrick; Ndidde, Susan] Mulago Hosp, Dept Hematol, Kampala, Uganda	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mulago National Referral Hospital	Lund, TC (corresponding author), Univ Minnesota Univ, Div Global Hlth, Dept Pediat, Minneapolis, MN 55455 USA.	lundx072@umn.edu		lund, Troy/0000-0001-9174-8919	Fulbright Foundation	Fulbright Foundation	This work was supported by the Fulbright Foundation to PS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badejoko BO, 2014, PEDIATRICS, V134, pE1082, DOI 10.1542/peds.2014-0654; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Effiong C E, 1975, J Natl Med Assoc, V67, P208; Gaetani GF, 1996, BLOOD, V88, P1084; Hori A, 2010, CANCER SCI, V101, P517, DOI 10.1111/j.1349-7006.2009.01394.x; Hsu J, 2014, PEDIATR HEMAT ONCOL, V31, P68, DOI 10.3109/08880018.2013.860649; Kandil HH, 1996, ANN TROP PAEDIATR, V16, P287, DOI 10.1080/02724936.1996.11747840; Kaplan M, 2004, PEDIATRICS, V114, P213; Kaplan M, 2001, PEDIATR RES, V50, P532, DOI 10.1203/00006450-200110000-00018; Kaplan M, 1996, BRIT J HAEMATOL, V93, P822, DOI 10.1046/j.1365-2141.1996.d01-1745.x; Kaplan Michael, 2002, Semin Neonatol, V7, P121, DOI 10.1053/siny.2002.0099; Maruyama Y, 2007, NEPHROL DIAL TRANSPL, V22, P1407, DOI 10.1093/ndt/gfl789; MELONI T, 1975, ACTA HAEMATOL-BASEL, V54, P284, DOI 10.1159/000208087; MELONI T, 1987, EARLY HUM DEV, V15, P317, DOI 10.1016/0378-3782(87)90026-0; Nunomura A, 1999, J NEUROSCI, V19, P1959; OWA JA, 1989, ACTA PAEDIATR SCAND, V78, P848, DOI 10.1111/j.1651-2227.1989.tb11162.x; Slusher TM, 2015, NEW ENGL J MED, V373, P1115, DOI 10.1056/NEJMoa1501074; SODEINDE O, 1995, ANN TROP PAEDIATR, V15, P107, DOI 10.1080/02724936.1995.11747757; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Tsou TC, 1996, CARCINOGENESIS, V17, P103, DOI 10.1093/carcin/17.1.103; TUGWELL P, 1973, LANCET, V1, P968; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731	25	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172980	10.1371/journal.pone.0172980	http://dx.doi.org/10.1371/journal.pone.0172980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235023	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200180
J	Vodstrcil, LA; Twin, J; Garland, SM; Fairley, CK; Hocking, JS; Law, MG; Plummer, EL; Fethers, KA; Chow, EPF; Tabrizi, SN; Bradshaw, CS				Vodstrcil, Lenka A.; Twin, Jimmy; Garland, Suzanne M.; Fairley, Christopher K.; Hocking, Jane S.; Law, Matthew G.; Plummer, Erica L.; Fethers, Katherine A.; Chow, Eric P. F.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.			The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LACTIC-ACID	Objectives To examine the influence of sexual activity on the composition and consistency of the vaginal microbiota over time, and distribution of Gardnerella vaginalis clades in young women. Methods Fifty-two participants from a university cohort were selected. Vaginal swabs were self-collected every 3-months for up to 12 months with 184 specimens analysed. The vaginal microbiota was characterised using Roche 454 V3/4 region 16S rRNA sequencing, and G. vaginalis clade typing by qPCR. Results A Lactobacillus crispatus dominated vaginal microbiota was associated with Caucasian ethnicity (adjusted relative risk ratio[ARRR] = 7.28, 95%CI: 1.37,38.57, p = 0.020). An L. iners (ARRR = 17.51, 95%CI: 2.18,140.33, p = 0.007) or G. vaginalis (ARRR = 14.03, 95%CI: 1.22,160.69, p = 0.034) dominated microbiota was associated with engaging in penilevaginal sex. Microbiota dominated by L. crispatus, L. iners or other lactobacilli exhibited greater longitudinal consistency of the bacterial communities present compared to ones dominated by heterogeneous non-lactobacilli (p<0.030); sexual activity did not influence consistency. Women who developed BV were more likely to have clade GV4 compared to those reporting no sex/practiced non-coital activities (OR = 11.82, 95%CI: 1.87,74.82, p = 0.009). Specimens were more likely to contain multiple G. vaginalis clades rather than a single clade if women engaged in penile-vaginal sex (RRR = 9.55, 95%CI: 1.33,68.38, p = 0.025) or were diagnosed with BV (RRR = 31.5, 95% CI: 1.69,586.87, p = 0.021). Conclusions Sexual activity and ethnicity influenced the composition of the vaginal microbiota of these young, relatively sexually inexperienced women. Women had consistent vaginal microbiota over time if lactobacilli were the dominant spp. present. Penile-vaginal sex did not alter the consistency of microbial communities but increased G. vaginalis clade diversity in young women with and without BV, suggesting sexual transmission of commensal and potentially pathogenic clades.	[Vodstrcil, Lenka A.; Fairley, Christopher K.; Fethers, Katherine A.; Chow, Eric P. F.; Bradshaw, Catriona S.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Fairley, Christopher K.; Chow, Eric P. F.; Bradshaw, Catriona S.] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia; [Vodstrcil, Lenka A.; Twin, Jimmy; Garland, Suzanne M.; Plummer, Erica L.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Dept Mol Microbiol, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Plummer, Erica L.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Law, Matthew G.] Univ New South Wales, Kirby Inst, Darlinghurst, NSW, Australia; [Tabrizi, Sepehr N.] Royal Childrens Hosp, Dept Microbiol, Melbourne, Vic, Australia	Monash University; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Royal Children's Hospital Melbourne	Vodstrcil, LA (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Vodstrcil, LA (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.; Vodstrcil, LA (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia.; Vodstrcil, LA (corresponding author), Murdoch Childrens Res Inst, Dept Mol Microbiol, Melbourne, Vic, Australia.	lvodstrcil@mshc.org.au	Hocking, Jane/AAD-5203-2021; Vodstrcil, Lenka/AAC-1896-2019; Chow, Eric P.F./W-6684-2019; Vodstrcil, Lenka/AAF-8722-2020; Plummer, Erica/AAK-8835-2021	Hocking, Jane/0000-0001-9329-8501; Chow, Eric P.F./0000-0003-1766-0657; Vodstrcil, Lenka/0000-0003-3679-9195; Plummer, Erica/0000-0001-5710-2671; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664; Law, Matthew/0000-0002-3540-8837	National Health and Medical Research Council of Australia [APP1020457]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The research presented was funded by the National Health and Medical Research Council of Australia (APP1020457)	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Albert AYK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135620; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; Fethers KA, 2011, SEX TRANSM DIS, V38, P124, DOI 10.1097/OLQ.0b013e3181f0bc37; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Hickey RJ, 2015, MBIO, V6, DOI 10.1128/mBio.00097-15; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Mayer BT, 2015, J INFECT DIS, V212, P793, DOI 10.1093/infdis/jiv079; Mendes-Soares H, 2014, J BACTERIOL, V196, P1458, DOI 10.1128/JB.01439-13; Mitchell CM, 2012, OBSTET GYNECOL, V120, P1306, DOI [10.1097/AOG.0b013e31827075ac, http://10.1097/AOG.0b013e31827075ac]; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schuyler JA, 2015, DIAGN MICROBIOL INFE; Schwebke JR, 2009, SEX TRANSM DIS, V36, P92, DOI 10.1097/OLQ.0b013e3181886727; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Twin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076892; Vodstrcil LA, 2013, PLOS ONE, V8; Witkin SS, 2013, MBIO, V4, DOI 10.1128/mBio.00460-13	31	55	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171856	10.1371/journal.pone.0171856	http://dx.doi.org/10.1371/journal.pone.0171856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234976	gold, Green Published			2022-12-27	WOS:000394688200036
J	Bellatorre, A; Jackson, SH; Choi, K				Bellatorre, Anna; Jackson, Sharon H.; Choi, Kelvin			Development of the diabetes typology model for discerning Type 2 diabetes mellitus with national survey data	PLOS ONE			English	Article							INSULIN-RESISTANCE; UNITED-STATES; METAANALYSIS; DISEASE; YOUTH; RISK; PREVALENCE; SEARCH; COHORT; WOMEN	Objective To classify individuals with diabetes mellitus (DM) into DM subtypes using population-based studies. Design Population-based survey Setting Individuals participated in 2003-2004, 2005-2006, or 2009-2010 the National Health and Nutrition Examination Survey (NHANES), and 2010 Coronary Artery Risk Development in Young Adults (CARDIA) survey (research materials obtained from the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center) Participants 3084, 3040 and 3318 US adults from the 2003-2004, 2005-2006 and 2009-2010 NHANES samples respectively, and 5,115 US adults in the CARDIA cohort Primary outcome measures We proposed the Diabetes Typology Model (DTM) through the use of six composite measures based on the Homeostatic Model Assessment (HOMA-IR , HOMA-%beta, high HOMA-%S), insulin and glucose levels, and body mass index and conducted latent class analyses to empirically classify individuals into different classes. Results Three empirical latent classes consistently emerged across studies (entropy = 0.81-0.998). These three classes were likely Type 1 DM, likely Type 2 DM, and atypical DM. The classification has high sensitivity (75.5%), specificity (83.3%), and positive predictive value (97.4%) when validated against C-peptide level. Correlates of Type 2 DM were significantly associated with model-identified Type 2 DM. Compared to regression analysis on known correlates of Type 2 DM using all diabetes cases as outcomes, using DTM to remove likely Type 1 DM and atypical DM cases results in a 2.5-5.3% r-square improvement in the regression analysis, as well as model fits as indicated by significant improvement in -2 log likelihood (p<0.01). Lastly, model-defined likely Type 2 DM was significantly associated with known correlates of Type 2 DM (e.g., age, waist circumference), which provide additional validation of the DTM-defined classes. Conclusions Our Diabetes Typology Model reflects a promising first step toward discerning likely DM types from population-based data. This novel tool will improve how large population-based studies can be used to examine behavioral and environmental factors associated with different types of DM.	[Bellatorre, Anna; Jackson, Sharon H.; Choi, Kelvin] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD)	Choi, K (corresponding author), Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA.	kelvin.choi@nih.gov	Choi, Kelvin/U-1806-2019		Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities [ZIAMD000006] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is supported by the Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Hamman RF, 2014, DIABETES CARE, V37, P3336, DOI 10.2337/dc14-0574; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Johnson JL, 2010, ENDOCR PRACT, V16, P47, DOI 10.4158/EP09031.OR; KATZEFF HL, 1985, DIABETOLOGIA, V28, P264, DOI 10.1007/BF00271682; Lawrence JM, 2014, DIABETES, V63, P3938, DOI 10.2337/db13-1891; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke A, 2013, EPIDEMIOLOGY, V24, P773, DOI 10.1097/EDE.0b013e31829ef01a; National Institutes of Health, 2014, COR ART RISK DEV YOU; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Palmer Jerry P., 2004, Diabetes, V53, P250; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rewers A, 2008, PEDIATRICS, V121, pE1258, DOI 10.1542/peds.2007-1105; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; United States Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, 2015, NAT HLTH NUTR EX SUR; US Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Whitsel E.A., 2012, CIRCULATION, V125, DOI [10.1161/circ.125.suppl_10.AP010, DOI 10.1161/CIRC.125.SUPPL_10.AP010]	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173103	10.1371/journal.pone.0173103	http://dx.doi.org/10.1371/journal.pone.0173103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253317	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300076
J	Cuervo, JJ; Moller, AP				Cuervo, Jose J.; Moller, Anders P.			Colonial, more widely distributed and less abundant bird species undergo wider population fluctuations independent of their population trend	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; TEMPORAL VARIABILITY; DENSITY-DEPENDENCE; FLIGHT DISTANCE; TIME-SERIES; BRAIN SIZE; INFORMATION-CENTERS; SEXUAL SELECTION; BLOOD PARASITES; CLIMATE-CHANGE	Understanding temporal variability in population size is important for conservation biology because wide population fluctuations increase the risk of extinction. Previous studies suggested that certain ecological, demographic, life-history and genetic characteristics of species might be related to the degree of their population fluctuations. We checked whether that was the case in a large sample of 231 European breeding bird species while taking a number of potentially confounding factors such as population trends or similarities among species due to common descent into account. When species-specific characteristics were analysed one by one, the magnitude of population fluctuations was positively related to coloniality, habitat, total breeding range, heterogeneity of breeding distribution and natal dispersal, and negatively related to urbanisation, abundance, relative number of subspecies, parasitism and proportion of polymorphic loci. However, when abundance (population size) was included in the analyses of the other parameters, only coloniality, habitat, total breeding range and abundance remained significantly related to population fluctuations. The analysis including all these predictors simultaneously showed that population size fluctuated more in colonial, less abundant species with larger breeding ranges. Other parameters seemed to be related to population fluctuations only because of their association with abundance or coloniality. The unexpected positive relationship between population fluctuations and total breeding range did not seem to be mediated by abundance. The link between population fluctuations and coloniality suggests a previously unrecognized cost of coloniality. The negative relationship between population size and population fluctuations might be explained by at least three types of non-mutually exclusive stochastic processes: demographic, environmental and genetic stochasticity. Measurement error in population indices, which was unknown, may have contributed to the negative relationship between population size and fluctuations, but apparently only to a minor extent. The association between population size and fluctuations suggests that populations might be stabilized by increasing population size.	[Cuervo, Jose J.] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain; [Moller, Anders P.] Univ Paris Saclay, AgroParisTech, CNRS, Ecol Systemat Evolut,Univ Paris Sud, Orsay, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cuervo, JJ (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain.	jjcuervo@mncn.csic.es	Cuervo, José Javier/K-1646-2014; Moller, Anders/O-6665-2016	Cuervo, José Javier/0000-0001-7943-7835; Moller, Anders/0000-0003-3739-4675	Spanish National Research Council [EST001196]; Spanish Ministry of Science and Innovation; European Regional Development Fund [CGL2008-00137/BOS]; Spanish Ministry of Economy and Competitiveness [CGL2013-48193-C3-3-P]	Spanish National Research Council; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	JJC was funded by the Spanish National Research Council (grant EST001196), by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (grant CGL2008-00137/BOS), and by the Spanish Ministry of Economy and Competitiveness (grant CGL2013-48193-C3-3-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, BIOL CONSERV, V137, P271, DOI 10.1016/j.biocon.2007.02.010; Andersson Malte, 1994; [Anonymous], 2014, R LANG ENV STAT COMP; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Belliure J, 2000, J EVOLUTION BIOL, V13, P480; Beninca E, 2015, P NATL ACAD SCI USA, V112, P6389, DOI 10.1073/pnas.1421968112; Bjorkvoll E, 2012, AM NAT, V180, P372, DOI 10.1086/666983; Blackburn TM, 1996, J ANIM ECOL, V65, P52, DOI 10.2307/5699; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; BOHNINGGAESE K, 1994, OIKOS, V70, P121, DOI 10.2307/3545706; BROWN CR, 1988, ECOLOGY, V69, P602, DOI 10.2307/1941009; BROWN JH, 1990, OIKOS, V59, P290, DOI 10.2307/3545139; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BULMER MG, 1975, BIOMETRICS, V31, P901, DOI 10.2307/2529815; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Cuervo JJ, 2001, EVOL ECOL, V15, P53, DOI 10.1023/A:1011913804309; Cuervo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077654; Curnutt JL, 1996, OIKOS, V76, P131, DOI 10.2307/3545755; Dale J, 2015, NATURE, V527, P367, DOI 10.1038/nature15509; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Dhondt AA, 1998, IBIS, V140, P580, DOI 10.1111/j.1474-919X.1998.tb04702.x; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Dochtermann NA, 2013, OECOLOGIA, V171, P153, DOI 10.1007/s00442-012-2402-0; Dochtermann NA, 2010, J ANIM ECOL, V79, P888, DOI 10.1111/j.1365-2656.2010.01686.x; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fisher DO, 2001, ECOLOGY, V82, P3531, DOI 10.1890/0012-9658(2001)082[3531:TEBOLH]2.0.CO;2; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Fowler MS, 2009, OIKOS, V118, P604, DOI 10.1111/j.1600-0706.2009.17321.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Freckleton RP, 2006, AM NAT, V167, P260, DOI 10.1086/498655; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gamelon M, 2014, AM NAT, V184, P673, DOI 10.1086/677929; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gilpin M.E., 1986, P19; Glutz von Blotzheim UN, 1966, HDB VOGEL MITTELEURO, V1-15; Greenwood JJD, 1996, PHILOS T R SOC B, V351, P265, DOI 10.1098/rstb.1996.0023; Grell J., 2010, UNTERRICHTSREZEPTE; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; HANSKI I, 1989, ANN ZOOL FENN, V26, P213; Hedrick P, 2005, EVOLUTION, V59, P1596; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Johnson CA, 2009, P R SOC B, V276, P3361, DOI 10.1098/rspb.2008.1958; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lande R., 2003, OXFORD SERIES ECOLOG; Lande R, 2006, AM NAT, V168, P76, DOI 10.1086/504851; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Lundberg P, 2000, TRENDS ECOL EVOL, V15, P460, DOI 10.1016/S0169-5347(00)01981-9; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martui R., 2003, ATLAS AVES REPRODUCT; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Miller DA, 2011, ECOLOGY, V92, P1658; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Moller AP, 2014, J EVOLUTION BIOL, V27, P34, DOI 10.1111/jeb.12272; Moller AP, 2010, ECOLOGY, V91, P2769, DOI 10.1890/09-1300.1; Moller AP, 2011, ETHOLOGY, V117, P529, DOI 10.1111/j.1439-0310.2011.01899.x; Moller AP, 2008, BEHAV ECOL, V19, P1305, DOI 10.1093/beheco/arn074; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Moller AP, 2006, BEHAV ECOL SOCIOBIOL, V60, P227, DOI 10.1007/s00265-006-0160-x; Moller AP, 2011, CLIM RES, V49, P201, DOI 10.3354/cr01030; Moller Anders Pape, 2010, Chinese Birds, V1, P97; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Moller AP, 2005, J EVOLUTION BIOL, V18, P223, DOI 10.1111/j.1420-9101.2004.00805.x; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Mullarney T, 2000, COMPLETE GUIDE BIRDS; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANNEKOEK J, 2005, TRIM 3 MANUAL; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PEIRCE MA, 1981, J NAT HIST, V15, P419, DOI 10.1080/00222938100770321; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; PROMISLOW D, 1994, EVOLUTION, V48, P2045, DOI 10.1111/j.1558-5646.1994.tb02232.x; Reed DH, 2004, ANIM CONSERV, V7, P1, DOI 10.1017/S1367943004003476; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reif J, 2010, IBIS, V152, P610, DOI 10.1111/j.1474-919X.2010.01036.x; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Rolland C, 1998, AM NAT, V151, P514, DOI 10.1086/286137; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Saether BE, 2005, ECOLOGY, V86, P693, DOI 10.1890/04-0878; Saether BE, 2007, J ANIM ECOL, V76, P315, DOI 10.1111/j.1365-2656.2006.01195.x; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Saether BE, 2011, J ANIM ECOL, V80, P215, DOI 10.1111/j.1365-2656.2010.01751.x; Saether BE, 2009, J ANIM ECOL, V78, P1063, DOI 10.1111/j.1365-2656.2009.01565.x; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; Seoane J, 2008, GLOBAL ECOL BIOGEOGR, V17, P111, DOI 10.1111/j.1466-8238.2007.00351.x; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Spottiswoode C, 2004, P ROY SOC B-BIOL SCI, V271, P267, DOI 10.1098/rspb.2003.2605; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Svensson L, 1984, IDENTIFICATION GUIDE; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Turchin P, 1996, RES POPUL ECOL, V38, P121, DOI 10.1007/BF02515720; Vucetich JA, 2000, CONSERV BIOL, V14, P1704, DOI 10.1111/j.1523-1739.2000.99359.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; WETTON JH, 1987, NATURE, V327, P147, DOI 10.1038/327147a0; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	141	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173220	10.1371/journal.pone.0173220	http://dx.doi.org/10.1371/journal.pone.0173220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253345	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300092
J	Liu, S; Wang, XD; Wang, Y; Shi, ZH; Cai, L; Liu, SL; Han, T; Zhou, YY; Wang, XP; Gao, S; Ji, Y				Liu, Shuai; Wang, Xiao-Dan; Wang, Ying; Shi, Zhihong; Cai, Li; Liu, Shuling; Han, Tong; Zhou, Yuying; Wang, Xinping; Gao, Shuo; Ji, Yong			Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies	PLOS ONE			English	Article							PARKINSON DISEASE DEMENTIA; BODY DEMENTIA; ALZHEIMERS-DISEASE; DIAGNOSIS; IDENTIFICATION; CONSORTIUM; BIOMARKERS; SYMPTOMS; CRITERIA	Dementia with Lewy bodies (DLB) is the second most common subtype of degenerative dementia. To our knowledge, available information about the clinical features of DLB in China remains limited. Our study therefore aimed to address this issue. Thirty-seven Chinese patients with probable DLB were recruited for this study. All subjects underwent neuropsychological assessment by trained neurologists, as well as undergoing MRI, C-11-PIB PET scans for A beta deposition and F-18-FDG PET scans for regional cerebral glucose metabolism. Our results showed that the gender ratio of patients was 16:21 (F:M). The mean age of onset was 69.5 +/- 9.0 years and the mean age at diagnosis was 71.8 +/- 9.1 years. At diagnosis, the prevalence of three core clinical features of DLB was: 64.9% for fluctuating cognition, 73.0% for visual hallucinations and 62.2% for parkinsonism. The result from C-11-PiB PET and F-18-FDG PET scans confirmed A beta deposition in the cortex and demonstrated hypometabolism in the bilateral temporoparietooccipital region, the frontal lobe, the insular lobe, and the posterior cingulate, precuneus and caudate nuclei. Our study elucidated the clinical features of Chinese DLB patients, and will improve the understanding and the early diagnosis of DLB in Chinese patients.	[Liu, Shuai; Wang, Xiao-Dan; Shi, Zhihong; Liu, Shuling; Zhou, Yuying; Wang, Xinping; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Shuai; Wang, Xiao-Dan; Shi, Zhihong; Liu, Shuling; Zhou, Yuying; Wang, Xinping; Ji, Yong] Tianjin Huanhu Hosp, Tianjin Dementia Inst, Tianjin, Peoples R China; [Wang, Ying; Cai, Li; Gao, Shuo] Tianjin Med Univ, Gen Hosp, PET CT Ctr, Tianjin, Peoples R China; [Han, Tong] Tianjin Huanhu Hosp, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University	Ji, Y (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.	jiyongusa@126.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81571057, 81300947]; Tianjin Science and Technology Support Program [12ZCZDSY02900]; Science and Technology Foundation of Tianjin Municipal Health Bureau [2014KR10, 2013KY15]; Key Project of Tianjin Municipal Health Bureau [14KG117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Support Program; Science and Technology Foundation of Tianjin Municipal Health Bureau; Key Project of Tianjin Municipal Health Bureau	Support was provided by National Natural Science Foundation of China to YJ (funding numbers: 81571057) and X-DW (funding numbers: 81300947) [http://www.nsfc.gov.cn/]; Tianjin Science and Technology Support Program to YJ (funding numbers: 12ZCZDSY02900) [http://www.tstc.gov.cn/]; Science and Technology Foundation of Tianjin Municipal Health Bureau to YJ (funding number: 2014KR10) and X-DW (funding number: 2013KY15) [http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm]; Key Project of Tianjin Municipal Health Bureau to YJ (funding number: 14KG117) [http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Alladi S, 2011, DEMENT GERIATR COGN, V32, P32, DOI 10.1159/000329862; Auning E, 2011, DEMENT GERIATR COGN, V32, P202, DOI 10.1159/000333072; Ballard C, 2000, DEMENT GERIATR COGN, V11, P219, DOI 10.1159/000017240; Ballard C, 1999, AM J PSYCHIAT, V156, P1039; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Chiba Y, 2015, INT J GERIATR PSYCH, V30, P316, DOI 10.1002/gps.4144; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; Collerton D, 2003, DEMENT GERIATR COGN, V16, P229, DOI 10.1159/000072807; Dalrymple-Alford J, 2001, J NEUROL NEUROSUR PS, V70, P148, DOI 10.1136/jnnp.70.2.148; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Donaghy P, 2015, AM J GERIAT PSYCHIAT, V23, P23, DOI 10.1016/j.jagp.2013.03.001; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; Galasko D, 1996, BRAIN COGNITION, V31, P166, DOI 10.1006/brcg.1996.0040; Gnanalingham KK, 1997, J NEUROL NEUROSUR PS, V62, P243, DOI 10.1136/jnnp.62.3.243; Han D, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-1; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Jellinger KA, 2007, NEURODEGENER DIS, V4, P428, DOI 10.1159/000107703; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Klein JC, 2010, NEUROLOGY, V74, P885, DOI 10.1212/WNL.0b013e3181d55f61; Lobotesis K, 2001, NEUROLOGY, V56, P643, DOI 10.1212/WNL.56.5.643; Lopez OL, 2002, ARCH NEUROL-CHICAGO, V59, P43, DOI 10.1001/archneur.59.1.43; Magierski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/809503; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Noe E, 2004, MOVEMENT DISORD, V19, P60, DOI 10.1002/mds.10633; Palmqvist S, 2009, INT J GERIATR PSYCH, V24, P1405, DOI 10.1002/gps.2277; Perneczky R, 2008, DEMENT GERIATR COGN, V25, P531, DOI 10.1159/000132084; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Sinha N, 2012, INT J GERIATR PSYCH, V27, P443, DOI 10.1002/gps.2749; Walker MP, 2000, BRIT J PSYCHIAT, V177, P252, DOI 10.1192/bjp.177.3.252; Wang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134956; Warr L, 2012, Q J NUCL MED MOL IM, V56, P39; Watson R, 2009, DEMENT GERIATR COGN, V28, P493, DOI 10.1159/000264614; Yoshida H, 2011, PSYCHIAT RES, V185, P211, DOI 10.1016/j.psychres.2009.06.012	40	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171802	10.1371/journal.pone.0171802	http://dx.doi.org/10.1371/journal.pone.0171802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253276	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300007
J	Navet, S; Buresi, A; Baratte, S; Andouche, A; Bonnaud-Ponticelli, L; Bassaglia, Y				Navet, Sandra; Buresi, Auxane; Baratte, Sebastien; Andouche, Aude; Bonnaud-Ponticelli, Laure; Bassaglia, Yann			The Pax gene family: Highlights from cephalopods	PLOS ONE			English	Article							PAIRED BOX GENE; CUTTLEFISH SEPIA-OFFICINALIS; SQUID EUPRYMNA-SCOLOPES; ECO-EVO-DEVO; EYE DEVELOPMENT; EXPRESSION PATTERNS; NERVOUS-SYSTEM; DEVELOPMENTAL EXPRESSION; PHYLOGENETIC ANALYSIS; POX-NEURO	Pax genes play important roles in Metazoan development. Their evolution has been extensively studied but Lophotrochozoa are usually omitted. We addressed the question of Pax paralog diversity in Lophotrochozoa by a thorough review of available databases. The existence of six Pax families (Pax1/9, Pax2/5/8, Pax3/7, Pax4/6, Pax beta, PoxNeuro) was confirmed and the lophotrochozoan Pax beta subfamily was further characterized. Contrary to the pattern reported in chordates, the Pax2/5/8 family is devoid of homeodomain in Lophotrochozoa. Expression patterns of the three main pax classes (pax2/5/8, pax3/7, pax4/6) during Sepia officinalis development showed that Pax roles taken as ancestral and common in metazoans are modified in S. officinalis, most likely due to either the morphological specificities of cephalopods or to their direct development. Some expected expression patterns were missing (e.g. pax6 in the developing retina), and some expressions in unexpected tissues have been found (e.g. pax2/5/8 in dermal tissue and in gills). This study underlines the diversity and functional plasticity of Pax genes and illustrates the difficulty of using probable gene homology as strict indicator of homology between biological structures.	[Navet, Sandra; Buresi, Auxane; Baratte, Sebastien; Andouche, Aude; Bonnaud-Ponticelli, Laure; Bassaglia, Yann] UPMC, Sorbonne Univ, Museum Natl Hist Nat, UCN,UA,UMR BOREA,CNRS7208,IRD207, Paris, France; [Baratte, Sebastien] Univ Paris Sorbonne, Sorbonne Univ, ESPE, Paris, France; [Bassaglia, Yann] Univ Paris Est Creteil Val Marne, Creteil, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Bassaglia, Y (corresponding author), UPMC, Sorbonne Univ, Museum Natl Hist Nat, UCN,UA,UMR BOREA,CNRS7208,IRD207, Paris, France.; Bassaglia, Y (corresponding author), Univ Paris Est Creteil Val Marne, Creteil, France.	yann.bassaglia@mnhn.fr	Bassaglia, Yann/AAN-7502-2020	Bassaglia, Yann/0000-0002-6627-7737	Agence Nationale de la Recherche (ANR) [JC/JC 0043]; Bourse de la Vocation Marcel Bleustein-Blanchet	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Bourse de la Vocation Marcel Bleustein-Blanchet	This work was supported by a grant JC/JC 0043 from Agence Nationale de la Recherche (ANR) and by a "Bourse de la Vocation Marcel Bleustein-Blanchet" to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arendt D, 2002, DEVELOPMENT, V129, P1143; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; Bassaglia Y, 2013, J EXP MAR BIOL ECOL, V447, P4, DOI 10.1016/j.jembe.2013.02.006; Bassaglia Y, 2012, GENE, V498, P203, DOI 10.1016/j.gene.2012.01.100; Bassham S, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-35; Blackburn DC, 2008, DEV DYNAM, V237, P2209, DOI 10.1002/dvdy.21634; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Boletsky S.v., 1989, Advances in Marine Biology, V25, P85, DOI 10.1016/S0065-2881(08)60188-1; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bonnaud-Ponticelli L, 2016, VIE MILIEU, V66, P3; BOYCOTT BB, 1961, PROC R SOC SER B-BIO, V153, P503, DOI 10.1098/rspb.1961.0015; Breitling R, 2000, DEV GENES EVOL, V210, P644, DOI 10.1007/s004270000106; Buckingham M, 2015, SEMIN CELL DEV BIOL, V44, P115, DOI 10.1016/j.semcdb.2015.09.017; Buresi A, 2016, DEV BIOL, V415, P143, DOI 10.1016/j.ydbio.2016.04.027; Buresi A, 2014, J COMP NEUROL, V522, P3004, DOI 10.1002/cne.23562; Buresi A, 2012, GENE EXPR PATTERNS, V12, P109, DOI 10.1016/j.gep.2012.02.001; Callaerts P, 1999, P NATL ACAD SCI USA, V96, P558, DOI 10.1073/pnas.96.2.558; Carbe C, 2013, J BIOL CHEM, V288, P12130, DOI 10.1074/jbc.M112.436865; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Colomb S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002197; Czerny T, 1997, MECH DEVELOP, V67, P179, DOI 10.1016/S0925-4773(97)00119-6; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Derby CD, 2014, MAR DRUGS, V12, P2700, DOI 10.3390/md12052700; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fabian P, 2015, FRONT GENET, V6, DOI [10.3382/fgene.2015.00228, 10.3389/fgene.2015.00228]; Favor J, 2001, GENETICS, V159, P1689; Franke FA, 2015, EVOL DEV, V17, P3, DOI 10.1111/ede.12110; Friedrich M, 2015, EVOL DEV, V17, P255, DOI 10.1111/ede.12137; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Glardon S, 1998, DEVELOPMENT, V125, P2701; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartmann B, 2003, MECH DEVELOP, V120, P177, DOI 10.1016/S0925-4773(02)00456-2; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; Holland LZ, 2010, INTEGR COMP BIOL, V50, P22, DOI 10.1093/icb/icq048; Hoshiyama D, 2007, FEBS LETT, V581, P1639, DOI 10.1016/j.febslet.2007.03.027; Hu MY, 2010, CELL TISSUE RES, V339, P571, DOI 10.1007/s00441-009-0921-8; Jiang YR, 2015, DEV BIOL, V397, P162, DOI 10.1016/j.ydbio.2014.10.013; Jiao S, 2015, COMP BIOCHEM PHYS B, V180, P7, DOI 10.1016/j.cbpb.2014.10.002; Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720; KILCHHERR F, 1986, NATURE, V321, P493, DOI 10.1038/321493a0; Kozmik Z, 1999, DEVELOPMENT, V126, P1295; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Loosli F, 1996, P NATL ACAD SCI USA, V93, P2658, DOI 10.1073/pnas.93.7.2658; Matus DQ, 2007, EVOL DEV, V9, P25, DOI 10.1111/j.1525-142X.2006.00135.x; Mayran A, 2015, SEMIN CELL DEV BIOL, V44, P135, DOI 10.1016/j.semcdb.2015.07.007; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Monsoro-Burq AH, 2015, SEMIN CELL DEV BIOL, V44, P87, DOI 10.1016/j.semcdb.2015.09.015; Moreira R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1817-5; Morino Y, 2013, ZOOL SCI, V30, P851, DOI 10.2108/zsj.30.851; Navet S, 2008, DEV DYNAM, V237, P1944, DOI 10.1002/dvdy.21614; Navet S, 2014, J MAR SCI TECH-TAIW, V22, P15, DOI 10.6119/JMST-013-0820-1; Navet S, 2009, GENE EXPR PATTERNS, V9, P461, DOI 10.1016/j.gep.2009.08.001; Nixon M., 2003, BRAINS LIVES CEPHALO; Nodl MT, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0175-8; Nodl MT, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0012-8; O'Brien EK, 2003, EVOL DEV, V5, P572, DOI 10.1046/j.1525-142X.2003.03062.x; O'Brien EK, 2000, MAR BIOTECHNOL, V2, P545, DOI 10.1007/s101260000039; Paixao-Cortes VR, 2015, SEMIN CELL DEV BIOL, V44, P64, DOI 10.1016/j.semcdb.2015.08.014; Paixao-Cortes VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073560; Passamaneck YJ, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0004-8; Passamaneck YJ, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-6; Pineda D, 2002, DEVELOPMENT, V129, P1423; Quigley IK, 2007, DEV GENES EVOL, V217, P459, DOI 10.1007/s00427-007-0156-1; Salo E, 2002, GENE, V287, P67, DOI 10.1016/S0378-1119(01)00863-0; Schmerer M, 2009, EVOL DEV, V11, P689, DOI 10.1111/j.1525-142X.2009.00376.x; Schmerer MW, 2013, DEV BIOL, V382, P149, DOI 10.1016/j.ydbio.2013.07.015; Seaver EC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-8; Shigeno S, 2010, ORIGINS CEPHALPOOD B, P23; Short S, 2008, J MOL EVOL, V66, P605, DOI 10.1007/s00239-008-9113-5; Short S, 2012, J EXP ZOOL PART B, V318B, P555, DOI 10.1002/jez.b.22460; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156; Suzuki T, 2000, DEVELOPMENT, V127, P1531; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Thanos S, 2004, J NEUROBIOL, V59, P8, DOI 10.1002/neu.20001; Thompson JA, 2011, PROG NEUROBIOL, V95, P334, DOI 10.1016/j.pneurobio.2011.08.012; Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421; Underhill DA, 2012, CRIT REV EUKAR GENE, V22, P161, DOI 10.1615/CritRevEukarGeneExpr.v22.i2.70; Vopalensky P, 2009, PHILOS T R SOC B, V364, P2819, DOI 10.1098/rstb.2009.0079; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wollesen T, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0505-z; Woodruff JB, 2007, DEV BIOL, V306, P824, DOI 10.1016/j.ydbio.2007.03.002; Yi BQ, 2009, EVOL DEV, V11, P669, DOI 10.1111/j.1525-142X.2009.00374.x; Yoshida M-A, 2014, SCI REP, V4	101	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172719	10.1371/journal.pone.0172719	http://dx.doi.org/10.1371/journal.pone.0172719			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253300	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300030
J	Caberlotto, E; Ruiz, L; Miller, Z; Poletti, M; Tadlock, L				Caberlotto, Elisa; Ruiz, Laetitia; Miller, Zane; Poletti, Mickael; Tadlock, Lauri			Effects of a skin-massaging device on the ex-vivo expression of human dermis proteins and in-vivo facial wrinkles	PLOS ONE			English	Article							GENE-EXPRESSION; VII COLLAGEN; FIBROBLASTS; CULTURE	Mechanical and geometrical cues influence cell behaviour. At the tissue level, almost all organs exhibit immediate mechanical responsiveness, in particular by increasing their stiffness in direct proportion to an applied mechanical stress. It was recently shown in cultured-cell models, in particular with fibroblasts, that the frequency of the applied stress is a fundamental stimulating parameter. However, the influence of the stimulus frequency at the tissue level has remained elusive. Using a device to deliver an oscillating torque that generates cyclic strain at different frequencies, we studied the effect(s) of mild skin massage in an ex vivo model and in vivo. Skin explants were maintained ex vivo for 10 days and massaged twice daily for one minute at various frequencies within the range of 65-85 Hz. Biopsies were analysed at D0, D5 and D10 and processed for immuno-histological staining specific to various dermal proteins. As compared to untreated skin explants, the massaging procedure clearly led to higher rates of expression, in particular for decorin, fibrillin, tropoelastin, and procollagen-1. The mechanical stimulus thus evoked an anti-aging response. Strikingly, the expression was found to depend on the stimulus frequency with maximum expression at 75Hz. We then tested whether this mechanical stimulus had an anti-aging effect in vivo. Twenty Caucasian women (aged 65-75y) applied a commercial anti-aging cream to the face and neck, followed by daily treatments using the anti-aging massage device for 8 weeks. A control group of twenty-two women, with similar ages to the first group, applied the cream alone. At W0, W4 and W8, a blinded evaluator assessed the global facial wrinkles, skin texture, lip area, cheek wrinkles, neck sagging and neck texture using a clinical grading scale. We found that combining the massaging device with a skin anti-aging formulation amplified the beneficial effects of the cream.	[Caberlotto, Elisa] LOreal Res & Innovat, Chevilly Larue, France; [Ruiz, Laetitia] LOreal Res & Innovat, Aulnay Sous Bois, France; [Miller, Zane; Poletti, Mickael; Tadlock, Lauri] LOreal Res & Innovat, Redmond, WA USA	L'Oreal Group; L'Oreal Group; L'Oreal Group	Caberlotto, E (corresponding author), LOreal Res & Innovat, Chevilly Larue, France.	ecaberlotto@rd.loreal.com			L'Oreal Research Innovation	L'Oreal Research Innovation	This work was supported by L'Oreal Research & Innovation. EC, LR, ZM, MP, and LT are employed by L'Oreal. L'Oreal was the sole funder for this study and all research, study design, data collection and analysis, decisions to publish and manuscript preparation was performed by L'Oreal employees or contractors.	Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Chung HJ, 2010, DERMATOL CLIN, V28, P93, DOI 10.1016/j.det.2009.10.011; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854; El-Domyati M, 2002, EXP DERMATOL, V11, P398, DOI 10.1034/j.1600-0625.2002.110502.x; Farran AJE, 2013, J TISSUE ENG REGEN M, V7, P213, DOI 10.1002/term.514; Hamed SH, 2012, J COSMET DERMATOL-US, V11, P239, DOI 10.1111/j.1473-2165.2012.00626.x; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; HOFFMAN H, 1952, AUST J EXP BIOL MED, V30, P541, DOI 10.1038/icb.1952.52; Huang CY, 2013, TRENDS MOL MED, V19, P555, DOI 10.1016/j.molmed.2013.05.005; Humbert P, 2015, CLIN INTERV AGING, V10, P387, DOI 10.2147/CIA.S69752; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jiang YY, 2015, PREP BIOCHEM BIOTECH, V45, P476, DOI 10.1080/10826068.2014.923444; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Khan S, 1997, ANNU REV BIOCHEM, V66, P785, DOI 10.1146/annurev.biochem.66.1.785; Kielty CM, 1997, MICROSC RES TECHNIQ, V38, P413, DOI 10.1002/(SICI)1097-0029(19970815)38:4<413::AID-JEMT9>3.0.CO;2-J; Kutty JK, 2010, J TISSUE ENG REGEN M, V4, P62, DOI 10.1002/term.219; Langton A. K., 2010, International Journal of Cosmetic Science, V32, P330, DOI 10.1111/j.1468-2494.2010.00574.x; Lee YH, 2011, YONSEI MED J, V52, P982, DOI 10.3349/ymj.2011.52.6.982; McMahon TA, 1984, MUSCLES REFLEXES AND; Phuong C, 2016, CUTAN OCUL TOXICOL, V35, P153, DOI 10.3109/15569527.2015.1065501; Portillo-Soto A, 2014, J ALTERN COMPLEM MED, V20, P932, DOI 10.1089/acm.2014.0160; Shin MS, 2015, J STRENGTH COND RES, V29, P2255, DOI 10.1519/JSC.0000000000000688; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sukharev Sergei, 2004, Sci STKE, V2004, pre4, DOI 10.1126/stke.2192004re4; Tong ZX, 2014, TISSUE ENG PT A, V20, P1922, DOI [10.1089/ten.tea.2013.0496, 10.1089/ten.TEA.2013.0496]; Trauer S, 2014, EUR J PHARM BIOPHARM, V86, P301, DOI 10.1016/j.ejpb.2013.11.004; Tunay VB, 2010, J EUR ACAD DERMATOL, V24, P138, DOI 10.1111/j.1468-3083.2009.03355.x; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Walchli C, 2014, J ALTERN COMPLEM MED, V20, P507, DOI 10.1089/acm.2012.0833; Willand MP, 2016, NEUROREHAB NEURAL RE, V30, P490, DOI 10.1177/1545968315604399; Zerdoum AB, 2014, JOVE-J VIS EXP, DOI 10.3791/51594	44	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172624	10.1371/journal.pone.0172624	http://dx.doi.org/10.1371/journal.pone.0172624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249037	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500049
J	Clarke, CS; Hunter, RM; Shemilt, I; Serra-Sastre, V				Clarke, Caroline S.; Hunter, Rachael M.; Shemilt, Ian; Serra-Sastre, Victoria			Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective	PLOS ONE			English	Article							JOINT ANALYSIS; FOLLOW-UP; CHEMOTHERAPY; METAANALYSIS; PLUS; SURVIVAL; REGIMENS; NETWORK; PHASE; TRIAL	Background Trastuzumab improves survival in HER2+ breast cancer patients, with some evidence of adverse cardiac side effects. Current recommendations are to give adjuvant trastuzumab for one year or until recurrence, although trastuzumab treatment for only 9 or 10 weeks has shown similar survival rates to 12-month treatment. We present here a multi-arm joint analysis examining the relative cost-effectiveness of different durations of adjuvant trastuzumab. Methods and findings Network meta-analysis (NMA) was used to examine which trials' data to include in the cost-effectiveness analysis (CEA). A network using FinHer (9 weeks vs. zero) and BCIRG006 (12 months vs. zero) trials offered the only jointly randomisable network so these trials were used in the CEA. The 3-arm CEA compared costs and quality-adjusted life-years (QALYs) associated with zero, 9-week and 12-month adjuvant trastuzumab durations in early breast cancer, using a decision tree followed by a Markov model that extrapolated the results to a lifetime time horizon. Pairwise incremental cost-effectiveness ratios (ICERs) were also calculated for each pair of regimens and used in budget impact analysis, and the Bucher method was used to check face validity of the findings. Addition of the PHARE trial (6 months vs. 12 months) to the network, in order to create a 4-arm CEA including the 6-month regimen, was not possible as late randomisation in this trial resulted in recruitment of a different patient population as evidenced by the NMA findings. The CEA results suggest that 9 weeks' trastuzumab is cost-saving and leads to more QALYs than 12 months', i.e. the former dominates the latter. The cost-effectiveness acceptability frontier (CEAF) favours zero trastuzumab at willingness-to-pay levels below 2,500 pound/QALY and treatment for 9 weeks above this threshold. The combination of the NMA and Bucher investigations suggests that the 9-week duration is as efficacious as the 12-month duration for distant-disease-free survival and overall survival, and safer in terms of fewer adverse cardiac events. Conclusions Our CEA results suggest that 9-week trastuzumab dominates 12-month trastuzumab in cost-effectiveness terms at conventional thresholds of willingness to pay for a QALY, and the 9-week regimen is also suggested to be as clinically effective as the 12-month regimen according to the NMA and Bucher analyses. This finding agrees with the results of the E2198 head-to-head study that compared 10 weeks' with 14 months' trastuzumab and found no significant difference. Appropriate trial design and reporting is critical if results are to be synthesisable with existing evidence, as selection bias can lead to recruitment of a different patient population from existing trials. Our analysis was not based on head-to-head trials' data, so the results should be viewed with caution. Short-duration trials would benefit from recruiting larger numbers of participants to reduce uncertainty in the synthesised results.	[Clarke, Caroline S.; Hunter, Rachael M.] UCL, UCL Res Dept Primary Care & Populat Hlth, London, England; [Shemilt, Ian] UCL, UCL Inst Educ, London, England; [Serra-Sastre, Victoria] Univ London, Dept Econ, London, England	University of London; University College London; University of London; University College London; UCL Institute of Education; University of London	Clarke, CS (corresponding author), UCL, UCL Res Dept Primary Care & Populat Hlth, London, England.	caroline.clarke@ucl.ac.uk	Hunter, Rachael Maree/H-7846-2019; Clarke, Caroline/B-7338-2015	Hunter, Rachael Maree/0000-0002-7447-8934; Shemilt, Ian/0000-0003-4862-2135; Clarke, Caroline/0000-0002-4676-1257				[Anonymous], 2006, TRAST ADJ TREATM EAR; Ara R, 2011, 12 NICE DSU U SHEFF; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Blackstone EA, 2013, AM HEALTH DRUG BENEF, V6, P469; Briggs A, 2006, HDB HLTH EC EVALUATI; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Calvert MJ, 2005, EUR J HEART FAIL, V7, P243, DOI 10.1016/j.ejheart.2005.01.012; Dedes KJ, 2007, ANN ONCOL, V18, P1493, DOI 10.1093/annonc/mdm185; Deeks JJAD, 2001, BMJ; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2011, 2 NICE DSU; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Guarneri V, 2008, CLIN BREAST CANCER, V8, P453, DOI 10.3816/CBC.2008.n.056; Hall PS, 2011, PHARMACOECONOMICS, V29, P415, DOI 10.2165/11588340-000000000-00000; Hall PS, 2009, EUR J CANCER, V45, P12, DOI 10.1016/j.ejca.2008.10.013; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Kurian AW, 2007, J CLIN ONCOL, V25, P634, DOI 10.1200/JCO.2006.06.3081; Millar JA, 2007, PHARMACOECONOMICS, V25, P429, DOI 10.2165/00019053-200725050-00006; Moja L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006243.pub2; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Neyt M, 2008, HEALTH POLICY, V87, P146, DOI 10.1016/j.healthpol.2007.11.003; NICE, 2006, FIN APPR DET TRAST A; NICE, 2013, EARL MET HER2 POS BR; NICE, 2009, CLIN GUID EARL LOC A; ONS, 2014, NAT STAT; ONS, 2015, INT LIF TABL ENGL WA; Peasgood T, 2010, EXPERT REV PHARM OUT, V10, P553, DOI 10.1586/ERP.10.65; Perez EA, 2004, J CLIN ONCOL, V22, P322, DOI 10.1200/JCO.2004.01.120; Perez EA, 2010, CANCER RES, P5640; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Petrelli F, 2012, MED ONCOL, V29, P503, DOI 10.1007/s12032-011-9897-9; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pinto AC, 2013, BREAST, V22, pS152, DOI 10.1016/j.breast.2013.07.029; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; PSSRU, 2015, HCHS PAY PRIC IND; Purmonen TT, 2011, ACTA ONCOL, V50, P344, DOI 10.3109/0284186X.2011.553841; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Schneider BP, 2015, BRIT J CANCER, V113, P1651, DOI 10.1038/bjc.2015.405; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sledge GW, 2006, BREAST CANC RES TREA; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Wade R., 2013, AFLIBERCEPT COMBINAT; Ward S, 2009, HEALTH TECHNOL ASSES, V13; White IR, 2015, STATA J, V15, P951, DOI 10.1177/1536867X1501500403; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; Yin WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021030	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172731	10.1371/journal.pone.0172731	http://dx.doi.org/10.1371/journal.pone.0172731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248984	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000395983500054
J	Deng, MJ; Lin, XD; Wen, CW; Dong, MJ; Lin, QT; Zhang, SZ; Xu, JP				Deng, Ming-Jie; Lin, Xiao-Dong; Wen, Chao-Wei; Dong, Min-Jian; Lin, Qiu-Ting; Zhang, Shang-Zhi; Xu, Jia-Ping			Metabolic changes in the midgut of Eri silkworm after oral administration of 1-deoxynojirimycin: A H-1-NMR-based metabonomic study	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; BOMBYX-MORI; PROTEOMIC ANALYSIS; NMR-SPECTROSCOPY; HIGH GLUCOSE; EX-VIVO; IN-VIVO; RAT; TREHALASE; PROTEIN	1-deoxynojirimycin (DNJ) is a natural D-glucose analogue and has a strong physiological activity in inhibiting a-glucosidase in vivo. The antidiabetic effects of DNJ in mice or other mammals were extensively explored, but the physiological and toxic roles of DNJ in insects was seldom reported. In this study, the biological effects of DNJ were examined in midgut extracts of fourth-instar larvae of Eri silkworm (Samia cynthia ricini, Saturniidae). Based on nuclear magnetic resonance (NMR) metabonomics technology, we analyzed the alterations of glycometabolism, lipids, and energy metabolism pathways in the midgut of S. cynthia ricini caused by DNJ. Pattern recognition analysis (partial least square-discriminant analysis, PLS-DA) showed that four groups of latex, 0.25% DNJ, 0.5% DNJ and the mixture of 0.5% DNJ and latex (1: 1) were distinctly different from the control group. Moreover, several metabolic pathways of DNJ-mediated modulation in the midgut were identified. Compared with the control group, alanine, succinate, glutamate, and fumarate concentrations decreased in three groups of 0.5% DNJ, latex, and the mixture, choline levels increased in two DNJ groups, and trehalose levels increased in all experimental groups. Therefore, these results suggest that DNJ modulated lipid metabolism by limiting the hydrolysis pathways of phospholipids metabolism. Additionally, DNJ has a potent negative effect on energy metabolism by inhibiting the hydrolysis of trehalose, glycolysis and the tricarboxylic acid (TCA) cycle. Overall, DNJ, as a single-ingredient, is an efficient substance for modulating lipid metabolism and inhibiting energy metabolism.	[Deng, Ming-Jie; Lin, Xiao-Dong; Wen, Chao-Wei; Dong, Min-Jian; Lin, Qiu-Ting] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China; [Deng, Ming-Jie; Zhang, Shang-Zhi; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China	Wenzhou Medical University; Anhui Agricultural University	Xu, JP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	jiapingxu@163.com	Xu, Jiaping/T-4327-2019	Xu, Jiaping/0000-0001-9020-7248	Natural Science Foundation of China [31472148]; Wenzhou Medical University [QTJ16008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University	This work was supported by the Natural Science Foundation of China (31472148, JPX), (http://www.nsfc.gov.cn/); the Start-up funding from Wenzhou Medical University (QTJ16008, MJD) (http://www.wmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2011, MOL PHARMACEUT, V8, P2390, DOI 10.1021/mp200313e; ANDERSON JM, 1967, J NEUROL NEUROSUR PS, V30, P295, DOI 10.1136/jnnp.30.4.295; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P28, DOI 10.1016/S1389-1723(99)80004-8; BOUNIAS M, 1993, BIOCHEM MOL BIOL INT, V31, P249; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Bucker R, 2014, J BIOL CHEM, V289, P30114, DOI 10.1074/jbc.M114.581348; Canavoso LE, 2004, INSECT BIOCHEM MOLEC, V34, P845, DOI 10.1016/j.ibmb.2004.05.008; Chikara H, 2008, INSECT BIOCHEM MOLEC, V37, P1348; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Deng MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131696; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Do HJ, 2014, J FUNCT FOODS, V7, P692, DOI 10.1016/j.jff.2013.12.016; Feng F, 2014, J PROTEOMICS, V108, P124, DOI 10.1016/j.jprot.2014.05.015; Gao HC, 2007, NEUROCHEM INT, V50, P386, DOI 10.1016/j.neuint.2006.09.012; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Kajimoto M, 2014, AM J PHYSIOL-HEART C, V306, pH1164, DOI 10.1152/ajpheart.00964.2013; Kite GC, 1997, J CHEM ECOL, V23, P119, DOI 10.1023/B:JOEC.0000006349.84075.f0; Kong WH, 2008, J AGR FOOD CHEM, V56, P2613, DOI 10.1021/jf073223i; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Li YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01377; Liu K, 2013, MOL NEUROBIOL, V48, P729, DOI 10.1007/s12035-013-8446-2; Mangia S, 2007, J CEREBR BLOOD F MET, V27, P1055, DOI 10.1038/sj.jcbfm.9600401; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; Matsumoto Y, 2011, PLOS ONE, V6, P589; Nakagawa K, 2007, J AGR FOOD CHEM, V55, P8928, DOI 10.1021/jf071559m; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Patterson Marc C, 2005, Semin Pediatr Neurol, V12, P144, DOI 10.1016/j.spen.2005.10.002; SCOFIELD AM, 1995, COMP BIOCHEM PHYS A, V112, P187, DOI 10.1016/0300-9629(95)00070-N; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025; Silva MCP, 2010, INSECT BIOCHEM MOLEC, V40, P733, DOI 10.1016/j.ibmb.2010.07.006; Sowers AD, 2006, COMP BIOCHEM PHYS A, V145, P176, DOI 10.1016/j.cbpa.2006.06.008; Spiga L, 2013, J MATERN-FETAL NEO M, V26, P20, DOI 10.3109/14767058.2013.832062; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Tyagi R, 2014, CHEM-BIOL INTERACT, V211, P20, DOI 10.1016/j.cbi.2013.12.016; Tyagi R, 2011, J APPL TOXICOL, V31, P663, DOI 10.1002/jat.1617; Tyagi R, 2012, METABOLOMICS, V8, P940, DOI 10.1007/s11306-011-0390-4; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Wasano N, 2009, PHYTOCHEMISTRY, V70, P880, DOI 10.1016/j.phytochem.2009.04.014; Wen CW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4676505; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xie YF, 2013, FLA ENTOMOL, V96, P1233, DOI 10.1653/024.096.0401; Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348; Zhao LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108678	51	10	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173213	10.1371/journal.pone.0173213	http://dx.doi.org/10.1371/journal.pone.0173213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249023	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500082
J	Mesarich, CH; Rees-George, J; Gardner, PP; Ghomi, FA; Gerth, ML; Andersen, MT; Rikkerink, EHA; Fineran, PC; Templeton, MD				Mesarich, Carl H.; Rees-George, Jonathan; Gardner, Paul P.; Ghomi, Fatemeh Ashari; Gerth, Monica L.; Andersen, Mark T.; Rikkerink, Erik H. A.; Fineran, Peter C.; Templeton, Matthew D.			Transposon insertion libraries for the characterization of mutants from the kiwifruit pathogen Pseudomonas syringae pv. actinidiae	PLOS ONE			English	Article							DICKEYA-DADANTII; GENETIC-ANALYSIS; AERUGINOSA; VIRULENCE; IDENTIFICATION; POPULATIONS; GENERATION; RADIATION; MOTILITY; PLATFORM	Pseudomonas syringae pv. actinidiae (Psa), the causal agent of kiwifruit canker, is one of the most devastating plant diseases of recent times. We have generated two mini-Tn5-based random insertion libraries of Psa ICMP 18884. The first, a 'phenotype of interest' (POI) library, consists of 10,368 independent mutants gridded into 96-well plates. By replica plating onto selective media, the POI library was successfully screened for auxotrophic and motility mutants. Lipopolysaccharide (LPS) biosynthesis mutants with 'Fuzzy-Spreader'-like morphologies were also identified through a visual screen. The second, a 'mutant of interest' (MOI) library, comprises around 96,000 independent mutants, also stored in 96-well plates, with approximately 200 individuals per well. The MOI library was sequenced on the Illumina MiSeq platform using Transposon-Directed Insertion site Sequencing (TraDIS) to map insertion sites onto the Psa genome. A grid-based PCR method was developed to recover individual mutants, and using this strategy, the MOI library was successfully screened for a putative LPS mutant not identified in the visual screen. The Psa chromosome and plasmid had 24,031 and 1,236 independent insertion events respectively, giving insertion frequencies of 3.65 and 16.6 per kb respectively. These data suggest that the MOI library is near saturation, with the theoretical probability of finding an insert in any one chromosomal gene estimated to be 97.5%. However, only 47% of chromosomal genes had insertions. This surprisingly low rate cannot be solely explained by the lack of insertions in essential genes, which would be expected to be around 5%. Strikingly, many accessory genes, including most of those encoding type III effectors, lacked insertions. In contrast, 94% of genes on the Psa plasmid had insertions, including for example, the type III effector HopAU1. These results suggest that some chromosomal sites are rendered inaccessible to transposon insertion, either by DNA-binding proteins or by the architecture of the nucleoid.	[Mesarich, Carl H.; Rees-George, Jonathan; Andersen, Mark T.; Rikkerink, Erik H. A.; Templeton, Matthew D.] New Zealand Inst Plant & Food Res Ltd, Bioprotect Portfolio, Auckland, New Zealand; [Mesarich, Carl H.] Massey Univ, Inst Agr & Environm, Lab Mol Plant Pathol, Palmerston North, New Zealand; [Mesarich, Carl H.; Gardner, Paul P.; Ghomi, Fatemeh Ashari; Fineran, Peter C.; Templeton, Matthew D.] Bioprotect Res Ctr, Canterbury, New Zealand; [Gardner, Paul P.; Ghomi, Fatemeh Ashari] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Gerth, Monica L.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Templeton, Matthew D.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; Massey University; University of Canterbury; University of Otago; University of Otago; University of Auckland	Mesarich, CH; Templeton, MD (corresponding author), New Zealand Inst Plant & Food Res Ltd, Bioprotect Portfolio, Auckland, New Zealand.; Mesarich, CH (corresponding author), Massey Univ, Inst Agr & Environm, Lab Mol Plant Pathol, Palmerston North, New Zealand.; Mesarich, CH; Templeton, MD (corresponding author), Bioprotect Res Ctr, Canterbury, New Zealand.; Templeton, MD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	c.mesarich@massey.ac.nz; matt.templeton@plantandfood.co.nz	Templeton, Matthew D./J-6966-2017; Mesarich, Carl H/E-4304-2015; Rikkerink, Erik H A/B-5752-2011; Gardner, Paul P./B-1978-2009; Fineran, Peter C/A-5766-2012	Templeton, Matthew D./0000-0003-0192-9041; Mesarich, Carl H/0000-0002-5207-4074; Rikkerink, Erik H A/0000-0003-4682-5078; Gardner, Paul P./0000-0002-7808-1213; Fineran, Peter C/0000-0002-4639-6704; Ashari Ghomi, Fatemeh/0000-0001-9786-4558; Gerth, Monica/0000-0002-7959-7852	New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant; Rutherford Discovery Fellowships from the Royal Society of New Zealand	New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant; Rutherford Discovery Fellowships from the Royal Society of New Zealand	This project was supported by the New Zealand Tertiary Education Commission Centre of Research excellence (CoRE) grant to the Bio-Protection Research Centre (BPRC). PCF and PPG were also supported by Rutherford Discovery Fellowships from the Royal Society of New Zealand.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barquist L, 2016, BIOINFORMATICS, V32, P1109, DOI 10.1093/bioinformatics/btw022; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Bouyioukos C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27978; Cagliero C, 2013, NUCLEIC ACIDS RES, V41, P6058, DOI 10.1093/nar/gkt325; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; CHU CP, 1990, J GEN MICROBIOL, V136, P875, DOI 10.1099/00221287-136-5-875; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Evans TJ, 2010, J APPL MICROBIOL, V109, P505, DOI 10.1111/j.1365-2672.2010.04669.x; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Ferguson GC, 2013, GENETICS, V195, P1319, DOI 10.1534/genetics.113.154948; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; FIRTH N, 1992, MOL GEN GENET, V232, P145, DOI 10.1007/BF00299147; Fujikawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21399; Guo QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19141; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kimura S, 2016, MBIO, V7, DOI 10.1128/mBio.01351-16; KING EO, 1954, J LAB CLIN MED, V44, P301; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kroupitski Y, 2009, J APPL MICROBIOL, V106, P1876, DOI 10.1111/j.1365-2672.2009.04152.x; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Manoharan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137355; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Monson R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01442; Monteil CL, 2013, NEW PHYTOL, V199, P800, DOI 10.1111/nph.12316; Patterson AG, 2015, NCUL ACIDS RES; Ponstingl H, 2010, F1000 POSTERS, V1, P313; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rio-Alvarez I, 2015, MOL PLANT PATHOL, V16, P685, DOI 10.1111/mpp.12227; Sambrook J., MOL CLONING LAB MANU; Santiago MF, 2002, CAN J MICROBIOL, V48, P1076, DOI 10.1139/W02-110; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Templeton MD, 2015, GENOME ANNOUNCEMENTS, V3; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Yoshioka S, 2016, PEERJ, V4, DOI 10.7717/peerj.1543; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zghidi-Abouzid O, 2016, RES MICROBIOL, V167, P247, DOI 10.1016/j.resmic.2016.02.001	63	14	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172790	10.1371/journal.pone.0172790	http://dx.doi.org/10.1371/journal.pone.0172790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249011	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500058
J	den Hartigh, LJ; Wang, SR; Goodspeed, L; Wietecha, T; Houston, B; Omer, M; Ogimoto, K; Subramanian, S; Gowda, GAN; O'Brien, KD; Kaiyala, KJ; Morton, GJ; Chait, A				den Hartigh, Laura J.; Wang, Shari; Goodspeed, Leela; Wietecha, Tomasz; Houston, Barbara; Omer, Mohamed; Ogimoto, Kayoko; Subramanian, Savitha; Gowda, G. A. Nagana; O'Brien, Kevin D.; Kaiyala, Karl J.; Morton, Gregory J.; Chait, Alan			Metabolically distinct weight loss by 10,12 CLA and caloric restriction highlight the importance of subcutaneous white adipose tissue for glucose homeostasis in mice	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; RECEPTOR-DEFICIENT MICE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; BODY-COMPOSITION; RISK MARKERS; OBESE HUMANS; SUPPLEMENTATION; TRANS-10; FAT	Background Widely used as a weight loss supplement, trans-10, cis-12 conjugated linoleic acid (10,12 CLA) promotes fat loss in obese mice and humans, but has also been associated with insulin resistance. Objective We therefore sought to directly compare weight loss by 10,12 CLA versus caloric restriction (CR, 15-25%), an acceptable healthy method of weight loss, to determine how 10,12 CLA-mediated weight loss fails to improve glucose metabolism. Methods Obese mice with characteristics of human metabolic syndrome were either supplemented with 10,12 CLA or subjected to CR to promote weight loss. Metabolic endpoints such as energy expenditure, glucose and insulin tolerance testing, and trunk fat distribution were measured. Results By design, 10,12 CLA and CR caused equivalent weight loss, with greater fat loss by 10,12 CLA accompanied by increased energy expenditure, reduced respiratory quotient, increased fat oxidation, accumulation of alternatively activated macrophages, and browning of subcutaneous white adipose tissue (WAT). Moreover, 10,12 CLA-supplemented mice better defended their body temperature against a cold challenge. However, 10,12 CLA concurrently induced the detrimental loss of subcutaneous WAT without reducing visceral WAT, promoted reduced plasma and WAT adipokine levels, worsened hepatic steatosis, and failed to improve glucose metabolism. Obese mice undergoing CR were protected from subcutaneous-specific fat loss, had improved hepatic steatosis, and subsequently showed the expected improvements in WAT adipokines, glucose metabolism and WAT inflammation. Conclusions These results suggest that 10,12 CLA mediates the preferential loss of subcutaneous fat that likely contributes to hepatic steatosis and maintained insulin resistance, despite significant weight loss and WAT browning in mice. Collectively, we have shown that weight loss due to 10,12 CLA supplementation or CR results in dramatically different metabolic phenotypes, with the latter promoting a healthier form of weight loss.	[den Hartigh, Laura J.; Wang, Shari; Goodspeed, Leela; Houston, Barbara; Omer, Mohamed; Ogimoto, Kayoko; Subramanian, Savitha; Morton, Gregory J.; Chait, Alan] Univ Washington, Dept Med, Metab, Seattle, WA 98105 USA; [Wietecha, Tomasz; O'Brien, Kevin D.] Univ Washington, Dept Med, Cardiol, Seattle, WA USA; [Gowda, G. A. Nagana] Univ Washington, Dept Anesthesiol & Pain Med, Northwest Metabol Res Ctr, Seattle, WA 98195 USA; [Kaiyala, Karl J.] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	den Hartigh, LJ (corresponding author), Univ Washington, Dept Med, Metab, Seattle, WA 98105 USA.	lauradh@u.washington.edu	O'Brien, Kevin Douglas/HDO-1461-2022; O'Brien, Kevin/CAH-4638-2022	O'Brien, Kevin Douglas/0000-0002-2293-9196; O'Brien, Kevin/0000-0002-2293-9196; Subramanian, Savitha/0000-0002-4866-2009	NIH National Center for Complimentary and Integrative Health [K01 AT007177]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK035816, P30 DK017047, U24 DK097153, P30 DK089503]; NIH National Heart, Lung, and Blood Institute [T32 HL007312]; University of Washington Nutrition Obesity Research Center; NIH Common Funds Project; Nutrition Obesity Research Center; University of Michigan; National Center for Complementary & Integrative Health [K01AT007177] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK035816] Funding Source: NIH RePORTER	NIH National Center for Complimentary and Integrative Health; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington Nutrition Obesity Research Center; NIH Common Funds Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; University of Michigan(University of Michigan System); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the NIH National Center for Complimentary and Integrative Health (K01 AT007177), NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (University of Washington Nutrition Obesity Research Center Pilot and Feasibility Award: P30 DK035816; University of Washington Diabetes Research Center Pilot and Feasibility Award: P30 DK017047; University of Michigan Pilot and Feasibility Award: U24 DK097153; and University of Michigan Nutrition Obesity Research Center: P30 DK089503), and NIH National Heart, Lung, and Blood Institute (T32 HL007312).; The following core facilities of the University of Washington Nutrition Obesity Research Center supported this work: Energy Balance and Glucose Metabolism Core, Metabolomics sub core, and Atherosclerosis subcore. Jarrell Nelson from the Energy Balance and Glucose Metabolism Core contributed significant work to calorimetry analyses. The authors also utilized Metabolomics Core Services supported by the NIH Common Funds Project and the Nutrition Obesity Research Center, both from the University of Michigan, with particular contribution of expertise from Arun Das.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Aprile M, 2014, PPAR RES, V2014, DOI 10.1155/2014/537865; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Blanchard PG, 2016, ACTA PHYSL OXF; Blanck HM, 2007, J AM DIET ASSOC, V107, P441, DOI 10.1016/j.jada.2006.12.009; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cai DM, 2012, BIOCHEM BIOPH RES CO, V422, P621, DOI 10.1016/j.bbrc.2012.05.038; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Close RN, 2007, AM J CLIN NUTR, V86, P797, DOI 10.1093/ajcn/86.3.797; den Hartigh LJ, 2013, J LIPID RES, V54, P2964, DOI 10.1194/jlr.M035188; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Evans M, 2002, J NUTR, V132, P450, DOI 10.1093/jn/132.3.450; Fisher FM, 2002, HORM METAB RES, V34, P650, DOI 10.1055/s-2002-38246; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gonzalez-Plaza J J, 2015, SURG OBES RELAT DIS; Gwang-woong G, 2013, J MICROBIOL BIOTECHN, V23, P1569, DOI 10.4014/jmb.1308.08008; Hamilton M, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0122-2; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jones JG, 2016, DIABETOLOGIA, V59, P1098, DOI 10.1007/s00125-016-3940-5; Kaiyala KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119391; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304; Kennedy A, 2010, J LIPID RES, V51, P1906, DOI 10.1194/jlr.M005447; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Kostogrys RB, 2012, J NUTR HEALTH AGING, V16, P482, DOI 10.1007/s12603-011-0354-4; Magkos F, 2016, CELL METAB; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; MORRISON WR, 1964, J LIPID RES, V5, P600; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pini M, 2016, FASEB J, V30, P241, DOI 10.1096/fj.15-276675; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Raff M, 2008, J NUTR, V138, P509, DOI 10.1093/jn/138.3.509; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Riserus U, 2004, DIABETOLOGIA, V47, P1016, DOI 10.1007/s00125-004-1421-8; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Saraf N, 2012, J PHARM PHARMACOL, V64, P161, DOI 10.1111/j.2042-7158.2011.01366.x; Schwartz A, 2010, OBES REV, V11, P531, DOI 10.1111/j.1467-789X.2009.00654.x; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Shen W, 2013, J LIPID RES; Shen W, 2016, ANNU REV NUTR, V36, P183, DOI 10.1146/annurev-nutr-071715-050924; Shen W, 2015, J NUTR BIOCHEM, V26, P616, DOI 10.1016/j.jnutbio.2014.12.016; Shimizu I, 2015, CURR OBES REP, V4, P224, DOI 10.1007/s13679-015-0157-8; Silveira MB, 2007, PUBLIC HEALTH NUTR, V10, P1181, DOI 10.1017/S1368980007000687; Steck SE, 2007, J NUTR, V137, P1188, DOI 10.1093/jn/137.5.1188; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7	65	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172912	10.1371/journal.pone.0172912	http://dx.doi.org/10.1371/journal.pone.0172912			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245284	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200041
J	Minamoto, T; Fukuda, M; Katsuhara, KR; Fujiwara, A; Hidaka, S; Yamamoto, S; Takahashi, K; Masuda, R				Minamoto, Toshifumi; Fukuda, Miho; Katsuhara, Koki R.; Fujiwara, Ayaka; Hidaka, Shunsuke; Yamamoto, Satoshi; Takahashi, Kohji; Masuda, Reiji			Environmental DNA reflects spatial and temporal jellyfish distribution	PLOS ONE			English	Article							WATER SAMPLES; EDNA; QUANTIFICATION; BIODIVERSITY; ABUNDANCE; BLOOMS; JAPAN; RATES; FISH	Recent development of environmental DNA (eDNA) analysis allows us to survey underwater macro-organisms easily and cost effectively; however, there have been no reports on eDNA detection or quantification for jellyfish. Here we present the first report on an eDNA analysis of marine jellyfish using Japanese sea nettle (Chrysaora pacifica) as a model species by combining a tank experiment with spatial and temporal distribution surveys. We performed a tank experiment monitoring eDNA concentrations over a range of time intervals after the introduction of jellyfish, and quantified the eDNA concentrations by quantitative real-time PCR. The eDNA concentrations peaked twice, at 1 and 8 h after the beginning of the experiment, and became stable within 48 h. The estimated release rates of the eDNA in jellyfish were higher than the rates previously reported in fishes. A spatial survey was conducted in June 2014 in Maizuru Bay, Kyoto, in which eDNA was collected from surface water and sea floor water samples at 47 sites while jellyfish near surface water were counted on board by eye. The distribution of eDNA in the bay corresponded with the distribution of jellyfish inferred by visual observation, and the eDNA concentration in the bay was similar to 13 times higher on the sea floor than on the surface. The temporal survey was conducted from March to November 2014, in which jellyfish were counted by eye every morning while eDNA was collected from surface and sea floor water at three sampling points along a pier once a month. The temporal fluctuation pattern of the eDNA concentrations and the numbers of observed individuals were well correlated. We conclude that an eDNA approach is applicable for jellyfish species in the ocean.	[Minamoto, Toshifumi; Fukuda, Miho; Katsuhara, Koki R.; Fujiwara, Ayaka; Hidaka, Shunsuke; Yamamoto, Satoshi] Kobe Univ, Fac Human Dev, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Takahashi, Kohji; Masuda, Reiji] Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan	Kobe University; Kyoto University	Minamoto, T (corresponding author), Kobe Univ, Fac Human Dev, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan.	minamoto@people.kobe-u.ac.jp	Minamoto, Toshifumi/C-6453-2009; Takahashi, Kohji/ABB-7995-2020	Minamoto, Toshifumi/0000-0002-5379-1622; 	CREST program from Japan Science and Technology Agency	CREST program from Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	The authors were funded by the CREST program from Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Barnes M. A., 2015, CONSERV GENET, V17, P1; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ellis T, 2004, J FISH BIOL, V65, P1233, DOI 10.1111/j.0022-1112.2004.00499.x; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fujiwara A, 2016, FRESHW SCI, V35, P748, DOI 10.1086/685882; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Hashizume H, 2017, ACTA TROP, V169, P1, DOI 10.1016/j.actatropica.2017.01.008; Ikawa Y, 2016, Br J Dermatol, V175, P837, DOI 10.1111/bjd.14856; Ikeda K, 2016, CONSERV GENET RESOUR, V8, P231, DOI 10.1007/s12686-016-0541-z; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kinoshita J, 2006, J OCEANOGR, V62, P607, DOI 10.1007/s10872-006-0080-4; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; LARSON RJ, 1986, J EXP MAR BIOL ECOL, V99, P107, DOI 10.1016/0022-0981(86)90231-5; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Morandini AC, 2010, ZOOTAXA, P1; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Sato Rumiko, 1996, Bulletin of the College of Agriculture and Veterinary Medicine Nihon University, V53, P65; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Uye Shin-ichi, 2004, Bulletin of the Japanese Society of Fisheries Oceanography, V68, P9; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786	40	52	58	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173073	10.1371/journal.pone.0173073	http://dx.doi.org/10.1371/journal.pone.0173073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245277	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200053
J	Ozuru, R; Saito, M; Kanemaru, T; Miyahara, S; Villanueva, SYAM; Murray, GL; Adler, B; Fujii, J; Yoshida, SI				Ozuru, Ryo; Saito, Mitsumasa; Kanemaru, Takaaki; Miyahara, Satoshi; Villanueva, Sharon Y. A. M.; Murray, Gerald L.; Adler, Ben; Fujii, Jun; Yoshida, Shin-ichi			Adipose tissue is the first colonization site of Leptospira interrogans in subcutaneously infected hamsters	PLOS ONE			English	Article							CHEMOTACTIC BEHAVIOR; REPORTER; KIDNEY; GROWTH; LIVER; MODEL	Leptospirosis is one of the most widespread zoonoses in the world, and its most severe form in humans, "Weil's disease," may lead to jaundice, hemorrhage, renal failure, pulmonary hemorrhage syndrome, and sometimes, fatal multiple organ failure. Although the mechanisms underlying jaundice in leptospirosis have been gradually unraveled, the pathophysiology and distribution of leptospires during the early stage of infection are not well understood. Therefore, we investigated the hamster leptospirosis model, which is the accepted animal model of human Weil's disease, by using an in vivo imaging system to observe the whole bodies of animals infected with Leptospira interrogans and to identify the colonization and growth sites of the leptospires during the early phase of infection. Hamsters, infected subcutaneously with 10 4 bioluminescent leptospires, were analyzed by in vivo imaging, organ culture, and microscopy. The results showed that the luminescence from the leptospires spread through each hamster's body sequentially. The luminescence was first detected at the injection site only, and finally spread to the central abdomen, in the liver area. Additionally, the luminescence observed in the adipose tissue was the earliest detectable compared with the other organs, indicating that the leptospires colonized the adipose tissue at the early stage of leptospirosis. Adipose tissue cultures of the leptospires became positive earlier than the blood cultures. Microscopic analysis revealed that the leptospires colonized the inner walls of the blood vessels in the adipose tissue. In conclusion, this is the first study to report that adipose tissue is an important colonization site for leptospires, as demonstrated by microscopy and culture analyses of adipose tissue in the hamster model of Weil's disease.	[Ozuru, Ryo; Miyahara, Satoshi; Villanueva, Sharon Y. A. M.; Yoshida, Shin-ichi] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Japan; [Ozuru, Ryo; Fujii, Jun] Tottori Univ, Div Bacteriol, Dept Microbiol & Immunol, Fac Med, Tottori, Japan; [Saito, Mitsumasa] Univ Occupat & Environm Hlth, Dept Microbiol, Fukuoka, Japan; [Kanemaru, Takaaki] Kyushu Univ Hosp, Morphol Core Unit, Fukuoka, Japan; [Murray, Gerald L.; Adler, Ben] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia; [Miyahara, Satoshi] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan; [Villanueva, Sharon Y. A. M.] Univ Philippines Manila, Dept Med Microbiol, Coll Publ Hlth, Manila, Philippines	Kyushu University; Tottori University; University of Occupational & Environmental Health - Japan; Kyushu University; Monash University; University of the Philippines System; University of the Philippines Manila	Ozuru, R (corresponding author), Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Japan.; Ozuru, R (corresponding author), Tottori Univ, Div Bacteriol, Dept Microbiol & Immunol, Fac Med, Tottori, Japan.	ozuru@med.tottori-u.ac.jp		Villanueva, Sharon Yvette Angelina/0000-0001-6958-4110; Miyahara, Satoshi/0000-0001-8522-860X; Ozuru, Ryo/0000-0002-0616-0190; Murray, Gerald/0000-0003-3330-4433	Science and Technology Research Partnership for Sustainable Development (SATREPS) Program of Japan Science and Technology Agency; Japan International Cooperation Agency; JSPS KAKENHI from the Japan Society for the Promotion of Science [JP25460536]	Science and Technology Research Partnership for Sustainable Development (SATREPS) Program of Japan Science and Technology Agency; Japan International Cooperation Agency; JSPS KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Science and Technology Research Partnership for Sustainable Development (SATREPS) Program of Japan Science and Technology Agency (https://www.jst.go.jp/) and the Japan International Cooperation Agency (http://www.jica.go.jp/) to SY, and JSPS KAKENHI (Grant Number JP25460536) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2005, BACTERIOLOGY, V2, P1865; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Aviat F, 2010, APPL ENVIRON MICROB, V76, P8135, DOI 10.1128/AEM.02199-10; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005; Chakraborty A, 2011, MICROBIOL IMMUNOL, V55, P494, DOI 10.1111/j.1348-0421.2011.00347.x; Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307; Davis JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000463; De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Fornazari F, 2012, J MICROBIOL METH, V90, P321, DOI 10.1016/j.mimet.2012.06.005; Gahan CGM, 2012, CURR GENE THER, V12, P12; Ge YG, 1997, J BACTERIOL, V179, P2289, DOI 10.1128/jb.179.7.2289-2299.1997; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Haake David A, 2006, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12e02s02; Islam MS, 2014, FEMS MICROBIOL LETT, V356, P39, DOI 10.1111/1574-6968.12495; JOHNSON RC, 1963, J BACTERIOL, V85, P976, DOI 10.1128/JB.85.5.976-982.1963; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lambert A, 2012, APPL ENVIRON MICROB, V78, P8467, DOI 10.1128/AEM.02288-12; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Miyahara S, 2014, INT J EXP PATHOL, V95, P271, DOI 10.1111/iep.12085; Murray GL, 2010, J CLIN MICROBIOL, V48, P2037, DOI 10.1128/JCM.02541-09; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Paixao MD, 2014, PREV VET MED, V115, P69, DOI 10.1016/j.prevetmed.2014.03.016; Ratet G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003359; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; STALHEIM OH, 1964, J BACTERIOL, V88, P55, DOI 10.1002/path.1700880106; STANECK JL, 1973, INFECT IMMUN, V7, P886, DOI 10.1128/IAI.7.6.886-897.1973; Villanueva SYAM, 2014, MICROBIOL-SGM, V160, P418, DOI 10.1099/mic.0.072439-0; WHO and ILS, 2003, HUM LEPT GUID DIAGN; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172973	10.1371/journal.pone.0172973	http://dx.doi.org/10.1371/journal.pone.0172973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245231	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200047
J	Cope, AJ; Sabo, C; Vasilaki, E; Barron, AB; Marshall, JAR				Cope, Alex J.; Sabo, Chelsea; Vasilaki, Eleni; Barron, Andrew B.; Marshall, James A. R.			A computational model of the integration of landmarks and motion in the insect central complex	PLOS ONE			English	Article							HEAD-DIRECTION; VISUAL CONTROL; BRAIN; ORIENTATION; SYSTEM; FLIGHT; POLARIZATION; DISSECTION; NAVIGATION; HOMOLOGY	The insect central complex (CX) is an enigmatic structure whose computational function has evaded inquiry, but has been implicated in a wide range of behaviours. Recent experimental evidence from the fruit fly (Drosophila melanogaster) and the cockroach (Blaberus discoidalis) has demonstrated the existence of neural activity corresponding to the animal's orientation within a virtual arena (a neural `compass'), and this provides an insight into one component of the CX structure. There are two key features of the compass activity: an offset between the angle represented by the compass and the true angular position of visual features in the arena, and the remapping of the 270 degrees visual arena onto an entire circle of neurons in the compass. Here we present a computational model which can reproduce this experimental evidence in detail, and predicts the computational mechanisms that underlie the data. We predict that both the offset and remapping of the fly's orientation onto the neural compass can be explained by plasticity in the synaptic weights between segments of the visual field and the neurons representing orientation. Furthermore, we predict that this learning is reliant on the existence of neural pathways that detect rotational motion across the whole visual field and uses this rotation signal to drive the rotation of activity in a neural ring attractor. Our model also reproduces the `transitioning' between visual landmarks seen when rotationally symmetric landmarks are presented. This model can provide the basis for further investigation into the role of the central complex, which promises to be a key structure for understanding insect behaviour, as well as suggesting approaches towards creating fully autonomous robotic agents.	[Cope, Alex J.; Sabo, Chelsea; Vasilaki, Eleni; Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Cope, Alex J.; Sabo, Chelsea; Vasilaki, Eleni; Marshall, James A. R.] Sheffield Robot, Sheffield, S Yorkshire, England; [Barron, Andrew B.] Macquarie Univ, Sydney, NSW, Australia	University of Sheffield; Macquarie University	Cope, AJ (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England.; Cope, AJ (corresponding author), Sheffield Robot, Sheffield, S Yorkshire, England.	a.cope@sheffield.ac.uk		Barron, Andrew/0000-0002-8135-6628; Vasilaki, Eleni/0000-0003-3705-7070; Marshall, James/0000-0002-1506-167X	Engineering and Physical Sciences Research Council [EP/J019534/1, EP/P006094/1]; Royal Society International Exchanges Grant; Australian Research Council [140100452]; EPSRC [EP/J019534/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society International Exchanges Grant; Australian Research Council(Australian Research Council); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JARM and EV acknowledge the Engineering and Physical Sciences Research Council (http://gow.epsrc.ac.uk/) grant numbers EP/J019534/1 and EP/P006094/1. JARM and ABB acknowledge support from a Royal Society International Exchanges Grant. ABB is supported by an Australian Research Council Future Fellowship Grant no 140100452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Berens P., 2009, CIRCSTAT MATLAB TOOL; Cope AJ, 2015, SPINECREATOR GRAPHIC; Cope AJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004887; Dewar ADM, 2015, BIOSYSTEMS, V136, P120, DOI 10.1016/j.biosystems.2015.07.008; DILL M, 1995, LEARN MEMORY, V2, P152, DOI 10.1101/lm.2.3-4.152; DYER FC, 1981, SCIENCE, V214, P1041, DOI 10.1126/science.214.4524.1041; Eaton John W, 2015, GNU OCTAVE VERSION 4; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; Guo C, 2015, LEARN MEMORY, V22, P56, DOI 10.1101/lm.036863.114; Haferlach T, 2007, ADAPT BEHAV, V15, P273, DOI 10.1177/1059712307082080; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Ibbotson MR, 2001, P ROY SOC B-BIOL SCI, V268, P2195, DOI 10.1098/rspb.2001.1770; Kathman ND, 2014, J EXP BIOL, V217, P4079, DOI 10.1242/jeb.112391; KIRCHNER WH, 1989, NATURWISSENSCHAFTEN, V76, P281, DOI 10.1007/BF00368643; Knierim JJ, 2012, ANNU REV NEUROSCI, V35, P267, DOI 10.1146/annurev-neuro-062111-150351; Labhart T, 2002, CURR OPIN NEUROBIOL, V12, P707, DOI 10.1016/S0959-4388(02)00384-7; MCCANN GD, 1965, PROC R SOC SER B-BIO, V163, P369, DOI 10.1098/rspb.1965.0074; Nezis P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/034005; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; Richmond P, 2014, NEUROINFORMATICS, V12, P307, DOI 10.1007/s12021-013-9208-z; Richmond P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018539; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Stringer SM, 2005, NEUROBIOL LEARN MEM, V83, P79, DOI 10.1016/j.nlm.2004.08.003; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; TAUBE JS, 1990, J NEUROSCI, V10, P420; Turner-Evans DB, 2016, CURR BIOL, V26, pR453, DOI 10.1016/j.cub.2016.04.006; Utting M, 2000, J COMP NEUROL, V416, P245; Varga AG, 2016, CURR BIOL, V26, P1816, DOI 10.1016/j.cub.2016.05.037; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; WOLF R, 1990, J COMP PHYSIOL A, V167, P269, DOI 10.1007/BF00188119; Wolf R, 1997, LEARN MEMORY, V4, P318, DOI 10.1101/lm.4.4.318; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Zenke F, 2016, PHILOS T R SOC LON B	45	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172325	10.1371/journal.pone.0172325	http://dx.doi.org/10.1371/journal.pone.0172325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241061	Green Published, Green Accepted, gold			2022-12-27	WOS:000395934400018
J	Zaprutko, T; Kopciuch, D; Kus, K; Merks, P; Nowicka, M; Augustyniak, I; Nowakowska, E				Zaprutko, Tomasz; Kopciuch, Dorota; Kus, Krzysztof; Merks, Piotr; Nowicka, Monika; Augustyniak, Izabela; Nowakowska, Elzbieta			Affordability of medicines in the European Union	PLOS ONE			English	Article							PRICES; SCHIZOPHRENIA; SUBSTITUTION; AVAILABILITY; COSTS	Background Medications and their prices are key issues for healthcare. Although access to medicines at affordable prices had been specified as a key objective of the European Health Policy, it seems that these goals have not been achieved. Therefore, we attempted an evaluation of affordability of selected medicines at full prices. Methods The analysis concerned 2012 and was conducted between 2013 and 2015 in all the European Union (EU) countries divided into 3 groups depending on the date of their accession to the EU. Finally, we considered 9 originators used in the treatment of schizophrenia and multiple sclerosis. Information on drug prices were collected from pharmacies. Participation in the study was voluntary and anonymous in order to avoid accusations of advertising. To evaluate affordability, several factors were used (e.g. minimum earnings and Gini coefficient). Due to unavailability in some countries, the exact number of analyzed medicines varies. Results Drug prices vary significantly between EU Member States. Almost eleven fold difference was observed between Germany (EUR 1451.17) and Croatia (EUR 132.77) in relation to Interferone beta-1a 22 mu g. Generally, prices were the highest in Germany. The cheapest drugs were found in various countries but never in the poorest ones like Bulgaria or Romania. Discrepancies in wages were observed too (the smallest minimum wage was EUR 138.00 in Bulgaria and the highest EUR 1801.00 in Luxembourg). Full price of olanzapine 5mg, however, was higher in Bulgaria (EUR 64.53) than, for instance, in Belgium (EUR 37.26). Conclusions Analyzed medications are still unaffordable for many citizens of the EU. Besides, access to medicines is also impaired e.g. due to parallel trade. Unaffordability of medications may lead to the patients' non-compliance and therefore to increased direct and indirect costs of treatment. Common European solutions are needed to achieve a real affordability and accessibility of medications.	[Zaprutko, Tomasz; Kopciuch, Dorota; Kus, Krzysztof; Nowakowska, Elzbieta] Poznan Univ Med Sci, Dept Pharmacoecon & Social Pharm, Poznan, Poland; [Merks, Piotr] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Dept Pharmaceut Technol, Torun, Poland; [Nowicka, Monika; Augustyniak, Izabela] Poznan Univ Med Sci, Dept Pharmacoecon & Social Pharm, Student Sci Soc, Poznan, Poland	Poznan University of Medical Sciences; Nicolaus Copernicus University; Poznan University of Medical Sciences	Zaprutko, T (corresponding author), Poznan Univ Med Sci, Dept Pharmacoecon & Social Pharm, Poznan, Poland.	tomekzaprutko@ump.edu.pl	Nowakowska, Elżbieta/CAJ-1814-2022; Merks, Piotr/P-5432-2015	Nowakowska, Elżbieta/0000-0001-5515-9551; Kopciuch, Dorota/0000-0001-6547-6112; Merks, Piotr/0000-0001-8966-3799; Kus, Krzysztof/0000-0002-8838-3629; Zaprutko, Tomasz/0000-0001-9737-9624	Aegate Ltd (Sp. z o.o. branch in Poland); Aegate Ltd branch in Poland	Aegate Ltd (Sp. z o.o. branch in Poland); Aegate Ltd branch in Poland	We would like to thank Aegate Ltd (Sp. z o.o. branch in Poland), for their support in paying the open access fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Aegate Ltd branch in Poland, for their support in paying the open access fee. We thank all people, who disinterestedly helped us in collecting data.	Aghaei N, 2016, INDIAN J PALLIAT CAR, V22, P163, DOI 10.4103/0973-1075.179610; Andersson K, 2007, HEALTH POLICY, V81, P376, DOI 10.1016/j.healthpol.2006.07.005; Bazargani YT, 2014, ESSENTIAL MED ARE MO, V12, DOI [10.1371/journal.pone.0087576, DOI 10.1371/JOURNAL.PONE.0087576]; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Brekke K, 2014, PRICE REGULATION PAR; Brekke K, 2011, COMP PHARM PRIC NORW; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cleemput I, 2012, INT J TECHNOL ASSESS, V28, P358, DOI 10.1017/S0266462312000529; Daltio CS, 2011, REV SAUDE PUBL, V45, P14, DOI 10.1590/S0034-89102010005000049; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Edejer T, 2003, MAKING CHOICES HLTH; Ernstsson O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159129; European Commission, PHARM MED PROD HUM U; European Commission, 2004, HIGH LEV GROUP HLTH; Gilbert J, 2004, IMBALANCED INNOVATIO; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Himmel W, 2005, INT J CLIN PHARM TH, V43, P472; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Kanavos P, 2011, PHARM DISTRIBUTION C; Kanavos P., 2011, EUROPEAN PARLIAMENTS; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Leopold Christine, 2012, South Med Rev, V5, P34; Leopold C, 2012, HEALTH POLICY, V104, P50, DOI 10.1016/j.healthpol.2011.09.008; Light DW, 2005, BRIT MED J, V331, P958, DOI 10.1136/bmj.331.7522.958; Machado M, 2011, REV PANAM SALUD PUBL, V29, P46; Mhlanga B, 2014, AFR J PRM HLTH CARE; Vogler S, 2015, VALUE HEALTH, V18, P484, DOI 10.1016/j.jval.2015.01.003; Vogler S, 2011, CROAT MED J, V52, P183, DOI 10.3325/cmj.2011.52.183; von der Schulenburg F, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-18; Wagner JL, 2004, ANNU REV PUBL HEALTH, V25, P475, DOI 10.1146/annurev.publhealth.25.101802.123042; World Health Organization, 2020, WHO GUID COUNTR PHAR, V2nd; Xi XY, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1008-8; Zaprutko T, 2015, PSYCHIAT QUART, V86, P569, DOI 10.1007/s11126-015-9354-6	35	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172753	10.1371/journal.pone.0172753	http://dx.doi.org/10.1371/journal.pone.0172753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241019	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400037
J	Zhang, L; Zhang, P; Li, QQ; Gaur, U; Liu, YP; Zhu, Q; Zhao, XL; Wang, Y; Yin, HD; Hu, YD; Liu, AP; Li, DY				Zhang, Long; Zhang, Pu; Li, Qingqing; Gaur, Uma; Liu, Yiping; Zhu, Qing; Zhao, Xiaoling; Wang, Yan; Yin, Huadong; Hu, Yaodong; Liu, Aiping; Li, Diyan			Genetic evidence from mitochondrial DNA corroborates the origin of Tibetan chickens	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; POLYNESIAN CHICKENS; DOMESTICATION; SEQUENCE; ASSOCIATION; DISPERSAL; HYPOXIA	Chicken is the most common poultry species and is important to human societies. Tibetan chicken (Gallus gallus domesticus) is a breed endemic to China that is distributed mainly on the Qinghai-Tibet Plateau. However, its origin has not been well characterized. In the present study, we sequenced partial mitochondrial DNA (mtDNA) control region of 239 and 283 samples from Tibetan and Sichuan indigenous chickens, respectively. Incorporating 1091 published sequences, we constructed the matrilineal genealogy of Tibetan chickens to further document their domestication history. We found that the genetic structure of the mtDNA haplotypes of Tibetan chickens are dominated by seven major haplogroups (A-G). In addition, phylogenetic and network analyses showed that Tibetan chickens are not distinguishable from the indigenous chickens in surrounding areas. Furthermore, some clades of Tibetan chickens may have originated from game fowls. In summary, our results collectively indicated that Tibetan chickens may have diverged from indigenous chickens in the adjacent regions and hybridized with various chickens.	[Zhang, Long; Zhang, Pu; Gaur, Uma; Liu, Yiping; Zhu, Qing; Zhao, Xiaoling; Wang, Yan; Yin, Huadong; Hu, Yaodong; Li, Diyan] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Li, Qingqing] Southwest Forestry Univ, Life Sci Coll, Kunming, Peoples R China; [Liu, Aiping] Sichuan Agr Univ, Coll Food Sci, Yaan, Peoples R China; [Li, Qingqing] Kunming Xianghao Technol Co Ltd, Kunming, Peoples R China	Sichuan Agricultural University; Southwest Forestry University - China; Sichuan Agricultural University	Li, DY (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	diyanli@sicau.edu.cn	Zhang, Long/Q-8657-2019	Zhang, Long/0000-0003-3553-9738; Li, Diyan/0000-0001-7490-3550	Program of Sichuan Agricultural University [02920400]; National Natural Science Foundation of China [NSFC31402063]; Sichuan Provincial Department of Science and Technology Program [2015JQ0023]; Key Discipline Construction Project of Biology in Yunnan province [50097505]; Doctoral Scientific Research Foundation of Southwest Forestry University [111441]; project of Thirteen Five-Year Province Crops and Livestock and Poultry Breeding Research [2016NYZ0043]	Program of Sichuan Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of Science and Technology Program; Key Discipline Construction Project of Biology in Yunnan province; Doctoral Scientific Research Foundation of Southwest Forestry University; project of Thirteen Five-Year Province Crops and Livestock and Poultry Breeding Research	This work was supported by the Program of Sichuan Agricultural University (02920400), the National Natural Science Foundation of China (NSFC31402063), the Sichuan Provincial Department of Science and Technology Program (2015JQ0023), the Key Discipline Construction Project of Biology in Yunnan province (50097505), the Doctoral Scientific Research Foundation of Southwest Forestry University (111441) and the project of Thirteen Five-Year Province Crops and Livestock and Poultry Breeding Research (2016NYZ0043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Program of Sichuan Agricultural University (02920400), the National Natural Science Foundation of China (NSFC31402063), the Sichuan Provincial Department of Science and Technology Program (2015JQ0023), the Key Discipline Construction Project of Biology in Yunnan province (50097505), the Doctoral Scientific Research Foundation of Southwest Forestry University (111441) and the project of Thirteen Five-Year Province Crops and Livestock and Poultry Breeding Research (2016NYZ0043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank Binlong Chen for help during sample collection.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao HG, 2007, ANIM GENET, V38, P514, DOI 10.1111/j.1365-2052.2007.01622.x; Bao HG, 2008, MITOCHONDR DNA, V19, P461, DOI 10.1080/19401730802449212; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; Liu YP, 2006, BIOCHEM GENET, V44, P18, DOI 10.1007/s10528-006-9012-7; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Miao YW, 2013, HEREDITY, V110, P277, DOI 10.1038/hdy.2012.83; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Peng MS, 2015, MOL ECOL RESOUR, V15, P1238, DOI 10.1111/1755-0998.12386; Peng MS, 2015, P NATL ACAD SCI USA, V112, pE1970, DOI 10.1073/pnas.1501151112; Sambrook J., 2001, MOL CLONING LAB MANU; Shi NN, 2014, MOL ECOL, V23, P5393, DOI 10.1111/mec.12955; Sigley G., 2013, CULTURAL HERITAGE PO, P235; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; Sun J, 2013, GENE, V529, P131, DOI 10.1016/j.gene.2013.06.075; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson VA, 2014, P NATL ACAD SCI USA, V111, P4826, DOI 10.1073/pnas.1320412111; Wang GD, 2014, ANNU REV ANIM BIOSCI, V2, P65, DOI 10.1146/annurev-animal-022513-114129; Wang MS, 2015, MOL BIOL EVOL, V32, P1880, DOI 10.1093/molbev/msv071; Wani CE, 2014, GENET RES INT, V2014, DOI 10.1155/2014/928420; Wu ZG, 2011, IMMUNOBIOLOGY, V216, P1177, DOI 10.1016/j.imbio.2011.05.012; Xiang H, 2014, P NATL ACAD SCI USA, V111, P17564, DOI 10.1073/pnas.1411882111; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215; Zhang H, 2008, POULTRY SCI, V87, P2112, DOI 10.3382/ps.2008-00122; Zhang H, 2007, POULTRY SCI, V86, P1384, DOI 10.1093/ps/86.7.1384; Zhang Hao, 2006, Scientia Agricultura Sinica, V39, P1507; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhao XL, 2016, MITOCHONDRIAL DNA A, V27, P3280, DOI 10.3109/19401736.2015.1015006	36	22	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172945	10.1371/journal.pone.0172945	http://dx.doi.org/10.1371/journal.pone.0172945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241078	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400053
J	Bothmann, L; Menzel, A; Menze, BH; Schunk, C; Kauermann, G				Bothmann, Ludwig; Menzel, Annette; Menze, Bjoern H.; Schunk, Christian; Kauermann, Goeran			Automated processing of webcam images for phenological classification	PLOS ONE			English	Article							DECIDUOUS BROADLEAF FOREST; CLIMATE-CHANGE; BAYESIAN-ANALYSIS; SPRING PHENOLOGY; PARAMETER INSTABILITY; VEGETATION PHENOLOGY; CHANGE-POINT; SURFACE; ECOSYSTEMS; FEEDBACKS	Along with the global climate change, there is an increasing interest for its effect on phenological patterns such as start and end of the growing season. Scientific digital webcams are used for this purpose taking every day one or more images from the same natural motive showing for example trees or grassland sites. To derive phenological patterns from the webcam images, regions of interest are manually defined on these images by an expert and subsequently a time series of percentage greenness is derived and analyzed with respect to structural changes. While this standard approach leads to satisfying results and allows to determine dates of phenological change points, it is associated with a considerable amount of manual work and is therefore constrained to a limited number of webcams only. In particular, this forbids to apply the phenological analysis to a large network of publicly accessible webcams in order to capture spatial phenological variation. In order to be able to scale up the analysis to several hundreds or thousands of webcams, we propose and evaluate two automated alternatives for the definition of regions of interest, allowing for efficient analyses of webcam images. A semi-supervised approach selects pixels based on the correlation of the pixels' time series of percentage greenness with a few prototype pixels. An unsupervised approach clusters pixels based on scores of a singular value decomposition. We show for a scientific webcam that the resulting regions of interest are at least as informative as those chosen by an expert with the advantage that no manual action is required. Additionally, we show that the methods can even be applied to publicly available webcams accessed via the internet yielding interesting partitions of the analyzed images. Finally, we show that the methods are suitable for the intended big data applications by analyzing 13988 webcams from the AMOS database. All developed methods are implemented in the statistical software package R and publicly available in the R package phenofun. Executable example code is provided as supplementary material.	[Bothmann, Ludwig; Kauermann, Goeran] Ludwig Maximilians Univ Munchen, Inst Stat, Munich, Germany; [Menzel, Annette; Schunk, Christian] Tech Univ Munich, Okoklimatol, Wissensch Zentrum Weihenstephan Ernahrung Landnut, Freising Weihenstephan, Germany; [Menzel, Annette; Menze, Bjoern H.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Menze, Bjoern H.] Tech Univ Munich, Dept Informat, Munich, Germany	University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Menzel, A (corresponding author), Tech Univ Munich, Okoklimatol, Wissensch Zentrum Weihenstephan Ernahrung Landnut, Freising Weihenstephan, Germany.; Menzel, A (corresponding author), Tech Univ Munich, Inst Adv Study, Garching, Germany.	amenzel@wzw.tum.de	Menzel, Annette/B-1105-2013	Menzel, Annette/0000-0002-7175-2512; Menze, Bjoern/0000-0003-4136-5690; Schunk, Christian/0000-0003-0605-3819	German Research Foundation (DFG); Technical University of Munich (TUM)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program.	Ahrends Hella Ellen, 2008, Journal of Geophysical Research - Part G - Biogeosciences, V113, DOI 10.1029/2007JG000650; Alberton B, 2014, ECOL INFORM, V19, P62, DOI 10.1016/j.ecoinf.2013.12.011; ANDREWS DWK, 1993, ECONOMETRICA, V61, P821, DOI 10.2307/2951764; Baglama J, 2015, PCA SYMMETRIC EIGEND; Dose V, 2004, GLOBAL CHANGE BIOL, V10, P259, DOI 10.1111/j.1529-8817.2003.00731.x; Filippa G, 2016, AGR FOREST METEOROL, V220, P141, DOI 10.1016/j.agrformet.2016.01.006; Fu YSH, 2014, GLOBAL ECOL BIOGEOGR, V23, P1255, DOI 10.1111/geb.12210; Graham EA, 2010, GLOBAL CHANGE BIOL, V16, P3014, DOI 10.1111/j.1365-2486.2010.02164.x; Gu Lianhong, 2009, P35, DOI 10.1007/978-1-4419-0026-5_2; HANSEN BE, 1992, J BUS ECON STAT, V10, P321, DOI 10.2307/1391545; Henneken R, 2013, AGR FOREST METEOROL, V168, P177, DOI 10.1016/j.agrformet.2012.09.001; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Hufkens K, 2012, REMOTE SENS ENVIRON, V117, P307, DOI 10.1016/j.rse.2011.10.006; Jacobs N, 2007, IEEE C COMP VIS PATT, DOI [10.1109/CVPR.2007.383258, DOI 10.1109/CVPR.2007.383258]; Jeganathan C, 2014, REMOTE SENS ENVIRON, V143, P154, DOI 10.1016/j.rse.2013.11.020; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Julitta T, 2014, AGR FOREST METEOROL, V198, P116, DOI 10.1016/j.agrformet.2014.08.007; Keenan TF, 2012, GLOBAL CHANGE BIOL, V18, P1971, DOI 10.1111/j.1365-2486.2012.02678.x; Klosterman ST, 2014, BIOGEOSCIENCES, V11, P4305, DOI 10.5194/bg-11-4305-2014; Liang L, 2009, LANDSCAPE ECOL, V24, P465, DOI 10.1007/s10980-009-9328-x; Menzel A, 2002, CLIMATIC CHANGE, V54, P379, DOI 10.1023/A:1016125215496; Menzel A., 2013, PHENOLOGY INTEGRATIV, P53; Menzel A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00110; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Pope KS, 2013, GLOBAL CHANGE BIOL, V19, P1518, DOI 10.1111/gcb.12130; R Core Team, 2013, R LANG ENV STAT COMP; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Rodriguez-Galiano VF, 2015, GEOPHYS RES LETT, V42, P2253, DOI 10.1002/2015GL063586; Schleip C, 2006, AGR FOREST METEOROL, V141, P179, DOI 10.1016/j.agrformet.2006.09.013; SCHWARTZ MD, 1992, MON WEATHER REV, V120, P2570, DOI 10.1175/1520-0493(1992)120<2570:PASSLC>2.0.CO;2; Sonnentag O, 2012, AGR FOREST METEOROL, V152, P159, DOI 10.1016/j.agrformet.2011.09.009; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zeileis A., 2002, J STAT SOFTW, V7, P1, DOI [DOI 10.18637/JSS.V007.I02, 10.18637/jss.v007.i02]; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhao JB, 2012, ECOL INFORM, V10, P65, DOI 10.1016/j.ecoinf.2012.03.001	39	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171918	10.1371/journal.pone.0171918	http://dx.doi.org/10.1371/journal.pone.0171918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235092	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200039
J	Mean, M; Garnier, A; Wenger, N; Castioni, J; Waeber, G; Marques-Vidal, P				Mean, Marie; Garnier, Antoine; Wenger, Nathalie; Castioni, Julien; Waeber, Gerard; Marques-Vidal, Pedro			Computer usage and task-switching during resident's working day: Disruptive or not?	PLOS ONE			English	Article							INTERRUPTIONS; ASSOCIATION; DOCTORS; PATIENT; TIME	Background Recent implementation of electronic health records (EHR) has dramatically changed medical ward organization. While residents in general internal medicine use EHR systems half of their working time, whether computer usage impacts residents' workflow remains uncertain. We aimed to observe the frequency of task-switches occurring during resident's work and to assess whether computer usage was associated with task-switching. Methods In a large Swiss academic university hospital, we conducted, between May 26 and July 24, 2015 a time-motion study to assess how residents in general internal medicine organize their working day. Results We observed 49 day and 17 evening shifts of 36 residents, amounting to 697 working hours. During day shifts, residents spent 5.4 hours using a computer (mean total working time: 11.6 hours per day). On average, residents switched 15 times per hour from a task to another. Task-switching peaked between 8: 00-9: 00 and 16: 00-17: 00. Task-switching was not associated with resident's characteristics and no association was found between taskswitching and extra hours (Spearman r = 0.220, p = 0.137 for day and r = 0.483, p = 0.058 for evening shifts). Computer usage occurred more frequently at the beginning or ends of day shifts and was associated with decreased overall task-switching. Conclusion Task-switching occurs very frequently during resident's working day. Despite the fact that residents used a cdomputer half of their working time, computer usage was associated with decreased task-switching. Whether frequent task-switches and computer usage impact the quality of patient care and resident's work must be evaluated in further studies.	[Mean, Marie; Garnier, Antoine; Wenger, Nathalie; Castioni, Julien; Waeber, Gerard; Marques-Vidal, Pedro] Univ Lausanne Hosp, Div Gen Internal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Mean, M (corresponding author), Univ Lausanne Hosp, Div Gen Internal Med, Lausanne, Switzerland.	marie.mean@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Garnier, Antoine/J-6454-2018	Marques-Vidal, Pedro M/0000-0002-4548-8500; Garnier, Antoine/0000-0001-8361-2210; Waeber, Gerard/0000-0003-4193-788X; Mean, Marie/0000-0003-0477-7899; Castioni, Julien/0000-0002-7260-9371	IT Department; Department of Internal Medicine of Lausanne university hospital	IT Department; Department of Internal Medicine of Lausanne university hospital	The study was sponsored by the IT Department and the Department of Internal Medicine of Lausanne university hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi J, 2014, JAMA-J AM MED ASSOC, V312, P2331, DOI 10.1001/jama.2014.12820; Dias C, 2013, HEALTH CARE MANAG, V32, P268, DOI 10.1097/HCM.0b013e31828ef60a268; Irani JS, 2009, J AM BOARD FAM MED, V22, P553, DOI 10.3122/jabfm.2009.05.080259; Kazmi Zainab, 2013, Inform Prim Care, V21, P30, DOI 10.14236/jhi.v21i1.37; Ouyang D, 2016, JAMA INTERN MED, V176, P252, DOI 10.1001/jamainternmed.2015.6831; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Weigl M, 2012, BMJ QUAL SAF, V21, P399, DOI 10.1136/bmjqs-2011-000188; Wenger N, 2017, ANN INTERN IN PRESS; Westbrook JI, 2008, MED J AUSTRALIA, V188, P506, DOI 10.5694/j.1326-5377.2008.tb01762.x; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65	10	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172878	10.1371/journal.pone.0172878	http://dx.doi.org/10.1371/journal.pone.0172878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235078	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200161
J	Nitahara, S; Kato, S; Usui, A; Urabe, T; Suzuki, K; Yamagishi, A				Nitahara, Shota; Kato, Shingo; Usui, Akira; Urabe, Tetsuro; Suzuki, Katsuhiko; Yamagishi, Akihiko			Archaeal and bacterial communities in deep-sea hydrogenetic ferromanganese crusts on old seamounts of the northwestern Pacific	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; TAKUYO-DAIGO SEAMOUNT; MICROBIAL COMMUNITIES; DIVERSITY; ABUNDANCE; SOIL; SEQUENCES; ALIGNMENT; FLUIDS; LIFE	Deep-sea ferromanganese crusts are found ubiquitously on the surface of seamounts of the world's oceans. Considering the wide distribution of the crusts, archaeal and bacterial communities on these crusts potentially play a significant role in biogeochemical cycling between oceans and seamounts; however little is known about phylogenetic diversity, abundance and function of the crust communities. To this end, we collected the crusts from the northwest Pacific basin and the Philippine Sea. We performed comprehensive analysis of the archaeal and bacterial communities of the collected crust samples by culture-independent molecular techniques. The distance between the sampling points was up to approximately 2,000 km. Surrounding sediments and bottom seawater were also collected as references near the sampling points of the crusts, and analyzed together. 16S rRNA gene analyses showed that the community structure of the crusts was significantly different from that of the seawater. Several members related to ammonia-oxidizers of Thaumarchaeota and Betaproteobacteria were detected in the crusts at most of all regions and depths by analyses of 16S rRNA and amoA genes, suggesting that the ammonia-oxidizing members are commonly present in the crusts. Although members related to the ammonia-oxidizers were also detected in the seawater, they differed from those in the crusts phylogenetically. In addition, members of uncultured groups of Alpha-, Delta-and Gammaproteobacteria were commonly detected in the crusts but not in the seawater. Comparison with previous studies of ferromanganese crusts and nodules suggests that the common members determined in the present study are widely distributed in the crusts and nodules on the vast seafloor. They may be key microbes for sustaining microbial ecosystems there.	[Nitahara, Shota; Kato, Shingo; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Dept Mol Biol, Hachioji, Tokyo, Japan; [Kato, Shingo; Suzuki, Katsuhiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Ore Genesis Res Unit, Project Team Dev New Generat Res Protocol Submari, Yokosuka, Kanagawa, Japan; [Usui, Akira] Kochi Univ, Ctr Adv Marine Core Res, Kochi, Kochi, Japan; [Urabe, Tetsuro] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; University of Tokyo	Yamagishi, A (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Mol Biol, Hachioji, Tokyo, Japan.	yamagish@toyaku.ac.jp	Suzuki, Katsuhiko/B-1143-2018	Suzuki, Katsuhiko/0000-0003-4266-5046; Yamagishi, Akihiko/0000-0001-5162-3927	Ministry of Education, Culture, Science and Technology (MEXT), Japan; Cabinet Office, Government of Japan	Ministry of Education, Culture, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cabinet Office, Government of Japan	This work was supported by the Ministry of Education, Culture, Science and Technology (MEXT), Japan, through a special coordination fund (Project TAIGA: Trans-crustal Advection and In-situ biogeochemical processes of Global sub-seafloor Aquifer)(http://www.mext.go.jp/a_menu/shinkou/hojyo/chukan-jigohyouka/1301256.htm), and partially by the Cabinet Office, Government of Japan, though the Next-generation technology for ocean resources exploration (called as Zipangu-in-the-ocean project) in the Cross-ministerial Strategic Innovation Promotion Program (SIP)(https://www.jamstec.go.jp/sip/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer B, 2016, ISME J, V10, P1051, DOI 10.1038/ismej.2015.200; Blothe M, 2015, ENVIRON SCI TECHNOL, V49, P7692, DOI 10.1021/es504930v; Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Durbin AM, 2010, ENV MICROBIOL REP, V2, P693, DOI 10.1111/j.1758-2229.2010.00163.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Glasby G.P., 2006, MARINE GEOCHEMISTRY, DOI [10.1007/3-540-32144-6_11, DOI 10.1007/3-540-32144-6_11]; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hein J.R., 2014, TREATISE GEOCHEMISTR, V13, P273, DOI [DOI 10.1016/B978-0-08-095975-7.01111-6, 10.1016/B978-0-08-095975-7.01111-6]; Hornek R, 2006, J MICROBIOL METH, V66, P147, DOI 10.1016/j.mimet.2005.11.001; Kato S., 2013, FRONT PLANT SCI, V4, P227, DOI [10.3389/fpls.2013.00227, DOI 10.3389/fmicb.2013.00085]; Kato S, 2015, DEEP SEA BIODIVERSIT, P103; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Lagostina L, 2015, ENV MICROBIOL REP, V7, P404, DOI 10.1111/1758-2229.12264; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Lee MD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01470; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nitahara S, 2011, FEMS MICROBIOL LETT, V321, P121, DOI 10.1111/j.1574-6968.2011.02323.x; Nozaki Y., 1997, EOS T AM GEOPHYS UN, V78, P221, DOI DOI 10.1029/97E000148; Pett-Ridge J, 2013, FEMS MICROBIOL ECOL, V85, P179, DOI 10.1111/1574-6941.12111; Pickard GL, 1990, DESCRIPTIVE PHYSICAL, P34; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Rona PA, 2003, SCIENCE, V299, P673, DOI 10.1126/science.1080679; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiraishi F, 2016, EARTH PLANET SC LETT, V447, P10, DOI 10.1016/j.epsl.2016.04.021; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Stephen JR, 1996, APPL ENVIRON MICROB, V62, P4147, DOI 10.1128/AEM.62.11.4147-4154.1996; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Templeton AS, 2009, NAT GEOSCI, V2, P872, DOI 10.1038/ngeo696; Tokumaru A, 2015, GEOCHEM J, V49, P233, DOI 10.2343/geochemj.2.0352; Tully BJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00161; Usui A., 1997, MANGANESE MINERALIZA, V119, P177, DOI [10.1144/GSL.SP.1997.119.01.12, DOI 10.1144/GSL.SP.1997.119.01.12]; Usui A., 2016, ORE GEOLOGY REV; Walsh EA, 2016, ISME J, V10, P979, DOI 10.1038/ismej.2015.175; Yli-Hemminki P, 2014, GEOMICROBIOL J, V31, P263, DOI 10.1080/01490451.2013.819050	54	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173071	10.1371/journal.pone.0173071	http://dx.doi.org/10.1371/journal.pone.0173071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235095	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200195
J	Hertsenberg, AJ; Shojaati, G; Funderburgh, ML; Mann, MM; Du, YQ; Funderburgh, JL				Hertsenberg, Andrew J.; Shojaati, Golnar; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Funderburgh, James L.			Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding	PLOS ONE			English	Article							KERATAN SULFATE PROTEOGLYCAN; TGF-BETA; INFLAMMATORY RESPONSE; PROTEIN TSG-6; IN-VIVO; TISSUE; INJURY; REPAIR; MODEL; DIFFERENTIATION	Corneal scarring limits vision for millions of individuals worldwide. Corneal transplantation (keratoplasty) is the standard of care for corneal opacity; however, it bears the risk of graft rejection and infection and is not universally available. Stem cell therapy holds promise as an alternative to keratoplasty. Stem cells from human corneal stroma (CSSC) induce regen-eration of transparent corneal tissue in a mouse wound-healing model. In this study we investigated the mechanism by which CSSC prevent deposition of fibrotic tissue. Infiltration by CD11b (+)/Ly6G (+) neutrophils and myeloperoxidase expression were increased in corneas 24 hr after corneal wounding but were reduced in CSSC-treated wounds. Secretion of TSG-6, a protein known to regulate neutrophil migration, was up-regulated in CSSC in response to TNFa and as CSSC differentiate to keratocytes. In vivo, wounded mouse corneas treated with CSSC contained human TSG-6. Inhibition of neutrophil infiltration into cornea by CSSC was reversed when TSG-6 expression was knocked down using siRNA. Silencing of TSG-6 expression in CSSC reduced their ability to block scarring and the expression of mRNA for fibrosis-associated proteins collagen III, tenascin C, and smooth muscle actin in wounded corneas. Neutropenic mice exhibited a significant reduction in corneal scarring and fibrotic mRNA expression 2 weeks after wounding. These results support the conclusion that neu-trophil infiltration is an essential event in the fibrotic response to corneal damage and that prevention of scarring by CSSC is mediated by secretion of TSG-6 by these cells.	[Hertsenberg, Andrew J.; Shojaati, Golnar; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Du, Yiqin/A-7727-2018	DU, YIQIN/0000-0002-4330-0957; Funderburgh, James/0000-0002-6192-6363	National Institutes of Health, National Eye Institute [RO1EY016415, P30 EY008098]; US Department of Defense, U.S. ARMY [W81XWH-14-1-0465]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY016415] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US Department of Defense, U.S. ARMY(United States Department of Defense); Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute RO1EY016415, JLF PI; US Department of Defense, U.S. ARMY, Grant W81XWH-14-1-0465, JLF PI; National Institutes of Health, National Eye Institute P30 EY008098 Core Grant for Vision Research, Robert L Hendricks PI; Eye and Ear Foundation of Pittsburgh, Unrestricted Grant for Vision Research, JLF; Research to Prevent Blindness, Inc. Unrestricted Grant for Vision Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian OW, 2016, CLIN IMMUNOL, V164, P78, DOI 10.1016/j.clim.2016.02.001; Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Beltran SR, 2015, J PERIODONTOL, V86, P62, DOI 10.1902/jop.2014.140187; Boote C, 2012, INVEST OPHTH VIS SCI, V53, P2786, DOI 10.1167/iovs.11-9305; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chrysanthopoulou A, 2014, J PATHOL, V233, P294, DOI 10.1002/path.4359; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Fagerholm P, 2014, INVEST OPHTH VIS SCI, V35, P2420; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409; Han YM, 1997, J INFECT DIS, V175, P1169, DOI 10.1086/516455; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Li Fei, 2014, World J Stem Cells, V6, P296, DOI 10.4252/wjsc.v6.i3.296; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Liu LY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088348, 10.1371/journal.pone.0104748]; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Mariotti SP., GLOBAL DATA VISUAL I; Marrazzo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021180; Matsuba M, 2011, EXP EYE RES, V93, P534, DOI 10.1016/j.exer.2011.06.018; McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; O'Brien TP, 1998, ARCH OPHTHALMOL-CHIC, V116, P1470, DOI 10.1001/archopht.116.11.1470; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Petrof G., 2014, COLD SPRING HARB PER, V4; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Saika S, 2016, EXP EYE RES, V142, P40, DOI 10.1016/j.exer.2014.12.015; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Tasheva ES, 1998, GENE, V218, P63, DOI 10.1016/S0378-1119(98)00390-4; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Ul Hassan W, 2014, WOUND REPAIR REGEN, V22, P313, DOI 10.1111/wrr.12173; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; Wang H, 2015, EUR J PHARMACOL, V751, P42, DOI 10.1016/j.ejphar.2015.01.040; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wilson SE, 2003, EXP EYE RES, V76, P193, DOI 10.1016/S0014-4835(02)00277-4; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Wu J, 2014, ACTA BIOMATER, V10, P751, DOI 10.1016/j.actbio.2013.09.038; Ylostalo JH, 2014, CYTOTHERAPY, V16, P1486, DOI 10.1016/j.jcyt.2014.07.010; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926; Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465	58	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171712	10.1371/journal.pone.0171712	http://dx.doi.org/10.1371/journal.pone.0171712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257425	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100009
J	Tractenberg, RE; Garver, A; Ljungberg, IH; Schladen, MM; Groah, SL				Tractenberg, Rochelle E.; Garver, Amanda; Ljungberg, Inger H.; Schladen, Manon M.; Groah, Suzanne L.			Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUESTIONNAIRE; PCORI; ENGAGEMENT; MODEL; CARE	The objectives of this study were to describe and demonstrate a new model of developing patient reported outcomes (PROs) that are patient-centered, and to test the hypothesis that following this model would result in a qualitatively different PRO than if the typical PRO development model were followed. The typical process of developing PROs begins with an initial list of signs or symptoms originating from clinicians or PRO developers; patient valida-tion of this list ensures that the list (i. e., the new PRO) is interpretable by patients, but not that patient perspectives are central or even represented. The new model begins with elici-tation from clinicians and patients independently and separately. These perspectives are formally analyzed qualitatively, and the results are iteratively integrated by researchers, sup-porting clinical relevance and patient centeredness. We describe the application of this new model to the development of a PRO for urinary signs and symptoms in individuals with neu-ropathic bladder, and test the hypothesis that the two processes generate qualitatively dif-ferent instruments using a national validation sample of 300 respondents. Of its 29 items, the new instrument included 13 signs/symptoms derived from existing clinical practice guidelines, with 16 others derived from the patient/focus groups. The three most-endorsed items came from the patients, and the three least-endorsed items came from clinical guide-lines. Thematic qualitative analysis of the elicitation process, as well as the results from our national sample, support the conclusion that the new model yields an instrument that is clini-cally interpretable, but more patient-centered, than the typical model would have done in this context.	[Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Collaborat Res Outcomes & Metr, Washington, DC 20007 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Tractenberg, Rochelle E.; Garver, Amanda; Ljungberg, Inger H.; Schladen, Manon M.; Groah, Suzanne L.] Georgetown Univ, Med Ctr, Dept Rehabil Med, Washington, DC 20007 USA; [Ljungberg, Inger H.; Schladen, Manon M.; Groah, Suzanne L.] MedStar Natl Rehabil Hosp, Washington, DC USA; [Schladen, Manon M.] MedStar Hlth Res Hlth Inst, Hyattsville, MD USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; MedStar Health Research Institute	Tractenberg, RE (corresponding author), Georgetown Univ, Med Ctr, Collaborat Res Outcomes & Metr, Washington, DC 20007 USA.	rochelle.tractenberg@gmail.com			PCORI grant [AD-1310-08215]	PCORI grant(Patient-Centered Outcomes Research Institute - PCORI)	This work was supported by PCORI grant number: AD-1310-08215 to SLG.	Anderson M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6023; [Anonymous], 2016, NVIVO PRODUCT RANGE; Basch E, 2011, VALUE HEALTH, V14, P965, DOI 10.1016/j.jval.2011.10.002; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brookes ST, 2004, AM J OBSTET GYNECOL, V191, P73, DOI 10.1016/j.ajog.2003.12.027; Carlos RC, 2012, J AM COLL RADIOL, V9, P725, DOI 10.1016/j.jacr.2012.06.008; Chen WH, 2014, EXPERT REV PHARM OUT, V14, P379, DOI 10.1586/14737167.2014.912133; Clayson D, 2005, BJU INT, V96, P350, DOI 10.1111/j.1464-410X.2005.05630.x; Concannon TW, 2012, J GEN INTERN MED, V27, P985, DOI 10.1007/s11606-012-2037-1; Creswell J. W., 2013, QUALITATIVE INQUIRY; Devine EB, 2013, J CLIN EPIDEMIOL, V66, pS122, DOI 10.1016/j.jclinepi.2013.04.007; Forsythe LP, 2016, J GEN INTERN MED, V31, P13, DOI 10.1007/s11606-015-3450-z; Francis DO, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0307-4; Frank L, 2015, QUAL LIFE RES, V24, P1033, DOI 10.1007/s11136-014-0893-3; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Halley MC, 2013, J COMP EFFECT RES, V2, P421, DOI [10.2217/cer.13.46, 10.2217/CER.13.46]; Hoffman A, 2010, HEALTH AFFAIR, V29, P1834, DOI 10.1377/hlthaff.2010.0675; Homma Y, 2008, INT J UROL, V15, P816, DOI 10.1111/j.1442-2042.2008.02121.x; Hoos A, 2015, THER INNOV REGUL SCI, V49, P929, DOI 10.1177/2168479015580384; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Lee CI, 2014, ACAD RADIOL, V21, P1156, DOI 10.1016/j.acra.2014.01.027; Marko NF, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.5.FOCUS12127; McLeod LD, 2011, EXPERT REV PHARM OUT, V11, P163, DOI [10.1586/erp.11.12, 10.1586/ERP.11.12]; Meisel ZF, 2012, ANN EMERG MED, V60, P309, DOI 10.1016/j.annemergmed.2012.03.021; Methodology Committee of the Patient- Centered Outcomes Research Institute PCORI, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI DOI 10.1001/JAMA.2012.466; READ JL, 1987, J CHRON DIS, V40, pS7, DOI 10.1016/S0021-9681(87)80027-9; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Schmittdiel JA, 2015, HEALTHCARE-J DEL SCI, V3, P80, DOI 10.1016/j.hjdsi.2015.02.005; Selby JV, 2015, JAMA-J AM MED ASSOC, V314, P2235, DOI 10.1001/jama.2015.15139; Selby JV, 2014, NEW ENGL J MED, V370, P592, DOI 10.1056/NEJMp1313061; [U. S. Department of Health and Human Services FDA Center for Devices and Radiological Health U. S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research U. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research], 2006, HLTH QUAL LIFE OUT, V4	32	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171114	10.1371/journal.pone.0171114	http://dx.doi.org/10.1371/journal.pone.0171114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257414	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100004
J	Zhao, JS; Salomon, MP; Shibata, D; Curtis, C; Siegmund, K; Marjoram, P				Zhao, Junsong; Salomon, Matthew P.; Shibata, Darryl; Curtis, Christina; Siegmund, Kimberly; Marjoram, Paul			Early mutation bursts in colorectal tumors	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; APPROXIMATE BAYESIAN COMPUTATION; CANCER STEM-CELLS; HUMAN-BREAST; MODEL; STATISTICS; DROSOPHILA; FRAMEWORK	Tumor growth is an evolutionary process involving accumulation of mutations, copy number alterations, and cancer stem cell (CSC) division and differentiation. As direct observation of this process is impossible, inference regarding when mutations occur and how stem cells divide is difficult. However, this ancestral information is encoded within the tumor itself, in the form of intratumoral heterogeneity of the tumor cell genomes. Here we present a framework that allows simulation of these processes and estimation of mutation rates at the various stages of tumor development and CSC division patterns for single-gland sequencing data from colorectal tumors. We parameterize the mutation rate and the CSC division pattern, and successfully retrieve their posterior distributions based on DNA sequence level data. Our approach exploits Approximate Bayesian Computation (ABC), a method that is becoming widely-used for problems of ancestral inference.	[Zhao, Junsong; Marjoram, Paul] Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA; [Salomon, Matthew P.] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Shibata, Darryl] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Curtis, Christina] Stanford Univ, Sch Med, Dept Med Oncol & Genet, Stanford, CA 94305 USA; [Siegmund, Kimberly; Marjoram, Paul] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA	University of Southern California; John Wayne Cancer Institute; University of Southern California; Stanford University; University of Southern California	Marjoram, P (corresponding author), Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA.	pmarjora@usc.edu			National Human Genome Research Institute [R01 HG006705]; National Cancer Institute [R21 CA185016, R21 CA151139, 5P30 CA014089, P01 CA196569]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Human Genome Research Institute: grant number R01 HG006705 and National Cancer Institute: grant numbers R21 CA185016, R21 CA151139, 5P30 CA014089 and P01 CA196569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blum MGB, 2013, STAT SCI, V28, P189, DOI 10.1214/12-STS406; Bodine DM, 1996, BLOOD, V88, P89; Bozic I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004731; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Chiba T, 2016, HEPATOL RES, V46, P50, DOI 10.1111/hepr.12548; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Fearnhead P, 2012, J R STAT SOC B, V74, P419, DOI 10.1111/j.1467-9868.2011.01010.x; Gomez-Lopez S, 2014, CELL MOL LIFE SCI, V71, P575, DOI 10.1007/s00018-013-1386-1; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Hearn JP, 2001, REPROD FERT DEVELOP, V13, P517, DOI 10.1071/RD01068; Hong JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069752; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Joyce P, 2008, STAT APPL GENET MOL, V7; Jung H, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1586; Kang H, 2015, J PATHOL, V237, P355, DOI 10.1002/path.4581; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; NORTON L, 1988, CANCER RES, V48, P7067; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Sehl ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135797; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tanaka S, 2015, J HEPATO-BIL-PAN SCI, V22, P531, DOI 10.1002/jhbp.248; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509; Wodarz A, 2006, CELL, V124, P1121, DOI 10.1016/j.cell.2006.03.004; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/432652; Zhao J, 2014, J THEOR BIOL, V359, P136, DOI 10.1016/j.jtbi.2014.05.027; Zwaka TP, 2005, STEM CELLS, V23, P146, DOI 10.1634/stemcells.2004-0248	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172516	10.1371/journal.pone.0172516	http://dx.doi.org/10.1371/journal.pone.0172516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257429	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100018
J	Chang, YL; Miyazawa, Y; Beguer-Pon, M				Chang, Yu-Lin; Miyazawa, Yasumasa; Beguer-Pon, Melanie			The dynamical impact of mesoscale eddies on migration of Japanese eel larvae	PLOS ONE			English	Article							PACIFIC SUBTROPICAL COUNTERCURRENT; ANGUILLA-JAPONICA; FISH LARVAE; TRANSPORT; EDDY; MORTALITY; BEHAVIOR; CURRENTS	In this study, we explore the dynamical role of mesoscale eddies on fish larvae migration using the example of Subtropical Counter Current eddies and the migration of Japanese eel larvae in the western North Pacific Ocean. An idealized experiment is conducted to isolate the effects of eddies, and use a three-dimensional particle-tracking method to simulate virtual eel larvae (v-larvae) migration, including both horizontal and vertical swimming behaviors. The impact of eddies strongly depends on the swimming speed of v-larvae relative to the eddy speed. Eddies accelerate the movement of v-larvae that swim slower than the propagation speed of the eddy, whereas faster-swimming v-larvae are dragged by eddies. A modified stream function that incorporates biological swimming ability explains the non-uniform trapping of v-larvae in mesoscale eddies. A high swimming speed and/or a small eddy rotation speed results in a weak trapping capacity. Simulations of v-larvae migration in realistic cases of eddy fields indicate that the abundance of eddies significantly affects the duration of larval migration, with the effects being largely dependent on the larvae swimming speed. We noted a negative relationship between the observed annual eel recruitment index in Taiwan and the eddy index subtropical countercurrent (STCC) region, which suggests a potentially important role of mesoscale eddies in eel larvae migration.	[Chang, Yu-Lin] Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan; [Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Beguer-Pon, Melanie] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	National Taiwan Normal University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Dalhousie University	Chang, YL (corresponding author), Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan.	ychang@ntnu.edu.tw	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272	Ministry of Science and Technology of Taiwan [102-2611-M-003-003-MY3]; JSPS [26287116]; Canadian Natural Sciences and Engineering Research Council (NSERC) [375118-08]; Canadian Foundation for Innovation (CFI) [13011]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	YLC was supported by the Ministry of Science and Technology of Taiwan under grant 102-2611-M-003-003-MY3. YM is supported by JSPS KAKENHI (26287116). MB-P was supported by the Ocean Tracking Network (OTN) through a network project grant (NETGP #375118-08) from the Canadian Natural Sciences and Engineering Research Council (NSERC) with additional support from the Canadian Foundation for Innovation (CFI, Project #13011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey KM, 1997, J FISH BIOL, V51, P135, DOI 10.1111/j.1095-8649.1997.tb06097.x; Beguer-Pon M, 2015, ICEJ MARINE SCI J; Beguer-Pon M, 2016, MAR ECOL PROG SER, V549, P183, DOI 10.3354/meps11706; Black K.P., 1990, ACANTHASTER CORAL RE, P151, DOI [10.1007/978-3-642-46726-4_9, DOI 10.1007/978-3-642-46726-4_9]; Blumberg A.F., 1987, 3 DIMENSIONAL COASTA, P1, DOI [10.1029/co004p0001, DOI 10.1029/CO004P0001]; Brodersen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002156; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2014, J PHYS OCEANOGR, V44, P818, DOI 10.1175/JPO-D-13-0162.1; Chang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150187; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chang YL, 2015, J PHYS OCEANOGR, V45, P1651, DOI 10.1175/JPO-D-14-0248.1; Chang YL, 2014, OCEAN DYNAM, V64, P259, DOI 10.1007/s10236-013-0680-7; Chow S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121801; DAVIDSON V. M., 1949, JOUR FISH RES BD CANADA, V7, P432; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Han YS, 2012, FISH OCEANOGR, V21, P281, DOI 10.1111/j.1365-2419.2012.00624.x; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Oey L-Y, 2013, TERR ATMOS OCEANIC S, V24; Ohashi K, 2015, ATMOS OCEAN, P1, DOI [10.1080/07055900.2015.1090390, DOI 10.1080/07055900.2015.1090390]; Press W., 1992, NUMERICAL RECIPES FO; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Sanchez-Velasco L, 2013, DEEP-SEA RES PT I, V75, P39, DOI 10.1016/j.dsr.2013.01.009; SHAW PT, 1994, J PHYS OCEANOGR, V24, P573, DOI 10.1175/1520-0485(1994)024<0573:ANSOTE>2.0.CO;2; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; SMITH DC, 1983, J PHYS OCEANOGR, V13, P1681, DOI 10.1175/1520-0485(1983)013<1681:TIOATL>2.0.CO;2; Uda M., 1969, J OCEANOGRAPHICAL SO, V25, P201, DOI [10.5928/kaiyou1942.25.201, DOI 10.5928/KAIYOU1942.25.201]; Wuenschel MJ, 2008, MAR BIOL, V154, P775, DOI 10.1007/s00227-008-0970-7; Xu FH, 2011, J PHYS OCEANOGR, V41, P1720, DOI 10.1175/2011JPO4589.1; Yamada Y, 2009, MAR ECOL PROG SER, V379, P241, DOI 10.3354/meps07912	35	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172501	10.1371/journal.pone.0172501	http://dx.doi.org/10.1371/journal.pone.0172501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253293	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300022
J	Ma, L; Wang, X; Liu, Y; Su, MZ; Huang, GH				Ma, Li; Wang, Xing; Liu, Yan; Su, Ming-Zhu; Huang, Guo-Hua			Temperature effects on development and fecundity of Brachmia macroscopa (Lepidoptera: Gelechiidae)	PLOS ONE			English	Article							APHIS-GOSSYPII HOMOPTERA; 2-SEX LIFE TABLE; AGE-STAGE; SPODOPTERA-EXIGUA; COTTON CULTIVAR; APHIDIDAE; PARAMETERS; NOCTUIDAE; REPRODUCTION; HYMENOPTERA	The current study investigated the impacts of temperature on the development and reproductivity of the sweet potato leaf folder, Brachmia macroscopa (Lepidoptera: Gelechiidae), in sweet potato leaves under laboratory conditions. We determined developmental time of B. macroscopa larval, pupal, and pre-adult stage at different temperatures. Male and female longevity, male and female lifespan, mortality of immature stages, oviposition period of B. macroscopa were also investigated under six constant temperatures (21 degrees C, 24 degrees C, 27 degrees C, 30 degrees C, 33 degrees C, 36 degrees C), based on age-stage, two-sex life tables. The results revealed that eggs in 36 degrees C were unable to hatch. At temperatures between 21 degrees C -33 degrees C, the duration of the pre-adult period, as well as the adult lifespan both for males and females, were shortened by increasing temperatures. The lowest larval mortality rate (15.33%) occurred at 27 degrees C. The age-stage-specific fecundity rates with the greatest number were, in order, 30 degrees C, 27 degrees C, 21 degrees C, 24 degrees C and 33 degrees C. The results show that B. macroscopa population levels could reach highest at the temperature of 27 degrees C.	[Ma, Li; Wang, Xing; Huang, Guo-Hua] Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Ma, Li; Wang, Xing; Liu, Yan; Su, Ming-Zhu; Huang, Guo-Hua] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, GH (corresponding author), Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Huang, GH (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	ghhuang@hunau.edu.cn			National Scientific and Technological Supporting Program of China [2012BAD27602]	National Scientific and Technological Supporting Program of China	The present research was supported by a grant from the National Scientific and Technological Supporting Program of China (No. 2012BAD27602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami S, 2014, ARTHROPOD-PLANT INTE, V8, P475, DOI 10.1007/s11829-014-9330-3; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR, 1993, APPL DEMOGRAPHY BIOL, P211; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1988, ENVIRON ENTOMOL, V17, P18, DOI 10.1093/ee/17.1.18; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Gabre RA, 2005, ACTA OECOL, V27, P179, DOI 10.1016/j.actao.2004.12.002; GHULAM-ULLAH CHAUDHRY, 1956, Bulletin of Entomological Research, V16, P869, DOI 10.1017/S0007485300037111; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Han Lan-Zhi, 2003, Acta Entomologica Sinica, V46, P184; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; Kogan M., 1978, B ENTOMOL SOC AM, V24, P175, DOI [10.1093/besa/24.2.175, DOI 10.1093/BESA/24.2.175]; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lewis EG, 1942, SANKHYA, V6, P93; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Naseri B, 2014, J AGR SCI TECH-IRAN, V16, P19; Pandey AK, 2008, BIOCONTROL, V53, P461, DOI 10.1007/s10526-007-9083-3; Park HH, 2014, J ASIA-PAC ENTOMOL, V17, P83, DOI 10.1016/j.aspen.2013.11.003; Ponomarenko M.G., 1997, Far Eastern Entomologist, V50, P1; Ramalho FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122490; Ratte H.T., 1985, P33; Razmjou J, 2006, J ECON ENTOMOL, V99, P1820, DOI 10.1603/0022-0493-99.5.1820; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Seto-Kuchi O., 1985, Proceedings of the Association for Plant Protection of Kyushu, V31, P143; Southwood TRE., 1978, ECOLOGICAL METHODS P; Tan R. R., 2011, CHANGJIANG VEGET, V4, P75; TANAKA F, 1978, JPN J APPL ENTOMOL Z, V22, P162, DOI 10.1303/jjaez.22.3_162; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu JZ, 2005, ANN ENTOMOL SOC AM, V98, P475, DOI 10.1603/0013-8746(2005)098[0475:LTAPOL]2.0.CO;2; Yu-Bing H., 2011, J AGR FOOD RES, V60, P337; Zhang P, 2015, PHYTOPARASITICA, V43, P107, DOI 10.1007/s12600-014-0420-7; Zhang ZJ, 2007, J APPL ENTOMOL, V131, P347, DOI 10.1111/j.1439-0418.2007.01186.x; Zhu FL, 2015, AUSTRAL ENTOMOL, V54, P71, DOI 10.1111/aen.12094	47	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173065	10.1371/journal.pone.0173065	http://dx.doi.org/10.1371/journal.pone.0173065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253321	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300067
J	Quednow, BB; Hulka, LM; Preller, KH; Baumgartner, MR; Eisenegger, C; Vonmoos, M				Quednow, Boris B.; Hulka, Lea M.; Preller, Katrin H.; Baumgartner, Markus R.; Eisenegger, Christoph; Vonmoos, Matthias			Stable self-serving personality traits in recreational and dependent cocaine users	PLOS ONE			English	Article							SOCIAL COGNITION; ASPERGER-SYNDROME; DECISION-MAKING; ADDICTION; DISORDERS; RELIABILITY; IMPULSIVITY; DYSFUNCTION; GUIDELINES; VALIDITY	Chronic cocaine use has been associated with impairments in social cognition, self-serving and antisocial behavior, and socially relevant personality disorders (PD). Despite the apparent relationship between Machiavellianism and stimulant use, no study has explicitly examined this personality concept in cocaine users so far. In the frame of the longitudinal Zurich Cocaine Cognition Study, the Machiavellianism Questionnaire (MACH-IV) was assessed in 68 recreational and 30 dependent cocaine users as well as in 68 psychostimulant-naive controls at baseline. Additionally, three closely related personality dimensions from the Temperament and Character Inventory (TCI)-cooperativeness, (social) reward dependence, and self-directedness-and the screening questionnaire of the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) were acquired. At the one-year follow-up, 57 cocaine users and 48 controls were reassessed with the MACH-IV. Finally, MACH-IV scores were correlated with measures of social cognition and interaction (cognitive/emotional empathy, Theory-of-Mind, prosocial behavior) and with SCID-II PD scores assessed at baseline. Both recreational and dependent cocaine users showed significantly higher Machiavellianism than controls, while dependent cocaine users additionally displayed significantly lower levels of TCI cooperativeness and self-directedness. During the one-year interval, MACH-IV scores showed high test-retest reliability and also the significant gap between cocaine users and controls remained. Moreover, in cocaine users, higher Machiavellianism correlated significantly with lower levels of cooperativeness and self-directedness, with less prosocial behavior, and with higher cluster B PD scores. However, Machiavellianism was not correlated with measures of cocaine use severity (r<-.15). Both recreational and dependent cocaine users display pronounced and stable Machiavellian personality traits. The lack of correlations with severity of cocaine use and its temporal stability indicates that a Machiavellian personality trait might represent a predisposition for cocaine use that potentially serves as a predictor for stimulant addiction.	[Quednow, Boris B.; Hulka, Lea M.; Preller, Katrin H.; Vonmoos, Matthias] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Expt & Clin Pharmacopsychol, Zurich, Switzerland; [Baumgartner, Markus R.] Univ Zurich, Zurich Inst Forens Med, Ctr Forens Hair Anal, Zurich, Switzerland; [Eisenegger, Christoph] Univ Vienna, Fac Psychol, Dept Basic Psychol Res & Res Methods, Neuropsychopharmacol & Biopsychol Unit, Vienna, Austria	University of Zurich; University of Zurich; University of Vienna	Vonmoos, M (corresponding author), Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Expt & Clin Pharmacopsychol, Zurich, Switzerland.	matthias.vonmoos@bli.uzh.ch	Preller, Katrin/AAD-8914-2019; Quednow, Boris B./A-1666-2008	Quednow, Boris B./0000-0001-7933-2865	Swiss National Science Foundation (SNSF) [PPOOP1-123516/1, PPOOP1-146326/1]; Olga Mayenfisch Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Olga Mayenfisch Foundation	The study was supported by grants from the Swiss National Science Foundation (SNSF; grant No. PPOOP1-123516/1 and PPOOP1-146326/1) and the Olga Mayenfisch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ain S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00454; [Anonymous], 1999, PERLEN PERL MUTT; [Anonymous], 1997, SKID 2 STRUKTURIERTE; APA, 1994, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bereczkei T, 2014, PERS INDIV DIFFER, V64, P168, DOI 10.1016/j.paid.2014.02.035; Bush DM, 2008, FORENSIC SCI INT, V174, P111, DOI 10.1016/j.forsciint.2007.03.008; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Christie R., 1970, STUDIES MACHIAVELLIA; Cohen J., 1983, APPL MULTIPLE REGRES; Cooper GAA, 2012, FORENSIC SCI INT, V218, P20, DOI 10.1016/j.forsciint.2011.10.024; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Edgington E.S., 2007, RANDOMIZATION TESTS; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Ersche KD, 2010, BIOL PSYCHIAT, V68, P770, DOI 10.1016/j.biopsych.2010.06.015; Fernandez-Montalvo J, 2007, AN SIST SANIT NAVAR, V30, P225; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Hoelzle C, 2008, FORENSIC SCI INT, V176, P13, DOI 10.1016/j.forsciint.2007.07.020; Hulka LM, 2015, PSYCHOL MED, V45, P3097, DOI 10.1017/S0033291715001063; Hulka LM, 2014, PSYCHOL MED, V44, P1015, DOI 10.1017/S0033291713001839; Hulka Lea M, 2013, Front Psychiatry, V4, P98, DOI 10.3389/fpsyt.2013.00098; Herrero MJ, 2008, SUBST USE MISUSE, V43, P1378, DOI 10.1080/10826080801922652; Jones D.N., 2009, HDB INDIVIDUAL DIFFE, P93; KAESTNER E, 1977, BRIT J ADDICT, V72, P245; KRANZLER HR, 1994, COMPR PSYCHIAT, V35, P335, DOI 10.1016/0010-440X(94)90272-0; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Linden M, 2007, Z MED PSYCHOL, V16, P135; Lyons M., 2010, J SOCIAL EVOLUTIONAR, V4, P194, DOI [10.1037/h0099290, DOI 10.1037/H0099290]; Maier LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129805; McHoskey JW, 2001, PERS INDIV DIFFER, V31, P791, DOI 10.1016/S0191-8869(00)00187-2; McNamara Patrick, 2007, Cogn Neuropsychiatry, V12, P285; Milivojevic D, 2012, AM J ADDICTION, V21, P462, DOI 10.1111/j.1521-0391.2012.00251.x; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Preller KH, 2014, P NATL ACAD SCI USA, V111, P2842, DOI 10.1073/pnas.1317090111; Quednow BB, 2004, NEUROPSYCHOPHARMACOL, V29, P982, DOI 10.1038/sj.npp.1300396; Quednow BB, 2017, CURR OPIN BEHAV SCI, V13, P55, DOI 10.1016/j.cobeha.2016.10.001; Stenason L, 2016, PERS INDIV DIFFER, V94, P59, DOI 10.1016/j.paid.2016.01.010; Sussner BD, 2006, DRUG ALCOHOL DEPEN, V83, P233, DOI 10.1016/j.drugalcdep.2005.11.022; Tobler PN, 2016, SOC COGN AFFECT NEUR, V11, P1017, DOI 10.1093/scan/nsw030; Verbeke WJ., 2011, J NEUROSCI PSYCHOL E, V4, P205, DOI DOI 10.1037/A0025802; Verdejo-Garcia A, 2014, P NATL ACAD SCI USA, V111, P2406, DOI 10.1073/pnas.1324287111; Volkow ND, 2011, NEURON, V69, P599, DOI 10.1016/j.neuron.2011.01.027; Vonmoos M, 2014, NEUROPSYCHOPHARMACOL, V39, P2200, DOI 10.1038/npp.2014.71; Vonmoos M, 2013, DRUG ALCOHOL DEPEN, V133, P61, DOI 10.1016/j.drugalcdep.2013.05.032; Vonmoos M, 2013, BRIT J PSYCHIAT, V203, P35, DOI 10.1192/bjp.bp.112.118091; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	47	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172853	10.1371/journal.pone.0172853	http://dx.doi.org/10.1371/journal.pone.0172853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253291	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000396011300043
J	Schindler, S; Schreiber, J; Bazin, PL; Trampel, R; Anwander, A; Geyer, S; Schonknecht, P				Schindler, Stephanie; Schreiber, Jan; Bazin, Pierre-Louis; Trampel, Robert; Anwander, Alfred; Geyer, Stefan; Schoenknecht, Peter			Intensity standardisation of 7T MR images for intensity-based segmentation of the human hypothalamus	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; WHITE-MATTER; HUMAN BRAIN; REGISTRATION; SCALE	The high spatial resolution of 7T MRI enables us to identify subtle volume changes in brain structures, providing potential biomarkers of mental disorders. Most volumetric approaches require that similar intensity values represent similar tissue types across different persons. By applying colour-coding to T1-weighted MP2RAGE images, we found that the high measurement accuracy achieved by high-resolution imaging may be compromised by inter-individual variations in the image intensity. To address this issue, we analysed the performance of five intensity standardisation techniques in high-resolution T1-weighted MP2RAGE images. Twenty images with extreme intensities in the GM and WM were standardised to a representative reference image. We performed a multi-level evaluation with a focus on the hypothalamic region-analysing the intensity histograms as well as the actual MR images, and requiring that the correlation between the whole-brain tissue volumes and subject age be preserved during standardisation. The results were compared with T1 maps. Linear standardisation using subcortical ROIs of GM and WM provided good results for all evaluation criteria: it improved the histogram alignment within the ROIs and the average image intensity within the ROIs and the whole-brain GM and WM areas. This method reduced the inter-individual intensity variation of the hypothalamic boundary by more than half, outperforming all other methods, and kept the original correlation between the GM volume and subject age intact. Mixed results were obtained for the other four methods, which sometimes came at the expense of unwarranted changes in the age-related pattern of the GM volume. The mapping of the T1 relaxation time with the MP2RAGE sequence is advertised as being especially robust to bias field inhomogeneity. We found little evidence that substantiated the T1 map's theoretical superiority over the T1-weighted images regarding the inter-individual image intensity homogeneity.	[Schindler, Stephanie; Schoenknecht, Peter] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Schindler, Stephanie; Bazin, Pierre-Louis; Trampel, Robert; Geyer, Stefan] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Schreiber, Jan; Anwander, Alfred] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Schreiber, Jan] Forschungszentrum Julich, Inst Neurosci & Med, Julich, Germany	Leipzig University; Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Research Center Julich	Schindler, S (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.; Schindler, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany.	Stephanie.Schindler@medizin.uni-leipzig.de	Schoenknecht, Peter/GVU-7600-2022; Anwander, Alfred/B-5874-2011	Anwander, Alfred/0000-0002-4861-4808; Schindler, Stephanie/0000-0003-1378-0053				*APA, 1994, DSM 4 DIAGN STAT MAN; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Bedekar D, 2010, MAGN RESON MED, V64, P907, DOI 10.1002/mrm.22445; Belluck P, 2013, NY TIMES; BESSON JAO, 1992, BRIT J PSYCHIAT, V160, P187, DOI 10.1192/bjp.160.2.187; Blu T, 2004, IEEE T IMAGE PROCESS, V13, P710, DOI 10.1109/TIP.2004.826093; Bosc M, 2003, NEUROIMAGE, V20, P643, DOI 10.1016/S1053-8119(03)00406-3; Cataldo R, 2013, J NEUROIMAGING, V23, P473, DOI 10.1111/j.1552-6569.2012.00713.x; Ceritoglu C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00043; Christensen JD, 2003, MAGN RESON IMAGING, V21, P817, DOI 10.1016/S0730-725X(03)00102-4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Gonzalez R.C., 2002, DIGIT IMAGE PROCESS, V2, P75; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hellier P, 2003, IEEE IMAGE PROC, P1109; Hutcheson M. C., 1995, THESIS; IZENMAN AJ, 1991, J AM STAT ASSOC, V86, P205, DOI 10.2307/2289732; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Jager F, 2006, VISION MODELING VISU, P269; Jager F., 2007, INFORM AKTUELL, P459; Jiang Z, 2004, SPEC FILE READER; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Lim JS, 1990, 2 DIMENSIONAL SIGNAL, P453; Lockhart SN, 2014, NEUROPSYCHOL REV, V24, P271, DOI 10.1007/s11065-014-9268-3; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lundgren J., 2007, SPLINEFIT COMPUTER P; Mai JK, 2007, ATLAS OF THE HUMAN B; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McAuliffe MJ, 2001, COMP MED SY, P381; Meier DS, 2003, NEUROIMAGE, V20, P1193, DOI 10.1016/S1053-8119(03)00354-9; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Robitaille N, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/347120; Schindler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066394; Silk TJ, 2011, J DEV BEHAV PEDIATR, V32, P158, DOI 10.1097/DBP.0b013e318206d58f; Steen RG, 1997, AM J NEURORADIOL, V18, P819; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Swaab DF, 2003, HUMAN HYPOTHALAMUS B; van der Zwaag W, 2016, NMR BIOMED, V29, P1274, DOI 10.1002/nbm.3275; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Wang LQ, 1998, MAGNET RESON MED, V39, P322, DOI 10.1002/mrm.1910390222; Yeatman JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5932; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	49	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173344	10.1371/journal.pone.0173344	http://dx.doi.org/10.1371/journal.pone.0173344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253330	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300102
J	Yao, CG; Lv, YP; Dong, SL; Zhao, YJ; Liu, HM				Yao, Chenguo; Lv, Yanpeng; Dong, Shoulong; Zhao, Yajun; Liu, Hongmei			Irreversible electroporation ablation area enhanced by synergistic high-and low-voltage pulses	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; IMPEDANCE SPECTROSCOPY; GENE ELECTROTRANSFER; ELECTRIC-FIELDS; CELLS; THERAPY; MICROSECOND; MEMBRANE; LIVER; MODEL	Irreversible electroporation (IRE) produced by a pulsed electric field can ablate tissue. In this study, we achieved an enhancement in ablation area by using a combination of short high-voltage pulses (HVPs) to create a large electroporated area and long low-voltage pulses (LVPs) to ablate the electroporated area. The experiments were conducted in potato tuber slices. Slices were ablated with an array of four pairs of parallel steel electrodes using one of the following four electric pulse protocols: HVP, LVP, synergistic HVP+LVP (SHLVP) or LVP+HVP. Our results showed that the SHLVPs more effectively necrotized tissue than either the HVPs or LVPs, even when the SHLVP dose was the same as or lower than the HVP or LVP doses. The HVP and LVP order mattered and only HVPs+LVPs (SHLVPs) treatments increased the size of the ablation zone because the HVPs created a large electroporated area that was more susceptible to the subsequent LVPs. Real-time temperature change monitoring confirmed that the tissue was non-thermally ablated by the electric pulses. Theoretical calculations of the synergistic effects of the SHLVPs on tissue ablation were performed. Our proposed SHLVP protocol provides options for tissue ablation and may be applied to optimize the current clinical IRE protocols.	[Yao, Chenguo; Lv, Yanpeng; Dong, Shoulong; Zhao, Yajun; Liu, Hongmei] Chongqing Univ, Sch Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China	Chongqing University	Yao, CG (corresponding author), Chongqing Univ, Sch Elect Engn, State Key Lab Power Transmiss Equipment & Syst Se, Chongqing, Peoples R China.	yaochenguo@cqu.edu.cn		Yao, Chenguo/0000-0002-1781-2756	National Natural Science Foundation of China [51321063, 51477022]; Graduate Scientific Research and Innovation Foundation of Chongqing [CYB16018]; Natural Science Foundation Project of CQ CSTC [cstc2014jcyjjq90001]; Fundamental Research Funds for the Central Universities [106112015CDJZR158804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Scientific Research and Innovation Foundation of Chongqing; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Project was supported by the National Natural Science Foundation of China (51321063) http://www.nsfc.gov.cn/ CY, the Graduate Scientific Research and Innovation Foundation of Chongqing (CYB16018) http://graduate.cqu.edu.cn/, the National Natural Science Foundation of China (51477022) http://www.nsfc.gov.cn/ CY, Natural Science Foundation Project of CQ CSTC (cstc2014jcyjjq90001) http://www.cstc.gov.cn/ CY, and Fundamental Research Funds for the Central Universities (106112015CDJZR158804) http://www.cqu.edu.cn/v1/ CY.	[Anonymous], 2011, IEEE T BIOMEDICAL EN; [Anonymous], 2016, SCI REPORTS; [Anonymous], 2015, J VASCULAR INTERVENT; Bhonsle SP, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-S3; Bonakdar M, 2015, IEEE T BIO-MED ENG, V62, P2674, DOI 10.1109/TBME.2015.2441636; Burgel SC, 2015, SENSOR ACTUAT B-CHEM, V210, P82, DOI 10.1016/j.snb.2014.12.016; Chen W, 2006, BURNS, V32, P52, DOI 10.1016/j.burns.2005.08.008; Chen XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09851; Chopinet L, 2013, J MEMBRANE BIOL, V246, P851, DOI 10.1007/s00232-013-9579-y; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Demiryurek Y, 2015, BBA-BIOMEMBRANES, V1848, P1706, DOI 10.1016/j.bbamem.2015.04.007; Dunki-Jacobs EM, 2014, BRIT J SURG, V101, P1113, DOI 10.1002/bjs.9536; Dymek K, 2015, INNOV FOOD SCI EMERG, V29, P55, DOI [10.1016/j.ifset.2014.08.006, 10.1016/j.ifset.20]; El-Hag AH, 2006, IEEE T NANOBIOSCI, V5, P157, DOI 10.1109/TNB.2006.880822; Fox M, 2005, LAB CHIP, V5, P943, DOI 10.1039/b503704b; Guo SQ, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.43; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; Hjouj M, 2010, J MEMBRANE BIOL, V236, P137, DOI 10.1007/s00232-010-9281-2; Ivorra A, 2010, SER BIOMED ENG, P1, DOI 10.1007/978-3-642-05420-4_1; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Jiang CL, 2014, ANN BIOMED ENG, V42, P193, DOI 10.1007/s10439-013-0882-7; Knorr D, 2002, P NUTR SOC, V61, P311, DOI 10.1079/PNS2002162; Liu Y, 2012, ONCOL LETT, V4, P450, DOI 10.3892/ol.2012.781; Miklavcic D., 2015, BIOMED ENG ONLINE S3, V14, P11; Muller KJ, 2001, J MEMBRANE BIOL, V184, P161, DOI 10.1007/s00232-001-0084-3; Neal RE, 2012, IEEE T BIO-MED ENG, V59, P1076, DOI 10.1109/TBME.2012.2182994; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Pakhomova ON, 2014, BBA-BIOMEMBRANES, V1838, P2547, DOI 10.1016/j.bbamem.2014.06.015; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Pasquet L, 2014, J MEMBRANE BIOL, V247, P1253, DOI 10.1007/s00232-014-9720-6; Pavlin M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09132; Pucihar G, 2002, BIOELECTROCHEMISTRY, V57, P167, DOI 10.1016/S1567-5394(02)00116-0; Pucihar G, 2011, IEEE T BIO-MED ENG, V58, P3279, DOI 10.1109/TBME.2011.2167232; Qiu H, 2014, IEEE T PLASMA SCI, V42, P3113, DOI 10.1109/TPS.2014.2308871; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Romeo S, 2013, BBA-BIOMEMBRANES, V1828, P1715, DOI 10.1016/j.bbamem.2013.03.007; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sano MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep14999; Saulis G, 2012, BBA-BIOMEMBRANES, V1818, P3032, DOI 10.1016/j.bbamem.2012.06.018; Somiari S, 2000, MOL THER, V2, P178, DOI 10.1006/mthe.2000.0124; Son RS, 2014, J MEMBRANE BIOL, V247, P1209, DOI 10.1007/s00232-014-9699-z; Stacey M, 2011, BIOELECTROCHEMISTRY, V82, P131, DOI 10.1016/j.bioelechem.2011.06.002; Suarez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113413; Sukas S, 2014, LAB CHIP, V14, P1821, DOI 10.1039/c3lc51433a; Sundararajan Raji, 2008, V423, P109, DOI 10.1007/978-1-59745-194-9_7; Tsuneyoshi Nakayama H.S., 2010, HIGHER MATH PHYS ENG, DOI 10.1007/b138494; Usaj M, 2009, RADIOL ONCOL, V43, P108, DOI 10.2478/v10019-009-0017-9; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Zgalin MK, 2012, J MEMBRANE BIOL, V245, P643, DOI 10.1007/s00232-012-9481-z	51	10	12	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173181	10.1371/journal.pone.0173181	http://dx.doi.org/10.1371/journal.pone.0173181			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253331	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300088
J	Zhang, Y; Ma, LM; Huang, J; Shuang, JQ; Chen, JP; Fan, ZN				Zhang, Yin; Ma, Limei; Huang, Jin; Shuang, Jinquan; Chen, Jianping; Fan, Zhining			The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model	PLOS ONE			English	Article							CELL CARCINOMA; INCORPORATED MEMBRANE; CANCER; ADENOCARCINOMA; INTERVENTION; OBSTRUCTION; THERAPY	Background The use of self-expanding metallic stents (SEMSs) is the current treatment of choice for malignant gastrointestinal obstructions. However, these stents can promote only drainage and have no antitumor effect. Some studies have reported that drug-eluting SEMSs may have tumor inhibition potential. The aim of this study was to evaluate the efficiency and safety of paclitaxel-eluting SEMSs (PEMSs) in rabbit esophageal cancer models. Materials and methods A PEMS was covered with a paclitaxel-incorporated membrane, in which the concentration of paclitaxel was 10% (wt/vol). The rabbit models were created endoscopically. Then, a PEMS or SEMS was endoscopically inserted into the rabbit esophagus. Two weeks after stent placement, the rabbits were sacrificed, and we evaluated the tumor volume, area of the wall defect, area of the tumor under endoscopic ultrasound (EUS) before and after stent placement, status of the proximal esophageal obstruction, tumor metastasis food-intake and weight loss. Results A total of 26 rabbits received stent insertion and survived until sacrifice, and migration occurred in 4 cases, 3 in SEMS group and 1 in PEMS group. For the remaining 22 rabbits, at the sacrificed time, the average tumor volume was 7.00 +/- 4.30 cm(3) in the SEMS group and 0.94 +/- 1.51 cm(3) in the PEMS group (P<0.05). The area of the esophageal wall defect was 0.70 +/- 0.63 cm(2) in the SEMS group and 0.17 +/- 0.16 cm(2) in the PEMS group (P<0.05). The tumor area under EUS was 4.40 +/- 1.47 cm(2) in the SEMS group and 1.30 +/- 1.06 cm(2) in the PEMS group (P<0.05). At the time of stent placement, tumor area under EUS was comparable in the two groups. Other indices did not significantly differ between the two groups. Conclusions SEMS and PEMS are both safe and effective to relieve dysphagia in rabbit esophageal cancer models. A PEMS can serve as an alternative tool for advanced esophageal cancer that may inhibit tumor growth by serving as a drug sustained-release platform. Clinical trials of the stent are warranted in the future.	[Zhang, Yin; Chen, Jianping] Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Digest Dis, Changzhou, Jiangsu, Peoples R China; [Zhang, Yin; Ma, Limei; Huang, Jin; Shuang, Jinquan; Fan, Zhining] Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Chen, JP (corresponding author), Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Digest Dis, Changzhou, Jiangsu, Peoples R China.; Fan, ZN (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China.	chenjianping2016@outlook.com; fanzhining@njmu.edu.cn			National Natural Science Foundation of China [81172266]; Science and Technology Support Program of Jiangsu Province [BE2010719]; Natural Science Foundation of Jiangsu Province [BK2011859]; Jiangsu Innovation of Medical Team and Leading Talents Cultivation [LJ201127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation of Medical Team and Leading Talents Cultivation	This work was supported by the National Natural Science Foundation of China (81172266), the Science and Technology Support Program of Jiangsu Province (BE2010719), the Natural Science Foundation of Jiangsu Province (BK2011859), and the Jiangsu Innovation of Medical Team and Leading Talents Cultivation (LJ201127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; de Cicco RL, 2004, CLIN CANCER RES, V10, P4480, DOI 10.1158/1078-0432.CCR-03-0670; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Guo QH, 2007, J CONTROL RELEASE, V118, P318, DOI 10.1016/j.jconrel.2006.12.030; Guo SR, 2010, J PHARM SCI-US, V99, P3009, DOI 10.1002/jps.22066; Huang J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-40; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085326; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Jeon SR, 2009, ENDOSCOPY, V41, P449, DOI 10.1055/s-0029-1214607; Jin CS, 2016, CANCER RES, V76, P5870, DOI 10.1158/0008-5472.CAN-15-3196; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Layke JC, 2006, AM FAM PHYSICIAN, V73, P2187; Lee DK, 2005, GASTROINTEST ENDOSC, V61, P296, DOI 10.1016/S0016-5107(04)02570-2; Lee SS, 2009, GASTROINTEST ENDOSC, V69, P1140, DOI 10.1016/j.gie.2008.08.005; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; Ortner MAEJ, 2004, ENDOSCOPY, V36, P421, DOI 10.1055/s-2004-814327; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Rozanes I, 2002, EUR J RADIOL, V43, P196, DOI 10.1016/S0720-048X(02)00154-7; Silber Sigmund, 2003, J Interv Cardiol, V16, P485, DOI 10.1046/j.1540-8183.2003.01065.x; Song TJ, 2011, GASTROINTEST ENDOSC, V73, P727, DOI 10.1016/j.gie.2010.11.048; Suk KT, 2007, GASTROINTEST ENDOSC, V66, P798, DOI 10.1016/j.gie.2007.05.037; Talukdar FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060996; Thomas GR, 2006, INT J CANCER, V118, P2379, DOI 10.1002/ijc.21695; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Wang ZM, 2015, GASTROINTEST ENDOSC, V82, P153, DOI 10.1016/j.gie.2015.02.034; Zhang Y, 2016, EXP THER MED, V12, P2928, DOI 10.3892/etm.2016.3708	27	12	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173262	10.1371/journal.pone.0173262	http://dx.doi.org/10.1371/journal.pone.0173262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253360	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300097
J	Chung, IY; Lee, JW; Lee, JS; Park, YR; Min, YH; Lee, Y; Yoon, TI; Sohn, G; Lee, SB; Kim, J; Kim, HJ; Ko, BS; Son, BH; Ahn, SH				Chung, Il Yong; Lee, Jong Won; Lee, Ji Sung; Park, Yu Rang; Min, Yul Ha; Lee, Yura; Yoon, Tae In; Sohn, Guiyun; Lee, Sae Byul; Kim, Jisun; Kim, Hee Jeong; Ko, Beom Seok; Son, Byung Ho; Ahn, Sei Hyun			Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer	PLOS ONE			English	Article							SURVIVAL; OBESITY; DIAGNOSIS; WOMEN	The aim of this study was to determine the relationship between the body mass index (BMI) at a breast cancer diagnosis and various factors including the hormone-receptor, menopause, and lymph-node status, and identify if there is a specific patient subgroup for which the BMI has an effect on the breast cancer prognosis. We retrospectively analyzed the data of 8,742 patients with non-metastatic invasive breast cancer from the research database of Asan Medical Center. The overall survival (OS) and breast-cancer-specific survival (BCSS) outcomes were compared among BMI groups using the Kaplan-Meier method and Cox proportional-hazards regression models with an interaction term. There was a significant interaction between BMI and hormone-receptor status for the OS (P = 0.029), and BCSS (P = 0.013) in lymph-node-positive breast cancers. Obesity in hormone-receptor-positive breast cancer showed a poorer OS (adjusted hazard ratio [HR] = 1.51, 95% confidence interval [CI] = 0.92 to 2.48) and significantly poorer BCSS (HR = 1.80, 95% CI = 1.08 to 2.99). In contrast, a high BMI in hormone-receptor-negative breast cancer revealed a better OS (HR = 0.44, 95% CI = 0.16 to 1.19) and BCSS (HR = 0.53, 95% CI = 0.19 to 1.44). Being underweight (BMI <18.50 kg/m(2)) with hormone-receptor-negative breast cancer was associated with a significantly worse OS (HR = 1.98, 95% CI = 1.00-3.95) and BCSS (HR = 2.24, 95% CI = 1.12-4.47). There was no significant interaction found between the BMI and hormonereceptor status in the lymph-node-negative setting, and BMI did not interact with the menopause status in any subgroup. In conclusion, BMI interacts with the hormone-receptor status in a lymph-node-positive setting, thereby playing a role in the prognosis of breast cancer.	[Chung, Il Yong; Lee, Jong Won; Lee, Yura; Yoon, Tae In; Sohn, Guiyun; Lee, Sae Byul; Kim, Jisun; Kim, Hee Jeong; Ko, Beom Seok; Son, Byung Ho; Ahn, Sei Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Lee, Ji Sung; Park, Yu Rang; Lee, Yura] Univ Ulsan, Coll Med, Clin Res Ctr, Asan Med Ctr, Seoul, South Korea; [Min, Yul Ha] Gachon Univ, Coll Nursing, Incheon, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Gachon University	Lee, JW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea.; Lee, JS (corresponding author), Univ Ulsan, Coll Med, Clin Res Ctr, Asan Med Ctr, Seoul, South Korea.	jongwonlee116@gmail.com; totoro96a@gmail.com		KIM, JISUN/0000-0002-4884-6107	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2016-668]; National Research Foundation of Korea - Korea government (MSIP) [2015R1C1A2A01053155]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1061]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea; National Research Foundation of Korea - Korea government (MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant (2016-668) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (http://en.ails.amc.seoul.kr/eng/ailse/main.do) and the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) grant funded by the Korea government (MSIP) (No. 2015R1C1A2A01053155). This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C1061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce-Salinas C, 2014, BREAST CANCER RES TR, V146, P183, DOI 10.1007/s10549-014-2977-8; Caan BJ, 2008, CANCER CAUSE CONTROL, V19, P1319, DOI 10.1007/s10552-008-9203-0; Carmichael AR, 2004, BREAST, V13, P93, DOI 10.1016/j.breast.2003.03.002; Cecchini RS, 2016, CANCER EPIDEM BIOMAR, V25, P51, DOI 10.1158/1055-9965.EPI-15-0334-T; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Copson ER, 2015, ANN ONCOL, V26, P101, DOI 10.1093/annonc/mdu509; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Jeon YW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1879-4; Kwan ML, 2012, BREAST CANCER RES TR, V132, P729, DOI 10.1007/s10549-011-1914-3; Ladoire S, 2014, EUR J CANCER, V50, P506, DOI 10.1016/j.ejca.2013.11.013; Ligibel JA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv179; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Niraula S, 2012, BREAST CANCER RES TR, V134, P769, DOI 10.1007/s10549-012-2073-x; Pan H, 2014, J CLIN ONCOL S15, V32, P5, DOI DOI 10.1200/JCO.2014.32.15_SUPPL.503; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Scholz C, 2015, BREAST CANCER RES TR, V151, P569, DOI 10.1007/s10549-015-3422-3; Sinicrope FA, 2011, J CLIN ONCOL, V29, P4, DOI 10.1200/JCO.2010.32.1752	19	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0170311	10.1371/journal.pone.0170311	http://dx.doi.org/10.1371/journal.pone.0170311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248981	gold, Green Submitted, Green Published			2022-12-27	WOS:000395983500002
J	Heo, DW; Kim, KN; Lee, MW; Lee, SB; Kim, CS				Heo, Dong Won; Kim, Kyoung Nam; Lee, Min Woo; Lee, Sung Bok; Kim, Chang-sik			Properties of pattern standard deviation in open-angle glaucoma patients with hemioptic neuropathy and bi-optic neuropathy	PLOS ONE			English	Article							CATARACT-EXTRACTION; PERIMETRY; FIELDS; MYOPIA; INDEX; ONSET	Purpose To evaluate the properties of pattern standard deviation (PSD) according to localization of the glaucomatous optic neuropathy. Methods We enrolled 242 eyes of 242 patients with primary open-angle glaucoma, with a best-corrected visual acuity >= 20/25, and no media opacity. Patients were examined via dilated fundus photography, spectral-domain optical coherence tomography, and Humphrey visual field examination, and divided into those with hemi-optic neuropathy (superior or inferior) and bi-optic neuropathy (both superior and inferior). We assessed the relationship between mean deviation (MD) and PSD. Using broken stick regression analysis, the tipping point was identified, i.e., the point at which MD became significantly associated with a paradoxical reversal of PSD. Results In 91 patients with hemi-optic neuropathy, PSD showed a strong correlation with MD (r = -0.973, beta = -0.965, p < 0.001). The difference between MD and PSD ("-MD-PSD") was constant (mean, -0.32 dB; 95% confidence interval, -2.48 similar to 1.84 dB) regardless of visual field defect severity. However, in 151 patients with bi-optic neuropathy, a negative correlation was evident between "-MD-PSD" and MD (r(2) = 0.907, p < 0.001). Overall, the MD tipping point was -14.0 dB, which was close to approximately 50% damage of the entire visual field (p < 0.001). Conclusions Although a false decrease of PSD usually begins at approximately 50% visual field damage, in patients with hemi-optic neuropathy, the PSD shows no paradoxical decrease and shows a linear correlation with MD.	[Heo, Dong Won; Kim, Kyoung Nam; Lee, Min Woo; Lee, Sung Bok; Kim, Chang-sik] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital	Kim, KN (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daejeon, South Korea.	kknace@cnuh.co.kr		Kim, Kyoung Nam/0000-0003-3898-3236; LEE, SUNG-BOK/0000-0002-9665-6463; Kim, Chang-sik/0000-0001-9595-244X				Ang GS, 2010, J GLAUCOMA, V19, P275, DOI 10.1097/IJG.0b013e3181b21fb9; Artes PH, 2011, INVEST OPHTH VIS SCI, V52, P4030, DOI 10.1167/iovs.10-6905; Aung T, 2001, OPHTHALMOLOGY, V108, P290, DOI 10.1016/S0161-6420(00)00497-8; Bland JM, 1996, BRIT MED J, V313, P744; Blumenthal EZ, 2003, OPHTHALMOLOGY, V110, P196, DOI 10.1016/S0161-6420(02)01297-6; Carrillo MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P929, DOI 10.1001/archopht.123.7.929; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; DRANCE SM, 1991, OPHTHALMOLOGY, V98, P1533; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; HART WM, 1982, OPHTHALMOLOGY, V89, P268; Hayashi K, 2001, AM J OPHTHALMOL, V132, P41, DOI 10.1016/S0002-9394(01)00920-5; Henson DB, 1999, INVEST OPHTH VIS SCI, V40, P3147; Koucheki B, 2004, AM J OPHTHALMOL, V138, P1022, DOI 10.1016/j.ajo.2004.08.006; LAM BL, 1991, OPHTHALMOLOGY, V98, P1066; Lee JW, 2014, JAMA OPHTHALMOL, V132, P1296, DOI 10.1001/jamaophthalmol.2014.2326; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Rao HL, 2013, J GLAUCOMA, V22, P164, DOI 10.1097/IJG.0b013e31822e8e37; Siddiqui MAR, 2007, J GLAUCOMA, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Siddiqui MAR, 2005, BRIT J OPHTHALMOL, V89, P1569, DOI 10.1136/bjo.2005.080655; STEWART WC, 1995, ARCH OPHTHALMOL-CHIC, V113, P875, DOI 10.1001/archopht.1995.01100070049024; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171960	10.1371/journal.pone.0171960	http://dx.doi.org/10.1371/journal.pone.0171960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249022	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500023
J	Holubar, M; Stavroulakis, MC; Maldonado, Y; Ioannidis, JPA; Contopoulos-Ioannidis, D				Holubar, Marisa; Stavroulakis, Maria Christina; Maldonado, Yvonne; Ioannidis, John P. A.; Contopoulos-Ioannidis, Despina			Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ROTAVIRUS VACCINATION; INFLUENZA VACCINATION; ECONOMIC EVALUATIONS; NASOPHARYNGEAL CARRIAGE; MENINGOCOCCAL DISEASE; PUBLIC-HEALTH; 7-VALENT; 13-VALENT; CHILDREN	Background Inclusion of vaccine herd-protection effects in cost-effectiveness analyses (CEAs) can impact the CEAs-conclusions. However, empirical epidemiologic data on the size of herdprotection effects from original studies are limited. Methods We performed a quantitative comparative analysis of the impact of herd-protection effects in CEAs for four childhood vaccinations (pneumococcal, meningococcal, rotavirus and influenza). We considered CEAs reporting incremental-cost-effectiveness-ratios (ICERs) (per quality-adjusted-life-years [QALY] gained; per life-years [LY] gained or per disability-adjusted-life-years [DALY] avoided), both with and without herd protection, while keeping all other model parameters stable. We calculated the size of the ICER-differences without vs with-herd-protection and estimated how often inclusion of herd-protection led to crossing of the cost-effectiveness threshold (of an assumed societal-willingness-to-pay) of $50,000 for more-developed countries or X3GDP/capita (WHO-threshold) for less-developed countries. Results We identified 35 CEA studies (20 pneumococcal, 4 meningococcal, 8 rotavirus and 3 influenza vaccines) with 99 ICER-analyses (55 per-QALY, 27 per-LY and 17 per-DALY). The median ICER-absolute differences per QALY, LY and DALY (without minus with herdprotection) were $15,620 (IQR: $877 to $48,376); $54,871 (IQR: $787 to $115,026) and $49 (IQR: $15 to $1,636) respectively. When the target-vaccination strategy was not cost-saving without herd-protection, inclusion of herd-protection always resulted in more favorable results. In CEAs that had ICERs above the cost-effectiveness threshold without herd-protection, inclusion of herd-protection led to crossing of that threshold in 45% of the cases. This impacted only CEAs for more developed countries, as all but one CEAs for less developed countries had ICERs below the WHO-cost-effectiveness threshold even without herdprotection. In several analyses, recommendation for the adoption of the target vaccination strategy depended on the inclusion of the herd protection effect. Conclusions Inclusion of herd-protection effects in CEAs had a substantial impact in the estimated ICERs and made target-vaccination strategies more attractive options in almost half of the cases where ICERs were above the societal-willingness to pay threshold without herd-protection. More empirical epidemiologic data are needed to determine the size of herd-protection effects across diverse settings and also the size of negative vaccine effects, e.g. from serotype substitution.	[Holubar, Marisa] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Stavroulakis, Maria Christina] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Pediat, New York, NY 10029 USA; [Maldonado, Yvonne; Contopoulos-Ioannidis, Despina] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Infect Dis,Fac Dev & Divers, Stanford, CA 94305 USA; [Maldonado, Yvonne; Contopoulos-Ioannidis, Despina] Stanford Univ, Fac Dev & Divers, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Contopoulos-Ioannidis, Despina] Stanford Univ, Meta Res Innovat Ctr, Stanford METRICS, Stanford, CA 94305 USA	Stanford University; Icahn School of Medicine at Mount Sinai; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Pediat Infect Dis,Fac Dev & Divers, Stanford, CA 94305 USA.; Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Fac Dev & Divers, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Meta Res Innovat Ctr, Stanford METRICS, Stanford, CA 94305 USA.	dcontop@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	NIAID NIH HHS [T32 AI052073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Advisory Committee on Immunization Practices (ACIP), GUID HLTH EC STUD; Gomez JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1025; [Anonymous], HIST EXCH RAT; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; Atkins KE, 2012, VACCINE, V30, P6766, DOI 10.1016/j.vaccine.2012.09.025; Baker CB, 2003, BRIT J PSYCHIAT, V183, P498, DOI 10.1192/bjp.183.6.498; Bakir M, 2013, VACCINE, V31, P979, DOI 10.1016/j.vaccine.2012.11.071; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Bergman A, 2008, SCAND J INFECT DIS, V40, P721, DOI 10.1080/00365540802014872; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Bilcke J, 2009, PHARMACOECONOMICS, V27, P281, DOI 10.2165/00019053-200927040-00002; Bilcke J, 2009, MED DECIS MAKING, V29, P33, DOI 10.1177/0272989X08324955; Blank PR, 2012, VACCINE, V30, P4267, DOI 10.1016/j.vaccine.2012.04.028; Boonacker CWB, 2011, PHARMACOECONOMICS, V29, P199, DOI 10.2165/11584930-000000000-00000; Bruijning-Verhagen P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-112; Bureau of Labor Statistics, CPI CONS PRIC IND IN; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Chuck AW, 2010, VACCINE, V28, P5485, DOI 10.1016/j.vaccine.2010.05.058; Clemens J, 2011, LANCET INFECT DIS, V11, P482, DOI 10.1016/S1473-3099(10)70318-2; Clements KM, 2011, VALUE HEALTH, V14, P800, DOI 10.1016/j.jval.2011.03.005; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Cost Effectiveness Analyses (CEA) Registry, CTR EV VAL RISK HLTH; De Wals P, 2002, VACCINE, V20, P2840, DOI 10.1016/S0264-410X(02)00161-5; Diez-Domingo J, 2011, VACCINE, V29, P9640, DOI 10.1016/j.vaccine.2011.10.038; Earnshaw SR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-101; Evans Christopher, 2004, Health Care Manag Sci, V7, P43, DOI 10.1023/B:HCMS.0000005397.93173.bb; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Getsios D, 2004, INT J TECHNOL ASSESS, V20, P280, DOI 10.1017/S0266462304001096; Giglio ND, 2010, VACCINE, V28, P2302, DOI 10.1016/j.vaccine.2009.12.070; Goossens LMA, 2008, VACCINE, V26, P1118, DOI 10.1016/j.vaccine.2007.11.070; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hepkema H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065036; Hoshi SL, 2012, VACCINE, V30, P3320, DOI 10.1016/j.vaccine.2012.02.033; Hubben GAA, 2007, VACCINE, V25, P3669, DOI 10.1016/j.vaccine.2007.01.088; Isaacman DJ, 2008, CLIN THER, V30, P341, DOI 10.1016/j.clinthera.2008.02.003; Jit M, 2009, VACCINE, V27, P6121, DOI 10.1016/j.vaccine.2009.08.030; Kauf TL, 2010, PHARMACOECONOMICS, V28, P449, DOI 10.2165/11535280-000000000-00000; Kim JJ, 2011, NEW ENGL J MED, V365, P1760, DOI 10.1056/NEJMp1110539; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Laxminarayan R., 2006, DIS CONTROL PRIORITI, V2nd ed.; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Loughlin AM, 2014, PEDIATR INFECT DIS J, V33, P504, DOI 10.1097/INF.0000000000000279; Mangen MJJ, 2010, VACCINE, V28, P2624, DOI 10.1016/j.vaccine.2010.01.014; Manski CF, 2010, P NATL ACAD SCI USA, V107, P3953, DOI 10.1073/pnas.0915009107; Marti Sebastian Garcia, 2013, Cost Eff Resour Alloc, V11, P21, DOI 10.1186/1478-7547-11-21; McIntosh EDG, 2005, VACCINE, V23, P1739, DOI 10.1016/j.vaccine.2004.08.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; National Institute for Health and Clinical Excellence (NICE), 2008, UPD GUID METH TECHN; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Newall AT, 2013, PHARMACOECONOMICS, V31, P693, DOI 10.1007/s40273-013-0060-7; Newall AT, 2011, VACCINE, V29, P8077, DOI 10.1016/j.vaccine.2011.08.050; Ogilvie I, 2009, VACCINE, V27, P4891, DOI 10.1016/j.vaccine.2009.05.061; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Payne DC, 2011, CLIN INFECT DIS, V53, P245, DOI 10.1093/cid/cir307; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Postma MJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-84; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Ray G Thomas, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P373, DOI 10.1586/14737167.8.4.373; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Rozenbaum MH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-462; Rubin JL, 2010, VACCINE, V28, P7634, DOI 10.1016/j.vaccine.2010.09.049; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Souza CPR, 2009, J BRAS EC SAUDE, V1, P3; Trotter CL, 2006, MED DECIS MAKING, V26, P38, DOI 10.1177/0272989X05284109; Tu HAT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-54; Tyo KR, 2011, VACCINE, V29, P6686, DOI 10.1016/j.vaccine.2011.06.091; Uiuena A, 2011, VACCINE, V29, P4963, DOI [10.1016/j.vaccine.2011.04.111, DOI 10.1016/J.VACCINE.2011.04.111]; Ultsch B, 2016, PHARMACOECONOMICS, V34, P227, DOI 10.1007/s40273-015-0335-2; van de Vooren K, 2014, PHARMACOECONOMICS, V32, P29, DOI 10.1007/s40273-013-0113-y; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vespa G, 2009, REV PANAM SALUD PUBL, V26, P518, DOI 10.1590/S1020-49892009001200007; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walker DG, 2010, VACCINE, V28, P2356, DOI 10.1016/j.vaccine.2009.06.035; Wisloff T, 2006, VACCINE, V24, P5690, DOI 10.1016/j.vaccine.2006.04.042	82	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172414	10.1371/journal.pone.0172414	http://dx.doi.org/10.1371/journal.pone.0172414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249046	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500041
J	Li, DW; Liu, MS; Cui, B; Fang, J; Guan, YZ; Ding, QY; Li, XG; Cui, LY				Li, Da-Wei; Liu, Mingsheng; Cui, Bo; Fang, Jia; Guan, Yu-Zhou; Ding, Qingyun; Li, Xiaoguang; Cui, Liying			The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population	PLOS ONE			English	Article							ELECTRODIAGNOSTIC CRITERIA; ALS; IMPROVES; ONSET	Objectives The accurate and early diagnosis of amyotrophic lateral sclerosis (ALS) is important for extending the life expectancy of patients. However, previous studies that have assessed the diagnostic sensitivities of the Awaji criteria (AC) and the revised El Escorial criteria (rEEC) in patients with ALS have been inconsistent, most of them were consensual regarding the advantage of Awaji over conventional criteria. Our study sought to compare the roles of AC and rEEC in the diagnosis of ALS. Methods Data from a total of 294 consecutive patients with ALS were collected between January 2014 and August 2015 in the Peking Union Medical College Hospital. The clinical and electrophysiological records of 247 patients were eventually analyzed. The primary outcome measures were the sensitivities of the AC and rEEC for the diagnosis of ALS. Results The sensitivity of probable or definite ALS as diagnosed with the AC (78%) was greater than that of the rEEC (36%, P < 0.001). Following the application of the AC, 103 of the 147 patients categorized as probable ALS-laboratory supported from the rEEC were upgraded to probable or definite ALS, and 44 were downgraded to possible ALS. Conclusions Our data demonstrated that the AC exhibited greater diagnostic sensitivity than the rEEC in a Chinese ALS population. The use of the AC should be considered in clinical practice.	[Li, Da-Wei; Liu, Mingsheng; Cui, Bo; Fang, Jia; Guan, Yu-Zhou; Ding, Qingyun; Li, Xiaoguang; Cui, Liying] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Cui, Liying] Chinese Acad Med Sci, Ctr Neurosci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Cui, LY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China.; Cui, LY (corresponding author), Chinese Acad Med Sci, Ctr Neurosci, Beijing, Peoples R China.	pumchcuily@sina.com			Sino-Germany Science Research Foundation [GZ876]	Sino-Germany Science Research Foundation	This study was supported by Sino-Germany Science Research Foundation (GZ876, http://www.sinogermanscience.org.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Benatar M, 2011, MUSCLE NERVE, V43, P461, DOI 10.1002/mus.21942; Boekestein WA, 2010, AMYOTROPH LATERAL SC, V11, P497, DOI 10.3109/17482961003777462; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chen A, 2010, MUSCLE NERVE, V42, P831, DOI 10.1002/mus.21841; Costa J, 2012, ARCH NEUROL-CHICAGO, V69, P1410, DOI 10.1001/archneurol.2012.254; Cui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137921; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P53, DOI 10.1080/17482960802521126; Dengler R, 2012, CLIN NEUROPHYSIOL, V123, P217, DOI 10.1016/j.clinph.2011.06.014; Douglass CP, 2010, J NEUROL NEUROSUR PS, V81, P646, DOI 10.1136/jnnp.2009.197434; Gawel M, 2014, AMYOTROPH LAT SCL FR, V15, P257, DOI 10.3109/21678421.2014.887118; Geevasinga N, 2016, CLIN NEUROPHYSIOLOGY; Geevasinga N, 2016, CLIN NEUROPHYSIOL, V127, P2684, DOI 10.1016/j.clinph.2016.04.005; Higashihara M, 2012, MUSCLE NERVE, V45, P175, DOI 10.1002/mus.22299; Jang JS, 2015, MUSCLE NERVE, V51, P822, DOI 10.1002/mus.24575; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Krarup C, 2011, CLIN NEUROPHYSIOL, V122, P414, DOI 10.1016/j.clinph.2010.06.027; Liu MS, 2014, ACTA NEUROL SCAND, V129, P163, DOI 10.1111/ane.12157; Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183; Noto Y, 2012, CLIN NEUROPHYSIOL, V123, P382, DOI 10.1016/j.clinph.2011.05.030; Riva N, 2016, J NEUROLOGY; Rooney J, 2015, J NEUROL NEUROSUR PS, V86, P496, DOI 10.1136/jnnp-2014-309601; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Schrooten M, 2011, ANN NEUROL, V70, P79, DOI 10.1002/ana.22380; Shahrizaila N, 2016, J NEUROL NEUROSUR PS, V87, P821, DOI 10.1136/jnnp-2015-312751; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Zou ZY, 2012, AMYOTROPH LATERAL SC, V13, P270, DOI 10.3109/17482968.2011.643900	28	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171522	10.1371/journal.pone.0171522	http://dx.doi.org/10.1371/journal.pone.0171522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249004	Green Submitted, gold, Green Published			2022-12-27	WOS:000395983500015
J	Galea, JT; Monsour, E; Nurena, CR; Blas, MM; Brown, B				Galea, Jerome T.; Monsour, Emmi; Nurena, Cesar R.; Blas, Magaly M.; Brown, Brandon			HPV vaccine knowledge and acceptability among Peruvian men who have sex with men and transgender women: A pilot, qualitative study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; HIV PREVENTION; RECTAL MICROBICIDES; RISK COMPENSATION; INFECTION; PERCEPTIONS; PRODUCT	Purpose Human papillomavirus (HPV) is the most common sexually transmitted infection globally and is responsible for a variety of cancers in men and women. An effective HPV vaccine licensed for use in girls and boys has been indicated for-but is not widely implemented in-men who have sex with men (MSM). Limited data are available for transgender women (TW). We explored the social and behavioral aspects related to HPV vaccine uptake and participation in HPV vaccine studies among Peruvian MSM and TW. Methods Focus groups and individual in-depth interviews were conducted to obtain the knowledge, thoughts, and opinions from Peruvian MSM and TW regarding HPV vaccination. Data were analyzed using systematic comparative and descriptive content analysis. Results Three focus groups and fifteen individual in-depth interviews were conducted among 36 MSM and TW. Participant mean age was 26 years (range 18-40). Though many participants were unfamiliar with HPV vaccination, most expressed positive attitudes. Participants expressed concerns about the potential for stigma when disclosing HPV vaccination. Conclusion Peruvian MSM and TW felt that HPV vaccination would be acceptable to themselves and their peers. Nonetheless, vaccine intake may be impeded by potential stigma. Findings from this study may guide HPV vaccine implementation in similar populations.	[Galea, Jerome T.] Socios Salud, Lima, Peru; [Galea, Jerome T.] Epictr Salud, Lima, Peru; [Galea, Jerome T.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Monsour, Emmi; Brown, Brandon] Univ Calif Riverside, Sch Med, Ctr Hlth Communities, Riverside, CA 92521 USA; [Nurena, Cesar R.] Univ Nacl Mayor San Marcos, Sch Anthropol, Lima, Peru; [Blas, Magaly M.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru	Harvard University; Harvard Medical School; University of California System; University of California Riverside; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia	Galea, JT (corresponding author), Socios Salud, Lima, Peru.; Galea, JT (corresponding author), Epictr Salud, Lima, Peru.; Galea, JT (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.	jerome_galea@hms.harvard.edu	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959	Merck Investigator Initiated Studies Program of Merck Co Inc.; Initiated Studies Program of Merck Co., Inc.	Merck Investigator Initiated Studies Program of Merck Co Inc.; Initiated Studies Program of Merck Co., Inc.	This work was supported in part by a research grant from the Merck Investigator Initiated Studies Program of Merck & Co Inc. The opinions expressed in this paper are of the authors and do not necessarily represent those of Merck & Co Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Magaly Blas and Brandon Brown received a research grant from the Investigator-Initiated Studies Program of Merck & Co., Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Brown Brandon, 2016, Transgend Health, V1, P94, DOI 10.1089/trgh.2016.0001; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Cakeres CF, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000327436.36161.80; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Colon-Lopez V, 2012, P R HEALTH SCI J, V31, P227; Cummings T, 2015, SEX TRANSM DIS, V42, P601, DOI 10.1097/OLQ.0000000000000358; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Galea JT, 2014, AM J PUBLIC HEALTH, V104, pE113, DOI 10.2105/AJPH.2013.301731; Giuliani M, 2016, HUM VACC IMMUNOTHER, V12, P1542, DOI 10.1080/21645515.2015.1115935; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Kasting ML, 2016, HUM VACC IMMUNOTHER, V12, P1435, DOI 10.1080/21645515.2016.1141158; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Lau JTF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057204; Loverro G, 2016, SEX TRANSM INFECT, V92, P67, DOI 10.1136/sextrans-2014-051987; Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5; Ministerio de Salud del Peru, 2014, INF NAC PROGR REAL P; Nadarzynski T, 2014, SEX TRANSM INFECT, V90, P515, DOI 10.1136/sextrans-2013-051357; Nurena CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058684; Owsianka Barbara, 2015, Przegl Epidemiol, V69, P53; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Sausa M, 2016, OCHO ASSESINATOS HOM, P21; Stanley M, 2012, NATURE, V488, pS10, DOI 10.1038/488S10a; Tang EC, 2016, SEX TRANSM INFECT, V92, P200, DOI 10.1136/sextrans-2015-052028	31	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172964	10.1371/journal.pone.0172964	http://dx.doi.org/10.1371/journal.pone.0172964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245234	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200046
J	Rao, HCY; Rakshith, D; Harini, BP; Gurudatt, DM; Satish, S				Rao, H. C. Yashavantha; Rakshith, Devaraju; Harini, Ballagere Puttaraju; Gurudatt, Doddahosuru Mahadevappa; Satish, Sreedharamurthy			Chemogenomics driven discovery of endogenous polyketide anti-infective compounds from endosymbiotic Emericella variecolor CLB38 and their RNA secondary structure analysis	PLOS ONE			English	Article							ENDOPHYTIC FUNGUS; ANTIBACTERIAL ACTIVITY; PROTEIN-STRUCTURE; I-TASSER; METABOLITES; SYNTHASE; IDENTIFICATION; CONSTITUENTS; GLIOMASTIX; PROBES	In the postgenomic era, a new strategy for chemical dereplication of polyketide anti-infective drugs requires novel genomics and chromatographic strategies. An endosymbiotic fungal strain CLB38 was isolated from the root tissue of Combretum latifolium Blume (Combretaceae) which was collected from the Western Ghats of India. The isolate CLB38 was then identified as Emericella variecolor by its characteristic stellate ascospores culture morphology and molecular analysis of ITS nuclear rDNA and intervening 5.8S rRNA gene sequence. ITS2 RNA secondary structure modeling clearly distinguished fungal endosymbiont E. variecolor CLB38 with other lifestyles in the same monophyletic clade. Ethyl acetate fraction of CLB38 explored a broad spectrum of antimicrobial activity against multidrug resistant pathogens. Biosynthetic PKS type-I gene and chromatographic approach afford two polyketide antimicrobial compounds which identified as evariquinone and isoindolones derivative emerimidine A. MIC of purified compounds against test microorganisms ranged between 3.12 mu g/ml and 12.5 mu g/ml. This research highlights the utility of E. variecolor CLB38 as an anticipate source for anti-infective polyketide metabolites evariquinone and emerimidine A to combat multidrug resistant microorganisms. Here we demonstrates a chemogenomics strategy via the feasibility of PKS type-I gene and chromatographic approach as a proficient method for the rapid prediction and discovery of new polyketides compounds from fungal endosymbionts.	[Rao, H. C. Yashavantha; Rakshith, Devaraju; Satish, Sreedharamurthy] Univ Mysore, Dept Studies Microbiol, Microbial Drugs Lab, Mysore, Karnataka, India; [Harini, Ballagere Puttaraju] Bangalore Univ, Dept Zool, Jnana Bharathi Campus, Bangalore, Karnataka, India; [Gurudatt, Doddahosuru Mahadevappa] Univ Mysore, Dept Studies Organ Chem, Mysore, Karnataka, India	University of Mysore; Bangalore University; University of Mysore	Rao, HCY; Satish, S (corresponding author), Univ Mysore, Dept Studies Microbiol, Microbial Drugs Lab, Mysore, Karnataka, India.	hcyrao@gmail.com; satish.micro@gmail.com	Sreedharamurthy, Satish/X-7781-2019	Sreedharamurthy, Satish/0000-0003-1164-4701; Yashavantha Rao, H.C/0000-0001-6010-0781	University Grants Commission (UGC) [DV9/405/Misc/2014-15]	University Grants Commission (UGC)(University Grants Commission, India)	This work was funded by the University Grants Commission (UGC; Award No: DV9/405/Misc/2014-15, Dated 38/02/2015).; H.C. Yashavantha Rao acknowledges University Grants Commission (UGC) for providing the fellowship. The authors also thank Central Instrumentation Facility, Institute of Excellence (IOE), and University with Potential for Excellence (UPE) for providing instrumentation facilities.	Barnett HL, 1956, ILLUSTRATED GENERA I, P218; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berkeley MJ, 1857, INTRO CRYPTOGAMIC BO; Bhagat J, 2012, WORLD J MICROB BIOT, V28, P963, DOI 10.1007/s11274-011-0894-0; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Bringmann G, 2003, PHYTOCHEMISTRY, V63, P437, DOI 10.1016/S0031-9422(03)00189-4; Buatong J, 2011, WORLD J MICROB BIOT, V27, P3005, DOI 10.1007/s11274-011-0765-8; Chairat M, 2015, COLOR TECHNOL, V131, P310, DOI 10.1111/cote.12158; Craney A, 2013, J ANTIBIOT, V66, P387, DOI 10.1038/ja.2013.25; Debnath B, 2014, INDIAN J ADV PLANT R, V1, P49; Deepika VB, 2016, MICROBIOL RES, V182, P125, DOI 10.1016/j.micres.2015.10.009; Figueroa M, 2009, BIOORGAN MED CHEM, V17, P2167, DOI 10.1016/j.bmc.2008.10.079; Frisvad JC, 1985, ADV PENICILLIUM ASPE, P437; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Fujimoto H, 2006, CHEM PHARM BULL, V54, P550, DOI 10.1248/cpb.54.550; GILLCAREY D, 1949, BRIT J EXP PATHOL, V30, P119; Hawas UW, 2012, ARCH PHARM RES, V35, P1749, DOI 10.1007/s12272-012-1006-x; Jumpathong J, 2011, WORLD J MICROB BIOT, V27, P1989, DOI 10.1007/s11274-011-0659-9; Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006; Kim JS, 2010, PLANT PATHOLOGY J, V26, P289, DOI 10.5423/PPJ.2010.26.3.289; Kusari P, 2016, RSC ADV, V6, P10011, DOI 10.1039/c5ra25042k; Lin X, 2010, FUNGAL DIVERS, V41, P41, DOI 10.1007/s13225-010-0017-5; Maccabe A P, 2001, APPL MYCOLOGY BIOTEC, V1, P239; Mathews DH, 2005, RNA WORLD, P631; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; Nopsiri Wimaluk, 2015, Chiang Mai University Journal of Natural Sciences, V14, P245, DOI 10.12982/cmujns.2015.0086; Packiaraj R., 2016, Studies in Fungi, V1, P104, DOI 10.5943/sif/1/1/10; Padhi S, 2015, ANN MICROBIOL; Padhi S, 2013, ANN MICROBIOL, V63, P793, DOI 10.1007/s13213-012-0534-4; Patel JD, 2014, ADV MICROBIOL, V4, P338; Patra J. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS50; Pei AN, 2012, FEMS MICROBIOL LETT, V335, P11, DOI 10.1111/j.1574-6968.2012.02632.x; Pornpakakul S, 2006, ARCH PHARM RES, V29, P140, DOI 10.1007/BF02974275; Rakshith D, 2016, APPL BIOASSAY GUIDED, V79, P1625; Rao HCY, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1389-5; Rao H. C. Yashavantha, 2015, Mycology-An International Journal On Fungal Biology, V6, P176, DOI 10.1080/21501203.2015.1113207; Rao HCY, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1370-3; Rao HCY, 2015, 3 BIOTECH, V5, P165, DOI 10.1007/s13205-014-0204-2; Rao HCY, 2015, FRONT LIFE SCI, V8, P200, DOI 10.1080/21553769.2015.1033768; Rao HCY, 2015, FRONT BIOL, V10, P528, DOI DOI 10.1007/s11515-015-1377-8; Rastogi G, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P29, DOI 10.1007/978-1-4419-7931-5_2; Raviraja NS, 2006, ENG LIFE SCI, V6, P515, DOI 10.1002/elsc.200620145; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadrati Nouari, 2013, Journal of Plant Protection Research, V53, P128, DOI 10.2478/jppr-2013-0019; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Summerbell RC, 2011, STUD MYCOL, P139, DOI 10.3114/sim.2011.68.06; Suthari S., 2014, INDIAN J PLANT SCI, V3, P86; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Wang JY, 2014, WORLD J MICROB BIOT, V30, P2639, DOI 10.1007/s11274-014-1686-0; Wang LW, 2012, APPL MICROBIOL BIOT, V93, P1231, DOI 10.1007/s00253-011-3472-3; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Wei H, 2004, TETRAHEDRON, V60, P6015, DOI 10.1016/j.tet.2004.05.021; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu ZS, 2013, FUNGAL DIVERS, V58, P127, DOI 10.1007/s13225-012-0192-7; Zhang GJ, 2011, PHYTOCHEMISTRY, V72, P1436, DOI 10.1016/j.phytochem.2011.04.014; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	63	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172848	10.1371/journal.pone.0172848	http://dx.doi.org/10.1371/journal.pone.0172848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245269	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000395980200036
J	Annis, GM; Pearsall, DR; Kahl, KJ; Washburn, EL; May, CA; Taylor, RF; Cole, JB; Ewert, DN; Game, ET; Doran, PJ				Annis, Gust M.; Pearsall, Douglas R.; Kahl, Katherine J.; Washburn, Erika L.; May, Christopher A.; Taylor, Rachael Franks; Cole, James B.; Ewert, David N.; Game, Edward T.; Doran, Patrick J.			Designing coastal conservation to deliver ecosystem and human well-being benefits	PLOS ONE			English	Article							GREAT-LAKES; SERVICES; INFORM; MAP	Conservation scientists increasingly recognize that incorporating human values into conservation planning increases the chances for success by garnering broader project acceptance. However, methods for defining quantitative targets for the spatial representation of human wellbeing priorities are less developed. In this study we employ an approach for identifying regionally important human values and establishing specific spatial targets for their representation based on stakeholder outreach. Our primary objective was to develop a spatially-explicit conservation plan that identifies the most efficient locations for conservation actions to meet ecological goals while sustaining or enhancing human well-being values within the coastal and nearshore areas of the western Lake Erie basin (WLEB). We conducted an optimization analysis using 26 features representing ecological and human well-being priorities (13 of each), and included seven cost layers. The influence that including human well-being had on project results was tested by running five scenarios and setting targets for human well-being at different levels in each scenario. The most important areas for conservation to achieve multiple goals are clustered along the coast, reflecting a concentration of existing or potentially restorable coastal wetlands, coastal landbird stopover habitat and terrestrial biodiversity, as well as important recreational activities. Inland important areas tended to cluster around trails and high quality inland landbird stopover habitat. Most concentrated areas of importance also are centered on lands that are already conserved, reflecting the lower costs and higher benefits of enlarging these conserved areas rather than conserving isolated, dispersed areas. Including human well-being features in the analysis only influenced the solution at the highest target levels.	[Annis, Gust M.; Pearsall, Douglas R.; Kahl, Katherine J.; Washburn, Erika L.; May, Christopher A.; Taylor, Rachael Franks; Ewert, David N.; Doran, Patrick J.] Nature Conservancy, Lansing, MI 48906 USA; [Cole, James B.] Nature Conservancy, St Louis, MO USA; [Game, Edward T.] Nature Conservancy, West End Brisbane, Qld, Australia; [Washburn, Erika L.] Univ Wisconsin, Lake Super Natl Estuarine Res Reserve, Superior, WI USA; [Taylor, Rachael Franks] NOAA, Off Coastal Management, Baldwin Grp, Traverse City, MI USA	Nature Conservancy; University of Wisconsin System; National Oceanic Atmospheric Admin (NOAA) - USA	Annis, GM (corresponding author), Nature Conservancy, Lansing, MI 48906 USA.	gannis@tnc.org		Game, Edward/0000-0003-4707-9281	DTE Energy Foundation; Consumers Energy Foundation	DTE Energy Foundation; Consumers Energy Foundation	The DTE Energy Foundation funded salaries for the following related to study design; data collection and analysis; workshops and meetings to vet mapping, data collection, analysis and implementation with conservation and community partners; and preparation of the manuscript: GMA, DRP, KJK, PJD, CAM, RFT, ELW, JBC and DNE (no grant number; www2.dteenergy.com). Consumers Energy Foundation provided salary support for ELW for coastal community interviews and data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2014, ECOL SOC, V19, DOI 10.5751/ES-07168-190453; Albert D. A., 2004, COASTAL WETLAND INVE; Allan JD, 2015, FRONT ECOL ENVIRON, V13, P418, DOI 10.1890/140328; Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; American Bird Conservancy, 2015, BIRD BIGGEST WEEK PA; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Bourgeau-Chavez L, 2015, REMOTE SENS-BASEL, V7, P8655, DOI 10.3390/rs70708655; Conservancy Nature, 2007, CONS ACT PLANN HDB D; Cowling RM, 2007, ORYX, V41, P135, DOI 10.1017/S003065307001949; Ebird, 2013, EBIRD ONL DAT BIRD D; EPA, 2015, LAK ER; Ewert D. N., 2012, WING GIS LAYER PRIOR; Ewert DN, 2006, ANN ARBOR, V1001, P48103; Game ET, 2011, CONSERV LETT, V4, P38, DOI 10.1111/j.1755-263X.2010.00140.x; Grantham HS, 2013, MAR POLICY, V38, P184, DOI 10.1016/j.marpol.2012.05.035; Great Lakes Restoration Initiative, 2014, GREAT LAK REST IN AC; Groves C., 2015, CONSERVATION PLANNIN; Gurney GG, 2015, CONSERV BIOL, V29, P1378, DOI 10.1111/cobi.12514; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Lake Erie Improvement Association, 2012, STRAT PLAN LAK ER PA; Lake Erie LaMP, 2008, LAKE ERIE LAKEWIDE M; Leach WD, 2002, SURVEYING DIVERSE ST, P15; Lovelace S, 2011, 146 NOAA NOS NCCOS, P146; MacMynowski DP, 2007, ENVIRON MANAGE, V39, P831, DOI 10.1007/s00267-006-0082-4; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Milner-Gulland EJ, 2014, CONSERV BIOL, V28, P1160, DOI 10.1111/cobi.12277; Ontario Ministry of Natural Resources, 2002, PROV LAND COV 2000; Pearsall D., 2012, TECHNICAL REPORT; Pearsall DR, 2013, ENVIRON PRAC, V15, P462, DOI 10.1017/S1466046613000410; Potter B. A., 2007, UPPER MISSISSIPPI RI; Saarinen JA, 2015, W LAKE ERIE RESTORAT; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Soulliere G. J., 2007, UPPER MISSISSIPPI RI; Sowa SP, 2007, ECOL MONOGR, V77, P301, DOI 10.1890/06-1253.1; Stephanson SL, 2014, CONSERV BIOL, V28, P1236, DOI 10.1111/cobi.12357; U.S. Department of Agriculture, 2014, 2012 AGR CENS REP GR; Washburn EL, 2013, SOC NATUR RESOUR, V26, P325, DOI 10.1080/08941920.2012.700762; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Watts ME, 2008, USER GUIDE APPL MARX	44	13	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172458	10.1371/journal.pone.0172458	http://dx.doi.org/10.1371/journal.pone.0172458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241018	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400022
J	Li, JX; Yang, BR; Shi, MM; Yuan, K; Guo, W; Li, MS; Wang, GJ				Li, Jingxin; Yang, Birong; Shi, Manman; Yuan, Kai; Guo, Wei; Li, Mingshun; Wang, Gejiao			Effects upon metabolic pathways and energy production by Sb(III) and As(III)/Sb(III)-oxidase gene aioA in Agrobacterium tumefaciens GW4	PLOS ONE			English	Article							NATURAL-WATERS; LEISHMANIA-BRAZILIENSIS; ANTIMONY-RESISTANT; ARSENITE; ENVIRONMENT; OXIDATION; ARSENATE; MECHANISMS; STRESS; IDENTIFICATION	Agrobacterium tumefaciens GW4 is a heterotrophic arsenite [As(III)]/antimonite [Sb(III)]-oxidizing strain. The As(III) oxidase AioAB is responsible for As(III) oxidation in the periplasm and it is also involved in Sb(III) oxidation in Agrobacterium tumefaciens 5A. In addition, Sb(III) oxidase AnoA and cellular H2O2 are also responsible for Sb(III) oxidation in strain GW4. However, the deletion of aioA increased the Sb(III) oxidation efficiency in strain GW4. In the present study, we found that the cell mobility to Sb(III), ATP and NADH contents and heat release were also increased by Sb(III) and more significantly in the aioA mutant. Proteomics and transcriptional analyses showed that proteins/genes involved in Sb(III) oxidation and resistance, stress responses, carbon metabolism, cell mobility, phosphonate and phosphinate metabolism, and amino acid and nucleotide metabolism were induced by Sb(III) and were more significantly induced in the aioA mutant. The results suggested that Sb(III) oxidation may produce energy. In addition, without periplasmic AioAB, more Sb(III) would enter bacterial cells, however, the cytoplasmic AnoA and the oxidative stress response proteins were significantly up-regulated, which may contribute to the increased Sb(III) oxidation efficiency. Moreover, the carbon metabolism was also activated to generate more energy against Sb(III) stress. The generated energy may be used in Sb transportation, DNA repair, amino acid synthesis, and cell mobility, and may be released in the form of heat.	[Li, Jingxin; Yang, Birong; Shi, Manman; Yuan, Kai; Guo, Wei; Li, Mingshun; Wang, Gejiao] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn			State Key Laboratory of Agricultural Microbiology, P.R. China	State Key Laboratory of Agricultural Microbiology, P.R. China	The present study was supported by a research funding of the State Key Laboratory of Agricultural Microbiology, P.R. China to GW. GW was responsible for study design and revision of the manuscript.; The present study was supported by a research funding of the State Key Laboratory of Agricultural Microbiology, P. R. China.	Abin CA, 2014, ENVIRON SCI TECHNOL, V48, P681, DOI 10.1021/es404098z; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brotherton MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081899; Carapito C, 2006, BIOCHIMIE, V88, P595, DOI 10.1016/j.biochi.2005.11.004; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Council of the European Communities, 1976, 76464EEC2329 COUNC E; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fasullo M, 2015, INT J MOL SCI, V16, P9431, DOI 10.3390/ijms16059431; Filella M, 2002, EARTH-SCI REV, V59, P265, DOI 10.1016/S0012-8252(02)00089-2; Filella M, 2002, EARTH-SCI REV, V57, P125, DOI 10.1016/S0012-8252(01)00070-8; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Filella M, 2009, ENVIRON CHEM, V6, P95, DOI 10.1071/EN09007; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; HEKSTRA D, 1993, J BACTERIOL, V175, P6546, DOI 10.1128/jb.175.20.6546-6552.1993; Kamat SS, 2011, NATURE, V480, P570, DOI 10.1038/nature10622; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kojima S, 2015, CURR OPIN MICROBIOL, V28, P66, DOI 10.1016/j.mib.2015.07.015; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Kulp TR, 2014, ENVIRON SCI TECHNOL, V48, P218, DOI 10.1021/es403312j; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Lenz G, 2014, J MOL BIOL, V426, P460, DOI 10.1016/j.jmb.2013.10.018; Li J, 2017, SCI REP IN PRESS; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Li JX, 2016, APPL ENVIRON MICROB, V82, P5482, DOI 10.1128/AEM.01375-16; Li JX, 2015, ENVIRON SCI TECHNOL, V49, P5980, DOI 10.1021/es506318b; Li X, 2000, BIOL TRACE ELEM RES, V77, P261, DOI 10.1385/BTER:77:3:261; Li X, 2014, RES MICROBIOL, V165, P605, DOI 10.1016/j.resmic.2014.07.010; Lialikova N N, 1974, Mikrobiologiia, V43, P941; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Maciaszczyk-Dziubinska E, 2011, BBA-BIOMEMBRANES, V1808, P1855, DOI 10.1016/j.bbamem.2011.03.014; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Moreira DD, 2015, PROTEOMICS, V15, P2999, DOI 10.1002/pmic.201400611; Murciego AM, 2007, ENVIRON POLLUT, V145, P15, DOI 10.1016/j.envpol.2006.04.004; Rosen B P, 1995, J Basic Clin Physiol Pharmacol, V6, P251; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Shi K, 2017, SCI REP IN PRESS; Tabata K, 2013, BMC MICROBIOL, V13, P153, DOI [10.1186/1471-2180-13-153, DOI 10.1186/1471-2180-13-153]; Terry LR, 2015, APPL ENVIRON MICROB, V81, P8478, DOI 10.1128/AEM.01970-15; USEPA, 1979, WAT REL FAT 129 PRIO, V1; Wadso I, 2009, J THERM ANAL CALORIM, V95, P843, DOI 10.1007/s10973-008-9467-3; Wang Q, 2015, ENVIRON MICROBIOL, V17, P1926, DOI 10.1111/1462-2920.12465; Wang Q, 2015, APPL ENVIRON MICROB, V81, P1959, DOI 10.1128/AEM.02981-14; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043176; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328; Weiss S, 2009, BIOCHIMIE, V91, P192, DOI 10.1016/j.biochi.2008.07.013; Wyatt MF, 2006, ANAL CHEM, V78, P199, DOI 10.1021/ac050732f; Xu C, 1998, J BIOCHEM-TOKYO, V123, P16; Zhang Y, 2007, MICROBIOL-SGM, V153, P3713, DOI 10.1099/mic.0.2007/011403-0; Zuo FL, 2014, RES MICROBIOL, V165, P581, DOI 10.1016/j.resmic.2014.05.040	54	8	8	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172823	10.1371/journal.pone.0172823	http://dx.doi.org/10.1371/journal.pone.0172823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241045	Green Published, gold			2022-12-27	WOS:000395934400044
J	Komegae, EN; Souza, TAM; Grund, LZ; Lima, C; Lopes-Ferreira, M				Komegae, Evilin Naname; Matozo Souza, Tais Aparecida; Grund, Lidiane Zito; Lima, Carla; Lopes-Ferreira, Monica			Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CUPRIZONE-INDUCED DEMYELINATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; BLOOD-BRAIN-BARRIER; T-CELLS; CNS DEMYELINATION; NITRIC-OXIDE; DISEASE; IL-10	The pathological condition of multiple sclerosis (MS) relies on innate and adaptive immunity. New types of agents that beneficially modify the course of MS, stopping the progression and repairing the damage appear promising. Here, we studied TnP, a small stable synthetic peptide derived from fish venom in the control of inflammation and demyelination in experimental autoimmune encephalomyelitis as prophylactic treatment. TnP decreased the number of the perivascular infiltrates in spinal cord, and the activity of MMP-9 by F4/80+ macrophages were decreased after different regimen treatments. TnP reduces in the central nervous system the infiltration of IFN-gamma-producing Th1 and IL-17A-producing Th17 cells. Also, treatment with therapeutic TnP promotes the emergence of functional Treg in the central nervous system entirely dependent on IL-10. Therapeutic TnP treatment accelerates the remyelination process in a cuprizone model of demyelination. These findings support the beneficial effects of TnP and provides a new therapeutic opportunity for the treatment of MS.	[Komegae, Evilin Naname; Matozo Souza, Tais Aparecida; Grund, Lidiane Zito; Lima, Carla; Lopes-Ferreira, Monica] Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil	Instituto Butantan	Lopes-Ferreira, M (corresponding author), Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil.	monica.lopesferreira@butantan.gov.br	Lima, Carla/B-6750-2019; Grund, Lidiane/AAJ-1844-2021; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Lima, Carla/0000-0002-8161-966X; Grund, Lidiane/0000-0001-6587-0283; Matozo, Tais/0000-0002-3129-8909; Lopes-Ferreira, Monica/0000-0003-0244-7482	Laboratorio Cristalia Produtos Quomicos Farmaceuticos LTDA; Sao Paulo Research Foundation-Fapesp [2013/07467-1, 2012/50001-0, 2010/51130-3, 2003/13751-2, 1998/14307-9]	Laboratorio Cristalia Produtos Quomicos Farmaceuticos LTDA; Sao Paulo Research Foundation-Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by research grants from Laboratorio Cristalia Produtos Quomicos Farmaceuticos LTDA and Sao Paulo Research Foundation-Fapesp (2013/07467-1; 2012/50001-0; 2010/51130-3; 2003/13751-2; 1998/14307-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by research grants from Laboratorio Cristalia Produtos Quimicos Farmaceuticos LTDA and Sao Paulo Research Foundation-Fapesp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012496, DOI 10.1371/JOURNAL.PONE.0012496]; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 1998, J IMMUNOL, V161, P3299; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; Cross AH, 2014, J INTERN MED, V275, P350, DOI 10.1111/joim.12203; Dai H, 2012, J NEUROIMMUNOL, V245, P1, DOI 10.1016/j.jneuroim.2012.01.005; Ebers GC, 2014, J NEUROL NEUROSUR PS, V71, pii16; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hunt David, 2012, Pract Neurol, V12, P25, DOI 10.1136/practneurol-2011-000092; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; KARPUS WJ, 1992, EUR J IMMUNOL, V22, P1757, DOI 10.1002/eji.1830220714; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; McGuigan C, 2016, J NEUROL NEUROSUR PS, V87, P117, DOI 10.1136/jnnp-2015-311100; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Mindur JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099068; Montalban X, 2016, N ENGL J MED; Neuhaus O, 2015, NEUROLOGY, V6, P702; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Praet J, 2014, NEUROSCI BIOBEHAV R, V47, P485, DOI 10.1016/j.neubiorev.2014.10.004; Racke MK, 2011, J IMMUNOL, V186, P1887, DOI 10.4049/jimmunol.1090138; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Runia TF, 2012, CNS NEUROL DISORD-DR, V11, P497; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shigetomi H, 2010, INFLAMM RES, V59, P679, DOI 10.1007/s00011-010-0205-5; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Sorensen PS, 2012, MULT SCLER J, V18, P143, DOI 10.1177/1352458511435105; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Thell K, 2016, P NATL ACAD SCI USA, V113, P3960, DOI 10.1073/pnas.1519960113; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002; Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171796	10.1371/journal.pone.0171796	http://dx.doi.org/10.1371/journal.pone.0171796			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235052	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200035
J	Marinkovic, E; Djokic, R; Lukic, I; Filipovic, A; Inic-Kanada, A; Kosanovic, D; Gavrovic-Jankulovic, M; Stojanovic, M				Marinkovic, Emilija; Djokic, Radmila; Lukic, Ivana; Filipovic, Ana; Inic-Kanada, Aleksandra; Kosanovic, Dejana; Gavrovic-Jankulovic, Marija; Stojanovic, Marijana			Modulation of functional characteristics of resident and thioglycollate-elicited peritoneal murine macrophages by a recombinant banana lectin	PLOS ONE			English	Article							DENDRITIC CELLS; IFN-GAMMA; TNF-ALPHA; TGF-BETA; ACTIVATION; SUPEROXIDE; ARGINASE; IL-12; MYELOPEROXIDASE; INFLAMMATION	We demonstrated that a recombinant banana lectin (rBanLec), which structural characteristics and physiological impacts highly resemble those reported for its natural counterparts, binds murine peritoneal macrophages and specifically modulates their functional characteristics. By using rBanLec in concentrations ranging from 1 mu g to 10 mu g to stimulate resident (RMs) and thioglycollate-elicited (TGMs) peritoneal macrophages from BALB/c and C57BL/6 mice, we have shown that effects of rBanLec stimulation depend on its concentration but also on the functional status of macrophages and their genetic background. rBanLec, in a positive dose-dependent manner, promotes the proliferation of TGMs from both BALB/c and C57BL/6 mice, while its mitogenic influence on RMs is significantly lower (BALB/c mice) or not detectable (C57BL/6 mice). In all peritoneal macrophages, irrespective of their type and genetic background, rBanLec, in a positive dose dependent manner, enhances the secretion of IL-10. rBanLec stimulation of RMs from both BALB/c and C57BL/6 resulted in a positive dose-dependent promotion of proinflammatory phenotype (enhancement of NO production and IL-12 and TNF alpha secretion, reduction of arginase activity). Positive dose-dependent skewing toward proinflammatory phenotype was also observed in TGMs from C57BL/6 mice. However, the enhancement of rBanLec stimulation promotes skewing of TGMs from BALB/c mice towards anti-inflammatory profile (reduction of NO production and IL-12 secretion, enhancement of arginase activity and TGF alpha and IL-4 secretion). Moreover, we established that rBanLec binds oligosaccharide structures of TLR2 and CD14 and that blocking of signaling via these receptors significantly impairs the production of TNFa and NO in BALB/c macrophages. Since the outcome of rBanLec stimulation depends on rBanLec concentration as well as on the functional characteristics of its target cells and their genetic background, further studies are needed to investigate its effects under physiological and specific pathological conditions.	[Marinkovic, Emilija; Djokic, Radmila; Lukic, Ivana; Filipovic, Ana; Kosanovic, Dejana; Stojanovic, Marijana] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Inic-Kanada, Aleksandra] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Gavrovic-Jankulovic, Marija] Univ Belgrade, Dept Biochem, Fac Chem, Belgrade, Serbia	Medical University of Vienna; University of Belgrade	Stojanovic, M (corresponding author), Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia.	mstojanovic@torlak.rs	Gavrovic-Jankulovic, Marija/AAE-4077-2022	Gavrovic-Jankulovic, Marija/0000-0002-8591-4391; Inic-Kanada, Aleksandra/0000-0001-7854-3812; Lukic, Ivana/0000-0002-6330-471X; Stojanovic, Marijana/0000-0002-8204-4183	Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]	Ministry of Education, Science, and Technological Development of the Republic of Serbia	This research was funded by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant number 172049) (http://www.mpn.gov.rs/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Bastos KRB, 2004, MICROBES INFECT, V6, P630, DOI 10.1016/j.micinf.2004.02.012; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cassado AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00225; Cassado AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022141; Cheung AHK, 2009, PHYTOMEDICINE, V16, P594, DOI 10.1016/j.phymed.2008.12.016; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; da Silva LCN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00020; DASILVA CJ, 2002, J BIOL CHEM, V277, P1845, DOI [DOI 10.1074/JBC.M109910200, 10.1074/jbc.M109910200]; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Kang TB, 2008, J BIOMED SCI, V15, P197, DOI 10.1007/s11373-007-9210-2; Kataoka H, 2006, CELL MICROBIOL, V8, P1199, DOI 10.1111/j.1462-5822.2006.00702.x; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; Lavelle EC, 2002, IMMUNOLOGY, V107, P268, DOI 10.1046/j.1365-2567.2002.01492.x; Mariano VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098512; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Marinkovic E, 2016, J FUNCT FOODS, V20, P68, DOI 10.1016/j.jff.2015.10.019; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Meo S. D., 2016, OXID MED CELL LONGEV; Meurs H, 2003, TRENDS PHARMACOL SCI, V24, P450, DOI 10.1016/S0165-6147(03)00227-X; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Sansone ACMB, 2016, INT J BIOL MACROMOL, V89, P19, DOI 10.1016/j.ijbiomac.2016.04.049; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; de Melo CML, 2010, PHYTOTHER RES, V24, P1631, DOI 10.1002/ptr.3156; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; PICK E, 1981, J RETICULOENDOTH SOC, V30, P581; Reis EAG, 2008, ACTA TROP, V108, P160, DOI 10.1016/j.actatropica.2008.05.025; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sodhi A, 2007, GLYCOCONJUGATE J, V24, P573, DOI 10.1007/s10719-007-9054-z; Stojanovic MM, 2010, INT IMMUNOPHARMACOL, V10, P120, DOI 10.1016/j.intimp.2009.10.007; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Wong JH, 2006, INT J BIOCHEM CELL B, V38, P234, DOI 10.1016/j.biocel.2005.09.004; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024	49	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172469	10.1371/journal.pone.0172469	http://dx.doi.org/10.1371/journal.pone.0172469			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235050	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200083
J	Shevchenko, A; Yang, YM; Knaust, A; Verbavatz, JM; Mai, HJ; Wang, B; Wang, CS; Shevchenko, A				Shevchenko, Anna; Yang, Yimin; Knaust, Andrea; Verbavatz, Jean-Marc; Mai, Huijuan; Wang, Bo; Wang, Changsui; Shevchenko, Andrej			Open sesame: Identification of sesame oil and oil soot ink in organic deposits of Tang Dynasty lamps from Astana necropolis in China	PLOS ONE			English	Article							BRASSICACEAE SEED OIL; MASS-SPECTROMETRY; ANIMAL FATS; PLANT OILS; OLIVE OIL; CANNABIS; TRIACYLGLYCEROLS; CHEMISTRY; XINJIANG; PROTEOMICS	Lamp illuminants evidence the exploitation of natural resources, animal and plant domestication, commerce, religious practices and nutrition of ancient populations. However, the physicochemical analysis of their major constituent D burned, degraded and aged mixture of triacylglycerols is imprecise and may lead to ambiguous interpretations. We applied proteomics to analyze fuel deposits from eight lamps dated by 6(th) to 8(th) centuries AD that were excavated at the Astana necropolis (Xinjiang, China) and determined their origin by identifying organism- specific proteins. Proteomics evidence corroborated and detailed the assignments of source organism relying upon comparative profiling of intact triacylglycerols by shotgun lipidomics. We found that ruminant (mostly, sheep) fat, cattle ghee and sesame oil were common combustibles in Astana and concluded that sesame as an oilseed appeared in China under Tang Dynasty concomitantly with the expansion of Buddhism.	[Shevchenko, Anna; Knaust, Andrea; Verbavatz, Jean-Marc; Shevchenko, Andrej] MPI Mol Cell Biol & Genet, Dresden, Germany; [Yang, Yimin; Mai, Huijuan; Wang, Changsui] Univ Chinese Acad Sci, Dept Archaeol & Anthropol, Beijing, Peoples R China; [Yang, Yimin; Mai, Huijuan; Wang, Changsui] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Wang, Bo] Xinjiang Uygur Autonomous Reg Museum, Urumqi, Peoples R China; [Verbavatz, Jean-Marc] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod, Paris, France	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Shevchenko, A (corresponding author), MPI Mol Cell Biol & Genet, Dresden, Germany.; Wang, CS (corresponding author), Univ Chinese Acad Sci, Dept Archaeol & Anthropol, Beijing, Peoples R China.; Wang, CS (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	cswang@ucas.ac.cn; shevchenko@mpi-cbg.de		Verbavatz, Jean-Marc/0000-0002-4654-1174; yang, yimin/0000-0003-2745-9498	National Science Foundation in China [41172164]; CAS Strategic Priority Research Program [XDA05130303]; Youth Innovation Promotion Association of CAS [2013281]	National Science Foundation in China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program; Youth Innovation Promotion Association of CAS	Support was provided by the National Science Foundation in China, grant 41172164 to CW; CAS Strategic Priority Research Program, grant XDA05130303 to CW; and Youth Innovation Promotion Association of CAS, grant 2013281 to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank Ms. Steffi Lenhard, Dr. Henrik Thomas, Dr. Kai Schuhmann and Dr. Hongen Jiang for expert technical support and useful discussions; Light Microscopy Facility at the MPI CBG in Dresden headed by Dr. Jan Peychl for valuable technical support. This study was supported by grants from the National Science Foundation in China (41172164) the CAS Strategic Priority Research Program (XDA05130303) and Youth Innovation Promotion Association of CAS (2013281).	Beckwith Christopher I., 1991, J ECON SOC HIST ORIE, V34, P183, DOI DOI 10.2307/3632244; BEDIGIAN D, 1985, BIOCHEM SYST ECOL, V13, P133, DOI 10.1016/0305-1978(85)90071-7; Bryant Edwin F., 2001, QUEST ORIGINS VEDIC, DOI DOI 10.1093/0195137779.001.0001; Bulone V, 2000, INT ARCH ALLERGY IMM, V123, P220, DOI 10.1159/000024447; Cartier Michel, 1994, ETUDES CHINOISES, V13, P417; Chen T, 2014, ECON BOT, V68, P59, DOI 10.1007/s12231-014-9261-z; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; Colombini MP, 2005, J MASS SPECTROM, V40, P890, DOI 10.1002/jms.865; Copley MS, 2005, ANALYST, V130, P860, DOI 10.1039/b500403a; DEBEAUNE SA, 1987, CURR ANTHROPOL, V28, P569, DOI 10.1086/203565; Dudd SN, 1998, ORG GEOCHEM, V29, P1345, DOI 10.1016/S0146-6380(98)00093-X; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Evershed RP, 2008, ARCHAEOMETRY, V50, P101, DOI 10.1111/j.1475-4754.2007.00368.x; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; Fuller DQ, 2003, ASIAN AGRI-HIST, V7, P127; GANGULI NC, 1973, J DAIRY SCI, V56, P19, DOI 10.3168/jds.S0022-0302(73)85109-4; Garnier N, 2009, INT J MASS SPECTROM, V284, P47, DOI 10.1016/j.ijms.2009.03.003; Hansen, 2012, SILK ROAD NEW HIST; Haugan E, 2014, ARCHAEOMETRY, V56, P951, DOI 10.1111/arcm.12054; Haugan E, 2013, J MICROSC-OXFORD, V252, P159, DOI 10.1111/jmi.12079; Heron C, 2013, ANTIQUITY, V87, P178, DOI 10.1017/S0003598X00048705; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Kimpe K, 2001, J CHROMATOGR A, V937, P87, DOI 10.1016/S0021-9673(01)01304-8; Knauer ER, 2011, CAMELS LOAD LIFE DEA; Leo G, 2011, ANAL CHEM, V83, P2056, DOI 10.1021/ac1027275; LI HL, 1974, ECON BOT, V28, P437; Lichtfouse E, 2000, RAPID COMMUN MASS SP, V14, P1337, DOI 10.1002/1097-0231(20000815)14:15<1337::AID-RCM9>3.0.CO;2-B; Mallory JP, 2008, TARIM MUMMIES ANCIEN; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mirabaud S, 2007, ANAL CHEM, V79, P6182, DOI 10.1021/ac070594p; Mottram HR, 1999, J CHROMATOGR A, V833, P209, DOI 10.1016/S0021-9673(98)01041-3; Oudemans TFM, 2007, ARCHAEOMETRY, V49, P571, DOI 10.1111/j.1475-4754.2007.00321.x; Qiu ZW, 2012, ECON BOT, V66, P255, DOI 10.1007/s12231-012-9204-5; Rao HY, 2015, J ARCHAEOL SCI, V53, P148, DOI 10.1016/j.jas.2014.10.010; Regert M, 2011, MASS SPECTROM REV, V30, P177, DOI 10.1002/mas.20271; Romanus K, 2008, ANAL BIOANAL CHEM, V390, P783, DOI 10.1007/s00216-007-1704-2; Schwudke D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004614; Sharma Hari, 2010, Ayu, V31, P134, DOI 10.4103/0974-8520.72361; Sheuchenko A, 2014, J PROTEOMICS, V105, P363, DOI 10.1016/j.jprot.2013.11.016; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 2009, J PROTEOMICS, V72, P137, DOI 10.1016/j.jprot.2009.01.012; Solazzo C., 2007, THEORY PRACTICE ARCH, V1650, P161; Solazzo C, 2008, ANAL CHEM, V80, P4590, DOI 10.1021/ac800515v; Song X, 2003, GAOCHANG KINDOM IMMI; Steele VJ, 2010, RAPID COMMUN MASS SP, V24, P3478, DOI 10.1002/rcm.4790; TOUW M, 1981, J PSYCHOACTIVE DRUGS, V13, P23, DOI 10.1080/02791072.1981.10471447; Twitchett D, 1965, ASIA MAJOR, V11, P211; USDA, 2013, USDA NAT NUTR DAT ST, V26; Valladas H, 2001, NATURE, V413, P479, DOI 10.1038/35097160; Vance SJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0453; Wang W., 2010, RES TRADITIONAL CHIN; Xie MS, 2016, QUATERN INT, V426, P158, DOI 10.1016/j.quaint.2016.04.015; Xin W, 2014, INT J KOREAN HIST, V19, P23, DOI 10.22372/ijkh.2014.19.1.23; Yang YM, 2014, J ARCHAEOL SCI, V45, P178, DOI 10.1016/j.jas.2014.02.005; Zurcher Erik, 2007, BUDDHIST CONQUEST CH, V3rd	57	8	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0158636	10.1371/journal.pone.0158636	http://dx.doi.org/10.1371/journal.pone.0158636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234998	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200001
J	Chung, SD; Kao, LT; Lin, HC; Xirasagar, S; Huang, CC; Lee, HC				Chung, Shiu-Dong; Kao, Li-Ting; Lin, Herng-Ching; Xirasagar, Sudha; Huang, Chung-Chien; Lee, Hsin-Chien			Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder	PLOS ONE			English	Article							LOW TESTOSTERONE LEVELS; CORONARY-HEART-DISEASE; OLDER MEN; BIOAVAILABLE TESTOSTERONE; DIAGNOSIS; ILLNESS; IMPACT; AGE	Androgen deprivation therapy (ADT) results in testosterone suppression, a hypothesized mechanism linking ADT to depressive symptoms. This study investigated the relationship between ADT and the risk of subsequently being diagnosed with depressive disorder (DD) during a 3-year follow-up period. The patient sample for this population-based, retrospective cohort study was retrieved from the Taiwan Longitudinal Health Insurance Database 2005. We included all 1714 patients aged over 40 years with a first-time diagnosis of prostate cancer (PC) during 2001 to 2010 who did not have an orchiectomy. Among them, we defined 868 patients who received ADT during the 3-year follow-up period as the study group, and 846 patients who did not receive ADT as the comparison group. The incidence rates of DD per 1000 person-years were 13.9 (95% confidence interval (CI): 9.5 similar to 19.6) and 6.7 (95% CI: 3.7 similar to 11.0), respectively. Cox proportional hazard regressions showed that the adjusted hazard ratio for DD for ADT recipients was 1.93 (95% CI: 1.03 similar to 3.62) relative to the comparison group. This study presents epidemiological evidence of an association between ADT and a subsequent DD diagnosis.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Kao, Li-Ting; Lin, Herng-Ching; Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Xirasagar, Sudha] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC USA; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; National Defense Medical Center; Taipei Medical University; University of South Carolina System; University of South Carolina Columbia; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Lee, HC (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Lee, HC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan.; Lee, HC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan.	ellalee@tmu.edu.tw	Xirasagar, Sudha/AAA-2350-2022; Huang, CC/AAX-5872-2021; Kao, Li-Ting/W-9287-2018	Huang, CC/0000-0003-0818-7175; Kao, Li-Ting/0000-0003-0692-7408; lee, hsin-chien/0000-0002-7557-8259				Aragon-Ching JB, 2007, FRONT BIOSCI-LANDMRK, V12, P4957, DOI 10.2741/2441; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Casey RG, 2012, ASIAN J ANDROL, V14, P226, DOI 10.1038/aja.2011.108; Chen Allen C, 2004, Curr Oncol Rep, V6, P209, DOI 10.1007/s11912-004-0051-0; Chen HM, 2014, NEUROUROL URODYNAM, V33, P511, DOI 10.1002/nau.22444; Chipperfield K, 2013, PSYCHO-ONCOLOGY, V22, P2169, DOI 10.1002/pon.3269; Chung SD, 2015, ACTA OPHTHALMOL, V93, pE176, DOI 10.1111/aos.12478; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Dinh KT, 2016, J CLIN ONCOL, V34, P1905, DOI 10.1200/JCO.2015.64.1969; Donovan KA, 2015, CANCER-AM CANCER SOC, V121, P4286, DOI 10.1002/cncr.29672; Gray RE, 2000, PSYCHO-ONCOLOGY, V9, P273, DOI 10.1002/1099-1611(200007/08)9:4<273::AID-PON463>3.0.CO;2-F; Hervouet S, 2013, HEALTH PSYCHOL, V32, P675, DOI 10.1037/a0031639; Howlader N., 2016, SEER CANC STAT REV 1; Huang CY, 2011, J AFFECT DISORDERS, V135, P395, DOI 10.1016/j.jad.2011.07.001; Jin C, 2016, PROSTATE CANCER P D, V19, P333, DOI 10.1038/pcan.2016.35; Labrie F, 2004, J ANDROL, V25, P305; Lee M, 2015, PSYCHO-ONCOLOGY, V24, P472, DOI 10.1002/pon.3608; McIntyre RS, 2006, PSYCHONEUROENDOCRINO, V31, P1029, DOI 10.1016/j.psyneuen.2006.06.005; Morgia G, 2016, UROLOGY, V96, P165, DOI 10.1016/j.urology.2016.06.024; Nguyen PL, 2015, EUR UROL, V67, P825, DOI 10.1016/j.eururo.2014.07.010; Pirl WF, 2002, PSYCHO-ONCOLOGY, V11, P518, DOI 10.1002/pon.592; Seidman SN, 2002, AM J PSYCHIAT, V159, P456, DOI 10.1176/appi.ajp.159.3.456; Seidman SN, 1999, AM J GERIAT PSYCHIAT, V7, P18; Shahinian VB, 2006, ARCH INTERN MED, V166, P465; Shores MM, 2005, J CLIN PSYCHIAT, V66, P7, DOI 10.4088/JCP.v66n0102; Shores MM, 2004, ARCH GEN PSYCHIAT, V61, P162, DOI 10.1001/archpsyc.61.2.162; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Timilshina N, 2012, CANCER-AM CANCER SOC, V118, P1940, DOI 10.1002/cncr.26477; Tsai MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129962; Vedhara K., 2005, HUMAN PSYCHONEUROIMM; Wang LH, 2016, ANDROLOGY-US, V4, P128, DOI 10.1111/andr.12141	31	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173266	10.1371/journal.pone.0173266	http://dx.doi.org/10.1371/journal.pone.0173266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253340	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300098
J	Janem, WF; Scannapieco, FA; Sabharwal, A; Tsompana, M; Berman, HA; Haase, EM; Miecznikowski, JC; Mastrandrea, LD				Janem, Waleed F.; Scannapieco, Frank A.; Sabharwal, Amarpeet; Tsompana, Maria; Berman, Harvey A.; Haase, Elaine M.; Miecznikowski, Jeffrey C.; Mastrandrea, Lucy D.			Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes	PLOS ONE			English	Article							NITRIC-OXIDE LEVELS; PERIODONTAL-DISEASE; GLYCEMIC CONTROL; SUBGINGIVAL PLAQUE; METABOLIC SYNDROME; PEDIATRIC OBESITY; CLINICAL-TRIAL; MELLITUS; ASSOCIATION; PREVALENCE	Background There is emerging evidence linking diabetes with periodontal disease. Diabetes is a well recognized risk factor for periodontal disease. Conversely, pro-inflammatory molecules released by periodontally-diseased tissues may enter the circulation to induce insulin resistance. While this association has been demonstrated in adults, there is little information regarding periodontal status in obese children with and without type 2 diabetes (T2D). We hypothesized that children with T2D have higher rates of gingivitis, elevated salivary inflammatory markers, and an altered salivary microbiome compared to children without T2D. Methods Three pediatric cohorts ages 10-19 years were studied: lean (normal weight-C), obese (Ob), and obese with T2D (T2D). Each subject completed an oral health survey, received a clinical oral examination, and provided unstimulated saliva for measurement of inflammatory markers and microbiome analysis. Results The diabetes group was less likely to have had a dental visit within the last six months. Body mass index (BMI) Z-scores and waist circumference/height ratios were similar between Ob and T2D cohorts. The number of carious lesions and fillings were similar for all three groups. The gingival index was greater in the T2D group compared to the Ob and C groups. Although salivary microbial diversity was minimal between groups, a few differences in bacterial genus composition were noted. Conclusions Obese children with T2D show a trend toward poorer oral health compared to normal weight and obese children without T2D. This study characterizes the salivary microbiome of children with and without obesity and T2D. This study supports a modest link between T2D and periodontal inflammation in the pediatric population.	[Janem, Waleed F.; Mastrandrea, Lucy D.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14228 USA; [Scannapieco, Frank A.; Sabharwal, Amarpeet; Haase, Elaine M.] Univ Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY USA; [Tsompana, Maria] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Berman, Harvey A.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, Buffalo, NY USA; [Miecznikowski, Jeffrey C.] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mastrandrea, LD (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14228 USA.	ldm@buffalo.edu	Scannapieco, Frank A./AAE-1584-2020; Haase, Elaine/G-8634-2016	Scannapieco, Frank A./0000-0002-8804-6593; Haase, Elaine/0000-0002-8169-0319; Tsompana, Maria/0000-0001-7546-3198	Endocrine Fellows Foundation; Colgate-Palmolive	Endocrine Fellows Foundation; Colgate-Palmolive	This work was supported by: Endocrine Fellows Foundation http://www.endocrinefellows.org/ (WFJ). This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. And by Colgate-Palmolive http://www.colgateprofessional.com/research (FAS, LDM). This funder had no role in the study design, data collection and analysis, or preparation of the manuscript. They did review the manuscript prior to submission for publication but made no revisions to the manuscript.	[Anonymous], 2014, PEDIATRICS, V134, P1224, DOI 10.1542/peds.2014-2984; [Anonymous], 2016, MIS REP GEN FASTQ WO; [Anonymous], 2016, COMPLEX200 V6 DSP PR; [Anonymous], HOMD 16S RRNA GENE S; Barnes VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105181; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Califano Joseph V, 2005, Pediatr Dent, V27, P189; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chee B, 2013, INT J EVID-BASED HEA, V11, P317, DOI 10.1111/1744-1609.12038; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chukkapalli SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143291; Crocker MK, 2011, PEDIATR CLIN N AM, V58, P1217, DOI 10.1016/j.pcl.2011.07.004; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Demmer RT, 2015, J DENT RES, V94, p201S, DOI 10.1177/0022034515590369; Edblad E, 2001, SWED DENT J, V25, P53; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Franchini R, 2011, J CLIN PERIODONTOL, V38, P1021, DOI 10.1111/j.1600-051X.2011.01770.x; Ge XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065520; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Gursoy UK, 2015, J DIABETES, V7, P681, DOI 10.1111/1753-0407.12228; Illumina, 16S MET SEQ LIB PREP; Javed F, 2014, J INVESTIG CLIN DENT, V5, P1, DOI 10.1111/jicd.12066; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Katagiri S, 2012, J DIABETES INVEST, V3, P402, DOI 10.1111/j.2040-1124.2012.00209.x; Katz J, 2011, QUINTESSENCE INT, V42, P595; Khorsavi Samani M, 2012, Minerva Stomatol, V61, P443; Kim EK, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-64; Knight ET, 2016, PERIODONTOL 2000, V71, P22, DOI 10.1111/prd.12110; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Lal S, 2007, PEDIATR DENT, V29, P426; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Nascimento GG, 2015, J CLIN PERIODONTOL; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ouellet-Morin I, 2011, BRAIN BEHAV IMMUN, V25, P640, DOI 10.1016/j.bbi.2010.12.020; Parwani SR, 2012, INT J DENT HYG, V10, P67, DOI 10.1111/j.1601-5037.2011.00508.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rai K, 2011, J CLIN PEDIATR DENT, V36, P181, DOI 10.17796/jcpd.36.2.x436ln878221g364; RAMS TE, 1993, J CLIN PERIODONTOL, V20, P147, DOI 10.1111/j.1600-051X.1993.tb00330.x; RCore Team, 2020, R LANG ENV STAT COMP; Riis JL, 2014, DEV PSYCHOBIOL, V56, P797, DOI 10.1002/dev.21149; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shojaee M, 2013, INT J MOL CELL MED, V2, P151; Singh S, 2008, INT J DIABETES DEV C, V28, P38, DOI 10.4103/0973-3930.43097; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Spooner R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33638; Stewart JE, 2001, J CLIN PERIODONTOL, V28, P306, DOI 10.1034/j.1600-051x.2001.028004306.x; Sundar NM, 2013, J CLIN DIAGN RES, V7, P1223, DOI 10.7860/JCDR/2013/5386.3068; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tremblay M, 2011, J CAN DENT ASSOC, V77, P1; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	65	38	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172647	10.1371/journal.pone.0172647	http://dx.doi.org/10.1371/journal.pone.0172647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253297	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300025
J	Kadhel, P; Costet, N; Toto, T; Janky, E; Multigner, L				Kadhel, Philippe; Costet, Nathalie; Toto, Teddy; Janky, Eustase; Multigner, Luc			The annual carnival in Guadeloupe (French West Indies) is associated with an increase in the number of conceptions and subsequent births nine months later: 2000-2011	PLOS ONE			English	Article							SEASONAL-VARIATION; REPRODUCTIVE HEALTH; YOUNG-ADULTS; TIME-SERIES; PATTERNS; RATIO; WOMEN	The seasonal patterns of conceptions and births differ between geographic areas. Several potential determinants of this variation have been identified, including biological, environmental and behavioral elements, but festive events are rarely mentioned. We investigated the possible association between the carnival and seasonal fertility variations in the French West Indies. We ran a retrospective registry-based study. The data were extracted from the registry of all births on Guadeloupe between 2000 and 2011 (n = 74,412), and from the Maternity Birth Register of the University Hospital, for all pregnancies of at least 14 completed weeks of gestation (observable conceptions) with an outcome recorded between 2007 and 2010 (n = 8,425). We compared data during and outside the carnival period for each year, including 2009, when there was no carnival due to a 44-day general strike. In all years other than 2009, the weekly number of births was higher for pregnancies initiated during the carnival period than for pregnancies initiated at other times, and the weekly number of observable conceptions was higher during the carnival period than at other times. Our findings support the hypothesis that carnivals in the French West Indies are associated with an increase in the number of conceptions and subsequent births.	[Kadhel, Philippe; Toto, Teddy; Janky, Eustase] Ctr Hosp, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe; Toto, Teddy; Janky, Eustase] Univ Pointe A Pitre Abymes, Pole Parent Enfant, Serv Gynecol & Obstet, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe] Univ Antilles, Campus Fouillole, Pointe A Pitre, Guadeloupe, France; [Kadhel, Philippe; Costet, Nathalie; Multigner, Luc] INSERM, U1085, IRSET, Rennes, France; [Costet, Nathalie; Multigner, Luc] Univ Rennes 1, Rennes, France	CHU Guadeloupe; Universite des Antilles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Kadhel, P (corresponding author), Ctr Hosp, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), Univ Pointe A Pitre Abymes, Pole Parent Enfant, Serv Gynecol & Obstet, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), Univ Antilles, Campus Fouillole, Pointe A Pitre, Guadeloupe, France.; Kadhel, P (corresponding author), INSERM, U1085, IRSET, Rennes, France.	philippe.kadhel@orange.fr	Multigner, Luc/I-2926-2015; Multigner, Luc/AAA-6214-2020	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; Costet, Nathalie/0000-0002-3706-4812; Kadhel, Philippe/0000-0001-8759-6895				BECKER S, 1991, ADV EXP MED BIOL, V286, P59; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; BRONSON FH, 1995, Q REV BIOL, V70, P141, DOI 10.1086/418980; Cheng C, 2013, PSYCHIAT CLIN NEUROS, V67, P426, DOI 10.1111/pcn.12076; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dorelien AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075806; Ellison PT, 2005, CAM S BIO EVOL ANTHR, V44, P379, DOI 10.1017/CBO9780511542343.014; Friger M, 2009, HUM REPROD, V24, P1492, DOI 10.1093/humrep/dep040; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Fukuda M, 1996, HUM REPROD, V11, P1244; Hawe E, 2015, HLTH STAT Q, V9, P5; Jasienska G, 2004, AM J HUM BIOL, V16, P563, DOI 10.1002/ajhb.20063; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; LAM DA, 1994, ANN NY ACAD SCI, V709, P9, DOI 10.1111/j.1749-6632.1994.tb30385.x; Passos MRL, 2010, REV ASSOC MED BRAS, V56, P420, DOI 10.1590/S0104-42302010000400014; Leridon H., 1986, POPULATION, V41, P559; Levine RJ, 1999, SCAND J WORK ENV HEA, V25, P34; Liu SJ, 2010, INT J GYNECOL OBSTET, V108, P161, DOI 10.1016/j.ijgo.2009.08.030; Luteijn JM, 2014, BIRTH DEFECTS RES A, V100, P260, DOI 10.1002/bdra.23231; Masukume G, 2016, EARLY HUM DEV, V97, P11, DOI 10.1016/j.earlhumdev.2015.12.002; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Regnier-Loilier A, 2011, POPUL SOC, V474, P1; Rodgers JL, 2005, DEMOGRAPHY, V42, P675, DOI 10.1353/dem.2005.0034; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-66; THOMPSON RW, 1973, AM ANTHROPOL, V75, P676, DOI 10.1525/aa.1973.75.3.02a00030; Tong V, 2011, MATERN CHILD HLTH J, V15, P281, DOI 10.1007/s10995-010-0576-9; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; UDRY JR, 1970, DEMOGRAPHY, V7, P325, DOI 10.2307/2060151; Vaiserman AM, 2007, DIABETOLOGIA, V50, P32, DOI 10.1007/s00125-006-0456-4; van Laar M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-365; World Health Organization, 2004, ICD1O WHO	35	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173102	10.1371/journal.pone.0173102	http://dx.doi.org/10.1371/journal.pone.0173102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253323	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300075
J	Ottman, N; Reunanen, J; Meijerink, M; Pietila, TE; Kainulainen, V; Klievink, J; Huuskonen, L; Aalvink, S; Skurnik, M; Boeren, S; Satokari, R; Mercenier, A; Palva, A; Smidt, H; de Vos, WM; Belzer, C				Ottman, Noora; Reunanen, Justus; Meijerink, Marjolein; Pietila, Taija E.; Kainulainen, Veera; Klievink, Judith; Huuskonen, Laura; Aalvink, Steven; Skurnik, Mikael; Boeren, Sjef; Satokari, Reetta; Mercenier, Annick; Palva, Airi; Smidt, Hauke; de Vos, Willem M.; Belzer, Clara			Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function	PLOS ONE			English	Article							INTESTINAL EPITHELIUM; BACTEROIDES-FRAGILIS; ULCERATIVE-COLITIS; GEN. NOV.; MUCIN; MICROBIOTA; BACTERIA; ENTEROCYTES; INFECTION; ADHERES	Gut barrier function is key in maintaining a balanced response between the host and its microbiome. The microbiota can modulate changes in gut barrier as well as metabolic and inflammatory responses. This highly complex system involves numerous microbiota-derived factors. The gut symbiont Akkermansia muciniphila is positively correlated with a lean phenotype, reduced body weight gain, amelioration of metabolic responses and restoration of gut barrier function by modulation of mucus layer thickness. However, the molecular mechanisms behind its metabolic and immunological regulatory properties are unexplored. Herein, we identify a highly abundant outer membrane pili-like protein of A. muciniphila MucT that is directly involved in immune regulation and enhancement of trans-epithelial resistance. The purified Amuc_1100 protein and enrichments containing all its associated proteins induced production of specific cytokines through activation of Toll-like receptor (TLR) 2 and TLR4. This mainly leads to high levels of IL-10 similar to those induced by the other beneficial immune suppressive microorganisms such as Faecalibacterium prausnitzii A2-165 and Lactobacillus plantarum WCFS1. Together these results indicate that outer membrane protein composition and particularly the newly identified highly abundant pili-like protein Amuc_1100 of A. muciniphila are involved in host immunological homeostasis at the gut mucosa, and improvement of gut barrier function.	[Ottman, Noora; Aalvink, Steven; de Vos, Willem M.; Belzer, Clara] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Ottman, Noora] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ottman, Noora] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Reunanen, Justus] Bioctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland; [Reunanen, Justus] Univ Oulu, Fac Med, Oulu, Finland; [Meijerink, Marjolein; Mercenier, Annick] Wageningen Univ, Anim Sci, Host Microbe Interact, Wageningen, Netherlands; [Meijerink, Marjolein] TNO, Dept Risk Anal Prod Dev, Zeist, Netherlands; [Pietila, Taija E.; Huuskonen, Laura; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Kainulainen, Veera] Univ Helsinki, Pharmacol, Fac Med, Helsinki, Finland; [Klievink, Judith; Skurnik, Mikael; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Klievink, Judith; Skurnik, Mikael; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Klievink, Judith] Univ Helsinki, Hematol Res Unit Helsinki, Helsinki, Finland; [Klievink, Judith] Helsinki Univ Hosp, Dept Hematol, Ctr Comprehens Canc, Helsinki, Finland; [Skurnik, Mikael] Helsinki Univ Cent Hosp, Diagnost Lab, Helsinki, Finland; [Boeren, Sjef] Wageningen Univ, Biochem Lab, Wageningen, Netherlands	Wageningen University & Research; University of Helsinki; Karolinska Institutet; University of Oulu; University of Oulu; Wageningen University & Research; Netherlands Organization Applied Science Research; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Wageningen University & Research	Belzer, C (corresponding author), Wageningen Univ, Microbiol Lab, Wageningen, Netherlands.	clara.belzer@wur.nl	Belzer, Clara/P-6500-2018; Smidt, Hauke/D-7054-2014; Skurnik, Mikael/I-8477-2019; Kainulainen, Veera/P-6166-2018; Ottman, Noora/C-2225-2018	Belzer, Clara/0000-0001-6922-836X; Smidt, Hauke/0000-0002-6138-5026; Skurnik, Mikael/0000-0001-8791-9260; Kainulainen, Veera/0000-0002-4557-9605; Aalvink, Steven/0000-0001-7554-1723; Satokari, Reetta/0000-0002-4258-3414; Huuskonen, Laura/0000-0001-6914-0712; Ottman, Noora/0000-0001-5011-9294	European Research Council [250172]; Netherlands Organization for Scientific Research (NWO); European Community [215553-2]; Finland Academy of Sciences [138902, 258439, 252803, 141130]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Finland Academy of Sciences	This work was supported by Advanced Research Grant 250172 (MicrobesInside) of the European Research Council (https://erc.europa.eu/) to WMdV, the Gravity (SIAM) and Spinoza grants of the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl/en) to WMdV, the European Community's Seventh Framework Programme (FP7/2007-2013, https://ec.europa.eu/research/fp7/) under grant agreement no215553-2 to NO, and the Finland Academy of Sciences (http://www.aka.fi/en) (138902 & 258439 to RS, 252803 to JR, 141130 to WMdV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhawi M, 2009, J MED MICROBIOL, V58, P1015, DOI 10.1099/jmm.0.009936-0; Belzer C, 2011, EUR J MICROBIOL IMMU, V1, P311, DOI 10.1556/EuJMI.1.2011.4.7; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2016, MICROBIAL PATHOGENES; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Geens MM, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/469583; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Hartmann P, 2013, HEPATOLOGY, V58, P108, DOI 10.1002/hep.26321; James SL, 2015, GUT, V64, P562, DOI 10.1136/gutjnl-2014-307198; Kainulainen V, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0337-9; Kainulainen V, 2013, APPL ENVIRON MICROB, V79, P6989, DOI 10.1128/AEM.01993-13; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; Kant R, 2014, J MED MICROBIOL, V63, P293, DOI 10.1099/jmm.0.064220-0; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Kuhn KA, 2013, SEMIN IMMUNOL, V25, P364, DOI 10.1016/j.smim.2013.10.002; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Ottman N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01157; Peran L, 2005, WORLD J GASTROENTERO, V11, P5185; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rescigno M, 2013, BEST PRACT RES CL GA, V27, P17, DOI 10.1016/j.bpg.2013.03.004; Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14; Rupakula A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0325; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Vigsnaes LK, 2012, BENEF MICROBES, V3, P287, DOI 10.3920/BM2012.0018; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	44	201	218	13	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173004	10.1371/journal.pone.0173004	http://dx.doi.org/10.1371/journal.pone.0173004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249045	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500069
J	Ropars, J; Lopez-Villavicencio, M; Snirc, A; Lacoste, S; Giraud, T				Ropars, Jeanne; Lopez-Villavicencio, Manuela; Snirc, Alodie; Lacoste, Sandrine; Giraud, Tatiana			Blue cheese-making has shaped the population genetic structure of the mould Penicillium roqueforti	PLOS ONE			English	Article							SOFTWARE; FUNGI	Background Penicillium roqueforti is a filamentous fungus used for making blue cheeses worldwide. It also occurs as a food spoiler and in silage and wood. Previous studies have revealed a strong population genetic structure, with specific traits associated with the different populations. Here, we used a large strain collection from worldwide cheeses published recently to investigate the genetic structure of P. roqueforti. Principal findings We found a genetic population structure in P. roqueforti that was consistent with previous studies, with two main genetic clusters (W+C+and W-C-, i.e., with and without horizontal gene transferred regions CheesyTer and Wallaby). In addition, we detected a finer genetic subdivision that corresponded to the environment and to protected designation of origin (PDO), namely the Roquefort PDO. We indeed found evidence for eight genetic clusters, one of the cluster including only strains from other environments than cheeses, and another cluster encompassing only strains from the Roquefort PDO. The W-C-and W+C+cheese clusters were not the most closely related ones, suggesting that there may have been two independent domestication events of P. roqueforti for making blue cheeses. Significance The additional population structure revealed here may be relevant for cheese-makers and for understanding the history of domestication in P. roqueforti.	[Ropars, Jeanne; Lopez-Villavicencio, Manuela; Lacoste, Sandrine] UPMC, Museum Natl Hist Nat, EPHE, UMR CNRS 7205,Inst Systemat Evolut Biodiversite, Paris, France; [Ropars, Jeanne; Snirc, Alodie; Giraud, Tatiana] Univ Paris Saclay, Univ Paris Sud, AgroParisTech, CNRS,Ecol Systemat Evolut, Orsay, France; [Ropars, Jeanne] INRA, Dept Mycol, Fungal Biol & Pathogen Unit, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE	Giraud, T (corresponding author), Univ Paris Saclay, Univ Paris Sud, AgroParisTech, CNRS,Ecol Systemat Evolut, Orsay, France.	tatiana.giraud@u-psud.fr		Giraud, Tatiana/0000-0002-2685-6478	ERC grant GenomeFun [309403]	ERC grant GenomeFun	This work has been funded by the ERC grant GenomeFun 309403 granted to TG (https://erc.europa.eu/). These funding sourced have covered the salary of JR, as well as all laboratory costs and genotyping analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gillot G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129849; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Labbe M., 2009, CHRONIQUES ROQUEFORT; Labbe M, 2004, GRAPHI IMPRIMEUR; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P401, DOI 10.1007/978-0-387-92207-2_12; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ropars J, 2014, MICROB CELL, P1; Ropars J, 2016, EVOLUTION; Ropars J, 2015, CURR BIOL, V25, P2562, DOI 10.1016/j.cub.2015.08.025; Ropars J, 2014, EVOL APPL, V7, P433, DOI 10.1111/eva.12140; Ropars J, 2012, INT J FOOD MICROBIOL, V155, P199, DOI 10.1016/j.ijfoodmicro.2012.02.005; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Samson RA, 2000, INTRO FOOD AIRBORNE; Yang YM, 2014, J ARCHAEOL SCI, V45, P178, DOI 10.1016/j.jas.2014.02.005	22	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171387	10.1371/journal.pone.0171387	http://dx.doi.org/10.1371/journal.pone.0171387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248964	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500012
J	Tseng, CM; Lin, IC; Chang, CY; Wang, HP; Chen, CC; Mo, LR; Lin, JT; Tai, CM				Tseng, Chao-Ming; Lin, I-Chang; Chang, Chi-Yang; Wang, Hsiu-Po; Chen, Chih-Cheng; Mo, Lein-Ray; Lin, Jaw-Town; Tai, Chi-Ming			Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding	PLOS ONE			English	Article							DOUBLE-BALLOON ENDOSCOPY; CT ENTEROCLYSIS; CAPSULE ENDOSCOPY; ENTEROSCOPY; ENTEROGRAPHY; DIAGNOSIS; METAANALYSIS; EXPERIENCE	Background and aim The role of computed tomography angiography (CTA) on the management of acute overt obscure gastrointestinal bleeding (OGIB) remains unclear. We designed a study to evaluate the impact of CTA before enteroscopy for acute overt OGIB. Methods All patients undergoing CTA followed by enteroscopy for acute overt OGIB were enrolled in this retrospective study. Clinical characteristics and diagnosis were compared between patients with positive and negative CTA findings. We evaluated the impact of CTA on subsequent enteroscopy. Results From February 2008 to March 2015, 71 patients including 25 patients with positive CTA findings and 46 patients with negative CTA findings, were enrolled. All 25 patients with positive CTA findings were confirmed to have mid GI lesions, a significantly higher proportion than among patients with negative CTA findings (100% vs. 52.2%, respectively; P < 0.001). CTA had a higher diagnostic yield for bleeding from tumor origin than from non-tumor origin (80.0% vs. 23.7%, respectively; P < 0.001). The diagnostic yield of CTA and enteroscopy was 35.2% and 73.2%, respectively. The lesions could be identified by the initial route of enteroscopy in more patients with positive CTA findings than in those with negative CTA findings (92.0% vs. 47.8%, respectively; P < 0.001). Lesions could be identified in seven of the 25 patients (28.0%) with positive CTA findings by using only push enteroscopy instead of single-balloon enteroscopy (SBE), but all 46 patients with negative CTA findings needed SBE for deep small-bowel examination. Conclusions CTA is useful in the diagnosis of acute overt OGIB, especially in patients with bleeding from tumors. In addition, it also can show the precise location of bleeding, and guide subsequent enteroscopic management.	[Tseng, Chao-Ming; Chang, Chi-Yang; Chen, Chih-Cheng; Mo, Lein-Ray; Lin, Jaw-Town; Tai, Chi-Ming] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tseng, Chao-Ming; Wang, Hsiu-Po; Chen, Chih-Cheng; Tai, Chi-Ming] Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan; [Lin, I-Chang] I Shou Univ, E Da Hosp, Dept Radiol, Kaohsiung, Taiwan; [Wang, Hsiu-Po] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Mo, Lein-Ray] Tainan Municipal Hosp, Div Gastroenterol, Tainan, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Fu Jen Catholic University	Tai, CM (corresponding author), I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Tai, CM (corresponding author), Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan.	chimingtai@gmail.com	CHEN, CHIH-CHENG/L-6568-2019	CHEN, CHIH-CHENG/0000-0003-0266-1534	E-Da Hospital, Taiwan [EDAHI105041]	E-Da Hospital, Taiwan	This study was supported by research grant from the E-Da Hospital, Taiwan (EDAHI105041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Concha R, 2007, J CLIN GASTROENTEROL, V41, P242, DOI 10.1097/01.mcg.0000225616.79223.75; Ell C, 2006, ENDOSCOPY, V38, P73, DOI 10.1055/s-2005-921131; Filippone A, 2008, ABDOM IMAGING, V33, P398, DOI 10.1007/s00261-007-9271-8; Fisher L, 2010, GASTROINTEST ENDOSC, V72, P471, DOI 10.1016/j.gie.2010.04.032; Gerson L, 2008, GASTROINTEST ENDOSC, V68, P920, DOI 10.1016/j.gie.2008.01.035; Gerson LB, 2015, AM J GASTROENTEROL, V110, P1265, DOI 10.1038/ajg.2015.246; Huprich JE, 2008, RADIOLOGY, V246, P562, DOI 10.1148/radiol.2462061920; Kamaoui I, 2010, AM J ROENTGENOL, V194, P629, DOI 10.2214/AJR.09.2760; Kulkarni Chinmay, 2012, Indian J Radiol Imaging, V22, P47, DOI 10.4103/0971-3026.95404; Lee SS, 2011, RADIOLOGY, V259, P739, DOI 10.1148/radiol.11101936; Ohmiya N, 2007, GASTROINTEST ENDOSC, V66, pS72, DOI 10.1016/j.gie.2007.05.041; Ohmiya N, 2015, DIGEST ENDOSC, V27, P285, DOI 10.1111/den.12423; Robles EPC, 2015, DIGEST ENDOSC, V27, P338, DOI 10.1111/den.12384; Pilleul F, 2006, RADIOLOGY, V241, P796, DOI 10.1148/radiol.2413051429; Pinto-Pais T, 2014, UNITED EUR GASTROENT, V2, P490, DOI 10.1177/2050640614554850; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Shim KN, 2013, CLIN ENDOSC, V46, P45, DOI 10.5946/ce.2013.46.1.45; SOS TA, 1978, AM J ROENTGENOL, V131, P1015, DOI 10.2214/ajr.131.6.1015; Tanaka S, 2008, GASTROINTEST ENDOSC, V68, P683, DOI 10.1016/j.gie.2008.03.1062; Wang Z, 2013, J MED IMAG RADIAT ON, V57, P263, DOI 10.1111/1754-9485.12035; Wu LM, 2010, WORLD J GASTROENTERO, V16, P3957, DOI 10.3748/wjg.v16.i31.3957; Xin L, 2011, GASTROINTEST ENDOSC, V74, P563, DOI 10.1016/j.gie.2011.03.1239; Yen HH, 2012, WORLD J GASTROENTERO, V18, P692, DOI 10.3748/wjg.v18.i7.692; Zhang BL, 2010, J GASTROEN HEPATOL, V25, P75, DOI 10.1111/j.1440-1746.2009.06016.x; Zhang BL, 2009, WORLD J GASTROENTERO, V15, P5740, DOI 10.3748/wjg.15.5740	25	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172754	10.1371/journal.pone.0172754	http://dx.doi.org/10.1371/journal.pone.0172754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248993	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500056
J	Benevenuto, RF; Agapito-Tenfen, SZ; Vilperte, V; Wikmark, OG; van Rensburg, PJ; Nodari, RO				Benevenuto, Rafael Fonseca; Agapito-Tenfen, Sarah Zanon; Vilperte, Vinicius; Wikmark, Odd-Gunnar; van Rensburg, Peet Jansen; Nodari, Rubens Onofre			Molecular responses of genetically modified maize to abiotic stresses as determined through proteomic and metabolomic analyses	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; GENE-EXPRESSION; DROUGHT STRESS; INORGANIC PYROPHOSPHATASE; INTERROGATE ALTERATIONS; SELF-INCOMPATIBILITY; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; MODIFIED CROPS; XYLEM SAP	Some genetically modified (GM) plants have transgenes that confer tolerance to abiotic stressors. Meanwhile, other transgenes may interact with abiotic stressors, causing pleiotropic effects that will affect the plant physiology. Thus, physiological alteration might have an impact on the product safety. However, routine risk assessment (RA) analyses do not evaluate the response of GM plants exposed to different environmental conditions. Therefore, we here present a proteome profile of herbicide-tolerant maize, including the levels of phytohormones and related compounds, compared to its near-isogenic non-GM variety under drought and herbicide stresses. Twenty differentially abundant proteins were detected between GM and non-GM hybrids under different water deficiency conditions and herbicide sprays. Pathway enrichment analysis showed that most of these proteins are assigned to energetic/carbohydrate metabolic processes. Among phytohormones and related compounds, different levels of ABA, CA, JA, MeJA and SA were detected in the maize varieties and stress conditions analysed. In pathway and proteome analyses, environment was found to be the major source of variation followed by the genetic transformation factor. Nonetheless, differences were detected in the levels of JA, MeJA and CA and in the abundance of 11 proteins when comparing the GM plant and its non-GM near-isogenic variety under the same environmental conditions. Thus, these findings do support molecular studies in GM plants Risk Assessment analyses.	[Benevenuto, Rafael Fonseca; Vilperte, Vinicius; Nodari, Rubens Onofre] Univ Fed Santa Catarina, Dept Crop Sci, Florianopolis, SC, Brazil; [Benevenuto, Rafael Fonseca; Agapito-Tenfen, Sarah Zanon; Wikmark, Odd-Gunnar] Genok Ctr Biosafety, Tromso, Norway; [Benevenuto, Rafael Fonseca] Western Norway Univ Appl Siences, Dept Engn & Nat Sci, Sogndal, Norway; [Wikmark, Odd-Gunnar] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [van Rensburg, Peet Jansen] North West Univ, Human Metabol, Potchefstroom, South Africa; [Vilperte, Vinicius] Leibniz Univ Hannover, Fac Nat Sci, Inst Plant Genet, Hannover, Germany	Universidade Federal de Santa Catarina (UFSC); North West University - South Africa; North West University - South Africa; Leibniz University Hannover	Benevenuto, RF (corresponding author), Univ Fed Santa Catarina, Dept Crop Sci, Florianopolis, SC, Brazil.; Benevenuto, RF (corresponding author), Genok Ctr Biosafety, Tromso, Norway.; Benevenuto, RF (corresponding author), Western Norway Univ Appl Siences, Dept Engn & Nat Sci, Sogndal, Norway.	rafaelb@hvl.no	Nodari, Rubens O/B-7006-2014; Agapito-Tenfen, Sarah/AAB-8998-2020	Nodari, Rubens O/0000-0002-8884-2426; Agapito-Tenfen, Sarah/0000-0002-9773-0856; Jansen van Rensburg, Peet/0000-0001-6911-1866; Vilperte, Vinicius/0000-0002-5741-8016; Wikmark, Odd-Gunnar/0000-0002-8005-138X	CAPES; CNPq; Norwegian Agency for Development Cooperation (Ministry of Foreign Affairs, Norway) under the GenOk South-America Research Hub grant [FAPEU 077/2012]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Norwegian Agency for Development Cooperation (Ministry of Foreign Affairs, Norway) under the GenOk South-America Research Hub grant	The authors would like to thank CAPES for scholarships provided to RB and CNPq for the scholarship to VV and RON. Financial support was provided by The Norwegian Agency for Development Cooperation (Ministry of Foreign Affairs, Norway) under the GenOk South-America Research Hub grant FAPEU 077/2012. The authors also thank the Metabolomic Centre of the Department of Biochemistry (North-West University, South Africa) for quantitative analysis of phytohormones and related compounds. This was a joint project between UFSC and GenOk - Center for Biosafety.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Agapito-Tenfen SZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0346-8; Agapito-Tenfen SZ, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-46; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Ahsan N, 2008, PLANT PHYSIOL BIOCH, V46, P1062, DOI 10.1016/j.plaphy.2008.07.002; Ahsan N, 2010, CHEMOSPHERE, V78, P224, DOI 10.1016/j.chemosphere.2009.11.004; AHTEG:, 2010, GUID DOC RISK ASS LI; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Anttonen MJ, 2010, J PROTEOME RES, V9, P6160, DOI 10.1021/pr100251p; Aumaitre LA, 2002, PROD ANIM, V15, P97; Balsamo GM, 2011, J AGR FOOD CHEM, V59, P11553, DOI 10.1021/jf202635r; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Behr C, 2004, United States patent application, Patent No. [US 10/919,423, 10919423]; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Bohn T, 2014, FOOD CHEM, V153, P207, DOI 10.1016/j.foodchem.2013.12.054; Borsani O, 2001, PLANT SCI, V161, P757, DOI 10.1016/S0168-9452(01)00467-8; Budak H, 2013, PLANT MOL BIOL, V83, P89, DOI 10.1007/s11103-013-0024-5; Castan M, 2016, ANAL GENETIC STABILI, P1; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2011, TRANSGENIC RES, V20, P939, DOI 10.1007/s11248-010-9453-y; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Cuhra M, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-015-0052-7; Davies H., 2010, Food Control, V21, P1601; de Graaf BHJ, 2006, NATURE, V444, P490, DOI 10.1038/nature05311; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Dodd IC, 2003, J PLANT GROWTH REGUL, V22, P32, DOI 10.1007/s00344-003-0023-x; Dogramaci M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1627-9; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Fang YZ, 2015, PESTIC BIOCHEM PHYS, V125, P45, DOI 10.1016/j.pestbp.2015.06.003; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Franz J. E., 1997, GLYPHOSATE UNIQUE GL; Fukuda A, 2006, PLANT PHYSIOL BIOCH, V44, P351, DOI 10.1016/j.plaphy.2006.06.012; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Goodger JQD, 2005, J EXP BOT, V56, P2389, DOI 10.1093/jxb/eri231; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; Gurian-Sherman D, 2012, HIGH DRY WHY GENETIC; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Heinemann JA, 2011, ENVIRON INT, V37, P1285, DOI 10.1016/j.envint.2011.05.006; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; ISHITANI M, 1995, PLANT MOL BIOL, V27, P307, DOI 10.1007/BF00020185; Kohzuma K, 2005, P 14 INT C PHOT FUND, V1, P8; Kohzuma K, 2009, PLANT CELL ENVIRON, V32, P209, DOI 10.1111/j.1365-3040.2008.01912.x; Kok EJ, 2008, REGUL TOXICOL PHARM, V50, P98, DOI 10.1016/j.yrtph.2007.09.007; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Lawlor DW, 2009, ANN BOT; Lehtimaki N, 2010, J PLANT PHYSIOL, V167, P1018, DOI 10.1016/j.jplph.2010.02.006; Marasco Erin K., 2007, P1, DOI 10.1007/978-1-4020-6031-1_1; Meng C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-162; Mesnage R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37855; Munoz-Mayor A, 2008, PHYSIOL PLANTARUM, V133, P288, DOI [10.1111/j.1399-3054.2008.01060.x, 10.1111/j.1399-3054.2008.01063.x]; Nilo R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-43; OSMOND CB, 1995, J EXP BOT, V46, P1351, DOI 10.1093/jxb/46.special_issue.1351; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Parvaiz Ahmad, 2012, African Journal of Biotechnology, V11, P2694, DOI 10.5897/AJB11.3203; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104; Rudd JJ, 2003, J EXP BOT, V54, P141, DOI 10.1093/jxb/54.380.141; Ruebelt MC, 2006, J AGR FOOD CHEM, V54, P2169, DOI 10.1021/jf052358q; Ruebelt MC, 2006, J AGR FOOD CHEM, V54, P2162, DOI 10.1021/jf052357y; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Seralini GE, 2007, ARCH ENVIRON CON TOX, V52, P596, DOI 10.1007/s00244-006-0149-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; van Dijk JP, 2010, REGUL TOXICOL PHARM, V58, pS21, DOI 10.1016/j.yrtph.2010.06.012; Vera-Estrella R, 2014, J PROTEOMICS, V111, P113, DOI 10.1016/j.jprot.2014.05.018; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Vorasoot N., 2003, SONGKLANAKARIN J SCI, V25, P283; Wilhite DA, 2007, WATER RESOUR MANAG, V21, P763, DOI 10.1007/s11269-006-9076-5; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zablotowicz RM, 2004, J ENVIRON QUAL, V33, P825, DOI 10.2134/jeq2004.0825; Zhang G, 2009, J EXP BOT; Zolla L, 2008, J PROTEOME RES, V7, P1850, DOI 10.1021/pr0705082	94	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173069	10.1371/journal.pone.0173069	http://dx.doi.org/10.1371/journal.pone.0173069			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245233	Green Published, gold			2022-12-27	WOS:000395980200052
J	Islam, S; Dasgupta, H; Roychowdhury, A; Bhattacharya, R; Mukherjee, N; Roy, A; Mandal, GK; Alam, N; Biswas, J; Mandal, S; Roychoudhury, S; Panda, CK				Islam, Saimul; Dasgupta, Hemantika; Roychowdhury, Anirban; Bhattacharya, Rittwika; Mukherjee, Nupur; Roy, Anup; Mandal, Gautam Kumar; Alam, Neyaz; Biswas, Jaydip; Mandal, Shyamsundar; Roychoudhury, Susanta; Panda, Chinmay Kumar			Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LONG CONTROL REGION; CERVICAL-CANCER; METHYLATION PATTERNS; PHYSICAL STATUS; NECK-CANCER; HIGH-RISK; TYPE-16; DNA; WOMEN	Objectives Human papillomavirus (HPV) causes tumors primarily Cervical cancer. Recently, inconsistent reports came up in Breast cancer (BC) too. In India, despite treatment 70,218 BC patients die each year. So, we explored the association of HPV, if any, with BC prognosis in Indian pre-therapeutic (PT) and Neo-adjuvant chemotherapy (NACT) patients with subsequent analysis of HPV profile. Methods HPV prevalence was checked and analysis of physical status, copy number, genome variation, promoter methylation and expression (mRNA and protein) of the prevalent subtype was done. Results High prevalence of HPV was observed in both PT (64.0%) and NACT (71.0%) cases with significant association with younger (20-45 yrs) PT patients. Interestingly, HPV infection was significantly increased from adjacent normal breast (9.5%, 2/21), fibro adenomas (30%, 3/10) to tumors (64.8%, 203/313) samples. In both PT and NACT cases, HPV16 was the most prevalent subtype (69.0%) followed by HPV18 and HPV33. Survival analysis illustrated hrHPV infected PT patients had worst prognosis. So, detailed analysis of HPV16 profile was done which showed Europian-G350 as the most frequent HPV16 variant along with high rate of integration. Moreover, low copy number and hyper-methylation of P97 early promoter were concordant with low HPV16 E6 and E7 mRNA and protein expression. Notably, four novel variations (KT020838, KT020840, KT020841 and KT020839) in the LCR region and two (KT020836 and KT020837) in the E6 region were identified for the first time along with two novel E6(boolean AND)E7*I (KU199314) and E6(boolean AND)E7*II (KU199315) fusion transcript variants. Conclusion Thus, significant association of hrHPV with prognosis of Indian BC patients led to additional investigation of HPV16 profile. Outcomes indicated a plausible role of HPV in Indian BC patients.	[Islam, Saimul; Dasgupta, Hemantika; Roychowdhury, Anirban; Bhattacharya, Rittwika; Mukherjee, Nupur; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, W Bengal, India; [Roy, Anup] North Bengal Med Coll & Hosp, Dept Pathol, Darjeeling, W Bengal, India; [Mandal, Gautam Kumar] Chittaranjan Natl Canc Inst, Dept Pathol, Kolkata, W Bengal, India; [Alam, Neyaz; Biswas, Jaydip] Chittaranjan Natl Canc Inst 37, Dept Surg Oncol, Kolkata, W Bengal, India; [Mandal, Shyamsundar] Chittaranjan Natl Canc Inst, Dept Epidemiol & Biostat, Kolkata, W Bengal, India; [Roychoudhury, Susanta] Saroj Gupta Canc Ctr & Res Inst, Kolkata, India		Panda, CK (corresponding author), Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, W Bengal, India.	ckpanda.cnci@gmail.com	Roychoudhury, Susanta/AAD-7946-2021; Roychowdhury, Anirban/GOV-3409-2022	Roychowdhury, Anirban/0000-0002-1571-9689; Mandal, Goutam/0000-0001-6150-0322	University Grant Commission Fellowship [F.2-3/2000 (SA-I), 2061030813, 20-06 / 2010]; Council of Scientific and Industrial Research, Government of India [60(0111)/14/EMR-II]; UGC-NET Fellowship [F.2-3/2000 (SA-I), 2061030813, 20-06 / 2010(i) EU-IV]	University Grant Commission Fellowship; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC-NET Fellowship	This work was supported by University Grant Commission Fellowship grant F.2-3/2000 (SA-I) (Sr. No. 2061030813, Ref. No.: 20-06 / 2010) to Mrs. H. Dasgupta and grants from Council of Scientific and Industrial Research, Government of India [no. 60(0111)/14/EMR-II of dt 03/11/2014] to Dr. C. K. Panda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Director, Chittaranjan National Cancer Institute, Kolkata, India. They thank Dr. Partha Sarathi Dasgupta, Emeritus Scientist, Chittaranjan National Cancer Institute, for his valuable suggestions during the study. We would also like to thank Mr. Sudip Samadder for his technical help. We would also like to extend our gratitude to Dr. Michel Favre, Genetics, Papillomavirus and Human Cancer Unit, Institeut Pasteur, France for providing HPV33 plasmid without which the present study would have been incomplete. We would like to thank Dr. H. zur Hausen and Dr. E. M. de Villiers for their generous gifts of HPV16/18 plasmids. Financial support for this work was provided by UGC-NET Fellowship grant F.2-3/2000 (SA-I) (Sr. No. 2061030813, Ref. No.: 20-06 / 2010(i) EU-IV dated 22.10.2010) to Mrs. H. Dasgupta and grants from Council of Scientific and Industrial Research, Government of India [No. 60 (0111)/14/EMR-II of dt 03/11/2014] to Dr. C. K. Panda.	Ajiro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046412; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bae JM, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0058-9; Bhattacharya N, 2004, GYNECOL ONCOL, V95, P352, DOI 10.1016/j.ygyno.2004.07.036; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chang YJ, 2013, J MED VIROL, V85, P1567, DOI 10.1002/jmv.23651; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; da Fonseca AJ, 2016, J MED VIROL, V88, P888, DOI 10.1002/jmv.24413; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; Dasgupta S, 2002, ORAL ONCOL, V38, P6, DOI 10.1016/S1368-8375(00)00131-7; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Dutta S, 2015, CANCER IMMUNOL IMMUN, V64, P843, DOI 10.1007/s00262-015-1693-5; Dutta S, 2015, J CLIN PATHOL, V68, P206, DOI 10.1136/jclinpath-2014-202611; Dutta S, 2012, INT J GYNECOL PATHOL, V31, P186, DOI 10.1097/PGP.0b013e3182399391; Egawa K, 2003, DERMATOLOGY, V207, P251, DOI 10.1159/000073085; Frega A, 2012, EUR J GYNAECOL ONCOL, V33, P164; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gumus M, 2006, J EXP CLIN CANC RES, V25, P515; Hedau S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-27; Herrera-Goepfert R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-445; Herrera-Goepfert R, 2011, BREAST, V20, P184, DOI 10.1016/j.breast.2010.11.006; Ignatoski KMW, 2005, NEOPLASIA, V7, P788, DOI 10.1593/neo.05106; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Koskinen WJ, 2003, INT J CANCER, V107, P401, DOI 10.1002/ijc.11381; Kozuka T, 2000, JPN J CANCER RES, V91, P271, DOI 10.1111/j.1349-7006.2000.tb00941.x; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Lawson JS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00277; Lawson JS, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00207; Li N, 2011, BREAST CANCER RES TR, V126, P515, DOI 10.1007/s10549-010-1128-0; Loginov VI, 2004, MOL BIOL+, V38, P549, DOI 10.1023/B:MBIL.0000037007.71787.b9; Maiti GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063440; Manzouri Leila, 2014, Adv Biomed Res, V3, P75, DOI 10.4103/2277-9175.125873; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Pientong C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-30; Pillai MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/ijc.24322; Psyrri A, 2008, NAT CLIN PRACT ONCOL, V5, P24, DOI 10.1038/ncponc0984; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Shuyama K, 2007, BRIT J CANCER, V96, P1554, DOI 10.1038/sj.bjc.6603765; Si HX, 2005, J CLIN VIROL, V32, P19, DOI 10.1016/j.jcv.2004.04.004; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; van Duin M, 2000, J GEN VIROL, V81, P317, DOI 10.1099/0022-1317-81-2-317; Wang T, 2012, MED ONCOL, V29, P48, DOI 10.1007/s12032-010-9812-9; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172760	10.1371/journal.pone.0172760	http://dx.doi.org/10.1371/journal.pone.0172760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245287	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200031
J	Hardy, L; Jespers, V; Van den Bulck, M; Buyze, J; Mwambarangwe, L; Musengamana, V; Vaneechoutte, M; Crucitti, T				Hardy, Liselotte; Jespers, Vicky; Van den Bulck, Magelien; Buyze, Jozefien; Mwambarangwe, Lambert; Musengamana, Viateur; Vaneechoutte, Mario; Crucitti, Tania			The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NEURAMINIDASE; WOMEN; ACID	Bacterial vaginosis (BV) is a difficult-to-treat recurrent condition in which health-associated lactobacilli are outnumbered by other anaerobic bacteria, such as Gardnerella vaginalis. Certain genotypes of G. vaginalis can produce sialidase, while others cannot. Sialidase is known to facilitate the destruction of the protective mucus layer on the vaginal epithelium by hydrolysis of sialic acid on the glycans of mucous membranes. This process possibly facilitates adhesion of bacterial cells on the epithelium since it has been linked with the development of biofilm in other pathogenic conditions. Although it has not been demonstrated yet, it is probable that G. vaginalis benefits from this mechanism by attaching to the vaginal epithelium to initiate biofilm development. In this study, using vaginal specimens of 120 women enrolled in the Ring Plus study, we assessed the association between the putative G. vaginalis sialidase A gene by quantitative polymerase chain reaction (qPCR), the diagnosis of BV according to Nugent score, and the occurrence of a BV-associated biofilm dominated by G. vaginalis by fluorescence in situ hybridisation (FISH). We detected the putative sialidase A gene in 75% of the G. vaginalis-positive vaginal specimens and found a strong association (p<0.001) between the presence of a G. vaginalis biofilm, the diagnosis of BV according to Nugent and the detection of high loads of the G. vaginalis sialidase A gene in the vaginal specimens. These results could redefine diagnosis of BV, and in addition might guide research for new treatment.	[Hardy, Liselotte; Jespers, Vicky] Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Grp, Antwerp, Belgium; [Hardy, Liselotte; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, Ghent, Belgium; [Hardy, Liselotte; Van den Bulck, Magelien; Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium; [Buyze, Jozefien] Inst Trop Med, Dept Clin Sci, Clin Trials Unit, Antwerp, Belgium; [Musengamana, Viateur] Rinda Ubuzima, Kigali, Rwanda	Institute of Tropical Medicine (ITM); Ghent University; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Hardy, L (corresponding author), Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Grp, Antwerp, Belgium.; Hardy, L (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, Ghent, Belgium.; Hardy, L (corresponding author), Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium.	liselotte.hardy@gmail.com	Vaneechoutte, Mario/A-6189-2009; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021; Buyze, Jozefien/B-8550-2014; Hardy, Liselotte/AAF-3515-2019	Vaneechoutte, Mario/0000-0002-4586-203X; Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Buyze, Jozefien/0000-0001-6780-380X; 	European & Developing Countries Clinical Trials Partnership (EDCTP) [SP.2011.41304.043]	European & Developing Countries Clinical Trials Partnership (EDCTP)	My Research Project was sponsored by The European & Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy' (grant code SP.2011.41304.043) (received by TC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Bruggemann H, 2005, SEMIN CUTAN MED SURG, V24, P67, DOI 10.1016/j.sder.2005.03.001; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Harvey HA, 2001, J AUTOIMMUN, V16, P257, DOI 10.1006/jaut.2000.0477; Huppert JS, 2012, J ADOLESCENT HEALTH, V51, P400, DOI 10.1016/j.jadohealth.2012.01.017; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Jiang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115326; LEPRAT R, 1980, ANN INST PASTEUR MIC, VB131, P209; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; LIPOVAC V, 1971, J BIOL CHEM, V246, P7642; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Moncla BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158687; Moncla BJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-78; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olson ME, 2002, CAN J VET RES, V66, P86; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Patterson JL, 2015, AM J OBSTET GYNECOL, V197, DOI [10.1097/QCO.0b013e32835c20cd, DOI 10.1097/QCO.0B013E32835C20CD]; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; SCANLON KL, 1989, ENZYME, V41, P143, DOI 10.1159/000469069; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Schurmans C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1680-y; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411	44	53	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172522	10.1371/journal.pone.0172522	http://dx.doi.org/10.1371/journal.pone.0172522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241058	Green Published, gold			2022-12-27	WOS:000395934400025
J	Mitchell, CL; Latuszek, CE; Vogel, KR; Greenlund, IM; Hobmeier, RE; Ingram, OK; Dufek, SR; Pecore, JL; Nip, FR; Johnson, ZJ; Ji, XH; Wei, HR; Gailing, O; Werner, T				Mitchell, Chelsea L.; Latuszek, Catrina E.; Vogel, Kara R.; Greenlund, Ian M.; Hobmeier, Rebecca E.; Ingram, Olivia K.; Dufek, Shannon R.; Pecore, Jared L.; Nip, Felicia R.; Johnson, Zachary J.; Ji, Xiaohui; Wei, Hairong; Gailing, Oliver; Werner, Thomas			alpha-amanitin resistance in Drosophila melanogaster: A genome-wide association approach	PLOS ONE			English	Article							GENETIC REFERENCE PANEL; RNA POLYMERASE-II; INSECTICIDE RESISTANCE; MYCOPHAGOUS DROSOPHILA; EMBRYONIC MIDGUT; INNATE IMMUNITY; LIFE-SPAN; POPULATION; EXPRESSION; AUTOPHAGY	We investigated the mechanisms of mushroom toxin resistance in the Drosophila Genetic Reference Panel (DGRP) fly lines, using genome-wide association studies (GWAS). While Drosophila melanogaster avoids mushrooms in nature, some lines are surprisingly resistant to alpha-amanitin-a toxin found solely in mushrooms. This resistance may represent a pre-adaptation, which might enable this species to invade the mushroom niche in the future. Although our previous microarray study had strongly suggested that pesticide-metabolizing detoxification genes confer alpha-amanitin resistance in a Taiwanese D. melanogaster line Ama-KTT, none of the traditional detoxification genes were among the top candidate genes resulting from the GWAS in the current study. Instead, we identified Megalin, Tequila, and widerborst as candidate genes underlying the alpha-amanitin resistance phenotype in the North American DGRP lines, all three of which are connected to the Target of Rapamycin (TOR) pathway. Both widerborst and Tequila are upstream regulators of TOR, and TOR is a key regulator of autophagy and Megalin-mediated endocytosis. We suggest that endocytosis and autophagy of alpha-amanitin, followed by lysosomal degradation of the toxin, is one of the mechanisms that confer alpha-amanitin resistance in the DGRP lines.	[Mitchell, Chelsea L.; Latuszek, Catrina E.; Greenlund, Ian M.; Hobmeier, Rebecca E.; Ingram, Olivia K.; Dufek, Shannon R.; Pecore, Jared L.; Werner, Thomas] Michigan Technol Univ, Dept Biol Sci, 1400 Townsend Dr, Houghton, MI 49931 USA; [Vogel, Kara R.] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA; [Nip, Felicia R.] Michigan State Univ, Coll Human Med, Ctr Clin, E Lansing, MI 48824 USA; [Johnson, Zachary J.] US Forest Serv, Salt Lake Ranger Dist 6944 S,3000 E, Salt Lake City, UT USA; [Ji, Xiaohui; Wei, Hairong; Gailing, Oliver] Michigan Technol Univ, Sch Forest Resources & Environm Sci, 1400 Townsend Dr, Houghton, MI 49931 USA	Michigan Technological University; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University College of Human Medicine; United States Department of Agriculture (USDA); United States Forest Service; Michigan Technological University	Werner, T (corresponding author), Michigan Technol Univ, Dept Biol Sci, 1400 Townsend Dr, Houghton, MI 49931 USA.	twerner@mtu.edu	Gailing, Oliver/X-2690-2019; wei, hairong/GNM-7061-2022	Gailing, Oliver/0000-0002-4572-2408; wei, hairong/0000-0002-3551-4998; Fernholz, Catrina/0000-0003-3389-3303	Michigan Technological University	Michigan Technological University	This work was funded by a start-up and a seed grant from Michigan Technological University to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Anholt RRH, 2001, BEHAV GENET, V31, P17, DOI 10.1023/A:1010201723966; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Auderset L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2108495; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Baltzer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006935; Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; Battlay P, 2016, G3-GENES GENOM GENET, V6, P2573, DOI 10.1534/g3.116.031054; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; Benjamin DR, 1995, MUSHROOMS POISONS PA; BILDER D, 1995, GENETICS, V141, P1087; Bozicevic V, 2016, MOL ECOL, V25, P1175, DOI 10.1111/mec.13464; Cabezas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016794; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; De S, 2014, MEMBRANES-BASEL, V4, P333, DOI 10.3390/membranes4030333; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Deretic V, 2009, DIGEST DIS, V27, P246, DOI 10.1159/000228557; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Durham MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5338; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Gleixner EM, 2014, CELL REP, V8, P10, DOI 10.1016/j.celrep.2014.05.035; GREENLEAF AL, 1979, CELL, V18, P613, DOI 10.1016/0092-8674(79)90116-8; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Huang CW, 2015, J GERONTOL A-BIOL, V70, P1461, DOI 10.1093/gerona/glv094; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; JAENIKE J, 1985, EVOLUTION, V39, P1295, DOI [10.2307/2408786, 10.1111/j.1558-5646.1985.tb05695.x]; JAENIKE J, 1979, EVOLUTION, V33, P741, DOI 10.1111/j.1558-5646.1979.tb04726.x; JAENIKE J, 1983, EVOLUTION, V37, P1023, DOI 10.1111/j.1558-5646.1983.tb05630.x; JAENIKE J, 1989, EVOLUTION, V43, P1467, DOI 10.1111/j.1558-5646.1989.tb02597.x; Jeon YK, 2016, ONCOTARGET, V7, P41811, DOI 10.18632/oncotarget.9619; Ji SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4458; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kalajdzic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040296; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lin R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005366; Lin R, 2014, AGING CELL, V13, P507, DOI 10.1111/acel.12200; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marriage TN, 2014, GENETICS, V198, P45, DOI 10.1534/genetics.114.162107; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; Mitchell CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127569; Mitchell CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093489; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; PHILLIPS JP, 1982, CAN J GENET CYTOL, V24, P151, DOI 10.1139/g82-014; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; REUTER R, 1990, DEVELOPMENT, V109, P289; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riedel F, 2011, DEVELOPMENT, V138, P149, DOI 10.1242/dev.056309; Spicer GS, 1996, EVOLUTION, V50, P2328, DOI 10.1111/j.1558-5646.1996.tb03620.x; Stump AD, 2011, ENVIRON ENTOMOL, V40, P1604, DOI 10.1603/EN11136; Vetter J, 1998, TOXICON, V36, P13, DOI 10.1016/S0041-0101(97)00074-3; Vonesch SC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005616; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047	61	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0173162	10.1371/journal.pone.0173162	http://dx.doi.org/10.1371/journal.pone.0173162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241077	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400057
J	Cohen, JF; Cohen, R; Bidet, P; Elbez, A; Levy, C; Bossuyt, PM; Chalumeau, M				Cohen, Jeremie F.; Cohen, Robert; Bidet, Philippe; Elbez, Annie; Levy, Corinne; Bossuyt, Patrick M.; Chalumeau, Martin			Efficiency of a clinical prediction model for selective rapid testing in children with pharyngitis: A prospective, multicenter study	PLOS ONE			English	Article							A STREPTOCOCCAL PHARYNGITIS; DIAGNOSIS; INFECTIONS; VALIDATION; MANAGEMENT; BOOTSTRAP; ACCURACY	Background There is controversy whether physicians can rely on signs and symptoms to select children with pharyngitis who should undergo a rapid antigen detection test (RADT) for group A streptococcus (GAS). Our objective was to evaluate the efficiency of signs and symptoms in selectively testing children with pharyngitis. Materials and methods In this multicenter, prospective, cross-sectional study, French primary care physicians collected clinical data and double throat swabs from 676 consecutive children with pharyngitis; the first swab was used for the RADT and the second was used for a throat culture (reference standard). We developed a logistic regression model combining signs and symptoms with GAS as the outcome. We then derived a model-based selective testing strategy, assuming that children with low and high calculated probability of GAS (<0.12 and >0.85) would be managed without the RADT. Main outcomes and measures were performance of the model (c-index and calibration) and efficiency of the model-based strategy (proportion of participants in whom RADT could be avoided). Results Throat culture was positive for GAS in 280 participants (41.4%). Out of 17 candidate signs and symptoms, eight were retained in the prediction model. The model had an optimism-corrected c-index of 0.73; calibration of the model was good. With the model-based strategy, RADT could be avoided in 6.6% of participants (95% confidence interval 4.7% to 8.5%), as compared to a RADT-for-all strategy. Conclusions This study demonstrated that relying on signs and symptoms for selectively testing children with pharyngitis is not efficient. We recommend using a RADT in all children with pharyngitis.	[Cohen, Jeremie F.; Chalumeau, Martin] Paris Descartes Univ, Necker Enfants Malad Hosp, AP HP, Dept Gen Pediat, Paris, France; [Cohen, Jeremie F.; Chalumeau, Martin] Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team, Res Ctr Epidemiol & Biostat, Sorbonne Paris Cite CRESS,Inserm UMR 1153, Paris, France; [Cohen, Jeremie F.; Bossuyt, Patrick M.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Acad Med Ctr, Amsterdam, Netherlands; [Cohen, Robert; Elbez, Annie; Levy, Corinne] Assoc Clin & Therapeut Infantile Val de Marne ACT, St Maur Des Fosses, France; [Cohen, Robert] Ctr Hosp Intercommunal Creteil, Dept Microbiol, Creteil, France; [Cohen, Robert] Univ Paris Est, IMRB GRC GEMINI, Creteil, France; [Bidet, Philippe] Paris Diderot Univ, Sorbonne Paris Cite, Hop Robert Debre, AP HP,Dept Microbiol, Paris, France; [Levy, Corinne] Ctr Hosp Intercommunal Creteil, Clin Res Ctr, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Cohen, JF (corresponding author), Paris Descartes Univ, Necker Enfants Malad Hosp, AP HP, Dept Gen Pediat, Paris, France.; Cohen, JF (corresponding author), Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team, Res Ctr Epidemiol & Biostat, Sorbonne Paris Cite CRESS,Inserm UMR 1153, Paris, France.; Cohen, JF (corresponding author), Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Acad Med Ctr, Amsterdam, Netherlands.	jeremie.cohen@inserm.fr	LEVY, Corinne/AAM-3541-2021; Bossuyt, Patrick M/AAR-1183-2021; Cohen, Jérémie/H-4707-2019; Bossuyt, Patrick M./B-4557-2016; Chalumeau, Martin/F-4293-2017; Cohen, Robert/AAM-4426-2021	LEVY, Corinne/0000-0002-1927-6360; Bossuyt, Patrick M/0000-0003-4427-0128; Cohen, Jérémie/0000-0003-3572-8985; Bossuyt, Patrick M./0000-0003-4427-0128; Chalumeau, Martin/0000-0001-8175-3706; Cohen, Robert/0000-0001-6151-0686	French Ministry of Health(PHRC Regional) [AOR 12089]; ACTIV; Agence Regionale de Sante d'Ile-de-France; Laboratory Guigoz - Societe Francaise de Pediatrie; Assistance Publique Hopitaux de Paris; Laboratory Groupe de Pedatrie Generale; Laboratory Groupe de Recherches Epidemiologiques en Pediatrie	French Ministry of Health(PHRC Regional); ACTIV; Agence Regionale de Sante d'Ile-de-France; Laboratory Guigoz - Societe Francaise de Pediatrie; Assistance Publique Hopitaux de Paris; Laboratory Groupe de Pedatrie Generale; Laboratory Groupe de Recherches Epidemiologiques en Pediatrie	This work was supported by a research grant from the French Ministry of Health (PHRC Regional 2012, AOR 12089). The clinical study was internally funded by ACTIV and externally by Dectrapharm, manufacturer of the rapid test. JFC was supported by educational grants from Agence Regionale de Sante d'Ile-de-France, Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pedatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie, and a research grant from Assistance Publique Hopitaux de Paris (Annee Medaille de l'Internat 2013). The Funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Bisno AL, 2002, CLIN INFECT DIS, V35, P126, DOI 10.1086/342056; BREESE BB, 1954, J PEDIATR-US, V44, P670, DOI 10.1016/S0022-3476(54)80008-4; Cohen JF, 2013, EUR J CLIN MICROBIOL, V32, P787, DOI 10.1007/s10096-012-1809-1; Cohen JF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010502.pub2; Cohen JF, 2015, CAN MED ASSOC J, V187, P23, DOI 10.1503/cmaj.140772; Cohen JF, 2013, J PEDIATR-US, V162, P1282, DOI 10.1016/j.jpeds.2013.01.050; Cohen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039085; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Gerber MA, 2004, CLIN MICROBIOL REV, V17, P571, DOI 10.1128/CMR.17.3.571-580.2004; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; Giraldez-Garcia C, 2011, EUR J PEDIATR, V170, P1059, DOI 10.1007/s00431-011-1410-0; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Le Marechal F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001482; Lean WL, 2014, PEDIATRICS, V134, P771, DOI 10.1542/peds.2014-1094; Matthys J, 2013, JAMA INTERN MED, V173, P77, DOI 10.1001/2013.jamainternmed.741; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Ruiz-Aragon J, 2010, AN PEDIATR, V72, P391, DOI 10.1016/j.anpedi.2009.12.012; Science M, 2015, CAN MED ASSOC J, V187, P13, DOI 10.1503/cmaj.141532; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Shaikh N, 2012, J PEDIATR-US, V160, P487, DOI 10.1016/j.jpeds.2011.09.011; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI [10.1002/(SICI)1097-0258(19960229)15:4&LT;361::AID-SIM168&GT;3.0.CO;2-4, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, DOI 10.1002/(SICI)1097-0258(19960229)15:4&LT;361::AID-SIM168&GT;3.0.CO;2-4]; van der Ploeg T, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-137; van der Ploeg T, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-143; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Walker CLF, 2006, J PEDIATR-US, V149, P64, DOI 10.1016/j.jpeds.2006.03.005	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172871	10.1371/journal.pone.0172871	http://dx.doi.org/10.1371/journal.pone.0172871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235012	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200159
J	Costa, M; Lio, G; Gomez, A; Sirigu, A				Costa, Manuela; Lio, Guillaume; Gomez, Alice; Sirigu, Angela			How components of facial width to height ratio differently contribute to the perception of social traits	PLOS ONE			English	Article							FACE; TESTOSTERONE; COOPERATION; MORPHOLOGY; JUDGMENTS	Facial width to height ratio (fWHR) is a morphological cue that correlates with sexual dimorphism and social traits. Currently, it is unclear how vertical and horizontal components of fWHR, distinctly capture faces' social information. Using a new methodology, we orthogonally manipulated the upper facial height and the bizygomatic width to test their selective effect in the formation of impressions. Subjects (n = 90) saw pair of faces and had to select the face expressing better different social traits (trustworthiness, aggressiveness and femininity). We further investigated how sex and fWHR components interact in the formation of these judgements. Across experiments, changes along the vertical component better predicted participants' ratings rather than the horizontal component. Faces with smaller height were perceived as less trustworthy, less feminine and more aggressive. By dissociating fWHR and testing the contribution of its components independently, we obtained a powerful and discriminative measure of how facial morphology guides social judgements.	[Costa, Manuela; Lio, Guillaume; Gomez, Alice; Sirigu, Angela] Lyon 1, UCBL, CNRS, Inst Cognit Sci Marc Jeannerod,UMR5229, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Costa, M; Sirigu, A (corresponding author), Lyon 1, UCBL, CNRS, Inst Cognit Sci Marc Jeannerod,UMR5229, Bron, France.	manuela.costa@isc.cnrs.fr; sirigu@isc.cnrs.fr	Gomez, Alice/C-2401-2009; Sirigu, Angela/L-4683-2017; Costa, Manuela/K-1177-2017	Gomez, Alice/0000-0003-4804-4419; Costa, Manuela/0000-0001-6251-7900	Centre National de la Recherche Scientifique; University Claude Bernard Lyon within the program "Investissement d'Avenir" [ANR-11-LABEX-0042]; Ministere de la Recherche Francaise	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Claude Bernard Lyon within the program "Investissement d'Avenir"(French National Research Agency (ANR)); Ministere de la Recherche Francaise	This work was funded by Centre National de la Recherche Scientifique and ANR-11-LABEX-0042 grant from the University Claude Bernard Lyon within the program "Investissement d'Avenir" to A.S. MC is funded by a fellowship from Ministere de la Recherche Francaise.	Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FRANCISCUS RG, 1991, AM J PHYS ANTHROPOL, V85, P419, DOI 10.1002/ajpa.1330850406; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Geniole SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030366; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072259; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hehman E, 2015, J EXP SOC PSYCHOL, V59, P51, DOI 10.1016/j.jesp.2015.03.007; Hehman E, 2014, PERS SOC PSYCHOL B, V40, P1624, DOI 10.1177/0146167214552791; Hehman E, 2013, PSYCHOL SCI, V24, P289, DOI 10.1177/0956797612451467; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lambert B, 2014, PSYCHONEUROENDOCRINO, V40, P60, DOI 10.1016/j.psyneuen.2013.10.015; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; PROFFIT WR, 1983, J DENT RES, V62, P566, DOI 10.1177/00220345830620051201; Raadsheer MC, 1999, J DENT RES, V78, P31, DOI 10.1177/00220345990780010301; Simonsen A, 2014, PSYCHOPHARMACOLOGY, V231, P2759, DOI 10.1007/s00213-014-3444-2; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Weinberg SM, 2016, CLEFT PALATE-CRAN J, V53, pE185, DOI 10.1597/15-199; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710	31	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172739	10.1371/journal.pone.0172739	http://dx.doi.org/10.1371/journal.pone.0172739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235081	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200125
J	Imai, N; Miyasaka, D; Shimada, H; Suda, K; Ito, T; Endo, N				Imai, Norio; Miyasaka, Dai; Shimada, Hayato; Suda, Ken; Ito, Tomoyuki; Endo, Naoto			Usefulness of a novel method for the screening of deep vein thrombosis by using a combined D-dimer- and age-based index before total hip arthroplasty	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; FONDAPARINUX; PLASMA; FIBRIN; DIAGNOSIS; SURGERY; VALUES; COHORT; TRIAL	Plasma D-dimer level is clinically useful for diagnosing patients with suspected deep vein thrombosis (DVT). However, the cut-off value for the D-dimer level remains controversial and undetermined with regard to total hip arthroplasty (THA). The objective of this study was to estimate the efficacy of an age- and D-dimer-based index for diagnosing DVTs in asymptomatic cases before THA. We enrolled 224 patients with no symptoms associated with DVT before THA. All the patients underwent ultrasonography, and the plasma D-dimer level was recorded about 1 month preoperatively. The optimal cut-off value was calculated using multiple logistic regression and receiver operating curve analyses. DVTs were detected in 13 patients (5.8%) using ultrasonography. Multiple logistic regression analysis demonstrated that age (odds ratio [OR]: 1.13; p = 0.007) and D-dimer value (OR: 1.74; p = 0.003) were related to the existence of preoperative DVT. A DVT index (0.12 x age + 0.45 x the D-dimer value) of 8.15 was the most reasonable cut-off value according to the receiver operating curve analysis. This value caused 100% sensitivity and 70.1% specificity, with an area under the curve (AUC) of 0.905 (range, 0.836-0.975). For age and D-dimer value, the AUCs were 0.828 (0.749-0.907) and 0.716 (0.522-0.910), respectively. This study demonstrated that age and D-dimer index can be useful in screening patients for DVTs before THA. This DVT index is also easy to calculate and may be clinically significant.	[Imai, Norio] Niigata Univ, Grad Sch Med & Dent Sci, Div Comprehens Care Geriatr, Niigata, Japan; [Imai, Norio; Miyasaka, Dai; Shimada, Hayato; Suda, Ken; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med, Niigata, Japan; [Ito, Tomoyuki] Saiseikai Niigata Daini Hosp, Dept Orthopaed Surg, Niigata, Japan	Niigata University; Niigata University	Imai, N (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Comprehens Care Geriatr, Niigata, Japan.; Imai, N (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med, Niigata, Japan.	imainorio2001@yahoo.co.jp	Miyasaka, Dai/AAA-4894-2020					BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Cosmi B, 2010, THROMB RES, V125, pS62, DOI 10.1016/S0049-3848(10)70016-5; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fuji T, 2008, INT ORTHOP, V32, P443, DOI 10.1007/s00264-007-0360-7; GAFFNEY PJ, 1995, BRIT J HAEMATOL, V90, P187, DOI 10.1111/j.1365-2141.1995.tb03399.x; Kamikura Y, 2005, THROMB RES, V115, P53, DOI 10.1016/j.thromres.2004.07.019; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; LIP GYH, 1995, CLIN SCI, V89, P205, DOI 10.1042/cs0890205; Niimi R, 2012, THROMB RES, V130, P759, DOI 10.1016/j.thromres.2011.11.046; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Sasaki S, 2009, J ORTHOP SCI, V14, P491, DOI 10.1007/s00776-009-1365-4; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Signorelli SS, 2016, ANGIOLOGY; Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Sudo A, 2009, INT J HEMATOL, V89, P572, DOI 10.1007/s12185-009-0323-4; Yamaguchi T, 2010, THROMB RES, V126, pE323, DOI 10.1016/j.thromres.2010.03.018; Yoshitaka T, 2008, MOD RHEUMATOL, V18, P359, DOI 10.1007/s10165-008-0068-6	18	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172849	10.1371/journal.pone.0172849	http://dx.doi.org/10.1371/journal.pone.0172849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235062	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200151
J	Pan, YB; Yuan, YF; Liu, GS; Wei, YC				Pan, Yunbao; Yuan, Yufen; Liu, Guoshi; Wei, Yongchang			P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients	PLOS ONE			English	Article							RISK-FACTORS; MUTATIONS; SUBTYPES; GENE; METAANALYSIS; THERAPY; TP53; KI67	Triple-negative breast cancer (TNBC) is an aggressive subgroup of breast cancer lack of effective target therapy. This study was to investigate the prognostic role of p53 and Ki-67 in 156 cases of TNBC patients. Logistic regression analysis was used to examine the association between clinical parameters and recurrence. Univariate and multivariate analyses were used to examine the association between clinical characteristics and disease-free survival (DFS) or overall survival (OS). Survival analyses using the Kaplan-Meier method were performed to examine the association between p53/Ki-67 and DFS and OS. Our data showed that p53 was positive in 71.3% and the Ki-67 high index was in 82.8% of TNBC. Elevated p53 and Ki-67 were associated with histological grade. The tumor size, lymph node involvement, and p53 expression are associated with risk of recurrence. Tumor size, lymph node involvement, family history, Ki-67 and p53 are independent variables associated with either DFS or OS. TNBC patients with positive p53 or Ki-67 high index or family history of cancer have a significant association with worse prognosis. This study suggests that p53, Ki-67 and family history are useful prognostic markers in TNBC.	[Pan, Yunbao] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Yuan, Yufen] Anyang Tumor Hosp, Dept Pathol, Anyang, Henan, Peoples R China; [Liu, Guoshi] Nanchang Univ, Affiliated Hosp 2, Dept Orthoped, Nanchang, Jiangxi, Peoples R China; [Wei, Yongchang] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Hubei, Peoples R China	Wuhan University; Nanchang University; Wuhan University	Pan, YB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China.; Wei, YC (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Hubei, Peoples R China.	panyunbao@outlook.com; weiyongchang8@163.com		Pan, Yunbao/0000-0002-6311-2945; Wei, Yongchang/0000-0001-7205-4663	National Natural Science Foundation of China [81372816, 81673033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the funds from the National Natural Science Foundation of China (81372816; 81673033).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0765-6; Adamo V, 2012, EUR J CANCER, V48, P642, DOI 10.1016/j.ejca.2011.06.028; Aleskandarany MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3084; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Biganzoli E, 2011, JPN J CLIN ONCOL, V41, P172, DOI 10.1093/jjco/hyq227; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Calhoun BC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2743-x; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Dumay A, 2013, INT J CANCER, V132, P1227, DOI 10.1002/ijc.27767; Feng X, 2016, ONCOTARGET; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gui Y, 2016, BIOMARK MED, V10, P771, DOI 10.2217/bmm-2015-0064; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jin MS, 2016, TUMOUR BIOL J INT SO; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kim JY, 2016, CANCER RES TREAT, V48, P1338, DOI 10.4143/crt.2015.430; Kim JY, 2016, ASS MUTATION EXPRESS; Kim MC, 2016, ANN SURG ONCOLOGY; Kim M, 2016, CANCER RES TREAT, V48, P1330, DOI 10.4143/crt.2015.463; Lee MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163254; Lee SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124658; Miyashita M, 2011, VIRCHOWS ARCH, V458, P65, DOI 10.1007/s00428-010-1009-2; Moslehi R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2369-z; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Pan B, 2016, ONCOTARGET, V7, P38864, DOI 10.18632/oncotarget.8778; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petrelli F, 2015, BREAST CANCER RES TR, V153, P477, DOI 10.1007/s10549-015-3559-0; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Tashima R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119565; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang W, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9323; Williams A. B., 2016, COLD SPRING HARB PER, V6; Yao H., 2016, ONCOTARGET	39	45	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172324	10.1371/journal.pone.0172324	http://dx.doi.org/10.1371/journal.pone.0172324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235003	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200068
J	Ogama, N; Sakurai, T; Nakai, T; Niida, S; Saji, N; Toba, K; Umegaki, H; Kuzuya, M				Ogama, Noriko; Sakurai, Takashi; Nakai, Toshiharu; Niida, Shumpei; Saji, Naoki; Toba, Kenji; Umegaki, Hiroyuki; Kuzuya, Masafumi			Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment	PLOS ONE			English	Article							GLOBAL FUNCTIONAL DECLINE; DWELLING OLDER-ADULTS; SUBCORTICAL HYPERINTENSITIES; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; DEPRESSIVE SYMPTOMS; LADIS LEUKOARAIOSIS; SUNNYBROOK DEMENTIA; NATIONAL INSTITUTE; EXECUTIVE FUNCTION	Background Instrumental activities of daily living (IADL) start to decline during the progression of amnestic mild cognitive impairment (aMCI) to Alzheimer disease (AD). Cognitive and physical decline are involved in the loss of functional independence. However, little is known about AD-related neural change that leads to IADL impairment. The purpose of this study was to clarify the effects of regional white matter hyperintensity (WMH) on IADL impairment in persons with AD and aMCI. Methods The participants were 347 female subjects aged 65-85 years diagnosed with AD (n = 227), aMCI (n = 44) or normal cognition (n = 76). IADL was assessed by the Lawton Index. Cognition, mood and mobility function were evaluated by comprehensive geriatric assessment batteries. WMH and brain atrophy were analyzed with brain magnetic resonance imaging, using an automatic segmentation program. Regional WMH was measured in the frontal, temporal, occipital and parietal lobes. Results Ability to carry out IADL of shopping, food preparation, mode of transportation, responsibility for own medication, and ability to handle finances was obviously impaired in the early stage of AD. Frontal WMH was specifically associated with disability to do shopping and food preparation even after adjusting for several confounders including brain atrophy. Conclusions IADL subcategories were differentially impaired along with cognitive status in persons with AD and aMCI. Frontal WMH was an important predictor of impaired ability to do shopping and food preparation. A preventive strategy for WMH might lead to suppression of IADL disability and slow the progression of AD.	[Ogama, Noriko; Sakurai, Takashi; Saji, Naoki; Toba, Kenji] Natl Ctr Geriatr & Gerontol, Ctr Comprehens Care & Res Memory Disorders, Obu, Japan; [Ogama, Noriko; Umegaki, Hiroyuki; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi, Japan; [Nakai, Toshiharu] Natl Ctr Geriatr & Gerontol, NeuroImaging & Informat, Obu, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Obu, Japan	National Center for Geriatrics & Gerontology; Nagoya University; National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Sakurai, T (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Comprehens Care & Res Memory Disorders, Obu, Japan.	tsakurai@ncgg.go.jp			National Center for Geriatrics and Gerontology [25-6, 27-21, 28-15]; Japanese Society for the Promotion of Science [26870765]	National Center for Geriatrics and Gerontology; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	T.S discloses a research grant from Research Funding of Longevity Sciences (25-6, 27-21) from National Center for Geriatrics and Gerontology (http://www.ncgg.go.jp/ncgg-kenkyu/index.html). N.S discloses a research grant from Research Funding of Longevity Sciences (28-15) from the National Center for Geriatrics and Gerontology (http://www.ncgg.go.jp/ncgg-kenkyu/index.html), and Grants-in-Aid for Scientific Research (B) (No. 26870765) from the Japanese Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Akisaki T, 2006, DIABETES-METAB RES, V22, P376, DOI 10.1002/dmrr.632; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albert SM, 2015, J GERONTOL A-BIOL, V70, P71, DOI 10.1093/gerona/glu088; Artaud F, 2015, J AM GERIATR SOC, V63, P1129, DOI 10.1111/jgs.13442; Behl P, 2007, ARCH NEUROL-CHICAGO, V64, P266, DOI 10.1001/archneur.64.2.266; Brown PJ, 2011, ARCH GEN PSYCHIAT, V68, P617, DOI 10.1001/archgenpsychiatry.2011.57; Burton CL, 2006, CLIN NEUROPSYCHOL, V20, P432, DOI 10.1080/13854040590967063; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gao FQ, 2011, J ALZHEIMERS DIS, V26, P379, DOI 10.3233/JAD-2011-0058; Gobbens Robbert J J, 2014, Curr Gerontol Geriatr Res, V2014, P358137, DOI 10.1155/2014/358137; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Hanyu H, 1999, EUR J NEUROL, V6, P195, DOI 10.1111/j.1468-1331.1999.tb00013.x; Honda Y, 2015, GERIATR GERONTOL INT, V15, P43, DOI 10.1111/ggi.12672; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Inzitari D, 2007, ARCH INTERN MED, V167, P81, DOI 10.1001/archinte.167.1.81; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Kamiya M, 2014, GERIATR GERONTOL INT, V14, P45, DOI 10.1111/ggi.12260; Kim HJ, 2013, J ALZHEIMERS DIS, V35, P129, DOI 10.3233/JAD-122320; Kondo N, 2008, PREV MED, V46, P457, DOI 10.1016/j.ypmed.2007.12.007; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JJ, 2015, PSYCHIAT INVEST, V12, P516, DOI 10.4306/pi.2015.12.4.516; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNeely AA, 2015, J ALZHEIMERS DIS, V43, P785, DOI 10.3233/JAD-140588; Moon SY, 2011, EUR NEUROL, V65, P223, DOI 10.1159/000318161; Nyunt MSZ, 2012, INT PSYCHOGERIATR, V24, P1633, DOI 10.1017/S1041610212000890; Ogama N, 2016, GERIATR GERONTOL INT, V16, P167, DOI 10.1111/ggi.12447; Ogama N, 2015, GERIATR GERONTOL INT, V15, P83, DOI 10.1111/ggi.12664; Ogama N, 2014, J AM MED DIR ASSOC, V15, P36, DOI 10.1016/j.jamda.2013.11.004; Okochi J., 2006, Geriatrics and Gerontology International, V6, P223, DOI 10.1111/j.1447-0594.2006.00352.x; Otsuka Y, 2012, AM J NEURORADIOL, V33, P726, DOI 10.3174/ajnr.A2853; Pantoni L, 2006, J AM GERIATR SOC, V54, P1095, DOI 10.1111/j.1532-5415.2006.00798.x; Ramirez J, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnagi.2010.00062, 10.3389/fnagi.2016.00062]; Ramirez J, 2016, ALZHEIMERS DEMENT, V12, P203, DOI 10.1016/j.jalz.2015.06.1886; Roy K, 2014, J ALZHEIMERS DIS, V42, P291, DOI 10.3233/JAD-131796; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sahin A, 2015, TURK J MED SCI, V45, P1353, DOI 10.3906/sag-1406-132; Saji N, 2015, GERIATR GERONTOL INT, V15, P17, DOI 10.1111/ggi.12673; Sakurai T, 2015, GERIATR GERONTOL INT, V15, P1, DOI 10.1111/ggi.12714; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Song HJ, 2014, J NUTR HEALTH AGING, V18, P765, DOI 10.1007/s12603-014-0452-1; Sugimoto T, 2016, CURR ALZHEIMER RES, V13, P718, DOI 10.2174/1567205013666160211124828; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Tomimoto H, 2015, GERIATR GERONTOL INT, V15, P3, DOI 10.1111/ggi.12661; Vidoni ED, 2010, J ALZHEIMERS DIS, V19, P517, DOI 10.3233/JAD-2010-1245; Yoon B, 2014, J STROKE CEREBROVASC, V23, pE365, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.040; Yoon B, 2013, NEUROL SCI, V34, P715, DOI 10.1007/s10072-012-1120-z; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	55	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172484	10.1371/journal.pone.0172484	http://dx.doi.org/10.1371/journal.pone.0172484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253275	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300021
J	Shen, GH; Lan, Y; Zhang, K; Ren, PW; Jia, ZY				Shen, Guohua; Lan, You; Zhang, Kan; Ren, Pengwei; Jia, Zhiyun			Comparison of F-18-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTEGRATED FDG-PET/CT; DIFFUSION-WEIGHTED MRI; LYMPH-NODE; COMPUTED-TOMOGRAPHY; QUALITATIVE ASSESSMENT; DIAGNOSTIC-VALUE; N-STAGE; CT; ACCURACY	Background Accurate clinical staging of mediastinal lymph nodes of patients with lung cancer is important in determining therapeutic options and prognoses. We aimed to compare the diagnostic performance of diffusion-weighted magnetic resonance imaging (DWI) and F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) in detecting mediastinal nodal metastasis of lung cancer. Methods Relevant studies were systematically searched in the MEDLINE, EMBASE, PUBMED, and Cochrane Library databases. Based on extracted data, the pooled sensitivity, specificity, positive and negative likelihood ratios (PLR and NLR) with individual 95% confidence intervals were calculated. In addition, the publication bias was assessed by Deek's funnel plot of the asymmetry test. The potential heterogeneity was explored by threshold effect analysis and subgroup analyses. Results Forty-three studies were finally included. For PET/CT, the pooled sensitivity and specificity were 0.65 (0.63-0.67) and 0.93 (0.93-0.94), respectively. The corresponding values of DWI were 0.72 (0.68-0.76) and 0.97 (0.96-0.98), respectively. The overall PLR and NLR of DWI were 13.15 (5.98-28.89) and 0.32 (0.27-0.39), respectively. For PET/CT, the corresponding values were 8.46 (6.54-10.96) and 0.38 (0.33-0.45), respectively. The Deek's test revealed no significant publication bias. Study design and patient enrollment were potential causes for the heterogeneity of DWI studies and the threshold was a potential source for PET/CT studies. Conclusion Both modalities are beneficial in detecting lymph nodes metastases in lung cancer without significant differences between them. DWI might be an alternative modality for evaluating nodal status of NSCLC.	[Shen, Guohua; Jia, Zhiyun] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China; [Lan, You; Zhang, Kan; Jia, Zhiyun] Sichuan Univ, West China Sch Med, Div Lab Med, Chengdu, Sichuan, Peoples R China; [Ren, Pengwei] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Jia, ZY (corresponding author), Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China.	zhiyunjia@hotmail.com			National Natural Science Foundation of China [81571637, 81271532]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China, Grant No. 81571637 and 81271532).	Al-Sarraf N, 2008, LUNG CANCER, V60, P62, DOI 10.1016/j.lungcan.2007.08.036; An YS, 2008, LUNG, V186, P327, DOI 10.1007/s00408-008-9109-3; Bille A, 2009, EUR J CARDIO-THORAC, V36, P440, DOI 10.1016/j.ejcts.2009.04.003; Booth Karen, 2013, Ulster Med J, V82, P75; Bryant AS, 2006, ANN THORAC SURG, V82, P417, DOI 10.1016/j.athoracsur.2005.12.047; Busard MPH, 2010, J MAGN RESON IMAGING, V31, P1117, DOI 10.1002/jmri.22139; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; [贺伟 He Wei], 2011, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V27, P2013; Hellwig D, 2007, J NUCL MED, V48, P1761, DOI 10.2967/jnumed.107.044362; Hu Man, 2008, Zhonghua Zhongliu Zazhi, V30, P306; Ichikawa T, 2006, AM J ROENTGENOL, V187, P181, DOI 10.2214/AJR.05.1005; Jeon TY, 2010, AM J ROENTGENOL, V195, P370, DOI 10.2214/AJR.09.3772; Kim BT, 2006, RADIOLOGY, V241, P501, DOI 10.1148/radiol.2412051173; Kim DW, 2012, NUCL MED MOLEC IMAG, V46, P196, DOI 10.1007/s13139-012-0141-0; Kim YN, 2012, EUR RADIOL, V22, P1537, DOI 10.1007/s00330-012-2388-3; Kim YK, 2007, CANCER-AM CANCER SOC, V109, P1068, DOI 10.1002/cncr.22518; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Koksal D, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-63; Kuo WH, 2012, ACAD RADIOL, V19, P685, DOI 10.1016/j.acra.2012.02.013; Lee AY, 2014, NUCL MED MOLEC IMAG, V48, P41, DOI 10.1007/s13139-013-0244-2; Lee JW, 2009, EUR J NUCL MED MOL I, V36, P1794, DOI 10.1007/s00259-009-1155-4; Lee SM, 2012, EUR RADIOL, V22, P1556, DOI 10.1007/s00330-012-2395-4; Li M, 2012, EUR J RADIOL, V81, P1886, DOI 10.1016/j.ejrad.2011.03.074; Li XL, 2012, RADIOTHER ONCOL, V102, P246, DOI 10.1016/j.radonc.2011.10.016; Lin WY, 2012, J CHIN MED ASSOC, V75, P203, DOI 10.1016/j.jcma.2012.04.004; Liu BJ, 2009, CHINESE MED J-PEKING, V122, P1749, DOI 10.3760/cma.j.issn.0366-6999.2009.15.006; Lv YL, 2011, J THORAC ONCOL, V6, P1350, DOI 10.1097/JTO.0b013e31821d4384; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Matsuki M, 2007, EUR RADIOL, V17, P201, DOI 10.1007/s00330-006-0281-7; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Morikawa M, 2009, J NUCL MED, V50, P81, DOI 10.2967/jnumed.108.056408; Nakayama J, 2010, J COMPUT ASSIST TOMO, V34, P1, DOI 10.1097/RCT.0b013e3181a9cc07; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Ohno Y, 2007, J MAGN RESON IMAGING, V26, P1071, DOI 10.1002/jmri.21106; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; Pak K, 2015, ANN NUCL MED, V29, P409, DOI 10.1007/s12149-015-0958-6; Pauls S, 2012, EUR J RADIOL, V81, P178, DOI 10.1016/j.ejrad.2010.09.001; Schmidt-Hansen M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009519.pub2; Shim SS, 2005, RADIOLOGY, V236, P1011, DOI 10.1148/radiol.2363041310; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sit Alva K Y, 2010, Asian Cardiovasc Thorac Ann, V18, P33, DOI 10.1177/0218492309352119; Sommer G, 2012, EUR RADIOL, V22, P2859, DOI 10.1007/s00330-012-2542-y; Tasci E, 2010, INTERACT CARDIOV TH, V10, P200, DOI 10.1510/icvts.2009.220392; Toba H, 2010, J MED INVESTIG, V57, P305, DOI 10.2152/jmi.57.305; Tournoy KG, 2007, THORAX, V62, P696, DOI 10.1136/thx.2006.072959; Usuda K, 2013, ANN SURG ONCOL, V20, P1676, DOI 10.1245/s10434-012-2799-z; Usuda K, 2011, ANN THORAC SURG, V91, P1689, DOI 10.1016/j.athoracsur.2011.02.037; Vansteenkiste JF, 1998, EUR J NUCL MED, V25, P1495, DOI 10.1007/s002590050327; Ventura E, 2010, CLIN IMAG, V34, P20, DOI 10.1016/j.clinimag.2009.03.012; Wang ZX, 2015, EUR J RADIOL, V84, P1371, DOI 10.1016/j.ejrad.2015.03.025; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu LM, 2012, J SURG RES, V178, P304, DOI 10.1016/j.jss.2012.03.074; Wu LM, 2012, J GASTROEN HEPATOL, V27, P1027, DOI 10.1111/j.1440-1746.2012.07112.x; Wu YH, 2013, INT J CANCER, V132, pE37, DOI 10.1002/ijc.27779; Xu L, 2014, J MAGN RESON IMAGING, V40, P200, DOI 10.1002/jmri.24343; Xu N, 2014, CHINESE MED J-PEKING, V127, P607, DOI 10.3760/cma.j.issn.0366-6999.20131691; Yamamura J, 2011, J COMPUT ASSIST TOMO, V35, P223, DOI 10.1097/RCT.0b013e3181fc5409; Yang WF, 2008, LUNG CANCER, V61, P35, DOI 10.1016/j.lungcan.2007.11.007; Yi CA, 2007, AM J ROENTGENOL, V188, P318, DOI 10.2214/AJR.05.2081; [曾治民 Zeng Zhimin], 2012, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V39, P706; [张晰 Zhang Xi], 2013, [中国医学计算机成像杂志, Chinese Computed Medical Imaging], V19, P213; Zhou Yi Yvonne, 2014, Perm J, V18, P18, DOI 10.7812/TPP/14-005	63	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173104	10.1371/journal.pone.0173104	http://dx.doi.org/10.1371/journal.pone.0173104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253364	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300077
J	Zhao, XY; Xia, S; Wang, EQ; Chen, YX				Zhao, Xinyu; Xia, Song; Wang, Erqian; Chen, Youxin			Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							0.5-PERCENT OPHTHALMIC SOLUTION; CYSTOID MACULAR EDEMA; TROMETHAMINE 0.5-PERCENT; POSTOPERATIVE INFLAMMATION; BROMFENAC 0.09-PERCENT; PREDNISOLONE ACETATE; SYSTEMATIC REVIEWS; 0.1-PERCENT; 0.4-PERCENT; PLACEBO	As a new ophthalmic non-steroidal anti-inflammatory drug ( NSAID) with prodrug structure, Nepafenac was supposed to have a better efficacy than conventional NSAIDs both in patients' tolerability and ocular inflammation associated with cataract surgery. However, many current studies reached contradictory conclusions on the superiority of Nepafenac over Ketorolac. The objective of our study is to evaluate the efficacy and patients' tolerability of Nepafenac and Ketorolac following cataract surgery. To clarify this, we conducted a meta-analysis of randomized controlled trials. Eleven articles were included in this study. The dataset consisted of 1165 patients, including 1175 cataract surgeries. Among them, 574 patients were in the Nepafenac group and 591 in the Ketorolac group. Our analysis indicated that these two drugs were equally effective in controlling post cataract surgery ocular inflammation, reducing macular edema, achieving a better visual ability and maintaining intraoperative mydriasis during cataract surgery. However, Nepafenac was more effective than Ketorolac in reducing the incidence of postoperative conjunctival hyperemia and ocular discomfort. This meta-analysis indicated that topical Nepafenac is superior to Ketorolac in patients' tolerability following cataract surgery. However, these two drugs are equally desirable in the management of anterior chamber inflammation, visual rehabilitation and intraoperative mydriasis. Given the limitations in our study, more researches with larger sample sizes and focused on more specific indicators such as peak aqueous concentrations of drugs or PEG2 levels are required to reach a firmer conclusion.	[Zhao, Xinyu; Xia, Song; Wang, Erqian; Chen, Youxin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, YX (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing, Peoples R China.	478252553@qq.com						Almeida DRP, 2012, J CATARACT REFR SURG, V38, P1537, DOI 10.1016/j.jcrs.2012.04.034; Bucci FA, 2007, AM J OPHTHALMOL, V144, P146, DOI 10.1016/j.ajo.2007.02.034; Bucci FA, 2011, ADV THER, V28, P1089, DOI 10.1007/s12325-011-0080-7; Bucci FA, 2011, CURR MED RES OPIN, V27, P2235, DOI 10.1185/03007995.2011.626018; DUFFIN RM, 1982, OPHTHALMOLOGY, V89, P966; Duong HVQ, 2007, J CATARACT REFR SURG, V33, P1925, DOI 10.1016/j.jcrs.2007.07.017; FLACH AJ, 1988, OPHTHALMOLOGY, V95, P1279; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Heier J, 1999, AM J OPHTHALMOL, V127, P253, DOI 10.1016/S0002-9394(98)00413-9; Heier JS, 2000, OPHTHALMOLOGY, V107, P2034, DOI 10.1016/S0161-6420(00)00365-1; Jones BM, 2013, ANN PHARMACOTHER, V47, P892, DOI 10.1345/aph.1R757; Ke TL, 2000, INFLAMMATION, V24, P371, DOI 10.1023/A:1007001131987; Lim CHL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004764.pub3; Malik Anu, 2016, Oman J Ophthalmol, V9, P150; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nardi M, 2007, CLIN OPHTHALMOL, V1, P527; Nichols J, 1998, Curr Opin Ophthalmol, V9, P40; O'Brien TP, 2005, CURR MED RES OPIN, V21, P1131, DOI 10.1185/030079905x50651; Ramakrishnan S, 2015, ASIA-PAC J OPHTHALMO, V4, P216, DOI 10.1097/APO.0000000000000089; ROBERTS CW, 1995, ARCH OPHTHALMOL-CHIC, V113, P725, DOI 10.1001/archopht.1995.01100060051031; Rossetti L, 1996, J CATARACT REFR SURG, V22, P794, DOI 10.1016/S0886-3350(96)80164-7; Sahu S, 2015, J CATARACT REFR SURG, V41, P2043, DOI 10.1016/j.jcrs.2015.10.061; Simone JN, 1999, J CATARACT REFR SURG, V25, P699, DOI 10.1016/S0886-3350(99)00023-1; Solomon KD, 2001, OPHTHALMOLOGY, V108, P331, DOI 10.1016/S0161-6420(00)00543-1; Tzelikis PF, 2015, BRIT J OPHTHALMOL, V99, P654, DOI 10.1136/bjophthalmol-2014-305803; Walters T, 2007, J CATARACT REFR SURG, V33, P1539, DOI 10.1016/j.jcrs.2007.05.015; Zanetti FR, 2012, INDIAN J OPHTHALMOL, V60, P277, DOI 10.4103/0301-4738.98705	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173254	10.1371/journal.pone.0173254	http://dx.doi.org/10.1371/journal.pone.0173254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253334	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300096
J	Dumanian, ZP; Tollemar, V; Ye, JX; Lu, MP; Zhu, YX; Liao, JY; Ameer, GA; He, TC; Reid, RR				Dumanian, Zari P.; Tollemar, Viktor; Ye, Jixing; Lu, Minpeng; Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.; He, Tong-Chuan; Reid, Russell R.			Repair of critical sized cranial defects with BMP9-transduced calvarial cells delivered in a thermoresponsive scaffold	PLOS ONE			English	Article							BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; BONE MORPHOGENETIC PROTEIN-2; HYDROGELS; DRUG; RECONSTRUCTION; POLYMER; BMP9	Large skeletal defects caused by trauma, congenital malformations, and post-oncologic resections of the calvarium present major challenges to the reconstructive surgeon. We previously identified BMP-9 as the most osteogenic BMP in vitro and in vivo. Here we sought to investigate the bone regenerative capacity of murine-derived calvarial mesenchymal progenitor cells (iCALs) transduced by BMP-9 in the context of healing critical-sized calvarial defects. To accomplish this, the transduced cells were delivered to the defect site within a thermoresponsive biodegradable scaffold consisting of poly(polyethylene glycol citrate-co-N-isopropylacrylamide mixed with gelatin (PPCN-g). A total of three treatment arms were evaluated: PPCN-g alone, PPCN-g seeded with iCALs expressing GFP, and PPCN-g seeded with iCALs expressing BMP-9. Defects treated only with PPCN-g scaffold did not statistically change in size when evaluated at eight weeks postoperatively (p = 0.72). Conversely, both animal groups treated with iCALs showed significant reductions in defect size after 12 weeks of follow-up (BMP9-treated: p = 0.0025; GFP-treated: p = 0.0042). However, H&E and trichrome staining revealed more complete osseointegration and mature bone formation only in the BMP9-treated group. These results suggest that BMP9-transduced iCALs seeded in a PPCN-g thermoresponsive scaffold is capable of inducing bone formation in vivo and is an effective means of creating tissue engineered bone for critical sized defects.	[Dumanian, Zari P.; Tollemar, Viktor; Reid, Russell R.] Univ Chicago, Med Ctr, Dept Surg, Sect Plast Surg, Chicago, IL 60637 USA; [Tollemar, Viktor; Ye, Jixing; Lu, Minpeng; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Orthoped Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Zhu, Yunxiao; Liao, Junyi; Ameer, Guillermo A.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Northwestern University; Northwestern University; Feinberg School of Medicine	Reid, RR (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Sect Plast Surg, Chicago, IL 60637 USA.	rreid@surgery.bsd.uchicago.edu	Junyi, Liao/AAP-9076-2020; Ameer, Guillermo/B-6765-2009		China Scholarship Council; National Institute of Dental and Craniofacial Research [DE020140]; Chicago Community Trust; National Center for Advancing Translational Sciences [UL1 TR000430]	China Scholarship Council(China Scholarship Council); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Chicago Community Trust; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the pre-doctoral fellowship from the China Scholarship Council (JY), National Institute of Dental and Craniofacial Research, DE020140, Chicago Community Trust, and the National Center for Advancing Translational Sciences, UL1 TR000430 granted to Dr. Russell Reid. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akbay E, 2014, AURIS NASUS LARYNX, V41, P56, DOI 10.1016/j.anl.2013.07.002; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023; Calori GM, 2009, INJURY, V40, P67; Cellesi F, 2012, THER DELIV, V3, P1395, DOI [10.4155/tde.12.114, 10.4155/TDE.12.114]; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chung EJ, 2011, ACTA BIOMATER, V7, P4057, DOI 10.1016/j.actbio.2011.07.001; Fujioka-Kobayashi M, J PERIODONTOL, V87, pe101, DOI [10.1902/jop.2016.150561, DOI 10.1902/J0P.2016.150561]; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Kunert-Keil C, 2015, ANN ANAT, V199, P79, DOI 10.1016/j.aanat.2013.12.001; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lu S, 2016, AM J TRANSL IN PRESS; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mangano FG, 2015, CASE REP DENT, V2015, DOI 10.1155/2015/941265; Misch CM, 2010, IMPLANT DENT, V19, P361, DOI 10.1097/ID.0b013e3181f8115b; Nakamura T, 2016, CLIN ORAL INVEST; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Shenaq DS, 2015, J CRANIOFAC SURG, V26, P1207, DOI 10.1097/SCS.0000000000001717; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Teven CM, 2015, GENES DIS, V2, P268, DOI 10.1016/j.gendis.2015.06.003; van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004; Yang J, 2014, BIOMACROMOLECULES, V15, P3942, DOI 10.1021/bm5010004; Ye JX, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/025021; Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908	38	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172327	10.1371/journal.pone.0172327	http://dx.doi.org/10.1371/journal.pone.0172327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249039	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500037
J	Moraes-Souza, RQ; Reinaque, AP; Soares, TS; Silva, ALT; Giunchetti, RC; Takano, MAS; Akamatsu, MA; Kubrusly, FS; Lucio-Macarini, F; Raw, I; Iourtov, D; Ho, PL; Bueno, LL; Fujiwara, RT; Volpato, GT				Moraes-Souza, Rafaianne Q.; Reinaque, Ana Paula; Soares, Thaigra S.; Silva, Ana Luiza T.; Giunchetti, Rodolfo C.; Takano, Maria A. S.; Akamatsu, Milena A.; Kubrusly, Flavia S.; Lucio-Macarini, Fernanda; Raw, Isaias; Iourtov, Dmitri; Ho, Paulo Lee; Bueno, Lilian L.; Fujiwara, Ricardo T.; Volpato, Gustavo T.			Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a model	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; PREGNANCY; IMMUNIZATION; EMBRYOPATHY; PREVENTION; CHAGASI; EXTENT; MICE	While the immunogenic potential of the vaccination against infectious diseases was extensively shown, data on the safety assessment of recombinant proteins in vaccine formulations administered during pregnancy are still scarce. In the current study, the antigenicity of a vaccine against leishmaniasis (based on Leishmania braziliensis recombinant protein peroxidoxin) during pregnancy and possible maternal reproductive outcomes and fetal anomalies after immunization with a leishmanial vaccine or adjuvant alone (Bordetella pertussis derived MPLA adjuvant) were assessed. Rats were mated and allocated in three groups: Control D rats received saline; Adjuvant D rats received the adjuvant MPLA, and Vaccine D rats received the combination of MPLA and peroxidoxin. The administration was subcutaneously at the dorsal region, three times (days 0, 7, 14 of pregnancy). On day 21 of pregnancy, all rats were bled for biochemical and immunological measurements. The gravid uterus was weighed with its contents, and the fetuses were analyzed. The immunization with peroxidoxin induced a significant production of circulating IgG levels compared to other groups but caused a significant in post-implantation loss (14.7%) when compared to Control (5.0%) and Adjuvant (4.4%) groups. Furthermore, a significantly high rate of fetal visceral anomalies, such as hydronephrosis and convoluted ureter, was also observed in animals that received vaccine when compared to Control or Adjuvant groups. These data indicate the importance of safety evaluation of vaccines during pregnancy and the limited use of peroxidoxin administration during pregnancy. More importantly, the safety monitoring of immunization with MPLA derived from Bordetella pertussis demonstrated no reproductive outcomes associated with adjuvant administration, suggesting its safe use during pregnancy.	[Moraes-Souza, Rafaianne Q.; Soares, Thaigra S.; Volpato, Gustavo T.] Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, MG, Brazil; [Reinaque, Ana Paula; Silva, Ana Luiza T.; Bueno, Lilian L.; Fujiwara, Ricardo T.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Lab Immunol & Genom Parasites, Belo Horizonte, MG, Brazil; [Giunchetti, Rodolfo C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cell Cell Interact, Belo Horizonte, MG, Brazil; [Takano, Maria A. S.; Akamatsu, Milena A.; Kubrusly, Flavia S.; Lucio-Macarini, Fernanda; Raw, Isaias; Iourtov, Dmitri; Ho, Paulo Lee] Butantan Inst, Div Technol Dev & Prod DDTP, Sao Paulo, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Instituto Butantan	Volpato, GT (corresponding author), Fed Univ Mato Grosso UFMT, Inst Biol & Hlth Sci, Lab Syst Physiol & Reprod Toxicol, Barra Do Garcas, MG, Brazil.	gtvolpato@yahoo.com	SAKAUCHI, MARIA APARECIDA/D-8728-2015; S macarini, fernanda/V-8252-2017; Ho, Paulo/P-8267-2015; Fujiwara, Ricardo Toshio/J-7579-2012; Akamatsu, Milena Apetito/V-8084-2017; Volpato, Gustavo Tadeu/A-5350-2013; Bueno, Lilian/AAQ-1939-2020; Volpato, Gustavo Tadeu/ABC-4863-2020	Ho, Paulo/0000-0003-3652-241X; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Akamatsu, Milena Apetito/0000-0002-8193-3448; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Bueno, Lilian/0000-0003-3510-4590; Volpato, Gustavo Tadeu/0000-0002-4753-3264; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Teixeira Silva, Ana Luiza/0000-0002-1152-9255; Sousa Soares, Thaigra/0000-0003-4402-0241; Moraes-Souza, Rafaianne/0000-0002-3639-5740; Kubrusly, Flavia/0000-0003-0646-583X	FAPEMIG; FAPESP; CAPES; CNPq; Fundacao Butantan, Brazil; CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil; CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by FAPEMIG, FAPESP, CAPES, CNPq and Fundacao Butantan, Brazil. RTF, RCG and PLH are research fellows (Bolsa de Produtividade em Pesquisa) from CNPq.; This work was supported by: Rafaianne Q. Moraes-Souza received CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) scholarship; Ana Paula Reinaque received CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) - DINTER allowance; part of this study was supported by grants from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); part of this study was supported by grants from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); part of this study was supported by grants from Fundacao Butantan; Ricardo T. Fujiwara, Rodolfo C. Giunchetti, and Paulo L. Ho received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	ALIVERTI V, 1979, TERATOLOGY, V20, P237, DOI 10.1002/tera.1420200208; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Boehme CC, 2006, EMERG INFECT DIS, V12, P359, DOI 10.3201/eid1202.050449d; Caldas AJM, 2003, ACTA TROP, V88, P39, DOI 10.1016/S0001-706X(03)00160-8; Chahoud I, 2005, BRAZ J MED BIOL RES, V38, P565, DOI 10.1590/S0100-879X2005000400010; Chahoud I, 1999, REPROD TOXICOL, V13, P375, DOI 10.1016/S0890-6238(99)00035-0; Daifalla NS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/348401; Damasceno DC, 2002, PHYTOMEDICINE, V9, P667, DOI 10.1078/094471102321616508; Damasceno DC, 2002, ANIM REPROD SCI, V72, P235, DOI 10.1016/S0378-4320(02)00094-5; Damasceno DC, 2008, ANOMALIAS CONGENITAS; Desale M, 2016, BEST PRACT RES CLIN, V16, P1; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; El Safi SH, 2007, NATURE REV MICROBIOL, V5, pS30, DOI DOI 10.1038/NRMICRO1766; ERIKSSON UJ, 1986, DIABETES, V35, P1356, DOI 10.2337/diabetes.35.12.1356; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; Figueiro EA, 2008, ARCH GYNECOL OBSTET, V278, P13, DOI 10.1007/s00404-007-0532-0; Figueiro-Filho Ernesto Antonio, 2004, Infect Dis Obstet Gynecol, V12, P31, DOI 10.1080/1064744042000210384; Fowden AL, 2009, HORM RES, V72, P257, DOI 10.1159/000245927; GOLDMAN AS, 1991, ISRAEL J MED SCI, V27, P469; HAGAY ZJ, 1995, AM J OBSTET GYNECOL, V173, P1036, DOI 10.1016/0002-9378(95)91323-8; HOD M, 1990, ISRAEL J MED SCI, V26, P541; Jimenez-Marco T, 2016, TRANSFUSION, V56, pS45, DOI 10.1111/trf.13344; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; KNOPFHOLZ J, 2014, CHOLESTEROL, V2014, P1; LIN H, 1993, J IMMUNOL, V151, P4562; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Manson JN, 1994, PRINCIPLES METHODS T, P989; Menezes-Souza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099216; Merkert S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071000; MICHELON T., 2006, REV AMRIGS, V50, P145; Miyaki C, 2010, VACCINE, V28, P2505, DOI 10.1016/j.vaccine.2010.01.044; Mueller M, 2006, J ANTIMICROB CHEMOTH, V58, P811, DOI 10.1093/jac/dkl342; Nascimento IP, 2012, BRAZ J MED BIOL RES, V45, P1102, DOI 10.1590/S0100-879X2012007500142; Neubert D., 1992, RISK ASSESSMENT PREN; PINTER E, 1986, TERATOLOGY, V33, P73, DOI 10.1002/tera.1420330110; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Rudge MVC, 2000, OBSTET BASICA, P42; SALEWSKI E, 1964, N-S ARCH PHARMACOL, P247; Santos TMM, 2015, CELL STRESS CHAPERON, V20, P595, DOI 10.1007/s12192-015-0581-4; Sarafana Sofia, 2007, Acta Med Port, V20, P355; Soares TD, 2015, BIRTH DEFECTS RES B, V104, P190, DOI 10.1002/bdrb.21152; Solecki Roland, 2003, Reproductive Toxicology, V17, P625, DOI 10.1016/S0890-6238(03)00092-3; Solecki R, 2013, REPROD TOXICOL, V35, P48, DOI 10.1016/j.reprotox.2012.06.006; STAPLES RE, 1964, STAIN TECHNOL, V39, P61; Sundar S, 2014, EXPERT REV VACCINES, V13, P489, DOI 10.1586/14760584.2014.894467; Tavares Mariana Vide, 2011, Acta Med Port, V24 Suppl 4, P1063; United States Environmental Protection Agency, 1996, OPPTS HARM TEST GUID; Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13; Volpato GT, 2015, AN ACAD BRAS CIENC, V87, P407, DOI 10.1590/0001-3765201520140354; Wilson JG, TERATOLOGY PRINCIPLE, P262	55	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172525	10.1371/journal.pone.0172525	http://dx.doi.org/10.1371/journal.pone.0172525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249007	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500045
J	Strom, CM; Anderson, B; Tsao, D; Zhang, K; Liu, Y; Livingston, K; Elzinga, C; Evans, M; Nguyen, Q; Wolfson, D; Rowland, C; Kolacki, P; Maxwell, M; Wang, JC; Rabin, D; Catanese, J; Owen, R; Braastad, C; Sun, WM				Strom, Charles M.; Anderson, Ben; Tsao, David; Zhang, Ke; Liu, Yan; Livingston, Kayla; Elzinga, Christopher; Evans, Matthew; Quoclinh Nguyen; Wolfson, David; Rowland, Charles; Kolacki, Paula; Maxwell, Megan; Wang, Jia-Chi; Rabin, Douglas; Catanese, Joseph; Owen, Renius; Braastad, Corey; Sun, Weimin			Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)	PLOS ONE			English	Article							FREE DNA ANALYSIS; MATERNAL PLASMA; TRISOMIES 21; ANEUPLOIDY; EXPERIENCE; TRISOMY-13; DIAGNOSIS; SOCIETY	We evaluated performance characteristics of a laboratory-developed, non-invasive prenatal screening (NIPS) assay for fetal aneuploidies. This assay employs massively parallel shotgun sequencing with full automation. GC sequencing bias correction and statistical smoothing were performed to enhance discrimination of affected and unaffected pregnancies. Maternal plasma samples from pregnancies with known aneuploidy status were used for assay development, verification, and validation. Assay verification studies using 2,085 known samples (1873 unaffected, 69 trisomy 21, 20 trisomy 18, 17 trisomy 13) demonstrated complete discrimination between autosomal trisomy (Z scores >8) and unaffected (Z scores <4) singleton pregnancies. A validation study using 552 known samples (21 trisomy 21, 10 trisomy 18, 1 trisomy 13) confirmed complete discrimination. Twin pregnancies showed similar results. Follow-up of abnormal results from the first 10,000 clinical samples demonstrated PPVs of 98% (41/42) for trisomy 21, 92% (23/25) for trisomy 18, and 69% (9/13) for trisomy 13. Adjustment for causes of false-positive results identified during clinical testing (eg, maternal duplications) improved PPVs to 100% for trisomy 21 and 96% for trisomy 18. This NIPS test demonstrates excellent discrimination between trisomic and unaffected pregnancies. The PPVs obtained in initial clinical testing are substantially higher than previously reported NIPS methods.	[Strom, Charles M.; Anderson, Ben; Tsao, David; Zhang, Ke; Liu, Yan; Livingston, Kayla; Quoclinh Nguyen; Kolacki, Paula; Maxwell, Megan; Wang, Jia-Chi; Rabin, Douglas; Catanese, Joseph; Owen, Renius; Sun, Weimin] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA; [Elzinga, Christopher; Evans, Matthew; Braastad, Corey] Athena Diagnost, Marlborough, MA USA; [Wolfson, David; Rowland, Charles] Celera Diagnost, Alameda, CA USA	Nichols Institute	Strom, CM (corresponding author), Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA.	charles.m.strom@questdiagnostics.com		Maxwell, Megan/0000-0003-2890-9243	Quest Diagnostics	Quest Diagnostics	This study and preparation of this manuscript were done as part of routine work at Quest Diagnostics. Athena Diagnostics and Celera Diagnostics are wholly owned subsidiaries of Quest Diagnostics. Quest Diagnostics provided support in the form of salaries for CMS, BA, DT, KZ, YL, KL, QN, PK, MM, JW, DR, JC, RO and WS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Athena/Quest Diagnostics provided support in the form of salaries for CB, ME, and CE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Celera/Quest Diagnostics provided support in the form of salary for DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, OBSTET GYNECOL, V126, pE31, DOI 10.1097/01.AOG.0000471172.63927.b6; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P21, DOI 10.1002/uog.12299; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Cheung SW, 2015, NEW ENGL J MED, V372, P1675, DOI 10.1056/NEJMc1412222; Choy KW, 2013, AMERICAN SOCIETY OF; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Devers PL, 2013, J GENET COUNS, V22, P291, DOI 10.1007/s10897-012-9564-0; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173; Meck JM, 2015, AM J OBSTET GYNECOL, V213, pe1; Medikare Veronica, 2011, J Reprod Infertil, V12, P181; Nicolaides KH, 2013, PRENATAL DIAG, V33, P575, DOI 10.1002/pd.4103; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Porreco RP, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.042; Quezada MS, 2015, ULTRASOUND OBST GYN, V45, P36, DOI 10.1002/uog.14664; Snyder MW, 2015, NEW ENGL J MED, V372, P1639, DOI 10.1056/NEJMoa1408408; Song YJ, 2013, PRENATAL DIAG, V33, P700, DOI 10.1002/pd.4160; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Stokowski R, 2015, PRENATAL DIAG, V35, P1243, DOI 10.1002/pd.4686; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Wang JC, 2015, GENET MED, V17, P234, DOI 10.1038/gim.2014.92; Yao H, 2014, ULTRASOUND OBST GYN, V44, P17, DOI 10.1002/uog.13361; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792	33	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0167130	10.1371/journal.pone.0167130	http://dx.doi.org/10.1371/journal.pone.0167130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248967	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500001
J	Shi, YQ; Cheng, YH; Wang, Y; Zhang, GM; Gao, RF; Xiang, CY; Feng, JJ; Lou, DF; Liu, Y				Shi, Yaqian; Cheng, Yinghui; Wang, Ying; Zhang, Guiming; Gao, Ruifang; Xiang, Caiyu; Feng, Jianjun; Lou, Dingfeng; Liu, Ying			Investigation of the fungal community structures of imported wheat using high-throughput sequencing technology	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DIVERSITY	This study introduced the application of high-throughput sequencing techniques to the investigation of microbial diversity in the field of plant quarantine. It examined the microbial diversity of wheat imported into China, and established a bioinformatics database of wheat pathogens based on high-throughput sequencing results. This study analyzed the nuclear ribosomal internal transcribed spacer (ITS) region of fungi through Illumina Miseq sequencing to investigate the fungal communities of both seeds and sieve-through. A total of 758,129 fungal ITS sequences were obtained from ten samples collected from five batches of wheat imported from the USA. These sequences were classified into 2 different phyla, 15 classes, 33 orders, 41 families, or 78 genera, suggesting a high fungal diversity across samples. Apairwise analysis revealed that the diversity of the fungal community in the sieve-through is significantly higher than those in the seeds. Taxonomic analysis showed that at the class level, Dothideomycetes dominated in the seeds and Sordariomycetes dominated in the sieve-through. In all, this study revealed the fungal community composition in the seeds and sieve-through of the wheat, and identified key differences in the fungal community between the seeds and sieve-through.	[Shi, Yaqian; Cheng, Yinghui; Wang, Ying; Zhang, Guiming; Gao, Ruifang; Xiang, Caiyu; Feng, Jianjun; Lou, Dingfeng; Liu, Ying] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen, Peoples R China; [Cheng, Yinghui; Wang, Ying; Zhang, Guiming; Gao, Ruifang; Xiang, Caiyu; Feng, Jianjun; Lou, Dingfeng] Shenzhen Sci Acad Inspect & Quarantine, Shenzhen Key Lab Inspect Res & Dev Alien Pests, Shenzhen, Peoples R China; [Cheng, Yinghui] Kunming Univ Sci & Technol, Kunming, Peoples R China	Kunming University of Science & Technology	Shi, YQ (corresponding author), Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen, Peoples R China.	chengyhciq@163.com			Science and technology plan projects of The General administration of quality supervision, inspection and Quarantine of the People's Republic of China [2015IK267]; Science and technology projects of the Shenzhen Entry-Exit Inspection and Quarantine Bureau [SZ2015219]	Science and technology plan projects of The General administration of quality supervision, inspection and Quarantine of the People's Republic of China; Science and technology projects of the Shenzhen Entry-Exit Inspection and Quarantine Bureau	This work is supported by The Science and technology plan projects of The General administration of quality supervision, inspection and Quarantine of the People's Republic of China (2015IK267); The Science and technology projects of the Shenzhen Entry-Exit Inspection and Quarantine Bureau (SZ2015219).	BERBEE ML, 1992, MOL BIOL EVOL, V9, P278; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Celio GJ, 2006, MYCOLOGIA, V98, P850, DOI 10.3852/mycologia.98.6.850; Critzer FJ, 2010, CURR OPIN BIOTECH, V21, P125, DOI 10.1016/j.copbio.2010.01.006; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Fan MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074617; Hashidoko Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1427, DOI 10.1271/bbb.69.1427; Jian F, 2004, J ECON ENTOMOL, V97, P1148, DOI 10.1603/0022-0493(2004)097[1148:MADOAR]2.0.CO;2; Kim M, 2013, J MICROBIOL BIOTECHN, V23, P1347, DOI 10.4014/jmb.1306.06068; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Pardo E, 2006, FOOD ADDIT CONTAM A, V23, P398, DOI 10.1080/02652030500376102; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Truyens S, 2014, INT J PHYTOREMEDIAT, V16, P643, DOI 10.1080/15226514.2013.837027; Yang CX, 2013, SCI CHINA LIFE SCI, V56, P73, DOI 10.1007/s11427-012-4423-7; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019	18	7	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171894	10.1371/journal.pone.0171894	http://dx.doi.org/10.1371/journal.pone.0171894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241020	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400011
J	Strand, R; Malmberg, F; Johansson, L; Lind, L; Sundbom, M; Ahlstrom, H; Kullberg, J				Strand, Robin; Malmberg, Filip; Johansson, Lars; Lind, Lars; Sundbom, Magnus; Ahlstrom, Hakan; Kullberg, Joel			A concept for holistic whole body MRI data analysis, Imiomics	PLOS ONE			English	Article							SEGMENTATION; REGISTRATION; WATER; FAT	Purpose To present and evaluate a whole-body image analysis concept, Imiomics (imaging omics) and an image registration method that enables Imiomics analyses by deforming all image data to a common coordinate system, so that the information in each voxel can be compared between persons or within a person over time and integrated with non-imaging data. Methods The presented image registration method utilizes relative elasticity constraints of different tissue obtained from whole-body water-fat MRI. The registration method is evaluated by inverse consistency and Dice coefficients and the Imiomics concept is evaluated by example analyses of importance for metabolic research using non-imaging parameters where we know what to expect. The example analyses include whole body imaging atlas creation, anomaly detection, and cross-sectional and longitudinal analysis. Results The image registration method evaluation on 128 subjects shows low inverse consistency errors and high Dice coefficients. Also, the statistical atlas with fat content intensity values shows low standard deviation values, indicating successful deformations to the common coordinate system. The example analyses show expected associations and correlations which agree with explicit measurements, and thereby illustrate the usefulness of the proposed Imiomics concept. Conclusions The registration method is well-suited for Imiomics analyses, which enable analyses of relationships to non-imaging data, e.g. clinical data, in new types of holistic targeted and untargeted big-data analysis.	[Strand, Robin; Malmberg, Filip; Johansson, Lars; Ahlstrom, Hakan; Kullberg, Joel] Uppsala Univ, Div Radiol, Dept Surg Sci, Uppsala, Sweden; [Strand, Robin; Malmberg, Filip] Uppsala Univ, Dept Informat Technol, Ctr Image Anal, Uppsala, Sweden; [Johansson, Lars; Ahlstrom, Hakan; Kullberg, Joel] Antaros Med AB, BioVenture Hub, Molndal, Sweden; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sundbom, Magnus] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Strand, R (corresponding author), Uppsala Univ, Div Radiol, Dept Surg Sci, Uppsala, Sweden.; Strand, R (corresponding author), Uppsala Univ, Dept Informat Technol, Ctr Image Anal, Uppsala, Sweden.	Robin.Strand@it.uu.se	Johansson, Lars/AAF-4845-2019; Kullberg, Joel/ABE-3997-2021	Sundbom, Magnus/0000-0002-6243-2859; Strand, Robin/0000-0001-7764-1787				Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2011, STAT PARAMETRIC MAPP; Baiker M, 2011, LECT NOTES COMPUT SC, V6892, P516, DOI 10.1007/978-3-642-23629-7_63; Berglund J, 2010, MAGN RESON MED, V63, P1659, DOI 10.1002/mrm.22385; Bezrukov I, 2015, J NUCL MED, V56, P1067, DOI 10.2967/jnumed.114.149476; Christensen GE, 2001, IEEE T MED IMAGING, V20, P568, DOI 10.1109/42.932742; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hedstrom A, THESIS; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Joshi AA, 2013, J MAGN RESON IMAGING, V37, P423, DOI 10.1002/jmri.23813; Karlsson A, 2015, J MAGN RESON IMAGING, V41, P1558, DOI 10.1002/jmri.24726; Khmelinskii A, 2011, MOL IMAGING BIOL, V13, P898, DOI 10.1007/s11307-010-0386-x; Kim J, 2013, MED PHYS, V40, DOI 10.1118/1.4828783; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Klein S, 2009, INT J COMPUT VISION, V81, P227, DOI 10.1007/s11263-008-0168-y; Kullberg J, 2015, P 10 ANN M ISMRM TOR; Kullberg J, 2009, J MAGN RESON IMAGING, V30, P185, DOI 10.1002/jmri.21820; Lester H, 1999, PATTERN RECOGN, V32, P129, DOI 10.1016/S0031-3203(98)00095-8; Li RJ, 2014, LECT NOTES COMPUT SC, V8675, P305, DOI 10.1007/978-3-319-10443-0_39; Li X, 2008, MED PHYS, V35, P1507, DOI 10.1118/1.2889758; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Machann J, 2010, RADIOLOGY, V257, P353, DOI 10.1148/radiol.10092284; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Malmberg F, 2014, COMPUT METHODS BIOME; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Plis SM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00229; Ruan D, 2006, P SPIE, V6144; Rueckert D, 2011, BIOL MED PHYS BIOMED, P131, DOI 10.1007/978-3-642-15816-2_5; Staring M, 2007, MED PHYS, V34, P4098, DOI 10.1118/1.2776236; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vovk U, 2006, NEUROIMAGE, V32, P54, DOI 10.1016/j.neuroimage.2006.03.020	32	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0169966	10.1371/journal.pone.0169966	http://dx.doi.org/10.1371/journal.pone.0169966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241015	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400002
J	Netto, SA; Fonseca, G				Netto, Sergio A.; Fonseca, Gustavo			Regime shifts in coastal lagoons: Evidence from free-living marine nematodes	PLOS ONE			English	Article							SPATIAL-PATTERNS; SMITHS LAKE; ECOLOGY; SEA	We test the validity of using the regime shift theory to account for differences in environmental state of coastal lagoons as a response to variation in connectivity with the sea, using free-living nematodes as a surrogate. The study is based on sediment samples from the inner and outer portions of 15 coastal lagoons (5 open to the sea, 5 intermittently open/closed, and 5 permanently closed lakes) along the southern coast of Brazil. Environmental data suggested that there are two contrasting environmental conditions, with coastal lakes being significantly different from open and intermittent lagoons. Marine nematode assemblages corroborate these two mutually exclusive alternative stable states (open vs. closed systems), but assemblages from the intermittently open/closed lagoons showed a gradual change in species composition between both systems independently of the environmental conditions. The gradient in the structural connectivity among lagoons and the sea, due to their regime shifts, changes the movement of resources and consumers and the internal physico-chemical gradients, directly affecting regional species diversity. Whereas openness to the sea increased similarity in nematode assemblage composition among connected lagoons, isolation increased dissimilarity among closed lagoons. Our results from a large-scale sampling program indicated that as lagoons lose connectivity with the sea, shifting the environmental state, local processes within individual intermittently open/closed lagoons and particularly within coastal lakes become increasingly more important in structuring these communities. The main implication of these findings is that depending on the local stable state we may end up with alternative regional patterns of biodiversity.	[Netto, Sergio A.] Univ Southern Santa Catarina, Marine Sci Lab, Tubarao, SC, Brazil; [Fonseca, Gustavo] Univ Fed Sao Paulo, Dept Ciencias Mar, Santos, Brazil	Universidade do Sul de Santa Catarina; Universidade Federal de Sao Paulo (UNIFESP)	Netto, SA (corresponding author), Univ Southern Santa Catarina, Marine Sci Lab, Tubarao, SC, Brazil.	sergio.netto@unisul.br	Netto, Sergio Antonio/AAH-3668-2019; Fonseca, Gustavo/F-5138-2018; Fonseca, Gustavo/B-7673-2011; Netto, Sergio A/G-1281-2012	Netto, Sergio Antonio/0000-0003-2486-640X; Fonseca, Gustavo/0000-0001-8625-4279; Fonseca, Gustavo/0000-0001-8625-4279; 	National Council for Scientific and Technological Development (CNPq) [473293/2010-2]; Foundation for Research and Innovation of the State of Santa Catarina (FAPESC) [09/2009]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research and Innovation of the State of Santa Catarina (FAPESC)	This work was supported by the National Council for Scientific and Technological Development (CNPq), Process 473293/2010-2, http://www.cnpq.br, and the Foundation for Research and Innovation of the State of Santa Catarina (FAPESC), Process 09/2009, http://www.fapesc.sc.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P1; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Barnes N, 2008, ESTUAR COAST SHELF S, V79, P328, DOI 10.1016/j.ecss.2008.03.017; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Basset A, 2006, AQUAT CONSERV, V16, P441, DOI 10.1002/aqc.767; Bianchelli S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34544; Bollmohr S, 2009, ESTUAR COAST SHELF S, V82, P50, DOI 10.1016/j.ecss.2008.12.008; Chapman PM, 2012, ESTUAR COAST SHELF S, V110, P32, DOI 10.1016/j.ecss.2012.01.010; Collins DG, 2014, HYDROBIOLOGIA, V734, P97, DOI 10.1007/s10750-014-1872-y; DAY J. W, 2013, ESTUARINE ECOLOGY; Duck RW, 2012, ESTUAR COAST SHELF S, V110, P2, DOI 10.1016/j.ecss.2012.03.007; Dye A, 2005, ESTUAR COAST SHELF S, V64, P357, DOI 10.1016/j.ecss.2005.02.029; Dye AH, 2006, AUSTRAL ECOL, V31, P913, DOI 10.1111/j.1442-9993.2006.01648.x; Everett JD, 2007, ESTUAR COAST SHELF S, V72, P690, DOI 10.1016/j.ecss.2006.12.001; Fonseca Gustavo, 2006, Braz. j. oceanogr., V54, P41, DOI 10.1590/S1679-87592006000100004; Giannini Paulo César Fonseca, 2010, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V5, P105; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Griffiths Shane Paul, 1999, International Journal of Salt Lake Research, V8, P307, DOI 10.1023/A:1009051520907; Haghani S, 2016, QUATERN INT, V408, P93, DOI 10.1016/j.quaint.2015.12.005; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hesp PA, 2009, LECT NOTES EARTH SCI, V107, P93; Ingels J, 2009, DEEP-SEA RES PT I, V56, P1521, DOI 10.1016/j.dsr.2009.04.010; Kraberg AC, 2011, MAR POLLUT BULL, V62, P7, DOI 10.1016/j.marpolbul.2010.09.010; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Netto SA, 2012, ESTUAR COAST, V35, P1069, DOI 10.1007/s12237-012-9488-9; NICHOLS MM, 1989, MAR GEOL, V88, P201, DOI 10.1016/0025-3227(89)90098-4; Perez-Ruzafa A, 2011, J COAST CONSERV, V15, P369, DOI 10.1007/s11852-010-0095-2; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; POLLARD DA, 1994, ESTUARIES, V17, P631, DOI 10.2307/1352411; R Core Team, 2021, R LANGUAGE ENV STAT; Ristau K, 2015, ECOL INDIC, V53, P196, DOI 10.1016/j.ecolind.2015.01.010; Schallenberg M, 2010, ESTUAR COAST SHELF S, V86, P587, DOI 10.1016/j.ecss.2009.11.001; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schock NT, 2014, WETLANDS, V34, P297, DOI 10.1007/s13157-013-0486-x; Somerfield P.J., 2005, P229, DOI 10.1002/9780470995129.ch6; Strotz LC, 2015, ESTUAR COAST SHELF S, V164, P340, DOI 10.1016/j.ecss.2015.07.048; Thorp JH, 2010, AQUAT ECOL SER, P1; Timber P, 2004, NEMATODE BEHAV, P227; Traunspurger W, 2002, FRESHWATER MEIOFAUNA: BIOLOGY AND ECOLOGY, P63; Viaroli P, 2008, AQUAT CONSERV, V18, pS105, DOI 10.1002/aqc.956; Whitfield AK, 2012, AFR J MAR SCI, V34, P163, DOI 10.2989/1814232X.2012.675041; Wieser W., 1953, STUDIE ARK ZOOL, V4, P439; WOODROFFE C. D., 1997, COASTAL EVOLUTION LA, P219; WoRMS Editorial Board, WORLD REGISTER MARIN; YEATES GW, 1993, J NEMATOL, V25, P315	47	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172366	10.1371/journal.pone.0172366	http://dx.doi.org/10.1371/journal.pone.0172366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235030	Green Published, gold			2022-12-27	WOS:000394688200074
J	Sigalla, GN; Mushi, D; Meyrowitsch, DW; Manongi, R; Rogathi, JJ; Gammeltoft, T; Rasch, V				Sigalla, Geofrey Nimrod; Mushi, Declare; Meyrowitsch, Dan Wolf; Manongi, Rachel; Rogathi, Jane Januarius; Gammeltoft, Tine; Rasch, Vibeke			Intimate partner violence during pregnancy and its association with preterm birth and low birth weight in Tanzania: A prospective cohort study	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; DAR-ES-SALAAM; DOMESTIC VIOLENCE; PERINATAL-MORTALITY; RISK-FACTORS; WOMEN; PREVALENCE; OUTCOMES; HEALTH; COMPLICATIONS	Introduction Intimate partner violence (IPV) is a public health problem that affects millions of women worldwide. The role of violence as an underlying factor in poor birth outcomes remains an area where strong evidence is lacking. The aim of this study was to determine the association between intimate partner violence (IPV) and preterm delivery (PTB) and low birth weight (LBW). Materials and methods A prospective cohort study was conducted among 1112 pregnant women attending antenatal care in Moshi-Tanzania. The women were enrolled before 24 weeks gestation, followedup at week 34 to determine exposure to violence during pregnancy, and after delivery to estimate gestation age at delivery and birth weight. Logistic regression analysis was performed to assess the association between exposure to IPV during pregnancy and PTB and LBW while adjusting for possible confounders. In addition, stratified analysis based on previous history of adverse pregnancy outcome was performed. Results One-third of the women experienced IPV during pregnancy, 22.3% reported emotional, 15.4% sexual and 6.3% physical violence. Women exposed to physical IPV were three times more likely to experience PTB (AOR = 2.9; CI 95%: 1.3-6.5) and LBW (AOR = 3.2; CI 95%: 1.3-7.7). Women with previous adverse pregnancy outcomes and exposure to physical IPV had a further increased risk of PTB (AOR = 4.5; CI 95%: 1.5-13.7) and LBW (AOR = 4.8; CI 95%: 1.6-14.8) compared to those without previous history of adverse outcome. Conclusion Women who are exposed to IPV during pregnancy are at increased risk of PTB and LBW. The risk is even stronger if the women additionally have suffered a previous adverse pregnancy outcome. Interventions addressing IPV are urgently needed to prevent occurrence and reoccurrence of PTB and LBW.	[Sigalla, Geofrey Nimrod; Mushi, Declare; Manongi, Rachel; Rogathi, Jane Januarius] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania; [Sigalla, Geofrey Nimrod] Evangel Lutheran Church Tanzania, Dept Hlth, Arusha, Tanzania; [Meyrowitsch, Dan Wolf] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Sigalla, GN (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania.; Sigalla, GN (corresponding author), Evangel Lutheran Church Tanzania, Dept Hlth, Arusha, Tanzania.	gnimrody@yahoo.com	Rasch, Vibeke/G-9393-2019; Mushi, Declare/H-2924-2019	Rasch, Vibeke/0000-0001-6557-0985; Meyrowitsch, Dan/0000-0003-1108-8987; Gammeltoft, Tine Mette/0000-0002-6723-2370; Manongi, Rachel/0000-0003-3841-974X	auspices of the interdisciplinary research project PAVE (The Impact of Violence on Reproductive Health in Tanzania and Vietnam) - DANIDA (the Danish International Development Agency) [12-006KU]	auspices of the interdisciplinary research project PAVE (The Impact of Violence on Reproductive Health in Tanzania and Vietnam) - DANIDA (the Danish International Development Agency)	This research was conducted under the auspices of the interdisciplinary research project PAVE (The Impact of Violence on Reproductive Health in Tanzania and Vietnam) which is funded by DANIDA (the Danish International Development Agency; project number 12-006KU). The funders had no role in study design, data collection and analysis, manuscript preparation, or decision to publish.	Nunes MAA, 2011, EUR J PUBLIC HEALTH, V21, P92, DOI 10.1093/eurpub/ckp241; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Barr WB, 2004, INT J GYNECOL OBSTET, V87, P38, DOI 10.1016/j.ijgo.2004.06.008; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Campbell J, 1999, AM J EPIDEMIOL, V150, P714; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Fawzy M, 2016, HUM FERTIL, V19, P9, DOI 10.3109/14647273.2016.1142214; Audi CAF, 2008, J PEDIAT-BRAZIL, V84, P60, DOI 10.2223/JPED.1744; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Kaye DK, 2006, TROP MED INT HEALTH, V11, P1576, DOI 10.1111/j.1365-3156.2006.01711.x; Mahande MJ, 2013, TROP MED INT HEALTH, V18, P962, DOI 10.1111/tmi.12111; Mahenge B, 2013, BJOG-INT J OBSTET GY, V120, P940, DOI 10.1111/1471-0528.12185; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Maman S, 2010, J INTERPERS VIOLENCE, V25, P1855, DOI 10.1177/0886260509354498; National Bureau of Statistics (Tanzania) & ICF Macro, 2011, TANZ DEM HLTH SURV 2; Ouyang FX, 2013, B WORLD HEALTH ORGAN, V91, P357, DOI 10.2471/BLT.12.111021; Romero-Gutierrez G, 2011, MIDWIFERY, V27, P750, DOI 10.1016/j.midw.2010.06.015; Sanchez SE, 2012, CHILD HLTH J, V17, P485; Sania A, 2014, PAEDIATR PERINAT EP, V28, P23, DOI 10.1111/ppe.12085; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; Stockl H, 2010, REPROD HEALTH MATTER, V18, P171, DOI 10.1016/S0968-8080(10)36525-6; Taylor CA, 2009, AM J PUBLIC HEALTH, V99, P175, DOI 10.2105/AJPH.2007.126722; Sclowitz IKT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-20; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; Urquia ML, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-42; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Watts C, 1999, PUTTING WOMEN 1 ETHI; Wegienka G, 2005, J WOMENS HEALTH, V14, P248, DOI 10.1089/jwh.2005.14.248; WHO, 2013, GLOB REG EST VIOL WO, V57; WHO, 2013, RESPONDING INTIMATE; World Health Organization, VIOLENCE AGAINST WOM	34	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172540	10.1371/journal.pone.0172540	http://dx.doi.org/10.1371/journal.pone.0172540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235031	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200090
J	Kuwata, H; Okamura, S; Hayashino, Y; Tsujii, S; Ishii, H				Kuwata, Hirohito; Okamura, Shintaro; Hayashino, Yasuaki; Tsujii, Satoru; Ishii, Hitoshi		Diabet Distress Care Registry T	Higher levels of physical activity are independently associated with a lower incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: A prospective cohort study, Diabetes Distress and Care Registry at Tenri (DDCRT15)	PLOS ONE			English	Article							GLYCEMIC CONTROL; PROLIFERATIVE RETINOPATHY; HIGH PREVALENCE; RISK-FACTORS; COMPLICATIONS; MORTALITY; MELLITUS; EPIDEMIOLOGY; NEPHROPATHY; PROGRESSION	We assessed the prospective association between baseline levels of physical activity (PA) and the incidence of newly developed diabetic retinopathy (DR) in patients with type 2 diabetes. Data from 1,814 patients with type 2 diabetes without DR were obtained from a Japanese diabetes registry at Tenri Hospital, Nara, Japan. To assess the independent correlations between baseline PA levels and newly developed DR, the participants were divided into five categories based on their PA levels. A Cox proportional hazards model with time-varying exposure information was used and adjusted for potential confounders to assess the independent correlations. At baseline, the mean age, BMI, and hemoglobin A1c levels of the patients were 65.5 years, 24.5 kg/m(2), and 7.2% (54 mmol/mol), respectively. After 2 years, newly developed DR was confirmed in 184 patients (10.1%). Patients with newly developed DR had longer duration of type 2 diabetes (14.7 versus 11.0 years, p < 0.0001), higher systolic blood pressure (139.2 versus 135.1 mmHg, p = 0.0012), lower estimated glomerular filtration rate (74.0 versus 77.1 mL/min/1.73 m(2), p = 0.0382), greater urinary albumin - creatinine ratio (4.00 versus 2.45 mg/mmol, p < 0.0039), and higher HbA1c levels (7.5 versus 7.2%, p = 0.0006) than those without newly developed DR. The multivariable-adjusted hazard ratios for DR development were 0.87 (95% CI, 0.53 - 1.40; p = 0.557), 0.83 (95% CI, 0.52 - 1.31; p = 0.421), 0.58 (95% CI, 0.35 - 0.94; p = 0.027), and 0.63 (95% CI, 0.42 - 0.94; p = 0.025) for the second, third, fourth, and fifth PA categories, respectively, compared with the reference category of patients with a mean PA of 0 metabolic equivalent of task-hours/week). Higher PA levels are independently associated with a lower incidence of DR in Japanese patients with type 2 diabetes.	[Kuwata, Hirohito; Ishii, Hitoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan; [Okamura, Shintaro; Hayashino, Yasuaki; Tsujii, Satoru] Tenriyorozu Hosp, Dept Endocrinol, Tenri, Nara, Japan	Nara Medical University	Ishii, H (corresponding author), Nara Med Univ, Dept Diabetol, Kashihara, Nara, Japan.	hit3910@gmail.com	Hayashino, Yasuaki/AAA-8637-2022	Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii, Satoru/0000-0002-1834-6515; Okamura, Shintaro/0000-0002-1205-6883	Manpei Suzuki Diabetes Foundation; Takeda Pharmaceutical Company Limited; JSPS KAKENHI [25460641]; Grants-in-Aid for Scientific Research [16K08897] Funding Source: KAKEN	Manpei Suzuki Diabetes Foundation; Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Manpei Suzuki Diabetes Foundation, the grants and endowment from Takeda Pharmaceutical Company Limited, and JSPS KAKENHI (Grant Number 25460641); however, they played no role in the design, conduct, data collection, analysis, or interpretation of the study, or in the preparation, review, or approval of the manuscript.	American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS20, DOI 10.2337/dc15-S007; Blomster JI, 2013, DIABETES OBES METAB, V15, P1008, DOI 10.1111/dom.12122; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Coker RH, 2009, J CLIN ENDOCR METAB, V94, P4258, DOI 10.1210/jc.2008-2033; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CRUICKSHANKS KJ, 1992, DIABETES CARE, V15, P1267, DOI 10.2337/diacare.15.10.1267; CRUICKSHANKS KJ, 1995, OPHTHALMOLOGY, V102, P1177, DOI 10.1016/S0161-6420(95)30893-7; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Fenwick E, 2012, CLIN EXP OPHTHALMOL, V40, P27, DOI 10.1111/j.1442-9071.2011.02599.x; FUKUDA M, 1983, Tohoku Journal of Experimental Medicine, V141, P331; Hayashino Y, 2013, EXP CLIN ENDOCR DIAB, V121, P628, DOI 10.1055/s-0033-1355424; Hayashino Y, 2014, DIABETES CARE, V37, P2459, DOI 10.2337/dc13-2312; Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005; Ito D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138037; Kamada M, 2014, J EPIDEMIOL, V24, P474, DOI 10.2188/jea.JE20140025; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KRISKA AM, 1991, J CLIN EPIDEMIOL, V44, P1207, DOI 10.1016/0895-4356(91)90153-Z; Kuwata H, 2016, DIABETOL INT; LAPORTE RE, 1986, PEDIATRICS, V78, P1027; LEHMANN R, 1995, DIABETOLOGIA, V38, P1313; Lu B, 2007, DIABETES RES CLIN PR, V75, P184, DOI 10.1016/j.diabres.2006.06.024; Mashitani T, 2015, ACTA DIABETOL, V52, P639, DOI 10.1007/s00592-015-0725-0; Mashitani T, 2014, DIABETES CARE, V37, P252, DOI 10.2337/dc13-0407; Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Murase N, 2002, J HLTH WELF STAT, V49, P1; Pradeepa R, 2010, DIABETES TECHNOL THE, V12, P755, DOI 10.1089/dia.2010.0069; Sclavo M, 2001, Ital Heart J Suppl, V2, P563; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Waden J, 2008, DIABETES CARE, V31, P230, DOI 10.2337/dc07-1238; Waden J, 2015, DIABETOLOGIA, V58, P929, DOI 10.1007/s00125-015-3499-6; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yasuaki Hayashino, 2016, ACTA DIABETOL; Zethelius B, 2014, EUR J PREV CARDIOL, V21, P244, DOI 10.1177/2047487313510893	39	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172890	10.1371/journal.pone.0172890	http://dx.doi.org/10.1371/journal.pone.0172890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257419	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100037
J	Whelan, FJ; Heirali, AA; Rossi, L; Rabin, HR; Parkins, MD; Surette, MG				Whelan, Fiona J.; Heirali, Alya A.; Rossi, Laura; Rabin, Harvey R.; Parkins, Michael D.; Surette, Michael G.			Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis	PLOS ONE			English	Article							PULMONARY EXACERBATIONS; RESPIRATORY-TRACT; GENE; COMMUNITIES; DISEASE; SPUTUM; EPIDEMIOLOGY; STABILITY; SEQUENCES; DYNAMICS	Cystic fibrosis (CF) manifests in the lungs resulting in chronic microbial infection. Most morbidity and mortality in CF is due to cycles of pulmonary exacerbations-episodes of acute inflammation in response to the lung microbiome-which are difficult to prevent and treat because their cause is not well understood. We hypothesized that longitudinal analyses of the bacterial component of the CF lung microbiome may elucidate causative agents within this community for pulmonary exacerbations. In this study, 6 participants were sampled thrice-weekly for up to one year. During sampling, sputum, and data (antibiotic usage, spirometry, and symptom scores) were collected. Time points were categorized based on relation to exacerbation as Stable, Intermediate, and Treatment. Retrospectively, a subset of were interrogated via 16S rRNA gene sequencing. When samples were examined categorically, a significant difference between the lung microbiota in Stable, Intermediate, and Treatment samples was observed in a subset of participants. However, when samples were examined longitudinally, no correlations between microbial composition and collected data (antibiotic usage, spirometry, and symptom scores) were observed upon exacerbation onset. In this study, we identified no universal indicator within the lung microbiome of exacerbation onset but instead showed that changes to the CF lung microbiome occur outside of acute pulmonary episodes and are patient-specific.	[Whelan, Fiona J.; Rossi, Laura; Surette, Michael G.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Heirali, Alya A.; Rabin, Harvey R.; Parkins, Michael D.; Surette, Michael G.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Rabin, Harvey R.; Parkins, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Surette, Michael G.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Calgary; University of Calgary; McMaster University	Surette, MG (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Surette, MG (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Surette, MG (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	surette@mcmaster.ca	Surette, Michael G/AAE-8825-2020; Whelan, Fiona/AAE-9386-2020	Whelan, Fiona/0000-0001-9165-4859	Cystic Fibrosis Canada; Cystic Fibrosis Canada Doctoral Studentship; Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship; Canada Research Chair in Interdisciplinary Microbiome Research	Cystic Fibrosis Canada; Cystic Fibrosis Canada Doctoral Studentship; Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Interdisciplinary Microbiome Research	This work was supported by grants from Cystic Fibrosis Canada to MGS and MDP. FJW is supported by a Cystic Fibrosis Canada Doctoral Studentship and a Canadian Institutes of Health Research (CIHR) Fredrick Banting and Charles Best Canadian Graduate Scholarship. MGS is supported as a Canada Research Chair in Interdisciplinary Microbiome Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2004, AM J RESP CRIT CARE, V169, P811, DOI 10.1164/rccm.200309-1306OC; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody LA, 2013, CHANGES CYSTIC FIBRO; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cuthbertson L, 2016, ISME J, V10, P1081, DOI 10.1038/ismej.2015.198; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elborn J. S., 2016, LANCET; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Hiatt PW, 1999, PEDIATRICS, V103, P619, DOI 10.1542/peds.103.3.619; Jarad NA, 2012, QJM-INT J MED, V105, P137, DOI 10.1093/qjmed/hcr149; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kramer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117436; Lam JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0856-5; Levesque C, 2003, ORAL MICROBIOL IMMUN, V18, P333, DOI 10.1034/j.1399-302X.2003.00085.x; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lynch S V., 2013, COLD SPRING HARB PER, V3; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Muzanye G, 2009, AFR HEALTH SCI, V9, P200; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Sakamoto H, 1998, Bull Tokyo Dent Coll, V39, P103; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Sibley CD, 2010, J MED MICROBIOL, V59, P534, DOI 10.1099/jmm.0.016592-0; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith DJ, 2014, EUR RESPIR J, V44, P922, DOI 10.1183/09031936.00203013; Surette MG, 2014, CYSTIC FIBROSIS LUNG; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Whelan FJ, 2015, ANN AM THORAC SOC, V12, pS207, DOI 10.1513/AnnalsATS.201506-353AW; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15; Ye Y, 2011, P IEEE INT C BIOINFO, V2010, P153, DOI DOI 10.1109/BIBM.2010.5706555; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	50	47	47	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172811	10.1371/journal.pone.0172811	http://dx.doi.org/10.1371/journal.pone.0172811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253277	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300038
J	El-Sayed, SE; Kora, MA; Sallam, HM; Claeson, KM; Seiffert, ER; Antar, MS				El-Sayed, Sanaa E.; Kora, Mahmoud A.; Sallam, Hesham M.; Claeson, Kerin M.; Seiffert, Erik R.; Antar, Mohammed S.			A new genus and species of marine catfishes (Siluriformes; Ariidae) from the upper Eocene Birket Qarun Formation, Wadi El-Hitan, Egypt	PLOS ONE			English	Article							AL-HITAN; FAYUM PROVINCE; MIDDLE; ICHTHYOFAUNA	Wadi El-Hitan, the UNESCO World Heritage Site, of the Fayum Depression in the northeast part of the Western Desert of Egypt, has produced a remarkable collection of Eocene vertebrates, in particular the fossil whales from which it derives its name. Here we describe a new genus and species of marine catfishes (Siluriformes; Ariidae), Qarmoutus hitanensis, from the base of the upper Eocene Birket Qarun Formation, based on a partial neurocranium including the complete left side, partial right dentary, left suspensorium, two opercles, left pectoral girdle and spine, nuchal plates, first and second dorsal spines, Weberian apparatus and a disassociated series of abdominal vertebrae. All of the elements belong to the same individual and some of them were found articulated. Qarmoutus gen. nov. is the oldest and the most complete of the Paleogene marine catfishes unearthed from the Birket Qarun Formation. The new genus exhibits distinctive features not seen in other African Paleogene taxa, such as different sculpturing on the opercle and pectoral girdle with respect to that on the neurocranium and nuchal plates, denticulate ornamentation on the skull bones arranged in longitudinal rows and forming a radiating pattern on the sphenotic, pterotic, extrascapular and the parieto-supraoccipital, indentations or pitted ornamentation on the nuchal plates as well as the parieto-supraoccipital process, strut-like radiating pattern of ornamentation on the opercle from the proximal articulation to margins, longitudinal, curved, reticulate ridges and tubercular ornamentations on the cleithrum, sinuous articulation between the parietosupraoccipital process and the anterior nuchal plate, long, narrow, and arrowhead shaped nuchal shield, very small otic capsules restricted to the prootic. Multiple parsimony and Bayesian morphological phylogenetic analyses of Ariidae, run with and without "molecular scaffolds", yield contradictory results for the placement of Qarmoutus; the genus is either a phylogenetically basal ariid, or it is deeply nested within the ariid clade containing New World species of Sciades.	[El-Sayed, Sanaa E.; Kora, Mahmoud A.; Sallam, Hesham M.] Mansoura Univ, Fac Sci, Dept Geol, Mansoura Univ Vertebrate Paleontol Ctr MUVP, Mansoura, Egypt; [Claeson, Kerin M.] Philadelphia Coll Osteopath Med, Dept Anat, Philadelphia, PA USA; [Seiffert, Erik R.] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Antar, Mohammed S.] Egyptian Environm Affairs Agcy, Dept Geol & Paleontol, Nat Conservat Sect, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University; University of Southern California	El-Sayed, SE (corresponding author), Mansoura Univ, Fac Sci, Dept Geol, Mansoura Univ Vertebrate Paleontol Ctr MUVP, Mansoura, Egypt.	sanaa_elsayed@mans.edu.eg	Sallam, Hesham/T-6534-2018	El-Sayed, Sanaa/0000-0002-0092-6212; Sallam, Hesham/0000-0001-6584-6312	Mansoura University research fund; Society of Vertebrate Paleontology	Mansoura University research fund; Society of Vertebrate Paleontology	This work was supported by Mansoura University research fund.; We thank the Egyptian Environmental Affairs Agency (EEAA) for facilitating the field work in the Wadi El-Hitan protectorate and its working team in the protectorate especially Mr. Bakry Abd Allah and Mr. Abdel- Samei Nada. We are grateful to MUVP team: Miss Iman El-Dawoudi, Miss Mai El-Amir and Mr. Farahat Ibrahim for their enthusiastic support and helping in unearthing, preparation and photographing the specimen. Thanks to John G. Lundberg, The Academy of Natural Sciences, Philadelphia, Alison M. Murray, Department of Biological Sciences, University of Alberta and Olga Otero Universite de Poitiers for their valuable comments and suggestion on the earlier version of the manuscript. In addition we thank Alexandre P. Marceniuk, Universidade Federal do Para, for providing the data matrix. Thanks to the Society of Vertebrate Paleontology for the SEDN grant in 2014 to the lead author (SE) in order to represent this work in the SVP 74th Annual Meeting in Berlin.	Abdel-Fattah ZA, 2011, SEDIMENT GEOL, V233, P111, DOI 10.1016/j.sedgeo.2010.11.001; Abdel-Fattah ZA, 2010, SEDIMENTOLOGY, V57, P446, DOI 10.1111/j.1365-3091.2009.01091.x; Anan T, 2014, J AFR EARTH SCI, V100, P614, DOI 10.1016/j.jafrearsci.2014.08.015; Andrews CW, 1904, TRUSTEES BRIT MUSEUM; Arratia G, 1995, J VERTEBR PALEONTOL, V15, P482, DOI 10.1080/02724634.1995.10011243; Baras E, 2003, CATFISHES, VOLS 1-2, P525; Betancur-R R, 2010, MOL PHYLOGENET EVOL, V55, P249, DOI 10.1016/j.ympev.2009.12.018; Betancur-R R, 2007, MOL PHYLOGENET EVOL, V45, P339, DOI 10.1016/j.ympev.2007.02.022; Betancur R, 2009, EVOLUTION, V63, P1232, DOI 10.1111/j.1558-5646.2009.00640.x; Bleeker, 1862, ATLAS ICHTHYOLOGIQUE, VII; Brochu Christopher A., 2000, Contributions from the Museum of Paleontology University of Michigan, V30, P251; DEPINNA MCC, 1993, THESIS CITY U NEW YO, P1; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Elewa A.M., 1998, EGYPT J GEOL, V42, P439; Ferraris Jr CJ, 2007, ZOOTAXA 0308, V1418, P628, DOI DOI 10.11646/ZOOTAXA.1418.1.1; Fink S. V., 1996, INTERRELATIONSHIPS F, P209, DOI DOI 10.1111/J.1096-3642.1981.TB01575.X; FROESE R., 2022, US; Gayet M, 2003, CATFISHES, VOLS 1-2, P491; GAYET M, 1990, Journal of African Zoology, V104, P241; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Gingrich PD, 2012, EGYPT J PALEONTOL, V11, P171; Greenwood P.H., 1974, Annals of the Geological Survey of Egypt, V4, P211; Haggag M.A., 1990, NEU JB GEOL PALAONT, V5, P295; Kailola Patricia J., 2004, Beagle, V20, P87; Longbottom A, 2010, PALAEONTOLOGY, V53, P571, DOI 10.1111/j.1475-4983.2010.00946.x; Marceniuk AP, 2007, ZOOTAXA, P1; Marceniuk AP, 2012, ZOOL J LINN SOC-LOND, V165, P534, DOI 10.1111/j.1096-3642.2012.00822.x; Mo T, 1991, ANATOMY RELATIONSHIP, P1; Murray AM, 2010, J VERTEBR PALEONTOL, V30, P665, DOI 10.1080/02724631003758060; Murray AM, 2004, PALAEONTOLOGY, V47, P711, DOI 10.1111/j.0031-0239.2004.00384.x; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Otero O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144358; Otero O, 2009, PALAEOGEOGR PALAEOCL, V274, P134, DOI 10.1016/j.palaeo.2009.01.005; PEYER B., 1928, ABHANDL BAYERISCHEN AKAD WINS MAT NAT, V32, P1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stromer E., 1904, NEUES JB MINERALOGIE, V1; Strougo Amin, 2013, Contributions from the Museum of Paleontology University of Michigan, V32, P111; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Underwood CJ, 2011, J VERTEBR PALEONTOL, V31, P707, DOI 10.1080/02724634.2011.563763; Underwood CJ, 2011, P GEOLOGIST ASSOC, V122, P47, DOI 10.1016/j.pgeola.2010.09.004; Vanscoy T, 2015, P ACAD NAT SCI PHILA, V164, P177, DOI 10.1635/053.164.0107; White E.I., 1926, B GEOL SURV NIGER, V10, P1, DOI DOI 10.1093/OXFORDJOURNALS.AFRAF.A100500; Whitley G. P., 1947, Australian Zoologist, V11, P129; Zalmout Iyad S., 2012, Museum of Paleontology Papers on Paleontology, V37, P1	45	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172409	10.1371/journal.pone.0172409	http://dx.doi.org/10.1371/journal.pone.0172409			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248973	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500040
J	Nakayama, DG; Santos, CD; Kishi, LT; Pedezzi, R; Santiago, AC; Soares-Costa, A; Henrique-Silva, F				Nakayama, Darlan Goncalves; Santos Junior, Cello Dias; Kishi, Luciano Takeshi; Pedezzi, Rafael; Santiago, Adelita Carolina; Soares-Costa, Andrea; Henrique-Silva, Flavio			A transcriptomic survey of Migdolus fryanus (sugarcane rhizome borer) larvae	PLOS ONE			English	Article							PATTERN-RECOGNITION PROTEIN; MANDUCA-SEXTA SERPIN-4; DIGESTIVE PROTEINASES; MOLECULAR-CLONING; INHIBITOR SERPIN; RNA INTERFERENCE; SERINE-PROTEASE; INSECT; EXPRESSION; MIDGUT	Sugarcane, a major crop grown in the tropical and subtropical areas of the world, is produced mainly for sucrose, which is used as a sweetener or for the production of bioethanol. Among the numerous pests that significantly affect the yield of sugarcane, the sugarcane rhizome borer (Migdolus fryanus, a cerambycidae beetle) is known to cause severe damage to the crops in Brazil. The absence of molecular information about this insect reinforces the need for studies and an effective method to control this pest. In this study, RNA-Seq technology was employed to study different parts of M. fryanus larvae. The generated data will help in further investigations about the taxonomy, development, and adaptation of this insect. RNA was extracted from six different parts (head, fat body, integument, hindgut, midgut, and foregut) using Trizol methodology. Using Illumina paired-end sequencing technology and the Trinity platform, trimming and de novo assembly was performed, resulting in 44,567 contigs longer than 200 nt for a reunion of data from all transcriptomes, with a mean length of 1,095.27 nt. Transcripts were annotated using BLAST against different protein databanks (Uniprot/Swissprot, PFAM, KEEG, SignalP 4.1, Gene Ontology, and CAZY) and were compared for similarity using a Venn diagram. Differential expression patterns were studied for select genes through qPCR and FPKM comprising important protein families (digestive peptidases, glucosyl hydrolases, serine protease inhibitors and otopetrin), which allowed a better understanding of the insect's digestion, immunity and gravity sensorial mechanisms.	[Nakayama, Darlan Goncalves; Soares-Costa, Andrea] Univ Fed Sao Carlos, Plant Biotechnol Lab, Dept Genet & Evolut, Sao Carlos, SP, Brazil; [Santos Junior, Cello Dias; Kishi, Luciano Takeshi; Pedezzi, Rafael; Santiago, Adelita Carolina; Henrique-Silva, Flavio] Univ Fed Sao Carlos, Mol Biol Lab, Dept Genet & Evolut, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Henrique-Silva, F (corresponding author), Univ Fed Sao Carlos, Mol Biol Lab, Dept Genet & Evolut, Sao Carlos, SP, Brazil.	dfhs@ufscar.br	Santos-Júnior, Célio D./F-5580-2013; Henrique-Silva, Flavio/A-1937-2013; Pedezzi, Rafael/J-5735-2015; Santiago, Adelita Carolina/R-9825-2017; Kishi, Luciano T/O-3982-2014; Soares-Costa, Andrea/D-8270-2012	Santos-Júnior, Célio D./0000-0002-1974-1736; Pedezzi, Rafael/0000-0001-9932-8847; Kishi, Luciano T/0000-0003-0449-4274; Goncalves Nakayama, Darlan/0000-0002-5633-3846; Henrique-Silva, Flavio/0000-0003-3329-4597	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp); ETH Bioenergia [2012/50060-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES); National Council for Scientific and Technological Development (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ETH Bioenergia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) and ETH Bioenergia (award number 2012/50060-7). DGN received a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).; DGN is a recipient of a scholarship from the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES). FHS is a recipient of a productivity scholarship from the National Council for Scientific and Technological Development (CNPq).	An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Arrigoni EB, 1988, B TECNICO COPERSUCAR, V40, P24; Asokan R, 2014, J PEST SCI, V87, P163, DOI 10.1007/s10340-013-0541-7; Bento J.M.S., 1995, SALVADOR, V58; Bragatto I, 2010, INSECT BIOCHEM MOLEC, V40, P861, DOI 10.1016/j.ibmb.2010.08.006; Brand P, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0451-9; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Chamankhah A, 2003, INSECT BIOCHEM MOLEC, V33, P355, DOI 10.1016/S0965-1748(02)00263-1; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Clem RJ, 2010, INSECT VIROLOGY, P389; Cristofoletti PT, 2001, J INSECT PHYSIOL, V47, P143, DOI 10.1016/S0022-1910(00)00098-6; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Fonseca FCDA, 2015, PLOS ONE, V10, P1; Fonseca FPP, 2012, INSECT BIOCHEM MOLEC, V42, P58, DOI 10.1016/j.ibmb.2011.10.008; Fonseca FPP, 2011, PROTEIN J, V30, P404, DOI 10.1007/s10930-011-9345-x; Fonseca LP, 1958, ARQUIVOS I BIOL SAO, V25, P29; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Geib SM, 2010, INSECT SCI, V17, P253, DOI 10.1111/j.1744-7917.2010.01323.x; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAVENA S, 1985, Anais da Sociedade Entomologica do Brasil, V14, P165; Grimaldi DA, 2010, ARTHROPOD STRUCT DEV, V39, P191, DOI 10.1016/j.asd.2009.10.008; Hegedus DD, 2008, GENE, V418, P15, DOI 10.1016/j.gene.2008.03.015; Hughes AL, 2012, IMMUNOGENETICS, V64, P549, DOI 10.1007/s00251-012-0610-8; Hughes I, 2004, DEV BIOL, V276, P391, DOI 10.1016/j.ydbio.2004.09.001; Hughes I, 2007, P NATL ACAD SCI USA, V104, P12023, DOI 10.1073/pnas.0705182104; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jiang R, 2011, J BIOL CHEM, V286, P35087, DOI 10.1074/jbc.M111.277343; Jurat-Fuentes JL., 2015, PLOS ONE, V5, P1; Kanagawa M, 2011, J BIOL CHEM, V286, P29158, DOI 10.1074/jbc.M111.256701; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pedezzi R, 2014, INSECT BIOCHEM MOLEC, V55, P31, DOI 10.1016/j.ibmb.2014.10.005; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Pigatti P, 1966, BIOLOGICO SAO PAULO, V23, P217; Pigatti P, 1962, BIOLOGICO SAO PAULO, V27, P201; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMUELS RI, 1995, COMP BIOCHEM PHYS B, V110, P661, DOI 10.1016/0305-0491(94)00205-9; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Scully ED, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-850; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sonobe H, 2006, J BIOL CHEM, V281, P29513, DOI 10.1074/jbc.M604035200; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUGUMARAN M, 1991, FEBS LETT, V295, P233, DOI 10.1016/0014-5793(91)81431-7; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Terra WR, 1996, COMP BIOCHEM PHYS B, V113, P725, DOI 10.1016/0305-0491(95)02037-3; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valencia A, 2013, GENE, V513, P260, DOI 10.1016/j.gene.2012.10.046; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Willis JD, 2011, J INSECT PHYSIOL, V57, P300, DOI 10.1016/j.jinsphys.2010.11.019; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016	70	6	6	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173059	10.1371/journal.pone.0173059	http://dx.doi.org/10.1371/journal.pone.0173059			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248990	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500072
J	Ramke, J; Gilbert, CE; Lee, AC; Ackland, P; Limburg, H; Foster, A				Ramke, Jacqueline; Gilbert, Clare E.; Lee, Arier C.; Ackland, Peter; Limburg, Hans; Foster, Allen			Effective cataract surgical coverage: An indicator for measuring quality-of-care in the context of Universal Health Coverage	PLOS ONE			English	Article							VISUAL-IMPAIRMENT; SURGERY; BLINDNESS; PREVALENCE; OUTCOMES; KENYA; PEEK	Objective To define and demonstrate effective cataract surgical coverage (eCSC), a candidate UHC indicator that combines a coverage measure (cataract surgical coverage, CSC) with quality (post-operative visual outcome). Methods All Rapid Assessment of Avoidable Blindness (RAAB) surveys with datasets on the online RAAB Repository on April 1 2016 were downloaded. The most recent study from each country was included. By country, cataract surgical outcome (CSOGood, 6/18 or better; CSOPoor, worse than 6/60), CSC (operated cataract as a proportion of operable plus operated cataract) and eCSC (operated cataract and a good outcome as a proportion of operable plus operated cataract) were calculated. The association between CSC and CSO was assessed by linear regression. Gender inequality in CSC and eCSC was calculated. Findings Datasets from 20 countries were included (2005-2013; 67,337 participants; 5,474 cataract surgeries). Median CSC was 53.7% (inter-quartile range[IQR] 46.1-66.6%), CSOGood was 58.9% (IQR 53.7-67.6%) and CSOPoor was 17.7% (IQR 11.3-21.1%). Coverage and quality of cataract surgery were moderately associated-every 1% CSC increase was associated with a 0.46% CSOGood increase and 0.28% CSOPoor decrease. Median eCSC was 36.7% (IQR 30.2-50.6%), approximately one-third lower than the median CSC. Women tended to fare worse than men, and gender inequality was slightly higher for eCSC (4.6% IQR 0.5-7.1%) than for CSC (median 2.3% IQR -1.5-11.6%). Conclusion eCSC allows monitoring of quality in conjunction with coverage of cataract surgery. In the surveys analysed, on average 36.7% of people who could benefit from cataract surgery had undergone surgery and obtained a good visual outcome.	[Ramke, Jacqueline] Univ New South Wales, Sch Social Sci, Fac Arts & Social Sci, Sydney, NSW, Australia; [Ramke, Jacqueline; Lee, Arier C.] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Gilbert, Clare E.; Foster, Allen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England; [Ackland, Peter] Int Agcy Prevent Blindness, London, England; [Limburg, Hans] Hlth Informat Serv, Nijenburg 32, Grootebroek, Netherlands	University of New South Wales Sydney; University of Auckland; University of London; London School of Hygiene & Tropical Medicine	Ramke, J (corresponding author), Univ New South Wales, Sch Social Sci, Fac Arts & Social Sci, Sydney, NSW, Australia.; Ramke, J (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland, New Zealand.	jramke@gmail.com	Ramke, Jacqueline/I-8844-2019	Ramke, Jacqueline/0000-0002-5764-1306; Foster, Allen/0000-0003-2368-4436				Ahmad K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131774; Bastawrous A, 2015, JAMA OPHTHALMOL, V133, P930, DOI 10.1001/jamaophthalmol.2015.1468; Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001728; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Congdon N, 2016, LANCET GLOB HEALTH, V4, pE96, DOI 10.1016/S2214-109X(15)00267-3; Danquah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094140; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115; Duerksen R, 2013, OPHTHAL EPIDEMIOL, V20, P301, DOI 10.3109/09286586.2013.821497; Essue BM, 2014, OPHTHALMOLOGY, V121, P2138, DOI 10.1016/j.ophtha.2014.05.014; Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; He W., 2016, AN AGING WORLD 2015; Health Information Services, RAAB REPOSITORY 2014; Henry JA, 2015, WORLD J SURG, V39, P822, DOI 10.1007/s00268-014-2937-9; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hogan D, 2016, DEV INDEX COVERAGE E; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Limburg H, 1998, Community Eye Health, V11, P3; Limburg H, 2005, BRIT J OPHTHALMOL, V89, P50, DOI 10.1136/bjo.2004.045369; Limburg H, 2005, BRIT J OPHTHALMOL, V89, P45, DOI 10.1136/bjo.2004.045351; Lodhia V, 2016, JMIR MHEALTH UHEALTH, V4, P72, DOI 10.2196/mhealth.4746; Mathenge W, 2012, OPHTHALMOLOGY, V119, P2033, DOI 10.1016/j.ophtha.2012.04.019; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Ng M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001730; Riaz Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001323.pub2; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2016, WHAT IS UN COV; World Health Organization, 2014, FINAL REPORT OF THE; World Health Organization, 2001, BACKGR PAP TECHN CON; World Health Organization, 1988, GUID HLTH HOUS; World Health Organization, 2013, UN EYE HLTH GLOB ACT; World Health Organization & World Bank, 2013, MON PROGR UN HLTH CO; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543	41	52	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172342	10.1371/journal.pone.0172342	http://dx.doi.org/10.1371/journal.pone.0172342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249047	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000395983500038
J	Saglimbene, V; Palmer, SC; Craig, JC; Ruospo, M; Nicolucci, A; Tonelli, M; Johnson, D; Lucisano, G; Williams, G; Valentini, M; D'Alonzo, D; Pellegrini, F; Strippoli, P; Salomone, M; Santoro, A; Maffei, S; Hegbrant, J; Tognoni, G; Strippoli, GFM				Saglimbene, Valeria; Palmer, Suetonia C.; Craig, Jonathan C.; Ruospo, Marinella; Nicolucci, Antonio; Tonelli, Marcello; Johnson, David; Lucisano, Giuseppe; Williams, Gabrielle; Valentini, Miriam; D'Alonzo, Daniela; Pellegrini, Fabio; Strippoli, Paolo; Salomone, Mario; Santoro, Antonio; Maffei, Stefano; Hegbrant, Joergen; Tognoni, Gianni; Strippoli, Giovanni F. M.		CE-DOSE Study Investigators	Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; STAGE RENAL-DISEASE; CARDIOVASCULAR EVENTS; EPOETIN-ALPHA; MORTALITY; ASSOCIATION; MORBIDITY; IMPACT	The increased risks of death and adverse events with erythropoiesis-stimulating agent (ESA) therapy targeting a higher hemoglobin level are established. It is uncertain whether the adverse effects of ESA therapy are related to dose and are mitigated when a fixed low ESA dose is used. We conducted a multicenter, prospective randomized open-label, blinded-endpoint (PROBE) trial to evaluate fixed low versus high dose ESA therapy on patient outcomes. We intended to recruit 2104 hemodialysis patients >18 years with anemia or receiving ESA treated at dialysis clinics in Italy. The intervention was fixed low (4000 IU epoetin alfa equivalent weekly) or high (18,000 IU epoetin alfa equivalent weekly) dose ESA for 12 months. Primary outcomes were serum transferrin, ferritin, albumin, C-reactive protein and ESA dose. Secondary outcomes were the composite of death or cardiovascular event, all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, cardiovascular hospitalization, and quality of life. Study recruitment was terminated after inclusion of 656 participants with convergence of ESA dose between groups during follow up. Fixed low dose ESA had uncertain effects on serum ferritin (delta of delta (DD) 3.9 ng/ml, 95% CI -85.0 to 92.8), transferrin (9.2 mg/dl, -6.3 to 24.8), transferrin saturation (3.7%, -5.0 to 12.3), serum albumin (-0.03 g/dl, -0.2 to 0.1), or C-reactive protein (-0.6 mg/l, -3.3 to 2.1). In addition, fixed dose therapy had inconclusive effects on the composite endpoint of mortality and cardiovascular events (hazard ratio [HR] 0.95, 95% CI 0.66 to 1.37), death (0.98, 0.64 to 1.52), nonfatal myocardial infarction (0.52, 0.18 to 1.52), nonfatal stroke (no events), hospital admission for cardiovascular causes (0.93, 0.50 to 1.72) or health-related quality of life. A fixed low ESA dose in hemodialysis patients has uncertain effects on serum parameters, mortality, cardiovascular events, and quality of life. Hemoglobin targets may be so entrenched in nephrology practice that a trial of ESA dose is no longer possible.	[Saglimbene, Valeria; Craig, Jonathan C.; Williams, Gabrielle; Strippoli, Giovanni F. M.] Univ Sydney, Sydney Sch Publ Hlth, Edward Ford Bldg, Sydney, NSW, Australia; [Saglimbene, Valeria; Ruospo, Marinella; Hegbrant, Joergen; Strippoli, Giovanni F. M.] Diaverum Renal Serv Grp, Lund, Sweden; [Palmer, Suetonia C.] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Ruospo, Marinella] Amedeo Avogadro Univ Eastern Piedmont, Novara, Italy; [Nicolucci, Antonio; Lucisano, Giuseppe] Ctr Outcomes Res & Clin Epidemiol CORESEARCH, Pescara, Italy; [Tonelli, Marcello] Univ Calgary, Cumming Sch Med, Hlth Sci Ctr, Foothills Campus, Calgary, AB, Canada; [Johnson, David] Univ Queensland, Princess Alexandra Hosp, Div Med, Dept Renal Med, Woolloongabba, Qld, Australia; [Johnson, David] Univ Queensland, Translat Res Inst, Woolloongabba, Qld, Australia; [Valentini, Miriam] Quintiles Srl, Milan, Italy; [D'Alonzo, Daniela] ASL Lanciano Vasto, Chieti, Italy; [Pellegrini, Fabio] Global Med Biogen Idec, Cambridge, MA USA; [Strippoli, Paolo] Osped A Perrino, Dept Nephrol & Dialysis, Brindisi, Italy; [Salomone, Mario; Maffei, Stefano] Osped Maggiore Chieri, Dept Nephrol & Dialysis, Chieri, Italy; [Santoro, Antonio] St Orsola Marcello Malpighi Hosp, Dept Nephrol & Dialysis, Bologna, Italy; [Tognoni, Gianni] Mario Negri Inst Pharmacol Res, Milan, Italy; [Strippoli, Giovanni F. M.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy	University of Sydney; Diaverum; University of Otago; University of Eastern Piedmont Amedeo Avogadro; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Queensland; University of Queensland; IQVIA; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universita degli Studi di Bari Aldo Moro	Strippoli, GFM (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Edward Ford Bldg, Sydney, NSW, Australia.; Strippoli, GFM (corresponding author), Diaverum Renal Serv Grp, Lund, Sweden.; Strippoli, GFM (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.	gfmstrippoli@gmail.com	Craig, Jonathan/E-2813-2013; Tonelli, Marcello/B-3028-2009; Johnson, David/F-2897-2011	Craig, Jonathan/0000-0002-2548-4035; Tonelli, Marcello/0000-0002-0846-3187; Johnson, David/0000-0001-5491-3460	Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA]) [FARM6X822T]	Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA])	The study received funding from the Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA]: grant number FARM6X822T). This trial was funded by the Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA]). The funder required the inclusion of specified outcomes during trial conduct, but played no role in finalizing the study design, data analysis, data interpretation, or report writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One or more of the authors are employed by a commercial company (Diaverum Renal Services Group: VS, MR, JH, GFMS, Quintiles srl: MV, Global Medical Biogen Idec: FP). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The funders provided support in the form of salaries for authors VS, MR, JH, GS, MV, FP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAHLMANN J, 1991, CONTRIB NEPHROL, V88, P90; Bellinghieri G, 2015, J RENAL NUTR, V25, P164, DOI 10.1053/j.jrn.2014.10.012; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Clement FM, 2009, ARCH INTERN MED, V169, P1104, DOI 10.1001/archinternmed.2009.112; Collins A J, 1998, Am J Kidney Dis, V32, pS133, DOI 10.1016/S0272-6386(98)70176-3; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hays R, 1995, P7994 RAND, P7994; Inrig JK, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-67; Italian Medicines Agency (AIFA) Research & Development Working Group, 2009, EUR J CLIN INVEST, V40, P69; Johnson DW, 2015, AM J KIDNEY DIS, V65, P49, DOI 10.1053/j.ajkd.2014.06.020; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-70; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; US Food and Drug Administration, 2011, FDA DRUG SAF COMM MO; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; Wyrwich KW, 2005, HEALTH SERV RES, V40, P577, DOI 10.1111/j.1475-6773.2005.0l374.x; Zhang Y, 2011, KIDNEY INT, V80, P663, DOI 10.1038/ki.2011.188; ZINS B, 1986, LANCET, V2, P1329	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172735	10.1371/journal.pone.0172735	http://dx.doi.org/10.1371/journal.pone.0172735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249030	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500055
J	Bryant, AE; Aldape, MJ; Bayer, CR; Katahira, EJ; Bond, L; Nicora, CD; Fillmore, TL; Clauss, TRW; Metz, TO; Webb-Robertson, BJ; Stevens, DL				Bryant, Amy E.; Aldape, Michael J.; Bayer, Clifford R.; Katahira, Eva J.; Bond, Laura; Nicora, Carrie D.; Fillmore, Thomas L.; Clauss, Therese R. W.; Metz, Thomas O.; Webb-Robertson, Bobbie-Jo; Stevens, Dennis L.			Effects of delayed NSAID administration after experimental eccentric contraction injury - A cellular and proteomics study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SKELETAL-MUSCLE INJURY; A STREPTOCOCCAL MYONECROSIS; SOFT-TISSUE INFECTIONS; VIMENTIN EXPRESSION; GENE-EXPRESSION; SATELLITE CELLS; PROTEIN; EXERCISE; APOPTOSIS	Background Acute muscle injuries are exceedingly common and non-steroidal anti-inflammatory drugs (NSAIDs) are widely consumed to reduce the associated inflammation, swelling and pain that peak 1-2 days post-injury. While prophylactic use or early administration of NSAIDs has been shown to delay muscle regeneration and contribute to loss of muscle strength after healing, little is known about the effects of delayed NSAID use. Further, NSAID use following non-penetrating injury has been associated with increased risk and severity of infection, including that due to group A streptococcus, though the mechanisms remain to be elucidated. The present study investigated the effects of delayed NSAID administration on muscle repair and sought mechanisms supporting an injury/NSAID/infection axis. Methods A murine model of eccentric contraction (EC)-induced injury of the tibialis anterior muscle was used to profile the cellular and molecular changes induced by ketorolac tromethamine administered 47 hr post injury. Results NSAID administration inhibited several important muscle regeneration processes and down-regulated multiple cytoprotective proteins known to inhibit the intrinsic pathway of programmed cell death. These activities were associated with increased caspase activity in injured muscles but were independent of any NSAID effect on macrophage influx or phenotype switching. Conclusions These findings provide new molecular evidence supporting the notion that NSAIDs have a direct negative influence on muscle repair after acute strain injury in mice and thus add to renewed concern about the safety and benefits of NSAIDS in both children and adults, in those with progressive loss of muscle mass such as the elderly or patients with cancer or AIDS, and those at risk of secondary infection after trauma or surgery.	[Bryant, Amy E.; Aldape, Michael J.; Bayer, Clifford R.; Katahira, Eva J.; Stevens, Dennis L.] US Dept Vet Affairs, Off Res & Dev, Boise, ID USA; [Bryant, Amy E.; Stevens, Dennis L.] Univ Washington, Sch Med, Seattle, WA USA; [Aldape, Michael J.] Northwest Nazarene Univ, Nampa, ID USA; [Bond, Laura] Boise State Univ, Boise, ID 83725 USA; [Nicora, Carrie D.; Fillmore, Thomas L.; Clauss, Therese R. W.; Metz, Thomas O.; Webb-Robertson, Bobbie-Jo] Pacific Northwest Natl Lab, Richland, WA 99352 USA	University of Washington; University of Washington Seattle; Idaho; Boise State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Bryant, AE (corresponding author), US Dept Vet Affairs, Off Res & Dev, Boise, ID USA.; Bryant, AE (corresponding author), Univ Washington, Sch Med, Seattle, WA USA.	amy.bryant@va.gov	Webb-Robertson, Bobbie-Jo/K-8230-2019	Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397	National Institute of Allergy and Infectious Diseases [R21A1101457]; Office of Research and Development, Medical Research Service, U.S. Department of Veterans Affairs [1101BX000395]; National Institute of General Medical Sciences [P20GM103408]; Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory (PNNL); PNNL [DE-AC05-76RL01830]; National Institute of General Medical Sciences of the National Institutes of Health [P2OGM103408, P2OGM109095, 1U54GM104944]; National Science Foundation [0619793, 0923535]; Murdock Charitable Trust; Idaho State Board of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109095, P20GM103408] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research and Development, Medical Research Service, U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory (PNNL); PNNL; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Murdock Charitable Trust; Idaho State Board of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Allergy and Infectious Diseases (Grant # R21A1101457, AEB), the Office of Research and Development, Medical Research Service, U.S. Department of Veterans Affairs (Grant # 1101BX000395, AEB), and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (Grant #P20GM103408 AEB, MJA). Proteomics analyses were performed in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy (DOE) Office of Science User Facility supported by the Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory (PNNL). PNNL is a multi-program laboratory operated by Battelle for the U.S. DOE under contract DE-AC05-76RL01830. Ingenuity Pathway Analysis and some statistical analyses were performed at the Biomolecular Research Center of Boise State University, Boise ID which is supported in part by Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grants #P2OGM103408, P2OGM109095, and 1U54GM104944. We also acknowledge support from the National Science Foundation, Grants #0619793 and #0923535; the MJ Murdock Charitable Trust; and the Idaho State Board of Education. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alleva DG, 2002, J LEUKOCYTE BIOL, V71, P677; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; [Anonymous], 2007, STATXACT SOFTWARE VE; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bean C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.525; Belcastro AN, 1998, MOL CELL BIOCHEM, V179, P135, DOI 10.1023/A:1006816123601; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bommer UA, 2015, CELL SIGNAL, V27, P1557, DOI 10.1016/j.cellsig.2015.04.011; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; BROOKS PM, 1991, NEW ENGL J MED, V324, P1716; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Bryant AE, 2015, CURR OPIN INFECT DIS, V28, P231, DOI 10.1097/QCO.0000000000000160; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao W, 2008, BBA-GEN SUBJECTS, V1780, P873, DOI 10.1016/j.bbagen.2008.02.007; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Choi SJ, 2014, J EXERC REHABIL, V10, P344, DOI 10.12965/jer.140171; Dee K, 2002, CELL DEATH DIFFER, V9, P209, DOI 10.1038/sj/cdd/4400930; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hakkarainen TW, 2015, JAMA SURG, V150, P223, DOI 10.1001/jamasurg.2014.2239; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Hamilton SM, 2014, J INFECT DIS, V209, P1429, DOI 10.1093/infdis/jit594; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kang W, 2014, P NATL ACAD SCI USA, V111, pE54, DOI 10.1073/pnas.1308768111; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Lamagni TL, 2008, EMERG INFECT DIS, V14, P202, DOI 10.3201/eid1402.070888; Leroy S, 2010, CLIN DRUG INVEST, V30, P179, DOI 10.2165/11532890-000000000-00000; Lieber Richard L, 2002, J Am Acad Orthop Surg, V10, P67; Linares GR, 2009, BONE, V44, P795, DOI 10.1016/j.bone.2009.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackey AL, 2012, SCAND J MED SCI SPOR, V22, pE8, DOI 10.1111/j.1600-0838.2012.01463.x; Mackey AL, 2007, J APPL PHYSIOL, V103, P425, DOI 10.1152/japplphysiol.00157.2007; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Mary C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052877; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McDade JR, 2014, HUM MOL GENET, V23, P1677, DOI 10.1093/hmg/ddt557; Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102; Messika J, 2014, J CRIT CARE, V29, P733, DOI 10.1016/j.jcrc.2014.05.021; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nuwayhid ZB, 2007, ANN EPIDEMIOL, V17, P878, DOI 10.1016/j.annepidem.2007.05.011; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Permpalung N, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/7431838; Peters D, 2003, J PHYSIOL-LONDON, V553, P947, DOI 10.1113/jphysiol.2003.048462; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Posey AD, 2011, CURR TOP DEV BIOL, V96, P203, DOI 10.1016/B978-0-12-385940-2.00008-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Schulz-Trieglaff O, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-4; SEJERSEN T, 1993, J CELL SCI, V106, P1291; Sidney S., 1956, NONPARAMETRIC STAT B; Soukup T, 2014, HISTOCHEM CELL BIOL; Souyri C, 2008, CLIN EXP DERMATOL, V33, P249, DOI 10.1111/j.1365-2230.2007.02652.x; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tondera D, 2004, J BIOL CHEM, V279, P31544, DOI 10.1074/jbc.M404704200; Trappe RA, 2002, AM J PHYSIOL-ENDOC M, V282, pE551, DOI 10.1152/ajpendo.00352.2001; Trappe TA, 2013, J APPL PHYSIOL, V115, P909, DOI 10.1152/japplphysiol.00061.2013; US Food and Drug Administration, 2015, SAF ANN FDA STRENGTH; Vafiadaki E, 2015, GENE, V566, P1, DOI 10.1016/j.gene.2015.04.077; Vaittinen S, 2001, J NEUROPATH EXP NEUR, V60, P588, DOI 10.1093/jnen/60.6.588; VATER R, 1994, HISTOCHEM J, V26, P916; Volker D, 2000, LAB ANIM-UK, V34, P423, DOI 10.1258/002367700780387732; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Webb-Robertson BJ, 2010, J PROTEOME RES; Webb-Robertson BJM, 2014, MOL CELL PROTEOMICS, V13, P3639, DOI 10.1074/mcp.M113.030932; Yang F, 2012, EXPERT REV PROTEOMIC, V9, P129, DOI [10.1586/EPR.12.15, 10.1586/epr.12.15]; Zhang PP, 2015, BIOCHEM BIOPH RES CO, V463, P102, DOI 10.1016/j.bbrc.2015.05.032; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	85	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172486	10.1371/journal.pone.0172486	http://dx.doi.org/10.1371/journal.pone.0172486			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245256	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200021
J	Kim, SH; Won, HK; Moon, SD; Kim, BK; Chang, YS; Kim, KW; Yoon, IY				Kim, Sae-Hoon; Won, Ha-Kyeong; Moon, Sung-Do; Kim, Byung-Keun; Chang, Yoon-Seok; Kim, Ki-Woong; Yoon, In-Young			Impact of self-reported symptoms of allergic rhinitis and asthma on sleep disordered breathing and sleep disturbances in the elderly with polysomnography study	PLOS ONE			English	Article							APNEA RISK; ASSOCIATION; POPULATION; ADULTS; CORTICOSTEROIDS; COMORBIDITIES; SENSITIZATION; INSOMNIA; HEALTH	Background Sleep disordered breathing (SDB) and sleep disturbances have been reported to be associated with allergic rhinitis and asthma. However, population-based studies of this issue in the elderly are rare. Objective To investigate the impact of self-reported rhinitis and asthma on sleep apnea and sleep quality using polysomnography in an elderly Korean population. Methods A total of 348 elderly subjects who underwent one-night polysomnography study among a randomly selected sample were enrolled. Study subjects underwent anthropometric and clinical evaluations. Simultaneously, the prevalence and co-morbid status of asthma and allergic rhinitis, and subjective sleep quality were evaluated using a self-reported questionnaire. Results Ever-diagnosis of allergic rhinitis was significantly more prevalent in subjects with SDB compared with those without SDB. Subjects with an ever-diagnosis of allergic rhinitis showed a higher O-2 desaturation index and mean apnea duration. Indices regarding sleep efficiency were affected in subjects with a recent treatment of allergic rhinitis or asthma. Waking after sleep onset was longer and sleep efficiency was lower in subjects who had received allergic rhinitis treatment within the past 12 months. Subjects who had received asthma treatment within the past 12 months showed significantly lower sleep efficiency than others. Conclusion Our study indicates that a history of allergic rhinitis is associated with increased risk of SDB in the elderly. Sleep disturbance and impaired sleep efficiency were found in the subjects who had received recent treatment of allergic rhinitis or asthma. Physicians should be aware of the high risk of sleep disorders in older patients with respiratory allergic diseases.	[Kim, Sae-Hoon; Won, Ha-Kyeong; Moon, Sung-Do; Kim, Byung-Keun; Chang, Yoon-Seok] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Sae-Hoon; Won, Ha-Kyeong; Moon, Sung-Do; Kim, Byung-Keun; Chang, Yoon-Seok] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Kim, Sae-Hoon; Kim, Byung-Keun; Chang, Yoon-Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Kim, Ki-Woong; Yoon, In-Young] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yoon, IY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea.	iyoon@snu.ac.kr		Moon, Sung do/0000-0001-5674-5122	Seoul National University Bundang Hospital [02-2011-054]	Seoul National University Bundang Hospital	Seoul National University Bundang Hospital provided financial support in the form of research fund (a grant No. 02-2011-054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptist AP, 2016, IMMUNOL ALLERGY CLIN, V36, P343, DOI 10.1016/j.iac.2015.12.010; Bauer BA, 1997, CHEST, V111, P303, DOI 10.1378/chest.111.2.303; Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V147, P1154, DOI 10.1177/0194599812459850; Bozek A, 2015, ANN ALLERG ASTHMA IM, V114, P199, DOI 10.1016/j.anai.2014.12.013; Rodriguez JC, 2015, MED CLIN N AM, V99, P431, DOI 10.1016/j.mcna.2014.11.013; Cheng HM, 2014, J ALLERGY CLIN IMMUN, V133, P1048, DOI 10.1016/j.jaci.2013.10.055; Corboz MR, 2008, PULM PHARMACOL THER, V21, P449, DOI 10.1016/j.pupt.2007.06.007; Ferguson BJ, 2004, OTOLARYNG HEAD NECK, V130, P617, DOI 10.1016/j.otohns.2004.02.001; FITZPATRICK MF, 1993, EUR RESPIR J, V6, P531; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; Gooneratne NS, 2006, ARCH INTERN MED, V166, P1732, DOI 10.1001/archinte.166.16.1732; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Kim MY, 2013, ANN ALLERG ASTHMA IM, V110, P253, DOI 10.1016/j.anai.2013.01.005; Krell Suzanne B, 2005, Sleep Breath, V9, P104, DOI 10.1007/s11325-005-0026-x; Larsson LG, 2001, RESP MED, V95, P423, DOI 10.1053/rmed.2001.1054; Lee SD, 2014, RESPIRATION, V87, P372, DOI 10.1159/000358442; McMillan A, 2016, BREATHE, V12, P51, DOI 10.1183/20734735.003216; Mehra R, 2008, J ALLERGY CLIN IMMUN, V121, P1096, DOI 10.1016/j.jaci.2008.04.002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Novak M, 1997, DRUG SAFETY, V16, P133, DOI 10.2165/00002018-199716020-00005; Pokladnikova J, 2008, ANN ALLERG ASTHMA IM, V101, P67, DOI 10.1016/S1081-1206(10)60837-X; Prasad B, 2014, SLEEP MED REV, V18, P165, DOI 10.1016/j.smrv.2013.04.004; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Rondon C, 2010, CURR OPIN ALLERGY CL, V10, P1, DOI 10.1097/ACI.0b013e328334f5fb; Rondon C, 2009, J ALLERGY CLIN IMMUN, V123, P1098, DOI 10.1016/j.jaci.2009.02.018; Shargorodsky J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131957; Simola M, 1999, ANN ALLERG ASTHMA IM, V82, P152, DOI 10.1016/S1081-1206(10)62589-6; Slavin RG, 2010, ALLERGY ASTHMA PROC, V31, P179, DOI 10.2500/aap.2010.31.3342; Song WJ, 2015, ALLERGY ASTHMA IMMUN, V7, P431, DOI 10.4168/aair.2015.7.5.431; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Staevska MT, 2004, CURR ALLERGY ASTHM R, V4, P193, DOI 10.1007/s11882-004-0026-0; Teodorescu M, 2015, JAMA-J AM MED ASSOC, V313, P156, DOI 10.1001/jama.2014.17822; Teodorescu M, 2010, CHEST, V138, P543, DOI 10.1378/chest.09-3066; Teodorescu M, 2009, CHEST, V135, P1125, DOI 10.1378/chest.08-1273; United Nations DoEaSA, 2013, STSEASERA348 UN DOEA; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485; Wilhelm CP, 2015, ANN ALLERG ASTHMA IM, V115, P96, DOI 10.1016/j.anai.2015.06.011; Yigla M, 2003, J ASTHMA, V40, P865, DOI 10.1081/JAS-120023577; Yonekura S, 2012, INT ARCH ALLERGY IMM, V157, P73, DOI 10.1159/000324475; Young T, 1997, J ALLERGY CLIN IMMUN, V99, pS757, DOI 10.1016/S0091-6749(97)70124-6	43	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173075	10.1371/journal.pone.0173075	http://dx.doi.org/10.1371/journal.pone.0173075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245272	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200054
J	Navarro, RM; Larralde, H				Mota Navarro, Roberto; Larralde, Hernan			A detailed heterogeneous agent model for a single asset financial market with trading via an order book	PLOS ONE			English	Article							STOCK RETURNS; LONG MEMORY; PRICE FLUCTUATIONS; VOLATILITY; DISTRIBUTIONS; EMERGENCE; IMPACT; RULES; POWER; LAW	We present an agent based model of a single asset financial market that is capable of replicating most of the non-trivial statistical properties observed in real financial markets, generically referred to as stylized facts. In our model agents employ strategies inspired on those used in real markets, and a realistic trade mechanism based on a double auction order book. We study the role of the distinct types of trader on the return statistics: specifically, correlation properties (or lack thereof), volatility clustering, heavy tails, and the degree to which the distribution can be described by a log-normal. Further, by introducing the practice of "profit taking", our model is also capable of replicating the stylized fact related to an asymmetry in the distribution of losses and gains.	[Mota Navarro, Roberto; Larralde, Hernan] Inst Ciencias Fis, Cuernavaca, Morelos, Mexico		Navarro, RM (corresponding author), Inst Ciencias Fis, Cuernavaca, Morelos, Mexico.	mvr@fis.unam.mx		Larralde, Hernan/0000-0002-6037-2629; Mota Navarro, Roberto/0000-0002-6077-7386	Consejo Nacional de Ciencia y Tecnologia [334238]; CONACyT	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia, grant number: 334238, URL: http://conacyt.gob.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Roberto Mota acknowledges financial support from CONACyT. We thank Gilberto Calvillo, Stephanie Rendon, Ana Contreras and Paulino Monroy for useful discussions.	Alfi V, 2009, EUR PHYS J B, V67, P385, DOI 10.1140/epjb/e2009-00028-4; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Bera A, 2015, FINANCIAL EC EMPIRIC; Bertella MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083488; Bonabeau E, 2002, HARVARD BUS REV, V80, P109; Bouchaud J., 1997, P CNRS WORKSH SCAL I; BROCK W, 1992, J FINANC, V47, P1731, DOI 10.2307/2328994; Brownlees C, 2011, J RISK, V14, P3, DOI 10.21314/JOR.2012.237; Challet D, 2003, QUANT FINANC, V3, P155, DOI 10.1088/1469-7688/3/3/301; Chiarella C., 2002, Quantitative Finance, V2, P346, DOI 10.1088/1469-7688/2/5/303; Chiarella C, 2009, J ECON DYN CONTROL, V33, P525, DOI 10.1016/j.jedc.2008.08.001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Consiglio A, 2005, QUANT FINANC, V5, P71, DOI 10.1080/14697680500041437; Cont R., 2007, LONG MEMORY EC; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Cristelli M, 2014, COMPLEXITY FINANCIAL; De Grauwe P, 2010, PUBLIC CHOICE, V144, P413, DOI 10.1007/s11127-010-9674-x; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Farmer JD, 2005, P NATL ACAD SCI USA, V102, P2254, DOI 10.1073/pnas.0409157102; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Gu GF, 2008, PHYSICA A, V387, P495, DOI 10.1016/j.physa.2007.10.012; Gu GF, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48002; Harris L., 2002, TRADING EXCHANGES MA; LiCalzi M, 2003, QUANT FINANC, V3, P470, DOI 10.1088/1469-7688/3/6/306; Liu Y, 1999, PHYS REV E; Liu YF, 2014, PHYSICA A, V407, P204, DOI 10.1016/j.physa.2014.04.004; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T., 2000, INT J THEOR APPL FIN, V3, P675, DOI DOI 10.1142/S0219024900000826; MANDELBROT B, 1967, OPER RES, V15, P1057, DOI 10.1287/opre.15.6.1057; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Maslov S, 2000, PHYSICA A, V278, P571, DOI 10.1016/S0378-4371(00)00067-4; Meng H, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/38003; Mike S, 2008, J ECON DYN CONTROL, V32, P200, DOI 10.1016/j.jedc.2007.01.025; Pagan A., 1996, J EMPIR FINANC, V3, P15, DOI DOI 10.1016/0927-5398(95)00020-8; Plerou V, 1999, PHYS REV E, V60, P6519, DOI 10.1103/PhysRevE.60.6519; Potters M, 2001, PHYSICA A; Preis T, 2006, EUROPHYS LETT, V75, P510, DOI 10.1209/epl/i2006-10139-0; Sbordone AM., 2010, EC POLICY REV, V16; Schmitt TA, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/38005; Tesfatsion L., 2006, HDB COMPUTATIONAL EC, V2; Xu HC, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/328498; Xu HC, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/563912; Yamamoto R, 2011, J ECON DYN CONTROL, V35, P1938, DOI 10.1016/j.jedc.2011.06.009; Zhang W, 2017, PHYSICA A, V467, P345, DOI 10.1016/j.physa.2016.10.044; Zhou J, 2017, COMPUT ECON, V50, P579, DOI 10.1007/s10614-016-9612-1	46	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0170766	10.1371/journal.pone.0170766	http://dx.doi.org/10.1371/journal.pone.0170766			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245251	gold, Green Submitted, Green Published			2022-12-27	WOS:000395980200004
J	Kim, M; Jeong, CW; Oh, SJ				Kim, Myong; Jeong, Chang Wook; Oh, Seung-June			Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysis	PLOS ONE			English	Review							URINARY-TRACT SYMPTOMS; PHOSPHATE PHOTOSELECTIVE VAPORIZATION; PRESSURE-FLOW; URETHRAL RESISTANCE; DETRUSOR INSTABILITY; PREOPERATIVE DEGREE; PROGNOSTIC VALUE; RESECTION; OUTCOMES; CONTRACTILITY	Purpose To investigate the diagnostic value of urodynamic bladder outlet obstruction (BOO) in the selection of patients for transurethral surgery of the prostate. Materials and methods We systematically searched online PubMed, Embase, and Cochrane Library databases from January 1989 to June 2014. Results A total of 19 articles met the eligibility criteria for this systematic review. The eligible studies included a total of 2321 patients with a median number of 92 patients per study (range: 12-437). Of the 19 studies, 15 conducted conventional transurethral prostatectomy (TURP), and 7 used other or multiple modalities. In urodynamic bladder outlet obstruction (BOO) positive patients, the pooled mean difference (MD) was significant for better improvement of the International Prostate Symptom Score (IPSS) (pooled MD, 3.48; 95% confidence interval [CI], 1.72-5.24; p < 0.01; studies, 16; participants, 1726), quality of life score (QoL) (pooled MD, 0.56; 95% CI, 0.14-1.02; p = 0.010; studies, 9; participants, 1052), maximal flow rate (Q(max)) (pooled MD, 3.86; 95% CI, 2.17-5.54; p < 0.01; studies, 17; participants, 1852), and post-void residual volume (PVR) (pooled MD, 32.46; 95% CI, 23.34-41.58; p < 0.01; studies, 10; participants, 1219) compared with that in non-BOO patients. Some comparisons showed between-study heterogeneity despite the strict selection criteria of the included studies. However, there was no clear evidence of publication bias in this meta-analysis. Conclusions Our meta-analysis results showed a significant association between urodynamic BOO and better improvements in all treatment outcome parameters. Preoperative UDS may add insight into postoperative outcomes after surgical treatment of benign prostatic hyperplasia.	[Kim, Myong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea; [Jeong, Chang Wook; Oh, Seung-June] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	sjo@snu.ac.kr	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539; Kim, Myong/0000-0001-6995-6850	Seoul National University Hospital Research Fund [23-2015-0050]	Seoul National University Hospital Research Fund	This study was supported by grant no 23-2015-0050 from Seoul National University Hospital Research Fund. The funders had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.; This study was supported by grant no 23-2015-0050 from Seoul National University Hospital Research Fund. The authors are indebted to Jung-Yun Lee (E-mail: jungyunlee@yuhs.ac), assistant professor, Department of Obstetrics and Gynecology, Yonsei University College of Medicine for his pro Bono technical advice on our first meta-analysis.	ABRAMS P, 1995, BRIT J UROL, V76, P11; ABRAMS PH, 1979, BRIT J UROL, V51, P129, DOI 10.1111/j.1464-410X.1979.tb02846.x; American Urological Association, 2010, PHARM MAN PREM EJ; Cho MC, 2010, UROLOGY, V75, P1460, DOI 10.1016/j.urology.2009.09.065; Daehlin L, 1999, BJU INT, V84, P628; de la Rosette JJMCH, 1998, NEUROUROL URODYNAM, V17, P99, DOI 10.1002/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.3.CO;2-5; delaRosette JJMCH, 1996, J UROLOGY, V156, P1428, DOI 10.1016/S0022-5347(01)65609-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckhardt MD, 2001, NEUROUROL URODYNAM, V20, P175; ElDin KE, 1996, J UROLOGY, V156, P1020, DOI 10.1016/S0022-5347(01)65691-X; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; GORMLEY EA, 1993, NEUROUROL URODYNAM, V12, P445, DOI 10.1002/nau.1930120502; Gotoh M, 1999, WORLD J UROL, V17, P274, DOI 10.1007/s003450050145; Gravas S, 2014, EAU GUIDELINES MANAG; Griffiths D, 1997, NEUROUROL URODYNAM, V16, P1, DOI 10.1002/(SICI)1520-6777(1997)16:1<1::AID-NAU1>3.0.CO;2-I; GRIFFITHS D, 1989, NEUROUROL URODYNAM, V8, P17, DOI 10.1002/nau.1930080104; Hakenberg OW, 2003, BJU INT, V91, P375, DOI 10.1046/j.1464-410X.2003.04078.x; Han DH, 2008, UROLOGY, V71, P657, DOI 10.1016/j.urology.2007.11.109; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFNER K, 1995, WORLD J UROL, V13, P59; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Ignjatovic I., 1997, International Urology and Nephrology, V29, P653, DOI 10.1007/BF02552182; Javle P, 1998, J UROLOGY, V160, P1713, DOI 10.1016/S0022-5347(01)62391-7; Kim SY, 2011, NECAS GUIDELINE UNDE; Kranse M, 1991, J UROLOGY, V145, P261; LIM CS, 1995, WORLD J UROL, V13, P34; Machino R, 2002, NEUROUROL URODYNAM, V21, P444, DOI 10.1002/nau.10057; Masumori N, 2010, BJU INT, V105, P1429, DOI 10.1111/j.1464-410X.2009.08978.x; Min DS, 2013, KOREAN J UROL, V54, P840, DOI 10.4111/kju.2013.54.12.840; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Monoski MA, 2006, UROLOGY, V68, P312, DOI 10.1016/j.urology.2006.02.020; Oh MM, 2012, ASIAN J ANDROL, V14, P556, DOI 10.1038/aja.2011.157; Paick JS, 2007, UROLOGY, V69, P859, DOI 10.1016/j.urology.2007.01.042; Porru D, 1999, NEUROUROL URODYNAM, V18, P647; Porru D, 2002, EUR UROL, V41, P246, DOI 10.1016/S0302-2838(02)00021-0; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; SCHAFER W, 1989, WORLD J UROL, V6, P198, DOI 10.1007/BF00328102; SCHAFER W, 1995, WORLD J UROL, V13, P47; SCHAFER W, 1990, UROL CLIN N AM, V17, P553; Seki N, 2006, UROLOGY, V67, P306, DOI 10.1016/j.urology.2005.08.015; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; SPANGBERG A, 1991, NEUROUROL URODYNAM, V10, P139, DOI 10.1002/nau.1930100202; Stoevelaar HJ, 2001, EUR UROL, V39, P13, DOI 10.1159/000052562; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tanaka Y, 2006, INT J UROL, V13, P1398, DOI 10.1111/j.1442-2042.2006.01589.x; van Venrooij GEPM, 2003, UROLOGY, V62, P672, DOI 10.1016/S0090-4295(03)00511-9; Vesely S, 2006, NEUROUROL URODYNAM, V25, P770, DOI 10.1002/nau.20233; Witjes WPJ, 1997, UROLOGY, V50, P55, DOI 10.1016/S0090-4295(97)00112-X	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172590	10.1371/journal.pone.0172590	http://dx.doi.org/10.1371/journal.pone.0172590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241023	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400027
J	Niemela, V; Landtblom, AM; Blennow, K; Sundblom, J				Niemela, Valter; Landtblom, Anne-Marie; Blennow, Kaj; Sundblom, Jimmy			Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; PROTEIN; PATHOLOGY; CARE	Introduction Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light (NFL) and total tau are elevated in Huntington's disease (HD) and may be used as markers of disease stage. Biomarkers are needed due to the slow disease progression and the limitations of clinical assessment. This study aims to validate the role of NFL and tau as biomarkers in HD. Methods CSF was obtained from a cohort of HD patients and premanifest HD-mutation carriers. Unified Huntington's Disease Rating Scale (UHDRS) testing was performed on all subjects at the time of sampling. NFL and tau concentrations were determined by ELISA. Spearman correlations were calculated with R version 3.2.3. Results 11 premanifest HD and 12 manifest HD subjects were enrolled. NFL and tau levels were correlated. NFL showed strong correlations with all items included in the clinical assessment (for example the total functional capacity (TFC) (r = - 0.70 p < 0.01) and total motor score (TMS) (r = 0.83p < 0.01). Tau showed slightly weaker correlations (eg. TMS (r = 0.67 p < 0.01); TFC (r = - 0.59 p < 0.01)). NFL was significantly correlated with 5-year probability of disease onset, whereas tau was not. Conclusion This study strengthens the case for NFL as a useful biomarker of disease stage. NFL was strongly correlated to all evaluated items in the UHDRS assessment. Tau also has a potential for use as a biomarker but correlations to clinical tests are weaker in this study. We suggest that NFL and possibly tau be used in clinical drug trials as biomarkers of disease progression that are potentially influenced by future disease-modifying therapies.	[Niemela, Valter; Landtblom, Anne-Marie] Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden; [Blennow, Kaj] Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal Campus, Molndal, Sweden; [Sundblom, Jimmy] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden	Uppsala University; University of Gothenburg; Uppsala University	Niemela, V (corresponding author), Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden.	valter.niemela@neuro.uu.se		Landtblom, Anne-Marie/0000-0001-9567-470X; Niemela, Valter/0000-0002-2576-9938	Selander Foundation; Aland Cultural Foundation	Selander Foundation; Aland Cultural Foundation	JS received funding by The Selander Foundation and Aland Cultural Foundation for this study. The funding sources had no influence on the design or conduct of the study, nor the decision to publish.	Axelsson M, 2014, MULT SCLER J, V20, P43, DOI 10.1177/1352458513490544; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Byrne LM, 2016, J HUNTINGTONS DIS, V5, P1, DOI 10.3233/JHD-160196; Cicognola C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0130-3; Constantinescu R, 2011, PARKINSONISM RELAT D, V17, P714, DOI 10.1016/j.parkreldis.2011.06.010; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Gratuze M, 2016, BRAIN, V139, P1014, DOI 10.1093/brain/aww021; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kuhle J, 2015, NEUROLOGY, V84, P1639, DOI 10.1212/WNL.0000000000001491; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Nopoulos PC, 2016, DIALOGUES CLIN NEURO, V18, P91; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Reilmann R, 2014, MOVEMENT DISORD, V29, P1335, DOI 10.1002/mds.26011; Rodrigues FB, 2016, J NEUROCHEMISTRY; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vagberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135886; Vinther-Jensen T, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000287; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Zielonka D, 2015, PARKINSONISM RELAT D, V21, P169, DOI 10.1016/j.parkreldis.2014.12.013	29	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172762	10.1371/journal.pone.0172762	http://dx.doi.org/10.1371/journal.pone.0172762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241046	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400040
J	Wang, WX; Li, KL; Wan, PJ; Lai, FX; Fu, Q; Zhu, TH				Wang, Weixia; Li, Kailong; Wan, Pinjun; Lai, Fengxiang; Fu, Qiang; Zhu, Tingheng			Ras-like family small GTPases genes in Nilaparvata lugens: Identification, phylogenetic analysis, gene expression and function in nymphal development	PLOS ONE			English	Article							INSECT BLATTELLA-GERMANICA; GTP-BINDING PROTEINS; SIGNAL-TRANSDUCTION PATHWAY; BROWN PLANTHOPPER; NUCLEAR RECEPTORS; CELL-GROWTH; ARF FAMILY; DROSOPHILA; ACTIVATION; RNAI	Twenty-nine cDNAs encoding Ras-like family small GTPases (RSGs) were cloned and sequenced from Nilaparvata lugens. Twenty-eight proteins are described here: 3 from Rho, 2 from Ras, 9 from Arf and 14 from Rabs. These RSGs from N.lugens have five conserved G-loop motifs and displayed a higher degree of sequence conservation with orthologues from insects. RT-qPCR analysis revealed NIRSGs expressed at all life stages and the highest expression was observed in hemolymph, gut or wing for most of NIRSGs. RNAi demonstrated that eighteen NIRSGs play a crucial role in nymphal development. Nymphs with silenced NIRSGs failed to molt, eclosion or development arrest. The qRT-PCR analysis verified the correlation between mortality and the down-regulation of the target genes. The expression level of nuclear receptors, Kr-h1, Hr3, FTZ-F1 and E93 involved in 20E and JH signal pathway was impacted in nymphs with silenced twelve NIRSGs individually. The expression of two halloween genes, Cyp314a1 and Cyp315a1 involved in ecdysone synthesis, decreased in nymphs with silenced NISar1 or NIArf1. Cyp307a1 increased in nymphs with silenced NIArf6. In N.lugens with silenced NISR beta, NISar1 and NIRab2 at 9th day individually, 0.0% eclosion rate and almost 100.0% mortality was demonstrated. Further analysis showed NISR beta could be served as a candidate target for dsRNA-based pesticides for N.lugens control.	[Wang, Weixia; Li, Kailong; Wan, Pinjun; Lai, Fengxiang; Fu, Qiang] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Tingheng] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University of Technology	Fu, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.; Zhu, TH (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	fuqiang@caas.cn; thzhu@zjut.edu.cn	Li, Kailong/AGZ-1532-2022	Li, Kailong/0000-0003-2386-6897	National Natural Science Foundation of China [31201512]; Zhejiang Provincial Natural Science Foundation of China [LY15C140004]; Rice Pest Management Research Group of the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Rice Pest Management Research Group of the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Science	This work is supported by the National Natural Science Foundation of China (31201512). Zhejiang Provincial Natural Science Foundation of China (LY15C140004). Rice Pest Management Research Group of the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Science.	Ackers JP, 2005, MOL BIOCHEM PARASIT, V141, P89, DOI 10.1016/j.molbiopara.2005.01.017; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Caron E, 2000, CURR BIOL, V10, pR489, DOI 10.1016/S0960-9822(00)00555-8; Catindig J. L., 2009, PLANTHOPPERS NEW THR, P191; Cetkovic H, 2007, J MOL EVOL, V64, P332, DOI 10.1007/s00239-006-0081-3; Chenette EJ, 2008, RAS ONCOPROTEINS, P1; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Dobrin SE, 2012, J INSECT PHYSIOL, V58, P228, DOI 10.1016/j.jinsphys.2011.11.009; Exton JH, 1998, J BIOL CHEM, V273, P19923, DOI 10.1074/jbc.273.32.19923; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goergen P, 2014, BEHAV GENET, V44, P155, DOI 10.1007/s10519-014-9643-0; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; He HJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-1; Hou L, 2012, DEV BIOL, V371, P13, DOI 10.1016/j.ydbio.2012.06.015; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee S, 2011, J INSECT PHYSIOL, V57, P356, DOI 10.1016/j.jinsphys.2010.12.003; Leibfried A, 2013, DEVELOPMENT, V140, P362, DOI 10.1242/dev.089250; Li KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142142; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Park DS, 2008, MOL GENET GENOMICS, V280, P163, DOI 10.1007/s00438-008-0353-2; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001; Ruvinsky A, 2007, OPEN EVOLUTION J, V107, P1; Schwartz TU, 2006, P NATL ACAD SCI USA, V103, P6823, DOI 10.1073/pnas.0602083103; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Stenmark H, 2001, GENOME BIOL, V2; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Torres IL, 2014, J CELL SCI, V127, P2151, DOI 10.1242/jcs.122028; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wan PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086675; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032086; Wang WX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev046; WEISFOGH T, 1964, J EXP BIOL, V41, P229; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xu WL, 2007, GENE, V389, P27, DOI 10.1016/j.gene.2006.09.014; Xue J, 2015, J ANIM FEED SCI, V12, P739	62	3	3	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172701	10.1371/journal.pone.0172701	http://dx.doi.org/10.1371/journal.pone.0172701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241066	gold, Green Submitted, Green Published			2022-12-27	WOS:000395934400031
J	Bozcal, E; Dagdeviren, M; Uzel, A; Skurnik, M				Bozcal, Elif; Dagdeviren, Melih; Uzel, Atac; Skurnik, Mikael			LuxCDE-luxAB-based promoter reporter system to monitor the Yersinia enterocolitica O:3 gene expression in vivo	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; SUICIDE VECTOR; OUTER CORE; LIPOPOLYSACCHARIDE; VIRULENCE; ANTIGEN; INFECTION; CONSTRUCTION; HOST; O-3	It is crucial to understand the in vitro and in vivo regulation of the virulence factor genes of bacterial pathogens. In this study, we describe the construction of a versatile reporter system for Yersinia enterocolitica serotype O:3 (YeO3) based on the luxCDABE operon. In strain YeO3-luxCDE we integrated the luciferase substrate biosynthetic genes, luxCDE, into the genome of the bacterium so that the substrate is constitutively produced. The luxAB genes that encode the luciferase enzyme were cloned into a suicide vector to allow cloning of any promoter-containing fragment upstream the genes. When the obtained suicide-construct is mobilized into YeO3-luxCDE bacteria, it integrates into the recipient genome via homologous recombination between the cloned promoter fragment and the genomic promoter sequence and thereby generates a single-copy and stable promoter reporter. Lipopolysaccharide (LPS) O-antigen (O-ag) and outer core hexasaccharide (OC) of YeO3 are virulence factors necessary to colonization of the intestine and establishment of infection. To monitor the activities of the OC and O-ag gene cluster promoters we constructed the reporter strains YeO3-P-oc::luxAB and YeO3-P-op1::luxAB, respectively. In vitro, at 37 degrees C both promoter activities were highest during logarithmic growth and decreased when the bacteria entered stationary growth phase. At 22 degrees C the OC gene cluster promoter activity increased during the late logarithmic phase. Both promoters were more active in late stationary phase. To monitor the promoter activities in vivo, mice were infected intragastrically and the reporter activities monitored by the IVIS technology. The mouse experiments revealed that both LPS promoters were well expressed in vivo and could be detected by IVIS, mainly from the intestinal region of orally infected mice.	[Bozcal, Elif] Istanbul Univ, Fac Sci, Dept Biol, Basic & Ind Microbiol Sect, Istanbul, Turkey; [Bozcal, Elif; Uzel, Atac] Ege Univ, Fac Sci, Dept Biol, Basic & Ind Microbiol Sect, Izmir, Turkey; [Bozcal, Elif; Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Medicum & Res Programs Unit, Immunobiol, Helsinki, Finland; [Dagdeviren, Melih] Ege Univ, Fac Sci, Dept Biol, Gen Biol Sect, Izmir, Turkey; [Dagdeviren, Melih] Ege Univ, Ctr Drug Res & Dev & Pharmacokinet Applicat, Izmir, Turkey; [Skurnik, Mikael] Helsinki Univ Hosp, HUSLAB, Div Clin Microbiol, Helsinki, Finland	Istanbul University; Ege University; University of Helsinki; Ege University; Ege University; University of Helsinki; Helsinki University Central Hospital	Skurnik, M (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Medicum & Res Programs Unit, Immunobiol, Helsinki, Finland.; Skurnik, M (corresponding author), Helsinki Univ Hosp, HUSLAB, Div Clin Microbiol, Helsinki, Finland.	mikael.skurnik@helsinki.fi	Dagdeviren, Melih/AAB-8381-2022; Uzel, Ataç/AAG-6765-2019; Dagdeviren, Melih/AFP-7027-2022; Dagdeviren, Elif Bozcal/E-8330-2019; Skurnik, Mikael/I-8477-2019	Dagdeviren, Melih/0000-0001-8048-3302; Uzel, Ataç/0000-0002-1304-0509; Dagdeviren, Melih/0000-0001-8048-3302; Dagdeviren, Elif Bozcal/0000-0003-2836-778X; Skurnik, Mikael/0000-0001-8791-9260	Center for International Mobility (CIMO) fellowship [KM -13-8757, TM-14-9081]; FEMS	Center for International Mobility (CIMO) fellowship; FEMS	This work was supported by the Center for International Mobility (CIMO) fellowship grants KM -13-8757 and TM-14-9081 (http://www.cimo.fi/ frontpage), FEMS (http://tems-microbiology.org/ fems-work/grants/fems-research-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHENDY A, 1992, INFECT IMMUN, V60, P870, DOI 10.1128/IAI.60.3.870-875.1992; Atosuo J, 2013, LUMINESCENCE, V28, P771, DOI 10.1002/bio.2435; Babic A, 2008, RES MICROBIOL, V159, P545, DOI 10.1016/j.resmic.2008.06.004; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bengoechea JA, 2002, MOL MICROBIOL, V44, P1045, DOI 10.1046/j.1365-2958.2002.02940.x; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Beutler B, 2002, J ENDOTOXIN RES, V8, P329, DOI 10.1179/096805102125000650; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bron PA, 2006, APPL ENVIRON MICROB, V72, P2876, DOI 10.1128/AEM.72.4.2876-2884.2006; Campbell-Valois FX, 2014, FEBS LETT, V588, P2428, DOI 10.1016/j.febslet.2014.05.022; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Drummond N, 2012, FOODBORNE PATHOG DIS, V9, P179, DOI 10.1089/fpd.2011.0938; Gonzalez RJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-147; Handley SA, 2004, INFECT IMMUN, V72, P1645, DOI 10.1128/IAI.72.3.1645-1656.2004; Hedges AJ, 2002, INT J FOOD MICROBIOL, V76, P207, DOI 10.1016/S0168-1605(02)00022-3; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kasperkiewicz K, 2015, INT J MED MICROBIOL, V305, P544, DOI 10.1016/j.ijmm.2015.07.001; Kong Y, 2011, CURR PROTOC MICROBIO, P960; Korpela MT, 1998, ANAL CHEM, V70, P4457, DOI 10.1021/ac980740e; Leskinen K, 2015, MICROBIOL-SGM, V161, P1282, DOI 10.1099/mic.0.000076; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Munder A, 2014, PATHOG DIS, V72, P74, DOI 10.1111/2049-632X.12184; Muszynski A, 2013, MICROBIOL-SGM, V159, P1782, DOI 10.1099/mic.0.066662-0; Najdenski H, 2003, FEMS IMMUNOL MED MIC, V38, P97, DOI 10.1016/S0928-8244(03)00183-4; Niehus E, 2002, MICROBIOL-SGM, V148, P3827, DOI 10.1099/00221287-148-12-3827; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Pan NJ, 2009, ANTIMICROB AGENTS CH, V53, P385, DOI 10.1128/AAC.00670-08; PEKKOLAHEINO K, 1987, ACTA PATH MICRO IM C, V95, P27; Pinta E, 2012, MOL MICROBIOL, V83, P125, DOI 10.1111/j.1365-2958.2011.07918.x; Rahman A, 2011, J PATHOG, V2011, DOI 10.4061/2011/239391; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; ROBINSBROWNE RM, 1985, INFECT IMMUN, V47, P774, DOI 10.1128/IAI.47.3.774-779.1985; Schaake J, 2014, INFECT IMMUN, V82, P960, DOI 10.1128/IAI.01001-13; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SKURNIK M, 1994, INFECT IMMUN, V62, P1252, DOI 10.1128/IAI.62.4.1252-1261.1994; SKURNIK M, 1984, J APPL BACTERIOL, V56, P355, DOI 10.1111/j.1365-2672.1984.tb01362.x; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Trcek J, 2010, MICROBIOL-SGM, V156, P2734, DOI 10.1099/mic.0.038240-0; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; ULITZUR S, 1979, P NATL ACAD SCI USA, V76, P265, DOI 10.1073/pnas.76.1.265; Zhang LJ, 1997, MOL MICROBIOL, V23, P63, DOI 10.1046/j.1365-2958.1997.1871558.x	47	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172877	10.1371/journal.pone.0172877	http://dx.doi.org/10.1371/journal.pone.0172877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235077	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200160
J	Darbor, KE; Lench, HC; Carter-Sowell, AR				Darbor, Kathleen E.; Lench, Heather C.; Carter-Sowell, Adrienne R.			Do People Eat the Pain Away? The Effects of Acute Physical Pain on Subsequent Consumption of Sweet-Tasting Food (vol 11, e0166931, 2016)	PLOS ONE			English	Correction																		Darbor KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166931	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173165	10.1371/journal.pone.0173165	http://dx.doi.org/10.1371/journal.pone.0173165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235007	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200201
J	Hellsten, SV; Eriksson, MM; Lekholm, E; Arapi, V; Perland, E; Fredriksson, R				Hellsten, Sofie V.; Eriksson, Mikaela M.; Lekholm, Emilia; Arapi, Vasiliki; Perland, Emelie; Fredriksson, Robert			The gene expression of the neuronal protein, SLC38A9, changes in mouse brain after in vivo starvation and high-fat diet	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; GLUTAMINE TRANSPORTER; SYSTEM-A; TRANSCRIPTIONAL CONTROL; MAMMALIAN TARGET; CELLS RESPOND; MTORC1; IDENTIFICATION; CLONING; KINASE	SLC38A9 is characterized as a lysosomal component of the amino acid sensing RagulatorRAG GTPase complex, controlling the mechanistic target of rapamycin complex 1 (mTORC1). Here, immunohistochemistry was used to map SLC38A9 in mouse brain and staining was detected throughout the brain, in cortex, hypothalamus, thalamus, hippocampus, brainstem and cerebellum. More specifically, immunostaining was found in areas known to be involved in amino acid sensing and signaling pathways e.g. piriform cortex and hypothalamus. SLC38A9 immunoreactivity co-localized with both GABAergic and glutamatergic neurons, but not with astrocytes. SLC38A9 play a key role in the mTORC1 pathway, and therefore we performed in vivo starvation and high-fat diet studies, to measure gene expression alterations in specific brain tissues and in larger brain regions. Following starvation, Slc38a9 was upregulated in brainstem and cortex, and in anterior parts of the brain (Bregma 3.2 to -2.1mm). After high-fat diet, Slc38a9 was specifically upregulated in hypothalamus, while overall downregulation was noticed throughout the brain (Bregma 3.2 to -8.6mm).	[Hellsten, Sofie V.; Eriksson, Mikaela M.; Lekholm, Emilia; Arapi, Vasiliki; Perland, Emelie; Fredriksson, Robert] Uppsala Univ, Dept Pharmaceut Biosci, Mol Neuropharmacol, Uppsala Se, Sweden	Uppsala University	Hellsten, SV (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Mol Neuropharmacol, Uppsala Se, Sweden.	Sofie.Hellsten@farmbio.uu.se		Fredriksson, Robert/0000-0002-2810-3226; Perland, Emelie/0000-0001-6672-2442; Lekholm, Emilia/0000-0001-8135-9127; Ceder, Mikaela/0000-0002-9681-5129	Swedish Research Council; Swedish Brain Foundation; Novo Nordisk foundation; Ahlens foundation; Engkvist Foundation; Gunvor and Josef Aners foundation; Magnus Bergvalls foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Ahlens foundation; Engkvist Foundation; Gunvor and Josef Aners foundation; Magnus Bergvalls foundation	This study was supported by the Swedish Research Council, The Swedish Brain Foundation, The Novo Nordisk foundation, Ahlens foundation, Engkvist Foundation, Gunvor and Josef Aners foundation and Magnus Bergvalls foundation.; This study was supported by the Swedish Research Council, The Swedish Brain Foundation, The Novo Nordisk foundation, Ahlens foundation, Engkvist Foundation, Gunvor and Josef Aners foundation and Magnus Bergvalls foundation. Thanks to Anders Eriksson for assistance with preparation of diet panels, and Mohamed Eltahir and Thi Cam Linh Nguyen for assistance with immunohistochemistry.	Bagchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095438; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boulland JL, 2003, GLIA, V41, P260, DOI 10.1002/glia.10188; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHRISTENSEN HN, 1965, J BIOL CHEM, V240, P3609; Closs EI, 2004, J NUTR, V134, p2752S, DOI 10.1093/jn/134.10.2752S; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Cota D, 2009, PHYSIOL BEHAV, V97, P520, DOI 10.1016/j.physbeh.2009.03.006; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; De Preter K, 2002, MODERN PATHOL, V15, P159, DOI 10.1038/modpathol.3880508; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Hagglund MGA, 2015, J MOL BIOL, V427, P1495, DOI 10.1016/j.jmb.2014.10.016; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hao S, 2010, PHARMACOL BIOCHEM BE, V94, P333, DOI 10.1016/j.pbb.2009.09.014; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; He Lei, 2009, Human Genomics, V3, P195; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 1980, J BIOL CHEM, V255, P4011; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; Muta K, 2015, ENDOCRINOLOGY, V156, P1398, DOI 10.1210/en.2014-1660; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Padbury JF, 2004, BIOCHEM BIOPH RES CO, V318, P529, DOI 10.1016/j.bbrc.2004.04.062; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Perland E, 2016, J MOL NEUROSCI, P1; Perland E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156912; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Roshanbin S, 2014, BRAIN RES, V1557, P12, DOI 10.1016/j.brainres.2014.02.014; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	63	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172917	10.1371/journal.pone.0172917	http://dx.doi.org/10.1371/journal.pone.0172917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235079	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200168
J	Hinaux, H; Recher, G; Alie, A; Legendre, L; Blin, M; Retaux, S				Hinaux, Helene; Recher, Gaelle; Alie, Alexandre; Legendre, Laurent; Blin, Maryline; Retaux, Sylvie			Lens apoptosis in the Astyanax blind cavefish is not triggered by its small size or defects in morphogenesis	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; ANTERIOR SEGMENT DYSGENESIS; EYE DEGENERATION; REGRESSIVE EVOLUTION; MEXICANUS; EXPRESSION; ZEBRAFISH; FISH; GENE; MECHANISMS	Blindness is a convergent trait in many cave animals of various phyla. Astyanax mexicanus cavefish is one of the best studied cave animals; however the mechanisms underlying eye degeneration in this species are not yet completely understood. The lens seems to play a central role, but only relatively late differentiation defects have been implicated in the cavefish lens apoptosis phenotype so far. Here, we used genetic crosses between Astyanax cavefish and surface fish to confirm that during development, lens size is independent of retina size. We then investigated whether the small size of the cavefish lens could directly cause cell death. Laser ablation experiments of lens placode cells in surface fish embryos showed that a small lens size is not sufficient to trigger lens apoptosis. We further examined potential lens morphogenesis defects through classical histology and live-imaging microscopy. From lens placode to lens ball, we found that lens invagination and formation of the lens epithelium and fiber cells occur normally in cavefish. We conclude that the main and deleterious defect in the Astyanax cavefish lens must concern the molecular control of lens cell function.	[Hinaux, Helene; Alie, Alexandre; Blin, Maryline; Retaux, Sylvie] Univ Paris Saclay, Univ Paris Sud, CNRS, DECA Grp,Paris Saclay Inst Neurosci,UMR9197, Ave Terrasse, Gif Sur Yvette, France; [Recher, Gaelle] Univ Paris Saclay, CNRS, USR3695, Plateforme BioEmergence, Ave Terrasse, Gif Sur Yvette, France; [Legendre, Laurent] Univ Paris Saclay, INRA, CNRS, UMS AMAGEN,UMS 3504,UMS 1374, Ave Terrasse, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Retaux, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, DECA Grp,Paris Saclay Inst Neurosci,UMR9197, Ave Terrasse, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr	Recher, Gaelle/AAB-8218-2019	Recher, Gaelle/0000-0001-9004-0118; RETAUX, Sylvie/0000-0003-0981-1478	Agence Nationale pour la Recherche (ANR); Centre National de la Recherche Scientifique (CNRS); Retina France; ANR	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Retina France; ANR(French National Research Agency (ANR))	Work was supported by Agence Nationale pour la Recherche (ANR) grants [ASTYCO] and [BLINDTEST], and by Centre National de la Recherche Scientifique (CNRS). HH received financial support from Retina France and ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Behrens M, 1998, GENE, V216, P319, DOI 10.1016/S0378-1119(98)00346-1; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; CAHN PH, 1958, B AM MUS NAT HIST, V115, P75; Casane D, 2016, ADV GENET, V95, P117, DOI 10.1016/bs.adgen.2016.03.001; Chen Q, 2004, J BIOL CHEM, V279, P17667, DOI 10.1074/jbc.M311678200; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Dahm R, 2007, EXP EYE RES, V85, P74, DOI 10.1016/j.exer.2007.02.015; Elipot Y, 2013, CURRENT BIOL; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Grainger RM, 1997, DEV GENET, V20, P246; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Hinaux H, 2016, DEVELOPMENT IN PRESS; Hinaux H, 2014, DEV NEUROBIOL; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Jeffery WR, 2009, CURR TOP DEV BIOL, V86, P191, DOI 10.1016/S0070-2153(09)01008-4; Jeffery WR, 1998, AM ZOOL, V38, P685; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kohli V, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-7; Li Z, 2000, DEV DYNAM, V218, P175, DOI 10.1002/(SICI)1097-0177(200005)218:1<175::AID-DVDY15>3.0.CO;2-K; Ma L, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-28; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Quinto-Su PA, 2007, METHOD CELL BIOL, V82, P113, DOI 10.1016/S0091-679X(06)82004-2; Retaux S, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-26; Sadoglu P., 1975, P419; Saravanamuthu SS, 2012, DEV BIOL, V362, P219, DOI 10.1016/j.ydbio.2011.11.011; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Strickler AG, 2007, DEV BIOL, V311, P512, DOI 10.1016/j.ydbio.2007.08.050; Strickler AG, 2007, DEV GENES EVOL, V217, P771, DOI 10.1007/s00427-007-0190-z; Wilkens H, 2010, HEREDITY, V105, P413, DOI 10.1038/hdy.2009.184; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Wilkens H, 2007, BIOL J LINN SOC, V92, P287, DOI 10.1111/j.1095-8312.2007.00840.x; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; YAMAMOTO Y, 1976, DEV GROWTH DIFFER, V18, P273; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; Zhao JY, 2012, AM J PATHOL, V180, P2230, DOI 10.1016/j.ajpath.2012.02.017	43	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172302	10.1371/journal.pone.0172302	http://dx.doi.org/10.1371/journal.pone.0172302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235048	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200065
J	Lavi, H; Assayag, M; Schwartz, A; Arish, N; Fridlender, ZG; Berkman, N				Lavi, Hadas; Assayag, Miri; Schwartz, Assaf; Arish, Nissim; Fridlender, Zvi G.; Berkman, Neville			The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; SERUM OSTEOPONTIN; DISEASE; SUSCEPTIBILITY; RISK; PROGRESSION; POPULATION; GRANULOMAS	Background Sarcoidosis is a systemic inflammatory disease of unknown etiology. Osteopontin (SPP1, OPN) is an extra cellular matrix glycoprotein and cytokine with a known role in granuloma formation and in autoimmune and inflammatory diseases. Objective To determine whether plasma OPN levels are elevated in patients with sarcoidosis and compare the frequency of four single nucleotide polymorphism (SNPs) variants in the OPN gene in sarcoidosis patients compared to healthy controls. Methods Demographic and clinical information, radiological studies and pulmonary function tests were evaluated in 113 patients with sarcoidosis and in 79 healthy controls. Blood samples were analyzed for SNPs of the OPN gene and for plasma OPN and CRP levels. Association between clinical features of disease and OPN levels as well as SNP frequencies was determined. Results Plasma OPN levels were higher in sarcoidosis patients than in healthy subjects, (median: 217 vs 122ng/ml, p<0.001). Area under the curve for receiver operator curves (ROC) was 0.798 (0.686-0.909 95% CI.) No differences were observed between sarcoidosis patients and controls in the frequency of any of the SNPs evaluated. Presence of lung parenchymal involvement was associated with SNP distribution at rs1126772 (p = 0.02). We found no correlation between SNPs distribution and plasma OPN levels. Conclusions Osteopontin protein levels are elevated in sarcoidosis. We found no evidence for an association between SNPs on the osteopontin gene and plasma OPN levels or the presence of sarcoidosis, however, an association between genotype and several phenotypic clinical parameters of disease was observed.	[Lavi, Hadas; Assayag, Miri; Schwartz, Assaf; Arish, Nissim; Fridlender, Zvi G.; Berkman, Neville] Hebrew Univ Jerusalem, Inst Pulm Med, Hadassah Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Berkman, N (corresponding author), Hebrew Univ Jerusalem, Inst Pulm Med, Hadassah Med Ctr, Jerusalem, Israel.	Neville@hadassah.org.il						Akahoshi M, 2004, HUM GENET, V114, P503, DOI 10.1007/s00439-004-1099-5; Arjomandi M, 2011, PEDIAT ALLER IMM PUL, V24, P207, DOI 10.1089/ped.2011.0095; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Bargagli E, 2013, J CLIN IMMUNOL, V33, P264, DOI 10.1007/s10875-012-9754-4; Bons JA, 2007, RESP MED, V101, P1687, DOI 10.1016/j.rmed.2007.03.002; Carlson I, 1997, LAB INVEST, V77, P103; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Chu ML, 2011, HUM IMMUNOL, V72, P525, DOI 10.1016/j.humimm.2011.03.016; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; CROSBY AH, 1995, GENOMICS, V27, P155, DOI 10.1006/geno.1995.1018; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Dubaniewicz A, 2005, EUR J HUM GENET, V13, P829, DOI 10.1038/sj.ejhg.5201370; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080150; Floe A, 2014, DAN MED J, V61; Fridlender ZG, 2010, RESP MED, V104, P1336, DOI 10.1016/j.rmed.2010.03.029; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Karamizadeh Z, 2013, J ENDOCRINOL INVEST, V36, P1090, DOI 10.3275/9098; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Koechl Silvano, 2005, V297, P13; Maeda K, 2001, LUNG, V179, P279, DOI 10.1007/s004080000068; Maver A, 2009, DIS MARKERS, V27, P295, DOI [10.1155/2009/864313, 10.3233/DMA-2009-0675]; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; NOWACK D, 1987, ARCH INTERN MED, V147, P481, DOI 10.1001/archinte.147.3.481; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Petrow PK, 2000, ARTHRITIS RHEUM, V43, P1597, DOI 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Schurmann Manfred, 2003, Am J Pharmacogenomics, V3, P233; Spagnolo P, 2007, INVEST OPHTH VIS SCI, V48, P3019, DOI 10.1167/iovs.06-1485; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Su R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-121; Typiak M, 2016, ADV EXP MED BIOL, V905, P57, DOI 10.1007/5584_2015_193; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yigla M, 2006, RESPIROLOGY, V11, P586, DOI 10.1111/j.1440-1843.2006.00891.x	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171945	10.1371/journal.pone.0171945	http://dx.doi.org/10.1371/journal.pone.0171945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253271	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300009
J	Liu, Q; Ma, YH; Wang, JL; Zhu, XF; Yang, YJ; Mei, YF				Liu, Qian; Ma, Yanhong; Wang, Junlan; Zhu, Xuefang; Yang, Yanjing; Mei, Yufeng			Demineralized bone matrix used for direct pulp capping in rats	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; MORPHOGENETIC PROTEIN-2; DENTAL-PULP; STEM-CELLS; DIFFERENTIATION; HYDROXYAPATITE; TISSUE	Objectives To evaluate the wound healing process following direct pulp capping with demineralized bone matrix (DBM) and calcium hydroxide (Ca(OH)(2)). Methods Fifty 8-weeks-old SPF Wistar male rats were divided into two groups: one was the DBM treated group, and the other was the Ca(OH)(2) treated group. Pulpotomy was performed on the maxillary first molar of one side of each rat, and the another side was left as the blank control. Rats were sacrificed after each observation period (1, 3, 7, 14 and 28 days) and specimen slices were made. Hematoxylin-Eosin (HE) staining was used for observing the changes of pulp tissue, and immunohistochemical staining was used for observing the expression of reparative dentinogenesis-related factors runt transcription factor 2 (Runx2), type I collagen (COL I), osteocalcin (OCN) and dentin sialoprotein (DSP). Results Inflammatory cell infiltration (ICI) and pulp tissue disorganization (PTD) could be observed in both the DBM and Ca(OH)(2) groups at all observation periods. The DBM group showed slighter ICI on 1 and 28 days and milder PTD on 28 days, with a significant difference (P<0.05). Reparative dentin formation (RDF) could initially be observed on 14 days postoperatively, and the DBM group showed more regular and thinner RDF with significant differences on 14 and 28 days compared with the Ca(OH)2 group (P<0.05). In both groups, the expression of Runx2, COL I, DSP and OCN were positive. Generally, the expression of these four factors in the DBM group was stronger than the Ca(OH)(2) group on the same observation periods. Conclusions DBM had the ability of inducing odontoblast differentiation and promoting dentinogenesis. DBM could initiate physiologic wound healing in pulp and had the ability to promote reparative dentin formation. Consequently, DBM may be an acceptable alternative for direct pulp capping.	[Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Key Lab Oral Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Stomatol Sch, Nanjing, Jiangsu, Peoples R China; [Liu, Qian; Wang, Junlan; Yang, Yanjing; Mei, Yufeng] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Pediat & Prevent Dent, Nanjing, Jiangsu, Peoples R China; [Ma, Yanhong] Xuzhou Cent Hosp, Dept Stomatol, Xuzhou, Jiangsu, Peoples R China; [Zhu, Xuefang] Nanchang Univ, Affiliated Stomatol Hosp, Key Lab Oral Biomed, Nanchang, Jiangxi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanchang University	Mei, YF (corresponding author), Nanjing Med Univ, Key Lab Oral Dis Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Mei, YF (corresponding author), Nanjing Med Univ, Stomatol Sch, Nanjing, Jiangsu, Peoples R China.; Mei, YF (corresponding author), Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Pediat & Prevent Dent, Nanjing, Jiangsu, Peoples R China.	yfmei@njmu.edu.cn	MA, YAN/HHN-2912-2022					BAUME LJ, 1981, INT DENT J, V31, P251; Bhatia M, 2007, ANN NY ACAD SCI, V1106, P219, DOI 10.1196/annals.1392.007; BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E; Briso André Luiz Fraga, 2006, Braz. oral res., V20, P219, DOI 10.1590/S1806-83242006000300007; Camilleri S, 2006, EUR J ORAL SCI, V114, P361, DOI 10.1111/j.1600-0722.2006.00399.x; Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Costa CAD, 2001, DENT MATER, V17, P230; FOREMAN PC, 1990, INT ENDOD J, V23, P283, DOI 10.1111/j.1365-2591.1990.tb00108.x; Fransson H, 2011, INT ENDOD J, V44, P259, DOI 10.1111/j.1365-2591.2010.01824.x; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Han NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088890; Hilton TJ, 2009, OPER DENT, V34, P615, DOI 10.2341/09-132-0; Islam I, 2006, J ENDODONT, V32, P193, DOI 10.1016/j.joen.2005.10.043; Ito S, 2004, J BIOMED MATER RES A, V69A, P11, DOI 10.1002/jbm.a.20066; Iwata H, 2002, CLIN ORTHOP RELAT R, P99; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Liu X, 2001, Zhonghua Kou Qiang Yi Xue Za Zhi, V36, P448; Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020; OWEN TA, 1990, P NATL ACAD SCI USA, V87, P9990, DOI 10.1073/pnas.87.24.9990; Pabaney AH, 2015, CLIN NEUROL NEUROSUR, V136, P66, DOI 10.1016/j.clineuro.2015.05.034; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009; Rabie ABM, 1997, CONNECT TISSUE RES, V36, P337, DOI 10.3109/03008209709160232; Raedel M, 2015, OUTCOMES OF DIRECT P; Saito T, 2004, J ENDODONT, V30, P205, DOI 10.1097/00004770-200404000-00005; Suzuki M, 2016, J DENT, V44, P27, DOI 10.1016/j.jdent.2015.11.005; Swarup SJ, 2014, J CLIN PEDIATR DENT, V38, P201, DOI 10.17796/jcpd.38.3.83121661121g6773; TORNECK CD, 1983, J ENDODONT, V9, P131, DOI 10.1016/S0099-2399(83)80031-4; Yamamoto R, 2015, J DENT RES, V94, P1120, DOI 10.1177/0022034515585715; Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258; Zhang M, 1999, HISTOCHEM CELL BIOL, V112, P325, DOI 10.1007/s004180050413; Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172693	10.1371/journal.pone.0172693	http://dx.doi.org/10.1371/journal.pone.0172693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253279	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300027
J	Peterson, CL; Bednar, MS; Bryden, AM; Keith, MW; Perreault, EJ; Murray, WM				Peterson, Carrie L.; Bednar, Michael S.; Bryden, Anne M.; Keith, Michael W.; Perreault, Eric J.; Murray, Wendy M.			Voluntary activation of biceps-to-triceps and deltoid-to-triceps transfers in quadriplegia	PLOS ONE			English	Article							SPINAL-CORD-INJURY; UPPER-LIMB SURGERY; ELBOW EXTENSION; INTERPOLATED TWITCH; TETRAPLEGIC PATIENTS; SURGICAL RESTORATION; ISOMETRIC ELBOW; TENDON TRANSFER; VALID MEASURE; MUSCLE	The biceps or the posterior deltoid can be transferred to improve elbow extension function for many individuals with C5 or C6 quadriplegia. Maximum strength after elbow reconstruction is variable; the patient's ability to voluntarily activate the transferred muscle to extend the elbow may contribute to the variability. We compared voluntary activation during maximum isometric elbow extension following biceps transfer (n = 5) and deltoid transfer (n = 6) in three functional postures. Voluntary activation was computed as the elbow extension moment generated during maximum voluntary effort divided by the moment generated with full activation, which was estimated via electrical stimulation. Voluntary activation was on average 96% after biceps transfer and not affected by posture. Individuals with deltoid transfer demonstrated deficits in voluntary activation, which differed by posture (80% in horizontal plane, 69% in overhead reach, and 70% in weight-relief), suggesting inadequate motor re-education after deltoid transfer. Overall, individuals with a biceps transfer better activated their transferred muscle than those with a deltoid transfer. This difference in neural control augmented the greater force-generating capacity of the biceps leading to increased elbow extension strength after biceps transfer (average 9.37 N-m across postures) relative to deltoid transfer (average 2.76 N-m across postures) in our study cohort.	[Peterson, Carrie L.; Bednar, Michael S.; Murray, Wendy M.] Edward Hines Jr VA Hosp, Hines, IL 60141 USA; [Peterson, Carrie L.; Perreault, Eric J.; Murray, Wendy M.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Peterson, Carrie L.; Perreault, Eric J.; Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bednar, Michael S.] Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg & Rehabil, 2160 S 1st Ave, Maywood, IL 60153 USA; [Bryden, Anne M.; Keith, Michael W.] MetroHealth, Cleveland FES Ctr, Cleveland, OH USA; [Bryden, Anne M.; Keith, Michael W.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Keith, Michael W.] Case Western Reserve Univ, Sch Med, Dept Orthopaed, Cleveland, OH USA; [Perreault, Eric J.; Murray, Wendy M.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Peterson, Carrie L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Northwestern University; Virginia Commonwealth University	Peterson, CL (corresponding author), Edward Hines Jr VA Hosp, Hines, IL 60141 USA.; Peterson, CL (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.; Peterson, CL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Peterson, CL (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.	clpeterson@vcu.edu	Perreault, Eric/B-7632-2009; Murray, Wendy/B-7629-2009; Murray, Wendy/AAD-6257-2022; Murray, Wendy M./D-1520-2009; Peterson, Carrie/C-6007-2016	Murray, Wendy/0000-0002-7547-621X; Murray, Wendy M./0000-0002-7547-621X; Peterson, Carrie/0000-0002-7169-2089; Bryden, Anne/0000-0003-4381-1156; Perreault, Eric/0000-0002-9860-6427	Rehabilitation Research and Development Services of the Department of Veterans Affairs [B7515R]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000377] Funding Source: NIH RePORTER	Rehabilitation Research and Development Services of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the Rehabilitation Research and Development Services of the Department of Veterans Affairs (Merit Review Award B7515R to WMM) http://www.research.va.gov/services/rrd.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekhuizen KS, 2008, ARCH PHYS MED REHAB, V89, P602, DOI 10.1016/j.apmr.2007.11.021; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Bonds Cale W, 2009, Tech Hand Up Extrem Surg, V13, P94, DOI 10.1097/BTH.0b013e318196c92d; Council MR., 1943, MED RES COUNCIL AIDS; Creasey Graham H, 2004, J Spinal Cord Med, V27, P365; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; DOWLING JJ, 1994, NEUROSCI LETT, V179, P25, DOI 10.1016/0304-3940(94)90926-1; Dunn JA, 2014, J HAND SURG-AM, V39, P317, DOI 10.1016/j.jhsa.2013.11.037; Frazer A, 2016, ANODAL TRANSCRANIAL; Friden J, 2012, PHYS MED REH CLIN N, V23, P33, DOI 10.1016/j.pmr.2011.11.002; FRIEDENBERG ZB, 1954, J BONE JOINT SURG AM, V36-A, P656, DOI 10.2106/00004623-195436030-00019; Gagnon D, 2008, J REHABIL RES DEV, V45, P863, DOI 10.1682/JRRD.2007.11.0189; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Hamou C, 2009, J HAND SURG-AM, V34A, P692, DOI 10.1016/j.jhsa.2008.12.002; Horstman AM, 2009, J APPL PHYSIOL, V107, P359, DOI 10.1152/japplphysiol.00362.2009; Hutchinson D, 2008, J HAND SURG-AM, V33A, P1331, DOI 10.1016/j.jhsa.2008.04.022; Johanson ME, 2006, J HAND SURG-AM, V31A, P747, DOI 10.1016/j.jhsa.2006.01.006; Johanson ME, 2011, J HAND SURG-AM, V36A, P480, DOI 10.1016/j.jhsa.2010.11.006; Kim HE, 2015, J NEUROPHYSIOL, V114, P427, DOI 10.1152/jn.01074.2014; Kirsch R F, 1996, IEEE Trans Rehabil Eng, V4, P403, DOI 10.1109/86.547942; Klein CS, 2001, J APPL PHYSIOL, V91, P1341, DOI 10.1152/jappl.2001.91.3.1341; Kozin SH, 2010, J HAND SURG-AM, V35A, P968, DOI 10.1016/j.jhsa.2010.03.011; Kuz JE, 1999, J HAND SURG-AM, V24A, P161; Langenderfer J, 2004, CLIN BIOMECH, V19, P664, DOI 10.1016/j.clinbiomech.2004.04.009; Leclercq C, 2008, HAND CLIN, V24, P185, DOI 10.1016/j.hcl.2008.02.003; Lieber RL, 2003, J HAND SURG-AM, V28A, P288, DOI 10.1053/jhsu.2003.50057; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Memberg WD, 2003, J REHABIL RES DEV, V40, P477, DOI 10.1682/JRRD.2003.11.0477; Memberg WD, 2001, CLIN BIOMECH, V16, P918, DOI 10.1016/S0268-0033(01)00071-7; MOBERG E, 1975, J BONE JOINT SURG AM, VA 57, P196, DOI 10.2106/00004623-197557020-00012; Mulcahey MJ, 2003, J HAND SURG-AM, V28A, P964, DOI 10.1016/S0363-5023(03)00485-4; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; RABISCHONG E, 1993, PARAPLEGIA, V31, P33, DOI 10.1038/sc.1993.6; Revol M, 1999, J HAND SURG-BRIT EUR, V24B, P235, DOI 10.1054/jhsb.1998.0184; Ridding MC, 2003, CLIN NEUROPHYSIOL, V114, P1437, DOI 10.1016/S1388-2457(03)00115-9; Song WG, 2016, EXP NEUROL, V277, P46, DOI 10.1016/j.expneurol.2015.12.008; Squitieri L, 2008, HAND CLIN, V24, P169, DOI 10.1016/j.hcl.2008.01.001; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Trombly C., 1989, OCCUPATIONAL THERAPY; Tsiampa VA, 2012, J PLAST SURG HAND SU, V46, P262, DOI 10.3109/2000656X.2012.684097; Turcsanyi I, 2010, J PLAST SURG HAND SU, V44, P156, DOI 10.3109/02844311.2010.488886; van Drongelen S, 2005, ARCH PHYS MED REHAB, V86, P1214, DOI 10.1016/j.apmr.2004.09.023; Vastamaki M, 2006, J HAND SURG-AM, V31A, P1490, DOI 10.1016/j.jhsa.2006.06.001; Wangdell J, 2012, J HAND SURG-AM, V37A, P1003, DOI 10.1016/j.jhsa.2012.01.026; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171141	10.1371/journal.pone.0171141	http://dx.doi.org/10.1371/journal.pone.0171141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253262	gold, Green Submitted, Green Published			2022-12-27	WOS:000396011300004
J	Sharon, G; Barash, A; Eisenberg-Degen, D; Grosman, L; Oron, M; Berger, U				Sharon, Gonen; Barash, Alon; Eisenberg-Degen, Davida; Grosman, Leore; Oron, Maya; Berger, Uri			Monumental megalithic burial and rock art tell a new story about the Levant Intermediate Bronze "Dark Ages"	PLOS ONE			English	Article								The Intermediate Bronze Age (IB) in the Southern Levant (ca. 2350-2000 BCE) is known as the "Dark Ages," following the collapse of Early Bronze urban society and predating the establishment of the Middle Bronze cities. The absence of significant settlements and monumental building has led to the reconstruction of IB social organization as that of nomadic, tribal society inhabiting rural villages with no central governmental system. Excavation in the Shamir Dolmen Field (comprising over 400 dolmens) on the western foothills of the Golan Heights was carried out following the discovery of rock art engravings on the ceiling of the central chamber inside one of the largest dolmens ever recorded in the Levant. Excavation of this multi-chambered dolmen, covered by a basalt capstone weighing some 50 tons, revealed a secondary multi-burial (of both adults and children) rarely described in a dolmen context in the Golan. Engraved into the rock ceiling above the multi-burial is a panel of 14 forms composed of a vertical line and downturned arc motif. 3D-scanning by structured-light technology was used to sharpen the forms and revealed the technique employed to create them. Building of the Shamir dolmens required a tremendous amount of labor, architectural mastery, and complex socio-economic organization well beyond the capacity of small, rural nomadic groups. The monumental megalithic burial of the Shamir dolmens indicates a hierarchical, complex, non-urban governmental system. This new evidence supports a growing body of recent criticism stemming from new discoveries and approaches that calls for rethinking our views of the Levantine IB "Dark Ages."	[Sharon, Gonen] Tel Hai Coll, Prehist Lab East Campus, Tel Hai, Upper Galilee, Israel; [Barash, Alon] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Eisenberg-Degen, Davida; Berger, Uri] Israel Antiqu Author, Jerusalem, Israel; [Grosman, Leore] Hebrew Univ Jerusalem, Inst Archaeol, Computerized Archeol Lab, Jerusalem, Israel; [Oron, Maya] Israel Antiqu Author, Dept Prehist, Jerusalem, Israel	Tel Hai Academy College; Bar Ilan University; Hebrew University of Jerusalem	Sharon, G (corresponding author), Tel Hai Coll, Prehist Lab East Campus, Tel Hai, Upper Galilee, Israel.	gonen@telhai.ac.il	Grosman, Leore/GRJ-0792-2022	Grosman, Leore/0000-0002-6976-6202; Barash, Alon/0000-0001-9682-6875; Sharon, Gonen/0000-0002-1226-2556				Albright WF, 1949, ARCHAEOLOGY PALESTIN; Anati E, 1999, NEAR EAST ARCHAEOL, V62, P22, DOI 10.2307/3210720; [Anonymous], [No title captured]; Arnold D., 1991, BUILDING EGYPT PHARA; BAHAT D, 1972, ISRAEL EXPLOR J, V22, P44; Bahat D., 1973, ERETZ ISR, V11, P58; Bar S, 2013, REV BIBLIQUE, V120, P161; Bar-Yosef Ofer, 2013, ARCHAEOLOGICAL SERIE, V19; Braemer F., 2003, P SEMINAR ARABIAN ST, V33, P169; Conder CR, 1885, HETH AND MOAB; Dever W. G., 1995, ARCHAEOLOGY SOC HOLY, P282; Diamond J., 2011, COLLAPSE SOC CHOOSE; DRONFIELD J, 1995, ANTIQUITY, V69, P539, DOI 10.1017/S0003598X00081928; Dubis E., 2001, ARCHEOLOGIA, Vlii, P91; Eisenberg-Degen D, 2013, ARTS, V2, P225, DOI 10.3390/arts2040225; Epstein C., 1985, ATIQOT, V17, P20; Epstein C., 1998, IAA REPORTS; EPSTEIN C., 1975, ERETZ ISRAEL, V12, P1; Fraser JA, 2015, DOLMENS LEVANT; Freikman M., 2014, MEGALITHIC STRUCTURE; Gilboa A, 2013, J ARCHAEOL SCI, V40, P1329, DOI 10.1016/j.jas.2012.09.018; Golani A., 2013, JEWELRY IRON AGE 2 L; Greenberg R., 2002, EARLY URBANIZATIONS; Grosman L, 2014, J EAST MEDITERR ARCH, V2, P48; Hartal M., 1987, DOLMENS ISRAEL; Hartal M.-Y., 2017, ARCHAEOLOGICAL SURVE; Ji C, 2008, HOEBAH DOLMEN FIELD; Khazanov, 1992, MONOGRAPHS WORLD ARC, P43; Kohl P., 2014, CAMBRIDGE WORLD PREH, P1571, DOI DOI 10.1017/CHO9781139017831.096; McCorriston J, 2011, ARAB ARCHAEOL EPIGR, V22, P1, DOI 10.1111/j.1600-0471.2011.00333.x; Nash G, 2006, DOC PRAEHIST, V33, P209; Polcaro A., 2014, B AM SCH ORIENT RES, V372, P1; Schaffer M, 2009, JUVENILE OSTEOLOGY L; Schath K, 2011, ANN DEP ANTIQ JORDAN, V55, P329; Scheltema G, 2008, MEGALITHIC JORDAN; Shamir Zingboym O., 2011, HADASHOT ARCHEOL, P123; Steimer-Herbet T., 2004, CLASSIFICATIONS SEPU; Steiner M. L., 2014, OHAL, P388; STEKELIS M., 1962, MITEKUFAT HAEVEN, V3, P33; Stekelis M, 1961, I PREHISTORIA ARQUEO; Stepansky Y, 2005, MEDITERR ARCHAEOL AR; Turville-Petre F, 1931, PALEST EXPLOR Q, V63, P155; Yassine K, 1985, B AM SCH ORIENT RES; Zingboym O., 2009, HADASHOT ARCHEOL, P121; ZOHAR M, 1989, ISRAEL EXPLOR J, V39, P18	45	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172969	10.1371/journal.pone.0172969	http://dx.doi.org/10.1371/journal.pone.0172969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN4XX	28253312	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300054
J	Visser, T; Bruxvoort, K; Maloney, K; Leslie, T; Barat, LM; Allan, R; Ansah, EK; Anyanti, J; Boulton, I; Clarke, SE; Cohen, JL; Cohen, JM; Cutherell, A; Dolkart, C; Eves, K; Fink, G; Goodman, C; Hutchinson, E; Lal, S; Mbonye, A; Onwujekwe, O; Petty, N; Pontarollo, J; Poyer, S; Schellenberg, D; Streat, E; Ward, A; Wiseman, V; Whitty, CJM; Yeung, SM; Cunningham, J; Chandler, CIR				Visser, Theodoor; Bruxvoort, Katia; Maloney, Kathleen; Leslie, Toby; Barat, Lawrence M.; Allan, Richard; Ansah, Evelyn K.; Anyanti, Jennifer; Boulton, Ian; Clarke, Sian E.; Cohen, Jessica L.; Cohen, Justin M.; Cutherell, Andrea; Dolkart, Caitlin; Eves, Katie; Fink, Gunther; Goodman, Catherine; Hutchinson, Eleanor; Lal, Sham; Mbonye, Anthony; Onwujekwe, Obinna; Petty, Nora; Pontarollo, Julie; Poyer, Stephen; Schellenberg, David; Streat, Elizabeth; Ward, Abigail; Wiseman, Virginia; Whitty, Christopher J. M.; Yeung, Shunmay; Cunningham, Jane; Chandler, Clare I. R.			Introducing malaria rapid diagnostic tests in private medicine retail outlets: A systematic literature review	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RANDOMIZED CONTROLLED-TRIAL; SPECIALIZED DRUG SHOPS; OF-THE-LITERATURE; HEALTH; MANAGEMENT; UGANDA; INTERVENTIONS; AVAILABILITY; COUNTRIES	Background Many patients with malaria-like symptoms seek treatment in private medicine retail outlets (PMR) that distribute malaria medicines but do not traditionally provide diagnostic services, potentially leading to overtreatment with antimalarial drugs. To achieve universal access to prompt parasite-based diagnosis, many malaria-endemic countries are considering scaling up malaria rapid diagnostic tests (RDTs) in these outlets, an intervention that may require legislative changes and major investments in supporting programs and infrastructures. This review identifies studies that introduced malaria RDTs in PMRs and examines study outcomes and success factors to inform scale up decisions. Methods Published and unpublished studies that introduced malaria RDTs in PMRs were systematically identified and reviewed. Literature published before November 2016 was searched in six electronic databases, and unpublished studies were identified through personal contacts and stakeholder meetings. Outcomes were extracted from publications or provided by principal investigators. Results Six published and six unpublished studies were found. Most studies took place in subSaharan Africa and were small-scale pilots of RDT introduction in drug shops or pharmacies. None of the studies assessed large-scale implementation in PMRs. RDT uptake varied widely from 8%-100%. Provision of artemisinin-based combination therapy (ACT) for patients testing positive ranged from 30%-99%, and was more than 85% in five studies. Of those testing negative, provision of antimalarials varied from 2%-83% and was less than 20% in eight studies. Longer provider training, lower RDT retail prices and frequent supervision appeared to have a positive effect on RDT uptake and provider adherence to test results. Performance of RDTs by PMR vendors was generally good, but disposal of medical waste and referral of patients to public facilities were common challenges. Conclusions Expanding services of PMRs to include malaria diagnostic services may hold great promise to improve malaria case management and curb overtreatment with antimalarials. However, doing so will require careful planning, investment and additional research to develop and sustain effective training, supervision, waste-management, referral and surveillance programs beyond the public sector.	[Visser, Theodoor; Anyanti, Jennifer; Cohen, Justin M.; Eves, Katie; Goodman, Catherine; Mbonye, Anthony] Clinton Hlth Access Initiat, Boston, MA USA; [Leslie, Toby; Anyanti, Jennifer; Cohen, Jessica L.; Dolkart, Caitlin; Lal, Sham; Onwujekwe, Obinna] London Sch Hyg Trop Med, Dept Global Hlth & Dev, London, England; [Maloney, Kathleen; Ansah, Evelyn K.; Boulton, Ian; Cohen, Justin M.; Eves, Katie; Fink, Gunther] Bill & Melinda Gates Fdn, Seattle, WA USA; [Bruxvoort, Katia; Allan, Richard; Clarke, Sian E.; Dolkart, Caitlin; Eves, Katie] US Presidents Malaria Initiat, US Agcy Int Dev, Washington, DC USA; [Bruxvoort, Katia; Allan, Richard; Boulton, Ian; Cutherell, Andrea; Eves, Katie; Hutchinson, Eleanor; Mbonye, Anthony; Petty, Nora] Mentor Initiat, Leicester, W Sussex, England; [Barat, Lawrence M.; Dolkart, Caitlin; Goodman, Catherine; Hutchinson, Eleanor; Onwujekwe, Obinna; Streat, Elizabeth; Yeung, Shunmay] Ghana Hlth Serv, Res Dev Div, Accra, Ghana; [Bruxvoort, Katia; Cohen, Justin M.; Cutherell, Andrea; Petty, Nora] Soc Family Hlth, Abuja, Nigeria; [Barat, Lawrence M.; Eves, Katie; Fink, Gunther; Mbonye, Anthony] TropMed Pharma Consulting, Lower Shiplake, Oxon, England; [Boulton, Ian; Cohen, Justin M.; Dolkart, Caitlin; Petty, Nora] London Sch Hyg Trop Med, Dept Dis Control, London, England; [Leslie, Toby; Cohen, Jessica L.; Eves, Katie; Lal, Sham; Petty, Nora] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Clarke, Sian E.; Dolkart, Caitlin] Populat Serv Int, Nairobi, Kenya; [Cutherell, Andrea; Goodman, Catherine] Minist Hlth, Kampala, Uganda; [Barat, Lawrence M.; Lal, Sham; Petty, Nora] Univ Enugu, Agbani, Enugu State, Nigeria; [Anyanti, Jennifer; Cohen, Jessica L.; Dolkart, Caitlin; Eves, Katie; Goodman, Catherine] Malaria Consortium, London, England; [Boulton, Ian; Cohen, Jessica L.; Cohen, Justin M.; Cutherell, Andrea; Dolkart, Caitlin; Fink, Gunther] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Eves, Katie; Fink, Gunther; Goodman, Catherine; Mbonye, Anthony] London Sch Hyg Trop Med, Dept Clin Res, London, England; [Maloney, Kathleen; Mbonye, Anthony] WHO, Global Malaria Program, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation; United States Agency for International Development (USAID); Ghana Health Service; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of New South Wales Sydney; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Visser, T (corresponding author), Clinton Hlth Access Initiat, Boston, MA USA.	tvisser@clintonhealthaccess.org	Boulton, Ian C/P-3529-2018; Clarke, Sian/AAF-5805-2019; Wiseman, Virginia/AAH-5011-2021; Onwujekwe, Obinna/O-6232-2014	Boulton, Ian C/0000-0002-5864-7224; Onwujekwe, Obinna/0000-0002-1214-4285; Ansah, Evelyn/0000-0003-0401-8606; Bruxvoort, Katia/0000-0001-8277-2431; Fernandez Barat, Laia/0000-0001-7528-9636; Chandler, Clare/0000-0001-6499-7522; Yeung, Shunmay/0000-0002-0997-0850; Wiseman, Virginia/0000-0002-7911-0741; Hutchinson, Eleanor/0000-0002-9718-2407; Goodman, Catherine/0000-0002-2241-3485; Cohen, Justin/0000-0003-4481-6784; Schellenberg, David/0000-0001-8222-0186	Gates Foundation [23451]; Department for International Development; ACT Consortium; Bill & Melinda Gates Foundation; London School of Hygiene & Tropical Medicine; US President's Malaria Initiative; London School of Hygiene & Tropical Medicine Institutional Strategic Support Fund; Welcome Trust; UNITAID; MRC [MR/N003810/1] Funding Source: UKRI; Medical Research Council [MR/N003810/1] Funding Source: researchfish	Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development; ACT Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); London School of Hygiene & Tropical Medicine; US President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); London School of Hygiene & Tropical Medicine Institutional Strategic Support Fund; Welcome Trust(Wellcome Trust); UNITAID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	One co-author (IB) is employed by a commercial company: TropMed Pharma Consulting. The co-author's contributions related to the manuscript were part of a project by the Roll Back Malaria initiative (RBM), a global platform of more than 500 partners that work in malaria, through a consultancy contract with Gates Foundation, contract Number 23451. The coauthor IB contributed to the manuscript by reviewing and editing the manuscript. The funder provided support in the form of salaries for the author [IB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other funding organizations include the Department for International Development (TV), the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene & Tropical Medicine (KB and LB), the Bill and Melinda Gates Foundation (KM), US President's Malaria Initiative (LMB) and a fellowship from the London School of Hygiene & Tropical Medicine Institutional Strategic Support Fund with the Welcome Trust (CIRC). JC is a staff member of the WHO Global Malaria Program and funded through a grant from UNITAID. Support for the meeting: Diagnostic Testing in the Retail Private Sector: Lessons Learned was provided by ACT Consortium, US President's Malaria Initiative, and the Roll Back Malaria initiative. Support for the consultative work on fever case management in the private health care sector in Africa was provided by ACT Consortium. Similar to the funders supporting IB, these funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries, costs related to organizing the meetings and/or research materials.	Altaras R, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1020-9; [Anonymous], MAL DIAGN LANDSC UPD; Ansah EK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1019; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Aung T, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0621-7; Awor P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0798-9; Awor P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115440; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Beisel U, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1083-2; Beyeler N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117165; Cabral C, 2015, SOC SCI MED, V136, P156, DOI 10.1016/j.socscimed.2015.05.027; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Cohen J, 2015, B WORLD HEALTH ORGAN, V93, P142, DOI 10.2471/BLT.14.142489; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; Ezeoke OP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-368; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hopkins H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2606; Hutchinson E, 2015, CRIT PUBLIC HEALTH, V25, P48, DOI 10.1080/09581596.2014.886762; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Mbonye AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129545; Onwujekwe O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133832; Population Services International ACTwatch, 2015, MAL MARK TRENDS SUBS; Poyer S, 2015, TROP MED INT HEALTH, V20, P744, DOI 10.1111/tmi.12491; Private health care sector, 2015, ACT CONS ANSW KEY QU; Private Sector Taskforce of the Roll Back Malaria Partnership Case Management Working Group, 2013, DIAGN TEST RET PRIV; Roll Back Malaria Partnership Case Management Working Group, 2013, KEY LEARN MAL PROGR; Smith F, 2009, TROP MED INT HEALTH, V14, P362, DOI 10.1111/j.1365-3156.2009.02232.x; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Wafula FN, 2010, INT J QUAL HEALTH C, V22, P316, DOI 10.1093/intqhc/mzq022; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2010, GUID TREATM MAL, V2nd; Whyte SR, 2002, SOCIAL LIVES MED; [World Health Organization Alliance for Health Policy and Systems Research], 2005, WORK NONST SECT ACH; World Health Organization, 2015, WORLD MAL REP 2015; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	43	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e1073093	10.1371/journal.pone.0173093	http://dx.doi.org/10.1371/journal.pone.0173093			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253315	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000396011300071
J	Jones, RA; Downing, K; Rinehart, NJ; Barnett, LM; May, T; McGillivray, JA; Papadopoulos, NV; Skouteris, H; Timperio, A; Hinkley, T				Jones, Rachel A.; Downing, Katherine; Rinehart, Nicole J.; Barnett, Lisa M.; May, Tamara; McGillivray, Jane A.; Papadopoulos, Nicole V.; Skouteris, Helen; Timperio, Anna; Hinkley, Trina			Physical activity, sedentary behavior and their correlates in children with Autism Spectrum Disorder: A systematic review	PLOS ONE			English	Review							SCHOOL-AGED CHILDREN; VIDEO GAME USE; PRESCHOOL-CHILDREN; HEALTH INDICATORS; YOUNG-ADULTS; MEDIA USE; YOUTH; ADOLESCENTS; BOYS; DETERMINANTS	Autism Spectrum Disorder affects up to 2.5% of children and is associated with harmful health outcomes (e.g. obesity). Low levels of physical activity and high levels of sedentary behaviors may contribute to harmful health outcomes. To systematically review the prevalence and correlates of physical activity and sedentary behaviors in children with Autism Spectrum Disorder, electronic databases (PsycINFO, SPORTDiscus, EMBASE, Medline) were searched from inception to November 2015. The review was registered with PROSPERO (CRD42014013849). Peer-reviewed, English language studies were included. Two reviewers screened potentially relevant articles. Outcomes of interest were physical activity and sedentary behaviour levels and their potential correlates. Data were collected and analysed in 2015. Of 35 included studies, 15 reported physical activity prevalence, 10 reported physical activity correlates, 18 reported sedentary behavior prevalence, and 10 reported sedentary behavior correlates. Estimates of children's physical activity (34-166 mins/day, average 86 mins/day) and sedentary behavior (126-558 mins/day in screen time, average 271 mins/day; 428-750 mins/day in total sedentary behavior, average 479 mins/day) varied across studies. Age was consistently inversely associated, and sex inconsistently associated with physical activity. Age and sex were inconsistently associated with sedentary behavior. Sample sizes were small. All but one of the studies were classified as having high risk of bias. Few correlates have been reported in sufficient studies to provide overall estimates of associations. Potential correlates in the physical environment remain largely unexamined. This review highlights varying levels of physical activity and sedentary behavior in children with Autism Spectrum Disorder. Research is needed to consistently identify the correlates of these behaviors. There is a critical need for interventions to support healthy levels of these behaviors.	[Jones, Rachel A.; Downing, Katherine; Timperio, Anna; Hinkley, Trina] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Jones, Rachel A.] Univ Wollongong, Fac Social Sci, Early Start Res Inst, Wollongong, NSW, Australia; [Rinehart, Nicole J.; May, Tamara; McGillivray, Jane A.; Papadopoulos, Nicole V.] Deakin Univ, Sch Psychol, Deakin Child Study Ctr, Burwood, Vic, Australia; [Barnett, Lisa M.] Deakin Univ, Sch Hlth & Social Dev, Burwood, Vic, Australia; [May, Tamara] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [May, Tamara] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Skouteris, Helen] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Burwood, Vic, Australia	Deakin University; University of Wollongong; Deakin University; Deakin University; University of Melbourne; Murdoch Children's Research Institute; Deakin University	Hinkley, T (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia.	trina.hinkley@deakin.edu.au	Timperio, Anna F/A-3086-2013; Skouteris, Helen/AAG-6494-2021; Barnett, Lisa/C-9997-2014	Timperio, Anna F/0000-0002-8773-5012; Barnett, Lisa/0000-0002-9731-625X; Rinehart, Nicole/0000-0001-6109-3958; May, Tamara/0000-0001-8705-4180; Hinkley, Trina/0000-0003-2742-8579; McGillivray, Jane/0000-0003-2000-6488; Papadopoulos, Nicole/0000-0001-9057-1672; Downing, Katherine/0000-0002-6552-8506	National Health and Medical Research Council [GNT1092876]; Alfred Deakin Postdoctoral Research Fellowship; National Heart Foundation of Australia Future Leader Fellowship [100046]; NHMRC ECF [APP1070571]; Deakin University's Faculty of Health; Deakin University Faculty of Health Postdoctoral Research Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alfred Deakin Postdoctoral Research Fellowship; National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); NHMRC ECF(National Health and Medical Research Council (NHMRC) of Australia); Deakin University's Faculty of Health; Deakin University Faculty of Health Postdoctoral Research Fellowship	KD is funded by a National Health and Medical Research Council Postgraduate Scholarship (GNT1092876); LMB is funded by an Alfred Deakin Postdoctoral Research Fellowship; AT is funded by a National Heart Foundation of Australia Future Leader Fellowship (Award 100046); TH is funded by an NHMRC ECF (APP1070571). The study was funded by Deakin University's Faculty of Health. NVP is funded by a Deakin University Faculty of Health Postdoctoral Research Fellowship. None of the funding bodies had any role in study design; collection, analysis, or interpretation of data; writing the report; or the decision to submit the report for publication.	Active Healthy Kids Australia, 2014, SPORT EN 2014 ACT HE; Active Healthy Kids Scotland, 2013, 2013 ACT HEALTH KIDS; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson SE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-366; Ayvazoglu NR, 2015, RES DEV DISABIL, V47, P93, DOI 10.1016/j.ridd.2015.08.015; Babic MJ, 2014, SPORTS MED, V44, P1589, DOI 10.1007/s40279-014-0229-z; Bandini LG, 2013, AUTISM, V17, P44, DOI 10.1177/1362361312437416; Beets MW, 2011, PEDIATRICS, V127, P658, DOI 10.1542/peds.2010-2021; Bhat AN, 2011, PHYS THER, V91, P1116, DOI 10.2522/ptj.20100294; Bingham DD, 2016, AM J PREV MED, V51, P384, DOI 10.1016/j.amepre.2016.04.022; Boddy LM, 2015, SCHOOL PSYCHOL INT, V36, P154, DOI 10.1177/0143034314564242; Boyd TK, 2015, INTERV SCH CLIN, V51, P19, DOI 10.1177/1053451215577476; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Carson V, 2016, J SCI MED SPORT, V19, P573, DOI 10.1016/j.jsams.2015.07.011; Carson V, 2015, PREV MED, V78, P115, DOI 10.1016/j.ypmed.2015.07.016; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Chonchaiya W, 2011, ACTA PAEDIATR, V100, P1033, DOI 10.1111/j.1651-2227.2011.02166.x; Christakis DA, 2016, JAMA PEDIATR, V170, P109, DOI 10.1001/jamapediatrics.2015.3372; Clark MLE, 2015, FOCUS AUTISM DEV DIS, V30, P174, DOI 10.1177/1088357614537353; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Cohen KE, 2015, J SPORT SCI, V33, P1908, DOI 10.1080/02640414.2015.1017734; Czerwinski F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1715-4; Davison K. K., 2006, International Journal of Behavioral Nutrition and Physical Activity, V3; De Craemer M, 2012, OBES REV, V13, P13, DOI 10.1111/j.1467-789X.2011.00941.x; Duch H, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-102; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Engelhardt CR, 2013, PEDIATRICS, V132, P1081, DOI 10.1542/peds.2013-2066; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Foran AC, 2013, PALAESTRA, V27, P42; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Gillette MLD, 2015, J DEV BEHAV PEDIATR, V36, P489, DOI 10.1097/DBP.0000000000000198; Gorely T, 2004, INT J BEHAV MED, V11, P152, DOI 10.1207/s15327558ijbm1103_4; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Healthy Active Kids New Zealand, 2014, NZ PHYS ACT REP CARD; Herman KM, 2015, APPL PHYSIOL NUTR ME, V40, P10, DOI 10.1139/apnm-2014-0039; Hill AP, 2015, PEDIATRICS, V136, P1051, DOI 10.1542/peds.2015-1437; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Hinkley T, 2014, PREV MED, V62, P182, DOI 10.1016/j.ypmed.2014.02.007; Hinkley T, 2012, AM J PREV MED, V43, P159, DOI 10.1016/j.amepre.2012.04.020; Hinkley T, 2012, MED SCI SPORT EXER, V44, P458, DOI 10.1249/MSS.0b013e318233763b; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Cillero IH, 2010, PREV MED, V51, P3, DOI 10.1016/j.ypmed.2010.04.012; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; King AC, 2010, EUR J PUBLIC HLTH; King AM, 2014, CHILD LANG TEACH THE, V30, P159, DOI 10.1177/0265659013510922; Kolle E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-36; Kuo MH, 2015, AUTISM, V19, P724, DOI 10.1177/1362361314552199; Kuo MH, 2014, AUTISM, V18, P914, DOI 10.1177/1362361313497832; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; LeBlanc A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128063; Macdonald Megan, 2011, BMC Res Notes, V4, P422, DOI 10.1186/1756-0500-4-422; MacMullin JA, 2016, AUTISM, V20, P45, DOI 10.1177/1362361314566047; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; May T, 2014, J AUTISM DEV DISORD, V44, P1077, DOI 10.1007/s10803-013-1964-y; Mazurek MO, 2013, PEDIATRICS, V132, P260, DOI 10.1542/peds.2012-3956; Mazurek MO, 2013, J AUTISM DEV DISORD, V43, P1258, DOI 10.1007/s10803-012-1659-9; Mazurek MO, 2013, RES AUTISM SPECT DIS, V7, P316, DOI 10.1016/j.rasd.2012.09.008; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Memari AH, 2013, PEDIATR OBES, V8, P150, DOI 10.1111/j.2047-6310.2012.00101.x; Memari AH, 2015, NEUROL RES INT; Mitchell J, 2012, EARLY CHILD DEV CARE, V182, P1411, DOI 10.1080/03004430.2011.619658; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Must A, 2015, J PHYS ACT HEALTH, V12, P529, DOI 10.1123/jpah.2013-0271; Must A, 2014, AUTISM, V18, P376, DOI 10.1177/1362361313479039; National Collaborating Centre for Methods and Tools, 2008, QUAL ASS TOOL QUANT; National Physical Activity Plan Alliance, 2014, US REP CARD PHYS ACT; Obrusnikova I, 2011, J DEV PHYS DISABIL, V23, P195, DOI 10.1007/s10882-010-9215-z; Orsmond GI, 2011, AUTISM, V15, P579, DOI 10.1177/1362361310386503; Ozen A, 2015, EDUC SCI-THEOR PRACT, V15, P1287; Pan CY, 2006, J AUTISM DEV DISORD, V36, P597, DOI 10.1007/s10803-006-0101-6; Pan CY, 2011, RES Q EXERCISE SPORT, V82, P491, DOI 10.1080/02701367.2011.10599782; Pan CY, 2011, RES AUTISM SPECT DIS, V5, P1042, DOI 10.1016/j.rasd.2010.11.010; Pan CY, 2005, RES Q EXERCISE SPORT, V76, pA116; ParticipACTION, 2015, BIGG RISK KEEP KIDS; Randall M, 2016, AUST NZ J PSYCHIAT, V50, P243, DOI 10.1177/0004867415595287; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Rinehart N, DEV DISORDE IN PRESS; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sanders T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0288-z; Sandt DDR, 2005, ADAPT PHYS ACT Q, V22, P146, DOI 10.1123/apaq.22.2.146; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shane HC, 2008, J AUTISM DEV DISORD, V38, P1499, DOI 10.1007/s10803-007-0527-5; Soden SE, 2012, J DEV BEHAV PEDIATR, V33, P618, DOI 10.1097/DBP.0b013e318260943c; Stratton G, 2014, ACT HLTH KIDS REP CA; Tatsumi Y, 2014, J PAEDIAT CHILD HLTH; Temmel CSD, 2013, HLTH FIT J CAN, V6, P81, DOI DOI 10.14288/HFJC.V6I1.146; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Tremblay L, 2012, CAN PSYCHOL, V53, P280, DOI 10.1037/a0030210; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tyler Kiley, 2014, Autism Res Treat, V2014, P312163, DOI 10.1155/2014/312163; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Viswanathan M, 2012, ASSESSING RISK BIAS; Wachob D, 2015, J AUTISM DEV DISORD, V45, P2641, DOI 10.1007/s10803-015-2424-7; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS; Xu HL, 2015, J OBES, V2015, DOI 10.1155/2015/546925; Zablotsky B, 2015, NATL HLTH STAT REP, P1	101	97	99	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172482	10.1371/journal.pone.0172482	http://dx.doi.org/10.1371/journal.pone.0172482			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245224	Green Published, gold			2022-12-27	WOS:000395980200020
J	Birner, A; Platzer, M; Bengesser, SA; Dalkner, N; Fellendorf, FT; Queissner, R; Pilz, R; Rauch, P; Maget, A; Hamm, C; Herzog-Eberhard, S; Mangge, H; Fuchs, D; Moll, N; Zelzer, S; Schutze, G; Schwarz, M; Reininghaus, B; Kapfhammer, HP; Reininghaus, EZ				Birner, Armin; Platzer, Martina; Bengesser, Susanne Astrid; Dalkner, Nina; Fellendorf, Frederike T.; Queissner, Robert; Pilz, Rene; Rauch, Philipp; Maget, Alexander; Hamm, Carlo; Herzog-Eberhard, Simone; Mangge, Harald; Fuchs, Dietmar; Moll, Natalie; Zelzer, Sieglinde; Schuetze, Gregor; Schwarz, Markus; Reininghaus, Bernd; Kapfhammer, Hans-Peter; Reininghaus, Eva Z.			Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; I DISORDER; TRYPTOPHAN; SCHIZOPHRENIA; METAANALYSIS; INDIVIDUALS; DEPRESSION; PATHWAY; BRAIN; METABOLISM	Introduction Bipolar disorder (BD) is a chronic psychiatric disease which can take most different and unpredictable courses. It is accompanied by unspecific brainstructural changes and cognitive decline. The neurobiological underpinnings of these processes are still unclear. Emerging evidence suggests that tryptophan catabolites (TRYCATs), which involve all metabolites of tryptophan towards the kynurenine (KYN) branch, are involved in the etiology as well as in the course of BD. They are proposed to be mediators of immune-inflammation and neurodegeneration. In this study we measured the levels of KYN and its main catabolites consisting of the neurotoxic hydroxykynurenine (3-HK), the more neuroprotective kynurenic acid (KYNA) and anthranilic acid (AA) and evaluated the ratios between end-products and substrates as proxies for the specific enzymatic activity (3-HK/KYN, KYNA/KYN, AA/KYN) as well as 3-HK/KYNA as a proxy for neurotoxic vs. neuroprotective end-product relation in individuals with BD compared to healthy controls (HC). Methods We took peripheral TRYCAT blood levels of 143 euthymic to mild depressive BD patients and 101 HC. For statistical analyses MANCOVA's controlled for age, sex, body mass index, cardiovascular disease and smoking were performed. Results The levels of KYNA (F = 5,579; p < .05) were reduced in BD compared to HC. The enzymatic activity of the kynurenine-3-monooxygenase (KMO) reflected by the 3-HK/KYN ratio was increased in BD individuals compared to HC (F = 5,394; p <. 05). Additionally the ratio of 3-HK/ KYNA was increased in individuals with BD compared to healthy controls (F = 11,357; p <. 01). Discussion In conclusion our findings subserve the concept of KYN -pathway alterations in the pathophysiology of BD. We present evidence of increased breakdown towards the neurotoxic branch in KYN metabolism even in a euthymic to mild depressive state in BD. From literature we know that depression and mania are accompanied by inflammatory states which should be capable to produce an even greater imbalance due to activation of key enzymes in the neurotoxic direction of KYN -conversion. These processes could finally be involved in the development of unspecific brain structural changes and cognitive deficits which are prevalent in BD. Further research should focus on state dependent changes in TRYCATs and its relation to cognition, brain structure and staging parameters.	[Birner, Armin; Platzer, Martina; Bengesser, Susanne Astrid; Dalkner, Nina; Fellendorf, Frederike T.; Queissner, Robert; Pilz, Rene; Rauch, Philipp; Maget, Alexander; Hamm, Carlo; Herzog-Eberhard, Simone; Reininghaus, Bernd; Kapfhammer, Hans-Peter; Reininghaus, Eva Z.] Med Univ Graz, Dept Psychiat & Psychotherapy, Graz, Austria; [Mangge, Harald; Zelzer, Sieglinde] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, Innsbruck, Austria; [Moll, Natalie; Schuetze, Gregor; Schwarz, Markus] Munich Univ LMU, Med Ctr, Inst Lab Med, Munich, Germany	Medical University of Graz; Medical University of Graz; Medical University of Innsbruck; University of Munich	Platzer, M (corresponding author), Med Univ Graz, Dept Psychiat & Psychotherapy, Graz, Austria.	martina.platzer@medunigraz.at	Fuchs, Dietmar/AAL-8011-2021; Hamm, Christian W./I-3155-2017	Fuchs, Dietmar/0000-0003-1627-9563; Hamm, Christian W./0000-0001-6763-4161; Fellendorf, Frederike/0000-0001-7215-3848; Mangge, Harald/0000-0003-4067-247X; Schwarz, Markus/0000-0001-8895-3743	Stadt Graf (City of Graz, Austria); Stad Graz; Bereich Wissenschaft; Kulturamt, Stigergasse 2 (Mariahilferplat), Graz; Austrian Society of Cardiology; pA Univ.-Klinik fur Innere Medizin II; Abteilung fur Kardiologie Wahringer Gurte	Stadt Graf (City of Graz, Austria); Stad Graz; Bereich Wissenschaft; Kulturamt, Stigergasse 2 (Mariahilferplat), Graz; Austrian Society of Cardiology; pA Univ.-Klinik fur Innere Medizin II; Abteilung fur Kardiologie Wahringer Gurte	The present study is part of the BIPFAT-study which was funded by the "Stadt Graf (City of Graz, Austria) (original project name: "Fettstoffwechselstrungen and anthropometrische Besonderheiten bei Patientlnnen mit bipolarer affektiver Strung"), Stad Graz, Bereich Wissenschaft, Kulturamt, Stigergasse 2 (Mariahilferplat), A-8011 Graz, Telefon: (0043/316) 872 4900, Fax: -4909, E-Mail: kulturamt@stadt.graz.at., and the Austrian Society of Cardiology with the Project title: "BIPFAT Erforschung der neurobiologischen Zusammenhange zwischen kardiovaskularen Komorbiditaten als auch Ubergewicht and bipolar affektiver Erkrankung," Austrian Society of Cardiology, pA Univ.-Klinik fur Innere Medizin II, Abteilung fur Kardiologie Wahringer Gurte 18-20. A-I 090 Wien Tel. : (+4311) 40 400-4614, Fax: (+43/1) 40 400-4216, e-mail: office@atcardio.at, http://wwwatcardo.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study is part of the BIPFAT-study which was funded by the "Stadt Graz" (City of Graz, Austria) (original project name: "Fettstoffwechselstorungen und anthropometrische Besonderheiten bei Patientlnnen mit bipolarer affektiver Storung") and by the Austrian Society of Cardiology (project title: "BIPFAT Erforschung der neurobiologischen Zusammenhange zwischen kardiovaskularen Komorbiditaten als auch Ubergewicht und bipolar affektiver Erkrankung").	Anderson G., 2013, METABOLIC SYNDROME N, P235; Anderson G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0541-1; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; BECK AT, 1994, BECK DEPRESSIONS INV; Bengesser SA, 2015, J AFFECT DISORDERS, V172, P367, DOI 10.1016/j.jad.2014.10.014; Beyer JL, 2009, INT REV PSYCHIATR, V21, P394, DOI 10.1080/09540260902962198; Campbell B, 2015, TARGETING BROADLY  P, P241; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; Erhardt S., 2016, NEUROPHARMACOLOGY; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Goldstein BI, 2009, BIPOLAR DISORD, V11, P657, DOI 10.1111/j.1399-5618.2009.00735.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; IGARI T, 1987, TOHOKU J EXP MED, V153, P79, DOI 10.1620/tjem.153.79; Johansson AS, 2013, J PSYCHIATR RES, V47, P1815, DOI 10.1016/j.jpsychires.2013.08.008; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kim YK, 2007, J AFFECT DISORDERS, V104, P91, DOI 10.1016/j.jad.2007.02.018; Lackner N., 2015, WORLD J BIOL PSYCHIA, P1; Lackner N, 2015, EUR ARCH PSY CLIN N, V265, P313, DOI 10.1007/s00406-014-0559-8; Langan C, 2009, MOL PSYCHIATR, V14, P833, DOI 10.1038/mp.2009.39; Lavebratt C, 2014, MOL PSYCHIATR, V19, P334, DOI 10.1038/mp.2013.11; Lovelace MD, 2016, NEUROPHARMACOLOGY; McIntyre RS, 2010, J AFFECT DISORDERS, V126, P366, DOI 10.1016/j.jad.2010.04.012; Miller CL, 2006, BRAIN RES, V1073, P25, DOI 10.1016/j.brainres.2005.12.056; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Nishimura Satoshi, 2009, Discov Med, V8, P55; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; Olsson SK, 2012, BIPOLAR DISORD, V14, P719, DOI 10.1111/bdi.12009; Olsson SK, 2010, J PSYCHIATR NEUROSCI, V35, P195, DOI 10.1503/jpn.090180; Oxenkrug G., 2016, ANN PSYCHIAT MENT HL, V4, P1059; Oxenkrug Gregory, 2015, Integr Mol Med, V2, P365; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Reininghaus EZ, 2015, J AFFECT DISORDERS, V171, P33, DOI 10.1016/j.jad.2014.09.006; Reininghaus EZ, 2014, BIPOLAR DISORD, V16, P432, DOI 10.1111/bdi.12166; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; RYDON HN, 1948, BRIT J EXP PATHOL, V29, P48; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Ulvik A, 2013, AM J CLIN NUTR, V98, P934, DOI 10.3945/ajcn.113.064998; Widner B, 2002, BRAIN BEHAV IMMUN, V16, P590, DOI 10.1016/S0889-1591(02)00006-5; Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	44	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172699	10.1371/journal.pone.0172699	http://dx.doi.org/10.1371/journal.pone.0172699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241062	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400030
J	Pang, JB; Deng, LF; Wang, GY				Pang, Jinbo; Deng, Lingfei; Wang, Gangyi			An evolutionarily stable strategy and the critical point of hog futures trading entities based on replicator dynamic theory: 2006-2015 data for China's 22 provinces	PLOS ONE			English	Article								Although frequent fluctuations in domestic hog prices seriously affect the stability and robustness of the hog supply chain, hog futures ( an effective hedging instrument) have not been listed in China. To better understand hog futures market hedging, it is important to study the steady state of intersubjective bidding. This paper uses evolutionary game theory to construct a game model between hedgers and speculators in the hog futures market, and replicator dynamic equations are then used to obtain the steady state between the two trading entities. The results show that the steady state is one in which hedgers adopt a "buy" strategy and speculators adopt a "do not speculate" strategy, but this type of extreme steady state is not easily realized. Thus, to explore the rational proportion of hedgers and speculators in the evolutionary stabilization strategy, bidding processes were simulated using weekly average hog prices from 2006 to 2015, such that the conditions under which hedgers and speculators achieve a steady state could be analyzed. This task was performed to achieve the stability critical point, and we show that only when the value of. is satisfied and the conditions of hog futures price changes and futures price are satisfied can hedgers and speculators achieve a rational proportion and a stable hog futures market. This market can thus provide a valuable reference for the development of the Chinese hog futures market and the formulation and guidance of relevant departmental policies.	[Pang, Jinbo; Deng, Lingfei; Wang, Gangyi] Northeast Agr Univ, Coll Econ & Management, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, GY (corresponding author), Northeast Agr Univ, Coll Econ & Management, Harbin, Heilongjiang, Peoples R China.	awgy@cau.edu.cn	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137	Youth Foundation of Humanities and Social Sciences of the Ministry of Education [13YJC790142]; National Natural Science Foundation [71303040]; China Postdoctoral Science Foundation [2013 M540268]; Planning Program of Philosophy and Social Sciences Research of Heilongjiang Province [15JYD04]	Youth Foundation of Humanities and Social Sciences of the Ministry of Education; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Planning Program of Philosophy and Social Sciences Research of Heilongjiang Province	This study was funded by the Youth Foundation of Humanities and Social Sciences of the Ministry of Education (Grant No. 13YJC790142); National Natural Science Foundation (Grant No. 71303040); China Postdoctoral Science Foundation (Grant No. 2013 M540268); Planning Program of Philosophy and Social Sciences Research of Heilongjiang Province (Grant No.15JYD04).	An Y., 2014, SECURITIES MARKET HE, V05, P46; Booth G., 1998, APPL FINANCIAL EC, V8, P73, DOI DOI 10.1080/096031098333276; Carter C., 1984, W J AGR EC, V9, P1; Carter CA, 2008, AM J AGR ECON, V90, P367, DOI 10.1111/j.1467-8276.2007.01122.x; Chang JZ, 1985, FOREIGN ECON MANAGE, V11, P15; Chen DQ, 2013, HUBEI AGR SCI, V52, P959; CRESSMAN R, 1995, GAME ECON BEHAV, V11, P237, DOI 10.1006/game.1995.1050; Deng LF, 2014, CHIN J ANIM SCI, V50, P13; Diao HH, 2011, SPEC ZONE ECON, V4, P136; ELAM EW, 1988, J FUTURES MARKETS, V8, P79, DOI 10.1002/fut.3990080107; Friedman D., 2001, Quantitative Finance, V1, P177, DOI 10.1088/1469-7688/1/1/313; Hartmann PA, 1980, THESIS; Kostanjcar Z, 2016, IEEE J-STSP, V10, P1040, DOI 10.1109/JSTSP.2016.2593099; Li HH, 2007, FEED CHINA, V13, P15; Liao Y, 2013, J AGROTECH EC, V9, P26; Liu J, 2013, EC SURV, V6, P125; Liu XL, 2015, PRICE MONTHLY, V9, P14; Martin L. L., 1997, Journal of Agricultural and Applied Economics, V29, P267; Peng DY, 2015, PRICE MONTHLY, V9, P23; Peng HF, 2016, J CENTRAL U FINANCE, V9, P92; Roger WG, 1970, FUTURES TRADING LIVE, P125; Shang JC, 2002, AUTOMAT ELECT POWER, V26, P7; [孙华丽 Sun Huali], 2016, [运筹与管理, Operations Research and Management Science], V25, P23; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Tian ZL, 2011, CHIN ANIM IND, V17, P50; Wang H, 2006, FINANCE EC, V20, P136; Wu Zhiyong, 2002, Automation of Electric Power Systems, V26, P7; Zeng LL, 2016, COMMUN RES, V6, P96; Zhang XT, 2010, CHIN J ANIM SCI, V46, P12	29	1	1	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172009	10.1371/journal.pone.0172009	http://dx.doi.org/10.1371/journal.pone.0172009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241024	Green Published, gold			2022-12-27	WOS:000395934400014
J	Uchizono, S; Tabuki, Y; Kawaguchi, N; Tanimura, T; Itoh, TQ				Uchizono, Shun; Tabuki, Yumi; Kawaguchi, Natsumi; Tanimura, Teiichi; Itoh, Taichi Q.			Mated Drosophila melanogaster females consume more amino acids during the dark phase	PLOS ONE			English	Article							SEX-PEPTIDE; FEEDING-BEHAVIOR; REPRODUCTIVE-BEHAVIOR; CIRCADIAN-RHYTHMS; FOOD-INTAKE; TASTE; METABOLISM; RECEPTOR; TAKEOUT; CLOCKS	To maintain homeostasis, animals must ingest appropriate quantities, determined by their internal nutritional state, of suitable nutrients. In the fruit fly Drosophila melanogaster, an amino acid deficit induces a specific appetite for amino acids and thus results in their increased consumption. Although multiple processes of physiology, metabolism, and behavior are under circadian control in many organisms, it is unclear whether the circadian clock also modulates such motivated behavior driven by an internal need. Differences in levels of amino acid consumption by flies between the light and dark phases of the day: night cycle were examined using a capillary feeder assay following amino acid deprivation. Female flies exhibited increased consumption of amino acids during the dark phase compared with the light phase. Investigation of mutants lacking a functional period gene (per(0)), a well-characterized clock gene in Drosophila, found no difference between the light and dark phases in amino acid consumption by per(0) flies. Furthermore, increased consumption of amino acids during the dark phase was observed in mated but not in virgin females, which strongly suggested that mating is involved in the rhythmic modulation of amino acid intake. Egg production, which is induced by mating, did not affect the rhythmic change in amino acid consumption, although egg-laying behavior showed a per(0) dependent change in rhythm. Elevated consumption of amino acids during the dark phase was partly induced by the action of a seminal protein, sex peptide (SP), on the sex peptide receptor (SPR) in females. Moreover, we showed that the increased consumption of amino acids during the dark phase is induced in mated females independently of their internal level of amino acids. These results suggest that a post-mating SP/SPR signal elevates amino acid consumption during the dark phase via the circadian clock.	[Uchizono, Shun; Kawaguchi, Natsumi; Tanimura, Teiichi; Itoh, Taichi Q.] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan; [Uchizono, Shun] Japan Soc Promot Sci, Tokyo, Japan; [Tabuki, Yumi] Tobata High Sch, Kitakyushu, Fukuoka, Japan; [Tanimura, Teiichi; Itoh, Taichi Q.] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University	Itoh, TQ (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan.; Itoh, TQ (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan.	taichi.itoh@kyudai.jp	Itoh, Taichi/AAV-1976-2021	Itoh, Taichi/0000-0003-0794-1711	Qdai-jump Research Program [28217]; MEXT KAKENHI on Innovative Areas [JP23115713]	Qdai-jump Research Program; MEXT KAKENHI on Innovative Areas	This work was supported in part by Qdai-jump Research Program to TQI (grant number: 28217) and by MEXT KAKENHI on Innovative Areas to TT (grant number: JP23115713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VW, 2016, CURR BIOL, V26, P184, DOI 10.1016/j.cub.2015.11.051; Andreani TS, 2015, SLEEP MED CLIN, V10, P413, DOI 10.1016/j.jsmc.2015.08.007; Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CRIPPS AW, 1975, BRIT J NUTR, V33, P17, DOI 10.1079/BJN19750005; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Haussmann IU, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1938; HAWKINS RL, 1994, PHYSIOL BEHAV, V56, P1061, DOI 10.1016/0031-9384(94)90344-1; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Howlader G, 2006, J INSECT PHYSIOL, V52, P779, DOI 10.1016/j.jinsphys.2006.05.001; Isaac RE, 2010, P ROY SOC B-BIOL SCI, V277, P65, DOI 10.1098/rspb.2009.1236; Itoh TQ, 2011, GENES CELLS, V16, P1159, DOI 10.1111/j.1365-2443.2011.01559.x; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; McCabe C, 1998, CHRONOBIOL INT, V15, P119, DOI 10.3109/07420529808998677; Oh Y, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001974; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Pfeiffenberger C., 2010, COLD SPRING HARB PRO, V2010; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; SANG JH, 1961, J EXP BIOL, V38, P793; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schulkin J., 1991, SODIUM HUNGER SEARCH; SIMPSON SJ, 1991, APPETITE, V17, P141, DOI 10.1016/0195-6663(91)90069-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tordoff MG, 2001, PHYSIOL REV, V81, P1567, DOI 10.1152/physrev.2001.81.4.1567; Toshima N, 2014, J INSECT PHYSIOL, V69, P89, DOI 10.1016/j.jinsphys.2014.06.019; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; TRUMPER S, 1993, J INSECT PHYSIOL, V39, P857, DOI 10.1016/0022-1910(93)90118-B; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Walker SJ, 2015, CURR BIOL, V25, P2621, DOI 10.1016/j.cub.2015.08.043; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; WOODRING JP, 1979, J INSECT PHYSIOL, V25, P903, DOI 10.1016/0022-1910(79)90102-1; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	44	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172886	10.1371/journal.pone.0172886	http://dx.doi.org/10.1371/journal.pone.0172886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241073	Green Submitted, Green Published, gold			2022-12-27	WOS:000395934400048
J	Amulen, DR; D'Haese, M; Ahikiriza, E; Agea, JG; Jacobs, FJ; de Graaf, DC; Smagghe, G; Cross, P				Amulen, Deborah Ruth; D'Haese, Marijke; Ahikiriza, Elizabeth; Agea, Jacob Godfrey; Jacobs, Frans J.; de Graaf, Dirk C.; Smagghe, Guy; Cross, Paul			The buzz about bees and poverty alleviation: Identifying drivers and barriers of beekeeping in sub-Saharan Africa	PLOS ONE			English	Article							DIVERSIFICATION; FARMERS; VULNERABILITY; AGRICULTURE; ADOPTION; SYSTEM	The potential of beekeeping to mitigate the exposure of rural sub-Sahara African farmers to economic stochasticity has been widely promoted by an array of development agencies. Robust outcome indicators of the success of beekeeping to improve household well-being are unfortunately lacking. This study aimed to identify the key drivers and barriers of beekeeping adoption at the household level, and quantified the associated income contribution in three agro-ecological zones in Uganda. Beekeepers were generally the most economically disadvantaged people in the study areas and tended to adopt beekeeping following contact with non-government organisations and access to training. Whilst incomes were not statistically lower than their non-beekeeping counterparts; their mean household well-being scores were significantly lower than non-beekeeping households. The inability of beekeeping to significantly improve well-being status can in part be attributed to a lack of both training in bee husbandry and protective equipment provision such as suits, gloves and smokers. These are critical tools for beekeepers as they provide the necessary confidence to manage honey bees. Rather than focussing solely on the socio-economic conditions of farmers to effectively adopt beekeeping, future research should also attempt to evaluate the effectiveness of development agencies' provision to the beekeeping sector.	[Amulen, Deborah Ruth; Smagghe, Guy] Univ Ghent, Dept Crop Protect, Ghent, Belgium; [Amulen, Deborah Ruth] Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda; [D'Haese, Marijke; Ahikiriza, Elizabeth] Univ Ghent, Dept Agr Econ, Ghent, Belgium; [Agea, Jacob Godfrey] Makerere Univ, Dept Extens & Innovat Studies, Kampala, Uganda; [Jacobs, Frans J.; de Graaf, Dirk C.] Univ Ghent, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Cross, Paul] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales	Ghent University; Makerere University; Ghent University; Makerere University; Ghent University; Bangor University	Amulen, DR (corresponding author), Univ Ghent, Dept Crop Protect, Ghent, Belgium.; Amulen, DR (corresponding author), Makerere Univ, Dept Livestock Ind Resources, Kampala, Uganda.	DeborahRuth.Amulen@ugent.be	de Graaf, Dirk C./HGD-4017-2022; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Ahikiriza, Elizabeth/0000-0001-6802-5077; D'Haese, Marijke/0000-0002-0544-3420	Erasmus Mundus action II- CARIBU scholarship	Erasmus Mundus action II- CARIBU scholarship	The study was part of a PhD exchange scholarship covered under Erasmus Mundus Action 2-CARIBU grant (http://www.caribu.be/). The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to Erasmus Mundus action II- CARIBU scholarship for financing the PhD study part which resulted in this study. More thanks to the staff of Ghent, Bangor and Maker ere University, for their supervision and mentorship during authorship of the article. Finally, we acknowledge the role of farmers and field coordinators in Uganda for accepting to be part of the study, and the apiculture governing body TUNADO for their coordinating role during sampling of beekeepers.	Abebe GK, 2013, AGR SYST, V122, P22, DOI 10.1016/j.agsy.2013.07.008; Aldo Hope, 2011, USING MULTIPLE PARTN; Asfaw A, 2004, AGR ECON-BLACKWELL, V30, P215, DOI [10.1016/j.agecon.2002.12.002, 10.1111/j.1574-0862.2004.tb00190.x]; Barbieri C, 2009, J RURAL STUD, V25, P58, DOI 10.1016/j.jrurstud.2008.06.001; Benin S., 2007, IFPRI DISCUSSION PAP; Berhane M Gebreyohannes, 2010, THESIS; Bhusal SJ, 2005, J I AGR ANIMAL SCI, V26, P117; Bigsten A, 2011, J AFR ECON, V20, P781, DOI 10.1093/jae/ejr017; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Carroll T, 2013, DEV PRACT, V23, P332, DOI 10.1080/09614524.2013.781123; CBI Market Intelligence, 2015, TRAD STAT HON EUR; Davies M, 2009, CLIMATE CHANGE ADAPT; Echevin D, 2013, WORLD DEV, V46, P211, DOI 10.1016/j.worlddev.2013.02.001; FAO, 2012, SMALLH FARM DAT IS C; Friis-Hansen Esbern, 2005, IMP ASS WORKSH MEX D; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Girma J, 2015, FOR POLICY EC; Girma J, 2015, FOREST POLICY ECON, V50, P259, DOI 10.1016/j.forpol.2014.08.001; Government of Kenya, 2009, NAT BEEK POL; Headey D, 2014, WORLD DEV, V56, P200, DOI 10.1016/j.worlddev.2013.10.015; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Heckman JJ, 1979, J ECONOMETRIC SOC, V47, P153; Hilmi M., 2011, BEEKEEPING SUSTAINAB; John Wasige Ejiet, 2009, ASSESSMENT IMPACT CL; Kalanzi F, 2015, INT J RES LAND USE S, V2, P81, DOI DOI 10.13140/RG.2.1.2647.4329; Kilimo Trust, 2011, MAKING MARKETS WORK; Kimitei R. K., 2012, P 1 NAT SCI TECHN IN; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003; Koekoek JF, 2006, EXPORT OPPORTUNITIES; Kouame EB-H, 2011, CSAE C EC DEV AFR; Leisher C, 2012, EXPLORING EVIDENCE L; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Meulman JJ, PRINCIPAL COMPONENTS; Mujuni A, 2012, J LIVEST RES RURAL D, V24; Paumgarten F, 2012, REV POLICY RES, V29, P229, DOI 10.1111/j.1541-1338.2011.00549.x; Pokhrel S, 2009, NEPAL J AGR ENV, V10; Ramirez A, 2013, PROCD SOC BEHV, V79, P101, DOI 10.1016/j.sbspro.2013.05.059; Reardon, 2002, STRATEGIES STIMULATI; Roling N, 2015, INT J AGR INNOV, V7, P83; Simtowe F., 2011, Quarterly Journal of International Agriculture, V50, P325; Tumbo SD, 2013, J SOCIO-ECON, V43, P24, DOI 10.1016/j.socec.2013.01.001; UBOS MAAIF, 2009, NAT LIV CENS REP; Wortmann C.S., 1999, UGANDAS AGROECOLOGIC	44	19	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172820	10.1371/journal.pone.0172820	http://dx.doi.org/10.1371/journal.pone.0172820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235072	Green Published, gold			2022-12-27	WOS:000394688200147
J	Fukasawa, LO; Goncalves, MG; Higa, FT; Castilho, EA; Ibarz-Pavon, AB; Sacchi, CT				Fukasawa, Lucila Okuyama; Goncalves, Maria Gisele; Higa, Fabio Takenori; Castilho, Euclides Ayres; Ibarz-Pavon, Ana Belen; Sacchi, Claudio Tavares			Use of cerebrospinal fluid and serum samples impregnated on FTA (TM) Elute filter paper for the diagnosis of infections caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL-MENINGITIS; CONJUGATE VACCINE; LATIN-AMERICA; IMPACT; SEROTYPES; MORTALITY; DISEASE; DNA	Background The lack of information regarding the burden of acute bacterial meningitis in Latin America leads to a reduction in the estimated incidence rates of the disease, and impairs public health decisions on the use and follow-up of preventive interventions, particularly, the evaluation of existing vaccination policies. The use of the real-time PCR in diagnostic routine procedures has resulted in a substantial increase in confirmed bacterial meningitis cases. However, in resource-poor countries, these assays are only available in reference laboratories. Sample transportation to these laboratories is a critical constraint, as it requires specialized, high cost courier services. To overcome this barrier we evaluated the use of FTA (TM) Elute filter paper cards for the conservation and processing of samples under normal environmental conditions, as they would be when transported from remote and under-equipped healthcare facilities to the reference centers. A total of 401 samples received in 2015 as part of Sao Paulo's national surveillance for routine diagnosis were selected for this study. Methods The sensitivity and specificity of real-time PCR were evaluated using fresh serum and cerebrospinal fluid (CSF) samples processed using our laboratory's standard DNA extraction, and processing the same samples after being dried and stored on FTA (TM) card, and DNA extracted following the manufacturer's instructions. Results The sensitivities for detection of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae from CSF dried and stored on FTA (TM) cards were 98%, 92%, and 100%, respectively, and with serum samples were 73%, 88%, and 100%, respectively. When compared to our laboratory's standard methodology, results showed high concordance, with Kappa index ranges of 0.9877-1.00 for CSF, and 0.8004-1.00 for serum samples. Conclusion The use of FTA (TM) cards for CSF and serum conservation and transport represents a rapid, reliable, and cost-effective alternative that will allow obtaining valuable epidemiological information that would otherwise be lost.	[Fukasawa, Lucila Okuyama; Goncalves, Maria Gisele; Higa, Fabio Takenori; Sacchi, Claudio Tavares] Adolfo Lutz Inst, Ctr Immunol, Sao Paulo, SP, Brazil; [Castilho, Euclides Ayres] Adolfo Lutz Inst, Sao Paulo, SP, Brazil; [Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA	Instituto Adolfo Lutz; Instituto Adolfo Lutz; Pan American Health Organization	Sacchi, CT (corresponding author), Adolfo Lutz Inst, Ctr Immunol, Sao Paulo, SP, Brazil.	ctsacchi@gmail.com		Tavares Sacchi, Claudio/0000-0002-5686-7979; Castilho, Euclides/0000-0002-7352-8784	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF); Secretaria de Estado da Saude de Sao Paulo	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF); Secretaria de Estado da Saude de Sao Paulo	Part of funding was provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF) and by Secretaria de Estado da Saude de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2014, PATHOG GLOB HEALTH, V108, P11, DOI 10.1179/2047773214Y.0000000126; Ambroise-Thomas P, 1975, Acta Trop, V32, P359; BARBOUR ML, 1993, PEDIATR INFECT DIS J, V12, P478, DOI 10.1097/00006454-199306000-00005; Bharucha T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004516; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Danovaro-Holliday MC, 2008, PLOS MED, V5, P530, DOI 10.1371/journal.pmed.0050087; Davis S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S21; Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009; DiFabio JL, 1997, MICROB DRUG RESIST, V3, P131, DOI 10.1089/mdr.1997.3.131; Durando P, 2012, J Prev Med Hyg, V53, P68; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Elliott I, 2013, CLIN MICROBIOL INFEC, V19, pE466, DOI 10.1111/1469-0691.12260; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; GE Healthcare Life Sciences, FTA EL SAMPL COLL CA; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; Maaroufi Y, 2007, J CLIN MICROBIOL, V45, P2305, DOI 10.1128/JCM.00102-07; Makwana N, 2007, CNS DRUGS, V21, P355, DOI 10.2165/00023210-200721050-00001; Manigart O, 2016, J CLIN MICROBIOL; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; McPherson S, 2013, J VIRAL HEPATITIS, V20, P638, DOI 10.1111/jvh.12084; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; PAHO, 2009, INF REG SIREVA 2 200; PAHO, 2010, INF REG SIREVA 2 200; Pan American Health Organization, 2007, INF REG SIREVA 2 DAT; Pan American Health Organization, 2011, INF REG SIREVA 2 201; Pan American Health Organization, 2008, INF REG SIREVA 2 200; Pan American Health Organization, 2012, INF REG SIREVA 2 201; Pan American Health Organization, 2013, INF REG SIREVA 2 201; Peltola H, 2010, PEDIATR INFECT DIS J, V29, P111, DOI 10.1097/INF.0b013e3181b4f041; Rajendram D, 2006, J MICROBIOL METH, V67, P582, DOI 10.1016/j.mimet.2006.05.010; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Selva L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147678; Selva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076970; Selva L, 2011, EMERG INFECT DIS, V17, P1125, DOI [10.3201/eid1706.100997, 10.3201/eid/1706.100997]; Suarez V, 2016, VACCINE, V34, P4738, DOI 10.1016/j.vaccine.2016.07.027; Tam PYI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152253; The WHO Young Infants Study Group, 1999, PEDIAT INFECT DIS S, V18, pS17; van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; World Health Organization, 1988, WHOEMCBAC983; World Health Organization, 2011, WHOIVB1112, P116; Wu HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-26	44	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172794	10.1371/journal.pone.0172794	http://dx.doi.org/10.1371/journal.pone.0172794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235065	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200138
J	Liu, H; Wang, KT; Chen, S; Sun, Q; Zhang, YK; Chen, L; Sun, XL				Liu, Heng; Wang, Ketao; Chen, Shuai; Sun, Qian; Zhang, Yuankai; Chen, Long; Sun, Xiulian			NFATc1 phosphorylation by DYRK1A increases its protein stability	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SIGNALING PATHWAY; FAMILY; CHROMOSOME-21; LYMPHOCYTES; REGULATORS; ACTIVATION; DROSOPHILA; KINASES; REGION	NFATs are transcription factors involved in immune activation and tumor progression. Previous reports showed that DYRK1A suppressed NFATc2 transcriptional activity through phosphorylation. Nonetheless, our results showed that DYRK1A increased NFATc1/alpha A protein level and subsequent transcriptional activity. DYRK1A phosphorylation of NFATc1/alpha A at S261, S278, S403 and S409 interfered with NFATc1 ubiquitination and ubiquitin-proteasome degradation. Our results imply that DYRK1A is a positive kinase in regulation of NFATc1.	[Liu, Heng; Wang, Ketao; Sun, Qian; Zhang, Yuankai; Sun, Xiulian] Shandong Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Liu, Heng; Chen, Shuai; Sun, Qian; Chen, Long] Shandong Univ, Qilu Hosp, Minist Hlth, Otolaryngol Key Lab, Jinan, Shandong, Peoples R China; [Sun, Xiulian] Shandong Univ, Qilu Hosp, Brain Res Inst, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Sun, XL (corresponding author), Shandong Univ, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China.; Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Brain Res Inst, Jinan, Shandong, Peoples R China.	xiulians@gmail.com			National Science Foundation of China [81101796, 81171030, 81322014]; Shenzhen Science and Technology Plan Projects [JCYJ20140418115815053]; Science and Technology Development Project of Shandong Province [jk22]; Foundation for Outstanding Young Scientist in Shandong Province [BS2013SW040]; Taishan Scholarship	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Plan Projects; Science and Technology Development Project of Shandong Province; Foundation for Outstanding Young Scientist in Shandong Province; Taishan Scholarship	This work was supported by National Science Foundation of China (81101796, 81171030, 81322014), Shenzhen Science and Technology Plan Projects (JCYJ20140418115815053), Science and Technology Development Project of Shandong Province (jk22), Foundation for Outstanding Young Scientist in Shandong Province (BS2013SW040). Sun Xiulian is the receiver of Taishan Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Rudolf R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00021; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342	18	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172985	10.1371/journal.pone.0172985	http://dx.doi.org/10.1371/journal.pone.0172985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235034	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200181
J	Smuck, M; Tomkins-Lane, C; Ith, MA; Jarosz, R; Kao, MCJ				Smuck, Matthew; Tomkins-Lane, Christy; Ith, Ma Agnes; Jarosz, Renata; Kao, Ming-Chih Jeffrey			Physical performance analysis: A new approach to assessing free-living physical activity in musculoskeletal pain and mobility-limited populations	PLOS ONE			English	Article							LUMBAR SPINAL STENOSIS; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; SEDENTARY BEHAVIOR; NATIONAL-HEALTH; ACTIVITY TIME; ACCELEROMETER; ADULTS; RELIABILITY; DISABILITY	Background Accurate measurement of physical performance in individuals with musculoskeletal pain is essential. Accelerometry is a powerful tool for this purpose, yet the current methods designed to evaluate energy expenditure are not optimized for this population. The goal of this study is to empirically derive a method of accelerometry analysis specifically for musculoskeletal pain populations. Methods We extracted data from 6,796 participants in the 2003-4 National Health and Nutrition Examination Survey (NHANES) including: 7-day accelerometry, health and pain questionnaires, and anthropomorphics. Custom macros were used for data processing, complex survey regression analyses, model selection, and statistical adjustment. After controlling for a multitude of variables that influence physical activity, we investigated whether distinct accelerometry profiles accompany pain in different locations of the body; and we identified the intensity intervals that best characterized these profiles. Results Unique accelerometry profiles were observed for pain in different body regions, logically clustering together based on proximity. Based on this, the following novel intervals (counts/minute) were identified and defined: Performance Sedentary (PSE) = 1-100, Performance Light 1 (PL1) = 101-350, Performance Light 2 (PL2) = 351-800, Performance Light 3 (PL3) = 801-2500, and Performance Moderate/Vigorous (PMV) = 2501-30000. The refinement of accelerometry signals into these new intervals, including 3 distinct ranges that fit inside the established light activity range, best captures alterations in real-life physical performance as a result of regional pain. Discussion and conclusions These new accelerometry intervals provide a model for objective measurement of real-life physical performance in people with pain and musculoskeletal disorders, with many potential uses. They may be used to better evaluate the relationship between pain and daily physical function, monitor musculoskeletal disease progression, gauge disease severity, inform exercise prescription, and quantify the functional impact of treatments. Based on these findings, we recommend that future studies of pain and musculoskeletal disorders analyze accelerometry output based on these new "physical performance" intervals.	[Smuck, Matthew; Ith, Ma Agnes; Jarosz, Renata] Stanford Univ, Dept Orthopaed Surg, PM&R Sect, Redwood City, CA 94063 USA; [Smuck, Matthew; Tomkins-Lane, Christy; Ith, Ma Agnes; Kao, Ming-Chih Jeffrey] Stanford Univ, Dept Orthopaed Surg, Wearable Hlth Lab, Redwood City, CA 94063 USA; [Tomkins-Lane, Christy] Mt Royal Univ, Dept Phys Educ & Recreat, Calgary, AB, Canada; [Kao, Ming-Chih Jeffrey] Stanford Univ, Dept Anesthesia & Pain Management, Redwood City, CA USA	Stanford University; Stanford University; Mount Royal University; Stanford University	Smuck, M (corresponding author), Stanford Univ, Dept Orthopaed Surg, PM&R Sect, Redwood City, CA 94063 USA.; Smuck, M (corresponding author), Stanford Univ, Dept Orthopaed Surg, Wearable Hlth Lab, Redwood City, CA 94063 USA.	msmuck@stanford.edu		Smuck, Matthew/0000-0002-2990-069X; Ith, Ma Agnes/0000-0002-5816-6842	NIBIB NIH HHS [U54 EB020405] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134606; Almeida GJ, 2016, PHYS THER, V96, P898, DOI 10.2522/ptj.20150407; Alschuler KN, 2011, CLIN J PAIN, V27, P707, DOI 10.1097/AJP.0b013e318217b7d0; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Conway J, 2011, SPINE J, V11, P816, DOI 10.1016/j.spinee.2010.10.019; de Groot IB, 2008, OSTEOARTHR CARTILAGE, V16, P436, DOI 10.1016/j.joca.2007.08.010; de Groot IB, 2008, CLIN ORTHOP RELAT R, V466, P2201, DOI 10.1007/s11999-008-0315-3; Dunlop DD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2472; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P3372, DOI 10.1002/art.30562; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P127, DOI 10.1002/art.27760; Feinglass J, 2012, ARCH PHYS MED REHAB, V93, P172, DOI 10.1016/j.apmr.2011.06.037; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gardiner PA, 2011, MED SCI SPORT EXER, V43, P2127, DOI 10.1249/MSS.0b013e31821b94f7; Hamer M, 2014, AM J PREV MED, V47, P452, DOI 10.1016/j.amepre.2014.05.044; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kao MCJ, 2014, PM&R, V6, P882, DOI 10.1016/j.pmrj.2014.03.004; Lee J, 2015, ARTHRIT CARE RES, V67, P366, DOI 10.1002/acr.22432; Lee J, 2013, ARTHRIT CARE RES, V65, P53, DOI 10.1002/acr.21754; Manns P, 2015, J AM GERIATR SOC, V63, P1314, DOI 10.1111/jgs.13490; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Pryce R, 2012, SPINE, V37, P1316, DOI 10.1097/BRS.0b013e31824a8314; Semanik PA, 2015, AM J PUBLIC HEALTH, V105, P560, DOI 10.2105/AJPH.2014.302270; Sirard JR, 2011, J PHYS ACT HEALTH, V8, P668, DOI 10.1123/jpah.8.5.668; Smuck M, 2014, SPINE J, V14, P209, DOI 10.1016/j.spinee.2013.11.010; Smuck M, 2011, SPINE J, V11, P824, DOI 10.1016/j.spinee.2011.08.432; Tomkins-Lane CC, 2015, SPINE J, V15, P577, DOI 10.1016/j.spinee.2014.10.015; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P2008, DOI 10.1016/j.apmr.2012.05.014; Tomkins-Lane CC, 2012, J BACK MUSCULOSKELET, V25, P177, DOI 10.3233/BMR-2012-0325; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P647, DOI 10.1016/j.apmr.2011.09.023; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vanhelst J, 2012, PERCEPT MOTOR SKILL, V114, P584, DOI 10.2466/03.26.PMS.114.2.584-594; WHO, 2001, WHO INT CLASS FUNCT; Winter CC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-233; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P447, DOI 10.1123/jpah.2013-0464	35	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172804	10.1371/journal.pone.0172804	http://dx.doi.org/10.1371/journal.pone.0172804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235039	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200141
J	Tsai, AYL; Chan, K; Ho, CY; Canam, T; Capron, R; Master, ER; Brautigam, K				Tsai, Alex Yi-Lin; Chan, Kin; Ho, Chi-Yip; Canam, Thomas; Capron, Resmi; Master, Emma R.; Brautigam, Katharina			Transgenic expression of fungal accessory hemicellulases in Arabidopsis thaliana triggers transcriptional patterns related to biotic stress and defense response	PLOS ONE			English	Article							PLANT-CELL WALL; RECEPTOR-LIKE KINASE; ETHYLENE BIOSYNTHESIS; BOTRYTIS-CINEREA; BINDING-PROTEINS; INCREASED RESISTANCE; NICOTIANA-TABACUM; SALICYLIC-ACID; POWDERY MILDEW; GENES	The plant cell wall is an abundant and renewable resource for lignocellulosic applications such as the production of biofuel. Due to structural and compositional complexities, the plant cell wall is, however, recalcitrant to hydrolysis and extraction of platform sugars. A cell wall engineering strategy to reduce this recalcitrance makes use of microbial cell wall modifying enzymes that are expressed directly in plants themselves. Previously, we constructed transgenic Arabidopsis thaliana constitutively expressing the fungal hemicellulases: Phanerochaete carnosa glucurnoyl esterase (PcGCE) and Aspergillus nidulans alpha-arabinofuranosidase (AnAF54). While the PcGCE lines demonstrated improved xylan extractability, they also displayed chlorotic leaves leading to the hypothesis that expression of such enzymes in planta resulted in plant stress. The objective of this study is to investigate the impact of transgenic expression of the aforementioned microbial hemicellulases in planta on the host arabidopsis. More specifically, we investigated transcriptome profiles by short read high throughput sequencing (RNAseq) from developmentally distinct parts of the plant stem. When compared to non-transformed wild-type plants, a subset of genes was identified that showed differential transcript abundance in all transgenic lines and tissues investigated. Intriguingly, this core set of genes was significantly enriched for those involved in plant defense and biotic stress responses. While stress and defense-related genes showed increased transcript abundance in the transgenic plants regardless of tissue or genotype, genes involved in photosynthesis ( light harvesting) were decreased in their transcript abundance potentially reflecting wide-spread effects of heterologous microbial transgene expression and the maintenance of plant homeostasis. Additionally, an increase in transcript abundance for genes involved in salicylic acid signaling further substantiates our finding that transgenic expression of microbial cell wall modifying enzymes induces transcriptome responses similar to those observed in defense responses.	[Tsai, Alex Yi-Lin; Brautigam, Katharina] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Tsai, Alex Yi-Lin] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA USA; [Chan, Kin; Ho, Chi-Yip] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Canam, Thomas] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Capron, Resmi; Master, Emma R.] Univ Toronto, Dept Chem Engn Appl Chem, Toronto, ON, Canada; [Brautigam, Katharina] Univ Toronto, Dept Biol, Mississauga, ON, Canada	University of Toronto; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Eastern Illinois University; University of Toronto; University of Toronto; University Toronto Mississauga	Brautigam, K (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Brautigam, K (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON, Canada.	katharina.braeutigam@utoronto.ca	Master, Emma/O-3554-2014	Master, Emma/0000-0002-6837-9817; Canam, Thomas/0000-0002-7674-5653; Braeutigam, Katharina/0000-0001-5655-7156	Government of Ontario [ORF-RE-05-005]; Natural Sciences and Engineering Research Council of Canada; University of Toronto; DOE Joint BioEnergy Institute by U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; U. S. Department of Energy	Government of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Toronto(University of Toronto); DOE Joint BioEnergy Institute by U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the Government of Ontario for the project Forest FAB: Applied Genomics for Functionalized Fiber and Biochemicals (ORF-RE-05-005), the Natural Sciences and Engineering Research Council of Canada. This work was also partly funded through the University of Toronto and the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alves MS, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010085; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; AVNI A, 1994, PLANT PHYSIOL, V106, P1049, DOI 10.1104/pp.106.3.1049; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Buanafina MMD, 2015, PLANTA, V242, P97, DOI 10.1007/s00425-015-2288-2; Chou HL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-58; COTE F, 1994, PLANT MOL BIOL, V26, P1379, DOI 10.1007/BF00016481; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1; Gandla ML, 2015, PHYTOCHEMISTRY, V112, P210, DOI 10.1016/j.phytochem.2014.06.002; Hall H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-14; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; ISHII T, 1992, PLANT CELL PHYSIOL, V33, P321, DOI 10.1093/oxfordjournals.pcp.a078257; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Klose H, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0443-3; Klose H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-53; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu R, 2013, J EXP BOT, V64, P5443, DOI 10.1093/jxb/ert307; Liu SA, 2015, ELIFE, V4, DOI 10.7554/eLife.07295; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989; Minic Z, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-6; Narusaka M, 2008, J GEN PLANT PATHOL, V74, P345, DOI 10.1007/s10327-008-0117-1; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogorelko G, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25435; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Pogorelko G, 2011, PLANT MOL BIOL, V77, P433, DOI 10.1007/s11103-011-9822-9; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Reem NT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00630; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Rodriguez C, 2009, MOL PLANT MICROBE IN, V22, P953, DOI 10.1094/MPMI-22-8-0953; SHARON A, 1993, PLANT PHYSIOL, V102, P1325, DOI 10.1104/pp.102.4.1325; Sindhu R, 2016, BIORESOURCE TECHNOL, V199, P76, DOI 10.1016/j.biortech.2015.08.030; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai AYL, 2012, PLANT BIOTECHNOL J, V10, P1077, DOI 10.1111/j.1467-7652.2012.00735.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Yano A, 1998, MOL PLANT MICROBE IN, V11, P115, DOI 10.1094/MPMI.1998.11.2.115; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140	64	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173094	10.1371/journal.pone.0173094	http://dx.doi.org/10.1371/journal.pone.0173094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253318	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300072
J	Drechsler, H; Ayers, C; Cutrell, J; Maalouf, N; Tebas, P; Bedimo, R				Drechsler, Henning; Ayers, Colby; Cutrell, James; Maalouf, Naim; Tebas, Pablo; Bedimo, Roger			Current use of statins reduces risk of HIV rebound on suppressive HAART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; ASSESS ADHERENCE; IN-VITRO; TRIAL; REPLICATION; CHOLESTEROL; EXPRESSION; INFECTION; DISEASE	Background Despite compelling evidence for activity against HIV-1 in vitro, a virologic effect of statins has not been shown in clinical studies. Given their short plasma half-lives, such an effect may be transient and only apparent during ongoing exposure. Methods We studied all HIV infected US-Veterans who started HAART 1995-2011, had a documented HIV viral load (VL) >1000 copies/mL, reached an undetectable VL on HAART, and had >= 1 follow-up VL within 13 months. We defined virologic failure (VF) as the first VL >1,000 copies/mL or the first of 2 consecutive VL >200 copies/mL. We built a time-updated drug exposure model for antiretrovirals (ARVs), statins, and other cardiovascular drugs (CVMs), investigating current use (yes/no), recent use (proportion of days used), and categorical use (ever/never). We used both multiply adjusted and inverse-probability-weighted (IPW) Cox models to explore the association between statin and CVM use and VF. Results 19,324 veterans met inclusion criteria. Median follow-up was 13 months (IQR: 5-32 months); 63% experienced VF after a median time of 9 months (IQR 4-21 months). Almost 1/3 patients ever used statins but exposure comprised only 41% of follow-up time covered after initial prescription. Unadjusted, current statin use was associated with a hazard ratio (HR) for VF of 0.60 (CI: 0.56-0.65). This remained statistically significant after multivariate adjustment (MVA) for demographics, HIV and HAART parameters [HR 0.81 (CI: 0.75-0.88), p < 0.001] and IPW (truncation < 1%/> 99%) HR: 0.83 (CI: 0.75-0.92), p < 0.001]. No independent association was observed for other CVMs. The association between categorical-statin use and VF after MVA was much weaker: HR 0.94 (CI: 0.88-1.00, p = 0.04). Conclusion Current statin exposure was associated with reduced risk of VF in univariate, multivariate, and inverse-probability-weighted models. Our results highlight the importance of timeupdated medication exposure models for observational studies.	[Drechsler, Henning; Cutrell, James; Maalouf, Naim; Bedimo, Roger] VA North Texas Hlth Care Syst, Med Serv, Infect Dis Sect, Dallas, TX 75216 USA; [Drechsler, Henning; Cutrell, James; Maalouf, Naim; Bedimo, Roger] Univ Texas Southwestern Sch Med, Div Infect Dis, Dept Med, Dallas, TX 75390 USA; [Ayers, Colby] Univ Texas Southwestern Sch Med, Dept Clin Sci, Div Biostat, Dallas, TX USA; [Tebas, Pablo] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Pennsylvania; Pennsylvania Medicine	Drechsler, H (corresponding author), VA North Texas Hlth Care Syst, Med Serv, Infect Dis Sect, Dallas, TX 75216 USA.; Drechsler, H (corresponding author), Univ Texas Southwestern Sch Med, Div Infect Dis, Dept Med, Dallas, TX 75390 USA.	Henning.Drechsler@va.gov		Tebas, Pablo/0000-0001-5345-7942				Arnet I, 2016, ANN PHARMACOTHER, V50, P360, DOI 10.1177/1060028016634106; Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Bijlsma MJ, 2016, PHARMACOEPIDEM DR S, V25, P325, DOI 10.1002/pds.3935; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Elahi S, 2016, AIDS, V30, P171, DOI 10.1097/QAD.0000000000000917; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Harrison AT, 2015, CHEM BIOL DRUG DES, V85, P290, DOI 10.1111/cbdd.12384; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Clemente MI, 2009, ANTIVIR THER, V14, P1101, DOI 10.3851/IMP1468; Jones RB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005545; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; MAZIERE JC, 1994, BIOMED PHARMACOTHER, V48, P63, DOI 10.1016/0753-3322(94)90077-9; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mitka M, 2015, JAMA-J AM MED ASSOC, V314, P657, DOI 10.1001/jama.2015.5498; Nabatov AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000470; Nakanjako D, 2015, TROP MED INT HEALTH, V20, P380, DOI 10.1111/tmi.12442; Nau DP, 2016, PROPORTION DAYS COVE; Negredo E, 2008, J ANTIMICROB CHEMOTH, V61, P400, DOI 10.1093/jac/dkm470; Overton ET, 2013, CLIN INFECT DIS, V56, P1471, DOI 10.1093/cid/cit053; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Ponroy N, 2015, J MED VIROL, V87, P141, DOI 10.1002/jmv.23998; Rao GA, 2011, GASTROENTEROLOGY, V140, P144, DOI 10.1053/j.gastro.2010.08.055; Riddler SA, 2007, HIV MED, V8, P280, DOI 10.1111/j.1468-1293.2007.00470.x; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Rodriguez Benigno, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P198, DOI 10.1177/1545109707300684; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Services PoAGfAaAUDoHaH, 2015, GUIDELINES USE ANTIR; Sklar PA, 2005, AIDS, V19, P1109, DOI 10.1097/01.aids.0000174461.31794.50; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thoemmes F, 2016, EMERG ADULTHOOD, V4, P40, DOI 10.1177/2167696815621645; Vigouroux C, 1999, DIABETES METAB, V25, P383; Waters L, 2005, JAIDS-J ACQ IMM DEF, V39, P637	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172175	10.1371/journal.pone.0172175	http://dx.doi.org/10.1371/journal.pone.0172175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249009	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500028
J	Thangaraju, K; Kiraly, R; Demeny, MA; Motyan, JA; Fuxreiter, M; Fesus, L				Thangaraju, Kiruphagaran; Kiraly, Robert; Demeny, Mate A.; Motyan, Janos Andras; Fuxreiter, Monika; Fesus, Laszlo			Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2	PLOS ONE			English	Article							OF-FUNCTION VARIANTS; TISSUE TRANSGLUTAMINASE; FACTOR-XIII; ISOPEPTIDASE ACTIVITY; COAGULATION-FACTOR; MISSENSE MUTATION; CROSS-LINKING; BINDING; GENE; IDENTIFICATION	Transglutaminases (TGMs) catalyze Ca2+-dependent transamidation of proteins with specified roles in blood clotting (F13a) and in cornification (TGM1, TGM3). The ubiquitous TGM2 has well described enzymatic and non-enzymatic functions but in-spite of numerous studies its physiological function in humans has not been defined. We compared data on non-synonymous single nucleotide variations (nsSNVs) and loss-of-function variants on TGM1-7 and F13a from the Exome aggregation consortium dataset, and used computational and biochemical analysis to reveal the roles of damaging nsSNVs of TGM2. TGM2 and F13a display rarer damaging nsSNV sites than other TGMs and sequence of TGM2, F13a and TGM1 are evolutionary constrained. TGM2 nsSNVs are predicted to destabilize protein structure, influence Ca2+ and GTP regulation, and non-enzymatic interactions, but none coincide with conserved functional sites. We have experimentally characterized six TGM2 allelic variants detected so far in homozygous form, out of which only one, p.Arg222Gln, has decreased activities. Published exome sequencing data from various populations have not uncovered individuals with homozygous loss-of-function variants for TGM2, TGM3 and TGM7. Thus it can be concluded that human transglutaminases differ in harboring damaging variants and TGM2 is under purifying selection suggesting that it may have so far not revealed physiological functions.	[Thangaraju, Kiruphagaran; Kiraly, Robert; Demeny, Mate A.; Motyan, Janos Andras; Fuxreiter, Monika; Fesus, Laszlo] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Fuxreiter, Monika] Univ Debrecen, Fac Med, MTA DE Momentum Lab Prot Dynam, Debrecen, Hungary; [Fesus, Laszlo] Univ Debrecen, Fac Med, Hungarian Acad Sci, MTA DE Stem Cell Apoptosis & Genom Res Grp, Debrecen, Hungary	University of Debrecen; University of Debrecen; Hungarian Academy of Sciences; University of Debrecen	Fesus, L (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary.; Fesus, L (corresponding author), Univ Debrecen, Fac Med, Hungarian Acad Sci, MTA DE Stem Cell Apoptosis & Genom Res Grp, Debrecen, Hungary.	fesus@med.unideb.hu	Mótyán, János András/AAA-1839-2021	Kiraly, Robert/0000-0002-1606-3132; Thangaraju, Kiruphagaran/0000-0002-3414-3638	Research University Grant of the University of Debrecen [RH/885/2013]; Hungarian Scientific Research Fund [OTKA NK 105046, OTKA NN 106562]; New Hungary Development Plan - European Social Fund [TAMOP-4.2.2.A-11/1/KONV- 2012-0023]; European Union Framework Programme 7 TRANSPATH ITN [289964]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Momentum programme of the Hungarian Academy of Sciences [LP2012-41]	Research University Grant of the University of Debrecen; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan - European Social Fund(European Social Fund (ESF)); European Union Framework Programme 7 TRANSPATH ITN; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Momentum programme of the Hungarian Academy of Sciences	This work was supported by the Research University Grant of the University of Debrecen (RH/885/2013) (RK), the Hungarian Scientific Research Fund (OTKA NK 105046) (LF), the New Hungary Development Plan via the TAMOP-4.2.2.A-11/1/KONV- 2012-0023 VED-ELEM project co-financed by the European Social Fund (LF), the European Union Framework Programme 7 TRANSPATH ITN 289964 (LF KT) and the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of the TAMOP 4.2.4. A/2-11-1-2012-0001 National Excellence Programme (RK). The support of the Hungarian Scientific Research Fund (OTKA NN 106562) and the Momentum programme (LP2012-41) of the Hungarian Academy of Sciences is gratefully acknowledged (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2002, EMBO J, V21, P2055, DOI 10.1093/emboj/21.9.2055; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; Biri B, 2016, BIOCHEM J, V473, P31, DOI 10.1042/BJ20150843; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Cardoso I, 2016, AMINO ACIDS; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; D'Eletto M, 2012, CELL DEATH DIFFER, V19, P1228, DOI 10.1038/cdd.2012.2; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Demuny M.A., 2015, TRANSGLUTAMINASES MU, P1, DOI [10.1007/978-4-431-55825-5_1, DOI 10.1007/978-4-431-55825-5_1]; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Feng JF, 1999, BIOCHEMISTRY-US, V38, P2224, DOI 10.1021/bi9823176; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; GENTILE V, 1991, J BIOL CHEM, V266, P478; Gfeller D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094507; Greg G., 2012, GENETICS, V13, P135; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Han Y, 2015, ADV SCI TECHNOLOGY L, V105, P44; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; HWANG KC, 1995, J BIOL CHEM, V270, P27058, DOI 10.1074/jbc.270.45.27058; Iismaa SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063346; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Kanchan K, 2015, CELL MOL LIFE SCI, V72, P3009, DOI 10.1007/s00018-015-1909-z; Kanchan K, 2013, BIOCHEM J, V455, P261, DOI 10.1042/BJ20130696; Kang SK, 2002, BIOCHEM BIOPH RES CO, V293, P383, DOI 10.1016/S0006-291X(02)00197-3; Katona E, 2014, HAEMOPHILIA, V20, P114, DOI 10.1111/hae.12267; Kharfi M, 2009, J INVEST DERMATOL, V129, P2512, DOI 10.1038/jid.2009.118; Kiraly R, 2016, AMINO ACIDS, V48, P31, DOI 10.1007/s00726-015-2063-5; Kiraly R, 2013, AMINO ACIDS, V44, P215, DOI 10.1007/s00726-011-1194-6; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li AH, 2015, NAT GENET, V47, P640, DOI 10.1038/ng.3270; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 1998, EXP EYE RES, V66, P531, DOI 10.1006/exer.1997.0463; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mishra S, 2006, BIOCHEM BIOPH RES CO, V347, P1166, DOI 10.1016/j.bbrc.2006.07.041; Muszbek L, 1996, CRIT REV CL LAB SCI, V33, P357, DOI 10.3109/10408369609084691; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Peyvandi Flora, 2004, Hum Mutat, V23, P98, DOI 10.1002/humu.9206; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rashida A, 2008, BRIT J HAEMATOL, V107, P468; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; Stieler M, 2013, ANGEW CHEM INT EDIT, V52, P11930, DOI 10.1002/anie.201305133; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tennessen JA, 2010, GENOME RES, V20, P1327, DOI 10.1101/gr.106161.110; Thangaraju K, 2016, AMINO ACIDS; Thangaraju K, 2016, ANAL BIOCHEM, V505, P36, DOI 10.1016/j.ab.2016.04.012; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van der Velden JJAJ, 2015, EXP DERMATOL, V24, P285, DOI 10.1111/exd.12650; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	85	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172189	10.1371/journal.pone.0172189	http://dx.doi.org/10.1371/journal.pone.0172189			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248968	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500029
J	Horwitz, A; Thomsen, MD; Wiegand, I; Horwitz, H; Klemp, M; Nikolic, M; Rask, L; Lauritzen, M; Benedek, K				Horwitz, Anna; Thomsen, Mia Dyhr; Wiegand, Iris; Horwitz, Henrik; Klemp, Marc; Nikolic, Miki; Rask, Lene; Lauritzen, Martin; Benedek, Krisztina			Visual steady state in relation to age and cognitive function	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; ALZHEIMERS-DISEASE; EVOKED POTENTIALS; ATTENTIONAL MODULATION; GABA CONCENTRATION; MEMORY TASK; TIME-COURSE; FREQUENCY; CORTEX; DECLINE	Neocortical gamma activity is crucial for sensory perception and cognition. This study examines the value of using non-task stimulation-induced EEG oscillations to predict cognitive status in a birth cohort of healthy Danish males (Metropolit) with varying cognitive ability. In particular, we examine the steady-state VEP power response (SSVEP-PR) in the alpha (8Hz) and gamma (36Hz) bands in 54 males (avg. age: 62.0 years) and compare these with 10 young healthy participants (avg. age 27.6 years). Furthermore, we correlate the individual alpha-to-gamma difference in relative visual-area power (Delta R-V) with cognitive scores for the older adults. We find that Delta R-V decrease with age by just over one standard deviation when comparing young with old participants (p<0.01). Furthermore, intelligence is significantly negatively correlated with Delta R-V in the older adult cohort, even when processing speed, global cognition, executive function, memory, and education (p<0.05). In our preferred specification, an increase in Delta R-V of one standard deviation is associated with a reduction in intelligence of 48% of a standard deviation (p<0.01). Finally, we conclude that the difference in cerebral rhythmic activity between the alpha and gamma bands is associated with age and cognitive status, and that Delta R-V therefore provide a non-subjective clinical tool with which to examine cognitive status in old age.	[Horwitz, Anna; Lauritzen, Martin] Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3, Copenhagen, Denmark; [Horwitz, Anna; Lauritzen, Martin] Univ Copenhagen, Ctr Hlth Aging, Blegdamsvej 3, Copenhagen, Denmark; [Horwitz, Anna; Thomsen, Mia Dyhr; Nikolic, Miki; Rask, Lene; Lauritzen, Martin; Benedek, Krisztina] Rigshosp, Dept Clin Neurophysiol, Nordre Ringvej 57, Glostrup, Denmark; [Wiegand, Iris] Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, Copenhagen, Denmark; [Horwitz, Henrik] Bispebjerg Hosp, Dept Clin Pharmacol, Bispebjerg Bakke 23, Copenhagen NV, Denmark; [Klemp, Marc] Brown Univ, Dept Econ & Populat Studies, Providence, RI 02912 USA; [Klemp, Marc] Brown Univ, Training Ctr, Providence, RI 02912 USA; [Klemp, Marc] Univ Copenhagen, Dept Econ, Oster Farimagsgade 5, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Brown University; Brown University; University of Copenhagen	Horwitz, A (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3, Copenhagen, Denmark.; Horwitz, A (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Blegdamsvej 3, Copenhagen, Denmark.; Horwitz, A (corresponding author), Rigshosp, Dept Clin Neurophysiol, Nordre Ringvej 57, Glostrup, Denmark.	anna.horwitz@protonmail.com	Benedek, Krisztina/AAZ-8887-2020	Wiegand, Iris/0000-0003-2160-7939; Horwitz, Anna/0000-0001-5767-4653; Klemp, Marc Patrick Brag/0000-0003-4076-6353; Lauritzen, Martin/0000-0002-1517-1131	Nordea Foundation via the University of Copenhagen	Nordea Foundation via the University of Copenhagen	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AH is funded by the Nordea Foundation via the University of Copenhagen.	Amthauer R, 2001, INTELLIGENZ STRUKTUR; Attar CH, 2010, NEUROIMAGE, V53, P1326, DOI 10.1016/j.neuroimage.2010.06.074; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Bigal ME, 2008, NEUROLOGY, V70, P2078, DOI 10.1212/01.wnl.0000313376.07248.28; Cattell R. B., 1971, ABILITIES THEIR STRU; Chance SA, 2011, CEREB CORTEX, V21, P1870, DOI 10.1093/cercor/bhq264; Cruz L, 2004, P NATL ACAD SCI USA, V101, P15846, DOI 10.1073/pnas.0407002101; DELEON AED, 1988, INT J NEUROSCI, V43, P123, DOI 10.3109/00207458808985789; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; DUFFY FH, 1984, ANN NEUROL, V16, P430, DOI 10.1002/ana.410160403; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Ellis KA, 2006, NEUROIMAGE, V31, P1741, DOI 10.1016/j.neuroimage.2006.02.014; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Gaetz W, 2012, HUM BRAIN MAPP, V33, P2035, DOI 10.1002/hbm.21339; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Grachev ID, 2001, J NEUROCHEM, V76, P582, DOI 10.1046/j.1471-4159.2001.00026.x; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HARMONY T, 1990, ELECTROEN CLIN NEURO, V75, P482, DOI 10.1016/0013-4694(90)90135-7; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; Jelic V, 1996, DEMENTIA, V7, P314, DOI 10.1159/000106897; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jessen S.B., 2015, CEREB CORTEX; Kashiwase Y, 2012, J COGNITIVE NEUROSCI, V24, P1779, DOI 10.1162/jocn_a_00212; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Krishnan GP, 2005, CLIN NEUROPHYSIOL, V116, P614, DOI 10.1016/j.clinph.2004.09.016; Lewis RS, 2007, BIOL PSYCHOL, V75, P239, DOI 10.1016/j.biopsycho.2007.03.004; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Macpherson H, 2012, PHYSIOL BEHAV, V107, P346, DOI 10.1016/j.physbeh.2012.08.006; Macpherson H, 2009, BRAIN COGNITION, V69, P571, DOI 10.1016/j.bandc.2008.12.003; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2008, BIOL PSYCHOL, V77, P292, DOI 10.1016/j.biopsycho.2007.11.003; Muller NG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143533; Muller M. M., 2016, J COGNITIVE NEUROSCI; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Osipova D, 2006, CLIN NEUROPHYSIOL, V117, P1990, DOI 10.1016/j.clinph.2006.05.034; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; Osler M, 2006, INT J EPIDEMIOL, V35, P541, DOI 10.1093/ije/dyi300; Perlstein WM, 2003, NEUROSCI LETT, V342, P191, DOI 10.1016/S0304-3940(03)00226-X; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Pietrzak RH, 2007, ARCH CLIN NEUROPSYCH, V22, P235, DOI 10.1016/j.acn.2007.01.018; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Regan D., 1989, HUMAN BRAIN ELECTROP; Rubin E., 1915, SYNSOPLEVEDE FIGURER; Sartucci F, 2010, BRAIN RES BULL, V82, P169, DOI 10.1016/j.brainresbull.2010.04.001; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Silberstein RB, 2001, INT J PSYCHOPHYSIOL, V42, P219, DOI 10.1016/S0167-8760(01)00167-2; Silberstein RB, 2000, INT J PSYCHOPHYSIOL, V39, P79, DOI 10.1016/S0167-8760(00)00118-5; SILBERSTEIN RB, 1995, EVOKED POTENTIAL, V96, P24, DOI 10.1016/0013-4694(94)00189-R; Sorensen L, 2016, HUM BRAIN MAPP, V37, P1148, DOI 10.1002/hbm.23091; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spaniol J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.005; Srinivasan R, 2007, EXP BRAIN RES, V180, P677, DOI 10.1007/s00221-007-0886-3; Stranahan AM, 2011, CEREB CORTEX, V21, P392, DOI 10.1093/cercor/bhq106; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van Deursen JA, 2008, J NEURAL TRANSM, V115, P1301, DOI 10.1007/s00702-008-0083-y; WILSON GF, 1986, PSYCHOPHYSIOLOGY, V23, P57, DOI 10.1111/j.1469-8986.1986.tb00594.x; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002; Zhang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072654	72	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0171859	10.1371/journal.pone.0171859	http://dx.doi.org/10.1371/journal.pone.0171859			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245274	gold, Green Submitted, Green Published			2022-12-27	WOS:000395980200009
J	Price, A; Garhyan, J; Gibas, C				Price, Adam; Garhyan, Jaishree; Gibas, Cynthia			The impact of RNA secondary structure on read start locations on the Illumina sequencing platform	PLOS ONE			English	Article							GENE-EXPRESSION; BIAS	High-throughput sequencing is subject to sequence dependent bias, which must be accounted for if researchers are to make precise measurements and draw accurate conclusions from their data. A widely studied source of bias in sequencing is the GC content bias, in which levels of GC content in a genomic region effect the number of reads produced during sequencing. Although some research has been performed on methods to correct for GC bias, there has been little effort to understand the underlying mechanism. The availability of sequencing protocols that target the specific location of structure in nucleic acid molecules enables us to investigate the underlying molecular origin of observed GC bias in sequencing. By applying a parallel analysis of RNA structure (PARS) protocol to bacterial genomes of varying GC content, we are able to observe the relationship between local RNA secondary structure and sequencing outcome, and to establish RNA secondary structure as the significant contributing factor to observed GC bias.	[Price, Adam; Gibas, Cynthia] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Garhyan, Jaishree] Jawaharlal Nehru Univ, New Delhi, India; [Garhyan, Jaishree] Forsyth Inst, Dept Immun & Infect Dis, Cambridge, MA USA	University of North Carolina; University of North Carolina Charlotte; Jawaharlal Nehru University, New Delhi; Harvard University; Forsyth Institute	Price, A (corresponding author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu	Price, Adam/AAA-3128-2019	Price, Adam/0000-0001-6114-6298; Gibas, Cynthia/0000-0002-1288-9543	National Institutes of Health [R01-GM072619]; Charlotte Research Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Research Institute	This project was supported by the National Institutes of Health award R01-GM072619 to CG, and an internal award from the Charlotte Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Chan CY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S33; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1, DOI DOI 10.1093/bioinformatics/btn594; Long JS, 1997, AM J SOCIOL, P328; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lyubetsky VA, 2006, MOL BIOL+, V40, P440, DOI 10.1134/S0026893306030113; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Schwartz JJ, 2009, P NATL ACAD SCI USA, V106, P20294, DOI 10.1073/pnas.0907404106; Sendler E, 2011, ANAL BIOCHEM, V419, P317, DOI 10.1016/j.ab.2011.08.013; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12468, DOI 10.1021/bi971218+; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Wan Y, 2016, METHOD MOL BIOL, P141; Wan Y, 2013, NAT PROTOC, V8, P849, DOI 10.1038/nprot.2013.045; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173023	10.1371/journal.pone.0173023	http://dx.doi.org/10.1371/journal.pone.0173023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245230	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200051
J	Kwong, HC; Kumar, CSC; Mah, SH; Chia, TS; Quah, CK; Loh, ZH; Chandraju, S; Lim, GK				Kwong, Huey Chong; Kumar, C. S. Chidan; Mah, Siau Hui; Chia, Tze Shyang; Quah, Ching Kheng; Loh, Zi Han; Chandraju, Siddegowda; Lim, Gin Keat			Novel biphenyl ester derivatives as tyrosinase inhibitors: Synthesis, crystallographic, spectral analysis and molecular docking studies	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; FT-IR; 1ST-ORDER HYPERPOLARIZABILITY; GENETIC ALGORITHM; LUMO ANALYSIS; NBO ANALYSIS; 2-(4-CHLOROPHENYL)-2-OXOETHYL; 4-METHOXYBENZOATE; 2-METHOXYBENZOATE; POTENT	Biphenyl-based compounds are clinically important for the treatments of hypertension and inflammatory, while many more are under development for pharmaceutical uses. In the present study, a series of 2-([1,1'-biphenyl]-4-yl)-2-oxoethyl benzoates, 2(a-q), and 2-([1,1'biphenyl]-4-yl)-2-oxoethyl pyridinecarboxylate, 2(r-s) were synthesized by reacting 1-([1,1'biphenyl]-4-yl)-2-bromoethan-1-one with various carboxylic acids using potassium carbonate in dimethylformamide at ambient temperature. Single-crystal X-ray diffraction studies revealed a more closely packed crystal structure can be produced by introduction of biphenyl moiety. Five of the compounds among the reported series exhibited significant antityrosinase activities, in which 2p, 2r and 2s displayed good inhibitions which are comparable to standard inhibitor kojic acid at concentrations of 100 and 250 mu g/m L. The inhibitory effects of these active compounds were further confirmed by computational molecular docking studies and the results revealed the primary binding site is active-site entrance instead of inner copper binding site which acted as the secondary binding site.	[Kwong, Huey Chong; Lim, Gin Keat] Univ Sains Malaysia, Sch Chem Sci, Gelugor, Penang, Malaysia; [Kumar, C. S. Chidan] Visvesvaraya Technol Univ, Vidya Vikas Inst Engn & Technol, Dept Chem Engn, Mysuru, Karnataka, India; [Mah, Siau Hui; Loh, Zi Han] Taylors Univ, Sch Biosci, Lakeside Campus, Subang Jaya, Selangor, Malaysia; [Chia, Tze Shyang; Quah, Ching Kheng] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, Gelugor, Penang, Malaysia; [Chandraju, Siddegowda] Univ Mysore, Sir MV PG Ctr, Dept Sugar Technol & Chem, Tubinakere, India	Universiti Sains Malaysia; Visvesvaraya Technological University; Taylor's University; Universiti Sains Malaysia; University of Mysore	Kumar, CSC (corresponding author), Visvesvaraya Technol Univ, Vidya Vikas Inst Engn & Technol, Dept Chem Engn, Mysuru, Karnataka, India.; Quah, CK (corresponding author), Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, Gelugor, Penang, Malaysia.	chidankumar@gmail.com; ckquah@usm.my	Quah, Ching Kheng/A-5525-2009; Mah, Siau Hui/AAE-6245-2019; Chia, Tze Shyang/F-8816-2012; Kwong, Huey Chong/S-7699-2019; Lim, Gin/G-7430-2011	Quah, Ching Kheng/0000-0002-3279-4349; Mah, Siau Hui/0000-0003-0370-4866; Chia, Tze Shyang/0000-0002-3782-7023; Lim, Gin/0000-0002-8485-3507; Kwong, Huey Chong/0000-0001-5130-8011	Malaysian Government; Universiti Sains Malaysia (USM) for Fundamental Research Grant Scheme (FRGS) [203.PFIZIK.6711563]	Malaysian Government; Universiti Sains Malaysia (USM) for Fundamental Research Grant Scheme (FRGS)	HCK thanks Malaysian Government for MyBrain15 (MyPhD) scholarship and wishes to offer his deep gratitude to Ivy Ye Wei Ng, student from School of Biosciences, Taylor's University, Malaysia, for anti-tyrosinase assay data collection. The authors thank the Malaysian Government and Universiti Sains Malaysia (USM) for Fundamental Research Grant Scheme (FRGS) (203.PFIZIK.6711563).	[Anonymous], 2015, DISC STUD V4 5 0 150; [Anonymous], 2016, DIFLUNISAL A2 ARONSO, P976; Bakheit Ahmed H H, 2015, Profiles Drug Subst Excip Relat Methodol, V40, P371, DOI 10.1016/bs.podrm.2015.01.003; Bao K, 2010, BIOORGAN MED CHEM, V18, P6708, DOI 10.1016/j.bmc.2010.07.062; Brudeli B, 2013, BIOORGAN MED CHEM, V21, P7134, DOI 10.1016/j.bmc.2013.09.004; Bruker, 2009, APEX2 SAINT SADABS; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Cincinelli R, 2016, EUR J MED CHEM, V112, P99, DOI 10.1016/j.ejmech.2016.02.001; Coates J., 2006, ENCY ANAL CHEM, P1, DOI 10.1002/9780470027318.a5606; Dai Y, 2006, J NAT PROD, V69, P1022, DOI 10.1021/np0600853; Ding YY, 2015, BIOORG MED CHEM LETT, V25, P2744, DOI 10.1016/j.bmcl.2015.05.040; Diwaker, 2015, J MOL STRUCT, V1092, P192, DOI 10.1016/j.molstruc.2015.03.028; Dong JY, 2015, EUR J MED CHEM, V101, P780, DOI 10.1016/j.ejmech.2015.07.015; Fun HK, 2012, ACTA CRYSTALLOGR E, V68, pO1876, DOI 10.1107/S1600536812022684; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3456, DOI 10.1107/S1600536811049233; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3379, DOI 10.1107/S1600536811048720; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3351, DOI 10.1107/S1600536811048264; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3154, DOI 10.1107/S1600536811045272; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO2836, DOI 10.1107/S160053681103947X; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO2854, DOI 10.1107/S1600536811040311; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3119, DOI 10.1107/S1600536811044564; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO3030, DOI 10.1107/S1600536811042851; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO2682, DOI 10.1107/S1600536811037500; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1802, DOI 10.1107/S160053681102383X; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1687, DOI 10.1107/S1600536811021246; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1724, DOI 10.1107/S1600536811023002; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1723, DOI 10.1107/S1600536811022963; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1599, DOI 10.1107/S1600536811020630; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1597, DOI 10.1107/S1600536811020629; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1582, DOI 10.1107/S1600536811020654; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1529, DOI 10.1107/S1600536811018988; Fun HK, 2011, ACTA CRYSTALLOGR E, V67, pO1528, DOI 10.1107/S1600536811018976; Gargano EM, 2016, BIOORG MED CHEM LETT, V26, P21, DOI 10.1016/j.bmcl.2015.11.047; Garudachari B, 2013, ACTA CRYSTALLOGR E, V69, pO551, DOI 10.1107/S1600536813006958; Garudachari B, 2013, ACTA CRYSTALLOGR E, V69, pO649, DOI 10.1107/S160053681300843X; Hohnholz D, 2000, SYNTHETIC MET, V110, P141, DOI 10.1016/S0379-6779(99)00291-X; Isloor AM, 2012, ACTA CRYSTALLOGR E, V68, pO513, DOI 10.1107/S1600536812002577; Ji T, 2007, ACTA CRYSTALLOGR E, V63, pO4766, DOI 10.1107/S1600536807055250; Jin Y, 2008, ACTA CRYSTALLOGR E, V64, pO507, DOI 10.1107/S1600536807066469; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Khamarui S, 2015, CHEM COMMUN, V51, P384, DOI 10.1039/c4cc07961b; Khan I, 2014, ACTA CRYSTALLOGR E, V70, P301, DOI 10.1107/S1600536814021643; Khan I, 2012, ACTA CRYSTALLOGR E, V68, pO3465, DOI 10.1107/S1600536812046995; Komarov I. V., 1999, RUSS J ORG CHEM+, V35, P1388; Kong XW, 2008, CHINESE CHEM LETT, V19, P149, DOI 10.1016/j.cclet.2007.11.025; Kumar CSC, 2015, MOLECULES, V20, P18827, DOI 10.3390/molecules201018827; Kumar CSC, 2014, SPECTROCHIM ACTA A, V128, P327, DOI 10.1016/j.saa.2014.02.185; Kumar CSC, 2014, SPECTROCHIM ACTA A, V126, P208, DOI 10.1016/j.saa.2014.01.145; Kumar CSC, 2014, SPECTROCHIM ACTA A, V124, P595, DOI 10.1016/j.saa.2014.01.063; Kumar Chandraju Sadolalu C, 2014, Z KRIST-CRYST MATER, P328; Marciasini L, 2012, CHEM COMMUN, V48, P1553, DOI 10.1039/c1cc14605j; Moorthy JN, 2007, ORG BIOMOL CHEM, V5, P1354, DOI 10.1039/b701706e; Mutahir S, 2016, BIOORG CHEM, V64, P13, DOI 10.1016/j.bioorg.2015.11.002; Nakamura K, 2003, PIGM CELL RES, V16, P494, DOI 10.1034/j.1600-0749.2003.00084.x; Nithitanakool S, 2009, MOLECULES, V14, P257, DOI 10.3390/molecules14010257; Poater J, 2006, CHEM-EUR J, V12, P2889, DOI 10.1002/chem.200500850; Putschogl FM, 2015, INT J HYG ENVIR HEAL, V218, P452, DOI 10.1016/j.ijheh.2015.03.009; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wu YN, 2014, ORG BIOMOL CHEM, V12, P6820, DOI 10.1039/c4ob01211a; YAMAMURA K, 1988, TETRAHEDRON LETT, V29, P1797, DOI 10.1016/S0040-4039(00)82046-8	63	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0170117	10.1371/journal.pone.0170117	http://dx.doi.org/10.1371/journal.pone.0170117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241010	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000395934400003
J	Bearss, JJ; Hunter, M; Dankmeyer, JL; Fritts, KA; Klimko, CP; Weaver, CH; Shoe, JL; Quirk, AV; Toothman, RG; Webster, WM; Fetterer, DP; Bozue, JA; Worsham, PL; Welkos, SL; Amemiya, K; Cote, CK				Bearss, Jeremy J.; Hunter, Melissa; Dankmeyer, Jennifer L.; Fritts, Kristen A.; Klimko, Christopher P.; Weaver, Chris H.; Shoe, Jennifer L.; Quirk, Avery V.; Toothman, Ronald G.; Webster, Wendy M.; Fetterer, David P.; Bozue, Joel A.; Worsham, Patricia L.; Welkos, Susan L.; Amemiya, Kei; Cote, Christopher K.			Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice	PLOS ONE			English	Article							MARROW-DERIVED MACROPHAGES; NITRIC-OXIDE SYNTHASE; MURINE MODEL; ANIMAL-MODELS; IFN-GAMMA; T-CELLS; INTRACELLULAR SURVIVAL; ADAPTIVE IMMUNITY; CXC CHEMOKINES; NADPH-OXIDASE	Burkholderia pseudomallei, the etiologic agent of melioidosis, is a Gram negative bacterium designated as a Tier 1 threat. This bacterium is known to be endemic in Southeast Asia and Northern Australia and can infect humans and animals by several routes. Inhalational melioidosis has been associated with monsoonal rains in endemic areas and is also a significant concern in the biodefense community. There are currently no effective vaccines for B. pseudomallei and antibiotic treatment can be hampered by non-specific symptomology and also the high rate of naturally occurring antibiotic resistant strains. Well-characterized animal models will be essential when selecting novel medical countermeasures for evaluation prior to human clinical trials. Here, we further characterize differences between the responses of BALB/c and C57BL/6 mice when challenged with low doses of a low-passage and well-defined stock of B. pseudomallei K96243 via either intraperitoneal or aerosol routes of exposure. Before challenge, mice were implanted with a transponder to collect body temperature readings, and daily body weights were also recorded. Mice were euthanized on select days for pathological analyses and determination of the bacterial burden in selected tissues (blood, lungs, liver, and spleen). Additionally, spleen homogenate and sera samples were analyzed to better characterize the host immune response after infection with aerosolized bacteria. These clinical, pathological, and immunological data highlighted and confirmed important similarities and differences between these murine models and exposure routes.	[Bearss, Jeremy J.] USAMRIID, Div Pathol, Frederick, MD USA; [Hunter, Melissa; Dankmeyer, Jennifer L.; Fritts, Kristen A.; Klimko, Christopher P.; Weaver, Chris H.; Shoe, Jennifer L.; Quirk, Avery V.; Toothman, Ronald G.; Webster, Wendy M.; Bozue, Joel A.; Worsham, Patricia L.; Welkos, Susan L.; Amemiya, Kei; Cote, Christopher K.] USAMRIID, Bacteriol Div, Frederick, MD 21702 USA; [Fetterer, David P.] USAMRIID, Div Biostat, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases	Cote, CK (corresponding author), USAMRIID, Bacteriol Div, Frederick, MD 21702 USA.	Christopher.k.cote.civ@mail.mil	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA) [CB3846 PPE-1]	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was funded by the Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA) (CB3846 PPE-1 Burkholderia) (www.dtra.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA). The authors would like to thank Dr. David DeShazer for his critical review of this manuscript and Ms. Lorraine Farinick for assistance with figure preparation. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army.	Aardema H, 2005, EPIDEMIOL INFECT, V133, P871, DOI 10.1017/S0950268805004103; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Amemiya K, 2006, VACCINE, V24, P1413, DOI 10.1016/j.vaccine.2005.09.021; Amemiya K, 2015, MICROB PATH; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; Barnes JL, 2004, CLIN IMMUNOL, V113, P22, DOI 10.1016/j.clim.2004.06.006; Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; BRENNER GJ, 1994, CELL IMMUNOL, V157, P510, DOI 10.1006/cimm.1994.1246; Caspi RR, 1997, EYE, V11, P209, DOI 10.1038/eye.1997.53; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Challacombe JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115951; Chen PS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003834; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chirakul S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104313; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Churuangsuk C, 2016, ASIAN PAC J TROP MED, V9, P250, DOI 10.1016/j.apjtm.2016.01.034; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; DANNENBERG AM, 1958, J EXP MED, V107, P153, DOI 10.1084/jem.107.1.153; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; Depke M, 2014, J PROTEOMICS, V103, P72, DOI 10.1016/j.jprot.2014.03.027; Doker TJ, 2014, CLIN INFECT DIS; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fisher NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-117; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Gee JE, 2014, EMERG INFECT DIS, V20, P682, DOI 10.3201/eid2004.130960; GRAUS YMF, 1993, CLIN EXP IMMUNOL, V92, P506; HANCOCK GE, 1986, INFECT IMMUN, V53, P26, DOI 10.1128/IAI.53.1.26-31.1986; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Harley VS, 1998, MICROBIOS, V96, P71; Hatcher Christopher L, 2015, Curr Trop Med Rep, V2, P62; Heinzel FP, 1998, CELL IMMUNOL, V184, P129, DOI 10.1006/cimm.1998.1267; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Horton RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063394; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Jenjaroen K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004152; Jiang XZ, 2010, IMMUNOLOGY, V129, P556, DOI 10.1111/j.1365-2567.2009.03157.x; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kaushik RS, 2000, CYTOKINE, V12, P1024, DOI 10.1006/cyto.2000.0685; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kohler J, 2011, MICROBES INFECT, V13, P914, DOI 10.1016/j.micinf.2011.05.004; Kuraguchi M, 2001, J PATHOL, V193, P517, DOI 10.1002/path.834; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Lauw FN, 2000, INFECT IMMUN, V68, P3888, DOI 10.1128/IAI.68.7.3888-3893.2000; Laws TR, 2011, MICROB PATHOGENESIS, V51, P471, DOI 10.1016/j.micpath.2011.07.002; Leakey AK, 1998, MICROB PATHOGENESIS, V24, P269, DOI 10.1006/mpat.1997.0179; Lever MS, 2009, INT J EXP PATHOL, V90, P16, DOI 10.1111/j.1365-2613.2008.00619.x; Limmathurotsakul D, 2015, EMERG INFECT DIS, V21; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2014, EMERG INFECT DIS, V20, P265, DOI 10.3201/eid2002.121891; Limmathurotsakul D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000694; Liu X, 2015, EMERG INFECT DIS, V21, P159, DOI 10.3201/eid2101.140042; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; McInnes EF, 2012, BACKGROUND LESIONS L, P48; MEDINA D, 1974, J NATL CANCER I, V53, P213, DOI 10.1093/jnci/53.1.213; Mulye M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002988; Nandi T, 2013, MBIO, V4, DOI 10.1128/mBio.00709-13; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Nieves W, 2014, CLIN VACCINE IMMUNOL, V21, P747, DOI 10.1128/CVI.00119-14; Nomiyama H, 2013, GENES CELLS, V18, P1, DOI 10.1111/gtc.12013; O'Sullivan BP, 2011, CHEST, V140, P239, DOI 10.1378/chest.10-3336; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Patil HG, 2016, J ORTHOP, V13, P40, DOI 10.1016/j.jor.2015.08.001; Pegoraro G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-98; Raja NS, 2016, INFECT DIS THERAPY; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Revelli DA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00164; Sahl JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121052; Sanford JP, 1991, HARRISONS PRINCIPLES, P606; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Soffler C, 2014, INT J EXP PATHOL, V95, P101, DOI 10.1111/iep.12068; St John JA, 2014, MBIO, V5, DOI 10.1128/mBio.00025-14; Stundick MV, 2013, VET PATHOL, V50, P877, DOI 10.1177/0300985813486812; Sun B, 1997, J IMMUNOL, V159, P1004; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Tabel H, 2000, MICROBES INFECT, V2, P1619, DOI 10.1016/S1286-4579(00)01318-6; Tamrakar SB, 2008, J APPL MICROBIOL, V105, P1361, DOI 10.1111/j.1365-2672.2008.03880.x; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Thomas RJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00101; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Ullrich RL, 1996, RADIAT RES, V146, P353, DOI 10.2307/3579468; van Schaik E, 2008, MICROBES INFECT, V10, P1291, DOI 10.1016/j.micinf.2008.07.028; Van Zandt KE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00120; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Wakeham J, 2000, INFECT IMMUN, V68, P6946, DOI 10.1128/IAI.68.12.6946-6953.2000; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Watkiss ERT, 2013, VIRUSES-BASEL, V5, P295, DOI 10.3390/v5010295; Weening EH, 2011, INFECT IMMUN, V79, P644, DOI 10.1128/IAI.00981-10; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; West TE, 2012, INT J EXP PATHOL, V93, P421, DOI 10.1111/j.1365-2613.2012.00842.x; West TE, 2010, AM J TROP MED HYG, V83, P1066, DOI 10.4269/ajtmh.2010.10-0306; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; YABUUCHI E, 1993, MICROBIOL IMMUNOL, V37, P823, DOI 10.1111/j.1348-0421.1993.tb01712.x; Yingst SL, 2014, J MED MICROBIOL, V63, P118, DOI 10.1099/jmm.0.059063-0; Zehnder AM, 2014, EMERG INFECT DIS, V20, P304, DOI 10.3201/eid2002.131314; Zumbrun EE, 2012, VIRUSES-BASEL, V4, P3468, DOI 10.3390/v4123468	114	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172627	10.1371/journal.pone.0172627	http://dx.doi.org/10.1371/journal.pone.0172627			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235018	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200102
J	Bohon, C				Bohon, Cara			Brain response to taste in overweight children: A pilot feasibility study	PLOS ONE			English	Article							OBESITY; FOOD	Understanding the neural response to food and food cues during early stages of weight gain in childhood may help us determine the drive processes involved in unhealthy eating behavior and risk for obesity. Healthy weight and overweight children ages 6-8 (N = 18; 10 with BMI between 5 th and 85 th % ile and 8 with BMI > 85 th % ile) underwent fMRI scans while anticipating and receiving tastes of chocolate milkshake. Parents completed a Children's Eating Behaviour Questionnaire. Results reveal greater response to milkshake taste receipt in overweight children in the right insula, operculum, precentral gyrus, and angular gyrus, and bilateral precuneus and posterior cingulate. No group differences were found for brain response to a visual food cue. Exploratory analyses revealed interactions between self-report measures of eating behavior and weight status on brain response to taste. This pilot study provides preliminary evidence of feasibility of studying young children's taste processing and suggests a possible developmental shift in brain response to taste.	[Bohon, Cara] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Bohon, C (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	cbohon@stanford.edu		Bohon, Cara/0000-0001-9978-3727	Child Health Research Institute; Lucile Packard Foundation for Childrens Health through Stanford CTSA [UL1 TR000093]; Career Development Award from the National Institute of Mental Health [1K23MH10679401A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH106794] Funding Source: NIH RePORTER	Child Health Research Institute; Lucile Packard Foundation for Childrens Health through Stanford CTSA; Career Development Award from the National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Child Health Research Institute and Lucile Packard Foundation for Childrens Health through Stanford CTSA grant # UL1 TR000093 awarded to the author. The author was also supported by a Career Development Award from the National Institute of Mental Health grant #1K23MH10679401A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohon C, 2011, INT J EAT DISORDER, V44, P585, DOI 10.1002/eat.20869; Boutelle KN, 2015, INT J OBESITY, V39, P620, DOI 10.1038/ijo.2014.206; Brownell KD, 2010, BEHAV RES THER, V48, P717, DOI 10.1016/j.brat.2010.05.018; Bruce AS, 2010, INT J OBESITY, V34, P1494, DOI 10.1038/ijo.2010.84; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Stoeckel L, 2010, GOLDILOCKS PRINCIPLE; UNGER R, 1990, CLIN PEDIATR, V29, P368, DOI 10.1177/000992289002900701	13	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172604	10.1371/journal.pone.0172604	http://dx.doi.org/10.1371/journal.pone.0172604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235080	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200099
J	Gabrovsek, P; Aleksovski, D; Mozetic, I; Grcar, M				Gabrovsek, Peter; Aleksovski, Darko; Mozetic, Igor; Grcar, Miha			Twitter sentiment around the Earnings Announcement events	PLOS ONE			English	Article								We investigate the relationship between social media, Twitter in particular, and stock market. We provide an in-depth analysis of the Twitter volume and sentiment about the 30 companies in the Dow Jones Industrial Average index, over a period of three years. We focus on Earnings Announcements and show that there is a considerable difference with respect to when the announcements are made: before the market opens or after the market closes. The two different timings of the Earnings Announcements were already investigated in the financial literature, but not yet in the social media. We analyze the differences in terms of the Twitter volumes, cumulative abnormal returns, trade returns, and earnings surprises. We report mixed results. On the one hand, we show that the Twitter sentiment (the collective opinion of the users) on the day of the announcement very well reflects the stock moves on the same day. We demonstrate this by applying the event study methodology, where the polarity of the Earnings Announcements is computed from the Twitter sentiment. Cumulative abnormal returns are high (2-4%) and statistically significant. On the other hand, we find only weak predictive power of the Twitter sentiment one day in advance. It turns out that it is important how to account for the announcements made after the market closes. These after-hours announcements draw high Twitter activity immediately, but volume and price changes in trading are observed only on the next day. On the day before the announcements, the Twitter volume is low, and the sentiment has very weak predictive power. A useful lesson learned is the importance of the proper alignment between the announcements, trading and Twitter data.	[Gabrovsek, Peter; Aleksovski, Darko; Mozetic, Igor; Grcar, Miha] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Aleksovski, D (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.	darko.aleksovski@ijs.si	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137; Mozetic, Igor/0000-0002-5466-0608	EC [610704, 640772]; Slovenian ARRS programme Knowledge Technologies [P2-103]	EC(European CommissionEuropean Commission Joint Research Centre); Slovenian ARRS programme Knowledge Technologies	This work was supported in part by the EC projects SIMPOL (no. 610704) and DOLFINS (no. 640772), and by the Slovenian ARRS programme Knowledge Technologies (no. P2-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alostad H, 2015, 2015 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY (WI-IAT), VOL 1, P523, DOI 10.1109/WI-IAT.2015.82; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Berkman H, 2009, J ACCOUNT RES, V47, P71, DOI 10.1111/j.1475-679X.2008.00312.x; Bollen J., 2011, ICWSM, P450; Campbell J., 1997, ECONOMETRICS FINANCI; Doyle JT, 2009, ACCOUNT REV, V84, P157, DOI 10.2308/accr.2009.84.1.157; Kaniel R, 2007, J BUS, P1; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02713; MacKinlay AC, 1997, J ECON LIT, V35, P13; Makrehchi M, 2013, 2013 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 1, P337, DOI 10.1109/WI-IAT.2013.48; Mao H., 2011, ARXIV11121051, P1; Mao Y., 2012, P 1 ACM INT WORKSHOP, P69, DOI DOI 10.1145/2392622.2392634; Mohammad SM, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3945; Mozetic I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155036; Novak PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144296; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Schroff S, 2013, COMMUNICATION; Souza TTP, 2015, TWITTER SENTIMENT AN; Souza TTP, 2016, NONLINEAR IMPACT EVI; Sprenger TO, 2014, EUR FINANC MANAG, V20, P926, DOI 10.1111/j.1468-036X.2013.12007.x; Sprenger TO, 2014, J BUS FINAN ACCOUNT, V41, P791, DOI 10.1111/jbfa.12086; Tafti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159226; Truong C, 2010, ACCOUNT FINANC, V50, P719, DOI 10.1111/j.1467-629X.2009.00338.x; Vapnik V., 2013, NATURE STAT LAERNING; Wang G, 2014, CROWDS WALL STREET E; Zheludev I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04213	27	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173151	10.1371/journal.pone.0173151	http://dx.doi.org/10.1371/journal.pone.0173151			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235103	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200199
J	Gawlitza, M; Bohme, J; Maros, M; Lobsien, D; Michalski, D; Groden, C; Hoffmann, KT; Forster, A				Gawlitza, Matthias; Boehme, Johannes; Maros, Mate; Lobsien, Donald; Michalski, Dominik; Groden, Christoph; Hoffmann, Karl-Titus; Foerster, Alex			FLAIR vascular hyperintensities and 4D MR angiograms for the estimation of collateral blood flow in anterior cerebral artery ischemia	PLOS ONE			English	Article							EVALUATION TRIAL EPITHET; MOYAMOYA-DISEASE; ENDOVASCULAR THERAPY; RANDOMIZED-TRIAL; INFARCT GROWTH; HUMAN BRAIN; STROKE; VESSELS; TERRITORY; REVASCULARIZATION	Purpose To assess FLAIR vascular hyperintensities (FVH) and dynamic (4D) angiograms derived from perfusion raw data as proposed magnetic resonance (MR) imaging markers of leptomeningeal collateral circulation in patients with ischemia in the territory of the anterior cerebral artery (ACA). Methods Forty patients from two tertiary care university hospitals were included. Infarct volumes and perfusion deficits were manually measured on DWI images and TTP maps, respectively. FVH and collateral flow on 4D MR angiograms were assessed and graded as previously specified. Results Forty-one hemispheres were affected. Mean DWI lesion volume was 8.2 (+/- 13.9; range 0-76.9) ml, mean TTP lesion volume was 24.5 (+/- 17.2, range 0-76.7) ml. FVH were observed in 26/41 (63.4%) hemispheres. Significant correlations were detected between FVH and TTP lesion volume (rho = 0.4; P<0.01) absolute (rho = 0.37; P<0.05) and relative mismatch volume (rho = 0.35; P<0.05). The modified ASITN/SIR score correlated inversely with DWI lesion volume (rho = -0.58; P< 0.01) and positively with relative mismatch (rho = 0.29; P< 0.05). ANOVA of the ASITN/SIR score revealed significant inter-group differences for DWI (P< 0.001) and TTP lesion volumes (P< 0.05). No correlation was observed between FVH scores and modified ASITH/SIR scores (rho = -0.16; P = 0.32). Conclusions FVH and flow patterns on 4D MR angiograms are markers of perfusion deficits and tissue at risk. As both methods did not show a correlation between each other, they seem to provide complimentary instead of redundant information. Previously shown evidence for the meaning of these specific MR signs in internal carotid and middle cerebral artery stroke seems to be transferrable to ischemic stroke in the ACA territory.	[Gawlitza, Matthias; Lobsien, Donald; Hoffmann, Karl-Titus] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Boehme, Johannes; Maros, Mate; Groden, Christoph; Foerster, Alex] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany; [Michalski, Dominik] Univ Hosp Leipzig, Dept Neurol, Leipzig, Germany	Leipzig University; Ruprecht Karls University Heidelberg; Leipzig University	Gawlitza, M (corresponding author), Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.	matthias.gawlitza@medizin.uni-leipzig.de	Maros, Máté E./ABB-3203-2021	Maros, Máté E./0000-0002-1589-8699; Hoffmann, Karl-Titus/0000-0001-7693-887X	German Research Foundation (DFG); Universitat Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Arboix A, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-30; Azizyan A, 2011, AM J NEURORADIOL, V32, P1771, DOI 10.3174/ajnr.A2265; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Cosnard G, 1999, NEURORADIOLOGY, V41, P342, DOI 10.1007/s002340050761; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; ENDO M, 1989, J NEUROSURG, V71, P180, DOI 10.3171/jns.1989.71.2.0180; Forster A, 2015, INT J STROKE, V10, P1287, DOI 10.1111/ijs.12531; Forster A, 2014, NEURORADIOLOGY, V56, P697, DOI 10.1007/s00234-014-1382-7; Forster A, 2015, J CEREB BLOOD FLOW M; Forster A, 2014, J NEUROIMAGING; Gawlitza M, 2014, AM J NEURORADIOL, V35, P1520, DOI 10.3174/ajnr.A3961; Gawlitza M, 2014, J NEURORADIOLOGY, V41, P227, DOI 10.1016/j.neurad.2013.10.004; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Haussen DC, 2013, J NEUROIMAGING, V23; Hermier M, 2005, NEUROLOGY, V65, P652, DOI 10.1212/01.wnl.0000173036.95976.46; Iancu-Gontard D, 2003, STROKE, V34, P1886, DOI 10.1161/01.STR.0000080382.61984.FE; Iwama T, 1997, CLIN NEUROL NEUROSUR, V99, pS134; Iwama T, 1998, NEUROSURGERY, V42, P1157, DOI 10.1097/00006123-199805000-00124; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kang SY, 2008, NEUROLOGY, V70, P2386, DOI 10.1212/01.wnl.0000314686.94007.d0; Kim SJ, 2014, ANN NEUROL, V76, P356, DOI 10.1002/ana.24211; Kufner A, 2015, AM J NEURORADIOL, V36, P1426, DOI 10.3174/ajnr.A4320; Kumral E, 2002, EUR J NEUROL, V9, P615, DOI 10.1046/j.1468-1331.2002.00452.x; Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008; Lee KY, 2009, NEUROLOGY, V72, P1134, DOI 10.1212/01.wnl.0000345360.80382.69; Lee MJ, 2015, STROKE, V46, P2800, DOI 10.1161/STROKEAHA.115.009828; Legrand L, 2015, AM J NEURORADIOL, V36, P269, DOI 10.3174/ajnr.A4088; Leng XY, 2016, CEREBROVASC DIS, V41, P27, DOI 10.1159/000441803; Menon BK, 2013, J CEREBR BLOOD F MET, V33, P365, DOI 10.1038/jcbfm.2012.171; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Richard S, 2011, NEUROL SCI, V32, P511, DOI 10.1007/s10072-011-0562-z; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sanossian N, 2009, AM J NEURORADIOL, V30, P564, DOI 10.3174/ajnr.A1388; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Seoa KD, 2013, CEREBROVASC DIS EXTR, V3, P46, DOI 10.1159/000350459; Sheth Sunil A, 2014, Curr Radiol Rep, V2, P29; Sheth SA, 2015, CURR OPIN NEUROL, V28, P10, DOI 10.1097/WCO.0000000000000166; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tatu L, 2012, FRONT NEUROL NEUROSC, V30, P99, DOI 10.1159/000333602; VANDEREECKEN HM, 1953, J NEUROPATH EXP NEUR, V12, P132, DOI 10.1097/00005072-195304000-00002; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687; Yoshioka K, 2013, NEURORADIOLOGY, V55, P165, DOI 10.1007/s00234-012-1092-y	45	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172570	10.1371/journal.pone.0172570	http://dx.doi.org/10.1371/journal.pone.0172570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234996	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200094
J	Soriano, M; Mohren, F; Ascarrunz, N; Dressler, W; Pena-Claros, M				Soriano, Marlene; Mohren, Frits; Ascarrunz, Nataly; Dressler, Wolfram; Pena-Claros, Marielos			Socio-ecological costs of Amazon nut and timber production at community household forests in the Bolivian Amazon	PLOS ONE			English	Article							LAND-COVER CHANGE; BERTHOLLETIA-EXCELSA; RURAL LIVELIHOODS; BRAZIL; PATTERNS; SUSTAINABILITY; DEFORESTATION; EXTRACTION; STRATEGIES; DEPENDENCE	The Bolivian Amazon holds a complex configuration of people and forested landscapes in which communities hold secure tenure rights over a rich ecosystem offering a range of livelihood income opportunities. A large share of this income is derived from Amazon nut (Bertholletia excelsa). Many communities also have long-standing experience with community timber management plans. However, livelihood needs and desires for better living conditions may continue to place these resources under considerable stress as income needs and opportunities intensify and diversify. We aim to identify the socioeconomic and biophysical factors determining the income from forests, husbandry, off-farm and two keystone forest products (i.e.,Amazon nut and timber) in the Bolivian Amazon region. We used structural equation modelling tools to account for the complex inter-relationships between socioeconomic and biophysical factors in predicting each source of income. The potential exists to increase incomes from existing livelihood activities in ways that reduce dependency upon forest resources. For example, changes in off-farm income sources can act to increase or decrease forest incomes. Market accessibility, social, financial, and natural and physical assets determined the amount of income community households could derive from Amazon nut and timber. Factors related to community households' local ecological knowledge, such as the number of non-timber forest products harvested and the number of management practices applied to enhance Amazon nut production, defined the amount of income these households could derive from Amazon nut and timber, respectively. The (inter) relationships found among socioeconomic and biophysical factors over income shed light on ways to improve forest-dependent livelihoods in the Bolivian Amazon. We believe that our analysis could be applicable to other contexts throughout the tropics as well.	[Soriano, Marlene; Ascarrunz, Nataly; Pena-Claros, Marielos] Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [Soriano, Marlene; Mohren, Frits; Pena-Claros, Marielos] Wageningen Univ, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Dressler, Wolfram] Univ Melbourne, Sch Geog, Melbourne, Vic, Australia	Wageningen University & Research; University of Melbourne	Soriano, M (corresponding author), Inst Boliviano Invest Forestal, Santa Cruz, Bolivia.; Soriano, M (corresponding author), Wageningen Univ, Forest Ecol & Forest Management Grp, Wageningen, Netherlands.	m.soriano.candia@gmail.com	Mohren, Godefridus M.J./C-5608-2015	Mohren, Godefridus M.J./0000-0002-7004-4602; Pena-Claros, Marielos/0000-0001-9134-6733; Soriano, Marlene/0000-0003-4739-402X	Netherlands Fellowship Program (NFP); International Foundation for Science, Stockholm, Sweden	Netherlands Fellowship Program (NFP); International Foundation for Science, Stockholm, Sweden(International Foundation for Science)	This research was supported by the Netherlands Fellowship Program (NFP fellowships) and the International Foundation for Science, Stockholm, Sweden to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A, 2014, WORLD DEV, V64, pS12, DOI 10.1016/j.worlddev.2014.03.006; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bebbington A, 1999, WORLD DEV, V27, P2021, DOI 10.1016/S0305-750X(99)00104-7; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Beneker C., 2010, ETFRN News, P59; Benneker C., 2005, POLICY PRACTICE DEV; Bojanic A, 2001, PROMAB SCI SERIES, V4; Bollen KA, 2014, STRUCT EQU MODELING, V21, P1, DOI 10.1080/10705511.2014.856691; Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107; Cardona WC, 2014, LAND USE POLICY, V39, P224, DOI 10.1016/j.landusepol.2014.02.013; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; Cotta JN, 2008, FOREST ECOL MANAG, V256, P28, DOI 10.1016/j.foreco.2008.03.026; Cushman KC, 2014, METHODS ECOL EVOL, V5, P573, DOI 10.1111/2041-210X.12187; Dauber E, 2005, FOREST ECOL MANAG, V214, P294, DOI 10.1016/j.foreco.2005.04.019; de Jong W, 2014, FOREST POLICY ECON, V48, P46, DOI 10.1016/j.forpol.2014.07.001; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duchelle AE, 2014, WORLD DEV, V64, pS149, DOI 10.1016/j.worlddev.2014.03.001; Eisenhauer N, 2015, PEDOBIOLOGIA, V58, P65, DOI 10.1016/j.pedobi.2015.03.002; Gomes CVA, 2012, J LAT AM GEOGR, V11, P99, DOI 10.1353/lag.2012.0018; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Grace JB, 2012, DESIGN ANAL LONG TER, P325; Haugaasen JMT, 2012, BIOTROPICA, V44, P205, DOI 10.1111/j.1744-7429.2011.00796.x; HJORTSO CN, 2006, BOT EC ANDES CENTRAL, P533; Jagger P, 2014, WORLD DEV, V64, pS43, DOI 10.1016/j.worlddev.2014.03.004; Kainer KA, 2014, J APPL ECOL, V51, P655, DOI 10.1111/1365-2664.12231; Killeen TJ, 2008, ECOL SOC, V13; Krishnakumar J, 2015, ENVIRON DEV SUSTAIN, V17, P837, DOI 10.1007/s10668-014-9578-x; Marsik M, 2011, PROG PHYS GEOG, V35, P353, DOI 10.1177/0309133311399492; Martinez Montano J. A., 2008, MARCO LEGAL MANEJO F; Meilby H, 2014, WORLD DEV, V64, pS113, DOI 10.1016/j.worlddev.2014.03.011; Metcalf CJE, 2009, J TROP ECOL, V25, P1, DOI 10.1017/S0266467408005646; Mostacedo Bonifacio, 2006, Ecología en Bolivia, V41, P99; Mutenje MJ, 2011, ECOL ECON, V70, P454, DOI 10.1016/j.ecolecon.2010.09.036; Pacheco D, 2006, OPENING COMMON PROPE, P1; Pacheco P., 2009, TRAYECTORIAS TENDENC; Pacheco P, 2010, FOREST POLICY ECON, V12, P271, DOI 10.1016/j.forpol.2009.12.002; Paiva PM, 2011, FOREST ECOL MANAG, V261, P508, DOI 10.1016/j.foreco.2010.11.001; Pena-Claros M, 2011, SUSTAINABLE MANAGEME, P200; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Perz SG, 2013, LAND USE POLICY, V34, P27, DOI 10.1016/j.landusepol.2013.01.009; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Quaedvlieg J, 2014, J RURAL STUD, V33, P41, DOI 10.1016/j.jrurstud.2013.10.004; Schure J, 2014, PRODUCING WOODFUEL U, pxx; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Shaanker RU, 2004, ENVIRON CONSERV, V31, P242, DOI 10.1017/S0376892904001596; Shackleton S, 2007, INT FOREST REV, V9, P697, DOI 10.1505/ifor.9.3.697; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Soriano M, 2012, FOREST ECOL MANAG, V268, P92, DOI 10.1016/j.foreco.2011.05.010; Stanley D, 2012, ETHNOBIOL CONSERV, V1, DOI 10.15451/ec2012-8-1.9-1-39; Steele MZ, 2014, FOR POLICY EC; Stoian D., 2000, International Tree Crops Journal, V10, P299; Urapotina J, 2011, HABLEMOS TIERRAS MIN, P125; World Bank, 2016, WORLD DEV IND 2016; Zeidemann V, 2013, ENVIRON CONSERV, V41, P1; Zenteno M, 2014, ENVIRON SCI POLICY, V40, P36, DOI 10.1016/j.envsci.2014.03.006; Zenteno M, 2013, FOREST POLICY ECON, V26, P12, DOI 10.1016/j.forpol.2012.09.011; Zonisig, 1997, ZONIFICACIO AGROECOL; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018	60	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0170594	10.1371/journal.pone.0170594	http://dx.doi.org/10.1371/journal.pone.0170594			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235090	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200007
J	Toosizadeh, N; Berry, C; Bime, C; Najafi, B; Kraft, M; Mohler, J				Toosizadeh, Nima; Berry, Cristine; Bime, Christian; Najafi, Bijan; Kraft, Monica; Mohler, Jane			Assessing upper-extremity motion: An innovative method to quantify functional capacity in patients with chronic obstructive pulmonary disease	PLOS ONE			English	Article							MUSCLE STRENGTH; WALK DISTANCE; COPD; RELIABILITY; LIMITATION; ENDURANCE; OUTCOMES; SPEED; TESTS; FEV1	Background Assessment of functional capacity is important in directing chronic obstructive pulmonary disease (COPD) care (e.g., rehabilitation and discharge readiness), and in predicting outcomes (e.g., exacerbation, hospitalization, and mortality). The 6-minute walk distance (6MWD) test for functional capacity assessment, may be time-consuming and burdensome. Objective The purpose of the current study was to evaluate an upper-extremity function (UEF) test for assessing functional capacity in older adults with COPD. Methods In this cross-sectional study, 49 older adults (>= 55 years) with diagnosed COPD were recruited, and pulmonary function measures and 6MWD were obtained. Participants wore wireless sensors on forearm and upper-arm and performed rapid elbow flexion for 20 seconds (the UEF test). Slowness was assessed by measuring elbow speed, and acceleration and weakness (muscle strength) were assessed by measuring power of movement and elbow moment. Results Speed, power, and moment UEF parameters were independently associated with 6MWD, when controlling for age, gender, and body mass index (BMI) (r = 0.78, p < .001). Elbow moment showed significant Pearson correlations with all pulmonary function measures and maximal inspiratory/expiratory pressure measures (r = 0.35-0.69, p < 0.02). Conclusions Results show promise of a quick upper-extremity measure of functional capacity in patients with COPD, and as an outcome measure in clinical COPD trials.	[Toosizadeh, Nima; Berry, Cristine; Najafi, Bijan; Mohler, Jane] Univ Arizona, Arizona Ctr Aging, Dept Med, Tucson, AZ 85721 USA; [Toosizadeh, Nima; Najafi, Bijan; Mohler, Jane] Univ Arizona, iCAMP, Dept Surg, Tucson, AZ 85721 USA; [Berry, Cristine; Bime, Christian; Kraft, Monica] Univ Arizona, Dept Med, Pulm Allergy Crit Care & Sleep Med, Tucson, AZ USA; [Najafi, Bijan] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Vasc Surg & Endovasc Therapy, Houston, TX 77030 USA	University of Arizona; University of Arizona; University of Arizona; Baylor College of Medicine	Toosizadeh, N (corresponding author), Univ Arizona, Arizona Ctr Aging, Dept Med, Tucson, AZ 85721 USA.	ntoosizadeh@aging.arizona.edu	Najafi, Bijan/AAK-5650-2020	Najafi, Bijan/0000-0002-0320-8101; Bime, Christian/0000-0003-4787-2685	Arizona Center on Aging	Arizona Center on Aging	The Arizona Center on Aging provided funding to enable this pilot project.	Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636; Andersson M, 2011, PRIM CARE RESP J, V20, P434, DOI 10.4104/pcrj.2011.00082; BALKE B, 1963, Rep Civ Aeromed Res Inst US, P1; Calik-Kutukcu E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-6; Carter R, 2003, CHEST, V123, P1408, DOI 10.1378/chest.123.5.1408; Clark CJ, 2000, EUR RESPIR J, V15, P92, DOI 10.1034/j.1399-3003.2000.15a17.x; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dourado VZ, 2006, CHEST, V129, P551, DOI 10.1378/chest.129.3.551; Eiser N, 2003, RESP MED, V97, P407, DOI 10.1053/rmed.2002.1462; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Ekberg-Aronsson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-98; Finlayson ML, 2010, PHYS MED REH CLIN N, V21, P357, DOI 10.1016/j.pmr.2009.12.003; Garrod Rachel, 2007, Prim Care Respir J, V16, P236, DOI 10.3132/pcrj.2007.00047; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; GUYATT GH, 1985, J CHRON DIS, V38, P517, DOI 10.1016/0021-9681(85)90035-9; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones P, 2012, INT J CHRONIC OBSTR, V7, P697, DOI 10.2147/COPD.S32675; Karpman C, 2014, INT J CHRONIC OBSTR, V9, P1315, DOI 10.2147/COPD.S54481; KILLIAN KJ, 1992, AM REV RESPIR DIS, V146, P935, DOI 10.1164/ajrccm/146.4.935; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Marin JM, 2001, AM J RESP CRIT CARE, V163, P1395, DOI 10.1164/ajrccm.163.6.2003172; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institutes of Health NH Lung and Blood Institute, 2012, MORB MORT 2012 CHART; Niewoehner DE, 2000, AM J RESP CRIT CARE, V161, P1201, DOI 10.1164/ajrccm.161.4.9907143; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Sciurba F, 2003, AM J RESP CRIT CARE, V167, P1522, DOI 10.1164/rccm.200203-166OC; Toosizadeh N, 2016, J AM COLL S IN PRESS; Toosizadeh N, 2015, J AM GERIATR SOC, V63, P1181, DOI 10.1111/jgs.13451	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172766	10.1371/journal.pone.0172766	http://dx.doi.org/10.1371/journal.pone.0172766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235045	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200132
J	Claassens, MM; van Schalkwyk, C; Floyd, S; Ayles, H; Beyers, N				Claassens, M. M.; van Schalkwyk, C.; Floyd, S.; Ayles, H.; Beyers, N.			Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys	PLOS ONE			English	Article							RANDOMIZED TRIAL; INTERVENTIONS; COMMUNITIES; HIV	Background High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough >= 2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of similar to 85%. Methods We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules. Results Among all participants, the sensitivity of using only cough >= 2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough < 2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough < 2 weeks, night sweats, and weight loss, increased the sensitivity to similar to 38%, while reducing specificity from similar to 95% to similar to 85% in SA and similar to 97% to similar to 92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%). Conclusion High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough >= 2 weeks.	[Claassens, M. M.; Beyers, N.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Cape Town, South Africa; [van Schalkwyk, C.] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal, Natl Res Fdn, South African Dept Sci & Technol, Stellenbosch, South Africa; [Floyd, S.; Ayles, H.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Ayles, H.] Univ Zambia, Zambia AIDS Related TB Project, Ridgeway Campus, Lusaka, Zambia	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of Zambia	Claassens, MM (corresponding author), Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Cape Town, South Africa.	mcla@sun.ac.za	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; van Schalkwyk, Cari/0000-0001-5154-1390; Ayles, Helen/0000-0003-4108-2842	Johns Hopkins University; Bill and Melinda Gates Foundation [19790.01]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Johns Hopkins University(Johns Hopkins University); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a subcontract from Johns Hopkins University with funds provided by grant number 19790.01 from the Bill and Melinda Gates Foundation. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Langendam MW, 2013, SYSTEMATIC REV SENSI; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Marais BJ, 2010, AM J RESP CRIT CARE, V181, P195, DOI 10.1164/ajrccm.181.2.195a; Samandari T, 2011, AM J RESP CRIT CARE, V183, P1103, DOI 10.1164/rccm.201004-0620OC; TB CARE I, 2014, INT STAND TUB CAR; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, SYST SCREEN ACT TUB	19	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172881	10.1371/journal.pone.0172881	http://dx.doi.org/10.1371/journal.pone.0172881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257424	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396021100035
J	E, MJ; Gong, Y; Yu, JP; Zhang, SY; Fan, QX; Jiang, YL; Wang, HT				E, Mingju; Gong, Ye; Yu, Jiangping; Zhang, Siyu; Fan, Qianxi; Jiang, Yunlei; Wang, Haitao			Low level of extra-pair paternity between nearest neighbors results from female preference for high-quality males in the yellow-rumped flycatcher (Ficedula zanthopygia)	PLOS ONE			English	Article							SEXUAL SELECTION; FREQUENT COPULATIONS; INBREEDING AVOIDANCE; BREEDING DENSITY; GENETIC QUALITY; PIED FLYCATCHER; MATE CHOICE; BIRDS; HETEROZYGOSITY; OPPORTUNITY	Extra-pair copulation is considered to be a means by which females can modify their initial mate choice, and females might obtain indirect benefits to offspring fitness by engaging in this behavior. Here, we examined the patterns of extra-pair paternity and female preferences in the yellow-rumped flycatcher (Ficedula zanthopygia). We found that female yellow-rumped flycatchers are more likely to choose larger and relatively highly heterozygous males than their social mates as extra-pair mates, that the genetic similarity of pairs that produced mixed-paternity offspring did not differ from the similarity of pairs producing only within-pair offspring, and that extra-pair offspring were more heterozygous than their half-siblings. These findings support the good genes hypothesis but do not exclude the compatibility hypothesis. Most female yellow-rumped flycatchers attained extra-pair paternity with distant males rather than their nearest accessible neighboring males, and no differences in genetic and phenotypic characteristics were detected between cuckolded males and their nearest neighbors. There was no evidence that extra-pair mating by female flycatchers reduced inbreeding. Moreover, breeding density, breeding synchrony and their interaction did not affect the occurrence of extra-pair paternity in this species. Our results suggest that the variation in extra-pair paternity distribution between nearest neighbors in some passerine species might result from female preference for highly heterozygous males.	[E, Mingju; Gong, Ye; Yu, Jiangping; Wang, Haitao] Northeast Normal Univ, Sch Life Sci, Jilin Prov Engn Lab Avian Ecol & Conservat Genet, Changchun, Peoples R China; [Zhang, Siyu] Northeast Normal Univ, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Peoples R China; [Fan, Qianxi] Northeast Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Jiang, Yunlei] Jilin Agr Univ, Anim Sci & Technol Inst, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Jilin Agricultural University	Wang, HT (corresponding author), Northeast Normal Univ, Sch Life Sci, Jilin Prov Engn Lab Avian Ecol & Conservat Genet, Changchun, Peoples R China.	wanght402@nenu.edu.cn			National Natural Science Foundation of China [31470458, 31270471]; Fundamental Research Funds for the Central Universities; Northeast Normal University [11SSXT151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Northeast Normal University	This research was supported by the National Natural Science Foundation of China (31470458 H.T.W.; 31270471 Y.L.J), the Fundamental Research Funds for the Central Universities and the Doctorial Innovation Fund of Northeast Normal University (grant 11SSXT151 M.J.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2007, BEHAV ECOL, V18, P477, DOI 10.1093/beheco/arm001; Andersson Malte, 1994; Annavi G, 2014, ECOL EVOL, V4, P2594, DOI 10.1002/ece3.1112; Arct A, 2015, BEHAV ECOL, V26, P959, DOI 10.1093/beheco/arv004; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; BAKER MC, 1987, ORNIS SCAND, V18, P186, DOI 10.2307/3676765; Balenger S, 2009, BEHAV ECOL SOCIOBIOL, V63, P403, DOI 10.1007/s00265-008-0674-5; Berzins A, 2010, BEHAV ECOL, V21, P1054, DOI 10.1093/beheco/arq104; BIRKHEAD TR, 1992, BIOL J LINN SOC, V45, P363, DOI 10.1111/j.1095-8312.1992.tb00649.x; BOLLINGER EK, 1991, BEHAV ECOL SOCIOBIOL, V29, P1, DOI 10.1007/BF00164288; Both C., 2004, ACTA ORN, V27, P131; Bouwman KM, 2005, BEHAVIOUR, V142, P1449, DOI 10.1163/156853905774831819; Brouwer L, 2011, MOL ECOL, V20, P4796, DOI 10.1111/j.1365-294X.2011.05325.x; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Crowe SA, 2009, ANIM BEHAV, V77, P183, DOI 10.1016/j.anbehav.2008.09.024; Ditchkoff SS, 2001, EVOLUTION, V55, P616, DOI 10.1554/0014-3820(2001)055[0616:MHCAVI]2.0.CO;2; DIXON A, 1994, NATURE, V371, P698, DOI 10.1038/371698a0; DUNN PO, 1994, BEHAV ECOL, V5, P123, DOI 10.1093/beheco/5.2.123; Edme A, 2016, J AVIAN BIOL, V47, P552, DOI 10.1111/jav.00839; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Formica VA, 2004, ECOLOGY, V85, P1125, DOI 10.1890/03-0029; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Friedl TWP, 2005, AUK, V122, P57, DOI 10.1642/0004-8038(2005)122[0057:EFIRBE]2.0.CO;2; GAUNT AS, 1999, GUIDELINES USE WILD; Gowaty PA., PARTNERSHIPS BIRDS, P21; Gray EM, 1996, BEHAV ECOL SOCIOBIOL, V38, P267, DOI 10.1007/s002650050242; Gray EM, 1997, ANIM BEHAV, V53, P625, DOI 10.1006/anbe.1996.0336; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2015, BEHAV ECOL, V26, P970, DOI 10.1093/beheco/arv031; HAMILTON WD, 1990, AM ZOOL, V30, P341; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hill CE, 2011, BEHAV ECOL, V22, P73, DOI 10.1093/beheco/arq171; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; Hyman J, 2006, ANIM BEHAV, V72, P209, DOI 10.1016/j.anbehav.2006.01.007; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johansson J, 2012, AM NAT, V179, P463, DOI 10.1086/664624; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Jones MGW, 2012, BEHAV ECOL SOCIOBIOL, V66, P1213, DOI 10.1007/s00265-012-1374-8; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kempenaers B., 1993, ORNIS SCAND, P24; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kim CH, 1998, KOREAN J ORNITHOL, V5, P17; Kokko H, 2005, BEHAV ECOL, V16, P724, DOI 10.1093/beheco/ari050; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Leder EH, 2008, MOL ECOL RESOUR, V8, P874, DOI 10.1111/j.1755-0998.2008.02096.x; Li JQ, 2016, BEHAV ECOL SOCIOBIOL, V70, P963, DOI 10.1007/s00265-016-2119-x; LIFJELD JT, 1992, BEHAV ECOL SOCIOBIOL, V31, P89, DOI 10.1007/BF00166341; Lindstedt ER, 2007, J AVIAN BIOL, V38, P214, DOI 10.1111/j.2007.0908-8857.03889.x; Lovlie H, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1296; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; MEEK SB, 1994, AUK, V111, P739; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MOLLER AP, 1992, AM NAT, V139, P1089, DOI 10.1086/285374; MOLLER AP, 1991, BEHAVIOUR, V118, P170, DOI 10.1163/156853991X00274; O'Loghlen AL, 1999, ANIM BEHAV, V58, P13, DOI 10.1006/anbe.1999.1125; OLoghlen AL, 1997, ANIM BEHAV, V53, P835, DOI 10.1006/anbe.1996.0348; Perlut NG, 2012, NORTHEAST NAT, V19, P335, DOI 10.1656/045.019.0214; Perreault S, 1997, BEHAV ECOL, V8, P612, DOI 10.1093/beheco/8.6.612; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Development Core Team, 2014, R LANG ENV STAT COMP; Reid JM, 2015, EVOLUTION, V69, P59, DOI 10.1111/evo.12557; Richardson DS, 2001, ANIM BEHAV, V62, P519, DOI 10.1006/anbe.2001.1778; Rosengrave P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0001; Russell E, 2000, AUST J ZOOL, V48, P161, DOI 10.1071/ZO99066; Segelbacher G, 2005, J ORNITHOL, V146, P99, DOI 10.1007/s10336-004-0062-5; Song X., 2013, PATTERNS INFLUENCING; Stewart IRK, 2006, CONDOR, V108, P399, DOI 10.1650/0010-5422(2006)108[399:TOEPAG]2.0.CO;2; Stewart SLM, 2010, BEHAV ECOL SOCIOBIOL, V64, P463, DOI 10.1007/s00265-009-0862-y; Stutchbury Bridget J.M., 1998, Ornithological Monographs, V49, P103; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vaclav R, 2007, J ORNITHOL, V148, P395, DOI 10.1007/s10336-007-0143-3; Valera F, 2003, BEHAV ECOL, V14, P403, DOI 10.1093/beheco/14.3.403; WAGNER RH, 1992, BEHAV ECOL SOCIOBIOL, V29, P455; Wang R, 1998, J TONGHUA TEACHERS C; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; Wei Zhongmin, 2012, Journal of Northeast Forestry University, V40, P141; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat D F, 1992, TRENDS ECOL EVOL, V7, P423; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; YEZERINAC SM, 1995, BEHAV ECOL SOCIOBIOL, V37, P179, DOI 10.1007/BF00176715; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	94	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172713	10.1371/journal.pone.0172713	http://dx.doi.org/10.1371/journal.pone.0172713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257431	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100024
J	Hou, PF; Zhu, LJ; Chen, XY; Qiu, ZQ				Hou, Pan-Fei; Zhu, Li-Jing; Chen, Xiao-Ying; Qiu, Zhu-Qiang			Age-related changes in CD4(+)CD25(+)FOXP3(+) regulatory T cells and their relationship with lung cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; CARCINOMA; COPD; EXPRESSION; DIAGNOSIS	Objectives CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) inhibit the anti-tumour immune response and reduce the effect of cancer immunotherapy. Although studies have demonstrated that the number and suppressive activity of Treg increase with age, it is not clear whether these changes correlate with a higher incidence of tumours in the elderly. This study was designed to explore the relationship between increase in CD4(+)CD25(+)FOXP3(+) Treg and the higher risk of lung cancer in the elderly. Methods Seventy lung cancer patients and 60 sex-and age-matched controls were recruited. Both groups were divided into three subgroups based on their age (young, middle-aged, or elderly). The proportion of CD4(+)CD25(+)FOXP3(+)/CD4(+) T cells was detected using flow cytometry, and the level of FOXP3 mRNA in the peripheral blood was examined with realtime RT-PCR. Results The levels of CD4(+)CD25(+)FOXP3(+)/CD4(+) T cells and FOXP3 mRNA were significantly higher in lung cancer patients than in healthy controls (t = 7.16, P < 0.01 and t = 3.65, P < 0.01, respectively). Within the healthy groups, the elderly group had larger proportion of CD4(+)CD25(+)FOXP3(+) Treg (F = 32.54, P < 0.01) and higher FOXP3 mRNA expression (F = 4.76, P < 0.01) than their younger counterparts. Among the six subgroups, the elderly lung cancer patients exhibited the highest levels of both CD4(+)CD25(+)FOXP3(+) Treg (11.81 +/- 2.40%) and FOXP3 mRNA (3.14 +/- 1.30). Conclusions The accumulation of CD4(+)CD25(+)FOXP3(+) Treg with age correlates well with the increasing incidence of lung cancer in the elderly.	[Hou, Pan-Fei; Qiu, Zhu-Qiang] Binzhou Med Univ, Rushan Hosp, Dept Clin Lab, Binzhou, Shandong, Peoples R China; [Zhu, Li-Jing] Binzhou Med Univ, Rushan Hosp, Dept Respirat, Binzhou, Shandong, Peoples R China; [Chen, Xiao-Ying] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Lab Med, Shanghai, Peoples R China	Binzhou Medical University; Binzhou Medical University; Shanghai Jiao Tong University	Zhu, LJ (corresponding author), Binzhou Med Univ, Rushan Hosp, Dept Respirat, Binzhou, Shandong, Peoples R China.	zhulijing830710@126.com	Hou, Panfei/W-2383-2019		Shandong Province Natural Science Foundation [ZR2014HP061]; projects of medical and health technology development program in Shandong province [2013WS0066]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); projects of medical and health technology development program in Shandong province	Support was provided by Shandong Province Natural Science Foundation, grant ZR2014HP061 [http://www.sdnsf.gov.cn/portal/] to Pan-Fei Hou and the projects of medical and health technology development program in Shandong province, grant 2013WS0066 [http://www.sdwskj.cn/] to Li-Jing Zhu. The funders played a role in data collection and analysis.	Anisimov VN, 2009, MECH AGEING DEV, V130, P105, DOI 10.1016/j.mad.2008.02.004; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Domagala-Kulawik J, 2011, SCAND J IMMUNOL, V73, P59, DOI 10.1111/j.1365-3083.2010.02474.x; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Lee KM, 2014, EUR J IMMUNOL, V44, P1728, DOI 10.1002/eji.201344062; Li F, 2014, CLIN CHEM LAB MED, V52, P1357, DOI 10.1515/cclm-2013-0878; Li JF, 2010, MOL MED REP, V3, P959, DOI 10.3892/mmr.2010.374; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Shen XH, 2010, J CANCER RES CLIN, V136, P1745, DOI 10.1007/s00432-010-0833-8; Tan DBA, 2014, IMMUNOBIOLOGY, V219, P975, DOI 10.1016/j.imbio.2014.07.005; The Ministry of Health of the People's Republic of China, 2008, 3 NATL RETROSPECT SP, V2, P344; Walecki M, 2015, MOL BIOL CELL, V26, P2845, DOI 10.1091/mbc.E14-08-1323; Wei TF, 2015, AM J CANCER RES, V5, P2190; Zhang XH, 2015, J GASTROINTEST ONCOL, V6, P307, DOI 10.3978/j.issn.2078-6891.2015.017; Zhi XY, 2012, J THORAC DIS, V4, P88, DOI 10.3978/j.issn.2072-1439.2010.08.01; Zhu LJ, 2012, INT J GERONTOL, V6, P187, DOI 10.1016/j.ijge.2012.01.013	24	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173048	10.1371/journal.pone.0173048	http://dx.doi.org/10.1371/journal.pone.0173048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253320	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300066
J	Mansor, MS; Ramli, R				Mansor, Mohammad Saiful; Ramli, Rosli			Foraging niche segregation in Malaysian babblers (Family: Timaliidae)	PLOS ONE			English	Article							TREE-SPECIES PREFERENCES; INSECTIVOROUS BIRDS; PENINSULAR MALAYSIA; TEMPERATE FOREST; TROPICAL FOREST; PASSERINE BIRDS; RESOURCE USE; RAIN-FOREST; ECOLOGY; DIVERSITY	Tropical rainforests are considered as hotspots for bird diversity, yet little is known about the system that upholds the coexistence of species. Differences in body size that are associated with foraging strategies and spatial distribution are believed to promote the coexistence of closely related species by reducing competition. However, the fact that many babbler species do not differ significantly in their morphology has challenged this view. We studied the foraging ecology of nine sympatric babbler species (i.e., Pellorneum capistratum, P. bicolor, P. malaccense, Malacopteron cinereum, M. magnum, Stachyris nigriceps, S. nigricollis, S. maculata, and Cyanoderma erythropterum) in the Krau Wildlife Reserve in Peninsular Malaysia. We investigated; i) how these babblers forage in the wild and use vegetation to obtain food, and ii) how these trophically similar species differ in spatial distribution and foraging tactics. Results indicated that most babblers foraged predominantly on aerial leaf litter and used gleaning manoeuvre in intermediate-density foliage but exhibited wide ranges of vertical strata usage, thus reducing interspecific competition. The principal component analysis indicated that two components, i.e., foraging height and substrate are important as mechanisms to allow the coexistence of sympatric babblers. The present findings revealed that these bird species have unique foraging niches that are distinct from each other, and this may apply to other insectivorous birds inhabiting tropical forests. This suggests that niche separation does occur among coexisting birds, thus following Gause' law of competitive exclusion, which states two species occupying the same niche will not stably coexist.	[Mansor, Mohammad Saiful; Ramli, Rosli] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Mansor, Mohammad Saiful] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia	Mansor, MS; Ramli, R (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.; Mansor, MS (corresponding author), Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia.	msaifulmansor@gmail.com; rosliramli@um.edu.my	Ramli, Rosli/A-8498-2010; Mansor, Mohammad Saiful/AFT-4431-2022	Ramli, Rosli/0000-0003-0410-9604; Mansor, Mohammad Saiful/0000-0002-8472-780X	University of Malaya [PG019-2013B]	University of Malaya(Universiti Malaya)	We are grateful to University of Malaya Research Fund (PG019-2013B) that provides financial support for this wildlife research.	Adamik P, 2004, ORNIS FENNICA, V81, P13; ALATALO RV, 1979, OIKOS, V33, P46, DOI 10.2307/3544510; Allen R.B., 1993, PERMANENT PLOT METHO; ALLEN RB, 1983, FRI B, V48; [Anonymous], 2001, PALEONTOLOGICAL STAT; Barbaro L, 2014, DIVERS DISTRIB, V20, P149, DOI 10.1111/ddi.12132; Black J.T, 1992, MULTIVARIATE DATA AN; Bohm SM, 2009, J ORNITHOL, V150, P799, DOI 10.1007/s10336-009-0401-7; BOWES GG, 1994, CAN J PLANT SCI, V74, P383, DOI 10.4141/cjps94-073; Braun-Blanquet J., 1932, STUDY PLANT COMMUNIT; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chen Chao-Chieh, 2008, Taiwan Journal of Forest Science, V23, P233; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Cloyed CS, 2014, COEVOLUTION, V2, P26, DOI DOI 10.1080/; DeWalt SJ, 2006, PLANT ECOL, V186, P203, DOI 10.1007/s11258-006-9123-6; Dinesen L, 1995, AFR J ECOL, V33, P420, DOI 10.1111/j.1365-2028.1995.tb01051.x; Vargas LE, 2011, J TROP ECOL, V27, P65, DOI 10.1017/S026646741000060X; Evans KL, 2005, P ROY SOC B-BIOL SCI, V272, P2155, DOI 10.1098/rspb.2005.3209; Farine DR, 2013, BEHAV ECOL SOCIOBIOL, V67, P321, DOI 10.1007/s00265-012-1452-y; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Freeman B, 2014, J FIELD ORNITHOL, V85, P23, DOI 10.1111/jofo.12046; Gabbe AP, 2002, CONSERV BIOL, V16, P462, DOI 10.1046/j.1523-1739.2002.00460.x; Gokula V., 2000, Tropical Ecology, V41, P195; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Hamer KC, 2015, BIOL CONSERV, V188, P82, DOI 10.1016/j.biocon.2014.09.026; HOLMES RT, 1981, OECOLOGIA, V48, P31, DOI 10.1007/BF00346985; HOLMES RT, 1988, WILSON BULL, V100, P377; Hsieh FS, 2011, J ORNITHOL, V152, P955, DOI 10.1007/s10336-011-0678-1; Hurst JM., 2007, PERMANENT PLOT METHO; KARR JR, 1983, ECOLOGY, V64, P1481, DOI 10.2307/1937503; Keddy P.A., 1989, COMPETITION; Kiszka J, 2011, MAR ECOL PROG SER, V433, P273, DOI 10.3354/meps09165; Kovach WL., 2007, MVSP A MULTIVARIATE; Lara C, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-015-0106-y; Lara C, 2011, CURR ZOOL, V57, P56, DOI 10.1093/czoolo/57.1.56; Luther D, 2011, AUK, V128, P201, DOI 10.1525/auk.2011.10262; MAC NALLY R, 1994, J ANIM ECOL, V63, P988; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Mansor MS, 2012, ACTA ORNITHOL, V47, P27, DOI 10.3161/000164512X653890; Mansor MS, 2015, SAINS MALAYS, V44, P687, DOI 10.17576/jsm-2015-4405-07; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; Mohd-Azlan J, 2012, EMU, V112, P287, DOI 10.1071/MU12018; Moradi HV, 2010, J TROP FOR SCI, V22, P36; MORRISON ML, 1987, AUK, V104, P225, DOI 10.1093/auk/104.2.225; MORRISON ML, 1984, CONDOR, V86, P146, DOI 10.2307/1367029; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Myers S., 2009, FIELD GUIDE BIRDS BO; Paiva VH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151340; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; Remsen J.V. Jr, 1990, Studies in Avian Biology, P144; Robertson OJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065299; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; ROLANDO A, 1985, B ZOOL, V52, P281, DOI 10.1080/11250008509440530; Roswag A, 2015, POPUL ECOL, V57, P601, DOI 10.1007/s10144-015-0508-z; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; SPSS Inc. Released, 2008, SPSS STAT WIND VERS; Styring AR, 2016, CURR ZOOL, V62, P345, DOI 10.1093/cz/zow022; Styring AR, 2004, J TROP ECOL, V20, P487, DOI 10.1017/S0266467404001579; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Terraube J, 2011, OIKOS, V120, P234, DOI 10.1111/j.1600-0706.2010.18554.x; Wagner JL, 2010, ECOLOGY, V62, P973; Watson DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142992; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Wereszczuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139852; Whelan CJ, 2001, ECOLOGY, V82, P219, DOI 10.1890/0012-9658(2001)082[0219:FSIFOI]2.0.CO;2; Yong DL, 2011, J TROP ECOL, V27, P1, DOI 10.1017/S0266467410000520; Yusof E, 2000, J WILDL PARKS, V18, P3; Zakria Nurulhuda, 2014, Check List, V10, P335; Zou FS, 2011, IBIS, V153, P269, DOI 10.1111/j.1474-919X.2011.01105.x	77	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172836	10.1371/journal.pone.0172836	http://dx.doi.org/10.1371/journal.pone.0172836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253284	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300041
J	Tarade, D; Ma, D; Pignanelli, C; Mansour, F; Simard, D; van den Berg, S; Gauld, J; McNulty, J; Pandey, S				Tarade, Daniel; Ma, Dennis; Pignanelli, Christopher; Mansour, Fadi; Simard, Daniel; van den Berg, Sean; Gauld, James; McNulty, James; Pandey, Siyaram			Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest	PLOS ONE			English	Article							SPINDLE CHECKPOINT; A-4 ANALOGS; TUBULIN POLYMERIZATION; ANTINEOPLASTIC AGENTS; CYTOTOXIC EVALUATION; ANTITUMOR-ACTIVITY; APOPTOSIS; PHOSPHATE; DESIGN; POTENT	The cis-stilbene, combretastatin A4 (CA4), is a potent microtubule targeting and vascular damaging agent. Despite promising results at the pre-clinical level and extensive clinical evaluation, CA4 has yet to be approved for therapeutic use. One impediment to the development of CA4 is an inherent conformational instability about the ethylene linker, which joins two aromatic rings. We have previously published preliminary data regarding structurally simplified biphenyl derivatives of CA4, lacking an ethylene linker, which retain anti-proliferative and pro-apoptotic activity, albeit at higher doses. Our current study provides a more comprehensive evaluation regarding the anti-proliferative and pro-apoptotic properties of biphenyl CA4 derivatives in both 2D and 3D cancerous and non-cancerous cell models. Computational analysis has revealed that cytotoxicity of CA4 and biphenyl analogues correlates with predicted tubulin affinity. Additional mechanistic evaluation of the biphenyl derivatives found that their anti-cancer activity is dependent on prolonged mitotic arrest, in a similar manner to CA4. Lastly, we have shown that cancer cells deficient in the extrinsic pathway of apoptosis experience delayed cell death following treatment with CA4 or analogues. Biphenyl derivatives of CA4 represent structurally simplified analogues of CA4, which retain a similar mechanism of action. The biphenyl analogues warrant in vivo examination to evaluate their potential as vascular damaging agents.	[Tarade, Daniel; Ma, Dennis; Pignanelli, Christopher; Mansour, Fadi; Simard, Daniel; Gauld, James; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada; [van den Berg, Sean; McNulty, James] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	University of Windsor; McMaster University	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada.	spandey@uwindsor.ca	Pignanelli, Christopher/N-7183-2019; McNulty, James/E-7871-2011; Pandey, Siyaram/AAI-5491-2020	Tarade, Daniel/0000-0001-7029-9640; Pignanelli, Christopher/0000-0001-7120-4818	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge Sasha Dowhayko for supplying peripheral blood mononuclear cells for our study. We acknowledge funding from NSERC to JM and SP. We gratefully acknowledge from Windsor Mold, the Couvillion family and Pajama Angels for their generous donations.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Alvarez C, 2008, BIOORGAN MED CHEM, V16, P5952, DOI 10.1016/j.bmc.2008.04.054; Assadieskandar A, 2013, BIOORGAN MED CHEM, V21, P2703, DOI 10.1016/j.bmc.2013.03.011; Beale TM, 2012, ACS MED CHEM LETT, V3, P177, DOI 10.1021/ml200149g; Bellina F, 2006, BIOORG MED CHEM LETT, V16, P5757, DOI 10.1016/j.bmcl.2006.08.087; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Chen H, 2013, J MED CHEM, V56, P685, DOI 10.1021/jm301864s; Cooney M, 2006, ASCO ANN M P; Dark GG, 1997, CANCER RES, V57, P1829; Dowlati A, 2002, CANCER RES, V62, P3408; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; GETAHUN Z, 1992, J MED CHEM, V35, P1058, DOI 10.1021/jm00084a011; Griggs J, 2001, LANCET ONCOL, V2, P82, DOI 10.1016/S1470-2045(00)00224-2; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Kanthou C, 2004, AM J PATHOL, V165, P1401, DOI 10.1016/S0002-9440(10)63398-6; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Kim KH, 2009, J NAT PROD, V72, P2061, DOI 10.1021/np900460j; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Lunt SJ, 2011, INT J CANCER, V129, P1979, DOI 10.1002/ijc.25848; Mahal K, 2015, INVEST NEW DRUG, V33, P541, DOI 10.1007/s10637-015-0215-9; Mendez-Callejas GM, 2014, CELL BIOL INT, V38, P296, DOI 10.1002/cbin.10199; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; McNulty J, 2015, BIOORG MED CHEM LETT, V25, P117, DOI 10.1016/j.bmcl.2014.10.090; Mendez G, 2011, APOPTOSIS, V16, P940, DOI 10.1007/s10495-011-0619-8; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; Odlo K, 2008, BIOORGAN MED CHEM, V16, P4829, DOI 10.1016/j.bmc.2008.03.049; Petit I, 2008, BLOOD, V111, P1951, DOI 10.1182/blood-2007-05-089219; Pettit GR, 2005, J MED CHEM, V48, P4087, DOI 10.1021/jm0205797; PETTIT GR, 1989, EXPERIENTIA, V45, P209, DOI 10.1007/BF01954881; Rajak H, 2013, CURR PHARM DESIGN, V19, P1923, DOI 10.2174/1381612811319100013; Rustin GJ, 2010, BRIT J CANCER, V102, P1355, DOI 10.1038/sj.bjc.6605650; Rustin GJS, 2003, J CLIN ONCOL, V21, P2815, DOI 10.1200/JCO.2003.05.185; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schobert R, 2010, J MED CHEM, V53, P6595, DOI 10.1021/jm100345r; Siemann DW, 2009, REV UPDATE CURRENT S; Simoni D, 2005, J MED CHEM, V48, P723, DOI 10.1021/jm049622b; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sun J, 2015, CHEM BIOL DRUG DES, V86, P1541, DOI 10.1111/cbdd.12617; Tarade D, 2016, MINIREVIEWS MED CHEM; Theeramunkong S, 2011, J MED CHEM, V54, P4977, DOI 10.1021/jm200555r; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Tron GC, 2005, J MED CHEM, V48, P3260, DOI 10.1021/jm049096o; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vitale I, 2007, APOPTOSIS, V12, P155, DOI 10.1007/s10495-006-0491-0; Wang L, 2002, J MED CHEM, V45, P1697, DOI 10.1021/jm010523x; Young SL, 2004, EXPERT OPIN INV DRUG, V13, P1171, DOI 10.1517/13543784.13.9.1171; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zheng SL, 2014, J MED CHEM, V57, P3369, DOI 10.1021/jm500002k; Zuo DY, 2015, CHEM-BIOL INTERACT, V227, P7, DOI 10.1016/j.cbi.2014.12.016	50	25	25	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171806	10.1371/journal.pone.0171806	http://dx.doi.org/10.1371/journal.pone.0171806			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253265	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300008
J	Wu, CH; Chen, YJ; Wang, MH; Chiou, LL; Tseng, WYI; Lee, HS				Wu, Cheng-Han; Chen, Yu-Jen; Wang, Mu-Hui; Chiou, Ling-Ling; Tseng, Wen-Yih Isaac; Lee, Hsuan-Shu			Diffusion tensor tractography reveals muscle reconnection during axolotl limb regeneration	PLOS ONE			English	Article							MOUSE SKELETAL-MUSCLE; VIVO MR TRACTOGRAPHY; FIBER TRACKING; ANISOTROPY; INJURY; ECHO	Axolotls have amazing ability to regenerate their lost limbs. Our previous works showed that after amputation the remnant muscle ends remained at their original location whilst sending satellite cells into the regenerating parts to develop into early muscle fibers in the late differentiation stage. The parental and the newly formed muscle fibers were not connected until very late stage. The present study used non-invasive diffusion tensor imaging (DTI) to monitor weekly axolotl upper arm muscles after amputation of their upper arms. DTI tractography showed that the regenerating muscle fibers became visible at 9-wpa (weeks post amputation), but a gap was observed between the regenerating and parental muscles. The gap was filled at 10-wpa, indicating reconnection of the fibers of both muscles. This was confirmed by histology. The DTI results indicate that 23% of the muscle fibers were reconnected at 10wpa. In conclusion, DTI can be used to visualize axolotls' skeletal muscles and the results of muscle reconnection were in accordance with our previous findings. This non-invasive technique will allow researchers to identify the timeframe in which muscle fiber reconnection takes place and thus enable the study of the mechanisms underlying this reconnection.	[Wu, Cheng-Han; Wang, Mu-Hui; Lee, Hsuan-Shu] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Chen, Yu-Jen; Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lee, Hsuan-Shu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan	Lee, HS (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Tseng, WYI (corresponding author), Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan.; Lee, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, HS (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Lee, HS (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	wytseng@ntu.edu.tw; benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434; Tseng, Wen-Yih Isaac/0000-0002-2314-6868	Ministry of Science and Technology, Taiwan [MOST 102-2314-B- 002 -127 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant to HSL from Ministry of Science and Technology (MOST 102-2314-B- 002 -127 -MY3), Taiwan (http://www.most.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Budzik JF, 2007, EUR RADIOL, V17, P3079, DOI 10.1007/s00330-007-0713-z; CLEVELAND GG, 1976, BIOPHYS J, V16, P1043, DOI 10.1016/S0006-3495(76)85754-2; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Diogo R, 2012, J ANAT, V221, P622, DOI 10.1111/j.1469-7580.2012.01567.x; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; HENKELMAN RM, 1994, MAGNET RESON MED, V32, P592, DOI 10.1002/mrm.1910320508; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Kragl M, 2008, COLD SH Q B, V73, P583, DOI 10.1101/sqb.2008.73.034; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Schwartz ED, 2005, J NEUROTRAUM, V22, P1388, DOI 10.1089/neu.2005.22.1388; Van Donkelaar CC, 1999, J ANAT, V194, P79, DOI 10.1046/j.1469-7580.1999.19410079.x; VanDoorn A, 1996, EUR J MORPHOL, V34, P5, DOI 10.1076/ejom.34.1.5.13156; Wu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116068; Zaraiskaya T, 2006, J MAGN RESON IMAGING, V24, P402, DOI 10.1002/jmri.20651; Zeng Hui, 2006, Chinese Medical Sciences Journal, V21, P276	21	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173425	10.1371/journal.pone.0173425	http://dx.doi.org/10.1371/journal.pone.0173425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253344	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300104
J	De Haan, RL; Schuiteman, MA; Vos, RJ				De Haan, Robert L.; Schuiteman, Matthew A.; Vos, Ronald J.			Residual soil nitrate content and profitability of five cropping systems in northwest Iowa	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; COVER CROPS; TILE DRAINAGE; MANAGEMENT; ROTATION; LOSSES; WATER; FERTILIZER; ALFALFA; FATE	Many communities in the Midwestern United States obtain their drinking water from shallow alluvial wells that are vulnerable to contamination by NO3-N from the surrounding agricultural landscape. The objective of this research was to assess cropping systems with the potential to produce a reasonable return for farmers while simultaneously reducing the risk of NO3-N movement into these shallow aquifers. From 2009 to 2013 we conducted a field experiment in northwest Iowa in which we evaluated five cropping systems for residual (late fall) soil NO3-N content and profitability. Soil samples were taken annually from the top 30 cm of the soil profile in June and August, and from the top 180 cm in November (late fall). The November samples were divided into 30 cm increments for analysis. Average residual NO3-N content in the top 180 cm of the soil profile following the 2010 to 2013 cropping years was 134 kg ha(-1) for continuous maize (Zea mays L.) with a cereal rye (Secale cereale L.) cover crop, 18 kg ha(-1) for perennial grass, 60 kg ha(-1) for a three year oat (Avena sativa L.)alfalfa (Medicago sativa L.)-maize rotation, 85 kg ha(-1) for a two year oat/red clover (Trifolium pratense L.)-maize rotation, and 90 kg ha(-1) for a three year soybean (Glycine max (L.) Merr.)-winter wheat (Triticum aestivum L.)-maize rotation. However, residual NO3-N in the 90 to 180 cm increment of the soil profile was not significantly higher in the oat-alfalfa-maize cropping system than the perennial grass system. For 2010 to 2013, average profit ($ ha(-1) yr(-1)) was 531 for continuous corn, 347 for soybean-winter wheat-maize, 264 for oat-alfalfa-maize, 140 for oat/red clover-maize, and -384 (loss) for perennial grass. Considering both residual soil NO3-N and profitability data, the oat-alfalfa-maize rotation performed the best in this setting. However, given current economic pressures widespread adoption is likely to require changes in public policy.	[De Haan, Robert L.] Dordt Coll, Dept Environm Studies, Sioux Ctr, IA 51250 USA; [Schuiteman, Matthew A.] AJS Farms, Sioux Ctr, IA USA; [Vos, Ronald J.] Dordt Coll, Dept Agr, Sioux Ctr, IA USA		De Haan, RL (corresponding author), Dordt Coll, Dept Environm Studies, Sioux Ctr, IA 51250 USA.	robert.dehaan@dordt.edu			Leopold Center for Sustainable Agriculture [E2009-22]; Iowa Department of Natural Resources [15ESDLQBROHRT001]; Dordt College; AJS Farms	Leopold Center for Sustainable Agriculture; Iowa Department of Natural Resources; Dordt College; AJS Farms	Funding for the study was provided by The Leopold Center for Sustainable Agriculture (Project E2009-22, https://www.leopold.iastate.edu/grants/e2009-22), by the Iowa Department of Natural Resources (Contract 15ESDLQBROHRT001), and by Dordt College. Mr. Matthew A. Schuiteman is employed by AJS Farms, a commercial company. AJS Farms provided support in the form of supplies and a salary for author MAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Kaisi M, 2004, AGRON J, V96, P1164, DOI 10.2134/agronj2004.1164; [Anonymous], CONS STEW PROGR; Barnhart SK, 2006, LATE SUMMER SEEDING; Culman SW, 2013, AGRON J, V105, P735, DOI 10.2134/agronj2012.0273; David MB, 2015, J ENVIRON QUAL, V44, P368, DOI 10.2134/jeq2014.01.0036; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; DeHaan L, 2014, PER CROPS FOOD SEC P; Dinnes DL, 2002, AGRON J, V94, P153, DOI 10.2134/agronj2002.0153; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Drury CF, 2014, J ENVIRON QUAL, V43, P587, DOI 10.2134/jeq2012.0495; Duffy MD, 2006, EVALUATING PROFITABI; Edwards W, 2008, PRICING FORAGE FIELD; Ferguson RB, 2015, J ENVIRON QUAL, V44, P449, DOI 10.2134/jeq2014.02.0085; Feyereisen GW, 2006, AGRON J, V98, P1416, DOI 10.2134/agronj2005.0134; Gardner JB, 2009, ECOL APPL, V19, P2167, DOI 10.1890/08-1122.1; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Huggins DR, 2001, AGRON J, V93, P477, DOI 10.2134/agronj2001.933477x; Iowa Department of Natural Resources, SOURC WAT PROT TARG; Johanns AM, CASH CORN SOYBEAN PR; Johanns AM, IOWA CORN SOYBEAN CO; Jones CS, 2016, J SOIL WATER CONSERV, V71, P206, DOI 10.2489/jswc.71.3.206; Ketterings QM, 2015, AGRON J, V107, P1365, DOI 10.2134/agronj14.0385; Ladoni M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143358; Lea PJ, 2006, ANN APPL BIOL, V149, P243, DOI 10.1111/j.1744-7348.2006.00101.x; McSwiney CP, 2010, ECOL APPL, V20, P648, DOI 10.1890/09-0077.1; Minnesota Department of Agriculture, 2012, MINN DEP AGR SUMM GR; Omernik J, 2016, J SOIL WATER CONSERV, V71, P167, DOI 10.2489/jswc.71.3.167; Plastina A, IOWA FARM CUSTOM RAT; Plastina A, CASH RENTAL RATES IO; R Core Team, 2013, R LANG ENV STAT COMP; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; Randall GW, 2001, J ENVIRON QUAL, V30, P337, DOI 10.2134/jeq2001.302337x; Russelle MP, 2001, J ENVIRON QUAL, V30, P30, DOI 10.2134/jeq2001.30130x; Sawyer J, 2013, SOIL PROFILE NITRATE, P1; Sebilo M, 2013, P NATL ACAD SCI USA, V110, P18185, DOI 10.1073/pnas.1305372110; Simons M, 2014, J EXP BOT, V65, P5657, DOI 10.1093/jxb/eru227; Stanger TF, 2008, AGRON J, V100, P643, DOI 10.2134/agronj2007.0280; Strock JS, 2004, J ENVIRON QUAL, V33, P1010, DOI 10.2134/jeq2004.1010; Thompson CA, 1987, IOWA GEOL, V12, P20; United States Department of Agriculture, SOURC WAT PROT PROGR; US EPA, BAS INF NITR DRINK W; VARVEL GE, 1990, AGRON J, V82, P958, DOI 10.2134/agronj1990.00021962008200050024x; Villamil MB, 2006, SOIL SCI SOC AM J, V70, P1936, DOI 10.2136/sssaj2005.0350; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136274; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; [No title captured]	47	6	6	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171994	10.1371/journal.pone.0171994	http://dx.doi.org/10.1371/journal.pone.0171994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248976	gold, Green Submitted, Green Published			2022-12-27	WOS:000395983500024
J	Gaube, P; Barcelo, C; McGillicuddy, DJ; Domingo, A; Miller, P; Giffoni, B; Marcovaldi, N; Swimmer, Y				Gaube, Peter; Barcelo, Caren; McGillicuddy, Dennis J., Jr.; Domingo, Andres; Miller, Philip; Giffoni, Bruno; Marcovaldi, Neca; Swimmer, Yonat			The use of mesoscale eddies by juvenile loggerhead sea turtles (Caretta caretta) in the southwestern Atlantic	PLOS ONE			English	Article							CENTRAL NORTH PACIFIC; DYNAMIC OCEAN; BEHAVIOR; CURRENTS; HABITAT; BRAZIL	Marine animals, such as turtles, seabirds and pelagic fishes, are observed to travel and congregate around eddies in the open ocean. Mesoscale eddies, large swirling ocean vortices with radius scales of approximately 50-100 km, provide environmental variability that can structure these populations. In this study, we investigate the use of mesoscale eddies by 24 individual juvenile loggerhead sea turtles (Caretta caretta) in the Brazil-Malvinas Confluence region. The influence of eddies on turtles is assessed by collocating the turtle trajectories to the tracks of mesoscale eddies identified in maps of sea level anomaly. Juvenile loggerhead sea turtles are significantly more likely to be located in the interiors of anticyclones in this region. The distribution of surface drifters in eddy interiors reveals no significant association with the interiors of cyclones or anticyclones, suggesting higher prevalence of turtles in anticyclones is a result of their behavior. In the southern portion of the Brazil-Malvinas Confluence region, turtle swimming speed is significantly slower in the interiors of anticyclones, when compared to the periphery, suggesting that these turtles are possibly feeding on prey items associated with anomalously low near-surface chlorophyll concentrations observed in those features.	[Gaube, Peter; McGillicuddy, Dennis J., Jr.] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Barcelo, Caren] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Domingo, Andres] Direcc Nacl Recursos Acuat, Montevideo, Uruguay; [Miller, Philip] Ctr Invest & Conservac Marina CICMAR, El Pinar, Canelones, Uruguay; [Giffoni, Bruno; Marcovaldi, Neca] Fundacao Pro Tamar ICMBio, Projecto TAMAR, Salvador, BA, Brazil; [Swimmer, Yonat] NOAA Fisheries, Long Beach, CA USA; [Gaube, Peter] Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98105 USA	Woods Hole Oceanographic Institution; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Gaube, P (corresponding author), Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA.; Gaube, P (corresponding author), Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98105 USA.	pgaube@apl.washington.edu	de Barros Giffoni, Bruno/AAT-7020-2020	McGillicuddy, Dennis/0000-0002-1437-2425; Gaube, Peter/0000-0002-3282-5803; Miller, Philip/0000-0003-4908-2716	Woods Hole Oceanographic Institution; National Aeronautics and Space Administration [NNX13AE47G]; National Science Foundation [1314109]; NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center; NASA [NNX13AE47G]; NOAA; NSF-GRFP [1314109]; NSF	Woods Hole Oceanographic Institution; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center; NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF))	Support was provided by: Woods Hole Oceanographic Institution [www.whoi.edu] to PG; National Aeronautics and Space Administration [www.nasa.gov] NNX13AE47G to PG and DJM; and National Science Foundation [www.nsf.gov] 1314109 to CB.; Thanks to Uruguay's and Brazil's scientific observers for deploying satellite transmitters and providing accompanying information on the bycatch turtles, as well as the skippers and crew of fishing vessels where turtles were captured and equipped with transmitters. Funding for satellite transmitters and ARGOS satellite time was made available for this project by NOAA National Marine Fisheries Service, Pacific Island Fisheries Science Center. We thank Dr. Francesco d'Ovidio for helpful comments and discussion on an earlier version of the manuscript and three anonymous reviewers for constructive feedback. We acknowledge Collecte Localis Satellites, AVISO (http://www.aviso.oceanobs.com) for the SLA observations, NOAA's Atlantic Oceanographic and Meteorological Laboratory AOML (http://www.aoml.noaa.gov/phod/index.php) for the drifter observations, NASA MEaSUREs Ocean Color Product Evaluation Project (ftp://ftp.oceancolor.ucsb.edu) for the CHL observations, NOAA National Climatic Data Center for the SST observations (data available at ftp://eclipse.ncdc.noaa.gov/pub/OI-daily-v2/NetCDF), and NOAA National Geophysical Data Center NGDC (http://www.ngdc.noaa.gov/mgg/fliers/06mgg01.html) for the global bathymetric data. A Woods Hole Postdoctoral Fellowship awarded to PG and NASA grant NNX13AE47G funded this work. CB is grateful for support from NOAA and the NSF-GRFP (Grant No. 1314109). DJM gratefully acknowledges support from NASA and NSF.	Barcelo C, 2013, MAR ECOL PROG SER, V479, P235, DOI 10.3354/meps10222; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bjorndal Karen A., 1997, P199; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Frick Michael G., 2010, Endangered Species Research, V9, P91, DOI 10.3354/esr00227; Fu LL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026245; Garver SA, 1997, J GEOPHYS RES-OCEANS, V102, P18607, DOI 10.1029/96JC03243; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Gaube P, 2013, J GEOPHYS RES-OCEANS, V118, P6349, DOI 10.1002/2013JC009027; Gaube P, 2014, J GEOPHYS RES-OCEANS, V119, P8195, DOI 10.1002/2014JC010111; Gaube P, 2015, J PHYS OCEANOGR, V45, P104, DOI 10.1175/JPO-D-14-0032.1; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Hansen DV, 1996, J ATMOS OCEAN TECH, V13, P900, DOI 10.1175/1520-0426(1996)013<0900:QCAIOW>2.0.CO;2; Hobday AJ, 2014, OCEANOGRAPHY, V27, P134, DOI 10.5670/oceanog.2014.92; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Kobayashi DR, 2011, ICES J MAR SCI, V68, P707, DOI 10.1093/icesjms/fsq185; Lumpkin R, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P39, DOI 10.1017/CBO9780511535901.003; Luschi P, 2006, S AFR J SCI, V102, P51; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lutz PL, 2002, BIOL SEA TURTLES, VII; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Marcovaldi MA, 1999, BIOL CONSERV, V91, P35, DOI 10.1016/S0006-3207(99)00043-9; Maritorena S, 2002, APPL OPTICS, V41, P2705, DOI 10.1364/AO.41.002705; Matano RP, 2010, OCEAN SCI, V6, P983, DOI 10.5194/os-6-983-2010; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 2016, ANNU REV MAR SCI, V8, P125, DOI 10.1146/annurev-marine-010814-015606; Mora O., 2006, COLLECTIVE VOLUME SC, V59, P608; Oliveira LR, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004900; Palma ED, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004720; Parker DM, 2005, FISH B-NOAA, V103, P142; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; Thompson PA, 2007, DEEP-SEA RES PT II, V54, P1003, DOI 10.1016/j.dsr2.2006.12.009; Wyneken J, 2008, MAR BIOL, V156, P171, DOI 10.1007/s00227-008-1074-0	51	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172839	10.1371/journal.pone.0172839	http://dx.doi.org/10.1371/journal.pone.0172839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249020	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500060
J	Kochem, M; Breslin, PAS				Kochem, Matthew; Breslin, Paul A. S.			Clofibrate inhibits the umami-savory taste of glutamate	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; MOLECULAR-MECHANISM; RECEPTOR; SWEET; RESPONSES; T1R; EXPRESSION; SECRETION; HORMONES; RELEASE	In humans, umami taste can increase the palatability of foods rich in the amino acids glutamate and aspartate and the 5'-ribonucleotides IMP and GMP. Umami taste is transduced, in part, by T1R1-T1R3, a heteromeric G-protein coupled receptor. Umami perception is inhibited by sodium lactisole, which binds to the T1R3 subunit in vitro. Lactisole is structurally similar to the fibrate drugs. Clofibric acid, a lipid lowering drug, also binds the T1R3 subunit in vitro. The purpose of this study was to determine whether clofibric acid inhibits the umami taste of glutamate in human subjects. Ten participants rated the umami taste intensity elicited by 20 mM monosodium glutamate (MSG) mixed with varying concentrations of clofibric acid (0 to 16 mM). In addition, fourteen participants rated the effect of 1.4 mM clofibric acid on umami enhancement by 5' ribonucleotides. Participants were instructed to rate perceived intensity using a general Labeled Magnitude Scale (gLMS). Each participant was tested in triplicate. Clofibric acid inhibited umami taste intensity from 20 mM MSG in a dose dependent manner. Whereas MSG neat elicited "moderate" umami taste intensity, the addition of 16 mM clofibric acid elicited only "weak" umami intensity on average, and in some subjects no umami taste was elicited. We further show that 1.4 mM clofibric acid suppressed umami enhancement from GMP, but not from IMP. This study provides in vivo evidence that clofibric acid inhibits glutamate taste perception, presumably via T1R1-T1R3 inhibition, and lends further evidence that the T1R1-T1R3 receptor is the principal umami receptor in humans. T1R receptors are expressed extra-orally throughout the alimentary tract and in regulatory organs and are known to influence glucose and lipid metabolism. Whether clofibric acid as a lipid-lowering drug affects human metabolism, in part, through T1R inhibition warrants further examination.	[Kochem, Matthew; Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Monell Chemical Senses Center	Breslin, PAS (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.; Breslin, PAS (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	Breslin@aesop.rutgers.edu		Breslin, Paul/0000-0001-5988-8401	NIH [DC 014286]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH DC 014286 to PASB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Baker VA, 2004, ENVIRON HEALTH PERSP, V112, P428, DOI 10.1289/ehp.6677; BARNETT D, 1977, BRIT J CLIN PHARMACO, V4, P455, DOI 10.1111/j.1365-2125.1977.tb00761.x; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Brand JG, 2000, J NUTR, V130, p942S, DOI 10.1093/jn/130.4.942S; Brown RJ, 2012, DIABETES CARE, V35, P959, DOI 10.2337/dc11-2424; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dotson CD, 2010, CURR OPIN INVEST DR, V11, P447; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; ENGER SC, 1977, ACTA MED SCAND, V201, P563; Galindo-Cuspinera V, 2006, CHEM SENSES, V31, P221, DOI 10.1093/chemse/bjj022; Gerspach AC, 2011, AM J PHYSIOL-ENDOC M, V301, pE317, DOI 10.1152/ajpendo.00077.2011; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; KOBAYASHI M, 1988, DIABETES CARE, V11, P495, DOI 10.2337/diacare.11.6.495; Kochem M, 2017, CHEM SENSES, V41, P79, DOI 10.1093/chemse/bjw104; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; MAGA JA, 1983, CRC CR REV FOOD SCI, V18, P231, DOI 10.1080/10408398309527364; Maillet EL, 2009, J MED CHEM, V52, P6931, DOI 10.1021/jm900823s; Mouritsen OG, 2012, FEBS J, V279, P3112, DOI 10.1111/j.1742-4658.2012.08690.x; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Simon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086454; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Temizkan S, 2015, EUR J CLIN NUTR, V69, P162, DOI 10.1038/ejcn.2014.208; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yasumatsu K, 2015, J PHYSIOL-LONDON, V593, P1021, DOI 10.1113/jphysiol.2014.284703; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	39	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172534	10.1371/journal.pone.0172534	http://dx.doi.org/10.1371/journal.pone.0172534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248971	Green Submitted, Green Published, gold			2022-12-27	WOS:000395983500046
J	Motta, V; Trevisi, P; Bertolini, F; Ribani, A; Schiavo, G; Fontanesi, L; Bosi, P				Motta, Vincenzo; Trevisi, Paolo; Bertolini, Francesca; Ribani, Anisa; Schiavo, Giuseppina; Fontanesi, Luca; Bosi, Paolo			Exploring gastric bacterial community in young pigs	PLOS ONE			English	Article							STREPTOCOCCUS-SUIS; SP-NOV; STOMACH; MICROBIOME; EPITHELIUM; PIGLETS	Microbiota plays an important role in the homeostasis of the gastrointestinal tract. Understanding the variations of the commensal microbiota composition is crucial for a more efficient control of enteric infectious diseases and for the reduction of the use of antibiotics in animal production, which are the main points of interest for improved animal healthcare and welfare and for consumer health protection. Even though the intestinal microbiota has been extensively studied, little is known about the gastric microbiota. This pilot study was aimed at a descriptive analysis of the gastric microbiota in healthy pigs and at the identification of any differences among four potentially distinct microbial niches in the stomach. Gastric mucosal samples from the oxyntic area, the pylorus and the gastric groove, and a sample of gastric contents were collected from four healthy weaned pigs. Bacterial DNA was isolated and extracted from each sample and amplicons from the V6 region of the 16S rRNA gene were sequenced using Ion Torrent PGM. The data were analysed by an "unsupervised" and a "supervised" approach in the Ribosomal Database Project (RDP) pipeline. Proteobacteria was the dominant phylum in all the samples. Differences in bacterial community composition were found between mucosal and content samples (one-way ANOSIM pairwise post hoc test, p < 0.05); instead, the different mucosal regions did not show differences between them. The mucosal samples were characterised by Herbiconiux and Brevundimonas, two genera which include cellulolytic and xylanolytic strains. Nevertheless, additional larger trials are needed to support the data presented in this pilot study and to increase the knowledge regarding the resident microbiota of the stomach.	[Motta, Vincenzo; Trevisi, Paolo; Bertolini, Francesca; Ribani, Anisa; Schiavo, Giuseppina; Fontanesi, Luca; Bosi, Paolo] Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy	University of Bologna	Bosi, P (corresponding author), Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy.	paolo.bosi@unibo.it	Fontanesi, Luca/L-1770-2014; bertolini, francesca/AAX-3836-2021	Fontanesi, Luca/0000-0001-7050-3760; Bertolini, Francesca/0000-0003-4181-3895; MOTTA, VINCENZO/0000-0002-1443-1309				Behrendt U, 2011, INT J SYST EVOL MICR, V61, P1039, DOI 10.1099/ijs.0.021352-0; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Buczolits S, 2001, SYST APPL MICROBIOL, V24, P368, DOI 10.1078/0723-2020-00052; Choi E, 2014, GUT, P1; Chu SJ, 2012, CURR OPIN GASTROEN, V28, P587, DOI 10.1097/MOG.0b013e328358e5cc; Cole JR, 2014, NUCLEIC ACIDS RES, V42, P1; Colombo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111447; Hamada M, 2012, INT J SYST EVOL MICR, V62, P795, DOI 10.1099/ijs.0.031260-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Kernaghan Shaun, 2012, Animal Health Research Reviews, V13, P110, DOI 10.1017/S1466252312000102; Kim BC, 2012, INT J SYST EVOL MICR, V62, P90, DOI 10.1099/ijs.0.028357-0; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Lopetuso LR, 2014, BEST PRACT RES CL GA, V28, P995, DOI 10.1016/j.bpg.2014.10.004; MacInnes JI, 2008, CAN J VET RES, V72, P242; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Mazzoni M, 2011, J ANAT, V219, P611, DOI 10.1111/j.1469-7580.2011.01415.x; Nordman H, 1998, BIOCHEM J, V331, P687, DOI 10.1042/bj3310687; Pedersen NR, 2012, J ANIM SCI, V90, P149, DOI 10.2527/jas.53832; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Priori D, 2014, J ANIM PHYSL ANIM NU; Sheh A, 2013, LANDES BIOSCIENCE, P505; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; VANGYLSWYK NO, 1987, INT J SYST BACTERIOL, V37, P102, DOI 10.1099/00207713-37-2-102; Varloud M, 2007, J ANIM SCI, V85, P2508, DOI 10.2527/jas.2006-182; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Yang I, 2013, FEMS MICROBIOL REV, V37, P736, DOI 10.1111/1574-6976.12027; Yuki N, 2000, APPL ENVIRON MICROB, V66, P5030, DOI 10.1128/AEM.66.11.5030-5034.2000; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173029	10.1371/journal.pone.0173029	http://dx.doi.org/10.1371/journal.pone.0173029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249050	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500070
J	Kondili, LA; Gaeta, GB; Ieluzzi, D; Zignego, AL; Monti, M; Gori, A; Soria, A; Raimondo, G; Filomia, R; Di Leo, A; Iannone, A; Massari, M; Corsini, R; Gulminetti, R; Comini, AG; Toniutto, P; Dissegna, D; Russo, FP; Zanetto, A; Rumi, MG; Brancaccio, G; Danieli, E; Brunetto, MR; Weimer, LE; Quaranta, MG; Vella, S; Puoti, M				Kondili, Loreta A.; Gaeta, Giovanni Battista; Ieluzzi, Donatella; Zignego, Anna Linda; Monti, Monica; Gori, Andrea; Soria, Alessandro; Raimondo, Giovanni; Filomia, Roberto; Di Leo, Alfredo; Iannone, Andrea; Massari, Marco; Corsini, Romina; Gulminetti, Roberto; Comini, Alberto Gatti; Toniutto, Pierluigi; Dissegna, Denis; Russo, Francesco Paolo; Zanetto, Alberto; Rumi, Maria Grazia; Brancaccio, Giuseppina; Danieli, Elena; Brunetto, Maurizia Rossana; Weimer, Liliana Elena; Quaranta, Maria Giovanna; Vella, Stefano; Puoti, Massimo			Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; WORLD COHORT; DASABUVIR; RIBAVIRIN; CIRRHOSIS; EFFICACY; SAFETY; PARITAPREVIR/RITONAVIR; GRAZOPREVIR; COMBINATION	Background There are few real-life data on the potential drug-drug interactions (DDIs) between anti-HCV direct-acting antivirals (DAAs) and the comedications used. Aim To assess the potential DDIs of DAAs in HCV-infected outpatients, according to the severity of liver disease and comedication used in a prospective multicentric study. Methods Data from patients in 15 clinical centers who had started a DAA regimen and were receiving comedications during March 2015 to March 2016 were prospectively evaluated. The DDIs for each regimen and comedication were assigned according to HepC Drug Interactions (www.hep-druginteractions.org) Results Of the 449 patients evaluated, 86 had mild liver disease and 363 had moderate-to-severe disease. The use of a single comedication was more frequent among patients with mild liver disease (p = 0.03), whereas utilization of more than three drugs among those with moderate- to-severe disease (p = 0.05). Of the 142 comedications used in 86 patients with mild disease, 27 (20%) may require dose adjustment/closer monitoring, none was contraindicated. Of the 322 comedications used in 363 patients with moderate-to-severe liver disease, 82 (25%) were classified with potential DDIs that required only monitoring and dose adjustments; 10 (3%) were contraindicated in severe liver disease. In patients with mild liver disease 30% (26/86) used at least one drug with a potential DDI whereas of the 363 patients with moderate-to-severe liver disease, 161 (44%) were at risk for one or more DDI. Conclusions Based on these results, we can estimate that 30 - 44% of patients undergoing DAA and taking comedications are at risk of a clinically significant DDI. This data indicates the need for increased awareness of potential DDI during DAA therapy, especially in patients with moderate- to-severe liver disease. For several drugs, the recommendation related to the DDI changes from "dose adjustment/closer monitoring", in mild to moderate liver disease, to "the use is contraindicated" in severe liver disease.	[Kondili, Loreta A.; Weimer, Liliana Elena; Quaranta, Maria Giovanna; Vella, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Rome, Italy; [Gaeta, Giovanni Battista; Brancaccio, Giuseppina] Univ Naples 2, Infect Dis, Naples, Italy; [Ieluzzi, Donatella] Azienda Ospedaliera Univ Integrata Verona, Clin Unit Gastroenterol, Verona, Italy; [Zignego, Anna Linda; Monti, Monica] Univ Florence, Ctr Syst Manifestat Hepatitis Viruses MaSVE, Dept Expt & Clin Med, Florence, Italy; [Gori, Andrea; Soria, Alessandro] Univ Milano Bicocca, San Gerardo Hosp, Dept Infect Dis, Monza, Italy; [Raimondo, Giovanni; Filomia, Roberto] Univ Hosp Messina, Dept Internal Med, Messina, Italy; [Di Leo, Alfredo; Iannone, Andrea] Univ Bari, Dept Emergency & Organ Transplantat, Gastroenterol Sect, Bari, Italy; [Massari, Marco; Corsini, Romina] Azienda Osped Santa Maria Nuova Reggio Emilia, Infect Dis, Reggio Emilia, Italy; [Gulminetti, Roberto; Comini, Alberto Gatti] Univ Pavia, Infect Dis, Pavia, Italy; [Toniutto, Pierluigi; Dissegna, Denis] Univ Udine, Dept Surg & Gastroenterol Sci, Gastroenterol, Udine, Italy; [Russo, Francesco Paolo; Zanetto, Alberto] Univ Hosp Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Rumi, Maria Grazia; Brancaccio, Giuseppina] Univ Milan, Div Hepatol Osped San Giuseppe, Milan, Italy; [Danieli, Elena; Puoti, Massimo] Azienda Osped Osped Niguarda Ca Granda, Div Infect Dis, Milan, Italy; [Brunetto, Maurizia Rossana] Univ Hosp Pisa, Hepatol Unit, Pisa, Italy	Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Florence; San Gerardo Hospital; University of Milano-Bicocca; AOU Policlinico Gaetano Martino; Universita degli Studi di Bari Aldo Moro; IRCCS Arcispedale S. Maria Nuova; University of Pavia; University of Udine; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Kondili, LA (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Rome, Italy.	loreta.kondili@iss.it	Massari, Marco/AAA-9907-2021; Puoti, Massimo/AAA-6580-2020; VELLA, STEFANO/V-8440-2019; RUSSO, FRANCESCO PAOLO/AAO-4597-2020; Zignego, Anna Linda/AAL-8205-2021; Brunetto, Maurizia/AAU-2906-2020; KONDILI, LORETA/J-8784-2016; Kondili, Loreta/AAY-6360-2020; Gori, Andrea/AAC-6078-2022; VELLA, STEFANO/ABI-3368-2020; Vella, Stefano/GZM-0519-2022; Corsini, Romina/ABB-4619-2021; Filomia, Roberto/AIA-8302-2022; Gaeta, Giovanni/AAQ-4294-2021; Chessa, Luchino/H-7561-2012	Massari, Marco/0000-0002-0745-7519; VELLA, STEFANO/0000-0003-2347-5984; RUSSO, FRANCESCO PAOLO/0000-0003-4127-8941; Brunetto, Maurizia/0000-0001-8364-9152; KONDILI, LORETA/0000-0003-2656-224X; Di Leo, Alfredo/0000-0003-2026-1200; Puoti, Massimo/0000-0003-3278-7138; Brancaccio, Giuseppina/0000-0001-5643-0139; Filomia, Roberto/0000-0002-8335-6816; SORIA, Alessandro/0000-0002-4447-2574; Crisanti, Andrea/0000-0002-2406-4426; Zanetto, Alberto/0000-0002-6734-7178; Toniutto, Pierluigi/0000-0002-2566-3041; IANNONE, ANDREA/0000-0002-5468-9515; Chessa, Luchino/0000-0002-9474-0995; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Quaranta, Maria Giovanna/0000-0002-1077-1488	Italian Ministry of Health Grant "Research Project PITER" [RF-2010-2315839]	Italian Ministry of Health Grant "Research Project PITER"	The authors received no specific funding for this work. However, the PITER platform has been supported by Italian Ministry of Health Grant "Research Project PITER2010" RF-2010-2315839 to SV.	Badri PS, 2016, ANTIMICROB AGENTS CH, V60, P105, DOI 10.1128/AAC.01778-15; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Ferenci P, 2015, J HEPATOL, V63, P1015, DOI 10.1016/j.jhep.2015.06.003; Forns X, 2015, J HEPATOL, V63, P564, DOI 10.1016/j.jhep.2015.04.009; Gentilucci UV, 2015, WORLD J GASTROENTERO, V28, P7412; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Kondili LA, 2015, DIGEST LIVER DIS, V47, P741, DOI 10.1016/j.dld.2015.05.022; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Langness JA, 2016, NAT REV GASTRO HEPAT, V13, P194, DOI 10.1038/nrgastro.2016.24; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Majumdar A, 2016, ALIMENT PHARM THER, V43, P1276, DOI 10.1111/apt.13633; Menon RM, 2015, J HEPATOL, V63, P20, DOI 10.1016/j.jhep.2015.01.026; Patel N, 2015, INFECT DIS THER, V4, P67, DOI 10.1007/s40121-015-0058-x; Polepally AR, 2016, CLIN PHARMACOKINET, V55, P1003, DOI 10.1007/s40262-016-0373-8; Shiffman ML, 2016, AM J GASTROENTEROL, V111, P845, DOI 10.1038/ajg.2016.108; Siederdissen CHZ, 2016, CLIN INFECT DIS, V62, P561, DOI 10.1093/cid/civ973; Soriano V, 2015, EXPERT OPIN DRUG MET, V11, P333, DOI 10.1517/17425255.2015.998997; Tapper EB, 2016, HEPATOLOGY, V64, P1893, DOI 10.1002/hep.28782; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; Vermehren J, 2016, ALIMENT PHARM THER, V44, P856, DOI 10.1111/apt.13769; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	23	30	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172159	10.1371/journal.pone.0172159	http://dx.doi.org/10.1371/journal.pone.0172159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245248	Green Published, gold			2022-12-27	WOS:000395980200012
J	Sarid, O; Slonim-Nevo, V; Pereg, A; Friger, M; Sergienko, R; Schwartz, D; Greenberg, D; Shahar, I; Chernin, E; Vardi, H; Eidelman, L; Segal, A; Ben-Yakov, G; Gaspar, N; Munteanu, D; Rozental, A; Mushkalo, A; Dizengof, V; Abu-Freha, N; Fich, A; Odes, S				Sarid, O.; Slonim-Nevo, V.; Pereg, A.; Friger, M.; Sergienko, R.; Schwartz, D.; Greenberg, D.; Shahar, I.; Chernin, E.; Vardi, H.; Eidelman, L.; Segal, A.; Ben-Yakov, G.; Gaspar, N.; Munteanu, D.; Rozental, A.; Mushkalo, A.; Dizengof, V.; Abu-Freha, N.; Fich, A.; Odes, S.		Israeli IBD Res Nucleus IIRN	Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INITIAL DIAGNOSIS; BRIEF COPE; HEALTH; IBD; QUESTIONNAIRE; IMPACT; COHORT; WOMEN; SENSE	Objective To identify coping strategies and socio-demographics impacting satisfaction with life and quality of life in Crohn's disease (CD). Methods 402 patients completed the Patient Harvey-Bradshaw Index, Brief COPE Inventory, Satisfaction with Life Scale (SWLS), Short Inflammatory Bowel Disease Questionnaire (SIBDQ). We performed structural equation modeling (SEM) of mediators of quality of life and satisfaction with life. Results The cohort comprised: men 39.3%, women 60.1%; P-HBI 4.75 and 5.74 (p = 0.01). In inactive CD (P-HBI <= 4), both genders had SWLS score 23.8; men had SIBDQ score 57.4, women 52.6 (p = 0.001); women reported more use of emotion-focused, problem-focused and dysfunctional coping than men. In active CD, SWLS and SIBDQ scores were reduced, without gender differences; men and women used coping strategies equally. A SEM model (all patients) had a very good fit (X-2(6) = 6.68, p = 0.351, X-2 /df = 1.114, SRMR = 0.045, RMSEA = 0.023, CFI = 0.965). In direct paths, economic status impacted SWLS (beta = 0.39) and SIBDQ (beta = 0.12), number of children impacted SWLS (beta = 0.10), emotion-focused coping impacted SWLS (beta = 0.11), dysfunctional coping impacted SWLS (beta = -0.25). In an indirect path, economic status impacted dysfunctional coping (beta = -0.26), dysfunctional coping impacted SIBDQ (beta = -0.36). A model split by gender and disease activity showed that in active CD economic status impacted SIBDQ in men (beta = 0.43) more than women (beta = 0.26); emotional coping impacted SWLS in women (beta = 0.36) more than men (beta = 0.14). Conclusions Gender differences in coping and the impacts of economic status and emotion-focused coping vary with activity of CD. Psychological treatment in the clinic setting might improve satisfaction with life and quality of life in CD patients.	[Sarid, O.; Slonim-Nevo, V.; Pereg, A.; Shahar, I.] Ben Gurion Univ Negev, Spitzer Dept Social Work, Beer Sheva, Israel; [Friger, M.; Sergienko, R.; Chernin, E.; Vardi, H.] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, Beer Sheva, Israel; [Schwartz, D.; Eidelman, L.; Segal, A.; Ben-Yakov, G.; Gaspar, N.; Munteanu, D.; Rozental, A.; Mushkalo, A.; Dizengof, V.; Abu-Freha, N.] Soroka Med Ctr, Dept Gastroenterol & Hepatol, Beer Sheva, Israel; [Greenberg, D.] Ben Gurion Univ Negev, Dept Hlth Syst Management, Fac Hlth Sci, Beer Sheva, Israel; [Odes, S.] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Odes, S (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	odes@bgu.ac.il	Sergienko, Ruslan/D-3721-2016; Abu Freha, Naim/AAJ-9585-2020; Yakov, Gil Ben/P-9276-2019	Sergienko, Ruslan/0000-0001-9583-008X; Sarid, Orly/0000-0002-6967-8755; Abu Freha, Naim/0000-0002-4844-3308; Ben Yakov, Gil/0000-0002-6832-0903; Greenberg, Dan/0000-0002-6759-3985	Leona M. and Harry B. Helmsley Charitable Trust [2012PG-IBD006]	Leona M. and Harry B. Helmsley Charitable Trust	The Leona M. and Harry B. Helmsley Charitable Trust (2012PG-IBD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrubaiy L, 2015, J CROHNS COLITIS, V9, P284, DOI 10.1093/ecco-jcc/jjv002; Anaby D, 2010, SOC INDIC RES, V96, P267, DOI 10.1007/s11205-009-9476-z; Bernklev T, 2005, EUR J GASTROEN HEPAT, V17, P1037, DOI 10.1097/00042737-200510000-00006; Bernklev T, 2004, SCAND J GASTROENTERO, V39, P365, DOI 10.1080/00365520310008386; Bjorkman I, 2014, J ADV NURS, V70, P1334, DOI 10.1111/jan.12294; Blunch N, 2008, INTRO STRUCTURAL EQU, P186; Boyce CJ, 2013, SOC INDIC RES, V111, P287, DOI 10.1007/s11205-012-0006-z; Burisch J, 2014, J CROHNS COLITIS, V8, P1030, DOI 10.1016/j.crohns.2014.01.028; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Casellas F, 2005, INFLAMM BOWEL DIS, V11, P488, DOI 10.1097/01.MIB.0000159661.55028.56; Clench-Aas J, 2011, QUAL LIFE RES, V20, P1307, DOI 10.1007/s11136-011-9859-x; Cooper C, 2008, J NERV MENT DIS, V196, P838, DOI 10.1097/NMD.0b013e31818b504c; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; EAGLY AH, 1984, J PERS SOC PSYCHOL, V46, P735, DOI 10.1037/0022-3514.46.4.735; Evertsz' FB, 2013, J CLIN GASTROENTEROL, V47, P850, DOI 10.1097/MCG.0b013e31828b2196; HARVEY RF, 1980, LANCET, V1, P514; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huppertz-Hauss G, 2015, INFLAMM BOWEL DIS, V21, P337, DOI 10.1097/MIB.0000000000000272; Iglesias-Rey Marta, 2013, J Crohns Colitis, V7, pe219, DOI 10.1016/j.crohns.2012.09.017; Irvine EJ, 1996, AM J GASTROENTEROL, V91, P1571; Jowett SL, 2001, AM J GASTROENTEROL, V96, P2921; Knowles SR, 2013, J CROHNS COLITIS, V7, pE344, DOI 10.1016/j.crohns.2013.01.018; Knowles SR, 2011, INFLAMM BOWEL DIS, V17, P2551, DOI 10.1002/ibd.21650; Landau R, 2003, INT J SOCIOLOGY SOCI, V23, P64, DOI DOI 10.1108/01443330310790408; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lee H, 2014, J CROSS-CULT GERONTO, V29, P429, DOI 10.1007/s10823-014-9241-x; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Manski CF, 2003, J EUR ECON ASSOC, V1, P181, DOI 10.1162/154247603322256800; McCombie AM, 2013, J CROHNS COLITIS, V7, P89, DOI 10.1016/j.crohns.2012.05.021; Naliboff BD, 2012, AM J GASTROENTEROL, V107, P451, DOI 10.1038/ajg.2011.377; Nuttman-Shwartz O, 2009, J TRAUMA STRESS, V22, P667, DOI 10.1002/jts.20463; Sewell JL, 2013, INFLAMM BOWEL DIS, V19, P627, DOI 10.1002/ibd.22986; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vazquez C, 2015, J HAPPINESS STUD, V16, P135, DOI 10.1007/s10902-014-9501-z; Wagner CD, 2006, PSYCHO-ONCOLOGY, V15, P109, DOI 10.1002/pon.928; Wagtmans MJ, 2001, AM J GASTROENTEROL, V96, P1541; Williet N, 2014, CLIN GASTROENTEROL H, V12, P1246, DOI 10.1016/j.cgh.2014.02.016	39	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172779	10.1371/journal.pone.0172779	http://dx.doi.org/10.1371/journal.pone.0172779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245260	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200032
J	Christensen, KA; Davidson, WS				Christensen, Kris A.; Davidson, William S.			Autopolyploidy genome duplication preserves other ancient genome duplications in Atlantic salmon (Salmo salar)	PLOS ONE			English	Article							PROVIDES INSIGHTS; EVOLUTION; GENE; INHERITANCE; VERTEBRATES; CHROMOSOME; SEQUENCE; FISHES	Salmonids (e.g. Atlantic salmon, Pacific salmon, and trouts) have a long legacy of genome duplication. In addition to three ancient genome duplications that all teleosts are thought to share, salmonids have had one additional genome duplication. We explored a methodology for untangling these duplications from each other to better understand them in Atlantic salmon. In this methodology, homeologous regions (paralogous/duplicated genomic regions originating from a whole genome duplication) from the most recent genome duplication were assumed to have duplicated genes at greater density and have greater sequence similarity. This assumption was used to differentiate duplicated gene pairs in Atlantic salmon that are either from the most recent genome duplication or from earlier duplications. From a comparison with multiple vertebrate species, it is clear that Atlantic salmon have retained more duplicated genes from ancient genome duplications than other vertebrates-often at higher density in the genome and containing fewer synonymous mutations. It may be that polysomic inheritance is the mechanism responsible for maintaining ancient gene duplicates in salmonids. Polysomic inheritance (when multiple chromosomes pair during meiosis) is thought to be relatively common in salmonids compared to other vertebrate species. These findings illuminate how genome duplications may not only increase the number of duplicated genes, but may also be involved in the maintenance of them from previous genome duplications as well.	[Christensen, Kris A.; Davidson, William S.] Simon Fraser Univ, Mol Biol & Biochem, Burnaby, BC, Canada	Simon Fraser University	Christensen, KA (corresponding author), Simon Fraser Univ, Mol Biol & Biochem, Burnaby, BC, Canada.	kris.christensen@wsu.edu	Davidson, Willie/M-1992-2019	Christensen, Kristen/0000-0003-0021-0326				Allendorf F.W., 1984, P1; Allendorf FW, 2015, J HERED, V106, P217, DOI 10.1093/jhered/esv015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Christensen KA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-325; DAVISSON MT, 1973, GENETICS, V73, P645; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Krzywinski MI, 2009, GENOME RES; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lomsadze A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku557; Macqueen DJ, 2014, P BIOL SCI, P281; Meirmans PG, 2013, HEREDITY, V110, P131, DOI 10.1038/hdy.2012.80; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Pan YZ, 1999, GENOMICS, V59, P282, DOI 10.1006/geno.1999.5874; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	30	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0173053	10.1371/journal.pone.0173053	http://dx.doi.org/10.1371/journal.pone.0173053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241055	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400056
J	Gismondi, A; Di Marco, G; Canini, A				Gismondi, Angelo; Di Marco, Gabriele; Canini, Antonella			Detection of plant microRNAs in honey	PLOS ONE			English	Article							ABIOTIC STRESSES; SMALL RNAS; BIOGENESIS; GENE; NUTRIENTS; BARCODE; HEALTH; CELLS; L.	For the first time in the literature, our group has managed to demonstrate the existence of plant RNAs in honey samples. In particular, in our work, different RNA extraction procedures were performed in order to identify a purification method for nucleic acids from honey. Purity, stability and integrity of the RNA samples were evaluated by spectrophotometric, PCR and electrophoretic analyses. Among all honey RNAs, we specifically revealed the presence of both plastidial and nuclear plant transcripts: RuBisCO large subunit mRNA, maturase K messenger and 18S ribosomal RNA. Surprisingly, nine plant microRNAs (miR482b, miR156a, miR396c, miR171a, miR858, miR162a, miR159c, miR395a and miR2118a) were also detected and quantified by qPCR. In this context, a comparison between microRNA content in plant samples (i.e. flowers, nectars) and their derivative honeys was carried out. In addition, peculiar microRNA profiles were also identified in six different monofloral honeys. Finally, the same plant microRNAs were investigated in other plant food products: tea, cocoa and coffee. Since plant microRNAs introduced by diet have been recently recognized as being able to modulate the consumer's gene expression, our research suggests that honey's benefits for human health may be strongly correlated to the bioactivity of plant microRNAs contained in this matrix.	[Gismondi, Angelo; Di Marco, Gabriele; Canini, Antonella] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, Rome, Italy	University of Rome Tor Vergata	Canini, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, Rome, Italy.	canini@uniroma2.it		Canini, Antonella/0000-0003-1132-8899; DI MARCO, Gabriele/0000-0002-1369-4895				Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Alvarez-Suarez JM, 2013, CURR MED CHEM, V20, P621, DOI 10.2174/092986713804999358; Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Baloch IA, 2013, PURE APPL BIOL, V2, P83, DOI DOI 10.19045/BSPAB.2013.23002; Bogdanov S, 2008, J AM COLL NUTR, V27, P677, DOI 10.1080/07315724.2008.10719745; Chambers C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-87; Crozier A., 2008, PLANT SECONDARY META; Dhuruvasan K, 2011, VIRUS RES, V157, P180, DOI 10.1016/j.virusres.2010.10.011; Di Marco G, 2017, PLANT BIOSY IN PRESS; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gismondi A, 2016, J ARCHAEOL SCI, V69, P75, DOI 10.1016/j.jas.2016.04.014; Gismondi A, 2015, J GENET, V94, P519, DOI 10.1007/s12041-015-0557-2; Gismondi A, 2013, PLANT SYST EVOL, V299, P1859, DOI 10.1007/s00606-013-0841-7; Gismondi A, 2012, CR BIOL, V335, P472, DOI 10.1016/j.crvi.2012.05.004; Guarrera PM, 2013, J ETHNOPHARMACOL, V146, P659, DOI 10.1016/j.jep.2013.01.036; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Jiang MX, 2012, BIOESSAYS, V34, P280, DOI 10.1002/bies.201100181; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leninger, 1976, BIOCHEMISTRY-US; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ling Hui, 2011, Chin J Cancer, V30, P739, DOI 10.5732/cjc.011.10243; Luo XY, 2014, SCI HORTIC-AMSTERDAM, V165, P281, DOI 10.1016/j.scienta.2013.10.030; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Pirro S, 2016, MICRORNA MORINGA OLE, V11, DOI [10.1371/journal.pone.0149495, DOI 10.1371/JOURNAL.PONE.0149495]; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wildman R.E.C., 2016, HDB NUTRACEUTICALS F; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Yockteng R, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300070; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	43	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172981	10.1371/journal.pone.0172981	http://dx.doi.org/10.1371/journal.pone.0172981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241034	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400054
J	Schrantee, A; Tremoleda, JL; Wylezinska-Arridge, M; Bouet, V; Hesseling, P; Meerhoff, GF; de Bruin, KM; Koeleman, J; Freret, T; Boulouard, M; Desfosses, E; Galineau, L; Gozzi, A; Dauphin, F; Gsell, W; Booij, J; Lucassen, PJ; Reneman, L				Schrantee, Anouk; Tremoleda, Jordi L.; Wylezinska-Arridge, Marzena; Bouet, Valentine; Hesseling, Peter; Meerhoff, Gideon F.; de Bruin, Kora M.; Koeleman, Jan; Freret, Thomas; Boulouard, Michel; Desfosses, Emilie; Galineau, Laurent; Gozzi, Alessandro; Dauphin, Francois; Gsell, Willy; Booij, Jan; Lucassen, Paul J.; Reneman, Liesbeth			Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate	PLOS ONE			English	Article							AMPHETAMINE TREATMENT; RAT-BRAIN; TRANSPORTER; SENSITIZATION; NEUROTRANSMISSION; METHAMPHETAMINE; NEUROTOXICITY; DYSFUNCTION; ISOFLURANE; RECEPTORS	Dexamphetamine (AMPH) is a psychostimulant drug that is used both recreationally and as medication for attention deficit hyperactivity disorder. Preclinical studies have demonstrated that repeated exposure to AMPH can induce damage to nerve terminals of dopamine (DA) neurons. We here assessed the underlying neurobiological changes in the DA system following repeated AMPH exposure and pre-treated rats with AMPH or saline (4 times 5 mg/kg s.c., 2 hours apart), followed by a 1-week washout period. We then used pharmacological MRI (phMRI) with a methylphenidate (MPH) challenge, as a sensitive and non-invasive in-vivo measure of DAergic function. We subsequently validated the DA-ergic changes postmortem, using a.o. high-performance liquid chromatography (HPLC) and autoradiography. In the AMPH pre-treated group, we observed a significantly larger BOLD response to the MPH challenge, particularly in DA-ergic brain areas and their downstream projections. Subsequent autoradiography studies showed that AMPH pre-treatment significantly reduced DA transporter (DAT) density in the caudate-putamen (CPu) and nucleus accumbens, whereas HPLC analysis revealed increases in the DA metabolite homovanillic acid in the CPu. Our results suggest that AMPH pre-treatment alters DAergic responsivity, a change that can be detected with phMRI in rats. These phMRI changes likely reflect increased DA release together with reduced DAT binding. The ability to assess subtle synaptic changes using phMRI is promising for both preclinical studies of drug discovery, and for clinical studies where phMRI can be a useful tool to non-invasively investigate DA abnormalities, e.g. in neuropsychiatric disorders.	[Schrantee, Anouk; Koeleman, Jan; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Schrantee, Anouk; Tremoleda, Jordi L.; Wylezinska-Arridge, Marzena; Gsell, Willy] Imperial Coll London, Biol Imaging Ctr, London, England; [Tremoleda, Jordi L.] Blizard Inst, Ctr Trauma Sci, London, England; [Wylezinska-Arridge, Marzena] UCL Inst Neurol, Neuroradiol Acad Unit, Dept Brain Repair & Rehabil, Queen Sq, London, England; [Bouet, Valentine; Freret, Thomas; Boulouard, Michel; Dauphin, Francois] Univ Caen Basse Normandie, Normandie Univ, GMPc, EA 4259, Caen, France; [Hesseling, Peter; Meerhoff, Gideon F.; Lucassen, Paul J.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [de Bruin, Kora M.; Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Desfosses, Emilie; Galineau, Laurent] Univ Francois Rabelais Tours, UMR Inserm U930, Tours, France; [Gozzi, Alessandro] Ctr Neurosci & Cognit Syst UNITN, Funct Neuroimaging Lab, Ist Italiano Tecnol, Rovereto, Italy; [Gsell, Willy] Katholieke Univ Leuven, Biomed MRI, Dept Imaging & Pathol, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of London; University College London; Universite de Caen Normandie; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Italiano di Tecnologia - IIT; KU Leuven	Schrantee, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands.; Schrantee, A (corresponding author), Imperial Coll London, Biol Imaging Ctr, London, England.	a.g.schrantee@amc.uva.nl	Booij, Jan/AAD-7159-2019; freret, thomas/AAA-2491-2019; freret, thomas/B-2068-2012; Dauphin, Francois/B-1642-2012; BOUET, Valentine/N-9593-2015; Gozzi, Alessandro/K-6342-2016; Gsell, Willy/AAG-3198-2020; Lucassen, Paul/ABA-3113-2020; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; freret, thomas/0000-0002-4446-4451; Gozzi, Alessandro/0000-0002-5731-4137; Lucassen, Paul/0000-0001-9708-9133; Gsell, Willy/0000-0001-7334-6107; Michel, Boulouard/0000-0003-3825-8659; Schrantee, Anouk/0000-0002-4035-4845; Reneman, Liesbeth/0000-0002-5912-9971	EU [40-41800-98-026]	EU(European Commission)	This study was supported by a EU grant to LR, PJL, WG and FD (ERA-NET PrioMedChild, a joined call of Priority Medicines for Children, grant no. 40-41800-98-026). The funding source had no role in the design and conduct of the study; collection, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Advokat Claire, 2007, J Atten Disord, V11, P8, DOI 10.1177/1087054706295605; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Belcher AM, 2005, NEUROPSYCHOPHARMACOL, V30, P2026, DOI 10.1038/sj.npp.1300771; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Bredeloux P, 2007, BRIT J PHARMACOL, V150, P711, DOI 10.1038/sj.bjp.0707151; Brodnik ZD, 2015, NEUROSCI LETT, V606, P129, DOI 10.1016/j.neulet.2015.08.046; Canese R, 2009, PSYCHOPHARMACOLOGY, V203, P143, DOI 10.1007/s00213-008-1379-1; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Chen YCI, 1997, MAGNET RESON MED, V38, P389, DOI 10.1002/mrm.1910380306; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Crunelle CL, 2009, ADDICT BIOL, V14, P500, DOI 10.1111/j.1369-1600.2009.00168.x; Easton N, 2009, NEUROPHARMACOLOGY, V57, P653, DOI 10.1016/j.neuropharm.2009.08.018; Fumagalli F, 1998, J NEUROSCI, V18, P4861; GIBB JW, 1994, AMPHETAMINE ITS ANAL, P269; Gozzi A, 2008, MAGN RESON IMAGING, V26, P999, DOI 10.1016/j.mri.2008.01.012; Gozzi A, 2008, NEUROPSYCHOPHARMACOL, V33, P1690, DOI 10.1038/sj.npp.1301547; Gozzi A, 2011, NEUROPSYCHOPHARMACOL, V36, P2431, DOI 10.1038/npp.2011.129; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Hebert MA, 1999, J PHARMACOL EXP THER, V288, P1334; Hewitt KN, 2005, PSYCHOPHARMACOLOGY, V180, P716, DOI 10.1007/s00213-005-2272-9; Huotari M, 2004, PSYCHOPHARMACOLOGY, V172, P1, DOI 10.1007/s00213-003-1627-3; Jenkins BG, 2004, J NEUROSCI, V24, P9553, DOI 10.1523/JNEUROSCI.1558-04.2004; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Klomp A, 2011, NEUROIMAGE; Knol RJJ, 2008, J NEUROSCI METH, V168, P341, DOI 10.1016/j.jneumeth.2007.10.028; McCann UD, 2004, NEUROSCI BIOBEHAV R, V27, P821, DOI 10.1016/j.neubiorev.2003.11.003; McKie S, 2005, PSYCHOPHARMACOLOGY, V180, P680, DOI 10.1007/s00213-005-2270-y; Narendran R, 2008, SYNAPSE, V62, P851, DOI 10.1002/syn.20566; Paxinos G, 1986, RAT BRAIN STEREOTACT; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Ren JQ, 2009, SYNAPSE, V63, P764, DOI 10.1002/syn.20659; Ricaurte GA, 2005, J PHARMACOL EXP THER, V315, P91, DOI 10.1124/jpet.105.087916; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; SAVASTA M, 1986, BRAIN RES, V375, P291, DOI 10.1016/0006-8993(86)90749-3; Schouw MLJ, 2013, EUR NEUROPSYCHOPHARM, V23, P1491, DOI 10.1016/j.euroneuro.2013.01.005; Schrantee A, 2015, NEUROPSYCHOPHARMACOL, V40, P1172, DOI 10.1038/npp.2014.301; Schwarz AJ, 2007, MAGN RESON IMAGING, V25, P811, DOI 10.1016/j.mri.2007.02.017; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Squillace M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.69; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P4, DOI 10.4088/JCP.v64n0101; Strupp JP, 1996, STIMULATE GUI BASED, pS607; Votaw J, 2003, ANESTHESIOLOGY, V98, P404, DOI 10.1097/00000542-200302000-00021; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172776	10.1371/journal.pone.0172776	http://dx.doi.org/10.1371/journal.pone.0172776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241065	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400041
J	Smith, SJ; Wang, JC; Gupta, VA; Dowling, JJ				Smith, Sarah J.; Wang, Jeffrey C.; Gupta, Vandana A.; Dowling, James J.			A novel early onset phenotype in a zebrafish model of merosin deficient congenital muscular dystrophy	PLOS ONE			English	Article							MUSCLE; PROTEIN	Merosin deficient congenital muscular dystrophy (MDC1A) is a severe neuromuscular disorder with onset in infancy that is associated with severe morbidities (particularly wheelchair dependence) and early mortality. It is caused by recessive mutations in the LAMA2 gene that encodes a subunit of the extracellular matrix protein laminin 211. At present, there are no treatments for this disabling disease. The zebrafish has emerged as a powerful model system for the identification of novel therapies. However, drug discovery in the zebrafish is largely dependent on the identification of phenotypes suitable for chemical screening. Our goal in this study was to elucidate novel, early onset abnormalities in the candyfloss (caf) zebrafish, a model of MDC1A. We uncovered and characterize abnormalities in spontaneous coiling, the earliest motor movement in the zebrafish, as a fully penetrant change specific to caf mutants that is ideal for future drug testing.	[Smith, Sarah J.; Dowling, James J.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Smith, Sarah J.; Dowling, James J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wang, Jeffrey C.; Gupta, Vandana A.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA USA; [Dowling, James J.] Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Dowling, James J.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Dowling, JJ (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.; Dowling, JJ (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Dowling, JJ (corresponding author), Hosp Sick Children, Div Neurol, Toronto, ON, Canada.; Dowling, JJ (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada.	james.dowling@sickkids.ca		Gupta, Vandana/0000-0002-4057-8451	CureCMD; Centre for Brain and Mental Health at Hospital for Sick Children; National Institute of Arthritis and Musculoskeletal [K01 AR062601]; Skin Diseases of National Institute of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062601] Funding Source: NIH RePORTER	CureCMD; Centre for Brain and Mental Health at Hospital for Sick Children; National Institute of Arthritis and Musculoskeletal(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Skin Diseases of National Institute of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by a grant from CureCMD, as well as through funds from the Centre for Brain and Mental Health at Hospital for Sick Children. VAG is supported by K01 AR062601 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of National Institute of Health.; We thank Ann Davidson for technical assistance with this project. This work was funded in part by a grant from CureCMD, as well as through funds from the Centre for Brain and Mental Health at Hospital for Sick Children. VAG is supported by K01 AR062601 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of National Institute of Health.	Allamand V, 2002, EUR J HUM GENET, V10, P91, DOI 10.1038/sj.ejhg.5200743; Bassett D., 2010, P AUSTR PHYS PHARM S, P537; Berger J, 2012, BIOCHEM BIOPH RES CO, V423, P785, DOI 10.1016/j.bbrc.2012.06.040; Durbeej M, 2015, CURR TOP MEMBR, V76, P31, DOI 10.1016/bs.ctm.2015.05.002; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Gupta V., 2012, PLOS ONE, V7; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; He ZW, 2013, EXP THER MED, V6, P1233, DOI 10.3892/etm.2013.1271; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; Mehuron T, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-14; Naganawa Y, 2011, DEV BIOL, V355, P194, DOI 10.1016/j.ydbio.2011.04.027; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Waugh TA, 2014, HUM MOL GENET, V23, P4651, DOI 10.1093/hmg/ddu185; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172648	10.1371/journal.pone.0172648	http://dx.doi.org/10.1371/journal.pone.0172648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241031	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400029
J	Sadowska, J; Gebczynski, AK; Konarzewski, M				Sadowska, Julita; Gebczynski, Andrzej K.; Konarzewski, Marek			Metabolic risk factors in mice divergently selected for BMR fed high fat and high carb diets	PLOS ONE			English	Article							SPONTANEOUS PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; FOOD-CONSUMPTION; OXIDATIVE STRESS; HUMAN OBESITY; EXERCISE; MUSCLE; EVOLUTION; RESPONSES; ORIGINS	Factors affecting contribution of spontaneous physical activity (SPA; activity associated with everyday tasks) to energy balance of humans are not well understood, as it is not clear whether low activity is related to dietary habits, precedes obesity or is a result of thereof. In particular, human studies on SPA and basal metabolic rates (BMR, accounting for > 50% of human energy budget) and their associations with diet composition, metabolic thrift and obesity are equivocal. To clarify these ambiguities we used a unique animal model D mice selected for divergent BMR rates (the H-BMR and L-BMR line type) presenting a 50% between-line type difference in the primary selected trait. Males of each line type were divided into three groups and fed either a high fat, high carb or a control diet. They then spent 4 months in individual cages under conditions emulating human "sedentary lifestyle", with SPA followed every month and measurements of metabolic risk indicators (body fat mass %, blood lipid profile, fasting blood glucose levels and oxidative damage in the livers, kidneys and hearts) taken at the end of study. Mice with genetically determined high BMR assimilated more energy and had higher SPA irrespective of type of diet. H-BMR individuals were characterized by lower dry body fat mass %, better lipid profile and lower fasting blood glucose levels, but higher oxidative damage in the livers and hearts. Genetically determined high BMR may be a protective factor against diet-induced obesity and most of the metabolic syndrome indicators. Elevated spontaneous activity is correlated with high BMR, and constitutes an important factor affecting individual capability to sustain energy balance even under energy dense diets.	[Sadowska, Julita; Gebczynski, Andrzej K.; Konarzewski, Marek] Univ Bialystok, Inst Biol, Bialystok, Poland	University of Bialystok	Sadowska, J (corresponding author), Univ Bialystok, Inst Biol, Bialystok, Poland.	julita.sadowska@uwb.edu.pl	Konarzewski, Marek/AAR-9952-2020	Konarzewski, Marek/0000-0001-7428-6521; Sadowska, Julita/0000-0003-1457-5254; Gebczynski, Andrzej/0000-0003-1711-2175	National Science Centre of Poland [2011/01/N/NZ8/02009]; Foundation for Polish Science (FNP) START stipend	National Science Centre of Poland(National Science Centre, Poland); Foundation for Polish Science (FNP) START stipend	This study was funded by the National Science Centre of Poland (grant no. 2011/01/N/NZ8/02009) grant awarded to JS.JS is a recipient of the Foundation for Polish Science (FNP) START stipend.; This study was funded by the National Science Centre of Poland (grant no. 2011/01/N/NZ8/02009). Special thanks to M. Lewoc, S. Plonowski and B. Lewonczuk for help with animal maintenance. We are grateful to Max Plank Institute for Ornithology in Radolfzell Germany for the calorimetry equipment. JS is supported by the Foundation for Polish Science (FNP).	Astrup A, 1996, AM J CLIN NUTR, V63, P879, DOI 10.1093/ajcn/63.6.879; Astrup A, 1999, AM J CLIN NUTR, V69, P1117; Blundell JE, 2012, DIS MODEL MECH, V5, P608, DOI 10.1242/dmm.009837; Bouchard C, 2007, INT J OBESITY, V31, P1337, DOI 10.1038/sj.ijo.0803610; Brzek P, 2016, PHYSL BEHAV; Brzek P, 2012, J EXP BIOL, V215, P3191, DOI 10.1242/jeb.065318; Bunger L, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P131, DOI 10.1142/9781860947162_0007; Buscemi S, 2005, INT J OBESITY, V29, P287, DOI 10.1038/sj.ijo.0802888; Copes LE, 2015, PHYSIOL BEHAV, V149, P86, DOI 10.1016/j.physbeh.2015.05.025; Coyle EF, 2000, AM J CLIN NUTR, V72, p512S, DOI 10.1093/ajcn/72.2.512S; Even PC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00096; Ferguson M, 2008, EXP GERONTOL, V43, P757, DOI 10.1016/j.exger.2008.04.016; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; FERRARO R, 1992, J CLIN INVEST, V90, P780, DOI 10.1172/JCI115951; Gavini CK, 2014, AM J PHYSIOL-ENDOC M, V306, pE635, DOI 10.1152/ajpendo.00555.2013; Gebczynski AK, 2009, J EVOLUTION BIOL, V22, P1212, DOI 10.1111/j.1420-9101.2009.01734.x; Gebczynski AK, 2006, ACTA THERIOL, V51, P345, DOI 10.1007/BF03195181; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Jung AP, 2010, MED SCI SPORT EXER, V42, P1826, DOI 10.1249/MSS.0b013e3181daf5e8; Kannan U, 2014, J CLIN DIAGN RES, V8, pBC8, DOI 10.7860/JCDR/2014/8519.4611; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; Kunz I, 2000, HYPERTENSION, V36, P26, DOI 10.1161/01.HYP.36.1.26; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lev-Ran A, 2001, DIABETES-METAB RES, V17, P347, DOI 10.1002/dmrr.230; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meek TH, 2010, INT J OBESITY, V34, P960, DOI 10.1038/ijo.2010.25; Melanson EL, 2009, EXERC SPORT SCI REV, V37, P93, DOI 10.1097/JES.0b013e31819c2f0b; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Rendeiro C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09589; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; SADOWSKA J, 2015, PHYSL BIOCH ZOOL, V88; Sadowska J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2576; Saris WHM, 2004, INT J OBESITY, V28, P759, DOI 10.1038/sj.ijo.0802631; Sawicka-Kapusta K, 1975, METHODS ECOLOGICAL E, P288; Sellayah D, 2014, ENDOCRINOLOGY, V155, P1573, DOI 10.1210/en.2013-2103; Speakman JR, 2013, ANNU REV NUTR, V33, P289, DOI 10.1146/annurev-nutr-071811-150711; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Speakman JR, 2006, APPETITE BODY WEIGHT; Swallow JG, 2001, J COMP PHYSIOL B, V171, P651, DOI 10.1007/s003600100216; Teske JA, 2012, INT J OBESITY, V36, P603, DOI 10.1038/ijo.2011.108; Thorburn A W, 2000, Obes Rev, V1, P87, DOI 10.1046/j.1467-789x.2000.00018.x; Vaanholt LM, 2008, INT J OBESITY, V32, P1566, DOI 10.1038/ijo.2008.136; Vaanholt LM, 2007, J EXP BIOL, V210, P2013, DOI 10.1242/jeb.001974; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; Wells JCK, 2012, DIS MODEL MECH, V5, P595, DOI 10.1242/dmm.009613; Weyer C, 2001, INT J OBESITY, V25, P593, DOI 10.1038/sj.ijo.0801610; Yavuzer H, 2016, HYPETENS RES, P1; Youngson NA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0337; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zombeck JA, 2011, BEHAV GENET, V41, P571, DOI 10.1007/s10519-010-9425-2; [No title captured]	58	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172892	10.1371/journal.pone.0172892	http://dx.doi.org/10.1371/journal.pone.0172892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235091	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200163
J	Simon, M; Mesmar, F; Helguero, L; Williams, C				Simon, Marisa; Mesmar, Fahmi; Helguero, Luisa; Williams, Cecilia			Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant	PLOS ONE			English	Article							ZIPPER KINASE MELK; MEDIATES SURVIVAL; MUTANT P53; STEM-CELLS; RESISTANCE; EXPRESSION; GROWTH; FEATURES; THERAPY	Triple-negative breast cancer (TNBC) is an aggressive, highly recurrent breast cancer subtype, affecting approximately one-fifth of all breast cancer patients. Subpopulations of treatment- resistant cancer stem cells within the tumors are considered to contribute to disease recurrence. A potential druggable target for such cells is the maternal embryonic leucinezipper kinase (MELK). MELK expression is upregulated in mammary stem cells and in undifferentiated cancers, where it correlates with poor prognosis and potentially mediates treatment resistance. Several MELK inhibitors have been developed, of which one, OTSSP167, is currently in clinical trials. In order to better understand how MELK and its inhibition influence TNBC, we verified its anti-proliferative and apoptotic effects in claudin-low TNBC cell lines MDA-MB-231 and SUM-159 using MTS assays and/or trypan blue viability assays together with analysis of PARP cleavage. Then, using microarrays, we explored which genes were affected by OTSSP167. We demonstrate that different sets of genes are regulated in MDA-MB-231 and SUM-159, but in both cell lines genes involved in cell cycle, mitosis and protein metabolism and folding were regulated. We identified p53 (TP53) as a potential upstream regulator of the regulated genes. Using western blot we found that OTSSP167 downregulates mutant p53 in all tested TNBC cell lines (MDA-MB-231, SUM159, and BT-549), but upregulates wild-type p53 in the luminal A subtype MCF-7 cell line. We propose that OTSSP167 might have context-dependent or off-target effects, but that one consistent mechanism of action could involve the destabilization of mutant p53.	[Simon, Marisa; Mesmar, Fahmi; Williams, Cecilia] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA; [Helguero, Luisa] Univ Aveiro, Inst Res Biomed, Dept Biosci, Aveiro, Portugal; [Williams, Cecilia] KTH Royal Inst Technol, Sch Biotechnol, Div Prote, SciLifeLab, Solna, Sweden; [Williams, Cecilia] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	University of Houston System; University of Houston; Universidade de Aveiro; Royal Institute of Technology; SciLifeLab; Karolinska Institutet	Williams, C (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.; Williams, C (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Div Prote, SciLifeLab, Solna, Sweden.; Williams, C (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	cecilia.williams@scilifelab.se	Helguero, Luisa/B-1221-2013; Williams, Cecilia/A-6677-2009; Cruz e Silva, Odete/AAH-5595-2020	Helguero, Luisa/0000-0001-8237-2390; Williams, Cecilia/0000-0002-0602-2062; 	Marie Curie Actions FP7-PEOPLE-COFUND via Swedish Governmental Agency for Innovation Systems (VINNOVA) program Mobility for Growth [291 795]; Swedish Cancer Society [CAN 2015/591]; faculty start-up funds; Summer Undergraduate Research Fellowship (SURF); Provost's Undergraduate Research Scholarship (PURS) from University of Houston;  [UID/B1M/04501/2013]	Marie Curie Actions FP7-PEOPLE-COFUND via Swedish Governmental Agency for Innovation Systems (VINNOVA) program Mobility for Growth; Swedish Cancer Society(Swedish Cancer Society); faculty start-up funds; Summer Undergraduate Research Fellowship (SURF); Provost's Undergraduate Research Scholarship (PURS) from University of Houston; 	This work was supported by Marie Curie Actions FP7-PEOPLE-2011-COFUND [GROWTH 291 795] via the Swedish Governmental Agency for Innovation Systems (VINNOVA) program Mobility for Growth (to C.W.), Swedish Cancer Society [CAN 2015/591] (to C.W.), and faculty start-up funds (to C.W.), Summer Undergraduate Research Fellowship (SURF, to M.S.) and Provost's Undergraduate Research Scholarship (PURS, to M.S.) from the University of Houston. Support for LAH through UID/B1M/04501/2013 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Marie Curie Actions FP7-PEOPLE-2011-COFUND [GROWTH 291 795] via the Swedish Governmental Agency for Innovation Systems (VINNOVA) program Mobility for Growth (to C.W.), Swedish Cancer Society [CAN 2015/591] (to C.W.), and faculty start-up funds (to C.W.), Summer Undergraduate Research Fellowship (SURF, to M.S.) and Provost's Undergraduate Research Scholarship (PURS, to M.S.) from the University of Houston. Support for LAH through UID/BIM/04501/2013 is acknowledged. The content is solely the responsibility of the authors and does not represent the official views of the funding agencies.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Bae YH, 2014, GENES GENOM, V36, P171, DOI 10.1007/s13258-013-0154-9; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Bergamaschi A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0436-4; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Braicu C, 2015, PLOS ONE, V10; Chen L, 2015, MED IMAGE ANAL, V23, P1, DOI 10.1016/j.media.2015.03.004; Cho YS, 2014, BIOCHEM BIOPH RES CO, V447, P7, DOI 10.1016/j.bbrc.2014.03.034; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Chung S, 2016, ONCOTARGET, V7, P18171, DOI 10.18632/oncotarget.7685; Chung SY, 2012, ONCOTARGET, V3, P1629; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Edvardsson K, 2011, MOL ENDOCRINOL, V25, P969, DOI 10.1210/me.2010-0452; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; He WX, 2015, EXP THER MED, V10, P1413, DOI 10.3892/etm.2015.2679; Hurvitz S, 2015, CURRENT OPINION OBST, V28, P1; Inoue H, 2016, ONCOTARGET, V7, P13621, DOI 10.18632/oncotarget.7297; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Ji W, 2016, PLOS ONE, V11, P1; Jiang JH, 2012, ONCOL REP, V28, P1139, DOI 10.3892/or.2012.1936; Jiang PF, 2013, INT J MOL SCI, V14, P21551, DOI 10.3390/ijms141121551; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung SH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-382; Kato T, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7755; Kig C, 2013, J BIOL CHEM, V288, P24200, DOI 10.1074/jbc.M113.471433; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Koleck TA, 2016, BREAST CANCER-TARGET, V8, P29, DOI 10.2147/BCTT.S88434; Kwok HF, 2015, AM J CANCER RES, V5, P52; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li HT, 2015, ONCOL LETT, V9, P149, DOI 10.3892/ol.2014.2618; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Luo J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2932; Midland AA, 2012, CELL RES, V22, P620, DOI 10.1038/cr.2012.25; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Moquet-Torcy G, 2014, NUCLEIC ACIDS RES, V42, P11011, DOI 10.1093/nar/gku814; Nakagawa M, 2011, ANTICANCER RES, V31, P2389; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Ovcaricek T, 2011, RADIOL ONCOL, V45, P46, DOI 10.2478/v10019-010-0054-4; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Shetzer Y, 2014, CARCINOGENESIS, V35, P1196, DOI 10.1093/carcin/bgu073; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; Tront JS, 2010, CANCER RES, V70, P9671, DOI 10.1158/0008-5472.CAN-10-2177; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang YB, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/830869; Williams C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2256; Yang J, 2015, ONCOTARGET, V6; Yu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084124, 10.1371/journal.pone.0061967]; Zhang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-664	61	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172832	10.1371/journal.pone.0172832	http://dx.doi.org/10.1371/journal.pone.0172832			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235006	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200149
J	Kowitt, SD; Noar, SM; Ranney, LM; Goldstein, AO				Kowitt, Sarah D.; Noar, Seth M.; Ranney, Leah M.; Goldstein, Adam O.			Public attitudes toward larger cigarette pack warnings: Results from a nationally representative US sample	PLOS ONE			English	Article							SMOKING STATUS; TOBACCO; LABELS; IMPACT; INTENTIONS; SUPPORT; TAX	A large body of evidence supports the effectiveness of larger health warnings on cigarette packages. However, there is limited research examining attitudes toward such warning labels, which has potential implications for implementation of larger warning labels. The purpose of the current study was to examine attitudes toward larger warning sizes on cigarette packages and examine variables associated with more favorable attitudes. In a nationally representative survey of U.S. adults (N = 5,014), participants were randomized to different warning size conditions, assessing attitude toward "a health warning that covered (25, 50, 75)% of a cigarette pack." SAS logistic regression survey procedures were used to account for the complex survey design and sampling weights. Across experimental groups, nearly three-quarters (72%) of adults had attitudes supportive of larger warning labels on cigarette packs. Among the full sample and smokers only (N = 1,511), most adults had favorable attitudes toward labels that covered 25% (78.2% and 75.2%, respectively), 50% (70% and 58.4%, respectively), and 75% (67.9% and 61%, respectively) of a cigarette pack. Young adults, females, racial/ethnic minorities, and non-smokers were more likely to have favorable attitudes toward larger warning sizes. Among smokers only, females and those with higher quit intentions held more favorable attitudes toward larger warning sizes. Widespread support exists for larger warning labels on cigarette packages among U.S. adults, including among smokers. Our findings support the implementation of larger health warnings on cigarette packs in the U.S. as required by the 2009 Tobacco Control Act.	[Kowitt, Sarah D.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27516 USA; [Noar, Seth M.] Univ North Carolina Chapel Hill, Sch Media & Journalism, Chapel Hill, NC 27516 USA; [Noar, Seth M.; Goldstein, Adam O.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27516 USA; [Ranney, Leah M.; Goldstein, Adam O.] Univ North Carolina Chapel Hill, Dept Family Med, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kowitt, SD (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27516 USA.	kowitt@email.unc.edu	Noar, Seth/AAT-9402-2021		National Cancer Institute [P50 CA180907]; FDA Center for Tobacco Products (CTP); NATIONAL CANCER INSTITUTE [P50CA180907] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grant number P50 CA180907 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P542; [Anonymous], 2010, FED REGISTER, V75; [Anonymous], 2009, QUANTITATIVE STUDY O; Behavioral Risk Factor Surveillance System, 2014, 2013 SUMMARY DATA QU; Blake KD, 2010, NICOTINE TOB RES, V12, P117, DOI 10.1093/ntr/ntp184; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V280, P1279, DOI 10.1001/jama.280.14.1279; Bondy SJ, 2010, NICOTINE TOB RES, V12, P43, DOI 10.1093/ntr/ntp171; Bonnie RJ, 2007, ENDING THE TOBACCO P; Boynton MH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3151-5; Brewer NT, 2016, JAMA INTERN MED, V176, P905, DOI 10.1001/jamainternmed.2016.2621; Campaign for Tobacco Free Kids, 2016, TOBACCO HEALTH WARNI; Canadian Cancer Society, 2014, CIGARETTE PACKAGE HE; Centers for Disease Control and Prevention, 2013, BEHAVIORAL RISK FACT; Dearing JW, 1996, AGENDA SETTING; Durkin S, 2015, TOB CONTROL, V24, pII26, DOI 10.1136/tobaccocontrol-2014-052058; Flynn BS, 1998, PREV MED, V27, P157, DOI 10.1006/pmed.1998.0308; Food and Drug Administration, 2016, FED REGISTER, V79, P1; Food and Drug Administration HHS, 2011, Fed Regist, V76, P36628; Gravely S, 2016, TOB CONTROL, V25, P89, DOI 10.1136/tobaccocontrol-2014-051742; Hall MG, 2016, ANN BEHAV MED; Hammond D, 2003, TOB CONTROL, V12, P391, DOI 10.1136/tc.12.4.391; Hammond D, 2016, TOBACCO LABELLING AN; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Heiser PF, 1997, AM J PUBLIC HEALTH, V87, P968, DOI 10.2105/AJPH.87.6.968; Huang Jidong, 2014, Tob Control, V23 Suppl 1, pi7, DOI 10.1136/tobaccocontrol-2013-051170; Jamal A., 2014, MMWR-MORBID MORTAL W, V63, P1108; Kamyab K, 2015, AM J PREV MED, V48, P89, DOI 10.1016/j.amepre.2014.07.032; Levy D.T., 2016, TOB CONTROL; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moreland-Russell S, 2016, TOB CONTROL, V25, pi6, DOI 10.1136/tobaccocontrol-2016-053089; Noar SM, 2016, SOC SCI MED, V164, P118, DOI 10.1016/j.socscimed.2016.06.011; Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978; Noar SM, JOURNALISM AND MASS; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Pearson Jennifer L, 2012, Am J Public Health, V102, pe107, DOI 10.2105/AJPH.2012.300804; Rose SW, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302751; SAS Institute Inc, SAS VERSION 9 3; U. S. Department of Health and Human Services, 2014, THE HEALTH CONSEQUEN; Unger JB, 1999, HEALTH EDUC RES, V14, P751, DOI 10.1093/her/14.6.751; Wakefield M, 2015, TOB CONTROL, V24, pII17, DOI 10.1136/tobaccocontrol-2014-052050; White V, 2015, TOB CONTROL, V24, pII42, DOI 10.1136/tobaccocontrol-2014-052084; Winickoff JP, 2011, AM J PUBLIC HEALTH, V101, P1234, DOI 10.2105/AJPH.2011.300146; World Health Organization, 2008, GUIDELINES FOR IMPLE	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171496	10.1371/journal.pone.0171496	http://dx.doi.org/10.1371/journal.pone.0171496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253257	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300006
J	Liu, B; Wang, CG; Liu, DX; He, N; Deng, X				Liu, Bing; Wang, Chaogang; Liu, Danxia; He, Ning; Deng, Xu			Hg tolerance and biouptake of an isolated pigmentation yeast Rhodotorula mucilaginosa	PLOS ONE			English	Article							BACTERIA HIGHLY RESISTANT; SACCHAROMYCES-CEREVISIAE; METAL TOLERANCE; MERCURY; BIOSORPTION; COPPER; BIOACCUMULATION; WATER; BIOREMEDIATION; REMOVAL	A pigmented yeast R1 with strong tolerance to Hg2+ was isolated. Phylogenetic identification based on the analysis of 26S rDNA and ITS revealed R1 is a Rhodotorula mucilaginosa species. R1 was able to grow in the presence of 80 mg/L Hg2+, but the lag phase was much prolonged compared to its growth in the absence of Hg2+. The maximum Hg2+ binding capacity of R1 was 69.9 mg/g, and dead cells could bind 15% more Hg2+ than living cells. Presence of organic substances drastically reduced bioavailability of Hg2+ and subsequently decreased Hg2+ removal ratio from aqueous solution, but this adverse effect could be remarkably alleviated by the simultaneous process of cell propagation and Hg2+ biouptake with actively growing R1. Furthermore, among the functional groups involved in Hg2+ binding, carboxyl group contributed the most, followed by amino & hydroxyl group and phosphate group. XPS analysis disclosed the mercury species bound on yeast cells was HgCl2 rather than HgO or Hg-0.	[Liu, Bing; Wang, Chaogang; Liu, Danxia; Deng, Xu] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China; [He, Ning] Xiamen Univ, Dept Chem Biochem Engn, Xiamen, Peoples R China; [Liu, Bing] Shenzhen Inst Informat Technol, Shenzhen, Peoples R China	Shenzhen University; Xiamen University; Shenzhen Institute of Information Technology	Deng, X (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China.; He, N (corresponding author), Xiamen Univ, Dept Chem Biochem Engn, Xiamen, Peoples R China.	hening@xmu.edu.cn; dengxu@szu.edu.cn		Wang, Chaogang/0000-0002-2207-3732	National Natural Science Foundation of China [51578339]; Shenzhen R$D Fund [JCYJ20140418193546101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen R$D Fund	This work was supported by the National Natural Science Foundation of China (No. 51578339) (https://www.nsfc.gov.on/) to XD; Shenzhen R$D Fund (JCYJ20140418193546101), (http://www.szsti.gov.cn/) to XD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatif A, 2016, J BASIC MICROBIOL; Abdulaziz A, 2016, J BASIC MICROB, V56, P845, DOI 10.1002/jobm.201500693; Balsalobre L, 2003, J BASIC MICROB, V43, P185, DOI 10.1002/jobm.200390021; Bilal M, 2013, J HAZARD MATER, V263, P322, DOI 10.1016/j.jhazmat.2013.07.071; Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005; Dash HR, 2014, ENVIRON SCI POLLUT R, V21, P2642, DOI 10.1007/s11356-013-2206-8; De J, 2007, ECOL INDIC, V7, P511, DOI 10.1016/j.ecolind.2006.05.002; Debelius B, 2009, ECOTOX ENVIRON SAFE, V72, P1503, DOI 10.1016/j.ecoenv.2009.04.006; Deng X, 2013, BIORESOURCE TECHNOL, V130, P69, DOI 10.1016/j.biortech.2012.11.133; Deng X, 2012, BIORESOURCE TECHNOL, V121, P342, DOI 10.1016/j.biortech.2012.07.017; Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8; Diffels JF, 2006, BIOCHIMIE, V88, P1639, DOI 10.1016/j.biochi.2006.08.008; Ghosh SK, 2004, B ENVIRON CONTAM TOX, V72, P21, DOI 10.1007/s00128-003-0236-5; Hai RT, 2013, ASIAN J CHEM, V25, P6528, DOI 10.14233/ajchem.2013.14339; Hesham AEL, 2012, ENVIRON SCI POLLUT R, V19, P3568, DOI 10.1007/s11356-012-0919-8; Hutson ND, 2007, ENVIRON SCI TECHNOL, V41, P1747, DOI 10.1021/es062121q; HYLAND MM, 1990, GEOCHIM COSMOCHIM AC, V54, P1957, DOI 10.1016/0016-7037(90)90264-L; Irazusta V, 2013, PROCESS BIOCHEM, V48, P803, DOI 10.1016/j.procbio.2013.04.006; Irazusta V, 2012, BIOMETALS, V25, P517, DOI 10.1007/s10534-012-9531-0; Jarboui R, 2012, ENVIRON TECHNOL, V33, P951, DOI 10.1080/09593330.2011.603753; Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2; Kefala MI, 1999, ENVIRON POLLUT, V104, P283, DOI 10.1016/S0269-7491(98)00178-X; Li CS, 2013, BIORESOURCE TECHNOL, V143, P46, DOI 10.1016/j.biortech.2013.05.114; Nascimento Andrea M A, 2003, Genet Mol Res, V2, P92; Nimick DA, 2013, SCI TOTAL ENVIRON, V443, P40, DOI 10.1016/j.scitotenv.2012.10.080; Okino S, 2002, B ENVIRON CONTAM TOX, V68, P712, DOI 10.1007/s001280312; Oyetibo GO, 2015, APPL MICROBIOL BIOT, V99, P3651, DOI 10.1007/s00253-014-6279-1; Rajpert L, 2013, CHEMOSPHERE, V91, P1257, DOI 10.1016/j.chemosphere.2013.02.022; Saksinchai S, 2012, FUNGAL DIVERS, V52, P123, DOI 10.1007/s13225-011-0115-z; Tristezza M, 2009, J MICROBIOL METH, V78, P286, DOI 10.1016/j.mimet.2009.06.012; Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022; Villegas LB., 2009, J BASIC MICROB, V49, P1; VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x; Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062; Williams GP, 2013, INDIAN J GEO-MAR SCI, V42, P402; Xu GC, 2015, J S CHINA NORMAL U, V47, P101; Zhang HM, 2015, CHIN J HOSP STAT, V1, P1, DOI DOI 10.1016/J.JNS.2015.02.038	37	7	8	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172984	10.1371/journal.pone.0172984	http://dx.doi.org/10.1371/journal.pone.0172984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253367	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300055
J	Liu, K; Mao, J; Song, LP; Fan, AR; Zhang, S; Wang, JY; Fan, NN; Liu, N; Ye, XY; Fu, HF; Zhou, ZC; Wang, Y; Wei, H; Liu, ZH; Li, ZY; Lai, LX; Wang, XM; Liu, L				Liu, Kai; Mao, Jian; Song, Lipu; Fan, Anran; Zhang, Sheng; Wang, Jianyu; Fan, Nana; Liu, Na; Ye, Xiaoying; Fu, Haifeng; Zhou, Zhongcheng; Wang, Yong; Wei, Hong; Liu, Zhonghua; Li, Ziyi; Lai, Liangxue; Wang, Xumin; Liu, Lin			DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; TELOMERE LENGTH; DEFINED FACTORS; SOMATIC-CELLS; MINIATURE PIG; GENERATION; INDUCTION; FIBROBLASTS; GENES	Pigs are proposed to be suitable large animal models for test of the efficacy and safety of induced pluripotent stem cells (iPSCs) for stem cell therapy, but authentic pig ES/iPS cell lines with germline competence are rarely produced. The pathways or signaling underlying the defective competent pig iPSCs remain poorly understood. By improving induction conditions using various small chemicals, we generated pig iPSCs that exhibited high pluripotency and differentiation capacity that can contribute to chimeras. However, their potency was reduced with increasing passages by teratoma formation test, and correlated with declined expression levels of Rex1, an important marker for naive state. By RNA-sequencing analysis, genes related to WNT signaling were upregulated and MAPK signaling and TGF beta pathways downregulated in pig iPSCs compared to fibroblasts, but they were abnormally expressed during passages. Notably, pathways involving in DNA repair and replication were upregulated at early passage, but downregulated in iPSCs during prolonged passage in cluster with fibroblasts. Our data suggests that reduced DNA repair and replication capacity links to the instability of pig iPSCs. Targeting these pathways may facilitate generation of truly pluripotent pig iPSCs, with implication in translational studies.	[Liu, Kai] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China; [Liu, Kai; Mao, Jian; Liu, Na; Ye, Xiaoying; Fu, Haifeng; Zhou, Zhongcheng; Liu, Lin] Nankai Univ, Collaborat Innovat Ctr Biotherapy 2011, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Song, Lipu; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Fan, Anran; Zhang, Sheng; Li, Ziyi] Jilin Univ, Hosp 1, Changchun, Peoples R China; [Wang, Jianyu; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Fan, Nana; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Yong; Wei, Hong] Third Mil Med Univ, Coll Basic Med Sci, Chongqing, Peoples R China	Capital Medical University; Nankai University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Jilin University; Northeast Agricultural University - China; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Army Medical University	Liu, L (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy 2011, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China.; Wang, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	wangxm@big.ac.cn; liulin@nankai.edu.cn	wang, xumin/HII-8627-2022; Liu, Na/E-5674-2012	Liu, Na/0000-0003-3832-5591	China MOST National Major Basic Research Program [2011CBA01002, 2012CB911202]; National Natural Science Foundation of China [31271587]; PCSIRT [IRT13023]	China MOST National Major Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by China MOST National Major Basic Research Program (2011CBA01002, 2012CB911202), National Natural Science Foundation of China (31271587), and PCSIRT (No. IRT13023). We thank Jianyong Han and Qiuyan Li for kindly providing Nong Da Small Xiang pig embryonic fibroblasts.	Adam SJ, 2008, METHOD ENZYMOL, V439, P39, DOI 10.1016/S0076-6879(07)00404-1; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Cozzi E, 2009, ORGANOGENESIS, V5, P288; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Dan JM, 2015, J CELL PHYSIOL, V230, P2337, DOI 10.1002/jcp.24980; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Du XG, 2015, STEM CELLS, V33, P3228, DOI 10.1002/stem.2089; Esteban MA, 2010, IUBMB LIFE, V62, P277, DOI 10.1002/iub.307; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao Y, 2014, DNA CELL BIOL, V33, P1, DOI 10.1089/dna.2013.2095; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Hall VJ, 2012, CELL REPROGRAM, V14, P204, DOI 10.1089/cell.2011.0089; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jeon BG, 2008, REPRODUCTION, V135, P815, DOI 10.1530/REP-07-0442; Ji GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074202; Ji GZ, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-36; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kues WA, 2013, STEM CELLS DEV, V22, P124, DOI 10.1089/scd.2012.0382; Kwon DJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/140639; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liu K, 2012, CELL REPROGRAM, V14, P505, DOI 10.1089/cell.2012.0047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Medvedev SP, 2011, STEM CELLS DEV, V20, P1099, DOI 10.1089/scd.2010.0249; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Muro Y, 2015, CLIN CHIM ACTA, V442, P102, DOI 10.1016/j.cca.2015.01.014; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Petkov S, 2014, CELL REPROGRAM, V16, P235, DOI 10.1089/cell.2014.0010; Roberts RM, 2009, CELL CYCLE, V8, P3078, DOI 10.4161/cc.8.19.9589; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135; West F, 2011, ANN NY ACAD SCI, V1245, P21, DOI 10.1111/j.1749-6632.2011.06337.x; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zhang SQ, 2015, STEM CELL REV REP, V11, P24, DOI 10.1007/s12015-014-9552-x; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang ZH, 2013, STEM CELLS DEV, V22, P2268, DOI 10.1089/scd.2012.0650; Zhao XY, 2010, CELL RES, V20, P383, DOI 10.1038/cr.2010.26; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	68	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173047	10.1371/journal.pone.0173047	http://dx.doi.org/10.1371/journal.pone.0173047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253351	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300065
J	Nackaerts, E; Heremans, E; Smits-Engelsman, BCM; Broeder, S; Vandenberghe, W; Bergmans, B; Nieuwboer, A				Nackaerts, Evelien; Heremans, Elke; Smits-Engelsman, Bouwien C. M.; Broeder, Sanne; Vandenberghe, Wim; Bergmans, Bruno; Nieuwboer, Alice			Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease	PLOS ONE			English	Article							MOTOR CONTROL; MICROGRAPHIA; DYSFUNCTION; TASKS	Background Handwriting in Parkinson's disease (PD) features specific abnormalities which are difficult to assess in clinical practice since no specific tool for evaluation of spontaneous movement is currently available. Objective This study aims to validate the `Systematic Screening of Handwriting Difficulties' (SOS-test) in patients with PD. Methods Handwriting performance of 87 patients and 26 healthy age-matched controls was examined using the SOS-test. Sixty-seven patients were tested a second time within a period of one month. Participants were asked to copy as much as possible of a text within 5 minutes with the instruction to write as neatly and quickly as in daily life. Writing speed (letters in 5 minutes), size (mm) and quality of handwriting were compared. Correlation analysis was performed between SOS outcomes and other fine motor skill measurements and disease characteristics. Intrarater, interrater and test-retest reliability were assessed using the intraclass correlation coefficient (ICC) and Spearman correlation coefficient. Results Patients with PD had a smaller (p = 0.043) and slower (p<0.001) handwriting and showed worse writing quality (p = 0.031) compared to controls. The outcomes of the SOS-test significantly correlated with fine motor skill performance and disease duration and severity. Furthermore, the test showed excellent intrarater, interrater and test-retest reliability (ICC > 0.769 for both Conclusion The SOS-test is a short and effective tool to detect handwriting problems in PD with excellent reliability. It can therefore be recommended as a clinical instrument for standardized screening of handwriting deficits in PD.	[Nackaerts, Evelien; Heremans, Elke; Broeder, Sanne; Nieuwboer, Alice] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Smits-Engelsman, Bouwien C. M.] Univ Cape Town, Dept Hlth & Rehabil Sci, Cape Town, South Africa; [Vandenberghe, Wim] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Vandenberghe, Wim] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Bergmans, Bruno] AZ Sint Jan Brugge Oostende, Dept Neurol, Brugge, Belgium	KU Leuven; University of Cape Town; KU Leuven; KU Leuven; University Hospital Leuven	Nackaerts, E (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.	evelien.nackaerts@kuleuven.be	; Nieuwboer, Alice/F-5643-2013	Nackaerts, Evelien/0000-0002-6580-4902; Broeder, Sanne/0000-0002-0891-3264; Nieuwboer, Alice/0000-0003-1193-6229	Research Foundation - Flanders (FWO) [G.0906.11]	Research Foundation - Flanders (FWO)(FWO)	The project was funded by the Research Foundation - Flanders (FWO) with grant number G.0906.11. In addition, EN and SB are research assistents, EH is a postdoctoral researcher and WV a senior clinical investigator of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly NM, 2007, AGE AGEING, V36, P395, DOI 10.1093/ageing/afm061; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; BROWN TL, 1990, AM J PSYCHOL, V103, P471, DOI 10.2307/1423319; Chen CC, 2005, J HAND SURG-BRIT EUR, V30B, P207, DOI 10.1016/j.jhsb.2004.12.005; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hayes J.R., 1996, SCI WRITING THEORIES, P1, DOI DOI 10.1007/978-94-007-1048-1_2; Heremans E., 2016, NEUROREHABIL NEURAL; Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kim EJ, 2005, PARKINSONISM RELAT D, V11, P57, DOI 10.1016/j.parkreldis.2004.08.005; Koerts J, 2009, CORTEX, V45, P922, DOI 10.1016/j.cortex.2009.02.014; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange KW, 2006, HUM MOVEMENT SCI, V25, P492, DOI 10.1016/j.humov.2006.05.006; Letanneux A, 2014, MOVEMENT DISORD, V29, P1467, DOI 10.1002/mds.25990; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nackaerts E, 2015, NEUROREHABIL NEURAL; Nackaerts E, 2016, MOVEMENT DISORD, V31, P1209, DOI 10.1002/mds.26565; Nackaerts E, 2016, NEUROREHAB NEURAL RE, V30, P431, DOI 10.1177/1545968315601361; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ponsen MM, 2008, PARKINSONISM RELAT D, V14, P199, DOI 10.1016/j.parkreldis.2007.07.019; Proud EL, 2015, ARCH PHYS MED REHAB, V96, P540, DOI 10.1016/j.apmr.2014.09.016; Proud EL, 2010, ARCH PHYS MED REHAB, V91, P794, DOI 10.1016/j.apmr.2010.01.008; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Rosenblum S, 2013, J NEUROL; San Luciano  M., 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0162799; Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628; Smits EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097614; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tucha O, 2006, HUM MOVEMENT SCI, V25, P536, DOI 10.1016/j.humov.2006.06.002; van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x; Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502; van Gemmert AWA, 1998, ACTA PSYCHOL, V100, P161, DOI 10.1016/S0001-6918(98)00032-8; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151881; Van Waelvelde H, 2012, PHYS OCCUP THER PEDI, V32, P306, DOI 10.3109/01942638.2012.678971; Wu T, 2015, BRAIN; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Zhi  N., 2016, IEEE J BIOMED HLTH I	44	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173157	10.1371/journal.pone.0173157	http://dx.doi.org/10.1371/journal.pone.0173157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4XX	28253374	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300084
J	Wu, SM; Yu, CW; Zhang, WT; Yin, SL; Chen, Y; Feng, Y; Ma, WT				Wu, Sanmao; Yu, Chunwu; Zhang, Wentao; Yin, Shaolin; Chen, Yong; Feng, Yu; Ma, Wentao			Tag mechanism as a strategy for the RNA replicase to resist parasites in the RNA world	PLOS ONE			English	Article							POLYMERASE RIBOZYME; PREBIOTIC EVOLUTION; ORIGIN; LIFE; 1ST; SIMULATION; CHEMISTRY; SELECTION; DYNAMICS; MODELS	The idea that life may have started with an "RNA world" is attractive. Wherein, a crucial event (perhaps at the very beginning of the scenario) should have been the emergence of a ribozyme that catalyzes its own replication, i.e., an RNA replicase. Although now there is experimental evidence supporting the chemical feasibility of such a ribozyme, the evolutionary dynamics of how the replicase could overcome the "parasite" problem (because other RNAs may also exploit this ribozyme) and thrive, as described in the scenario, remains unclear. It has been suggested that spatial limitation may have been important for the replicase to confront parasites. However, more studies showed that such a mechanism is not sufficient when this ribozyme's altruistic trait is taken into full consideration. "Tag mechanism", which means labeling the replicase with a short subsequence for recognition in replication, may be a further mechanism supporting the thriving of the replicase. However, because parasites may also "equip" themselves with the tag, it is far from clear whether the tag mechanism could take effect. Here, we conducted a computer simulation using a Monte-Carlo model to study the evolutionary dynamics surrounding the development of a tag-driven (polymerase-type) RNA replicase in the RNA world. We concluded that (1) with the tag mechanism the replicase could resist the parasites and become prosperous, (2) the main underlying reason should be that the parasitic molecules, especially those strong parasites, are more difficult to appear in the tag-driven system, and (3) the tag mechanism has a synergic effect with the spatial limitation mechanism-while the former provides "time" for the replicase to escape from parasites, the latter provides "space" for the replicase to escape. Notably, tags may readily serve as "control handles", and once the tag mechanism was exploited, the evolution towards complex life may have been much easier.	[Wu, Sanmao; Yin, Shaolin; Chen, Yong; Feng, Yu; Ma, Wentao] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Yu, Chunwu; Zhang, Wentao] Wuhan Univ, Coll Comp Sci, Wuhan, Peoples R China	Wuhan University; Wuhan University	Ma, WT (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China.	mwt@whu.edu.cn			National Natural Science Foundation of China [31571367, 31170958]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31571367, 31170958). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bernhardt HS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-23; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; CECH TR, 1989, NATURE, V339, P507, DOI 10.1038/339507a0; Cheng LKL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002204; Colizzi ES, 2014, GENOME BIOL EVOL, V6, P1990, DOI 10.1093/gbe/evu150; Coveney PV, 2012, CHEM SOC REV, V41, P5430, DOI 10.1039/c2cs35018a; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce G. F., 2006, THE RNA WORLD, P23; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; LOVETT ST, 1993, GENETICS, V135, P631; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2007, BIOSYSTEMS, V90, P28, DOI 10.1016/j.biosystems.2006.06.005; Ma WT, 2006, ORIGINS LIFE EVOL B, V36, P413, DOI 10.1007/s11084-005-9006-1; Ma WT, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0150-5; Ma WT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0548-1; Ma WT, 2014, CHEM BIODIVERS, V11, P1998, DOI 10.1002/cbdv.201400188; Ma WT, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-21; Ma WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035454; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Ma WT, 2010, BIOSYSTEMS, V99, P201, DOI 10.1016/j.biosystems.2009.11.003; McCaskill JS, 2001, BIOL CHEM, V382, P1343, DOI 10.1515/BC.2001.167; Mutschler H, 2015, NAT CHEM, V7, P502, DOI [10.1038/NCHEM.2251, 10.1038/nchem.2251]; Pressman A, 2015, CURR BIOL, V25, pR953, DOI 10.1016/j.cub.2015.06.016; Robertson M.P., 2012, COLD SPRING HARB PER, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A003608; Scheuring I, 2003, ORIGINS LIFE EVOL B, V33, P319, DOI 10.1023/A:1025742505324; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2003, ORIGINS LIFE EVOL B, V33, P313, DOI 10.1023/A:1025704003507; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szilagyi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003193; Takeuchi N, 2007, J MOL EVOL, V65, P668, DOI 10.1007/s00239-007-9044-6; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Takeuchi N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002024; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-11; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	44	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172702	10.1371/journal.pone.0172702	http://dx.doi.org/10.1371/journal.pone.0172702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253281	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300028
J	Wu, XH; Lai, WY; Lin, HT; Liu, YZ				Wu, Xiaohang; Lai, Weiyi; Lin, Haotian; Liu, Yizhi			Association of OGG1 and MTHFR polymorphisms with age-related cataract: A systematic review and meta-analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; S-TRANSFERASE M1; SENILE CORTICAL CATARACT; APOLIPOPROTEIN-E; EPHA2 POLYMORPHISMS; ESTONIAN PATIENTS; RISK PREDICTION; NULL GENOTYPE; SUSCEPTIBILITY; XRCC1	Purpose To discern and confirm genetic biomarkers that help identify populations at high risk for agerelated cataract (ARC). Methods A literature search was performed in the PubMed, Web of Science and China National Knowledge Internet databases for genetic association studies published before June 26, 2016 regarding ARC susceptibility. All genetic polymorphisms reported were systematically reviewed, followed by extraction of candidate genes/loci with sufficient genotype data in >= 3 studies for the meta-analysis. A random/fixed-effects model was used to calculate the pooled odds ratios and 95% confidence intervals to evaluate the associations considering multiple genetic models. Sensitivity analysis was also performed. Results A total of 144 polymorphisms in 36 genes were reported in the 61 previous genetic association studies. Thereby, three polymorphisms of two genes (8-oxoguanine DNA glycosylase-1 [OGG1]; methylenetetrahydrofolate reductase NADPH [MTHFR]) in eight studies were included in the meta-analysis. Regarding the OGG1-rs1052133, the GG (OR = 1.925; 95% CI, 1.181-3.136; p = 0.009) and CG (OR = 1.384; 95% CI, 1.171-1.636; p< 0.001) genotypes indicated higher risk of ARC. For the MTHFR gene, the CC+ TT genotype of rs1801133 might be protective (OR, 0.838; 95% CI, 0.710-0.989; p = 0.036), whereas the AA+CC genotype of rs1801131 indicated increased risk for the mixed subtype (OR = 1.517; 95% CI, 1.113-2.067; p = 0.008). Conclusions Polymorphisms of OGG1 and MTHFR genes are associated with ARC susceptibility and may help identify populations at high risk for ARC.	[Wu, Xiaohang; Lai, Weiyi; Lin, Haotian; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	haot.lin@hotmail.com; yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022	Lin, Haotian/0000-0003-4672-9721	Ministry of Science and Technology of China Grants (973 program) [2015CB964600]; Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]; Key Research Plan for the National Natural Science Foundation of China in Cultivation Project [91546101]; Outstanding Young Teacher Cultivation Projects in Guangdong Province [YQ2015006]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; clinical research and translational medical center of pediatric cataract in Guangzhou city; Pearl River Science and Technology New Star [2014J2200060]; Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation or Distinguished Young Scholars of China [2014A030306030]; Youth Science and Technology Innovation Talents Funds in a Special Support Plan for High Level Talents in Guangdong Province [2014TQ01R573]; Science and Technology Program of Guangdong Province [20136020400003]; Young Teacher Top Support project of Sun Yat-sen University [2015ykzd11]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology [2015QN01]	Ministry of Science and Technology of China Grants (973 program); Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China; Key Research Plan for the National Natural Science Foundation of China in Cultivation Project; Outstanding Young Teacher Cultivation Projects in Guangdong Province; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; clinical research and translational medical center of pediatric cataract in Guangzhou city; Pearl River Science and Technology New Star; Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation or Distinguished Young Scholars of China; Youth Science and Technology Innovation Talents Funds in a Special Support Plan for High Level Talents in Guangdong Province; Science and Technology Program of Guangdong Province; Young Teacher Top Support project of Sun Yat-sen University; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	This study was supported by the Ministry of Science and Technology of China Grants (973 program, 2015CB964600)-YL, the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010-2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of the Ministry of Health)-YL, the Key Research Plan for the National Natural Science Foundation of China in Cultivation Project (No.91546101)-YL, the Outstanding Young Teacher Cultivation Projects in Guangdong Province(No.YQ2015006)-HL, Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase) HL, the clinical research and translational medical center of pediatric cataract in Guangzhou city, the Pearl River Science and Technology New Star (Grant No. 2014J2200060)-HL, Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China (Grant No. 2014A030306030) HL, the Youth Science and Technology Innovation Talents Funds in a Special Support Plan for High Level Talents in Guangdong Province (Grant No. 2014TQ01R573)-HL, the Science and Technology Program of Guangdong Province (Grant No. 20136020400003) -HL, the Young Teacher Top Support project of Sun Yat-sen University (Grant No. 2015ykzd11)-HL and Fundamental Research Funds of the State Key Laboratory of Ophthalmology (Grant No. 2015QN01)-HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2014, META GENE, V2, P307, DOI 10.1016/j.mgene.2014.02.002; Andersson ME, 2007, MOL VIS, V13, P993; Asbell PA, 2005, LANCET, V365, P599; Azeem AAA, 2009, BRATISL MED J, V110, P678; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Celik SK, 2015, ADV CLIN EXP MED, V24, P113, DOI 10.17219/acem/38143; Celojevic D, 2016, OPHTHALMIC GENET, V37, P14, DOI 10.3109/13816810.2014.902080; Celojevic D, 2013, OPHTHALMIC GENET, V34, P140, DOI 10.3109/13816810.2012.746377; Chandra A, 2016, OPHTHALMIC GENET, V37, P19, DOI 10.3109/13816810.2014.907921; Chi XX, 2015, MOL VIS, V21, P335; Ehrenberg M, 2010, MOL VIS, V16, P1771; Fletcher AE, 2010, OPHTHALMIC RES, V44, P191, DOI 10.1159/000316476; Gharib AF, 2014, MOL VIS, V20, P661; Guven M, 2007, CURR EYE RES, V32, P447, DOI 10.1080/02713680701338108; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang SQ, 2013, AGE, V35, P2435, DOI 10.1007/s11357-013-9512-4; Jiang ZX, 2012, MOL VIS, V18, P1247; Juronen E, 2000, INVEST OPHTH VIS SCI, V41, P2262; Li SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116463; Liao RF, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/103950; Lim LS, 2009, AM J EPIDEMIOL, V169, P1267, DOI 10.1093/aje/kwp045; Lin QH, 2014, OPHTHALMIC RES, V52, P124, DOI 10.1159/000363139; Lin QH, 2013, MOL VIS, V19, P1572; Liu XC, 2015, CURR EYE RES, V40, P676, DOI 10.3109/02713683.2014.957325; Liu YY, 2011, MOL BIOL REP, V38, P1301, DOI 10.1007/s11033-010-0230-z; Luo YF, 2011, CURR EYE RES, V36, P632, DOI 10.3109/02713683.2011.571358; Mamata M, 2011, MOL VIS, V17, P1203; Manne Mamata, 2012, Oman J Ophthalmol, V5, P32, DOI 10.4103/0974-620X.94764; Maraini G, 2003, MOL VIS, V9, P397; Meyer D, 2003, PHARMACOGENETICS, V13, P285, DOI 10.1097/00008571-200305000-00008; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Padma G, 2011, MOL VIS, V17, P127; Pendergrass W, 2005, INVEST OPHTH VIS SCI, V46, P4661, DOI 10.1167/iovs.05-0808; Qi R, 2015, INT J CLIN EXP MED, V8, P19448; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Rudolph T, 2011, OPHTHALMIC GENET, V32, P75, DOI 10.3109/13816810.2010.544360; Saadat I, 2012, MOL VIS, V18, P1996; Saadat M, 2006, OCCUP ENVIRON MED, V63, P503, DOI 10.1136/oem.2005.022343; Saadat M, 2004, BIOCHEM BIOPH RES CO, V319, P1287, DOI 10.1016/j.bbrc.2004.05.121; Sen SK, 2008, INDIAN J CLIN BIOCHE, V23, P255, DOI 10.1007/s12291-008-0057-8; Shi YF, 2008, MOL VIS, V14, P1850; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Shiels A, 2008, MOL VIS, V14, P2042; Sireesha R, 2012, EXP EYE RES, V98, P67, DOI 10.1016/j.exer.2012.03.002; Skiljic D, 2015, OPHTHALMIC GENET, V36, P188, DOI 10.3109/13816810.2015.1005316; Stamenkovic M, 2014, CLIN EXP OPHTHALMOL, V42, P277, DOI 10.1111/ceo.12180; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Sun L, 2010, INVEST OPHTH VIS SCI, V51, P6381, DOI 10.1167/iovs.10-5815; Sun W, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0065-4; Sundaresan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033001; Tamer L, 2005, CURR EYE RES, V30, P835, DOI 10.1080/02713680591003799; Tan AG, 2016, JAMA OPHTHALMOLOGY; Tan AG, 2015, INVEST OPHTH VIS SCI, V56, P216, DOI 10.1167/iovs.14-15531; Tan W, 2011, MOL VIS, V17, P1553; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Unal M, 2007, EXP EYE RES, V85, P328, DOI 10.1016/j.exer.2007.06.003; Utheim OA, 2008, ACTA OPHTHALMOL, V86, P401, DOI 10.1111/j.1600-0420.2007.01070.x; von Otter M, 2010, NEUROMOL MED, V12, P229, DOI 10.1007/s12017-009-8103-0; von Otter M, 2010, MECH AGEING DEV, V131, P105, DOI 10.1016/j.mad.2009.12.007; Wang C, 2015, INT J CLIN EXP PATHO, V8, P16036; Wang SH, 2015, IEEE SIGNAL PROC LET, V22, DOI 10.1109/LSP.2015.2464791; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu M, 2015, MOL VIS, V21, P412; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071003; Zetterberg M, 2005, AM J OPHTHALMOL, V140, P932, DOI 10.1016/j.ajo.2005.05.026; Zetterberg M, 2004, BRIT J OPHTHALMOL, V88, P716, DOI 10.1136/bjo.2003.032698; Zhang HX, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0341-y; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052384, 10.1371/journal.pone.0066569]; Zhang Y, 2013, CELL STRESS CHAPERON, V18, P703, DOI 10.1007/s12192-013-0420-4; Zhang Y, 2011, MOL VIS, V17, P2325; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zheng C, 2014, J INT MED RES, V42, P153, DOI 10.1177/0300060513504702; Zheng LR, 2014, GRAEF ARCH CLIN EXP, V252, P1259, DOI 10.1007/s00417-014-2679-2; Zhou J, 2010, INVEST OPHTH VIS SCI, V51, P3924, DOI 10.1167/iovs.10-5240; Zhou Z, 2011, MOL VIS, V17, P2292	79	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172092	10.1371/journal.pone.0172092	http://dx.doi.org/10.1371/journal.pone.0172092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253266	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300014
J	Wang, LL; Xia, LS; Zhang, DD				Wang, Lili; Xia, Lisheng; Zhang, Dandan			Face-body integration of intense emotional expressions of victory and defeat	PLOS ONE			English	Article							FACIAL EXPRESSIONS; FEARFUL FACES; PERCEPTION; ERP; AUTOMATICITY; VALIDATION; COMPONENTS; DYNAMICS; BODIES; SYSTEM	Human facial expressions can be recognized rapidly and effortlessly. However, for intense emotions from real life, positive and negative facial expressions are difficult to discriminate and the judgment of facial expressions is biased towards simultaneously perceived body expressions. This study employed event-related potentials (ERPs) to investigate the neural dynamics involved in the integration of emotional signals from facial and body expressions of victory and defeat. Emotional expressions of professional players were used to create pictures of face-body compounds, with either matched or mismatched emotional expressions in faces and bodies. Behavioral results showed that congruent emotional information of face and body facilitated the recognition of facial expressions. ERP data revealed larger P1 amplitudes for incongruent compared to congruent stimuli. Also, a main effect of body valence on the P1 was observed, with enhanced amplitudes for the stimuli with losing compared to winning bodies. The main effect of body expression was also observed in N170 and N2, with winning bodies producing larger N170/N2 amplitudes. In the later stage, a significant interaction of congruence by body valence was found on the P3 component. Winning bodies elicited lager P3 amplitudes than losing bodies did when face and body conveyed congruent emotional signals. Beyond the knowledge based on prototypical facial and body expressions, the results of this study facilitate us to understand the complexity of emotion evaluation and categorization out of laboratory.	[Wang, Lili] Huaiyin Normal Univ, Sch Educ Sci, Huaian, Peoples R China; [Xia, Lisheng; Zhang, Dandan] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Zhang, Dandan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China	Huaiyin Normal University; Shenzhen University; Beijing Normal University	Zhang, DD (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.; Zhang, DD (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.	zhangdd05@gmail.com			National Natural Science Foundation of China [31571120, 31300869]; National Key Basic Research Program of China [2014CB744600]; Nature Science Foundation of JiangSu Province [BK20130415]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of JiangSu Province(Natural Science Foundation of Jiangsu Province)	This study was funded by the National Natural Science Foundation of China (31571120, 31300869), the National Key Basic Research Program of China (2014CB744600), and the Nature Science Foundation of JiangSu Province (BK20130415).	Aviezer H, 2015, EMOTION; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Aviezer H, 2011, EMOTION, V11, P1406, DOI 10.1037/a0023578; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Borgomaneri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14122; Borgomaneri S, 2015, CORTEX, V65, P232, DOI 10.1016/j.cortex.2015.01.014; Borhani K, 2016, BIOL PSYCHOL, V115, P1, DOI 10.1016/j.biopsycho.2015.12.010; Borhani K, 2015, SOC COGN AFFECT NEUR, V10, P1092, DOI 10.1093/scan/nsu167; Cacioppo JT, 1999, J PERS SOC PSYCHOL, V76, P839, DOI 10.1037/0022-3514.76.5.839; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Carroll JM, 1996, J PERS SOC PSYCHOL; Crawford LE, 2002, PSYCHOL SCI, V13, P449, DOI 10.1111/1467-9280.00479; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00181; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Gratton G., 1989, J PSYCHOPHYSIOL, V3, P14; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gu Y.h., 2013, PLOS ONE, V8; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hortensius R., 2014, NEW FRONTIERS SOCIAL, V21, P153, DOI [10.1007/978-3-319-02904-7_9, DOI 10.1007/978-3-319-02904-7_9]; in 't Veld EMJH, 2014, SOC NEUROSCI-UK, V9, P249, DOI 10.1080/17470919.2014.890668; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Luck SJ, 2007, INTRO EVENT RELATED, V18; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Matsumoto D, 2006, J PERS SOC PSYCHOL, V91, P568, DOI 10.1037/0022-3514.91.3.568; Matsumoto D, 2012, EVOL HUM BEHAV, V33, P520, DOI 10.1016/j.evolhumbehav.2012.01.005; Meeren HKM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24831; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Smith E, 2013, INT J PSYCHOPHYSIOL, V88, P17, DOI 10.1016/j.ijpsycho.2012.12.004; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; Thoma P, 2013, PSYCHIAT RES, V209, P98, DOI 10.1016/j.psychres.2012.11.012; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Willis ML, 2011, EMOTION, V11, P514, DOI 10.1037/a0022571; [张丹丹 Zhang Dandan], 2015, [心理学报, Acta Psychologica Sinica], V47, P963; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188; Zhang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049517	56	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0171656	10.1371/journal.pone.0171656	http://dx.doi.org/10.1371/journal.pone.0171656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245245	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200008
J	Bosco, DB; Roycik, MD; Jin, YH; Schwartz, MA; Lively, TJ; Zorio, DAR; Sang, QXA				Bosco, Dale B.; Roycik, Mark D.; Jin, Yonghao; Schwartz, Martin A.; Lively, Ty J.; Zorio, Diego A. R.; Sang, Qing-Xiang Amy			A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; OBESITY; RISK; PROGELATINASE; SPECIFICITIES; FIBRONECTIN; COLLAGENASE; ANTAGONIST	Development of adipose tissue requires the differentiation of less specialized cells, such as human mesenchymal stem cells (hMSCs), into adipocytes. Since matrix metalloproteinases (MMPs) play critical roles in the cell differentiation process, we conducted investigations to determine if a novel mercaptosulfonamide-based MMP inhibitor (MMPI), YHJ-7-52, could affect hMSC adipogenic differentiation and lipid accumulation. Enzyme inhibition assays, adipogenic differentiation experiments, and quantitative PCR methods were employed to characterize this inhibitor and determine its effect upon adipogenesis. YHJ-7-52 reduced lipid accumulation in differentiated cells by comparable amounts as a potent hydroxamate MMPI, GM6001. However, YHJ-7-82, a non-inhibitory structural analog of YHJ-7-52, in which the zinc-binding thiol group is replaced by a hydroxyl group, had no effect on adipogenesis. The two MMPIs (YHJ-7-52 and GM6001) were also as effective in reducing lipid accumulation in differentiated cells as T0070907, an antagonist of peroxisome-proliferator activated receptor gamma (PPAR-gamma), at a similar concentration. PPAR-gamma is a typical adipogenic marker and a key regulatory protein for the transition of preadiopocyte to adipocyte. Moreover, MMP inhibition was able to suppress lipid accumulation in cells cotreated with Troglitazone, a PPAR-gamma agonist. Our results indicate that MMP inhibitors may be used as molecular tools for adipogenesis and obesity treatment research.	[Bosco, Dale B.; Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Roycik, Mark D.; Jin, Yonghao; Schwartz, Martin A.; Lively, Ty J.; Zorio, Diego A. R.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Bosco, Dale B.; Zorio, Diego A. R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Roycik, Mark D.] Jacksonville Univ, Dept Biol & Marine Sci, Jacksonville, FL USA; [Jin, Yonghao] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Jacksonville University; State University System of Florida; Florida A&M University	Sang, QXA (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.; Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu			Florida Department of Health James and Esther King Biomedical Research Program [1KF04]; Florida State University; Molecular Design and Synthesis (MDS) Foundation	Florida Department of Health James and Esther King Biomedical Research Program; Florida State University; Molecular Design and Synthesis (MDS) Foundation	This work was supported in part by grants from the Florida Department of Health James and Esther King Biomedical Research Program (Grant 1KF04), Florida State University, and anonymous donors for an Endowed Chair Professorship in Cancer Research (to QXAS), and by the Molecular Design and Synthesis (MDS) Foundation (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; Hurst DR, 2005, BIOCHEM J, V392, P527, DOI 10.1042/BJ20050545; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Jin YH, 2002, TETRAHEDRON LETT, V43, P7319, DOI 10.1016/S0040-4039(02)01750-1; Jin YH, 2013, J MED CHEM, V56, P4357, DOI 10.1021/jm400529f; Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lilla J, 2002, AM J PATHOL, V160, P1551, DOI 10.1016/S0002-9440(10)61100-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nakamura T, 2003, BIOCHEM BIOPH RES CO, V303, P306, DOI 10.1016/S0006-291X(03)00325-5; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Park HI, 2003, J BIOL CHEM, V278, P51646, DOI 10.1074/jbc.M310109200; Park HI, 2002, J BIOL CHEM, V277, P35168, DOI 10.1074/jbc.M205071200; Pavlov TS, 2009, MOL PHARMACOL, V76, P1333, DOI 10.1124/mol.109.056911; Poulos SP, 2016, EXP BIOL MED, V241, P449, DOI 10.1177/1535370215619041; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; Sang QXA, 1999, ANN NY ACAD SCI, V878, P538, DOI 10.1111/j.1749-6632.1999.tb07720.x; Sang QXA, 2000, BIOCHEM BIOPH RES CO, V274, P780, DOI 10.1006/bbrc.2000.3212; Sang QXA, 1996, J PROTEIN CHEM, V15, P243, DOI 10.1007/BF01887112; Schwartz M, 2013, U.S. Patent, Patent No. 8404866; SCHWARTZ MA, 1995, Patent No. 5455262; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Van Hul M, 2012, CLIN EXP PHARMACOL P, V39, P544, DOI 10.1111/j.1440-1681.2012.05714.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; White CM, 1998, PHARMACOTHERAPY, V18, P588; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; [No title captured]	57	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e017292	10.1371/journal.pone.0172925	http://dx.doi.org/10.1371/journal.pone.0172925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234995	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200171
J	van den Hoff, J; Kilpatrick, R; Welsford, D				van den Hoff, John; Kilpatrick, Robbie; Welsford, Dirk			Southern elephant seals (Mirounga leonina Linn.) depredate toothfish longlines in the midnight zone	PLOS ONE			English	Article							MARINE MAMMALS; KERGUELEN ISLANDS; FISHING GEAR; FISHERY; BYCATCH; OCEAN; PREDATOR; IMPACTS; ECOLOGY; CROZET	Humans have devised fishing technologies that compete with marine predators for fish resources world-wide. One such fishery for the Patagonian toothfish (Dissostichus eleginoides) has developed interactions with a range of predators, some of which are marine mammals capable of diving to extreme depths for extended periods. A deep-sea camera system deployed within a toothfish fishery operating in the Southern Ocean acquired the first-ever video footage of an extreme-diver, the southern elephant seal (Mirounga leonina), depredating catch from longlines set at depths in excess of 1000m. The interactions recorded were non-lethal, however independent fisheries observer reports confirm elephant seal-longline interactions can be lethal. The seals behaviour of depredating catch at depth during the line soak-period differs to other surface-breathing species and thus presents a unique challenge to mitigate their by-catch. Deployments of deep-sea cameras on exploratory fishing gear prior to licencing and permit approvals would gather valuable information regarding the nature of interactions between deep diving/dwelling marine species and long-line fisheries operating at bathypelagic depths. Furthermore, the positive identification by sex and age class of species interacting with commercial fisheries would assist in formulating management plans and mitigation strategies founded on species-specific life-history strategies.	[van den Hoff, John; Kilpatrick, Robbie; Welsford, Dirk] Australian Antarctic Div, Kingston, Tas, Australia	Australian Antarctic Division	van den Hoff, J (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.	john_van@aad.gov.au		Welsford, Dirk/0000-0001-5379-5052	Australian government	Australian government(Australian GovernmentCGIAR)	This was an Australian government funded project.	Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Beaman R. J., 2011, KERGUELEN PLATEAU BA; BRIGGS K, 1975, J MAMMAL, V56, P224, DOI 10.2307/1379622; Collins MA, 2010, ADV MAR BIOL, V58, P227, DOI 10.1016/S0065.2881(10)58004.0; Costa DP, 2003, J ACOUST SOC AM, V113, P1155, DOI 10.1121/1.1538248; Cottin J.-Y., 2011, KERGUELEN PLATEAU MA, P29; Danovaro R, 2014, TRENDS ECOL EVOL, V29, P465, DOI 10.1016/j.tree.2014.06.002; Delord K, 2010, POLAR BIOL, V33, P367, DOI 10.1007/s00300-009-0713-3; Gotz T, 2015, ANIM CONSERV, V18, P102, DOI 10.1111/acv.12141; Green K, 1998, POLAR BIOL, V20, P273, DOI 10.1007/s003000050303; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hindell MA, 2011, KERGUELEN PLATEAU MA, P203, DOI DOI 10.1007/S003960050133; Irigoien X, 2014, NATURE COMMUNICATION; Kilpatrick R, 2011, DEEP-SEA RES PT I, V58, P486, DOI 10.1016/j.dsr.2011.02.006; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lord C, 2006, CCAMLR SCI, V13, P1; McMahon Clive R., 2000, Polar Record, V36, P250; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; Moreno CA, 2008, CCAMLR SCI, V15, P79; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; O'Toole M, 2014, MAR ECOL PROG SER, V502, P281, DOI 10.3354/meps10709; Park YH, 2011, KERGUELEN PLATEAU MA, V2011, P43; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Purves MG, 2004, CCAMLR SCI, V11, P111; R Core Team, R LANG ENV STAT COMP; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Roche C, 2007, CCAMLR SCI, V14, P67; Slip DJ., 1997, THESIS; Slip DJ, 1994, ELEPHANT SEALS POPUL, P237; Soffker M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118113; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; van den Hoff J, 2008, MAR MAMMAL SCI, V24, P239, DOI 10.1111/j.1748-7692.2007.00181.x; WELSFORD D.C., 2011, KERGUELEN PLATEAU MA, P125; Welsford DC, 2013, INFORM REV COMMONWEA; Welsford DC, 2014, 2006042 FRDS AUSTR A; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur A.F, 2012, ZERO INFLATED MODELS	41	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172396	10.1371/journal.pone.0172396	http://dx.doi.org/10.1371/journal.pone.0172396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234988	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200077
J	Yang, Q; Du, PA; Wang, Y; Liang, B				Yang, Qiang; Du, Ping-an; Wang, Yong; Liang, Bin			A rough set approach for determining weights of decision makers in group decision making	PLOS ONE			English	Article							INTERACTIVE PROCEDURE; EXTENSION; MODEL; AGGREGATION; METHODOLOGY; INFORMATION; OPERATORS; SYSTEM; TOPSIS	This study aims to present a novel approach for determining the weights of decision makers (DMs) based on rough group decision in multiple attribute group decision-making (MAGDM) problems. First, we construct a rough group decision matrix from all DMs' decision matrixes on the basis of rough set theory. After that, we derive a positive ideal solution (PIS) founded on the average matrix of rough group decision, and negative ideal solutions (NISs) founded on the lower and upper limit matrixes of rough group decision. Then, we obtain the weight of each group member and priority order of alternatives by using relative closeness method, which depends on the distances from each individual group member' decision to the PIS and NISs. Through comparisons with existing methods and an on-line business manager selection example, the proposed method show that it can provide more insights into the subjectivity and vagueness of DMs' evaluations and selections.	[Yang, Qiang; Du, Ping-an] Univ Elect Sci & Technol China, Sch Mechatron Engn, Chengdu, Peoples R China; [Wang, Yong; Liang, Bin] Southwest China Inst Elect Technol, Chengdu, Peoples R China	University of Electronic Science & Technology of China	Du, PA (corresponding author), Univ Elect Sci & Technol China, Sch Mechatron Engn, Chengdu, Peoples R China.	dupingan@uestc.edu.cn						Bell RL, 2003, SCI EDUC, V87, P352, DOI 10.1002/sce.10063; BODILY SE, 1979, MANAGE SCI, V25, P1035, DOI 10.1287/mnsc.25.10.1035; CHANG PL, 1994, FUZZY SET SYST, V63, P131, DOI 10.1016/0165-0114(94)90344-1; Chen Xiao-hong, 2006, Systems Engineering and Electronics, V28, P1695; Clemons EK, 1990, J MANAGEMENT INF FAL, P9; Efe B, 2016, APPL SOFT COMPUT, V38, P106, DOI 10.1016/j.asoc.2015.09.037; EISENHARDT KM, 1988, ACAD MANAGE J, V31, P737, DOI 10.2307/256337; Fu C, 2010, EUR J OPER RES, V206, P601, DOI 10.1016/j.ejor.2010.03.011; Hsu HM, 1996, FUZZY SET SYST, V79, P279, DOI 10.1016/0165-0114(95)00185-9; Hwang C.-L., 1987, GROUP DECISION MAKIN, P145; Ingersoll J.E., 1987, THEORY FINANCIAL DEC; Khelifa SB, 2000, OPTIMISATION DECISIO, P213; Kim SH, 1999, EUR J OPER RES, V118, P139, DOI 10.1016/S0377-2217(98)00309-9; Kim SH, 1999, COMPUT OPER RES, V26, P755, DOI 10.1016/S0305-0548(98)00091-4; LAFFONT JJ, 1991, Q J ECON, V106, P1089, DOI 10.2307/2937958; Li DF, 2009, APPL SOFT COMPUT, V9, P219, DOI 10.1016/j.asoc.2008.04.006; Lin YH, 2008, AUTOMAT CONSTR, V17, P792, DOI 10.1016/j.autcon.2008.02.011; Liu PD, 2011, EXPERT SYST APPL, V38, P1053, DOI 10.1016/j.eswa.2010.07.144; Mirkin B. G., 1979, GROUP CHOICE; PAWLAK Z, 1994, EUR J OPER RES, V72, P443, DOI 10.1016/0377-2217(94)90415-4; Pohekar SD, 2004, RENEW SUST ENERG REV, V8, P365, DOI 10.1016/j.rser.2003.12.007; RAMANATHAN R, 1994, EUR J OPER RES, V79, P249, DOI 10.1016/0377-2217(94)90356-5; Rodger JA, 2014, INT J ADV MANUF TECH, V70, P711, DOI 10.1007/s00170-013-5311-4; Shih HS, 2007, MATH COMPUT MODEL, V45, P801, DOI 10.1016/j.mcm.2006.03.023; SIMON HA, 1979, AM ECON REV, V69, P493; Song WY, 2013, INT J PROD RES, V51, P6681, DOI 10.1080/00207543.2013.832435; STEWART TJ, 1992, OMEGA-INT J MANAGE S, V20, P569, DOI 10.1016/0305-0483(92)90003-P; THEIL H, 1963, MANAGE SCI, V9, P380, DOI 10.1287/mnsc.9.3.380; Triantaphyllou E, 1996, INT J APPROX REASON, V14, P281, DOI 10.1016/0888-613X(95)00119-2; Xu JP, 2011, KNOWL-BASED SYST, V24, P1196, DOI 10.1016/j.knosys.2011.05.007; Ye F, 2009, EXPERT SYST APPL, V36, P9350, DOI 10.1016/j.eswa.2009.01.015; Yue ZL, 2013, INFORM FUSION, V14, P551, DOI 10.1016/j.inffus.2013.01.003; Yue ZL, 2013, APPL MATH MODEL, V37, P112, DOI 10.1016/j.apm.2012.02.008; Yue ZL, 2012, APPL MATH MODEL, V36, P2896, DOI 10.1016/j.apm.2011.09.068; Yue ZL, 2012, EXPERT SYST APPL, V39, P6343, DOI 10.1016/j.eswa.2011.12.016; Yue ZL, 2011, APPL MATH MODEL, V35, P1926, DOI 10.1016/j.apm.2010.11.001; Yue ZL, 2011, KNOWL-BASED SYST, V24, P146, DOI 10.1016/j.knosys.2010.07.014; Zanakis SH, 1998, EUR J OPER RES, V107, P507, DOI 10.1016/S0377-2217(97)00147-1; Zavadskas EK, 2009, INFORMATICA-LITHUAN, V20, P305; Zhai LY, 2010, EXPERT SYST APPL, V37, P8888, DOI 10.1016/j.eswa.2010.06.007; Zhai LY, 2009, ADV ENG INFORM, V23, P222, DOI 10.1016/j.aei.2008.10.010; Zhang ZM, 2013, INFORM FUSION, V14, P460, DOI 10.1016/j.inffus.2013.02.001; Zhou LG, 2012, KNOWL-BASED SYST, V36, P268, DOI 10.1016/j.knosys.2012.07.006	43	7	7	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172679	10.1371/journal.pone.0172679	http://dx.doi.org/10.1371/journal.pone.0172679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234974	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200112
J	Chicote, JU; DeSalle, R; Garcia-Espana, A				Chicote, Javier U.; DeSalle, Rob; Garcia-Espana, Antonio			Phosphotyrosine phosphatase R3 receptors: Origin, evolution and structural diversification	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DOMAIN; IDENTIFICATION; REGULATORS; GENES; PTPRQ	Subtype R3 phosphotyrosine phosphatase receptors (R3 RPTPs) are single-spanning membrane proteins characterized by a unique modular composition of extracellular fibronectin repeats and a single cytoplasmatic protein tyrosine phosphatase (PTP) domain. Vertebrate R3 RPTPs consist of five members: PTPRB, PTPRJ, PTPRH and PTPRO, which dephosphorylate tyrosine residues, and PTPRQ, which dephosphorylates phophoinositides. R3 RPTPs are considered novel therapeutic targets in several pathologies such as ear diseases, nephrotic syndromes and cancer. R3 RPTP vertebrate receptors, as well as their known invertebrate counterparts from animal models: PTP52F, PTP10D and PTP4e from the fruitfly Drosophila melanogaster and F44G4.8/DEP-1 from the nematode Caenorhabditis elegans, participate in the regulation of cellular activities including cell growth and differentiation. Despite sharing structural and functional properties, the evolutionary relationships between vertebrate and invertebrate R3 RPTPs are not fully understood. Here we gathered R3 RPTPs from organisms covering a broad evolutionary distance, annotated their structure and analyzed their phylogenetic relationships. We show that R3 RPTPs (i) have probably originated in the common ancestor of animals (metazoans), (ii) are variants of a single ancestral gene in protostomes (arthropods, annelids and nematodes); (iii) a likely duplication of this ancestral gene in invertebrate deuterostomes (echinodermes, hemichordates and tunicates) generated the precursors of PTPRQ and PTPRB genes, and (iv) R3 RPTP groups are monophyletic in vertebrates and have specific conserved structural characteristics. These findings could have implications for the interpretation of past studies and provide a framework for future studies and functional analysis of this important family of proteins.	[Chicote, Javier U.; Garcia-Espana, Antonio] Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Inst Invest Saniaria Pere Virgili, Tarragona, Spain; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Universitat Rovira i Virgili; American Museum of Natural History (AMNH)	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Hosp Univ Tarragona Joan 23, Inst Invest Saniaria Pere Virgili, Tarragona, Spain.	antonio.garciaespana@urv.cat	garcia-espana, antonio/I-4756-2015	garcia-espana, antonio/0000-0002-9957-3161; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584	Spanish MINECO; European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO [CSD00065]; Sackler Institute for Comparative Genomics; Korein Foundation; Lewis and Dorothy Cullman Program in Molecular Systematics	Spanish MINECO(Spanish Government); European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO; Sackler Institute for Comparative Genomics; Korein Foundation; Lewis and Dorothy Cullman Program in Molecular Systematics	This work was supported by Spanish MINECO and the European Regional Development Fund (ERDF) grant CONSOLIDER INGENIO 2010 CSD00065 (A.G.E), and the Sackler Institute for Comparative Genomics, the Korein Foundation and the Lewis and Dorothy Cullman Program in Molecular Systematics (R.D.).	Agosti D, 1996, CLADISTICS, V12, P65; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2005, METHODS, V35, P90, DOI 10.1016/j.ymeth.2004.07.012; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Behjati S, 2014, NAT GENET, V46, P376, DOI 10.1038/ng.2921; Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Byrum CA, 2006, DEV BIOL, V300, P194, DOI 10.1016/j.ydbio.2006.08.050; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Chicote J U, 2017, PLOS ONE FORTHCOMING; DeSalle R., 2015, J PHYLOGENET EVOL BI, V3, pE116; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hedges BS, 2009, TIMETREE LIFE; Hendriks WJAJ, 2013, BBA-MOL BASIS DIS, V1832, P1673, DOI 10.1016/j.bbadis.2013.05.022; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; HUELSENBECK J, 2005, MRBAYES VERSION 3 1; Jeon M, 2015, SEMIN CELL DEV BIOL, V37, P119, DOI 10.1016/j.semcdb.2014.09.005; Jeon M, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-3; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kaessmann H, 2002, GENOME RES, V12, P1642, DOI 10.1101/gr.520702; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Ono K, 1999, J MOL EVOL, V48, P654, DOI 10.1007/PL00006509; Ono-Koyanagi K, 2000, J MOL EVOL, V50, P302, DOI 10.1007/s002399910035; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Pulido R, 2013, HUM MOL GENET, V22, pR66, DOI 10.1093/hmg/ddt347; Santhanam A, 2013, FEBS J, V280, P476, DOI 10.1111/j.1742-4658.2012.08696.x; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; Wheeler WC, 1995, MOL PHYLOGENET EVOL, V4, P1, DOI 10.1006/mpev.1995.1001; Yu KR, 2013, ACTA CRYSTALLOGR D, V69, P1522, DOI 10.1107/S0907444913010457	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172887	10.1371/journal.pone.0172887	http://dx.doi.org/10.1371/journal.pone.0172887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257417	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100036
J	Hequet, D; Rouzier, R				Hequet, Delphine; Rouzier, Roman			Determinants of geographic inequalities in HPV vaccination in the most populated region of France	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; YOUNG-ADULT WOMEN; UNITED-STATES; LOW-INCOME; CERVICAL ABNORMALITIES; GENERAL-PRACTITIONERS; ADOLESCENT GIRLS; NATIONAL-HEALTH; CARE PROVIDERS; REDUCTION	Background In France, there are recommendations and reimbursements for human papillomavirus (HPV) vaccination but no HPV vaccination programs. Therefore, vaccination is largely determined by parents' initiative, which can lead to inequalities. The objective of this study was to determine the factors associated with poorer vaccination coverage rates in the most populated region of France. Methods The data of this study were obtained from the National Health Insurance between 2011 and 2013. Correlations between vaccination initiation rate (at least 1 dose reimbursed) and socio-demographic/cultural factors were assessed using Pearson's product-moment correlation coefficient. Multivariate analyses were performed using logistic regression. Results In total, 121,636 girls received at least one HPV vaccine dose. The vaccination rate for girls born from 1996 to 1999 was 18.7%. Disparities in vaccination coverage rates were observed between the 8 departments of the region, ranging from 12.9% to 22.6%. At the department level, unemployment, proportion of immigrants and foreigners, and coverage by CMU health insurance ("Couverture Maladie Universelle", a health insurance plan for those who are not otherwise covered through business or employment and who have a low income) were significantly inversely correlated with vaccination rates, whereas urban residence, medical density, income and use of medical services were not related to coverage. In the multivariate model, only the percentage of foreigners remained independently associated with lower vaccination coverage. At the individual level, the use of medical services was a strong driver of HPV vaccination initiation. Conclusion We observed geographic disparities in HPV vaccination initiation coverage. Even if no clear factor was identified as a vaccination determinant, we observed a failure of vaccination only based on parents' initiative. Therefore, an organized policy on HPV vaccination, such as school-based programs, can help improve coverage rates.	[Hequet, Delphine; Rouzier, Roman] Inst Curie Rene Huguenin, Dept Surg, 35 Rue Dailly, St Cloud, France; [Hequet, Delphine; Rouzier, Roman] Univ Versailles St Quentin, Equipe Accueil Risk & Safety Clin Med Women & Per, 2 Ave Source Bievre, Montigny Le Bretonneux, France	Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Hequet, D (corresponding author), Inst Curie Rene Huguenin, Dept Surg, 35 Rue Dailly, St Cloud, France.; Hequet, D (corresponding author), Univ Versailles St Quentin, Equipe Accueil Risk & Safety Clin Med Women & Per, 2 Ave Source Bievre, Montigny Le Bretonneux, France.	delphine.hequet@gmail.com	; Rouzier, Roman/G-2953-2018	Hequet, Delphine/0000-0001-8926-5651; Rouzier, Roman/0000-0002-8167-6808	Institut National Du Cancer: PAIR_GYNECOLOGIE	Institut National Du Cancer: PAIR_GYNECOLOGIE	This work was funded by Institut National Du Cancer: PAIR_2012 GYNECOLOGIE to Roman Rouzier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSM, 2015, VACC ANT HPV RISQ MA; Bagcchi S, 2015, LANCET ONCOL, V16, pE111, DOI 10.1016/S1470-2045(15)70068-9; Blake KD, 2015, AM J PREV MED, V48, P402, DOI 10.1016/j.amepre.2014.10.024; Bruno DM, 2014, VACCINE, V32, P4149, DOI 10.1016/j.vaccine.2014.05.058; Bynum SA, 2014, J ADOLESCENT HEALTH, V54, P190, DOI 10.1016/j.jadohealth.2013.08.006; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; Conseil National de lOrdre des Me A decins, DEM MED REG IL DE FR; Crowe E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1458; Cummings T, 2012, VACCINE, V30, P5496, DOI 10.1016/j.vaccine.2012.06.057; Fisher H, 2013, INT J EPIDEMIOL, V42, P896, DOI 10.1093/ije/dyt049; Fowler B, 2016, J COMMUN HEALTH, V41, P825, DOI 10.1007/s10900-016-0160-3; Gelman A, 2013, J ADOLESCENT HEALTH, V53, P756, DOI 10.1016/j.jadohealth.2013.07.002; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Haut Conseil de la sante publique, 2014, AV REL UT VACC INF P; Henry KA, 2016, CANCER EPIDEM BIOMAR, V25, P309, DOI 10.1158/1055-9965.EPI-15-0658; Institut de Veille Sanitaire, DOSS THEM VACC HPV 2; Institut National de la Statistique et des Etudes Economiques (INSEE), REV SAL NET ANN MOYE; Institut National de la Statistique et des Etudes Economiques (INSEE), POP IMM SEL PRINC PA; Institut National de la Statistique et des Etudes Economiques (INSEE), POP PRINC NAT 2013 C; Institut National de la Statistique et des Etudes Economiques (INSEE), TAUX CHOM LOC COMP R; Joseph NP, 2014, J PEDIATR ADOL GYNEC, V27, P83, DOI 10.1016/j.jpag.2013.08.011; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lefevere E, 2015, VACCINE, V33, P5188, DOI 10.1016/j.vaccine.2015.07.088; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; Poole T, 2012, VACCINE, V31, P84, DOI 10.1016/j.vaccine.2012.10.099; R Core Team, 2012, R LANG ENV STAT COMP; Schmidt S, 2014, AM J PUBLIC HEALTH, V104, P946, DOI 10.2105/AJPH.2013.301828; Schreiber SMS, 2015, J ADOLESCENT HEALTH, V56, P402, DOI 10.1016/j.jadohealth.2014.12.008; Smith PJ, 2016, VACCINE, V34, P1604, DOI 10.1016/j.vaccine.2016.01.061; Tanday S, 2015, LANCET ONCOL, V16, pE57, DOI 10.1016/S1470-2045(14)71194-5; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Wang W, 2015, VACCINE, V33, P2570, DOI 10.1016/j.vaccine.2015.04.010; Wei FF, 2013, AM J PREV MED, V44, P154, DOI 10.1016/j.amepre.2012.09.061	35	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172906	10.1371/journal.pone.0172906	http://dx.doi.org/10.1371/journal.pone.0172906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257434	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100041
J	Corleis, B; Lisanti, AC; Korner, C; Schiff, AE; Rosenberg, ES; Allen, TM; Altfeld, M; Kwon, DS				Corleis, Bjorn; Lisanti, Antonella C.; Koerner, Christian; Schiff, Abigail E.; Rosenberg, Eric S.; Allen, Todd M.; Altfeld, Marcus; Kwon, Douglas S.			Early type I Interferon response induces upregulation of human beta-defensin 1 during acute HIV-1 infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTOR-3; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; EPITHELIAL-CELLS; HUMAN BETA-DEFENSIN-3; HOST-DEFENSE; INHIBIT HIV; T-CELLS; EXPRESSION	HIV-1 is able to evade innate antiviral responses during acute infection to establish a chronic systemic infection which, in the absence of antiretroviral therapy (ART), typically progresses to severe immunodeficiency. Understanding these early innate immune responses against HIV-1 and their mechanisms of failure is relevant to the development of interventions to better prevent HIV-1 transmission. Human beta defensins (HBDs) are antibacterial peptides but have recently also been associated with control of viral replication. HBD1 and 2 are expressed in PBMCs as well as intestinal tissue, but their expression in vivo during HIV-1 infection has not been characterized. We demonstrate that during acute HIV-1 infection, HBD1 but not HBD2 is highly upregulated in circulating monocytes but returns to baseline levels during chronic infection. HBD1 expression in monocytes can be induced by HIV-1 in vitro, although direct infection may not entirely account for the increase in HBD1 during acute infection. We provide evidence that HIV-1 triggers antiviral IFN-alpha responses, which act as a potent inducer of HBD1. Our results show the first characterization of induction of an HBD during acute and chronic viral infection in humans. HBD1 has been reported to have low activity against HIV-1 compared to other defensins, suggesting that in vivo induced defensins may not significantly contribute to the robust early antiviral response against HIV1. These data provide important insight into the in vivo kinetics of HBD expression, the mechanism of HBD1 induction by HIV-1, and the role of HBDs in the early innate response to HIV-1 during acute infection.	[Corleis, Bjorn; Lisanti, Antonella C.; Koerner, Christian; Schiff, Abigail E.; Allen, Todd M.; Altfeld, Marcus; Kwon, Douglas S.] Harvard Med Sch, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02115 USA; [Rosenberg, Eric S.; Kwon, Douglas S.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Koerner, Christian] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Heinrich Pette Institute	Kwon, DS (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02115 USA.; Kwon, DS (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	dkwon@mgh.harvard.edu	Körner, Christian/ABB-8335-2020; Altfeld, Marcus/AAE-7306-2019; Allen, Todd/F-5473-2011	Körner, Christian/0000-0002-3431-7319; Altfeld, Marcus/0000-0001-5972-2997; Allen, Todd/0000-0002-6609-1318	National Institute of Allergy and Infectious Disease [P01 AI074415, R01DK101354]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part with federal funds from the National Institute of Allergy and Infectious Disease through P01 AI074415 (TMA and MA) and R01DK101354 (DSK). DSK is funded by an award from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alp S, 2005, EUR J MED RES, V10, P1; Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Book M, 2007, CRIT CARE, V11, DOI 10.1186/cc5694; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb; Brenchley JM, 2008, CURR OPIN HIV AIDS, V3, P356, DOI 10.1097/COH.0b013e3282f9ae9c; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Campbell JH., 2014, AIDS; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Drewes JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094375; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Estrada-Aguirre JA, 2014, CURR HIV RES, V12, P220, DOI 10.2174/1570162X12666140708102722; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Feng ZM, 2013, FEBS J, V280, P3365, DOI 10.1111/febs.12328; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Garraud Olivier, 2010, Inflammation & Allergy Drug Targets, V9, P322; Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147; Gootenberg DB, 2017, CURR OPIN INFECT DIS, V30, P31, DOI 10.1097/QCO.0000000000000341; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Lehner T, 2011, Adv Dent Res, V23, P19, DOI 10.1177/0022034511399081; Mangan NE, 2012, IMMUNOL CELL BIOL, V90, P510, DOI 10.1038/icb.2012.13; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meisch JP, 2013, INFLAMM BOWEL DIS, V19, P942, DOI 10.1097/MIB.0b013e318280b11a; Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reinwald S, 2008, J IMMUNOL, V180, P5890, DOI 10.4049/jimmunol.180.9.5890; Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Scagnolari C, 2016, IMMUNOBIOLOGY, V221, P282, DOI 10.1016/j.imbio.2015.10.007; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tomescu C, 2007, J IMMUNOL, V179, P2097, DOI 10.4049/jimmunol.179.4.2097; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Weinberg A, 2006, Adv Dent Res, V19, P42; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zahoor MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106418; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x; Zilbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015389	72	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173161	10.1371/journal.pone.0173161	http://dx.doi.org/10.1371/journal.pone.0173161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253319	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300085
J	Kather, JN; Zollner, FG; Schad, LR; Melchers, SM; Sinn, HP; Marx, A; Gaiser, T; Weis, CA				Kather, Jakob Nikolas; Zoellner, Frank Gerrit; Schad, Lothar R.; Melchers, Susanne Maria; Sinn, Hans-Peter; Marx, Alexander; Gaiser, Timo; Weis, Cleo-Aron			Identification of a characteristic vascular belt zone in human colorectal cancer	PLOS ONE			English	Article							INTRATUMOR HETEROGENEITY; TUMOR MICROENVIRONMENT; MICROVESSEL DENSITY; MAGNETIC-RESONANCE; SOLID TUMORS; ANGIOGENESIS; MODEL; QUANTIFICATION; METAANALYSIS; INTERFACE	Blood vessels in cancer Intra-tumoral blood vessels are of supreme importance for tumor growth, metastasis and therapy. Yet, little is known about spatial distribution patterns of these vessels. Most experimental or theoretical tumor models implicitly assume that blood vessels are equally abundant in different parts of the tumor, which has far-reaching implications for chemotherapy and tumor metabolism. In contrast, based on histological observations, we hypothesized that blood vessels follow specific spatial distribution patterns in colorectal cancer tissue. We developed and applied a novel computational approach to identify spatial patterns of angiogenesis in histological whole-slide images of human colorectal cancer. A characteristic spatial pattern of blood vessels in colorectal cancer In 33 of 34 (97%) colorectal cancer primary tumors blood vessels were significantly aggregated in a sharply limited belt-like zone at the interface of tumor tissue to the intestinal lumen. In contrast, in 11 of 11 (100%) colorectal cancer liver metastases, a similar hypervascularized zone could be found at the boundary to surrounding liver tissue. Also, in an independent validation cohort, we found this vascular belt zone: 22 of 23 (96%) samples of primary tumors and 15 of 16 (94%) samples of liver metastases exhibited the above-mentioned spatial distribution. Summary and implications We report consistent spatial patterns of tumor vascularization that may have far-reaching implications for models of drug distribution, tumor metabolism and tumor growth: luminal hypervascularization in colorectal cancer primary tumors is a previously overlooked feature of cancer tissue. In colorectal cancer liver metastases, we describe a corresponding pattern at the invasive margin. These findings add another puzzle piece to the complex concept of tumor heterogeneity.	[Kather, Jakob Nikolas] Heidelberg Univ, Univ Heidelberg Hosp, Dept Med Oncol & Internal Med 6, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kather, Jakob Nikolas; Marx, Alexander; Gaiser, Timo; Weis, Cleo-Aron] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Kather, Jakob Nikolas; Zoellner, Frank Gerrit; Schad, Lothar R.] Heidelberg Univ, Med Fac Mannheim, Inst Comp Assisted Clin Med, Mannheim, Germany; [Melchers, Susanne Maria] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Sinn, Hans-Peter] Heidelberg Univ, Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kather, JN (corresponding author), Heidelberg Univ, Univ Heidelberg Hosp, Dept Med Oncol & Internal Med 6, Natl Ctr Tumor Dis, Heidelberg, Germany.; Kather, JN (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany.; Kather, JN (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Comp Assisted Clin Med, Mannheim, Germany.	jakob.kather@nct-heidelberg.de	Weis, Cleo-Aron/GVT-8400-2022; Sinn, Hans-Peter/C-5661-2008; Zöllner, Frank G/A-2725-2012; Kather, Jakob Nikolas/D-4279-2015	Sinn, Hans-Peter/0000-0003-2836-6699; Zöllner, Frank G/0000-0003-3405-1394; Kather, Jakob Nikolas/0000-0002-3730-5348	Studienstiftung des Deutschen Volkes	Studienstiftung des Deutschen Volkes	JNK received financial support from Studienstiftung des Deutschen Volkes (no grant number, http://www.studienstiftung.de/en/). The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsat C, 2011, ISRN Obstet Gynecol, V2011, P354861, DOI 10.5402/2011/354861; Bender JL, 2013, J MED INTERNET RES, V15; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Brannon-Peppas L, 2012, ADV DRUG DELIVER REV, V64, P206, DOI 10.1016/j.addr.2012.09.033; Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8; Caie PD, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-156; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; Domsch S, 2014, Z MED PHYS, V24, P231, DOI 10.1016/j.zemedi.2014.03.009; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Ekdawi SN, 2015, J CONTROL RELEASE, V207, P101, DOI 10.1016/j.jconrel.2015.04.006; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Halama N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24116; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Heindl A, 2015, LAB INVEST, V95, P377, DOI 10.1038/labinvest.2014.155; Jayasinghe C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1013-7; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Kather JN, 2015, ONCOTARGET, V6, P19163, DOI 10.18632/oncotarget.4383; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Muralidharan Vijayaragavan, 2014, HPB Surg, V2014, P954604, DOI 10.1155/2014/954604; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Peddareddigari VG, 2010, CANCER MICROENVIRON, V3, P149, DOI 10.1007/s12307-010-0038-3; Pina Y, 2009, OPHTHALMIC RES, V41, P160, DOI 10.1159/000209670; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Raman V, 2006, CANCER RES, V66, P9929, DOI 10.1158/0008-5472.CAN-06-0886; Righi A, 2015, HISTOPATHOLOGY, V66, P982, DOI 10.1111/his.12602; Rijken PFJW, 2000, INT J RADIAT ONCOL, V48, P571, DOI 10.1016/S0360-3016(00)00686-6; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SCHAD LR, 1993, MAGN RESON IMAGING, V11, P889, DOI 10.1016/0730-725X(93)90206-S; Stahl PR, 2015, PATHOL ONCOL RES; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tozer GM, 2003, BRIT J RADIOL, V76, pS23, DOI 10.1259/bjr/30165281; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wainwright J, 2005, ENV MODELLING FINDIN; Welsch U, 2010, ROMEIS MIKROSKOPISCH; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Yuan Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005298; Zlobec I, 2009, WORLD J GASTROENTERO, V15, P5898, DOI 10.3748/wjg.15.5898	45	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0171378	10.1371/journal.pone.0171378	http://dx.doi.org/10.1371/journal.pone.0171378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253263	gold, Green Published			2022-12-27	WOS:000396011300005
J	Caminer, MA; Mila, B; Jansen, M; Fouquet, A; Venegas, PJ; Chavez, G; Lougheed, SC; Ron, SR				Caminer, Marcel A.; Mila, Borja; Jansen, Martin; Fouquet, Antoine; Venegas, Pablo J.; Chavez, German; Lougheed, Stephen C.; Ron, Santiago R.			Systematics of the Dendropsophus leucophyllatus species complex (Anura: Hylidae): Cryptic diversity and the description of two new species	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; FROGS; BIODIVERSITY; AMPHIBIA; TREEFROG; COMMUNITIES	Genetic data in studies of systematics of Amazonian amphibians frequently reveal that purportedly widespread single species in reality comprise species complexes. This means that real species richness may be significantly higher than current estimates. Here we combine genetic, morphological, and bioacoustic data to assess the phylogenetic relationships and species boundaries of two Amazonian species of the Dendropsophus leucophyllatus species group: D. leucophyllatus and D. triangulum. Our results uncovered the existence of five confirmed and four unconfirmed candidate species. Among the confirmed candidate species, three have available names: Dendropsophus leucophyllatus, Dendropsophus triangulum, and Dendropsophus reticulatus, this last being removed from the synonymy of D. triangulum. A neotype of D. leucophyllatus is designated. We describe the remaining two confirmed candidate species, one from Bolivia and another from Peru. All confirmed candidate species are morphologically distinct and have much smaller geographic ranges than those previously reported for D. leucophyllatus and D. triangulum sensu lato. Dendropsophus leucophyllatus sensu stricto occurs in the Guianan region. Dendropsophus reticulatus comb. nov. corresponds to populations in the Amazon basin of Brazil, Ecuador, and Peru previously referred to as D. triangulum. Dendropsophus triangulum sensu stricto is the most widely distributed species; it occurs in Amazonian Ecuador, Peru and Brazil, reaching the state of Para A. We provide accounts for all described species including an assessment of their conservation status.	[Caminer, Marcel A.; Venegas, Pablo J.; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [Caminer, Marcel A.; Mila, Borja] CSIC, Natl Museum Nat Sci, Natl Museum Nat Sci, Madrid, Spain; [Jansen, Martin] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Fouquet, Antoine] Ctr Rech Montabo, CNRS Guyane USR LEEISA, Cayenne, French Guiana; [Venegas, Pablo J.; Chavez, German] Urb Huertos De San Antonio, CORBIDI, Ctr Ornitol & Biodiversidad, Div Herpetol, Lima, Peru; [Lougheed, Stephen C.] Queens Univ, Dept Biol, Kingston, ON, Canada	Pontificia Universidad Catolica del Ecuador; Consejo Superior de Investigaciones Cientificas (CSIC); Senckenberg Gesellschaft fur Naturforschung (SGN); Ifremer; Queens University - Canada	Ron, SR (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador.	santiago.r.ron@gmail.com	Ron, Santiago/J-4203-2019; Rodríguez, Marcel Adrián Caminer/I-1687-2019	Ron, Santiago/0000-0001-6300-9350; Rodríguez, Marcel Adrián Caminer/0000-0002-5827-7462; Chavez, German/0000-0002-9291-156X; Jansen, Martin/0000-0002-2631-4601; venegas, pablo/0000-0002-6501-4492	BIOPAT; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA)	BIOPAT; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA)	This work was supported by BIOPAT. Field and laboratory work were funded by grants from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative; SRR principal investigator), and a grant from Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department for SRR. AFs contribution to this work has benefited from an Investissement dAvenir grant managed by Agence Nationale de la Recherche (CEBA, ref.ANR-10-LABX-25-01), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US GUID; Beireis GC, 1783, SCHRIFTEN BERLIN GES, V4, P178; BLAIR WF, 1958, AM NAT, V92, P27, DOI 10.1086/282007; Bohme W., 1981, Bonner Zoologische Beitraege, V32, P283; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Charif RA, 2010, RAVEN PRO 1 4 USERS; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Coloma LA, 2012, ZOOTAXA, P1; CONDIT JOHN M., 1964, J OHIO HERPETOLOGICAL SOC, V4, P85, DOI 10.2307/1562641; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Daudin FM, 1802, HIST NATURELLE RAINE; De La Riva Ignacio, 1997, Amphibia-Reptilia, V18, P433, DOI 10.1163/156853897X00486; De la Riva Ignacio, 2000, Revista Espanola de Herpetologia, V14, P19; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman W.E., 1974, Occasional Papers Mus Nat Hist Univ Kans, VNo. 27, P1; Duellman W. E., 1977, TIERREICH, V95, P1, DOI DOI 10.2307/1443200; Duellman W.E., 2005, CUSCO AMAZONICO THE; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; DUELLMAN WE, 1978, MISCELLANEOUS PUBLIC, V65, P1; ESRI, 2010, ARCMAP 10 0; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Ferreira RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142893; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2015, ZOOTAXA, V4052, P39, DOI 10.11646/zootaxa.4052.1.2; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Frank N., 1995, COMPLETE GUIDE SCI C; Frost D. R., 2016, AMPHIBIANS SPECIES W; Fund W, 2014, ECOREGION; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goin CJ, 1957, J WASHINGTON ACAD SC, V47, P60; Gunther A.C.L.G., 1869, P ZOOL SOC LOND, V1868, P478; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jansen Martin, 2009, Salamandra, V45, P233; Jansen Martin, 2008, Herpetological Review, V39, P459; Jungfer KH, 2010, SALAMANDRA, V46, P204; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Maddison WP., 2021, MESQUITE MODULAR SYS; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MARQUEZ R, 1993, BIOTROPICA, V25, P426, DOI 10.2307/2388866; Marquez R, 2002, GUIA SONORA RANAS SA; McDiarmid R. W., 1994, MEASURING MONITORING; Moravec J, 2004, HERPETOZOA, V17, P90; Moravec Jiri, 2000, Casopis Narodniho Muzea Rada Prirodovedna, V169, P1; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2007, TRACE 1 4; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rodriguez L. O., 1994, GUIDE FROGS IQUITOS, V22; Ron SR, 2016, AMPHIBIAWEBECUADOR V; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; Salducci MD, 2002, CR BIOL, V325, P141, DOI 10.1016/S1631-0691(02)01423-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schulze A, 2015, ZOOTAXA, V4016, P1, DOI 10.11646/zootaxa.4016.1.1; Schulze Arne, 2009, Salamandra, V45, P75; Sierra R., 1999, MAPA VEGETACION ECUA; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TITUS TA, 1989, HERPETOLOGICA, V45, P17; Toledo LF, 2014, ACTA ETHOLOGICA; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Zwickl DJ., 2006, GENETIC ALGORITHM AP	68	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171785	10.1371/journal.pone.0171785	http://dx.doi.org/10.1371/journal.pone.0171785			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248998	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500018
J	Findlay, KP; Seakamela, SM; Meyer, MA; Kirkman, SP; Barendse, J; Cade, DE; Hurwitz, D; Kennedy, AS; Kotze, PGH; McCue, SA; Thornton, M; Vargas-Fonseca, OA; Wilke, CG				Findlay, Ken P.; Seakamela, S. Mduduzi; Meyer, Michael A.; Kirkman, Stephen P.; Barendse, Jaco; Cade, David E.; Hurwitz, David; Kennedy, Amy S.; Kotze, Pieter G. H.; McCue, Steven A.; Thornton, Meredith; Vargas-Fonseca, O. Alejandra; Wilke, Christopher G.			Humpback whale "super-groups" - A novel low-latitude feeding behaviour of Southern Hemisphere humpback whales (Megaptera novaeangliae) in the Benguela Upwelling System	PLOS ONE			English	Article							WEST-COAST; CETACEAN DISTRIBUTION; POPULATION-STRUCTURE; BALEEN WHALES; MOVEMENTS; MIGRATION; ABUNDANCE; WATERS; DESTINATIONS; AUSTRALIA	Southern Hemisphere humpback whales (Megaptera novaeangliae) generally undertake annual migrations from polar summer feeding grounds to winter calving and nursery grounds in subtropical and tropical coastal waters. Evidence for such migrations arises from seasonality of historic whaling catches by latitude, Discovery and natural mark returns, and results of satellite tagging studies. Feeding is generally believed to be limited to the southern polar region, where Antarctic krill (Euphausia superba) has been identified as the primary prey item. Non-migrations and / or suspended migrations to the polar feeding grounds have previously been reported from a summer presence of whales in the Benguela System, where feeding on euphausiids (E. lucens), hyperiid amphipods (Themisto gaudichaudii), mantis shrimp (Pterygosquilla armata capensis) and clupeid fish has been described. Three recent research cruises (in October/November 2011, October/November 2014 and October/November 2015) identified large tightly-spaced groups (20 to 200 individuals) of feeding humpback whales aggregated over at least a one-month period across a 220 nautical mile region of the southern Benguela System. Feeding behaviour was identified by lunges, strong milling and repetitive and consecutive diving behaviours, associated bird and seal feeding, defecations and the pungent "fishy" smell of whale blows. Although no dedicated prey sampling could be carried out within the tightly spaced feeding aggregations, observations of E. lucens in the region of groups and the full stomach contents of mantis shrimp from both a co-occurring predatory fish species (Thyrsites atun) and one entangled humpback whale mortality suggest these may be the primary prey items of at least some of the feeding aggregations. Reasons for this recent novel behaviour pattern remain speculative, but may relate to increasing summer humpback whale abundance in the region. These novel, predictable, inter-annual, low latitude feeding events provide considerable potential for further investigation of Southern Hemisphere humpback feeding behaviours in these relatively accessible low-latitude waters.	[Findlay, Ken P.; Barendse, Jaco; Thornton, Meredith] Univ Pretoria, Mammal Res Inst, Whale Unit, ZA-0001 Pretoria, Wynberg, South Africa; [Findlay, Ken P.] Cape Peninsula Univ Technol, Res Chair Oceans Econ, Cape Town, South Africa; [Seakamela, S. Mduduzi; Meyer, Michael A.; Kirkman, Stephen P.; Kotze, Pieter G. H.; McCue, Steven A.] Dept Environm Affairs, Branch Oceans & Coasts, Cape Town, South Africa; [Barendse, Jaco] 16 Ebor Rd, Wynberg, South Africa; [Barendse, Jaco] Marine Stewardship Council, 1 Snow Hill, London, England; [Cade, David E.] Stanford Univ, Hopkins Marine Stn, Dept Biol, 120 Ocean View Blvd, Pacific Grove, CA 93950 USA; [Hurwitz, David] 12 Victory Way, Cape Town, South Africa; [Kennedy, Amy S.] Alaska Fisheries Sci Ctr, Marine Mammal Lab, 7600 Sand Point Way NE, Seattle, WA USA; [Vargas-Fonseca, O. Alejandra] ConserBio Fdn, Heredia, Costa Rica; [Wilke, Christopher G.] Dept Agr Forestry & Fisheries, Branch Fisheries Management, Foretrust Bldg, Cape Town, South Africa	University of Pretoria; Cape Peninsula University of Technology; Department of Environment, Forestry & Fisheries; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Findlay, KP (corresponding author), Univ Pretoria, Mammal Res Inst, Whale Unit, ZA-0001 Pretoria, Wynberg, South Africa.; Findlay, KP (corresponding author), Cape Peninsula Univ Technol, Res Chair Oceans Econ, Cape Town, South Africa.	findlayk@cput.ac.za	Barendse, Jaco/F-7064-2012; Seakamela, S Mduduzi/HGA-6807-2022; Kennedy, Amy/O-9947-2017; Kirkman, Stephen/AAA-9139-2021; Findlay, Ken P/A-5766-2019	Barendse, Jaco/0000-0003-2859-4501; Kennedy, Amy/0000-0002-5282-9676; Kirkman, Stephen/0000-0001-5428-7375; Findlay, Ken P/0000-0001-7154-8805; Vargas Fonseca, Olga Alejandra/0000-0002-9131-4624	Simon's Town Boat Company	Simon's Town Boat Company	David Hurwitz is employed by The Simon's Town Boat Company. The Simon's Town Boat Company provided support in the form of salary for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Acevedo J, 2014, MAR MAMMAL SCI, V30, P433, DOI 10.1111/mms.12048; Acevedo J, 2011, REV BIOL MAR OCEANOG, V46, P483, DOI 10.4067/S0718-19572011000300018; Bannister J. L., 1967, Norsk Hvalfangsttidende Sandefjord, V56, P78; BARAFF LS, 1991, MAR MAMMAL SCI, V7, P197, DOI 10.1111/j.1748-7692.1991.tb00567.x; Barendse J, 2011, AFR J MAR SCI, V33, P353, DOI 10.2989/1814232X.2011.637343; Barendse J, 2010, AFR J MAR SCI, V32, P1, DOI 10.2989/18142321003714203; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Best P.B., 1979, FISH B S AFR, V12, P1; BEST PB, 1995, MAR ECOL PROG SER, V118, P1, DOI 10.3354/meps118001; Bortolotto GA, 2016, MARINE BIODIVERSITY, V9; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Brown SG, 1977, VOYAGE DISCOVERY, P569; Carvalho I, 2014, MAR BIOL, V161, P805, DOI 10.1007/s00227-013-2379-1; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Dalla Rosa L, 2008, POLAR BIOL, V31, P771, DOI 10.1007/s00300-008-0415-2; Danielwicz Daniel, 2009, JMBA2 Biodiversity Records, V6348, P1; Dawbin W.H., 1966, SEASONAL MIGRATORY C, P145; Dawbin WH, 1956, MIGRATIONS HUMPBACK, P147; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; Felix F, 2014, AQUAT MAMM, V40, P329, DOI 10.1578/AM.40.4.2014.329; Findlay K. P., 2002, Memoirs of the Queensland Museum, V47, P411; Findlay Ken, 2011, Journal of Cetacean Research and Management, P163; Findlay KP, 1996, MAR MAMMAL SCI, V12, P354, DOI 10.1111/j.1748-7692.1996.tb00589.x; FINDLAY KP, 1995, S AFR J MARINE SCI, V15, P279; Findlay KP, 2011, AFRICAN J MARINE SCI, P33; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Garrigue C, 2015, ROYAL SOC OPEN SCI, V2, DOI [10.1098/rsos.150489, DOI 10.1098/RS0S.150489]; Garrigue C, 2010, J MAMMAL, V91, P109, DOI 10.1644/09-MAMM-A-033R.1; GENDRON D, 1993, MAR MAMMAL SCI, V9, P76, DOI 10.1111/j.1748-7692.1993.tb00428.x; Gill Peter C., 1998, Records of the Queen Victoria Museum, V107, P1; GRIFFITHS CL, 1988, S AFR J MARINE SCI, V7, P45, DOI 10.2989/025776188784379008; Harmer S.F., 1931, P LINN SOC LOND, V142, P85, DOI [10.1111/j.1095-8312.1931.tb01464.x, DOI 10.1111/J.1095-8312.1931.TB01464.X]; Harmer SF, 1927, P LINN SOC LONDON, V1928, P51; Hauser N, 2010, MAR MAMMAL SCI, V26, P679, DOI 10.1111/j.1748-7692.2009.00363.x; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Hinton MAC, REPORT PAPERS LEFT L; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; Huggett J, 2009, PROG OCEANOGR, V83, P197, DOI 10.1016/j.pocean.2009.07.048; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; IWC (International Whaling Commission), 1998, ANN G REP SUBC COMPR; IWC (International Whaling Commission), 2016, ANN H REP SUBC OTH S; Kasamatsu F, 2000, POLAR BIOL, V23, P466, DOI 10.1007/s003009900107; KELLOGG REMINGTON, 1929, SMITHSONIAN INST ANN REPT BOARD OF REGENTS, V1928, P467; Laws R.M., 1977, ADAPTATIONS ANTARCTI, P411; LAWS RM, 1985, AM SCI, V73, P26; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; Mackintosh NA, 1942, SO STOCKS WHALEBONE, P197; Matthews LH, 1938, DISCOVERY REP, V17, P7; Minton Gianna, 2010, Journal of Cetacean Research and Management, V11, P301; Moore SE, 2002, PROG OCEANOGR, V55, P249, DOI 10.1016/S0079-6611(02)00082-4; Morch JA, 1911, P ZOOL SOC LOND, V1911, P661; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; NEMOTO T, 1980, Scientific Reports of the Whales Research Institute Tokyo, P97; Norris K. S., 1967, P101; Nowacek D.P., 2011, PLOS ONE, V6; Olsen O, 1914, BERGENS MUSEUM ARBOK, V5, P1; Omura H., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P105; Owen K, 2015, MAR ECOL PROG SER, V541, P231, DOI 10.3354/meps11551; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Rayner G. W., 1940, Discovery Reports Cambridge, V19, P245; Risting S., 1912, KNOLHVALEN NORSK FIS, V11, P437; Rock J., 2006, Journal of Cetacean Research and Management, V8, P301; Rosenbaum HC, 2014, CONSERV BIOL, V28, P604, DOI 10.1111/cobi.12225; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stockin Karen A., 2005, Aquatic Mammals, V31, P120, DOI 10.1578/AM.31.1.2005.120; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Verheye HM, 2015, ENV DEV; WHITEHEAD H, 1988, CAN J ZOOL, V66, P217, DOI 10.1139/z88-031; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113	79	44	44	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172002	10.1371/journal.pone.0172002	http://dx.doi.org/10.1371/journal.pone.0172002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249036	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500025
J	Garcia-Alvarez, M; Alcoceba, M; Lopez-Parra, M; Puig, N; Anton, A; Balanzategui, A; Prieto-Conde, I; Jimenez, C; Sarasquete, ME; Chillon, MC; Gutierrez, ML; Corral, R; Alonso, JM; Queizan, JA; Vidan, J; Pardal, E; Penarrubia, MJ; Bastida, JM; Garcia-Sanz, R; Marin, L; Gonzalez, M				Garcia-Alvarez, Maria; Alcoceba, Miguel; Lopez-Parra, Miriam; Puig, Noemi; Anton, Alicia; Balanzategui, Ana; Prieto-Conde, Isabel; Jimenez, Cristina; Sarasquete, Maria E.; Carmen Chillon, M.; Laura Gutierrez, Maria; Corral, Rocio; Maria Alonso, Jose; Antonio Queizan, Jose; Vidan, Julia; Pardal, Emilia; Jesus Penarrubia, Maria; Bastida, Jose M.; Garcia-Sanz, Ramon; Marin, Luis; Gonzalez, Marcos			HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; NATURAL-HISTORY; CELIAC-DISEASE; CLASS-I; LEUKEMIA; RISK; POPULATION; DIFFERENTIATION; IMMUNOGLOBULIN; ABNORMALITIES	Introduction Molecular alterations leading progression of asymptomatic CLL-like high-count monoclonal B lymphocytosis (hiMBL) to chronic lymphocytic leukemia (CLL) remain poorly understood. Recently, genome-wide association studies have found 6p21.3, where the human leukocyte antigen (HLA) system is coded, to be a susceptibility risk region for CLL. Previous studies have produced discrepant results regarding the association between HLA and CLL development and outcome, but no studies have been performed on hiMBL. Aims We evaluated the role of HLA class I (-A, -B and -C) and class II (-DRB1 and -DQB1) in hiMBL/CLL susceptibility, hiMBL progression to CLL, and treatment requirement in a large series of 263 patients diagnosed in our center with hiMBL (n = 156) or Binet A CLL (n = 107). Results No consistent association between HLA specificities and hiMBL or CLL susceptibility was found. With a median follow-up of 7.7 years, 48/156 hiMBLs (33%) evolved to asymptomatic CLLs, while 16 hiMBLs (10%) and 44 CLLs (41%) required treatment. No HLA specificities were found to be significantly associated with hiMBL progression or treatment in the whole cohort. However, within antigen-experienced immunoglobulin heavy-chain (IGHV)-mutated hiMBLs, which represents the highest proportion of hiMBL cases (81%), the presence of HLA-DQB1*03 showed a trend to a higher risk of progression to CLL (60% vs. 26%, P = 0.062). Moreover, HLA-DQB1*02 specificity was associated with a lesser requirement for 15-year treatment (10% vs. 36%, P = 0.012). Conclusion In conclusion, our results suggest a role for HLA in IGHV-mutated hiMBL prognosis, and are consistent with the growing evidence of the influence of 6p21 on predisposition to CLL. Larger non-biased series are required to enable definitive conclusions to be drawn.	[Garcia-Alvarez, Maria; Alcoceba, Miguel; Lopez-Parra, Miriam; Puig, Noemi; Anton, Alicia; Balanzategui, Ana; Prieto-Conde, Isabel; Jimenez, Cristina; Sarasquete, Maria E.; Carmen Chillon, M.; Corral, Rocio; Bastida, Jose M.; Garcia-Sanz, Ramon; Marin, Luis; Gonzalez, Marcos] Univ Hosp Salamanca HUS IBSAL, Dept Hematol, Salamanca, Spain; [Alcoceba, Miguel; Maria Alonso, Jose; Antonio Queizan, Jose; Vidan, Julia; Pardal, Emilia; Jesus Penarrubia, Maria; Garcia-Sanz, Ramon; Gonzalez, Marcos] Soc Hematol & Hemotherapy SCLHH, Cooperat Working Grp Lymphomas & Lymphoproliferat, Castilla Leon, Spain; [Alcoceba, Miguel; Carmen Chillon, M.; Marin, Luis; Gonzalez, Marcos] CIBERONC, Madrid, Spain; [Laura Gutierrez, Maria] Canc Res Ctr IBMCC CSIC USAL, Dept Med, Cytometry Serv NUCLEUS, Salamanca, Spain; [Laura Gutierrez, Maria] IBSAL Univ Salamanca, Salamanca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Garcia-Sanz, R (corresponding author), Univ Hosp Salamanca HUS IBSAL, Dept Hematol, Salamanca, Spain.; Garcia-Sanz, R (corresponding author), Soc Hematol & Hemotherapy SCLHH, Cooperat Working Grp Lymphomas & Lymphoproliferat, Castilla Leon, Spain.	rgarcias@usal.es	Chillón, M. Carmen/E-1339-2018; Gutiérrez, María Laura ML/J-4313-2016; sarasquete, Maria E/U-8063-2018; Jiménez, Cristina/A-1532-2019; Alcoceba, Miguel/AAH-2784-2020; Bastida, Jose Maria/F-5726-2016; Gutiérrez, María Laura/AAY-9195-2020; Alcoceba, Miguel/B-7873-2017; Garcia-Sanz, Ramon/B-7986-2017; Alcoceba, Miguel/GXH-4002-2022	Chillón, M. Carmen/0000-0003-1624-6059; Gutiérrez, María Laura ML/0000-0003-2997-6317; sarasquete, Maria E/0000-0001-7335-3657; Jiménez, Cristina/0000-0002-5543-5154; Bastida, Jose Maria/0000-0002-8007-3909; Gutiérrez, María Laura/0000-0003-2997-6317; Alcoceba, Miguel/0000-0002-3819-4846; Garcia-Sanz, Ramon/0000-0003-4120-2787; Alcoceba, Miguel/0000-0002-3819-4846; Marin Rubio, Luis Alberto/0000-0002-9882-0036; Pardal, Emilia/0000-0001-7712-7876	Hematology and Hemotherapy Society of Castilla-Leon [1 FUCALHH-2010]; Instituto de Salud Carlos III (ISCIII) [RTICC-RD12/0036/0069, CIBERONC CB16/12/00233, CEI-2010-1-0010]; European Union FEDER program	Hematology and Hemotherapy Society of Castilla-Leon; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Union FEDER program(European Commission)	This work was supported in part by Grants from the Hematology and Hemotherapy Society of Castilla-Leon (#1 FUCALHH-2010), and the Instituto de Salud Carlos III (ISCIII), award numbers (#2) RTICC-RD12/0036/0069, (#3) CIBERONC CB16/12/00233, and (#4) Innocampus; CEI-2010-1-0010. All ISCIII funding was co-sponsored by the European Union FEDER program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoceba M, 2008, TISSUE ANTIGENS, V71, P548, DOI 10.1111/j.1399-0039.2008.01048.x; Alcoceba M, 2011, TISSUE ANTIGENS, V78, P249, DOI 10.1111/j.1399-0039.2011.01766.x; Alcoceba M, 2013, BLOOD, V122, P1448, DOI 10.1182/blood-2013-02-483420; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Borgerding A, 2010, EXP HEMATOL, V38, P213, DOI 10.1016/j.exphem.2009.12.007; Caporaso NE, 2010, CYTOM PART B-CLIN CY, V78B, pS115, DOI 10.1002/cyto.b.20555; Casabonne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052808; Chaperot L, 1999, EXP HEMATOL, V27, P1185, DOI 10.1016/S0301-472X(99)00057-0; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Drenou B, 2004, BRIT J HAEMATOL, V127, P40, DOI 10.1111/j.1365-2141.2004.05151.x; Drenou B, 2002, BRIT J HAEMATOL, V119, P417, DOI 10.1046/j.1365-2141.2002.03814.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; Gonzalez M, 1999, HAEMATOLOGICA, V84, P779; Marin IGGY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/257517; Gragert L, 2014, BLOOD, V124, P2657, DOI 10.1182/blood-2014-02-558767; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kern W, 2012, BRIT J HAEMATOL, V157, P86, DOI 10.1111/j.1365-2141.2011.09010.x; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; Lech-Maranda E, 2007, HAEMATOL-HEMATOL J, V92, P710, DOI 10.3324/haematol.10910; Liu Y, 2015, INT J CLIN EXP MED, V8, P11490; Machulla HKG, 2001, INT J CANCER, V92, P203, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1167>3.0.CO;2-A; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Molica S, 2011, HAEMATOL-HEMATOL J, V96, P277, DOI 10.3324/haematol.2010.030189; Montes-Ares O, 2006, BRIT J HAEMATOL, V135, P517, DOI 10.1111/j.1365-2141.2006.06334.x; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Parikh SA, 2014, HAEMATOLOGICA, V99, P140, DOI 10.3324/haematol.2013.086066; Plot L, 2009, AUTOIMMUN REV, V8, P316, DOI 10.1016/j.autrev.2008.10.001; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rossi D, 2009, BRIT J HAEMATOL, V146, P64, DOI 10.1111/j.1365-2141.2009.07711.x; Sebastian E, 2012, AM J PATHOL, V181, P1879, DOI 10.1016/j.ajpath.2012.07.028; Seliger B, 2006, INT J CANCER, V118, P129, DOI 10.1002/ijc.21312; Shah N, 2011, LEUKEMIA, V25, P1036, DOI 10.1038/leu.2011.30; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3959, DOI 10.1200/JCO.2008.21.2704; Shanafelt TD, 2009, BLOOD, V113, P4188, DOI 10.1182/blood-2008-09-176149; Slager SL, 2013, SEMIN HEMATOL, V50, P296, DOI 10.1053/j.seminhematol.2013.09.007; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Strati P, 2015, BLOOD, V126, P454, DOI 10.1182/blood-2015-02-585059; Swerdlow SH, 2008, WHO CLASSIFICATION T; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vardi A, 2013, BLOOD, V121, P4521, DOI 10.1182/blood-2012-12-471698; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang SS, 2010, BLOOD, V115, P4820, DOI 10.1182/blood-2010-01-266775; Wilkinson ST, 2012, BLOOD, V119, P1459, DOI 10.1182/blood-2011-07-363820	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172978	10.1371/journal.pone.0172978	http://dx.doi.org/10.1371/journal.pone.0172978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249016	gold, Green Submitted, Green Published			2022-12-27	WOS:000395983500068
J	Garcia-Posadas, L; Soriano-Romani, L; Lopez-Garcia, A; Diebold, Y				Garcia-Posadas, Laura; Soriano-Romani, Laura; Lopez-Garcia, Antonio; Diebold, Yolanda			An engineered human conjunctival-like tissue to study ocular surface inflammatory diseases	PLOS ONE			English	Article							AIR-LIQUID INTERFACE; AMNIOTIC MEMBRANE; EPITHELIAL-CELLS; AUTOLOGOUS FIBRIN; DRY EYE; CULTURE; TRANSPLANTATION; COLLAGEN; SCAFFOLD; MODEL	The aim of this study was to develop a three-dimensional model of the human conjunctiva that can be used to perform physiology and pathophysiology experiments. Fibrin-based matrices (derived from human plasma or plasma cryoprecipitate) were used as scaffolds, and primary cells were obtained from conjunctival tissue. Conjunctival constructs were analyzed by immunofluorescent staining and scanning electron microscopy and cell proliferation was measured with alamarBlue (R) assay. After characterizing the constructs, four different experimental conditions were analyzed in cryoprecipitate matrices: controls, airlifted cultures (to increase cell stratification), partially desiccated cultures (to mimic dry eye disease), and IL-13-treated cultures (to mimic allergy). Constructs were stained with hematoxylin/eosin to observe changes in morphology. High molecular weight glycoconjugates were identified by HPA staining. MUC5AC and IL-6 secretion was evaluated by ELISA. The fibrin-based matrices supported conjunctival cell growth. Epithelial cells grew on the surface of the scaffolds and underwent stratification that increased over time. These cells had microvilli, which suggests cell polarization and functionality. Fibroblasts were integrated in the scaffold and showed elongated shape. Compared to controls, air-lifted construct had increased epithelial stratification and upregulated MUC5AC secretion. Increased MUC5AC secretion also occurred in partially desiccated and IL-13-treated cultures. The inflammatory status of cells was evaluated by IL-6 levels which were increased in air-lifted and partially desiccated cultures, but not in IL-13-treated ones. In conclusion, we have developed a new three-dimensional model of human conjunctiva that can be used to study ocular surface inflammatory diseases.	[Garcia-Posadas, Laura; Soriano-Romani, Laura; Lopez-Garcia, Antonio; Diebold, Yolanda] Univ Valladolid, Inst Appl Ophthalmobiol IOBA, Ocular Surface Grp, Valladolid, Spain; [Garcia-Posadas, Laura; Soriano-Romani, Laura; Lopez-Garcia, Antonio; Diebold, Yolanda] CIBER BBN Biomed Res Networking Ctr Bioengn Bioma, Valladolid, Spain	Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Garcia-Posadas, L (corresponding author), Univ Valladolid, Inst Appl Ophthalmobiol IOBA, Ocular Surface Grp, Valladolid, Spain.; Garcia-Posadas, L (corresponding author), CIBER BBN Biomed Res Networking Ctr Bioengn Bioma, Valladolid, Spain.	Laura_GarciaPosadas@meei.harvard.edu	Soriano-Romaní, Laura/F-4897-2018; García-Posadas, Laura/P-9962-2018; Diebold, Yolanda/A-9087-2016	Soriano-Romaní, Laura/0000-0001-7513-9224; García-Posadas, Laura/0000-0001-9921-8541; Diebold, Yolanda/0000-0003-2990-9368	FEDER-CICYT Grant [MAT2013-47501-C2-1-R]; Ministry of Economy and Competitiveness, Spain; FPI Scholarship Program [BES-2011-046381]; Ministry of Economy and Competitiveness	FEDER-CICYT Grant; Ministry of Economy and Competitiveness, Spain; FPI Scholarship Program; Ministry of Economy and Competitiveness	This work was supported by FEDER-CICYT Grant MAT2013-47501-C2-1-R, Ministry of Economy and Competitiveness, Spain (YD), http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.29bfd64be21cddc5f09dfd1001432ea0/?vgnextoid=fae4b9746e160210VgnVCM1000001034e20aRCRD& and FPI Scholarship Program BES-2011-046381, Ministry of Economy and Competitiveness (LG-P), http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.29bfd64be21cddc5f09dfd1001432ea0/?vgnextoid=fae4b9746e160210VgnVCM1000001034e20aRCRD&vgnextchannel=fae4b9746e160210VgnVCM1000001034e20aRCRD.	Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379; Basu D, 2014, INDIAN J ANAESTH, V58, P529, DOI 10.4103/0019-5049.144647; Bielory L, 2000, J ALLERGY CLIN IMMUN, V106, P1019, DOI 10.1067/mai.2000.111238; Bielory L, 2013, CURR OPIN ALLERGY CL, V13, P537, DOI 10.1097/ACI.0b013e328364d843; Costa LCMC, 2015, J APPL ORAL SCI, V23, P169, DOI 10.1590/1678-775720140187; Cavet ME, 2013, MOL VIS, V19, P1515; Cennamo GL, 2008, EYE, V22, P138, DOI 10.1038/sj.eye.6702873; Chung E, 2015, ACTA BIOMATER, V17, P78, DOI 10.1016/j.actbio.2015.01.012; Chung SH, 2007, EXP EYE RES, V85, P226, DOI 10.1016/j.exer.2007.04.005; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Dartt D a, 2014, CURR OPIN ALLERGY CL, V14, P1; Callejas FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100537; de la Puente P, 2011, J BIOMED MATER RES A, V99A, P648, DOI 10.1002/jbm.a.33231; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2; Drechsler CC, 2015, J TISSUE ENG REGENER; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Eidet JR, 2015, J FUNCT BIOMATER, V6, P1064, DOI 10.3390/jfb6041064; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Fukuda Ken, 2006, Allergol Int, V55, P121, DOI 10.2332/allergolint.55.121; Garcia-Posadas L, 2013, INVEST OPHTH VIS SCI, V54, P7143, DOI 10.1167/iovs.13-12866; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Han B, 2002, CORNEA, V21, P505, DOI 10.1097/00003226-200207000-00013; Howlett J, 2014, J Curr Glaucoma Pract, V8, P63, DOI 10.5005/jp-journals-10008-1163; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koufakis DI, 2006, INVEST OPHTH VIS SCI, V47, P541, DOI 10.1167/iovs.05-0804; Lee J, 2011, GRAEF ARCH CLIN EXP, V249, P1327, DOI 10.1007/s00417-011-1655-3; Leonardi A, 2006, GRAEF ARCH CLIN EXP, V244, P1240, DOI 10.1007/s00417-006-0285-7; Li YK, 2015, SCI WORLD J; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Lodish H, 2000, MOL CELL BIOL; MANCEL E, 1993, AM J OPHTHALMOL, V115, P792, DOI 10.1016/S0002-9394(14)73650-5; Ono K, 2007, MOL VIS, V13, P1138; Rosellini A, 2007, INT J DEV BIOL, V51, P739, DOI 10.1387/ijdb.062198ar; Safinaz MK, 2014, CELL TISSUE BANK, V15, P619, DOI 10.1007/s10561-014-9436-y; Schrader S, 2009, CURR EYE RES, V34, P913, DOI 10.3109/02713680903198045; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Snell RS, 2013, CLIN ANATOMY EYE, P90; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Tan YH, 2011, AM J PHYSIOL-CELL PH, V301, pC115, DOI 10.1152/ajpcell.00375.2010; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; Tatematsu Y, 2012, BONE MARROW TRANSPL, V47, P416, DOI 10.1038/bmt.2011.89; Tost F, 2012, MED SCI MONITOR, V18, pBR188, DOI 10.12659/MSM.882728; Yokoyama F, 2007, J GASTROEN HEPATOL, V22, P2310, DOI 10.1111/j.1440-1746.2006.04729.x; Yoshizawa M, 2004, J ORAL MAXIL SURG, V62, P980, DOI 10.1016/j.joms.2004.02.010; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang JA, 2013, CORNEA, V32, P928, DOI 10.1097/ICO.0b013e3182801622; Zhou HF, 2014, BIOMATERIALS, V35, P7398, DOI 10.1016/j.biomaterials.2014.05.024	53	16	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0171099	10.1371/journal.pone.0171099	http://dx.doi.org/10.1371/journal.pone.0171099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248962	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500010
J	Schnichels, S; Schneider, N; Hohenadl, C; Hurst, J; Schatz, A; Januschowski, K; Spitzer, MS				Schnichels, Sven; Schneider, Nele; Hohenadl, Christine; Hurst, Jose; Schatz, Andreas; Januschowski, Kai; Spitzer, Martin S.			Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment	PLOS ONE			English	Article							ACID; SUBSTITUTES; VITRECTOMY	The efficacy of two novel artificial vitreous body substitutes (VBS) consisting of highly bio-compatible thiolated cross-linked hyaluronic acid (HA)-based hydrogels in comparison to silicone oil in a model of retinal detachment was investigated. Pars plana vitrectomy (23G) was performed in the right eye of 24 pigmented rabbits. Retinal detachment of two quadrants was induced by creating a small retinotomy near the vascular arcade and injecting balanced salt solution (BSS) subretinally. The retina was reattached by injecting air, which was followed by increasing the infusion pressure, and the retinal tear was treated by endolaser photocoagulation. At the end of the procedure, the eye was filled either with 5000-cs silicone oil (after fluid air exchange) or the respective hydrogel (with two different viscosities). Follow- up examination included slit lamp examination, funduscopy, intraocular pressure measurements (IOP), optical coherence tomography (OCT) and electroretinogram (ERG) measurements. After a maximum follow-up of four weeks both eyes were removed, examined macroscopically, photographed, and prepared for histology. Of the eight rabbits that received silicone oil, seven (87.5%) developed a recurrent retinal detachment with pronounced proliferative vitreoretinopathy within the first two weeks after surgery. In contrast, in the hydrogel treated eyes, the retina stayed attached in the majority of the cases (73.3%). IOP and retinal morphology were normal as long as the retina remained re-attached. In conclusions, this model of retinal detachment, both thiolated crosslinked hyaluronate hydrogels showed superior efficacy when compared to silicone oil. These hydrogels have a promising potential as novel vitreous body substitutes.	[Schnichels, Sven; Schneider, Nele; Hurst, Jose; Schatz, Andreas; Januschowski, Kai; Spitzer, Martin S.] Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hohenadl, Christine] Croma Pharma GmbH, Leobendorf, Austria; [Spitzer, Martin S.] Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Martinistr 52, Hamburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Spitzer, MS (corresponding author), Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany.; Spitzer, MS (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Martinistr 52, Hamburg, Germany.	mspitzer@uke.de		Schnichels, Sven/0000-0002-2385-5517; Hurst, Jose/0000-0002-8697-2569	Croma Pharma, Leobendorf, Austria	Croma Pharma, Leobendorf, Austria	The study was supported by Croma Pharma, Leobendorf, Austria that provided the hydrogels and paid for some of the animal experiments. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun J, 2016, RETINA; Azarmina Mohsen, 2011, J Ophthalmic Vis Res, V6, P109; Barth H, 2016, GRAEF ARCH CLIN EXP, V254, P697, DOI 10.1007/s00417-015-3256-z; Gjorloff K, 2004, DOC OPHTHALMOL, V109, P163, DOI 10.1007/s10633-004-3924-5; Hotta K, 2005, RETINA-J RET VIT DIS, V25, P167, DOI 10.1097/00006982-200502000-00009; Joussen AM, 2011, ACTA OPHTHALMOL, V89, pE483, DOI 10.1111/j.1755-3768.2011.02139.x; Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; LEE B, 1992, BIORHEOLOGY, V29, P521; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MEREDITH TA, 1985, BRIT J OPHTHALMOL, V69, P254, DOI 10.1136/bjo.69.4.254; Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042; PRUETT RC, 1979, ARCH OPHTHALMOL-CHIC, V97, P2325, DOI 10.1001/archopht.1979.01020020541006; Schramm C, 2012, INVEST OPHTH VIS SCI, V53, P613, DOI 10.1167/iovs.11-7322; Schultheiss M, 2012, RETINA-J RET VIT DIS, V32, P1343, DOI 10.1097/IAE.0b013e318232c37c; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Szurman P, 2009, KLIN MONATSBL AUGENH, V226, P718, DOI 10.1055/s-0028-1109653; THALER A, 1986, DOC OPHTHALMOL, V62, P41, DOI 10.1007/BF00140545	18	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172895	10.1371/journal.pone.0172895	http://dx.doi.org/10.1371/journal.pone.0172895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248989	gold, Green Submitted, Green Published			2022-12-27	WOS:000395983500061
J	Arts, DL; Abu-Hanna, A; Medlock, SK; van Weert, HCPM				Arts, Derk L.; Abu-Hanna, Ameen; Medlock, Stephanie K.; van Weert, Henk C. P. M.			Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial	PLOS ONE			English	Article							EURO HEART SURVEY; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULANTS; PRIMARY-CARE; RISK FACTOR; METAANALYSIS; PRACTITIONERS; BARRIERS	Background Adherence to guidelines pertaining to stroke prevention in patients with atrial fibrillation is poor. Decision support systems have shown promise in increasing guideline adherence. Aims To improve guideline adherence with a non-obtrusive clinical decision support system integrated in the workflow. Secondly, we seek to capture reasons for guideline non-adherence. Design and setting A cluster randomized controlled trial in Dutch general practices. Method A decision support system was developed that implemented properties positively associated with effectiveness: real-time, non-interruptive and based on data from electronic health records. Recommendations were based on the Dutch general practitioners guideline for atrial fibrillation that uses the CHA(2)DS(2)-VAsc for stroke risk stratification. Usage data and responses to the recommendations were logged. Effectiveness was measured as adherence to the guideline. We used a chi square to test for group differences and a mixed effects model to correct for clustering and baseline adherence. Results Our analyses included 781 patients. Usage of the system was low (5%) and declined over time. In total, 76 notifications received a response: 58% dismissal and 42% acceptance. At the end of the study, both groups had improved, by 8% and 5% respectively. There was no statistically significant difference between groups (Control: 50%, Intervention: 55% P = 0.23). Clustered analysis revealed similar results. Only one usable reasons for non-adherence was captured. Conclusion Our study could not demonstrate the effectiveness of a decision support system in general practice, which was likely due to lack of use. Our findings should be used to develop next generation decision support systems that are effective in the challenging setting of general practice.	[Arts, Derk L.; van Weert, Henk C. P. M.] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Arts, Derk L.; Abu-Hanna, Ameen; Medlock, Stephanie K.] Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Arts, DL (corresponding author), Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.; Arts, DL (corresponding author), Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands.	d.l.arts@amc.nl		Abu-Hanna, Ameen/0000-0003-4324-7954; Arts, Derk/0000-0001-5702-5856	Boehringer Ingelheim; ZORRO foundation	Boehringer Ingelheim(Boehringer Ingelheim); ZORRO foundation	DA was Funded by Boehringer Ingelheim with an unrestricted grant through the ZORRO foundation (no website available).	[Anonymous], 1981, J Fam Pract, V13, P671; Arts DL, 2016, INT J MED INFORM, V89, P55, DOI 10.1016/j.ijmedinf.2016.02.009; Arts DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067806; Arts DL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-193; Ash Joan S, 2007, AMIA Annu Symp Proc, P26; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Cabana Rand CS, 1999, WHY DONT PHYS FOLLOW, P0718; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cook DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122153; Dinh T, 2007, INT J CLIN PRACT, V61, P24, DOI 10.1111/j.1742-1241.2006.01241.x; Dutch College of General Practitioners Guideline Development Group for Atrial fibrillation, 2013, HUISARTS WETENSCHAP, V56, P392; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; Eckman MH, 2014, CIRC-CARDIOVASC QUAL, V7, P680, DOI 10.1161/CIRCOUTCOMES.114.001163; Eslami S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-81; Goud R, 2010, INT J MED INFORM, V79, P430, DOI 10.1016/j.ijmedinf.2010.03.001; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kawamoto K, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-17; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lugtenberg M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0205-z; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; McCoy AB, 2012, J AM MED INFORM ASSN, V19, P346, DOI 10.1136/amiajnl-2011-000185; Medlock S, 2016, J AM MED INFORM ASSO; Moja L, 2014, AM J PUBLIC HEALTH, V104, pE12, DOI 10.2105/AJPH.2014.302164; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Palomaki A, 2015, EUR J NEUROL; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Team R. D. C, 2011, R LANG ENV STAT COMP; Wilson FP, 2015, LANCET, V385, P1966, DOI 10.1016/S0140-6736(15)60266-5; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	38	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0170974	10.1371/journal.pone.0170974	http://dx.doi.org/10.1371/journal.pone.0170974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4LY	28245247	Green Submitted, gold, Green Published			2022-12-27	WOS:000395980200006
J	Castillo, ERD; Taffarel, A; Maronna, MM; Cigliano, MM; Palacios-Gimenez, OM; Cabral-de-Mello, DC; Marti, DA				Castillo, Elio R. D.; Taffarel, Alberto; Maronna, Maximiliano M.; Marta Cigliano, Maria; Palacios-Gimenez, Octavio M.; Cabral-de-Mello, Diogo C.; Marti, Dardo A.			Phylogeny and chromosomal diversification in the Dichroplus elongatus species group (Orthoptera, Melanoplinae)	PLOS ONE			English	Article							NEO-SEX CHROMOSOMES; COMPLEX ROBERTSONIAN SYSTEM; HISTONE H3 GENES; EVOLUTIONARY DYNAMICS; PRATENSIS MELANOPLINAE; GEOGRAPHIC-DISTRIBUTION; FUSION POLYMORPHISMS; REPETITIVE DNA; RIBOSOMAL-RNAS; B-CHROMOSOME	In an attempt to track the chromosomal differentiation in the Dichroplus elongatus species group, we analyzed the karyotypes of four species with classical cytogenetic and mapping several multigene families through fluorescent in situ hybridization (FISH). We improved the taxon sampling of the D. elongatus species group adding new molecular data to infer the phylogeny of the genus and reconstruct the karyotype evolution. Our molecular analyses recovered a fully resolved tree with no evidence for the monophyly of Dichroplus. However, we recovered several stable clades within the genus, including the D. elongatus species group, under the different strategies of tree analyses (Maximum Parsimony and Maximum Likelihood). The chromosomal data revealed minor variation in the D. elongatus species group's karyotypes caused by chromosome rearrangements compared to the phylogenetically related D. maculipennis species group. The karyotypes of D. intermedius and D. exilis described herein showed the standard characteristics found in most Dichroplini, 2n = 23/24, X0 male XX female, Fundamental number (FN) = 23/24. However, we noticed two established pericentric inversions in D. intermedius karyotype, raising the FN to 27 male/28 female. A strong variation in the heterochromatic blocks distribution was evidenced at interespecific level. The multigene families' mapping revealed significant variation, mainly in rDNA clusters. These variations are probably caused by micro chromosomal changes, such as movement of transposable elements (TEs) and ectopic recombination. These observations suggest a high genomic dynamism for these repetitive DNA sequences in related species. The reconstruction of the chromosome character "variation in the FN" posits the FN = 23/24 as the ancestral state, and it is hypothesized that variations due to pericentric inversions has arisen independently three times in the evolutionary history of Dichroplus. One of these independent events occurred in the D. elongatus species group, where D. intermedius is the unique case with the highest FN described in the tribe Dichroplini.	[Castillo, Elio R. D.; Taffarel, Alberto; Marti, Dardo A.] Consejo Nacl Invest Cient & Tecn, UNaM FCEQyN, Inst Biolog Subtrop, Lab Genet Evolut, Felix Azara 1552,Piso 6, Posadas, Misiones, Argentina; [Taffarel, Alberto] CEDIT, Posadas, Misiones, Argentina; [Maronna, Maximiliano M.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Rua Matao,Travessa 14, Sao Paulo, Brazil; [Marta Cigliano, Maria] UNLP, CONICET, CCT La Plata, CEPAVE,Museo La Plata, La Plata, Buenos Aires, Argentina; [Palacios-Gimenez, Octavio M.; Cabral-de-Mello, Diogo C.] UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Rio Claro, SP, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidade Estadual Paulista	Castillo, ERD (corresponding author), Consejo Nacl Invest Cient & Tecn, UNaM FCEQyN, Inst Biolog Subtrop, Lab Genet Evolut, Felix Azara 1552,Piso 6, Posadas, Misiones, Argentina.	castillo.eliorodrigo@gmail.com	Cabral-de-Mello, Diogo C/F-5328-2010; Maronna, Maximiliano/AAY-6734-2020; Maronna, Maximiliano M/G-9432-2016; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012	Maronna, Maximiliano/0000-0002-2590-639X; Maronna, Maximiliano M/0000-0002-2590-639X; Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655; Castillo, Elio Rodrigo Daniel/0000-0003-0154-8337; Taffarel, Alberto/0000-0002-9479-5152	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [11420100100312]; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2014/11763-8, 2014/02038-8]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [304758/2014-0]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundagao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors received specific funding from: Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2011-2013 N 11420100100312]; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (process numbers 2014/11763-8; 2014/02038-8) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (process number 304758/2014-0).	Belyayev A, 2001, HEREDITY, V86, P738, DOI 10.1046/j.1365-2540.2001.00891.x; Bidau C. J., 1995, Proceedings of the Kew chromosome conference IV, held at the Jodrell Laboratory, Royal Botanic Gardens, Kew, UK, 30 August-2 September 1994., P381; Bidau CJ, 2002, CYTOGENET GENOME RES, V96, P66, DOI 10.1159/000063048; BIDAU CJ, 1991, GENET SEL EVOL, V23, P353, DOI 10.1051/gse:19910501; BIDAU CJ, 1990, HEREDITY, V64, P145, DOI 10.1038/hdy.1990.19; Bidau CJ, 2000, GENETICA, V110, P185, DOI 10.1023/A:1017908213431; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Cabral-De-Mello DC, 2011, CYTOGENET GENOME RES, V132, P89, DOI 10.1159/000317476; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Carbonell C, 2006, ESPECIES ACRIDOMORFO; Castillo E.R.D., 2011, REV CIENC TECNOL, V16, P31; Castillo ERD, 2016, ZOOL SCI, V33, P303, DOI 10.2108/zs150165; Castillo ERD, 2014, EUR J ENTOMOL, V111, P321, DOI 10.14411/eje.2014.047; Castillo ERD, 2010, GENETICA, V138, P775, DOI 10.1007/s10709-010-9458-8; Castillo Elio Rodrigo Daniel, 2009, Check List, V5, P475; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Colombo P, 2005, CLADISTICS, V21, P375, DOI 10.1111/j.1096-0031.2005.00068.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dinghi PA, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2174.1.6; Frandsen PB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0283-7; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, TREE ANAL USING NEW; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hewitt G.M., 1979, ANIMAL CYTOGENETICS; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Litzenberger G, 2001, HEREDITY, V86, P54, DOI 10.1046/j.1365-2540.2001.00806.x; Mandrioli M, 2000, GENETICA, V108, P191, DOI 10.1023/A:1004199902680; Mesa A., 1963, Revista de la Sociedad Uruguaya de Entomologia, V5, P37; Mesa A, 1982, ANNIS SOC ENT FR, V18, P526; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; Palacios-Gimenez OM, 2015, CHROMOSOMA, V124, P353, DOI 10.1007/s00412-015-0505-1; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pollock DD, 2000, MOL BIOL EVOL, V17, P1854, DOI 10.1093/oxfordjournals.molbev.a026286; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Remis MI, 2004, CYTOGENET GENOME RES, V106, P359, DOI 10.1159/000079313; Remis MI, 2000, HEREDITY, V84, P548, DOI 10.1046/j.1365-2540.2000.00697.x; Robinson O, 2016, MOL BIOL EVOL; Rodrigo Castillo Elio, 2010, Journal of Orthoptera Research, V19, P213, DOI 10.1665/034.019.0207; RONDEROS R A, 1967, REVISTA DEL MUSEO DE LA PLATA SECCION ZOOLOGIA, V10, P69; Ronderos R. A., 1968, Revista del Museo de La Plata Zoologia, V10, P271; Ronderos RA, 1976, NEOTROPICA, V22, P41; Rosetti Natalia, 2010, Journal of Orthoptera Research, V19, P261, DOI 10.1665/034.019.0212; Rufas J., 1985, ORTHOPTERA, V1, P227; SAEZ FA, 1977, GENETICA, V47, P105, DOI 10.1007/BF00120174; Saez FA, 1971, RECIENTES ADELANTOS, P111; Sambrook J., 2001, MOL CLONING LAB MANU; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Taffarel A, 2015, EUR J ENTOMOL, V112, P11, DOI 10.14411/eje.2015.010; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Veronica Guzman Noelia, 2010, Journal of Orthoptera Research, V19, P253, DOI 10.1665/034.019.0211; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL	66	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172352	10.1371/journal.pone.0172352	http://dx.doi.org/10.1371/journal.pone.0172352			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245223	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200019
J	Lucas-Cuevas, AG; Camacho-Garcia, A; Llinares, R; Quesada, JIP; Llana-Belloch, S; Perez-Soriano, P				Gabriel Lucas-Cuevas, Angel; Camacho-Garcia, Andres; Llinares, Raul; Priego Quesada, Jose Ignacio; Llana-Belloch, Salvador; Perez-Soriano, Pedro			Influence of custom-made and prefabricated insoles before and after an intense run	PLOS ONE			English	Article							TIBIAL STRESS-FRACTURE; GROUND REACTION FORCE; SHOCK ATTENUATION; LOWER-EXTREMITY; IMPACT FORCES; PERCEIVED EXERTION; MIDSOLE THICKNESS; OVERUSE INJURIES; PLANTAR PRESSURE; STRIKE PATTERN	Each time the foot contacts the ground during running there is a rapid deceleration that results in a shock wave that is transmitted from the foot to the head. The fatigue of the musculoskeletal system during running may decrease the ability of the body to absorb those shock waves and increase the risk of injury. Insoles are commonly prescribed to prevent injuries, and both custom-made and prefabricated insoles have been observed to reduce shock accelerations during running. However, no study to date has included a direct comparison of their behaviour measured over the same group of athletes, and therefore great controversy still exists regarding their effectiveness in reducing impact loading during running. The aim of the study was to analyse the acute differences in stride and shock parameters while running on a treadmill with custom-made and prefabricated insoles. Stride parameters (stride length, stride rate) and shock acceleration parameters (head and tibial peak acceleration, shock magnitude, acceleration rate, and shock attenuation) were measured using two triaxial accelerometers in 38 runners at 3.33 m/s before and after a 15-min intense run while using the sock liner of the shoe (control condition), prefabricated insoles and custom-made insoles. No differences in shock accelerations were found between the custom-made and the control insoles. The prefabricated insoles increased the head acceleration rate (post-fatigue, p = 0.029) compared to the control condition. The custom-made reduced tibial (pre-fatigue, p = 0.041) and head acceleration rates (pre-fatigue and post-fatigue, p = 0.01 and p = 0.046) compared to the prefabricated insoles. Neither the stride nor the acceleration parameters were modified as a result of the intense run. In the present study, the acute use of insoles (custom-made, prefabricated) did not reduce shock accelerations compared to the control insoles. Therefore, their effectiveness at protecting against injuries associated with elevated accelerations is not supported and remains unclear.	[Gabriel Lucas-Cuevas, Angel; Priego Quesada, Jose Ignacio; Llana-Belloch, Salvador; Perez-Soriano, Pedro] Univ Valencia, Dept Phys Educ & Sports, Res Grp Sport Biomech GIBD, Valencia, Spain; [Camacho-Garcia, Andres; Llinares, Raul] Univ Politecn Valencia, Alcoy, Spain; [Priego Quesada, Jose Ignacio] Univ Valencia, Dept Physiol, Biophys & Med Phys Grp, Valencia, Spain	University of Valencia; Universitat Politecnica de Valencia; University of Valencia	Lucas-Cuevas, AG (corresponding author), Univ Valencia, Dept Phys Educ & Sports, Res Grp Sport Biomech GIBD, Valencia, Spain.	angel.lucas@uv.es	García, Andrés Camacho/G-2037-2010; Llinares, Raul/AAB-1334-2019; Priego-Quesada, Jose Ignacio/D-3424-2013	García, Andrés Camacho/0000-0001-8542-4264; Priego-Quesada, Jose Ignacio/0000-0002-0375-1454	Spanish Government (Ministerio de Educacion, Cultura y Deporte, Grant FPU); Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion, Convocatoria Proyectos I+D Excelencia, Subprograma de Generacion de Conocimiento [DEP2013-48420-P]	Spanish Government (Ministerio de Educacion, Cultura y Deporte, Grant FPU); Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion, Convocatoria Proyectos I+D Excelencia, Subprograma de Generacion de Conocimiento	This work was supported by the Spanish Government (Ministerio de Educacion, Cultura y Deporte, Grant FPU; and Ministerio de Economia y Competitividad, Subdireccion General de Proyectos de Investigacion, Convocatoria Proyectos I+D Excelencia, Subprograma de Generacion de Conocimiento, 2013, Grant DEP2013-48420-P).	Aguinaldo A, 2003, J APPL BIOMECH, V19, P353, DOI 10.1123/jab.19.4.353; [Anonymous], RES RANDOMIZER; Garcia-Perez JA, 2014, SPORT BIOMECH, V13, P259, DOI 10.1080/14763141.2014.909527; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Butler RJ, 2007, GAIT POSTURE, V26, P219, DOI 10.1016/j.gaitpost.2006.09.015; CAMPBELL G, 1982, PROSTHET ORTHOT INT, V6, P48; Campbell G J, 1984, J Rehabil Res Dev, V21, P57; Cavanagh P.R., 1980, RUNNING SHOE BOOK; Chambon N, 2014, GAIT POSTURE, V40, P58, DOI 10.1016/j.gaitpost.2014.02.005; Clansey AC, 2012, MED SCI SPORT EXER, V44, P1917, DOI 10.1249/MSS.0b013e318259480d; Clinghan R, 2008, BRIT J SPORT MED, V42, P189, DOI 10.1136/bjsm.2007.038844; Creaby MW, 2011, ERGONOMICS, V54, P665, DOI 10.1080/00140139.2011.592600; Crowell HP, 2011, CLIN BIOMECH, V26, P78, DOI 10.1016/j.clinbiomech.2010.09.003; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Derrick TR, 2004, MED SCI SPORT EXER, V36, P832, DOI 10.1249/01.MSS.0000126779.65353.CB; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; Dixon SJ, 2007, MIL MED, V172, P446, DOI 10.7205/MILMED.172.4.446; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Dixon SJ, 2003, MED SCI SPORT EXER, V35, P472, DOI 10.1249/01.MSS.0000053733.64049.27; Foch E, 2015, GAIT POSTURE, V41, P706, DOI 10.1016/j.gaitpost.2015.01.031; Lucas-Cuevas AG, 2014, J SPORT SCI, V32, P1712, DOI 10.1080/02640414.2014.915422; Gerlach KE, 2005, MED SCI SPORT EXER, V37, P657, DOI 10.1249/01.MSS.0000158994.29358.71; Giandolini M, 2016, J BIOMECH, V49, P1765, DOI 10.1016/j.jbiomech.2016.04.001; Gijon-Nogueron G, 2014, PROSTHET ORTHOT INT; Gijon-Nogueron G, 2013, PROSTHET ORTHOT INT, V37, P495, DOI 10.1177/0309364613482844; Grech C, 2016, J ORTHOP, V13, P148, DOI 10.1016/j.jor.2016.03.011; Hinz P, 2008, GAIT POSTURE, V27, P535, DOI 10.1016/j.gaitpost.2007.06.005; Hirschmuller A, 2011, BRIT J SPORT MED, V45, P959, DOI 10.1136/bjsm.2008.055830; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; HUNTER S, 1995, FOOT ORTHOTICS THERA; Lan-Yuen Guo, 2006, Biomedical Engineering, Applications Basis Communications, V18, P73; Laughton CA, 2003, J APPL BIOMECH, V19, P153, DOI 10.1123/jab.19.2.153; Lee YC, 2012, WORK, V41, P1114, DOI 10.3233/WOR-2012-0290-1114; Lucas-Cuevas AG, 2015, INT J SPORTS MED, V36, P826, DOI 10.1055/s-0035-1548813; Lucas-Cuevas AG, 2014, ERGONOMICS, V57, P1590, DOI 10.1080/00140139.2014.938129; McArdle W.D., 2006, ESSENTIALS EXERCISE; Mercer JA, 2003, J SPORT SCI, V21, P911, DOI 10.1080/0264041031000140383; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Mizrahi J, 2000, ANN BIOMED ENG, V28, P463, DOI 10.1114/1.284; Mizrahi J, 2012, INJURY SKELETAL BIOM; Nagel A, 2008, GAIT POSTURE, V27, P152, DOI 10.1016/j.gaitpost.2006.12.012; Nielsen RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099877; NIGG BM, 1987, J BIOMECH, V20, P951, DOI 10.1016/0021-9290(87)90324-1; Nigg BM, 2015, BRIT J SPORT MED; O'Leary K, 2008, J AM PODIAT MED ASSN, V98, P36, DOI 10.7547/0980036; Parks T. W., 1987, DIGITAL FILTER DESIG; PRATT DJ, 1989, CLIN BIOMECH, V4, P51, DOI 10.1016/0268-0033(89)90068-5; RADIN EL, 1991, J ORTHOPAED RES, V9, P398, DOI 10.1002/jor.1100090312; TenBroek TM, 2013, FOOTWEAR SCI, V5, P27, DOI 10.1080/19424280.2012.744360; Tessutti V, 2010, J SCI MED SPORT, V13, P151, DOI 10.1016/j.jsams.2008.07.008; Van Ginckel A, 2009, GAIT POSTURE, V29, P387, DOI 10.1016/j.gaitpost.2008.10.058; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; Weist R, 2004, AM J SPORT MED, V32, P1893, DOI 10.1177/0363546504265191; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7; Windle CM, 1999, GAIT POSTURE, V9, P31, DOI 10.1016/S0966-6362(99)00002-8; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	57	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173179	10.1371/journal.pone.0173179	http://dx.doi.org/10.1371/journal.pone.0173179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245273	gold, Green Submitted, Green Published			2022-12-27	WOS:000395980200058
J	Huang, KL; Liu, SY; Chou, CCK; Lee, YH; Cheng, TJ				Huang, Kuo-Liang; Liu, Szu-Yuan; Chou, Charles C. K.; Lee, Yi-Hsin; Cheng, Tsun-Jen			The effect of size-segregated ambient particulate matter on Th1/Th2-like immune responses in mice	PLOS ONE			English	Article							AIR-POLLUTION; CHEMICAL-COMPOSITION; DENDRITIC CELLS; MOUSE MODELS; ASTHMA; EXPOSURE; PARTICLES; COARSE; HEALTH; LUNG	Background Particulate matter (PM) has been associated with increased pulmonary and cardiovascular mortality and morbidity. Additionally, PM is known to exacerbate asthma. However, whether ambient PM exposure contributes to the onset of asthma, especially in non-atopic children and adults, is less conclusive. The current study aimed to evaluate the effects of size-fractioned PM on lung immune responses in healthy BALB/c mice. Methods and principal findings We collected PM10, PM2.5, PM1 and PM0.1 samples from October 2012 to August 2013 in the Taipei Basin. These PM samples were representative of urban traffic pollution. The samples were extracted and sonicated in phosphate-buffered saline (PBS). Female BALB/c mice were exposed to the samples via intratracheal instillation at three different doses: 1.75 mg/kg (35 mu g/per mouse), 5 mg/kg (100 mu g/per mouse), and 12.5 mg/kg (250 mu g/per mouse). The mice were exposed on days 0 and 7, and PBS alone was used as a control. Following the exposures, the expression profiles of inflammatory cells and cytokines in bronchoalveolar lavage fluid (BALF) were assessed. Exposure to PM10 resulted in inflammatory responses, including the recruitment of neutrophils and the induction of T helper 1 (Th1) cell-related cytokine release, such as TNF-alpha and IFN-gamma. Furthermore, an allergic immune response, including the recruitment of eosinophils and the up-regulation of T helper 2 (Th2) cell-related cytokine release, such as IL-5 and IL-13, was also observed in the BALF of mice exposed to PM10. Conclusions Our study showed that exposure to PM alone caused mixed Th1/Th2 inflammatory responses in healthy mice. These findings support the hypothesis that PM may contribute to the onset of asthma.	[Huang, Kuo-Liang] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Pulm Med, New Taipei, Taiwan; [Huang, Kuo-Liang; Liu, Szu-Yuan; Cheng, Tsun-Jen] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chou, Charles C. K.] Acad Sinica, Res Ctr Environm Change, Taipei, Taiwan; [Lee, Yi-Hsin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Pathol, New Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; Academia Sinica - Taiwan; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital	Cheng, TJ (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.	tcheng@ntu.edu.tw	Chou, Charles C.-K./R-3578-2016	Chou, Charles C.-K./0000-0003-3960-5333; Huang, Kuo-Liang/0000-0001-6176-9989; CHENG, TSUN-JEN/0000-0002-2613-8230	National Science Council of Taiwan [NSC 101-2314-B-002-005-116-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of Taiwan (https://www.most.gov.tw/) (grant number NSC 101-2314-B-002-005-116-MY2). The funders had no role in the study design, data collection, analysis and interpretation, decision to publish or preparation of the manuscript.	Alexis NE, 2006, J ALLERGY CLIN IMMUN, V117, P1396, DOI 10.1016/j.jaci.2006.02.030; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barbe F, 2014, CYTOKINE GROWTH F R, V25, P681, DOI 10.1016/j.cytogfr.2014.07.001; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bezemer GFG, 2011, J INNATE IMMUN, V3, P150, DOI 10.1159/000321725; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Cho SH, 2009, ENVIRON HEALTH PERSP, V117, P1682, DOI 10.1289/ehp.0900730; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; de Haar C, 2008, J ALLERGY CLIN IMMUN, V121, P1246, DOI 10.1016/j.jaci.2008.01.010; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470; Dye JA, 2001, ENVIRON HEALTH PERSP, V109, P395, DOI 10.2307/3434787; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379; Goldsmith Carroll-Ann W., 1999, Reviews on Environmental Health, V14, P121; Gugamsetty B, 2012, AEROSOL AIR QUAL RES, V12, P476, DOI 10.4209/aaqr.2012.04.0084; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Happo MS, 2010, INHAL TOXICOL, V22, P17, DOI 10.3109/08958370902862426; Happo MS, 2008, INHAL TOXICOL, V20, P1215, DOI 10.1080/08958370802147282 ; Heinrich J, 1999, ENVIRON HEALTH PERSP, V107, P53, DOI 10.2307/3434289; Hirota JA, 2015, AM J RESP CELL MOL, V52, P96, DOI 10.1165/rcmb.2014-0158OC; Huang KL, 2015, J HAZARD MATER, V297, P304, DOI 10.1016/j.jhazmat.2015.05.023; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lee YL, 2007, PEDIAT ALLERG IMM-UK, V18, P188, DOI 10.1111/j.1399-3038.2006.00504.x; Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010; Li N, 2009, ENVIRON HEALTH PERSP, V117, P1116, DOI 10.1289/ehp.0800319; Lin M, 2002, ENVIRON HEALTH PERSP, V110, P575, DOI 10.1289/ehp.02110575; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Matthews NC, 2016, AM J RESP CELL MOL, V54, P250, DOI 10.1165/rcmb.2015-0084OC; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Park YM, 2010, ALLERGY ASTHMA IMMUN, V2, P87, DOI 10.4168/aair.2010.2.2.87; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schlesinger RB, 2003, INHAL TOXICOL, V15, P197, DOI 10.1080/08958370304503; Steerenberg PA, 2005, INHAL TOXICOL, V17, P133, DOI 10.1080/08958370590904490; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; US-EPA, 2004, AIR QUAL CRIT PART M; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Williams MA, 2007, J ALLERGY CLIN IMMUN, V119, P488, DOI 10.1016/j.jaci.2006.10.022; Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x	59	38	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173158	10.1371/journal.pone.0173158	http://dx.doi.org/10.1371/journal.pone.0173158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245275	Green Published, gold, Green Submitted			2022-12-27	WOS:000395980200057
J	Hwang, M; Lim, B; Song, JS; Yu, HT; Ryu, AJ; Lee, YS; Joung, B; Shim, EB; Pak, HN				Hwang, Minki; Lim, Byounghyun; Song, Jun-Seop; Yu, Hee Tae; Ryu, Ah-Jin; Lee, Young-Seon; Joung, Boyoung; Shim, Eun Bo; Pak, Hui-Nam			Ganglionated plexi stimulation induces pulmonary vein triggers and promotes atrial arrhythmogenecity: In silico modeling study	PLOS ONE			English	Article							CATHETER ABLATION; FIBRILLATION; DYNAMICS; LOCALIZATION; MECHANISMS; ARRHYTHMIA; MYOCYTES; INSIGHTS; REENTRY	Background The role of the autonomic nervous system (ANS) on atrial fibrillation (AF) is difficult to demonstrate in the intact human left atrium (LA) due to technical limitations of the current electrophysiological mapping technique. We examined the effects of the ANS on the initiation and maintenance of AF by employing a realistic in silico human left atrium (LA) model integrated with a model of ganglionated plexi (GPs). Methods We incorporated the morphology of the GP and parasympathetic nerves in a three-dimensional (3D) realistic LA model. For the model of ionic currents, we used a human atrial model. GPs were stimulated by increasing the I-K[ACh], and sympathetic nerve stimulation was conducted through a homogeneous increase in the ICa-L. ANS-induced wave-dynamics changes were evaluated in a model that integrated a patient's LA geometry, and we repeated simulation studies using LA geometries from 10 different patients. Results The two-dimensional model of pulmonary vein (PV) cells exhibited late phase 3 early after-depolarization-like activity under 0.05 mu M acetylcholine (ACh) stimulation. In the 3D simulation model, PV tachycardia was induced, which degenerated to AF via GP (0.05 mu M ACh) and sympathetic (7.0xI(Ca-L)) stimulations. Under sustained AF, local reentries were observed at the LA-PV junction. We also observed that GP stimulation reduced the complex fractionated atrial electrogram (CFAE)-cycle length (CL, p < 0.01) and the life span of phase singularities (p< 0.01). GP stimulation also increased the overlap area of the GP and CFAE areas (CFAE-CL <= 120ms, p < 0.01). When 3 patterns of virtual ablations were applied to the 3D AF models, circumferential PV isolation including the GP was the most effective in terminating AF. Conclusion Cardiac ANS stimulations demonstrated triggered activity, automaticity, and local reentries at the LA-PV junction, as well as co-localized GP and CFAE areas in the 3D in silico GP model of the LA.	[Hwang, Minki; Lim, Byounghyun; Song, Jun-Seop; Yu, Hee Tae; Lee, Young-Seon; Joung, Boyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea; [Ryu, Ah-Jin; Shim, Eun Bo] Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea	Yonsei University; Yonsei University Health System; Kangwon National University	Pak, HN (corresponding author), Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea.	ebshim@kangwon.ac.kr; hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Joung, Boyoung/0000-0001-9036-7225; Song, Jun-Seop/0000-0002-5886-4210; Pak, Hui-Nam/0000-0002-3256-3620	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059391]	Korea Health 21 R&D Project, Ministry of Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza F, 2014, J AM COLL CARDIOL, V64, P2455, DOI 10.1016/j.jacc.2014.09.053; Buch E, 2015, HEART RHYTHM OFFICIA; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Cha TJ, 2005, CIRCULATION, V111, P728, DOI 10.1161/01.CIR.0000155240.05251.D0; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Cheng TH, 1996, MOL CELL BIOCHEM, V157, P157; Chou CC, 2005, CIRCULATION, V111, P2889, DOI 10.1161/CIRCULATIONAHA.104.498758; Chugh A, 2013, J AM COLL CARDIOL, V62, P2326, DOI 10.1016/j.jacc.2013.07.055; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Haissaguerre M, 2014, CIRCULATION, V130, P530, DOI 10.1161/CIRCULATIONAHA.113.005421; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Lee YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150779; Morotti S, 2016, J MOL CELL CARDIOL, V96, P63, DOI 10.1016/j.yjmcc.2015.07.030; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; OUADID H, 1995, J CARDIOVASC PHARM, V25, P282, DOI 10.1097/00005344-199502000-00014; Patterson E, 2006, J AM COLL CARDIOL, V47, P1196, DOI 10.1016/j.jacc.2005.12.023; Sarmast F, 2003, CARDIOVASC RES, V59, P863, DOI 10.1016/S0008-6363(03)00540-6; Vandersickel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084595; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Yun Y, 2014, J KOREAN MED SCI, V29, P370, DOI 10.3346/jkms.2014.29.3.370; Zahid S, 2016, CARDIOVASC RES, V110, P443, DOI 10.1093/cvr/cvw073; ZHOU Jing, 2007, ELECT COMPONENT DEVI, V09, P18, DOI DOI 10.1111/J.1540-8167.2006.00679.X; Zozor S, 2003, IEEE T BIO-MED ENG, V50, P412, DOI 10.1109/TBME.2003.809505	28	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172931	10.1371/journal.pone.0172931	http://dx.doi.org/10.1371/journal.pone.0172931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245283	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200043
J	Hirooka, K; Saito, W; Namba, K; Mizuuchi, K; Iwata, D; Hashimoto, Y; Ishida, S				Hirooka, Kiriko; Saito, Wataru; Namba, Kenichi; Mizuuchi, Kazuomi; Iwata, Daiju; Hashimoto, Yuki; Ishida, Susumu			Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi- Harada disease treated with systemic corticosteroids	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INFLAMMATION; RECURRENCE; THERAPY	Purpose To determine if early post-treatment central choroidal thickness (CCT) changes can predict sunset glow fundus (SGF) development in patients with Vogt-Koyanagi-Harada (VKH) disease treated using systemic corticosteroids. Methods This retrospective case series included 39 eyes of 21 treatment-naive patients with acute VKH disease who could be followed up for more than 12 months after systemic corticosteroid therapy. The eyes were divided into two groups according to whether SGF was present or absent at 12 months (9 eyes of 5 patients versus 30 eyes of 16 patients, respectively). Using enhanced depth imaging optical coherence tomography, CCT values were measured before treatment, then at 1 week and 1 and 3 months after treatment in both groups and compared between the two groups. Results Development of SGF was found 4-11 months after treatment. Mean post-treatment CCT decreased significantly at all examinations compared with baseline in both groups, along with resolution of serous retinal detachment. One week after treatment, mean CCT was significantly higher in eyes with SGF than in those without (P = 0.024). SGF was present at 12 months in 9 of 22 eyes with CCT values > 410 mu m at 1 week after starting treatment, in contrast with none of 17 eyes with CCT <= 410 mu m at this time (P = 0.003). Conclusions The current study suggested the potential validity of early post-treatment CCT as a feasible index to alert future progression to SGF in patients with VKH disease treated using systemic corticosteroids.	[Hirooka, Kiriko; Saito, Wataru; Namba, Kenichi; Mizuuchi, Kazuomi; Iwata, Daiju; Hashimoto, Yuki; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Saito, Wataru] Kaimeido Eye & Dent Clin, Sapporo, Hokkaido, Japan	Hokkaido University	Saito, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.; Saito, W (corresponding author), Kaimeido Eye & Dent Clin, Sapporo, Hokkaido, Japan.	wsaito@med.hokudai.ac.jp		Saito, Wataru/0000-0001-8181-6252				GOTO H, 1990, INT OPHTHALMOL CLIN, V30, P279, DOI 10.1097/00004397-199030040-00014; Greco A, 2013, AUTOIMMUN REV, V12, P1033, DOI 10.1016/j.autrev.2013.01.004; Hashizume K, 2014, ACTA OPHTHALMOL, V92, pE490, DOI 10.1111/aos.12384; Hirooka K, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0171-3; Hirooka K, 2015, GRAEF ARCH CLIN EXP, V253, P609, DOI 10.1007/s00417-014-2927-5; Keino H, 2002, GRAEF ARCH CLIN EXP, V240, P878, DOI 10.1007/s00417-002-0538-z; Keino H, 2006, AM J OPHTHALMOL, V141, P1140, DOI 10.1016/j.ajo.2006.01.017; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; Nakai K, 2012, GRAEF ARCH CLIN EXP, V250, P1089, DOI 10.1007/s00417-011-1910-7; Nakayama M, 2012, RETINA-J RET VIT DIS, V32, P2061, DOI 10.1097/IAE.0b013e318256205a; OHNO S, 1988, JPN J OPHTHALMOL, V32, P334; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Read RW, 2001, AM J OPHTHALMOL, V131, P599, DOI 10.1016/S0002-9394(01)00937-0; SUGIURA S, 1978, JPN J OPHTHALMOL, V22, P9; Tagawa Y, 2016, BRIT J OPHTHALMOL, V100, P473, DOI 10.1136/bjophthalmol-2014-306439; Takahashi H, 2014, RETINA-J RET VIT DIS, V34, P775, DOI 10.1097/IAE.0b013e3182a6b3f6; Takemoto Y, 2016, ACTA OPHTHALMOL, V94, pE629, DOI 10.1111/aos.13024	17	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172612	10.1371/journal.pone.0172612	http://dx.doi.org/10.1371/journal.pone.0172612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241069	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400028
J	Chong, JU; Hwang, HK; Lee, JH; Yun, M; Kang, CM; Lee, WJ				Chong, Jae Uk; Hwang, Ho Kyoung; Lee, Jin Ho; Yun, Mijin; Kang, Chang Moo; Lee, Woo Jung			Clinically determined type of F-18-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR BURDEN; PREOPERATIVE F-18-FDG PET/CT; TOTAL LESION GLYCOLYSIS; RADIATION-THERAPY; FDG-PET; VOLUME; ADENOCARCINOMA; RECURRENCE; DIFFERENTIATION	Purpose To investigate the association between clinical PET (positron emission tomography) type and oncologic outcome in resectable pancreatic cancer. Methods Between January 2008 and October 2012, patients who underwent potentially curative resection for resectable pancreatic ductal adenocarcinoma without neoadjuvant treatment were retrospectively investigated. Clinical PET type was defined as follows: pancreatic cancer with similar 18 FDG uptake to renal calyx was determined as kidney-type (K-type), and relatively lower 18 FDG uptake than that of renal calyx was regarded as Non-K type. Results A total of 53 patients were enrolled. After agreement-based reclassification, agreement based K-type (aK-type) was noted in 34 patients (64.2%), and agreement based Non-K type (aNon K-type) was found in 19 patients (35.8%). There was a significant difference between aK-type and aNon K-type pancreatic cancer (tumor size (P = 0.030), adjusted CA 19 - 9 (P = 0.007), maximum standard uptake value (SUVmax, P<0.001), metabolic tumor volume (MTV2.5, P<0.001), total lesion glycolysis (TLG, P<0.001)). K-type pancreatic cancer (n = 31) showed a significantly shorter disease-free time compared with Non-K type (n = 16) (10.8 vs. 24.1 months, P = 0.013). It was also noted that aK-type showed inferior diseasefree survival to that of aNon-K type pancreatic cancer (11.9 vs. 28.6 months, P = 0.012). Conclusions Clinical PET type is a reliable clinical marker to estimate aggressive tumor biology and can be utilized in predicting tumor recurrence and necessity for postoperative chemotherapy.	[Chong, Jae Uk; Hwang, Ho Kyoung; Kang, Chang Moo; Lee, Woo Jung] Yonsei Univ, Coll Med, Dept Surg, Div Hepatobil & Pancreat Surg, Seoul, South Korea; [Chong, Jae Uk; Hwang, Ho Kyoung; Yun, Mijin; Kang, Chang Moo; Lee, Woo Jung] Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea; [Lee, Jin Ho] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Surg, Goyang, South Korea; [Yun, Mijin] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System	Kang, CM (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Div Hepatobil & Pancreat Surg, Seoul, South Korea.; Kang, CM (corresponding author), Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea.	cmkang@yuhs.ac		Yun, Mijin/0000-0002-1712-163X; Lee, Woo jung/0000-0001-9273-261X; Kang, Chang Moo/0000-0002-5382-4658; Hwang, Ho Kyoung/0000-0003-4064-7776				Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Ahn SJ, 2014, ANN NUCL MED, V28, P430, DOI 10.1007/s12149-014-0833-x; Bang S, 2006, J CLIN GASTROENTEROL, V40, P923, DOI 10.1097/01.mcg.0000225672.68852.05; Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330; Choi HJ, 2015, EUR J NUCL MED MOL I, V42, P841, DOI 10.1007/s00259-014-2907-3; Choi HJ, 2014, YONSEI MED J, V55, P1498, DOI 10.3349/ymj.2014.55.6.1498; Choi M, 2010, AM J CLIN ONCOL-CANC, V33, P257, DOI 10.1097/COC.0b013e3181a76a0b; Dai T, 2014, CURR TREAT OPTION ON, V15, P351, DOI 10.1007/s11864-014-0301-9; Dholakia AS, 2014, INT J RADIAT ONCOL, V89, P539, DOI 10.1016/j.ijrobp.2014.02.031; Donswijk ML, 2014, PET CLIN, V9, P421, DOI 10.1016/j.cpet.2014.07.001; Epelbaum R, 2013, J NUCL MED, V54, P12, DOI 10.2967/jnumed.112.107466; Fukukura Y, 2014, EUR J RADIOL, V83, P612, DOI 10.1016/j.ejrad.2013.12.016; Heinrich S, 2008, ANN SURG, V248, P1014, DOI 10.1097/SLA.0b013e318190a6da; Jacene HA, 2009, J NUCL MED, V50, P1760, DOI 10.2967/jnumed.109.063321; Kang CM, 2007, J SURG RES, V140, P31, DOI 10.1016/j.jss.2006.10.007; Kang CM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003452; Kang CM, 2014, PANCREATOLOGY, V14, P515, DOI 10.1016/j.pan.2014.08.003; Kang CM, 2013, SURG ONCOL, V22, P123, DOI 10.1016/j.suronc.2013.02.007; Kawada N, 2015, PANCREAS, V44, P655, DOI 10.1097/MPA.0000000000000313; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555; Lodge MA, 1999, EUR J NUCL MED, V26, P22, DOI 10.1007/s002590050355; Min JH, 2015, EUR J RADIOL, V84, P1036, DOI 10.1016/j.ejrad.2015.03.002; Minamimoto R, 2007, ANN NUCL MED, V21, P217, DOI 10.1007/s12149-007-0012-4; Moon SH, 2013, KOREAN J RADIOL, V14, P1, DOI 10.3348/kjr.2013.14.1.1; Nakamoto Y, 2000, CANCER-AM CANCER SOC, V89, P2547, DOI 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V; Obara P, 2013, CHINESE J CANCER RES, V25, P615, DOI 10.3978/j.issn.1000-9604.2013.11.10; Park MS, 2009, RADIOLOGY, V250, P110, DOI 10.1148/radiol.2493080226; Shi S, 2015, CANCER LETT, V360, P227, DOI 10.1016/j.canlet.2015.02.014; Smith TAD, 2001, NUCL MED BIOL, V28, P1, DOI 10.1016/S0969-8051(00)00177-3; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Toriihara A, 2015, AM J NUCL MED MOLEC, V5, P204; Wang XY, 2014, HEPATO-GASTROENTEROL, V61, P2102, DOI 10.5754/hge14394; Xu HX, 2014, EUR J NUCL MED MOL I, V41, P1093, DOI 10.1007/s00259-014-2688-8; YAMADA S, 1995, J NUCL MED, V36, P1301; Yamamoto T, 2015, ANN SURG ONCOL, V22, P677, DOI 10.1245/s10434-014-4046-2	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172606	10.1371/journal.pone.0172606	http://dx.doi.org/10.1371/journal.pone.0172606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235029	Green Submitted, gold, Green Published			2022-12-27	WOS:000394688200100
J	Kanazawa, H; Imoto, K; Okada, M; Yamawaki, H				Kanazawa, Hiroki; Imoto, Keisuke; Okada, Muneyoshi; Yamawaki, Hideyuki			Canstatin inhibits hypoxia-induced apoptosis through activation of integrin/focal adhesion kinase/Akt signaling pathway in H9c2 cardiomyoblasts	PLOS ONE			English	Article							COLLAGEN ALPHA-CHAIN; VIVO TUMOR-GROWTH; IV COLLAGEN; ENDOTHELIAL-CELLS; HEART-FAILURE; DILATED CARDIOMYOPATHY; CARDIAC FIBROBLASTS; AKT ACTIVATION; CYTOCHROME-C; IN-VITRO	A hypoxic stress which causes apoptosis of cardiomyocytes is the main problem in the ischemic heart disease. Canstatin, a non-collagenous fragment of type IV collagen alpha 2 chain, is an endogenous anti-angiogenic factor. We have previously reported that canstatin has a cytoprotective effect on cardiomyoblasts. In the present study, we examined the effects of canstatin on hypoxia-induced apoptosis in H9c2 cardiomyoblasts. Cell counting assay was performed to determine a cell viability. Western blotting was performed to detect expression of cleaved casepase-3 and phosphorylation of focal adhesion kinase (FAK) and Akt. Immunocytochemical staining was performed to observe a distribution of a v integrin. Hypoxia (1% O-2, 48 h) significantly decreased cell viability and increased cleaved caspase- 3 expression. Canstatin (10-250 ng/ml) significantly inhibited these changes in a concentration-dependent manner. Cilengitide (1 mu M), an alpha(v)beta(3) and alpha(v)beta(5) integrin inhibitor, significantly prevented the protective effects of canstatin on cell viability. Canstatin significantly increased phosphorylation of FAK and Akt under hypoxic condition, which were inhibited by cilengitide. LY294002, an inhibitor of phosphatidylinositol-3 kinase/Akt pathway, suppressed the canstatin-induced Akt phosphorylation and reversed the protective effects of canstatin. It was observed that hypoxia caused a localization of a v integrin to focal adhesion. In summary, we for the first time clarified that canstatin inhibits hypoxia-induced apoptosis via FAK and Akt pathways through activating integrins in H9c2 cardiomyoblasts.	[Kanazawa, Hiroki; Imoto, Keisuke; Okada, Muneyoshi; Yamawaki, Hideyuki] Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Towada, Aomori, Japan	Kitasato University	Okada, M (corresponding author), Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Towada, Aomori, Japan.	mokada@vmas.kitasato-u.ac.jp			JSPS [16K08028]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by JSPS KAKENHI Grant Number 16K08028 [Grant-in-Aid for Scientific Research (C)] (MO) (URL: http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Graf K, 2000, HYPERTENSION, V35, P978, DOI 10.1161/01.HYP.35.4.978; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; He GA, 2004, BIOCHEM BIOPH RES CO, V318, P354, DOI 10.1016/j.bbrc.2004.04.038; He GA, 2003, BIOCHEM BIOPH RES CO, V312, P801, DOI 10.1016/j.bbrc.2003.11.003; Hu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.369; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hwang S, 2015, FREE RADICAL BIO MED, V89, P229, DOI 10.1016/j.freeradbiomed.2015.08.005; Kalinowski L, 2008, J APPL PHYSIOL, V104, P1504, DOI 10.1152/japplphysiol.00861.2007; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Lane D, 2010, ONCOGENE, V29, P3519, DOI 10.1038/onc.2010.107; Legler DF, 2001, J CELL SCI, V114, P1545; Liu B, 2013, CELL PHYSIOL BIOCHEM, V32, P655, DOI 10.1159/000354469; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Moe GW, 2016, HEART FAIL REV, V21, P157, DOI 10.1007/s10741-016-9532-0; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Noutsias M, 2001, CIRCULATION, V104, P275; Okada M, 2016, APOPTOSIS, V21, P887, DOI 10.1007/s10495-016-1262-1; Okada M, 2015, EUR J PHARMACOL, V750, P20, DOI 10.1016/j.ejphar.2015.01.019; Otani K, 2015, BIOCHEM BIOPH RES CO, V467, P683, DOI 10.1016/j.bbrc.2015.10.084; Panka DJ, 2003, J BIOL CHEM, V278, P37632, DOI 10.1074/jbc.M307339200; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Riopel M, 2013, ACTA BIOMATER, V9, P8140, DOI 10.1016/j.actbio.2013.05.035; Sanchis-Gomar F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.33; Shewchuk LJ, 2010, CAN J PHYSIOL PHARM, V88, P324, DOI 10.1139/Y09-131; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Watanabe T, 1998, JPN HEART J, V39, P753; Yamanishi A, 1998, PATHOL RES PRACT, V194, P413, DOI 10.1016/S0344-0338(98)80032-0; Zhou JB, 2016, CIRC RES, V118, P1208, DOI 10.1161/CIRCRESAHA.116.308544	43	33	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173051	10.1371/journal.pone.0173051	http://dx.doi.org/10.1371/journal.pone.0173051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235037	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200191
J	Lung, T; Howard, K; Etherton-Beer, C; Sim, M; Lewin, G; Arendts, G				Lung, Tom; Howard, Kirsten; Etherton-Beer, Christopher; Sim, Moira; Lewin, Gill; Arendts, Glenn			Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH UTILITIES INDEX; AGED CARE; MULTIATTRIBUTE; INSTRUMENTS; AGREEMENT; RELIABILITY; RESIDENTS; ADULTS; PROXY	Background Accurately assessing changes in the quality of life of older people living permanently in nursing homes is important. The multi-attribute utility instrument most commonly used and recommended to assess health-related quality of life in the nursing home population is the three-level EuroQol EQ-5D-3L. To date, there have been no studies using the Health Utilities Index Mark III (HUI3). The purpose of this study was to compare the level of agreement and sensitivity to change of the EQ-5D-3L and HUI3 in a nursing home population. Methods EQ-5D-3L and HUI3 scores were measured as part of a cluster randomised controlled trial of nurse led care coordination in a nursing home population in Perth, Western Australia at baseline and 6-month follow up. Results Both measures were completed for 199 residents at baseline and 177 at 6-month follow-up. Mean baseline utility scores for EQ-5D-3L (0.45; 95% CI 0.41-0.49) and HUI3 (0.15; 95% CI 0.10-0.20) were significantly different (Wilcoxon signed rank test, p < 0.01) and agreement was poor to moderate between absolute scores from each instrument (intra-class correlation coefficient = 0.63). The EQ-5D-3L appeared more sensitive to change over the 6-month period. Conclusion Our findings show that the EQ-5D-3L and HUI3 estimate different utility scores among nursing home residents. These differences should be taken into account, particularly when considering the implications of the cost-effectiveness of particular interventions and we conclude that the HUI3 is no better suited to measuring health-related quality of life in a nursing home population when compared to the EQ-5D-3L.	[Lung, Tom] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Lung, Tom; Howard, Kirsten] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia; [Etherton-Beer, Christopher] Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Crawley, WA, Australia; [Sim, Moira] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Lewin, Gill] Curtin Univ, Fac Hlth Sci, Sch Nursing Midwifery & Paramed, Bentley, WA, Australia; [Arendts, Glenn] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Emergency Med, Crawley, WA, Australia	George Institute for Global Health; University of Sydney; University of Sydney; Royal Perth Hospital; University of Western Australia; Edith Cowan University; Curtin University; University of Western Australia	Lung, T (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.; Lung, T (corresponding author), Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia.	tlung@georgeinstitute.org.au	Lung, Thomas/J-9686-2017; Etherton-Beer, Christopher/B-2714-2014	Lung, Thomas/0000-0001-9978-6311; Etherton-Beer, Christopher/0000-0001-5148-0188; Arendts, Glenn/0000-0001-7830-7756; Howard, Kirsten/0000-0002-0918-7540	Wicking Trust; HCF Research Foundation	Wicking Trust; HCF Research Foundation	This work was funded by the JO and JR Wicking Trust to GA. TL receives salary support as the HCF Research Foundation Postdoctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson K, 2012, GERONTOLOGIST, V52, P632, DOI 10.1093/geront/gnr137; Arendts G, 2014, ARCH GERONTOL GERIAT, V58, P15, DOI 10.1016/j.archger.2013.07.004; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockis E, 2016, REV NICE METHODS ACR; Bulamu NB, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0372-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen G, 2015, DIABETES RES CLIN PR, V109, P326, DOI 10.1016/j.diabres.2015.05.011; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cohen J., 1988, STAT POWER ANAL BEHA; Comans TA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-58; Commission AGP., 2005, EC IMPL AG AUSTR; Devine A, 2014, J CLIN EPIDEMIOL, V67, P1035, DOI 10.1016/j.jclinepi.2014.04.005; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Grutters JPC, 2007, QUAL LIFE RES, V16, P1439, DOI 10.1007/s11136-007-9237-x; Holland R, 2004, HEALTH ECON, V13, P793, DOI 10.1002/hec.858; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Kane RA, 2003, J GERONTOL A-BIOL, V58, P240; Kunz S, 2010, QUAL LIFE RES, V19, P425, DOI 10.1007/s11136-010-9600-1; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Maes IHL, 2011, EAR HEARING, V32, P428, DOI 10.1097/AUD.0b013e3181fdf09f; Makai P, 2014, SOC SCI MED, V102, P83, DOI 10.1016/j.socscimed.2013.11.050; Makai P, 2012, QUAL LIFE RES, V21, P801, DOI 10.1007/s11136-011-9997-1; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Richardson J, 2015, MED DECIS MAKING, V35, P276, DOI 10.1177/0272989X14543107; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tamim H, 2002, MED CARE, V40, P1186, DOI 10.1097/00005650-200212000-00006; Tong A, 2013, J PEDIATR-US, V163, P1179, DOI 10.1016/j.jpeds.2013.04.066; van Leeuwen KM, 2015, VALUE HEALTH, V18, P35, DOI 10.1016/j.jval.2014.09.006; Viney R, 2011, VALUE HEALTH, V14, P928, DOI 10.1016/j.jval.2011.04.009; Wolfs CAG, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-33	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172796	10.1371/journal.pone.0172796	http://dx.doi.org/10.1371/journal.pone.0172796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234983	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200140
J	Oberbauer, AM; Keller, GG; Famula, TR				Oberbauer, A. M.; Keller, G. G.; Famula, T. R.			Long-term genetic selection reduced prevalence of hip and elbow dysplasia in 60 dog breeds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RISK-FACTORS; RETROSPECTIVE COHORT; INHERITED DISORDERS; GENOMIC SELECTION; GOLDEN-RETRIEVERS; JOINT PHENOTYPE; CANINE; HERITABILITY; OSTEOCHONDROSIS	Canine hip dysplasia (CHD) and elbow dysplasia (ED) impact the health and welfare of all dogs. The first formally organized assessment scheme to improve canine health centered on reducing the prevalence of these orthopedic disorders. Phenotypic screening of joint conformation remains the currently available strategy for breeders to make selection decisions. The present study evaluated the efficacy of employing phenotypic selection on breed improvement of hips and elbows using the Orthopedic Foundation for Animals complete database spanning the 1970-2015 time period. Sixty breeds having more than 1000 unique hip evaluations and 500 elbow evaluations (1,056,852 and 275,129 hip and elbow records, respectively) were interrogated to derive phenotypic improvement, sex and age at time of assessment effects, correlation between the two joints, heritability estimates, estimated breeding values (EBV), and effectiveness of maternal/paternal selection. The data demonstrated that there has been overall improvement in hip and elbow conformation with a reduction in EBV for disease liability, although the breeds differed in the magnitude of the response to selection. Heritabilities also differed substantially across the breeds as did the correlation of the joints; in the absence of a universal association of these differences with breed size, popularity, or participation in screening, it appears that the breeds themselves vary in genetic control. There was subtle, though again breed specific, impact of sex and older ages on CHD and ED. There was greater paternal impact on a reduction of CHD. In the absence of direct genetic tests for either of these two diseases, phenotypic selection has proven to be effective. Furthermore, the data underscore that selection schemes must be breed specific and that it is likely the genetic profiles will be unique across the breeds for these two conditions. Despite the advances achieved with phenotypic selection, incorporation of EBVs into selection schemes should accelerate advances in hip and elbow improvement.	[Oberbauer, A. M.; Famula, T. R.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Keller, G. G.] Orthoped Fdn Anim, Columbia, MO USA	University of California System; University of California Davis	Oberbauer, AM (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	amoberbauer@ucdavis.edu						[Anonymous], 2008, P 23 IEWG; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Beuing R, 2000, J ANIM BREED GENET, V117, P375, DOI 10.1046/j.1439-0388.2000.00267.x; Breur G. J., 2001, The genetics of the dog, P267, DOI 10.1079/9780851995205.0267; Cachon T, 2010, VET COMP ORTHOPAED, V23, P28, DOI 10.3415/VCOT-08-11-0116; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Cook CR, 2009, VET SURG, V38, P144, DOI 10.1111/j.1532-950X.2008.00481.x; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Czerwinski V, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6110075; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; Fels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096618; Fels L, 2014, MAMM GENOME, V25, P262, DOI 10.1007/s00335-014-9507-1; Fitzpatrick N, 2009, VET SURG, V38, P213, DOI 10.1111/j.1532-950X.2008.00489.x; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Genevois JP, 2008, VET COMP ORTHOPAED, V21, P21, DOI 10.3415/VCOT-07-02-0014; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Group IEW, 1990, P 2 ANN M SAN FRANC; GUTHRIE S, 1990, J SMALL ANIM PRACT, V31, P93, DOI 10.1111/j.1748-5827.1990.tb00730.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hart BL, 2016, VET MED SCI, V2, P191, DOI 10.1002/vms3.34; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hazewinkel H, 2007, 22 ANN M INT ELBOW W; Hazewinkel H, 1995, P 7 INT ELB WORK GRO; HEDHAMMAR A, 1979, J AM VET MED ASSOC, V174, P1012; Henricson B, 1966, J Small Anim Pract, V7, P673, DOI 10.1111/j.1748-5827.1966.tb04393.x; Hou YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076390; Janutta V, 2007, BERLINER MUNCHENER T, V121, P102; Kaneene JB, 1997, J AM VET MED ASSOC, V211, P1542; Kaneene JB, 2009, VET SURG, V38, P398, DOI 10.1111/j.1532-950X.2008.00475.x; Keller G, 1993, CANINE PRACTICE; Keller GG, 2011, VET J, V189, P197, DOI 10.1016/j.tvjl.2011.06.019; Lavrijsen ICM, 2014, PREV VET MED, V114, P114, DOI 10.1016/j.prevetmed.2014.02.001; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Leroy G, 2011, ANIMAL GENETICS; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; Lynch M., 1998, GENETICS ANAL QUANTI; Maki K, 2000, J ANIM SCI, V78, P1141; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Maki K, 2002, ANIMAL SCI; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Meuwissen T, 2016, ANIM FRONT, V6, P6, DOI 10.2527/af.2016-0002; Michelsen J, 2013, VET J, V196, P12, DOI 10.1016/j.tvjl.2012.11.009; Morgan JP, 2000, HEREDITARY BONE JOIN; Oberbauer A, 2015, CANINE GENETICS EPID, V2, P1; Ohlerth S, 2001, AM J VET RES, V62, P846, DOI 10.2460/ajvr.2001.62.846; Parker HG, 2012, MAMM GENOME, V23, P19, DOI 10.1007/s00335-011-9387-6; Paster ER, 2005, JAVMA-J AM VET MED A, V226, P387, DOI 10.2460/javma.2005.226.387; Phavaphutanon J, 2009, AM J VET RES, V70, P1094, DOI 10.2460/ajvr.70.9.1094; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; POPOVITCH CA, 1995, J AM VET MED ASSOC, V206, P648; R DCT, 2015, R LANG ENV STAT COMP; RENDEL JM, 1950, J GENET, V50, P1, DOI 10.1007/BF02986789; Rettenmaier JL, 2002, VET RADIOL ULTRASOUN, V43, P313, DOI 10.1111/j.1740-8261.2002.tb01010.x; Sanchez-Molano E, 2014, J ANIM BREED GENET, V131, P134, DOI 10.1111/jbg.12056; Sanchez-Molano E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00097; Sanchez-Molano E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-833; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; SMITH GK, 1995, J AM VET MED ASSOC, V206, P642; Soo M, 2015, NEW ZEAL VET J, V63, P69, DOI 10.1080/00480169.2014.949893; Sorensen DA., 2002, STAT BIOL HEALTH; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Tomlinson JL, 2000, AM J VET RES, V61, P1492, DOI 10.2460/ajvr.2000.61.1492; van Hagen MAE, 2004, PREV VET MED, V63, P39, DOI 10.1016/j.prevetmed.2004.01.007; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson B, 2011, VET J, V189, P160, DOI 10.1016/j.tvjl.2011.06.014; Wilson BJ, 2015, NEW ZEAL VET J, V63, P67, DOI 10.1080/00480169.2015.985562; Wilson BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077470; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9	76	37	37	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172918	10.1371/journal.pone.0172918	http://dx.doi.org/10.1371/journal.pone.0172918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234985	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200169
J	Scarpellini, B; Zanoni, M; Cecilia, M; Sucupira, A; Truong, HHM; Janini, LMR; da Silva, ID; Diaz, RS				Scarpellini, Bruno; Zanoni, Michelle; Cecilia, Maria; Sucupira, Araripe; Truong, Hong-Ha M.; Janini, Luiz Mario Ramos; da Silva, Ismael Dale; Diaz, Ricardo Sobhie			Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment (vol 11, e0161920, 2016)	PLOS ONE			English	Correction													Scarpellini, Bruno/AAK-2424-2020; Araripe Sucupira, Maria Cecilia/K-1931-2012	Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382				Scarpelini B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161920	1	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173164	10.1371/journal.pone.0173164	http://dx.doi.org/10.1371/journal.pone.0173164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235085	Green Published, gold			2022-12-27	WOS:000394688200200
J	Yao, Y; Strauss-Albee, DM; Zhou, JLQ; Malawista, A; Garcia, MN; Murray, KO; Blish, CA; Montgomery, RR				Yao, Yi; Strauss-Albee, Dara M.; Zhou, Julian Q.; Malawista, Anna; Garcia, Melissa N.; Murray, Kristy O.; Blish, Catherine A.; Montgomery, Ruth R.			The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection	PLOS ONE			English	Article							NKG2C(+) NK CELLS; CYTOMEGALOVIRUS-INFECTION; ADAPTIVE IMMUNITY; IN-VITRO; INNATE; RECEPTOR; PATHOGENESIS; EXPRESSION; EXPANSION; SUSCEPTIBILITY	West Nile virus (WNV) typically leads to asymptomatic infection but can cause severe neuroinvasive disease or death, particularly in the elderly. Innate NK cells play a critical role in antiviral defenses, yet their role in human WNV infection is poorly defined. Here we demonstrate that NK cells mount a robust, polyfunctional response to WNV characterized by cytolytic activity, cytokine and chemokine secretion. This is associated with downregulation of activating NK cell receptors and upregulation of NK cell activating ligands for NKG2D. The NK cell response did not differ between young and old WNV-naive subjects, but a history of symptomatic infection is associated with more IFN-. producing NK cell subsets and a significant decline in a specific NK cell subset. This NK repertoire skewing could either contribute to or follow heightened immune pathogenesis from WNV infection, and suggests that NK cells could play an important role in WNV infection in humans.	[Yao, Yi; Zhou, Julian Q.; Malawista, Anna; Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Strauss-Albee, Dara M.; Blish, Catherine A.] Stanford Univ, Sch Med, Stanford Immunol, Stanford, CA 94305 USA; [Strauss-Albee, Dara M.; Blish, Catherine A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Garcia, Melissa N.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Garcia, Melissa N.; Murray, Kristy O.] Texas Childrens Hosp, Houston, TX 77030 USA; [Montgomery, Ruth R.] Yale Univ, Sch Med, Program Human Translat Immunol, New Haven, CT 06520 USA	Yale University; Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Yale University	Montgomery, RR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Blish, CA (corresponding author), Stanford Univ, Sch Med, Stanford Immunol, Stanford, CA 94305 USA.; Blish, CA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Montgomery, RR (corresponding author), Yale Univ, Sch Med, Program Human Translat Immunol, New Haven, CT 06520 USA.	cblish@stanford.edu; Ruth.Montgomery@yale.edu		Blish, Catherine/0000-0001-6946-7627; Montgomery, Ruth/0000-0002-8661-4454; Zhou, Julian/0000-0001-9602-2092	National Institutes of Health [HHS N272201100019C, U19-AI089992, R01-AI091816, DP2AI112193]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]; National Science Foundation [DGE-114740]; Ruth L. Kirschstein National Research Service Award [1F31AI118469-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112193, U19AI089992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Claude D. Pepper Older Americans Independence Center; National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (HHS N272201100019C, U19-AI089992, R01-AI091816 and DP2AI112193), pilot funds from the Human Immunology Project Consortium; HIPC), and the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342). DMS-A was supported by National Science Foundation training grant (DGE-114740) and Ruth L. Kirschstein National Research Service Award (1F31AI118469-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Blish Catherine A, 2016, Pathog Immun, V1, P165; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Cannon JG, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12177; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hazeldine J, 2013, AGEING RES REV, V12, P1069, DOI 10.1016/j.arr.2013.04.003; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hwang I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051858; James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kay AW, 2016, METHODS MOL BIOL, V1441, P13, DOI 10.1007/978-1-4939-3684-7_2; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764; Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Maffei R, 2013, HAEMATOLOGICA, V98, P1115, DOI 10.3324/haematol.2012.073080; Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Montgomery RR, 2016, CLIN EXP IM IN PRESS; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; Nolan MS, 2013, EMERG INFECT DIS, V19, P137, DOI 10.3201/eid1901.121135; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qian F, 2015, CLIN VACCINE IMMUNOL, V22, P6, DOI 10.1128/CVI.00508-14; Qian F, 2014, VIRAL IMMUNOL, V27, P39, DOI 10.1089/vim.2013.0074; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Richner JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005027; Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x; Rolle A, 2014, J CLIN INVEST, V124, P5305, DOI 10.1172/JCI77440; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Siren J, 2004, J GEN VIROL, V85, P2357, DOI 10.1099/vir.0.80105-0; Solana R, 2014, CURR OPIN IMMUNOL, V29, P56, DOI 10.1016/j.coi.2014.04.002; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Strauss-Albee DM, 2014, J IMMUNOL, V193, P4871, DOI 10.4049/jimmunol.1401821; Sun J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2191; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Xie G, 2016, J VIROL, V90, P1333, DOI 10.1128/JVI.02488-15; Zhang MJ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-3; Zitvogel L, 2006, CURR TOP MICROBIOL, V298, P157	61	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172625	10.1371/journal.pone.0172625	http://dx.doi.org/10.1371/journal.pone.0172625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235099	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200101
J	Yin, J; Zhao, J; Hu, WM; Yang, GP; Yu, H; Wang, RH; Wang, LJ; Zhang, GQ; Fu, WF; Dai, L; Li, WZ; Liao, BY; Zhang, SX				Yin, Jun; Zhao, Jian; Hu, Weimin; Yang, Guangping; Yu, Hui; Wang, Ruihao; Wang, Linjing; Zhang, Guoqian; Fu, Wenfan; Dai, Lu; Li, Wanzhen; Liao, Boyu; Zhang, Shuxu			Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer	PLOS ONE			English	Article							STEM-CELLS; TUMOR SUPPRESSORS; LIN28; MICRORNAS; SENSITIVITY; BIOGENESIS; EXPRESSION; REGULATOR; ONCOGENES; FAMILY	Radio- and chemo-resistance represent major obstacles in the therapy of non-small-cell lung cancer (NSCLC) and the underlying molecular mechanisms are not known. In the present study, during induction of radio-or chemo-resistance in NSCLC cells, dynamic analyses revealed that decreased expression of let-7 induced by irradiation or cisplatin resulted in increased expression of its target gene LIN28, and increased expression of LIN28 then contributed to further decreased expression of let-7 by inhibiting its maturation and biogenesis. Moreover, we showed that down-regulation of let-7 and up-regulation of LIN28 expression promoted resistance to irradiation or cisplatin by regulating the single-cell proliferative capability of NSCLC cells. Consequently, in NSCLC cells, let-7 and LIN28 can form a double-negative feedback loop through mutual inhibition, and disturbance of the let-7/LIN28 double-negative feedback loop induced by irradiation or chemotherapeutic drugs can result in radio-and chemo-resistance. In addition, low expression of let-7 and high expression of LIN28 in NSCLC patients was associated significantly with resistance to radiotherapy or chemotherapy. Therefore, our study demonstrated that disturbance of the let-7/LIN28 double- negative feedback loop is involved in the regulation of radio-and chemo-resistance, and that let-7 and LIN28 could be employed as predictive biomarkers of response to radiotherapy or chemotherapy in NSCLC patients.	[Yin, Jun; Yu, Hui; Wang, Ruihao; Wang, Linjing; Zhang, Guoqian; Li, Wanzhen; Liao, Boyu; Zhang, Shuxu] Guangzhou Med Univ, Dept Radiotherapy, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China; [Zhao, Jian; Yang, Guangping; Fu, Wenfan; Dai, Lu] Guangzhou Med Univ, Dept Chest Surg, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China; [Hu, Weimin] Guangzhou Med Univ, Dept Abdominal Surg, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Zhang, SX (corresponding author), Guangzhou Med Univ, Dept Radiotherapy, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China.	tottijun@163.com		Zhang, Shuxu/0000-0001-9416-0782	National Natural Science Foundation of China [81501969, 81572258]; Characteristic Innovation Project of Education of Guangdong Province [2014KTSCX104]; Science and Technology Program of Guangzhou [201607010031]; Scientific Research Project of Guangzhou Municipal University [1201410198, 1201630087]; China Postdoctoral Science Foundation [2016M602450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Characteristic Innovation Project of Education of Guangdong Province; Science and Technology Program of Guangzhou; Scientific Research Project of Guangzhou Municipal University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (81501969, 81572258) to JY and JZ (http://www.nsfc.gov.cn/), Characteristic Innovation Project of Education of Guangdong Province (2014KTSCX104) to SZ (http://www.gdhed.edu.cn/), Science and Technology Program of Guangzhou (201607010031) to JZ (http://www.gzsi.gov.cn/), Scientific Research Project of Guangzhou Municipal University (1201410198, 1201630087) to WH and JY (http://www.gzedu.gov.cn/) and Project funded by China Postdoctoral Science Foundation (2016M602450) to JY (http://jj.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora H, 2011, EXP MOL MED, V43, P298, DOI 10.3858/emm.2011.43.5.031; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Gettinger S, 2011, CLIN CHEST MED, V32, P839, DOI 10.1016/j.ccm.2011.08.017; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; He HT, 2014, ONCOL LETT, V7, P1352, DOI 10.3892/ol.2014.1935; Jiang ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094639; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kraemer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077484; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shi F, 2014, INT J MOL SCI, V15, P19119, DOI 10.3390/ijms151019119; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Zhao J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1713-z	33	32	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172787	10.1371/journal.pone.0172787	http://dx.doi.org/10.1371/journal.pone.0172787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235063	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200136
J	Freeman, K; Tsertsvadze, A; Taylor-Phillips, S; McCarthy, N; Mistry, H; Manuel, R; Mason, J				Freeman, Karoline; Tsertsvadze, Alexander; Taylor-Phillips, Sian; McCarthy, Noel; Mistry, Hema; Manuel, Rohini; Mason, James			Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gastroenteritis: Test evaluation and meta-analysis in the absence of a reference standard	PLOS ONE			English	Article							DIAGNOSIS; PERFORMANCE; ASSAY	Objective Multiplex gastrointestinal pathogen panel (GPP) tests simultaneously identify bacterial, viral and parasitic pathogens from the stool samples of patients with suspected infectious gastroenteritis presenting in hospital or the community. We undertook a systematic to compare the accuracy of GPP tests with standard microbiology techniques. Review methods Searches in Medline, Embase, Web of Science and the Cochrane library were undertaken from inception to January 2016. Eligible studies compared GPP tests with standard microbiology techniques in patients with suspected gastroenteritis. Quality assessment of included studies used tailored QUADAS-2. In the absence of a reference standard we analysed test performance taking GPP tests and standard microbiology techniques in turn as the benchmark test, using random effects meta-analysis of proportions. Results No study provided an adequate reference standard with which to compare the test accuracy of GPP and conventional tests. Ten studies informed a meta-analysis of positive and negative agreement. Positive agreement across all pathogens was 0.93 (95% CI 0.90 to 0.96) when conventional methods were the benchmark and 0.68 (95% CI: 0.58 to 0.77) when GPP provided the benchmark. Negative agreement was high in both instances due to the high proportion of negative cases. GPP testing produced a greater number of pathogen-positive findings than conventional testing. It is unclear whether these additional ` positives' are clinically important. Conclusions GPP testing has the potential to simplify testing and accelerate reporting when compared to conventional microbiology methods. However the impact of GPP testing upon the management, treatment and outcome of patients is poorly understood and further studies are needed to evaluate the health economic impact of GPP testing compared with standard methods. The review protocol is registered with PROSPERO as CRD42016033320.	[Freeman, Karoline; Tsertsvadze, Alexander; Taylor-Phillips, Sian; McCarthy, Noel; Mistry, Hema; Mason, James] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [McCarthy, Noel] NIHR Hlth Protect Res Unit Gastrointestinal Infec, Oxford, England; [Manuel, Rohini] NIHR Hlth Protect Res Unit Gastrointestinal Infec, London, England	University of Warwick	Mason, J (corresponding author), Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.	J.Mason@warwick.ac.uk	Taylor-Phillips, Sian/AAW-8544-2021; Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; McCarthy, Noel/0000-0003-1113-1017; Mistry, Hema/0000-0002-5023-1160; Freeman, Karoline/0000-0002-9963-2918; Taylor-Phillips, Sian/0000-0002-1841-4346	NIHR HTA [15/17/03]	NIHR HTA	This review was commissioned by the NIHR HTA Programme as project number 15/17/03. The views expressed in this report are those of the authors and not necessarily those of the NIHR HTA Programme. Any errors are the responsibility of the authors.	Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15; Branch DD, 2007, BIOST DO BIOM OOSA G; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Claas EC, 2013, J MICROBIOL BIOTECHN, V23, P1041, DOI 10.4014/jmb.1212.12042; Coste JF, 2013, J CLIN MICROBIOL, V51, P1841, DOI 10.1128/JCM.03366-12; Deng JK, 2015, DIAGN MICR INFEC DIS, V83, P325, DOI 10.1016/j.diagmicrobio.2015.07.024; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Glasziou P, 2008, ANN INTERN MED, V149, P816, DOI 10.7326/0003-4819-149-11-200812020-00009; Gu ZM, 2015, J MOL DIAGN, V17, P715, DOI 10.1016/j.jmoldx.2015.06.003; Halligan E, 2014, CLIN MICROBIOL INFEC, V20, pO460, DOI 10.1111/1469-0691.12476; Medus C, 2006, J FOOD PROTECT, V69, P1870, DOI 10.4315/0362-028X-69.8.1870; Mengelle C, 2013, CLIN MICROBIOL INFEC, V19, pE458, DOI 10.1111/1469-0691.12255; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pankhurst L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18530; Public Health England, 2013, UK STAND MICR INV GA; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; U.S Food and Drug Administration, 2012, EV AUT CLASS 3 DES D; Duong VT, 2016, J CLIN MICROBIOL, V54, P1094, DOI 10.1128/JCM.03321-15; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	20	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173196	10.1371/journal.pone.0173196	http://dx.doi.org/10.1371/journal.pone.0173196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253337	Green Submitted, gold, Green Published			2022-12-27	WOS:000396011300091
J	Li, Z; Duan, XG; Chen, S; Wu, J				Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing			Improving the reversibility of thermal denaturation and catalytic efficiency of Bacillus licheniformis alpha-amylase through stabilizing a long loop in domain B	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; THERMOSTABILITY; DETERMINANTS; RESIDUES; SITE	The reversibility of thermal denaturation and catalytic efficiency of Bacillus licheniformis aamylase were improved through site-directed mutagenesis. By using multiple sequence alignment and PoPMuSiC algorithm, Ser187 and Asn188, which located within a long loop in Domain B of Bacillus licheniformis alpha-amylase, were selected for mutation. In addition, Ala269, which is adjacent to Ser187 and Asn188, was also investigated. Seven mutants carrying the mutations S187D, N188T, N188S, A269K, A269K/S187D, S187D/N188T, and A269K/S187D/N188T were generated and characterized. The most thermostable mutant, A269K/S187D/N188T, exhibited a 9-fold improvement in half-life at 95 degrees C and pH 5.5, compared with that of the wild-type enzyme. Mutant A269K/S187D/N188T also exhibited improved catalytic efficiency. The catalytic efficiency of mutant A269K/S187D/N188T reached 5.87x10(3)+/- 0.17 g.L-(1).s-(1) at pH 5.5, which is 1.84-fold larger than the corresponding value determined for the wild-type enzyme. Furthermore, the structure analysis showed that immobilization of the loop containing Ser187 and Asn188 plays a significant role in developing the properties of Bacillus licheniformis a-amylase.	[Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China; [Li, Zhu; Duan, Xuguo; Chen, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Duan, Xuguo] Nanjing Forestry Univ, Coll Light Ind Sci & Engn, Dept Food Sci & Engn, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Nanjing Forestry University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Natural Science Foundation of China [31571776]; National Science Fund for Distinguished Young Scholars [31425020]; Project of Outstanding Science and Technological Innovation Group of Jiangsu Province; Production and Research Prospective Joint Research Project of Jiangsu Province [BY2015019-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Project of Outstanding Science and Technological Innovation Group of Jiangsu Province; Production and Research Prospective Joint Research Project of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (31571776), the National Science Fund for Distinguished Young Scholars (31425020), the Project of Outstanding Science and Technological Innovation Group of Jiangsu Province (Jing Wu), and the Production and Research Prospective Joint Research Project of Jiangsu Province (BY2015019-32).	Ali Mamdouh Ben, 2001, Enzyme and Microbial Technology, V28, P537, DOI 10.1016/S0141-0229(01)00294-0; Alikhajeh J, 2010, ACTA CRYSTALLOGR F, V66, P121, DOI 10.1107/S1744309109051938; [Anonymous], 2014, APPL MICROBIOL BIOT, V98, P8937; Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Declerck N, 2002, BIOLOGIA, V57, P203; Declerck N, 2003, PROTEIN ENG, V16, P287, DOI 10.1093/proeng/gzg032; Declerck N, 2000, J MOL BIOL, V301, P1041, DOI 10.1006/jmbi.2000.4025; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V248, P372, DOI 10.1006/bbrc.1998.8970; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZF, 2010, APPL MICROBIOL BIOT, V85, P553, DOI 10.1007/s00253-009-2157-7; Li Z, 2016, J BIOTECHNOL, V222, P65, DOI 10.1016/j.jbiotec.2016.02.013; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Nielsen JE, 2000, BBA-PROTEIN STRUCT M, V1543, P253, DOI 10.1016/S0167-4838(00)00240-5; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Offen WA, 2015, ACTA CRYSTALLOGR F, V71, P66, DOI 10.1107/S2053230X14026508; Sharma A, 2013, PROCESS BIOCHEM, V48, P201, DOI 10.1016/j.procbio.2012.12.018; Shaw A, 1999, CURR OPIN BIOTECH, V10, P349, DOI 10.1016/S0958-1669(99)80063-9; Suvd D, 2001, J BIOCHEM, V129, P461, DOI 10.1093/oxfordjournals.jbchem.a002878; SUZUKI Y, 1989, J BIOL CHEM, V264, P18933; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; TOMAZIC SJ, 1988, J BIOL CHEM, V263, P3092; VIHINEN M, 1989, CRIT REV BIOCHEM MOL, V24, P329, DOI 10.3109/10409238909082556	33	8	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173187	10.1371/journal.pone.0173187	http://dx.doi.org/10.1371/journal.pone.0173187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253342	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300089
J	Liu, L; Han, YX; Jin, MW				Liu, Li; Han, Yongxin; Jin, Mingwu			Fast alternating projection methods for constrained tomographic reconstruction	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; COMPRESSED SENSING ABOCS; CT IMAGE-RECONSTRUCTION; CONVEX-OPTIMIZATION; ALGORITHMS; STRATEGY	The alternating projection algorithms are easy to implement and effective for large-scale complex optimization problems, such as constrained reconstruction of X-ray computed tomography (CT). A typical method is to use projection onto convex sets (POCS) for data fidelity, nonnegative constraints combined with total variation (TV) minimization (so called TV-POCS) for sparse-view CT reconstruction. However, this type of method relies on empirically selected parameters for satisfactory reconstruction and is generally slow and lack of convergence analysis. In this work, we use a convex feasibility set approach to address the problems associated with TV-POCS and propose a framework using full sequential alternating projections or POCS (FS-POCS) to find the solution in the intersection of convex constraints of bounded TV function, bounded data fidelity error and non-negativity. The rationale behind FS-POCS is that the mathematically optimal solution of the constrained objective function may not be the physically optimal solution. The breakdown of constrained reconstruction into an intersection of several feasible sets can lead to faster convergence and better quantification of reconstruction parameters in a physical meaningful way than that in an empirical way of trial-and-error. In addition, for large-scale optimization problems, first order methods are usually used. Not only is the condition for convergence of gradient-based methods derived, but also a primal-dual hybrid gradient (PDHG) method is used for fast convergence of bounded TV. The newly proposed FS-POCS is evaluated and compared with TV-POCS and another convex feasibility projection method (CPTV) using both digital phantom and pseudo-real CT data to show its superior performance on reconstruction speed, image quality and quantification.	[Liu, Li; Han, Yongxin] Tianjin Univ, Sch Elect & Informat Syst, Tianjin, Peoples R China; [Jin, Mingwu] Univ Texas Arlington, Dept Phys, POB 19059, Arlington, TX 76019 USA	Tianjin University; University of Texas System; University of Texas Arlington	Jin, MW (corresponding author), Univ Texas Arlington, Dept Phys, POB 19059, Arlington, TX 76019 USA.	mingwu@uta.edu		Jin, Mingwu/0000-0003-3987-2896	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [1R03EB021600-01A1]; NATIONAL CANCER INSTITUTE [R15CA199020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB021600] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	M.J. is partially supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering under the grant number 1R03EB021600-01A1 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9182259&icde=30948525&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC). The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Chambolle A, 2011, J MATH IMAGING VIS, V40, P120, DOI 10.1007/s10851-010-0251-1; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Choi K, 2014, PHYS MED BIOL, V59, P3097, DOI 10.1088/0031-9155/59/12/3097; Choi K, 2010, MED PHYS, V37, P5113, DOI 10.1118/1.3481510; Defrise M, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/6/065002; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Duchi John, 2008, P 25 INT C MACH LEAR; Esser E, 2010, SIAM J IMAGING SCI, V3, P1015, DOI 10.1137/09076934X; Fessler JA, 1999, IEEE T IMAGE PROCESS, V8, P688, DOI 10.1109/83.760336; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079709; Jensen TL, 2012, BIT, V52, P329, DOI 10.1007/s10543-011-0359-8; Jiang M, 2003, IEEE T IMAGE PROCESS, V12, P957, DOI 10.1109/TIP.2003.815295; Kim D, 2015, IEEE T MED IMAGING, V34, P167, DOI 10.1109/TMI.2014.2350962; Li JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140579; Liu L, 2016, NEUROCOMPUTING, V173, P256, DOI 10.1016/j.neucom.2014.11.101; Liu L, 2015, COMPUT BIOL MED, V56, P97, DOI 10.1016/j.compbiomed.2014.11.001; Liu Y, 2014, IEEE T MED IMAGING, V33, P749, DOI 10.1109/TMI.2013.2295738; Niu SZ, 2014, PHYS MED BIOL, V59, P2997, DOI 10.1088/0031-9155/59/12/2997; Niu TY, 2014, PHYS MED BIOL, V59, P1801, DOI 10.1088/0031-9155/59/7/1801; Niu TY, 2012, MED PHYS, V39, P4588, DOI 10.1118/1.4729837; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2013, MED PHYS, V40, DOI 10.1118/1.4790698; Sidky EY, 2012, PHYS MED BIOL, V57, P3065, DOI 10.1088/0031-9155/57/10/3065; Stark H, 1998, WILEY S TEL; Wang J, 2009, MED PHYS, V36, P252, DOI 10.1118/1.3036112; Wu DF, 2013, PHYS MED BIOL, V58, P4047, DOI 10.1088/0031-9155/58/12/4047; Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130793; Zhang H., 2016, TEXTURE PRESERVING B; Zhu M., 2008, UCLA CAM REPORT, V34, P8	34	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172938	10.1371/journal.pone.0172938	http://dx.doi.org/10.1371/journal.pone.0172938			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253298	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300048
J	Toi, CS; Webb, CE; Haniotis, J; Clancy, J; Doggett, SL				Toi, Cheryl S.; Webb, Cameron E.; Haniotis, John; Clancy, John; Doggett, Stephen L.			Seasonal activity, vector relationships and genetic analysis of mosquito-borne Stratford virus	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; AEDES-NOTOSCRIPTUS DIPTERA; BARMAH FOREST VIRUS; ARBOVIRUS EVOLUTION; NORTHERN-TERRITORY; VIGILAX DIPTERA; MAROOCHY SHIRE; CULICIDAE; TRANSMISSION; AUSTRALIA	There are many gaps to be filled in our understanding of mosquito-borne viruses, their relationships with vectors and reservoir hosts, and the environmental drivers of seasonal activity. Stratford virus (STRV) belongs to the genus Flavivirus and has been isolated from mosquitoes and infected humans in Australia but little is known of its vector and reservoir host associations. A total of 43 isolates of STRV from mosquitoes collected in New South Wales between 1995 and 2013 was examined to determine the genetic diversity between virus isolates and their relationship with mosquito species. The virus was isolated from six mosquito species; Aedes aculeatus, Aedes alternans, Aedes notoscriptus, Aedes procax, Aedes vigilax, and Anopheles annulipes. While there were distinct differences in temporal and spatial activity of STRV, with peaks of activity in 2006, 2010 and 2013, a sequence homology of 95.9%-98.4% was found between isolates and the 1961 STRV prototype with 96.2%-100% identified among isolates. Temporal differences but no apparent nucleotide divergence by mosquito species or geographic location was evident. The result suggests the virus is geographically widespread in NSW (albeit only from coastal regions) and increased local STRV activity is likely to be driven by reservoir host factors and local environmental conditions influencing vector abundance. While STRV may not currently be associated with major outbreaks of human disease, with the potential for urbanisation and climate change to increase mosquito-borne disease risks, and the possibility of genomic changes which could produce pathogenic strains, understanding the drivers of STRV activity may assist the development of strategic response to public health risks posed by zoonotic flaviviruses in Australia.	[Toi, Cheryl S.; Webb, Cameron E.; Haniotis, John; Clancy, John; Doggett, Stephen L.] Westmead Hosp, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Dept Med Entomol, Westmead, NSW, Australia; [Webb, Cameron E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Toi, CS (corresponding author), Westmead Hosp, NSW Hlth Pathol, Ctr Infect Dis & Microbiol Lab Serv, Dept Med Entomol, Westmead, NSW, Australia.	cheryl.toi@health.nsw.gov.au		Webb, Cameron/0000-0003-1029-5140	NSW Ministry of Health; Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney	NSW Ministry of Health; Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney	All STRV isolates were part of the New South Wales Arbovirus and Mosquito Monitoring Program, which is funded by the NSW Ministry of Health. Additional funding for analysis and manuscript preparation was provided by Centre for Infectious Diseases and Microbiology-Public Health and Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90, DOI 10.5694/j.1326-5377.1986.tb101087.x; Boyd AM, 1999, J MED ENTOMOL, V36, P186, DOI 10.1093/jmedent/36.2.186; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Ciota AT, 2010, VIRUSES-BASEL, V2, P2594, DOI 10.3390/v2122594; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doggett SL., 2009, ARBOVIRUS RES AUSTR, V10, P28; Doggett Stephen L., 1997, Arbovirus Research in Australia, V7, P79; DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Endersby NM, 2013, INFECT GENET EVOL, V18, P191, DOI 10.1016/j.meegid.2013.04.035; Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759; Hardy CM, 2015, MITOCHONDR DNA, P1; Hardy CM, 2014, MITOCHONDR DNA, P1; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; HAWKES RA, 1985, MED J AUSTRALIA, V143, P555, DOI 10.5694/j.1326-5377.1985.tb119949.x; Hemmerter S, 2009, MOL PHYLOGENET EVOL, V50, P317, DOI 10.1016/j.ympev.2008.11.016; Hu W, 2010, ENVIRON ENTOMOL, V39, P88, DOI 10.1603/EN07037; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7; Jacups SP, 2009, J VECTOR ECOL, V34, P311, DOI [10.1111/j.1948-7134.2009.00039.x, 10.3376/038.034.0217]; Jacups SP, 2008, TROP MED INT HEALTH, V13, P943, DOI 10.1111/j.1365-3156.2008.02095.x; Jacups SP, 2011, J MED ENTOMOL, V48, P453, DOI 10.1603/ME10193; Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008; Jansen CC, 2009, J AM MOSQUITO CONTR, V25, P272, DOI 10.2987/09-5908.1; Johansen Cheryl A., 2005, Arbovirus Research in Australia, V9, P164; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kay BH, 2008, AUST J ENTOMOL, V47, P142, DOI 10.1111/j.1440-6055.2008.00641.x; Kay BH, 2007, AM J TROP MED HYG, V76, P417, DOI 10.4269/ajtmh.2007.76.417; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; LINDSAY MDA, 1993, J VIROL, V67, P3576, DOI 10.1128/JVI.67.6.3576-3585.1993; MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; May FJ, 2013, J GEN VIROL, V94, P1462, DOI 10.1099/vir.0.049940-0; Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0; Poidinger M, 1997, AM J TROP MED HYG, V57, P230, DOI 10.4269/ajtmh.1997.57.230; Poidinger M, 2000, VIRUS RES, V68, P7, DOI 10.1016/S0168-1702(00)00143-X; Potter A, 2014, VECTOR-BORNE ZOONOT, V14, P740, DOI 10.1089/vbz.2014.1617; Puslednik L, 2012, J BIOGEOGR, V39, P1333, DOI 10.1111/j.1365-2699.2012.02683.x; Roche SE, 2013, AUST VET J, V91, P5, DOI 10.1111/avj.12018; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell R. C., 1993, MOSQUITOES MOSQUITO; Russell RC, 2004, AUST J ENTOMOL, V43, P271, DOI 10.1111/j.1326-6756.2004.00436.x; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; Ryan PA, 1999, J MED ENTOMOL, V36, P856, DOI 10.1093/jmedent/36.6.856; Ryan PA, 2000, AUST J ENTOMOL, V39, P212, DOI 10.1046/j.1440-6055.2000.00169.x; Ryan PA, 1997, AM J TROP MED HYG, V57, P476, DOI 10.4269/ajtmh.1997.57.476; Sammels LM, 1999, J GEN VIROL, V80, P739, DOI 10.1099/0022-1317-80-3-739; Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402; Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Hurk AF, 2009, AM J TROP MED HYG, V81, P457, DOI 10.4269/ajtmh.2009.81.457; Warrilow D, 2014, GENOME ANNOUNC, V2; Watson TM, 2000, J MED ENTOMOL, V37, P380, DOI 10.1603/0022-2585(2000)037[0380:ANDCSA]2.0.CO;2; Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508; Watson TM, 1998, J MED ENTOMOL, V35, P104, DOI 10.1093/jmedent/35.2.104; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Webb CE, 1999, J AM MOSQUITO CONTR, V15, P242; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1	62	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173105	10.1371/journal.pone.0173105	http://dx.doi.org/10.1371/journal.pone.0173105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253306	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300078
J	Cannito, S; Morello, E; Bocca, C; Foglia, B; Benetti, E; Novo, E; Chiazza, F; Rogazzo, M; Fantozzi, R; Povero, D; Sutti, S; Bugianesi, E; Feldstein, AE; Albano, E; Collino, M; Parola, M				Cannito, Stefania; Morello, Elisabetta; Bocca, Claudia; Foglia, Beatrice; Benetti, Elisa; Novo, Erica; Chiazza, Fausto; Rogazzo, Mara; Fantozzi, Roberto; Povero, Davide; Sutti, Salvatore; Bugianesi, Elisabetta; Feldstein, Ariel E.; Albano, Emanuele; Collino, Massimo; Parola, Maurizio			Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER-DISEASE; EXTRACELLULAR VESICLES; ENDOTHELIAL-CELLS; NATURAL-HISTORY; CANCER-CELLS; MICROPARTICLES; HEPATOCYTES; MECHANISMS; FIBROSIS	Non-Alcoholic Fatty Liver Disease (NAFLD) is a major form of chronic liver disease in the general population in relation to its high prevalence among overweight/obese individuals and patients with diabetes type II or metabolic syndrome. NAFLD can progress to steatohepatitis (NASH), fibrosis and cirrhosis and end-stage of liver disease but mechanisms involved are still incompletely characterized. Within the mechanisms proposed to mediate the progression of NAFLD, lipotoxicity is believed to play a major role. In the present study we provide data suggesting that microvesicles (MVs) released by fat-laden cells undergoing lipotoxicity can activate NLRP3 inflammasome following internalization by either cells of hepatocellular origin or macrophages. Inflammasome activation involves NF-kB-mediated up-regulation of NLRP3, pro-caspase-1 and pro-Interleukin-1, then inflammasome complex formation and Caspase-1 activation leading finally to an increased release of IL-1 beta. Since the release of MVs from lipotoxic cells and the activation of NLRP3 inflammasome have been reported to occur in vivo in either clinical or experimental NASH, these data suggest a novel rational link between lipotoxicity and increased inflammatory response.	[Cannito, Stefania; Morello, Elisabetta; Bocca, Claudia; Foglia, Beatrice; Novo, Erica; Parola, Maurizio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Benetti, Elisa; Chiazza, Fausto; Rogazzo, Mara; Fantozzi, Roberto; Collino, Massimo] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Povero, Davide; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Sutti, Salvatore; Albano, Emanuele] Univ Amedeo Avogadro East Piedmont, Dept Hlth Sci, Novara, Italy; [Sutti, Salvatore; Albano, Emanuele] Univ Amedeo Avogadro East Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol, Turin, Italy	University of Turin; University of Turin; University of California System; University of California San Diego; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Turin	Parola, M (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.	maurizio.parola@unito.it	Foglia, Beatrice/AAF-4279-2020; Chiazza, Fausto/I-5559-2015; Foglia, Beatrice/E-5592-2017; Collino, Massimo/AAK-8532-2020; Sutti, Salvatore/X-5716-2019	Foglia, Beatrice/0000-0001-7973-9681; Foglia, Beatrice/0000-0001-7973-9681; Collino, Massimo/0000-0001-8782-3496; Sutti, Salvatore/0000-0002-0192-8199; Cannito, Stefania/0000-0001-9883-6882; novo, erica/0000-0003-2586-4246; Chiazza, Fausto/0000-0001-7273-0051	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy) [15274]; University of Torino (Fondo di Ateneo)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy)(Fondazione AIRC per la ricerca sul cancro); University of Torino (Fondo di Ateneo)	This study has been funded by: i) Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, Italy), IG-2014 grant, project code 15274, (to MP); ii) the University of Torino (Fondo di Ateneo ex 60%, to EN and MP).	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Cannito S, 2015, ONCOTARGET, V6, P2206, DOI 10.18632/oncotarget.2943; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Csak T, 2014, LIVER INT, V34, P1402, DOI 10.1111/liv.12537; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ertunc M. E., 2016, J LIPID RES IN PRESS; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hirsova P, 2016, GASTROENTEROLOGY, V150, P956, DOI 10.1053/j.gastro.2015.12.037; Hirsova P, 2015, CELL MOL GASTROENTER, V1, P17, DOI 10.1016/j.jcmgh.2014.11.005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Locatelli I, 2014, HEPATOLOGY, V60, P531, DOI 10.1002/hep.27141; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Pan QW, 2012, GUT, V61, P1330, DOI 10.1136/gutjnl-2011-300449; Povero D, 2015, CELL MOL GASTROENTER, V1, P646, DOI 10.1016/j.jcmgh.2015.07.007; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Roberts Eve A, 2007, Clin Liver Dis, V11, P155, DOI 10.1016/j.cld.2007.02.008; Schattenberg JM, 2016, GASTROENTEROLOGY, V150, P815, DOI 10.1053/j.gastro.2016.02.064; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vivoli E, 2016, CLIN SCI, V130, P1793, DOI 10.1042/CS20160400; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	54	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172575	10.1371/journal.pone.0172575	http://dx.doi.org/10.1371/journal.pone.0172575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249038	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500048
J	Kulkarni, D; De Laender, F				Kulkarni, Devdutt; De laender, Frederik			The combined effects of biotic and abiotic stress on species richness and connectance	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; SECONDARY EXTINCTIONS; LATITUDINAL GRADIENT; POPULATION-DYNAMICS; ECOLOGICAL NETWORKS; TROPHIC CASCADES; BIODIVERSITY; DIVERSITY; COMMUNITY; MODEL	Food web structure and species richness are both subject to biotic (e.g. predation pressure and resource limitation) and abiotic stress (e.g. environmental change). We investigated the combined effects of both types of stress on richness and connectance, and on their relationship, in a predator-prey system. To this end, we developed a mathematical two trophic level food-web model to investigate the effects of biotic and abiotic stress on food web connectance and species richness. We found negative effects of top-down and bottom-up control on prey and predator richness, respectively. Effects of top-down and bottom-up control were stronger when initial connectance was high and low, respectively. Bottom-up control could either aggravate or buffer negative effects of top-down control. Abiotic stress affecting predator richness had positive indirect effects on prey richness, but only when initial connectance was low. However, no indirect effects on predator richness were observed following direct effects on prey richness. Top-down and bottom-up control selected for weakly connected prey and highly connected predators, thereby decreasing and increasing connectance, respectively. Our simulations suggest a broad range of negative and positive richness-connectance relationships, thereby revisiting the often found negative relationship between richness and connectance in food webs. Our results suggest that (1) initial foodweb connectance strongly influences the effects of biotic stress on richness and the occurrence of indirect effects on richness; and (2) the shape of the richness-connectance relationship depends on the type of biotic stress.	[Kulkarni, Devdutt; De laender, Frederik] Univ Namur, Res Unit Environm & Evolutionary Biol URBE, Lab Environm Ecosyst Ecol, Namur, Belgium	University of Namur	Kulkarni, D (corresponding author), Univ Namur, Res Unit Environm & Evolutionary Biol URBE, Lab Environm Ecosyst Ecol, Namur, Belgium.	devdutt.kulkarni@unamur.be	De Laender, Frederik/D-2783-2014	De Laender, Frederik/0000-0002-4060-973X	Centre d'etudes et de recherches universitaires de Namur, University of Namur, Belgium; University of Namur [48454E1]; F.R.S.-FNRS [2.4520.11]	Centre d'etudes et de recherches universitaires de Namur, University of Namur, Belgium; University of Namur; F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS)	DK was funded by a postdoctoral fellowship from the Centre d'etudes et de recherches universitaires de Namur, University of Namur, Belgium. FDL was funded by the University of Namur (FSR Impulsionnel 48454E1); https://www.unamur.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research used resources of the "Plateforme Technologique de Calcul Intensif (PTCI) (http://www.ptci.unamur.be) located at the University of Namur, Belgium, which is supported by the F.R.S.-FNRS under the convention No. 2.4520.11. The PTCI is member of the "Consortium des Equipements de Calcul Intensif (CECI)" (http://www.ceci-hpc.be). We are very grateful to Carlos J. Melian for insightful discussions and detailed constructive comments on the manuscript. We also thank two anonymous reviewers whose comments helped us improve quality of the manuscript.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Amarasekare P, 2014, AM NAT, V184, pE50, DOI 10.1086/677386; Baiser B, 2012, GLOBAL ECOL BIOGEOGR, V21, P579, DOI 10.1111/j.1466-8238.2011.00705.x; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Binzer A, 2016, GLOBAL CHANGE BIOL, V22, P220, DOI 10.1111/gcb.13086; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; BRIAND F, 1983, ECOLOGY, V64, P253, DOI 10.2307/1937073; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Cirtwill AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1589; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; De Laender F, 2014, ECOL LETT, V17, P72, DOI 10.1111/ele.12210; De Laender F, 2013, INTEGR ENVIRON ASSES, V9, pE34, DOI 10.1002/ieam.1428; Dias ATC, 2013, OECOLOGIA, V172, P667, DOI 10.1007/s00442-012-2541-3; Duffy JE, 2002, OIKOS, P99; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Ganser AM, 2013, FRESHW SCI, V32, P1168, DOI 10.1899/12-132.1; Gilljam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9412; Gravel D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019374; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hubbell Stephen P., 2001, V32, pi; Katano I, 2015, OIKOS, V124, P1427, DOI 10.1111/oik.02430; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Lu XK, 2016, NAT CLIM CHANGE, V6, P875, DOI 10.1038/NCLIMATE3002; Lurgi M, 2016, THEOR ECOL-NETH, V9, P3, DOI 10.1007/s12080-015-0264-x; Malaj E, 2014, P NATL ACAD SCI USA, V111, P9549, DOI 10.1073/pnas.1321082111; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McMahon TA, 2012, ECOL LETT, V15, P714, DOI 10.1111/j.1461-0248.2012.01790.x; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Mrowicki RJ, 2015, OIKOS, V124, P1555, DOI 10.1111/oik.02138; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petchey OL, 2000, J ANIM ECOL, V69, P874, DOI 10.1046/j.1365-2656.2000.00446.x; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2010, PHILOS T R SOC B, V365, P2081, DOI 10.1098/rstb.2010.0011; PIMM SL, 1979, OIKOS, V33, P351, DOI 10.2307/3544322; Preuss TG, 2009, ECOL MODEL, V220, P310, DOI 10.1016/j.ecolmodel.2008.09.018; R Development Core Team, 2008, R LANG ENV STAT COMP; Radchuk V, 2016, OIKOS, V125, P424, DOI 10.1111/oik.02220; Rawcliffe R, 2010, FRESHWATER BIOL, V55, P600, DOI 10.1111/j.1365-2427.2009.02280.x; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Saleem M, 2013, ISME J, V7, P1912, DOI 10.1038/ismej.2013.95; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schmid-Araya JM, 2002, J ANIM ECOL, V71, P1056, DOI 10.1046/j.1365-2656.2002.00668.x; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Smit MGD, 2001, ECOTOX ENVIRON SAFE, V48, P43, DOI 10.1006/eesa.2000.1983; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Takemoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157929; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Townsend CR, 1998, ECOL LETT, V1, P200; Van den Brink PJ, 2002, ENVIRON TOXICOL CHEM, V21, P2500, DOI [10.1897/1551-5028(2002)021<2500:PMACBR>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2500:PMACBR&gt;2.0.CO;2]; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vazquez DP, 2004, AM NAT, V164, pE1, DOI 10.1086/421445; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	61	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172828	10.1371/journal.pone.0172828	http://dx.doi.org/10.1371/journal.pone.0172828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248985	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500059
J	Olivo, G; Wiemerslage, L; Swenne, I; Zhukowsky, C; Salonen-Ros, H; Larsson, EM; Gaudio, S; Brooks, SJ; Schioth, HB				Olivo, Gaia; Wiemerslage, Lyle; Swenne, Ingemar; Zhukowsky, Christina; Salonen-Ros, Helena; Larsson, Elna-Marie; Gaudio, Santino; Brooks, Samantha J.; Schioth, Helgi B.			Limbic-thalamo-cortical projections and reward-related circuitry integrity affects eating behavior: A longitudinal DTI study in adolescents with restrictive eating disorders	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; ANOREXIA-NERVOSA; SPATIAL STATISTICS; COGNITIVE CONTROL; DIFFUSION; MICROSTRUCTURE; FORNIX; WOMEN; ACTIVATION; GIRLS	Few studies have used diffusion tensor imaging (DTI) to investigate the micro-structural alterations of WM in patients with restrictive eating disorders (rED), and longitudinal data are lacking. Twelve patients with rED were scanned at diagnosis and after one year of family-based treatment, and compared to twenty-four healthy controls (HCs) through DTI analysis. A tract-based spatial statistics procedure was used to investigate diffusivity parameters: fractional anisotropy (FA) and mean, radial and axial diffusivities (MD, RD and AD, respectively). Reduced FA and increased RD were found in patients at baseline in the corpus callosum, corona radiata and posterior thalamic radiation compared with controls. However, no differences were found between follow-up patients and controls, suggesting a partial normalization of the diffusivity parameters. In patients, trends for a negative correlation were found between the baseline FA of the right anterior corona radiata and the Eating Disorder Examination Questionnaire total score, while a positive trend was found between the baseline FA in the splenium of corpus callosum and the weight loss occurred between maximal documented weight and time of admission. A positive trend for correlation was also found between baseline FA in the right anterior corona radiata and the decrease in the Obsessive-Compulsive Inventory Revised total score over time. Our results suggest that the integrity of the limbic-thalamo-cortical projections and the reward-related circuitry are important for cognitive control processes and reward responsiveness in regulating eating behavior.	[Olivo, Gaia; Wiemerslage, Lyle; Zhukowsky, Christina; Gaudio, Santino; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Funct Pharmacol, Uppsala, Sweden; [Swenne, Ingemar] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Salonen-Ros, Helena] Uppsala Univ, Dept Neurosci Child & Adolescent Psychiat, Uppsala, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Gaudio, Santino] Univ Campus Biomed Roma, Area Diagnost Imaging, CIR, Rome, Italy; [Brooks, Samantha J.] Univ Cape Town, Deptartment Psychiat & Mental Hlth, Cape Town, South Africa	Uppsala University; Uppsala University; Uppsala University; Uppsala University; University Campus Bio-Medico - Rome Italy; University of Cape Town	Olivo, G (corresponding author), Uppsala Univ, Dept Neurosci, Funct Pharmacol, Uppsala, Sweden.	gaia.olivo.6493@student.uu.se	Brooks, Samantha/AAJ-2159-2020; Schioth, Helgi/AAQ-7239-2020	Larsson, Elna-Marie/0000-0001-6308-1387; Wiemerslage, Lyle/0000-0002-6857-0136; Olivo, Gaia/0000-0002-7514-4493; Brooks, Samantha/0000-0002-9146-6257	Formas; Swedish Research Council; Swedish Brain Research Foundation; Gunvoroch Josef Aners Foundation; Karlssons Foundation; LR Akerhams Foundation; Kempe-Carlgrenska Foundation; Tore Nilsons Foundation; Gillbergska Foundation	Formas(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Research Foundation; Gunvoroch Josef Aners Foundation; Karlssons Foundation; LR Akerhams Foundation; Kempe-Carlgrenska Foundation; Tore Nilsons Foundation; Gillbergska Foundation	The studies were supported by Formas, the Swedish Research Council, the Swedish Brain Research Foundation, Gunvoroch Josef Aners Foundation, A Karlssons Foundation, LR Akerhams Foundation, Kempe-Carlgrenska Foundation, Tore Nilsons Foundation and the Gillbergska Foundation.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks SJ, 2014, PSYCHIAT RES-NEUROIM, V224, P246, DOI 10.1016/j.pscychresns.2014.10.001; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cha J, 2016, HUM BRAIN MAPP; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Ehrlich S, 2015, J PSYCHIATR NEUROSCI, V40, P307, DOI 10.1503/jpn.140249; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fairburn CG, 2007, BEHAV RES THER, V45, P1705, DOI 10.1016/j.brat.2007.01.010; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Frank GKW, 2015, CNS SPECTRUMS, V20, P391, DOI 10.1017/S1092852915000012; Frank GKW, 2013, J AM ACAD CHILD PSY, V52, P1066, DOI 10.1016/j.jaac.2013.07.007; Frieling H, 2012, J PSYCHIATR RES, V46, P1237, DOI 10.1016/j.jpsychires.2012.06.005; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Garrett AS, 2014, J PSYCHIATR RES, V57, P26, DOI 10.1016/j.jpsychires.2014.06.013; Hayes DJ, 2015, BRAIN STIMUL, V8, P758, DOI 10.1016/j.brs.2015.03.005; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kazlouski D, 2011, PSYCHIAT RES-NEUROIM, V192, P109, DOI 10.1016/j.pscychresns.2010.12.006; Kilford EJ, 2016, NEUROSCI BIOBEHAV RE; Koch K, 2014, HUM BRAIN MAPP, V35, P1469, DOI 10.1002/hbm.22284; Li W, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.436; Magioncalda P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.442; Mansson J, 2016, INT J EAT DISORDER, V49, P92, DOI 10.1002/eat.22379; Monzon BM, 2016, WORLD J PSYCHIATR, V6, P177, DOI 10.5498/wjp.v6.i1.177; Nagahara Y, 2014, PROG NEURO-PSYCHOPH, V51, P72, DOI 10.1016/j.pnpbp.2014.01.009; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Onoda K, 2012, J NEUROL, V259, P261, DOI 10.1007/s00415-011-6165-z; Rosling A, 2016, UPSALA J MED SCI, V121, P50, DOI 10.3109/03009734.2016.1141810; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Travis KE, 2015, NEUROIMAGE-CLIN, V9, P648, DOI 10.1016/j.nicl.2015.10.008; Via E, 2014, J PSYCHIATR NEUROSCI, V39, P367, DOI 10.1503/jpn.130135; Vogel K, 2016, NEUROIMAGE-CLIN, V11, P614, DOI 10.1016/j.nicl.2016.04.002; Wierenga CE, 2015, BIOL PSYCHIAT, V77, P642, DOI 10.1016/j.biopsych.2014.09.024; Xu JS, 2013, HUM BRAIN MAPP, V34, P1044, DOI 10.1002/hbm.21491; Yau WYW, 2013, INT J EAT DISORDER, V46, P701, DOI 10.1002/eat.22154	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172129	10.1371/journal.pone.0172129	http://dx.doi.org/10.1371/journal.pone.0172129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28248991	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000395983500026
J	Palmu, AA; Rinta-Kokko, H; Nohynek, H; Nuorti, JP; Kilpi, TM; Jokinen, J				Palmu, Arto A.; Rinta-Kokko, Hanna; Nohynek, Hanna; Nuorti, J. Pekka; Kilpi, Terhi M.; Jokinen, Jukka			Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study	PLOS ONE			English	Article							PLACEBO-CONTROLLED-TRIAL; CHILDHOOD PNEUMONIA; DOUBLE-BLIND; HOSPITALIZATIONS; AGE; PREVENTION; ADMISSIONS; EFFICACY; YOUNGER; DISEASE	Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 using a 2+1 schedule (3, 5, 12 months). We estimated the direct and indirect effects of PCV10 on pneumonia among children to evaluate the public health impact of the vaccine. Methods We conducted a nation-wide population-based, observational study comparing rates of pneumonia in children before and after the NVP introduction. For the total (direct and indirect) effect, the cohort of vaccine-eligible children (born June 1, 2010 or later) was followed until the end of 2013 (age range 3-42 months). For the indirect effect, a cohort of older children (age range 7-71 months) not eligible for the PCV vaccination was followed from 2011 to 2013. Both cohorts were compared with two season-and age-matched reference cohorts before NVP introduction. Hospitals' in-and outpatient discharge notifications with ICD-10 diagnoses compatible with pneumonia (J10.0, J11.0, J12-J18, J85.1 or J86) as set by the hospital pediatricians were collected from the national Care Register. The main outcome was hospital-treated primary pneumonia (HTPP), defined as primary diagnosis of pneumonia after in-patient hospitalization. We compared rates of pneumonia in the NVP target and reference cohorts by using Poisson regression models. Results The rate of HTPP episodes was 5.3/1000 person-years in the combined reference cohorts and 4.1/1000 person-years in the target cohort vaccine-eligible children. Compared with the reference cohort, the relative rate reduction in target cohort was 23% (95% CI 18-28) and the absolute reduction 1.3/1000 person-years. In the indirect effect evaluation, we observed continued increase in HTPP incidence until 2011 with a subsequent reduction of 18% (95% CI 10-25) during years 2012 to 2013. Number of empyema diagnoses remained low. Conclusions A substantial decrease in pneumonia rates was observed both among vaccine-eligible children and among older, unvaccinated children after PCV10 introduction.	[Palmu, Arto A.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Tampere, Finland; [Rinta-Kokko, Hanna; Kilpi, Terhi M.; Jokinen, Jukka] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Nohynek, Hanna; Nuorti, J. Pekka] Natl Inst Hlth & Welf, Dept Hlth Secur, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Palmu, AA (corresponding author), Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Tampere, Finland.	arto.palmu@thl.fi		Palmu, Arto A./0000-0001-8071-8896	National Institute for Health and Welfare; GlaxoSmithKline	National Institute for Health and Welfare; GlaxoSmithKline(GlaxoSmithKline)	The current study was funded by the National Institute for Health and Welfare (THL). The authors are employees of the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline for a Nationwide effectiveness trial of the ten-valent pneumococcal conjugate vaccine. AAP, HRK, TMK, and JJ are coinvestigators in the trial. GlaxoSmithKline had no role in the funding or conduct of the current study.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; AGRESTI A, 2004, CATEGORICAL DATA ANA; Berglund A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112211; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Pirez MC, 2014, PEDIATR INFECT DIS J, V33, P753, DOI 10.1097/INF.0000000000000294; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153141; Fernandez JP, 2015, REV CHIL PEDIATR-CHI, V86, P168, DOI 10.1016/j.rchipe.2015.04.026; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Greenberg D, 2015, VACCINE, V33, P4623, DOI 10.1016/j.vaccine.2015.06.062; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Kilpi T., 2014, ICAAC 2014; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lindstrand A, 2014, PEDIATRICS, V134, pE1528, DOI 10.1542/peds.2013-4177; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; McCullagh P, 1989, GEN LINEAR MODELS; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saxena S, 2015, J INFECTION, V71, P428, DOI 10.1016/j.jinf.2015.06.011; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657	29	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172690	10.1371/journal.pone.0172690	http://dx.doi.org/10.1371/journal.pone.0172690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249015	Green Published, gold			2022-12-27	WOS:000395983500050
J	Bastias, CC; Fortunel, C; Valladares, F; Baraloto, C; Benavides, R; Cornwell, W; Markesteijn, L; de Oliveira, AA; Sansevero, JBB; Vaz, MC; Kraft, NJB				Bastias, Cristina C.; Fortunel, Claire; Valladares, Fernando; Baraloto, Christopher; Benavides, Raquel; Cornwell, William; Markesteijn, Lars; de Oliveira, Alexandre A.; Sansevero, Jeronimo B. B.; Vaz, Marcel C.; Kraft, Nathan J. B.			Intraspecific leaf trait variability along a boreal-to-tropical community diversity gradient	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; SPECIES RICHNESS; LATITUDINAL GRADIENT; BETA-DIVERSITY; NEUTRAL THEORY; MECHANISMS; NICHE; PATTERNS; ECOLOGY; EXTENT	Disentangling the mechanisms that shape community assembly across diversity gradients is a central matter in ecology. While many studies have explored community assembly through species average trait values, there is a growing understanding that intraspecific trait variation (ITV) can also play a critical role in species coexistence. Classic biodiversity theory hypothesizes that higher diversity at species-rich sites can arise from narrower niches relative to species-poor sites, which would be reflected in reduced ITV as species richness increases. To explore how ITV in woody plant communities changes with species richness, we compiled leaf trait data (leaf size and specific leaf area) in a total of 521 woody plant species from 21 forest communities that differed dramatically in species richness, ranging from boreal to tropical rainforests. At each forest, we assessed ITV as an estimate of species niche breadth and we quantified the degree of trait overlap among co-occurring species as a measure of species functional similarity. We found ITV was relatively invariant across the species richness gradient. In addition, we found that species functional similarity increased with diversity. Contrary to the expectation from classic biodiversity theory, our results rather suggest that neutral processes or equalizing mechanisms can be acting as potential drivers shaping community assembly in hyperdiverse forests.	[Bastias, Cristina C.; Valladares, Fernando; Benavides, Raquel] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, Madrid, Spain; [Fortunel, Claire; Vaz, Marcel C.; Kraft, Nathan J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fortunel, Claire; Vaz, Marcel C.; Kraft, Nathan J. B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Valladares, Fernando] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Baraloto, Christopher] INRA, UMR Ecol Forets Guyane, Kourou 97387, French Guiana; [Benavides, Raquel] Albert Ludwigs Univ Freiburg, Inst Biol, Geobot, Freiburg, Germany; [Cornwell, William] Univ New South Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Markesteijn, Lars] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Markesteijn, Lars] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England; [Markesteijn, Lars] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor LL57 2DG, Gwynedd, Wales; [de Oliveira, Alexandre A.] Univ Sao Paulo, Dept Ecol, Sao Paulo, SP, Brazil; [Sansevero, Jeronimo B. B.] Inst Pesquisas Jardim Bot Rio de Janeiro, Jardim Bot, Rio De Janeiro, Brazil; [Sansevero, Jeronimo B. B.] Univ Fed Rural Rio de Janeiro UFRRJ, DCA, Inst Florestas, Rio De Janeiro, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University System of Maryland; University of Maryland College Park; University of California System; University of California Los Angeles; Universidad Rey Juan Carlos; INRAE; University of Freiburg; University of New South Wales Sydney; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Oxford; Bangor University; Universidade de Sao Paulo; Jardim Botanico do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Bastias, CC (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, Madrid, Spain.	crbasc@gmail.com	Kraft, Nathan J. B./A-2817-2012; Bastias, Cristina C./C-3657-2017; Caritá Vaz, Marcel/AAZ-6135-2021; Fortunel, Claire/GNO-9511-2022; Markesteijn, Lars/S-9744-2018; Baraloto, Christopher/ABG-2500-2020; Benavides, Raquel/AAQ-5427-2020; Sansevero, Jerônimo B.B/O-6812-2018; Oliveira, Alexandre/ABH-1255-2020; Cornwell, William/I-4083-2019; de Oliveira, Alexandre Adalardo/G-8830-2012	Kraft, Nathan J. B./0000-0001-8867-7806; Bastias, Cristina C./0000-0002-2479-2001; Caritá Vaz, Marcel/0000-0002-6003-8583; Fortunel, Claire/0000-0002-8367-1605; Markesteijn, Lars/0000-0003-3046-3121; Baraloto, Christopher/0000-0001-7322-8581; Benavides, Raquel/0000-0003-2328-5371; Sansevero, Jerônimo B.B/0000-0002-3389-2581; Oliveira, Alexandre/0000-0001-5526-8109; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Cornwell, Will/0000-0003-4080-4073	European Union Seventh Framework Programme [265171]; Ecometas excellence network [CGL2014-53840-REDT]; Spanish Government [AP2010-5600]; Marie Curie IEF fellowship [302445]; Investissement d'Avenir' grant [ANR-10-LABX-0025]; NSF [DEB-0743103/0743800]; Institut National de la Recherche Agronomique (INRA); Institute Interamericano para Pesquisas em Mudancas Globais (IAI); CAPES; Wageningen graduate school; Production Ecology and Resource Conservation (PERC); Center for Tropical Forest Science; University of California, Berkeley, Department of Integrative, Biology; NSF graduate fellowship; DDIG;  [S2013/MAE-2719]	European Union Seventh Framework Programme(European Commission); Ecometas excellence network; Spanish Government(Spanish GovernmentEuropean Commission); Marie Curie IEF fellowship(European Commission); Investissement d'Avenir' grant(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); Institut National de la Recherche Agronomique (INRA); Institute Interamericano para Pesquisas em Mudancas Globais (IAI); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wageningen graduate school; Production Ecology and Resource Conservation (PERC); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of California, Berkeley, Department of Integrative, Biology; NSF graduate fellowship(National Science Foundation (NSF)); DDIG; 	Leaf data used to come to this manuscript resulted from many different studies involving different funding sources: European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 265171; Spanish-funded project REMEDINAL3eCM (S2013/MAE-2719); Ecometas excellence network (CGL2014-53840-REDT); a FPU grant by the Spanish Government (AP2010-5600); a Marie Curie IEF fellowship (FP7-PEOPLE-2011-IEF. no. 302445); a Investissement d'Avenir' grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025); a collaborative NSF DEB-0743103/0743800 and Institut National de la Recherche Agronomique (INRA); Institute Interamericano para Pesquisas em Mudancas Globais (IAI); CAPES; Wageningen graduate school, Production Ecology and Resource Conservation (PE& Center for Tropical Forest Science and the University of California, Berkeley, Department of Integrative, Biology; a NSF graduate fellowship and a DDIG.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Ainley LB, 2016, OECOLOGIA; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Baraloto C, 2010, FUNCT ECOL, V24, P208, DOI 10.1111/j.1365-2435.2009.01600.x; Barton K., 2015, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; de Bello F, 2013, J VEG SCI, V24, P807, DOI 10.1111/jvs.12008; de Bello F, 2009, J VEG SCI, V20, P475, DOI 10.1111/j.1654-1103.2009.01042.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Eugene Avery Thomas, 2002, FOREST MEASUREMENTS; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Fortunel C, 2014, J ECOL, V102, P145, DOI 10.1111/1365-2745.12160; Galloway LF, 1995, EVOLUTION, V49, P1095, DOI 10.1111/j.1558-5646.1995.tb04436.x; Garnier E, 2001, NEW PHYTOL, V152, P69, DOI 10.1046/j.0028-646x.2001.00239.x; Gavrilets Sergey, 2004, P1; Gotelli Nicholas J., 2011, P39; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill JL, 2001, PROG PHYS GEOG, V25, P326, DOI 10.1177/030913330102500302; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Hulshof CM, 2013, J VEG SCI, V24, P921, DOI 10.1111/jvs.12041; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2015, P NATL ACAD SCI USA, V112, P797, DOI 10.1073/pnas.1413650112; Kraft NJB, 2014, OIKOS, V123, P1391, DOI 10.1111/oik.01311; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kumordzi BB, 2015, J ECOL, V103, P1610, DOI 10.1111/1365-2745.12458; Lake JK, 2009, SCIENCE, V324, p1015c, DOI 10.1126/science.1169721; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; Le Bagousse-Pinguet Y, 2015, J ECOL, V103, P1647, DOI 10.1111/1365-2745.12480; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Leps J, 2006, PRESLIA, V78, P481; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Markesteijn L, 2007, AM J BOT, V94, P515, DOI 10.3732/ajb.94.4.515; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Miller P. C., 1979, Topics in plant population biology., P428; Mouillot D, 2005, OECOLOGIA, V145, P345, DOI 10.1007/s00442-005-0151-z; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Narwani A, 2013, ECOL LETT, V16, P1373, DOI 10.1111/ele.12182; Paine CET, 2011, OIKOS, V120, P720, DOI 10.1111/j.1600-0706.2010.19110.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PLATNICK NI, 1991, J NAT HIST, V25, P1083, DOI 10.1080/00222939100770701; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2016, P NATL ACAD SCI USA, V113, P674, DOI 10.1073/pnas.1523683113; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Svensson EI, 2006, EVOLUTION, V60, P1242; Umana MN, 2015, ECOL LETT, V18, P1329, DOI 10.1111/ele.12527; Vaz Marcel Carita, 2011, THESIS; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; von Felten S, 2009, ECOLOGY, V90, P1389; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitmore T.C, 1996, REV SOME ASPECTS TRO; Yeboah D, 2016, ECOL EVOL, V6, P842, DOI 10.1002/ece3.1944	74	19	21	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172495	10.1371/journal.pone.0172495	http://dx.doi.org/10.1371/journal.pone.0172495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241033	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400023
J	Kear, BP; Larsson, D; Lindgren, J; Kundrat, M				Kear, Benjamin P.; Larsson, Dennis; Lindgren, Johan; Kundrat, Martin			Exceptionally prolonged tooth formation in elasmosaurid plesiosaurians	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; KRISTIANSTAD BASIN; SAUROPTERYGIA; REPLACEMENT; REPTILIA; NONMARINE; REMAINS; LINES; REASSESSMENT; PHYLOGENY	Elasmosaurid plesiosaurians were globally prolific marine reptiles that dominated the Mesozoic seas for over 70 million years. Their iconic body-plan incorporated an exceedingly long neck and small skull equipped with prominent intermeshing 'fangs'. How this bizarre dental apparatus was employed in feeding is uncertain, but fossilized gut contents indicate a diverse diet of small pelagic vertebrates, cephalopods and epifaunal benthos. Here we report the first plesiosaurian tooth formation rates as a mechanism for servicing the functional dentition. Multiple dentine thin sections were taken through isolated elasmosaurid teeth from the Upper Cretaceous of Sweden. These specimens revealed an average of 950 daily incremental lines of von Ebner, and infer a remarkably protracted tooth formation cycle of about 2-3 years-other polyphyodont amniotes normally take similar to 1-2 years to form their teeth. Such delayed odontogenesis might reflect differences in crown length and function within an originally uneven tooth array. Indeed, slower replacement periodicity has been found to distinguish larger caniniform teeth in macrophagous pliosaurid plesiosaurians. However, the archetypal sauropterygian dental replacement system likely also imposed constraints via segregation of the developing tooth germs within discrete bony crypts; these partly resorbed to allow maturation of the replacement teeth within the primary alveoli after displacement of the functional crowns. Prolonged dental formation has otherwise been linked to tooth robustness and adaption for vigorous food processing. Conversely, elasmosaurids possessed narrow crowns with an elongate profile that denotes structural fragility. Their apparent predilection for easily subdued prey could thus have minimized this potential for damage, and was perhaps coupled with selective feeding strategies that ecologically optimized elasmosaurids towards more delicate middle trophic level aquatic predation.	[Kear, Benjamin P.] Uppsala Univ, Museum Evolut, Uppsala, Sweden; [Larsson, Dennis] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Lindgren, Johan] Lund Univ, Dept Geol, Lund, Sweden; [Kundrat, Martin] Univ Pavol Jozef Safarik, Fac Sci, Ctr Interdisciplinary Biosci, Jesenna 5, Sk Kosice, Slovakia	Uppsala University; Uppsala University; Lund University; University of Pavol Jozef Safarik Kosice	Kear, BP (corresponding author), Uppsala Univ, Museum Evolut, Uppsala, Sweden.	benjamin.kear@em.uu.se	Kundrát, Martin/F-4959-2017	Kundrát, Martin/0000-0001-9361-2273	Australian Research Council [LP100100339]; Swedish Research Council [2011-3637, 2011-3587]	Australian Research Council(Australian Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by BK: Australian Research Council (LP100100339); Swedish Research Council (2011-3637). JL: Swedish Research Council (2011-3587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrews C.W, 1913, DESCRIPTIVE CATALOGU, V2; Araujo R., 2013, PALAEONTOL ELECTRON, V16, P25; Bardet Nathalie, 1995, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V65, P179; Berkovitz B.K., 2000, P186, DOI 10.1017/CBO9780511542626.013; BERRY WILLIAM B. N., 1968, NATURE [LONDON], V217, P938, DOI 10.1038/217938b0; Chatterjee S., 1989, Geological Society Special Publication, P197, DOI 10.1144/GSL.SP.1989.047.01.15; Cicimurri David J., 2001, Transactions of the Kansas Academy of Science, V104, P129, DOI 10.1660/0022-8443(2001)104[0129:AEWSCA]2.0.CO;2; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; Cruickshank ARI, 2002, PALAEONTOLOGY, V45, P557, DOI 10.1111/1475-4983.00249; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; Dean M.C., 2000, P119, DOI 10.1017/CBO9780511542626.009; Dean MC, 1998, ARCH ORAL BIOL, V43, P1009, DOI 10.1016/S0003-9969(98)00069-7; DEAN MC, 1999, HUMAN GROWTH PAST, P111; Druckenmiller PS, 2008, ZOOTAXA, P1; Edmund A.G., 1969, BIOLOGY REPTILIA, V1, P117; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Foffa D, 2014, J ANAT, V225, P209, DOI 10.1111/joa.12200; Gasparini Z, 2003, J VERTEBR PALEONTOL, V23, P104, DOI 10.1671/0272-4634(2003)23[104:TEPACF]2.0.CO;2; Gren JA, 2014, GEOL MAG, V151, P134, DOI 10.1017/S0016756813000526; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kear BP, 2007, J VERTEBR PALEONTOL, V27, P241, DOI 10.1671/0272-4634(2007)27[241:TCOTAE]2.0.CO;2; Kear BP, 2011, ZOOL J LINN SOC-LOND, V161, P663, DOI 10.1111/j.1096-3642.2010.00648.x; Kear BP, 2006, J VERTEBR PALEONTOL, V26, P196, DOI 10.1671/0272-4634(2006)26[196:PRFCHN]2.0.CO;2; Kear BP, 2002, AUST J ZOOL, V50, P671, DOI 10.1071/ZO01073; Kear BP, 2001, ALCHERINGA, V25, P387, DOI 10.1080/03115510108619228; Kear BP, 2005, J VERTEBR PALEONTOL, V25, P792, DOI 10.1671/0272-4634(2005)025[0792:ANEPFT]2.0.CO;2; Kierdorf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074597; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; McHenry C. R., 2009, THESIS; McHenry CR, 2005, SCIENCE, V310, P75, DOI 10.1126/science.1117241; Neenan JM, 2014, J ANAT, V224, P603, DOI 10.1111/joa.12162; Otero RA, 2014, J VERTEBR PALEONTOL, V34, P100, DOI 10.1080/02724634.2013.780953; PANNELLA G, 1972, ASTROPHYS SPACE SCI, V16, P212, DOI 10.1007/BF00642735; Persson P.O., 1959, ARK FO R MINERALOGI, V2, P431; Rasband W., 2006, IMAGEJ; Rieppel Olivier, 2001, Palaeontologische Zeitschrift, V75, P207; Sachs S, J VERTEBR P IN PRESS; Sachs S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070877; Sassoon J, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150384; Sassoon J, 2012, PALAEONTOLOGY, V55, P743, DOI 10.1111/j.1475-4983.2012.01151.x; Sato T, 2005, LIFE O PAST, P249; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Shang Qing-Hua, 2007, Palaeoworld, V16, P254, DOI 10.1016/j.palwor.2007.05.007; Sorensen AM, 2015, PALAEOGEOGR PALAEOCL, V433, P191, DOI 10.1016/j.palaeo.2015.05.025; Sorensen AM, 2013, CRETACEOUS RES, V42, P85, DOI 10.1016/j.cretres.2013.02.002; STORRS GW, 1993, AM J SCI, V293A, P63, DOI 10.2475/ajs.293.A.63; TAYLOR MA, 1992, PHILOS T ROY SOC B, V335, P247, DOI 10.1098/rstb.1992.0022; TAYLOR MA, 1987, ZOOL J LINN SOC-LOND, V91, P171, DOI 10.1111/j.1096-3642.1987.tb01727.x; TAYLOR MA, 1981, NATURE, V290, P628, DOI 10.1038/290628a0; Underwood CJ, 1999, P YORKS GEOL SOC, V52, P269, DOI 10.1144/pygs.52.3.269; Welles S. P., 1962, Publications Dep Geol University California, V44, P1; Welles S. P., 1943, Memoirs of the University of California, V13, P125; Whitlock JA, 2013, INT J ORAL SCI, V5, P66, DOI 10.1038/ijos.2013.36; Wings O, 2007, ACTA PALAEONTOL POL, V52, P1; Zammit M, 2008, COMP BIOCHEM PHYS A, V150, P124, DOI 10.1016/j.cbpa.2007.09.004	59	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172759	10.1371/journal.pone.0172759	http://dx.doi.org/10.1371/journal.pone.0172759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241059	Green Published, Green Submitted, gold			2022-12-27	WOS:000395934400039
J	Dry, SM; Garrett, SB; Koenig, BA; Brown, AF; Burgess, MM; Hult, JR; Longstaff, H; Wilcox, ES; Contreras, SKM; Martinez, A; Boyd, EA; Dohan, D				Dry, Sarah M.; Garrett, Sarah B.; Koenig, Barbara A.; Brown, Arleen F.; Burgess, Michael M.; Hult, Jen R.; Longstaff, Holly; Wilcox, Elizabeth S.; Contreras, Sigrid Karina Madrigal; Martinez, Arturo; Boyd, Elizabeth A.; Dohan, Daniel			Community recommendations on biobank governance: Results from a deliberative community engagement in California	PLOS ONE			English	Article							PUBLIC DELIBERATION; BIOLOGICAL SAMPLES; CONSENT; POLICY; PARTICIPATION; PERSPECTIVES; WILLINGNESS; MEDICINE; ISSUES; DONATE	United States-based biorepositories are on the cusp of substantial change in regulatory oversight at the same time that they are increasingly including samples and data from large populations, e.g. all patients in healthcare system. It is appropriate to engage stakeholders from these populations in new governance arrangements. We sought to describe community recommendations for biorepository governance and oversight using deliberative community engagement (DCE), a qualitative research method designed to elicit lay perspectives on complex technical issues. We asked for stakeholders to provide input on governance of large biorepositories at the University of California (UC), a public university. We defined state residents as stakeholders and recruited residents from two large metropolitan areas, Los Angeles (LA) and San Francisco (SF). In LA, we recruited English and Spanish speakers; in SF the DCE was conducted in English only. We recruited individuals who had completed the 2009 California Health Interview Survey and were willing to be re-contacted for future studies. Using stratified random sampling (by age, education, race/ethnicity), we contacted 162 potential deliberants of whom 53 agreed to participate and 51 completed the 4-day DCE in June (LA) and September-October (SF), 2013. Each DCE included discussion among deliberants facilitated by a trained staff and simultaneously-translated in LA. Deliberants also received a briefing book describing biorepository operations and regulation. During the final day of the DCE, deliberants voted on governance and oversight recommendations using an audience response system. This paper describes 23 recommendations (of 57 total) that address issues including: educating the public, sharing samples broadly, monitoring researcher behavior, using informative consent procedures, and involving community members in a transparent process of biobank governance. This project demonstrates the feasibility of obtaining meaningful input on biorepository governance from diverse lay stake-holders. Such input should be considered as research institutions respond to changes in biorepository regulation.	[Dry, Sarah M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Garrett, Sarah B.; Dohan, Daniel] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Koenig, Barbara A.] Univ Calif San Francisco, Inst Hlth & Aging, Dept Social & Behav Sci, San Francisco, CA 94143 USA; [Brown, Arleen F.] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA; [Brown, Arleen F.] Univ Calif Los Angeles, Hlth Serv Res, Los Angeles, CA USA; [Burgess, Michael M.] Univ British Columbia, Dept Biomed Eth, Vancouver, BC, Canada; [Hult, Jen R.] Genentech Inc, San Francisco, CA 94080 USA; [Longstaff, Holly] Simon Fraser Univ, Off Res Eth, Burnaby, BC, Canada; [Wilcox, Elizabeth S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Martinez, Arturo] Univ Calif Los Angeles, Ctr Clin & Translat Sci Inst, Los Angeles, CA USA; [Boyd, Elizabeth A.] Univ Calif Off President, Oakland, CA USA	University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of British Columbia; Roche Holding; Genentech; Simon Fraser University; University of British Columbia; University of California System; University of California Los Angeles; University of California System	Dohan, D (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	Daniel.dohan@ucsf.edu	Garrett, Sarah/AAO-6784-2020; Burgess, Michael/AAS-7840-2021	Garrett, Sarah/0000-0002-3238-5692; Brown, Arleen/0000-0001-9948-8955; Longstaff, Holly/0000-0002-1662-0832	National Center for Advancing Translational Sciences (NCATS) [UL1 TR000004-07S2, UL1 TR000124]; National Institutes of Health-National Human Genome Research Institute, BK [NIH P20 HG007243]; National Human Genome Research Institute (NHGRI) [P20 HG007243]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG007243] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health-National Human Genome Research Institute, BK; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by UL1 TR000004-07S2, National Center for Advancing Translational Sciences (NCATS), DD, SD UL1 TR000124, National Center for Advancing Translational Sciences (NCATS), AB NIH P20 HG007243, National Institutes of Health-National Human Genome Research Institute, BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genentech, Inc. provided support in the form of salaries for author JRH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; The study was supported by National Center for Advancing Translational Sciences (NCATS) grants UL1 TR000004-0752 (Grady, PI) and UL1 TR000124 (Dubinett, PI); National Human Genome Research Institute (NHGRI) grant P20 HG007243 (Somkin, PI).	Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; Abelson J, 2013, J PUBLIC DELIBERATIO; Allyse MA, 2015, AM J BIOETHICS, V15, P1, DOI 10.1080/15265161.2015.1062175; [Anonymous], [No title captured]; [Anonymous], 2007, UK BIOB ETH GOV FRAM; Brothers KB, 2011, AM J MED GENET A, V155A, P2982, DOI 10.1002/ajmg.a.34304; Bryant J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1416-5; Burgess M, 2008, PERS MED, V5, P285, DOI 10.2217/17410541.5.3.285; Burgess MM, 2014, PUBLIC UNDERST SCI, V23, P48, DOI 10.1177/0963662512472160; California Health Interview Survey, 2011, CHIS 2009 METH SER; Carman KL, 2015, SOC SCI MED, V133, P11, DOI 10.1016/j.socscimed.2015.03.024; Caulfield T, 2003, BMC MED ETHICS, V4, P1, DOI DOI 10.1186/1472-6939-4-1; Chalmers D, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0124-2; Chen DT, 2005, ARCH INTERN MED, V165, P652, DOI 10.1001/archinte.165.6.652; Dove ES, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-158; Flick U., 2014, SAGE HDB QUALITATIVE, P3; Garrett SB, 2015, CLIN TRANSL SCI; Gayet-Ageron A, 2016, EUR J HUM GENET NATU; Glasmeier AK, 2016, LIV WAG CALC; Gornick MC, 2014, J EMPIR RES HUM RES, V9, P22, DOI 10.1177/1556264614544277; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; HHS (US Department of Health and Human Services), 2011, FED REGISTER, V76, P44; Lemke AA, 2012, AM J MED GENET A, V158A, P1029, DOI 10.1002/ajmg.a.34414; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Moore A, 2014, J POLIT PHILOS, V22, P302, DOI 10.1111/jopp.12028; O'Doherty KC, 2010, PUBLIC HEALTH GENOM, V13, P197, DOI 10.1159/000279621; O'Doherty K.C., 2013, RES ETHICS, V9, P55, DOI DOI 10.1177/1747016113488858; O'Doherty KC, 2012, SOC SCI MED, V75, P1604, DOI 10.1016/j.socscimed.2012.06.026; Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006; Precision Medicine Initiative (PMI) Working Group, 2015, PREC MED IN COH PROG; Saha K, 2011, NATURE, V478, P312, DOI 10.1038/478312a; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Skloot R, 2011, IMMORTAL LIFE HENRIE; Swede H, 2007, GENET MED, V9, P141, DOI 10.1097/GIM.0b013e3180330039; The Nuffield Council on Bioethics, 2015, COLL LINK US DAT BIO; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363; U.S. Department of Health and Human Services, 2015, FED REGISTER, V80, P53931; UCLA Center for Health Policy Research, CAL HLTH INT SURV WH; van Draanen J, ASSESSING RES NEEDS; Williams I, 2014, LEADERSH HEALTH SERV, V27, P5, DOI 10.1108/LHS-01-2013-0002	40	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172582	10.1371/journal.pone.0172582	http://dx.doi.org/10.1371/journal.pone.0172582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28235046	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200096
J	Konstantopoulos, A; Liu, YC; Teo, EPW; Lwin, NC; Yam, GHF; Mehta, JS				Konstantopoulos, Aris; Liu, Yu-Chi; Teo, Ericia Pei Wen; Lwin, Nyein Chan; Yam, Gary Hin Fai; Mehta, Jodhbir S.			Early wound healing and refractive response of different pocket configurations following presbyopic inlay implantation	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; INCISION LENTICULE EXTRACTION; MULTIFOCAL INTRAOCULAR-LENS; ONE-YEAR SAFETY; FEMTOSECOND LASER; VISUAL OUTCOMES; HYDROGEL INLAY; CORNEAL INLAY; PSEUDOPHAKIC MONOVISION; EFFICACY	Background Presbyopic inlays have mostly been implanted under a corneal flap. Implantation in a pocket has advantages including less postoperative dry eye and neurotrophic effect, and better biomechanical corneal stability. This study investigated the effect of different pocket and flocket dimensions on corneal stability and refractive power after Raindrop T implantation, and the associated wound healing response. Methodology Ten New Zealand White rabbits had bilateral pocket Raindrop T implantation. Eyes were allocated to 4 groups: pockets with 4mm, 6mm, and 8mm diameters, and 8mm flocket. They were examined pre-operatively, at day 1, weeks 1, 2, 3 and 4 post-surgery with anterior segment optical coherence tomography, corneal topography and in-vivo confocal microscopy. After euthanasia (week 4), CD11b, heat shock protein (HSP) 47 and fibronectin corneal immunohistochemistry was performed. Results Corneal thickness (mean +/- SD) increased from 360.0 +/- 16.2 mu m pre-operatively to 383.9 +/- 32.5, 409.4 +/- 79.3, 393.6 +/- 35.2, 396.4 +/- 50.7 and 405 +/- 20.3 mu m on day 1, weeks 1,2,3 and 4 respectively (p<0.008, all time-points). Corneal refractive power increased by 11.1 +/- 5.5, 7.5 +/- 2.5, 7.5 +/- 3.1, 7.0 +/- 3.6 and 6.3 +/- 2.9D (p<0.001). Corneal astigmatism increased from 1.1 +/- 0.3D to 2.3 +/- 1.6, 1.7 +/- 0.7, 1.8 +/- 1.0, 1.6 +/- 0.9 and 1.6 +/- 0.9D respectively (p = 0.033). CT, refractive power change and astigmatism were not different between groups. The 8mm pocket and 8mm flocket groups had the least stromal keratocyte reflectivity. CD11b, fibronectin or HSP47 weren't detected. Conclusions Anatomical and refractive stability was achieved by 1 week; the outcomes were not affected by pocket or flocket configuration. No scarring or inflammation was identified. The 8mm pocket and flocket showed the least keratocyte activation, suggesting they might be the preferred configuration.	[Konstantopoulos, Aris; Liu, Yu-Chi; Teo, Ericia Pei Wen; Lwin, Nyein Chan; Yam, Gary Hin Fai; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Konstantopoulos, Aris; Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Konstantopoulos, Aris] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Mehta, Jodhbir S.] Nanyang Technol Univ, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; University of Southampton; University Hospital Southampton NHS Foundation Trust; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.; Mehta, JS (corresponding author), Nanyang Technol Univ, Singapore, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020; Yam, Gary Hin-Fai/ABE-1710-2020	Liu, Yu Chi/0000-0001-5408-0382; 	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme	This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013) and administered by the Singapore Ministry of Health's National Medical Research Council.	Baily C, 2014, J CATARACT REFR SURG, V40, P1341, DOI 10.1016/j.jcrs.2013.11.047; Garza EB, 2013, J REFRACT SURG, V29, P166, DOI 10.3928/1081597X-20130129-01; Chayet A, 2013, J CATARACT REFR SURG, V39, P1713, DOI 10.1016/j.jcrs.2013.05.038; Chen SH, 2012, J REFRACT SURG, V28, P15, DOI 10.3928/1081597X-20111228-02; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Finkelman YM, 2009, J CATARACT REFR SURG, V35, P998, DOI 10.1016/j.jcrs.2009.01.035; Garza EB, 2015, J CATARACT REFR SURG, V41, P306, DOI 10.1016/j.jcrs.2014.05.046; Hayashi S, 2002, J MORPHOL, V254, P247, DOI 10.1002/jmor.10030; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Ito M, 2009, J CATARACT REFR SURG, V35, P710, DOI 10.1016/j.jcrs.2008.12.019; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Konstantopoulos A, 2015, EXPERT REV MED DEVIC, V12, P341, DOI 10.1586/17434440.2015.1007124; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077797; Limnopoulou AN, 2013, J REFRACT SURG, V29, P12, DOI 10.3928/1081597X-20121210-01; Liu YC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/928608; Luger MHA, 2013, CORNEA, V32, P644, DOI 10.1097/ICO.0b013e31825f02f5; Malandrini A, 2014, J CATARACT REFR SURG, V40, P545, DOI 10.1016/j.jcrs.2013.08.057; Menassa N, 2012, J CATARACT REFR SURG, V38, P765, DOI 10.1016/j.jcrs.2011.11.051; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Ostrin LA, 2004, J CATARACT REFR SURG, V30, P1435, DOI 10.1016/j.jcrs.2003.12.045; Riau AK, 2014, INVEST OPHTH VIS SCI, V55, P3186, DOI 10.1167/iovs.14-14434; Ryan A, 2013, J CATARACT REFR SURG, V39, P1226, DOI 10.1016/j.jcrs.2013.03.016; Santhiago MR, 2012, J REFRACT SURG, V28, P144, DOI 10.3928/1081597X-20111122-02; Tan XW, 2013, J MATER SCI-MATER M, V24, P967, DOI 10.1007/s10856-012-4848-3; van der Linden JW, 2013, INT OPHTHALMOL, V33, P493, DOI 10.1007/s10792-013-9727-5; van der Linden JW, 2012, J CATARACT REFR SURG, V38, P68, DOI 10.1016/j.jcrs.2011.06.034; Wilkins MR, 2013, OPHTHALMOLOGY, V120, P2449, DOI 10.1016/j.ophtha.2013.07.048; Yoo A, 2015, J REFRACT SURG, V31, P454, DOI 10.3928/1081597X-20150623-03	29	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172014	10.1371/journal.pone.0172014	http://dx.doi.org/10.1371/journal.pone.0172014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235010	Green Published, gold			2022-12-27	WOS:000394688200042
J	Xia, T; Zhou, JY; Mou, YP; Xu, XW; Zhang, RC; Zhou, YC; Chen, RG; Lu, C; Huang, CJ				Xia, Tao; Zhou, Jia-Yu; Mou, Yi-Ping; Xu, Xiao-Wu; Zhang, Ren-Chao; Zhou, Yu-Cheng; Chen, Rong-Gao; Lu, Chao; Huang, Chao-Jie			Risk factors for postoperative pancreatic fistula after laparoscopic distal pancreatectomy using stapler closure technique from one single surgeon	PLOS ONE			English	Article							THICK PANCREAS; STUMP CLOSURE; REMNANT; SPLEEN; CONSERVATION; METAANALYSIS; TRANSECTION; MULTICENTER; MANAGEMENT; MORBIDITY	Laparoscopic distal pancreatectomy (LDP) is a safe and reliable treatment for tumors in the body and tail of the pancreas. Postoperative pancreatic fistula (POPF) is a common complication of pancreatic surgery. Despite improvement in mortality, the rate of POPF still remains high and unsolved. To identify risk factors for POPF after laparoscopic distal pancreatectomy, clinicopathological variables on 120 patients who underwent LDP with stapler closure were retrospectively analyzed. Univariate and multivariate analyses were performed to identify risk factors for POPF. The rate of overall and clinically significant POPF was 30.8% and13.3%, respectively. Higher BMI (>= 25kg/m(2)) (p-value = 0.025) and longer operative time (p-value = 0.021) were associated with overall POPF but not clinically significant POPF. Soft parenchymal texture was significantly associated with both overall (p-value = 0.012) and clinically significant POPF (p-value = 0.000). In multivariable analyses, parenchymal texture (OR, 2.933, P-value = 0.011) and operative time (OR, 1.008, P-value = 0.022) were risk factors for overall POPF. Parenchymal texture was an independent predictive factor for clinically significant POPF (OR, 7.400, P-value = 0.001).	[Xia, Tao; Zhou, Jia-Yu; Chen, Rong-Gao; Lu, Chao] Zhejiang Univ, Sch Med, Dept Surg, Hangzhou, Zhejiang, Peoples R China; [Mou, Yi-Ping; Xu, Xiao-Wu; Zhang, Ren-Chao; Zhou, Yu-Cheng; Huang, Chao-Jie] Zhejiang Prov Peoples Hosp, Dept Gastrointestinal Pancreat Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital	Mou, YP (corresponding author), Zhejiang Prov Peoples Hosp, Dept Gastrointestinal Pancreat Surg, Hangzhou, Zhejiang, Peoples R China.	yipingmou@126.com	Zhou, Jiayu/M-1559-2019					Akita H, 2015, LANGENBECK ARCH SURG, V400, P843, DOI 10.1007/s00423-015-1339-2; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cecka F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482906; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Distler M, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-54; Dorcaratto D, 2012, J LAPAROENDOSC ADV S, V22, P242, DOI 10.1089/lap.2011.0417; Dumitrascu T, 2014, J HEPATO-BIL-PAN SCI, V21, P654, DOI 10.1002/jhbp.110; Eguchi H, 2011, DIGEST SURG, V28, P50, DOI 10.1159/000322406; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P1691, DOI 10.1007/s11605-008-0636-2; Go JE, 2015, ANN SURG TREAT RES, V88, P318, DOI 10.4174/astr.2015.88.6.318; Goh BKP, 2008, ARCH SURG-CHICAGO, V143, P956, DOI 10.1001/archsurg.143.10.956; Hede P, 2015, INT J COLORECTAL DIS, V30, P1201, DOI 10.1007/s00384-015-2280-0; Javed AA, 2015, J GASTROINTEST SURG, V19, P2028, DOI 10.1007/s11605-015-2920-2; Kawabata Y, 2013, EUR SURG RES, V50, P71, DOI 10.1159/000349977; Kawai M, 2013, AM J SURG, V206, P352, DOI 10.1016/j.amjsurg.2012.11.023; Kimura W, 1996, SURGERY, V120, P885, DOI 10.1016/S0039-6060(96)80099-7; Kleeff J, 2007, ANN SURG, V245, P573, DOI 10.1097/01.sla.0000251438.43135.fb; Knaebel HP, 2005, BRIT J SURG, V92, P539, DOI 10.1002/bjs.5000; Malleo G, 2015, SURG ENDOSC, V29, P1952, DOI 10.1007/s00464-014-3890-2; Mendoza AS, 2016, SURG ENDOSC, V30, P649, DOI 10.1007/s00464-015-4255-1; Montorsi M, 2012, ANN SURG, V256, P853, DOI 10.1097/SLA.0b013e318272dec0; Nakamura M, 2014, HEPATO-GASTROENTEROL, V61, P834, DOI 10.5754/hge13949; Nakamura M, 2013, J HEPATO-BIL-PAN SCI, V20, P421, DOI 10.1007/s00534-012-0578-7; Okano K, 2008, J HEPATO-BILIARY-PAN, V15, P353, DOI 10.1007/s00534-008-1328-8; Okano K, 2013, SURG TODAY, V43, P141, DOI 10.1007/s00595-012-0235-4; Okano K, 2011, J HEPATO-BIL-PAN SCI, V18, P815, DOI 10.1007/s00534-011-0393-6; Probst P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008688.pub2; Ricci C, 2015, J GASTROINTEST SURG, V19, P1415, DOI 10.1007/s11605-015-2841-0; Ridolfini MP, 2007, WORLD J GASTROENTERO, V13, P5096, DOI 10.3748/wjg.v13.i38.5096; Sahakyan MA, 2015, SURG ENDOSCOPY; Seeliger H, 2010, AM J SURG, V200, P311, DOI 10.1016/j.amjsurg.2009.10.022; Shi N, 2015, ANN SURG ONCOLOGY; Sledzianowski JF, 2005, SURGERY, V137, P180, DOI 10.1016/j.surg.2004.06.063; Strasberg SM, 2002, J AM COLL SURGEONS, V194, P746, DOI 10.1016/S1072-7515(02)01202-4; Sugimoto M, 2013, J HEPATO-BIL-PAN SCI, V20, P538, DOI 10.1007/s00534-013-0596-0; Unek T, 2013, HEPATO-GASTROENTEROL, V60, P1778, DOI 10.5754/hge13274; Venkat R, 2012, ANN SURG, V255, P1048, DOI 10.1097/SLA.0b013e318251ee09; WARSHAW AL, 1988, ARCH SURG-CHICAGO, V123, P550; Weber SM, 2009, ANN SURG ONCOL, V16, P2825, DOI 10.1245/s10434-009-0597-z; Yan JF, 2015, J ZHEJIANG UNIV-SC B, V16, P573, DOI 10.1631/jzus.B1400257; Yu L, 2014, HEPATO-GASTROENTEROL, V61, P2091, DOI 10.5754/hge13932; Zhang H, 2015, BRIT J SURG, V102, P4, DOI 10.1002/bjs.9653; Zhang MZ, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0411-2; Zhou W, 2010, AM J SURG, V200, P529, DOI 10.1016/j.amjsurg.2009.12.022	45	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172857	10.1371/journal.pone.0172857	http://dx.doi.org/10.1371/journal.pone.0172857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235064	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200154
J	Juga, AJC; Hens, N; Osman, N; Aerts, M				Juga, Adelino J. C.; Hens, Niel; Osman, Nafissa; Aerts, Marc			A flexible method to model HIV serodiscordance among couples in Mozambique	PLOS ONE			English	Article								Whereas the number of people newly infected by HIV is continuing to decline globally, the epidemic continues to expand in many parts of the world. As the HIV/AIDS epidemic has matured in many countries, it is believed that the proportion of new infections occurring within couples has risen. Across countries, including Mozambique, a sizeable proportion of couples with HIV infection are discordant. A serodiscordant couple is a couple in which one partner has tested positive for HIV and the other has not. To describe the HIV serodiscordance among couples, a variety of association measures can be used. In this paper, we propose the serodiscordance measure (SDM) as a new alternative measure. Focus is on the specification of flexible marginal and random effects models for multivariate correlated binary data together with a full-likelihood estimation method, to adequately and directly describe the measure of interest. Fitting joint models allows examining the effects of different risk factors and other covariates on the probability to be HIV positive for each member within a couple, and estimating common effects for both probabilities more efficiently, while accounting for the association between their infection status. Moreover, the interpretation of the proposed association parameter SDM is more direct and relevant and effects of covariates can be studied as well. Results show that the HIV prevalence for the province where a couple was located as well as the union number for the woman within a couple are factors associated with HIV serodiscordance. These findings are important for the Mozambican public health policy makers to design national prevention plans, which include policies to stimulate regular HIV testing for couples as well as adolescents and young adults, prior to getting married or living together as a couple.	[Juga, Adelino J. C.] Eduardo Mondlane Univ, Dept Math & Informat, Fac Sci, Maputo, Mozambique; [Juga, Adelino J. C.; Hens, Niel; Aerts, Marc] Hasselt Univ, BioStat I, Diepenbeek, Belgium; [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Hens, Niel] Univ Antwerp, Epidemiol & Social Med ESOC, Fac Med & Hlth Sci, Antwerp, Belgium; [Osman, Nafissa] Maputo Cent Hosp, Dept Obstet & Gynaecol, Maputo, Mozambique; [Osman, Nafissa] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Eduardo Mondlane University; Hasselt University; University of Antwerp; University of Antwerp; Eduardo Mondlane University	Juga, AJC (corresponding author), Eduardo Mondlane Univ, Dept Math & Informat, Fac Sci, Maputo, Mozambique.; Juga, AJC (corresponding author), Hasselt Univ, BioStat I, Diepenbeek, Belgium.	adelino.juga@gmail.com	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program	Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program provided financial support.; This study was only possible thanks to the financial support of the Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program. The authors would also like to acknowledge the support given by the Mozambican Health Ministry (MISAU) and Demography Health Survey (DHS) Program for providing the INSIDA survey data. The authors would also like to thank the editors and the reviewers for their interesting and helpful comments and suggestions.	Agresti A, 2013, CATEGORICAL DATA ANA; Akaike H, 1973, REPRODUCED BREAKTHRO, V1, P267; [Anonymous], 2014, PSYCHOLOGY; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; DALE JR, 1986, BIOMETRICS, V42, P909, DOI 10.2307/2530704; Dokubo EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106760; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Ewayo O, 2010, LANCET INFECT DIS, V10, P770, DOI [10.1016/S1473-3099(10)70189-4, DOI 10.1016/S1473-3099(10)70189-4]; Faes C, 2008, J AM STAT ASSOC, V103, P149, DOI 10.1198/016214507000000419; Fishel JD, 2011, HIV COUPLES MOZAMBIQ; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE), 2010, INQ NAC PREV RISC CO, P333; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lovasi Gina S, 2012, Open Epidemiol J, V5, P13; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Thomas SL, 2001, RES HIGH EDUC, V42, P517, DOI 10.1023/A:1011098109834	18	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172959	10.1371/journal.pone.0172959	http://dx.doi.org/10.1371/journal.pone.0172959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253283	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300053
J	Lu, J; Li, XH; Wang, QY; Pei, G				Lu, Jing; Li, Xiaohang; Wang, Qinying; Pei, Gang			Dopamine D-2 receptor and beta-arrestin 2 mediate Amyloid-beta elevation induced by antiparkinson's disease drugs, levodopa and piribedil, in neuronal cells	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; DOPA-INDUCED DYSKINESIA; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; ALPHA-SYNUCLEIN; STEM-CELLS; FOLLOW-UP; G-PROTEIN; IN-VIVO	Although levodopa is the first-line medication for the treatment of Parkinson's disease (PD) showing unsurpassable efficiency, its chronic use causes dyskinesia. Accordingly, dopamine agonists are increasingly employed as monotherapy or in combination with levodopa to reduce the risk of motor complications. It is well recognized that patients with PD often exhibit cognitive deficits. However, clinical and animal studies assessing the effects of dopaminergic medications on cognition are controversial. Amyloid-beta (A beta) is one of the major hallmarks of Alzheimer's disease (AD), leading to progressive memory loss and cognitive deficit. Interestingly, the abnormal accumulation of A beta is also detected in PD patients with cognitive deficits. Evidence indicated that levodopa induced a mild increase of A beta plaque number and size in the brain of AD mouse. However, the underlying mechanism is unclear. Here we present that both levodopa and piribedil enhance the generation of A beta and the activity gamma-secretase in human neuronal cells and primary neurons isolated from AD mouse. This effect was reduced by either the antagonism or the knockdown of dopamine D-2 receptor (D2R). We further showed that in the cells expressing beta-arrestin 2-biased D2R mutant, piribedil promoted cellular A beta production to the extent comparable to the wild-type D2R whereas this activity was absent in those with G protein-biased D2R mutant. Moreover, the knockdown of beta-arrestin 2 attenuated the increases of A beta generation gamma-secretase activity mediated by levodopa or piribedil. Thus, our study suggests that targeting-mediated beta-arrestin function may have potential risk in the modulation of A beta pathology.	[Lu, Jing; Li, Xiaohang; Wang, Qinying; Pei, Gang] Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, Shanghai, Peoples R China; [Pei, Gang] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biochem, Shanghai, Peoples R China.; Pei, G (corresponding author), Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai, Peoples R China.	gpei@sibs.ac.cn		Li, Xiaohang/0000-0002-7316-2196	Ministry of Science and Technology of China [2015CB964502, 2014CB964802]; National Natural Science Foundation of China [31371419]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Ministry of Science and Technology of China (2015CB964502, 2014CB964802) and the National Natural Science Foundation of China (31371419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambree O, 2009, NEUROBIOL AGING, V30, P1192, DOI 10.1016/j.neurobiolaging.2007.11.010; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Clayton CC, 2014, J BIOL CHEM, V289, P33663, DOI 10.1074/jbc.M114.605378; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cote SR, 2015, NEUROSCI LETT, V585, P33, DOI 10.1016/j.neulet.2014.11.023; Eckart C, 2014, NEUROIMAGE, V94, P185, DOI 10.1016/j.neuroimage.2014.03.011; Hernandez VS, 2014, NEUROPHARMACOLOGY, V82, P88, DOI 10.1016/j.neuropharm.2013.11.013; Himeno E, 2011, ANN NEUROL, V69, P248, DOI 10.1002/ana.22319; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Itoh A, 1996, J NEUROCHEM, V66, P1113; Joyce JN, 1998, NEUROPSYCHOPHARMACOL, V19, P472, DOI 10.1016/S0893-133X(98)00044-X; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Kulisevsky J, 1996, BRAIN, V119, P2121, DOI 10.1093/brain/119.6.2121; Kulisevsky J, 2000, MOVEMENT DISORD, V15, P613, DOI 10.1002/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166415; Mytilineou C, 2003, J PHARMACOL EXP THER, V304, P792, DOI 10.1124/jpet.102.042267; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Peritore CS, 2012, NEUROREPORT, V23, P989, DOI 10.1097/WNR.0b013e32835a4ea4; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; Pizzolato G, 1996, NEUROLOGY, V47, P1065, DOI 10.1212/WNL.47.4.1065; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Solis O, 2017, CEREB CORTEX, V27, P435, DOI 10.1093/cercor/bhv231; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Urs NM, 2015, P NATL ACAD SCI USA, V112, pE2517, DOI 10.1073/pnas.1502740112; Vo A, 2016, PSYCHOPHARMACOLOGY, V233, P2753, DOI 10.1007/s00213-016-4322-x; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P11, DOI 10.1016/0925-4927(96)02809-0; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19	38	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173240	10.1371/journal.pone.0173240	http://dx.doi.org/10.1371/journal.pone.0173240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253352	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300094
J	Wang, ZW; Xiao, XY; Ge, RB; Li, JJ; Johnson, CW; Rassoulian, C; Olumi, AF				Wang, Zongwei; Xiao, Xingyuan; Ge, Rongbin; Li, Jijun; Johnson, Cameron W.; Rassoulian, Cyrus; Olumi, Aria F.			Metformin inhibits the proliferation of benign prostatic epithelial cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNALING PATHWAY; CYCLE PROGRESSION; CANCER-CELLS; HYPERPLASIA; INSULIN; EXPRESSION; RISK; RECEPTOR; D1	Objective Benign prostatic hyperplasia (BPH) is the most common proliferative abnormality of the prostate affecting elderly men throughout the world. Epidemiologic studies have shown that diabetes significantly increases the risk of developing BPH, although whether anti-diabetic medications preventing the development of BPH remains to be defined. We have previously found that stromally expressed insulin-like growth factor 1 (IGF-1) promotes benign prostatic epithelial cell proliferation through paracrine mechanisms. Here, we seek to understand if metformin, a first line medication for the treatment of type 2 diabetes, inhibits the proliferation of benign prostatic epithelial cells through reducing the expression of IGF-1 receptor (IGF-1R) and regulating cell cycle. Methods BPE cell lines BPH-1 and P69, murine fibroblasts3T3 and primary human prostatic fibroblasts were cultured and tested in this study. Cell proliferation and the cell cycle were analyzed by MTS assay and flow cytometry, respectively. The expression of IGF-1R was determined by western-blot and immunocytochemistry. The level of IGF-1 secretion in culture medium was measured by ELISA. Results Metformin (0.5-10mM, 6-48h) significantly inhibited the proliferation of BPH-1 and P69 cells in a dose-dependent and time-dependent manner. Treatment with metformin for 24 hours lowered the G(2)/M cell population by 43.24% in P69 cells and 24.22% in BPH-1 cells. On the other hand, IGF-1 (100ng/mL, 24h) stimulated the cell proliferation (increased by 28.81% in P69 cells and 20.95% in BPH-1 cells) and significantly enhanced the expression of IGF-1R in benign prostatic epithelial cells. Metformin (5mM) abrogated the proliferation of benign prostatic epithelial cells induced by IGF-1. In 3T3 cells, the secretion of IGF-1 was significantly inhibited by metformin from 574.31pg/ml to 197.61pg/ml. The conditioned media of 3T3 cells and human prostatic fibroblasts promoted the proliferation of epithelial cells and the expression of IGF-1R in epithelial cells. Metformin abrogated the proliferation of benign prostatic epithelial cells promoted by 3T3 conditioned medium. Conclusions Our study demonstrates that metformin inhibits the proliferation of benign prostatic epithelial cells by suppressing the expression of IGF-1R and IGF-1 secretion in stromal cells. Metformin lowers the G2/M cell population and simultaneously increases the G0/G1 population. Findings here might have significant clinical implications in management of BPH patients treated with metformin.	[Wang, Zongwei; Xiao, Xingyuan; Johnson, Cameron W.; Rassoulian, Cyrus; Olumi, Aria F.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Xiao, Xingyuan] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Dept Urol, Wuhan, Peoples R China; [Ge, Rongbin] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Li, Jijun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Huazhong University of Science & Technology; University of Massachusetts System; University of Massachusetts Worcester; Shanghai Jiao Tong University	Wang, ZW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.	zwang0@mgh.harvard.edu	wang, zongwei/HIA-0279-2022		NIH/National Institute for Diabetes and Digestive and Kidney Diseases [NIH/R01 DK091353]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091353] Funding Source: NIH RePORTER	NIH/National Institute for Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH/National Institute for Diabetes and Digestive and Kidney Diseases (NIH/R01 DK091353) to AFO.	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; Bourke J B, 1966, Br J Urol, V38, P18, DOI 10.1111/j.1464-410X.1966.tb09675.x; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chen Z, 2015, INT J CLIN EXP MED, V8, P11289; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; COHEN P, 1991, J CLIN ENDOCR METAB, V73, P401, DOI 10.1210/jcem-73-2-401; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; Dekanty A, 2006, J BIOL CHEM, V281, P6136, DOI 10.1074/jbc.M505839200; Dong GY, 1997, J CLIN ENDOCR METAB, V82, P2198, DOI 10.1210/jc.82.7.2198; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Ge RB, 2015, ONCOTARGET, V6, P28973, DOI 10.18632/oncotarget.5023; Gong EM, 2004, AM J CHINESE MED, V32, P331, DOI 10.1142/S0192415X04001989; Hammarsten J, 1999, BLOOD PRESSURE, V8, P29, DOI 10.1080/080370599438365; Hammarsten J, 2001, EUR UROL, V39, P151, DOI 10.1159/000052430; Hammarsten J, 2009, PROSTATE CANCER P D, V12, P160, DOI 10.1038/pcan.2008.50; Jiang Y, 2006, J CELL BIOCHEM, V98, P208, DOI 10.1002/jcb.20771; Kaplan-Lefko PJ, 2008, ONCOGENE, V27, P2868, DOI 10.1038/sj.onc.1210943; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; MCNEAL JE, 1978, INVEST UROL, V15, P340; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Papatsoris AG, 2001, TRENDS MOL MED, V7, P288, DOI 10.1016/S1471-4914(01)02015-9; Patel AK, 2006, BRIT MED J, V333, P535, DOI 10.1136/bmj.38946.616551.BE1; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Ren M, 2009, ACTA PHARMACOL SIN, V30, P113, DOI 10.1038/aps.2008.8; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Starborg M, 1996, J CELL SCI, V109, P143; Vignozzi L, 2016, NAT REV UROL, V13, P108, DOI 10.1038/nrurol.2015.301; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZW, 2012, DIABETES, V61, P2134, DOI 10.2337/db11-1763; Wang ZW, 2011, DIFFERENTIATION, V82, P261, DOI 10.1016/j.diff.2011.04.004; Yu CR, 2003, CANCER RES, V63, P1822; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200	39	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173335	10.1371/journal.pone.0173335	http://dx.doi.org/10.1371/journal.pone.0173335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253329	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300101
J	Hermosilla, S; You, P; Aifah, A; Abildayev, T; Akilzhanova, A; Kozhamkulov, U; Muminov, T; Darisheva, M; Zhussupov, B; Terlikbayeva, A; El-Bassel, N; Schluger, N				Hermosilla, Sabrina; You, Paul; Aifah, Angela; Abildayev, Tleukhan; Akilzhanova, Ainur; Kozhamkulov, Ulan; Muminov, Talgat; Darisheva, Meruert; Zhussupov, Baurzhan; Terlikbayeva, Assel; El-Bassel, Nabila; Schluger, Neil			Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan	PLOS ONE			English	Article							C VIRUS-INFECTION; HIV; DIAGNOSIS; DETERMINANTS; TRANSMISSION; BACILLI; DISEASE; GENDER; HEALTH; LUNG	Background Sputum smear-positive tuberculosis (TB) patients have a high risk of transmission and are of great epidemiological and infection control significance. Little is known about the smear-positive populations in high TB burden regions, such as Kazakhstan. The objective of this study is to characterize the smear-positive population in Kazakhstan and identify associated modifiable risk factors. Methods Data on incident TB cases' (identified between April 2012 and March 2014) socio-demographic, risk behavior, and comorbidity characteristics were collected in four regions of Kazakhstan through structured survey and medical record review. We used multivariable logistic regression to determine factors associated with smear positivity. Results Of the total sample, 193 (34.3%) of the 562 study participants tested smear-positive. In the final adjusted multivariable logistic regression model, sex (adjusted odds ratio (aOR) = 2.0, 95% CI:1.3-3.1, p < 0.01), incarceration (aOR = 3.6, 95% CI: 1.2-11.1, p = 0.03), alcohol dependence (aOR = 2.6, 95% CI: 1.2-5.7, p = 0.02), diabetes (aOR = 5.0, 95% CI: 2.4-10.7, p < 0.01), and physician access (aOR = 2.7, 95% CI: 1.3-5.5p < 0.01) were associated with smear-positivity. Conclusions Incarceration, alcohol dependence, diabetes, and physician access are associated with smear positivity among incident TB cases in Kazakhstan. To stem the TB epidemic, screening, treatment and prevention policies should address these factors.	[Hermosilla, Sabrina; You, Paul; Schluger, Neil] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Aifah, Angela; El-Bassel, Nabila] Columbia Univ, Sch Social Work, 1255 Amsterdam Ave, New York, NY USA; [Abildayev, Tleukhan] Natl Ctr TB Problems, Alma Ata, Kazakhstan; [Akilzhanova, Ainur; Kozhamkulov, Ulan] Nazarbayev Univ, Ctr Life Sci, 53 Kabanbay Batyr Ave, Astana, Kazakhstan; [Muminov, Talgat] Natl Assoc TB Specialists, Alma Ata, Kazakhstan; [Darisheva, Meruert; Zhussupov, Baurzhan; Terlikbayeva, Assel] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan	Columbia University; Columbia University; Nazarbayev University	Hermosilla, S (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	sh2405@columbia.edu	Zhussupov, Baurzhan/AAR-8305-2021; Kozhamkulov, Ulan/H-6805-2016; Schluger, Neil/ABA-1793-2021; Hermosilla, Sabrina/D-6599-2017; Akilzhanova, Ainur R/N-6931-2015	Kozhamkulov, Ulan/0000-0002-9782-7631; Hermosilla, Sabrina/0000-0002-4166-815X; Akilzhanova, Ainur R/0000-0001-6161-8355; Aifah, Angela/0000-0002-2811-8487; Terlikbayeva, Assel/0000-0002-4067-1998	Kazakhstan Ministry of Education and Science; National Institute of Mental Health (NIMH) [T32MH096724]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096724] Funding Source: NIH RePORTER	Kazakhstan Ministry of Education and Science(Government of the Republic of Kazakhstan); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The primary recipient of this grant was the Center for Life Sciences of Nazarbayev University (http://cls.nu.edu.kz/cls/about/) which received funding from the Kazakhstan Ministry of Education and Science (http://edu.gov.kz/ru/). The Global Health Research Center of Central Asia (GHRCCA) had a subcontract with the Nazarbayev University Center for Life Sciences to develop methodologies, implement the field data collection, and analyze the study results. Dr. Hermosilla received additional funding from the National Institute of Mental Health (NIMH https://www.nimh.nih.gov/index.shtml) T32MH096724.	Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; [Anonymous], 2015, KAZAKHSTAN AOSOTRO; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boum Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0638-5; Bumburidi Ekaterina, 2006, MMWR Suppl, V55, P11; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; El-Bassel N, 2013, AIDS BEHAV, V17, P2490, DOI 10.1007/s10461-013-0484-2; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Grenfell P, 2013, DRUG ALCOHOL DEPEN, V129, P180, DOI 10.1016/j.drugalcdep.2012.11.013; Hermosilla S, 2014, PUBLIC HLTH; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kapustina V, 2014, EUROPEAN RESP J, V44, pP3574, DOI [10.1183/09031936.0000381424, DOI 10.1183/09031936.0000381424]; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Kocurek EG, 2016, OBSTET GYN CLIN N AM, V43, P307, DOI 10.1016/j.ogc.2016.01.003; Kuznetsov VN, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/693963; Lamprecht B, 2013, EUR RESPIR J, V42, P858, DOI 10.1183/09031936.00047613; Lombardi G, 2014, TREND MICROBIOLOGICA, P14; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Maric-Bilkan C, 2016, HYPERTENSION, V67, P802, DOI 10.1161/HYPERTENSIONAHA.115.06967; Ministry of Health National Center of T, 2008, GUID TUB CONTR REP K; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Reis NRS, 2011, INT J TUBERC LUNG D, V15, P1397, DOI 10.5588/ijtld.10.0636; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Sakundarno Mateus, 2009, BMC Pulm Med, V9, P16, DOI 10.1186/1471-2466-9-16; Steingart KR, 2006, SPUTUM PROCESSING ME, V6; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Terlikbayeva A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-262; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; (UNICEF) UNCsF, STAT KAZ UNICEF; van den Hof S, 2013, INT J TUBERC LUNG D, V17, P526, DOI 10.5588/ijtld.12.0703; Volkmann T, 2015, INT J TUBERC LUNG D, V19, P111, DOI 10.5588/ijtld.14.0516; Wan TTH, 2007, INT J PUBLIC POLICY, V2, P217; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, TUB COUNTR WORK SUMM; Yohanes A, 2011, SMEAR POSITIVE PULMO, P325	41	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172942	10.1371/journal.pone.0172942	http://dx.doi.org/10.1371/journal.pone.0172942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249005	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500065
J	Liu, YL; Lan, HY; Teng, ZJ; Guo, C; Yao, DZ				Liu, Yanling; Lan, Haiying; Teng, Zhaojun; Guo, Cheng; Yao, Dezhong			Facilitation or disengagement? Attention bias in facial affect processing after short-term violent video game exposure	PLOS ONE			English	Article							VISUAL-SEARCH; PROSOCIAL BEHAVIOR; EMOTIONAL FACES; N2PC COMPONENT; AGGRESSION; SHIFTS; CROWD; PLAY; DESENSITIZATION; RECOGNITION	Previous research has been inconsistent on whether violent video games exert positive and/ or negative effects on cognition. In particular, attentional bias in facial affect processing after violent video game exposure continues to be controversial. The aim of the present study was to investigate attentional bias in facial recognition after short term exposure to violent video games and to characterize the neural correlates of this effect. In order to accomplish this, participants were exposed to either neutral or violent video games for 25 min and then event-related potentials (ERPs) were recorded during two emotional search tasks. The first search task assessed attentional facilitation, in which participants were required to identify an emotional face from a crowd of neutral faces. In contrast, the second task measured disengagement, in which participants were required to identify a neutral face from a crowd of emotional faces. Our results found a significant presence of the ERP component, N2pc, during the facilitation task; however, no differences were observed between the two video game groups. This finding does not support a link between attentional facilitation and violent video game exposure. Comparatively, during the disengagement task, N2pc responses were not observed when participants viewed happy faces following violent video game exposure; however, a weak N2pc response was observed after neutral video game exposure. These results provided only inconsistent support for the disengagement hypothesis, suggesting that participants found it difficult to separate a neutral face from a crowd of emotional faces.	[Liu, Yanling; Lan, Haiying; Teng, Zhaojun; Guo, Cheng] Southwest Univ, Fac Psychol, Lab Mental Hlth & Social Adaptat, Res Ctr Mental Hlth Educ, Chongqing, Peoples R China; [Liu, Yanling; Yao, Dezhong] Univ Elect Sci & Technol China, Key Lab Neuro Informat, Minist Educ, Sch Life Sci & Technol,Ctr Informat Med, Chengdu, Peoples R China	Southwest University - China; University of Electronic Science & Technology of China	Guo, C (corresponding author), Southwest Univ, Fac Psychol, Lab Mental Hlth & Social Adaptat, Res Ctr Mental Hlth Educ, Chongqing, Peoples R China.; Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Key Lab Neuro Informat, Minist Educ, Sch Life Sci & Technol,Ctr Informat Med, Chengdu, Peoples R China.	guochen@swu.edu.cn; dyao@uestc.edu.cn	Teng, Zhaojun/GOG-9599-2022	Teng, Zhaojun/0000-0002-6726-177X	National Social Science Foundation for Education of China [BBA140049]; Humanities and Social Science Research Base project of Chongqing in SWU [14SK13033]; Fundamental Research Funds for the Central Universities [SWU1609320]	National Social Science Foundation for Education of China; Humanities and Social Science Research Base project of Chongqing in SWU; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Social Science Foundation for Education of China (BBA140049), the Humanities and Social Science Research Base project of Chongqing in SWU (14SK13033), and the Fundamental Research Funds for the Central Universities (SWU1609320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; ANDERSON CA, 1986, PERS SOC PSYCHOL B, V12, P390, DOI 10.1177/0146167286124002; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Bailey K, 2013, BRAIN RES, V1504, P35, DOI 10.1016/j.brainres.2013.02.019; Bartholow BD, 2006, J EXP SOC PSYCHOL, V42, P532, DOI 10.1016/j.jesp.2005.08.006; Becker DV, 2011, J EXP PSYCHOL GEN, V140, P637, DOI 10.1037/a0024060; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Dai Q, 2009, PROG NEURO-PSYCHOPH, V33, P921, DOI 10.1016/j.pnpbp.2009.04.012; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2007, BIOL PSYCHOL, V74, P108, DOI 10.1016/j.biopsycho.2006.06.008; Elson M, 2014, EUR PSYCHOL, V19, P33, DOI 10.1027/1016-9040/a000147; Engelhardt CR, 2015, PSYCHOL SCI, V26, P1187, DOI 10.1177/0956797615583038; Engelhardt CR, 2011, J EXP SOC PSYCHOL, V47, P1033, DOI 10.1016/j.jesp.2011.03.027; Ferguson CJ, 2015, PERSPECT PSYCHOL SCI, V10, P646, DOI 10.1177/1745691615592234; Ferguson CJ, 2012, AGGRESS VIOLENT BEH, V17, P220, DOI 10.1016/j.avb.2012.02.007; Gao X, 2014, J SW U NATURAL SCI E, V6, P1; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Greitemeyer T, 2014, PERS SOC PSYCHOL B, V40, P578, DOI 10.1177/0146167213520459; Greitemeyer T, 2014, J EXP SOC PSYCHOL, V50, P52, DOI 10.1016/j.jesp.2013.09.004; Grubert A, 2016, J COGNITIVE NEUROSCI, V28, P319, DOI 10.1162/jocn_a_00898; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hilgard J, 2006, OVERESTIMATED EFFECT; Holmes A, 2009, PSYCHOPHYSIOLOGY, V46, P62, DOI 10.1111/j.1469-8986.2008.00750.x; Ivarsson M, 2013, PSYCHOSOM MED, V75, P390, DOI 10.1097/PSY.0b013e3182906a4c; Jerabeck JM, 2013, COMPUT HUM BEHAV, V29, P2573, DOI 10.1016/j.chb.2013.06.034; Kirsh SJ, 2006, J INTERPERS VIOLENCE, V21, P571, DOI 10.1177/0886260506286840; Kirsh SJ, 2007, AGGRESSIVE BEHAV, V33, P353, DOI 10.1002/ab.20191; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ., 2012, OXFORD HDB EVENT REL, P329, DOI [DOI 10.1093/OXFORDHB/9780195374148.001.0001, 10.1093/oxfordhb/9780195374148.013.0161, DOI 10.1093/OXFORDHB/9780195374148.013.0161]; Markey PM, 2010, REV GEN PSYCHOL, V14, P82, DOI 10.1037/a0019000; Mather M, 2006, J GERONTOL B-PSYCHOL, V61, pP54, DOI 10.1093/geronb/61.1.P54; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; Morey R. D., 2014, BAYESFACTOR COMPUTAT; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Regenbogen C, 2010, SOC NEUROSCI-UK, V5, P221, DOI 10.1080/17470910903315989; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Szycik GR, 2016, BRAIN IMAGING BEHAV, P1; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Weber R, 2006, MEDIA PSYCHOL, V8, P39, DOI 10.1207/S1532785XMEP0801_4; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhen S. J., 2013, J S CHINA NORMAL U S, V2, P67; Zhong Y., 2013, STUD PSYCHOL BEHAV, V11, P732	50	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172940	10.1371/journal.pone.0172940	http://dx.doi.org/10.1371/journal.pone.0172940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249033	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500064
J	Pedersen, ER; Naranjo, D; Marshall, GN				Pedersen, Eric R.; Naranjo, Diana; Marshall, Grant N.			Recruitment and retention of young adult veteran drinkers using Facebook	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; IDENTIFICATION TEST AUDIT; MENTAL-HEALTH-SERVICES; OEF/OIF VETERANS; ALCOHOL-USE; MILITARY PERSONNEL; PROBLEM DRINKING; PTSD SYMPTOMS; PRIMARY-CARE; BARRIERS	The objective of this study was to describe the feasibility of using Facebook as a platform to recruit and retain young adult veteran drinkers into an online-alcohol use intervention study. Facebook's wide accessibility and popularity among the age group that comprises the majority of veterans from the conflicts in Iraq and Afghanistan make it a compelling resource through which research can extend its reach to this otherwise hard-to-reach group. We developed a series of Facebook advertisement campaigns to reach veteran drinkers not specifically searching for alcohol treatment. In doing so, we recruited 793 valid veteran participants in approximately two weeks for an advertising cost of $4.53 per obtained participant. The study sample consisted primarily of male veterans, between 19 and 34 years of age, who were drinking at moderate to heavy levels. Although about half of the sample reported mental health comorbidity, few had received any mental health or substance use treatment in the past year. Facebook appears to be a valuable mechanism through which to recruit young veterans with unmet behavioral health needs, although more specific efforts may be needed to engage certain types of veterans after initial study enrollment.	[Pedersen, Eric R.; Naranjo, Diana; Marshall, Grant N.] RAND Corp, Dept Behav & Policy Sci, Santa Monica, CA 90401 USA	RAND Corporation	Pedersen, ER (corresponding author), RAND Corp, Dept Behav & Policy Sci, Santa Monica, CA 90401 USA.	ericp@rand.org			National Institute on Alcohol Abuse and Alcoholism [R34 AA022400]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by a grant from the National Institute on Alcohol Abuse and Alcoholism (R34 AA022400, "Brief Online Intervention to Reduce Heavy Alcohol Use among Young Adult Veterans") awarded to Eric R. Pedersen.	Bagalman E., 2013, MENTAL DISORDERS OEF; Baltar F, 2012, INTERNET RES, V22, P57, DOI 10.1108/10662241211199960; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 1998, J GEN INTERN MED, V13, P379, DOI 10.1046/j.1525-1497.1998.00118.x; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Brief DJ, 2013, J CONSULT CLIN PSYCH, V81, P890, DOI 10.1037/a0033697; Britton PC, 2012, QUAL LIFE RES, V21, P1857, DOI 10.1007/s11136-011-0104-4; Bull SS, 2012, AM J PREV MED, V43, P467, DOI 10.1016/j.amepre.2012.07.022; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Chu JL, 2013, J ADOLESCENT HEALTH, V52, P792, DOI 10.1016/j.jadohealth.2012.12.002; Department of Veterans Affairs, 2015, VET POP STAT FISC YE; Department of Veterans Affairs, 2016, FACTS STAT WOM VET; Department of Veterans Affairs, 2015, AN VA HLTH CAR UT AM; DeViva JC, 2016, PSYCHOL TRAUMA-US, V8, P310, DOI 10.1037/tra0000075; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Fox AB, 2015, PSYCHOL SERV, V12, P49, DOI 10.1037/a0038269; Garcia HA, 2014, MIL MED, V179, P273, DOI 10.7205/MILMED-D-13-00076; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jones R, 2015, J ASSOC NURSE AIDS C, V26, P368, DOI 10.1016/j.jana.2015.01.004; Kapp JM, 2013, J CANCER EDUC, V28, P134, DOI 10.1007/s13187-012-0443-z; Kaysen D, 2011, ADDICT NEWSL AM PSYC, V50, P14, DOI DOI 10.1037/E523322013-003]; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kulesza Magdalena, 2015, Mil Behav Health, V3, P230; Litz B.T, 1993, PTSD CHECKL PCL REL; Lohse B, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2713; Lohse B, 2013, J NUTR EDUC BEHAV, V45, P69, DOI 10.1016/j.jneb.2012.06.006; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Morgan AJ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2262; National Alliance on Mental Illness, 2018, VET ACT DUT; Nelson KM, 2007, PUBLIC HEALTH REP, V122, P93, DOI 10.1177/003335490712200113; Office of the Deputy Under Secretary of Defense, 2013 2012 2011 2010; Pedersen ER, 2016, PILOT RANDOMIZ UNPUB; Pedersen ER, J BEHAV HLT IN PRESS; Pedersen ER, 2016, CURR OPIN PSYCHOL, V9, P38, DOI 10.1016/j.copsyc.2015.09.011; Pedersen ER, 2016, ADDICT SCI CLIN PRAC, V11, DOI 10.1186/s13722-016-0055-8; Pedersen ER, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3996; Nguyen P, 2013, J ADOLESCENT HEALTH, V53, P98, DOI 10.1016/j.jadohealth.2013.02.007; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Ramo Danielle E, 2014, Internet Interv, V1, P58; Ridout B, 2014, DRUG ALCOHOL REV, V33, P667, DOI 10.1111/dar.12141; Sadler AG, 2013, J TRAUMA STRESS, V26, P401, DOI 10.1002/jts.21811; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2011, J TRAUMA STRESS, V24, P699, DOI 10.1002/jts.20693; Schell T.L., 2008, INVISIBLE WOUNDS WAR; Schumm JA, 2012, ALCOHOL RES-CURR REV, V34, P401; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Tanielian T., 2011, NEEDS ASSESSMENT NEW; Veterans Health Administration, 2001, AN VA HLTH CAR UT OP; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Weathers FW, 2013, THEPTSDCHECKLISTFORD; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052	56	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172972	10.1371/journal.pone.0172972	http://dx.doi.org/10.1371/journal.pone.0172972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN4NF	28249027	Green Published, Green Submitted, gold			2022-12-27	WOS:000395983500067
J	Smeets, MWJ; Bierings, R; Meems, H; Mul, FPJ; Geerts, D; Vlaar, APJ; Voorberg, J; Hordijk, PL				Smeets, Michel W. J.; Bierings, Ruben; Meems, Henriet; Mul, Frederik P. J.; Geerts, Dirk; Vlaar, Alexander P. J.; Voorberg, Jan; Hordijk, Peter L.			Platelet- independent adhesion of calcium-loaded erythrocytes to von Willebrand factor	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; VONWILLEBRAND-FACTOR; SICKLE ERYTHROCYTES; VASCULAR ENDOTHELIUM; ADHERENCE; BLOOD; THROMBOSIS; RELEASE; DISEASE; FLOW	Adhesion of erythrocytes to endothelial cells lining the vascular wall can cause vaso-occlusive events that impair blood flow which in turn may result in ischemia and tissue damage. Adhesion of erythrocytes to vascular endothelial cells has been described in multiple hemolytic disorders, especially in sickle cell disease, but the adhesion of normal erythrocytes to endothelial cells has hardly been described. It was shown that calcium-loaded erythrocytes can adhere to endothelial cells. Because sickle erythrocyte adhesion to ECs can be enhanced by ultra-large von Willebrand factor multimers, we investigated whether calcium loading of erythrocytes could promote binding to endothelial cells via ultra-large von Willebrand factor multimers. We used (immunofluorescent) live-cell imaging of washed erythrocytes perfused over primary endothelial cells at venular flow rate. Using this approach, we show that calcium-loaded erythrocytes strongly adhere to histamine-stimulated primary human endothelial cells. This adhesion is mediated by ultra-large von Willebrand factor multimers. Von Willebrand factor knockdown or ADAMTS13 cleavage abolished the binding of erythrocytes to activated endothelial cells under flow. Platelet depletion did not interfere with erythrocyte binding to von Willebrand factor. Our results reveal platelet-independent adhesion of calcium-loaded erythrocytes to endothelium-derived von Willebrand factor. Erythrocyte adhesion to von Willebrand factor may be particularly relevant for venous thrombosis, which is characterized by the formation of erythrocyte-rich thrombi.	[Smeets, Michel W. J.; Mul, Frederik P. J.; Hordijk, Peter L.] Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands; [Bierings, Ruben; Meems, Henriet; Voorberg, Jan] Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Plasma Prot, Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Dept Pediat Oncol Hematol, Med Ctr, Rotterdam, Netherlands; [Vlaar, Alexander P. J.] Amsterdam Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Hordijk, Peter L.] Vrije Univ Amsterdam, Dept Physiol, Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Hordijk, PL (corresponding author), Acad Med Ctr, Sanquin, Landsteiner Lab, Dept Mol Cell Biol, Amsterdam, Netherlands.; Hordijk, PL (corresponding author), Vrije Univ Amsterdam, Dept Physiol, Med Ctr, Amsterdam, Netherlands.	p.hordijk@vumc.nl	Bierings, Ruben/AAQ-8854-2020; Geerts, Dirk/K-8260-2015	Bierings, Ruben/0000-0002-1205-9689; Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X; Vlaar, Alexander/0000-0002-3453-7186; Voorberg, Jan/0000-0003-4585-2621				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bogdanova A, 2013, INT J MOL SCI, V14, P9848, DOI 10.3390/ijms14059848; BOOKCHIN RM, 1980, NATURE, V284, P561, DOI 10.1038/284561a0; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen JM, 2011, BLOOD, V117, P3680, DOI 10.1182/blood-2010-08-302539; Chiou E, 2015, INT J BIOCHEM CELL B, V65, P40, DOI 10.1016/j.biocel.2015.05.013; De Ceunynck K, 2013, BLOOD, V121, P270, DOI 10.1182/blood-2012-07-442285; Du VX, 2014, SEMIN THROMB HEMOST, V40, P72, DOI 10.1055/s-0033-1363470; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hermand P, 2003, J BIOL CHEM, V278, P4892, DOI 10.1074/jbc.M211282200; Hovav T, 1999, BRIT J HAEMATOL, V106, P178; Jiang Aixiang, 2007, J Bioinform Comput Biol, V5, P875, DOI 10.1142/S0219720007002989; Kaestner L, 2012, BIOELECTROCHEMISTRY, V87, P89, DOI 10.1016/j.bioelechem.2011.08.004; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; KAUL DK, 1993, BLOOD, V81, P2429; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Kroll MH, 1996, BLOOD, V88, P1525; LEVINE JD, 1982, BLOOD, V60, P531; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Makhro A, 2013, AM J PHYSIOL-CELL PH, V305, pC1123, DOI 10.1152/ajpcell.00031.2013; Makhro A, 2010, AM J PHYSIOL-CELL PH, V298, pC1315, DOI 10.1152/ajpcell.00407.2009; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Shahani T, 2010, BLOOD, V115, P4902, DOI 10.1182/blood-2009-07-232546; Smith BD, 1997, BLOOD, V89, P3451, DOI 10.1182/blood.V89.9.3451; STEL HV, 1984, BLOOD, V63, P1408; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SUGIHARA K, 1992, BLOOD, V80, P2634; Tokarev AA, 2011, BIOPHYS J, V100, P799, DOI 10.1016/j.bpj.2010.12.3740; TSAI HM, 1990, BLOOD, V75, P261; VANSCHRAVENDIJK MR, 1992, BLOOD, V80, P2105; Wautier MP, 2007, BLOOD, V110, P894, DOI 10.1182/blood-2006-10-048298; WICK TM, 1993, AM J HEMATOL, V42, P284, DOI 10.1002/ajh.2830420308; WICK TM, 1987, J CLIN INVEST, V80, P905, DOI 10.1172/JCI113151; WILEY JS, 1982, BLOOD, V60, P92; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	46	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173077	10.1371/journal.pone.0173077	http://dx.doi.org/10.1371/journal.pone.0173077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28249049	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500073
J	Kan-Dapaah, K; Rahbar, N; Soboyejo, W				Kan-Dapaah, Kwabena; Rahbar, Nima; Soboyejo, Wole			Polymeric composite devices for localized treatment of early-stage breast cancer	PLOS ONE			English	Article							THERMAL THERAPY; HYDROGELS; CHEMOTHERAPY; PRODIGIOSIN; ABLATION	For early-stage breast cancers mastectomy is an aggressive form of treatment. Therefore, there is a need for new treatment strategies that can enhance the use of lumpectomy by eliminating residual cancer cells with limited side effects to reduce local recurrence. Although, various radiotherapy-based methods have been developed, residual cells are found in 20-55% of the time at the first operation. Furthermore, some current treatment methods result in poor cosmesis. For the last decade, the authors have been exploring the use of polymeric composite materials in single and multi-modal implantable biomedical devices for post-operative treatment of breast cancer. In this paper, the concept and working principles of the devices, as well as selected results from experimental and numerical investigations, are presented. The results show the potential of the biomedical implants for cancer treatment.	[Kan-Dapaah, Kwabena] Univ Ghana, Dept Biomed Engn, Accra, Greater Accra, Ghana; [Rahbar, Nima] Worcester Polytech Inst, Dept Civil & Environm Engn, Worcester, MA 01609 USA; [Soboyejo, Wole] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Soboyejo, Wole] Princeton Univ, Princeton Inst Sci & Technol Mat PRISM, Princeton, NJ 08544 USA; [Soboyejo, Wole] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA; [Soboyejo, Wole] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA	University of Ghana; Worcester Polytechnic Institute; Princeton University; Princeton University; Worcester Polytechnic Institute; Worcester Polytechnic Institute	Rahbar, N (corresponding author), Worcester Polytech Inst, Dept Civil & Environm Engn, Worcester, MA 01609 USA.	nrahbar@wpi.edu	Rahbar, Nima/D-3005-2012	Rahbar, Nima/0000-0003-0159-0025	African Centres of Excellence: Pan-African Materials Institute [P126974]; Division of Civil, Mechanical and Manufacturing Innovation [1261284]	African Centres of Excellence: Pan-African Materials Institute; Division of Civil, Mechanical and Manufacturing Innovation(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by African Centres of Excellence: Pan-African Materials Institute (Grant. No. P126974) www.worldbank.org, K.K-D. N.R. W.O.S.; and Division of Civil, Mechanical and Manufacturing Innovation (Grant. No. 1261284) to N.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREZOVICH IA, 1989, RADIOL CLIN N AM, V27, P589; Carrey J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3551582; Chakaravarthi G, 2015, INT J HYPERTHER, V31, P737, DOI 10.3109/02656736.2015.1068957; Danyuo Y, 2016, MAT SCI ENG C-MATER, V59, P19, DOI 10.1016/j.msec.2015.09.090; Danyuo Y, 2014, MAT SCI ENG C-MATER, V42, P734, DOI 10.1016/j.msec.2014.06.008; de Baere T, 2015, ANN ONCOL, V26, P987, DOI 10.1093/annonc/mdv037; Fu G, 2011, MAT SCI ENG C-MATER, V31, P1084, DOI 10.1016/j.msec.2011.03.009; Gao HF, 2013, HEPATO-GASTROENTEROL, V60, P1906, DOI 10.5754/hge.13498; Habash Riadh W. Y., 2006, Critical Reviews in Biomedical Engineering, V34, P459, DOI 10.1615/CritRevBiomedEng.v34.i6.20; Hassett MJ, 2006, JNCI-J NATL CANCER I, V98, P1108, DOI 10.1093/jnci/djj305; Jochelson Maxine, 2012, Am Soc Clin Oncol Educ Book, P65, DOI 10.14694/EdBook_AM.2012.32.65; Kampinga HH, 2006, INT J HYPERTHER, V22, P191, DOI 10.1080/02656730500532028; Kan-Dapaah K, 2015, J MECH BEHAV BIOMED, V49, P118, DOI 10.1016/j.jmbbm.2015.04.023; Kan-Dapaah K, 2015, MED PHYS, V42, P2203, DOI 10.1118/1.4915955; Kan-Dapaah K, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918271; Kan-Dapaah K, 2014, J APPL PHYS, V116, DOI 10.1063/1.4903736; Kim S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203905; Krishnan S, 2010, INT J HYPERTHER, V26, P775, DOI 10.3109/02656736.2010.485593; Li J., 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1038/0NC.2016.90; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Martin J, 2013, DIAGN INTERV RADIOL, V19, P501, DOI 10.5152/dir.2013.13070; Murphy JO, 2013, MINERVA CHIR, V68, P139; Oni Y, 2011, MAT SCI ENG C-MATER, V31, P67, DOI 10.1016/j.msec.2010.07.016; Paul DR, 2008, POLYMER, V49, P3187, DOI 10.1016/j.polymer.2008.04.017; Reitsamer R, 2008, BREAST CANCER-TOKYO, V15, P40, DOI 10.1007/s12282-007-0001-4; Roussakow S., 2013, C PAPERS MED, DOI [10.1155/2013/428027, DOI 10.1155/2013/428027]; Stafford R. Jason, 2010, Critical Reviews in Biomedical Engineering, V38, P79, DOI 10.1615/CritRevBiomedEng.v38.i1.70; Theriault C, 2012, MAT SCI ENG C-MATER, V32, P2242, DOI 10.1016/j.msec.2012.06.010; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vaz A, 2010, IEEE T CIRCUITS-II, V57, P95, DOI 10.1109/TCSII.2010.2040314; Vo T, 2007, AM J SURG, V194, P527, DOI 10.1016/j.amjsurg.2007.06.012	32	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172542	10.1371/journal.pone.0172542	http://dx.doi.org/10.1371/journal.pone.0172542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245288	gold, Green Submitted, Green Published			2022-12-27	WOS:000395980200024
J	Kawaguchi, A; Suzuki, T; Ohara, Y; Takahashi, K; Sato, Y; Ainai, A; Nagata, N; Tashiro, M; Hasegawa, H				Kawaguchi, Akira; Suzuki, Tadaki; Ohara, Yuki; Takahashi, Kenta; Sato, Yuko; Ainai, Akira; Nagata, Noriyo; Tashiro, Masato; Hasegawa, Hideki			Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection	PLOS ONE			English	Article							NC/NGA MICE; ATOPIC-DERMATITIS; H1N1 INFLUENZA; ASTHMA; CELLS; ANTIGEN; HYPERREACTIVITY; SENSITIZATION; EOSINOPHILIA; EPITHELIUM	Influenza A virus is the respiratory pathogen responsible for influenza. Infection by the 2009 pandemic influenza A (H1N1) virus caused severe lower airway inflammation and pneumonia. Asthma is a chronic inflammatory disorder of the airways that affects the entire brachial tree, and was one of the commonest underlying medical conditions among patients hospitalized with the 2009 pandemic influenza virus infection. Although respiratory virus infections are the major causes of asthma exacerbation, the mechanism by which influenza exacerbates asthma is poorly understood. Animal models of disease comorbidity are crucial to understanding host-pathogen interactions and elucidating complex pathologies. Existing murine models of influenza virus infection in asthmatics show that asthmatic mice are highly resistant to influenza virus infection, which contradicts clinical observations in humans. Here, we developed a murine model of influenza virus/asthma comorbidity using NC/Nga mice, which are highly sensitive to allergic reactions such as atopic dermatitis and allergic airway inflammation. This model was then used to examine the impact of allergic airway inflammation on lung pathology in the 2009 pandemic influenza virus infected mice. The results showed that induction of acute allergic airway inflammation in pre-existing influenza virus infection had additive effects on exacerbation of lung pathology, which mirrors findings in human epidemiological studies. In contrast, pre-existing allergic airway inflammation protected from subsequent influenza virus infection, which was compatible with those of previous murine models of influenza virus infection in asthmatic mice. These variable outcomes of this murine model indicate that the temporal relation between allergic airway inflammation and influenza virus infection might play a critical role in asthma and influenza comorbidity. Thus, this murine model will further our understanding of how influenza virus infection affects an asthmatic host and may aid the development of strategies to improve treatments and outcomes for asthmatics harboring influenza virus infection.	[Kawaguchi, Akira; Suzuki, Tadaki; Ohara, Yuki; Takahashi, Kenta; Sato, Yuko; Ainai, Akira; Nagata, Noriyo; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo, Japan; [Kawaguchi, Akira; Ainai, Akira; Tashiro, Masato] Natl Inst Infect Dis, Ctr Influenza Virus Res, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Suzuki, T (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo, Japan.	tksuzuki@niid.go.jp	Hasegawa, Hideki/C-7978-2014; Suzuki, Tadaki/ABH-2661-2020	Suzuki, Tadaki/0000-0002-3820-9542	Japanese Ministry of Health, Labor, and Welfare; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The work described in this report was supported by grants from the Japanese Ministry of Health, Labor, and Welfare, and Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainai A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130208; [Anonymous], 2014, INFL FACT SHEET; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Chen Z, 1998, VACCINE, V16, P1544, DOI 10.1016/S0264-410X(98)00043-7; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Funaguchi N, 2007, CLIN EXP PHARMACOL P, V34, P766, DOI 10.1111/j.1440-1681.2007.04636.x; Furuya Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005180; Ishikawa H, 2012, J CLIN IMMUNOL, V32, P256, DOI 10.1007/s10875-011-9619-2; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwasaki T, 2001, J VET MED SCI, V63, P413, DOI 10.1292/jvms.63.413; Jacoby DB, 2002, JAMA-J AM MED ASSOC, V287, P755, DOI 10.1001/jama.287.6.755; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jenkins HA, 2003, CHEST, V124, P32, DOI 10.1378/chest.124.1.32; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lin JY, 2006, INT IMMUNOPHARMACOL, V6, P241, DOI 10.1016/j.intimp.2005.08.009; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x; Morokata T, 2000, IMMUNOL LETT, V72, P119, DOI 10.1016/S0165-2478(00)00188-7; Morokata T, 1999, IMMUNOL LETT, V70, P127, DOI 10.1016/S0165-2478(99)00134-0; Nishino R, 2013, TOXICOLOGY, V309, P1, DOI 10.1016/j.tox.2013.03.018; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Samarasinghe AE, 2014, IMMUNOL CELL BIOL, V92, P449, DOI 10.1038/icb.2013.113; Sasakawa T, 2001, INT ARCH ALLERGY IMM, V126, P239, DOI 10.1159/000049520; Stumm CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095959; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; van der Wiel E, 2013, J ALLERGY CLIN IMMUN, V131, P646, DOI 10.1016/j.jaci.2012.12.1567; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vestergaard C, 2000, MOL MED TODAY, V6, P209, DOI 10.1016/S1357-4310(00)01683-X; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; Yamamoto N, 2001, J VIROL, V75, P499, DOI 10.1128/JVI.75.1.499-505.2001	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173008	10.1371/journal.pone.0173008	http://dx.doi.org/10.1371/journal.pone.0173008			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245238	Green Published, Green Submitted, gold			2022-12-27	WOS:000395980200049
J	Kilkenny, MF; Dunstan, L; Busingye, D; Purvis, T; Reyneke, M; Orgill, M; Cadilhac, DA				Kilkenny, Monique F.; Dunstan, Libby; Busingye, Doreen; Purvis, Tara; Reyneke, Megan; Orgill, Mary; Cadilhac, Dominique A.			Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD	PLOS ONE			English	Article							SELF-MANAGEMENT; EDUCATION-PROGRAM; AUSTRALIA; STROKE; OUTCOMES; CARE	Background There is limited evidence on whether having pre-existing cardiovascular disease (CVD) or risk factors for CVD such as diabetes, ensures greater knowledge of risk factors important for motivating preventative behaviours. Our objective was to compare knowledge among the Australian public participating in a health check program and their risk status. Methods Data from the Stroke Foundation 'Know your numbers' program were used. Staff in community pharmacies provided opportunistic health checks (measurement of blood pressure and diabetes risk assessment) among their customers. Participants were categorised: 1) CVD +/- risk of CVD: history of stroke, heart disease or kidney disease, and may have risk factors; 2) risk of CVD only: reported having high blood pressure, high cholesterol, diabetes or atrial fibrillation; and 3) CVD risk free (no CVD or risk of CVD). Multivariable logistic regression analyses were performed including adjustment for age and sex. Findings Among 4,647 participants, 12% had CVD (55% male, 85% aged 55+ years), 47% were at risk of CVD (40% male, 72% 55+ years) and 41% were CVD risk free (33% male, 27% 55+ years). Participants with CVD (OR: 0.66; 95% CI: 0.55, 0.80) or risk factors for CVD (OR: 0.65; 95% CI: 0.57, 0.73) had poorer knowledge of the risk factors for diabetes/CVD compared to those who were CVD risk free. After adjustment, only participants with risk factors for CVD (OR: 0.80; 95% CI: 0.69, 0.93) had poorer knowledge. Older participants (55+ years) and men had poorer knowledge of diabetes/CVD risk factors and complications of diabetes. Conclusions Participants with poorer knowledge of risk factors were older, more often male or were at risk of developing CVD compared with those who were CVD risk free. Health education in these high risk groups should be a priority, as diabetes and CVD are increasing in prevalence throughout the world.	[Kilkenny, Monique F.; Busingye, Doreen; Purvis, Tara; Reyneke, Megan; Cadilhac, Dominique A.] Monash Univ, Stroke & Ageing Res, Sch Clin Sci Monash Hlth, Dept Med, Clayton, Vic, Australia; [Kilkenny, Monique F.; Purvis, Tara; Cadilhac, Dominique A.] Florey Inst Neurosci & Mental Hlth, Stroke Div Publ Hlth, Heidelberg, Vic, Australia; [Dunstan, Libby] Stroke Fdn, Brisbane, Qld, Australia; [Orgill, Mary] Stroke Fdn, Melbourne, Vic, Australia; [Cadilhac, Dominique A.] Univ Melbourne, Melbourne, Vic 3010, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Kilkenny, MF (corresponding author), Monash Univ, Stroke & Ageing Res, Sch Clin Sci Monash Hlth, Dept Med, Clayton, Vic, Australia.; Kilkenny, MF (corresponding author), Florey Inst Neurosci & Mental Hlth, Stroke Div Publ Hlth, Heidelberg, Vic, Australia.	monique.kilkenny@monash.edu	Cadilhac, D A/I-1912-2014	Cadilhac, D A/0000-0001-8162-682X; Kilkenny, Monique F/0000-0002-3375-287X; BUSINGYE, DOREEN/0000-0002-4744-9070; Purvis, Tara/0000-0003-3332-5357	NHMRC Early Career Fellowships [1109426]; NHMRC Public Health/National Heart Foundation Future Leader Research Fellowship [1063761]	NHMRC Early Career Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Public Health/National Heart Foundation Future Leader Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Dr Monique Kilkenny is supported by a NHMRC Early Career Fellowships (1109426). A/Prof Dominique Cadilhac is supported by a NHMRC Public Health/National Heart Foundation Future Leader Research Fellowship (1063761). We acknowledge that the Know your numbers Program was a government funded program in the Australian states of New South Wales Health and Queensland Health.	Adams RJ, 2009, INT J PUBLIC HEALTH, V54, P183, DOI 10.1007/s00038-009-7113-x; Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; Aljoudi AS, 2009, ANN SAUDI MED, V29, P15, DOI 10.4103/0256-4947.51813; Alliance NVDP, 2012, GUID MAN ABS CARD RI; Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Cadilhac DA, 2015, INT J STROKE, V10, P110, DOI 10.1111/ijs.12018; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Fenwick EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080593; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Kilkenny MF, 2016, PREV MED, V86, P1, DOI 10.1016/j.ypmed.2016.01.015; Kilkenny MF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1227; Kilkenny MF, 2010, INT J STROKE, V5, P344, DOI 10.1111/j.1747-4949.2010.00456.x; Lee TI, 2007, INT J MED INFORM, V76, P655, DOI 10.1016/j.ijmedinf.2006.05.030; Lynch EB, 2006, AM J EPIDEMIOL, V164, P1171, DOI 10.1093/aje/kwj334; Molsted S, 2012, HEALTH EDUC RES, V27, P804, DOI 10.1093/her/cyr053; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Persell SD, 2004, PREV MED, V39, P746, DOI 10.1016/j.ypmed.2004.02.045; Slark J, 2012, J STROKE CEREBROVASC, V21, P358, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.010; Zeng Y, 2012, J CLIN NURS, V21, P2886, DOI 10.1111/j.1365-2702.2012.04118.x	20	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172941	10.1371/journal.pone.0172941	http://dx.doi.org/10.1371/journal.pone.0172941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245267	Green Published, gold			2022-12-27	WOS:000395980200044
J	Le Port, A; Bernard, T; Hidrobo, M; Birba, O; Rawat, R; Ruel, MT				Le Port, Agnes; Bernard, Tanguy; Hidrobo, Melissa; Birba, Ousmane; Rawat, Rahul; Ruel, Marie T.			Delivery of iron-fortified yoghurt, through a dairy value chain program, increases hemoglobin concentration among children 24 to 59 months old in Northern Senegal: A cluster-randomized control trial	PLOS ONE			English	Article							INTERVENTIONS; FOODS	Background Innovative strategies are needed to enhance the nutritional impact of agriculture. Value chain approaches, which use supply chains to add value (usually economic) to products as they move from producers to consumers, can be used to increase access to nutritious foods and improve nutritional status. This study tested whether a dairy value chain could be used to distribute a micronutrient-fortified yoghurt (MNFY) (conditional upon the producer supplying a minimum amount of cow milk/day) to improve hemoglobin and reduce anemia among preschool children in a remote area in Northern Senegal. Methods A cluster randomized control trial was used to compare 204 children (24 to 59 months of age at baseline) from households who received the MNFY coupled to a behavior change communication (BCC) campaign focusing on anemia prevention to 245 children from a control group (receiving BCC only) after one year. Randomization was done at the level of the family concession (households from the same family) (n = 321). Eligible households had a child of the target age and were willing to deliver milk to the dairy factory. Changes in anemia and hemoglobin between groups were assessed using mixed regression models. Key findings Anemia prevalence was very high at baseline (80%) and dropped to close to 60% at endline, with no differences between intervention groups. Hemoglobin increased by 0.55 g/dL, 95% CI (0.27; 0.84) more in the intervention compared to the control group after one year, in models that controlled for potentially confounding factors. The impact was greater (0.72 g/dL, 95% CI (0.34; 1.12)) for boys, compared to girls (0.38 g/dL, 95% CI (-0.03; 0.80)). Conclusion The dairy value chain was a successful strategy to distribute MNFY among pastoralists in Northern Senegal, and increase Hb concentrations among their children. This study is one of the first proofs of concept showing that a nutrition-sensitive agriculture value chain approach can contribute to improved child nutrition in a remote pastoralist population.	[Le Port, Agnes; Birba, Ousmane; Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal; [Bernard, Tanguy] Int Food Policy Res Inst, Markets Trade & Inst, Dakar, Senegal; [Bernard, Tanguy] Univ Bordeaux, UMR CNRS 5113, GREThA, Bordeaux, France; [Hidrobo, Melissa; Ruel, Marie T.] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CGIAR; International Food Policy Research Institute (IFPRI)	Le Port, A (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal.	a.leport@cgiar.org		Ruel, Marie/0000-0002-9506-348X; Le Port, Agnes/0000-0002-8337-6569	European Union through the Consortium of International Agricultural Research Centers (CGIAR) Research Programs on Policies, Institutions and Markets (PIM); Agriculture for Nutrition and Health (A4NH)	European Union through the Consortium of International Agricultural Research Centers (CGIAR) Research Programs on Policies, Institutions and Markets (PIM); Agriculture for Nutrition and Health (A4NH)	This work was funded by the European Union through the Consortium of International Agricultural Research Centers (CGIAR) Research Programs on Policies, Institutions and Markets (PIM); and Agriculture for Nutrition and Health (A4NH).	Agence Nationale de la Statistique et de la Demographie (ANSD) [Senegal] and ICF International, 2012, SEN DEM HLTH MULT IN; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2011, CARTE SANITAIRE SENE; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Bernard T, 2016, FIELD EXCHANGE, V51, P26; Bernard T, 2015, NUTRITION INCENTIVES; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; De-Regil LM, 2011, COCHRANE DATABASE SY; Feeley AB, 2016, MATERN CHILD NUTR, V12, P64, DOI 10.1111/mcn.12304; Gera T, 2012, AM J CLIN NUTR, V96, P309, DOI 10.3945/ajcn.111.031500; Guyon A, 2015, ESSENTIAL NUTRITION; Jennifer S A Coates, 2007, HOUSEHOLD FOOD INSE; Littrell M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-331; Macharia-Mutie CW, 2012, J NUTR, V142, P1756, DOI 10.3945/jn.112.157578; Olney DK, 2012, J NUTR, V142, p178S, DOI 10.3945/jn.110.137182; Parisse M., 2012, FIELD ACTIONS SCI RE; Sazawal S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-514; Stoltzfus RJ, 2011, J NUTR, V141, p756S, DOI 10.3945/jn.110.128793; Theo C, 2014, MATERN CHILD NUTR, P481	20	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172198	10.1371/journal.pone.0172198	http://dx.doi.org/10.1371/journal.pone.0172198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245227	gold, Green Submitted, Green Published			2022-12-27	WOS:000395980200014
J	Liang, D; Zhu, TT; Ni, ZY; Lin, LJ; Tang, Y; Wang, ZH; Wang, X; Wang, J; Lv, XL; Xia, H				Liang, Dong; Zhu, Tingting; Ni, Zhiyou; Lin, Lijin; Tang, Yi; Wang, Zhihui; Wang, Xun; Wang, Jin; Lv, Xiulan; Xia, Hui			Ascorbic acid metabolism during sweet cherry (Prunus avium) fruit development	PLOS ONE			English	Article							L-GALACTOSE PHOSPHORYLASE; VITAMIN-C CONTENT; OXIDATIVE STRESS; OVER-EXPRESSION; APPLE LEAVES; BIOSYNTHESIS; PATHWAY; GENES; ACCUMULATION; PLANTS	To elucidate metabolism of ascorbic acid (AsA) in sweet cherry fruit (Prunus avium 'Hongdeng'), we quantified AsA concentration, cloned sequences involved in AsA metabolism and investigated their mRNA expression levels, and determined the activity levels of selected enzymes during fruit development and maturation. We found that AsA concentration was highest at the petal-fall period (0 days after anthesis) and decreased progressively during ripening, but with a slight increase at maturity. AsA did nevertheless continue to accumulate over time because of the increase in fruit fresh weight. Fulllength cDNAs of 10 genes involved in the L-galactose pathway of AsA biosynthesis and 10 involved in recycling were obtained. Gene expression patterns of GDP-L-galactose phosphorylase (GGP2), L-galactono-1, 4-lactone dehydrogenase (GalLDH), ascorbate peroxidase (APX3), ascorbate oxidase (AO2), glutathione reductase (GR1), and dehydroascorbate reductase (DHAR1) were in accordance with the AsA concentration pattern during fruit development, indicating that genes involved in ascorbic acid biosynthesis, degradation, and recycling worked in concert to regulate ascorbic acid accumulation in sweet cherry fruit.	[Liang, Dong; Lin, Lijin; Tang, Yi; Wang, Xun; Wang, Jin; Lv, Xiulan; Xia, Hui] Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China; [Zhu, Tingting; Ni, Zhiyou; Wang, Zhihui] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Lv, XL; Xia, H (corresponding author), Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China.	xllvjj@163.com; susanxia_2001@163.com						Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Bartoli CG, 2005, PLANT CELL ENVIRON, V28, P1073, DOI 10.1111/j.1365-3040.2005.01338.x; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Castro JC, 2015, BIOL PLANTARUM, V59, P783, DOI 10.1007/s10535-015-0540-z; Cocetta G, 2012, J PLANT PHYSIOL, V169, P1059, DOI 10.1016/j.jplph.2012.03.010; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; Cruz-Rus E, 2010, J PLANT PHYSIOL, V167, P739, DOI 10.1016/j.jplph.2009.12.017; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Eltelib HA, 2011, J PLANT PHYSIOL, V168, P619, DOI 10.1016/j.jplph.2010.09.003; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Gallie DR, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/795964; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Hancock RD, 2005, J AGR FOOD CHEM, V53, P5248, DOI 10.1021/jf0503863; Hancock RD, 2007, FUNCT PLANT BIOL, V34, P1080, DOI 10.1071/FP07221; Huang M, 2014, J PLANT PHYSIOL, V171, P1205, DOI 10.1016/j.jplph.2014.03.010; Imai T, 2009, PHYSIOL PLANTARUM, V136, P139, DOI 10.1111/j.1399-3054.2009.01213.x; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Li MJ, 2011, J AM SOC HORTIC SCI, V136, P231, DOI 10.21273/JASHS.136.4.231; Li MJ, 2010, PLANT PHYSIOL BIOCH, V48, P216, DOI 10.1016/j.plaphy.2010.01.015; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Liu FH, 2015, FOOD CHEM, V188, P399, DOI 10.1016/j.foodchem.2015.05.036; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Ma FW, 2003, PLANT SCI, V165, P819, DOI 10.1016/S0168-9452(03)00277-2; Mellidou I, 2012, PLANT PHYSIOL, V160, P1613, DOI 10.1104/pp.112.203786; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Sanmartin M, 2003, PLANTA, V216, P918, DOI 10.1007/s00425-002-0944-9; Sanmartin M, 2007, PLANTA, V225, P873, DOI 10.1007/s00425-006-0399-5; Shalata A, 2001, PHYSIOL PLANTARUM, V112, P487, DOI 10.1034/j.1399-3054.2001.1120405.x; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Zhang CM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00122; Zheng YB, 2000, PLANT PHYSIOL BIOCH, V38, P403, DOI 10.1016/S0981-9428(00)00755-5	39	13	14	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172818	10.1371/journal.pone.0172818	http://dx.doi.org/10.1371/journal.pone.0172818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245268	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200034
J	Yan, JF; Huang, WJ; Zhao, JF; Fu, HY; Zhang, GY; Huang, XJ; Lv, BD				Yan, Jun-Feng; Huang, Wen-Jie; Zhao, Jian-Feng; Fu, Hui-Ying; Zhang, Gao-Yue; Huang, Xiao-Jun; Lv, Bo-Dong			The platelet-derived growth factor receptor/STAT3 signaling pathway regulates the phenotypic transition of corpus cavernosum smooth muscle in rats	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; CELL PHENOTYPE; VENOOCCLUSIVE DYSFUNCTION; MOLECULAR-MECHANISMS; PDGFR-BETA; PROLIFERATION; FIBROSIS; DISEASE; MODEL; MODULATION	Erectile dysfunction (ED) is a common clinical disease that is difficult to treat. We previously found that hypoxia modulates the phenotype of primary corpus cavernosum smooth muscle cells (CCSMCs) in rats, but the underlying molecular mechanism is still unknown. Plateletderived growth factor receptor (PDGFR)-related signaling pathways are correlated with cell phenotypic transition, but research has been focused more on vascular smooth muscle and tracheal smooth muscle and less on CCSMCs. Here, we investigated the role of PDGFRrelated signaling pathways in penile CCSMCs, which were successfully isolated from rats and cultured in vitro. PDGF-BB at 5, 10, or 20 ng/ml altered CCSMC morphology from the original elongated, spindle shape to a broader shape and promoted the synthetic phenotype and expression of the related proteins vimentin and collagen-I, while inhibiting the contractile phenotype and expression of the related proteins smooth muscle (SM) a-actin (alpha-SMA) and desmin. Inhibition of PDGFR activity via siRNA or the PDGFR inhibitor crenolanib inhibited vimentin and collagen-I expression, increased a-SMA and desmin expression, and considerably inhibited serine-threonine protein kinase (AKT) and signal transducer and activator of transcription 3 (STAT3) phosphorylation. STAT3 knockdown promoted the contractile phenotype, inhibited vimentin and collagen-I expression, and increased a-SMA and desmin expression, whereas AKT knockdown did not affect phenotype-associated proteins. STAT3 overexpression in CCSMC cells weakened the suppressive effect of PDGFR inhibition on the morphology and phenotypic transformation induced by PDGF-BB. Through activation of the PDGFR/STAT3 signaling pathway, PDGF promoted the synthetic phenotype transition; thus, regulation of this pathway might contribute to ED therapy.	[Yan, Jun-Feng; Huang, Wen-Jie; Zhang, Gao-Yue] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou, Zhejiang, Peoples R China; [Zhao, Jian-Feng; Huang, Xiao-Jun; Lv, Bo-Dong] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China; [Fu, Hui-Ying; Lv, Bo-Dong] Zhejiang Prov Key Lab Tradit Chinese Med, Androl Lab Integrat Chinese & Western Med, Hangzhou, Zhejiang, Peoples R China; [Fu, Hui-Ying] Zhejiang Chinese Med Univ, Clin Med Coll 2, Cent Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Lv, BD (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China.; Lv, BD (corresponding author), Zhejiang Prov Key Lab Tradit Chinese Med, Androl Lab Integrat Chinese & Western Med, Hangzhou, Zhejiang, Peoples R China.	bodonglv0571@163.com	fu, huiying/GZG-2399-2022; Yan, Junfeng/GRF-5811-2022; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X	 [81571431];  [LY15H040010]	; 	This work was supported by the following: 81571431 (http://www.nsfc.gov.cn/). LY15H040010 (http://www.zinsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa A, 2001, J ENDOCRINOL, V170, P395, DOI 10.1677/joe.0.1700395; BochatonPiallat ML, 1996, ARTERIOSCL THROM VAS, V16, P815, DOI 10.1161/01.ATV.16.6.815; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Chowdhury S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070528; Christ GJ, 1997, MOL UROL, V1, P47; DAHIYA R, 1993, BIOCHEM MOL BIOL INT, V30, P559; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2; Doanes AM, 1998, BIOCHEM MOL BIOL INT, V45, P279; Dutzmann J, 2015, CARDIOVASC RES, V106, P365, DOI 10.1093/cvr/cvv103; Ferrini MG, 2009, J SEX MED, V6, P415, DOI 10.1111/j.1743-6109.2008.01105.x; Gentile V, 1996, J ANDROL, V17, P96; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; HEDIN U, 1987, DIFFERENTIATION, V33, P239, DOI 10.1111/j.1432-0436.1987.tb01563.x; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Inoue K, 2002, ATHEROSCLEROSIS, V161, P353, DOI 10.1016/S0021-9150(01)00662-1; Kovanecz I, 2009, BJU INT, V103, P1396, DOI 10.1111/j.1464-410X.2008.08251.x; Lagonigro MS, 2006, J PATHOL, V208, P615, DOI 10.1002/path.1945; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Liao XH, 2015, J BIOL CHEM, V290, P19641, DOI 10.1074/jbc.M114.630111; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Luo Jin-tai, 2015, Zhonghua Nan Ke Xue, V21, P593; Lv BD, 2014, CELL TISSUE RES, V357, P823, DOI 10.1007/s00441-014-1902-0; Madi HA, 2009, AM J PHYSIOL-CELL PH, V297, pC1307, DOI 10.1152/ajpcell.00608.2008; Matei D, 2007, CANCER BIOL THER, V6, P1951, DOI 10.4161/cbt.6.12.4976; Moreland RB, 1998, INT J IMPOT RES, V10, P113, DOI 10.1038/sj.ijir.3900328; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Nehra A, 1996, J UROLOGY, V156, P1320, DOI 10.1016/S0022-5347(01)65578-2; Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pilatz A, 2005, EUR UROL, V47, P710, DOI 10.1016/j.eururo.2005.01.008; Qiu XF, 2011, BJU INT, V108, P1866, DOI 10.1111/j.1464-410X.2011.10162.x; Rosa RG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093229; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Seidel P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-145; Sharifiaghdas F, 2011, UROL J, V8, P54; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Tran T, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-117; User HM, 2003, J UROLOGY, V169, P1175, DOI 10.1097/01.ju.0000048974.47461.50; Wei AY, 2012, INT J IMPOT RES, V24, P196, DOI 10.1038/ijir.2012.16; Xie GL, 2011, MOL VIS, V17, P32; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105186	47	15	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172191	10.1371/journal.pone.0172191	http://dx.doi.org/10.1371/journal.pone.0172191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245285	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200013
J	Ngugi, AK; Agoi, F; Mahoney, MR; Lakhani, A; Mang'ongo, D; Nderitu, E; Armstrong, R; Macfarlane, S				Ngugi, Anthony K.; Agoi, Felix; Mahoney, Megan R.; Lakhani, Amyn; Mang'ongo, David; Nderitu, Esther; Armstrong, Robert; Macfarlane, Sarah			Utilization of health services in a resource-limited rural area in Kenya: Prevalence and associated household-level factors	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARE; MALNUTRITION; CHILDREN	Background and methods Knowledge of utilization of health services and associated factors is important in planning and delivery of interventions to improve health services coverage. We determined the prevalence and factors associated with health services utilization in a rural area of Kenya. Our findings inform the local health management in development of appropriately targeted interventions. We used a cluster sample survey design and interviewed household key informants on history of illness for household members and health services utilization in the preceding month. We estimated prevalence and performed random effects logistic regression to determine the influence of individual and household level factors on decisions to utilize health services. Results and conclusions 1230/6,440 (19.1%, 95% CI: 18.3%-20.2%) household members reported an illness. Of these, 76.7% (95% CI: 74.2%-79.0%) sought healthcare in a health facility. The majority (94%) of the respondents visited dispensary-level facilities and only 60.1% attended facilities within the study sub-counties. Of those that did not seek health services, 43% self-medicated by buying non-prescription drugs, 20% thought health services were too costly, and 10% indicated that the sickness was not serious enough to necessitate visiting a health facility. In the multivariate analyses, relationship to head of household was associated with utilization of health services. Relatives other than the nuclear family of the head of household were five times less likely to seek medical help (Odds Ratio 0.21 (95% CI: 0.05-0.87)). Dispensary level health facilities are the most commonly used by members of this community, and relations at the level of the household influence utilization of health services during an illness. These data enrich the perspective of the local health management to better plan the allocation of healthcare resources according to need and demand. The findings will also contribute in the development of community-level health coverage interventions that target the disadvantaged household groups.	[Ngugi, Anthony K.; Agoi, Felix; Lakhani, Amyn; Macfarlane, Sarah] Aga Khan Univ, Fac Hlth Sci East Africa, Ctr Populat Hlth Sci, Nairobi, Kenya; [Agoi, Felix; Lakhani, Amyn] Aga Khan Univ, Fac Hlth Sci East Africa, Dept Community Hlth, Mombasa, Kenya; [Mahoney, Megan R.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Mahoney, Megan R.] Aga Khan Univ, Fac Hlth Sci East Africa, Dept Family Med, Nairobi, Kenya; [Mang'ongo, David] Kaloleni Subcty, Subcty Hlth Management, Mariakani, Kilifi County, Kenya; [Nderitu, Esther] Aga Khan Univ East Africa, Sch Nursing & Midwifery, Nairobi, Kenya; [Armstrong, Robert] Aga Khan Univ, Fac Hlth Sci East Africa, Coll Med, Nairobi, Kenya; [Macfarlane, Sarah] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA	Aga Khan University; Aga Khan University; Stanford University; Aga Khan University; Aga Khan University; University of California System; University of California San Francisco	Ngugi, AK (corresponding author), Aga Khan Univ, Fac Hlth Sci East Africa, Ctr Populat Hlth Sci, Nairobi, Kenya.	anthony.ngugi@aku.edu		Mahoney, Megan/0000-0001-9166-9575; Armstrong, Robert/0000-0001-9319-3961				Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Centers for Disease Control and Prevention, 2013, EP VERS; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Chuma J, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1472-6963-12-413, 10.1186/1471-2458-12-20]; Chuma J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-22; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Girma F, 2011, ETHIOP J HLTH SCI, V21; Glenngard Anna H, 2007, Health Res Policy Syst, V5, P3, DOI 10.1186/1478-4505-5-3; Government of Kenya, 2010, DEVOLVED GOVERNMENT; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kenya National Bureau of Statistics, 2010, KENY NAT POP HOUS CE; Kenya National Bureau of Statistics ICF Macro, 2010, KENY DEM HLTH SURV; Kevany S, 2012, J PUBLIC HEALTH AFR, V3, P46, DOI 10.4081/jphia.2012.e13; Ministry of Health, 2003, KENY HOUS HLTH EXP U; Muriithi MK, 2013, EUR SCI J, V9, P151; Obare V, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0123-1; Onwujekwe O, 2005, ANN TROP MED PARASIT, V99, P473, DOI 10.1179/136485905X51283; Onwujekwe O, 2005, SOC SCI MED, V61, P455, DOI 10.1016/j.socscimed.2004.11.066; Opiyo C., 2003, GEOGRAPHIC DIMENSION; Statacorp, 2013, STAT V13; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Bank, 2013, PHYS PER 1 000 PEOPL	27	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172728	10.1371/journal.pone.0172728	http://dx.doi.org/10.1371/journal.pone.0172728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN3UW	28241032	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400034
J	Xu, P; Xiao, ER; Xu, D; Zhou, Y; He, F; Liu, BY; Zeng, L; Wu, ZB				Xu, Peng; Xiao, En-Rong; Xu, Dan; Zhou, Yin; He, Feng; Liu, Bi-Yun; Zeng, Lei; Wu, Zhen-Bin			Internal nitrogen removal from sediments by the hybrid system of microbial fuel cells and submerged aquatic plants	PLOS ONE			English	Article							VALLISNERIA-SPIRALIS L.; ELECTRICITY-GENERATION; BACTERIAL DIVERSITY; WATER INTERFACE; ORGANIC-MATTER; POWER; DENITRIFICATION; DEGRADATION; PERFORMANCE; PHOSPHORUS	Sediment internal nitrogen release is a significant pollution source in the overlying water of aquatic ecosystems. This study aims to remove internal nitrogen in sediment-water microcosms by coupling sediment microbial fuel cells (SMFCs) with submerged aquatic plants. Twelve tanks including four treatments in triplicates were designed: open-circuit (SMFC-o), closed-circuit (SMFC-c), aquatic plants with open-circuit (P-SMFC-o) and aquatic plants with closed-circuit (P-SMFC-c). The changes in the bio-electrochemical characteristics of the nitrogen levels in overlying water, pore water, sediments, and aquatic plants were documented to explain the migration and transformation pathways of internal nitrogen. The results showed that both electrogenesis and aquatic plants could facilitate the mineralization of organic nitrogen in sediments. In SMFC, electrogenesis promoted the release of ammonium from the pore water, followed by the accumulation of ammonium and nitrate in the overlying water. The increased redox potential of sediments due to electrogenesis also contributed to higher levels of nitrate in overlying water when nitrification in pore water was facilitated and denitrification at the sediment-water interface was inhibited. When the aquatic plants were introduced into the closed-circuit SMFC, the internal ammonium assimilation by aquatic plants was advanced by electrogenesis; nitrification in pore water and denitrification in sediments were also promoted. These processes might result in the maximum decrease of internal nitrogen with low nitrogen levels in the overlying water despite the lower power production. The P-SMFC-c reduced 8.1%, 16.2%, 24.7%, and 25.3% of internal total nitrogen compared to SMFC-o on the 55th, 82th, 136th, and 190th days, respectively. The smaller number of Nitrospira and the larger number of Bacillus and Pseudomonas on the anodes via high throughput sequencing may account for strong mineralization and denitrification in the sediments under closed-circuit. The coupled P-SMFC system has shown good potential for the efficient removal of internal nitrogen.	[Xu, Peng; Xiao, En-Rong; Xu, Dan; Zhou, Yin; He, Feng; Liu, Bi-Yun; Zeng, Lei; Wu, Zhen-Bin] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China; [Xu, Peng; Zhou, Yin; Zeng, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Dan] Wuhan Univ Technol, Coll Resources & Environm Engn, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University of Technology	Xiao, ER (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China.	erxiao@ihb.ac.cn	He, Feng/HHS-6457-2022; Zhou, yixin/HGE-2329-2022	He, Feng/0000-0002-1996-0744; 	National Natural Science Foundation of China [51308530]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07101007-005]; Key Research Program of the Chinese Academy of Sciences [KFZD-SW-302-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by grants from National Natural Science Foundation of China (51308530), Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07101007-005), the Key Research Program of the Chinese Academy of Sciences (KFZD-SW-302-02).	[Anonymous], 2002, WATER WASTEWATER MON, V4th; Bao S.D., 2000, AGROCHEMICAL ANAL SO, V3rd ed.; Beutel MW, 2008, WATER RES, V42, P1953, DOI 10.1016/j.watres.2007.11.027; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; BRODRICK S, 1987, B ENVIRON CONTAM TOX, V38, P377, DOI 10.1007/BF01606601; Chae KJ, 2009, BIORESOURCE TECHNOL, V100, P3518, DOI 10.1016/j.biortech.2009.02.065; Chiranjeevi P, 2013, ECOL ENG, V51, P181, DOI 10.1016/j.ecoleng.2012.12.014; de Carcer DA, 2011, APPL MICROBIOL BIOT, V89, P605, DOI 10.1007/s00253-010-2903-x; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; De Schamphelaire L, 2010, APPL ENVIRON MICROB, V76, P2002, DOI 10.1128/AEM.02432-09; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; Finch AS, 2011, BIORESOURCE TECHNOL, V102, P312, DOI 10.1016/j.biortech.2010.06.149; Forshay KJ, 2011, HYDROBIOLOGIA, V668, P21, DOI 10.1007/s10750-011-0619-2; Han C, 2016, SCI TOTAL ENVIRON, V569, P1232, DOI 10.1016/j.scitotenv.2016.06.198; Han HJ, 2014, ECOL ENG, V73, P146, DOI 10.1016/j.ecoleng.2014.09.016; He Z, 2007, BIOSENS BIOELECTRON, V22, P3252, DOI 10.1016/j.bios.2007.01.010; He Z, 2009, ENVIRON SCI TECHNOL, V43, P3391, DOI 10.1021/es803492c; Heiss EM, 2012, CONT SHELF RES, V45, P78, DOI 10.1016/j.csr.2012.06.002; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Hemminga MA, 1998, J SEA RES, V39, P183, DOI 10.1016/S1385-1101(98)00004-5; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Hong SW, 2010, ENVIRON POLLUT, V158, P185, DOI 10.1016/j.envpol.2009.07.022; Hong SW, 2009, BIORESOURCE TECHNOL, V100, P3029, DOI 10.1016/j.biortech.2009.01.030; Hou LJ, 2012, CONT SHELF RES, V35, P86, DOI 10.1016/j.csr.2012.01.004; Ji B, 2014, BIOTECHNOL LETT, V36, P719, DOI 10.1007/s10529-013-1417-x; Jong BC, 2006, ENVIRON SCI TECHNOL, V40, P6449, DOI 10.1021/es0613512; Kim JK, 2005, BIORESOURCE TECHNOL, V96, P1897, DOI 10.1016/j.biortech.2005.01.040; Kim JR, 2008, BIOTECHNOL BIOENG, V99, P1120, DOI 10.1002/bit.21687; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kouzuma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077443; Lee DE, 2016, J MICROBIOL, V54, P296, DOI 10.1007/s12275-016-5571-4; Li HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142586; Maerki M, 2009, LIMNOL OCEANOGR, V54, P428, DOI 10.4319/lo.2009.54.2.0428; Martins G, 2014, BIORESOURCE TECHNOL, V151, P419, DOI 10.1016/j.biortech.2013.10.048; Mohan SV, 2011, BIORESOURCE TECHNOL, V102, P7036, DOI 10.1016/j.biortech.2011.04.033; Ni ZK, 2015, ECOL ENG, V79, P42, DOI 10.1016/j.ecoleng.2015.03.005; Pereira CI, 2009, APPL ENVIRON MICROB, V75, P345, DOI 10.1128/AEM.01958-08; Racchetti E, 2010, HYDROBIOLOGIA, V652, P127, DOI 10.1007/s10750-010-0324-6; Reimers CE, 2006, GEOBIOLOGY, V4, P123, DOI 10.1111/j.1472-4669.2006.00071.x; Reimers CE, 2013, GEOCHIM COSMOCHIM AC, V121, P582, DOI 10.1016/j.gca.2013.08.004; Rismani-Yazdi H, 2007, BIOTECHNOL BIOENG, V97, P1398, DOI 10.1002/bit.21366; Rozendal RA, 2006, ENVIRON SCI TECHNOL, V40, P5206, DOI 10.1021/es060387r; SABATY M, 1994, ARCH MICROBIOL, V162, P335, DOI 10.1007/BF00263781; Sajana TK, 2014, AQUACULT ENG, V61, P17, DOI 10.1016/j.aquaeng.2014.05.004; Sajana TK, 2013, AQUACULT ENG, V57, P101, DOI 10.1016/j.aquaeng.2013.09.002; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Soana E, 2015, BIOGEOCHEMISTRY, V124, P387, DOI 10.1007/s10533-015-0104-5; Soana E, 2014, AQUAT ECOL, V48, P11, DOI 10.1007/s10452-013-9462-z; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Timmers RA, 2012, BIORESOURCE TECHNOL, V108, P60, DOI 10.1016/j.biortech.2011.10.088; Wang S., 2013, SEL TOP SIGNAL PROCE, V1, P1, DOI DOI 10.1016/J.SUSC0M.2010.10.002.(AVAILABLE; Xie YH, 2005, AQUAT BOT, V81, P85, DOI 10.1016/j.aquabot.2004.12.001; Yan ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10709; Ye R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20100; Zhai J, 2012, ENVIRON TECHNOL, V33, P1999, DOI 10.1080/09593330.2012.655320; Zhang JQ, 2013, BIORESOURCE TECHNOL, V149, P44, DOI 10.1016/j.biortech.2013.09.043; Zhang YF, 2012, WATER RES, V46, P6445, DOI 10.1016/j.watres.2012.09.022	59	29	32	5	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172757	10.1371/journal.pone.0172757	http://dx.doi.org/10.1371/journal.pone.0172757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241072	gold, Green Submitted, Green Published			2022-12-27	WOS:000395934400038
J	Burkhamer, J; Kriebel, D; Clapp, R				Burkhamer, Jessica; Kriebel, David; Clapp, Richard			The increasing toll of adolescent cancer incidence in the US	PLOS ONE			English	Article							YOUNG-ADULTS; CHILDHOOD-CANCER; CLASSIFICATION; TRENDS	Cancer incidence is rising among adolescents ("teens"). The causes of the increase are unknown but studying incidence patterns and trends may produce insights into etiology. Using data from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program we described trends of cancer incidence among teens (15-19 year olds). We reviewed and summarized incidence patterns for histologic cancer groups and the most frequently diagnosed sites of cancer among teens during 2008-2012 reported by the SEER Cancer Statistics Review. We calculated annual incidence rates for the years 1975-2012 and used linear regression analysis to evaluate trends and calculate rates of change. Incidence for all sites combined increased annually by 0.67% for males and 0.62% for females during the period 1975 through 2012 -resulting in more than a 25% increase over 38 years. The biggest annual incidence increases occurred in non-Hodgkin lymphoma (NHL) (2.16% females; 1.38% males), thyroid cancer (2.12% females; 1.59% males), acute myeloid leukemia (AML) (1.73% females) and testicular cancer (1.55% males). Incidence rates for most histologic groups and sites showed steady long term increases over the 38 years of data. Despite improvements in survival, rising incidence trends mean growing numbers of young adults are undergoing painful and costly cancer treatments. A concerted research program is vital to investigate causes of steadily rising teen cancer rates.	[Burkhamer, Jessica; Kriebel, David] Univ Massachusetts, Dept Publ Hlth, Lowell, MA 01854 USA; [Kriebel, David; Clapp, Richard] Univ Massachusetts Lowell, Lowell Ctr Sustainable Prod, Lowell, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell	Burkhamer, J (corresponding author), Univ Massachusetts, Dept Publ Hlth, Lowell, MA 01854 USA.	jessica.burkhamer@gmail.com						Alliance DoHaHSaLYA, 2006, CLOS GAP RES CAR IMP; [Anonymous], RES DAT 1973 2012; Barr RD, 2006, CANCER, V106, P1425, DOI 10.1002/cncr.21773; Birch JM, 2002, BRIT J CANCER, V87, P1267, DOI 10.1038/sj.bjc.6600647; Bleyer A, 2006, CANC EPIDEMIOLOGY OL; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Buka I, 2007, PEDIATR CLIN N AM, V54, P177, DOI 10.1016/j.pcl.2006.11.010; Clapp Richard W., 2008, Reviews on Environmental Health, V23, P1; FRITSCHI L, 1995, INT J CANCER, V60, P355, DOI 10.1002/ijc.2910600314; Fritz A, 2000, INT CLASSIFICATION D; GLASER SL, 1990, CANCER-AM CANCER SOC, V66, P2196, DOI 10.1002/1097-0142(19901115)66:10<2196::AID-CNCR2820661026>3.0.CO;2-R; GOUVEIAVIGEANT T, 2003, TOXIC CHEM CHILDHOOD; Howlader N, 2015, SEER CANC STAT REV 1; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Landgren O, 2007, HEMATOL ONCOL CLIN N, V21, P825, DOI 10.1016/j.hoc.2007.07.001; Linet MS, 2016, INT J CANCER, V138, P1862, DOI 10.1002/ijc.29924; Morgan DJ, 2015, JAMA INTERN MED, V175, P1960, DOI 10.1001/jamainternmed.2015.5614; National Cancer Institute DoCCPS, 2015, JOINP TREND AN; President's Cancer Panel, 2010, 2008 2009 ANN REP; Surveillance Epidemiology and End Results Program (SEER) National Cancer Institute, 2015, TREND ALG; Surveillance Epidemiology and End Results Program (SEER) National Cancer Institute, 2015, SEER PROGR; Surveillance Epidemiology and End Results (SEER) Program, PROGR POP 1969 2012; Swerdlow SH, 2008, WHO CLASSIFICATION T	23	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172986	10.1371/journal.pone.0172986	http://dx.doi.org/10.1371/journal.pone.0172986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235028	gold, Green Published, Green Submitted			2022-12-27	WOS:000394688200182
J	Chowdhury, EA; Western, MJ; Nightingale, TE; Peacock, OJ; Thompson, D				Chowdhury, Enhad A.; Western, Max J.; Nightingale, Thomas E.; Peacock, Oliver J.; Thompson, Dylan			Assessment of laboratory and daily energy expenditure estimates from consumer multi-sensor physical activity monitors	PLOS ONE			English	Article							RESTING METABOLIC-RATE; COMBINED HEART-RATE; WEARABLE DEVICES; HEALTHY-ADULTS; VALIDITY; ACCELEROMETRY; ACCURACY; ACTIHEART; INTERVENTION; CHALLENGES	Wearable physical activity monitors are growing in popularity and provide the opportunity for large numbers of the public to self-monitor physical activity behaviours. The latest generation of these devices feature multiple sensors, ostensibly similar or even superior to advanced research instruments. However, little is known about the accuracy of their energy expenditure estimates. Here, we assessed their performance against criterion measurements in both controlled laboratory conditions (simulated activities of daily living and structured exercise) and over a 24 hour period in free-living conditions. Thirty men (n = 15) and women (n = 15) wore three multi-sensor consumer monitors (Microsoft Band, Apple Watch and Fitbit Charge HR), an accelerometry-only device as a comparison (Jawbone UP24) and validated research-grade multi-sensor devices (BodyMedia Core and individually calibrated Actiheart (TM)). During discrete laboratory activities when compared against indirect calorimetry, the Apple Watch performed similarly to criterion measures. The Fitbit Charge HR was less consistent at measurement of discrete activities, but produced similar free-living estimates to the Apple Watch. Both these devices underestimated free-living energy expenditure (-394 kcal/d and -405 kcal/d, respectively; P<0.01). The multi-sensor Microsoft Band and accelerometry-only Jawbone UP24 devices underestimated most laboratory activities and substantially underestimated free-living expenditure (-1128 kcal/d and -998 kcal/d, respectively; P<0.01). None of the consumer devices were deemed equivalent to the reference method for daily energy expenditure. For all devices, there was a tendency for negative bias with greater daily energy expenditure. No consumer monitors performed as well as the research-grade devices although in some (but not all) cases, estimates were close to criterion measurements. Thus, whilst industry-led innovation has improved the accuracy of consumer monitors, these devices are not yet equivalent to the best research-grade devices or indeed equivalent to each other. We propose independent quality standards and/or accuracy ratings for consumer devices are required.	[Chowdhury, Enhad A.; Western, Max J.; Nightingale, Thomas E.; Peacock, Oliver J.; Thompson, Dylan] Univ Bath, Dept Hlth, Bath, Avon, England	University of Bath	Thompson, D (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	D.Thompson@bath.ac.uk	Nightingale, Tom E/Q-8525-2019	Nightingale, Tom E/0000-0003-2947-4931; Chowdhury, Enhad/0000-0003-1491-6119; Western, Max James/0000-0003-1107-8498	National Prevention Research Initiative (NPRI) [MR/J00040X/1]; Alzheimer's Research Trust; Alzheimer's Society, Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; Stroke Association; Wellcome Trust; Welsh Assembly Government; World Cancer Research Fund; MRC [MR/J00040X/1] Funding Source: UKRI; Medical Research Council [MR/J00040X/1] Funding Source: researchfish	National Prevention Research Initiative (NPRI); Alzheimer's Research Trust; Alzheimer's Society, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Wellcome Trust(Wellcome Trust); Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded in part through grant (MR/J00040X/1) from the National Prevention Research Initiative (NPRI) to DT. Funding partners are: Alzheimers Research Trust, Alzheimers Society, Biotechnology and Biological Sciences Research Council, British Heart Foundation; Cancer Research UK; Chief Scientists Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency; Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Bai Y, 2016, MED SCI SPORT EXER, V48, P151, DOI 10.1249/MSS.0000000000000727; Bond DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100821; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Cadmus-Bertram LA, 2015, AM J PREV MED, V49, P414, DOI 10.1016/j.amepre.2015.01.020; Calabro MA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0119-7; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Chiauzzi E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0319-2; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Diaz KM, 2015, INT J CARDIOL, V185, P138, DOI 10.1016/j.ijcard.2015.03.038; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; McCaig DC, 2016, APPETITE, V107, P323, DOI 10.1016/j.appet.2016.08.107; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; Murakami H, 2016, JAMA INT MED; Nightingale T E, 2015, BMJ Open Sport Exerc Med, V1; Nightingale TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126086; Nightingale TE, 2014, MED SCI SPORT EXER, V46, P1849, DOI 10.1249/MSS.0000000000000291; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Peacock OJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0892-x; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Piwek L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001953; Powell AC, 2014, JAMA-J AM MED ASSOC, V311, P1851, DOI 10.1001/jama.2014.2564; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Schoenfeld AJ, 2016, JAMA INTERN MED, V176, P704, DOI 10.1001/jamainternmed.2016.0326; Sperlich B., 2016, BRIT J SPORT MED; Spierer DK, 2011, EUR J APPL PHYSIOL, V111, P659, DOI 10.1007/s00421-010-1672-7; Staudenmayer J, 2012, MED SCI SPORT EXER, V44, pS61, DOI 10.1249/MSS.0b013e3182399e0f; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Thompson D, 2015, EXERC SPORT SCI REV, V43, P67, DOI 10.1249/JES.0000000000000039; Thompson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056427; Thompson D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004337; van Hees VT, 2016, METHOD INFORM MED, V55, P525, DOI 10.3414/ME15-05-0013; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Wallen MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154420; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; Western MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126156; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	48	58	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171720	10.1371/journal.pone.0171720	http://dx.doi.org/10.1371/journal.pone.0171720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234979	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200032
J	Hauser, DDW; Laidre, KL; Stern, HL; Moore, SE; Suydam, RS; Richard, PR				Hauser, Donna D. W.; Laidre, Kristin L.; Stern, Harry L.; Moore, Sue E.; Suydam, Robert S.; Richard, Pierre R.			Habitat selection by two beluga whale populations in the Chukchi and Beaufort seas	PLOS ONE			English	Article							ARCTIC MARINE MAMMALS; DELPHINAPTERUS-LEUCAS; EASTERN CHUKCHI; COOK INLET; SEXUAL SEGREGATION; KILLER WHALE; PATTERNS; SUMMER; VARIABILITY; ECOSYSTEM	There has been extensive sea ice loss in the Chukchi and Beaufort seas where two beluga whale (Delphinapterus leucas) populations occur between July-November. Our goal was to develop population-specific beluga habitat selection models that quantify relative use of sea ice and bathymetric features related to oceanographic processes, which can provide context to the importance of changing sea ice conditions. We established habitat selection models that incorporated daily sea ice measures (sea ice concentration, proximity to ice edge and dense ice) and bathymetric features (slope, depth, proximity to the continental slope, Barrow Canyon, and shore) to establish quantitative estimates of habitat use for the Eastern Chukchi Sea ('Chukchi') and Eastern Beaufort Sea ('Beaufort') populations. We applied 'used v. available' resource selection functions to locations of 65 whales tagged from 1993-2012, revealing large variations in seasonal habitat selection that were distinct between sex and population groups. Chukchi whales of both sexes were predicted to use areas in close proximity to Barrow Canyon (typically < 200 km) as well as the continental slope in summer, although deeper water and denser ice were stronger predictors for males than females. Habitat selection differed more between sexes for Beaufort belugas. Beaufort males selected higher ice concentrations (>= 40%) than females (0-40%) in July-August. Proximity to shore (< 200 km) strongly predicted summer habitat of Beaufort females, while distance to the ice edge was important for male habitat selection, especially during westward migration in September. Overall, our results indicate that sea ice variables were rarely the primary drivers of beluga summer-fall habitat selection. While diminished sea ice may indirectly affect belugas through changes in the ecosystem, associations with bathymetric features that affect prey availability seemed key to habitat selection during summer and fall. These results provide a benchmark by which to assess future changes in beluga habitat use of the Pacific Arctic.	[Hauser, Donna D. W.; Laidre, Kristin L.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hauser, Donna D. W.; Laidre, Kristin L.; Stern, Harry L.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Moore, Sue E.] Natl Marine Fisheries Serv, Off Sci & Technol, NOAA, 7600 Sand Point Way NE, Seattle, WA USA; [Suydam, Robert S.] North Slope Borough, Dept Wildlife Management, Barrow, AK USA; [Richard, Pierre R.] Freshwater Inst Fisheries & Oceans Canada, 501 Univ Crescent, Winnipeg, MB, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada	Hauser, DDW (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.; Hauser, DDW (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA.	dhauser@uw.edu	Moore, Sue E/M-2103-2018	Hauser, Donna/0000-0001-8236-7372	Alaska Beluga Whale Committee; North Slope Borough of Alaska; National Marine Fisheries Service (NMFS); Alaska Department of Fish and Game; National Fish and Wildlife Foundation; Minerals Management Service; Village of Point Lay; Fisheries and Oceans Canada; Fisheries Joint Management Committee; Environmental Studies Revolving Fund; NMFS; NASA Climate Indicators Program [NNX13AN28G, NNX16AG33G]; University of Washington's (UW) Integrative Graduate Education and Research Traineeship Program on Ocean Change (National Science Foundation) [DGE-1068839]; UW School of Aquatic & Fishery Sciences; Inuvialuit Hunter and Trapper Committees of Inuvik; Inuvialuit Hunter and Trapper Committees of Aklavik; Inuvialuit Hunter and Trapper Committees of Tuktoyaktuk; Polar Continental Shelf Project	Alaska Beluga Whale Committee; North Slope Borough of Alaska; National Marine Fisheries Service (NMFS); Alaska Department of Fish and Game; National Fish and Wildlife Foundation; Minerals Management Service; Village of Point Lay; Fisheries and Oceans Canada; Fisheries Joint Management Committee; Environmental Studies Revolving Fund; NMFS; NASA Climate Indicators Program; University of Washington's (UW) Integrative Graduate Education and Research Traineeship Program on Ocean Change (National Science Foundation); UW School of Aquatic & Fishery Sciences; Inuvialuit Hunter and Trapper Committees of Inuvik; Inuvialuit Hunter and Trapper Committees of Aklavik; Inuvialuit Hunter and Trapper Committees of Tuktoyaktuk; Polar Continental Shelf Project(Natural Resources Canada)	Tagging of Chukchi belugas was funded by the Alaska Beluga Whale Committee, North Slope Borough of Alaska, National Marine Fisheries Service (NMFS), Alaska Department of Fish and Game, National Fish and Wildlife Foundation, Minerals Management Service, and Village of Point Lay. Tagging of Beaufort belugas was funded by the Fisheries and Oceans Canada, Fisheries Joint Management Committee, Environmental Studies Revolving Fund, Minerals Management Service, and NMFS. Analyses by D.D.W.H, K.L.L., and H.L. S. were partially funded by NASA Climate Indicators Program Grants (NNX13AN28G and NNX16AG33G) and fellowships to D.D.W. Hauser from the University of Washington's (UW) Integrative Graduate Education and Research Traineeship Program on Ocean Change (National Science Foundation DGE-1068839) and UW School of Aquatic & Fishery Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the long-term collaborative efforts of the communities of Point Lay, AK and the Inuvialuit Settlement Region, NWT who have facilitated our tagging efforts. For Chukchi belugas, L. Lowry, K. Frost, G. O'Corry-Crowe, D. Pikok, R. Small, T. Romano, J. Tazruk, B. and M. Tracey, J. Rexford, J. Orr, A. Ashby, V. Dollarhide, L. Ferreira, L. Pierce, L. Stalker, H. Smith, R. Hobbs, R. Hoover, T. Nukapigak, M. Sparck, S. Speckman, D. Susook, C. Aniskette, J. Tuckfield, C. Rea, G. Marshall, N. Hank, L. Hansen, L. Hoberecht, L. Quakenbush, T. Robeck, A. Simon, G. and K. VanBlaricom, J. Taylor, J. Edwards, D. Ramey, B. Achootchook, and J. Citta have supported various aspects of tagging and data processing. J. Orr, A. Martin, and B. Leblanc offered field assistance and data processing of Beaufort beluga data. Thanks also to the Inuvialuit Hunter and Trapper Committees of Inuvik, Aklavik, and Tuktoyaktuk and the Polar Continental Shelf Project for the support and assistance tagging Beaufort belugas. We thank R. Wilson for useful discussion of resource selection modeling approaches and example R code for model validation. R. McGovern processed sea ice data for predictive mapping of habitat selection models and gave feedback on R code for mapping. Helpful feedback and review of earlier drafts were provided by R. Hobbs and D.E. Schindler. We appreciate comments from K. Frost and an anonymous reviewer who substantially improved the manuscript.	Amante C., 2009, NGDC24 NOAA NESDIS; Ardyna M, 2014, GEOPHYS RES LETT, V41, P6207, DOI 10.1002/2014GL061047; Arrigo KR, 2015, PROG OCEANOGR, V136, P60, DOI 10.1016/j.pocean.2015.05.002; Ashjian CJ, 2010, ARCTIC, V63, P179; Asselin NC, 2011, POLAR BIOL, V34, P1973, DOI 10.1007/s00300-011-0990-5; Bailleul Frederic, 2012, Endangered Species Research, V17, P27, DOI 10.3354/esr00420; Barber DG, 2001, ARCTIC, V54, P305; Beck CA, 2003, J ANIM ECOL, V72, P280, DOI 10.1046/j.1365-2656.2003.00704.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carmack EC, 2002, ARCTIC, V55, P29; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Citta JJ, 2013, ARCTIC, V66, P389; Colbeck GJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2552; Danielson SL, 2014, PROG OCEANOGR, V125, P40, DOI 10.1016/j.pocean.2014.04.006; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Fijn RC, 2013, ARDEA, V101, P3, DOI 10.5253/078.101.0102; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Freitas C, 2008, J APPL ECOL, V45, P1213, DOI 10.1111/j.1365-2664.2008.01505.x; Frey KE, 2015, PROG OCEANOGR, V136, P32, DOI 10.1016/j.pocean.2015.05.009; Frost K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P39; Frost Kathryn J., 2010, Journal of Cetacean Research and Management, V11, P293; Goetz KT, 2007, MAR ECOL PROG SER, V330, P247, DOI 10.3354/meps330247; Goetz Kimberly T., 2012, Endangered Species Research, V16, P135, DOI 10.3354/esr00394; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2015, PROG OCEANOGR, V136, P92, DOI 10.1016/j.pocean.2015.05.006; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Harwood LA, 2002, ARCTIC, V55, P77; Hauser DDW, 2016, GLOBAL CHANGE BIOL; Hauser DDW, 2015, MAR ECOL PROG SER, V541, P245, DOI 10.3354/meps11530; Hauser DDW, 2014, POLAR BIOL, V37, P1171, DOI 10.1007/s00300-014-1510-1; Higdon JW, 2012, MAR MAMMAL SCI, V28, pE93, DOI 10.1111/j.1748-7692.2011.00489.x; Hornby CA, 2016, POLAR BIOL, P1; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Huntington HP, 2009, MAR POLICY, V33, P77, DOI 10.1016/j.marpol.2008.04.003; Jay CV, 2012, MAR ECOL PROG SER, V468, P1, DOI 10.3354/meps10057; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kuletz KJ, 2015, PROG OCEANOGR, V136, P175, DOI 10.1016/j.pocean.2015.05.012; Laidre KL, 2015, POLAR BIOL, P1; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Laidre KL, 2006, CAN FIELD NAT, V120, P457, DOI 10.22621/cfn.v120i4.355; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Llinas L, 2009, DEEP-SEA RES PT II, V56, P1290, DOI 10.1016/j.dsr2.2008.10.020; Logerwell E, 2011, POLAR BIOL, V34, P1783, DOI 10.1007/s00300-011-1028-8; Loseto LL, 2006, CAN J ZOOL, V84, P1743, DOI 10.1139/Z06-160; Loseto LL, 2015, SCI TOTAL ENVIRON, V509, P226, DOI 10.1016/j.scitotenv.2014.10.110; Loseto LL, 2009, J EXP MAR BIOL ECOL, V374, P12, DOI 10.1016/j.jembe.2009.03.015; Majewski AR, 2016, POLAR BIOL, V39, P1087, DOI 10.1007/s00300-015-1857-y; Manly B.F.J., 2002, RESOURCE SELECTION A; Moore SE, 2000, ARCTIC, V53, P448; Moore SE, 2000, ARCTIC, V53, P432; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Noren SR, 2016, J EXP BIOL, V219, P2828, DOI 10.1242/jeb.143644; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; OCorryCrowe GM, 1997, MOL ECOL, V6, P955, DOI 10.1046/j.1365-294X.1997.00267.x; Orr JR, 2001, ARCTIC, V54, P299; Parker-Stetter SL, 2011, POLAR BIOL, V34, P1543, DOI 10.1007/s00300-011-1014-1; Pickart RS, 2013, DEEP-SEA RES PT I, V79, P106, DOI 10.1016/j.dsr.2013.05.003; Quakenbush Lori T., 2015, U S National Marine Fisheries Service Marine Fisheries Review, V77, P70; R Development Core Team, 2012, R LANG ENV STAT COMP; Rainville L, 2011, OCEANOGRAPHY, V24, P136, DOI 10.5670/oceanog.2011.65; Reeves RR, 2014, MAR POLICY, V44, P375, DOI 10.1016/j.marpol.2013.10.005; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Richard P.R., 1997, ENV STUDIES RES FUND, V134; Richard PR, 2001, ARCTIC, V54, P223, DOI 10.14430/arctic783; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Schulze LM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007985; Shelden KEW, 2003, MAR MAMMAL SCI, V19, P529, DOI 10.1111/j.1748-7692.2003.tb01319.x; SMITH TG, 1992, CAN J ZOOL, V70, P2405, DOI 10.1139/z92-322; Stafford KM, 2013, MAR ECOL PROG SER, V474, P287, DOI 10.3354/meps10076; Stafford KM, 2016, DEEP SEA RES 2; STAUBIN DJ, 1990, CAN J ZOOL, V68, P359, DOI 10.1139/z90-051; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Suydam RS, 2001, ARCTIC, V54, P237; Wang MY, 2015, PROG OCEANOGR, V136, P50, DOI 10.1016/j.pocean.2015.01.001; Weingartner T, 2005, DEEP-SEA RES PT II, V52, P3150, DOI 10.1016/j.dsr2.2005.10.015; Whitehead H, 2000, CETACEAN SOCIETIES, P154; Wilson RR, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00193.1; Wood KR, 2015, PROG OCEANOGR, V136, P12, DOI 10.1016/j.pocean.2015.05.005; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021880; Zuur Alain F., 2009, P1	85	26	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172755	10.1371/journal.pone.0172755	http://dx.doi.org/10.1371/journal.pone.0172755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235041	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200130
J	Milin, P; Feldman, LB; Ramscar, M; Hendrix, P; Baayen, RH				Milin, Petar; Feldman, Laurie Beth; Ramscar, Michael; Hendrix, Peter; Baayen, R. Harald			Discrimination in lexical decision	PLOS ONE			English	Article							MORPHO-ORTHOGRAPHIC SEGMENTATION; MORPHOLOGICAL FAMILY-SIZE; INDIVIDUAL-DIFFERENCES; WORD RECOGNITION; INTERACTIVE-ACTIVATION; SKILLED READERS; MODEL; ACQUISITION; LANGUAGE; DYNAMICS	In this study we present a novel set of discrimination-based indicators of language processing derived from Naive Discriminative Learning (NDL) theory. We compare the effectiveness of these new measures with classical lexical-distributional measures-in particular, frequency counts and form similarity measures-to predict lexical decision latencies when a complete morphological segmentation of masked primes is or is not possible. Data derive from a re-analysis of a large subset of decision latencies from the English Lexicon Project, as well as from the results of two new masked priming studies. Results demonstrate the superiority of discrimination-based predictors over lexical-distributional predictors alone, across both the simple and primed lexical decision tasks. Comparable priming after masked CORNER and CORNEA type primes, across two experiments, fails to support early obligatory segmentation into morphemes as predicted by the morpho-orthographic account of reading. Results fit well with NDL theory, which, in conformity with Word and Paradigm theory, rejects the morpheme as a relevant unit of analysis. Furthermore, results indicate that readers with greater spelling proficiency and larger vocabularies make better use of orthographic priors and handle lexical competition more efficiently.	[Milin, Petar] Univ Sheffield, Dept Journalism Studies, Sheffield, S Yorkshire, England; [Feldman, Laurie Beth] SUNY Albany, Haskins Labs, Albany, NY 12222 USA; [Feldman, Laurie Beth] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Ramscar, Michael; Hendrix, Peter; Baayen, R. Harald] Eberhard Karls Univ Tubingen, Seminar Sprachwissensch, Tubingen, Germany	University of Sheffield; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Eberhard Karls University of Tubingen	Milin, P (corresponding author), Univ Sheffield, Dept Journalism Studies, Sheffield, S Yorkshire, England.	p.milin@sheffield.ac.uk	Milin, Petar/AAT-6895-2020	Milin, Petar/0000-0001-9708-7031; Baayen, Harald/0000-0003-3178-3944	Alexander von Humboldt foundation through an Alexander von Humboldt research chair awarded from the Ministry of Education, Science and Technological Development of the Republic of Serbia [179006, 179033]; National Institute of Child Health and Human Development [HD 01994]	Alexander von Humboldt foundation through an Alexander von Humboldt research chair awarded from the Ministry of Education, Science and Technological Development of the Republic of Serbia; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Alexander von Humboldt foundation through an Alexander von Humboldt research chair awarded to R. H. Baayen, by Grants 179006 and 179033 from the Ministry of Education, Science and Technological Development of the Republic of Serbia to Petar Milin, and by the National Institute of Child Health and Human Development HD 01994 to Haskins Laboratories (http://www.sfs.unituebingen.de/gl/projekte.html).	ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; Dunabeitia JA, 2011, LANG COGNITIVE PROC, V26, P509, DOI 10.1080/01690965.2010.499215; Andrews S, 2013, J MEM LANG, V68, P279, DOI 10.1016/j.jml.2012.12.001; Andrews S, 2012, J EXP PSYCHOL LEARN, V38, P152, DOI 10.1037/a0024953; Andrews S, 2010, J EXP PSYCHOL GEN, V139, P299, DOI 10.1037/a0018366; [Anonymous], 2014, R LANG ENV STAT COMP; Baayen R, 2015, OUT CAGE SHADOWS; Baayen RH, 2006, J MEM LANG, V55, P290, DOI 10.1016/j.jml.2006.03.008; Baayen R. H, 1995, CELEX LEXICAL DATABA; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Baayen RH, 2007, MENT LEX, V2, P419, DOI 10.1075/ml.2.3.06baa; Baayen RH, 2017, J MEMORY LA IN PRESS; Baayen RH, 2015, MIXED EFFEC IN PRESS; Baayen RH, 2016, APHASIOLOGY; Baayen RH, 2015, COMPREHENSION UNPUB; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bauer L, 2013, OXFORD REFERENCE GUI; Beyersmann E., 2014, PSYCHONOMIC B REV; Beyersmann E, 2016, PSYCHON B REV, V23, P533, DOI 10.3758/s13423-015-0927-z; Blevins JP, 2003, LANGUAGE, V79, P737, DOI 10.1353/lan.2003.0206; Bodner GE, 2003, PSYCHON B REV, V10, P645, DOI 10.3758/BF03196527; BOOIJ GE, 1986, LINGUISTICS, V24, P503, DOI 10.1515/ling.1986.24.3.503; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bowers JS, 2005, J MEM LANG, V52, P131, DOI 10.1016/j.jml.2004.09.003; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burgess C, 1998, BEHAV RES METH INS C, V30, P272, DOI 10.3758/BF03200655; Burnard L., 1995, USERS GUIDE BRIT NAT; Burt JS, 2002, J MEM LANG, V46, P518, DOI 10.1006/jmla.2001.2818; Chan KY, 2009, J EXP PSYCHOL HUMAN, V35, P1934, DOI 10.1037/a0016902; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Chen T, 2015, XGBOOST EXTREME GRAD; Chen Z., 2008, CORRELATIVE LEARNING, V49; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Danks D, 2003, J MATH PSYCHOL, V47, P109, DOI 10.1016/S0022-2496(02)00016-0; Dunteman G., 1989, PRINCIPAL COMPONENTS, DOI [10.4135/9781412985475, DOI 10.4135/9781412985475]; Ellis NC, 2006, APPL LINGUIST, V27, P1, DOI 10.1093/applin/ami038; Feldman LB, 2008, J EXP PSYCHOL LEARN, V34, P680, DOI 10.1037/0278-7393.34.3.680; Feldman LB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00111; Feldman LB, 2009, PSYCHON B REV, V16, P684, DOI 10.3758/PBR.16.4.684; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Fu A, 2015, H2O H2O R INTERFACE; Geeraert K, 2017, TOPICS COGN IN PRESS; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; Heister J., 2012, LEXICAL RESOURCES PS, V3, P27; Hendrix P., 2015, EXPT EXPLORATIONS DI; Howell D. C., 2005, MEDIAN ABSOLUTE DEVI; KNUTH D., 1973, THE ART OF COMPUTER, V3; Kucera H., 1967, COMPUTATIONAL ANAL P; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Love BC, 2004, PSYCHOL REV, V111, P309, DOI 10.1037/0033-295X.111.2.309; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Marelli M, 2014, Q J EXPT PS IN PRESS; Marelli M, 2015, PSYCHOL REV, V122, P485, DOI 10.1037/a0039267; Marsolek CJ, 2008, TRENDS COGN SCI, V12, P176, DOI 10.1016/j.tics.2008.02.005; Martin FMD, 2004, COGNITION, V94, P1, DOI 10.1016/j.cognition.2003.10.015; Martin FMD, 2004, J EXP PSYCHOL LEARN, V30, P1271, DOI 10.1037/0278-7393.30.6.1271; Masson MEJ, 2003, MASKED PRIMING STATE, P57; Matthews Peter H., 1974, MORPHOLOGY INTRO THE; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Meyer D., 2015, E1071 TU WIEN; Milin P., 2009, ANALOGY GRAMMAR FORM, P214, DOI DOI 10.1093/ACPR0F:0S0/9780199547548.003.0010; Milin P, 2009, J MEM LANG, V60, P50, DOI 10.1016/j.jml.2008.08.007; Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Minsky M, 1972, PERCEPTRONS; Mulder K, 2014, J MEM LANG, V72, P59, DOI 10.1016/j.jml.2013.12.004; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Oehrn CR, 2015, CURR BIOL, V25, P2307, DOI 10.1016/j.cub.2015.07.032; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pham H, 2015, LANGUAGE COGNITION A; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Ramscar M, 2015, HANDB SPRACH KOMMUN, V39, P75; Ramscar M, 2014, TOP COGN SCI, V6, P5, DOI 10.1111/tops.12078; Ramscar M, 2013, LANGUAGE, V89, P760, DOI 10.1353/lan.2013.0068; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; Ramscar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022501; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Rastle K, 2004, PSYCHON B REV, V11, P1090, DOI 10.3758/BF03196742; Rastle K, 2008, LANG COGNITIVE PROC, V23, P942, DOI 10.1080/01690960802069730; Recchia G, 2015, Q J EXP PSYCHOL, V68, P1584, DOI 10.1080/17470218.2014.941296; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Romo R, 1999, CURR OPIN NEUROBIOL, V9, P487, DOI 10.1016/S0959-4388(99)80073-7; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Schreuder R, 1997, J MEM LANG, V37, P118, DOI 10.1006/jmla.1997.2510; SCHREUDER R, 1994, J MEM LANG, V33, P357, DOI 10.1006/jmla.1994.1017; Schreuder R., 1995, MORPHOLOGICAL ASPECT, P131, DOI DOI 10.1002/0470018860.S00254; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shaoul C., 2015, DISCRIMINAT IN PRESS; Shaoul C, 2010, BEHAV RES METHODS, V42, P393, DOI 10.3758/BRM.42.2.393; Stefanowitsch Anatol., 2003, INT J CORPUS LINGUIS, V8, P209, DOI [10.1075/ijcl.8.2.03ste, DOI 10.1075/IJCL.8.2.03STE]; TAFT M, 1975, J VERB LEARN VERB BE, V14, P638, DOI 10.1016/S0022-5371(75)80051-X; TAFT M, 1981, J VERB LEARN VERB BE, V20, P289, DOI 10.1016/S0022-5371(81)90439-4; TAFT M, 1994, LANG COGNITIVE PROC, V9, P271, DOI 10.1080/01690969408402120; TAFT M, 1976, J VERB LEARN VERB BE, V15, P607, DOI 10.1016/0022-5371(76)90054-2; TAFT M, 1988, LINGUISTICS, V26, P657, DOI 10.1515/ling.1988.26.4.657; TAFT M, 1979, J VERB LEARN VERB BE, V18, P21, DOI 10.1016/S0022-5371(79)90544-9; Tiedemann J, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P2214; Trimmer PC, 2012, J THEOR BIOL, V302, P39, DOI 10.1016/j.jtbi.2012.02.014; van Rij J., 2015, ITSADUG INTERPRETING; Vitevitch MS, 2008, J SPEECH LANG HEAR R, V51, P408, DOI 10.1044/1092-4388(2008/030); Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wurm LH, 2014, J MEM LANG, V72, P37, DOI 10.1016/j.jml.2013.12.003; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971	114	71	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171935	10.1371/journal.pone.0171935	http://dx.doi.org/10.1371/journal.pone.0171935			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EL5VB	28235015	Green Accepted, Green Published, gold			2022-12-27	WOS:000394688200040
J	Nolte, S; Osborne, RH; Dwinger, S; Elsworth, GR; Conrad, ML; Rose, M; Harter, M; Dirmaier, J; Zill, JM				Nolte, Sandra; Osborne, Richard H.; Dwinger, Sarah; Elsworth, Gerald R.; Conrad, Melanie L.; Rose, Matthias; Haerter, Martin; Dirmaier, Joerg; Zill, Joerdis M.			German translation, cultural adaptation, and validation of the Health Literacy Questionnaire (HLQ)	PLOS ONE			English	Article							SOCIETAL BURDEN; OUTCOMES; OSTEOARTHRITIS; INDEXES	The Health Literacy Questionnaire (HLQ), developed in Australia in 2012 using a 'validity-driven' approach, has been rapidly adopted and is being applied in many countries and languages. It is a multidimensional measure comprising nine distinct domains that may be used for surveys, needs assessment, evaluation and outcomes assessment as well as for informing service improvement and the development of interventions. The aim of this paper is to describe the German translation of the HLQ and to present the results of the validation of the culturally adapted version. The HLQ comprises 44 items, which were translated and culturally adapted to the German context. This study uses data collected from a sample of 1,058 persons with chronic conditions. Statistical analyses include descriptive and confirmatory factor analyses. In one-factor congeneric models, all scales demonstrated good fit after few model adjustments. In a single, highly restrictive nine-factor model (no cross-loadings, no correlated errors) replication of the original English-language version was achieved with fit indices and psychometric properties similar to the original HLQ. Reliability for all scales was excellent, with a Cronbach's Alpha of at least 0.77. High to very high correlations between some HLQ factors were observed, suggesting that higher order factors may be present. Our rigorous development and validation protocol, as well as strict adaptation processes, have generated a remarkable reproduction of the HLQ in German. The results of this validation provide evidence that the HLQ is robust and can be recommended for use in German-speaking populations.	[Nolte, Sandra; Conrad, Melanie L.; Rose, Matthias] Charite Univ Med Berlin, Dept Psychosomat Med, Ctr Internal Med & Dermatol, Berlin, Germany; [Nolte, Sandra; Osborne, Richard H.; Elsworth, Gerald R.] Deakin Univ, Sch Hlth & Social Dev, Populat Hlth Strateg Res Ctr, Geelong, Vic, Australia; [Dwinger, Sarah; Haerter, Martin; Dirmaier, Joerg; Zill, Joerdis M.] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Rose, Matthias] Univ Massachusetts, Sch Med, Outcomes Measurement Sci, Quantitat Hlth Sci, Worcester, MA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deakin University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Massachusetts System; University of Massachusetts Worcester	Nolte, S (corresponding author), Charite Univ Med Berlin, Dept Psychosomat Med, Ctr Internal Med & Dermatol, Berlin, Germany.; Nolte, S (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Populat Hlth Strateg Res Ctr, Geelong, Vic, Australia.	sandra.nolte@charite.de	Nolte, Sandra/B-7498-2008; Conrad, Melanie/AAH-8431-2019; Osborne, Richard H/A-9447-2010	Nolte, Sandra/0000-0001-6185-9423; Osborne, Richard H/0000-0002-9081-2699; Dwinger, Sarah/0000-0003-4868-5662; Harter, Martin/0000-0001-7443-9890; Conrad, Melanie Lynn/0000-0002-8811-5536	Kaufmannische Krankenkasse Hannover (KKH); National Health and Medical Research Council (NHMRC) [APP1059122]	Kaufmannische Krankenkasse Hannover (KKH); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors would like to thank the health insurance company Kaufmannische Krankenkasse Hannover (KKH) for funding this project (https://www.kkh.de). The funding was obtained by JD and MH. RHO is funded in part through a National Health and Medical Research Council (NHMRC) Senior Research Fellowship #APP1059122 (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Batterham Roy W, 2014, BMC Public Health, V14, P694, DOI 10.1186/1471-2458-14-694; Beauchamp A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2056-z; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bollen KA, 1989, STRUCTURAL EQUATIONS; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Buchbinder R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3468; Busija L, 2013, J CLIN EPIDEMIOL, V66, P994, DOI 10.1016/j.jclinepi.2013.03.012; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dwinger S, 2015, HEALTH EXPECT, V18, P2776, DOI 10.1111/hex.12252; Dwinger S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-337; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hawkins M, 2013, HLTH LITERACY QUESTI; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Joreskog Karl G., 1996, PRELIS; Klokker L, 2015, QUAL LIFE RES, V24, P2423, DOI 10.1007/s11136-015-0976-9; Little R. J. A., 2002, STAT ANAL MISSING DA; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Schuler M, 2013, QUAL LIFE RES, V22, P1391, DOI 10.1007/s11136-012-0268-6; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Sorensen K, 2015, EUR J PUBLIC HLTH; Sorensen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-948; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Trochim William M K, 2004, Health Promot Pract, V5, P8, DOI 10.1177/1524839903258020; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; van de Schoot R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00770	32	52	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172340	10.1371/journal.pone.0172340	http://dx.doi.org/10.1371/journal.pone.0172340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL5VB	28234987	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200070
J	Tak, H; Negi, S; Ganapathi, TR				Tak, Himanshu; Negi, Sanjana; Ganapathi, T. R.			Overexpression of MusaMYB31, a R2R3 type MYB transcription factor gene indicate its role as a negative regulator of lignin biosynthesis in banana	PLOS ONE			English	Article							EMBRYOGENIC-CELL SUSPENSIONS; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; PHENYLPROPANOID PATHWAY; TRANSGENIC TOBACCO; CHILLING INJURY; REPRESSION; FRUIT; LIGNIFICATION; FAMILY	Lignin and polyphenols are important cellular components biosynthesized through phenyl-propanoid pathway. Phenylpropanoid pathway in plants is regulated by some important transcription factors including R2R3 MYB transcription factors. In this study, we report the cloning and functional characterization of a banana R2R3-MYB transcription factor (MusaMYB31) by overexpression in transgenic banana plants and evaluated its potential role in regulating biosynthesis of lignin and polyphenols. Sequence analysis of MusaMYB31 indicated its clustering with members of subgroup 4 (Sg4) of R2R3MYB family which are well known for their role as repressors of lignin biosynthesis. Expression analysis indicated higher expression of MusaMYB31 in corm and root tissue, known for presence of highly lignified tissue than other organs of banana. Overexpression of MusaMYB31 in banana cultivar Rasthali was carried out and four transgenic lines were confirmed by GUS histochemical staining, PCR analysis and Southern blot. Histological and biochemical analysis suggested reduction of cell wall lignin in vascular elements of banana. Transgenic lines showed alteration in transcript levels of general phenylpropanoid pathway genes including lignin biosynthesis pathway genes. Reduction of total polyphenols content in transgenic lines was in line with the observation related to repression of general phenylpropanoid pathway genes. This study suggested the potential role of MusaMYB31 as repressor of lignin and polyphenols biosynthesis in banana.	[Tak, Himanshu; Negi, Sanjana; Ganapathi, T. R.] Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India; [Tak, Himanshu; Negi, Sanjana] Homi Bhabha Natl Inst, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.	trgana@barc.gov.in			Department of Atomic Energy, Govt. of India	Department of Atomic Energy, Govt. of India(Department of Atomic Energy (DAE))	Department of Atomic Energy, Govt. of India funded the study.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Cai Y, 2016, NAT COMMUN; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00577; Cavallini E, 2015, PLANT PHYSIOL, V167, P1448, DOI 10.1104/pp.114.256172; Colquhoun TA, 2011, J EXP BOT, V62, P1133, DOI 10.1093/jxb/erq342; Cote FX, 1996, PHYSIOL PLANTARUM, V97, P285, DOI 10.1034/j.1399-3054.1996.970211.x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kamdee C, 2014, POSTHARVEST BIOL TEC, V97, P68, DOI 10.1016/j.postharvbio.2014.06.004; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; Negi S, 2015, PROTOPLASMA; Negi S, 2015, TRANSGENIC RES, V24, P571, DOI 10.1007/s11248-014-9860-6; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; Omer S, 2013, PLANT CELL REP, V32, P161, DOI 10.1007/s00299-012-1350-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shi Ming-Zhu, 2014, Recent Pat Biotechnol, V8, P47, DOI 10.2174/1872208307666131218123538; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamagnone L, 1998, PLANT CELL, V10, P135, DOI 10.1105/tpc.10.2.135; Torney F, 2007, CURR OPIN BIOTECH, V18, P193, DOI 10.1016/j.copbio.2007.03.006; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Wang WQ, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0154399, 10.1371/journal.pone.0164947]; Xu Q, 2014, J EXP BOT, V65, P4349, DOI 10.1093/jxb/eru208; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351; Zhang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01360; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	39	22	25	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172695	10.1371/journal.pone.0172695	http://dx.doi.org/10.1371/journal.pone.0172695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234982	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200118
J	Liberton, M; Chrisler, WB; Nicora, CD; Moore, RJ; Smith, RD; Koppenaal, DW; Pakrasi, HB; Jacobs, JM				Liberton, Michelle; Chrisler, William B.; Nicora, Carrie D.; Moore, Ronald J.; Smith, Richard D.; Koppenaal, David W.; Pakrasi, Himadri B.; Jacobs, Jon M.			Phycobilisome truncation causes widespread proteome changes in Synechocystis sp PCC 6803	PLOS ONE			English	Article							MASS-SPECTROMETRY; PHOTOSYSTEM-I; ENERGY-DISSIPATION; NEUTRON-SCATTERING; ANTENNA SIZE; CYANOBACTERIA; MUTANTS; PRODUCTIVITY; CONSEQUENCES; PCC-6803	In cyanobacteria such as Synechocystis sp. PCC 6803, large antenna complexes called phycobilisomes (PBS) harvest light and transfer the energy to the photosynthetic reaction centers. Modification of the light harvesting machinery in cyanobacteria has widespread consequences, causing changes in cell morphology and physiology. In the current study, we investigated the effects of PBS truncation on the proteomes of three Synechocystis 6803 PBS antenna mutants. These range from the progressive truncation of phycocyanin rods in the CB and CK strains, to full removal of PBS in the PAL mutant. Comparative quantitative protein results revealed surprising changes in protein abundances in the mutant strains. Our results showed that PBS truncation in Synechocystis 6803 broadly impacted core cellular mechanisms beyond light harvesting and photosynthesis. Specifically, we observed dramatic alterations in membrane transport mechanisms, where the most severe PBS truncation in the PAL strain appeared to suppress the cellular utilization and regulation of bicarbonate and iron. These changes point to the role of PBS as a component critical to cell function, and demonstrate the continuing need to assess systems-wide protein based abundances to understand potential indirect phenotypic effects.	[Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Chrisler, William B.; Koppenaal, David W.] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA USA; [Nicora, Carrie D.; Moore, Ronald J.; Smith, Richard D.; Jacobs, Jon M.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99354 USA	Washington University (WUSTL); United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jacobs, JM (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99354 USA.	Jon.Jacobs@pnnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; U.S. Department of Energy [DE-AC05-76RLO 1830]; National Science Foundation [DGE-1143954]	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center - the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported as part of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. Work was performed in the Environmental Molecular Sciences Laboratory, a U. S. Department of Energy Office of Biological and Environmental Research national scientific user facility located at Pacific Northwest National Laboratory in Richland, Washington. Pacific Northwest National Laboratory is operated by Battelle for the U.S. Department of Energy under Contract No. DE-AC05-76RLO 1830. AYN has been partially supported by the National Science Foundation Graduate Research Fellowship Program (DGE-1143954).	Adir N, 2005, PHOTOSYNTHESIS RES; AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Baier A, 2014, J BIOL CHEM, V289, P11755, DOI 10.1074/jbc.M113.520601; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Bernat G, 2009, PHOTOSYNTH RES, V99, P205, DOI 10.1007/s11120-008-9398-7; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Grossman AR, 1993, MICROBIOLOGY MOL BIO; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kirst H, 2014, BBA-BIOENERGETICS, V1837, P1653, DOI 10.1016/j.bbabio.2014.07.009; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klotz A, 2016, CURR BIOL, V26, P2862, DOI 10.1016/j.cub.2016.08.054; Kwon JH, 2013, ALGAL RES, V2, P188, DOI 10.1016/j.algal.2013.04.008; Lea-Smith DJ, 2014, PLANT PHYSIOL, V165, P705, DOI 10.1104/pp.114.237206; Liberton M, 2013, PHOTOSYNTH RES, V118, P17, DOI 10.1007/s11120-013-9940-0; Liberton M, 2013, J BIOL CHEM, V288, P3632, DOI 10.1074/jbc.M112.416933; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; May AP, 1999, TRENDS BIOCHEM SCI, V24, P12, DOI 10.1016/S0968-0004(98)01310-3; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Nagarajan Aparna, 2014, Life-Basel, V4, P903, DOI 10.3390/life4040903; Nagy G, 2011, BIOCHEM J, V436, P225, DOI 10.1042/BJ20110180; Nguyen AY, 2017, PHOTOSYNTH RES; Olive J, 1997, BBA-BIOENERGETICS, V1319, P275, DOI 10.1016/S0005-2728(96)00168-5; Page LE, 2012, APPL ENVIRON MICROB, V78, P6349, DOI 10.1128/AEM.00499-12; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Stadnichuk IN, 2009, PHOTOSYNTH RES, V99, P227, DOI 10.1007/s11120-009-9402-x; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Trautner C, 2013, J BACTERIOL, V195, P5370, DOI 10.1128/JB.00615-13; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; Vermaas W. F., 2001, ENCY LIFE SCI, P1, DOI DOI 10.1002/9780470015902.A0021539; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105952	48	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173251	10.1371/journal.pone.0173251	http://dx.doi.org/10.1371/journal.pone.0173251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253354	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300095
J	Marshall, A; Celentano, A; Cirillo, N; McCullough, M; Porter, S				Marshall, Alison; Celentano, Antonio; Cirillo, Nicola; McCullough, Michael; Porter, Stephen			Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease	PLOS ONE			English	Article							CELL ALPHA CHEMOATTRACTANT; CD8(+) T-CELLS; IFN-GAMMA; CXC-CHEMOKINE; I-TAC; INTERFERON-GAMMA; LICHEN-PLANUS; ATTRACTANT CHEMOKINE; PERIODONTAL-DISEASE; INDUCED EXPRESSION	The IFN-gamma-inducible chemokines CXCL9, CXCL10, and CXCL11 play a key role in many inflammatory conditions, particularly those mediated by T cells. Therefore, the production of these chemokines in peripheral tissues could be instrumental in the pathophysiology of tissue-specific immunological diseases such as oral lichen planus (OLP). In the present study, we assessed the production of keratinocyte-derived CXCL9/10/11 under basal and inflammatory conditions and investigated whether these chemokines were involved in the pathogenesis of OLP. We used semi-quantitative PCR, ELISA, chemotaxis assays, and fluorescence-activated cell sorting (FACS) to assess the expression and functional role of CXCL9/10/11 in oral keratinocytes (three strains of normal human oral keratinocytes (NHOK), and the H357 oral cancer cell line) in the presence or absence of IFN-gamma. CXCL9/10/11 were also assessed in tissues from normal patients and those with oral lichen planus (OLP). The time course study in oral keratinocytes treated with IFN-gamma showed that expression of CXCL9/10/11 chemokines was significantly enhanced by IFN-gamma in a time-dependent manner. In particular, CXCL10, a prominent chemokine that was overexpressed by IFN-gamma-stimulated NHOK, was able to effectively recruit CD4 lymphocytes, mainly CD4+CD45RA- cells. Significantly higher levels of CXCL9/10/11 were found in tissues from patients with OLP compared to normal oral mucosa. Taken together, the results demonstrate that normal oral keratinocytes produce chemotactic molecules that mediate T cell recruitment. This study furthers understanding of chemokine production in oral keratinocytes and their role in the pathophysiology of oral mucosa, with particular relevance to OLP.	[Marshall, Alison; Porter, Stephen] UCL, UCL Eastman Dent Inst, London, England; [Celentano, Antonio] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Celentano, Antonio; Cirillo, Nicola; McCullough, Michael] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia; [Celentano, Antonio; Cirillo, Nicola; McCullough, Michael] Univ Melbourne, Oral Hlth CRC, Melbourne, Vic 3010, Australia	University of London; University College London; University of Naples Federico II; University of Melbourne; University of Melbourne	Celentano, A (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy.; Celentano, A (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.; Celentano, A (corresponding author), Univ Melbourne, Oral Hlth CRC, Melbourne, Vic 3010, Australia.	antony.celentano@gmail.com	Celentano, Antonio/AAZ-7647-2020	Celentano, Antonio/0000-0003-4293-2511; McCullough, Michael/0000-0001-7829-4684; Cirillo, NIcola/0000-0003-1429-1323; Porter, Stephen/0000-0002-3328-2759				Albanesi C, 2000, J IMMUNOL, V165, P1395, DOI 10.4049/jimmunol.165.3.1395; Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617; Altenburg A, 1999, J IMMUNOL, V162, P4140; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boorsma DM, 1998, ARCH DERMATOL RES, V290, P335, DOI 10.1007/s004030050314; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Danielsson K, 2013, J EUR ACAD DERMATOL, V27, P1410, DOI 10.1111/jdv.12027; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Fukui A, 2013, MICROBIOL IMMUNOL, V57, P198, DOI 10.1111/1348-0421.12022; Gasperini S, 1999, J IMMUNOL, V162, P4928; Gemmell E, 2001, CLIN EXP IMMUNOL, V125, P134, DOI 10.1046/j.1365-2249.2001.01511.x; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hiroi M, 2003, BIOCHEM J, V376, P393, DOI 10.1042/BJ20030842; Ichimura M, 2006, J ORAL PATHOL MED, V35, P167, DOI 10.1111/j.1600-0714.2006.00402.x; Kabashima H, 2002, CYTOKINE, V20, P70, DOI 10.1006/cyto.2002.1985; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Kearney S, 2013, IMMUNOL RES, V55, P187, DOI 10.1007/s12026-012-8362-y; Khan A, 2003, J ORAL PATHOL MED, V32, P77, DOI 10.1034/j.1600-0714.2003.00077.x; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Miura M, 2001, J IMMUNOL, V167, P3494, DOI 10.4049/jimmunol.167.6.3494; Ohta K, 2008, J DENT RES, V87, P1160, DOI 10.1177/154405910808701211; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rabin RL, 1999, J IMMUNOL, V162, P3840; Redondo P, 1998, EXP DERMATOL, V7, P175, DOI 10.1111/j.1600-0625.1998.tb00320.x; Romagnani P, 2002, AM J PATHOL, V161, P195, DOI 10.1016/S0002-9440(10)64171-5; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sauty A, 1999, J IMMUNOL, V162, P3549; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501; Sebastiani S, 2002, J INVEST DERMATOL, V118, P1052, DOI 10.1046/j.1523-1747.2002.01771.x; Spandau U, 1998, J INVEST DERMATOL, V111, P1003, DOI 10.1046/j.1523-1747.1998.00426.x; Taubman MA, 2001, CRIT REV ORAL BIOL M, V12, P125, DOI 10.1177/10454411010120020301; Tensen CP, 1999, J INVEST DERMATOL, V112, P716, DOI 10.1046/j.1523-1747.1999.00581.x; Thornhill MH, 2001, ACTA ODONTOL SCAND, V59, P174, DOI 10.1080/000163501750266774; Tokuriki A, 2002, J DERMATOL SCI, V28, P234, DOI 10.1016/S0923-1811(01)00172-4; Tornwall J, 1999, LAB INVEST, V79, P1719; Van den Brule FA, 2000, CELL ADHES COMMUN, V7, P321; Van Raemdonck K, 2014, CYTOKINE GROWTH FACT, V22; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96; Wenzel J, 2006, J CUTAN PATHOL, V33, P672, DOI 10.1111/j.1600-0560.2006.00527.x; Wu CL, 2009, J ETHNOPHARMACOL, V122, P48, DOI 10.1016/j.jep.2008.11.024; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	57	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0172821	10.1371/journal.pone.0172821	http://dx.doi.org/10.1371/journal.pone.0172821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253295	Green Published, gold, Green Submitted			2022-12-27	WOS:000396011300039
J	Martin, B; Tamanai-Shacoori, Z; Bronsard, J; Ginguene, F; Meuric, V; Mahe, F; Bonnaure-Mallet, M				Martin, Benedicte; Tamanai-Shacoori, Zohreh; Bronsard, Julie; Ginguene, Franck; Meuric, Vincent; Mahe, Fabrice; Bonnaure-Mallet, Martine			A new mathematical model of bacterial interactions in two-species oral biofilms	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-GORDONII; CARBOHYDRATE-METABOLISM; PROTEOMICS; VIRULENCE; PROFILES; DISTINCT; DISEASE	Periodontitis are bacterial inflammatory diseases, where the bacterial biofilms present on the tooth-supporting tissues switch from a healthy state towards a pathogenic state. Among bacterial species involved in the disease, Porphyromonas gingivalis has been shown to induce dysbiosis, and to induce virulence of otherwise healthy bacteria like Streptococcus gordonii. During biofilm development, primary colonizers such as S. gordonii first attach to the surface and allow the subsequent adhesion of periodontal pathogens such as P. gingivalis. Interactions between those two bacteria have been extensively studied during the adhesion step of the biofilm. The aim of the study was to understand interactions of both species during the growing phase of the biofilm, for which little knowledge is available, using a mathematical model. This two-species biofilm model was based on a substrate-dependent growth, implemented with damage parameters, and validated thanks to data obtained on experimental biofilms. Three different hypothesis of interactions were proposed and assayed using this model: independence, competition between both bacteria species, or induction of toxicity by one species for the other species. Adequacy between experimental and simulated biofilms were found with the last hypothetic mathematical model. This new mathematical model of two species bacteria biofilms, dependent on different substrates for growing, can be applied to any bacteria species, environmental conditions, or steps of biofilm development. It will be of great interest for exploring bacterial interactions in biofilm conditions.	[Martin, Benedicte; Tamanai-Shacoori, Zohreh; Bronsard, Julie; Meuric, Vincent; Bonnaure-Mallet, Martine] Univ Europeenne Bretagne, Univ Rennes 1, EA Microbiol Risques Infect 1254, Rennes, France; [Ginguene, Franck; Mahe, Fabrice] Univ Europeenne Bretagne, Univ Rennes 1, CNRS, Inst Rech Math Rennes, Rennes, France; [Meuric, Vincent; Bonnaure-Mallet, Martine] Ctr Hosp Univ, Rennes, France	Universite de Bretagne Occidentale; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; Universite de Rennes; CHU Rennes	Martin, B (corresponding author), Univ Europeenne Bretagne, Univ Rennes 1, EA Microbiol Risques Infect 1254, Rennes, France.	benedicte.martin@univ-rennes1.fr	Bronsard, Julie/AAL-7406-2020; Meuric, Vincent/AAW-7709-2020; Bronsard, Julie/AAL-7399-2020	Bronsard, Julie/0000-0002-4714-0241; Meuric, Vincent/0000-0001-5411-4001; MARTIN, Benedicte/0000-0003-0897-5884; Bonnaure-Mallet, martine/0000-0001-5214-7803; TAMANAI-SHACOORI, Zohreh/0000-0003-2287-3438	Conseil Regional de Bretagne, France [F3/48 CPER]; Fondation "Sourire Quand Meme," France; Biosit, France (AAP); Fondation "Sourire Quand Meme"; Research Federative Structure Biosit (Rennes)	Conseil Regional de Bretagne, France(Region Bretagne); Fondation "Sourire Quand Meme," France; Biosit, France (AAP); Fondation "Sourire Quand Meme"; Research Federative Structure Biosit (Rennes)	This work was supported by the Conseil Regional de Bretagne, France (F3/48 CPER): MBM; the Fondation "Sourire Quand Meme," France (www.gueules-cassees.asso.fr): MBM BM; and Biosit, France (AAP2015) (www.biosit.univ-rennes1.fr): BM FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Conseil Regional de Bretagne, France (F3/48 CPER), the Fondation "Sourire Quand Meme" and the Research Federative Structure Biosit (Rennes). We also thank all people of the Microscopy Rennes Imaging Center (Biosit) for technical assistance for microscopy experiments.	Barnard JP, 1999, INFECT IMMUN, V67, P6558; Cao B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153616; Chawla A, 2010, MOL MICROBIOL, V78, P1510, DOI 10.1111/j.1365-2958.2010.07420.x; Cook GS, 1998, J PERIODONTAL RES, V33, P323, DOI 10.1111/j.1600-0765.1998.tb02206.x; Cugini C, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.19804; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Fagerlind MG, 2012, J THEOR BIOL, V295, P23, DOI 10.1016/j.jtbi.2011.10.007; Flemming HC, 2010, THE BIOFILM MATRIX; Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11; Grenier D, 1996, MICROBIOL-UK, V142, P955, DOI 10.1099/00221287-142-4-955; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Ilie O, 2012, J THEOR BIOL, V309, P159, DOI 10.1016/j.jtbi.2012.05.024; Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-98; MARSH PD, 1985, J GEN MICROBIOL, V131, P2505; Masuda K, 2001, ANAEROBE, V7, P209, DOI 10.1006/anae.2001.0383; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Meuric V, 2013, MOL ORAL MICROBIOL, V28, P40, DOI 10.1111/omi.12004; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Picioreanu C, 1999, THESIS; Pollanen MT, 2013, INT J MOL SCI, V14, P17221, DOI 10.3390/ijms140817221; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; SHAH HN, 1993, CLIN INFECT DIS, V16, pS404, DOI 10.1093/clinids/16.Supplement_4.S404; SHAH HN, 1993, FEMS IMMUNOL MED MIC, V6, P165; Shao HJ, 2010, PERIODONTOL 2000, V52, P53, DOI 10.1111/j.1600-0757.2009.00318.x; Shen Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27537; Simionato MR, 2006, INFECT IMMUN, V74, P6419, DOI 10.1128/IAI.00639-06; SLOTS J, 1978, INFECT IMMUN, V19, P254, DOI 10.1128/IAI.19.1.254-264.1978; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; Wright CJ, 2014, MICROBIOLOGYOPEN, V3, P383, DOI 10.1002/mbo3.177; Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3; Zhang ZS, 2011, ANTIMICROB AGENTS CH, V55, P1075, DOI 10.1128/AAC.01329-10	44	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							E0173153	10.1371/journal.pone.0173153	http://dx.doi.org/10.1371/journal.pone.0173153			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253369	Green Submitted, Green Published, gold			2022-12-27	WOS:000396011300082
J	Watanabe, S; Ogasawara, T; Tamura, Y; Saito, T; Ikeda, T; Suzuki, N; Shimosawa, T; Shibata, S; Chung, UI; Nangaku, M; Uchida, S				Watanabe, Sumiyo; Ogasawara, Toru; Tamura, Yoshifuru; Saito, Taku; Ikeda, Toshiyuki; Suzuki, Nobuchika; Shimosawa, Tatsuo; Shibata, Shigeru; Chung, Ung-il; Nangaku, Masaomi; Uchida, Shunya			Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; COTRANSPORTER; DISEASE; RAT; PERSPECTIVES; TRAFFICKING; GLOMERULI; MUTATION; VECTORS; THERAPY	Although techniques for cell-specific gene expression via viral transfer have advanced, many challenges (e.g., viral vector design, transduction of genes into specific target cells) still remain. We investigated a novel, simple methodology for using adenovirus transfer to target specific cells of the kidney tubules for the expression of exogenous proteins. We selected genes encoding sodium-dependent phosphate transporter type 2a (NPT2a) in the proximal tubule, sodium-potassium-2-chloride cotransporter (NKCC2) in the thick ascending limb of Henle (TALH), and aquaporin 2 (AQP2) in the collecting duct. The promoters of the three genes were linked to a GFP-coding fragment, the final constructs were then incorporated into an adenovirus vector, and this was then used to generate gene-manipulated viruses. After flushing circulating blood, viruses were directly injected into the renal arteries of rats and were allowed to site-specifically expression in tubule cells, and rats were then euthanized to obtain kidney tissues for immunohistochemistry. Double staining with adenovirus-derived EGFP and endogenous proteins were examined to verify orthotopic expression, i.e. "adenovirus driven NPT2a-EGFP and endogenous NHE3 protein", "adenovirus driven NKCC2-EGFP and endogenous NKCC2 protein" and "\adenovirus driven AQP2-EGFP and endogenous AQP2 protein". Owing to a lack of finding good working anti-NPT2a antibody, an antibody against a different protein (sodium-hydrogen exchanger 3 or NHE3) that is also specifically expressed in the proximal tubule was used. Kidney structures were well-preserved, and other organ tissues did not show EGFP staining. Our gene transfer method is easier than using genetically engineered animals, and it confers the advantage of allowing the manipulation of gene transfer after birth. This is the first method to successfully target gene expression to specific cells in the kidney tubules. This study may serve as the first step for safe and effective gene therapy in the kidney tubule diseases.	[Watanabe, Sumiyo; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiyo; Shimosawa, Tatsuo; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiyo; Tamura, Yoshifuru; Shibata, Shigeru; Uchida, Shunya] Teikyo Univ, Dept Internal Med, Sch Med, Itabashi Ku, Tokyo, Japan; [Ogasawara, Toru] Univ Tokyo, Dept Oral & Maxillofacial Surg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Saito, Taku] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Tokyo, Japan; [Ikeda, Toshiyuki] Univ Tokyo, Dept Blood Transfus, Fac Med, Tokyo, Japan; [Suzuki, Nobuchika] Nippon Med Sch, Dept Bioregulat, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Teikyo University; University of Tokyo; University of Tokyo; University of Tokyo; Nippon Medical School	Watanabe, S (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo, Japan.; Watanabe, S (corresponding author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan.; Watanabe, S (corresponding author), Teikyo Univ, Dept Internal Med, Sch Med, Itabashi Ku, Tokyo, Japan.	swatanabe@bmw.t.u-tokyo.ac.jp	Ogasawara, Toru/I-1629-2014; Ikeda, Toshiyuki/GVS-5588-2022	Ogasawara, Toru/0000-0002-2996-081X; Shibata, Shigeru/0000-0002-6868-0626	Ministry of Education, Culture, Sports, Science and Technology of Japan [19590936, 22890196]; Japan Society for the Promotion of Science (JSPS KAKENHI) [25670846]; Grants-in-Aid for Scientific Research [15H05788] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant-in-aid scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19590936, 22890196) and by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 25670846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armando I, 2015, TRANSL RES, V165, P505, DOI 10.1016/j.trsl.2014.07.006; Capasso C, 2014, VIRUSES-BASEL, V6, P832, DOI 10.3390/v6020832; Chikatsu N, 2003, ENDOCR J, V50, P91, DOI 10.1507/endocrj.50.91; Choi YK, 2003, GENE THER, V10, P559, DOI 10.1038/sj.gt.3301926; Curran J, 2015, ANNU REV PHYSIOL, V77, P505, DOI 10.1146/annurev-physiol-021014-071838; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Edvardsson VO, 2013, PEDIATR NEPHROL, V28, P1923, DOI 10.1007/s00467-012-2329-z; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heikkila P, 1996, GENE THER, V3, P21; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Isaka Yoshitaka, 2006, Clin Exp Nephrol, V10, P229, DOI 10.1007/s10157-006-0442-7; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Yao XL, 2011, CURR CANCER DRUG TAR, V11, P810, DOI 10.2174/156800911796798896; Zhu GM, 1997, KIDNEY INT, V52, P992, DOI 10.1038/ki.1997.421	24	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0168638	10.1371/journal.pone.0168638	http://dx.doi.org/10.1371/journal.pone.0168638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253301	gold, Green Published, Green Submitted			2022-12-27	WOS:000396011300001
J	Yang, B; Huang, ZC; Feng, WH; Wei, W; Zhang, JL; Liao, Y; Li, LH; Liu, XL; Wu, ZQ; Cai, B; Bai, YJ; Wang, LL				Yang, Bin; Huang, Zhuochun; Feng, Weihua; Wei, Wei; Zhang, Junlong; Liao, Yun; Li, Linhui; Liu, Xinle; Wu, Zhiqiang; Cai, Bei; Bai, Yangjuan; Wang, Lanlan			The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis (vol 11, e0155345, 2016)	PLOS ONE			English	Correction																		Yang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155345	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2017	12	3							e0173531	10.1371/journal.pone.0173531	http://dx.doi.org/10.1371/journal.pone.0173531			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4XX	28253339	Green Published, Green Submitted, gold			2022-12-27	WOS:000396011300106
J	Malhotra, R; Kurian, N; Zhou, XH; Jiang, FY; Monkley, S; DeMicco, A; Clausen, IG; Delgren, G; Edenro, G; Ahdesmaki, MJ; Clausen, M; Oberg, L; Israelsson, E; Belfield, G; Vaarala, O				Malhotra, Rajneesh; Kurian, Nisha; Zhou, Xiao-Hong; Jiang, Fanyi; Monkley, Susan; DeMicco, Amy; Clausen, Ib G.; Delgren, Goran; Edenro, Goran; Ahdesmaki, Miika J.; Clausen, Maryam; Oberg, Lisa; Israelsson, Elisabeth; Belfield, Graham; Vaarala, Outi			Altered regulation and expression of genes by BET family of proteins in COPD patients	PLOS ONE			English	Article							BROMODOMAIN INHIBITION; CIGARETTE-SMOKE; LIPOPOLYSACCHARIDE; REVEALS	Background BET proteins (BRD2, BRD3, BRDT and BRD4) belong to the family of bromodomain containing proteins, which form a class of transcriptional co-regulators. BET proteins bind to acetylated lysine residues in the histones of nucleosomal chromatin and function either as co-activators or co-repressors of gene expression. An imbalance between HAT and HDAC activities resulting in hyperacetylation of histones has been identified in COPD. We hypothesized that pan-BET inhibitor (JQ1) treatment of BET protein interactions with hyperacety-lated sites in the chromatin will regulate excessive activation of pro-inflammatory genes in key inflammatory drivers of alveolar macrophages (AM) in COPD. Methods and findings Transcriptome analysis of AM from COPD patients indicated up-regulation of macrophage M1 type genes upon LPS stimulation. Pan-BET inhibitor JQ1 treatment attenuated expression of multiple genes, including pro-inflammatory cytokines and regulators of innate and adaptive immune cells. We demonstrated for the first time that JQ1 differentially modulated LPS-induced cytokine release from AM or peripheral blood mononuclear cells (PBMC) of COPD patients compared to PBMC of healthy controls. Using the BET regulated gene signature, we identified a subset of COPD patients, which we propose to benefit from BET inhibition. Conclusions This work demonstrates that the effects of pan-BET inhibition through JQ1 treatment of inflammatory cells differs between COPD patients and healthy controls, and the expression of BET protein regulated genes is altered in COPD. These findings provide evidence of histone hyperacetylation as a mechanism driving chronic inflammatory changes in COPD.	[Malhotra, Rajneesh; Kurian, Nisha; Zhou, Xiao-Hong; Jiang, Fanyi; Monkley, Susan; DeMicco, Amy; Clausen, Ib G.; Edenro, Goran; Oberg, Lisa; Israelsson, Elisabeth; Belfield, Graham; Vaarala, Outi] AstraZeneca, Resp Inflammat & Autoimmun iMed, Pepparedsleden 1, Molndal, Sweden; [Delgren, Goran] Sahlgrens Univ Hosp, Transplantat Ctr, Thoraxtransplantat, Gothenburg, Sweden; [Ahdesmaki, Miika J.] AstraZeneca, Oncol iMed, Cambridge CB2 0RE, England; [Clausen, Maryam] AstraZeneca, Discovery Sci, Pepparedsleden 1, Molndal, Sweden; [Vaarala, Outi] Univ Helsinki, Clinicum, Helsinki, Finland	AstraZeneca; Sahlgrenska University Hospital; AstraZeneca; AstraZeneca; University of Helsinki	Malhotra, R (corresponding author), AstraZeneca, Resp Inflammat & Autoimmun iMed, Pepparedsleden 1, Molndal, Sweden.	rajneesh.malhotra@astrazeneca.com	Kurian, Nisha/AAE-9279-2020	Kurian, Nisha/0000-0002-8384-9928; Monkley, Susan/0000-0001-9174-6278; Ahdesmaki, Miika/0000-0002-9091-7773	AstraZeneca	AstraZeneca(AstraZeneca)	All of the authors with the exception of Goran Delgren are employed by the commercial company "AstraZeneca", and AstraZeneca provided support in the form of salaries for AZ authors, funding for the project and materials. The study design, data collection and analysis, decision to publish, and preparation of the manuscript was performed by AZ employees. The one author not employed by AstraZeneca, i.e., Goran Delgren, received no specific funding for this work. There are no patents, products in development or marketed products to declare The specific roles of these authors are articulated in the 'author contributions' section.	Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; Arthur D, K MEANS ADVANTAGES C; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Chan CH, 2015, EUR J IMMUNOL, V45, P287, DOI 10.1002/eji.201444862; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deeney JT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151329, DOI 10.1371/J0URNAL.P0NE.0151329]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Ghurye RR, 2015, CYTOKINE, V71, P415, DOI 10.1016/j.cyto.2014.11.013; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malhotra R, 2015, EXPERT REV RESP MED, V9, P153, DOI 10.1586/17476348.2015.1000865; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Reynier F, 2012, MOL MED, V18, P1303, DOI 10.2119/molmed.2012.00230; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0173115	10.1371/journal.pone.0173115	http://dx.doi.org/10.1371/journal.pone.0173115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248992	Green Published, gold, Green Submitted			2022-12-27	WOS:000395983500078
J	Sun, S; Wu, Y; Lin, XY; Wang, J; Yu, JM; Sun, Y; Miao, YL; Li, QP; Sanguinet, KA; Liu, B				Sun, Shuai; Wu, Ying; Lin, Xiuyun; Wang, Jie; Yu, Jiamiao; Sun, Yue; Miao, Yiling; Li, Qiuping; Sanguinet, Karen A.; Liu, Bao			Hybrid weakness in a rice interspecific hybrid is nitrogen-dependent, and accompanied by changes in gene expression at both total transcript level and parental allele partitioning	PLOS ONE			English	Article							PHOTOSYNTHETIC EFFICIENCY; EVOLUTION; VIGOR; WHEAT; HETEROSIS; REDUCTASE; MUTANTS; SYSTEMS	Background Hybrid weakness, a phenomenon opposite to heterosis, refers to inferior growth and development in a hybrid relative to its pure-line parents. Little attention has been paid to the phenomenological or mechanistic aspect of hybrid weakness, probably due to its rare occurrence. Methodology/Principal findings Here, using a set of interspecific triploid F1 hybrids between Oryza sativa, ssp. japonica (genome AA) and a tetraploid wild rice species, O. alta (genome, CCDD), we investigated the phenotypic and physiological differences between the F1 hybrids and their parents under normal and nitrogen-limiting conditions. We quantified the expression levels of 21 key genes involved in three important pathways pertinent to the assayed phenotypic and physiological traits by real-time qRT-PCR. Further, we assayed expression partitioning of parental alleles for eight genes in the F1 hybrids relative to the in silico "hybrids" (parental cDNA mixture) under both normal and N-limiting conditions by using locus-specific cDNA pyrosequencing. Conclusions/Significance We report that the F1 hybrids showed weakness in several phenotypic traits at the final seedling-stage compared with their corresponding mid-parent values (MPVs). Nine of the 21 studied genes showed contrasted expression levels between hybrids and parents (MPVs) under normal vs. N-limiting conditions. Interestingly, under N-limiting conditions, the overtly enhanced partitioning of maternal allele expression in the hybrids for eight assayed genes echo their attenuated hybrid weakness in phenotypes, an observation further bolstered by more resemblance of hybrids to the maternal parent under N-limiting conditions compared to normal conditions in a suite of measured physiological traits. Our observations suggest that both overall expression level and differential partitioning of parental alleles of critical genes contribute to condition-specific hybrid weakness.	[Sun, Shuai; Wu, Ying; Wang, Jie; Yu, Jiamiao; Sun, Yue; Miao, Yiling; Li, Qiuping; Liu, Bao] Northeast Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wu, Ying; Sun, Yue; Sanguinet, Karen A.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China	Northeast Normal University - China; Washington State University; Jilin Academy of Agricultural Sciences	Liu, B (corresponding author), Northeast Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China.; Sanguinet, KA (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	karen.sanguinet@wsu.edu; baoliu@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	State Key Basic Research and Development Plan of China [2013CBA01404]; Graduate Student Innovation Fund of NENU [12SSXT130]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Graduate Student Innovation Fund of NENU	This work was supported by the State Key Basic Research and Development Plan of China (2013CBA01404) and the Graduate Student Innovation Fund of NENU (12SSXT130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 1980, HYBRID CROP PLANTS; Boegh E, 2002, REMOTE SENS ENVIRON, V81, P179, DOI 10.1016/S0034-4257(01)00342-X; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Covelo F, 2008, PLANT SOIL, V311, P109, DOI 10.1007/s11104-008-9662-9; FONSECA S, 1968, CROP SCI, V8, P85, DOI 10.2135/cropsci1968.0011183X000800010025x; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Grant V., 1978, GENETICS FLOWERING P; Guo RX, 2006, THEOR APPL GENET, V112, P1271, DOI 10.1007/s00122-006-0228-z; HIREL B, 1980, PLANT PHYSIOL, V66, P619, DOI 10.1104/pp.66.4.619; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jones W., 1926, J AM SOC AGRON, V18, P423, DOI [10.2134/agronj1926.00021962001800050010x, DOI 10.2134/AGRONJ1926.00021962001800050010X]; Kohler C, 2010, TRENDS GENET, V26, P142, DOI 10.1016/j.tig.2009.12.006; Kondo M, 2003, PLANT SOIL, V255, P189, DOI 10.1023/A:1026142904714; Ladha JK, 2003, PLANT SOIL, V252, P151, DOI 10.1023/A:1024175307238; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariam AL, 1996, THEOR APPL GENET, V93, P664, DOI 10.1007/BF00224060; Mochida K, 2004, MOL GENET GENOMICS, V270, P371, DOI 10.1007/s00438-003-0939-7; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; NAKAYASHIKI T, 1995, MOL GEN GENET, V249, P139, DOI 10.1007/BF00290359; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; PONTOPPIDAN B, 1994, EUR J BIOCHEM, V225, P529, DOI 10.1111/j.1432-1033.1994.00529.x; Programme UNE, 2013, GLOB ENV OUTL 2000; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Quinet M., 2010, J EXP BOT; ROMAGNOLI S, 1990, THEOR APPL GENET, V80, P769, DOI 10.1007/BF00224190; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Shi WM, 2010, PLANT SOIL, V326, P291, DOI 10.1007/s11104-009-0007-0; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Sprague G. F., 1983, Heterosis. Reappraisal of theory and practice, P47; Tabuchi M, 2005, PLANT J, V42, P641, DOI 10.1111/j.1365-313X.2005.02406.x; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Wang XT, 2016, NEW PHYTOL, V209, P1264, DOI 10.1111/nph.13678; Wu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132911; Xu CM, 2014, MOL BIOL EVOL, V31, P1066, DOI 10.1093/molbev/msu085; Yang CW, 2014, P NATL ACAD SCI USA, V111, P11882, DOI 10.1073/pnas.1412839111; Yao H, 2013, P NATL ACAD SCI USA, V110, P2665, DOI 10.1073/pnas.1221966110; Yoshida S, 1971, LABORATORY MANUAL FO; Zang A, 2009, J EXPT BOT; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhang L, 2008, PLANT SOIL, V303, P55, DOI 10.1007/s11104-007-9442-y; Zhu G, 1993, LAB MANUAL PLANT PHY	50	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2017	12	3							e0172919	10.1371/journal.pone.0172919	http://dx.doi.org/10.1371/journal.pone.0172919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4NF	28248994	gold, Green Published, Green Submitted			2022-12-27	WOS:000395983500063
J	Sangare, SA; Rondinaud, E; Maataoui, N; Maiga, AI; Guindo, I; Maiga, A; Camara, N; Dicko, OA; Dao, S; Diallo, S; Bougoudogo, F; Andremont, A; Maiga, II; Armand-Lefevre, L				Sangare, Samba Adama; Rondinaud, Emilie; Maataoui, Naouale; Maiga, Almoustapha Issiaka; Guindo, Ibrehima; Maiga, Aminata; Camara, Namory; Dicko, Oumar Agaly; Dao, Sounkalo; Diallo, Souleymane; Bougoudogo, Flabou; Andremont, Antoine; Maiga, Ibrahim Izetiegouma; Armand-Lefevre, Laurence			Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali	PLOS ONE			English	Article							ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; CARBAPENEMASE; SPREAD; GENES; INFECTIONS; AFRICA	The worldwide dissemination of extended-spectrum beta-lactamase producing Enterobacteriaceae, (ESBL-E) and their subset producing carbapenemases (CPE), is alarming. Limited data on the prevalence of such strains in infections from patients from Sub-Saharan Africa are currently available. We determined, here, the prevalence of ESBL-E/CPE in bacteriemic patients in two teaching hospitals from Bamako (Mali), which are at the top of the health care pyramid in the country. During one year, all Enterobacteriaceae isolated from bloodstream infections (E-BSI), were collected from patients hospitalized at the Point G University Teaching Hospital and the pediatric units of Gabriel Toure A University Teaching Hospital. Antibiotic susceptibility testing, enzyme characterization and strain relatedness were determined. A total of 77 patients had an E-BSI and as many as 48 (62.3%) were infected with an ESBL-E. ESBL-E BSI were associated with a previous hospitalization (OR 3.97 95% IC [1.32; 13.21]) and were more frequent in hospital-acquired episodes (OR 3.66 95% IC [1.07; 13.38]). Among the 82 isolated Enterobacteriaceae, 58.5% were ESBL-E (20/31 Escherichia coli, 20/26 Klebsiella pneumoniae and 8/15 Enterobacter cloacae). The remaining (5 Salmonella Enteritidis, 3 Morganella morganii 1 Proteus mirabilis and 1 Leclercia adecarboxylata) were ESBL negative. CTX-M-1 group enzymes were highly prevalent (89.6%) among ESBLs; the remaining ones being SHV. One E. coli produced an OXA-181 carbapenemase, which is the first CPE described in Mali. The analysis of ESBL-E relatedness suggested a high rate of cross transmission between patients. In conclusion, even if CPE are still rare for the moment, the high rate of ESBL-BSI and frequent cross transmission probably impose a high medical and economic burden to Malian hospitals.	[Sangare, Samba Adama; Maiga, Almoustapha Issiaka] Ctr Hosp Univ Gabriel Toure, Bacteriol Lab, Bamako, Mali; [Sangare, Samba Adama; Rondinaud, Emilie; Maataoui, Naouale; Andremont, Antoine; Armand-Lefevre, Laurence] Ctr Hosp Univ Bichat Claude Bernard, Bacteriol Lab, Paris, France; [Sangare, Samba Adama; Maiga, Almoustapha Issiaka; Guindo, Ibrehima; Diallo, Souleymane; Bougoudogo, Flabou] Univ Sci Tech & Technol Bamako, Fac Pharm, Bamako, Mali; [Rondinaud, Emilie; Maataoui, Naouale; Andremont, Antoine; Armand-Lefevre, Laurence] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France; [Guindo, Ibrehima; Bougoudogo, Flabou] INSERM, Bamako, Mali; [Maiga, Aminata; Dicko, Oumar Agaly; Maiga, Ibrahim Izetiegouma] Ctr Hosp Univ Point G, Bacteriol Lab, Bamako, Mali; [Dao, Sounkalo; Maiga, Ibrahim Izetiegouma] Univ Sci Tech & Technol Bamako, Fac Med & Odonto Stomatol, Bamako, Mali; [Diallo, Souleymane] Ctr Infectiol Charles Merieux, Bamako, Mali	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; University of Science & Technology of Bamako; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Science & Technology of Bamako	Armand-Lefevre, L (corresponding author), Ctr Hosp Univ Bichat Claude Bernard, Bacteriol Lab, Paris, France.; Armand-Lefevre, L (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France.	laurence.armand@aphp.fr	ARMAND-LEFEVRE, Laurence/A-4751-2018; Guindo, Ibrehima/AAA-4873-2021	ARMAND-LEFEVRE, Laurence/0000-0002-2013-3252; Guindo, Ibrehima/0000-0003-3130-4763	USTTB; University of Sciences, Techniques, and Technologies of Bamako (USTTB) of Mali	USTTB; University of Sciences, Techniques, and Technologies of Bamako (USTTB) of Mali	USTTB provided financial assistance under the "Training Program of Trainers" (Dr Sangare).; We would like to thank the two hospitals that participated in our study. We acknowledge the University of Sciences, Techniques, and Technologies of Bamako (USTTB) of Mali for financial assistance under the "Training Program of Trainers".	Agyekum A, 2016, DIAGN MICR INFEC DIS, V84, P328, DOI 10.1016/j.diagmicrobio.2015.12.010; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Beyrouthy R, 2013, J ANTIMICROB CHEMOTH, V68, P1558, DOI 10.1093/jac/dkt051; Coque T M, 2008, Euro Surveill, V13; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Dropa M, 2015, J INFECT DEV COUNTR, V9, P890, DOI 10.3855/jidc.6241; Duval V, 2009, ANTIMICROB AGENTS CH, V53, P4957, DOI 10.1128/AAC.00675-09; Flokas ME, 2016, J INFECT; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hendrik TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140754; Hogberg LD, 2014, LANCET INFECT DIS, V14, P1179, DOI 10.1016/S1473-3099(14)70987-9; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V70, P23, DOI 10.1093/jac/dku356; Mendonca N, 2006, DIAGN MICR INFEC DIS, V56, P415, DOI 10.1016/j.diagmicrobio.2006.06.023; Ndir A, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0114-7; Ndir A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143729; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Ouedraogo AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1655-3; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Raji MA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1005-x; Rezai MS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/309478; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Stewardson AJ, 2016, EURO SURVEILL, V21; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Wang Q, 2016, EUR J CLIN MICROBIOL, V35, P1679, DOI 10.1007/s10096-016-2710-0; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Bank, 2016, TECH REPT	30	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0172652	10.1371/journal.pone.0172652	http://dx.doi.org/10.1371/journal.pone.0172652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245252	Green Submitted, gold, Green Published			2022-12-27	WOS:000395980200026
J	Uehara, T; Watanabe, M; Suzuki, H; Furusawa, Y; Arano, Y				Uehara, Tomoya; Watanabe, Mariko; Suzuki, Hiroyuki; Furusawa, Yoshiya; Arano, Yasushi			Amino acid transport system - A substrate predicts the therapeutic effects of particle radiotherapy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CARBON ION RADIOTHERAPY; IN-VIVO; CLINICAL-APPLICATIONS; C-11-METHIONINE PET; PROTEIN-SYNTHESIS; METHIONINE-PET; IMAGING AGENTS; TUMOR-TISSUE; CELL-LINES	L-[methyl-C-11]Methionine (C-11-Met) is useful for estimating the therapeutic efficacy of particle radiotherapy at early stages of the treatment. Given the short half-life of C-11, the development of longer-lived F-18- and I-123-labeled probes that afford diagnostic information similar to C-11-Met, are being sought. Tumor uptake of C-11-Met is involved in many cellular functions such as amino acid transport System-L, protein synthesis, and transmethylation. Among these processes, since the energy-dependent intracellular functions involved with C-11-Met are more reflective of the radiotherapeutic effects, we evaluated the activity of the amino acid transport System-A as an another energy-dependent cellular function in order to estimate radiotherapeutic effects. In this study, using a carbon-ion beam as the radiation source, the activity of System-A was evaluated by a specific System-A substrate, alpha-[1-C-14]-methyl-aminoisobutyric acid (C-14-MeAIB). Cellular growth and the accumulation of C-14-MeAIB or C-14-Met were evaluated over time in vitro in cultured human salivary gland (HSG) tumor cells (3-Gy) or in vivo in murine xenografts of HSG tumors (6- or 25-Gy) before and after irradiation with the carbon-ion beam. Post 3-Gy irradiation, in vitro accumulation of C-14-Met and C-14-MeAIB decreased over a 5-day period. In xenografts of HSG tumors in mice, tumor re-growth was observed in vivo on day-10 after a 6-Gy irradiation dose, but no re-growth was detected after the 25-Gy irradiation dose. Consistent with the growth results, the in vivo tumor accumulation of C-14-MeAIB did not decrease after the 6-Gy irradiation dose, whereas a significant decrease was observed after the 25-Gy irradiation dose. These results indicate that the activity of energy dependent System-A transporter may reflect the therapeutic efficacy of carbon-ion radiotherapy and suggests that longer half-life radionuclide-labeled probes for System-A may also provide widely available probes to evaluate the effects of particle radiotherapy on tumors at early stage of the treatment.	[Uehara, Tomoya; Watanabe, Mariko; Suzuki, Hiroyuki; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Furusawa, Yoshiya] Natl Inst Radiol Sci, Natl Inst Quantum & Radiol Sci & Technol, Chiba, Japan	Chiba University; National Institutes for Quantum Science & Technology	Uehara, T (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan.	tuehara@chiba-u.jp	Furusawa, Yoshiya/A-4487-2012	Furusawa, Yoshiya/0000-0003-4213-7331; Suzuki, Hiroyuki/0000-0002-9560-4274	JSPS [08838332]; Special Coordination Funds for Research Projects; Heavy Ions at the National Institute of Radiological Sciences-Heavy-Ion Medical accelerator in Chiba (NIRS-HIMAC)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Research Projects; Heavy Ions at the National Institute of Radiological Sciences-Heavy-Ion Medical accelerator in Chiba (NIRS-HIMAC)	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) Grant Number 08838332 and by the Special Coordination Funds for Research Projects with Heavy Ions at the National Institute of Radiological Sciences-Heavy-Ion Medical accelerator in Chiba (NIRS-HIMAC).	BUSTANY P, 1986, J NEURO-ONCOL, V3, P397, DOI 10.1007/BF00165590; Buus S, 2004, RADIOTHER ONCOL, V73, P289, DOI 10.1016/j.radonc.2004.09.009; Cascini GL, 2006, J NUCL MED, V47, P1241; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Dosanjh M, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120660; Dosanjh M, 2010, BRIT J RADIOL, V83, P811, DOI 10.1259/bjr/49490647; Furusawa Y, 2000, RADIAT RES, V154, P485, DOI 10.1667/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2; Hambermeier A, 2015, AMINO ACIDS, V47, P335, DOI [10.1007/s00726-014-1863-3, DOI 10.1007/S00726-014-1863-3]; Harris SM, 2013, J NUCL MED, V54, P1902, DOI 10.2967/jnumed.112.118125; Heiss P, 1999, J NUCL MED, V40, P1367; Heiss WD, 2014, J NUCL MED, V55, P1219, DOI 10.2967/jnumed.114.142661; ISHIWATA K, 1993, J NUCL MED, V34, P1936; Iwata H, 2014, INT J RADIAT ONCOL, V90, pS779, DOI 10.1016/j.ijrobp.2014.05.2254; Jager PL, 2001, J NUCL MED, V42, P432; Jeraj R, 2015, J NUCL MED, V56, P1752, DOI 10.2967/jnumed.114.141424; Kagawa K, 2002, INT J RADIAT ONCOL, V54, P928, DOI 10.1016/S0360-3016(02)02949-8; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kitagawa A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3670742; Kondo T., 2013, RAD EMERG MED, V2, P1; KUBOTA K, 1995, NUCL MED BIOL, V22, P193, DOI 10.1016/0969-8051(94)00099-6; KUBOTA R, 1995, J NUCL MED, V36, P484; Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Laser BS, 2013, NEURO-ONCOLOGY, V15, P506, DOI 10.1093/neuonc/nos321; Luckerath K, 2015, ONCOTARGET, V6, P8418; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; McConathy J, 2012, MED RES REV, V32, P868, DOI 10.1002/med.20250; Nagren K, 2000, J LABELLED COMPD RAD, V43, P1013, DOI 10.1002/1099-1344(200009)43:10<1013::AID-JLCR387>3.0.CO;2-H; Nishii R, 2013, ANN NUCL MED, V27, P808, DOI 10.1007/s12149-013-0750-4; Nishimura T, 2014, BBA-BIOMEMBRANES, V1838, P1306, DOI 10.1016/j.bbamem.2014.01.004; Okayasu R, 2012, INT J CANCER, V130, P991, DOI 10.1002/ijc.26445; Ono M, 2013, BRAIN RES, V1535, P24, DOI 10.1016/j.brainres.2013.08.037; Salem A, 2006, EUR J CANCER, V42, P1720, DOI 10.1016/j.ejca.2006.02.021; Samnick S, 2001, NUCL MED BIOL, V28, P13, DOI 10.1016/S0969-8051(00)00176-1; Schlaff CD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-88; SHIRASUNA K, 1986, CANCER RES, V46, P1418; Sutinen E, 2001, EUR J NUCL MED, V28, P847, DOI 10.1007/s002590100548; Toubaru S, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-143; Tsujii H, 2014, CARBON ION RADIOTHER; Uehara T, 2009, NUCL MED BIOL, V36, P985, DOI 10.1016/j.nucmedbio.2009.07.005; Van de Wiele C, 2003, INT J RADIAT ONCOL, V55, P5, DOI 10.1016/S0360-3016(02)04122-6; Wang YC, 2013, JACC-CARDIOVASC IMAG, V6, P512, DOI 10.1016/j.jcmg.2012.06.017; Watabe T, 2017, EUR J NUCL MED MOL I, V44, P321, DOI 10.1007/s00259-016-3487-1; Yu WP, 2015, NUCL MED BIOL, V42, P8, DOI 10.1016/j.nucmedbio.2014.07.002; Zhang H, 2004, CLIN CANCER RES, V10, P1764, DOI 10.1158/1078-0432.CCR-0190-3	47	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2017	12	2							e0173096	10.1371/journal.pone.0173096	http://dx.doi.org/10.1371/journal.pone.0173096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN4LY	28245294	gold, Green Published, Green Submitted			2022-12-27	WOS:000395980200055
J	Vandbakk, K; Welde, B; Kruken, AH; Baumgart, J; Ettema, G; Karlsen, T; Sandbakk, O				Vandbakk, Kristine; Welde, Boye; Kruken, Andrea Hovstein; Baumgart, Julia; Ettema, Gertjan; Karlsen, Trine; Sandbakk, Oyvind			Effects of upper-body sprint-interval training on strength and endurance capacities in female cross-country skiers	PLOS ONE			English	Article							SKIING SPRINT; METABOLIC ADAPTATIONS; PROGRAMMING PUZZLE; GENDER-DIFFERENCES; OXYGEN-UPTAKE; PERFORMANCE; EXERCISE; MUSCLE; DETERMINANTS; EFFICIENCY	This study compared the effects of adding upper-body sprint-intervals or continuous double poling endurance training to the normal training on maximal upper-body strength and endurance capacity in female cross-country skiers. In total, 17 female skiers (age: 18.1 +/- 0.8yr, body mass: 60 +/- 7 kg, maximal oxygen uptake (VO2max): 3.30 +/- 0.37 L min(-1)) performed an 8-week training intervention. Here, either two weekly sessions of six to eight 30-s maximal upper-body double poling sprint-intervals (SIG, n = 8) or 45-75 min of continuous low-tomoderate intensity double poling on roller skis (CG, n = 9) were added to their training. Before and after the intervention, the participants were tested for physiological and kinematical responses during submaximal and maximal diagonal and double poling treadmill roller skiing. Additionally, we measured maximal upper-body strength (1RM) and average power at 40% 1RM in a poling-specific strength exercise. SIG improved absolute VO2max in diagonal skiing more than CG (8% vs 2%, p< 0.05), and showed a tendency towards higher bodymass normalized VO2max (7% vs 2%, p = 0.07). Both groups had an overall improvement in double poling peak oxygen uptake (10% vs 6% for SIG and CG) (both p< 0.01), but no group-difference was observed. SIG improved 1RM strength more than CG (18% vs 10%, p< 0.05), while there was a tendency for difference in average power at 40% 1RM (20% vs 14%, p = 0.06). Oxygen cost and kinematics (cycle length and rate) in double poling and diagonal remained unchanged in both groups. In conclusion, our study demonstrates that adding upper-body sprint-interval training is more effective than continuous endurance training in improving upper-body maximal strength and VO2max.	[Vandbakk, Kristine; Welde, Boye] Nord Univ, Dept Sports Sci & Phys Educ, Levanger, Norway; [Welde, Boye] UiT, Sch Sport Sci, Tromso, Norway; [Kruken, Andrea Hovstein; Karlsen, Trine] Norwegian Univ Sci & Technol, NTNU, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging,Fac Med & Hlth Sci, Trondheim, Norway; [Baumgart, Julia; Ettema, Gertjan; Sandbakk, Oyvind] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Ctr Elite Sports Res, Fac Med & Hlth Sci, Trondheim, Norway; [Karlsen, Trine] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway	Nord University; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Welde, B (corresponding author), Nord Univ, Dept Sports Sci & Phys Educ, Levanger, Norway.; Welde, B (corresponding author), UiT, Sch Sport Sci, Tromso, Norway.	boye.welde@nord.no	Karlsen, Trine/F-6376-2019; Welde, Boye/AAN-3785-2020; Ettema, Gertjan/C-2104-2018	Karlsen, Trine/0000-0002-1410-7728; Welde, Boye/0000-0003-3805-1615; Baumgart, Julia Kathrin/0000-0001-5628-6050				Andersson E, 2016, MED SCI SPORTS EXERC; Bannister E. W., 1991, MODELING ELITE ATHLE; Barnett C, 2004, J SCI MED SPORT, V7, P314, DOI 10.1016/S1440-2440(04)80026-4; Bayati M, 2011, J SPORT SCI MED, V10, P571; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buchheit M, 2013, SPORTS MED, V43, P927, DOI 10.1007/s40279-013-0066-5; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Danielsen J, 2015, MED SCI SPORT EXER, V47, P2586, DOI 10.1249/MSS.0000000000000723; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Hegge AM, 2016, EUR J APPL PHYSIOL, V116, P291, DOI 10.1007/s00421-015-3281-y; Hegge AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127509; Hoff J, 1999, MED SCI SPORT EXER, V31, P870, DOI 10.1097/00005768-199906000-00016; Holmberg HC, 2007, SCAND J MED SCI SPOR, V17, P437, DOI 10.1111/j.1600-0838.2006.00592.x; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Iaia FM, 2010, SCAND J MED SCI SPOR, V20, P11, DOI 10.1111/j.1600-0838.2010.01193.x; INGJER F, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P25; Kraemer WJ., 2006, PHYSL ASSESSMENT HUM, P119; Losnegard T, 2014, J SPORT MED PHYS FIT, V54, P389; Medbo JI, 2000, SCAND J CLIN LAB INV, V60, P367, DOI 10.1080/003655100750019279; Nilsson JE, 2004, EUR J APPL PHYSIOL, V92, P121, DOI 10.1007/s00421-004-1042-4; Osteras S, 2016, J STRENGTH CONDITION; Pellegrini B, 2013, HUM MOVEMENT SCI, V32, P1415, DOI 10.1016/j.humov.2013.07.010; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; Sandbakk O, 2014, SCAND J MED SCI SPOR, V24, P28, DOI 10.1111/j.1600-0838.2012.01482.x; Sandbakk O, 2016, MED SCI SPORTS EXERC; Sandbakk O, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00326; Sandbakk O, 2016, MED SCI SPORT EXER, V48, P1091, DOI 10.1249/MSS.0000000000000862; Sandbakk O, 2014, HUM MOVEMENT SCI, V38, P251, DOI 10.1016/j.humov.2014.10.004; Sandbakk O, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00293; Sandbakk O, 2013, EUR J APPL PHYSIOL, V113, P1979, DOI 10.1007/s00421-013-2629-4; Sandbakk O, 2011, EUR J APPL PHYSIOL, V111, P947, DOI 10.1007/s00421-010-1719-9; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Smith GA, 2008, HDB SPORTS MED SCI C, P32, DOI [DOI 10.1002/9780470693834.CH2, 10.1002/9780470693834.ch2]; Stoggl T, 2011, SCAND J MED SCI SPOR, V21, P791, DOI 10.1111/j.1600-0838.2009.01078.x; Stoggl T, 2007, MED SCI SPORT EXER, V39, P1160, DOI 10.1249/mss.0b013e3180537201; Stoggl T, 2006, MED SCI SPORT EXER, V38, P586, DOI 10.1249/01.mss.0000190789.46685.22; Stoggl T, 2016, MED SCI SPORTS EXERC; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P85, DOI [10.1123/ijspp.2013-0203, 10.1123/IJSPP.2013-0203]; Terzis G, 2006, SCAND J MED SCI SPOR, V16, P121, DOI 10.1111/j.1600-0838.2005.00463.x; Trilk JL, 2011, EUR J APPL PHYSIOL, V111, P1591, DOI 10.1007/s00421-010-1777-z; Vesterinen V, 2009, J SPORT SCI, V27, P1069, DOI 10.1080/02640410903081860; Zinner C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00426	46	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0172706	10.1371/journal.pone.0172706	http://dx.doi.org/10.1371/journal.pone.0172706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28241030	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000395934400032
J	de la Roque, ED; Smeralda, G; Quignard, JF; Freund-Michel, V; Courtois, A; Marthan, R; Muller, B; Guibert, C; Dubois, M				de la Roque, Eric Dumas; Smeralda, Gwladys; Quignard, Jean-Francois; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Muller, Bernard; Guibert, Christelle; Dubois, Mathilde			Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; GUANYLATE-CYCLASE MODULATORS; CAPACITATIVE CA2+ ENTRY; IMPAIRS ALVEOLARIZATION; LUNG DEVELOPMENT; GROWTH-FACTORS; HYPEROXIA; HYPOXIA; MODEL; INHIBITION	Bronchopulmonary dysplasia (BPD) consists of an arrest of pulmonary vascular and alveolar growth, with persistent hypoplasia of the pulmonary microvasculature and alveolar simplification. In 25 to 40% of the cases, BPD is complicated by pulmonary hypertension (BPD-PH) that significantly increases the risk of morbidity. In vivo studies suggest that increased pulmonary vascular tone could contribute to late PH in BPD. Nevertheless, an alteration in vasoreactivity as well as the mechanisms involved remain to be confirmed. The purpose of this study was thus to assess changes in pulmonary vascular reactivity in a murine model of BPD-PH. Newborn Wistar rats were exposed to either room air (normoxia) or 90%O-2 (hyperoxia) for 14 days. Exposure to hyperoxia induced the well-known features of BPD-PH such as elevated right ventricular systolic pressure, right ventricular hypertrophy, pulmonary vascular remodeling and decreased pulmonary vascular density. Intrapulmonary arteries from hyperoxic pups showed decreased endothelium-dependent relaxation to acetylcholine without any alteration of relaxation to the NO-donor sodium nitroprusside. This functional alteration was associated with a decrease of lung eNOS phosphorylation at the Ser1177 activating site. In pups exposed to hyperoxia, serotonin and phenylephrine induced exacerbated contractile responses of intrapulmonary arteries as well as intracellular calcium response in pulmonary arterial smooth muscle cells (PASMC). Moreover, the amplitude of the store-operated Ca2+ entry (SOCE), induced by store depletion using a SERCA inhibitor, was significantly greater in PASMC from hyperoxic pups. Altogether, hyperoxia-induced BPD-PH alters the pulmonary arterial reactivity, with effects on both endothelial and smooth muscle functions. Reduced activating eNOS phosphorylation and enhanced Ca2+ signaling likely account for alterations of pulmonary arterial reactivity.	[de la Roque, Eric Dumas; Smeralda, Gwladys; Quignard, Jean-Francois; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Muller, Bernard; Guibert, Christelle; Dubois, Mathilde] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [de la Roque, Eric Dumas; Smeralda, Gwladys; Quignard, Jean-Francois; Freund-Michel, Veronique; Courtois, Arnaud; Marthan, Roger; Muller, Bernard; Guibert, Christelle; Dubois, Mathilde] INSERM, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [de la Roque, Eric Dumas; Marthan, Roger] CHU Bordeaux, Ctr Invest Clin CIC 0005, Serv Reanimat Neonatale & Explorat Fonct Resp, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dubois, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France.; Dubois, M (corresponding author), INSERM, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France.	mathilde.dubois@u-bordeaux.fr	, GUIBERT/M-2357-2014	, GUIBERT/0000-0003-3253-5694; Dumas De La Roque, Eric/0000-0002-5555-0267; courtois, arnaud/0000-0002-0996-7133; FREUND-MICHEL, Veronique/0000-0001-8912-6117; Marthan, Roger/0000-0001-5412-5712				Baker CD, 2014, PEDIAT ALLER IMM PUL, V27, P8, DOI 10.1089/ped.2013.0323; Baker CD, 2014, CURR OPIN PEDIATR, V26, P306, DOI 10.1097/MOP.0000000000000095; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Belik J, 2004, J APPL PHYSIOL, V96, P725, DOI 10.1152/japplphysiol.00825.2003; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Britt RD, 2015, AM J PHYSIOL-LUNG C, V309, pL537, DOI 10.1152/ajplung.00232.2015; BUSH A, 1990, ARCH DIS CHILD, V65, P739, DOI 10.1136/adc.65.7.739; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Dubois M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082594; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Gilbert G, 2014, CARDIOVASC RES, V103, P313, DOI 10.1093/cvr/cvu069; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; GORENFLO M, 1991, Pediatric Pathology, V11, P851; Grisafi D, 2012, LUNG, V190, P419, DOI 10.1007/s00408-012-9382-z; Grover TR, 2005, AM J PHYSIOL-LUNG C, V288, pL648, DOI 10.1152/ajplung.00288.2004; Han RNN, 2004, CIRC RES, V94, P1115, DOI 10.1161/01.RES.0000125624.85852.1E; Hilgendorff A, 2014, AM J RESP CELL MOL, V50, P233, DOI 10.1165/rcmb.2013-0014TR; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; Levy M, 2005, PEDIATR RES, V57, p21R, DOI 10.1203/01.PDR.0000159575.58834.8D; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Mourani PM, 2004, AM J RESP CRIT CARE, V170, P1006, DOI 10.1164/rccm.200310-1483oc; Potter CF, 1999, PEDIATR RES, V45, P8, DOI 10.1203/00006450-199901000-00003; Pourageaud F, 2005, N-S ARCH PHARMACOL, V372, P14, DOI 10.1007/s00210-005-1082-2; Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216; Roberts JD, 2000, CIRC RES, V87, P140, DOI 10.1161/01.RES.87.2.140; Rodat L, 2007, PFLUG ARCH EUR J PHY, V454, P41, DOI 10.1007/s00424-006-0178-y; Smith LJ, 2010, PAEDIATR RESPIR REV, V11, P135, DOI 10.1016/j.prrv.2009.12.006; Song Michael Y, 2011, Pulm Circ, V1, P84; Sopi RB, 2007, AM J PHYSIOL-LUNG C, V293, pL1029, DOI 10.1152/ajplung.00182.2007; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Thompson MA, 2015, BBA-MOL CELL RES, V1853, P2506, DOI 10.1016/j.bbamcr.2015.06.008; Tourneux P, 2009, AM J PHYSIOL-LUNG C, V297, pL1103, DOI 10.1152/ajplung.00293.2009; Wagenaar GTM, 2015, AM J PHYSIOL-LUNG C, V309, pL1037, DOI 10.1152/ajplung.00333.2015; Wang C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-123; Wang YF, 2015, J MOL MED, V93, P327, DOI 10.1007/s00109-014-1216-4; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Yang K, 2015, AM J PHYSIOL-CELL PH, V308, pC869, DOI 10.1152/ajpcell.00349.2014; Young SL, 2002, AM J PHYSIOL-LUNG C, V282, pL379, DOI 10.1152/ajplung.00462.2000; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Yuan XJ, 1997, AM J PHYSIOL-LUNG C, V272, pL44, DOI 10.1152/ajplung.1997.272.1.L44	44	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173044	10.1371/journal.pone.0173044	http://dx.doi.org/10.1371/journal.pone.0173044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235094	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200189
J	Die, JV; Baldwin, RL; Rowland, LJ; Li, R; Oh, S; Li, CJ; Connor, EE; Ranilla, MJ				Die, Jose V.; Baldwin, Ransom L.; Rowland, Lisa J.; Li, Robert; Oh, Sunghee; Li, Congjun; Connor, Erin E.; Ranilla, Maria-Jose			Selection of internal reference genes for normalization of reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis in the rumen epithelium	PLOS ONE			English	Article							ADAPTATION; EXPRESSION; NUTRITION	The rumen is lined on the luminal side by a stratified squamous epithelium that is responsible for not only absorption, but also transport, extensive short-chain fatty acid (SCFA) metabolism and protection. Butyrate has been demonstrated to initiate the differentiation of the tissue following introduction of solid feed to the weaning neonate as well as affecting the metabolism of other nutrients and absorption of nutrients in in vitro experiments. The objective of the present study was to validate expression stability of eight putative reference genes bovine rumen, considering the intrinsic heterogeneity of bovine rumen with regard to different luminal characteristics due to direct infusion of butyrate to double the intra-ruminal content of the rumen liquor. Our focus was on identifying stable reference genes which are suitable to normalize real-time RT-qPCR experiments from rumen samples collected from clinical assays, irrespective of localization within the organ and the across physiological state. The most stably expressed genes included: ACTB, UXT, DBNDD2, RPS9, DDX54 and HMBS. Their high stability values suggest these reference genes will facilitate better evaluation of variation of across an array of conditions including: localization within the rumen, differences among cattle fed an array of rations, as well as response to development in the weaning animal. Moreover, we anticipate these reference genes may be useful for expression studies in other ruminants.	[Die, Jose V.; Rowland, Lisa J.] ARS, Genet Improvement Fruits & Vegetables Lab, USDA, Beltsville, MD USA; [Baldwin, Ransom L.; Li, Robert; Li, Congjun; Connor, Erin E.] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD USA; [Oh, Sunghee] Jeju Natl Univ, Dept Comp Sci & Stat, Jeju City, Jeju Do, South Korea; [Ranilla, Maria-Jose] Univ Leon, Dept Anim Prod, Leon, Spain; [Die, Jose V.] Univ Cordoba, Dept Genet, Cordoba, Spain	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Jeju National University; Universidad de Leon; Universidad de Cordoba	Baldwin, RL (corresponding author), ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD USA.	ransom.baldwin@ars.usda.gov	Ranilla, Maria Jose/F-2395-2016; Die, Jose V./H-3381-2019; Li, Cong-jun/J-8572-2014	Ranilla, Maria Jose/0000-0002-4000-7704; Die, Jose V./0000-0002-7506-8590; Li, Cong-jun/0000-0003-1389-9820	Fulbright/Ministry of Education of Spain Visiting Scholarship [PRX14/00601]	Fulbright/Ministry of Education of Spain Visiting Scholarship	This work was supported by the Fulbright/Ministry of Education of Spain Visiting Scholarship PRX14/00601 to Dr. Marioa Jose A Ranilla. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldwin RL VI, 2012, GENE REGUL SYST BIO, V6, P67, DOI 10.4137/GRSB.S9687; Crews DH, 2005, GENET MOL RES, V4, P152; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; GALFI P, 1991, PHYSIOLOGICAL ASPECTS OF DIGESTION AND METABOLISM IN RUMINANTS, P49; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenfield TL, 2001, J DAIRY SCI, V84, P2469, DOI 10.3168/jds.S0022-0302(01)74697-8; Gross JJ, 2015, J ANIM PHYSIOL AN N, V99, P747, DOI 10.1111/jpn.12259; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2011, ACCREDIT QUAL ASSUR, V16, P399, DOI 10.1007/s00769-011-0769-y; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Lane MA, 2002, J ANIM SCI, V80, P1538; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li CJ, 2016, GENE REGUL SYST BIO, V10, P1, DOI 10.4137/GRSB.S35607; McLeod KR, 2000, J ANIM SCI, V78, P760; Naeem A, 2012, J DAIRY SCI, V95, P1807, DOI 10.3168/jds.2011-4709; Penner GB, 2011, J ANIM SCI, V89, P1108, DOI 10.2527/jas.2010-3378; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2013, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Steele MA, 2011, PHYSIOL GENOMICS, V43, P308, DOI 10.1152/physiolgenomics.00117.2010; Stevens CE, 1969, PHYSL DIGESTION META, P101; Tao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130525; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; Yohe TT, 2014, PERFORMANCE DEV RUME; Zhu WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121280; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172674	10.1371/journal.pone.0172674	http://dx.doi.org/10.1371/journal.pone.0172674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234977	Green Submitted, Green Published, gold			2022-12-27	WOS:000394688200111
J	Gerritsen, MG; Willemink, MJ; Pompe, E; van der Bruggen, T; van Rhenen, A; Lammers, JWJ; Wessels, F; Sprengers, RW; de Jong, PA; Minnema, MC				Gerritsen, M. G.; Willemink, M. J.; Pompe, E.; van der Bruggen, T.; van Rhenen, A.; Lammers, J. W. J.; Wessels, F.; Sprengers, R. W.; de Jong, P. A.; Minnema, M. C.			Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; ACUTE-LEUKEMIA; BONE-MARROW; CHEMOTHERAPY; PNEUMONIA	We performed a prospective study in patients with chemotherapy induced febrile neutropenia to investigate the diagnostic value of low-dose computed tomography compared to standard chest radiography. The aim was to compare both modalities for detection of pulmonary infections and to explore performance of low-dose computed tomography for early detection of invasive fungal disease. The low-dose computed tomography remained blinded during the study. A consensus diagnosis of the fever episode made by an expert panel was used as reference standard. We included 67 consecutive patients on the first day of febrile neutropenia. According to the consensus diagnosis 11 patients (16.4%) had pulmonary infections. Sensitivity, specificity, positive predictive value and negative predictive value were 36%, 93%, 50% and 88% for radiography, and 73%, 91%, 62% and 94% for low-dose computed tomography, respectively. An uncorrected McNemar showed no statistical difference (p = 0.197). Mean radiation dose for low-dose computed tomography was 0.24 mSv. Four out of 5 included patients diagnosed with invasive fungal disease had radiographic abnormalities suspect for invasive fungal disease on the low-dose computed tomography scan made on day 1 of fever, compared to none of the chest radiographs. We conclude that chest radiography has little value in the initial assessment of febrile neutropenia on day 1 for detection of pulmonary abnormalities. Low-dose computed tomography improves detection of pulmonary infiltrates and seems capable of detecting invasive fungal disease at a very early stage with a low radiation dose.	[Gerritsen, M. G.; van Rhenen, A.; Minnema, M. C.] Univ Med Ctr Utrecht, Dept Haematol, Ctr Canc, Utrecht, Netherlands; [Gerritsen, M. G.] Univ Amsterdam, Acad Med Ctr, Dept Haematol, Amsterdam, Netherlands; [Willemink, M. J.; Pompe, E.; Wessels, F.; de Jong, P. A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Pompe, E.; Lammers, J. W. J.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [van der Bruggen, T.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Sprengers, R. W.] Meander Med Ctr, Dept Radiol, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum	Minnema, MC (corresponding author), Univ Med Ctr Utrecht, Dept Haematol, Ctr Canc, Utrecht, Netherlands.	M.C.minnema@umcutrecht.nl	Willemink, Martin/M-3650-2013; Willemink, Martin/GRX-4798-2022	Willemink, Martin/0000-0002-6991-6557; Willemink, Martin/0000-0002-6991-6557				de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Garcia Javier Barreda, 2013, Ann Am Thorac Soc, V10, P432, DOI 10.1513/AnnalsATS.201304-097OC; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Heussel CP, 1999, J CLIN ONCOL, V17, P796, DOI 10.1200/JCO.1999.17.3.796; Hummel M, 2008, ANN HEMATOL, V87, P291, DOI 10.1007/s00277-007-0391-6; Janssen A, 2011, EUR J HAEMATOL, V87, P419, DOI 10.1111/j.1600-0609.2011.01678.x; Kim HJ, 2014, CANCER RES TREAT, V46, P393, DOI 10.4143/crt.2013.132; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Orasch C, 2010, BONE MARROW TRANSPL, V45, P521, DOI 10.1038/bmt.2009.187; Pagano L, 2012, ANN HEMATOL, V91, P767, DOI 10.1007/s00277-011-1373-2; Patsios D, 2010, RESP MED, V104, P600, DOI 10.1016/j.rmed.2009.11.003; SICKLES EA, 1975, ARCH INTERN MED, V135, P715, DOI 10.1001/archinte.135.5.715; Yolin-Raley DS, 2015, J NATL COMPR CANC NE, V13, P184, DOI 10.6004/jnccn.2015.0027	18	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172256	10.1371/journal.pone.0172256	http://dx.doi.org/10.1371/journal.pone.0172256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235014	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200058
J	Gianfagna, F; Grippi, C; Ahrens, W; Bailey, MES; Bornhorst, C; De Henauw, S; Foraita, R; Koni, AC; Krogh, V; Marild, S; Molnar, D; Moreno, L; Pitsiladis, Y; Russo, P; Siani, A; Tornaritis, M; Veidebaum, T; Iacoviello, L				Gianfagna, Francesco; Grippi, Claudio; Ahrens, Wolfgang; Bailey, Mark E. S.; Boernhorst, Claudia; De Henauw, Stefan; Foraita, Ronja; Koni, Anna C.; Krogh, Vittorio; Marild, Staffan; Molnar, Denes; Moreno, Luis; Pitsiladis, Yannis; Russo, Paola; Siani, Alfonso; Tornaritis, Michael; Veidebaum, Toomas; Iacoviello, Licia			The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort	PLOS ONE			English	Article							CHILDHOOD OBESITY; GENE; ASSOCIATION; HOMEOSTASIS; OVERWEIGHT; EXPRESSION; SECRETION; PEPTIDES; LEPTIN; ENERGY	Background and aims Neuromedin U (NMU) is a hypothalamic neuropeptide with important roles in several metabolic processes, recently suggested as potential therapeutic target for obesity. We analysed the associations between NMU gene variants and haplotypes and body mass index (BMI) in a large sample of European children. Methods and results From a large European multi-center study on childhood obesity, 4,528 children (2.0-9.9 years, mean age 6.0-1.8 SD; boys 52.2%) were randomly selected, stratifying by age, sex and country, and genotyped for tag single nucleotide polymorphisms (SNPs; rs6827359, T: C; rs12500837, T: C; rs9999653, C: T) of NMU gene, then haplotypes were inferred. Regression models were applied to estimate the associations between SNPs or haplotypes and BMI as well as other anthropometric measures. BMI was associated with all NMU SNPs (p<0.05). Among five haplotypes inferred, the haplotype carrying the minor alleles (CCT, frequency = 22.3%) was the only associated with lower BMI values (beta = -0.16, 95% CI:0.28,- 0.04, p = 0.006; z-score, beta = -0.08, 95% CI:-0.14,-0.01, p = 0.019) and decreased risk of overweight/obesity (OR = 0.81, 95% CI: 0.68,0.97, p = 0.020) when compared to the most prevalent haplotype (codominant model). Similar significant associations were also observed using the same variables collected after two years' time (BMI, beta = -0.25, 95% CI:-0.41,-0.08, p = 0.004; z-score, beta = -0.10, 95% CI:-0.18,-0.03, p = 0.009; overweight/obesity OR = 0.81, 95% CI: 0.66,0.99, p = 0.036). The association was age-dependent in girls (interaction between CCT haplotypes and age, p = 0.008), more evident between 7 and 9 years of age. The CCT haplotype was consistently associated with lower levels of fat mass, skinfold thickness, hip and arm circumferences both at T0 and at T1, after adjustment for multiple testing (FDR-adjusted p<0.05). Conclusions This study shows an association between a NMU haplotype and anthropometric indices, mainly linked to fat mass, which appears to be age-and sex-specific in children. Genetic variations within or in linkage with this haplotype should be investigated to identify functional variants responsible for the observed phenotypic variation.	[Gianfagna, Francesco; Grippi, Claudio; Iacoviello, Licia] Ist Neurol Mediterraneo Neuromed, IRCCS, Dept Epidemiol & Prevent, Lab Mol & Nutr Epidemiol, Pozzilli, Isernia, Italy; [Gianfagna, Francesco] Univ Insubria, Dept Clin & Expt Med, EPIMED Res Ctr, Varese, Italy; [Ahrens, Wolfgang; Boernhorst, Claudia; Foraita, Ronja] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Inst Stat, Fac Math & Comp Sci, Bremen, Germany; [Bailey, Mark E. S.; Koni, Anna C.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [De Henauw, Stefan] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Ghent, Belgium; [Krogh, Vittorio] Ist Nazl Tumori, Fdn IRCCS, Dept Prevent & Predict Med, Milan, Italy; [Marild, Staffan] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden; [Molnar, Denes] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Moreno, Luis] Univ Zaragoza, Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Pitsiladis, Yannis] Univ Brighton, Ctr Sport & Exercise Sci & Med, Brighton, E Sussex, England; [Russo, Paola; Siani, Alfonso] CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy; [Tornaritis, Michael] Res & Educ Inst Child Hlth, Strovolos, Cyprus; [Veidebaum, Toomas] Natl Inst Hlth Dev, Dept Chron Dis, Tallinn, Estonia	IRCCS Neuromed; University of Insubria; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; University of Glasgow; Ghent University; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Gothenburg; University of Pecs; University of Zaragoza; University of Brighton; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); National Institute for Health Development - Estonia	Gianfagna, F (corresponding author), Ist Neurol Mediterraneo Neuromed, IRCCS, Dept Epidemiol & Prevent, Lab Mol & Nutr Epidemiol, Pozzilli, Isernia, Italy.; Gianfagna, F (corresponding author), Univ Insubria, Dept Clin & Expt Med, EPIMED Res Ctr, Varese, Italy.	francesco.gianfagna@uninsubria.it	Molnár, Dénes/AAB-6820-2022; Gianfagna, Francesco/K-4561-2016; Iacoviello, Licia/AGX-7071-2022; Krogh, Vittorio/K-2628-2016; Siani, Alfonso/B-7925-2015; Iacoviello, Licia/K-4676-2016; Moreno, Luis/S-1780-2019; Russo, Paola/AAW-8308-2020; Krogh, Vittorio/AAA-9171-2019; Ahrens, Wolfgang/A-2740-2012	Gianfagna, Francesco/0000-0003-4615-0816; Iacoviello, Licia/0000-0003-0514-5885; Krogh, Vittorio/0000-0003-0122-8624; Iacoviello, Licia/0000-0003-0514-5885; Moreno, Luis/0000-0003-0454-653X; Krogh, Vittorio/0000-0003-0122-8624; Pitsiladis, Yannis/0000-0001-6210-2449; Grippi, Claudio/0000-0002-6258-2662; Bailey, Mark E. S./0000-0002-9788-2278; Ahrens, Wolfgang/0000-0003-3777-570X; Bornhorst, Claudia/0000-0001-9004-1540; Marild, Staffan/0000-0001-6517-2020	European Community [016181]; EU; Fondazione Umberto Veronesi, Young Investigator Research Programme award; Italian Ministry of Health, Young Investigator Grant [167/GR-2011-02351736]	European Community(European Commission); EU(European Commission); Fondazione Umberto Veronesi, Young Investigator Research Programme award(Fondazione Umberto Veronesi); Italian Ministry of Health, Young Investigator Grant	This study was supported by the European Community within the Sixth RTD Framework Programme Contract no. 016181 - FOOD (WA) and by the grant from EU for the IDEFICS study. This analysis was partially supported by the Fondazione Umberto Veronesi, 2014 Young Investigator Research Programme award (FG) and the Italian Ministry of Health 2011, Young Investigator Grant n. 167/GR-2011-02351736 (FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted as part of the IDEFICS study (http://www.idefics.eu). We are grateful for the support provided by school boards, headmasters and communities. We thank the IDEFICS children and their parents for participating in this extensive examination. This study was supported by the European Community within the Sixth RTD Framework Programme Contract no. 016181 (FOOD) and by the grant from EU for the IDEFICS study. This analysis was partially supported by the Fondazione Veronesi (2014 Young Investigator Research Programme award to FG) and the Italian Ministry of Health 2011 (Young Investigator Grant n. 167/GR-2011-02351736 to FG). We thank Daniela Cugino and Iolanda Santimone for samples genotyping at the Fondazione Giovanni Paolo II, Campobasso, Italy, and Benedetta Izzi for her helpful comments.	Ahrens W, 2006, NUTR METAB CARDIOVAS, V16, P302, DOI 10.1016/j.numecd.2006.01.011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bechtold DA, 2009, AM J PHYSIOL-ENDOC M, V297, pE545, DOI 10.1152/ajpendo.00255.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cugino D, 2013, INT J OBESITY, V37, P1539, DOI 10.1038/ijo.2013.21; De Henauw S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.31; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Fukue Y, 2006, FEBS LETT, V580, P3485, DOI 10.1016/j.febslet.2006.05.025; Gianfagna F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070632; Gianfagna F, 2012, THROMB RES, V129, P320, DOI 10.1016/j.thromres.2011.11.014; Hainerova I, 2006, J CLIN ENDOCR METAB, V91, P5057, DOI 10.1210/jc.2006-1442; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hanada T, 2003, BIOCHEM BIOPH RES CO, V311, P954, DOI 10.1016/j.bbrc.2003.10.098; HASHIMOTO T, 1995, CHEM PHARM BULL, V43, P1154; Ivanov TR, 2002, ENDOCRINOLOGY, V143, P3813, DOI 10.1210/en.2002-220121; Jethwa PH, 2005, AM J PHYSIOL-ENDOC M, V289, pE301, DOI 10.1152/ajpendo.00404.2004; Koni AC, 2011, INT J OBESITY, V35, pS113, DOI 10.1038/ijo.2011.43; Lauria F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048876; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; Mitchell JD, 2009, CARDIOVASC RES, V81, P353, DOI 10.1093/cvr/cvn302; Nandha KA, 1999, PEPTIDES, V20, P1203, DOI 10.1016/S0196-9781(99)00124-2; Niimi M, 2001, ENDOCRINE, V16, P201, DOI 10.1385/ENDO:16:3:201; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Tyrrell VJ, 2001, INT J OBESITY, V25, P273, DOI 10.1038/sj.ijo.0801531; Vigo E, 2007, AM J PHYSIOL-ENDOC M, V293, pE1265, DOI 10.1152/ajpendo.00425.2007	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172698	10.1371/journal.pone.0172698	http://dx.doi.org/10.1371/journal.pone.0172698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235053	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000394688200119
J	Inoue, K; Arai, M; Fukushi, M				Inoue, Kazumasa; Arai, Moeko; Fukushi, Masahiro			Dispersion of radiocesium-contaminated bottom sediment caused by heavy rainfall in Joso City, Japan	PLOS ONE			English	Article							POWER-PLANT ACCIDENT; METROPOLITAN TOKYO; DOSE-RATE	A large-scale heavy rainfall disaster occurred in Joso City, Japan, in September 2015, and one third of the city area (40 km(2)) was flooded by the Kinu River. Artificial radionuclides such as Cs-134 and Cs-137 were known to have accumulated in the river bottom sediment after their release in the 2011 Fukushima Dai-ichi Nuclear Power Plant accident. It was thought that these radionuclides might have been dispersed by the rainfall disaster. A car-borne survey of absorbed dose rate in air had been made by the authors in Joso City in August 2015. Then, the present study made a second car-borne survey in October 2015, to evaluate changes in the rate after the rainfall disaster. The absorbed dose rate in air and the standard deviation (range) measured in the flooded areas of Joso City after the disaster were 68 +/- 9 nGy h(-1) (39-98 nGy h(-1)), which was 10% higher than the rate before it. Additionally, higher dose rates (>60 nGy h(-1)) were observed for the flooded areas after the disaster; furthermore, up to 886 Bq kg(-1) of activity concentration from Cs-134 and Cs-137 was observed in these flooded areas, and this was 11 times higher than the activity concentration before the disaster. These results suggested the dispersion of artificial radionuclides accumulated in the bottom sediment of the Kinu River after the Fukushima Daiichi Nuclear Power Plant accident occurred by the heavy rainfall disaster.	[Inoue, Kazumasa; Arai, Moeko; Fukushi, Masahiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan	Tokyo Metropolitan University	Fukushi, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan.	fukushi@tmu.ac.jp			Tokyo Metropolitan University	Tokyo Metropolitan University	This work was funded by the strategic research fund of Tokyo Metropolitan University (2014-2015).	ABE S, 1981, J NUCL SCI TECHNOL, V18, P21, DOI 10.3327/jnst.18.21; Cabinet Office Government of Japan, 2016, DAM SIT KANT TOH HEA; Furukawa M, 2012, RAD EMERG MED, V1, P11; Gifu Disaster Mitigation Center, 2015, STRENGTH DIS PREV ME; Hosoda M, 2016, JPN J HLTH PHYS, V51, P41, DOI DOI 10.5453/JHPS.51.41; Hosoda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124433; Ibaraki Prefecture Government, 2011, RAD CNCENTR MAP SOIL; Inoue K, 2015, RADIAT PROT DOSIM, V167, P231, DOI 10.1093/rpd/ncv251; Inoue K, 2016, J ENVIRON RADIOACTIV, V158, P1, DOI 10.1016/j.jenvrad.2016.03.022; Inoue K, 2016, J RADIOANAL NUCL CH, V307, P507, DOI 10.1007/s10967-015-4164-8; Inoue K, 2015, J RADIOANAL NUCL CH, V303, P2159, DOI 10.1007/s10967-014-3669-x; Joso City Office, 2016, VER REP JOS CIT KIN; Joso City Office, 2012, AIR DOS RAT RAD RAYS; Maedera F, 2016, RADIAT PROT DOSIM, V168, P561, DOI 10.1093/rpd/ncv370; Minato S., 2001, Radioisotopes, V50, P463, DOI 10.3769/radioisotopes.50.10_463; Ministry of Agriculture Forestry and Fisheries., 2012, SUMM VERS RES RES DI; Ministry of the Environment, 2016, PUBL WAT RAD SUBST M; Torii T, 2012, JAEA TECHNOL; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, LEV EFF RAD EXP DUE; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Yuuki Y, 2014, OYO TECH REP, V33, P105	21	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0171788	10.1371/journal.pone.0171788	http://dx.doi.org/10.1371/journal.pone.0171788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28234986	gold, Green Submitted, Green Published			2022-12-27	WOS:000394688200034
J	Kollgaard, T; Enevold, C; Bendtzen, K; Hansen, PR; Givskov, M; Holmstrup, P; Nielsen, CH				Kollgaard, Tania; Enevold, Christian; Bendtzen, Klaus; Hansen, Peter R.; Givskov, Michael; Holmstrup, Palle; Nielsen, Claus H.			Cholesterol crystals enhance TLR2-and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PERIODONTAL PATHOGENS; GINGIPAINS; DISEASE; INFLAMMASOMES; ASSOCIATION; ACTIVATION; CELLS; IDENTIFICATION; MACROPHAGES	Cholesterol deposits and pro-inflammatory cytokines play an essential role in the pathogenesis of atherosclerosis, a predominant cause of cardiovascular disease (CVD). Epidemiological evidence has linked periodontal disease (PD) with atherosclerotic CVD. Accordingly, viable periodontal pathogens, including Porphyromonas gingivalis, have been found in atherosclerotic plaques in humans and mice. We aimed to determine whether cholesterol crystals (CHCs) and oral bacteria synergize in the stimulation of human monocytes. Incubation of human monocytes with CHCs induced secretion of interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, IL-6, and IL-8. Moreover, CHCs markedly enhanced secretion of IL-1 beta by monocytes stimulated with the toll-like receptor (TLR) 4 agonist Escherichia coli lipopolysaccharide (LPS), and the TLR2 agonist Staphylococcus aureus lipoteichoic acid. Notably, CHCs also enhanced IL-1 beta secretion induced by P. gingivalis LPS and IL-1 beta secretion induced by whole P. gingivalis bacteria. This enhancement was abrogated by the NLRP3 inflammasome inhibitors Z-YVAD-FMK and glibenclamide. CHCs had no effect on cytokine production induced by P. gingivalis gingipains. Taken together, our findings support that CHCs, via stimulation of NLRP3 inflammasomes, act in synergy with the periodontal pathogen P. gingivalis to promote monocyte secretion of pro-atherogenic cytokines.	[Kollgaard, Tania; Enevold, Christian; Bendtzen, Klaus; Nielsen, Claus H.] Copenhagen Univ Hosp, Inst Inflammat Res, Ctr Rheumatol & Spine Dis, Rigshosp, Copenhagen, Denmark; [Hansen, Peter R.] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Copenhagen, Denmark; [Givskov, Michael] Univ Copenhagen, Costerton Biofilm Ctr, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Holmstrup, Palle; Nielsen, Claus H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Nielsen, CH (corresponding author), Copenhagen Univ Hosp, Inst Inflammat Res, Ctr Rheumatol & Spine Dis, Rigshosp, Copenhagen, Denmark.; Nielsen, CH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark.	claushnielsen@hotmail.com	Hansen, Peter Riis/AAR-7659-2020	Givskov, Michael/0000-0001-5004-8609; Hansen, Peter Riis/0000-0002-9056-535X; Nielsen, Claus Henrik/0000-0001-7543-9016; Enevold, Christian/0000-0002-2748-1997	Danish Council for Independent Research [1333-00190A]; Aase og Ejnar Danielsens Fond [10-001018]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Aase og Ejnar Danielsens Fond	This work was funded by Danish Council for Independent Research (grant number: 1333-00190A, grant recipient: Tania Kollgaard, TK), (URL: http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom) and Aase og Ejnar Danielsens Fond (grant number: 10-001018 (grant recipient: TK), (URL: http://www.danielsensfond.dk/Default.aspx). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Belstrom D, 2012, MICROBES INFECT, V14, P411, DOI 10.1016/j.micinf.2011.12.004; Belstrom D, 2011, INFECT IMMUN, V79, P1559, DOI 10.1128/IAI.01036-10; Bendtzen K, 2014, DISCOV MED, V17, P309; Borch TS, 2010, SCAND J IMMUNOL, V71, P440, DOI 10.1111/j.1365-3083.2010.02390.x; Champaiboon C, 2014, ATHEROSCLEROSIS, V235, P38, DOI 10.1016/j.atherosclerosis.2014.04.007; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Fitzpatrick RE, 2011, HIGH MOL WEIGHT GING, V1, P109; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Grenier D, 2010, TOXINS, V2, P341, DOI 10.3390/toxins2030341; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hirose K, 1997, MICROBIOL IMMUNOL, V41, P21, DOI 10.1111/j.1348-0421.1997.tb01168.x; Hussain M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00045; Ikejima T, 2016, INTERLEUKIN INDUCES, V162, P215; Jain S, 2013, INFECT IMMUN, V81, P1277, DOI 10.1128/IAI.01036-12; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Moreira DM, 2015, AM J CARDIOVASC DRUG, V15, P1, DOI 10.1007/s40256-014-0094-z; Nielsen CH, 2007, CLIN EXP IMMUNOL, V147, P287, DOI 10.1111/j.1365-2249.2006.03283.x; Ogawa T, 1996, FEMS IMMUNOL MED MIC, V14, P1, DOI 10.1111/j.1574-695X.1996.tb00261.x; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Sugawara S, 2000, J IMMUNOL, V165, P411, DOI 10.4049/jimmunol.165.1.411; Uehara A, 2008, CELL MICROBIOL, V10, P1181, DOI 10.1111/j.1462-5822.2008.01119.x; Vahabi S, 2011, J PERIODONTOL IMPLAN, V3, P51; Veillard F, 2012, BIOL CHEM, V393, P1471, DOI 10.1515/hsz-2012-0222; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003	39	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0172773	10.1371/journal.pone.0172773	http://dx.doi.org/10.1371/journal.pone.0172773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235036	Green Published, Green Submitted, gold			2022-12-27	WOS:000394688200134
J	Laurito, M; Ayala, AM; Almiron, WR; Gardenal, CN				Laurito, Magdalena; Ayala, Ana M.; Almiron, Walter R.; Gardenal, Cristina N.			Molecular identification of two Culex (Culex) species of the neotropical region (Diptera: Culicidae)	PLOS ONE			English	Article							WEST-NILE-VIRUS; DNA BARCODING REVEALS; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; SEQUENCE ALIGNMENT; PIPIENS COMPLEX; VECTOR; QUINQUEFASCIATUS; CLASSIFICATION; ARGENTINA	Culex bidens and C. interfor, implicated in arbovirus transmission in Argentina, are sister species, only distinguishable by feature of the male genitalia; however, intermediate specimens of the species in sympatry have been found. Fourth-instar larvae and females of both species share apomorphic features, and this lack of clear distinction creates problems for specific identification. Geometric morphometric traits of these life stages also do not distinguish the species. The aim of the present study was to assess the taxonomic status of C. bidens and C. interfor using two mitochondrial genes and to determine the degree of their reproductive isolation using microsatellite loci. Sequences of the ND4 and COI genes were concatenated in a matrix of 993 nucleotides and used for phylogenetic and distance analyses. Bayesian and maximum parsimony inferences showed a well resolved and supported topology, enclosing sequences of individuals of C. bidens (0.83 BPP, 73 BSV) and C. interfor (0.98 BPP, 97 BSV) in a strong sister relationship. The mean K2P distance within C. bidens and C. interfor was 0.3% and 0.2%, respectively, and the interspecific variation was 2.3%. Bayesian clustering also showed two distinct mitochondrial lineages. All sequenced mosquitoes were successfully identified in accordance with the best close match algorithm. The low genetic distance values obtained indicate that the species diverged quite recently. Most morphologically intermediate specimens of C. bidens from Co A rdoba were heterozygous for the microsatellite locus GT51; the significant heterozygote excess observed suggests incomplete reproductive isolation. However, C. bidens and C. interfor should be considered good species: the ventral arm of the phallosome of the male genitalia and the ND4 and COI sequences are diagnostic characters.	[Laurito, Magdalena; Almiron, Walter R.] Univ Nacl Cordoba, Inst Invest Biol Tecnol IIByT, CONICET UNC, CIEC, Cordoba, Argentina; [Ayala, Ana M.; Gardenal, Cristina N.] Univ Nacl Cordoba, IDEA, CONICET, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Laurito, M (corresponding author), Univ Nacl Cordoba, Inst Invest Biol Tecnol IIByT, CONICET UNC, CIEC, Cordoba, Argentina.	mlaurito@conicet.gov.ar		Ayala, Ana Maria/0000-0002-4598-9612	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2013-1254]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	PICT 2013-1254 http://www.agencia.mincyt.gob.ar/ Agencia Nacional de Promocion Cientifica y Tecnologica. ML.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Batovska J, 2016, ECOL EVOL, V6, P3001, DOI 10.1002/ece3.2095; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; Cameron EC, 2010, J MED ENTOMOL, V47, P527, DOI 10.1603/ME09259; Costa-da-Silva AL, 2005, MEM I OSWALDO CRUZ, V100, P639, DOI 10.1590/S0074-02762005000600007; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Demari-Silva B, 2011, J MED ENTOMOL, V48, P272, DOI 10.1603/ME09293; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca DM, 1998, MOL ECOL, V7, P1617; Fontes G, 1998, MEM I OSWALDO CRUZ, V93, P705, DOI 10.1590/S0074-02761998000600001; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gomes B, 2012, ECOL EVOL, V2, P1889, DOI 10.1002/ece3.307; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARBACH R E, 1986, Mosquito Systematics, V18, P139; Harbach R. E., 2016, MOSQUITO TAXONOMIC I; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 2011, ACTA TROP, V120, P1, DOI 10.1016/j.actatropica.2011.06.005; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Harbach RE, 2016, SYST BIODIVERS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoyos-Lopez R, 2015, MEM I OSWALDO CRUZ, V110, P719, DOI 10.1590/0074-02760280040; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x; Kothera L, 2009, J MED ENTOMOL, V46, P236, DOI 10.1603/033.046.0208; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laurito M, 2015, ZOOTAXA, V4052, P573, DOI 10.11646/zootaxa.4052.5.5; Laurito M, 2015, ZOOMORPHOLOGY, V134, P447, DOI 10.1007/s00435-015-0271-x; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Laurito M, 2013, ZOOTAXA, V3652, P117, DOI 10.11646/zootaxa.3652.1.4; Maddison WP, 2012, MESQUITE3 04 MODULAR; McDowell JR, 2002, FISH B-NOAA, V100, P537; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Morais SA, 2012, REV INST MED TROP SP, V54, P325, DOI 10.1590/S0036-46652012000600007; Navarro JC, 2004, J MED ENTOMOL, V41, P575, DOI 10.1603/0022-2585-41.4.575; NEILAN BA, 1994, BIOTECHNIQUES, V17, P708; Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Sabattini MS, 1998, OVERVIEW ARBOVIROLOG, P113; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Spinsanti LI, 2009, REV FACULTAD CIENCIA, V66, P52; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; Versteirt V, 2012, ZOOTAXA, P21, DOI 10.11646/zootaxa.3191.1.2; Vesgueiro FT, 2011, MEM I OSWALDO CRUZ, V106, P1, DOI 10.1590/S0074-02762011000100001; Walter Reed Biosystematics Unit, 2001, WALTER REED BIOSYSTE; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	58	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2017	12	2							e0173052	10.1371/journal.pone.0173052	http://dx.doi.org/10.1371/journal.pone.0173052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL5VB	28235083	Green Published, gold, Green Submitted			2022-12-27	WOS:000394688200192
J	Li, YP; Xu, HY; Su, SS; Ye, JR; Chen, JJ; Jin, XR; Lin, Q; Zhang, DQ; Ye, CE; Chen, CS				Li, Yuping; Xu, Hanyan; Su, Shanshan; Ye, Junru; Chen, Junjie; Jin, Xuru; Lin, Quan; Zhang, Dongqing; Ye, Caier; Chen, Chengshui			Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATION; TUMOR-TISSUE; PERIPHERAL-BLOOD; CANCER-PATIENTS; DIAGNOSTIC-ACCURACY; GEFITINIB; RESISTANCE; PREDICTOR; SAMPLES; NSCLC	Background Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive epidermal growth factor receptor (EGFR) mutations detection in lung cancer patients, but the existing methods have limitations in sensitivity or in availability. In this study, we evaluated the performance of a novel assay called ADx-SuperARMS in detecting EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. Methods A total of 109 patients with metastatic advanced adenocarcinoma were recruited who provided both blood samples and matched tumor tissue samples. EGFR mutation status in plasma samples were tested with ADx-SuperARMS EGFR assay and tumor tissue samples were tested with ADx- ARMS EGFR assay. The clinical sensitivity, specificity, positive prediction value (PPV), and negative prediction value (NPV) of ADx-SuperARMS EGFR assay were calculated by using EGFR mutation status in tumor tissue as standard reference. A receiver operating characteristic (ROC) analysis was implemented and an area under the curve (AUC) was calculated to evaluate sensitivity and specificity of exon 19 deletion (E19Del) and L858R mutation detection. The objective response rate (ORR) were calculated according to the EGFR mutation status determined by ADx-superARMS as well. Results 0.2% analytical sensitivity and 100% specificity of the ADx-SuperARMS EGFR assays for EGFR E19Del, L858R, and T790M mutants were confirmed by using a series of diluted cell line DNA. In the clinical study, EGFR mutations were detected in 45.9% (50/109) of the plasma samples and in 56.9% (62/109) of the matched tumor tissue samples. The sensitivity, specificity, PPV and NPV of the ADx-SuperARMS EGFR assay for plasma EGFR mutation detection were 82.0% (50/61), 100% (48/48), 100% (50/50), and 81.4% (48/59), respectively. In ROC analysis, ADx-SuperARMS achieved sensitivity and specificity of 88% and 99% in E19Dels as well as sensitivity and specificity of 89% and 100% in L858R, respectively. Among the 35 patients who were plasma EGFR mutation positive and treated with first generation of EGFR-tyrosine kinase inhibitors (TKIs), 23 (65.7%) achieved partial response, 11 (31.4%) sustained disease, and 1 (2.9%) progressive disease. The ORR and disease control rate (DCR) were 65.7% and 97.1%, respectively. Conclusions ADx-SuperARMS EGFR assay is likely to be a highly sensitive and specific method to non-invasively detect plasma EGFR mutations of patients with advanced lung adenocarcinoma. The EGFR mutations detected by ADx-SuperARMS EGFR assay could predict the efficacy of the treatment with first generation of EGFR-TKIs. Hence, EGFR blood testing with ADx-SuperARMS could address the unmet clinical needs.	[Li, Yuping; Xu, Hanyan; Su, Shanshan; Ye, Junru; Chen, Junjie; Jin, Xuru; Lin, Quan; Zhang, Dongqing; Chen, Chengshui] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Zhejiang, Peoples R China; [Ye, Caier] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chen, CS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Zhejiang, Peoples R China.	wzchencs1@163.com	yu, yanbo/GZM-8474-2022; li, yu/HGL-9518-2022; LI, Yue/GRS-8071-2022; Li, yu/HHZ-5236-2022		Natural Science Foundation of Zhejiang Province [LY15H010007]; Wenzhou Municipal Science and Technology Bureau [ZH2017001]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau	This study was funded by grants from the Natural Science Foundation of Zhejiang Province[LY15H010007 to Yuping Li] and the Wenzhou Municipal Science and Technology Bureau(CN)[ZH2017001 to Yuping Li].	Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Errico Alessia, 2014, Nat Rev Clin Oncol, V11, P684, DOI 10.1038/nrclinonc.2014.186; Esposito A, 2014, CANCER TREAT REV, V40, P648, DOI 10.1016/j.ctrv.2013.10.003; Ettinger DS, 2016, J NATL COMPR CANC NE, V14, P255, DOI 10.6004/jnccn.2016.0031; Gettinger S, 2011, CLIN CHEST MED, V32, P839, DOI 10.1016/j.ccm.2011.08.017; Hasegawa T, 2015, INTERNAL MED, V54, P1977, DOI 10.2169/internalmedicine.54.4394; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Kawamura T, 2016, CANCER SCI, V107, P1001, DOI 10.1111/cas.12963; Khozin S, 2017, CLIN CANCER RES, V23, P2131, DOI 10.1158/1078-0432.CCR-16-1773; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Lababede O, 2011, CHEST, V139, P183, DOI 10.1378/chest.10-1099; Li XF, 2014, TRANSL ONCOL, V7, P341, DOI 10.1016/j.tranon.2014.04.006; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Liu XQ, 2013, J CLIN PATHOL, V66, P1065, DOI 10.1136/jclinpath-2013-201728; Lowes LE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091505; Luo J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06269; Ma ML, 2016, GENE, V591, P58, DOI 10.1016/j.gene.2016.06.053; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McGuire S, 2014, ADV NUTR, V5, P456, DOI 10.3945/an.114.006171; Minguet J, 2016, INT J CANCER, V138, P2549, DOI 10.1002/ijc.29915; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Mok Tony S, 2017, N Engl J Med, V376, P629, DOI 10.1056/NEJMoa1612674; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nurwidya Fariz, 2016, Chonnam Med J, V52, P151, DOI 10.4068/cmj.2016.52.3.151; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Perez-Barrios C, 2016, TRANSL LUNG CANCER R, V5, P665, DOI 10.21037/tlcr.2016.12.03; QIAGEN, 2014, THER EGFR PLASM RGQ; Qian X, 2016, ONCOTARGET, V7, P29154, DOI 10.18632/oncotarget.8684; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sorensen BS, 2014, CANCER-AM CANCER SOC, V120, P3896, DOI 10.1002/cncr.28964; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Uchida J, 2015, CLIN CHEM, V61, P1191, DOI 10.1373/clinchem.2015.241414; US Food & Drug Administration, 2016, PREM APPR P150044 CO; Wang Z, 2014, PR GR LAK SYMP VLSI, P9, DOI 10.1145/2591513.2591519; Weber B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-294; Wei WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168795; Wu YL, 2013, LUNG CANCER, V81, P280, DOI 10.1016/j.lungcan.2013.03.004; Xu F, 2012, ONCOTARGETS THER, V5, P439, DOI 10.2147/OTT.S37289; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang H, 2013, J MOL DIAGN, V15, P819, DOI 10.1016/j.jmoldx.2013.06.006; Zhou YC, 2017, ONCOTARGET, V8, P15023, DOI 10.18632/oncotarget.14706; Zhu GS, 2015, J MOL DIAGN, V17, P265, DOI 10.1016/j.jmoldx.2015.01.004	53	43	53	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183331	10.1371/journal.pone.0183331	http://dx.doi.org/10.1371/journal.pone.0183331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829813	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100039
J	Li, YY; Jia, XY; Liu, BZ; Qi, YM; Zhang, XB; Ji, R; Yu, YB; Zuo, XL; Li, YQ				Li, Yueyue; Jia, Xinyong; Liu, Baozhen; Qi, Yanmei; Zhang, Xiubin; Ji, Rui; Yu, Yanbo; Zuo, Xiuli; Li, Yanqing			Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2	PLOS ONE			English	Article							DOSE POLYETHYLENE-GLYCOL; COLONOSCOPY PREPARATION; AFTERNOON COLONOSCOPY; MAGNESIUM CITRATE; QUALITY; IMPACT; SCALE; BISACODYL; EFFICACY; 4-LITER	Background Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation. Aim To evaluate the efficacy of supplemental preparation in bowel cleansing quality among patients with Bristol stool form 1 and 2, as well as the feasibility of tailored bowel preparation guided by Bristol stool form scale. Methods Patients with Bristol stool form 1 and 2 from 3 Chinese tertiary hospitals randomly received either 2 L PEG-ELP (group A) or 10 mg bisacodyl plus 2 L PEG-ELP (group B); patients with Bristol stool form 3 to 7 received 2 L PEG-ELP (group C) for bowel preparation. The primary endpoint is the rate of adequate bowel reparation for the whole colon. The adequate bowel preparation rate for separate colon segments, the polyp detection rate (PDR), tolerability, acceptability, sleeping quality and compliance were evaluated as secondary endpoints. Results 700 patients were randomized. In per-protocol analysis, patients in group B attained significantly higher successful preparation rate than group A (88.7% vs. 61.2%, p<0.001) and similar with group C (88.7% vs. 85.0%, p = 0.316). The PDR in group B was significantly higher than group A (43.2% vs. 25.7%, p<0.001). Acceptability was much higher in group B and C. Conclusions 10 mg bisacodyl plus 2 L PEG-ELP can significantly improve both bowel preparation quality and PDR in patients with Bristol stool form 1 and 2. Bristol stool form scale may be an easy and efficient guide for tailored bowel preparation before colonoscopy.	[Li, Yueyue; Ji, Rui; Yu, Yanbo; Zuo, Xiuli; Li, Yanqing] Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Dept Gastroenterol, Jinan, Peoples R China; [Jia, Xinyong; Zhang, Xiubin] Shandong Univ, Qianfoshan Hosp, Dept Endoscopy, Jinan, Peoples R China; [Liu, Baozhen; Qi, Yanmei] Binzhou Peoples Hosp, Dept Gastroenterol, Binzhou, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Dept Gastroenterol, Jinan, Peoples R China.	liyanqing@sdu.edu.cn	yu, yanbo/GZM-8474-2022; li, yu/HGL-9518-2022; LI, Yue/GRS-8071-2022; Li, yu/HHZ-5236-2022		National Natural Science Foundation of China [81330012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (Grant No. 81330012), www.nsfc.gov.cn/publish/portal1/. The author YQL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmania M, 2014, GASTROINTEST ENDOSC, V79, P408, DOI 10.1016/j.gie.2013.08.035; Calderwood AH, 2010, GASTROINTEST ENDOSC, V72, P686, DOI 10.1016/j.gie.2010.06.068; Chokshi RV, 2012, GASTROINTEST ENDOSC, V75, P1197, DOI 10.1016/j.gie.2012.01.005; Chung YW, 2009, J CLIN GASTROENTEROL, V43, P448, DOI 10.1097/MCG.0b013e3181662442; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Enestvedt BK, 2012, CLIN GASTROENTEROL H, V10, P1225, DOI 10.1016/j.cgh.2012.08.029; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Gavin DR, 2013, GUT, V62, P242, DOI 10.1136/gutjnl-2011-301848; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Hassan C, 2012, CLIN GASTROENTEROL H, V10, P501, DOI 10.1016/j.cgh.2011.12.037; HEATON KW, 1991, GUT, V32, P73, DOI 10.1136/gut.32.1.73; Lai EJ, 2009, GASTROINTEST ENDOSC, V69, P620, DOI 10.1016/j.gie.2008.05.057; Lebwohl B, 2010, DIGEST DIS SCI, V55, P2014, DOI 10.1007/s10620-009-1079-7; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Liu XD, 2014, GUT, V63, P125, DOI 10.1136/gutjnl-2012-304292; Longcroft-Wheaton G, 2012, J CLIN GASTROENTEROL, V46, P57, DOI 10.1097/MCG.0b013e318233a986; Malhotra A, 2016, COLORECTAL DIS, V18, P200, DOI 10.1111/codi.13084; Manabe N, 2009, ALIMENT PHARM THER, V30, P930, DOI 10.1111/j.1365-2036.2009.04118.x; Manes G, 2014, ENDOSCOPY, V46, P662, DOI 10.1055/s-0034-1365800; Martinez AP, 2012, REV LAT-AM ENFERM, V20, P583, DOI 10.1590/S0104-11692012000300021; Matro R, 2010, AM J GASTROENTEROL, V105, P1954, DOI 10.1038/ajg.2010.160; Ness RM, 2001, AM J GASTROENTEROL, V96, P1797, DOI 10.1016/S0002-9270(01)02437-6; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Parente F, 2015, DIGEST LIVER DIS, V47, P857, DOI 10.1016/j.dld.2015.06.008; Repici A, 2012, ALIMENT PHARM THER, V36, P717, DOI 10.1111/apt.12026; Rex DK, 2002, AM J GASTROENTEROL, V97, P1696; Rex DK, 2014, CLIN GASTROENTEROL H, V12, P458, DOI 10.1016/j.cgh.2013.11.003; Saltzman JR, 2015, GASTROINTEST ENDOSC, V81, P781, DOI 10.1016/j.gie.2014.09.048; Senore C, 2011, J MED SCREEN, V18, P128, DOI 10.1258/jms.2011.010135; Sharma VK, 1998, GASTROINTEST ENDOSC, V47, P167, DOI 10.1016/S0016-5107(98)70351-7; Tae JW, 2012, GASTROINTEST ENDOSC, V76, P804, DOI 10.1016/j.gie.2012.05.026	31	43	53	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171563	10.1371/journal.pone.0171563	http://dx.doi.org/10.1371/journal.pone.0171563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28829813	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400007
